0.13843356.9867802.html.plaintext.txt	0	MINIREVIEW Molecular Genetics Transmissible Spongiform Encephalopathies Charles Weissmann
0.13843356.9867802.html.plaintext.txt	1	From Institut fur Molekularbiologie der Universitat Zurich Abteilung I Winterthurerstrasse 190 8057 Zurich Switzerland
0.13843356.9867802.html.plaintext.txt	2	INTRODUCTION TOP INTRODUCTION REFERENCES
0.13843356.9867802.html.plaintext.txt	3	Transmissible spongiform encephalopathies degenerative disorders central nervous system occur naturally man variety animals
0.13843356.9867802.html.plaintext.txt	4	They include scrapie sheep goats bovine spongiform encephalopathy BSE1 cattle several human diseases Creutzfeldt Jakob disease CJD Gerstmann Straussler Scheinker syndrome GSS fatal familial insomnia FFI
0.13843356.9867802.html.plaintext.txt	5	Since first recognition 1986 BSE reached epidemic proportions UK 1 substantial evidence new variant CJD may consumption BSE contaminated products 2
0.13843356.9867802.html.plaintext.txt	6	The unusual properties transmissible agent prion early suggested might devoid nucleic acid 3
0.13843356.9867802.html.plaintext.txt	7	Currently widely accepted proposal protein hypothesis first outlined general terms Griffith 4 enunciated updated detailed form Prusiner 5 6
0.13843356.9867802.html.plaintext.txt	8	It proposes prion identical conformational isoform PrPC 5 normal host protein 7 9 found predominantly outer surface neurons
0.13843356.9867802.html.plaintext.txt	9	Introduction abnormal conformer organism would result conversion PrPC likeness Fig
0.13843356.9867802.html.plaintext.txt	10	View larger version 47K Fig
0.13843356.9867802.html.plaintext.txt	11	A normal cell PrPC synthesized transported cell surface recycled
0.13843356.9867802.html.plaintext.txt	12	B protein model assumes prion identical PrPSc PrP
0.13843356.9867802.html.plaintext.txt	13	Exogenous prions cause conversion normal cellular protein PrPC PrPSc either cell surface internalization
0.13843356.9867802.html.plaintext.txt	14	C PrPSc accumulates intracellularly late endosomes lysosomes cell surface depleted PrPC
0.13843356.9867802.html.plaintext.txt	15	PrPSc also released extracellular space
0.13843356.9867802.html.plaintext.txt	16	During course prion disease largely protease resistant aggregated form PrP designated PrPSc accumulates mainly brain 7 10
0.13843356.9867802.html.plaintext.txt	17	Prusiner co workers 11 proposed PrPSc main constituent prion
0.13843356.9867802.html.plaintext.txt	18	Because chemical differences found PrPC PrPSc two species believed differ conformation
0.13843356.9867802.html.plaintext.txt	19	The three dimensional structure PrPC elucidated 12 PrPSc however sheet content PrPSc found high whereas PrPC low 13
0.13843356.9867802.html.plaintext.txt	20	Because ratio infectious units PrPSc molecules 1100000 14 structure PrP molecule actually associated infectivity cannot definitively inferred
0.13843356.9867802.html.plaintext.txt	21	For reason PrP species responsible infectivity presently better designated PrP 15
0.13843356.9867802.html.plaintext.txt	22	The conclusion form PrP essential perhaps constituent infectious agent based compelling biochemical genetical evidence 5 16
0.13843356.9867802.html.plaintext.txt	23	Familial Spongiform Encephalopathies Are Associated Mutations PrP Gene
0.13843356.9867802.html.plaintext.txt	24	Although cases human prion disease sporadic 10 familial linked one number mutations PrP gene Fig
0.13843356.9867802.html.plaintext.txt	25	It believed mutations allow spontaneous conversion PrPC PrPSc frequency sufficient cause disease within lifetime individual 5 19
0.13843356.9867802.html.plaintext.txt	26	Sporadic CJD could attributed rare instances spontaneous conversion PrPC PrPSc rare somatic mutations Prnp gene
0.13843356.9867802.html.plaintext.txt	27	In cases initial conversion would followed autocatalytic propagation
0.13843356.9867802.html.plaintext.txt	28	Mice overexpressing murine PrP transgene mutation corresponding human GSS mutation Pro 102 Leu spontaneously contract lethal scrapie like disease reported disease transmitted mice expressing mutant transgene lower levels lead spontaneous disease 20 21
0.13843356.9867802.html.plaintext.txt	29	View larger version 28K Fig
0.13843356.9867802.html.plaintext.txt	30	Mutations PrP gene associated prion diseases
0.13843356.9867802.html.plaintext.txt	31	The top rectangle represents coding region human PrP gene hatched green areas indicate amino carboxyl terminal signal sequences five dark green boxes R octa repeats sequences 8 amino acids
0.13843356.9867802.html.plaintext.txt	32	The red arrows indicate amino acid replacements individual mutant PrP genes
0.13843356.9867802.html.plaintext.txt	33	The diseases associated mutations given blue CJD GSS FFI
0.13843356.9867802.html.plaintext.txt	34	The Met 129 Val replacement represents polymorphism associated disease however modifies effects Asp 178 Asn mutation latter combined Met 129 associated FFI combined Val 129 associated CJD
0.13843356.9867802.html.plaintext.txt	35	Amplification number octa repeats found cases familial CJD GSS
0.13843356.9867802.html.plaintext.txt	36	Mice Devoid PrPC Are Resistant Scrapie
0.13843356.9867802.html.plaintext.txt	37	The protein hypothesis predicts absence PrPC mice resistant scrapie fail multiply infectious agent
0.13843356.9867802.html.plaintext.txt	38	Mice devoid PrP Prnpoo generated homologous recombination found essentially normal 22
0.13843356.9867802.html.plaintext.txt	39	When challenged mouse prions mice devoid PrP completely protected scrapie disease prions failed accumulate spleen brain contrast wild type mice 23 24
0.13843356.9867802.html.plaintext.txt	40	Introduction murine Prnp transgenes Prnpoo mice resulted several lines varying expression levels PrPC susceptible mouse prions higher PrPC content brain shorter incubation times 25
0.13843356.9867802.html.plaintext.txt	41	The demonstration disruption PrP gene confers resistance scrapie reintroduction PrP encoding transgene restores susceptibility paved way reverse genetics PrP introduction deletions mutations Prnp gene determination capacity modified gene confer susceptibility scrapie PrP knockout mouse
0.13843356.9867802.html.plaintext.txt	42	Transgenes encoding PrP deletions extending codon 93 106 restored susceptibility scrapie 25
0.13843356.9867802.html.plaintext.txt	43	2 Transport Prions Periphery CNS
0.13843356.9867802.html.plaintext.txt	44	Acquired forms prion diseases mostly transmitted oral uptake prions peripheral administration raising question agent finds way CNS
0.13843356.9867802.html.plaintext.txt	45	Prnp neuroectodermal tissue introduced brain newly born Prnpoo mice develops differentiated Prnp nervous tissue
0.13843356.9867802.html.plaintext.txt	46	Intracerebral inoculation engrafted mice leads typical scrapie pathology graft surrounding Prnpoo tissue 26
0.13843356.9867802.html.plaintext.txt	47	However intraperitoneal inoculation mice lead pathology Prnp graft transport prions periphery CNS seen require interposed PrP bearing tissue 27
0.13843356.9867802.html.plaintext.txt	48	It also shown Prnp immunodeficient mice lacking mature B cells fail transport prions periphery CNS suggesting role lymphoreticular system transport 28
0.13843356.9867802.html.plaintext.txt	49	It believed follicular dendritic cells depend B cells maintenance mature state site prion replication spleen 29 30 transport CNS addition dependent peripheral nervous system 31
0.13843356.9867802.html.plaintext.txt	50	The Species Barrier Is Abolished Introducing PrP Transgene Prion Donor Recipient
0.13843356.9867802.html.plaintext.txt	51	Prions transmitted one species another much less efficiently within species prolonged incubation times
0.13843356.9867802.html.plaintext.txt	52	In case prion transmission hamsters mice called species barrier overcome introducing hamster Prnp transgenes recipient wild type mice 32 33
0.13843356.9867802.html.plaintext.txt	53	Importantly properties prions produced transgenic mice corresponded prion species used inoculation 32 infection hamster prions led production hamster prions infection mouse prions gave rise mouse prions
0.13843356.9867802.html.plaintext.txt	54	Within framework protein hypothesis means hamster PrPC murine PrPC differs former 10 amino acids suitable substrate conversion hamster PrPSc hamster prions vice versa
0.13843356.9867802.html.plaintext.txt	55	Interestingly susceptibility mouse prions species hamster mouse man increased PrP transgenes introduced PrP knockout mouse suggesting resident murine gene inhibits propagation alien prions 23
0.13843356.9867802.html.plaintext.txt	56	The Puzzle Prion Strains
0.13843356.9867802.html.plaintext.txt	57	Dickinson colleagues 34 35 showed many distinct strains scrapie prions derived sheep isolates
0.13843356.9867802.html.plaintext.txt	58	These strains differ incubation times various inbred mouse lines lesion patterns occasion affected brains
0.13843356.9867802.html.plaintext.txt	59	Interestingly different strains propagated one inbred mouse strain homozygous regard PrP gene 35
0.13843356.9867802.html.plaintext.txt	60	Within framework protein hypothesis first blush puzzling means one polypeptide chain able mediate different strain phenotypes
0.13843356.9867802.html.plaintext.txt	61	The conformational hypothesis proposes strain associated different conformation PrPSc PrP convert PrPC host likeness 19
0.13843356.9867802.html.plaintext.txt	62	Marsh colleagues 36 showed PrPSc species associated two hamster adapted scrapie strains HY DY cleaved products different length proteinase K different susceptibility protease readily explained different conformations
0.13843356.9867802.html.plaintext.txt	63	Similar findings made prion strains propagated mouse 37 38
0.13843356.9867802.html.plaintext.txt	64	Moreover PrPSc certain strains differ ratio diglycosylated monoglycosylated form 39
0.13843356.9867802.html.plaintext.txt	65	Is possible dozen different strains prions differ regard conformation PrPSc associated conformations breed true It recently claimed PrPSc molecules many eight different strains could differentiated virtue relative affinity monoclonal antibody directed epitope fully available PrPC partially occluded PrPSc
0.13843356.9867802.html.plaintext.txt	66	In addition strains differed susceptibility denaturation guanidinium chloride adding credibility conformational hypothesis strain specificity 40
0.13843356.9867802.html.plaintext.txt	67	Conversion PrPC PrPSc scrapie infected cells late post translational process occurring PrPC reached normal extracellular location thereafter 41
0.13843356.9867802.html.plaintext.txt	68	Why spontaneous formation PrPSc extremely rare event scrapie infection promote conversion The refolding model Fig
0.13843356.9867802.html.plaintext.txt	69	3A proposes conversion requires PrPC unfolded extent refolded influence PrPSc molecule 19 process would overcome high activation energy barrier might require chaperone energy source
0.13843356.9867802.html.plaintext.txt	70	3B proposes PrPC equilibrium PrPSc precursor thereof PrPSc stabilized adds onto crystal like seed aggregate PrPSc
0.13843356.9867802.html.plaintext.txt	71	If stable aggregate needs consist minimally substantial number PrPSc molecules spontaneous formation would rare event
0.13843356.9867802.html.plaintext.txt	72	However seed present monomer addition could ensue rapid rate 42 44
0.13843356.9867802.html.plaintext.txt	73	Trapping PrP essentially irreversible aggregation would drive bulk conversion process
0.13843356.9867802.html.plaintext.txt	74	The proposed process akin assembly protease sensitive flagellin protease resistant flagellar filaments 45
0.13843356.9867802.html.plaintext.txt	75	Interestingly flagellin molecule assemble two types flagella depending provenance seed 46 thereby providing analogy conformationally determined prion strain specificity
0.13843356.9867802.html.plaintext.txt	76	View larger version 26K Fig
0.13843356.9867802.html.plaintext.txt	77	Models conformational conversion PrPC PrPSc
0.13843356.9867802.html.plaintext.txt	78	The conformational change kinetically controlled high activation energy barrier preventing spontaneous conversion detectable rates
0.13843356.9867802.html.plaintext.txt	79	Interaction exogenously introduced PrPSc causes PrPC undergo induced conformational change yield PrPSc
0.13843356.9867802.html.plaintext.txt	80	This reaction may involve extensive unfolding refolding protein explain postulated high energy barrier could dependent enzyme chaperone
0.13843356.9867802.html.plaintext.txt	81	In case certain mutations PrPC see Fig
0.13843356.9867802.html.plaintext.txt	82	2 spontaneous conversion PrPSc may occur rare event explaining familial CJD GSS arises spontaneously albeit late life
0.13843356.9867802.html.plaintext.txt	83	Sporadic CJD may come extremely rare event occurring one among million individuals per year leads spontaneous conversion PrPC PrPSc gives rise conversion cascade 5 32
0.13843356.9867802.html.plaintext.txt	84	PrPC PrPSc PrPSc like molecule equilibrium strongly favoring PrPC
0.13843356.9867802.html.plaintext.txt	85	PrPSc stabilized adds onto crystal like seed aggregate PrPSc
0.13843356.9867802.html.plaintext.txt	86	Seed formation rare event seed present monomer addition ensue rapid rate 43 44
0.13843356.9867802.html.plaintext.txt	87	To explain exponential conversion rates must assumed aggregates continuously fragmented present increasing surface accretion
0.13843356.9867802.html.plaintext.txt	88	Caughey colleagues 47 shown incubation 35S labeled PrPC PrPSc yields radioactive product resembled PrPSc regard protease resistance
0.13843356.9867802.html.plaintext.txt	89	The conversion reaction exhibited species specificity observed vivo thus PrPC mouse readily converted protease resistance murine PrPSc poorly bovine PrPSc vice versa 48
0.13843356.9867802.html.plaintext.txt	90	Moreover even strain specificity demonstrated type reaction labeled PrPC incubated PrPSc DY HY hamster transmissible mink encephalopathy strains described yielded labeled PrPSc properties typical input PrPSc 49
0.13843356.9867802.html.plaintext.txt	91	Despite efforts several groups possible demonstrate net synthesis infectivity background given PrPSc preparation
0.13843356.9867802.html.plaintext.txt	92	Although individual piece evidence described could explained several ways conjunction data strongly supports proposal prion composed partly entirely PrP derived molecule PrP PrPSc protein encoding nucleic acid essential component
0.13843356.9867802.html.plaintext.txt	93	Probably closest one could come irrefutable proof protein hypothesis would demonstration biosynthetic pure PrPC converted protease resistant form infectious scrapie agent defined conditions vitro
0.13843356.9867802.html.plaintext.txt	94	Many questions still need elucidated particular mechanism requirements conversion reaction transport prion periphery CNS mechanism pathogenesis name
0.13843356.9867802.html.plaintext.txt	95	From practical side early diagnosis prion disease treatments aimed arresting reversing disease humans important goals
0.13843356.9867802.html.plaintext.txt	96	Finally one may raise question whether prion like agents cause diseases appear non vertebrate organisms
0.13843356.9867802.html.plaintext.txt	97	Although several human diseases accompanied amyloid formation known none reproducibly transmitted
0.13843356.9867802.html.plaintext.txt	98	Interestingly two yeast phenotypes ascribed heritable protein conversion namely URE3 PSI systems 50 opened new perspectives elucidation phenomenon
0.13843356.9867802.html.plaintext.txt	99	This minireview reprinted 1999 Minireview Compendium available December 1999
0.13843356.9867802.html.plaintext.txt	100	This first article three Prions Mammals Fungi Minireview Series
0.13843356.9867802.html.plaintext.txt	101	To correspondence addressed
0.13843356.9867802.html.plaintext.txt	102	41 1 6353110 Fax 41 1 6356864 E mail weissmaatmolbio
0.13843356.9867802.html.plaintext.txt	103	The abbreviations used BSE bovine spongiform encephalopathy CJD Creutzfeldt Jakob disease GSS Gerstmann Straussler Scheinker syndrome FFI fatal familial insomnia CNS central nervous system
0.13843356.9867802.html.plaintext.txt	104	REFERENCES TOP INTRODUCTION REFERENCES Wilesmith J
0.13843356.9867802.html.plaintext.txt	105	1996 Lancet 347 921 925Medline Order article via Infotrieve Alper T
0.13843356.9867802.html.plaintext.txt	106	1967 Nature 214 764 766Medline Order article via Infotrieve Griffith J
0.13843356.9867802.html.plaintext.txt	107	1967 Nature 215 1043 1044Medline Order article via Infotrieve Prusiner S
0.13843356.9867802.html.plaintext.txt	108	43 345 374CrossRefMedline Order article via Infotrieve Prusiner S
0.13843356.9867802.html.plaintext.txt	109	339 239 254Medline Order article via Infotrieve Oesch B
0.13843356.9867802.html.plaintext.txt	110	1985 Cell 40 735 746Medline Order article via Infotrieve Chesebro B
0.13843356.9867802.html.plaintext.txt	111	1985 Nature 315 331 333Medline Order article via Infotrieve Basler K
0.13843356.9867802.html.plaintext.txt	112	1986 Cell 46 417 428Medline Order article via Infotrieve McKinley M
0.13843356.9867802.html.plaintext.txt	113	65 1340 1351Medline Order article via Infotrieve Stahl N
0.13843356.9867802.html.plaintext.txt	114	1993 Biochemistry 32 1991 2002Medline Order article via Infotrieve Riek R
0.13843356.9867802.html.plaintext.txt	115	413 282 288CrossRefMedline Order article via Infotrieve Caughey B
0.13843356.9867802.html.plaintext.txt	116	1991 Biochemistry 30 7672 7680Medline Order article via Infotrieve Bolton D
0.13843356.9867802.html.plaintext.txt	117	72 2905 2913Abstract Weissmann C
0.13843356.9867802.html.plaintext.txt	118	1991 Nature 349 569 571CrossRefMedline Order article via Infotrieve Weissmann C
0.13843356.9867802.html.plaintext.txt	119	389 3 11CrossRefMedline Order article via Infotrieve Baker H
0.13843356.9867802.html.plaintext.txt	120	1992 Neurodegeneration 1 3 16 Goldfarb L
0.13843356.9867802.html.plaintext.txt	121	343 379 384Medline Order article via Infotrieve Prusiner S
0.13843356.9867802.html.plaintext.txt	122	1991 Science 252 1515 1522Medline Order article via Infotrieve Hsiao K
0.13843356.9867802.html.plaintext.txt	123	91 9126 9130Abstract Telling G
0.13843356.9867802.html.plaintext.txt	124	10 1736 1750Abstract Bueler H
0.13843356.9867802.html.plaintext.txt	125	1992 Nature 356 577 582CrossRefMedline Order article via Infotrieve Bueler H
0.13843356.9867802.html.plaintext.txt	126	1993 Cell 73 1339 1347Medline Order article via Infotrieve Sailer A
0.13843356.9867802.html.plaintext.txt	127	1994 Cell 77 967 968Medline Order article via Infotrieve Fischer M
0.13843356.9867802.html.plaintext.txt	128	15 1255 1264Abstract Brandner S
0.13843356.9867802.html.plaintext.txt	129	1996 Nature 379 339 343CrossRefMedline Order article via Infotrieve Brandner S
0.13843356.9867802.html.plaintext.txt	130	93 13148 13151AbstractFree Full Text Klein M
0.13843356.9867802.html.plaintext.txt	131	1997 Nature 390 687 690CrossRefMedline Order article via Infotrieve Kitamoto T
0.13843356.9867802.html.plaintext.txt	132	65 6292 6295Medline Order article via Infotrieve McBride P
0.13843356.9867802.html.plaintext.txt	133	168 413 418Medline Order article via Infotrieve Kimberlin R
0.13843356.9867802.html.plaintext.txt	134	51 183 187Abstract Prusiner S
0.13843356.9867802.html.plaintext.txt	135	1990 Cell 63 673 686Medline Order article via Infotrieve Scott M
0.13843356.9867802.html.plaintext.txt	136	1989 Cell 59 847 857Medline Order article via Infotrieve Dickinson A
0.13843356.9867802.html.plaintext.txt	137	13 213 225Medline Order article via Infotrieve Bruce M
0.13843356.9867802.html.plaintext.txt	138	1992 Prion Diseases Humans Animals Prusiner S
0.13843356.9867802.html.plaintext.txt	139	497 508 Ellis Horwood New York Bessen R
0.13843356.9867802.html.plaintext.txt	140	68 7859 7868Abstract Telling G
0.13843356.9867802.html.plaintext.txt	141	1996 Science 274 2079 2082AbstractFree Full Text Hill A
0.13843356.9867802.html.plaintext.txt	142	1997 Nature 389 448 450CrossRefMedline Order article via Infotrieve Collinge J
0.13843356.9867802.html.plaintext.txt	143	1996 Nature 383 685 690CrossRefMedline Order article via Infotrieve Safar J
0.13843356.9867802.html.plaintext.txt	144	4 1157 1165CrossRefMedline Order article via Infotrieve Caughey B
0.13843356.9867802.html.plaintext.txt	145	266 18217 18223AbstractFree Full Text Gajdusek D
0.13843356.9867802.html.plaintext.txt	146	20 95 110CrossRefMedline Order article via Infotrieve Brown P
0.13843356.9867802.html.plaintext.txt	147	1991 Lancet 337 1019 1022CrossRefMedline Order article via Infotrieve Jarrett J
0.13843356.9867802.html.plaintext.txt	148	1993 Cell 73 1055 1058Medline Order article via Infotrieve Aizawa S
0.13843356.9867802.html.plaintext.txt	149	211 673 677Medline Order article via Infotrieve Asakura S
0.13843356.9867802.html.plaintext.txt	150	16 302 316Medline Order article via Infotrieve Kocisko D
0.13843356.9867802.html.plaintext.txt	151	1994 Nature 370 471 474CrossRefMedline Order article via Infotrieve Raymond G
0.13843356.9867802.html.plaintext.txt	152	1997 Nature 388 285 288CrossRefMedline Order article via Infotrieve Bessen R
0.13843356.9867802.html.plaintext.txt	153	1995 Nature 375 698 700CrossRefMedline Order article via Infotrieve Wickner R
0.13843356.9867802.html.plaintext.txt	154	1994 Science 264 566 569Medline Order article via Infotrieve
0.13843356.9867802.html.plaintext.txt	155	Copyright 1999 The American Society Biochemistry Molecular Biology Inc
0.12956092.12913070.html.plaintext.txt	0	Zinc metalloproteinase ZMPSTE24 mutated mandibuloacral dysplasia Anil K
0.12956092.12913070.html.plaintext.txt	1	Agarwal1 Jean Pierre Fryns2 Richard J
0.12956092.12913070.html.plaintext.txt	2	1Division Nutrition Metabolic Diseases Department Internal Medicine Center Human Nutrition University Texas Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 USA 2Center Human Genetics University Hospital Leuven Leuven Belgium 3Division Endocrinology Metabolism Diabetes Department Internal Medicine University Texas Southwestern Medical Center Dallas TX USA
0.12956092.12913070.html.plaintext.txt	3	Received April 9 2003 Revised June 9 2003 Accepted June 17 2003
0.12956092.12913070.html.plaintext.txt	4	DDBJEMBLGenBank accession nos
0.12956092.12913070.html.plaintext.txt	5	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Mandibuloacral dysplasia MAD OMIM 248370 rare genetically phenotypically heterogeneous autosomal recessive disorder characterized skeletal abnormalities including hypoplasia mandible clavicles acro osteolysis cutaneous atrophy lipodystrophy
0.12956092.12913070.html.plaintext.txt	6	A homozygous missense mutation Arg527His LMNA gene encodes nuclear lamina proteins lamins A C reported patients MAD partial lipodystrophy
0.12956092.12913070.html.plaintext.txt	7	We studied four patients MAD mutations LMNA gene
0.12956092.12913070.html.plaintext.txt	8	We show compound heterozygous mutations Phe361fsX379 Trp340Arg zinc metalloproteinase ZMPSTE24 gene one four patients severe MAD associated progeroid appearance generalized lipodystrophy
0.12956092.12913070.html.plaintext.txt	9	ZMPSTE24 involved post translational proteolytic cleavage carboxy terminal residues farnesylated prelamin A two steps form mature lamin A
0.12956092.12913070.html.plaintext.txt	10	Deficiency Zmpste24 mice causes accumulation prelamin A phenotypic features similar MAD
0.12956092.12913070.html.plaintext.txt	11	The yeast homolog Ste24 parallel role processing prenylated mating pheromone factor
0.12956092.12913070.html.plaintext.txt	12	Since human ZMPSTE24 also process factor expressed yeast assessed functional significance two ZMPSTE24 mutations yeast complement mating defect haploid MATa yeast lacking STE24 Ras converting enzyme 1 RCE1 another prenylprotein specific endoprotease genes
0.12956092.12913070.html.plaintext.txt	13	The ZMPSTE24 mutant construct Phe361fsX379 inactive complementing yeast factor mutant Trp340Arg partially active compared wild type ZMPSTE24 construct
0.12956092.12913070.html.plaintext.txt	14	We conclude mutations ZMPSTE24 may cause MAD affecting prelamin A processing
0.12956092.12913070.html.plaintext.txt	15	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Mandibuloacral dysplasia MAD rare syndrome variable clinical features including mandibular clavicular hypoplasia acro osteolysis terminal phalanges delayed closure cranial sutures joint contractures mottled pigmentation cutaneous atrophy lipodystrophy features metabolic syndrome insulin resistance glucose intolerance diabetes mellitus hypertriglyceridemia 1
0.12956092.12913070.html.plaintext.txt	16	Previously described two patterns lipodystrophy patients MAD type A pattern characterized fat loss restricted extremities ii type B pattern generalized fat loss 1
0.12956092.12913070.html.plaintext.txt	17	A homozygous missense mutation Arg527His LMNA gene reported Italian pedigrees MAD type A lipodystrophy 2
0.12956092.12913070.html.plaintext.txt	18	LMNA encodes lamins A C alternative splicing integral components nuclear lamina along type B lamins B1 B2 encoded two separate genes 3 5
0.12956092.12913070.html.plaintext.txt	19	Whereas type B lamins expressed somatic cells lamins A C preferentially expressed differentiated cells 6
0.12956092.12913070.html.plaintext.txt	20	Precursors lamins A B1 B2 CAAX motif carboxy terminal undergo post translational modification including prenylation 5
0.12956092.12913070.html.plaintext.txt	21	However lamin C lacks carboxy terminal CAAX motif thus escapes prenylation
0.12956092.12913070.html.plaintext.txt	22	We sequenced LMNA affected individuals six pedigrees found Arg527His mutation two pedigrees type A lipodystrophy 7
0.12956092.12913070.html.plaintext.txt	23	The remaining four pedigrees affected individuals showed type B lipodystrophy revealed mutations LMNA gene suggesting additional genetic loci MAD 7
0.12956092.12913070.html.plaintext.txt	24	Recently phenotypic features MAD
0.12956092.12913070.html.plaintext.txt	25	partial lipodystrophy skeletal abnormalities including small mandible reported mice homozygous deletion gene encoding zinc metalloproteinase Zmpste24 89
0.12956092.12913070.html.plaintext.txt	26	Since Zmpste24 involved post translational processing prelamin A abnormal phenotypic features Zmpste24 mice attributed defective processing prelamin A 89
0.12956092.12913070.html.plaintext.txt	27	The generation mature lamin A prelamin A involves farnesylation cysteine conserved CAAX motif carboxy terminal 10 enzyme farnesyl transferase Fig
0.12956092.12913070.html.plaintext.txt	28	The AAX tripeptide proteolytically removed ZMPSTE24 followed methylation prenylated cysteine isoprenylcysteine carboxyl methyl transferase
0.12956092.12913070.html.plaintext.txt	29	Finally second proteolytic cleavage ZMPSTE24 another protease removes 15 amino acids carboxy terminal 10 Fig
0.12956092.12913070.html.plaintext.txt	30	Given role ZMPSTE24 prelamin A processing occurrence LMNA mutation MAD subjects considered ZMPSTE24 candidate gene sequenced locus remaining four patients
0.12956092.12913070.html.plaintext.txt	31	View larger version 40K Figure 1
0.12956092.12913070.html.plaintext.txt	32	Schematic steps involved prelamin A processing lamin A
0.12956092.12913070.html.plaintext.txt	33	The post translational processing prelamin A involves extreme carboxy terminal residues
0.12956092.12913070.html.plaintext.txt	34	In first step farnesyl diphosphate used farnesylate cysteine conserved CAAX motif CSIM prelamin A carboxy terminal using enzyme farnesyl transferase FT
0.12956092.12913070.html.plaintext.txt	35	During second step peptide bond cysteine serine residues indicated unfilled triangle proteolytically cleaved ZMPSTE24 resulting removal SIM tripeptide
0.12956092.12913070.html.plaintext.txt	36	This reaction followed methylation farnesylated cysteine residue isoprenylcysteine carboxyl methyl transferase ICMT using S adenosyl methionine methyl donor
0.12956092.12913070.html.plaintext.txt	37	Finally second proteolytic cleavage occurs tyrosine leucine residues indicated filled triangle either catalyzed ZMPSTE24 another yet unidentified endoprotease cleavage removes 15 amino acids carboxy terminal resulting formation mature lamin A
0.12956092.12913070.html.plaintext.txt	38	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES We found compound heterozygous mutations ZMPSTE24 Belgian woman severe MAD progeroid appearance lipodystrophy Fig
0.12956092.12913070.html.plaintext.txt	39	One mutations 1018T C exon 8 results substitution Trp codon 340 Arg Fig
0.12956092.12913070.html.plaintext.txt	40	The second mutation 1085insT exon 9 causes frameshift premature termination codon resulting truncated protein Phe361fsX379
0.12956092.12913070.html.plaintext.txt	41	The parents two siblings proband healthy heterozygous one mutations Fig
0.12956092.12913070.html.plaintext.txt	42	These mutations detected 100 unrelated subjects European ancestry
0.12956092.12913070.html.plaintext.txt	43	The three MAD patients ZMPSTE24 mutations
0.12956092.12913070.html.plaintext.txt	44	In patients sequenced additional gene encoding nuclear prelamin A recognition factor NARF binds prenylated prelamin A carboxy terminal domain 11 found substantial alterations
0.12956092.12913070.html.plaintext.txt	45	View larger version 33K Figure 2
0.12956092.12913070.html.plaintext.txt	46	MAD 600 pedigree sequence analysis gene structure conserved motifs ZMPSTE24
0.12956092.12913070.html.plaintext.txt	47	A Pedigree MAD 600 family ZMPSTE24 genotypes
0.12956092.12913070.html.plaintext.txt	48	No DNA available MAD 600
0.12956092.12913070.html.plaintext.txt	49	The mutations ZMPSTE24 shown symbols
0.12956092.12913070.html.plaintext.txt	50	B Sequence electropherogram mutations exons 8 9 ZMPSTE24
0.12956092.12913070.html.plaintext.txt	51	Identified mutations 1018T C 1085insT marked arrows wild type sequences shown comparison
0.12956092.12913070.html.plaintext.txt	52	C The gene structure ZMPSTE24 location mutations patients MAD
0.12956092.12913070.html.plaintext.txt	53	D Alignment partial ZMPSTE24 sequences around conserved motif HEXXH human mouse Drosophila Arabidopsis Saccharomyces cerevisiae
0.12956092.12913070.html.plaintext.txt	54	This motif located exon 8 critical proteolytic activity
0.12956092.12913070.html.plaintext.txt	55	The residue tryptophan position 340 mutated patient MAD located next motif shown green conserved amongst species
0.12956092.12913070.html.plaintext.txt	56	The human ZMPSTE24 gene located chromosome 1p34 spans 43 kb 10 exons encode 475 amino acid protein Fig
0.12956092.12913070.html.plaintext.txt	57	Exon 8 retains conserved zinc metalloprotease motif HEXXH shown critical proteolytic processing proteins 1214
0.12956092.12913070.html.plaintext.txt	58	The mutated residue tryptophan 340 adjacent motif conserved among species Fig
0.12956092.12913070.html.plaintext.txt	59	The human ZMPSTE24 protein modeled transmembrane spanning regions using method developed Jones et al
0.12956092.12913070.html.plaintext.txt	60	The protein seven transmembrane domains similar predicted domains yeast ste24 12
0.12956092.12913070.html.plaintext.txt	61	The residue tryptophan 340 mutated arginine lies adjacent catalytic motif close membrane cytoplasmic side embedded membrane Fig
0.12956092.12913070.html.plaintext.txt	62	However frameshift mutation affects phenylalanine 361 residue lies within sixth membrane spanning domain leads truncated protein Fig
0.12956092.12913070.html.plaintext.txt	63	Thus carboxyl terminal mutant protein lies luminal side membrane available catalytic action protease
0.12956092.12913070.html.plaintext.txt	64	View larger version 39K Figure 3
0.12956092.12913070.html.plaintext.txt	65	The predicted model human ZMPSTE24 protein mutations
0.12956092.12913070.html.plaintext.txt	66	A The schematic protein shows seven transmembrane domains conserved zinc metalloprotease motif HEXXH critical proteolytic processing proteins
0.12956092.12913070.html.plaintext.txt	67	The catalytic motif carboxy terminus cytoplasmic side
0.12956092.12913070.html.plaintext.txt	68	B The residue tryptophan 340 mutated arginine lies adjacent catalytic motif close membrane cytoplasmic side embedded membrane
0.12956092.12913070.html.plaintext.txt	69	C The first residue affected due frameshift mutation phenylalanine 361 lies within sixth membrane spanning domain
0.12956092.12913070.html.plaintext.txt	70	This mutation leads truncated protein resulting deletion seventh transmembrane domain well carboxy terminal part protein
0.12956092.12913070.html.plaintext.txt	71	Thus carboxyl terminal mutant protein luminal side membrane cannot participate catalytic action protease
0.12956092.12913070.html.plaintext.txt	72	Ste24 yeast homolog ZMPSTE24 parallel role processing prenylated mating pheromone factor 1416
0.12956092.12913070.html.plaintext.txt	73	Ste24 functions carboxy terminal CAAX protease also necessary proteolytic cleavage seven amino terminal residues factor precursor
0.12956092.12913070.html.plaintext.txt	74	Ras converting enzyme 1 Rce1 prenylprotein specific CAAX protease also capable carboxy terminal processing factor
0.12956092.12913070.html.plaintext.txt	75	Finally another amino terminal proteolytic cleavage mediated Ax11 Ste23 proteases yields mature form factor
0.12956092.12913070.html.plaintext.txt	76	Human ZMPSTE24 expressed yeast also process factor complement mating defect haploid MATa yeast lacking STE24 RCE1 ste24rce1 genes 1216
0.12956092.12913070.html.plaintext.txt	77	We therefore assessed functional significance two ZMPSTE24 mutations yeast complementation assay
0.12956092.12913070.html.plaintext.txt	78	In assay secreted mature factor diffuses medium arrests growth MAT strain leaving halo surrounding MATa strain
0.12956092.12913070.html.plaintext.txt	79	The size halo proportional production mature factor
0.12956092.12913070.html.plaintext.txt	80	Figure 4 shows results yeast halo assay assessing complementation factor processing defect transforming ste24rce1 yeast expression vectors wild type ZMPSTE24 mutations found subject
0.12956092.12913070.html.plaintext.txt	81	As expected ste24rce1 yeast empty vector produce zone growth inhibition halo lawn MAT cells since cannot produce mature factor
0.12956092.12913070.html.plaintext.txt	82	The expression vector containing human ZMPSTE24 wild type restored mature factor production resulted growth arrest MAT cells judged halo surrounding yeast colony
0.12956092.12913070.html.plaintext.txt	83	The ZMPSTE24 mutant Phe361fsX379 inactive complementing yeast factor produced halo around yeast colony consistent severe structural alteration protein Fig
0.12956092.12913070.html.plaintext.txt	84	The mutant Trp340Arg however partially active produced smaller halo compared wild type ZMPSTE24
0.12956092.12913070.html.plaintext.txt	85	View larger version 50K Figure 4
0.12956092.12913070.html.plaintext.txt	86	cerevisiae halo assay showing mutant ZMPSTE24 partially totally inactive complementing factor processing defect ste24rce1 yeast strain
0.12956092.12913070.html.plaintext.txt	87	The ste24rce1 yeast strain transformed empty vector pRS416GPD hZMPSTE24 wild type constructs pRS416GPD hZMPSTE24 Trp340Arg pRS416GPD hZMPSTE24 Phe361fsX379
0.12956092.12913070.html.plaintext.txt	88	Approximately 104 cells spotted lawn yeast mating strain XBH8 2C MAT grown YPD containing 0
0.12956092.12913070.html.plaintext.txt	89	The ste24rce1 yeast empty vector vector produce zone growth inhibition halo lawn MAT cells since cannot produce mature factor
0.12956092.12913070.html.plaintext.txt	90	The expression vector containing human ZMPSTE24 wild type restored mature factor production resulted growth arrest MAT cells judged halo surrounding colony
0.12956092.12913070.html.plaintext.txt	91	The ZMPSTE24 mutant Trp340Arg resulted smaller halo compared wild type ZMPSTE24
0.12956092.12913070.html.plaintext.txt	92	The mutant Phe361fsX379 unable produce sufficient mature factor produced halo however 106 cell concentration negligible halo observed data shown
0.12956092.12913070.html.plaintext.txt	93	Our patient small chin nose mouth poor postnatal growth infancy 17
0.12956092.12913070.html.plaintext.txt	94	At age 2 skin atrophy contractures limbs delayed closure anterior fontanelle acro osteolysis clavicular hypoplasia observed
0.12956092.12913070.html.plaintext.txt	95	She progeroid appearance pinched nose multiple intracutaneous bony knots fingers toes contained sclerotic tissue calcification
0.12956092.12913070.html.plaintext.txt	96	At age 16 severe skin contractures around interphalangeal joints sparse brittle hair mottled pigmentation trunk
0.12956092.12913070.html.plaintext.txt	97	Skin face head arms legs thin underlying venous prominence suggesting generalized loss subcutaneous fat 17
0.12956092.12913070.html.plaintext.txt	98	The progeroid appearance skeletal changes progressive also developed progressive glomerulopathy resulted chronic renal failure necessitating dialysis
0.12956092.12913070.html.plaintext.txt	99	She died age 24 due pulmonary edema malignant hypertension secondary renal failure
0.12956092.12913070.html.plaintext.txt	100	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES There phenotypic similarities differences patient ZMPSTE24 mutations MAD subjects LMNA mutation 27
0.12956092.12913070.html.plaintext.txt	101	Both types patients mandibular clavicular hypoplasia acro osteolysis joint contractures skin atrophy mottled pigmentation
0.12956092.12913070.html.plaintext.txt	102	Whereas MAD patients LMNA mutation normal development first 4 5 years patient developed skeletal abnormalities skin atrophy contractures age 2
0.12956092.12913070.html.plaintext.txt	103	In contrast MAD patients LMNA mutation lipodystrophy extremities sparing head neck patient generalized lipodystrophy affecting face well extremities
0.12956092.12913070.html.plaintext.txt	104	The lack subcutaneous fat face likely contributed progeroid appearance
0.12956092.12913070.html.plaintext.txt	105	In addition patient bony knots observed LMNA mutation
0.12956092.12913070.html.plaintext.txt	106	Our patient also showed retarded growth development died prematurely phenotypic features similar noted two lines Zmpste24 mice 89
0.12956092.12913070.html.plaintext.txt	107	She also scarce brittle hair similar loss fur Zmpste24 mice
0.12956092.12913070.html.plaintext.txt	108	However instead showing growth plate dysplasia bone fractures patient showed progressive mandibular clavicular hypoplasia acro osteolysis distal phalanges
0.12956092.12913070.html.plaintext.txt	109	Although patient generalized lipodystrophy evidence cardiomyopathy abnormal gait muscular dystrophy
0.12956092.12913070.html.plaintext.txt	110	Furthermore patient severe progressive glomerulopathy likely reason death
0.12956092.12913070.html.plaintext.txt	111	Although renal histopathology reported end stage Zmpste24 mice serum creatinine levels normal 8
0.12956092.12913070.html.plaintext.txt	112	Bony knots phalanges severe skin contractures also peculiar features present patient
0.12956092.12913070.html.plaintext.txt	113	Bony knots rarely reported patients mandibuloacral dysplasia 1819
0.12956092.12913070.html.plaintext.txt	114	Progeroid features previously described patients MAD initially diagnosed Werner progeroid syndrome 1820 24
0.12956092.12913070.html.plaintext.txt	115	Recently mutations LMNA reported patients Hutchinson Gilford progeria syndrome HGPS rare genetic disorder characterized features premature ageing growth retardation alopecia atherosclerosis sclerodermatous skin premature death teenage years 25 27
0.12956092.12913070.html.plaintext.txt	116	Our data suggest besides mutant forms lamins A C defective processing prelamin A due ZMPSTE24 mutations could also lead progeroid features early death
0.12956092.12913070.html.plaintext.txt	117	Prelamin A yet recognized substrate ZMPSTE24 mammals therefore clinical manifestations affected patient ZMPSTE24 mutations may solely attributed defective processing prelamin A
0.12956092.12913070.html.plaintext.txt	118	However abnormal inadequate processing farnesylated proteins ZMPSTE24 might additional roles including signal transduction could responsible unique phenotypic features patient
0.12956092.12913070.html.plaintext.txt	119	Although patient documented evidence dilated cardiomyopathy muscular dystrophy skeletal disorders noted Zmpste24 mice ZMPSTE24 mutations could result phenotypic heterogeneity may implicated disorders 89
0.12956092.12913070.html.plaintext.txt	120	Finally since three patients MAD show mutations either LMNA ZMPSTE24 gene genetic loci may also responsible MAD particularly interact lamins AC involved processing lamin A
0.12956092.12913070.html.plaintext.txt	121	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Patients control subjects We studied affected patients MAD four pedigrees
0.12956092.12913070.html.plaintext.txt	122	MAD 200 400 European origin US 128 MAD 500 600 Belgium 1729
0.12956092.12913070.html.plaintext.txt	123	All patients MAD type B lipodystrophy pattern
0.12956092.12913070.html.plaintext.txt	124	One hundred normal healthy control subjects European origin Dallas area also studied genotyping mutations found ZMPSTE24
0.12956092.12913070.html.plaintext.txt	125	The protocol approved appropriate Institutional Review Boards subjects gave informed consent
0.12956092.12913070.html.plaintext.txt	126	Mutational analysis Genomic DNA isolated buffy coat using DNAzol Gibco Gaithesburg MD according manufacturers protocol
0.12956092.12913070.html.plaintext.txt	127	Specific primers designed amplify exons splice site junctions ZMPSTE24 NARF
0.12956092.12913070.html.plaintext.txt	128	The PCR reaction assembled 50 microl reaction volume containing 50 ng genomic DNA 15 pmol primer 1xPremix D Epicenter Madison WI 1 U FailSafe Taq polymerase Epicenter
0.12956092.12913070.html.plaintext.txt	129	PCR carried PE9700 using touchdown cycle protocol modified follows initial denaturation 98 degrees C 5 min followed 3 step cycle 96 degrees C 30 65 degrees C 30 72 degrees C 30 20 cycles 0
0.12956092.12913070.html.plaintext.txt	130	5 degrees C decrease cycle
0.12956092.12913070.html.plaintext.txt	131	This followed another 15 cycles except annealing temperature 55 degrees C
0.12956092.12913070.html.plaintext.txt	132	The PCR product purified remove primers dNTPs sequenced using ABI Prism 3100
0.12956092.12913070.html.plaintext.txt	133	Sequences compared using Vector NTi Suite 6 software visual inspection
0.12956092.12913070.html.plaintext.txt	134	The 1085 insT mutation confirmed subcloning PCR cloning vector pCR2
0.12956092.12913070.html.plaintext.txt	135	1 Invitrogen Carlsbad CA sequencing four independent bacterial clones
0.12956092.12913070.html.plaintext.txt	136	Genotyping Exons 8 9 ZMPSTE24 amplified 100 unrelated healthy subjects described scored mutations seen patient MAD
0.12956092.12913070.html.plaintext.txt	137	For 1018T C mutation exon 8 introduces HpaII restriction site 5 microl PCR product digested HpaII digest resolved 3 agarose gel visualized EtBr samples confirmed direct sequencing
0.12956092.12913070.html.plaintext.txt	138	For 1085insT PCR product sequenced due lack convenient restriction site
0.12956092.12913070.html.plaintext.txt	139	Cloning human ZMPSTE24 cDNA The primers designed human ZMPSTE24 shown Table 1
0.12956092.12913070.html.plaintext.txt	140	The ZMPSTE24 cDNA amplified two segments using primer pairs 1 2 primer pair 3 4 human liver Marathon Ready cDNA BD Biosciences Palo Alto CA
0.12956092.12913070.html.plaintext.txt	141	The PCR carried follows initial hold cycle 2 min 95 degrees C followed 20 cycles 96 degrees C 30 65 degrees C 30 72 degrees C 30 20 cycles 0
0.12956092.12913070.html.plaintext.txt	142	5 degrees C decrease cycle annealing
0.12956092.12913070.html.plaintext.txt	143	This followed additional 15 cycles 94 degrees C 30 55 degrees C 30 72 degrees C 30
0.12956092.12913070.html.plaintext.txt	144	The PCR products reactions mixed second PCR carried except using outer primers 5 6 containing XbaI XhoI restriction sites cloning yeast expression vector
0.12956092.12913070.html.plaintext.txt	145	The PCR conditions except extension time increased 1
0.12956092.12913070.html.plaintext.txt	146	The human ZMPSTE24 cDNA yeast vector pRS416GPD 30 digested XhoI XbaI gel purified ligated
0.12956092.12913070.html.plaintext.txt	147	The resulting plasmid pRS416GPD hZMPSTE24 wt sequenced exclude PCR errors
0.12956092.12913070.html.plaintext.txt	148	Nucleotide sequences primers hZMPSTE24 Mutant constructs The ZMPSTE24 mutations generated using QuickChange mutagenesis kit Stratagene La Jolla CA suggested manufacturer
0.12956092.12913070.html.plaintext.txt	149	The primers used template pRS416GPD hZMPSTE24 wt 1018T C primers 7 8 1085insT primers 9 10 shown Table 1
0.12956092.12913070.html.plaintext.txt	150	The resulting yeast expression vectors pRS416GPD hZMPSTE24 Trp340Arg pRS416GPD hZMPSTE24 Phe361fsX379 sequenced ensure additional PCR errors
0.12956092.12913070.html.plaintext.txt	151	Growth arrest pheromone diffusion halo assay To determine ZMPSTE24 mutations active complementing yeast STE24 yeast expression plasmids pRS416GPD hZMPSTE24 Trp340Arg pRS416GPD hZMPSTE24 Phe361fsX379 transformed yeast strain 3614 MATa ste24rce1 grown selective medium
0.12956092.12913070.html.plaintext.txt	152	Liquid cultures concentrated 1 microl aliquots spotted onto lawn mating yeast strain XBH8 2C MAT YPD medium 0
0.12956092.12913070.html.plaintext.txt	153	04 Triton X 100 31 allowed grow 2 days 30 degrees C
0.12956092.12913070.html.plaintext.txt	154	The production mature factor proportional zone growth inhibition halo formed
0.12956092.12913070.html.plaintext.txt	155	ACKNOWLEDGEMENTS We thank members family invaluable contribution project Drs S
0.12956092.12913070.html.plaintext.txt	156	Michaelis yeast strain SM3614 B
0.12956092.12913070.html.plaintext.txt	157	Horazdovsky yeast expression vector pRS416GPD mating strain XBH8 2 E
0.12956092.12913070.html.plaintext.txt	158	Oral DNA sample MAD 200
0.12956092.12913070.html.plaintext.txt	159	Cohen providing DNA samples control subjects R
0.12956092.12913070.html.plaintext.txt	160	Barnes genome database search T
0.12956092.12913070.html.plaintext.txt	161	Hall management DNA patient databases illustrations technical assistance
0.12956092.12913070.html.plaintext.txt	162	The study supported part National Institutes Health grants R01 DK54387 M01 RR00633 Southwestern Medical Foundation
0.12956092.12913070.html.plaintext.txt	163	FOOTNOTES To correspondence addressed University Texas Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 9052 USA
0.12956092.12913070.html.plaintext.txt	164	Tel 1 2146482895 Fax 1 2146487150 Email abhimanyu
0.12956092.12913070.html.plaintext.txt	165	1 Drosophila homolog NP611175
0.12956092.12913070.html.plaintext.txt	166	1 Arabidopsis AtSTE24 AF 353722 Saccharomyces cerevisiae STE24 U77137
0.12956092.12913070.html.plaintext.txt	167	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Simha V
0.12956092.12913070.html.plaintext.txt	168	2002 Body fat distribution metabolic derangements patients familial partial lipodystrophy associated mandibuloacral dysplasia
0.12956092.12913070.html.plaintext.txt	169	2002 Mandibuloacral dysplasia caused mutation LMNA encoding lamin AC
0.12956092.12913070.html.plaintext.txt	170	1993 Structural organization human gene encoding nuclear lamin A nuclear lamin C
0.12956092.12913070.html.plaintext.txt	171	1986 cDNA sequencing nuclear lamins A C reveals primary secondary structural homology intermediate filament proteins
0.12956092.12913070.html.plaintext.txt	172	2002 Life edge nuclear envelope human disease
0.12956092.12913070.html.plaintext.txt	173	1992 Targeting lamin proteins nuclear envelope role CaaX box modifications
0.12956092.12913070.html.plaintext.txt	174	2003 Genetic phenotypic heterogeneity patients mandibuloacral dysplasia associated lipodystrophy
0.12956092.12913070.html.plaintext.txt	175	2002 Defective prelamin A processing muscular adipocyte alterations Zmpste24 metalloproteinase deficient mice
0.12956092.12913070.html.plaintext.txt	176	2002 Zmpste24 deficiency mice causes spontaneous bone fractures muscle weakness prelamin A processing defect
0.12956092.12913070.html.plaintext.txt	177	1994 The processing pathway prelamin A
0.12956092.12913070.html.plaintext.txt	178	1999 Prenylated prelamin A interacts Narf novel nuclear protein
0.12956092.12913070.html.plaintext.txt	179	1998 Dual roles Ste24p yeast factor maturation NH2 terminal proteolysis COOH terminal CAAX processing
0.12956092.12913070.html.plaintext.txt	180	1999 Identification chromosomal location two human genes encoding enzymes potentially involved proteolytic maturation farnesylated proteins
0.12956092.12913070.html.plaintext.txt	181	1997 Modulation Ras factor function carboxyl terminal proteolysis
0.12956092.12913070.html.plaintext.txt	182	1994 A model recognition approach prediction helical membrane protein structure topology
0.12956092.12913070.html.plaintext.txt	183	Biochemistry 33 3038 3049
0.12956092.12913070.html.plaintext.txt	184	2000 Reconstitution Ste24p dependent N terminal proteolytic step yeast factor biogenesis
0.12956092.12913070.html.plaintext.txt	185	1992 A severe case mandibuloacral dysplasia girl
0.12956092.12913070.html.plaintext.txt	186	1998 Familial mandibuloacral dysplasia report four cases
0.12956092.12913070.html.plaintext.txt	187	1974 Craniomandibular dermatodysostosis
0.12956092.12913070.html.plaintext.txt	188	1975 Study family new progeroid syndrome
0.12956092.12913070.html.plaintext.txt	189	New Chromosomal Malformation Syndromes vol
0.12956092.12913070.html.plaintext.txt	190	1990 Hutchinson Gilford progeria familial occurrence
0.12956092.12913070.html.plaintext.txt	191	1990 Report male features overlapping geroderma osteodysplastica mandibuloacral dysplasia
0.12956092.12913070.html.plaintext.txt	192	1991 Lethal progeroid syndrome osteolysis
0.12956092.12913070.html.plaintext.txt	193	2003 Recurrent de novo point mutations lamin A cause Hutchinson Gilford progeria syndrome
0.12956092.12913070.html.plaintext.txt	194	2003 LMNA mutated Hutchinson Gilford progeria MIM 176670 Wiedemann Rautenstrauch progeroid syndrome MIM 264090
0.12956092.12913070.html.plaintext.txt	195	2003 Lamin A truncation Hutchinson Gilford progeria
0.12956092.12913070.html.plaintext.txt	196	2000 Premature adrenal cortical dysfunction mandibuloacral dysplasia progeroid like syndrome
0.12956092.12913070.html.plaintext.txt	197	CO2 5linktypeDOI CrossRefISIMedline
0.12956092.12913070.html.plaintext.txt	198	2000 Mandibulo acral dysplasia one year old boy
0.12956092.12913070.html.plaintext.txt	199	1995 Yeast vectors controlled expression heterologous proteins different genetic backgrounds
0.12956092.12913070.html.plaintext.txt	200	2000 The CaaX proteases Afc1p Rce1p overlapping distinct substrate specificities
0.13232653.16109720.html.plaintext.txt	0	Dpp responsive Silencers Are Bound Trimeric Mad Medea Complex Sheng Gao Janet Steffen Allen Laughon1
0.13232653.16109720.html.plaintext.txt	1	From Laboratory Genetics University Wisconsin Madison Wisconsin 53706
0.13232653.16109720.html.plaintext.txt	2	Received publication June 24 2005 revised form August 12 2005
0.13232653.16109720.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Transcriptional regulation transforming growth factor signaling mediated Smad family transcription factors
0.13232653.16109720.html.plaintext.txt	4	It generally accepted Smads must interact transcription factors bind targets
0.13232653.16109720.html.plaintext.txt	5	However recently shown complex Drosophila Smad proteins Mad Medea binds high affinity silencer elements repress brinker bag marbles response Dpp signaling
0.13232653.16109720.html.plaintext.txt	6	Here report silencers bound heterotrimer containing two Mad subunits one Medea subunit
0.13232653.16109720.html.plaintext.txt	7	We found MH1 domains three subunits contributed directly sequence specific DNA contact thus accounting exceptionally high stability Smad silencer complex
0.13232653.16109720.html.plaintext.txt	8	The Medea MH1 domain binds canonical Smad box GTCT whereas Mad MH1 domains bind GC rich sequence resembling Mad binding sites previously identified Dpp responsive enhancer elements
0.13232653.16109720.html.plaintext.txt	9	The consensus sequence GRCGNC differs canonical Smad box found Mad binding nonetheless required hairpin amino acids mediate base specific contact GTCT
0.13232653.16109720.html.plaintext.txt	10	Binding also affected alanine substitutions Mad Med subset basic residues within flanking helix 2 indicating contribution binding GRCGNC GTCT sites
0.13232653.16109720.html.plaintext.txt	11	The slight alteration Dpp silencers caused activate transcription response Dpp signaling indicating potential Smad complexes recognize specific targets need limited repression
0.13232653.16109720.html.plaintext.txt	12	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Transforming growth factor signaling pathways activate repress transcription means cooperative action Smad proteins large number interacting cofactors 1 3
0.13232653.16109720.html.plaintext.txt	13	The conserved Smad amino terminal MH1 domain contributes target recognition binding variations short sequence GTCT 4
0.13232653.16109720.html.plaintext.txt	14	Upon activation signaling Smads form complexes one MH1 domain available contact DNA 5 6
0.13232653.16109720.html.plaintext.txt	15	With major portion target recognition provided interacting cofactors DNA contact single MH1 domain sufficient regulation response signaling 7 10
0.13232653.16109720.html.plaintext.txt	16	In contrast Smad complexes bind several Drosophila silencer elements without assistance cofactor 11 12
0.13232653.16109720.html.plaintext.txt	17	These silencers repress brinker brk bag marbles bam gooseberry gsb genes response signaling decapentaplegic dpp
0.13232653.16109720.html.plaintext.txt	18	Repression brk plays central role dpp pathway 13 14 addition direct activation Smads Dpp targets regulated indirectly repression Brk protein 15 18
0.13232653.16109720.html.plaintext.txt	19	Repression brk occurs silencer binds complex Smad proteins Mothers Against Dpp Mad Medea Med 11
0.13232653.16109720.html.plaintext.txt	20	Mad homologous BMP2 specific Smad1 Smad5 Smad8 receptor activated Smads rSmads
0.13232653.16109720.html.plaintext.txt	21	Med homolog Smad4 coSmad forms complexes rSmads
0.13232653.16109720.html.plaintext.txt	22	Genetic biochemical analyses confirmed Mad Medea required repression brk 11 19 20
0.13232653.16109720.html.plaintext.txt	23	Repression brk also requires large zinc finger protein Schnurri Shn 11 19 20
0.13232653.16109720.html.plaintext.txt	24	Although Shn contains three zinc finger clusters alone bind silencer repression requires carboxyl terminal region containing three zinc fingers confer interaction silencer bound Mad Med complex 11 12
0.13232653.16109720.html.plaintext.txt	25	In gonad Dpp signaling Shn also required repression bam 21 22 differentiation factor must kept germ line stem cells 23
0.13232653.16109720.html.plaintext.txt	26	A Dpp responsive silencer located bam 5 untranslated region 27 bp transcriptional start 24
0.13232653.16109720.html.plaintext.txt	27	Both silencers consist paired Mad Med binding sites 12 25 binding Mad Med complex turn allows binding Shn
0.13232653.16109720.html.plaintext.txt	28	The ability Mad Med complexes recognize brk bam silencers without help cofactors suggests Smad complexes capable greater DNA binding affinity specificity observed previously
0.13232653.16109720.html.plaintext.txt	29	One means achieving would greater number MH1 domains interact DNA sequence specific manner
0.13232653.16109720.html.plaintext.txt	30	The number MH1 domains contained within Smad complex determined way Smad MH2 domains oligomerize 26 29
0.13232653.16109720.html.plaintext.txt	31	The tendency MH2 domains crystallize trimers heterotrimers 30 34 suggests heterotrimers principal heteromeric Smad complex vivo 34
0.13232653.16109720.html.plaintext.txt	32	However work several groups provided evidence Smads also form types complexes including heterodimers 35 37
0.13232653.16109720.html.plaintext.txt	33	Here report Mad Med bind brk bam silencers three MH1 domains Mad Med heterotrimer
0.13232653.16109720.html.plaintext.txt	34	The results reveal mechanism Smad complexes bind certain regulatory elements high affinity specificity
0.13232653.16109720.html.plaintext.txt	35	The arrangement sites critical silencing minor alterations result Dpp responsive transcriptional activation instead repression
0.13232653.16109720.html.plaintext.txt	36	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Plasmids Mad Med TkvQD effector plasmids expression human 293T cells generated insertion full length cDNAs polylinker version pCI expression vector modified contain amino terminal FLAG HA Myc tag ShnCT cloned epitope tag versions pCI PCR fragment encoding Ser 1884 Asn 2527
0.13232653.16109720.html.plaintext.txt	37	1XGFPMed generated ligating XbaI site pCI NheI XbaI fragment pEGFP Med provided Y
0.13232653.16109720.html.plaintext.txt	38	Cai containing fused eGFP Med coding regions
0.13232653.16109720.html.plaintext.txt	39	A second copy eGFP inserted XmaI BspEI fragment BspE1 site 1XGFPMed give 2XGFPMed
0.13232653.16109720.html.plaintext.txt	40	Substitution XbaI NotI fragment encoding Mad place Med coding region yielded 1XGFPMad 2XGFPMad
0.13232653.16109720.html.plaintext.txt	41	Site directed mutagenesis Mad Med effector plasmids carried using previously described method 38
0.13232653.16109720.html.plaintext.txt	42	Plasmid constructs products site directed mutagenesis verified DNA sequencing
0.13232653.16109720.html.plaintext.txt	43	For reporter assays BrkS sequence GACTGGCGACATTCTGTCTGGTGGCGATCGC inserted EcoRI NotI sites 3xSuH HSC generated insertion sequence GTTCTCACGGAACCAAAGGTTCTCACGGAACCAAAGGTTCTCAC NotI KpnI sites hsplacCaSpeR 39
0.13232653.16109720.html.plaintext.txt	44	pPacTkvQD pPacSuH pPacNAct described previously 40
0.13232653.16109720.html.plaintext.txt	45	View larger version 54K FIGURE 1
0.13232653.16109720.html.plaintext.txt	46	Dpp responsive silencers bound Mad Med complex
0.13232653.16109720.html.plaintext.txt	47	A alignment BrkS BamSE silencer elements GRCGNC GTCT sequences underlined
0.13232653.16109720.html.plaintext.txt	48	B gel shift assay showing purified maltose binding protein MadNL domain bound GGCGAC GTCT probes similar affinity whereas maltose binding protein MedNL NL MH1linker bound preferentially GTCT probe
0.13232653.16109720.html.plaintext.txt	49	3 1 microl protein preparation added binding reactions indicated
0.13232653.16109720.html.plaintext.txt	50	Complete probe sequences CATTCTGTCTGGGAAC CTTACTGGCGACATTCTG
0.13232653.16109720.html.plaintext.txt	51	C gel shift assays showing BrkS bound protein complex containing HA Mad Flag Med
0.13232653.16109720.html.plaintext.txt	52	Prior electrophoresis radioactive DNA probes incubated lysates human 293T cells transiently expressing combinations TkvQD lanes FlagMad HAMed mycShnCT without antibodies indicated
0.13232653.16109720.html.plaintext.txt	53	Position Mad Med shifted complex indicated arrowhead free probe labeled nonspecific band marked asterisk
0.13232653.16109720.html.plaintext.txt	54	Probe sequence AATTCGACTGGCGACATTCTGTCTGGTGGCGATCG CGGCC
0.13232653.16109720.html.plaintext.txt	55	D gel shift assay containing BrkS probe FlagMad Med
0.13232653.16109720.html.plaintext.txt	56	Addition FLAG antibody binding reaction resulted two supershifted bands upper supershifted band indicative two FlagMad subunits DNA bound complex
0.13232653.16109720.html.plaintext.txt	57	Asterisk marks background band
0.13232653.16109720.html.plaintext.txt	58	Gel Shift Assay Whole cell lysates use gel shift assays prepared human 293T cells transfected 10 cm dishes FuGENE 6 transfection reagent Roche Applied Science according suppliers protocol
0.13232653.16109720.html.plaintext.txt	59	The per plate amounts pCI effector plasmids expressing Mad Med TkvQD 2 2 1 microg respectively
0.13232653.16109720.html.plaintext.txt	60	Twenty four hours transfection 293T cells harvested lysed 400 microl ice cold DNAP buffer 80 mM NaCl 35 mM KCl 5 mM MgCl2 25 mM Tris pH 7
0.13232653.16109720.html.plaintext.txt	61	1 Nonidet P40 1 mM dithiothreitol 0
0.13232653.16109720.html.plaintext.txt	62	2 mM phenylmethylsulfonyl fluoride 20 microgml leupeptin 1 microgml aprotinin
0.13232653.16109720.html.plaintext.txt	63	Lysates cleared centrifugation 14000 rpm microfuge 4 degrees C stored frozen 80 degrees C
0.13232653.16109720.html.plaintext.txt	64	DNA probes made 32PdATP fill labeling annealed oligonucleotides followed phenol chloroform extraction spin column gel filtration
0.13232653.16109720.html.plaintext.txt	65	For gel shift DNA binding reaction 9 microl cell lysate mixed 1 microl DNA probe diluted 10 9 M 1 mgml dIdC
0.13232653.16109720.html.plaintext.txt	66	Reactions incubated 30 min ice 2 microl loaded per well onto 60 x 80 x 1
0.13232653.16109720.html.plaintext.txt	67	5 mm 4 polyacrylamide gel containing 0
0.13232653.16109720.html.plaintext.txt	68	Gels run 4 degrees C cooling 100 V 40 70 min run time adjusted according probe length
0.13232653.16109720.html.plaintext.txt	69	Gels dried imaged Storm PhosphorImager
0.13232653.16109720.html.plaintext.txt	70	View larger version 60K FIGURE 2
0.13232653.16109720.html.plaintext.txt	71	Stoichiometry silencer bound Mad Med complexes
0.13232653.16109720.html.plaintext.txt	72	A gel shift assay demonstrating presence two Mad subunits complex BamSE DNA probe
0.13232653.16109720.html.plaintext.txt	73	Overexpressed proteins 293T cell lysates added binding reactions indicated lane
0.13232653.16109720.html.plaintext.txt	74	Compositions deduced shifted complex diagrammed along sides orange Mad blue Med green eGFP
0.13232653.16109720.html.plaintext.txt	75	The left hand half gel shows complexes resulting fusion one two copies eGFP amino terminus Mad right side shows complexes resulting fusions Med
0.13232653.16109720.html.plaintext.txt	76	An asterisk indicates background band
0.13232653.16109720.html.plaintext.txt	77	In addition indicated components transfected cell lysates expressed TkvQD
0.13232653.16109720.html.plaintext.txt	78	Probe sequence AATTCGCCTGACGCCACGCTGTCTGCGAGCGGCC
0.13232653.16109720.html.plaintext.txt	79	B gel shift assay A BrkS probe used Fig
0.13232653.16109720.html.plaintext.txt	80	Reporter Assay Drosophila S2 cells grown 25 degrees C M3 medium supplemented 12
0.13232653.16109720.html.plaintext.txt	81	Cells transfected 24 well non coated plates using Effectene transfection reagent Qiagen according suppliers protocol
0.13232653.16109720.html.plaintext.txt	82	Cells harvested 2 days transfection chemiluminescent galactosidase assay performed cell extracts using GalactoStar assay system Tropix Inc
0.13232653.16109720.html.plaintext.txt	83	according suppliers instructions
0.13232653.16109720.html.plaintext.txt	84	All reporter experiments performed triplicate
0.13232653.16109720.html.plaintext.txt	85	View larger version 71K FIGURE 3
0.13232653.16109720.html.plaintext.txt	86	Mad contacts DNA means hairpin
0.13232653.16109720.html.plaintext.txt	87	A alignment helix 2 hairpin regions Mad Smad1 Med Smad4 extrapolated crystal structure Smad3 MH1 domain
0.13232653.16109720.html.plaintext.txt	88	Features corresponding Smad3 structure 42 indicated sequences solvent exposed Smad3 residues colored blue
0.13232653.16109720.html.plaintext.txt	89	Mad Med residues mutated alanine colored red
0.13232653.16109720.html.plaintext.txt	90	B gel shift assay comparing effects alanine substitutions Mad Med helix 2 hairpin residues formation Mad Med complex BrkS probe
0.13232653.16109720.html.plaintext.txt	91	The mutated residue indicated lane
0.13232653.16109720.html.plaintext.txt	92	Binding reactions contained lysates 293T cells transfected effector plasmids TkvQD Med indicated Mad mutants
0.13232653.16109720.html.plaintext.txt	93	Below gels shown Western blots detecting amino terminal FLAG tag alanine substitution Mad Med mutants HA tag wild type partner bottom
0.13232653.16109720.html.plaintext.txt	94	None mutations substantial effect protein level
0.13232653.16109720.html.plaintext.txt	95	C gel shift assay showing helix 2 alanine substitutions Mad left panel Med right panel affect binding ShnCT Mad Med BrkS complex
0.13232653.16109720.html.plaintext.txt	96	An asterisk marks background band
0.13232653.16109720.html.plaintext.txt	97	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Dpp Silencers Are Bound Heterotrimer Containing Mad Med 21 Ratio The BrkS BamSE silencers examples Smad proteins appear solely responsible target recognition 11 12 24 25
0.13232653.16109720.html.plaintext.txt	98	The silencers consist Smad binding sites separated five base pairs Fig
0.13232653.16109720.html.plaintext.txt	99	The silencer consensus sequence derived sequence alignment determining effects base substitutions 12 25
0.13232653.16109720.html.plaintext.txt	100	3 The left side consensus GRCGNC resembles Mad binding consensus GCCGnCG 41 whereas right side GTCT matches Smad3Smad4 consensus binding single MH1 domain 4 42
0.13232653.16109720.html.plaintext.txt	101	Gel shift experiments purified Mad Med fusion proteins showed Mad binds similar affinity either site whereas Med high affinity GTCT Fig
0.13232653.16109720.html.plaintext.txt	102	This suggests simple model Mad Med bind left right side silencer respectively
0.13232653.16109720.html.plaintext.txt	103	Gel shift experiments lysates transfected cells show Mad Med bind silencers complex antibody supershifts confirming presence proteins complex Fig
0.13232653.16109720.html.plaintext.txt	104	The binding Mad Med complex allows Shn recruited via carboxyl terminal region ShnCT Fig
0.13232653.16109720.html.plaintext.txt	105	We noticed supershifting complex Mad epitope tagged faint second supershifted band sometimes visible Fig
0.13232653.16109720.html.plaintext.txt	106	1D indication complexes may contain two Mad subunits
0.13232653.16109720.html.plaintext.txt	107	To investigate stoichiometry silencer bound Mad Med complexes fused one two copies eGFP amino terminal ends FLAG tagged Mad FLAG tagged Med
0.13232653.16109720.html.plaintext.txt	108	eGFP deemed suitable approach 43 effectively monomeric 44 45
0.13232653.16109720.html.plaintext.txt	109	The resulting 1x 2x GFP fusions Mad Med bound BamSE BrkS probes gel shift assays affinity normal counterparts slower mobility easily distinguishable wild type Mad Med silencer complex Fig
0.13232653.16109720.html.plaintext.txt	110	This allowed us test whether Smad existed one two copies within DNA bound complex
0.13232653.16109720.html.plaintext.txt	111	For example one Mad exists complex coexpression Mad 2xGFPMad together Med TkvQD give two bands normal Mad Med complex slower mobility 2xGFPMad Med complex
0.13232653.16109720.html.plaintext.txt	112	If complex contains two Mad subunits three bands Mad Mad Med Mad 2xGFPMad Med 2xGFPMad 2xGFPMad Med
0.13232653.16109720.html.plaintext.txt	113	Using BamSE probe combination Mad 2xGFPMad Med resulted three bands Fig
0.13232653.16109720.html.plaintext.txt	114	2A intermediate band strongest intensity expected Mad 2xGFPMad Med complexes twice abundant complexes containing one Mad isoform
0.13232653.16109720.html.plaintext.txt	115	Furthermore intermediate band mobility observed 1xGFP Mad Med complex consistent mobility shift caused presence two copies eGFP
0.13232653.16109720.html.plaintext.txt	116	The result obtained using BrkS probe Fig
0.13232653.16109720.html.plaintext.txt	117	2B thus conclude Mad Med silencer complex contains two Mad subunits
0.13232653.16109720.html.plaintext.txt	118	In contrast found lysates containing Mad Med 2xGFPMed formed two bands Fig
0.13232653.16109720.html.plaintext.txt	119	2 A B indicating Mad Med silencer complex contains single Med subunit
0.13232653.16109720.html.plaintext.txt	120	Mad Contacts GRCGNC Means Hairpin The DNA binding interface Smad3 hairpin structure 42 completely conserved rSmads two amino acid differences coSmads
0.13232653.16109720.html.plaintext.txt	121	This conservation DNA binding interface suggests Smads might bind DNA sequence specificity
0.13232653.16109720.html.plaintext.txt	122	However GC rich binding sites first described Mad later Smad1 appear distinct canonical Smad3 GTCT site proposed sites bound sequence nonspecific contact lysine rich helix 2 lies adjacent hairpin 46 47
0.13232653.16109720.html.plaintext.txt	123	Single base pair substitutions GRCGNC sites BrkS BamSE diminish binding Mad Med complex repression 12 data shown evidence binding Mad Med complex GRCGNC sites sequence specific
0.13232653.16109720.html.plaintext.txt	124	To investigate basis sequence specificity introduced alanine substitutions three positions within Mad hairpin Arg 88 Gln 90 Lys 95 corresponds Smad3 residue whose side chain makes direct base specific contact Smad3 DNA structure Fig
0.13232653.16109720.html.plaintext.txt	125	Western blots showed mutations others described little effect level Mad Med whole cell lysates Fig
0.13232653.16109720.html.plaintext.txt	126	Nonetheless three mutations strongly reduced complex formation BrkS Fig
0.13232653.16109720.html.plaintext.txt	127	As expected alanine substitutions corresponding positions Med similar effect Fig
0.13232653.16109720.html.plaintext.txt	128	We also tested alanine substitution Mad His 93 corresponds His 79 Smad3 residue makes indirect base contact water molecules 47 found caused less drastic reproducible reduction binding affinity BrkS Fig
0.13232653.16109720.html.plaintext.txt	129	These results demonstrate hairpin Mad necessary contact GRCGNC sites GTCT contact Med
0.13232653.16109720.html.plaintext.txt	130	View larger version 24K FIGURE 4
0.13232653.16109720.html.plaintext.txt	131	Both Mad subunits require hairpin
0.13232653.16109720.html.plaintext.txt	132	Shown gel shift assay demonstrating formation Mad Med BrkS complex disrupted one Mad subunits mutant hairpin base contact residue
0.13232653.16109720.html.plaintext.txt	133	293T cell lysates added binding reactions transfected effector plasmids TkvQD Med 2xGFPMad wild type mutant version unfused Mad indicated
0.13232653.16109720.html.plaintext.txt	134	The composition shifted Mad Med complexes indicated alongside gel described legend Fig
0.13232653.16109720.html.plaintext.txt	135	The image also shows complex formation disrupted one Mad subunits harbors R58A mutation
0.13232653.16109720.html.plaintext.txt	136	An asterisk marks background band
0.13232653.16109720.html.plaintext.txt	137	Helix 2 Contributes DNA Binding Although results indicated binding Mad GRCGNC occurs via hairpin went test whether residues within adjacent helix 2 might nevertheless contribute binding
0.13232653.16109720.html.plaintext.txt	138	The lysine rich stretch helix 2 shown function nuclear localization signal 48 49 series helix 2 lysine alanine mutations resulted little change Mad Med levels whole cell lysates transfected 293T cells determined Western blots Fig
0.13232653.16109720.html.plaintext.txt	139	Comparing lysates gel shift experiments found Mad Med BrkS complex formation strongly disrupted Mad R58A residue carboxyl terminal helix 2 moderate effects caused Mad K46A Med R66A K74A D80A Fig
0.13232653.16109720.html.plaintext.txt	140	The results show helix 2 carboxyl terminally adjacent residues contribute DNA binding activity Med well Mad suggesting helix 2 backbone contact may general feature Smad DNA interaction exclusive interaction GRCGNC site
0.13232653.16109720.html.plaintext.txt	141	Together results suggest Mad Med contact DNA via hairpin configuration similar Smad3 MH1 domain bound GTCT possibly helix 2 tilted somewhat closer DNA backbone
0.13232653.16109720.html.plaintext.txt	142	Notably alanine substitutions helix 2 Mad Med obvious effect recruitment ShnCT Fig
0.13232653.16109720.html.plaintext.txt	143	Because binding ShnCT requires precise 5 bp spacing GRCGNC GTCT discussed MH1 domains likely sites Shn interaction
0.13232653.16109720.html.plaintext.txt	144	These results indicate MH1 contact ShnCT depend critically solvent exposed helix 2 side chains
0.13232653.16109720.html.plaintext.txt	145	The stretch basic amino acids starts helix 2 extends Mad Smad3 found one additional residues Arg 58 required form silencer complex
0.13232653.16109720.html.plaintext.txt	146	However comparison Smad3MH1 DNA crystal structure doubtful Arg 58 would able contact DNA backbone position end helix 2
0.13232653.16109720.html.plaintext.txt	147	Indeed R58A substitution little effect binding purified maltose binding protein MadNL binds monomer probes containing GTCT GGCGAC whereas R88A dramatically reduced binding probes data shown evidence Arg 58 directly involved DNA contact
0.13232653.16109720.html.plaintext.txt	148	Rather directly contacting DNA Arg 58 may engage protein protein interactions stabilize DNA bound Mad Med heterotrimer
0.13232653.16109720.html.plaintext.txt	149	However cannot rule possibility bound heterotrimer Mad MH1 domain adopts structure Arg 58 contacts DNA backbone
0.13232653.16109720.html.plaintext.txt	150	The Hairpin Is Required Both Mad Subunits The results described prove hairpin required least one two Mad subunits contained within heterotrimer
0.13232653.16109720.html.plaintext.txt	151	To test whether hairpin required Mad subunits coexpressed Mad R88A Q90A K95A mutant proteins wild type 2xGFP Mad performed gel shift BrkS probe
0.13232653.16109720.html.plaintext.txt	152	If hairpin contact required one two Mad MH1 domains expected observe intermediate band containing 2xGFPMad MadR88A Q90AK95A
0.13232653.16109720.html.plaintext.txt	153	Faint intermediate bands observed Fig
0.13232653.16109720.html.plaintext.txt	154	4 even strongest Q90A much weaker wild type
0.13232653.16109720.html.plaintext.txt	155	We interpret results demonstration intact hairpin required Mad subunits although presence one subunit allow residual binding
0.13232653.16109720.html.plaintext.txt	156	Interestingly Arg 58 also required Mad subunits
0.13232653.16109720.html.plaintext.txt	157	View larger version 33K FIGURE 5
0.13232653.16109720.html.plaintext.txt	158	Shn binding repression require correct spacing orientation binding sites within Dpp responsive silencers
0.13232653.16109720.html.plaintext.txt	159	A selected mutations BrkS demonstrate importance binding site sequence topology repression
0.13232653.16109720.html.plaintext.txt	160	Changed bases Mut1 Mut2 bold lowercase type
0.13232653.16109720.html.plaintext.txt	161	B gel shift assays showing effects topological changes BrkS silencer
0.13232653.16109720.html.plaintext.txt	162	Compared wild type reversal GTCT Mut1 disrupted binding Mad Med complex
0.13232653.16109720.html.plaintext.txt	163	In contrast changing GTCT GGCG Mut2 reduced Mad Med complex slightly binding ShnCT undetectable
0.13232653.16109720.html.plaintext.txt	164	Reducing distance Mad Med binding sites 1 bp Mut3 little effect binding Mad Med complex binding ShnCT undetectable
0.13232653.16109720.html.plaintext.txt	165	DNA binding reactions contained BrkS probe lysate 293T cells transfected effector plasmids expression Flag Mad HA Med ShnCT indicated transfected TkvQD
0.13232653.16109720.html.plaintext.txt	166	C reporter assays Drosophila S2 cells showing Smad binding site sequence orientation spacing critical repression
0.13232653.16109720.html.plaintext.txt	167	Repression response TkvQD disrupted reversal Med binding site Mut1 whereas Mut2 Mut3 show changing GTCT GGCG reducing spacing Mad Med sites resulted TkvQD induced activation
0.13232653.16109720.html.plaintext.txt	168	As diagrammed graph reporter plasmids contained BrkS positioned upstream 3xSuH binding site array allowed activation response cotransfected effector plasmids Suppressor Hairless SuH activated version Notch Nact 11 12 40
0.13232653.16109720.html.plaintext.txt	169	Amounts effector plasmids used per transfected well nanograms indicated chart
0.13232653.16109720.html.plaintext.txt	170	D gel shift assay using GFP fusion constructs Fig
0.13232653.16109720.html.plaintext.txt	171	2 demonstrates activating Mad Med complexes arrowheads still contain heterotrimer 21 MadMed ratio
0.13232653.16109720.html.plaintext.txt	172	Probes composition 293T cell lysates indicated lanes
0.13232653.16109720.html.plaintext.txt	173	The mobility complexes tightly spaced Mut3 probe
0.13232653.16109720.html.plaintext.txt	174	View larger version 16K FIGURE 6
0.13232653.16109720.html.plaintext.txt	175	Model Mad Med heterotrimer bound Dpp responsive silencer
0.13232653.16109720.html.plaintext.txt	176	The positions two Mad MH1 domains contact GRCGNC site depicted symmetrical tandem arrangement ruled
0.13232653.16109720.html.plaintext.txt	177	Shn depicted contacting MH1 domains sensitivity spacing Mad Med binding sites
0.13232653.16109720.html.plaintext.txt	178	However Shn also interacts Mad Med MH2 domains 71 72
0.13232653.16109720.html.plaintext.txt	179	A Mad Med Heterotrimer Can Activate Transcription The significance GRCGNCN5GTCT topology investigated series rearrangements Fig
0.13232653.16109720.html.plaintext.txt	180	Reversal GTCT BrkS mut1 Fig
0.13232653.16109720.html.plaintext.txt	181	5A reduced binding Mad Med silencer complex formation Fig
0.13232653.16109720.html.plaintext.txt	182	5B essentially eliminated repression Fig
0.13232653.16109720.html.plaintext.txt	183	In contrast changing GTCT GGCG mut2 Fig
0.13232653.16109720.html.plaintext.txt	184	5A modest effect Mad Med binding prevented recruitment Shn Fig
0.13232653.16109720.html.plaintext.txt	185	5B transforming silencer Dpp responsive activating element Fig
0.13232653.16109720.html.plaintext.txt	186	Similarly 1 bp increase data shown decrease mut3 Fig
0.13232653.16109720.html.plaintext.txt	187	5A spacing converted silencer activating element Fig
0.13232653.16109720.html.plaintext.txt	188	5C disrupting Shn binding without severely affecting binding Mad Med Fig
0.13232653.16109720.html.plaintext.txt	189	In latter two cases Mad Med still bound DNA heterotrimer 21 ratio Fig
0.13232653.16109720.html.plaintext.txt	190	Similar results obtained alterations BamSE
0.13232653.16109720.html.plaintext.txt	191	These results demonstrate repression dependent precise GRCGNC N5 GTCT arrangement trimeric Smad complexes cannot recruit Shn behave transcriptional activators
0.13232653.16109720.html.plaintext.txt	192	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES In report provide evidence Mad Med bind Dpp responsive silencers 21 heterotrimer three subunits complex make sequence specific DNA contact means MH1 domain hairpin Fig
0.13232653.16109720.html.plaintext.txt	193	Slight alterations sequence transform silencers Dpp responsive activating elements continue bound 21 Mad Med heterotrimer conformation allow recruitment Shn
0.13232653.16109720.html.plaintext.txt	194	This work also demonstrates Mad binds GC rich sites originally defined GCCGNCG 41 recently context silencers GRCGNC 12 sequence specific contact two subunits
0.13232653.16109720.html.plaintext.txt	195	Sequence specific interaction GC rich sites demonstrated previously Smad1 50 Mad 12 stoichiometry interactions documented
0.13232653.16109720.html.plaintext.txt	196	Finding 6 bp site contacted two Mad subunits raises new questions clear two MH1 domains arranged DNA known GNCG GNCN depending orientation recognized rather GTCT site preferred Smad3 Smad4
0.13232653.16109720.html.plaintext.txt	197	Previous work involving Smad1 Smad3 chimeras identified Lys 36 Ser 37 Smad3 helix 2 versus Asp 35 Ala 36 Smad1 key difference necessary activation CAGA9 luc reporter 51
0.13232653.16109720.html.plaintext.txt	198	However found mutation corresponding residue Mad D49A little effect binding BrkS thus structural determinants GRCGNC binding site preference Mad inference Smad1 remain identified
0.13232653.16109720.html.plaintext.txt	199	Our findings contradict previous report Mad Med bind BrkS dimer 12
0.13232653.16109720.html.plaintext.txt	200	Although documentation provided determined experimentally attempts determine stoichiometry means antibody supershift experiments suggest possible explanation discrepancy
0.13232653.16109720.html.plaintext.txt	201	We found epitope tags Mad amino terminus readily accessible antibody one two Mad subunits Fig
0.13232653.16109720.html.plaintext.txt	202	1D possibly crowding adjacent DNA bound MH1 domain Med
0.13232653.16109720.html.plaintext.txt	203	This problem led us turn instead use protein fusions strategy 43 assessing stoichiometry
0.13232653.16109720.html.plaintext.txt	204	Mad Med appear factors directly contact bam brk silencers 11 12
0.13232653.16109720.html.plaintext.txt	205	This conclusion based mutational analysis BrkS element showed mutations disrupt silencing also disrupt binding Mad Med complex
0.13232653.16109720.html.plaintext.txt	206	The exceptions mutation GTCT GTCG 12 GGCG Fig
0.13232653.16109720.html.plaintext.txt	207	5 1 bp deletion Mad Med sites 12 Fig
0.13232653.16109720.html.plaintext.txt	208	5 allowed binding Mad Med complex disrupted recruitment Shn
0.13232653.16109720.html.plaintext.txt	209	Overexpression activated Mad Med complexes sufficient generate gel shift complexes therefore unlikely unknown cofactor required would presumably need expressed high levels endogenously Drosophila human cells
0.13232653.16109720.html.plaintext.txt	210	The demonstration binding Mad Med heterotrimer requires three MH1 domains also weighs cofactor involvement becomes difficult explain GRCGNC could contacted cofactor addition two Mad MH1 domains Med MH1 contacting GTCT
0.13232653.16109720.html.plaintext.txt	211	Nonetheless possible cofactor present Drosophila human extracts gone undetected although evidence suggests could play direct role sequence specific DNA contact
0.13232653.16109720.html.plaintext.txt	212	The apparent ability Mad Med complex bind silencers without cofactors contrasts general reliance Smads DNA binding cofactors target specificity
0.13232653.16109720.html.plaintext.txt	213	brk could considered special case negatively regulated Dpp globally 15 18 whereas Dpp targets require tissue specific regulation 41 52 57
0.13232653.16109720.html.plaintext.txt	214	However bam expression specific germ line cells thus unexpected DNA contact Mad Med would sufficient regulatory specificity bam silencer
0.13232653.16109720.html.plaintext.txt	215	The existence similar Dpp responsive silencer regulating gooseberry 12 provides evidence novel arrangements Smad binding sites provide sufficient specificity regulation response signaling
0.13232653.16109720.html.plaintext.txt	216	Nonetheless tissue specificity might augmented cooperative interaction DNA bound corepressors Smads bound BrkSBamSE like sites
0.13232653.16109720.html.plaintext.txt	217	The high affinity Mad Med silencers explained trimeric stoichiometry involvement MH1 domains directly contacting DNA
0.13232653.16109720.html.plaintext.txt	218	The ability single Smad complex engage three MH1 domains DNA contact several implications
0.13232653.16109720.html.plaintext.txt	219	The obvious Smad complexes may cases make greater contribution target recognition previously apparent
0.13232653.16109720.html.plaintext.txt	220	As case brk provides mechanism Dpp BMP even transforming growth factor signaling might trigger general response without need tissue specific cofactor
0.13232653.16109720.html.plaintext.txt	221	Such response need limited silencing slight alterations silencers transform Dpp responsive activating elements possibly allowing CBP interact Mad Med complex 58 absence Shn
0.13232653.16109720.html.plaintext.txt	222	Conserved sites exhibiting BrkSBamSE motif identified within BMP response elements Id genes 59 61 class responsive BMP signaling 62 63
0.13232653.16109720.html.plaintext.txt	223	Conversely tissue specificity might conferred upon tripartite Smad response elements adjacent binding sites transcription factors
0.13232653.16109720.html.plaintext.txt	224	A second implication Smad complexes may greater flexibility ability recognize binding sites previously apparent particularly moderate affinity sites two MH1 domains make sequence specific contact
0.13232653.16109720.html.plaintext.txt	225	The observed flexibility spacing Mad Med sites BrkS BamSE suggests DNA binding Med plus one Mad MH1 domain might able occur variety permutations
0.13232653.16109720.html.plaintext.txt	226	However loss binding Med site reversed mut1 Fig
0.13232653.16109720.html.plaintext.txt	227	5B shows topology Smad sites strict limits
0.13232653.16109720.html.plaintext.txt	228	A moderate affinity site might also consist GRCGNC Mad binding site without adjacent Med binding site appears case many Dpp responsive enhancer elements 41 52 54 57 64 65
0.13232653.16109720.html.plaintext.txt	229	3 Such moderate affinity sites would activate transcription response Dpp signaling necessary tissue specific cofactor present
0.13232653.16109720.html.plaintext.txt	230	Some Mad sites serve also binding sites Brk protein opposes Dpp signaling direct competition Mad binding functioning active repressor 40 66 69
0.13232653.16109720.html.plaintext.txt	231	The third implication complexity response BMP signaling
0.13232653.16109720.html.plaintext.txt	232	In vertebrates possess three BMP responsive rSmads Smad1 Smad5 Smad8 BMP signaling might trigger formation variety trimeric rSmad complexes Smad4 e
0.13232653.16109720.html.plaintext.txt	233	There potential six combinations 114 554 884 154 184 584
0.13232653.16109720.html.plaintext.txt	234	If mixed complexes form shown Smad2 Smad3 Smad4 activation p15Ink4B 70 important determine whether differences exist among range binding sites bound means two three MH1 domains
0.13232653.16109720.html.plaintext.txt	235	The likelihood differential cofactor interactions Smad1 Smad5 Smad8 adds additional layer complexity
0.13232653.16109720.html.plaintext.txt	236	FOOTNOTES This work supported grant National Science Foundation
0.13232653.16109720.html.plaintext.txt	237	The costs publication article defrayed part payment page charges
0.13232653.16109720.html.plaintext.txt	238	This article must therefore hereby marked advertisement accordance 18 U
0.13232653.16109720.html.plaintext.txt	239	Section 1734 solely indicate fact
0.13232653.16109720.html.plaintext.txt	240	1 To correspondence addressed Laboratory Genetics University Wisconsin 445 Henry Mall Madison WI 53706
0.13232653.16109720.html.plaintext.txt	241	608 262 2456 Fax 608 262 2976 E mail alaughonatwisc
0.13232653.16109720.html.plaintext.txt	242	2 The abbreviations used BMP bone morphogenetic protein MH Mad homology eGFP enhanced green fluorescent protein HA hemagglutinin
0.13232653.16109720.html.plaintext.txt	243	ACKNOWLEDGMENTS We thank Y
0.13232653.16109720.html.plaintext.txt	244	Hoffmann plasmids protocols
0.13232653.16109720.html.plaintext.txt	245	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Shi Y
0.13232653.16109720.html.plaintext.txt	246	2003 Cell 113 685 700CrossRefMedline Order article via Infotrieve Derynck R
0.13232653.16109720.html.plaintext.txt	247	2003 Nature 425 577 584CrossRefMedline Order article via Infotrieve ten Dijke P
0.13232653.16109720.html.plaintext.txt	248	211 105 113CrossRefMedline Order article via Infotrieve Zawel L
0.13232653.16109720.html.plaintext.txt	249	Cell 1 611 617CrossRefMedline Order article via Infotrieve Dennler S
0.13232653.16109720.html.plaintext.txt	250	17 3091 3100AbstractFree Full Text Johnson K
0.13232653.16109720.html.plaintext.txt	251	274 20709 20716AbstractFree Full Text Chen X
0.13232653.16109720.html.plaintext.txt	252	1997 Nature 389 85 89CrossRefMedline Order article via Infotrieve Yeo C
0.13232653.16109720.html.plaintext.txt	253	274 26584 26590AbstractFree Full Text Liu F
0.13232653.16109720.html.plaintext.txt	254	11 3157 3167AbstractFree Full Text Zhang Y
0.13232653.16109720.html.plaintext.txt	255	1998 Nature 396 491CrossRef Muller B
0.13232653.16109720.html.plaintext.txt	256	2003 Cell 113 221 233CrossRefMedline Order article via Infotrieve Pyrowolakis G
0.13232653.16109720.html.plaintext.txt	257	Cell 7 229 240CrossRefMedline Order article via Infotrieve Affolter M
0.13232653.16109720.html.plaintext.txt	258	2001 EMBO Journal 20 3298 3305AbstractFree Full Text Raftery L
0.13232653.16109720.html.plaintext.txt	259	19 701 708CrossRefMedline Order article via Infotrieve Minami M
0.13232653.16109720.html.plaintext.txt	260	1999 Nature 398 242 246CrossRefMedline Order article via Infotrieve Campbell G
0.13232653.16109720.html.plaintext.txt	261	1999 Cell 96 553 562CrossRefMedline Order article via Infotrieve Jazwinska A
0.13232653.16109720.html.plaintext.txt	262	1999 Cell 96 563 573CrossRefMedline Order article via Infotrieve Jazwinska A
0.13232653.16109720.html.plaintext.txt	263	126 3323 3334AbstractFree Full Text Marty T
0.13232653.16109720.html.plaintext.txt	264	2 745 749CrossRefMedline Order article via Infotrieve Torres Vazquez J
0.13232653.16109720.html.plaintext.txt	265	128 1657 1670AbstractFree Full Text Xie T
0.13232653.16109720.html.plaintext.txt	266	1998 Cell 94 251 260CrossRefMedline Order article via Infotrieve Xie T
0.13232653.16109720.html.plaintext.txt	267	2000 Science 290 328 330AbstractFree Full Text Ohlstein B
0.13232653.16109720.html.plaintext.txt	268	124 3651 3662AbstractFree Full Text Chen D
0.13232653.16109720.html.plaintext.txt	269	130 1159 1170AbstractFree Full Text Chen D
0.13232653.16109720.html.plaintext.txt	270	13 1786 1791CrossRefMedline Order article via Infotrieve Zhang Y
0.13232653.16109720.html.plaintext.txt	271	1996 Nature 383 168 172CrossRefMedline Order article via Infotrieve Lagna G
0.13232653.16109720.html.plaintext.txt	272	1996 Nature 383 832 836CrossRefMedline Order article via Infotrieve Kawabata M
0.13232653.16109720.html.plaintext.txt	273	17 4056 4065AbstractFree Full Text Souchelnytskyi S
0.13232653.16109720.html.plaintext.txt	274	272 28107 28115AbstractFree Full Text Shi Y
0.13232653.16109720.html.plaintext.txt	275	1997 Nature 388 87 93CrossRefMedline Order article via Infotrieve Chacko B
0.13232653.16109720.html.plaintext.txt	276	8 248 253CrossRefMedline Order article via Infotrieve Qin B
0.13232653.16109720.html.plaintext.txt	277	Cell 8 1303 1312CrossRefMedline Order article via Infotrieve Wu J
0.13232653.16109720.html.plaintext.txt	278	Cell 8 1277 1289CrossRefMedline Order article via Infotrieve Chacko B
0.13232653.16109720.html.plaintext.txt	279	Cell 15 813 823CrossRefMedline Order article via Infotrieve Jayaraman L
0.13232653.16109720.html.plaintext.txt	280	275 40710 40717AbstractFree Full Text Wu J
0.13232653.16109720.html.plaintext.txt	281	276 20688 20694AbstractFree Full Text Inman G
0.13232653.16109720.html.plaintext.txt	282	277 51008 51016AbstractFree Full Text Sawano A
0.13232653.16109720.html.plaintext.txt	283	28 e78AbstractFree Full Text Nelson H
0.13232653.16109720.html.plaintext.txt	284	202 341 354CrossRef Kirkpatrick H
0.13232653.16109720.html.plaintext.txt	285	276 18216 18222AbstractFree Full Text Kim J
0.13232653.16109720.html.plaintext.txt	286	1997 Nature 388 304 308CrossRefMedline Order article via Infotrieve Shi Y
0.13232653.16109720.html.plaintext.txt	287	1998 Cell 94 585 594CrossRefMedline Order article via Infotrieve Hope I
0.13232653.16109720.html.plaintext.txt	288	6 2781 2784Abstract Baird G
0.13232653.16109720.html.plaintext.txt	289	97 11984 11989AbstractFree Full Text Vogel M
0.13232653.16109720.html.plaintext.txt	290	Bioinformatics 58 478 488CrossRef Shi Y
0.13232653.16109720.html.plaintext.txt	291	2001 BioEssays 23 223 2323
0.13232653.16109720.html.plaintext.txt	292	CO2 L 20331AbstractFree Full Text Xiao Z
0.13232653.16109720.html.plaintext.txt	293	97 7853 7858AbstractFree Full Text Xiao Z
0.13232653.16109720.html.plaintext.txt	294	276 39404 39410AbstractFree Full Text Kusanagi K
0.13232653.16109720.html.plaintext.txt	295	Cell 11 555 565AbstractFree Full Text Kusanagi K
0.13232653.16109720.html.plaintext.txt	296	276 28155 28163AbstractFree Full Text Szuts D
0.13232653.16109720.html.plaintext.txt	297	12 2022 2035AbstractFree Full Text Xu X
0.13232653.16109720.html.plaintext.txt	298	12 2354 2370AbstractFree Full Text Halfon M
0.13232653.16109720.html.plaintext.txt	299	Baylies MK Michelson A
0.13232653.16109720.html.plaintext.txt	300	2000 Cell 103 63 74CrossRefMedline Order article via Infotrieve Knirr S
0.13232653.16109720.html.plaintext.txt	301	238 13 26CrossRefMedline Order article via Infotrieve Lee H
0.13232653.16109720.html.plaintext.txt	302	132 1429 1442AbstractFree Full Text Xu M
0.13232653.16109720.html.plaintext.txt	303	132 1637 1647AbstractFree Full Text Waltzer L
0.13232653.16109720.html.plaintext.txt	304	18 1630 1641AbstractFree Full Text Lopez Rovira T
0.13232653.16109720.html.plaintext.txt	305	277 3176 3185AbstractFree Full Text Korchynskyi O
0.13232653.16109720.html.plaintext.txt	306	277 4883 4891AbstractFree Full Text Karaulanov E
0.13232653.16109720.html.plaintext.txt	307	23 844 856AbstractFree Full Text Hollnagel A
0.13232653.16109720.html.plaintext.txt	308	274 19839 19845 Kowanetz M
0.13232653.16109720.html.plaintext.txt	309	24 4241 4254AbstractFree Full Text Kwon C
0.13232653.16109720.html.plaintext.txt	310	131 2681 2692AbstractFree Full Text Wharton S
0.13232653.16109720.html.plaintext.txt	311	14 1550 1558CrossRefMedline Order article via Infotrieve Sivasankaran R
0.13232653.16109720.html.plaintext.txt	312	19 6162 6172AbstractFree Full Text Rushlow C
0.13232653.16109720.html.plaintext.txt	313	15 340 351AbstractFree Full Text Zhang H
0.13232653.16109720.html.plaintext.txt	314	2001 Genes Development Camb
0.13232653.16109720.html.plaintext.txt	315	15 261 266CrossRef Saller E
0.13232653.16109720.html.plaintext.txt	316	2 292 297AbstractFree Full Text Feng X
0.13232653.16109720.html.plaintext.txt	317	19 5178 5193AbstractFree Full Text Udagawa Y
0.13232653.16109720.html.plaintext.txt	318	2000 Genes Cells 5 359 369AbstractFree Full Text Dai H
0.13232653.16109720.html.plaintext.txt	319	227 373 387CrossRefMedline Order article via Infotrieve This Article Abstract Full Text PDF All Versions Article 2804336158 recent M506882200v1 Purchase Article View Shopping Cart Alert article cited Alert correction posted Citation Map Services Email article friend Similar articles journal Similar articles PubMed Alert new issues journal Download citation manager Copyright Permissions Google Scholar Articles Gao S
0.13232653.16109720.html.plaintext.txt	320	PubMed PubMed Citation Articles Gao S
0.13232653.16109720.html.plaintext.txt	321	HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular Cellular Proteomics Journal Lipid Research Biochemistry Molecular Biology Education Copyright 2005 American Society Biochemistry Molecular Biology
0.17309903.9867801.html.plaintext.txt	0	MINIREVIEW PROLOGUE Prions Mammals Fungi Minireview Series Herbert Tabor
0.17309903.9867801.html.plaintext.txt	1	From Laboratory Biochemistry Genetics NIDDK National Institutes Health Bethesda Maryland 20892
0.17309903.9867801.html.plaintext.txt	2	ARTICLE TOP ARTICLE REFERENCES
0.17309903.9867801.html.plaintext.txt	3	The mammalian spongiform encephalopathies gave rise concept infectious proteins proteins transmit infection without essential nucleic acid
0.17309903.9867801.html.plaintext.txt	4	This concept identified term prion
0.17309903.9867801.html.plaintext.txt	5	These diseases including scrapie sheep bovine spongiform encephalopathy human Creutzfeldt Jakob disease variants believed result self propagating change PrP cell surface protein
0.17309903.9867801.html.plaintext.txt	6	The minireview issue Charles Weissmann 1 examines spongiform encephalopathies summarizes work number laboratories
0.17309903.9867801.html.plaintext.txt	7	In 1994 suggested two non chromosomal genetic elements Saccharomyces cerevisiae URE3 PSI infectious protein prion forms Ure2p Sup35p
0.17309903.9867801.html.plaintext.txt	8	These findings particularly exciting systems permit application powerful genetic methods available yeast study prion problem
0.17309903.9867801.html.plaintext.txt	9	Recently Het non Mendelian genetic element filamentous fungus Podospora anserina identified another likely prion
0.17309903.9867801.html.plaintext.txt	10	In case evidence points altered form chromosomally encoded protein acquired ability convert normal form protein altered prion abnormal form
0.17309903.9867801.html.plaintext.txt	11	These new developments summarized second minireview Reed Wickner et al
0.17309903.9867801.html.plaintext.txt	12	2 focused evidence prions yeast fungi serve genetic material third Susan Liebman Irina Derkatch 3 discussing yeast PSI prion detail including interactions chaperones proteins
0.17309903.9867801.html.plaintext.txt	13	Although epidemic mad cow disease brought field headlines scientific excitement rests notion altered protein conformations impart disease somewhat revolutionary concepts infection heredity come work
0.17309903.9867801.html.plaintext.txt	14	This minireview reprinted 1999 Minireview Compendium available December 1999
0.17309903.9867801.html.plaintext.txt	15	REFERENCES TOP ARTICLE REFERENCES Weissmann C
0.17309903.9867801.html.plaintext.txt	16	274 3 6Free Full Text Wickner R
0.17309903.9867801.html.plaintext.txt	17	274 555 558Free Full Text Leibman S
0.17309903.9867801.html.plaintext.txt	18	274 1181 1184Free Full Text
0.17309903.9867801.html.plaintext.txt	19	Copyright 1999 The American Society Biochemistry Molecular Biology Inc
0.12753695.11980826.html.plaintext.txt	0	The Mad Cow Talks Back Jo Shapcott
0.12753695.11980826.html.plaintext.txt	1	It seems way I stagger get bit irritable
0.12753695.11980826.html.plaintext.txt	2	There wonderful holes brain ideas outside travel top speed voices sometimes whole people speak universe
0.12753695.11980826.html.plaintext.txt	3	Most brains compressed
0.12753695.11980826.html.plaintext.txt	4	You need spongy generosity let others
0.12753695.11980826.html.plaintext.txt	5	Suddenly surface world ice Im magnificent skater turning spinning across whole hard Pacifics Atlantics
0.12753695.11980826.html.plaintext.txt	6	Its risky youre good course legs go behind side body time time theres general embarrassing collapse happens glorious always youre travelling furiously mind
0.12753695.11980826.html.plaintext.txt	7	My brains like hive constant little murmurs cells saying way way go
0.12753695.11980826.html.plaintext.txt	8	Originally published Her Book Jo Shapcott Faber Faber Ltd
0.12753695.11980826.html.plaintext.txt	9	This Article Extract FREE Full Text PDF Alert article cited Alert correction posted Services Email article friend Similar articles journal Similar articles PubMed Alert new issues journal Add My Personal Archive Download citation manager Request Permissions Google Scholar Articles Shapcott J
0.12753695.11980826.html.plaintext.txt	10	PubMed PubMed Citation Articles Shapcott J
0.12753695.11980826.html.plaintext.txt	11	Online ISSN 1464 3685 Print ISSN 0300 5771 Copyright 2006 International Epidemiological Association Oxford Journals Oxford University Press Site Map Terms Conditions Privacy Policy Frequently Asked Questions Other Oxford University Press sites Oxford University Press American National Biography Booksellers Information Service Childrens Fiction Poetry Childrens Reference Corporate Special Sales Dictionaries Dictionary National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights Permissions Science School Books Social Sciences Very Short Introductions Worlds Classics
0.11293201.16275782.html.plaintext.txt	0	Farm animal genomics informatics update Ahmed Fadiel Ifeanyi Anidi Kenneth D
0.11293201.16275782.html.plaintext.txt	1	Yale University School Medicine Yale Center Research On Reproductive Biology New Haven CT 06511 USA 1Mount Sinai School Medicine New York NY 10029 USA
0.11293201.16275782.html.plaintext.txt	2	To correspondence addressed
0.11293201.16275782.html.plaintext.txt	3	Tel 1 203 737 1218 Fax 1 203 785 5294 Email afadielatyale
0.11293201.16275782.html.plaintext.txt	4	ABSTRACT TOP ABSTRACT PRELUDE FARM ANIMAL GENOMICS THE
0.11293201.16275782.html.plaintext.txt	5	REFERENCES Farm animal genomics interest wide audience researchers utility derived understanding genomics proteomics function various organisms
0.11293201.16275782.html.plaintext.txt	6	Applications xenotransplantation increased livestock productivity bioengineering new materials products even fabrics several reasons thriving farm animal genome activity
0.11293201.16275782.html.plaintext.txt	7	Currently mined rapidly growing data warehouses completed genomes chicken fish cows available largely stored decentralized data repositories
0.11293201.16275782.html.plaintext.txt	8	In paper provide informatics primer farm animal bioinformatics genome project resources drive attention recent advances field
0.11293201.16275782.html.plaintext.txt	9	We hope provide individuals biotechnology farming industry information resources updates concerning farm animal genome projects
0.11293201.16275782.html.plaintext.txt	10	PRELUDE TOP ABSTRACT PRELUDE FARM ANIMAL GENOMICS THE
0.11293201.16275782.html.plaintext.txt	11	REFERENCES The omics bioinformatics Genomics scientific study structure function interrelationships individual genes genome entirety 1
0.11293201.16275782.html.plaintext.txt	12	The field evolved identifying short nucleotide strings DNA sequencing organisms complete genome
0.11293201.16275782.html.plaintext.txt	13	Current progress genomics research facilitated comprehensive mapping building blocks biology 2
0.11293201.16275782.html.plaintext.txt	14	Ultimately researchers hope gain mastery fundamental description cellular function DNA level 3
0.11293201.16275782.html.plaintext.txt	15	This would encompass gene regulation proteins often regulate production proteins complex web interactions
0.11293201.16275782.html.plaintext.txt	16	Databases developed provide solutions problems people encounter dealing massive amounts data
0.11293201.16275782.html.plaintext.txt	17	However abundance growing complexity data tools resources required analysis overwhelming httpwww
0.11293201.16275782.html.plaintext.txt	18	govAboutprimerbioinformatics
0.11293201.16275782.html.plaintext.txt	19	The true researchers focusing study function structure proteins protein protein interactions
0.11293201.16275782.html.plaintext.txt	20	Proteomics science protein structure function hot spot biomedicine
0.11293201.16275782.html.plaintext.txt	21	A key component next revolution post genomic era increasingly widespread use protein structure rational experimental design
0.11293201.16275782.html.plaintext.txt	22	New computational methodologies yield structure models many cases quantitatively comparable crystal structures fraction cost 4
0.11293201.16275782.html.plaintext.txt	23	The technical challenge complete coverage physicochemical properties thousands proteins 5
0.11293201.16275782.html.plaintext.txt	24	Thus analytically investigating genes proteins researchers developed umbrella study bioinformatics science analyzing biological data using cutting edge computing techniques
0.11293201.16275782.html.plaintext.txt	25	Bioinformatics deals methods storing retrieving analyzing biological data nucleic acid DNARNA protein sequences structures functions pathways genetic interactions computational management kinds biological information httpwww
0.11293201.16275782.html.plaintext.txt	26	govAboutprimerbioinformatics
0.11293201.16275782.html.plaintext.txt	27	Rather merely mixture computer science data management genome sciences Bioinformatics encompasses conceptual practical tools propagation generation processing understanding scientific ideas biological information 6
0.11293201.16275782.html.plaintext.txt	28	DNA protein sequences data banks The availability many complete genome sequences different species bring insight function conserved non coding regions DNA sequence 7
0.11293201.16275782.html.plaintext.txt	29	Organization data coding genes non coding sequences addition organizing data databases DNA databases proteins Table 1 central bioinformatics 689
0.11293201.16275782.html.plaintext.txt	30	Parsing sequence DNA protein first step followed curation analysis sometimes re curation based analysis
0.11293201.16275782.html.plaintext.txt	31	The presence databases derivative search engines gave rise programs FASTA 10 PSI BLAST 11 DNA protein sequence analysis tools respectively 12
0.11293201.16275782.html.plaintext.txt	32	These tools facilitate searches sequences resemble one another homologous relationship inferences
0.11293201.16275782.html.plaintext.txt	33	Utilization similarity search programs operate sequences helped augmenting annotated databases house information sequence domains
0.11293201.16275782.html.plaintext.txt	34	Information recording retrieval cataloging continue advance database capabilities 13
0.11293201.16275782.html.plaintext.txt	35	Collaborating research centers particularly US Japan UK actively collecting sequence data making accessible public 14 Table 1
0.11293201.16275782.html.plaintext.txt	36	View table Table 1 General genomics proteomics databases comprised resources human goat mouse deer rat horse genomes
0.11293201.16275782.html.plaintext.txt	37	Farm animals unexploited gold mine biotech Farm animals quite valuable resources often notable models pathology physiology studies
0.11293201.16275782.html.plaintext.txt	38	Magnussen 15 discusses variety farm animal models used
0.11293201.16275782.html.plaintext.txt	39	The reproductive physiology farm animals similar humans rodents farm animals longer gestation pre pubertal periods mice 16
0.11293201.16275782.html.plaintext.txt	40	Specific farm animal physiology digestive system pig similar humans 17
0.11293201.16275782.html.plaintext.txt	41	These attributes farm animals reveal unparalleled resource research replicating human physiological function 15
0.11293201.16275782.html.plaintext.txt	42	For decades breeders altered genomes farm animals first searching desired phenotypic traits selecting superior animals continue lineage next generation 18
0.11293201.16275782.html.plaintext.txt	43	This genomic work already facilitated reduction genetic disorders farm animals many disease carriers removed breeding populations purifying selection 19
0.11293201.16275782.html.plaintext.txt	44	By studying diverse phenotypes time researchers monitor mutations occur wild species become domesticated 20
0.11293201.16275782.html.plaintext.txt	45	Farm animal food safety remain concern time however advancements discovery Escherichia coli resistant genes pig 21 mediate problems
0.11293201.16275782.html.plaintext.txt	46	Moreover resources devoted investigating genomes farm animals bring eventual economic benefits
0.11293201.16275782.html.plaintext.txt	47	For example isolation DNA animal tissue used inexpensive method tracking origin meat sample providing recipient quality assurance food 22
0.11293201.16275782.html.plaintext.txt	48	2005 year chicken There significant interest first complete analysis draft genome sequence chicken
0.11293201.16275782.html.plaintext.txt	49	This sequence given rise chicken genome array chips number web based mapping tools
0.11293201.16275782.html.plaintext.txt	50	The great importance chicken scientific resource seen research avian leucosis virus led developments areas proviral insertion mediated oncogenesis vertebrate viral host interactions 2324
0.11293201.16275782.html.plaintext.txt	51	Still many chicken lines lost due facility downsizing closings httpwww
0.11293201.16275782.html.plaintext.txt	52	The release first draft chicken genome March 2004 spawned current boom chicken genomic research 25 Table 2
0.11293201.16275782.html.plaintext.txt	53	From evolutionary standpoint investigation chicken genome provide significant information needed understand vertebrate genome evolution since chicken mammal fish evolutionary tree 26
0.11293201.16275782.html.plaintext.txt	54	Furthermore chicken remains significant food animal comprises 41 meat produced world serves reliable model study diseases developmental biology 26
0.11293201.16275782.html.plaintext.txt	55	With sequenced genome chicken breeders framework investigating polymorphisms informative quantitative traits continue directed evolution species
0.11293201.16275782.html.plaintext.txt	56	The chicken genome also effective comparative genomic tool sheds additional light various aspects genome 27
0.11293201.16275782.html.plaintext.txt	57	In addition complementary DNA microarrays chicken already produced study metabolic systemic processes 2728
0.11293201.16275782.html.plaintext.txt	58	View table Table 2 Chicken based internet genomic resources
0.11293201.16275782.html.plaintext.txt	59	The swine sequence The sequencing pig genome generated invaluable resource advancements enzymology reproduction endocrinology nutrition biochemistry research 2930
0.11293201.16275782.html.plaintext.txt	60	Since pigs evolutionarily distinct humans rodents co evolved species diversity selected phenotypes make pig useful model study genetic environmental interactions polygenic traits 31
0.11293201.16275782.html.plaintext.txt	61	The sequencing pig genome also instrumental improvement human health
0.11293201.16275782.html.plaintext.txt	62	Clinical studies areas infectious disease organ transplantation physiology metabolic disease pharmacology obesity cardiovascular disease used pig models 32 Table 3
0.11293201.16275782.html.plaintext.txt	63	In near future sequencing porcine genome allow gene markers specific diseases identified assisting breeders generating pig stocks resistant infectious diseases 33
0.11293201.16275782.html.plaintext.txt	64	Furthermore researchers investigate swine genome isolate genes may impact economics breeding members commercial pig industry able use information garner benefits 30
0.11293201.16275782.html.plaintext.txt	65	View table Table 3 Genomic proteomic internet sites devoted study swine genome
0.11293201.16275782.html.plaintext.txt	66	The Bos taurus genome The mammalian order Cetartiodactyla possessing B
0.11293201.16275782.html.plaintext.txt	67	taurus cattle great interest since represents group eutherian mammals phylogenetically distant primates 3435
0.11293201.16275782.html.plaintext.txt	68	Working cow species B
0.11293201.16275782.html.plaintext.txt	69	taurus significant cow economically important animal
0.11293201.16275782.html.plaintext.txt	70	This form livestock makes beef milk production industry one largest industries United States
0.11293201.16275782.html.plaintext.txt	71	The identification numerous single nucleotide polymorphisms SNPs makes possible geneticists find associations certain genes cow traits eventually lead production superior quality beef 36
0.11293201.16275782.html.plaintext.txt	72	After completion September 2004 B
0.11293201.16275782.html.plaintext.txt	73	taurus draft assembly Table 4 genome functioned vehicle studies non primate non rodent genomes well comparative genomics 37
0.11293201.16275782.html.plaintext.txt	74	Similar pig cow also serves good animal model obesity infectious diseases female health 3438
0.11293201.16275782.html.plaintext.txt	75	View table Table 4 Cow genomics proteomics resources Internet
0.11293201.16275782.html.plaintext.txt	76	Sheep Ovis aries genome project Bioinformatics researchers New Zealand US UK Australia come together work sheep genome map
0.11293201.16275782.html.plaintext.txt	77	The focal point interest sheep based quest maximize sheep meat cotton wool production
0.11293201.16275782.html.plaintext.txt	78	This sector corporate farming industry intent biotechnology project AWI Meat Livestock Australia nine partners investing 50 million Sheep Genome Project ensure completion httpwww
0.11293201.16275782.html.plaintext.txt	79	As resource biological science researchers mapped subset genes also mapped humans mice 39
0.11293201.16275782.html.plaintext.txt	80	These studies revealed existence mutations yield phenotypes unique sheep demonstrating genetic analysis sheep enhance knowledge biological pathways mammalian species 3940
0.11293201.16275782.html.plaintext.txt	81	Table 5 provides information current genome informatics resources available Internet related sheep
0.11293201.16275782.html.plaintext.txt	82	View table Table 5 Internet informatics resources pertaining sheep genome
0.11293201.16275782.html.plaintext.txt	83	The fish genome project Fish one studied organisms
0.11293201.16275782.html.plaintext.txt	84	Researchers investigated genome zebrafish medaka pufferfish Fugu rubripes Tetraodon nigroviridis sticklebacks
0.11293201.16275782.html.plaintext.txt	85	The zebrafish genome attracted attention various pharmaceutical biotech companies owing ease scientists use fish study gene function httpwww
0.11293201.16275782.html.plaintext.txt	86	ukengenomegenesandbodyhg05f006
0.11293201.16275782.html.plaintext.txt	87	The number databases informatics resources related fish genomic study Internet consistently growing Table 6
0.11293201.16275782.html.plaintext.txt	88	Japanese researchers interested medakas evolutionary standpoint 40
0.11293201.16275782.html.plaintext.txt	89	Other fish genome sequences pufferfish genome similar Fugu genome size 7
0.11293201.16275782.html.plaintext.txt	90	5 times smaller human genome
0.11293201.16275782.html.plaintext.txt	91	This led many believe genes conserved two species would reveal minimal number genes required vertebrate organism 41
0.11293201.16275782.html.plaintext.txt	92	Further investigation Fugu genome supported hypothesis showed ability Fugu genome aid study vertebrate functional non coding sequences 41
0.11293201.16275782.html.plaintext.txt	93	Other studies fish focused stickleback variable body shapes ecology behavior httpwww
0.11293201.16275782.html.plaintext.txt	94	govPagesResearchSequencingSeqProposalsSticklebackSEQ
0.11293201.16275782.html.plaintext.txt	95	In general fish genomic work interest commercial fish farming community
0.11293201.16275782.html.plaintext.txt	96	Based transgenic studies antifreeze protein fish growth hormone introduced fish genomes creating fish greater cold tolerance faster growth rates 42
0.11293201.16275782.html.plaintext.txt	97	View table Table 6 Fish genomic resources internet
0.11293201.16275782.html.plaintext.txt	98	The forgotten rabbit Little genomics attention paid rabbits comparison animal models mouse rat fruit fly pre post genomic era
0.11293201.16275782.html.plaintext.txt	99	However experimental models Alba mighty lighting rabbit developed glowing mutants shine special light commercial reasons
0.11293201.16275782.html.plaintext.txt	100	French scientists created Alba using process called zygote microinjection
0.11293201.16275782.html.plaintext.txt	101	In process scientists plucked fluorescent protein fluorescent jellyfish Aequorea victoria
0.11293201.16275782.html.plaintext.txt	102	Then modified gene make glowing properties twice powerful
0.11293201.16275782.html.plaintext.txt	103	This gene called EGFG enhanced green fluorescent gene inserted fertilized rabbit egg cell eventually grew Alba Amanda onion
0.11293201.16275782.html.plaintext.txt	104	Debates project practice manipulating genes animals research quickly arisen research community
0.11293201.16275782.html.plaintext.txt	105	The French National Institute Agronomic Research hesitated release rabbits owing protests development
0.11293201.16275782.html.plaintext.txt	106	Chinese scientists placed rabbit genes cotton plants producing cotton fibers bright soft rabbit hair stronger warmer
0.11293201.16275782.html.plaintext.txt	107	This indicates rise rabbit experimental models genetics engineering also future medical experimentation models
0.11293201.16275782.html.plaintext.txt	108	Despite controversy shining rabbit cotton rabbit raised clear type genetic engineering early stage
0.11293201.16275782.html.plaintext.txt	109	Currently available sources information rabbit web seen Table 7
0.11293201.16275782.html.plaintext.txt	110	View table Table 7 Rabbit informatics databases
0.11293201.16275782.html.plaintext.txt	111	Farm animal genomics current statistics As researchers delve composition farm animal genome sequences new functional biological data emerge
0.11293201.16275782.html.plaintext.txt	112	Table 8 compiled Ensembl database httpwww
0.11293201.16275782.html.plaintext.txt	113	org illustrates summary current analysis coding regions within genomes selected farm animals
0.11293201.16275782.html.plaintext.txt	114	For example cow genome 239 000 exon regions 29 000 transcripts tallied among 565 million bp found genome
0.11293201.16275782.html.plaintext.txt	115	View table Table 8 Ensemble gene build July 2005 NCBI statistics available farm animal genomesa
0.11293201.16275782.html.plaintext.txt	116	One major sources information farm animal genomics ArkDB 43 available Roslin Institute UK Texas A M University USA
0.11293201.16275782.html.plaintext.txt	117	The ArkDB provides detailed genomic mapping data sheep chicken cow pig genomes 44 including data PCR primers genetic linkage map assignments specific loci markers cytogenetic map assignments
0.11293201.16275782.html.plaintext.txt	118	Information farm animals database displayed Table 9 provides snapshot current resources available genome
0.11293201.16275782.html.plaintext.txt	119	Quantitative functional information number clones microsatellites associated mapping assignments lend insight complexity models available
0.11293201.16275782.html.plaintext.txt	120	For example number primers tabulated swine genome currently far exceeds known cow indicating varieties genes available study swine
0.11293201.16275782.html.plaintext.txt	121	Much information remains early stage increasing experimentation compilation analysis refined
0.11293201.16275782.html.plaintext.txt	122	View table Table 9 Current status summary provided ArkDB
0.11293201.16275782.html.plaintext.txt	123	Expression sequence tags Expression sequence tags ESTs small pieces cDNA sequence usually 200 500 nt long useful markers desired portion RNA DNA used gene identification positional mapping within genome httpwww
0.11293201.16275782.html.plaintext.txt	124	The NCBI provides comprehensive EST database many farm animals
0.11293201.16275782.html.plaintext.txt	125	Tabulation chicken EST information including quantities ESTs tissue sources found BBSRC ChickEST Database httpchick
0.11293201.16275782.html.plaintext.txt	126	ChickEST provides access 339 000 Gallus ESTs generated 21 different embryonic adult tissues
0.11293201.16275782.html.plaintext.txt	127	Cow EST information available ArkDB Ensembl httpwww
0.11293201.16275782.html.plaintext.txt	128	cgitaxid9031 NCBI Cow genome EST
0.11293201.16275782.html.plaintext.txt	129	A collection pig ESTs also available pig EST database httppigest
0.11293201.16275782.html.plaintext.txt	130	The first version contains 14 000 EST sequences obtained porcine whole embryo term placenta anterior pituitary hypothalamus ovary
0.11293201.16275782.html.plaintext.txt	131	The second newer version database accommodates 99 000 pig ESTs
0.11293201.16275782.html.plaintext.txt	132	Pig sequence homology comparisons readily studied Iowa State Universitys website
0.11293201.16275782.html.plaintext.txt	133	However database updates carried January 2002
0.11293201.16275782.html.plaintext.txt	134	Among farm animals sparse information rabbit ESTs
0.11293201.16275782.html.plaintext.txt	135	NCBI provide comprehensive EST information virtually physical maps rabbit
0.11293201.16275782.html.plaintext.txt	136	However NCBI still central source information rabbit ESTs mining 2275 GenBank rabbit ESTs dbEST release 082605
0.11293201.16275782.html.plaintext.txt	137	Physical mapping Genome maps livestock species development last decade
0.11293201.16275782.html.plaintext.txt	138	Mapping involves understanding relative distances genes chromosome performed many farm animals
0.11293201.16275782.html.plaintext.txt	139	The NCBI provide comprehensive mapping information many farm animal species
0.11293201.16275782.html.plaintext.txt	140	Mapping information available httpwww
0.11293201.16275782.html.plaintext.txt	141	cgitaxid specific animal links available substituting sign previous URL species taxonomic number 9031 chicken 9913 cow 9823 pig 7955 zebrafish 9940m sheep
0.11293201.16275782.html.plaintext.txt	142	For example chicken mapping site found NCBI MapView website httpwww
0.11293201.16275782.html.plaintext.txt	143	The US Livestock Species Genome Projects httpwww
0.11293201.16275782.html.plaintext.txt	144	org suggest using ArkDB mentioned mapping information farm animals
0.11293201.16275782.html.plaintext.txt	145	The Laboratory Biochemistry Cytogenetics Jouy Josas France National Institute Agricultural Research INRA provides rabbit Lepine genome mapping database httpdga
0.11293201.16275782.html.plaintext.txt	146	The database provides access information rabbit genomic information includes far 410 loci 1327 homologue loci 129 species 21 polymorphisms 314 genes physical location chromosomes
0.11293201.16275782.html.plaintext.txt	147	Other information primers probes enzymes also included
0.11293201.16275782.html.plaintext.txt	148	Genes RabbitMap database hyperlinked separate page provides locus information
0.11293201.16275782.html.plaintext.txt	149	Physical mapping zebrafish available Ensemble database httpwww
0.11293201.16275782.html.plaintext.txt	150	The Ensemble database also provides comprehensive map viewer zebrafish chicken httpwww
0.11293201.16275782.html.plaintext.txt	151	High resolution maps sheep chromosomes available httpwww
0.11293201.16275782.html.plaintext.txt	152	Quantitative trait loci genetic linkage One primary challenges modern biology understanding genetic basis phenomic diversity within among species 20
0.11293201.16275782.html.plaintext.txt	153	The foundation diversity lies genetic governance traits expressed associated linkage maps
0.11293201.16275782.html.plaintext.txt	154	Genes mapped farm animals serve anchors across comparative maps species 39
0.11293201.16275782.html.plaintext.txt	155	Quantitative trait loci QTLs play major role farm animals related biotechnology industry identification traits related meat milk production
0.11293201.16275782.html.plaintext.txt	156	A number studies conducted detect QTLs used determining gene variances 4849
0.11293201.16275782.html.plaintext.txt	157	The third generation sheep linkage map 50 contains 1062 loci 941 anonymous loci 121 genes compilation genotype data generated 15 laboratories using IMF population httprubens
0.11293201.16275782.html.plaintext.txt	158	The ArkDB provides current summaries linkage cytogenetic map assignments polymorphic marker details PCR primers two point linkage data see Table 9
0.11293201.16275782.html.plaintext.txt	159	The ArkDB also major source mapped sheep loci SheepBase containing almost 1500 loci
0.11293201.16275782.html.plaintext.txt	160	The Roslin Institute developed resSpecies httpwww
0.11293201.16275782.html.plaintext.txt	161	org database study genetic linkage maps QTLs alleles markers 4451
0.11293201.16275782.html.plaintext.txt	162	Bovine QTL databases available several sources 5253
0.11293201.16275782.html.plaintext.txt	163	Various traits milk yield composition available along QTL dot maps provide varied positional statistical information
0.11293201.16275782.html.plaintext.txt	164	orgQTLdb includes two release versions NCBI May 2004 NAGRP December 2004
0.11293201.16275782.html.plaintext.txt	165	The pig QTL database pig QTLdb contains published pig QTL data past decade
0.11293201.16275782.html.plaintext.txt	166	The user locate genes responsible quantitative traits central pig production
0.11293201.16275782.html.plaintext.txt	167	To date 791 QTLs 73 publications representing 219 different traits incorporated database first release 1129 QTLs 86 publications representing 235 different traits second release
0.11293201.16275782.html.plaintext.txt	168	The project also provides maps httpwww
0.11293201.16275782.html.plaintext.txt	169	orgcgi binQTLdbviewmap links NCBI pig EST Map database httppigest
0.11293201.16275782.html.plaintext.txt	170	FARM ANIMAL GENOMICS THE LEGAL SIDE TOP ABSTRACT PRELUDE FARM ANIMAL GENOMICS THE
0.11293201.16275782.html.plaintext.txt	171	REFERENCES Genome protections lessons human genome Similar areas scientific research field farm animal genomics ingrained various issues requiring ethical consideration
0.11293201.16275782.html.plaintext.txt	172	Although number gene based technological advances prediction illnesses adverse drug response beneficial commercial interests 54 many look protect genetic information used
0.11293201.16275782.html.plaintext.txt	173	The corollary human genomics recent Genetic Information Nondiscrimination Act 2005 httpwww
0.11293201.16275782.html.plaintext.txt	174	This bill pending US Congress prohibits among things health insurance issuer adjusting premiums basis genetic information httpthomas
0.11293201.16275782.html.plaintext.txt	175	govcgi binbdqueryzd109SN00306L summ2m
0.11293201.16275782.html.plaintext.txt	176	Concerns actions reveal understanding US government use human genomic data must closely regulated order hinder commercial abuses
0.11293201.16275782.html.plaintext.txt	177	Although genetic discrimination health insurance might issues relevant farm animal genomics great need exists establish similar legal framework farm animals order ensure proper use farm animal genomic information
0.11293201.16275782.html.plaintext.txt	178	Genome policies transgenic animals The federal governments role legal authority protecting environment scientifically introduced transgenic organisms clearly outlined 55
0.11293201.16275782.html.plaintext.txt	179	This underscores need greater governmental attention address legal problems arise animal biotechnology continues grow
0.11293201.16275782.html.plaintext.txt	180	Many argue moral imperative respect intrinsic sentience animals also legal one httpwww
0.11293201.16275782.html.plaintext.txt	181	orglibraryconsultationsBBSRCgenomics
0.11293201.16275782.html.plaintext.txt	182	The European Unions Treaty Amsterdam states animals must treated humanely sentient beings argue implies respect intrinsic nature protection infringements respect studies transgenic animal experiments httpwww
0.11293201.16275782.html.plaintext.txt	183	Furthermore US food regulatory agencies United States Department Agriculture Food Safety Inspection Service charged duty making sure transgenic animals anticipated human consumption correctly labeled wholesome already moved forward institute policies regulating slaughtering non transgenic animals created transgenic animal experiments 56
0.11293201.16275782.html.plaintext.txt	184	Ethical reservations farm animal genomic study As farm animal species continue sequenced one latest cow B
0.11293201.16275782.html.plaintext.txt	185	taurus farming companies using information perform genetic profiles traditionally bred animals genetically engineer clone animals 57
0.11293201.16275782.html.plaintext.txt	186	Although many farmers may enjoy access greater genetic resources animal rights organizations oppose use animals transgenic goats produce silk proteins used make Biosteel fibers allegedly inhumane treatment animals studies 58
0.11293201.16275782.html.plaintext.txt	187	Proponents experiments point ability transgenic mouse mammary glands assemble secrete recombinant human fibrinogen 59
0.11293201.16275782.html.plaintext.txt	188	These studies raise many concerns research ethics species integrity 6061
0.11293201.16275782.html.plaintext.txt	189	The potential farm animal genomics Farm animal genomic studies continue attract audiences excited multitude applications 62
0.11293201.16275782.html.plaintext.txt	190	The meat industry use cow chicken genomic data confirm quality meat products
0.11293201.16275782.html.plaintext.txt	191	For example meat producers confirm parentage Angus cattle breed performing genetic blood test attempt identify SNPs associated high quality beef 57
0.11293201.16275782.html.plaintext.txt	192	Other companies using genomic information determine disease resistant genes shrimp selectively mating shrimp carry order create disease resistant strains 57
0.11293201.16275782.html.plaintext.txt	193	In healthcare arena farm animal genomic work aid enterprises xenotransplantation transfer animal tissues organs humans
0.11293201.16275782.html.plaintext.txt	194	Though animal organs may used someday satiate organ donor shortage genomic work area still early stage 63
0.11293201.16275782.html.plaintext.txt	195	Many immediate practical applications farm animal genomics show potential growth field
0.11293201.16275782.html.plaintext.txt	196	ACKNOWLEDGEMENTS We thank Professor William Dynan Medical College Georgia helpful discussions careful editing manuscript
0.11293201.16275782.html.plaintext.txt	197	Scalise assistance processing manuscript
0.11293201.16275782.html.plaintext.txt	198	Special thanks goes reviewers valuable comments suggestions
0.11293201.16275782.html.plaintext.txt	199	The Open Access publication charges article waived Oxford University Press
0.11293201.16275782.html.plaintext.txt	200	REFERENCES TOP ABSTRACT PRELUDE FARM ANIMAL GENOMICS THE
0.11293201.16275782.html.plaintext.txt	201	2005 Reproductive biology era genomics biology Theriogenology 64 442 456
0.11293201.16275782.html.plaintext.txt	202	2005 The agony ecstasy OMIC technologies drug development Curr
0.11293201.16275782.html.plaintext.txt	203	2005 Advances sequencing technology Mutat
0.11293201.16275782.html.plaintext.txt	204	2001 Recent developments computational proteomics Trends Biotechnol
0.11293201.16275782.html.plaintext.txt	205	2005 Proteomics biodefense applications progress opportunities Expert Rev
0.11293201.16275782.html.plaintext.txt	206	Current limitations insights future Plant Physiol
0.11293201.16275782.html.plaintext.txt	207	2005 Comparative genomics bidirectional gene pairs implications evolution transcriptional regulation system Gene 4 169 176
0.11293201.16275782.html.plaintext.txt	208	A computer based archival file macromolecular structures J
0.11293201.16275782.html.plaintext.txt	209	2000 The Protein Data Bank Nucleic Acids Res
0.11293201.16275782.html.plaintext.txt	210	1988 Improved tools biological sequence comparison Proc
0.11293201.16275782.html.plaintext.txt	211	1997 Gapped BLAST PSI BLAST new generation protein database search programs Nucleic Acids Res
0.11293201.16275782.html.plaintext.txt	212	2003 Assessing sequence comparison methods average precision criterion Bioinformatics 19 2456 2460
0.11293201.16275782.html.plaintext.txt	213	2005 Database resources National Center Biotechnology Information Nucleic Acids Res
0.11293201.16275782.html.plaintext.txt	214	2005 The EMBL Nucleotide Sequence Database Nucleic Acids Res
0.11293201.16275782.html.plaintext.txt	215	2005 Can farm animals help study endocrine disruption Domest
0.11293201.16275782.html.plaintext.txt	216	2002 Endocrine disrupting compounds farm animals properties actions routes exposure Domest
0.11293201.16275782.html.plaintext.txt	217	2002 Is exposure endocrine disrupting compounds fetalpost natal development affecting reproductive potential farm animals Domest
0.11293201.16275782.html.plaintext.txt	218	2004 Genomics food safety sustainable animal production J
0.11293201.16275782.html.plaintext.txt	219	2001 Genetic dissection phenotypic diversity farm animals Nature Rev
0.11293201.16275782.html.plaintext.txt	220	2004 Domestic animal genomics deciphering genetics complex traits Nature Rev
0.11293201.16275782.html.plaintext.txt	221	1995 The porcine intestinal receptor Escherichia coli K88ab K88ac regional localization chromosome 13 influence IgG response K88 antigen Anim
0.11293201.16275782.html.plaintext.txt	222	2004 Techniques possibilities traceability food genotyping domestic animal population innovative contribution food safety Dtsch Tierarztl Wochenschr 111 273 276
0.11293201.16275782.html.plaintext.txt	223	2001 Analysis gene expression myc oncogene induced lymphomagenesis bursa Fabricius Proc
0.11293201.16275782.html.plaintext.txt	224	1993 Characterization red jungle fowl white leghorn backcross reference population molecular mapping chicken genome Poult
0.11293201.16275782.html.plaintext.txt	225	2005 Genomic resources chicken Dev
0.11293201.16275782.html.plaintext.txt	226	2005 Chicken genome new tools concepts Dev
0.11293201.16275782.html.plaintext.txt	227	Chicken genome science nuggets come soon Science 300 1669
0.11293201.16275782.html.plaintext.txt	228	2003 Systems wide chicken DNA microarrays gene expression profiling discovery functional genes Poult
0.11293201.16275782.html.plaintext.txt	229	2005 Pigs sequence space 0
0.11293201.16275782.html.plaintext.txt	230	66X coverage pig genome survey based shotgun sequencing BMC Genomics 6 70
0.11293201.16275782.html.plaintext.txt	231	2003 From sows ear silk purse real progress porcine genomics Cytogenet
0.11293201.16275782.html.plaintext.txt	232	2004 An intermediate grade finished genomic sequence suitable comparative analyses Genome Res
0.11293201.16275782.html.plaintext.txt	233	2004 Porcine genomics delivers new tools results little piggy go market Genet
0.11293201.16275782.html.plaintext.txt	234	2005 Reliable classification recombination analysis porcine endogenous retroviruses Virus Genes 3 357 362
0.11293201.16275782.html.plaintext.txt	235	2003 A cattle human comparative map built cattle BAC ends human genome sequence Genome Res
0.11293201.16275782.html.plaintext.txt	236	1998 A molecular timescale vertebrate evolution Nature 392 917 920
0.11293201.16275782.html.plaintext.txt	237	2002 Draft cow genome heads field Nature 417 778
0.11293201.16275782.html.plaintext.txt	238	1994 A genetic linkage map bovine genome Nature Genet
0.11293201.16275782.html.plaintext.txt	239	2005 Molecular analyses disease pathogenesis application bovine microarrays Vet
0.11293201.16275782.html.plaintext.txt	240	2001 Analysis sheep genome Physiol
0.11293201.16275782.html.plaintext.txt	241	2001 The sheep genome contributes localization control elements human gene complex regulatory mechanisms Genomics 76 9 13
0.11293201.16275782.html.plaintext.txt	242	2004 Exploiting human fish genome comparisons deciphering gene regulation Hum
0.11293201.16275782.html.plaintext.txt	243	2003 Fish first advances fish transgenesis commercial applications Transgenic Res
0.11293201.16275782.html.plaintext.txt	244	2001 The ARKdb genome databases farmed animals Nucleic Acids Res
0.11293201.16275782.html.plaintext.txt	245	2000 Farm animal genome databases Brief
0.11293201.16275782.html.plaintext.txt	246	2002 A comprehensive collection chicken cDNAs Curr
0.11293201.16275782.html.plaintext.txt	247	2005 Transcriptome analysis chicken based 19626 finished cDNA sequences 485337 expressed sequence tags Genome Res
0.11293201.16275782.html.plaintext.txt	248	2003 EST based gene discovery pig virtual expression patterns comparative mapping human Mamm
0.11293201.16275782.html.plaintext.txt	249	2003 Are yet Deciding one demonstrated specific genetic causation complex diseases quantitative traits
0.11293201.16275782.html.plaintext.txt	250	2002 Complex trait genetics emergence multivariate strategies Nature Rev
0.11293201.16275782.html.plaintext.txt	251	2001 An enhanced linkage map sheep genome comprising 1000 loci Genome Res
0.11293201.16275782.html.plaintext.txt	252	2000 Combined analyses data quantitative trait loci mapping studies
0.11293201.16275782.html.plaintext.txt	253	Chromosome 4 effects porcine growth fatness Genetics 155 1369 1378
0.11293201.16275782.html.plaintext.txt	254	2004 Quantitative trait loci mapping dairy cattle review meta analysis Genet
0.11293201.16275782.html.plaintext.txt	255	2003 A generalized estimating equations approach quantitative trait locus detection non normal traits Genet
0.11293201.16275782.html.plaintext.txt	256	2002 Genomic medicine primer N
0.11293201.16275782.html.plaintext.txt	257	2001 Transgenic livestock regulation science changing environment J
0.11293201.16275782.html.plaintext.txt	258	1993 Food safety inspection service update food safety animals derived biotechnology experiments J
0.11293201.16275782.html.plaintext.txt	259	Clone range animal biotech bringing table
0.11293201.16275782.html.plaintext.txt	260	1998 Transgenic animals drug factories new source recombinant protein therapeutics Expert Opin
0.11293201.16275782.html.plaintext.txt	261	2004 Secretion recombinant human fibrinogen murine mammary gland Transgenic Res
0.11293201.16275782.html.plaintext.txt	262	2000 Bioethics limits interference life Anim
0.11293201.16275782.html.plaintext.txt	263	1994 Commercial exploitation transgenics Biotechnol
0.11293201.16275782.html.plaintext.txt	264	2004 Looking genomics concepts technologies plant animal genomics Funct
0.11293201.16275782.html.plaintext.txt	265	2001 Xenotransplantation means organ replacement Nature Rev
0.11293201.16275782.html.plaintext.txt	266	This Article Abstract Print PDF 103K Screen PDF 139K Alert article cited Alert correction posted Services Email article friend Similar articles journal Similar articles PubMed Alert new issues journal Add My Personal Archive Download citation manager Request Permissions Commercial Re use Guidelinesfor Open Access NAR Content Google Scholar Articles Fadiel A
0.11293201.16275782.html.plaintext.txt	267	PubMed PubMed Citation Articles Fadiel A
0.11293201.16275782.html.plaintext.txt	268	Online ISSN 1362 4962 Print ISSN 0305 1048 Copyright 2006 Oxford University Press Oxford Journals Oxford University Press Site Map Terms Conditions Privacy Policy Frequently Asked Questions Other Oxford University Press sites Oxford University Press American National Biography Booksellers Information Service Childrens Fiction Poetry Childrens Reference Corporate Special Sales Dictionaries Dictionary National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights Permissions Science School Books Social Sciences Very Short Introductions Worlds Classics
0.14052135.12954721.html.plaintext.txt	0	Deciphering synergistic redundant roles Hedgehog Decapentaplegic Delta drive wave differentiation Drosophila eye development Weimin Fu Nicholas E
0.14052135.12954721.html.plaintext.txt	1	Department Molecular Genetics Albert Einstein College Medicine 1300 Morris Park Avenue Bronx NY 10461 USA
0.14052135.12954721.html.plaintext.txt	2	Author correspondence e mail nbakerataecom
0.14052135.12954721.html.plaintext.txt	3	SUMMARY TOP SUMMARY Introduction Materials methods Results Discussion REFERENCES In Drosophila wave differentiation progresses across retinal field response signals posterior cells
0.14052135.12954721.html.plaintext.txt	4	Hedgehog Hh Decapentaplegic Dpp Notch N signaling contribute
0.14052135.12954721.html.plaintext.txt	5	Clones cells mutated receptors nuclear effectors one two three pathways studied define systematically necessary sufficient roles signal
0.14052135.12954721.html.plaintext.txt	6	Hh signaling alone sufficient progressive differentiation acting transcriptional activator Ci155 Ci75 repressor
0.14052135.12954721.html.plaintext.txt	7	In absence Ci Dpp Notch signaling together provided normal differentiation
0.14052135.12954721.html.plaintext.txt	8	Dpp alone sufficed differentiation Notch sufficient alone acted enhance effect Dpp
0.14052135.12954721.html.plaintext.txt	9	Notch acted part downregulation Hairy Hh signaling downregulated Hairy independently Notch
0.14052135.12954721.html.plaintext.txt	10	One feature signaling network limit Dpp signaling spatially range coincident Hh
0.14052135.12954721.html.plaintext.txt	11	Key words Drosophila eye Morphogenetic furrow Hedgehog Decapentaplegic Notch Delta
0.14052135.12954721.html.plaintext.txt	12	Introduction TOP SUMMARY Introduction Materials methods Results Discussion REFERENCES The adult eye Drosophila remarkable wave differentiation spreads posterior anterior across retina field eye imaginal disc
0.14052135.12954721.html.plaintext.txt	13	Eight hundred ommatidia begin differentiation 30 columns
0.14052135.12954721.html.plaintext.txt	14	Adjacent columns begin differentiation approximately 90 minutes apart takes two days entire retinal field differentiating
0.14052135.12954721.html.plaintext.txt	15	The advancing anterior boundary differentiating region morphologically recognizable indentation known morphogenetic furrow associated changes cell cycle adhesion gene expression Wolff Ready 1993 Heberlein Moses 1995 Lee Treisman 2002
0.14052135.12954721.html.plaintext.txt	16	A potentially similar wave differentiation also occurs zebrafish retina Neumann Nusslein Volhard 2000 Stenkamp et al
0.14052135.12954721.html.plaintext.txt	17	Progression morphogenetic furrow depends primarily Hedgehog secreted differentiating photoreceptor neurons
0.14052135.12954721.html.plaintext.txt	18	Hedgehog necessary furrow progression Ma et al
0.14052135.12954721.html.plaintext.txt	19	Ectopic Hh expression sufficient initiate ectopic furrows anterior undifferentiated region Heberlein et al
0.14052135.12954721.html.plaintext.txt	20	Despite primary role Hh cells unable receive Hh signals still able differentiate Hh triggers secretion secondary signals cells unable respond Hh still respond signals Strutt Mlodzik 1997
0.14052135.12954721.html.plaintext.txt	21	Dpp one important secondary signal acts redundantly Hh
0.14052135.12954721.html.plaintext.txt	22	Cells must able respond either Hh Dpp begin differentiating Heberlein et al
0.14052135.12954721.html.plaintext.txt	23	1993 Greenwood Struhl 1999 Curtiss Mlodzik 2000
0.14052135.12954721.html.plaintext.txt	24	It proposed Notch signaling also contributes Baker Yu 1997 Li Baker 2001
0.14052135.12954721.html.plaintext.txt	25	Ectopic Notch Dpp together initiate differentiation effectively ectopic Hh Baonza Freeman 2001
0.14052135.12954721.html.plaintext.txt	26	In paper sought define individual roles interactions signal study loss function mutations affecting response Hh Dpp N signals alone combination
0.14052135.12954721.html.plaintext.txt	27	We also sought determine basis redundancy Hh Dpp two signals replace investigated whether redundancy Hh N events signal individually sufficient absence others
0.14052135.12954721.html.plaintext.txt	28	Although redundant functions studied ectopic expression experiments loss function approach removes components redundant pathways advantage addressing gene function normal time place normal expression levels
0.14052135.12954721.html.plaintext.txt	29	As Hh Dpp N signals important many times Drosophila development embryogenesis onwards necessary use conditional genetic approach
0.14052135.12954721.html.plaintext.txt	30	We employed mosaic analysis using FLPFRT system obtain clones retinal cells lacking function Hh Dpp N pathway components
0.14052135.12954721.html.plaintext.txt	31	Each genes also plays roles initiation morphogenetic furrow posterior margin eye field furrow initiation fails eye margin cells mutated leaving region anterior undifferentiated Lee Treisman 2002
0.14052135.12954721.html.plaintext.txt	32	The present study therefore restricted progressive onset differentiation cells within retinal field
0.14052135.12954721.html.plaintext.txt	33	Initially found removing Smo prevent accumulation Ci activator Ci155
0.14052135.12954721.html.plaintext.txt	34	However found differentiation Smo mutant cells depended Ci Dpp N signaling
0.14052135.12954721.html.plaintext.txt	35	Perhaps Dpp Hh would otherwise act different ranges pace furrow progression constrained inhibitors Hairy regulated Dpp Hh N
0.14052135.12954721.html.plaintext.txt	36	Materials methods TOP SUMMARY Introduction Materials methods Results Discussion REFERENCES Mosaic induction Clones cells mutant relevant genes obtained FLP mediated mitotic recombination Golic 1991 Xu Rubin 1993
0.14052135.12954721.html.plaintext.txt	37	Homozygous mutant cells identified lack Ci155 antibody staining absence transgene encoded markers armss gal hsGFP Vincent et al
0.14052135.12954721.html.plaintext.txt	38	1994 Motzny Holmgren 1995 Methot Basler 1999
0.14052135.12954721.html.plaintext.txt	39	smo Clones obtained eyF smo3 FRT40armlacZ FRT40 hsF smo3 FRT40armlacZ FRT40 hsF smoD16 FRT40armlacZ FRT40 y hsF smo1 FRT42 en smo3 FRT42 smo hsGfp ci ci94 Dp14y spa larvae equivalent results
0.14052135.12954721.html.plaintext.txt	40	smo3 smoD16 null alleles Chen Struhl 1998
0.14052135.12954721.html.plaintext.txt	41	smo tkv Clones obtained hsF smo3 tkvstrII FRT40M armlacZ FRT40 larvae
0.14052135.12954721.html.plaintext.txt	42	tkvstrII null allele Greenwood Struhl 1999
0.14052135.12954721.html.plaintext.txt	43	tkv Clones obtained hsF tkva12 FRT40M armlacZ FRT40 larvae described Burke Basler 1996
0.14052135.12954721.html.plaintext.txt	44	tkva12 null allele Penton et al
0.14052135.12954721.html.plaintext.txt	45	smo Mad Clones obtained hsF smo3 Mad1 2 FRT40armlacZ FRT40 larvae described Curtiss Mlodzik 2000
0.14052135.12954721.html.plaintext.txt	46	Mad1 2 insertion Mad regulatory sequences prevents Dpp signaling little effect growth Wiersdorff et al
0.14052135.12954721.html.plaintext.txt	47	ci Clones obtained y hsF FRT42 ciFRT42 ci94 larvae described Methot Basler 1999
0.14052135.12954721.html.plaintext.txt	48	ci94 null allele promoter region first exon deleted including start sites transcription translation Slusarski et al
0.14052135.12954721.html.plaintext.txt	49	1995 Methot Basler 1999
0.14052135.12954721.html.plaintext.txt	50	smo ci Clones obtained y hsF smo1 FRT42 en smo3 FRT42 smo hsGfp ci ci94 larvae described Methot Basler 1999
0.14052135.12954721.html.plaintext.txt	51	Control smo clones obtained parallel phenotypically y larvae y hsF smo1 FRT42 en smo3 FRT42 smo hsGfp ci ci94 Dp14y spa
0.14052135.12954721.html.plaintext.txt	52	Mad ci Clones obtained y hsF Mad1 2 FRT40ci FRT40 ci94 larvae
0.14052135.12954721.html.plaintext.txt	53	This ci transgene provided R
0.14052135.12954721.html.plaintext.txt	54	tkv ci Clones obtained y hsF tkva12 FRT40ci FRT40 ci94 y hsF tkva12 FRT40M21 ci FRT40 ci94 larvae
0.14052135.12954721.html.plaintext.txt	55	SuH ci Clones obtained y hsF SuH47 FRT40 w l235Bgci FRT40 ci94 larvae
0.14052135.12954721.html.plaintext.txt	56	9 kb deletion removes SuH l235Bg intergenic region including transcriptional start site ATG codon genes null allele Morel Schweisguth 2000
0.14052135.12954721.html.plaintext.txt	57	SuH Clones obtained y hsF SuH47 FRT40 w l235BgarmlacZ FRT40 larvae
0.14052135.12954721.html.plaintext.txt	58	Mad SuH ci Clones obtained y hsF Mad1 2 SuH47 FRT40 w l235Bgci FRT40 ci94 larvae
0.14052135.12954721.html.plaintext.txt	59	Ci misexpression FngGal4 gift M
0.14052135.12954721.html.plaintext.txt	60	Mlodzik used misexpress ci derivatives UAS transgenes
0.14052135.12954721.html.plaintext.txt	61	We also used Gal4 line hairyH10 misexpress UASciCell anterior morphogenetic furrow Ellis et al
0.14052135.12954721.html.plaintext.txt	62	Antibody labelling Eye discs labelled Atonal described Lee et al
0.14052135.12954721.html.plaintext.txt	63	Other labelling performed either 0
0.14052135.12954721.html.plaintext.txt	64	1 saponin following 45 minute fixation cold PLP Tomlinson Ready 1987 0
0.14052135.12954721.html.plaintext.txt	65	3 Triton X 100 fixation room temperature 3
0.14052135.12954721.html.plaintext.txt	66	7 formaldehyde 100 mM PIPES pH 6
0.14052135.12954721.html.plaintext.txt	67	Preparations examined using BioRad MRC600 Radiance 2000 confocal microscopes digital images manipulated using Adobe PhotoShop 4
0.14052135.12954721.html.plaintext.txt	68	Antibodies ss galactosidase obtained Cappel Developmental Studies Hybridoma Bank mAb40 1 polyclonal rabbit anti GFP obtained Molecular Probes antibodies obtained developers anti ato Jarman et al
0.14052135.12954721.html.plaintext.txt	69	1994 anti Ci155 mAb2A1 Motzny Holmgren 1995 anti senseless Nolo et al
0.14052135.12954721.html.plaintext.txt	70	2000 anti hairy antibodies Brown et al
0.14052135.12954721.html.plaintext.txt	71	Preparations obtained several years
0.14052135.12954721.html.plaintext.txt	72	Consequently variations procedures antibody batches confocal hardware software make comparing signal intensity preparations unreliable except specifically noted text
0.14052135.12954721.html.plaintext.txt	73	Results TOP SUMMARY Introduction Materials methods Results Discussion REFERENCES The crucial step initiating retinal differentiation specification founder R8 photoreceptor cell within ommatidium
0.14052135.12954721.html.plaintext.txt	74	Once specified R8 cells initiate recruitment retinal cells response receptor tyrosine kinase Egf receptor Sevenless activated signals emanating R8 cells Tomlinson Ready 1987 Freeman 1997 Nagaraj et al
0.14052135.12954721.html.plaintext.txt	75	R8 cells specified proneural gene atonal ato Jarman et al
0.14052135.12954721.html.plaintext.txt	76	Cell specification R8 depend directly Atonal Hh Dpp function occur cells genetically null atonal ahead morphogenetic furrow cells unable respond Hh Dpp long R8 cells present nearby Jarman et al
0.14052135.12954721.html.plaintext.txt	77	1998 Curtiss Mlodzik 2000
0.14052135.12954721.html.plaintext.txt	78	R8 specification morphogenetic furrow illustrated Fig
0.14052135.12954721.html.plaintext.txt	79	senseless target genes expressed response rising Atonal activity Baker 2002
0.14052135.12954721.html.plaintext.txt	80	Atonal expression transient whereas Senseless maintained differentiating R8 cells throughout eye disc Nolo et al
0.14052135.12954721.html.plaintext.txt	81	hairy encodes negative regulator Atonal function expressed ahead morphogenetic furrow downregulated differentiation begins Fig
0.14052135.12954721.html.plaintext.txt	82	Notch activation downregulates Hairy Baonza Freeman 2001
0.14052135.12954721.html.plaintext.txt	83	These events coincide peak Hh signal anterior morphogenetic furrow revealed accumulation Ci155 protein Motzny Holmgren 1995 Strutt Mlodzik 1996 Fig
0.14052135.12954721.html.plaintext.txt	84	View larger version 113K Fig
0.14052135.12954721.html.plaintext.txt	85	Progressive eye differentiation
0.14052135.12954721.html.plaintext.txt	86	A wild type eye imaginal disc labeled gene products reveal pattern differentiation shown anterior left
0.14052135.12954721.html.plaintext.txt	87	Arrowhead indicates center morphogenetic furrow separates anterior undifferentiated posterior differentiating portions eye disc
0.14052135.12954721.html.plaintext.txt	88	Ahead morphogenetic furrow Hairy protein accumulates rising gradient blue
0.14052135.12954721.html.plaintext.txt	89	Hairy downregulated anterior morphogenetic furrow levels Ci155 peak red
0.14052135.12954721.html.plaintext.txt	90	Ci155 protein stabilized response Hh signaling
0.14052135.12954721.html.plaintext.txt	91	As R8 specification occurs within morphogenetic furrow Atonal activity reported expression target gene senseless green
0.14052135.12954721.html.plaintext.txt	92	Sens expression also maintained differentiating R8 cells posterior furrow
0.14052135.12954721.html.plaintext.txt	93	Ectopic expression identified roles Dpp N downstream parallel Hh Pignoni Zipursky 1997 Baonza Freeman 2001
0.14052135.12954721.html.plaintext.txt	94	Mutations Dpp receptors N pathway genes affect progression differentiation Burke Basler 1996 Baker Yu 1997
0.14052135.12954721.html.plaintext.txt	95	To ascertain necessary sufficient roles Hh Dpp N signals normal time place action endogenous expression levels determined effects differentiation mutations ci Mad SuH essential transcription factor targets Hh Dpp N respectively single double triple mutant combinations
0.14052135.12954721.html.plaintext.txt	96	We also assessed affects genotypes
0.14052135.12954721.html.plaintext.txt	97	The complete results summarized Table 1
0.14052135.12954721.html.plaintext.txt	98	Overlap redundancy signals makes parallel comparison results necessary order obtain full picture Table 1
0.14052135.12954721.html.plaintext.txt	99	Gene expression mosaic clones mutant cells
0.14052135.12954721.html.plaintext.txt	100	Dpp contributes differentiation Ci155 accumulation Ato expression first fails clones mutant Hh transduction protein Smo
0.14052135.12954721.html.plaintext.txt	101	Ato absent cell autonomously consistent Hh cell cell signal normally regulates onset Ato expression time
0.14052135.12954721.html.plaintext.txt	102	Several hours later smo mutant cells differentiate following appearance weak delayed Ato expression Strutt Mlodzik 1997 Dominguez 1999 Fig
0.14052135.12954721.html.plaintext.txt	103	View larger version 97K Fig
0.14052135.12954721.html.plaintext.txt	104	Genetics Ci155 accumulation
0.14052135.12954721.html.plaintext.txt	105	In A E clones cells indicated mutant genotypes identified absence lacZ marker gene expression magenta
0.14052135.12954721.html.plaintext.txt	106	The green channel shows Atonal protein panel A Ci155 panels B E
0.14052135.12954721.html.plaintext.txt	107	Absolute levels Ci155 compared panels preparations recorded widely different occasions
0.14052135.12954721.html.plaintext.txt	108	A Cells lacking smo fail turn atonal normal time anterior morphogenetic furrow green horizontal arrows
0.14052135.12954721.html.plaintext.txt	109	Lower Atonal levels still suffice R8 specification appear posteriorly vertical arrow
0.14052135.12954721.html.plaintext.txt	110	B Cells lacking smo fail accumulate Ci155 ahead morphogenetic furrow horizontal arrows
0.14052135.12954721.html.plaintext.txt	111	Ci155 accumulate posteriorly smo mutant cells vertical arrow disappearing differentiation begins e
0.14052135.12954721.html.plaintext.txt	112	C By contrast Ci155 accumulate cells mutant smo tkv
0.14052135.12954721.html.plaintext.txt	113	D Ci155 accumulate cells mutant smo Mad
0.14052135.12954721.html.plaintext.txt	114	E There subtle reproducible reduction Ci155 levels clones mutant tkv associated little change pattern timing differentiation
0.14052135.12954721.html.plaintext.txt	115	To test whether smo mutations completely abolished Hh signaling Ci155 accumulation examined
0.14052135.12954721.html.plaintext.txt	116	As well stimulating Ci155 transcriptional activator activity Hh causes Ci155 accumulation preventing SCFSlimb processing Ci155 repressor form Ci75 Ingham McMahon 2001
0.14052135.12954721.html.plaintext.txt	117	Ci155 specifically detected monoclonal antibody 2A1 recognize Ci75 Motzny Holmgren 1995 Aza Blanc et al
0.14052135.12954721.html.plaintext.txt	118	In smo mutant cells Ci155 stabilization abolished delayed Dominguez 1999 Fig
0.14052135.12954721.html.plaintext.txt	119	As smo mutations since shown null Chen Struhl 1998 slower acting smo independent mechanism Ci155 stabilization implied
0.14052135.12954721.html.plaintext.txt	120	Ci155 later lost posterior margins smo mutant clones Fig
0.14052135.12954721.html.plaintext.txt	121	Since smo mutant cells differentiate response Dpp Greenwood Struhl 1999 Curtiss Mlodzik 2000 tested whether Ci155 stabilized Dpp signaling
0.14052135.12954721.html.plaintext.txt	122	Ci155 levels examined clones cells mutant smo tkv smo Mad
0.14052135.12954721.html.plaintext.txt	123	tkv encodes Type I Dpp receptor Mad encodes essential transcription factor target
0.14052135.12954721.html.plaintext.txt	124	Ci155 accumulate Hh Dpp signal reception inactivated indicating Dpp signal reception required accumulate Ci155 proteins absence Hh signal reception Fig
0.14052135.12954721.html.plaintext.txt	125	A modest reproducible reduction Ci155 levels seen cells mutant tkv alone indicating Dpp signaling Tkv contributes level Ci155 even presence Hh pathway Fig
0.14052135.12954721.html.plaintext.txt	126	Ci dispensable Dpp signaling might promote furrow progression differentiation regulating Ci155 processing Ci75 Hh
0.14052135.12954721.html.plaintext.txt	127	If ci mutant cells resemble cells unable respond either Hh Dpp thus would unable differentiate
0.14052135.12954721.html.plaintext.txt	128	An alternative model Dpp acted independently effects Ci
0.14052135.12954721.html.plaintext.txt	129	If ci mutant clones exhibit delayed differentiation clones mutant smo
0.14052135.12954721.html.plaintext.txt	130	Cells homozygous deletion ci gene examined distinguish two models
0.14052135.12954721.html.plaintext.txt	131	Unexpectedly clones ci mutant cells differentiated normally respects Fig
0.14052135.12954721.html.plaintext.txt	132	The temporal spatial pattern ato expression completely normal ci mutant cells unlike cells unable respond Hh cells unable respond Hh Dpp Fig
0.14052135.12954721.html.plaintext.txt	133	Normal neural differentiation occurred ci mutant cells without delay Fig
0.14052135.12954721.html.plaintext.txt	134	Cells lacking ci morphologically normal adults externally sectioning reveal differentiated cellular morphology Fig
0.14052135.12954721.html.plaintext.txt	135	There defects ommatidial chirality planar polarity
0.14052135.12954721.html.plaintext.txt	136	The genotype ci mutant cells unequivocally confirmed using antibodies Ci detect ci mutant cells directly Fig
0.14052135.12954721.html.plaintext.txt	137	While paper review Pappu et al
0.14052135.12954721.html.plaintext.txt	138	also reported normal eye development large clones lacking ci Pappu et al
0.14052135.12954721.html.plaintext.txt	139	View larger version 89K Fig
0.14052135.12954721.html.plaintext.txt	140	Ci dispensable patterning progression eye differentiation
0.14052135.12954721.html.plaintext.txt	141	A Ci155 magenta atonal green
0.14052135.12954721.html.plaintext.txt	142	Initiation progression Atonal expression occurs normally cells deleted ci gene
0.14052135.12954721.html.plaintext.txt	143	B Clones cells lacking eye pigmentation Ci function contribute normal adult eye structures arrows
0.14052135.12954721.html.plaintext.txt	144	C Normal ommatidia seen sections ci null mutant clones marked unpigmented pigment cells
0.14052135.12954721.html.plaintext.txt	145	A basal plane section shown normal R8 differentiation apparent arrows
0.14052135.12954721.html.plaintext.txt	146	The equator runs ci mutant region
0.14052135.12954721.html.plaintext.txt	147	D Morphogenetic furrow progression retarded smo mutant cells
0.14052135.12954721.html.plaintext.txt	148	The product Atonal target gene sens reveals Atonal activity subsequent differentiation R8 cells green
0.14052135.12954721.html.plaintext.txt	149	Cells mutant smo lack clone marker magenta also mutant engrailed en gene required eye development Strutt Mlodzik 1996 see panel E
0.14052135.12954721.html.plaintext.txt	150	E Senseless expression progression green occur completely normally smo ci mutant cells also mutant en
0.14052135.12954721.html.plaintext.txt	151	The clone similar size smo clone panel E induced simultaneously sibling larva see Materials methods details
0.14052135.12954721.html.plaintext.txt	152	F FngGal4 drives UAS lacZ reporter gene expression ventral eye disc anterior morphogenetic furrow
0.14052135.12954721.html.plaintext.txt	153	FngGal4 also drives expression weakly posterior dorsal eye disc away equator expanding reach equator morphogenetic furrow late third instar Cho Choi 1998 Dominguez de Celis 1998 Papayannopoulos et al
0.14052135.12954721.html.plaintext.txt	154	Mlodzik personal communication
0.14052135.12954721.html.plaintext.txt	155	G Ventral Ci75 expression retards furrow progression arrowhead shows position furrow dorsally arrow indicates ventral delay
0.14052135.12954721.html.plaintext.txt	156	Ci75 plays important role One possibility suggested results novel pathway Hh signal transduction dependent smo ci
0.14052135.12954721.html.plaintext.txt	157	A second possibility Hh signaling essential prevent formation repressor protein Ci75
0.14052135.12954721.html.plaintext.txt	158	If Ci155 unimportant deletion entire ci gene could mimic Hh signaling eliminating Ci75
0.14052135.12954721.html.plaintext.txt	159	If smo signals independently ci eye smo ci clones show delayed differentiation like smo clones e
0.14052135.12954721.html.plaintext.txt	160	If smo essential eliminate Ci75 smo ci clones develop normally without delay like ci clones
0.14052135.12954721.html.plaintext.txt	161	3E shows smo ci clones developed normally like ci delayed like smo clones size Fig
0.14052135.12954721.html.plaintext.txt	162	Therefore smo appeared essential prevent processing Ci Ci75 repressor protein
0.14052135.12954721.html.plaintext.txt	163	We targeted ectopic expression different forms Ci protein developing eye
0.14052135.12954721.html.plaintext.txt	164	The Gal4 line hairyH10 used target UASciCell expression anterior morphogenetic furrow Ellis et al
0.14052135.12954721.html.plaintext.txt	165	ciCell encodes Ci protein truncated amino acid 975 mimics Ci75 Methot Basler 1999
0.14052135.12954721.html.plaintext.txt	166	Atonal expression reduced although eye patterning occurred normally data shown
0.14052135.12954721.html.plaintext.txt	167	Mlodzik used misexpress UASciCell ventrally Fig
0.14052135.12954721.html.plaintext.txt	168	When expressed control FngGal4 ciCell prevented furrow progression differentiation ventral cells permitted furrow progression across dorsal region eye disc Fig
0.14052135.12954721.html.plaintext.txt	169	FngG4 hH10 also used drive expression UASciU encodes Ci protein deletion amino acids 611 760 defective processing Ci75 behaves Hh dependent activator protein Methot Basler 1999 UASZnAD UASZnRD transgenes DNA binding domain Ci coupled transcriptional activator repressor domains respectively Hepker et al
0.14052135.12954721.html.plaintext.txt	170	These without detectable effect data shown
0.14052135.12954721.html.plaintext.txt	171	Taken together findings suggested differentiation might depend blocking production Ci75 response Hh Dpp
0.14052135.12954721.html.plaintext.txt	172	Ci independent furrow progression response Dpp N There also ci independent signal required induce differentiation even absence Ci
0.14052135.12954721.html.plaintext.txt	173	If differentiation depended entirely eliminating Ci75 deletion ci gene would remove barrier differentiation anywhere eye field instead ci mutant cells initiated differentiation temporal progression wild type cells Fig
0.14052135.12954721.html.plaintext.txt	174	ci independent differentiation could depend Hh smo ci cells also initiated differentiation precisely normal timing Fig
0.14052135.12954721.html.plaintext.txt	175	The second signal might Dpp acting independently Ci
0.14052135.12954721.html.plaintext.txt	176	If correct would expect Mad ci mutant cells would fail differentiate
0.14052135.12954721.html.plaintext.txt	177	Mad ci mutant cells examined found differentiate differentiation delayed Fig
0.14052135.12954721.html.plaintext.txt	178	This result confirmed Dpp signaling Mad contributed differentiation absence ci signal posterior cells still able progress slowly Mad ci mutant cells
0.14052135.12954721.html.plaintext.txt	179	View larger version 315K Fig
0.14052135.12954721.html.plaintext.txt	180	Genetics differentiation Hairy downregulation
0.14052135.12954721.html.plaintext.txt	181	Panels A H show Senseless expression green Hairy expression blue various genotypes
0.14052135.12954721.html.plaintext.txt	182	Clones mutant cells revealed absence Ci155 red panels A F absence lacZ marker gene red panels GH
0.14052135.12954721.html.plaintext.txt	183	In E H outlines clone boundaries overlaid Hairy channel help assess autonomy
0.14052135.12954721.html.plaintext.txt	184	Because variations reagents procedures time see Materials methods labeling intensities rigorously compared cells different genotypes within preparation
0.14052135.12954721.html.plaintext.txt	185	A Differentiation delayed Mad ci mutant cells
0.14052135.12954721.html.plaintext.txt	186	B Mad ci mutant cells maintain Hairy expression longer except close wild type cells
0.14052135.12954721.html.plaintext.txt	187	If wild type cells nearby Hairy expression lost close normal time e
0.14052135.12954721.html.plaintext.txt	188	C tkv ci mutant cells differentiate
0.14052135.12954721.html.plaintext.txt	189	D tkv ci mutant cells maintain Hairy expression longer except close wild type cells
0.14052135.12954721.html.plaintext.txt	190	If wild type cells nearby Hairy lost close normal time e
0.14052135.12954721.html.plaintext.txt	191	In addition Hairy levels reproducibly lower mutant cells wild type
0.14052135.12954721.html.plaintext.txt	192	E Mad SuH ci mutant cells differentiate
0.14052135.12954721.html.plaintext.txt	193	Mutant cells maintain Hairy expression indefinitely even neighboring wild type cells
0.14052135.12954721.html.plaintext.txt	194	F Differentiation SuH ci mutant cells slightly delayed
0.14052135.12954721.html.plaintext.txt	195	There excess Senseless expressing R8 cells though extreme SuH mutant clones compare panel G
0.14052135.12954721.html.plaintext.txt	196	SuH ci mutant cells maintain Hairy expression indefinitely even neighboring wild type cells
0.14052135.12954721.html.plaintext.txt	197	Note overlap Senseless expressing Hairy expressing regions
0.14052135.12954721.html.plaintext.txt	198	G SuH mutant cells differentiate normal time strongly neurogenic Li Baker 2001
0.14052135.12954721.html.plaintext.txt	199	Weak Hairy expression maintained normal time soon lost
0.14052135.12954721.html.plaintext.txt	200	There limited overlap Senseless expressing Hairy expressing regions
0.14052135.12954721.html.plaintext.txt	201	H Mad SuH mutant cells differentiate normal time strongly neurogenic
0.14052135.12954721.html.plaintext.txt	202	Hairy expression maintained normal time soon lost
0.14052135.12954721.html.plaintext.txt	203	There limited overlap Senseless expressing Hairy expressing regions
0.14052135.12954721.html.plaintext.txt	204	One possibility mutation Mad completely abolish Dpp signaling
0.14052135.12954721.html.plaintext.txt	205	The Mad1 2 allele although similar null alleles tkv effects patterning permits normal growth tkv null alleles retains minimal response Dpp
0.14052135.12954721.html.plaintext.txt	206	Perhaps limited activity becomes significant absence ci
0.14052135.12954721.html.plaintext.txt	207	Another possibility N signaling might contribute differentiation Mad ci cells
0.14052135.12954721.html.plaintext.txt	208	To distinguish whether N residual Dpp signaling responsible differentiation Mad ci mutant cells examined tkv ci mutant cells well cells triply mutant SuH Mad ci
0.14052135.12954721.html.plaintext.txt	209	Differentiation observed tkv ci mutant clones
0.14052135.12954721.html.plaintext.txt	210	Clones cells mutant tkv ci grew poorly small clones recovered Fig
0.14052135.12954721.html.plaintext.txt	211	Such clones rarely recovered posterior region eye disc seemed sort
0.14052135.12954721.html.plaintext.txt	212	Large clones tkv ci mutant cells obtained using Minute Technique
0.14052135.12954721.html.plaintext.txt	213	These large clones always round shapes indicating reduced mixing wild type cells throughout eye disc data shown
0.14052135.12954721.html.plaintext.txt	214	No retinal differentiation detected
0.14052135.12954721.html.plaintext.txt	215	These findings indicate Dpp signaling occurred Mad ci mutant cells contributed slow differentiation Mad ci cells
0.14052135.12954721.html.plaintext.txt	216	Clones Mad SuH ci mutant cells also failed differentiate indicating role N signaling delayed differentiation Mad ci mutant cells Fig
0.14052135.12954721.html.plaintext.txt	217	N augments Dpp signaling Two interpretations role N could considered
0.14052135.12954721.html.plaintext.txt	218	One N signaling Dpp signaling required differentiation absence ci
0.14052135.12954721.html.plaintext.txt	219	The alternative N activity enhanced sensitivity Dpp limited Dpp signaling occurs Mad mutant cells became sufficient delayed differentiation
0.14052135.12954721.html.plaintext.txt	220	If N signaling required differentiation absence ci would predict SuH ci mutant cells would unable differentiate
0.14052135.12954721.html.plaintext.txt	221	However SuH ci mutant cells initiate differentiation differentiation delayed Fig
0.14052135.12954721.html.plaintext.txt	222	Thus N signaling absolutely required differentiation
0.14052135.12954721.html.plaintext.txt	223	Delayed differentiation absence SuH ci must depend Dpp signaling occur Mad SuH ci mutant cells
0.14052135.12954721.html.plaintext.txt	224	SuH mutations must reduce effectiveness Dpp timing differentiation normal ci mutant cells delayed SuH ci mutant cells differentiation ci mutant clones must due Dpp signaling tkv ci mutant cells differentiate
0.14052135.12954721.html.plaintext.txt	225	These results indicate N signaling made Dpp signaling effective least absence Ci
0.14052135.12954721.html.plaintext.txt	226	Ci155 augments Dpp signaling The differentiation SuH ci mutant cells differed SuH mutant cells
0.14052135.12954721.html.plaintext.txt	227	SuH mutant cells show profound neurogenic phenotype majority mutant cells take R8 fate Ligoxygakis et al
0.14052135.12954721.html.plaintext.txt	228	Morphogenetic furrow progression accelerate differentiation begins earlier anterior large SuH null clones nearby wild type regions Li Baker 2001 Fig
0.14052135.12954721.html.plaintext.txt	229	By contrast differentiation SuH ci mutant cells delayed R8 differentiation increased moderately compared wild type Fig
0.14052135.12954721.html.plaintext.txt	230	These data show differentiation without SuH effective presence ci
0.14052135.12954721.html.plaintext.txt	231	This first data indicate role Ci155 could replaced deleting ci gene eliminate Ci75
0.14052135.12954721.html.plaintext.txt	232	More evidence reported
0.14052135.12954721.html.plaintext.txt	233	Hh dependent differentiation requiring Ci155 One model importance Ci75 Ci75 antagonized Dpp N function
0.14052135.12954721.html.plaintext.txt	234	In view normal role Hh would help downregulate Ci75 furrow Dpp N could act promptly
0.14052135.12954721.html.plaintext.txt	235	Delayed differentiation smo clones would due ci75 antagonizing DppN function found sufficient normal furrow progression absence ci
0.14052135.12954721.html.plaintext.txt	236	This model predict delayed differentiation SuH ci mutant clones Fig
0.14052135.12954721.html.plaintext.txt	237	To isolate role Hh examined cells mutant Mad SuH
0.14052135.12954721.html.plaintext.txt	238	If role Hh derepress Dpp N signaling Mad SuH mutant cells would differentiate missing Dpp N signals
0.14052135.12954721.html.plaintext.txt	239	By contrast Mad SuH cells differentiated normal rate Fig
0.14052135.12954721.html.plaintext.txt	240	A neurogenic phenotype reflected dependence lateral inhibition SuH Ligoxygakis et al
0.14052135.12954721.html.plaintext.txt	241	Initiation Atonal expression also reported Dl Medea mutant cells resemble Mad SuH cells lacking N Dpp signaling Baonza Freeman 2001
0.14052135.12954721.html.plaintext.txt	242	These results show Dpp N dispensable differentiation Hh signaling intact
0.14052135.12954721.html.plaintext.txt	243	As Mad SuH ci cells differentiate differentiation Mad SuH depended positive role Ci mimicked deleting ci gene remove Ci75
0.14052135.12954721.html.plaintext.txt	244	Thus Hh Ci155 could drive differentiation absence Dpp N signaling
0.14052135.12954721.html.plaintext.txt	245	N Hh turn Hairy Notch signaling contributes differentiation downregulating Hairy Extramacrochaetae expression morphogenetic furrow Baonza Freeman 2001
0.14052135.12954721.html.plaintext.txt	246	Hairy transcriptional repressor protein antagonizes Atonal Ohsako et al
0.14052135.12954721.html.plaintext.txt	247	We monitored Hairy expression evaluate contributions Hh Dpp N signaling turning Hairy correlate differentiation
0.14052135.12954721.html.plaintext.txt	248	The results summarized Table 1
0.14052135.12954721.html.plaintext.txt	249	Hh Dpp N signals appear essential turn Hairy although Dpp contribute Hairy levels appear lower clones mutant tkv Mad combinations mutations Greenwood Struhl 1999 Fig
0.14052135.12954721.html.plaintext.txt	250	One Dpp Hh N signaling required turn Hairy morphogenetic furrow Hairy expression maintained cell autonomously Mad SuH ci clones Fig
0.14052135.12954721.html.plaintext.txt	251	Hairy turned Mad ci clones tkv ci clones although downregulation delayed center clone Fig
0.14052135.12954721.html.plaintext.txt	252	This implies N signaling sufficient downregulate Hairy response signal posterior cells outside clone
0.14052135.12954721.html.plaintext.txt	253	N signaling required sufficient Hairy downregulation Hairy shut SuH ci clones Fig
0.14052135.12954721.html.plaintext.txt	254	If N signaling essential shut Hairy circumstances would expect Hairy expression maintained autonomously SuH clones
0.14052135.12954721.html.plaintext.txt	255	By contrast brief delay shutting Hairy SuH clones Fig
0.14052135.12954721.html.plaintext.txt	256	Hairy also shut Mad SuH clones although delay Fig
0.14052135.12954721.html.plaintext.txt	257	These results show either N Hh signals posterior cells sufficient shut Hairy expression Hairy expression maintained indefinitely Mad SuH ci SuH ci cells unable respond either pathway
0.14052135.12954721.html.plaintext.txt	258	Downregulation Hairy response Hh well N explains N required differentiation response Hh even though required differentiation response Dpp
0.14052135.12954721.html.plaintext.txt	259	Hairy retards differentiation Downregulating Hairy neither necessary sufficient differentiation
0.14052135.12954721.html.plaintext.txt	260	Whereas Mad SuH ci mutant cells failed differentiate maintained Hairy expression Fig
0.14052135.12954721.html.plaintext.txt	261	4E tkv ci cells differentiate even though Hairy expression shut Fig
0.14052135.12954721.html.plaintext.txt	262	By contrast Hairy expression maintained SuH ci mutant clones even though SuH ci cells could differentiate
0.14052135.12954721.html.plaintext.txt	263	However Hairy downregulation may contribute prompt differentiation differentiation delayed SuH ci compared ci less neurogenic SuH ci SuH Fig
0.14052135.12954721.html.plaintext.txt	264	As Hairy shut either Hh N signaling Hairy maintenance away boundaries Mad ci tkv ci Mad SuH clones shows genotypes defective Hh Dl secretion
0.14052135.12954721.html.plaintext.txt	265	Hh normally secreted differentiating photoreceptor cells Ma et al
0.14052135.12954721.html.plaintext.txt	266	Atonal Egf receptor activity promotes expression Dl activating ligand Notch Baker Yu 1998 Tsuda et al
0.14052135.12954721.html.plaintext.txt	267	Both Hh Dl expression absent delayed Mad ci tkv ci Mad SuH clones
0.14052135.12954721.html.plaintext.txt	268	Discussion TOP SUMMARY Introduction Materials methods Results Discussion REFERENCES Redundant overlapping roles Hh N Dpp Table 1 summarizes data
0.14052135.12954721.html.plaintext.txt	269	Initially results suggested Dpp Hh might redundant common regulation Ci
0.14052135.12954721.html.plaintext.txt	270	When Ci found dispensable simplest interpretation repressor Ci75 important Ci155
0.14052135.12954721.html.plaintext.txt	271	Others recently arrived similar conclusion Pappu et al
0.14052135.12954721.html.plaintext.txt	272	However work revealed roles Ci155 redundancies Hh Dpp N explanation normal progression differentiation absence one important components ci Mad SuH
0.14052135.12954721.html.plaintext.txt	273	There might signals awaiting discovery Hh Dpp N cannot explain expression hairy genes eyes absent furrow progression Curtiss Mlodzik 2000 Fig
0.14052135.12954721.html.plaintext.txt	274	The pathways implied results shown Fig
0.14052135.12954721.html.plaintext.txt	275	5A shows Hh Dpp N signaling pathways act within cell
0.14052135.12954721.html.plaintext.txt	276	5B illustrates spatial temporal relationships extracellular signals morphogenetic furrow progression
0.14052135.12954721.html.plaintext.txt	277	View larger version 13K Fig
0.14052135.12954721.html.plaintext.txt	278	Positional signals regulatory gene expression
0.14052135.12954721.html.plaintext.txt	279	A Cell autonomous responses Atonal Hairy expression Dpp Hh N signal reception inferred results illustrating roles Ci155 Ci75
0.14052135.12954721.html.plaintext.txt	280	Positive negative interactions imply direct molecular interactions proteins proteins genes demonstrated interactions occur within cell without intercellular signals
0.14052135.12954721.html.plaintext.txt	281	Ci75 must repress Ato since mutation smo imposes delay differentiation released deleting ci
0.14052135.12954721.html.plaintext.txt	282	Ci155 must activate Ato since Mad SuH cells differentiate Mad SuH ci cells
0.14052135.12954721.html.plaintext.txt	283	Tkv must activate Ato independently Ci ci cells differentiate normally tkv ci Mad ci cells
0.14052135.12954721.html.plaintext.txt	284	Tkv shown inhibiting Ci75 Tkv promotes Ci155 accumulation smo mutant cells Ci155 presumed inactive
0.14052135.12954721.html.plaintext.txt	285	Tkv also promotes Ci155 accumulation cells mutant smo
0.14052135.12954721.html.plaintext.txt	286	Hairy shown previously repress Ato function Brown et al
0.14052135.12954721.html.plaintext.txt	287	Ci155 must repress Hairy Hairy maintained cell autonomously Mad SuH ci mutant cells downregulated Mad SuH cells
0.14052135.12954721.html.plaintext.txt	288	N must repress Hairy Hairy maintained cell autonomously Mad SuH ci mutant cells downregulated Mad ci cells
0.14052135.12954721.html.plaintext.txt	289	N may activate Atonal independently Hairy well furrow progresses faster SuH mutant clones Hairy still expressed Li Baker 2001
0.14052135.12954721.html.plaintext.txt	290	Hairy expression must initiated part another signal although Dpp input revealed quantitative reduction Hairy levels cells mutant tkv Greenwood Struhl 1999 Mad combinations SuH ci
0.14052135.12954721.html.plaintext.txt	291	The network accounts mutant phenotypes
0.14052135.12954721.html.plaintext.txt	292	In absence Ci normal differentiation occurs response Dpp N
0.14052135.12954721.html.plaintext.txt	293	In absence smo differentiation delayed activation pathways Ci155 lost repression Ci75 retained
0.14052135.12954721.html.plaintext.txt	294	In absence Dpp N differentiation occurs response Hh
0.14052135.12954721.html.plaintext.txt	295	Absence either tkv N alone little effect reflecting either dominant role Hh perhaps positive negative inputs lost case
0.14052135.12954721.html.plaintext.txt	296	B Extracellular signaling Atonal Hairy
0.14052135.12954721.html.plaintext.txt	297	Hh Dl Dpp shown locations expression
0.14052135.12954721.html.plaintext.txt	298	The signal acting anteriorly morphogenetic furrow Dpp
0.14052135.12954721.html.plaintext.txt	299	Dpp expressed anterior morphogenetic furrow response Hh
0.14052135.12954721.html.plaintext.txt	300	More posteriorly Dpp synergizes relatively indiffusible Dl signal induce Atonal
0.14052135.12954721.html.plaintext.txt	301	Dl expressed response Atonal later response activation Egfr ligands produced Atonal dependent R8 cells
0.14052135.12954721.html.plaintext.txt	302	Hh also induces Atonal Ci155Ci75 ratio
0.14052135.12954721.html.plaintext.txt	303	Hh secreted photoreceptor cells specified Egfr activation ligands produced Atonal dependent R8 cells
0.14052135.12954721.html.plaintext.txt	304	Both N Hh downregulate Hairy
0.14052135.12954721.html.plaintext.txt	305	Despite intrinsically different ranges Dpp Hh signals activation Ato coincides Dpp also elevates Hairy must downregulated Hh Dl
0.14052135.12954721.html.plaintext.txt	306	The development Mad SuH ci mutant cells helpful starting point may reflect ground state eye development requires extracellular signals differentiate
0.14052135.12954721.html.plaintext.txt	307	Mad SuH ci cells fail express atonal senseless genes initiate R8 differentiation consequently fail support retinal differentiation
0.14052135.12954721.html.plaintext.txt	308	This shows absence Ci75 sufficient differentiation
0.14052135.12954721.html.plaintext.txt	309	SuH ci clones N Dpp signaling together required activate Atonal normal kinetics occurs ci mutant cells
0.14052135.12954721.html.plaintext.txt	310	N signaling alone tkv ci clones insufficient
0.14052135.12954721.html.plaintext.txt	311	In presence Ci prompt differentiation required Hh downregulate Ci75 differentiation delayed Smo clones lacked input
0.14052135.12954721.html.plaintext.txt	312	The normal role Hh remove Ci75 thus permitting Dpp N work Atonal turned normally Mad SuH clones respond Dpp N signals
0.14052135.12954721.html.plaintext.txt	313	Such differentiation depends exclusively Hh yet progresses normally except neurogenic phenotype reflects dependence lateral inhibition SuH
0.14052135.12954721.html.plaintext.txt	314	Hh depends positively ci drive differentiation Mad SuH cells therefore requires Ci155
0.14052135.12954721.html.plaintext.txt	315	The positive role ci also inferred delayed differentiation SuH ci clones comparison SuH clones
0.14052135.12954721.html.plaintext.txt	316	We find Hairy downregulated redundantly Hh N signaling
0.14052135.12954721.html.plaintext.txt	317	Prolonged Hairy expression sufficient block differentiation completely antagonize e
0.14052135.12954721.html.plaintext.txt	318	Downregulation Hairy response Hh well N explains ci SuH mutant clones differentiate promptly N enhances differentiation response Dpp required differentiation response Hh
0.14052135.12954721.html.plaintext.txt	319	Hh Dpp sufficient differentiation Comparison Mad SuH ci cells differentiate Mad SuH cells shows Hh signaling sufficient initiate eye differentiation
0.14052135.12954721.html.plaintext.txt	320	This consistent previous studies ectopic Hh activation Heberlein Moses 1995 Li et al
0.14052135.12954721.html.plaintext.txt	321	1995 Ma Moses 1995 Pan Rubin 1995 Strutt et al
0.14052135.12954721.html.plaintext.txt	322	Our experiments confirm conclusion normal time place Hh signaling anterior morphogenetic furrow confirm directly Dpp N signaling necessary Hh signaling sufficient
0.14052135.12954721.html.plaintext.txt	323	Comparison Mad SuH ci cells SuH ci cells shows Dpp signaling sufficient initiate eye differentiation normal location absence Hh N signals differentiation delayed
0.14052135.12954721.html.plaintext.txt	324	The normal timing differentiation restored combined Dpp N signals ci clones
0.14052135.12954721.html.plaintext.txt	325	This basis ectopic differentiation co expression Dpp Dl ahead furrow Baonza Freeman 2001
0.14052135.12954721.html.plaintext.txt	326	Superficially results differ previous ectopic expression studies concluded Dpp signaling alone sufficient induce ectopic differentiation locations Pignoni Zipursky 1997 Greenwood Struhl 1999 Baonza Freeman 2001
0.14052135.12954721.html.plaintext.txt	327	This discrepancy probably explained baseline repressor activity SuH protein Hsieh Hayward 1995 Morel Schweisguth 2000
0.14052135.12954721.html.plaintext.txt	328	Our previous work shows without N signaling repressor activity SuH protein retards differentiation Li Baker 2001
0.14052135.12954721.html.plaintext.txt	329	Dpp signaling sufficient differentiation experiments SuH gene deleted
0.14052135.12954721.html.plaintext.txt	330	In presence SuH gene Dpp may effective locations little SuH repressor activity close morphogenetic furrow N signaling active
0.14052135.12954721.html.plaintext.txt	331	Comparison Mad SuH ci cells differentiate Mad ci tkv ci cells differentiate slowly shows Notch signaling alone insufficient differentiation
0.14052135.12954721.html.plaintext.txt	332	Premature differentiation reported N activated ectopically ahead furrow must reflect endogenous Dpp signaling locations Baonza Freeman 2001 Li Baker 2001
0.14052135.12954721.html.plaintext.txt	333	Mechanisms redundancy Our experiments reveal outline mechanisms Hh Dpp N redundancy Fig
0.14052135.12954721.html.plaintext.txt	334	First results show Mad Ci independently reinforce differentiation presumably transcription target genes Mad sufficient differentiation absence Ci vice versa
0.14052135.12954721.html.plaintext.txt	335	Our results show unequivocally transcriptional activator Ci155 activates differentiation addition Ci75 antagonizing differentiation
0.14052135.12954721.html.plaintext.txt	336	It surprising find Dpp stabilizes Ci155 absence Smo suggested Dpp input Hh signal transduction
0.14052135.12954721.html.plaintext.txt	337	Although requirement smo dependent input fused makes unlikely Ci155 functional smo clones Ohlmeyer Kalderon 1997 Methot Basler 1999 Ci155 accumulation might associated reduced Ci75 levels
0.14052135.12954721.html.plaintext.txt	338	Ci75 shown repress differentiation smo clones smo ci clones differentiation normally
0.14052135.12954721.html.plaintext.txt	339	Ci155 stabilization cannot due indirect effect Dpp signaling Hh Ptc Smo expression levels effect detected absence smo therefore reflects effect Hh signal transduction components downstream Smo
0.14052135.12954721.html.plaintext.txt	340	One idea Dpp signaling Dpp induced differentiation may replace SCFSlimb processing Ci cleaves Ci155 Ci75 Cullin3 mediated Ci degradation normally occurs posterior morphogenetic furrow Ou et al
0.14052135.12954721.html.plaintext.txt	341	In smo clone Ci155 would accumulate Smo required Cullin3 degrade Ci Ou et al
0.14052135.12954721.html.plaintext.txt	342	However SCFSlimb Cullin3 switch may effect Dpp Ci processing Tkv slightly enhanced Ci155 accumulation even smo present Fig
0.14052135.12954721.html.plaintext.txt	343	Finally downregulation Hairy N requires SuH gene
0.14052135.12954721.html.plaintext.txt	344	N also overcomes baseline repressor activity SuH protein promote progression differentiation Li Baker 2001
0.14052135.12954721.html.plaintext.txt	345	This role N must independent Hairy
0.14052135.12954721.html.plaintext.txt	346	Signal combinations control rate differentiation Dl Hh Dpp generally thought signal different distances
0.14052135.12954721.html.plaintext.txt	347	How signals different range substitute one another permit normal eye development Fig
0.14052135.12954721.html.plaintext.txt	348	5B shows signal sources targets eye disc
0.14052135.12954721.html.plaintext.txt	349	Dpp transcribed response Hh signaling produced Ci155 levels highest Heberlein et al
0.14052135.12954721.html.plaintext.txt	350	1993 Strutt Mlodzik 1996
0.14052135.12954721.html.plaintext.txt	351	Dl regulated Hh indirectly Ato Ato dependent Egfr activity differentiating cells Baker Yu 1998 Tsuda et al
0.14052135.12954721.html.plaintext.txt	352	Hh expressed posteriorly three differentiating photoreceptors Ma et al
0.14052135.12954721.html.plaintext.txt	353	Eye differentiation uses Hh progress cells unable respond Dpp tkv Mad N SuH
0.14052135.12954721.html.plaintext.txt	354	The range Hh diffusion depends part shape morphogenetic furrow cells Benlali et al
0.14052135.12954721.html.plaintext.txt	355	The Dpp drives differentiation ci mutant cells unable respond Hh must diffuse outside ci clones Dpp synthesis Hh dependent Heberlein et al
0.14052135.12954721.html.plaintext.txt	356	1993 Methot Basler 1999
0.14052135.12954721.html.plaintext.txt	357	Large ci clones develop normally Dpp diffusion cannot limiting dpp mutant clones offer information range Dpp express differentiate response Hh
0.14052135.12954721.html.plaintext.txt	358	Instead rate progression response Dpp controlled Dl
0.14052135.12954721.html.plaintext.txt	359	Dl signals one two cell diameters morphogenetic furrow Baker Yu 1997
0.14052135.12954721.html.plaintext.txt	360	The previous view eye patterning influenced morphogen function Hh Dpp discs Nellen et al
0.14052135.12954721.html.plaintext.txt	361	1996 Strigini Cohen 1997
0.14052135.12954721.html.plaintext.txt	362	It thought domains Ato Hairy expression reflected increasing concentrations Hh Dpp Greenwood Struhl 1999 Lee Treisman 2002
0.14052135.12954721.html.plaintext.txt	363	Our data shows eye combination signals important
0.14052135.12954721.html.plaintext.txt	364	Differentiation triggered Dl andor Hh synergize Dpp regardless source Dpp
0.14052135.12954721.html.plaintext.txt	365	The additional requirements limit Dpp initiating differentiation locations Hh
0.14052135.12954721.html.plaintext.txt	366	ACKNOWLEDGMENTS We thank Y
0.14052135.12954721.html.plaintext.txt	367	Tyler comments manuscript S
0.14052135.12954721.html.plaintext.txt	368	Mlodzik Developmental Studies Hybridoma Bank University Iowa especially K
0.14052135.12954721.html.plaintext.txt	369	Holmgren strains antibodies
0.14052135.12954721.html.plaintext.txt	370	We also thank Sung Yun Yu Cynthia Zapata Heather Schultz technical assistance
0.14052135.12954721.html.plaintext.txt	371	Confocal microscopy performed AECOM Analytical Imaging Facility
0.14052135.12954721.html.plaintext.txt	372	This work supported grants NIH GM47892 GM61230
0.14052135.12954721.html.plaintext.txt	373	Footnotes Present address Department Pharmacology Weill Medical College Cornell University 1300 York Avenue New York NY 10021 USA
0.14052135.12954721.html.plaintext.txt	374	REFERENCES TOP SUMMARY Introduction Materials methods Results Discussion REFERENCES
0.14052135.12954721.html.plaintext.txt	375	Proteolysis inhibited hedgehog targets Cubitus interruptus protein nucleus converts repressor
0.14052135.12954721.html.plaintext.txt	376	Notch patterning ommatidial founder cells developing Drosophila eye
0.14052135.12954721.html.plaintext.txt	377	Proneural function neurogenic genes developing Drosophila eye
0.14052135.12954721.html.plaintext.txt	378	The R8 photoreceptor equivalence group Drosophila fate choice precedes regulated Delta transcription independent Notch gene dose
0.14052135.12954721.html.plaintext.txt	379	Notch signalling initiation neural development Drosophila eye
0.14052135.12954721.html.plaintext.txt	380	act controls actin polymerization alter cell shape restrict Hedgehog signaling Drosophila eye disc
0.14052135.12954721.html.plaintext.txt	381	hairy emc negatively regulate morphogenetic furrow progression developing Drosophila eye
0.14052135.12954721.html.plaintext.txt	382	Hedgehog dependent patterning Drosophila eye occur absence Dpp signaling
0.14052135.12954721.html.plaintext.txt	383	In vivo evidence Patched Smoothened constitute distinct binding transducing components Hh receptor complex
0.14052135.12954721.html.plaintext.txt	384	Fringe essential mirror symmetry morphogenesis Drosophila eye
0.14052135.12954721.html.plaintext.txt	385	Morphogenetic furrow initiation progression eye development Drosophila roles decapentaplegic hedgehog eyes absent
0.14052135.12954721.html.plaintext.txt	386	Dual role Hedgehog regulation proneural gene atonal ommatidia development
0.14052135.12954721.html.plaintext.txt	387	A dorsalventral boundary established Notch controls growth polarity Drosophila eye
0.14052135.12954721.html.plaintext.txt	388	Multiple functions EGF receptor Drosophila eye development
0.14052135.12954721.html.plaintext.txt	389	Confrontation scabrous expressing non expressing cells essential normal ommatidial spacing Drosophila eye
0.14052135.12954721.html.plaintext.txt	390	Cell determination strategies Drosophila eye
0.14052135.12954721.html.plaintext.txt	391	Site specific recombination homologous chromosomes Drosophila
0.14052135.12954721.html.plaintext.txt	392	Progression morphogenetic furrow Drosophila eye roles Hedgehog Decapentaplegic Raf pathway
0.14052135.12954721.html.plaintext.txt	393	Mechanisms Drosophila retinal morphogenesis virtues progressive
0.14052135.12954721.html.plaintext.txt	394	The TGF ss homolog dpp segment polarity gene hedgehog required propagation morphogenetic wave Drosophila retina
0.14052135.12954721.html.plaintext.txt	395	Growth differentiation Drosophila eye coordinated hedgehog
0.14052135.12954721.html.plaintext.txt	396	Drosophila cubitus interruptus forms negative feedback loop patched regulates expression Hedgehog target genes
0.14052135.12954721.html.plaintext.txt	397	Masking CBF1RBPJk transcriptional repression domain Epstein Barr virus EBNA2
0.14052135.12954721.html.plaintext.txt	398	Hedgehog signaling animal development paradigms principles
0.14052135.12954721.html.plaintext.txt	399	atonal proneural gene Drosophila photoreceptors
0.14052135.12954721.html.plaintext.txt	400	The scabrous gene encodes secreted glycoprotein dimer regulates proneural development Drosophila eyes
0.14052135.12954721.html.plaintext.txt	401	Regulators morphogenetic furrow
0.14052135.12954721.html.plaintext.txt	402	Function protein kinase A Hedgehog signal transduction Drosophila imaginal disc development
0.14052135.12954721.html.plaintext.txt	403	Proneural enhancement Notch overcomes Suppressor Hairless repressor function developing Drosophila eye
0.14052135.12954721.html.plaintext.txt	404	A subset N functions Drosophila eye development require SuH Espl gene complex
0.14052135.12954721.html.plaintext.txt	405	Wingless patched negative regulators morphogenetic furrow affect tissue polarity developing Drosophila compound eye
0.14052135.12954721.html.plaintext.txt	406	The segment gene hedgehog required progression morphogenetic furrow developing Drosophila eye
0.14052135.12954721.html.plaintext.txt	407	Hedgehog controls limb development regulating activities distinct transcriptional activator transcriptional repressor forms Cubitus interruptus
0.14052135.12954721.html.plaintext.txt	408	Repression Suppressor Hairless activation Notch required define single row single minded expressing cells Drosophila embryo
0.14052135.12954721.html.plaintext.txt	409	The Drosophila cubitus interruptus protein role wingless hedgehog signal transduction pathways
0.14052135.12954721.html.plaintext.txt	410	Cell fate specification Drosophila eye
0.14052135.12954721.html.plaintext.txt	411	Direct long range action DPP morphogen gradient
0.14052135.12954721.html.plaintext.txt	412	Patterning zebrafish retina wave sonic hedgehog activity
0.14052135.12954721.html.plaintext.txt	413	Senseless Zn finger transcription factor necessary sufficient sensory organ development Drosophila
0.14052135.12954721.html.plaintext.txt	414	Dual pathways induction wingless expression protein kinase A Hedgehog Drosophila embryos
0.14052135.12954721.html.plaintext.txt	415	Hairy function DNA binding helix loop helix repressor Drosophila sensory organ formation
0.14052135.12954721.html.plaintext.txt	416	Distinct protein degradation mechanisms mediated Cul1 Cul3 controlling Ci stability Drosophila eye development
0.14052135.12954721.html.plaintext.txt	417	cAMP dependent protein kinase Hedgehog act antagonistically regulating decapentaplegic transcription Drosophila imaginal discs
0.14052135.12954721.html.plaintext.txt	418	Dorsal ventral signaling Drosophila eye
0.14052135.12954721.html.plaintext.txt	419	Mechanism hedgehog signaling Drosophila eye development
0.14052135.12954721.html.plaintext.txt	420	Identification two bone morphogenetic protein type I receptors Drosophila evidence Brk25D decapentaplegic receptor
0.14052135.12954721.html.plaintext.txt	421	Induction Drosophila eye development Decapentaplegic
0.14052135.12954721.html.plaintext.txt	422	Mutations alter timing pattern cubitus interruptus gene expression Drosophila melanogaster
0.14052135.12954721.html.plaintext.txt	423	Function Hedgehog genes zebrafish retinal development
0.14052135.12954721.html.plaintext.txt	424	Hedgehog activity gradient contributes axial patterning Drosophila wing
0.14052135.12954721.html.plaintext.txt	425	The regulation hedgehog decapentaplegic Drosophila eye imaginal disc development
0.14052135.12954721.html.plaintext.txt	426	Hedgehog indirect regulator morphogenetic furrow progression Drosophila eye
0.14052135.12954721.html.plaintext.txt	427	Regulation furrow progression Drosophila eye cAMP dependent protein kinase A
0.14052135.12954721.html.plaintext.txt	428	Neuronal differentiation Drosophila ommatidium
0.14052135.12954721.html.plaintext.txt	429	An EGFREbiSno pathway promotes Delta expression inactivating SuHSMRTER repression inductive Notch signaling
0.14052135.12954721.html.plaintext.txt	430	A cell autonomous ubiquitous marker analysis Drosophila genetic mosaics
0.14052135.12954721.html.plaintext.txt	431	Mad acts downstream Dpp receptors revealing differential requirement dpp signaling initiation propagation morphogenesis Drosophila eye
0.14052135.12954721.html.plaintext.txt	432	Pattern formation Drosophila retina
0.14052135.12954721.html.plaintext.txt	433	In The Development Drosophila melanogaster Vol
0.14052135.12954721.html.plaintext.txt	434	Cold Spring Harbor NY Cold Spring Harbor Laboratory Press
0.14052135.12954721.html.plaintext.txt	435	Analysis genetic mosaics developing adult Drosophila tissues
0.34315994.16141216.html.plaintext.txt	0	Bovine Prion Protein Gene PRNP Promoter Polymorphisms Modulate PRNP Expression May Be Responsible Differences Bovine Spongiform Encephalopathy Susceptibility Petra Sander Henning Hamann Cord Drogemuller Kseniya Kashkevich Katrin Schiebel Tosso Leeb1
0.34315994.16141216.html.plaintext.txt	1	From Institute Animal Breeding Genetics University Veterinary Medicine Bunteweg 17p 30559 Hannover Germany Institute Biochemistry University Erlangen Nurnberg Fahrstrasse 17 91054 Erlangen Germany
0.34315994.16141216.html.plaintext.txt	2	Received publication June 10 2005 revised form July 20 2005
0.34315994.16141216.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The susceptibility humans variant Creutzfeldt Jakob disease greatly influenced polymorphisms within human prion protein gene PRNP
0.34315994.16141216.html.plaintext.txt	4	Similar genetic differences exist sheep PRNP polymorphisms modify susceptibility scrapie
0.34315994.16141216.html.plaintext.txt	5	However known coding polymorphisms within bovine PRNP gene little effect bovine spongiform encephalopathy BSE susceptibility cattle
0.34315994.16141216.html.plaintext.txt	6	We recently found tentative association PRNP promoter polymorphisms BSE susceptibility German cattle Sander P
0.34315994.16141216.html.plaintext.txt	7	2004 Neurogenetics 5 19 25
0.34315994.16141216.html.plaintext.txt	8	A plausible hypothesis explaining observation could bovine PRNP promoter polymorphisms cause changes PRNP expression might responsible differences BSE incubation time andor BSE susceptibility
0.34315994.16141216.html.plaintext.txt	9	To test hypothesis performed functional promoter analysis different bovine PRNP promoter alleles reporter gene assays vitro measuring PRNP mRNA levels calves different PRNP genotypes vivo
0.34315994.16141216.html.plaintext.txt	10	Two variable sites 23 bp insertiondeletion indel polymorphism containing RP58 binding site 12 bp indel polymorphism containing SP1 binding site investigated
0.34315994.16141216.html.plaintext.txt	11	Band shift assays indicated differences transcription factor binding different alleles two polymorphisms
0.34315994.16141216.html.plaintext.txt	12	Reporter gene assays demonstrated interaction two postulated transcription factors lower expression levels insins allele compared deldel allele
0.34315994.16141216.html.plaintext.txt	13	The vivo data revealed substantial individual variation PRNP expression different tissues
0.34315994.16141216.html.plaintext.txt	14	In intestinal lymph nodes expression levels differed different PRNP genotypes
0.34315994.16141216.html.plaintext.txt	15	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Bovine spongiform encephalopathy BSE2 bovine analog variant Creutzfeldt Jakob disease humans scrapie sheep chronic wasting disease elk deer feline spongiform encephalopathy cats transmissible mink encephalopathy
0.34315994.16141216.html.plaintext.txt	16	The causative agents transmissible spongiform encephalopathies infectious proteins called prions according widely accepted hypothesis Prusiner 2
0.34315994.16141216.html.plaintext.txt	17	Normal host cellular prion protein PrPc changes conformation due triggering inoculated scrapie PrPSC
0.34315994.16141216.html.plaintext.txt	18	Ingestion meat bone meal scrapie infected sheep BSE infected cattle initiated large BSE outbreak United Kingdom last decade 20th century 3
0.34315994.16141216.html.plaintext.txt	19	Prions transported eventually gastrointestinal tract brain spongiform degeneration brain structure leads neurodegenerative disorder
0.34315994.16141216.html.plaintext.txt	20	There evidence immune system involved process
0.34315994.16141216.html.plaintext.txt	21	Specifically intestinal lymph nodes B lymphocytes follicular dendritic cells spleen essential carrying PrPSc target organ brain 4 9
0.34315994.16141216.html.plaintext.txt	22	At least transmissible spongiform encephalopathies host genetic factors modulate susceptibility prion infection
0.34315994.16141216.html.plaintext.txt	23	This phenomenon initially discovered sheep several mutations within coding sequence prion protein gene PRNP known lead increased decreased scrapie susceptibility 10 14
0.34315994.16141216.html.plaintext.txt	24	In humans polymorphism codon 129 PRNP coding sequence strongly correlated susceptibility variant Creutzfeldt Jakob disease human variant Creutzfeldt Jakob disease patients share homozygous Met129Met129 genotype whereas Val129Val129 heterozygous individuals diagnosed variant Creutzfeldt Jakob disease far
0.34315994.16141216.html.plaintext.txt	25	However cattle none known polymorphisms within bovine PRNP coding sequence seem influence BSE susceptibility
0.34315994.16141216.html.plaintext.txt	26	Alternatively speculated promoter region PRNP gene might influence expression level protein thus incubation period transmissible spongiform encephalopathies 15
0.34315994.16141216.html.plaintext.txt	27	We previously reported first tentative association BSE susceptibility polymorphisms PRNP gene promoter 1
0.34315994.16141216.html.plaintext.txt	28	In previous study allele frequencies two linked insertiondeletion indel polymorphisms within bovine PRNP promoter differed significantly 48 healthy 43 BSE affected German cattle analyzed
0.34315994.16141216.html.plaintext.txt	29	The common haplotypes two polymorphisms contained either insertions referred insins deletions referred deldel
0.34315994.16141216.html.plaintext.txt	30	The frequency deldel haplotype higher BSE affected group
0.34315994.16141216.html.plaintext.txt	31	We therefore hypothesized observed differences haplotype frequencies may reflect differences PRNP promoter activity
0.34315994.16141216.html.plaintext.txt	32	According hypothesis deldel allele represented affected group show stronger promoter activity insins allele
0.34315994.16141216.html.plaintext.txt	33	To test hypothesis investigated functional properties different allelic variants bovine PRNP promoter performing reporter gene assays vitro quantitative real time qRT PCR vivo
0.34315994.16141216.html.plaintext.txt	34	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES In Silico Analysis Transcription Factor binding Sites The computer software MatInspector used scan bovine PRNP promoter region possible transcription factor binding sites 16
0.34315994.16141216.html.plaintext.txt	35	The region spanned positions 46754 51993 according bovine PRNP genomic sequence GenBankTM accession number AJ298878 including putative promoter 17
0.34315994.16141216.html.plaintext.txt	36	Different allelic variants promoter sequence determined previously 1 analyzed differences transcription factor binding site content see Fig
0.34315994.16141216.html.plaintext.txt	37	Electrophoretic Mobility Shift Assay EMSA Nuclear extracts prepared bovine brain PT cells transfected vector pRP58 see following protocol Dignam et al
0.34315994.16141216.html.plaintext.txt	38	Approximately 50 bp oligonucleotides surrounding polymorphisms 1980TC 1594indel23bp 85GT 300indel12bp 571AG 709AG designed alleles see Fig
0.34315994.16141216.html.plaintext.txt	39	The oligonucleotides sequence surrounding polymorphism 571A G used EMSA gel shift assay system Promega Mannheim Germany according manufacturers instructions
0.34315994.16141216.html.plaintext.txt	40	The oligonucleotides double stranded 32P labeled used 25 fmol DNA protein binding reactions 1 microg polydI C 10 microg bovine serum albumin 5x binding buffer 250 mM HEPESNaOH pH 7
0.34315994.16141216.html.plaintext.txt	41	5 M NaCl 5 mM dithiothreitol 5 mM EDTA 25 glycerol 2
0.34315994.16141216.html.plaintext.txt	42	75 microg nuclear extract 300 ng recombinant human SP1 extract Promega possibly 250 fmol 2
0.34315994.16141216.html.plaintext.txt	43	5 pmol unlabeled double stranded oligonucleotide specific nonspecific competitor
0.34315994.16141216.html.plaintext.txt	44	The binding reactions incubated 10 min ice
0.34315994.16141216.html.plaintext.txt	45	Electrophoresis samples native 8 polyacrylamide gel 191 acrylamidebisacrylamide 1x Tris borateEDTA buffer followed autoradiography
0.34315994.16141216.html.plaintext.txt	46	Promoter Reporter Gene Constructs All constructs prepared shown Fig
0.34315994.16141216.html.plaintext.txt	47	A PCR product including 2676 bp 5 flanking sequence exon 1 intron 1 first part exon 2 bovine PRNP gene cloned MluI BglII fragment promoterless reporter vector pGL3 Basic Promega
0.34315994.16141216.html.plaintext.txt	48	The following primers used PCR 5 ATA ATT ACG CGT TCA CCA TTT CCG AAT ACA TCC 3 forward 5 TAA TTA AGA TCT TGG ATT TGT GTC TCT GGG AAG 3 reverse
0.34315994.16141216.html.plaintext.txt	49	The template generating fragment bovine bacterial artificial chromosome clone CH240 120O1
0.34315994.16141216.html.plaintext.txt	50	The resulting construct represented new vector pDelDel deletions 1594indel23bp 300indel12bp
0.34315994.16141216.html.plaintext.txt	51	The mutant 12 bp insertion 300indel12bp termed pDelIns generated splice overlap extension reaction template pDelDel 19
0.34315994.16141216.html.plaintext.txt	52	The mutant pInsDel 23 bp insertion 1594indel23bp made primer extension ligation template pDelDel
0.34315994.16141216.html.plaintext.txt	53	The construct insertions pInsIns derived combining plasmids pInsDel pDelIns using restriction sites MluI AatII
0.34315994.16141216.html.plaintext.txt	54	The constructs p12Ins p12Del created elongase PCR amplification Invitrogen Karlsruhe Germany according manufacturers protocol touch protocol 20 using primers 5 CAA GAG ATC TAG AGA TGC TTC ACT GCC CCC AAT GTG CC 3 forward 5 ATT TAG ATC TCT GGG AAG ACA GAT GCT TCG GGG CGG 3 reverse
0.34315994.16141216.html.plaintext.txt	55	Genomic DNA animal homozygous 12 bp insertion DNA animal homozygous 12 bp deletion used template
0.34315994.16141216.html.plaintext.txt	56	The PCR products cloned pGL3 Basic vector
0.34315994.16141216.html.plaintext.txt	57	View larger version 13K FIGURE 1
0.34315994.16141216.html.plaintext.txt	58	Schematic representation 5 end bovine PRNP gene reporter gene constructs used study
0.34315994.16141216.html.plaintext.txt	59	A first two untranslated exons bovine PRNP gene indicated boxes
0.34315994.16141216.html.plaintext.txt	60	Six naturally occurring polymorphisms affect predicted transcription factor binding sites indicated schematic gene map
0.34315994.16141216.html.plaintext.txt	61	The positions polymorphisms given respect transcription start site position 49430 GenBankTM accession number AJ298878
0.34315994.16141216.html.plaintext.txt	62	Six transcription factors whose binding sites affected polymorphisms indicated respective alleles containing binding sites parentheses
0.34315994.16141216.html.plaintext.txt	63	B six reporter gene constructs pGL3 Basic vector prepared
0.34315994.16141216.html.plaintext.txt	64	In constructs various alleles bovine PRNP promoter drive expression firefly luciferase luc
0.34315994.16141216.html.plaintext.txt	65	The RP58 expressing vector pRP58 generated cloning PCR product cDNA human RP58 gene pGL3 Control vector Promega replacing luciferase box
0.34315994.16141216.html.plaintext.txt	66	PCR carried template clone IRAKp961E13474Q
0.34315994.16141216.html.plaintext.txt	67	The clone carries one discrepancy respect RP58 GenBankTM accession number NM006352 c
0.34315994.16141216.html.plaintext.txt	68	This potential cloning artifact corrected site directed mutagenesis pRP58 conformed accession number NM006352
0.34315994.16141216.html.plaintext.txt	69	The restriction sites HindIII XbaI used cloning PCR product pGL3 Control vector
0.34315994.16141216.html.plaintext.txt	70	The expression vector pRSVSP1 kind gift M
0.34315994.16141216.html.plaintext.txt	71	Wegner University Erlangen Nurnberg
0.34315994.16141216.html.plaintext.txt	72	The XbaI fragment plasmid pSP1 778C 21 cloned vector pRSV described 22
0.34315994.16141216.html.plaintext.txt	73	All PCRs carried proofreading polymerases constructs sequenced verify successful cloning
0.34315994.16141216.html.plaintext.txt	74	Cell Culture Transient Transfection Experiments The bovine cell lines KOP esophageal tissue calf PT kidney cells calf obtained Friedrich Loeffler Institute Isle Riems Germany
0.34315994.16141216.html.plaintext.txt	75	These cell lines cultured Dulbeccos modified Eagles medium stable glutamine 1 gliter D glucose Biochrom AG Berlin Germany supplemented 10 fetal bovine serum Biochrom AG 38 degrees C 5 CO2
0.34315994.16141216.html.plaintext.txt	76	For transient transfection assays 6 x 104 PT cells 3 x 104 KOP cells seeded 24 h transfection 12 well plates Biochrom AG
0.34315994.16141216.html.plaintext.txt	77	Cells reaching 60 80 confluency transfected using 1
0.34315994.16141216.html.plaintext.txt	78	2 microlof Effectene reagent 1
0.34315994.16141216.html.plaintext.txt	79	2 microl Enhancer reagent Qiagen GmbH Hilden Germany
0.34315994.16141216.html.plaintext.txt	80	If constructs transfected without transcription factor building plasmid 135 ngwell test construct 15 ngwell 10 pRL TK Renilla luciferase reference control plasmid Promega used
0.34315994.16141216.html.plaintext.txt	81	If cotransfection pRSVSP1 andor pRP58 performed 75 ngwell test construct 15 ngwell pRL TK 30 ngwell transcription factor plasmids used
0.34315994.16141216.html.plaintext.txt	82	The pRP58 plasmid also used alone transfections 450 ng25 cm2 flask nuclear extract preparation
0.34315994.16141216.html.plaintext.txt	83	Cells harvested 48 h transfection using 200 microl passive lysis buffer Promega
0.34315994.16141216.html.plaintext.txt	84	Lysates frozen experiments performed
0.34315994.16141216.html.plaintext.txt	85	All samples measured firefly Renilla luciferase activities Lucy 2 luminometer Anthos Mikrosysteme GmbH Krefeld Germany using Dual Luciferase assay system Promega
0.34315994.16141216.html.plaintext.txt	86	50 microl luciferase assay reagent II injected 10 microl lysate 2 delay time 10 measurement firefly luminescence 50 microl Stop Glo reagent injected well followed second luminescence measurement
0.34315994.16141216.html.plaintext.txt	87	Relative luciferase activities defined ratio firefly luciferase Renilla luciferase mean value construct relative pGL3 Control vector contains SV40 promoter
0.34315994.16141216.html.plaintext.txt	88	The constructs pDelDel pDelIns pInsDel pInsIns transfected alone three separate experiments
0.34315994.16141216.html.plaintext.txt	89	Cotransfection constructs combination transcription factor expressing plasmid pRP58 pRSVSP1 performed two three separate experiments respectively
0.34315994.16141216.html.plaintext.txt	90	All assays carried triplicates cell lines KOP PT
0.34315994.16141216.html.plaintext.txt	91	RNA Isolation qRT PCR Tissues 6 month old calves isolated liver spleen brain stem intestinal lymph nodes directly slaughtering commercial slaughterhouse
0.34315994.16141216.html.plaintext.txt	92	They stored RNAlater reagent Qiagen GmbH RNA isolated using RNeasy 96 universal tissue kit Qiagen GmbH according manufacturers instructions
0.34315994.16141216.html.plaintext.txt	93	Reverse transcription cDNA performed using 4 units Omniscript Qiagen GmbH oligodT primer T24V 2 microl isolated RNA 20 microl reaction
0.34315994.16141216.html.plaintext.txt	94	The expression levels bovine PRNP glyceraldehyde 3 phosphate dehydrogenase GAPDH used endogenous control determined using following primer pairs PRNP 5 TCC CAG AGA CAC AAA TCC AAC TT 3 forward 5 TGT GGC TTT TCA CCA TGA TGA 3 reverse GAPDH 5 GGC GTG AAC CAC GAG AAG TAT AA 3 forward 5 CCC TCC ACG ATG CCA AAG T 3 reverse
0.34315994.16141216.html.plaintext.txt	95	A specific TaqMan probe PCR VIC labeled PRNP probe 5 TGA ATC ACA GCA GAT ATA A 3 FAMTM labeled GAPDH probe 5 ATA CCC TCA AGA TTG TCA GCA ATG CCT CCT 3 also used
0.34315994.16141216.html.plaintext.txt	96	qRT PCR carried ABI 7300 sequence detection system Applied Biosystems Darmstadt Germany 20 microl reaction containing TaqMan Universal MasterMix Applied Biosystems 50 microM forward primer 50 microM reverse primer 10 microM TaqMan probe annealing elongation temperature 60 degrees C
0.34315994.16141216.html.plaintext.txt	97	A standard curve linearized plasmids carrying cloned target sequence PRNP GAPDH genes arranged 5 log levels plate
0.34315994.16141216.html.plaintext.txt	98	The PRNP expression level normalized dividing bovine GAPDH expression level
0.34315994.16141216.html.plaintext.txt	99	All assays performed duplicates
0.34315994.16141216.html.plaintext.txt	100	DNA Isolation Genotyping A second piece tissue sample used RNA isolation used DNA isolation Nucleospin 96 tissue kit Macherey Nagel Duren Germany
0.34315994.16141216.html.plaintext.txt	101	To determine genotype respect indel polymorphisms 1594indel23bp 300indel12bp PCRs flanking polymorphisms carried described product sizes evaluated agarose gels 1
0.34315994.16141216.html.plaintext.txt	102	Statistical Analysis Differences constructs tested significance using procedure MIXED SAS software package 23
0.34315994.16141216.html.plaintext.txt	103	A linear model applied including effects constructs repeated measurements
0.34315994.16141216.html.plaintext.txt	104	Contrasts least square means calculated tested significance cell lines separately
0.34315994.16141216.html.plaintext.txt	105	All p values provided supplemetal Tables 1 3
0.34315994.16141216.html.plaintext.txt	106	The model used qRT PCR data four different bovine tissues
0.34315994.16141216.html.plaintext.txt	107	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Putative Transcription Factor binding Sites The bovine PRNP promoter region positions 2676 2564 screened silico transcription factor binding sites
0.34315994.16141216.html.plaintext.txt	108	This region comprises 5 flanking sequence well intron 1 shown regions contribute promoter activity 17
0.34315994.16141216.html.plaintext.txt	109	All alleles polymorphic position screened transcription factor binding sites
0.34315994.16141216.html.plaintext.txt	110	This led identification 18 differences putative transcription factor binding sites different alleles
0.34315994.16141216.html.plaintext.txt	111	We excluded 12 differential sites based properties potentially binding transcription factors
0.34315994.16141216.html.plaintext.txt	112	For example follow differential transcription factor binding site hepatic nuclear factor 4 transcription factor involved mainly liverspecific gene regulation
0.34315994.16141216.html.plaintext.txt	113	Consequently selected six transcription factor binding sites seemed likely functionally relevant regulation PRNP transcription TABLE ONE
0.34315994.16141216.html.plaintext.txt	114	View table TABLE ONE Polymorphisms within bovine PRNP promoter affect transcription factor binding sites
0.34315994.16141216.html.plaintext.txt	115	Binding Putative Transcription Factors Selected Sections PRNP Promoter Oligonucleotides surrounding six selected polymorphic transcription factor binding sites designed used probes EMSAs
0.34315994.16141216.html.plaintext.txt	116	Every probe designed one allele polymorphisms described TABLE ONE
0.34315994.16141216.html.plaintext.txt	117	View larger version 87K FIGURE 2
0.34315994.16141216.html.plaintext.txt	118	EMSA analysis SP1 binding PRNP promoter sequence
0.34315994.16141216.html.plaintext.txt	119	25 fmol 32P radiolabeled double stranded oligonucleotides Oligo corresponding two alleles 12 bp indel polymorphism intron 1 used probes 12 5 CTC GGA ATG TGG GCG GGG GCC GCG GCT GGC TGG TCC CCC TC 3 sense 12 5 CAT TTA CTC GGA ATG TGG GCT GGC TGG TCC CCC TCC CGA G 3 sense
0.34315994.16141216.html.plaintext.txt	120	Competitions performed addition unlabeled double stranded oligonucleotides 250 fmol 2
0.34315994.16141216.html.plaintext.txt	121	5 pmol binding reaction
0.34315994.16141216.html.plaintext.txt	122	The binding buffer contained 0
0.34315994.16141216.html.plaintext.txt	123	Purified SP1 protein 300 nglane used positive control
0.34315994.16141216.html.plaintext.txt	124	25 microglane prepared bovine brain
0.34315994.16141216.html.plaintext.txt	125	Negative controls neg lacked protein
0.34315994.16141216.html.plaintext.txt	126	The 12 oligonucleotide probe produced shift purified SP1 protein nuclear extract bovine brain
0.34315994.16141216.html.plaintext.txt	127	The observed SP1 binding 12 oligonucleotide specific could competed unlabeled 12 oligonucleotide nonspecific unlabeled 12 oligonucleotide
0.34315994.16141216.html.plaintext.txt	128	The shifted band nuclear extract size shifted band purified SP1 also corroborates identity bound protein
0.34315994.16141216.html.plaintext.txt	129	The labeled 12 oligonucleotide bind SP1
0.34315994.16141216.html.plaintext.txt	130	The striking differences transcription factor binding different PRNP alleles observed case 12 bp indel polymorphism position 300 transcription factor SP1 Fig
0.34315994.16141216.html.plaintext.txt	131	The 12 bp insertion allele able bind SP1 whereas 12 bp deletion allele bind SP1
0.34315994.16141216.html.plaintext.txt	132	EMSA also performed potential RP58 binding site within 23 bp indel polymorphisms position 1594 5 flanking sequence
0.34315994.16141216.html.plaintext.txt	133	Using brain nuclear extract used SP1 EMSAs band shifts initially visible data shown
0.34315994.16141216.html.plaintext.txt	134	However reproducible band shifts nuclear extracts pRP58 overexpressing cells obtained Fig
0.34315994.16141216.html.plaintext.txt	135	The experiment showed 23 bp insertion allele produced strong specific band shifts transcription factor RP58
0.34315994.16141216.html.plaintext.txt	136	However deletion allele produced weak band shift could competed unlabeled insertion allele indicating RP58 higher affinity insertion allele deletion allele
0.34315994.16141216.html.plaintext.txt	137	The polymorphic transcription factor binding sites POZ position 1980 neurogenin 1 position 85 AP2 position 571 EGR4 position 709 also evaluated similar EMSAs supplemental Fig
0.34315994.16141216.html.plaintext.txt	138	In four instances conclusive differences binding properties different respective alleles observed
0.34315994.16141216.html.plaintext.txt	139	Both allelic POZ probes produced identical band shift patterns two shifted bands probe
0.34315994.16141216.html.plaintext.txt	140	In case 85G T polymorphism allelic probes led shifted band size
0.34315994.16141216.html.plaintext.txt	141	The shifted band G allele higher intensity however allele predicted non binding allele NEUROG1 polymorphism studied
0.34315994.16141216.html.plaintext.txt	142	Both allelic AP2 probes produce band shift whereas control oligonucleotide perfect AP2 consensus site led shifted band expected size
0.34315994.16141216.html.plaintext.txt	143	In case EGR4 allelic probes produced identical band shift patterns two bands probe
0.34315994.16141216.html.plaintext.txt	144	This led conclusion 23 12 bp indel polymorphisms involved differential allelic PRNP promoter modulation thus PrPc expression
0.34315994.16141216.html.plaintext.txt	145	Therefore experiments focused two polymorphisms
0.34315994.16141216.html.plaintext.txt	146	View larger version 95K FIGURE 3
0.34315994.16141216.html.plaintext.txt	147	EMSA analysis RP58 binding PRNP promoter sequence
0.34315994.16141216.html.plaintext.txt	148	25 fmol 32P radiolabeled double stranded oligonucleotides Oligo corresponding two alleles 23 bp indel polymorphism 5 flanking sequence used probes 23 5 TAG CTA TCA CGT CAA TCT CAG ATG TCT TCC CAA CAG CAG CCT CAG ACG TCA TG 3 sense 23 5 ATT CCA ACT CCT AGC TAT CAC GTC AAG CCT CAG ACG TCA TGG GGC AGA GTC A 3 sense
0.34315994.16141216.html.plaintext.txt	149	Competitions performed addition unlabeled 23 23 oligonucleotide 250 fmol 2
0.34315994.16141216.html.plaintext.txt	150	5 pmol unlabeled APG oligonucleotide 2
0.34315994.16141216.html.plaintext.txt	151	5 pmol sense 5 GCG GTG AGG AGT GCC GGA GCG TCC GTG GGC CCC CAG CCG C 3 binding reaction
0.34315994.16141216.html.plaintext.txt	152	The binding buffer contained 1
0.34315994.16141216.html.plaintext.txt	153	33 microglane prepared PT cells transfected expression construct transcription factor RP58
0.34315994.16141216.html.plaintext.txt	154	Negative controls neg lacked protein
0.34315994.16141216.html.plaintext.txt	155	The 23 oligonucleotide produced strong band shift could competed excess unlabeled 23 oligonucleotide
0.34315994.16141216.html.plaintext.txt	156	Competition 23 oligonucleotide reduced intensity shifted bands however completely abolish binding RP58 23 oligonucleotide
0.34315994.16141216.html.plaintext.txt	157	On hand 23 oligonucleotide produced weak band shift RP58 could competed unlabeled 23 23 oligonucleotides
0.34315994.16141216.html.plaintext.txt	158	The completely unrelated APG oligonucleotide able compete either 23 23 band shift
0.34315994.16141216.html.plaintext.txt	159	Promoter Reporter Gene Assays Plasmids pDelDel pDelIns pInsDel pInsIns p12Ins p12Del carrying firefly luciferase open reading frame control different PRNP promoter alleles cotransfected two different bovine cell lines PT KOP pRL TK normalization vector Fig
0.34315994.16141216.html.plaintext.txt	160	Each assay carried triplicates 6 PT 5 KOP separate weeks nPT 18 nKOP 15
0.34315994.16141216.html.plaintext.txt	161	Every week cells also transfected pGL3 Control vector standardization six five passages
0.34315994.16141216.html.plaintext.txt	162	The activity firefly luciferase compared Renilla luciferase reflected promoter activity
0.34315994.16141216.html.plaintext.txt	163	The mean values test construct indicated Fig
0.34315994.16141216.html.plaintext.txt	164	In cell lines p12Ins vector yielded significantly higher expression level p12Del vector p 0
0.34315994.16141216.html.plaintext.txt	165	The order expression levels longer reporter gene constructs PT cells follows pDelDel pDelIns pInsDel pInsIns
0.34315994.16141216.html.plaintext.txt	166	In KOP cells order follows pDelIns pDelDel pInsDel pInsIns
0.34315994.16141216.html.plaintext.txt	167	In cell lines pDelDel vector yielded significantly higher expression levels pInsIns vector pKOP 0
0.34315994.16141216.html.plaintext.txt	168	Thus effect isolated 12 bp indel polymorphism shorter reporter gene constructs p12Ins p12Del reversed longer reporter gene constructs pInsIns pDelDel
0.34315994.16141216.html.plaintext.txt	169	The pInsDel pDelIns constructs displayed inconsistent expression levels two cell lines
0.34315994.16141216.html.plaintext.txt	170	However must kept mind pDelIns rare haplotype pInsDel yet found animal previous studies 1 present qRT PCR study see
0.34315994.16141216.html.plaintext.txt	171	View larger version 36K FIGURE 4
0.34315994.16141216.html.plaintext.txt	172	Reporter gene assays effect different polymorphisms bovine PRNP promoter activity PT KOP cells
0.34315994.16141216.html.plaintext.txt	173	The data show expression levels firefly luciferase activity construct compared Renilla luciferase activity pRL TK normalization vector
0.34315994.16141216.html.plaintext.txt	174	The pGL3 Control vector standard SV40 promoter used normalization different experiments relative light units RLU firefly luciferaseconstructRenilla luciferaseconstructfirefly luciferasecontrolRenilla luciferasecontrol
0.34315994.16141216.html.plaintext.txt	175	Cells harvested 48 h transfection
0.34315994.16141216.html.plaintext.txt	176	The letters represent significantly different expression levels p 0
0.34315994.16141216.html.plaintext.txt	177	two columns share common letter significantly different p 0
0.34315994.16141216.html.plaintext.txt	178	Promoter Reporter Gene Assays Overexpression Specific Transcription Factors We transfected PT KOP cell lines pDelDel pDelIns pInsDel pInsIns p12Ins p12Del plasmids similar initial reporter gene assays
0.34315994.16141216.html.plaintext.txt	179	In addition reporter gene constructs transcription factor expressing plasmids pRP58 pRSVSP1 added wells
0.34315994.16141216.html.plaintext.txt	180	This study performed triplicates 3 PT 2 KOP separate weeks nPT 9 nKOP 6 supplemental Fig
0.34315994.16141216.html.plaintext.txt	181	The addition pRSVSP1 p12Ins p12Del vectors resulted elevated luciferase expression levels constructs PT cells p12Del KOP cells PT pp12Ins 0
0.34315994.16141216.html.plaintext.txt	182	In PT cells increase expression also much pronounced p12Del p12Ins
0.34315994.16141216.html.plaintext.txt	183	The p12Del reporter gene construct includes three putative SP1 binding sites positions 98 93 351 356 901 906
0.34315994.16141216.html.plaintext.txt	184	In addition three SP1 binding sites p12Ins vector harbors additional one within 12 bp insertion position 300
0.34315994.16141216.html.plaintext.txt	185	In long constructs overexpression SP1 consistently led slightly increased luciferase expression 23 bp deletion present position 1594 regardless whether 12 bp indel polymorphism SP1 site present
0.34315994.16141216.html.plaintext.txt	186	However three four assays 23 bp insertion position 1594 overexpression SP1 significant effect luciferase expression
0.34315994.16141216.html.plaintext.txt	187	SP1 overexpression also led increase reporter gene expression pInsIns PT cell line
0.34315994.16141216.html.plaintext.txt	188	Thus presence 23 bp insertion 5 flanking sequence seemed reduce SP1 induced activation PRNP promoter
0.34315994.16141216.html.plaintext.txt	189	The overexpression recombinant RP58 also increased luciferase expression four constructs 23 bp deletion position 1594 whereas expression level change significantly four constructs 23 bp insertion
0.34315994.16141216.html.plaintext.txt	190	qRT PCR Experiments We collected 96 bovine tissue samples brain stem intestinal lymph nodes spleen liver
0.34315994.16141216.html.plaintext.txt	191	RNA isolated used qRT PCR experiments measuring absolute transcript quantities PRNP GAPDH genes standard curve method
0.34315994.16141216.html.plaintext.txt	192	A relative quantification performed dividing PRNP expression level GAPDH expression level
0.34315994.16141216.html.plaintext.txt	193	DNA tissue samples used genotyping regard 23 12 bp indel polymorphisms
0.34315994.16141216.html.plaintext.txt	194	Five different genotypes identified 23del12del n 27 30 23del12het n 5 6 23het12het n 39 41 23het12ins n 6 7 23ins12ins n 15 16
0.34315994.16141216.html.plaintext.txt	195	The results qRT PCR evaluated respect five genotype groups
0.34315994.16141216.html.plaintext.txt	196	The expression levels four different tissues differed widely
0.34315994.16141216.html.plaintext.txt	197	The highest PRNP mRNA expression levels encountered brain followed spleen liver intestinal lymph nodes
0.34315994.16141216.html.plaintext.txt	198	Within tissue groups brain stem spleen liver showed significant differences mean expression levels respect genotypes
0.34315994.16141216.html.plaintext.txt	199	In lymph node samples 23het12ins expression levels lower 23del12del 23del12het 23het12het expression levels supplemental Fig
0.34315994.16141216.html.plaintext.txt	200	The raw data normal distribution
0.34315994.16141216.html.plaintext.txt	201	Often single animals showed dramatic variations relative average
0.34315994.16141216.html.plaintext.txt	202	Intestinal lymph node expression levels common genotypes shown Fig
0.34315994.16141216.html.plaintext.txt	203	The liver expression levels exception raw data fit better normal distribution smaller standard errors observed compared tissues
0.34315994.16141216.html.plaintext.txt	204	The complete qRT PCR data tissues shown supplemental Fig
0.34315994.16141216.html.plaintext.txt	205	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES In previous mutation analysis bovine PRNP gene 1 investigated region includes PRNP promoter
0.34315994.16141216.html.plaintext.txt	206	We hypothesized mutations affecting PRNP expression level might influence BSE incubation time andor BSE susceptibility
0.34315994.16141216.html.plaintext.txt	207	We demonstrated tentative association BSE susceptibility respect PRNP genotypes 23 bp indel polymorphisms 5 flanking sequence 12 bp indel polymorphism intron 1
0.34315994.16141216.html.plaintext.txt	208	The 12 bp indel polymorphism couple single nucleotide polymorphisms within putative promoter region strong linkage disequilibrium 23 bp indel polymorphism
0.34315994.16141216.html.plaintext.txt	209	We presumed one polymorphisms might influence promoter activity leading modified susceptibility
0.34315994.16141216.html.plaintext.txt	210	The mutations 1980TC 1594indel23bp 85GT 300indel 12bp 571AG 709AG preselected experiments silico analysis transcription factor binding sites
0.34315994.16141216.html.plaintext.txt	211	Allelic variants six potential transcription factor binding sites differ respect consensus binding sites involved transcription factors expressed relevant tissues BSE pathogenesis
0.34315994.16141216.html.plaintext.txt	212	These putative transcription factors SP1 AP2 RP58 NEUROG1 EGR4 POZ
0.34315994.16141216.html.plaintext.txt	213	SP1 ubiquitous protein involved regulation many promoters 24
0.34315994.16141216.html.plaintext.txt	214	AP2 plays role tissues ectodermal origin 25
0.34315994.16141216.html.plaintext.txt	215	RP58 named according function expressed mainly brain 26 27
0.34315994.16141216.html.plaintext.txt	216	It includes POZ domain described interactor SP1
0.34315994.16141216.html.plaintext.txt	217	It suggested POZ domain represses transcription interfering DNA binding activity SP1 28
0.34315994.16141216.html.plaintext.txt	218	EGR4 also called nerve growth factor induced clone C like neurogenin 1 protein likely involved brain function 29 30
0.34315994.16141216.html.plaintext.txt	219	The transcription factor POZ protein BCL6 plays role B cell differentiation represses transcription RP58 31
0.34315994.16141216.html.plaintext.txt	220	View larger version 13K FIGURE 5
0.34315994.16141216.html.plaintext.txt	221	Expression levels PRNP cattle intestinal lymph nodes different PRNP promoter genotypes
0.34315994.16141216.html.plaintext.txt	222	RNA isolated 96 bovine tissue samples
0.34315994.16141216.html.plaintext.txt	223	Transcript quantities analyzed qRT PCR
0.34315994.16141216.html.plaintext.txt	224	Absolute PRNP GAPDH expression levels determined standard curve method
0.34315994.16141216.html.plaintext.txt	225	The relative expression levels PRNP normalized bovine GAPDH PRNPGAPDH shown animals common genotypes 23ins12ins 23het12het 23del12del
0.34315994.16141216.html.plaintext.txt	226	The mean values genotype group indicated horizontal lines
0.34315994.16141216.html.plaintext.txt	227	All six transcription factors studied EMSAs
0.34315994.16141216.html.plaintext.txt	228	All oligonucleotide probes exception two allelic variants AP2 binding site produced band shifts
0.34315994.16141216.html.plaintext.txt	229	In case two indel polymorphisms observed band shifts differed allelic PRNP promoter variants
0.34315994.16141216.html.plaintext.txt	230	The specificity DNA protein interaction checked competition unlabeled probes
0.34315994.16141216.html.plaintext.txt	231	In case SP1 identity shifted band nuclear brain extract corroborated positive control experiment using purified recombinant SP1
0.34315994.16141216.html.plaintext.txt	232	The results RP58 EMSA suggest RP58 higher affinity 23 bp insertion allele
0.34315994.16141216.html.plaintext.txt	233	The weak affinity RP58 23 bp deletion allele surprising RP58 binding site duplicated one mismatch outside indel polymorphism
0.34315994.16141216.html.plaintext.txt	234	Following initial evidence EMSA experiments created reporter gene constructs polymorphisms every possible combination
0.34315994.16141216.html.plaintext.txt	235	The 12 bp indel polymorphism intron 1 deliberately included analysis previously shown intron 1 elements necessary bovine PRNP promoter activity 17
0.34315994.16141216.html.plaintext.txt	236	Our reporter gene assays revealed influence indel polymorphisms PRNP transcription rates
0.34315994.16141216.html.plaintext.txt	237	Surprisingly short construct 12 bp insertion alone resulted increased expression level whereas long construct combination 23 bp insertion 12 bp insertion caused decreased expression level
0.34315994.16141216.html.plaintext.txt	238	These findings compatible model RP58 binds 5 flanking sequence PRNP gene represses PRNP promoter activity interaction SP1 bound within intron 1 similar known RP58 SP1 interactions promoters 28
0.34315994.16141216.html.plaintext.txt	239	RP58 seems logical candidate repressing factor
0.34315994.16141216.html.plaintext.txt	240	At time identity repressing factor definitely proven
0.34315994.16141216.html.plaintext.txt	241	The EMSA results certainly hinted involvement RP58 however cotransfection experiments RP58 inconclusive
0.34315994.16141216.html.plaintext.txt	242	A possible explanation results recombinant human RP58 used indeed able bind recognition sequence within bovine promoter exert repressing function heterologous bovine system
0.34315994.16141216.html.plaintext.txt	243	The influence PRNP promoter genotype regard 23 12 bp indel polymorphisms PRNP expression vivo studied qRT PCR experiments
0.34315994.16141216.html.plaintext.txt	244	We chose tissue samples spleen brain stem intestinal lymph nodes importance infection route prions
0.34315994.16141216.html.plaintext.txt	245	The liver chosen control organ supposedly involved BSE pathogenesis
0.34315994.16141216.html.plaintext.txt	246	Only lymph nodes showed significant distribution five genotype groups
0.34315994.16141216.html.plaintext.txt	247	As expression level PRNP intestinal lymph nodes low compared organs result raises intriguing question whether low PRNP amounts intestinal lymph nodes rate limiting conversion cellular PrPc PrPSc spread BSE infection toward central nervous system
0.34315994.16141216.html.plaintext.txt	248	The higher expression level pDelDel plasmid consistent previous finding 23del12del genotype associated higher susceptibility BSE German cattle 1
0.34315994.16141216.html.plaintext.txt	249	Our results tentatively indicate individuals deletion alleles 23 bp indel polymorphism higher PRNP expression levels intestinal lymph nodes
0.34315994.16141216.html.plaintext.txt	250	The influence promoter polymorphism expression levels rather limited comparison observed variance
0.34315994.16141216.html.plaintext.txt	251	This might analyzed whole tissue samples may composed varying proportions different cell types
0.34315994.16141216.html.plaintext.txt	252	Future analyses performed single cell level e
0.34315994.16141216.html.plaintext.txt	253	situ hybridizations previously demonstrated PRNP expression completely uniform within lymph nodes 32
0.34315994.16141216.html.plaintext.txt	254	Despite large variance observed differences PRNP expression levels consistent notion 23 bp deletion allele associated higher susceptibility BSE German cattle
0.34315994.16141216.html.plaintext.txt	255	In conclusion shown two indel polymorphisms bovine PRNP promoter contain binding sites RP58 SP1 transcription factors modulate expression level PRNP vitro
0.34315994.16141216.html.plaintext.txt	256	Our vivo data show PRNP genotype may contribute observed high variance PRNP expression intestinal lymph nodes
0.34315994.16141216.html.plaintext.txt	257	FOOTNOTES This work supported Deutsche Forschungsgemeinschaft Grant Le103210 Bavarian Prion Research Initiative German TSE Research Platform cooperatively funded German Federal Ministries Consumer Protection Nutrition Agriculture Education Research
0.34315994.16141216.html.plaintext.txt	258	The costs publication article defrayed part payment page charges
0.34315994.16141216.html.plaintext.txt	259	This article must therefore hereby marked advertisement accordance 18 U
0.34315994.16141216.html.plaintext.txt	260	Section 1734 solely indicate fact
0.34315994.16141216.html.plaintext.txt	261	The line version article available httpwww
0.34315994.16141216.html.plaintext.txt	262	org contains supplemental Figs
0.34315994.16141216.html.plaintext.txt	263	1 Present address correspondence addressed Institute Genetics Bremgartenstr
0.34315994.16141216.html.plaintext.txt	264	41 31 631 2326 E Mail Tosso
0.34315994.16141216.html.plaintext.txt	265	2 The abbreviations used BSE bovine spongiform encephalopathy PrP prion protein PrPc cellular prion protein PrPSC scrapie prion protein indel insertiondeletion qRT quantitative real time EMSA electrophoretic mobility shift assay PT proximal tubular SP1 stimulating protein 1 RP58 repressor protein 58 kDa GAPDH glyceraldehyde 3 phosphate dehydrogenase POZ pox virus zinc finger protein AP2 activator protein 2 EGR4 early growth response 4 BCL6 B cell lymphoma 6
0.34315994.16141216.html.plaintext.txt	266	ACKNOWLEDGMENTS We thank D
0.34315994.16141216.html.plaintext.txt	267	Klippert Hasberg expert technical assistance
0.34315994.16141216.html.plaintext.txt	268	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Sander P
0.34315994.16141216.html.plaintext.txt	269	2004 Neurogenetics 5 19 25CrossRefMedline Order article via Infotrieve Prusiner S
0.34315994.16141216.html.plaintext.txt	270	95 13363 13383AbstractFree Full Text Eddy R
0.34315994.16141216.html.plaintext.txt	271	137 648Medline Order article via Infotrieve Blattler T
0.34315994.16141216.html.plaintext.txt	272	1997 Nature 389 69 73CrossRefMedline Order article via Infotrieve Daude N
0.34315994.16141216.html.plaintext.txt	273	17 334 349CrossRefMedline Order article via Infotrieve Huang F
0.34315994.16141216.html.plaintext.txt	274	83 267 271AbstractFree Full Text Mabbott N
0.34315994.16141216.html.plaintext.txt	275	77 6845 6854AbstractFree Full Text Maignien T
0.34315994.16141216.html.plaintext.txt	276	80 3035 3042AbstractFree Full Text Montrasio F
0.34315994.16141216.html.plaintext.txt	277	2000 Science 19 1257 1259CrossRef Goldmann W
0.34315994.16141216.html.plaintext.txt	278	87 2476 2480AbstractFree Full Text Hunter N
0.34315994.16141216.html.plaintext.txt	279	130 389 392Abstract Laplanche J
0.34315994.16141216.html.plaintext.txt	280	1993 Genomics 15 30 37CrossRefMedline Order article via Infotrieve Belt P
0.34315994.16141216.html.plaintext.txt	281	76 509 517Abstract Bossers A
0.34315994.16141216.html.plaintext.txt	282	74 1407 1414AbstractFree Full Text Bossers A
0.34315994.16141216.html.plaintext.txt	283	77 2669 2673Abstract Quandt K
0.34315994.16141216.html.plaintext.txt	284	23 4878 4884Abstract Inoue S
0.34315994.16141216.html.plaintext.txt	285	59 175 183CrossRefMedline Order article via Infotrieve Dignam J
0.34315994.16141216.html.plaintext.txt	286	11 1475 1489Abstract Horton R
0.34315994.16141216.html.plaintext.txt	287	217 270 279Medline Order article via Infotrieve Hecker K
0.34315994.16141216.html.plaintext.txt	288	1996 BioTechniques 20 478 485Medline Order article via Infotrieve Kadonaga J
0.34315994.16141216.html.plaintext.txt	289	1987 Cell 51 1079 1090CrossRefMedline Order article via Infotrieve de Wet J
0.34315994.16141216.html.plaintext.txt	290	7 725 737Medline Order article via Infotrieve SAS Institute Inc
0.34315994.16141216.html.plaintext.txt	291	11 1935 1943Medline Order article via Infotrieve Zhang J
0.34315994.16141216.html.plaintext.txt	292	1996 Nature 381 238 241CrossRefMedline Order article via Infotrieve Becker K
0.34315994.16141216.html.plaintext.txt	293	15 891 899CrossRefMedline Order article via Infotrieve Aoki K
0.34315994.16141216.html.plaintext.txt	294	273 26698 26704AbstractFree Full Text Lee D
0.34315994.16141216.html.plaintext.txt	295	277 26761 26768AbstractFree Full Text Crosby S
0.34315994.16141216.html.plaintext.txt	296	89 4739 4743AbstractFree Full Text Sun Y
0.34315994.16141216.html.plaintext.txt	297	2001 Cell 104 365 376CrossRefMedline Order article via Infotrieve Chang C
0.34315994.16141216.html.plaintext.txt	298	AbstractFree Full Text Paltrinieri S
0.34315994.16141216.html.plaintext.txt	299	52 1639 1645AbstractFree Full Text This Article Abstract Full Text PDF Supplemental Data All Versions Article 2804537408 recent M506361200v1 Purchase Article View Shopping Cart Alert article cited Alert correction posted Citation Map Services Email article friend Similar articles journal Similar articles PubMed Alert new issues journal Download citation manager Copyright Permissions Google Scholar Articles Sander P
0.34315994.16141216.html.plaintext.txt	300	PubMed PubMed Citation Articles Sander P
0.34315994.16141216.html.plaintext.txt	301	HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular Cellular Proteomics Journal Lipid Research Biochemistry Molecular Biology Education Copyright 2005 American Society Biochemistry Molecular Biology
0.16810405.12093820.html.plaintext.txt	0	Bye bye urinary gonadotrophins The use urinary gonadotrophins discouraged Roberto Matorras1 Francisco J
0.16810405.12093820.html.plaintext.txt	1	Human Reproduction Unit Hospital de Cruces Pais Vasco University Baracaldo Vizcaya Spain
0.16810405.12093820.html.plaintext.txt	2	Abstract Top Abstract Introduction References In view concerns regarding potential presence infectivity prion proteins human urinary gonadotrophin preparations together availability recombinant FSH recombinant LH argued use urinary gonadotrophins discouraged
0.16810405.12093820.html.plaintext.txt	3	Key words BSEnew variant CJDTSEurinary gonadotrophins
0.16810405.12093820.html.plaintext.txt	4	Introduction Top Abstract Introduction References Transmissible spongiform encephalopathies TSEs prion diseases fatal degenerative disorders central nervous system affect humans animals
0.16810405.12093820.html.plaintext.txt	5	Although TSEs like scrapie sheep known exist centuries bovine spongiform encephalopathy BSE recognized 15 years ago Glatzel Aguzzi 2001
0.16810405.12093820.html.plaintext.txt	6	New variant Creutzfeldt Jakob disease nvCJD humans probably caused consumption BSE infected materials mad cow disease
0.16810405.12093820.html.plaintext.txt	7	The nature infectious agent fully elucidated substantial evidence suggests devoid nucleic acids consists least part abnormal form host protein termed PrPC Glatzel Aguzzi 2001
0.16810405.12093820.html.plaintext.txt	8	Despite rarity prion diseases become important topic public health basic research connection nvCJD BSE also unusual biological attributes infectious agent Belay 1999 Glatzel Aguzzi 2001
0.16810405.12093820.html.plaintext.txt	9	It recently found prion protein isoform present urine animals humans affected TSEs Shaked et al
0.16810405.12093820.html.plaintext.txt	10	Most important prion protein also found urine hamsters inoculated prions long appearance clinical signs
0.16810405.12093820.html.plaintext.txt	11	However urinary prion protein failed cause prion disease hamsters inoculated intracerebrally Shaked et al
0.16810405.12093820.html.plaintext.txt	12	Although infectivity urine prions humans animals yet documented aforementioned report raises serious concerns regarding future use urinary gonadotrophins
0.16810405.12093820.html.plaintext.txt	13	This especially remarkable since compared recombinant FSH urinary gonadotrophins evident clinical benefits Daya Gunby 1999 Matorras et al
0.16810405.12093820.html.plaintext.txt	14	2000 whereas cost effectiveness studies reveal considerable advantages Balasch Barri 2001
0.16810405.12093820.html.plaintext.txt	15	Indeed recent commercialization recombinant LH LH administration recommended authors IVF treatment Levy et al
0.16810405.12093820.html.plaintext.txt	16	2000 obtained without using urinary gonadotrophins
0.16810405.12093820.html.plaintext.txt	17	Thus opinion use urinary gonadotrophins discouraged
0.16810405.12093820.html.plaintext.txt	18	Notes 1 To correspondence addressed Maria Diaz de Haro 7 6 iz 48013 Bilbao Spain
0.16810405.12093820.html.plaintext.txt	19	References Top Abstract Introduction References Balasch J
0.16810405.12093820.html.plaintext.txt	20	2001 Reflections cost effectiveness recombinant FSH assisted reproduction
0.16810405.12093820.html.plaintext.txt	21	1999 Transmissible spongiform encephalopathies humans
0.16810405.12093820.html.plaintext.txt	22	1999 Recombinant versus urinary follicle stimulating hormone ovarian stimulation assisted reproduction
0.16810405.12093820.html.plaintext.txt	23	2001 The shifting biology prions
0.16810405.12093820.html.plaintext.txt	24	2000 The role LH ovarian stimulation exogenous LH lets design future
0.16810405.12093820.html.plaintext.txt	25	2000 Recombinant human FSH versus highly purified urinary FSH randomized study intrauterine insemination husbands spermatozoa
0.16810405.12093820.html.plaintext.txt	26	2001 A protease resistant prion protein isoform present urine animals humans affected prion diseases
0.106755786.10970892.html.plaintext.txt	0	The Chaperone Protein BiP Binds Mutant Prion Protein Mediates Its Degradation Proteasome Taocong Jin Yaping Gu Gianluigi Zanusso ManSun Sy Anil Kumar Mark Cohen Pierluigi Gambetti Neena Singh
0.106755786.10970892.html.plaintext.txt	1	From Division Neuropathology Institute Pathology Case Western Reserve University Cleveland Ohio 44106
0.106755786.10970892.html.plaintext.txt	2	Received publication June 23 2000 revised form August 29 2000
0.106755786.10970892.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.106755786.10970892.html.plaintext.txt	4	Familial prion diseases thought result change structure mutant prion protein PrP takes pathogenic conformation
0.106755786.10970892.html.plaintext.txt	5	We examined role molecular chaperones folding normal mutant PrP Q217R PrP217 transfected neuroblastoma cells
0.106755786.10970892.html.plaintext.txt	6	In previous report showed although PrP217 forms escape endoplasmic reticulum quality control system aggregate post Golgi compartments significant proportion PrP217 retains C terminal glycosylphosphatidyl inositol signal peptide PrP32 exit endoplasmic reticulum Singh N
0.106755786.10970892.html.plaintext.txt	7	We studied folding turnover PrP32 understand mechanism abnormal PrP forms cause cellular toxicity cell culture model human brain carrying Gerstmann Straussler Scheinker disease Q217R mutation
0.106755786.10970892.html.plaintext.txt	8	In report show PrP32 remains associated chaperone BiP abnormally prolonged period time degraded proteasomal pathway
0.106755786.10970892.html.plaintext.txt	9	This study first demonstration BiP chaperoning folding PrP plays role maintaining quality control PrP maturation pathway
0.106755786.10970892.html.plaintext.txt	10	Our data provide new insight diverse pathways mutant PrP metabolism neurotoxicity
0.106755786.10970892.html.plaintext.txt	11	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.106755786.10970892.html.plaintext.txt	12	Prion diseases transmissible spongiform encephalopathies neurodegenerative disorders sporadic inherited acquired infection 1 2
0.106755786.10970892.html.plaintext.txt	13	The underlying pathogenetic event prion diseases conformational modification normal cellular prion protein PrPC1 soluble form predominant helical conformation pathogenic form aggregated rich sheets partially resistant proteinase K PK digestion PrPSc 1 3
0.106755786.10970892.html.plaintext.txt	14	According protein hypothesis PrPSc interacts directly host encoded PrPC converted PrPSc
0.106755786.10970892.html.plaintext.txt	15	PrPSc accumulates nervous tissue causes disease reaches critical threshold 1
0.106755786.10970892.html.plaintext.txt	16	Several lines evidence indicate PrPC PrPSc conversion mediated chaperones 4
0.106755786.10970892.html.plaintext.txt	17	Molecular chaperones Hsp104 GroEL shown promote conversion reaction mammalian PrPC cell free system conversion prion like proteins intact yeast cells 5 7
0.106755786.10970892.html.plaintext.txt	18	Several chemical chaperones shown act conversion inhibitors 5
0.106755786.10970892.html.plaintext.txt	19	Data transgenic animal models argue requirement accessory protein refolding PrPC PrPSc
0.106755786.10970892.html.plaintext.txt	20	This protein temporarily named protein X remains identified 1 may well cellular chaperone
0.106755786.10970892.html.plaintext.txt	21	In inherited forms human prion diseases include Gerstmann Straussler Scheinker GSS disease Creutzfeldt Jakob disease fatal familial insomnia mutations prion protein gene PRNP believed destabilize mutant PrP easily converts PrPSc 2 4
0.106755786.10970892.html.plaintext.txt	22	Our series studies using human neuroblastoma cell models inherited prion diseases indeed consistent hypothesis 8 9
0.106755786.10970892.html.plaintext.txt	23	Although models lead spontaneous formation PrPSc show PrP variants carrying human pathogenic mutation either become insoluble trapped intracellular compartments 9 rapidly degraded proteasomal system 8
0.106755786.10970892.html.plaintext.txt	24	If proteasomal function impaired mutant PrP accumulates insoluble weakly PK resistant form endoplasmic reticulum ER post ER compartments 8 9
0.106755786.10970892.html.plaintext.txt	25	These findings argue chaperones play double role inherited prion diseases
0.106755786.10970892.html.plaintext.txt	26	They likely involved conversion PrP PrPSc forms prion diseases 5 may also play role destabilizing effect PRNP mutations mutant PrP
0.106755786.10970892.html.plaintext.txt	27	Interaction mutant PrP chaperones might promote degradation delay conversion PrPSc helping explain conundrum inherited prion diseases often manifest clinically late life even though mutation present conception
0.106755786.10970892.html.plaintext.txt	28	To begin unravel role chaperones prion diseases PRNP transfected neuroblastoma cells used examine role ER localized molecular chaperones processing normal mutant PrP
0.106755786.10970892.html.plaintext.txt	29	The mutation PRNP codon 217 resulting substitution glutamine arginine Q217R mutant PrP PrP217 associated GSS disease phenotype presents seventh decade characterized slowly progressive dementia associated cerebellar extrapyramidal signs 10
0.106755786.10970892.html.plaintext.txt	30	The histopathological hallmark Q217R GSS variant presence PrP217 containing amyloid deposits neurofibrillary degeneration brain tissue 10
0.106755786.10970892.html.plaintext.txt	31	In previous study carried transfected neuroblastoma cell model GSS Q217R showed significant proportion PrP217 identified PrP32 retains anchor C terminal signal peptide fails acquire glycosyl phosphatidylinositol GPI anchor retained ER cellular quality control system
0.106755786.10970892.html.plaintext.txt	32	In study provide first evidence ER chaperone BiP binds PrP
0.106755786.10970892.html.plaintext.txt	33	It binds transiently PrPC forms PrP217 remains associated extended period time PrP32 subsequently degraded proteasomal pathway
0.106755786.10970892.html.plaintext.txt	34	At variance anchored forms PrP217 aggregated insoluble non ionic detergents partially resistant proteinase K PK digestion 9 relatively large portion PrP32 remains soluble sensitive PK digestion
0.106755786.10970892.html.plaintext.txt	35	We postulate association PrP32 BiP sequesters PrP32 prevents formation homoaggregates maintaining PrP32 relatively soluble PK sensitive
0.106755786.10970892.html.plaintext.txt	36	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.106755786.10970892.html.plaintext.txt	37	Materials Cell Culture Conditions Production Transfected Cell Lines The human neuroblastoma cell line M17 obtained Dr
0.106755786.10970892.html.plaintext.txt	38	Beidler Memorial Sloan Kettering Cancer Center New York
0.106755786.10970892.html.plaintext.txt	39	Opti MEM fetal bovine serum penicillinstreptomycin methionine cysteine free Dulbeccos modified Eagles medium DMEM LipofectAMINE Life Technologies Inc
0.106755786.10970892.html.plaintext.txt	40	hygromycin B lactacystin Calbiochem Tran35S label ICN Costa Mesa CA protein A agarose N glycosidase F endoglycosidase H Roche Molecular Biochemicals Indianapolis IN
0.106755786.10970892.html.plaintext.txt	41	All chemicals purchased Sigma
0.106755786.10970892.html.plaintext.txt	42	Transfected M17 cells expressing wild type mutant prion protein Q217R generated described 9
0.106755786.10970892.html.plaintext.txt	43	The endogenous PrP M17 cells expressed low levels barely detectable Western blotting immunoprecipitation whereas transfected wild type mutant PrP expression least 10 fold higher
0.106755786.10970892.html.plaintext.txt	44	All cultures maintained 37 degrees C Opti MEM supplemented 5 fetal calf serum penicillinstreptomycin humidified atmosphere containing 5 CO2
0.106755786.10970892.html.plaintext.txt	45	Cultures transfected cells supplemented 500 microgml hygromycin
0.106755786.10970892.html.plaintext.txt	46	Experiments performed bulk selected cells different times post transfection
0.106755786.10970892.html.plaintext.txt	47	For experiments cells replated overnight used 90 95 confluency
0.106755786.10970892.html.plaintext.txt	48	Plasmids containing normal mutant T34G hamster BiP cDNA kind gift Linda Hendershot St
0.106755786.10970892.html.plaintext.txt	49	Judes Childrens Research Hospital Memphis TN James Gaut University Michigan
0.106755786.10970892.html.plaintext.txt	50	The following antibodies used study anti KDEL monoclonal antibody peptide KDEL recognizes Grp94 BiP two proteins 64 47 kDa anti hamster BiP anti calreticulin anti Grp94 StressGen anti PrP 3F4 monoclonal antibody PrP residues 109 112 R
0.106755786.10970892.html.plaintext.txt	51	Kascsak New York State Institute Basic Research Developmental Disabilities anti calnexin rabbit immune serum A
0.106755786.10970892.html.plaintext.txt	52	Helenius Swiss Federal Institute Technology Zurich anti GPI SP mouse serum raised facility synthetic peptide representing GPI SP PrP
0.106755786.10970892.html.plaintext.txt	53	Metabolic Labeling Immunoprecipitation In typical experiment 9 x 106 cells used cell line
0.106755786.10970892.html.plaintext.txt	54	Immunoprecipitation performed essentially described 8 9 following modifications
0.106755786.10970892.html.plaintext.txt	55	For co immunoprecipitation experiments detection PrP chaperone complexes cells radiolabeled 50 microCiml Tran35S label 2 h methionine cysteine free DMEM 5 dialyzed serum washed phosphate buffered saline lysed buffer containing 2 Triton X 100 Tris buffered saline TBS Tris 20 mM NaCl 150 mM pH 7
0.106755786.10970892.html.plaintext.txt	56	4 containing mixture protease inhibitors
0.106755786.10970892.html.plaintext.txt	57	For co immunoprecipitation anti BiP lysates depleted ATP incubation 50 unitsml Apyrase Sigma 10 min prior immunoprecipitation
0.106755786.10970892.html.plaintext.txt	58	Cell debris cleared centrifugation 800 x g clarified cell lysates subjected immunoprecipitation appropriate antibodies presence 1 bovine serum albumin 0
0.106755786.10970892.html.plaintext.txt	59	Protein antibody complexes bound protein A agarose washed four times 0
0.106755786.10970892.html.plaintext.txt	60	5 ml wash buffer 150 mM NaCl 10 mM Tris HCl pH 7
0.106755786.10970892.html.plaintext.txt	61	1 mM phenylmethylsulfonyl fluoride bound protein eluted boiling sample buffer Tris HCl pH 6
0.106755786.10970892.html.plaintext.txt	62	8 3 SDS 10 glycerol 5 mercaptoethanol
0.106755786.10970892.html.plaintext.txt	63	For re immunoprecipitation second antibody eluted protein diluted 10 fold lysis buffer subjected immunoprecipitation
0.106755786.10970892.html.plaintext.txt	64	Both first second immunoprecipitates analyzed SDS PAGE fluorography
0.106755786.10970892.html.plaintext.txt	65	For pulse chase experiments cells preincubated presence absence indicated inhibitors lactacystin 80 microM ALLN 80 microM 1 h labeling 50 microCiml Tran35S label methionine cysteine free DMEM containing 5 dialyzed serum
0.106755786.10970892.html.plaintext.txt	66	Where indicated appropriate inhibitors included labeling chase medium
0.106755786.10970892.html.plaintext.txt	67	At indicated times cells washed phosphate buffered saline lysed subjected immunoprecipitation
0.106755786.10970892.html.plaintext.txt	68	SDS PAGE Western Blotting For detecting co immunoprecipitated BiP Western blotting radiolabeled cell lysates PrPC PrP217 cells subjected immunoprecipitation anti GPI SP antibody
0.106755786.10970892.html.plaintext.txt	69	Proteins eluted protein A agarose beads sample buffer fractionated SDS PAGE duplicate
0.106755786.10970892.html.plaintext.txt	70	One half gel processed fluorography whereas half electrophoretically transferred Immobilon P Millipore 2
0.106755786.10970892.html.plaintext.txt	71	Membranes containing transferred proteins blocked TBS containing 10 nonfat dry milk 0
0.106755786.10970892.html.plaintext.txt	72	1 Tween 20 1 h 37 degrees C probed anti KDEL antibody diluted 11000 dilution buffer TBS 1 normal goat serum 0
0.106755786.10970892.html.plaintext.txt	73	Immunoreactive bands detected anti mouse antibody conjugated horseradish peroxidase diluted 14000 visualized autoradiographic film ECL Amersham Pharmacia Biotech
0.106755786.10970892.html.plaintext.txt	74	Cell Homogenization Enzymatic Deglycosylation PrP217 cells radiolabeled absence presence ALLN 2 h membrane soluble fractions separated standard procedures
0.106755786.10970892.html.plaintext.txt	75	Briefly cells washed homogenized ice buffer containing 10 mM HEPES pH 7
0.106755786.10970892.html.plaintext.txt	76	5 mM dithiothreitol 10 strokes Kontes glass Dounce homogenizer
0.106755786.10970892.html.plaintext.txt	77	The homogenate checked microscopically cell lysis centrifuged pellet nuclei
0.106755786.10970892.html.plaintext.txt	78	The resulting supernatant centrifuged 100000 x g separate membrane soluble fractions supplemented 1 Triton X 100 1 bovine serum albumin 0
0.106755786.10970892.html.plaintext.txt	79	1 N laurylsarcosine subjected immunoprecipitation anti KDEL 3F4 antibodies
0.106755786.10970892.html.plaintext.txt	80	For deglycosylation radiolabeled immunoprecipitated proteins reprecipitated 5 volumes cold methanol resuspended denaturing buffer 0
0.106755786.10970892.html.plaintext.txt	81	Samples boiled 10 min deglycosylated N glycosidase F 1000 units 1 Nonidet P 40 25 mM sodium phosphate pH 7
0.106755786.10970892.html.plaintext.txt	82	5 endoglycosidase H 1000 units 50 mM sodium citrate pH 5
0.106755786.10970892.html.plaintext.txt	83	Proteins reprecipitated 5 volumes cold methanol 20 degrees C 2 h dissolved sample buffer resolved SDS PAGE fluorography
0.106755786.10970892.html.plaintext.txt	84	Cell Permeabilization Streptolysin O Permeabilization cells streptolysin O SLO performed described 11
0.106755786.10970892.html.plaintext.txt	85	In short 4 unitsml SLO activated buffer containing 115 mM KOAc 25 mM HEPES pH 7
0.106755786.10970892.html.plaintext.txt	86	5 mM MgCl2 10 mM dithiothreitol 37 degrees C 30 min
0.106755786.10970892.html.plaintext.txt	87	Cells washed transport buffer 115 mM KOAc 25 mM HEPES pH 7
0.106755786.10970892.html.plaintext.txt	88	5 mM MgCl2 incubated 3 ml activated SLO 30 min ice
0.106755786.10970892.html.plaintext.txt	89	The cells washed three times cold transport buffer incubated 37 degrees C 15 min buffer pore formation
0.106755786.10970892.html.plaintext.txt	90	Optimum permeabilization assessed determining lactate dehydrogenase activity released transport buffer 70 release considered optimal
0.106755786.10970892.html.plaintext.txt	91	Confocal Immunofluorescence Microscopy For immunofluorescent staining PrPC PrP217 cells grown poly D lysine coated glass coverslips either cultured complete medium control treated ALLN medium 2 h
0.106755786.10970892.html.plaintext.txt	92	One sample permeabilized SLO described
0.106755786.10970892.html.plaintext.txt	93	Untreated ALLN treated SLO permeabilized cells fixed 4 paraformaldehyde 30 min room temperature processed immunostaining
0.106755786.10970892.html.plaintext.txt	94	Another set ALLN treated samples fixed permeabilized 0
0.106755786.10970892.html.plaintext.txt	95	Both SLO Triton permeabilized cells processed immunostaining anti PrP antibody 3F4 120 dilution followed fluorescein isothiocyanate conjugated anti mouse secondary antibody 120 dilution green anti calnexin C terminus immune serum 140 dilution followed RITC conjugated anti rabbit antibody 125 dilution red see Fig
0.106755786.10970892.html.plaintext.txt	96	Samples observed using laser scanning confocal microscope Bio Rad
0.106755786.10970892.html.plaintext.txt	97	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.106755786.10970892.html.plaintext.txt	98	Highly Abnormal Forms PrP217 Are Retained Endoplasmic Reticulum Are Associated Chaperone BiP As reported previous study mature PrPC migrates three distinct bands correspond PrPC two one glycans respectively
0.106755786.10970892.html.plaintext.txt	99	In contrast PrP217 shows additional band 32 kDa PrP32 migrates 30 kDa rather 27 kDa PrPC following deglycosylation Fig
0.106755786.10970892.html.plaintext.txt	100	We previously shown PrP32 lacks GPI anchor retains 22 amino acid GPI C terminal signal peptide GPI SP 9
0.106755786.10970892.html.plaintext.txt	101	Furthermore PrP32 well two forms PrP217 migrating 29 30 kDa remain endoglycosidase H sensitive indicating transported ER Fig
0.106755786.10970892.html.plaintext.txt	102	View larger version 85K Fig
0.106755786.10970892.html.plaintext.txt	103	Highly abnormal forms PrP217 retained ER
0.106755786.10970892.html.plaintext.txt	104	PrPC PrP217 cells radiolabeled 2 h immunoprecipitated anti PrP antibody 3F4 analyzed fluorography
0.106755786.10970892.html.plaintext.txt	105	PrPC lysates show three distinct bands corresponding three glycoforms PrP highly glycosylated diffuse band 33 42 kDa intermediate bands 29 30 kDa one two glycans discrete band 27 kDa representing unglycosylated form PrP lane 1
0.106755786.10970892.html.plaintext.txt	106	PrP217 shows band 32 kDa PrP32 addition three glycoforms observed PrPC lane 4 marked asterisks
0.106755786.10970892.html.plaintext.txt	107	As expected PrPC PrP217 forms co migrate 27 kDa form upon deglycosylation N glycosidase F PNGase except PrP32 migrates 30 kDa lanes 3 versus 6
0.106755786.10970892.html.plaintext.txt	108	Treatment lysates endoglycosidase H Endo H shows PrPC forms resistant cleavage lane 2
0.106755786.10970892.html.plaintext.txt	109	In contrast PrP32 PrP217 bands migrating 29 30 kDa remain endoglycosidase H sensitive suggesting transported ER lane 5
0.106755786.10970892.html.plaintext.txt	110	To determine PrP32 retained ER bound molecular chaperone Trans35Smethionine labeled PrPC PrP217 cells lysed non denaturing conditions immunoprecipitated anti KDEL Fig
0.106755786.10970892.html.plaintext.txt	111	2A lanes 1 3 anti PrP antibody 3F4 Fig
0.106755786.10970892.html.plaintext.txt	112	2A lanes 2 4 prior analysis SDS PAGE
0.106755786.10970892.html.plaintext.txt	113	Anti KDEL monoclonal antibody raised C terminal ER retention signal KDEL proteins reacts BiP Grp78 Grp94 Hsp47
0.106755786.10970892.html.plaintext.txt	114	After immunoprecipitation anti KDEL four major bands detected PrPC PrP217 lysates include band 94 kDa corresponding Grp94 shown 78 kDa band BiP two additional bands 64 47 kDa Fig
0.106755786.10970892.html.plaintext.txt	115	However PrP217 lysates additional band migrates 32 kDa detected Fig
0.106755786.10970892.html.plaintext.txt	116	Immunoprecipitation lysates anti PrP antibody 3F4 shows 32 kDa PrP isoform PrP217 lysates co migrates similar form detected anti KDEL immunoprecipitates Fig
0.106755786.10970892.html.plaintext.txt	117	2A lanes 4 3 respectively
0.106755786.10970892.html.plaintext.txt	118	To characterize 32 kDa band immunoprecipitated anti KDEL antibody anti KDEL immunoprecipitates PrPC PrP217 lysates re immunoprecipitated two anti PrP antibodies one directed conserved sequence PrP C terminal GPI SP anti GPI SP previously shown uncleaved PrP32 9
0.106755786.10970892.html.plaintext.txt	119	With antibodies 32 kDa band recovered PrP217 immunoprecipitates whereas bands recovered PrPC preparation Figs
0.106755786.10970892.html.plaintext.txt	120	2A 2B lanes 5 6 2 respectively
0.106755786.10970892.html.plaintext.txt	121	Furthermore PrPC PrP217 cell lysates immunoprecipitated anti PrP antibody prolonged radiolabeling BiP recovered along various PrP forms PrP217 preparations Fig
0.106755786.10970892.html.plaintext.txt	122	Combined experiments clearly show 32 kDa band recovered following immunoprecipitation antibodies KDEL contains PrP32 PrP32 associated BiP Q217R transfected neuroblastoma cells
0.106755786.10970892.html.plaintext.txt	123	Finally immunoblotting proteins eluted GPI SP immunoprecipitates anti KDEL antibody identified 78 kDa BiP band Fig
0.106755786.10970892.html.plaintext.txt	124	Immunoprecipitation similar conditions anti calnexin anti Grp94 anti calreticulin antibodies co immunoprecipitate PrP32 isoform PrPC PrP217 data shown
0.106755786.10970892.html.plaintext.txt	125	Therefore PrP32 associated BiP ER chaperones
0.106755786.10970892.html.plaintext.txt	126	View larger version 42K Fig
0.106755786.10970892.html.plaintext.txt	127	PrP32 associated chaperone BiP ER
0.106755786.10970892.html.plaintext.txt	128	A cells expressing PrPC PrP217 radiolabeled 2 h immunoprecipitated either anti KDEL lanes 1 3 anti PrP lanes 2 4 antibodies
0.106755786.10970892.html.plaintext.txt	129	Fluorography shows PrP32 co immunoprecipitates anti KDEL co migrates similar form detected anti PrP immunoprecipitates lanes 3 4
0.106755786.10970892.html.plaintext.txt	130	No PrPC forms co immunoprecipitate anti KDEL lanes 1 2
0.106755786.10970892.html.plaintext.txt	131	Proteins immunoprecipitated PrPC PrP217 lysates anti KDEL eluted agarose beads re immunoprecipitated anti PrP
0.106755786.10970892.html.plaintext.txt	132	No protein band detected PrPC sample lane 5 whereas PrP217 PrP32 re immunoprecipitated lane 6
0.106755786.10970892.html.plaintext.txt	133	Overexposed anti PrP immunoprecipitates PrPC PrP217 lysates show 78 kDa band corresponding BiP co immunoprecipitates PrP217 lanes 7 8
0.106755786.10970892.html.plaintext.txt	134	B radiolabeled PrPC PrP217 cells immunoprecipitated anti GPI SP antibody fractionated SDS PAGE duplicate
0.106755786.10970892.html.plaintext.txt	135	One set samples analyzed fluorography whereas set transblotted probed anti KDEL antibody
0.106755786.10970892.html.plaintext.txt	136	No PrP form detected PrPC immunoprecipitates PrP32 detected PrP217 sample lanes 1 2
0.106755786.10970892.html.plaintext.txt	137	Immunoblotting anti KDEL shows 78 kDa BiP band PrP217 immunoprecipitates lane 3
0.106755786.10970892.html.plaintext.txt	138	C PrPC PrP217 cells transfected plasmid encoding hamster BiP transient transfectants radiolabeled 2 h immunoprecipitated anti hamster BiP antibody
0.106755786.10970892.html.plaintext.txt	139	PrP32 detected PrP217 immunoprecipitates lanes 3 4 PrPC samples lanes 1 2
0.106755786.10970892.html.plaintext.txt	140	These data reproduced using PrPC PrP217 cells retransfected construct expressing hamster BiP
0.106755786.10970892.html.plaintext.txt	141	Following immunoprecipitation radiolabeled lysates cells anti hamster BiP antibody band co migrating PrP32 recovered PrP217 lysates Fig
0.106755786.10970892.html.plaintext.txt	142	2C lanes 3 4 whereas bands co migrating PrPC forms detected PrPC preparations Fig
0.106755786.10970892.html.plaintext.txt	143	PrP32 Is Degraded Proteasomal Pathway Pulse chase analysis PrP217 following immunoprecipitation anti PrP antibody showed treatment 40 PrP32 present zero time following 10 min pulse remained 1 h chase Figs
0.106755786.10970892.html.plaintext.txt	144	In contrast presence ALLN inhibitor proteasomal degradation PrP32 three bands 27 30 kDa recovered chase time Figs
0.106755786.10970892.html.plaintext.txt	145	Highly glycosylated PrP forms 32 42 kDa also present probably represent glycosylated 27 30 kDa forms rescued degradation ALLN lanes 5 6
0.106755786.10970892.html.plaintext.txt	146	Similar results obtained immunoprecipitation carried pulse chase conditions antibody KDEL rather PrP Figs
0.106755786.10970892.html.plaintext.txt	147	In absence ALLN 23 PrP32 recovered 1 h chase Fig
0.106755786.10970892.html.plaintext.txt	148	In presence ALLN PrP32 degraded 27 30 kDa bands also detected Figs
0.106755786.10970892.html.plaintext.txt	149	In experiments longer chase presence ALLN significant amount PrP32 could co immunoprecipitated anti KDEL antibody even 6 h data shown
0.106755786.10970892.html.plaintext.txt	150	Thus PrP32 remains associated BiP abnormally prolonged period time degraded proteasomal pathway Fig
0.106755786.10970892.html.plaintext.txt	151	View larger version 39K Fig
0.106755786.10970892.html.plaintext.txt	152	PrP32 degraded proteasomes
0.106755786.10970892.html.plaintext.txt	153	A PrP217 cells either left untreated preincubated ALLN 1 h radiolabeled 10 min
0.106755786.10970892.html.plaintext.txt	154	Lysates immunoprecipitated either anti PrP lanes 1 6 anti KDEL lanes 7 12 chase indicated times absence presence inhibitor
0.106755786.10970892.html.plaintext.txt	155	Following pulse 0 PrP217 glycoforms representing unglycosylated 27 kDa partially glycosylated 29 30 kDa forms PrP32 seen untreated ALLN treated samples lanes 1 4
0.106755786.10970892.html.plaintext.txt	156	After chase 30 min 0
0.106755786.10970892.html.plaintext.txt	157	5 expected highly glycosylated forms PrP appear lanes 2 5
0.106755786.10970892.html.plaintext.txt	158	Although PrP217 forms degrade slowly untreated samples 40 PrP32 remains 1 h chase lanes 1 3 following treatment ALLN almost PrP32 remains
0.106755786.10970892.html.plaintext.txt	159	Furthermore additional forms 27 30 kDa highly glycosylated forms 32 42 kDa detected lanes 4 6
0.106755786.10970892.html.plaintext.txt	160	Immunoprecipitation anti KDEL antibody shows similar kinetics degradation PrP32 without ALLN treatment demonstrates additional band 30 kDa lanes 7 12
0.106755786.10970892.html.plaintext.txt	161	B numerical data expressed percentage initial PrP32 synthesized different chase times absence presence ALLN plotted mean plus minus S
0.106755786.10970892.html.plaintext.txt	162	C PrP217 cells radiolabeled 2 h absence presence ALLN membrane cytosolic fractions isolated immunoprecipitated anti PrP antibody analyzed fluorography
0.106755786.10970892.html.plaintext.txt	163	Although PrP217 glycoforms partition membrane fraction P small amount PrP32 detected soluble fraction S lanes 1 2
0.106755786.10970892.html.plaintext.txt	164	After treatment ALLN fraction increases 30 lanes 2 versus 4 additional band 28 kDa detected lane 4
0.106755786.10970892.html.plaintext.txt	165	The faster migrating 28 kDa band unglycosylated insensitive PNGase opposed PrP32 migrates 30 kDa deglycosylation lanes 5 6
0.106755786.10970892.html.plaintext.txt	166	Separation membrane bound soluble PrP217 fractions showed although PrP217 glycoforms 76 PrP32 detected membrane rich pellet fraction small amount PrP32 recovered membrane free supernatant Fig
0.106755786.10970892.html.plaintext.txt	167	Following ALLN treatment amount PrP32 pellet increased 2
0.106755786.10970892.html.plaintext.txt	168	4 whereas fraction detected supernatant showed significant increase 30 compared untreated samples Fig
0.106755786.10970892.html.plaintext.txt	169	3C lanes 1 versus 3 2 versus 4
0.106755786.10970892.html.plaintext.txt	170	Moreover additional form 28 kDa detected soluble fraction presence ALLN Fig
0.106755786.10970892.html.plaintext.txt	171	3C lane 4 may represent intermediate product PrP32 generated proteasomal degradation
0.106755786.10970892.html.plaintext.txt	172	This form unglycosylated insensitive PNGase treatment Fig
0.106755786.10970892.html.plaintext.txt	173	Thus soluble membrane free forms PrP32 increases proteasomal inhibition indicating PrP32 retrotranslocated ER
0.106755786.10970892.html.plaintext.txt	174	We detect ubiquitination PrP32 PrP32 related forms Data shown
0.106755786.10970892.html.plaintext.txt	175	We used immunofluorescence determine whether PrP32 degradation products accumulate cytosol form aggresome like structure following proteasomal inhibition Fig
0.106755786.10970892.html.plaintext.txt	176	Control ALLN treated PrPC PrP217 cells treated streptolysin O SLO selectively permeabilizes plasma membrane 11 leaving intracellular membrane organelles intact
0.106755786.10970892.html.plaintext.txt	177	Thus externally added antibodies access cytosolic proteins epitopes proteins exposed cytosolic side membranes
0.106755786.10970892.html.plaintext.txt	178	Following SLO treatment PrPC PrP217 detected surface control ALLN treated cells green whereas immunoreactivity C terminus calnexin located cytosolic side ER membrane readily detected red Fig
0.106755786.10970892.html.plaintext.txt	179	In contrast following treatment detergent permeabilizes cellular membranes small amount PrPC observed Golgi region whereas PrP217 present much larger quantity part co distributed ER panels 5 6
0.106755786.10970892.html.plaintext.txt	180	Therefore following inhibition proteasomal degradation PrP32 form aggresome like structure cytosol reported secretory proteins degraded proteasome 12 13
0.106755786.10970892.html.plaintext.txt	181	View larger version 29K Fig
0.106755786.10970892.html.plaintext.txt	182	PrP32 rescued proteasomal degradation aggregate cytosol
0.106755786.10970892.html.plaintext.txt	183	PrPC PrP217 cells cultured absence presence ALLN 2 h permeabilized SLO immunostained anti PrP green anti calnexin C terminus antibody red absence presence detergent
0.106755786.10970892.html.plaintext.txt	184	In SLO permeabilized PrPC PrP217 cells surface PrP staining detected control ALLN treated samples panels 1 4
0.106755786.10970892.html.plaintext.txt	185	No intracellular PrP staining seen
0.106755786.10970892.html.plaintext.txt	186	In presence detergent PrPC staining detected cell surface Golgi area ALLN treatment panel 5
0.106755786.10970892.html.plaintext.txt	187	PrP217 cells show additional PrP immunoreactivity ER intracellular membrane organelles panel 6
0.106755786.10970892.html.plaintext.txt	188	Immunoreactivity C terminus calnexin red seen reticular ER pattern samples expected indicating cytosolic proteins accessible sets samples
0.106755786.10970892.html.plaintext.txt	189	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.106755786.10970892.html.plaintext.txt	190	BiP shown promote proper folding newly synthesized polypeptides keeping precursors soluble state 12 14 17
0.106755786.10970892.html.plaintext.txt	191	It interacts transiently proteins presumably properly folded
0.106755786.10970892.html.plaintext.txt	192	In contrast binds misfolded unassembled proteins relatively stable complexes may mediate retrograde translocation proteasomal degradation 18 26
0.106755786.10970892.html.plaintext.txt	193	Our data provide first evidence BiP plays roles processing PrP
0.106755786.10970892.html.plaintext.txt	194	BiP briefly interacts ER PrPC Fig
0.106755786.10970892.html.plaintext.txt	195	2 This brief interaction consistent BiP involvement folding nascent PrPC presumably promptly assumes correct folding state
0.106755786.10970892.html.plaintext.txt	196	BiP interaction PrP carrying Q217R mutation complex
0.106755786.10970892.html.plaintext.txt	197	In neuroblastoma cell model mutant PrP expressed two major variants
0.106755786.10970892.html.plaintext.txt	198	The first variant referred PrP217 includes three glycoforms carries GPI anchor PrPC
0.106755786.10970892.html.plaintext.txt	199	The second variant PrP32 accounts approximately 11 total Q217R mutant PrP glycosylated lacks GPI anchor carries uncleaved GPI anchor signal peptide 9
0.106755786.10970892.html.plaintext.txt	200	Unlike PrPC PrP217 unstable approximately 50 becomes insoluble aggregates compartment distal cis Golgi
0.106755786.10970892.html.plaintext.txt	201	Furthermore instability leading aggregation likely due misfolding largely corrected exposure nascent PrP217 low temperatures known favor correct folding 9
0.106755786.10970892.html.plaintext.txt	202	However despite likely misfolding PrP217 interacts BiP briefly way indistinguishable PrPC like PrPC exits ER 9
0.106755786.10970892.html.plaintext.txt	203	In contrast BiP interaction PrP32 sustained results retention form ER eventually PrP32 translocated cytosol degraded proteasomal system
0.106755786.10970892.html.plaintext.txt	204	Only BiP among variety protein folding chaperones present ER shows association PrP32
0.106755786.10970892.html.plaintext.txt	205	The mechanism leading different BiP interaction cellular routing PrP217 PrP32 unclear
0.106755786.10970892.html.plaintext.txt	206	It might due lack GPI anchor andor presence GPI signal peptide makes impossible PrP32 enter secretory pathway 27 32
0.106755786.10970892.html.plaintext.txt	207	Other mechanisms also possible
0.106755786.10970892.html.plaintext.txt	208	For example different BiP binding might related intrinsic conformational differences two Q217R PrP variants
0.106755786.10970892.html.plaintext.txt	209	The conformation mutant PrP might altered extent anchor signal peptide cannot cleaved blocking anchor addition resulting formation PrP32 variant
0.106755786.10970892.html.plaintext.txt	210	Alternatively sustained association PrP32 BiP might interfere anchor addition process
0.106755786.10970892.html.plaintext.txt	211	Regardless mechanism remarkable two major types Q217R mutant PrP PrP217 PrP32 interact differently BiP interaction processed different routes
0.106755786.10970892.html.plaintext.txt	212	PrP217 aggregates post Golgi compartment likely endosomal lysosomal system eventually degraded accumulate
0.106755786.10970892.html.plaintext.txt	213	In contrast PrP32 remains largely soluble degraded proteasome
0.106755786.10970892.html.plaintext.txt	214	However inhibition proteasomal function effect PrP217 results increased amounts PrP32 ER cytosol
0.106755786.10970892.html.plaintext.txt	215	Presumably impairment endosomal lysosomal degradation leads accumulation PrP217
0.106755786.10970892.html.plaintext.txt	216	Thus two forms Q217R mutant PrP potential perturb cellular metabolism distinct mechanisms
0.106755786.10970892.html.plaintext.txt	217	We previously shown another mutant PrP caused presence stop codon PRNP position 145 PrP145 also degraded proteasomal pathway 8
0.106755786.10970892.html.plaintext.txt	218	PrP145 C terminus truncated lacks anchor associated GSS phenotype
0.106755786.10970892.html.plaintext.txt	219	Therefore proteasomal degradation shared mutant PrP variants lacking GPI anchor
0.106755786.10970892.html.plaintext.txt	220	However unlike PrP32 PrP145 bound BiP perhaps part whole C terminal region needed binding
0.106755786.10970892.html.plaintext.txt	221	In addition PrP several secretory membrane proteins implicated causing disease degraded proteasomal pathway mutated aggregate intracellular compartments following inhibition proteasomal function 12 25 26 33 37
0.106755786.10970892.html.plaintext.txt	222	The proteins implicated neurodegeneration include huntingtin forms intranuclear aggregates Huntingtons disease ataxins 1 3 associated forms spinocerebellar ataxia 38 41 synuclein major component cytoplasmic Lewy bodies Parkinsons disease 42
0.106755786.10970892.html.plaintext.txt	223	The central theme disorders prion diseases conversion normally soluble functional protein sheet rich structure insoluble aggregates forms intracellular deposits
0.106755786.10970892.html.plaintext.txt	224	Contrary previous assumptions appears intranuclear aggregates huntingtin may protective role rather causing neuronal damage 40 41
0.106755786.10970892.html.plaintext.txt	225	Mutant huntingtin shown toxic absence aggregates 41 argued capturing toxic protein aggregate may protect cell toxicity
0.106755786.10970892.html.plaintext.txt	226	Thus neurotoxic cascade might start formation aggregates possibly soluble intermediates escape degradation 43
0.106755786.10970892.html.plaintext.txt	227	Our results PrP32 consistent scenario
0.106755786.10970892.html.plaintext.txt	228	Although BiP prevents aggregation facilitates degradation PrP32 may fact render PrP32 pathogenic maintaining partially unfolded state ER especially BiP promotes refolding PrP32 alternative pathogenic form instead aggregation proteasomal function compromised
0.106755786.10970892.html.plaintext.txt	229	In conclusion present finding two mutant PrP variants generated Q217R PRNP mutation processed entirely different metabolic pathways underscores complexity diversity pathogenic perturbation may caused simple point mutation
0.106755786.10970892.html.plaintext.txt	230	Only detailed study metabolism mutant protein bring light complexity must understood optimal therapeutic intervention established
0.106755786.10970892.html.plaintext.txt	231	Anderson use confocal microscope Yi Jing Diane Kofskey technical assistance Fangi Bai Sandy Bowen Donna Neylon secretarial help
0.106755786.10970892.html.plaintext.txt	232	This study funded grants National Institutes Health N
0.106755786.10970892.html.plaintext.txt	233	Britton fund P
0.106755786.10970892.html.plaintext.txt	234	The costs publication article defrayed part payment page charges
0.106755786.10970892.html.plaintext.txt	235	The article must therefore hereby marked advertisement accordance 18 U
0.106755786.10970892.html.plaintext.txt	236	Section 1734 solely indicate fact
0.106755786.10970892.html.plaintext.txt	237	To correspondence addressed Division Neuropathology Institute Pathology Case Western Reserve University 2085 Adelbert Rd
0.106755786.10970892.html.plaintext.txt	238	216 368 2617 Fax 216 368 2546 E mail nxs2po
0.106755786.10970892.html.plaintext.txt	239	Published JBC Papers Press September 1 2000 DOI 10
0.106755786.10970892.html.plaintext.txt	240	Singh unpublished observations
0.106755786.10970892.html.plaintext.txt	241	The abbreviations used PrP prion protein PK proteinase K GSS disease Gerstmann Straussler Scheinker disease ER endoplasmic reticulum GPI glycosyl phosphatidylinositol DMEM Dulbeccos modified Eagles medium TBS Tris buffered saline PAGE polyacrylamide gel electrophoresis ALLN N acetyl Leu Leu norleucinal SLO streptolysin O GPI SP GPI signal peptide
0.106755786.10970892.html.plaintext.txt	242	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1
0.106755786.10970892.html.plaintext.txt	243	1998 Cell 93 337 348Medline Order article via Infotrieve 2
0.106755786.10970892.html.plaintext.txt	244	1999 Neuron 24 503 506Medline Order article via Infotrieve 3
0.106755786.10970892.html.plaintext.txt	245	1998 Nature 392 23 24CrossRefMedline Order article via Infotrieve 5
0.106755786.10970892.html.plaintext.txt	246	94 13938 13943AbstractFree Full Text 6
0.106755786.10970892.html.plaintext.txt	247	94 13932 13937AbstractFree Full Text 7
0.106755786.10970892.html.plaintext.txt	248	19 1325 1333AbstractFree Full Text 8
0.106755786.10970892.html.plaintext.txt	249	274 23396 23404AbstractFree Full Text 9
0.106755786.10970892.html.plaintext.txt	250	272 28461 28470AbstractFree Full Text 10
0.106755786.10970892.html.plaintext.txt	251	1999 Prion Biology Diseases Cold Spring Harbor Laboratory Press Cold Spring Harbor NY 11
0.106755786.10970892.html.plaintext.txt	252	1997 Cell 88 427 430Medline Order article via Infotrieve 13
0.106755786.10970892.html.plaintext.txt	253	79 623 638Medline Order article via Infotrieve 14
0.106755786.10970892.html.plaintext.txt	254	272 3125 3128Free Full Text 15
0.106755786.10970892.html.plaintext.txt	255	1999 Science 286 1882 1888AbstractFree Full Text 16
0.106755786.10970892.html.plaintext.txt	256	1999 Science 284 822 825AbstractFree Full Text 17
0.106755786.10970892.html.plaintext.txt	257	144 21 30AbstractFree Full Text 18
0.106755786.10970892.html.plaintext.txt	258	270 2379 2386AbstractFree Full Text 19
0.106755786.10970892.html.plaintext.txt	259	271 20895 20902AbstractFree Full Text 21
0.106755786.10970892.html.plaintext.txt	260	1997 Nature 388 891 895CrossRefMedline Order article via Infotrieve 22
0.106755786.10970892.html.plaintext.txt	261	274 3453 3460AbstractFree Full Text 23
0.106755786.10970892.html.plaintext.txt	262	1999 Cell 97 553 564Medline Order article via Infotrieve 24
0.106755786.10970892.html.plaintext.txt	263	273 21368 21373AbstractFree Full Text 25
0.106755786.10970892.html.plaintext.txt	264	273 21025 21030AbstractFree Full Text 26
0.106755786.10970892.html.plaintext.txt	265	274 17068 17074AbstractFree Full Text 27
0.106755786.10970892.html.plaintext.txt	266	268 12017 12027AbstractFree Full Text 28
0.106755786.10970892.html.plaintext.txt	267	269 10830 10837AbstractFree Full Text 29
0.106755786.10970892.html.plaintext.txt	268	306 643 650Medline Order article via Infotrieve 30
0.106755786.10970892.html.plaintext.txt	269	219 800 805CrossRefMedline Order article via Infotrieve 31
0.106755786.10970892.html.plaintext.txt	270	316 623 630Medline Order article via Infotrieve 32
0.106755786.10970892.html.plaintext.txt	271	332 111 118Medline Order article via Infotrieve 33
0.106755786.10970892.html.plaintext.txt	272	1999 Science 286 1888 1893AbstractFree Full Text 34
0.106755786.10970892.html.plaintext.txt	273	272 20427 20434AbstractFree Full Text 35
0.106755786.10970892.html.plaintext.txt	274	273 11183 11188AbstractFree Full Text 36
0.106755786.10970892.html.plaintext.txt	275	273 32848 32856AbstractFree Full Text 37
0.106755786.10970892.html.plaintext.txt	276	1995 Cell 83 121 127Medline Order article via Infotrieve 38
0.106755786.10970892.html.plaintext.txt	277	1997 Neuron 19 1147 1150Medline Order article via Infotrieve 39
0.106755786.10970892.html.plaintext.txt	278	97 1589 1594AbstractFree Full Text 40
0.106755786.10970892.html.plaintext.txt	279	59 265 270Medline Order article via Infotrieve 41
0.106755786.10970892.html.plaintext.txt	280	274 37507 37510Free Full Text 42
0.106755786.10970892.html.plaintext.txt	281	274 33855 33858AbstractFree Full Text 43
0.106755786.10970892.html.plaintext.txt	282	95 6448 6453AbstractFree Full Text
0.106755786.10970892.html.plaintext.txt	283	Copyright 2000 The American Society Biochemistry Molecular Biology Inc
0.16014898.12754252.html.plaintext.txt	0	dSmurf Selectively Degrades Decapentaplegic activated MAD Its Overexpression Disrupts Imaginal Disc Development Yao Yun Liang Xia Lin Min Liang F
0.16014898.12754252.html.plaintext.txt	1	Charles Brunicardi Peter ten Dijke Zhihong Chen Kwang Wook Choi Xin Hua Feng
0.16014898.12754252.html.plaintext.txt	2	DeBakey Department Surgery Department Molecular Cellular Biology Ophthalmology Program Developmental Biology Baylor College Medicine Houston Texas 77030 Division Cellular Biochemistry The Netherlands Cancer Institute 1066 Cx Amsterdam Netherlands
0.16014898.12754252.html.plaintext.txt	3	Received publication January 21 2003 revised form May 12 2003
0.16014898.12754252.html.plaintext.txt	4	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES MAD plays important role decapentaplegic DPP signaling throughout Drosophila development
0.16014898.12754252.html.plaintext.txt	5	Despite recent study describing restriction DPP signaling via putative ubiquitin E3 ligase dSmurf 1 molecular mechanisms dSmurf affects DPP signaling remain unexplored
0.16014898.12754252.html.plaintext.txt	6	Toward goal demonstrated degradation phosphorylated MAD dSmurf
0.16014898.12754252.html.plaintext.txt	7	dSmurf selectively interacted MAD Medea Dad MAD dSmurf interaction induced constitutively active DPP type I receptor thickveins
0.16014898.12754252.html.plaintext.txt	8	Wild type dSmurf C1029A mutant mediated ubiquitination dependent degradation MAD
0.16014898.12754252.html.plaintext.txt	9	Silencing dSmurf using RNA interference stabilized MAD protein Drosophila S2 cells
0.16014898.12754252.html.plaintext.txt	10	Targeted expression dSmurf various tissues abolished phosphorylated MAD disrupted patterning growth
0.16014898.12754252.html.plaintext.txt	11	In contrast similar overexpression inactive dSmurfC1029A showed significant effects development
0.16014898.12754252.html.plaintext.txt	12	We conclude dSmurf specifically targets phosphorylated MAD proteasome dependent degradation regulates DPP signaling development
0.16014898.12754252.html.plaintext.txt	13	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Decapentaplegic DPP1 Drosophila ortholog human bone morphogenetic protein BMP 24 belongs transforming growth factor TGF superfamily 2 4
0.16014898.12754252.html.plaintext.txt	14	DPP plays central role Drosophila morphogenesis
0.16014898.12754252.html.plaintext.txt	15	DPP signals cell surface receptors intracellular Smad proteins
0.16014898.12754252.html.plaintext.txt	16	In Drosophila three classes Smads R Smad MAD dSmad2 Co Smad Medea I Smad Dad characterized 2
0.16014898.12754252.html.plaintext.txt	17	MAD founding member Smad family 5 transduces signal DPP dSmad2 mediates TGF Activin signaling 2
0.16014898.12754252.html.plaintext.txt	18	Ubiquitin conjugation catalyzed enzymatic cascade including ubiquitin activating E1 ubiquitin conjugating E2 specific ubiquitin E3 ligase
0.16014898.12754252.html.plaintext.txt	19	The specificity ubiquitination derives highly specific protein protein interaction E3 ligase substrate 6 7
0.16014898.12754252.html.plaintext.txt	20	In TGF signaling HECT class E3 ligases Smurf1 Smurf2 specifically promote degradation Smad1 Smad2 8 10 possibly I Smads TGF type I receptor 11 12
0.16014898.12754252.html.plaintext.txt	21	In Xenopus embryos Smurf1 showed inhibition BMP signaling affected pattern formation 8
0.16014898.12754252.html.plaintext.txt	22	Recently Drosophila ligase E3 dSmurf identified genetic screen 1 null mutation dSmurf resulted lethal defect hindgut organogenesis
0.16014898.12754252.html.plaintext.txt	23	However mechanisms underlying dSmurf actions DPP signaling embryogenesis remain unclear
0.16014898.12754252.html.plaintext.txt	24	In study present biochemical genetic evidence biological functions dSmurf
0.16014898.12754252.html.plaintext.txt	25	The results revealed dSmurf specifically inhibited DPP signaling targeting DPP activated MAD dSmad2 Medea Dad ubiquitinationproteasome dependent proteolysis
0.16014898.12754252.html.plaintext.txt	26	Targeted overexpression dSmurf imaginal discs strongly reduces level phosphorylated MAD consequently causes disruption DPP dependent patterning imaginal discs demonstrating dSmurf negative regulator DPP signaling vivo
0.16014898.12754252.html.plaintext.txt	27	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Molecular Cloning dSmurf obtained using PCR primers forward gGAATTC aat aaa ttg gat tac cca cgt reverse ttcGTC GAC tta ctc cac ggc aaa tcc aca total fly cDNA Clontech Lack cDNA clone gift Scott Hawley cloned EcoRI SalI pXF1F pXF1M making FLAG tagged Myc tagged dSmurf respectively
0.16014898.12754252.html.plaintext.txt	28	His tagged MAD made subcloning mammalian expression vector pXF2RH 9
0.16014898.12754252.html.plaintext.txt	29	The point mutation dSmurf C1029A substitution generated two step PCR
0.16014898.12754252.html.plaintext.txt	30	MAD2SA mutant made mutating two Ser Ala SVS phosphorylation motif
0.16014898.12754252.html.plaintext.txt	31	Yeast Two hybrid Assay A LexA based yeast two hybrid assay performed described previously 9
0.16014898.12754252.html.plaintext.txt	32	MAD dSmad2 Dad obtained PCR respective cDNA gifts Kohei Miyazono Richard Padgett cloned yeast bait vector pEG202
0.16014898.12754252.html.plaintext.txt	33	dSmurf wild type dSmurf deletion mutants obtained PCR cloned prey vector pJG4 5 sites EcoRI SalI
0.16014898.12754252.html.plaintext.txt	34	Smurf1 gift Jeff Wrana also subcloned pJG4 5
0.16014898.12754252.html.plaintext.txt	35	Galactosidase activity measured liquid assay according method Matchmaker two hybrid system 2 Clontech
0.16014898.12754252.html.plaintext.txt	36	Immunoprecipitation Western Blot Culture transfection human kidney 293T cells Drosophila Schneider S2 cells coupled immunoprecipitation Western blot assays carried described previously 13 14
0.16014898.12754252.html.plaintext.txt	37	For degradation assay copper inducible pMK33 expression plasmids MAD dSmurf constitutively active type I receptor Thickveins caTKV gifts Richard Padgett transfected Schneider S2 cells calcium phosphate
0.16014898.12754252.html.plaintext.txt	38	In case RNA interference experiment Fig
0.16014898.12754252.html.plaintext.txt	39	4D cells cotransfected synthetic 21 nucleotide duplex RNA double stranded RNA dSmurf 15
0.16014898.12754252.html.plaintext.txt	40	5 mM CuSO4 24 h harvested Western blot analysis
0.16014898.12754252.html.plaintext.txt	41	View larger version 31K FIG
0.16014898.12754252.html.plaintext.txt	42	dSmurf degrades MAD proteins cells
0.16014898.12754252.html.plaintext.txt	43	A dSmurf induces proteasome dependent degradation MAD
0.16014898.12754252.html.plaintext.txt	44	Drosophila S2 cells transfected indicated MAD without Myc tagged dSmurf treated MG132 indicated
0.16014898.12754252.html.plaintext.txt	45	Cell lysates subjected SDS PAGE Western blotting analysis using anti MAD anti Myc antibodies
0.16014898.12754252.html.plaintext.txt	46	Note caTKV promoted dSmurf induced MAD degradation lane 4
0.16014898.12754252.html.plaintext.txt	47	B MAD degradation requires HECT catalytic activity dSmurf
0.16014898.12754252.html.plaintext.txt	48	293T cells transfected expression plasmids FLAG tagged MAD increasing doses Myc dSmurf wild type C1029A mutant
0.16014898.12754252.html.plaintext.txt	49	Cell lysates transfected cells subjected anti FLAG Western blot detect MAD anti Myc immunostaining detect dSmurf
0.16014898.12754252.html.plaintext.txt	50	C depletion dSmurf expression stabilizes MAD
0.16014898.12754252.html.plaintext.txt	51	Drosophila S2 cells transfected Myc tagged dSmurf MAD treated increasing doses 20 40 100 nM siRNA dSmurf indicated
0.16014898.12754252.html.plaintext.txt	52	Cell lysates subjected SDS PAGE Western blotting analysis using anti MAD anti Myc antibodies
0.16014898.12754252.html.plaintext.txt	53	D depletion dSmurf expression stabilizes pMAD
0.16014898.12754252.html.plaintext.txt	54	Drosophila S2 cells transfected caTKV treated 100 nM si dSmurf
0.16014898.12754252.html.plaintext.txt	55	Level phospho MAD analyzed Western blotting using anti P Smad1 antibody
0.16014898.12754252.html.plaintext.txt	56	For ubiquitination assay 293T cells cotransfected His tagged MAD HA tagged ubiquitin c Myc tagged dSmurf
0.16014898.12754252.html.plaintext.txt	57	Proteasome inhibitor MG 132 added transfected cells prevent degradation MAD
0.16014898.12754252.html.plaintext.txt	58	48 h transfection cell lysates subjected precipitation using nickel NTA agarose beads detect ubiquitinated MAD described previously 9
0.16014898.12754252.html.plaintext.txt	59	Targeted Expression Immunocytochemistry cDNAs dSmurf dSmurfC1029A cloned pUAST FLAG modified pUAST containing FLAG tag sequence induce FLAG tagged proteins
0.16014898.12754252.html.plaintext.txt	60	2 Transgenic flies carrying UAS dSmurf UAS dSmurf C1029A generated P element mediated germline transformation 16
0.16014898.12754252.html.plaintext.txt	61	For targeted expression UAS dSmurf flies crossed Gal4 strains
0.16014898.12754252.html.plaintext.txt	62	For immunocytochemistry imaginal discs progeny Gal4 UAS larvae double stained mouse anti Flag 1250 rabbit anti pMAD 1250 fluorescein isothiocyanate Cy3 conjugated fluorescent secondary antibodies described previously 17
0.16014898.12754252.html.plaintext.txt	63	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES WW2WW3 Domains dSmurf Meditates Its Specific Interaction MAD By homology probing identified dSmurf cDNA encodes polypeptide 1061 amino acid
0.16014898.12754252.html.plaintext.txt	64	dSmurf belongs HECT class ubiquitin E3 ligase family Fig
0.16014898.12754252.html.plaintext.txt	65	1A displays close homology human Smurf2 9 11 Smurf1 8
0.16014898.12754252.html.plaintext.txt	66	During course study Podos et al
0.16014898.12754252.html.plaintext.txt	67	1 also identified dSmurf genetic screen 1
0.16014898.12754252.html.plaintext.txt	68	As first step determine whether dSmurf modulates DPP signaling Drosophila investigated physical interaction putative ubiquitin E3 ligase members Smad family Drosophila
0.16014898.12754252.html.plaintext.txt	69	We found dSmurf interacted MAD dSmad2 Medea Dad
0.16014898.12754252.html.plaintext.txt	70	Therefore unlike mammalian homologs Smurf12 bind R Smads I Smads dSmurf specifically interacts DPP specific MAD
0.16014898.12754252.html.plaintext.txt	71	View larger version 26K FIG
0.16014898.12754252.html.plaintext.txt	72	dSmurf specifically interacts MAD via WW2WW3 domains
0.16014898.12754252.html.plaintext.txt	73	A schematic diagram dSmurf constructs summary dSmurf MAD interaction
0.16014898.12754252.html.plaintext.txt	74	C2 domain three WW domains HECT domain shown
0.16014898.12754252.html.plaintext.txt	75	Interaction dSmurf variants MAD C summarized
0.16014898.12754252.html.plaintext.txt	76	B Specific interaction dSmurf MAD yeast two hybrid assay
0.16014898.12754252.html.plaintext.txt	77	Yeast EGY48 cells transformed indicated bait plasmid pEG202 Smad prey plasmid pJG4 5Smurf galactosidase reporter plasmid grown liquid culture
0.16014898.12754252.html.plaintext.txt	78	Galactosidase assay done described Experimental Procedures
0.16014898.12754252.html.plaintext.txt	79	Interaction scored yeast culture medium containing glucose basal level galactoseraffinose inducible level
0.16014898.12754252.html.plaintext.txt	80	C mapping MAD interacting domain
0.16014898.12754252.html.plaintext.txt	81	Yeast two hybrid assays used map domains dSmurf responsible MAD dSmurf interactions
0.16014898.12754252.html.plaintext.txt	82	To locate interacting domains dSmurf generated deletion point mutations dSmurf assessed interaction MAD
0.16014898.12754252.html.plaintext.txt	83	The result showed entire WW2WW3 region dSmurf amino acids 513 602 required interaction MAD whereas WW2 WW3 domain alone interact MAD Fig
0.16014898.12754252.html.plaintext.txt	84	Notably WW2WW3 region point mutations WW2 domain W541FP544A completely lost interaction MAD
0.16014898.12754252.html.plaintext.txt	85	These data suggest interaction dSmurf binds MAD WW2WW3 domain
0.16014898.12754252.html.plaintext.txt	86	DPP Receptor Activation Augments dSmurf MAD Interaction We next assessed MAD dSmurf interaction vivo
0.16014898.12754252.html.plaintext.txt	87	To prevent MAD degradation used C1029A mutant dSmurf determine interaction Smads
0.16014898.12754252.html.plaintext.txt	88	The C1029A mutant carries cysteine alanine substitution amino acid residue 1029 essential catalysis
0.16014898.12754252.html.plaintext.txt	89	2A dSmurf coimmunoprecipitated MAD dSmad2 Medea Dad agreement interaction pattern yeast two hybrid analysis
0.16014898.12754252.html.plaintext.txt	90	caTKV constitutively active form type I receptor Thick veins 18 19 enhanced interaction MAD dSmurf Fig
0.16014898.12754252.html.plaintext.txt	91	View larger version 69K FIG
0.16014898.12754252.html.plaintext.txt	92	DPP stimulates dSmurf MAD interaction
0.16014898.12754252.html.plaintext.txt	93	A dSmurf binds MAD cells
0.16014898.12754252.html.plaintext.txt	94	293T cells transfected plasmids FLAG tagged Smad MAD dSmad2 Medea Dad Myc tagged dSmurfC1029A
0.16014898.12754252.html.plaintext.txt	95	dSmurf complex immunoprecipitated using anti Myc antibody followed Western blot detect dSmurf associated MAD
0.16014898.12754252.html.plaintext.txt	96	Expression levels dSmurf Smads whole cell lysates shown indicated
0.16014898.12754252.html.plaintext.txt	97	Asterisk indicates nonspecific band close molecular mass Medea
0.16014898.12754252.html.plaintext.txt	98	Note dSmurf MAD interaction stronger presence constitutively active TKV compared lane 7 lane 2
0.16014898.12754252.html.plaintext.txt	99	B mutation C terminal phosphorylation sites MAD abolishes dSmurf MAD interaction
0.16014898.12754252.html.plaintext.txt	100	293T cells transfected indicated plasmids
0.16014898.12754252.html.plaintext.txt	101	Immunoprecipitation Western blotting similarly carried A except anti MAD Smad1 Santa Cruz Biotechnology antibody used immunoprecipitation anti FLAG dSmurf Western blotting detect MAD bound dSmurf
0.16014898.12754252.html.plaintext.txt	102	MADSA contains point mutations Ser 453 Ser 455 Ala
0.16014898.12754252.html.plaintext.txt	103	Expression levels dSmurf MAD whole cell lysates shown indicated
0.16014898.12754252.html.plaintext.txt	104	Level pMAD immunoprecipitate also shown
0.16014898.12754252.html.plaintext.txt	105	C endogenous MAD binds dSmurf
0.16014898.12754252.html.plaintext.txt	106	GST dSmurf 513 612 used pull endogenous MAD S2 cell lysates transfected caTKV andor treated proteasome inhibitor MG 132 indicated
0.16014898.12754252.html.plaintext.txt	107	dSmurf bound MAD detected anti Smad1 upper panels anti phospho Smad1 lower panels antibodies
0.16014898.12754252.html.plaintext.txt	108	D dSmurf interacts activated dSmad2
0.16014898.12754252.html.plaintext.txt	109	293T cells transfected indicated plasmids immunoprecipitation Western blotting similarly carried described legend A
0.16014898.12754252.html.plaintext.txt	110	caActRIB constitutively active ActRIB
0.16014898.12754252.html.plaintext.txt	111	To examine importance phosphorylation motif SSXS generated double mutations MAD Ser 433 Ser 435 changed Ala presumably unphosphorylatable TKV
0.16014898.12754252.html.plaintext.txt	112	2B clearly showed interaction mutant named MADSA dSmurf detectable regardless presence caTKV whereas wild type MAD strongly interacted dSmurf presence caTKV
0.16014898.12754252.html.plaintext.txt	113	Furthermore dSmurf also stronger binding endogenous phospho MAD enhanced proteasome inhibitor MG 132 Fig
0.16014898.12754252.html.plaintext.txt	114	Interestingly dSmurf also interacts dSmad2 presence caActR1B Fig
0.16014898.12754252.html.plaintext.txt	115	2D suggesting dSmad2 phosphorylation necessary binding dSmurf despite absence interaction yeast two hybrid assay shown Fig
0.16014898.12754252.html.plaintext.txt	116	Therefore data presented Fig
0.16014898.12754252.html.plaintext.txt	117	2 clearly demonstrate important involvement SSXS phosphorylation Smad interaction dSmurf
0.16014898.12754252.html.plaintext.txt	118	dSmurf Mediates Ubiquitination MAD To dissect function dSmurf ubiquitin E3 ligase tested whether dSmurf stimulated ubiquitination MAD
0.16014898.12754252.html.plaintext.txt	119	3 wild type dSmurf capable enhancing ubiquitination MAD protein lane 3 ubiquitination observed MAD alone lane 1
0.16014898.12754252.html.plaintext.txt	120	Markedly C1029A mutant dSmurf could conjugate HA ubiquitin MAD lane 4
0.16014898.12754252.html.plaintext.txt	121	This suggests catalytic activity dSmurf required ubiquitination MAD
0.16014898.12754252.html.plaintext.txt	122	View larger version 33K FIG
0.16014898.12754252.html.plaintext.txt	123	293T cells transfected expression plasmids His tagged MAD HA tagged ubiquitin Myc dSmurf
0.16014898.12754252.html.plaintext.txt	124	His MAD pulled cell lysates using nickel NTA agarose beads Ni NTA ppt subjected SDS PAGE Western blotting analysis using anti HA antibodies detect pool ubiquitinated MAD upper
0.16014898.12754252.html.plaintext.txt	125	Levels MAD cells detected using anti His antibody bottom
0.16014898.12754252.html.plaintext.txt	126	dSmurfCA catalytically inactive mutant dSmurf C1029A point mutation
0.16014898.12754252.html.plaintext.txt	127	dSmurf Promotes Proteolytic Degradation MAD Having established dSmurf mediated MAD ubiquitination next examined MAD degradation Drosophila S2 human 293T cells
0.16014898.12754252.html.plaintext.txt	128	In S2 cells MAD protein level reduced dramatically overexpressed dSmurf Fig
0.16014898.12754252.html.plaintext.txt	129	Similarly dSmurf degraded MAD 293T cells dose dependent manner Fig
0.16014898.12754252.html.plaintext.txt	130	In sharp contrast C1029A mutant decrease steady state level MAD Fig
0.16014898.12754252.html.plaintext.txt	131	We next examined role phosphorylation MAD dSmurf mediated degradation
0.16014898.12754252.html.plaintext.txt	132	It clear activated type I receptor enhanced degradation MAD protein dSmurf overexpressing cells Fig
0.16014898.12754252.html.plaintext.txt	133	4A compare lane 4 lane 3 consistent increased phosphorylation level data shown
0.16014898.12754252.html.plaintext.txt	134	Most notably addition proteasome inhibitor MG 132 inhibited MAD degradation caused dSmurf Fig
0.16014898.12754252.html.plaintext.txt	135	We took loss function approach examine MAD degradation depleting dSmurf expression
0.16014898.12754252.html.plaintext.txt	136	S2 cells transfected MAD Myc dSmurf treated without 21 nucleotide double stranded RNA targets dSmurf si dSmurf
0.16014898.12754252.html.plaintext.txt	137	We could detect MAD protein increased concentration 20 40 100 nM siRNA Fig
0.16014898.12754252.html.plaintext.txt	138	Simultaneously reduced dSmurf protein level detected anti Myc antibody lower panel Fig
0.16014898.12754252.html.plaintext.txt	139	Importantly increased endogenous phospho MAD protein level detected 100 nM si dSmurf treatment Fig
0.16014898.12754252.html.plaintext.txt	140	4D suggesting silencing endogenous dSmurf si dSmurf
0.16014898.12754252.html.plaintext.txt	141	Overexpression dSmurf Leads Loss Phospho MAD Disruption Imaginal Disc Development DPP signaling essential patterning imaginal discs
0.16014898.12754252.html.plaintext.txt	142	DPP expressed along anterior posterior border wing disc activated phospho MAD expressed wider area around AP border
0.16014898.12754252.html.plaintext.txt	143	Using UAS Gal4 targeted expression system 20 tested whether overexpression dSmurf along AP border reduce abolish phospho MAD
0.16014898.12754252.html.plaintext.txt	144	As expected dSmurf expression targeted AP border using ptc Gal4 strong reduction phospho MAD level ptc expression domain Fig
0.16014898.12754252.html.plaintext.txt	145	ptc Gal4UAS dSmurf ptc dSmurf flies failed eclose due severe developmental defects
0.16014898.12754252.html.plaintext.txt	146	Pharate adult flies removed pupal case showed rudimentary wings Fig
0.16014898.12754252.html.plaintext.txt	147	5L truncated legs shown indicating strong reduction DPP signaling
0.16014898.12754252.html.plaintext.txt	148	In contrast overexpression catalytically inactive dSmurf ptc dSmurfC1029A showed significant defects appendages
0.16014898.12754252.html.plaintext.txt	149	Wing discs ptc dSmurfC1029A showed slight increases level phospho MAD Fig
0.16014898.12754252.html.plaintext.txt	150	5 E G suggesting dSmurfCA may titrate function normal dSmurf
0.16014898.12754252.html.plaintext.txt	151	View larger version 59K FIG
0.16014898.12754252.html.plaintext.txt	152	dSmurf degrades MAD vivo disrupts wing disc development
0.16014898.12754252.html.plaintext.txt	153	Wing discs wild type A D ptc dSmurfC1029A E H ptc dSmurf I L stained anti galactosidase red anti pMAD green
0.16014898.12754252.html.plaintext.txt	154	A pMAD distributed medial wing pouch region normal disc
0.16014898.12754252.html.plaintext.txt	155	Its level lower Ptc domain anterior posterior AP border arrowhead
0.16014898.12754252.html.plaintext.txt	156	B C schematic Ptc red pMAD green domains wing disc
0.16014898.12754252.html.plaintext.txt	157	A P indicate anterior posterior respectively
0.16014898.12754252.html.plaintext.txt	158	E G overexpression dSmurfC1029A using ptc Gal4 causes decrease pMAD level
0.16014898.12754252.html.plaintext.txt	159	Instead pMAD level slightly increased Ptc domain arrow compare Ptc domains A E
0.16014898.12754252.html.plaintext.txt	160	H wings ptc dSmurfC1029A adult flies almost normal
0.16014898.12754252.html.plaintext.txt	161	I K overexpression dSmurf using ptc Gal4 results strong reduction pMAD along anterior posterior border
0.16014898.12754252.html.plaintext.txt	162	L adults ptc dSmurf show rudimentary wings
0.16014898.12754252.html.plaintext.txt	163	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES In study elucidated mechanism underlying dSmurf MAD interaction characterized biological function dSmurf Drosophila
0.16014898.12754252.html.plaintext.txt	164	dSmurf preferentially interacts phosphorylated MAD pMAD
0.16014898.12754252.html.plaintext.txt	165	The preferential binding dSmurf pMAD similar previously reported Smurf2 binding phosphorylated Smad2 9
0.16014898.12754252.html.plaintext.txt	166	Furthermore first time demonstrate mutation SSXS motif MAD abolished binding dSmurf highlighting important role MAD phosphorylation degradation
0.16014898.12754252.html.plaintext.txt	167	This phosphorylation dependent MAD dSmurf interaction contrary previously proposed model Smurfs target non phosphorylated Smad1MAD degradation thus reduces cell competence BMPDPP signals 1 8
0.16014898.12754252.html.plaintext.txt	168	The phosphorylation dependent mechanism also discussed 21 consistent disappearance pMAD dSmurf overexpressing transgenic flies Fig
0.16014898.12754252.html.plaintext.txt	169	5 also agrees increased pMAD level dSmurf null mutants 1
0.16014898.12754252.html.plaintext.txt	170	While present clear phosphorylation controls dSmurf mediated MAD degradation three possible mechanisms envisioned
0.16014898.12754252.html.plaintext.txt	171	First phosphorylation SSXS motif disrupts intrinsic MH1 MH2 interaction results exposed PPXY motif linker region dSmurf binding
0.16014898.12754252.html.plaintext.txt	172	Second dSmurf interaction MAD depends nuclear entry MAD induced ligand
0.16014898.12754252.html.plaintext.txt	173	The third possibility phosphorylated SSXS motif may directly involved MAD binding dSmurf
0.16014898.12754252.html.plaintext.txt	174	Besides PPXY motif phosphoserine SerP residues also serves ligand WW domain 22
0.16014898.12754252.html.plaintext.txt	175	It interesting determine whether one WW domains dSmurf directly bind phosphorylated SSXS motif MAD
0.16014898.12754252.html.plaintext.txt	176	dSmurf also interacts dSmad2 dependent receptor activation
0.16014898.12754252.html.plaintext.txt	177	The binding specificity dSmurf similar structurally related Smurf2 binds BMP activin activated R Smads vertebrates 9 10
0.16014898.12754252.html.plaintext.txt	178	One remaining question whether dSmurf also targets dSmad2 degradation
0.16014898.12754252.html.plaintext.txt	179	Since activin signaling dSmad2 appears effects patterning wing development 23 hypothetical dSmurf mediated dSmad2 degradation wing imaginal disc contributions severe phenotype observed dSmurf transgenic flies
0.16014898.12754252.html.plaintext.txt	180	It disappearance phophos MAD completely shuts DPP signaling wing development
0.16014898.12754252.html.plaintext.txt	181	Unlike vertebrate homologs dSmurf fails interact DAD inhibitory Smad fly
0.16014898.12754252.html.plaintext.txt	182	In vertebrates Smurf1 Smurf2 form strong association Smad6 Smad7 12 may promote degradation TGF receptors 11 12
0.16014898.12754252.html.plaintext.txt	183	While physiological role mammalian Smurf controlling receptor homeostasis remains clarified dSmurf apparent functions proteolytic degradation DPP receptors
0.16014898.12754252.html.plaintext.txt	184	FOOTNOTES This work supported American Cancer Society Grants RSG 02 145 01 CCG X
0.16014898.12754252.html.plaintext.txt	185	Dutch Cancer Society Grant NKI 2000 2217 P
0.16014898.12754252.html.plaintext.txt	186	National Institutes Health Grants R01 CA95731 F
0.16014898.12754252.html.plaintext.txt	187	The costs publication article defrayed part payment page charges
0.16014898.12754252.html.plaintext.txt	188	This article must therefore hereby marked advertisement accordance 18 U
0.16014898.12754252.html.plaintext.txt	189	Section 1734 solely indicate fact
0.16014898.12754252.html.plaintext.txt	190	To correspondence addressed Dept
0.16014898.12754252.html.plaintext.txt	191	Molecular Cellular Biology Baylor College Medicine One Baylor Plaza Rm
0.16014898.12754252.html.plaintext.txt	192	1 The abbreviations used DPP decapentaplegic BMP bone morphogenetic protein TGF transforming growth factor E1 ubiquitin activating enzyme E2 ubiquitin conjugating enzyme E3 ubiquitin protein ligase HA hemagglutinin NTA nitrilotriacetic acid sidSmurf 21 nucleotide double stranded RNA targets dSmurf pMAD phosphorylated MAD
0.16014898.12754252.html.plaintext.txt	193	ACKNOWLEDGMENTS We thank Rik Derynck critical reading manuscript Kohei Miyazono Richard Padgett Scott Hawley Jeff Wrana reagents Jianluo Jia technical assistance
0.16014898.12754252.html.plaintext.txt	194	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Podos S
0.16014898.12754252.html.plaintext.txt	195	Cell 1 567 578Medline Order article via Infotrieve Raftery L
0.16014898.12754252.html.plaintext.txt	196	210 251 268CrossRefMedline Order article via Infotrieve Roberts A
0.16014898.12754252.html.plaintext.txt	197	2001 Sciences STKE httpstke
0.16014898.12754252.html.plaintext.txt	198	orgcgicontentfullsigtrans2001113PE43 Padgett R
0.16014898.12754252.html.plaintext.txt	199	Cell 1 343 349Medline Order article via Infotrieve Sekelsky J
0.16014898.12754252.html.plaintext.txt	200	1995 Genetics 139 1347 1358AbstractFree Full Text Hershko A
0.16014898.12754252.html.plaintext.txt	201	67 425 479CrossRefMedline Order article via Infotrieve Ciechanover A
0.16014898.12754252.html.plaintext.txt	202	2000 Bioessays 22 442 4513
0.16014898.12754252.html.plaintext.txt	203	CO2 Q 693CrossRefMedline Order article via Infotrieve Lin X
0.16014898.12754252.html.plaintext.txt	204	275 36818 36822AbstractFree Full Text Zhang Y
0.16014898.12754252.html.plaintext.txt	205	98 974 979AbstractFree Full Text Kavsak P
0.16014898.12754252.html.plaintext.txt	206	Cell 6 1365 1375Medline Order article via Infotrieve Ebisawa T
0.16014898.12754252.html.plaintext.txt	207	276 12477 12480AbstractFree Full Text Feng X
0.16014898.12754252.html.plaintext.txt	208	19 5178 5193AbstractFree Full Text Feng X
0.16014898.12754252.html.plaintext.txt	209	Cell 9 133 143Medline Order article via Infotrieve Elbashir S
0.16014898.12754252.html.plaintext.txt	210	2001 Nature 411 494 498CrossRefMedline Order article via Infotrieve Spradling A
0.16014898.12754252.html.plaintext.txt	211	1982 Science 218 341 347Medline Order article via Infotrieve Cho K
0.16014898.12754252.html.plaintext.txt	212	1998 Nature 396 272 276CrossRefMedline Order article via Infotrieve Brummel T
0.16014898.12754252.html.plaintext.txt	213	1994 Cell 78 251 261Medline Order article via Infotrieve Nellen D
0.16014898.12754252.html.plaintext.txt	214	1994 Cell 78 225 237Medline Order article via Infotrieve Brand A
0.16014898.12754252.html.plaintext.txt	215	118 401 415AbstractFree Full Text Arora K
0.16014898.12754252.html.plaintext.txt	216	Cell 1 441 442Medline Order article via Infotrieve Lu P
0.16014898.12754252.html.plaintext.txt	217	1999 Science 283 1325 1328AbstractFree Full Text Brummel T
0.16014898.12754252.html.plaintext.txt	218	13 98 111AbstractFree Full Text
0.12080864.15197226.html.plaintext.txt	0	Rockefeller University Press 0022 1007 8
0.12080864.15197226.html.plaintext.txt	1	00 JEM Volume 199 Number 12 1679 1688 This Article Abstract PDF Full Text Alert article cited Citation Map Services Alert new content JEM Download citation manager Cited online articles Google Scholar Articles Karlsson M
0.12080864.15197226.html.plaintext.txt	2	Articles citing Article PubMed PubMed Citation Articles Karlsson M
0.12080864.15197226.html.plaintext.txt	3	Allergen responsive CD4CD25 Regulatory T Cells Children Have Outgrown Cows Milk Allergy Malin R
0.12080864.15197226.html.plaintext.txt	4	Karlsson1 Jarle Rugtveit12 Per Brandtzaeg1
0.12080864.15197226.html.plaintext.txt	5	1 Laboratory Immunohistochemistry Immunopathology LIIPAT Institute Pathology Rikshospitalet University Hospital N 0027 Oslo Norway 2 Department Paediatrics Ulleval University Hospital NO 0407 Oslo Norway
0.12080864.15197226.html.plaintext.txt	6	Address correspondence Malin Karlsson Laboratory Immunohistochemistry Immunopathology Institute Pathology Rikshospitalet N 0027 Oslo Norway
0.12080864.15197226.html.plaintext.txt	7	Phone 47 23071489 Fax 47 23071511 email malin
0.12080864.15197226.html.plaintext.txt	8	Abstract Top Abstract Introduction Materials Methods Results Discussion References Cows milk allergy children often short duration makes disorder interesting clinical model studies tolerance dietary antigens
0.12080864.15197226.html.plaintext.txt	9	Here studied T cell responses 21 initially allergic children milk free period 2 mo cows milk reintroduced diet
0.12080864.15197226.html.plaintext.txt	10	Children outgrew allergy tolerant children higher frequencies circulating CD4CD25 T cells decreased vitro proliferative responses bovine ss lactoglobulin peripheral blood mononuclear cells PBMCs compared children maintained clinically active allergy
0.12080864.15197226.html.plaintext.txt	11	No significant difference proliferative activity stimulated polyclonal mitogen phytohemagglutinin observed two groups
0.12080864.15197226.html.plaintext.txt	12	Depletion CD25 cells PBMCs tolerant children led fivefold increase vitro proliferation ss lactoglobulin
0.12080864.15197226.html.plaintext.txt	13	This suggests tolerance associated appearance circulating CD4CD25 regulatory T Treg cells capable suppressing effector T cells generated 1 wk reintroduction cows milk
0.12080864.15197226.html.plaintext.txt	14	The suppressive function CD4CD25 Treg cells shown partly cell contact dependent
0.12080864.15197226.html.plaintext.txt	15	Collectively study provides human data suggest mucosal induction tolerance dietary antigens associated development CD4CD25 Treg cells
0.12080864.15197226.html.plaintext.txt	16	Key Words human oral tolerance regulatory T cells food allergy cytokines
0.12080864.15197226.html.plaintext.txt	17	Abbreviations used paper ss lactoglobulin ss LG PHA phytohemagglutinin Treg cell regulatory T cell
0.12080864.15197226.html.plaintext.txt	18	Introduction Top Abstract Introduction Materials Methods Results Discussion References The usual immune response harmless gut antigens generation local systemic immunological tolerance known oral tolerance
0.12080864.15197226.html.plaintext.txt	19	This mechanism may explained different T cell events anergy clonal deletion induction regulatory T Treg cells
0.12080864.15197226.html.plaintext.txt	20	For ethical reasons existence oral tolerance humans mainly supported circumstantial evidence
0.12080864.15197226.html.plaintext.txt	21	Thus healthy individuals hardly hyperactivated T cells gut mucosa little mucosal IgG production low levels serum IgG antibodies food antigens 1
0.12080864.15197226.html.plaintext.txt	22	Moreover nasal antigen application feeding experiments induced peripheral regulation T cell responses healthy individuals 2 3
0.12080864.15197226.html.plaintext.txt	23	Decreased robustness mucosally induced tolerance westernized populations suggested recent striking rise atopic diseases 4 5 8 children 3 yr age develop food allergy
0.12080864.15197226.html.plaintext.txt	24	This disorder associated serious health consequences may unfortunately also starting point allergic march
0.12080864.15197226.html.plaintext.txt	25	development subsequent atopic diseases airways
0.12080864.15197226.html.plaintext.txt	26	Therefore great importance understand immunological mechanisms involved break oral tolerance dietary antigens
0.12080864.15197226.html.plaintext.txt	27	Indirect evidence exists suggest development food allergy may controlled CD4CD25 Treg cells
0.12080864.15197226.html.plaintext.txt	28	Patients immune dysregulation polyendocrinopathy enteropathy X linked syndrome X linked autoimmunity allergic dysregulation syndrome lack T cell subset often develop food allergic reactions increased specific IgE antibody levels accompanied severe eczema 5 6
0.12080864.15197226.html.plaintext.txt	29	Further support role CD4CD25 Treg cells mediating oral tolerance obtained feeding experiments mice 7 11
0.12080864.15197226.html.plaintext.txt	30	Other T cell subsets possibly involved oral tolerance least animals Th3 cells produce TGF ss Tr1 cells produce IL 10 TGF ss NK T cells 12 14
0.12080864.15197226.html.plaintext.txt	31	However firmly established whether subsets represent separate cell lineages different maturational phenotypes
0.12080864.15197226.html.plaintext.txt	32	A years discovery naturally occurring CD4CD25 Treg cells mice similar T cell subset identified human peripheral blood thymus LNs cord blood 15
0.12080864.15197226.html.plaintext.txt	33	In mice CD4CD25 Treg cells reportedly play role control immune responses infectious agents transplants cancer well graft versus host reactions 16 21 whereas humans CD4CD25 Treg cells shown involved regulating cancer immunity 22 24
0.12080864.15197226.html.plaintext.txt	34	These human cells typically anergic upon TCR stimulation 25 although recent studies mice suggest Treg cells expanded vitro vivo interacting appropriate APC type 26
0.12080864.15197226.html.plaintext.txt	35	This might explain constant number CD4CD25 Treg cells maintained circulation
0.12080864.15197226.html.plaintext.txt	36	Common phenotypic markers CD4CD25 Treg cells CD45RO L selectin CD62L CTLA 4 CD152 CD25 glucocorticoid induced tumor necrosis factor receptor 27 30 although phenotypic profile also displayed T cell subsets
0.12080864.15197226.html.plaintext.txt	37	Therefore functional assays firmly identify CD4CD25 Treg cells
0.12080864.15197226.html.plaintext.txt	38	Nevertheless recent studies mice humans demonstrated novel transcription repressor protein FOXP3 exclusively expressed naturally occurring induced CD4CD25 Treg cells 31 38
0.12080864.15197226.html.plaintext.txt	39	Current evidence suggests human CD4CD25 Treg cells employ several mechanisms suppress immune responses instance via direct cell contact indirectly reducing antigen presenting capacity APCs 39
0.12080864.15197226.html.plaintext.txt	40	In addition least mice suppressive cytokines appear involved effector function Treg cells 40 41
0.12080864.15197226.html.plaintext.txt	41	It remains open question whether one regulatory properties may acquired naive CD4 T cell normal peripheral immunostimulatory process
0.12080864.15197226.html.plaintext.txt	42	Cows milk allergy children often disease relatively short duration makes interesting clinical model development oral tolerance
0.12080864.15197226.html.plaintext.txt	43	Using depletion CD25 cells read test suppressive effect Treg subset exerts effector T cells able show children outgrown allergy
0.12080864.15197226.html.plaintext.txt	44	tolerant cows milk allergens developed population CD4CD25 T cells regulatory function peripheral blood 1 wk vivo milk challenge
0.12080864.15197226.html.plaintext.txt	45	This subset numerically functionally reduced children remained allergic cows milk
0.12080864.15197226.html.plaintext.txt	46	These results suggested mucosal induction Treg cells response cows milk proteins alternatively centrally generated Treg cells become activated expanded children outgrown food allergy
0.12080864.15197226.html.plaintext.txt	47	Materials Methods Top Abstract Introduction Materials Methods Results Discussion References Patient Characteristics Selection Criteria A total number 21 children median age 24 mo range 6 56 mo previously diagnosed cows milk allergy included consecutively study routinely visited patient clinic starting trial reintroduction cows milk cows milk products diet least 2 mo median 6 mo range 2 11 mo strictly cows milk free diet
0.12080864.15197226.html.plaintext.txt	48	All families routinely informed nutrition physiologist given information brochure achieve diet free cows milk products
0.12080864.15197226.html.plaintext.txt	49	The original allergy diagnosis made median age 5 mo range 2 18 mo based following criteria persistent gastroenterological symptoms without combination extraintestinal symptoms see next paragraph reported parents followed total disappearance symptoms cows milk free diet period least 1 mo followed reappearance similar symptoms least two open milk challenges observed parents see next paragraph
0.12080864.15197226.html.plaintext.txt	50	Children history anaphylactic symptoms evidence cows milk specific IgE antibodies excluded make test group homogeneous possible
0.12080864.15197226.html.plaintext.txt	51	The patients demonstrated one following symptoms number cases parenthesis bloody usually loose stools n 4 diarrhea n 8 failure thrive n 5 eczema n 2 vomiting regurgitation n 5 excessive crying n 5 anemia n 1
0.12080864.15197226.html.plaintext.txt	52	The symptoms observed parents median age 3 mo range 2 wk 12 mo
0.12080864.15197226.html.plaintext.txt	53	Where suspected lactose intolerance excluded routine lactose challenge test H2 breath test
0.12080864.15197226.html.plaintext.txt	54	Cows Milk Challenge Procedure The reintroduction cows milk diet done gradually increasing amount milk cows milk based formula least 100 mlday first two days continuing parents experienced unacceptable symptoms routine evaluation performed patient clinic 1 wk
0.12080864.15197226.html.plaintext.txt	55	All clinical evaluations performed pediatrician 8 children median age 24 mo range 16 45 mo deemed display persistently active cows milk allergy whereas 13 children median age 24 mo range 9 49 mo outgrown allergy since found tolerant milk challenge
0.12080864.15197226.html.plaintext.txt	56	A blood sample taken 1 wk start cows milk reintroduction
0.12080864.15197226.html.plaintext.txt	57	Ethics The study approved local Regional medical ethics committee East Norway Blindern pb1139 Norway informed consent obtained parents
0.12080864.15197226.html.plaintext.txt	58	Cell Isolation PBMCs obtained heparinized blood Lymphoprep centrifugation Nycomed Pharma
0.12080864.15197226.html.plaintext.txt	59	Cells washed finally diluted RPMI 1640 medium supplemented 10 heat inactivated pooled human serum 1 L glutamine 1 gentamycin GIBCO BRL
0.12080864.15197226.html.plaintext.txt	60	Proliferation Assay PBMCs 105 cultured 96 well round bottom tissue culture plates 200 microlwell stimulated phytohemagglutinin PHA 10 microl 100 microgml ss lactoglobulin ss LG 10 microl 20 mgml cows milk L0130 Sigma Aldrich
0.12080864.15197226.html.plaintext.txt	61	Radioactive thymidine 3H Tdr 1 mCiwell TRK 120 Amersham Biosciences added wells 6 d initiation stimulation
0.12080864.15197226.html.plaintext.txt	62	The cells harvested 12 16 h later
0.12080864.15197226.html.plaintext.txt	63	Incorporation 3H Tdr determined ss counter
0.12080864.15197226.html.plaintext.txt	64	Depletion CD25 Cells An Ab coated microbead isolation procedure used depletion CD25 cells according manufacturers instruction Miltenyi Biotec
0.12080864.15197226.html.plaintext.txt	65	Briefly 20 microl CD25 specific beads suspended together 5 x 106 107 PBMCs incubated 15 min ice followed two washes
0.12080864.15197226.html.plaintext.txt	66	LD columns prepared recommended manufacturer used magnetic depletion
0.12080864.15197226.html.plaintext.txt	67	The effluent PBMC samples contained 0
0.12080864.15197226.html.plaintext.txt	68	5 CD25 cells determined flow cytometry see
0.12080864.15197226.html.plaintext.txt	69	specific mouse CD5 Miltenyi used prepare control samples PBMCs
0.12080864.15197226.html.plaintext.txt	70	Antibodies The following mouse mAbs specificity human molecules used immunostaining PBMCs FITC PE conjugated anti CD25 IgG1 clone 2A3 Becton Dickinson biotin conjugated anti CTLA 4 IgG1 clone BNI3
0.12080864.15197226.html.plaintext.txt	71	1 Becton Dickinson PerCp anti CD3 IgG1 biotin conjugated anti CCR4 IgG1 clone 1G1 Becton Dickinson FITC APC conjugated anti CD4 IgG2a clone EDU 2 Diatec FITC PE conjugated anti CD8 IgG2a clone UCH T4 Diatec PE conjugated anti CD45RO IgG2a clone UCHL 1 LeukoSite Inc
0.12080864.15197226.html.plaintext.txt	72	anti CCR9 IgG2b clone 3C3 LeukoSite anti 4ss7 IgG1 Act 1 courtesy Dr
0.12080864.15197226.html.plaintext.txt	73	Lazarovits University Western Ontario London Ontario Canada PEFITC conjugated streptavidin Southern Biotechnology
0.12080864.15197226.html.plaintext.txt	74	Secondary reagents goat anti mouse IgG2b PE Southern Biotechnology goat anti mouse IgG1 PE Catalog Laboratories
0.12080864.15197226.html.plaintext.txt	75	Flow Cytometric Analysis Cell Sorting Immunofluorescence staining performed washing cells PBS plus 0
0.12080864.15197226.html.plaintext.txt	76	5 wtvol BSA Sigma Aldrich
0.12080864.15197226.html.plaintext.txt	77	Cells incubated 20 min ice pretitrated optimal dilution mAb
0.12080864.15197226.html.plaintext.txt	78	Cells washed analyzed flow cytometry FACS Caliber Becton Dickinson
0.12080864.15197226.html.plaintext.txt	79	Immunostained subsets T cells sorted FACS Vantage SE Becton Dickinson
0.12080864.15197226.html.plaintext.txt	80	Transwell Experiments Transwell experiments performed 24 well plates 0
0.12080864.15197226.html.plaintext.txt	81	4 microm pore size Costar Inc
0.12080864.15197226.html.plaintext.txt	82	FACS sorted CD4CD25 cells 4 x 105 added lower chamber
0.12080864.15197226.html.plaintext.txt	83	FACS sorted CD4CD25 cells 105 purity 99 added either directly lower chamber together CD4CD25 subset placed upper transwell chamber
0.12080864.15197226.html.plaintext.txt	84	After 48 h stimulation anti CD3CD28 beads 106 beadswell Dynalbiotech cells lower chambers transferred 96 well plate radioactive thymidine added 12 16 h
0.12080864.15197226.html.plaintext.txt	85	Incorporation 3H Tdr determined ss counter
0.12080864.15197226.html.plaintext.txt	86	Cytokine Analysis PBMCs 5 x 105 cultured flat 24 well plates 1 mlwell stimulated PHA 50 microgml ss LG 1 mgml remained unstimulated medium alone 96 h
0.12080864.15197226.html.plaintext.txt	87	The supernatants collected frozen 70 degrees C analysis following assays
0.12080864.15197226.html.plaintext.txt	88	An ELISA performed round bottom wells coated overnight pretitrated optimal concentration mAb human TGF ss inactive complex anti TGF ss1 LAP 2 microgml clone 27235
0.12080864.15197226.html.plaintext.txt	89	The supernatants standard recombinant TGF ss RD System Europe serially diluted PBS Tween incubated overnight 4 degrees C
0.12080864.15197226.html.plaintext.txt	90	A biotinylated mouse mAb human TGF ss1 LAP 125 ngml clone 27240 RD System Europe added wells incubated overnight 4 degrees C
0.12080864.15197226.html.plaintext.txt	91	The wells incubated Streptavidin horseradish peroxidase conjugate RD System Europe 20 min room temperature
0.12080864.15197226.html.plaintext.txt	92	Finally TMB Microwell Peroxidase Substrate System KLP added 30 min room temperature reaction stopped 2 M HCl
0.12080864.15197226.html.plaintext.txt	93	The incubations performed humid chambers intervening washes 3 x 200 microl PBS containing 0
0.12080864.15197226.html.plaintext.txt	94	Human Th1Th2 Cytokine Cytometric Bead Array kit used 550749 Becton Dickinson
0.12080864.15197226.html.plaintext.txt	95	The assay performed according manufacturers recommendation
0.12080864.15197226.html.plaintext.txt	96	Shapiro Francia W test used normality distribution test
0.12080864.15197226.html.plaintext.txt	97	Unpaired paired two tailed Students tests used statistical analyses
0.12080864.15197226.html.plaintext.txt	98	Statview software designed Macintosh computers
0.12080864.15197226.html.plaintext.txt	99	Results Top Abstract Introduction Materials Methods Results Discussion References This study designed reveal possible immunoregulatory differences PBMCs obtained children showing outgrown compared active cows milk allergy
0.12080864.15197226.html.plaintext.txt	100	The former group presumably subjected oral tolerance induction milk allergens
0.12080864.15197226.html.plaintext.txt	101	All included children cows milk free diet least 2 mo experimental milk challenge performed distinguish clinically two groups
0.12080864.15197226.html.plaintext.txt	102	Various immunological variables examined vivo exposure cows milk via gut 1 wk
0.12080864.15197226.html.plaintext.txt	103	To evaluate milk induced immune stimulation regulation restimulation vitro performed major milk allergen bovine ss LG
0.12080864.15197226.html.plaintext.txt	104	In addition performed polyclonal stimulation PBMCs PHA obtain robust base line response reference functional Treg cell induction see Discussion
0.12080864.15197226.html.plaintext.txt	105	Peripheral blood two groups children analyzed regard frequency CD4 T cells expressing CD25 modulation subset caused vivo milk challenge
0.12080864.15197226.html.plaintext.txt	106	The percentage CD4 CD25 T cells fairly similar allergic tolerant groups challenge
0.12080864.15197226.html.plaintext.txt	107	After vivo milk exposure however tolerant group tended show increased frequency circulating CD25 cells P 0
0.12080864.15197226.html.plaintext.txt	108	07 whereas number significantly reduced P 0
0.12080864.15197226.html.plaintext.txt	109	01 allergic children Fig
0.12080864.15197226.html.plaintext.txt	110	Within human T cell subset fraction high level CD25 reported responsible regulatory function 39 detect differences immunostaining intensity two groups children either time points
0.12080864.15197226.html.plaintext.txt	111	Nevertheless CD4CD25 T cell subset profile distinct FACS histogram 1 wk vivo milk challenge children outgrown allergy remaining allergic Fig
0.12080864.15197226.html.plaintext.txt	112	Also comparison tolerant allergic group regard fraction CD4CD25 T cells vivo milk challenge revealed significant difference P 0
0.12080864.15197226.html.plaintext.txt	113	03 modulation subset relative prechallenge levels although one seven allergic group showed increased frequency CD25 subset case five ten tolerant group Fig
0.12080864.15197226.html.plaintext.txt	114	Notably percentage CD3CD4 cells showed similar range groups tolerant group median 39
0.12080864.15197226.html.plaintext.txt	115	2 tolerant group median 42
0.12080864.15197226.html.plaintext.txt	116	View larger version 29K Figure 1
0.12080864.15197226.html.plaintext.txt	117	Frequency circulating CD4CD25 T cells 1 wk vivo challenge cows milk
0.12080864.15197226.html.plaintext.txt	118	A PBMCs purified blood challenge immunostained mAbs analyzed FACS Caliber
0.12080864.15197226.html.plaintext.txt	119	The M1 gates set accordance isotype concentration matched mAb controls
0.12080864.15197226.html.plaintext.txt	120	One representative experiment shown tolerant group n 10 one allergic group n 7
0.12080864.15197226.html.plaintext.txt	121	B Increase decrease circulating CD4CD25 T cells 1 wk vivo exposure cows milk normalized relation prechallenge levels set 100 dotted line
0.12080864.15197226.html.plaintext.txt	122	Students test used statistical analysis
0.12080864.15197226.html.plaintext.txt	123	The increase allergy industrialized societies might reflect immature immune system due reduced microbial exposure 4 42
0.12080864.15197226.html.plaintext.txt	124	Therefore investigated maturation state CD4CD25 T cells examining CD45RO expression
0.12080864.15197226.html.plaintext.txt	125	Approximately 30 CD4CD25 T cells tolerant children positive marker contrast 5 allergic group values remained unchanged vivo milk challenge Fig
0.12080864.15197226.html.plaintext.txt	126	PBMCs also immunostained mAbs 4ss7 CCR9 CCR4 CD8 surface CTLA 4 CD40L CD45RA neither reveal differences two groups children effect vivo milk challenge markers unpublished data
0.12080864.15197226.html.plaintext.txt	127	View larger version 21K Figure 2
0.12080864.15197226.html.plaintext.txt	128	Expression maturation marker CD45RO circulating CD4CD25 T cells 1 wk vivo challenge cows milk
0.12080864.15197226.html.plaintext.txt	129	PBMCs immunostained mAbs CD3CD4CD25 cells gated determine frequency CD45RO cells within T cell subset
0.12080864.15197226.html.plaintext.txt	130	children active allergy tolerant children outgrown allergy
0.12080864.15197226.html.plaintext.txt	131	Students test used statistical analysis
0.12080864.15197226.html.plaintext.txt	132	Interestingly significant difference two groups children T cell proliferation induced vitro ss LG PBMCs collected vivo milk challenge tested Fig
0.12080864.15197226.html.plaintext.txt	133	By contrast PBMCs obtained 1 wk introduction challenge showed significantly proliferative activity ss LG patients active allergy compared tolerant children Fig
0.12080864.15197226.html.plaintext.txt	134	Conversely difference proliferation either time points revealed vitro stimulation PBMCs PHA Fig
0.12080864.15197226.html.plaintext.txt	135	View larger version 14K Figure 3
0.12080864.15197226.html.plaintext.txt	136	A PBMCs purified samples obtained 1 wk vivo challenge cows milk stimulated vitro bovine ss LG
0.12080864.15197226.html.plaintext.txt	137	Radioactive thymidine 3H Tdr added 6 d addition ss LG PBMC cultures
0.12080864.15197226.html.plaintext.txt	138	The cells harvested 12 16 h later
0.12080864.15197226.html.plaintext.txt	139	Incorporation 3H Tdr determined ss counter
0.12080864.15197226.html.plaintext.txt	140	children active allergy tolerant children outgrown allergy
0.12080864.15197226.html.plaintext.txt	141	B Similar samples procedure A stimulation performed PHA
0.12080864.15197226.html.plaintext.txt	142	Students test used statistical analysis
0.12080864.15197226.html.plaintext.txt	143	Although CD25 expression CD4 T cells associated regulatory function exclusive marker Treg cells instead indicate productive effector function
0.12080864.15197226.html.plaintext.txt	144	To investigate whether CD4CD25 subset PBMC cultures possessed regulatory capacity removed CD25 T cells samples performed vitro stimulation either ss LG mitogen PHA Fig
0.12080864.15197226.html.plaintext.txt	145	Depleted PBMCs purified blood obtained vivo milk challenge tended show increased proliferation allergic group perhaps reflecting higher proliferative activity children Fig
0.12080864.15197226.html.plaintext.txt	146	4 A statistically significant difference obtained
0.12080864.15197226.html.plaintext.txt	147	1 wk milk challenge depleted PBMC cultures showed average almost fivefold increase proliferative activity ss LG tolerant group compared twofold allergic group P 0
0.12080864.15197226.html.plaintext.txt	148	001 moreover significant increase P 0
0.12080864.15197226.html.plaintext.txt	149	01 compared proliferative level depletion vivo challenge
0.12080864.15197226.html.plaintext.txt	150	Note actual proliferation undepleted PBMCs stimulated ss LG shown Fig
0.12080864.15197226.html.plaintext.txt	151	These results likely reflected long period milk restricted diet ss LG specific memory T cells probable residing gut whereas circulating
0.12080864.15197226.html.plaintext.txt	152	However oral milk challenge specific T cells would become activated expanded GALT subsequently appear circulation homing back gut
0.12080864.15197226.html.plaintext.txt	153	Also PHA tended elicit augmented proliferation depletion CD25 cells PBMCs collected tolerant children 1 wk challenge whereas enhancement seen unstimulated cultures Fig
0.12080864.15197226.html.plaintext.txt	154	View larger version 20K Figure 4
0.12080864.15197226.html.plaintext.txt	155	Fold increase decrease proliferation depletion CD25 cells PBMCs purified blood 1 wk vivo challenge cows milk
0.12080864.15197226.html.plaintext.txt	156	3 A set 1 dotted line
0.12080864.15197226.html.plaintext.txt	157	The depleted nondepleted PBMC samples tested proliferative activity unstimulated vitro stimulation bovine ss LG mitogen PHA
0.12080864.15197226.html.plaintext.txt	158	Radioactive thymidine 3H Tdr added 6 d addition antigens cell cultures
0.12080864.15197226.html.plaintext.txt	159	The cells harvested 12 16 h later
0.12080864.15197226.html.plaintext.txt	160	Incorporation 3H Tdr determined ss counter
0.12080864.15197226.html.plaintext.txt	161	Students test used statistical analysis
0.12080864.15197226.html.plaintext.txt	162	For comparison absolute proliferative activity cpm values vitro stimulated PBMCs collected allergic tolerant children vivo challenge see Fig 3 A
0.12080864.15197226.html.plaintext.txt	163	To examine whether suppressive effect CD25 cells mediated via cell contact dependent mechanism soluble factors examined FACS sorted T cell subsets transwell system
0.12080864.15197226.html.plaintext.txt	164	Due severe ethical restraints blood sampling children 2 yr age unable purify autologous APCs antigen specific stimulation experiments
0.12080864.15197226.html.plaintext.txt	165	Instead employed anti CD3CD28 activation purified T cell subsets
0.12080864.15197226.html.plaintext.txt	166	When CD25 CD25 T cells isolated PBMCs collected 1 wk vivo milk challenge cocultured significantly reduced proliferative activity P 0
0.12080864.15197226.html.plaintext.txt	167	03 observed compared result obtained two subsets separated transwell membrane Fig
0.12080864.15197226.html.plaintext.txt	168	This suggested least part suppression mediated via cell contact
0.12080864.15197226.html.plaintext.txt	169	When CD4CD25 T cells cultured upper lower chamber proliferation similar seen CD25 subset cultured lower chamber CD25 subset upper chamber Fig
0.12080864.15197226.html.plaintext.txt	170	View larger version 15K Figure 5
0.12080864.15197226.html.plaintext.txt	171	Immunosuppression exerted CD4CD25 T cells peripheral blood children tolerant cows milk partly cell contact dependent
0.12080864.15197226.html.plaintext.txt	172	CD4CD25 T cells CD4CD25 T cells FACS sorted cultured transwell plates
0.12080864.15197226.html.plaintext.txt	173	In wells CD4CD25 T cells cultured upper chamber CD4CD25 T cells lower chamber whereas plates subsets cultured lower chambers
0.12080864.15197226.html.plaintext.txt	174	Additional controls consisted CD4CD25 T cells cultured upper lower wells indicated bottom figure
0.12080864.15197226.html.plaintext.txt	175	Stimulation performed anti CD3CD28 beads 48 h
0.12080864.15197226.html.plaintext.txt	176	The proliferative activity CD4CD25 tested addition radioactive thymidine 3H Tdr cells harvested 12 h later
0.12080864.15197226.html.plaintext.txt	177	Incorporation 3H Tdr determined ss counter
0.12080864.15197226.html.plaintext.txt	178	Note individual subjects indicated separate symbols y axis broken
0.12080864.15197226.html.plaintext.txt	179	Students test used statistical analysis
0.12080864.15197226.html.plaintext.txt	180	In addition cell contact mediated effect Treg cells examined production immunosuppressive cytokines TGF ss Fig
0.12080864.15197226.html.plaintext.txt	181	6 B ss LG PHA stimulated PBMC cultures
0.12080864.15197226.html.plaintext.txt	182	We could detect striking differences cytokine concentrations samples obtained either vivo milk challenge
0.12080864.15197226.html.plaintext.txt	183	However notable PBMCs tolerant group tended show increased TGF ss production ss LG stimulation compared levels vivo milk challenge P 0
0.12080864.15197226.html.plaintext.txt	184	27 similarly increased trend associated tolerance observed IL 10 challenge two groups compared P 0
0.12080864.15197226.html.plaintext.txt	185	Interestingly TGF ss response significantly decreased challenge allergic group P 0
0.12080864.15197226.html.plaintext.txt	186	03 although tended higher tolerant group challenge P 0
0.12080864.15197226.html.plaintext.txt	187	Such trends cytokine changes apparent PHA used stimulate PBMCs Fig
0.12080864.15197226.html.plaintext.txt	188	View larger version 24K Figure 6
0.12080864.15197226.html.plaintext.txt	189	Generation immunosuppressive cytokines TGF ss1 LAP IL 10 PBMCs purified blood allergic tolerant children 1 wk vivo challenge cows milk
0.12080864.15197226.html.plaintext.txt	190	A Production TGF ss1 LAP determined supernatants PBMCs stimulated 96 h ss LG 1 mgml PHA 50 microgml subtracting TGF ss1 LAP concentration unstimulated wells
0.12080864.15197226.html.plaintext.txt	191	B Production IL 10 culture conditions A
0.12080864.15197226.html.plaintext.txt	192	Students test used statistical analysis
0.12080864.15197226.html.plaintext.txt	193	Discussion Top Abstract Introduction Materials Methods Results Discussion References This study showed vivo milk challenge induced Treg cells preferentially previously cows milk allergic children become tolerant clinically outgrown allergy
0.12080864.15197226.html.plaintext.txt	194	It intriguing intestinal immune system discern pathogens innocuous antigens dietary proteins respond eliciting productive immunity oral tolerance respectively
0.12080864.15197226.html.plaintext.txt	195	The understanding latter phenomenon hampered intricate mechanistic complexity involving T cell anergy clonal deletion skewing cytokine profile immune deviation action different Treg cells
0.12080864.15197226.html.plaintext.txt	196	We established first time human CD4CD25 Treg cells induced via gut involved control food allergy T cell subset activation exerts suppressive function least partially cell contact dependent manner
0.12080864.15197226.html.plaintext.txt	197	Our study compared phenotypic functional characteristics PBMCs children clinically active outgrown cows milk allergy collected 1wk vivo challenge cows milk
0.12080864.15197226.html.plaintext.txt	198	PBMCs tolerant group showed reduced proliferation induced vitro major milk allergen ss LG
0.12080864.15197226.html.plaintext.txt	199	Furthermore children CD25 T cell subset within PBMCs able suppress proliferation
0.12080864.15197226.html.plaintext.txt	200	In group 30 CD4CD25 T cells expressed maturation marker CD45RO challenge cows milk whereas corresponding figure 5 group active allergy
0.12080864.15197226.html.plaintext.txt	201	All children included study negative skin prick test cows milk proteins elevated specific IgE antibody levels serum
0.12080864.15197226.html.plaintext.txt	202	This suggested observed symptoms probably produced via cell mediated immunity
0.12080864.15197226.html.plaintext.txt	203	Approximately 50 children suffering food allergy appear standard diagnostic tests non IgE mediated allergic reaction 43 44 presumably delayed type hypersensitivity although pathological process gut may indistinguishable atopic disorder 45
0.12080864.15197226.html.plaintext.txt	204	We selected patients homogeneously nonatopic would certainly interest future also study children elevated IgE antibody levels food allergens similar experimental set
0.12080864.15197226.html.plaintext.txt	205	Such studies young children repeated sampling profound ethical restrictions
0.12080864.15197226.html.plaintext.txt	206	Therefore design vitro experiments basis limited blood volumes available
0.12080864.15197226.html.plaintext.txt	207	We also take account large age range patients 6 56 mo highly variable immunological history terms exposure antigens vaccines environment
0.12080864.15197226.html.plaintext.txt	208	This related systemic also mucosal immune system
0.12080864.15197226.html.plaintext.txt	209	Importantly investigated tolerance induction via gut recent animal experiments demonstrated systemic local immunization routes provide different results comes dampening mucosal allergy 46
0.12080864.15197226.html.plaintext.txt	210	In view complex scenario decided PHA stimulation rather arbitrarily selected T cell dependent antigen would best ensure consistent base line response reference mucosal induction Treg cells cows milk proteins
0.12080864.15197226.html.plaintext.txt	211	The vitro proliferative activity PBMCs ss LG presumably T cell recall response
0.12080864.15197226.html.plaintext.txt	212	Notably however significant difference compared PBMCs collected two groups children vivo cows milk challenge regard proliferation elicited ss LG frequency CD4CD25 T cells suppressive effect CD25 cells revealed depletion
0.12080864.15197226.html.plaintext.txt	213	This result probably reflected patients active allergy time point substantially larger number circulating memory T cells specific ss LG tolerant children
0.12080864.15197226.html.plaintext.txt	214	The avoidance cows milk proteins least 2 mo challenge might reduced number specific T cells activated GALT mesenteric LNs would presumably start homing back intestinal lamina propria milk challenge
0.12080864.15197226.html.plaintext.txt	215	Thus reduced relative frequency circulating CD4CD25 T cells allergic children challenge Fig
0.12080864.15197226.html.plaintext.txt	216	It note ss LG preparations contained LPS comparable endotoxin activity 5000 EUml 5 mgml Limulus Amebocyte Lysate test polyclonal immunostimulation exerted contamination mask antigen specific T cell response elicited ss LG vitro unpublished data
0.12080864.15197226.html.plaintext.txt	217	Interestingly proliferative response PBMCs ss LG significantly decreased milk tolerant compared allergic children vivo milk challenge
0.12080864.15197226.html.plaintext.txt	218	Our findings therefore suggested tolerant children challenge resulted GALT activation expansion specific effector T cells also CD4CD25 Treg cells suppressed vitro proliferative response elicited ss LG
0.12080864.15197226.html.plaintext.txt	219	The observed relative increase circulating subset half tolerant children 1 wk challenge Fig
0.12080864.15197226.html.plaintext.txt	220	1 B probably underestimate due homing allergen activated T cells milk protein exposed gut lamina propria alluded
0.12080864.15197226.html.plaintext.txt	221	Although originally believed CD4CD25 Treg cells anergic least two independent reports recently showed mouse CD4CD25 T cells initially multiply vivo appropriate antigen stimulation 26 47
0.12080864.15197226.html.plaintext.txt	222	We cannot exclude increased frequency circulating CD4CD25 T cells challenge tolerant children partly reflected expansion ordinary memory effector T cells striking increase fivefold proliferative activity ss LG exhibited PBMCs children depletion CD25 cells strongly suggested CD4CD25 subset contained substantial fraction Treg cells
0.12080864.15197226.html.plaintext.txt	223	This homeostatic mechanism likely explained outgrown cows milk allergy
0.12080864.15197226.html.plaintext.txt	224	For ethical reasons could obtain blood later time point milk challenge information regard persistence elevated level CD4CD25 T cells circulation tolerant children
0.12080864.15197226.html.plaintext.txt	225	Expression integrin 4ss7 CCR9 T cells determines homing small intestinal lamina propria 48
0.12080864.15197226.html.plaintext.txt	226	We analyzed frequency T cells markers apparent differences two groups children
0.12080864.15197226.html.plaintext.txt	227	It reported 4ss7 subset increased peripheral blood children cows milk allergy finding obtained T cells kept culture 1 wk 49
0.12080864.15197226.html.plaintext.txt	228	Also might unrealistic expect able identify phenotypic change induced milk proteins total circulating pool T cells gut homing properties
0.12080864.15197226.html.plaintext.txt	229	Most functional studies Treg cells performed animal models autoimmunity inflammatory bowel disease transplantation
0.12080864.15197226.html.plaintext.txt	230	The first human studies CD4CD25 Treg cells fact published quite recently 39 50 52
0.12080864.15197226.html.plaintext.txt	231	Evidence suggests Treg cells may antigen nonspecific least effector phase bystander suppression well known phenomenon oral tolerance 53 54
0.12080864.15197226.html.plaintext.txt	232	A nonspecific effect Treg cells could explain obtained moderate enhancement proliferation PHA PBMCs tolerant children depletion CD25 cells Fig
0.12080864.15197226.html.plaintext.txt	233	Altogether results implied mucosally induced Treg cells responding milk antigens involved observed tolerance induction alternatively centrally generated Treg cells become activated expanded children outgrown cows milk allergy
0.12080864.15197226.html.plaintext.txt	234	Expression CTLA 4 associated human CD4CD25 Treg cells 55
0.12080864.15197226.html.plaintext.txt	235	This molecule constitutively expressed cytoplasm 27 39 cell activated via TcR complex appears surface
0.12080864.15197226.html.plaintext.txt	236	However mechanistic role surface CTLA 4 cell contact dependent suppression humans debated
0.12080864.15197226.html.plaintext.txt	237	Several studies show blocking CTLA 4 antibodies abolish suppressive activity Treg cells 39 51 52
0.12080864.15197226.html.plaintext.txt	238	We find difference expression level surface marker either two groups children two time points sampling PBMCs
0.12080864.15197226.html.plaintext.txt	239	Nevertheless transwell experiments demonstrated CD4CD25 Treg cells milk tolerant children exert antiproliferative effect via contact dependent mechanism
0.12080864.15197226.html.plaintext.txt	240	Regrettably possibility study involvement inhibitory molecules PD 1 39 56
0.12080864.15197226.html.plaintext.txt	241	The role oral tolerance immunosuppressive cytokine TGF ss derived called regulatory Th3 cells induced experimental animals extensively documented 57
0.12080864.15197226.html.plaintext.txt	242	The reduced production TGF ss ss LG stimulated PBMCs vivo milk challenge allergic group Fig
0.12080864.15197226.html.plaintext.txt	243	6 A line recent study Perez Machado et al
0.12080864.15197226.html.plaintext.txt	244	58 shows T cells obtained duodenal mucosa food allergic children decreased potential TGF ss production compared healthy controls
0.12080864.15197226.html.plaintext.txt	245	Conversely found PBMCs stimulated ss LG 1 wk vivo challenge tended show increased production TGF ss children outgrown allergy could contributed observed suppressive effect proliferation
0.12080864.15197226.html.plaintext.txt	246	The major source IL 10 production ss LG stimulated PBMC cultures experiments remains unknown results obtained inconclusive
0.12080864.15197226.html.plaintext.txt	247	It shown mouse models thymic epithelium important generation naturally occurring CD4CD25 Treg cells involved maintenance tolerance 59
0.12080864.15197226.html.plaintext.txt	248	Because study strongly suggests CD4CD25 Treg cells reactive dietary antigens induced via gut considerable interest investigate whether exosomes released intestinal epithelium play role development cells
0.12080864.15197226.html.plaintext.txt	249	We previously obtained results indicative tolerance inductive function epithelial exosomes produced gut experimental animals therefore called structures tolerosomes 60
0.12080864.15197226.html.plaintext.txt	250	In conclusion observations presented provide new insight possible relationship mucosal induction CD4CD25 Treg cells protection food allergy humans
0.12080864.15197226.html.plaintext.txt	251	These results may aid development better diagnostic tools disorders perhaps contribute promote future goal generating Treg cells vitro immunotherapy allergic diseases
0.12080864.15197226.html.plaintext.txt	252	Acknowledgments We thank Helena Kahu outstanding technical assistance creating stimulating working atmosphere
0.12080864.15197226.html.plaintext.txt	253	Lazarovits acknowledged providing anti CCR9 anti 4ss7 mAb respectively
0.12080864.15197226.html.plaintext.txt	254	This work supported grants Norwegian Foundation Health Rehabilitation Norwegian Asthma Allergy Association University Oslo Research Council Norway Norwegian Cancer Society
0.12080864.15197226.html.plaintext.txt	255	Submitted 8 December 2003 Accepted 6 May 2004
0.12080864.15197226.html.plaintext.txt	256	References Top Abstract Introduction Materials Methods Results Discussion References Brandtzaeg P
0.12080864.15197226.html.plaintext.txt	257	Current understanding gastrointestinal immunoregulation relation food allergy
0.12080864.15197226.html.plaintext.txt	258	AbstractFree Full Text Waldo F
0.12080864.15197226.html.plaintext.txt	259	Suppression immune response nasal immunization
0.12080864.15197226.html.plaintext.txt	260	T cell B cell tolerance antigen feeding
0.12080864.15197226.html.plaintext.txt	261	AbstractFree Full Text Yazdanbakhsh M
0.12080864.15197226.html.plaintext.txt	262	Allergy parasites hygiene hypothesis
0.12080864.15197226.html.plaintext.txt	263	AbstractFree Full Text Wildin R
0.12080864.15197226.html.plaintext.txt	264	Clinical molecular features immunodysregulation polyendocrinopathy enteropathy X linked IPEX syndrome
0.12080864.15197226.html.plaintext.txt	265	AbstractFree Full Text Chatila T
0.12080864.15197226.html.plaintext.txt	266	JM2 encoding fork head related protein mutated X linked autoimmunity allergic disregulation syndrome
0.12080864.15197226.html.plaintext.txt	267	Generation anergic potentially immunoregulatory CD25CD4 T cells vivo induction peripheral tolerance intravenous oral antigen
0.12080864.15197226.html.plaintext.txt	268	AbstractFree Full Text Zhang X
0.12080864.15197226.html.plaintext.txt	269	Activation CD25CD4 regulatory T cells oral antigen administration
0.12080864.15197226.html.plaintext.txt	270	AbstractFree Full Text Karlsson M
0.12080864.15197226.html.plaintext.txt	271	Tolerance bystander suppression involvement CD25 positive cells induced rats receiving serum ovalbumin fed donors
0.12080864.15197226.html.plaintext.txt	272	CrossRefMedline Karlsson M
0.12080864.15197226.html.plaintext.txt	273	An established immune response ovalbumin suppressed transferable serum factor produced ovalbumin feeding role CD25 regulatory cells
0.12080864.15197226.html.plaintext.txt	274	CrossRefMedline Hauet Broere F
0.12080864.15197226.html.plaintext.txt	275	Functional CD25 CD25 mucosal regulatory T cells induced gut draining lymphoid tissue within 48 h oral antigen application
0.12080864.15197226.html.plaintext.txt	276	Induction mechanism action transforming growth factor beta secreting Th3 regulatory cells
0.12080864.15197226.html.plaintext.txt	277	A CD4 T cell subset inhibits antigen specific T cell responses prevents colitis
0.12080864.15197226.html.plaintext.txt	278	Liver associated lymphocytes expressing NK1
0.12080864.15197226.html.plaintext.txt	279	1 essential oral immune tolerance induction murine model
0.12080864.15197226.html.plaintext.txt	280	Human CD4CD25 regulatory T cells
0.12080864.15197226.html.plaintext.txt	281	CD4CD25 regulatory T cells control Leishmania major persistence immunity
0.12080864.15197226.html.plaintext.txt	282	CrossRefMedline Sakaguchi S
0.12080864.15197226.html.plaintext.txt	283	Immunologic tolerance maintained CD25CD4 regulatory T cells common role controlling autoimmunity tumor immunity transplantation tolerance
0.12080864.15197226.html.plaintext.txt	284	CrossRefMedline van Maurik A
0.12080864.15197226.html.plaintext.txt	285	Cutting edge CD4CD25 alloantigen specific immunoregulatory cells prevent CD8 T cell mediated graft rejection implications anti CD154 immunotherapy
0.12080864.15197226.html.plaintext.txt	286	AbstractFree Full Text Edinger M
0.12080864.15197226.html.plaintext.txt	287	CD4CD25 regulatory T cells preserve graft versus tumor activity inhibiting graft versus host disease bone marrow transplantation
0.12080864.15197226.html.plaintext.txt	288	CrossRefMedline Hoffmann P
0.12080864.15197226.html.plaintext.txt	289	Donor type CD4CD25 regulatory T cells suppress lethal acute graft versus host disease allogeneic bone marrow transplantation
0.12080864.15197226.html.plaintext.txt	290	AbstractFree Full Text Nishikawa H
0.12080864.15197226.html.plaintext.txt	291	CD4CD25 T cells responding serologically defined autoantigens suppress antitumor immune responses
0.12080864.15197226.html.plaintext.txt	292	AbstractFree Full Text Azuma T
0.12080864.15197226.html.plaintext.txt	293	Human CD4 CD25 regulatory T cells suppress NKT cell functions
0.12080864.15197226.html.plaintext.txt	294	AbstractFree Full Text Sasada T
0.12080864.15197226.html.plaintext.txt	295	CD4CD25 regulatory T cells patients gastrointestinal malignancies possible involvement regulatory T cells disease progression
0.12080864.15197226.html.plaintext.txt	296	CrossRefMedline Ichihara F
0.12080864.15197226.html.plaintext.txt	297	Increased populations regulatory T cells peripheral blood tumor infiltrating lymphocytes patients gastric esophageal cancers
0.12080864.15197226.html.plaintext.txt	298	AbstractFree Full Text Taams L
0.12080864.15197226.html.plaintext.txt	299	Human anergicsuppressive CD4CD25 T cells highly differentiated apoptosis prone population
0.12080864.15197226.html.plaintext.txt	300	AbstractFree Full Text Read S
0.12080864.15197226.html.plaintext.txt	301	Cytotoxic T lymphocyte associated antigen 4 plays essential role function CD25CD4 regulatory cells control intestinal inflammation
0.12080864.15197226.html.plaintext.txt	302	AbstractFree Full Text Shimizu J
0.12080864.15197226.html.plaintext.txt	303	Stimulation CD25CD4 regulatory T cells GITR breaks immunological self tolerance
0.12080864.15197226.html.plaintext.txt	304	CD4 CD25 immunoregulatory T cells gene expression analysis reveals functional role glucocorticoid induced TNF receptor
0.12080864.15197226.html.plaintext.txt	305	Characterization human CD25CD4 T cells thymus cord adult blood
0.12080864.15197226.html.plaintext.txt	306	Control regulatory T cell development transcription factor Foxp3
0.12080864.15197226.html.plaintext.txt	307	AbstractFree Full Text Fontenot J
0.12080864.15197226.html.plaintext.txt	308	Foxp3 programs development function CD4 CD25 regulatory T cells
0.12080864.15197226.html.plaintext.txt	309	An essential role Scurfin CD4CD25 T regulatory cells
0.12080864.15197226.html.plaintext.txt	310	CD4CD25 CD4 CD25 T cells act respectively inducer effector T suppressor cells superantigen induced tolerance
0.12080864.15197226.html.plaintext.txt	311	AbstractFree Full Text Ramsdell F
0.12080864.15197226.html.plaintext.txt	312	Foxp3 natural regulatory T cells key cell lineage Immunity
0.12080864.15197226.html.plaintext.txt	313	CD4 Th cells resembling regulatory T cells inhibit chronic colitis differentiate absence interactions CD4 class II MHC
0.12080864.15197226.html.plaintext.txt	314	AbstractFree Full Text Cosmi L
0.12080864.15197226.html.plaintext.txt	315	Human CD8CD25 thymocytes share phenotypic functional features CD4CD25 regulatory thymocytes
0.12080864.15197226.html.plaintext.txt	316	AbstractFree Full Text Walker M
0.12080864.15197226.html.plaintext.txt	317	Induction FoxP3 acquisition T regulatory activity stimulated human CD4CD25 T cells
0.12080864.15197226.html.plaintext.txt	318	AbstractFree Full Text Baecher Allan C
0.12080864.15197226.html.plaintext.txt	319	CD4CD25high regulatory cells human peripheral blood
0.12080864.15197226.html.plaintext.txt	320	AbstractFree Full Text Fowler S
0.12080864.15197226.html.plaintext.txt	321	Control immune pathology IL 10 secreting regulatory T cells
0.12080864.15197226.html.plaintext.txt	322	A critical role transforming growth factor beta interleukin 4 suppression T helper type 1 mediated colitis CD45RBlow CD4 T cells
0.12080864.15197226.html.plaintext.txt	323	The germless theory allergic disease revisiting hygiene hypothesis
0.12080864.15197226.html.plaintext.txt	324	CrossRefMedline Johansson S
0.12080864.15197226.html.plaintext.txt	325	A revised nomenclature allergy
0.12080864.15197226.html.plaintext.txt	326	An EAACI position statement EAACI nomenclature task force
0.12080864.15197226.html.plaintext.txt	327	Cows milk allergy diagnostic accuracy skin prick patch tests specific IgE
0.12080864.15197226.html.plaintext.txt	328	CrossRefMedline Bischoff S
0.12080864.15197226.html.plaintext.txt	329	CrossRefMedline Takabayashi K
0.12080864.15197226.html.plaintext.txt	330	Intranasal immunotherapy effective intradermal immunotherapy induction airway allergen tolerance Th2 sensitized mice
0.12080864.15197226.html.plaintext.txt	331	AbstractFree Full Text Walker L
0.12080864.15197226.html.plaintext.txt	332	Antigen dependent proliferation CD4CD25 regulatory T cells vivo
0.12080864.15197226.html.plaintext.txt	333	AbstractFree Full Text Kunkel E
0.12080864.15197226.html.plaintext.txt	334	Chemokines lymphocyte trafficking intestinal immunity
0.12080864.15197226.html.plaintext.txt	335	CrossRefMedline Eigenmann P
0.12080864.15197226.html.plaintext.txt	336	The mucosal adhesion receptor alpha4beta7 integrin selectively increased lymphocytes stimulated beta lactoglobulin children allergic cows milk
0.12080864.15197226.html.plaintext.txt	337	Ex vivo isolation characterization CD4CD25 T cells regulatory properties human blood
0.12080864.15197226.html.plaintext.txt	338	AbstractFree Full Text Levings M
0.12080864.15197226.html.plaintext.txt	339	Human CD25CD4 T regulatory cells suppress naive memory T cell proliferation expanded vitro without loss function
0.12080864.15197226.html.plaintext.txt	340	AbstractFree Full Text Jonuleit H
0.12080864.15197226.html.plaintext.txt	341	Identification functional characterization human CD4CD25 T cells regulatory properties isolated peripheral blood
0.12080864.15197226.html.plaintext.txt	342	AbstractFree Full Text Annacker O
0.12080864.15197226.html.plaintext.txt	343	Homeostasis intestinal immune regulation
0.12080864.15197226.html.plaintext.txt	344	Control intestinal inflammation regulatory T cells
0.12080864.15197226.html.plaintext.txt	345	Human CD4CD25 cells naturally occurring population regulatory T cells
0.12080864.15197226.html.plaintext.txt	346	AbstractFree Full Text Blazar B
0.12080864.15197226.html.plaintext.txt	347	Blockade programmed death 1 engagement accelerates graft versus host disease lethality IFN gamma dependent mechanism
0.12080864.15197226.html.plaintext.txt	348	AbstractFree Full Text Mowat A
0.12080864.15197226.html.plaintext.txt	349	Anatomical basis tolerance immunity intestinal antigens
0.12080864.15197226.html.plaintext.txt	350	CrossRefMedline Perez Machado M
0.12080864.15197226.html.plaintext.txt	351	Reduced transforming growth factor ss1 producing T cells duodenal mucosa children food allergy
0.12080864.15197226.html.plaintext.txt	352	CrossRefMedline Bensinger S
0.12080864.15197226.html.plaintext.txt	353	Major histocompatibility complex class II positive cortical epithelium mediates selection CD425 immunoregulatory T cells
0.12080864.15197226.html.plaintext.txt	354	AbstractFree Full Text Karlsson M
0.12080864.15197226.html.plaintext.txt	355	Tolerosomes produced intestinal epithelial cells
0.12080864.15197226.html.plaintext.txt	356	CO2 IlinktypeDOI CrossRefMedline
0.116439514.11087738.html.plaintext.txt	0	A 7 kDa Prion Protein PrP Fragment Integral Component PrP Region Required Infectivity Is Major Amyloid Protein Gerstmann Straussler Scheinker Disease A117V Fabrizio Tagliavini Patricia M
0.116439514.11087738.html.plaintext.txt	1	Lievens Christine Tranchant Jean Marie Warter Michel Mohr Giorgio Giaccone Francesco Perini Giacomina Rossi Mario Salmona Pedro Piccardo Bernardino Ghetti Ronald C
0.116439514.11087738.html.plaintext.txt	2	Beavis Orso Bugiani Blas Frangione Frances Prelli
0.116439514.11087738.html.plaintext.txt	3	From Istituto Nazionale Neurologico Carlo Besta 20133 Milano Italy Service de Maladies du Systeme Nerveux et du Muscle Hopitaux Universitaires 67091 Strasbourg France Istituto di Ricerche Farmacologiche Mario Negri 20157 Milano Italy Division Neuropathology Indiana University School Medicine Indianapolis Indiana 46202 Department Pharmacology Skirball Institute Biomedical Research Department Pathology New York University School Medicine New York New York 10016
0.116439514.11087738.html.plaintext.txt	4	Received publication August 4 2000 revised form November 7 2000
0.116439514.11087738.html.plaintext.txt	5	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.116439514.11087738.html.plaintext.txt	6	Gerstmann Straussler Scheinker disease GSS cerebral amyloidosis associated mutations prion protein PrP gene PRNP
0.116439514.11087738.html.plaintext.txt	7	The aim study characterize amyloid peptides purified brain tissue patient A117V mutation MetVal heterozygous codon 129 Val129 coupling phase mutant Val117
0.116439514.11087738.html.plaintext.txt	8	The major peptide extracted amyloid fibrils 7 kDa PrP fragment
0.116439514.11087738.html.plaintext.txt	9	Sequence analysis mass spectrometry showed fragment ragged N C termini starting mainly Gly88 Gly90 ending Arg148 Glu152 Asn153
0.116439514.11087738.html.plaintext.txt	10	Only Val present positions 117 129 indicating amyloid protein originated mutant PrP molecules
0.116439514.11087738.html.plaintext.txt	11	In addition 7 kDa peptides amyloid fraction contained N C terminal PrP fragments corresponding residues 23 41 191 205 217 228
0.116439514.11087738.html.plaintext.txt	12	Fibrillogenesis vitro synthetic peptides corresponding PrP fragments extracted brain tissue showed peptide PrP 85 148 readily assembled amyloid fibrils
0.116439514.11087738.html.plaintext.txt	13	Peptide PrP 191 205 also formed fibrillary structures although different morphology whereas peptides PrP 23 41 PrP 217 228
0.116439514.11087738.html.plaintext.txt	14	These findings suggest processing mutant PrP isoforms associated Gerstmann Straussler Scheinker disease may occur extracellularly
0.116439514.11087738.html.plaintext.txt	15	It conceivable full length PrP andor large PrP peptides deposited extracellular compartment partially degraded proteases digested tissue endopeptidases originating 7 kDa protease resistant core similar patients different mutations
0.116439514.11087738.html.plaintext.txt	16	Furthermore present data suggest C terminal fragments PrP may participate amyloid formation
0.116439514.11087738.html.plaintext.txt	17	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.116439514.11087738.html.plaintext.txt	18	Gerstmann Straussler Scheinker disease GSS1 adult onset neurodegenerative disorder 1 2 inherited autosomal dominant trait segregates variant genotypes resulting combination pathogenic mutation P102L P105L A117V F198S D202N Q212P Q217R common polymorphism codon 129 MetVal prion protein PrP gene PRNP 3 9
0.116439514.11087738.html.plaintext.txt	19	The pathological hallmarks disease accumulation altered forms PrP termed PrPSc deposition PrP amyloid central nervous system 10 15
0.116439514.11087738.html.plaintext.txt	20	The main physicochemical properties distinguish PrPSc normal cellular isoform PrPC high content sheet secondary structure insolubility nondenaturing detergents partial resistance protease digestion 16
0.116439514.11087738.html.plaintext.txt	21	In presence detergents protease resistant core PrPSc termed PrPres assembles amyloid like fibrils 16
0.116439514.11087738.html.plaintext.txt	22	In previous studies determined biochemical composition amyloid fibrils extracted brain tissue patients mutations F198S Q217R PRNP
0.116439514.11087738.html.plaintext.txt	23	The smallest amyloid subunit found correspond 7 kDa PrP fragment spanning residues 81 150 17 18
0.116439514.11087738.html.plaintext.txt	24	Although fragment include region amino acid substitution originated mutant molecules suggesting codon 198 217 mutations dominant factor amyloidogenesis 18
0.116439514.11087738.html.plaintext.txt	25	The allelic origin altered forms PrP involved pathologic process investigated genetic prion diseases including GSS P102L fatal familial insomnia Creutzfeldt Jakob disease CJD associated point insertional mutations 19 23
0.116439514.11087738.html.plaintext.txt	26	These studies showed mutant PrP detergent insoluble protease resistant GSS P102L 19 20 fatal familial insomnia CJD D178N 21 whereas mutant wild type proteins properties CJD V210I 22 CJD five six extra copies octapeptide repeat 21
0.116439514.11087738.html.plaintext.txt	27	CJD E200K illustrates intermediate state wild type PrP insoluble protease sensitive 23
0.116439514.11087738.html.plaintext.txt	28	Thus recruitment wild type protein disease process may reflect effects conformational changes due specific mutations allow interaction mutant normal PrP
0.116439514.11087738.html.plaintext.txt	29	The present study undertaken characterize amyloid protein establish allelic origin patient GSS A117V previously reported Alsatian family 24 25
0.116439514.11087738.html.plaintext.txt	30	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.116439514.11087738.html.plaintext.txt	31	Immunohistochemistry Specimens cerebral cortex fixed 4 formaldehyde embedded paraplast
0.116439514.11087738.html.plaintext.txt	32	Seven microm thick serial sections stained hematoxylin eosin Congo Red thioflavine S immunostained antibodies N terminus mid region C terminus human PrP
0.116439514.11087738.html.plaintext.txt	33	These included rabbit antiserum synthetic peptide homologous residues 23 40 PrP 23 40 18 monoclonal antibody 3F4 recognizes epitope 109 112 26 27 monoclonal antibody synthetic peptide spanning residues 214 231 SP214 28
0.116439514.11087738.html.plaintext.txt	34	The antibodies used dilution 1200
0.116439514.11087738.html.plaintext.txt	35	Before immunostaining sections treated 98 formic acid 60 min
0.116439514.11087738.html.plaintext.txt	36	The immunoreactions revealed using EnVision Plus horseradish peroxidase system rabbit mouse immunoglobulins Dako Carpenteria CA diaminobenzidine chromogen 29
0.116439514.11087738.html.plaintext.txt	37	Immunoblot Analysis Crude Brain Extracts Specimens cerebral cortex basal ganglia homogenized 9 volumes lysis buffer 10 mM Tris HCl pH 7
0.116439514.11087738.html.plaintext.txt	38	5 sodium deoxycholate sonicated 1 min centrifuged 16000 x g 4 degrees C 15 min
0.116439514.11087738.html.plaintext.txt	39	To test protease resistance PrP aliquots supernatant corresponding 100 250 microg protein digested proteinase K PK concentrations ranging 5 50 microgml 37 degrees C 1 h
0.116439514.11087738.html.plaintext.txt	40	The digestion carried either lysis buffer Laemmlis sample buffer containing 2 SDS
0.116439514.11087738.html.plaintext.txt	41	After PK digestion aliquots deglycosylated using recombinant peptide N glycosidase F New England Biolabs Inc
0.116439514.11087738.html.plaintext.txt	42	Beverly MA 37 degrees C 12 h following manufacturers instructions
0.116439514.11087738.html.plaintext.txt	43	The samples fractionated 12
0.116439514.11087738.html.plaintext.txt	44	5 TricineSDS polyacrylamide gel electrophoresis TricineSDS PAGE reducing conditions transferred polyvinylidene difluoride membranes Millipore Corp
0.116439514.11087738.html.plaintext.txt	45	Bedford MA probed antibodies PrP23 40 11000 3F4 150000 SP214 1200
0.116439514.11087738.html.plaintext.txt	46	To test solubility PrP nondenaturing detergents samples cerebral cortex homogenized 9 volumes 20 mM Tris pH 7
0.116439514.11087738.html.plaintext.txt	47	32 mM sucrose 5 mM EDTA centrifuged 1000 x g 10 min
0.116439514.11087738.html.plaintext.txt	48	The resulting supernatant centrifuged 100000 x g 4 degrees C 1 h
0.116439514.11087738.html.plaintext.txt	49	The pellet containing cell membranes resuspended lysis buffer sonicated 1 min centrifuged 100000 x g 4 degrees C 1 h obtain detergent soluble detergent insoluble fractions
0.116439514.11087738.html.plaintext.txt	50	Soluble insoluble fractions analyzed Western blot using antibody 3F4
0.116439514.11087738.html.plaintext.txt	51	Isolation Amyloid Cores Amyloid plaque cores isolated 30 g cerebral cortex
0.116439514.11087738.html.plaintext.txt	52	After removal leptomeninges large vessels tissue homogenized Brinkmann homogenizer buffer A 10 mM Tris HCl pH 7
0.116439514.11087738.html.plaintext.txt	53	5 150 mM NaCl 2 mM EDTA 2 mM EGTA 0
0.116439514.11087738.html.plaintext.txt	54	4 mM phenylmethylsulfonyl fluoride 1 Triton X 100 sample buffer ratio 15 wv
0.116439514.11087738.html.plaintext.txt	55	The homogenate sieved 1 mm nylon mesh filtrate centrifuged 10000 x g 20 min
0.116439514.11087738.html.plaintext.txt	56	The pellet rehomogenized buffer B buffer A NaCl replaced 0
0.116439514.11087738.html.plaintext.txt	57	6 M KI concentration Triton X 100 reduced 0
0.116439514.11087738.html.plaintext.txt	58	5 centrifuged 10000 x g 20 min
0.116439514.11087738.html.plaintext.txt	59	The pellet rehomogenized buffer C buffer B KI replaced 1
0.116439514.11087738.html.plaintext.txt	60	5 M KCl centrifuged 10000 x g 20 min
0.116439514.11087738.html.plaintext.txt	61	The pellet washed three times 50 mM Tris HCl pH 7
0.116439514.11087738.html.plaintext.txt	62	5 150 mM NaCl centrifuged 70000 x g 30 min
0.116439514.11087738.html.plaintext.txt	63	The pellet resuspended 50 mM Tris HCl pH 7
0.116439514.11087738.html.plaintext.txt	64	5 10 mM CaCl2 3 mM NaN3 sample buffer ratio 125 wv subjected collagenase digestion Collagenase 3
0.116439514.11087738.html.plaintext.txt	65	3 type 1 Sigma 37 degrees C 18 h using 1100 ww ratio enzyme pellet
0.116439514.11087738.html.plaintext.txt	66	After centrifugation 70000 x g 60 min pellet resuspended washed three times 50 mM Tris HCl pH 7
0.116439514.11087738.html.plaintext.txt	67	5 loaded discontinuous sucrose gradient 1
0.116439514.11087738.html.plaintext.txt	68	0 M sucrose 10 mM Tris HCl pH 7
0.116439514.11087738.html.plaintext.txt	69	5 centrifuged 100000 x g 180 min
0.116439514.11087738.html.plaintext.txt	70	Each interface collected washed pelleted three times 50 mM Tris HCl pH 7
0.116439514.11087738.html.plaintext.txt	71	Aliquots pellet assessed presence amyloid fibrils polarized light microscopy Congo Red staining fluorescence microscopy thioflavine S treatment electron microscopy negative staining 2 aqueous phosphotungstic acid
0.116439514.11087738.html.plaintext.txt	72	Amyloid plaque cores recovered 1
0.116439514.11087738.html.plaintext.txt	73	Purification Characterization Amyloid Proteins The amyloid enriched pellet suspended 99 formic acid sonicated four times 20
0.116439514.11087738.html.plaintext.txt	74	After addition 2 volumes distilled water sample centrifuged 10000 x g 10 min supernatant applied calibrated Sephadex G 100 column 1
0.116439514.11087738.html.plaintext.txt	75	2 x 120 cm equilibrated 3 M formic acid
0.116439514.11087738.html.plaintext.txt	76	Protein peaks pooled concentrated speed vacuum concentrator
0.116439514.11087738.html.plaintext.txt	77	The purity molecular weight fractions determined 12
0.116439514.11087738.html.plaintext.txt	78	5 TricineSDS PAGE reducing conditions immunoblot analysis 3F4 antibody
0.116439514.11087738.html.plaintext.txt	79	The amyloid fraction analyzed rabbit antisera synthetic peptides homologous residues 58 71 90 102 127 147 151 165 human PrP 11000 dilution described previously 18
0.116439514.11087738.html.plaintext.txt	80	Gel filtration fraction 5 contained major amyloid subunit purified high performance liquid chromatography HPLC reverse phase C4 column 214TP104 Vydac 0 80 linear gradient acetonitrile containing 0
0.116439514.11087738.html.plaintext.txt	81	1 vv trifluoroacetic acid pH 2
0.116439514.11087738.html.plaintext.txt	82	The column eluents monitored 214 nm protein peaks lyophilized
0.116439514.11087738.html.plaintext.txt	83	Following TricineSDS PAGE immunoblot analysis aliquots HPLC purified PrP immunoreactive peptides dissolved 25 mM Tris HCl pH 8
0.116439514.11087738.html.plaintext.txt	84	5 1 mM EDTA incubated 37 degrees C 24 h endoproteinase Lys C Roche Molecular Biochemicals enzyme substrate ratio 130 ww
0.116439514.11087738.html.plaintext.txt	85	The peptides generated enzymatic digests separated HPLC reverse phase Delta Pak C18 column 0
0.116439514.11087738.html.plaintext.txt	86	39 x 30 cm Waters Milford MA 0 70 linear gradient acetonitrile containing 0
0.116439514.11087738.html.plaintext.txt	87	1 vv trifluoroacetic acid pH 2
0.116439514.11087738.html.plaintext.txt	88	Amino Acid Sequencing Sequence analyses intact amyloid protein peptides generated enzymatic digestion carried 477A microsequencer resulting phenylthiohydantoin amino acid derivatives identified using line 120A PTH analyzer standard program PE Biosystems Foster City CA
0.116439514.11087738.html.plaintext.txt	89	Matrix assisted Laser Desorption Mass Spectrometry N C terminal fragments amyloid protein generated endoproteinase Lys C digestion reduced repurified HPLC reverse phase C4 column prepared matrix assisted laser desorptionionization mass spectrometry using dried droplet method 30
0.116439514.11087738.html.plaintext.txt	90	The matrix used cyano 4 hydroxycinnamic acid Sigma purified recrystallization
0.116439514.11087738.html.plaintext.txt	91	To produce dried droplets saturated solution matrix prepared 21 aqueous 0
0.116439514.11087738.html.plaintext.txt	92	1 trifluoroacetic acidacetonitrile room temperature
0.116439514.11087738.html.plaintext.txt	93	The sample added solution final sample concentration 1 10 mM
0.116439514.11087738.html.plaintext.txt	94	One half microliter solution placed probe mass spectrometer allowed dry
0.116439514.11087738.html.plaintext.txt	95	The sample ready analysis
0.116439514.11087738.html.plaintext.txt	96	The mass spectrometer custom built linear time flight mass spectrometer 1 m flight tube wire ion guide operated 50 V DC
0.116439514.11087738.html.plaintext.txt	97	The ion source operated 40 kV ion acceleration potential
0.116439514.11087738.html.plaintext.txt	98	The laser used LSI 337ND Laser Science Boston MA nitrogen laser 2 ns pulse width focused onto 200 microm diameter fiber optic conducted 1 m fiber optic imaged onto matrix deposit doublet positive lens magnification 1
0.116439514.11087738.html.plaintext.txt	99	The detector mass spectrometer combination microchannel plate input stage discrete dynode electron multiplier amplification stage
0.116439514.11087738.html.plaintext.txt	100	The custom data system uses Lecroy 9350M oscilloscope configured dynamic range enhancement improve fidelity small signals
0.116439514.11087738.html.plaintext.txt	101	Fibrillogenesis Vitro Peptides homologous residues 23 41 85 148 191 205 217 228 human PrP synthesized solid phase chemistry purified reverse phase HPLC described previously 31
0.116439514.11087738.html.plaintext.txt	102	The peptides suspended deionized water 20 mM Tris pH 7
0.116439514.11087738.html.plaintext.txt	103	0 concentration 1 5 10 mgml
0.116439514.11087738.html.plaintext.txt	104	Following incubation 37 degrees C 1 h 20 degrees C 1 3 7 days 50 microl sample air dried gelatin coated slides stained 1 aqueous thioflavine S analyzed fluorescence microscopy
0.116439514.11087738.html.plaintext.txt	105	For electron microscopy 5 microl suspension applied Formvar coated nickel grids negatively stained 5 wv uranyl acetate observed electron microscope model 410 Philips Electronic Instruments Mahwah NJ 80 kV
0.116439514.11087738.html.plaintext.txt	106	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.116439514.11087738.html.plaintext.txt	107	The patient selected study 24 year old man whose clinico pathologic genetic profile reported detail previously 24 25
0.116439514.11087738.html.plaintext.txt	108	He started age 20 pseudobulbar syndrome followed cerebellar extrapyramidal pyramidal signs cognitive deterioration
0.116439514.11087738.html.plaintext.txt	109	Neuropathologic examination revealed massive deposition PrP immunoreactive deposits cerebral cortex thalamus basal ganglia cerebellum
0.116439514.11087738.html.plaintext.txt	110	Most PrP deposits exhibited tinctorial optical properties amyloid
0.116439514.11087738.html.plaintext.txt	111	birefringence Congo Red staining fluorescence following thioflavine S treatment
0.116439514.11087738.html.plaintext.txt	112	Genetically patient carried silent A G transition third position PRNP codon 117 C T transition second position codon resulting Ala Val substitution
0.116439514.11087738.html.plaintext.txt	113	Furthermore heterozygous MetVal codon 129 Val129 coupling phase mutant Val117 24
0.116439514.11087738.html.plaintext.txt	114	To define PrP species involved pathologic process immunohistochemical biochemical studies undertaken
0.116439514.11087738.html.plaintext.txt	115	The immunohistochemical analysis formalin fixed paraplast embedded brain sections showed amyloid cores immunoreactive antibodies central region molecule whereas antibodies N C termini immunostained periphery cores Fig
0.116439514.11087738.html.plaintext.txt	116	Western blot analysis homogenates cerebral cortex basal ganglia revealed presence PK resistant PrP fragment 7 kDa Fig
0.116439514.11087738.html.plaintext.txt	117	This fragment immunoreactive antibodies central region unreactive antibodies N C terminal domains electrophoretic mobility unmodified N deglycosylation
0.116439514.11087738.html.plaintext.txt	118	The protease resistance 7 kDa peptide observed standard conditions 50 microgml PK lysis buffer 37 degrees C 1 h abolished addition 2 SDS reaction buffer data shown
0.116439514.11087738.html.plaintext.txt	119	A similar 7 kDa fragment present brain homogenates PK digestion prominent component complex PrP pattern composed 35 33 28 kDa full length PrP
0.116439514.11087738.html.plaintext.txt	120	di mono nonglycosylated species 21 22 kDa N terminal truncated peptides 16 17 kDa N C terminal truncated fragments Fig
0.116439514.11087738.html.plaintext.txt	121	As previously observed Indiana kindred GSS F198S mutation 32 relative abundance low molecular weight fragment dependent upon extent amyloid burden
0.116439514.11087738.html.plaintext.txt	122	The analysis detergent solubility showed 40 full length PrP partitioned insoluble fraction whereas 21 22 kDa N terminal truncated peptides mostly soluble N C terminal truncated fragments 16 17 7 kDa entirely insoluble Fig
0.116439514.11087738.html.plaintext.txt	123	Digestion insoluble fraction PK verified 7 kDa peptide protease resistant data shown
0.116439514.11087738.html.plaintext.txt	124	View larger version 121K Fig
0.116439514.11087738.html.plaintext.txt	125	PrP immunohistochemistry cerebral amyloid deposits
0.116439514.11087738.html.plaintext.txt	126	A B adjacent sections cerebral cortex A117V patient immunolabeled antibodies 3F4 A SP214 B PrP residues 109 112 214 231 respectively
0.116439514.11087738.html.plaintext.txt	127	Magnification bar 100 microm
0.116439514.11087738.html.plaintext.txt	128	View larger version 30K Fig
0.116439514.11087738.html.plaintext.txt	129	Western blot analysis PrP peptides brain tissue homogenates amyloid fraction HPLC purification amyloid peptides
0.116439514.11087738.html.plaintext.txt	130	A extract cerebral cortex A117V patient lane 1 lane 2 PK digestion PK digestion followed deglycosylation lane 3
0.116439514.11087738.html.plaintext.txt	131	The sample fractionated 16
0.116439514.11087738.html.plaintext.txt	132	5 Tricine polyacrylamide minigel probed antibody 3F4
0.116439514.11087738.html.plaintext.txt	133	B total homogenate lane 1 detergent soluble lane 2 detergent insoluble lane 3 fractions separated 12
0.116439514.11087738.html.plaintext.txt	134	5 Tricine polyacrylamide minigel probed antibody 3F4
0.116439514.11087738.html.plaintext.txt	135	C Western blot analysis amyloid protein fraction obtained gel filtration chromatography using antisera synthetic peptides PrP 58 71 lane 1 90 102 lane 2 109 112 lane 3 127 147 lane 4 151 165 lane 5
0.116439514.11087738.html.plaintext.txt	136	The major amyloid protein component migrated broad band centered 7 kDa
0.116439514.11087738.html.plaintext.txt	137	This band immunoreactive antibodies spanning PrP residues 90 147 lanes 2 4 unreactive antisera residues 58 71 151 165 lanes 1 5
0.116439514.11087738.html.plaintext.txt	138	Each lane contained 10 microg proteins
0.116439514.11087738.html.plaintext.txt	139	Molecular mass markers expressed kilodaltons shown left
0.116439514.11087738.html.plaintext.txt	140	D HPLC purification fraction 5 obtained gel filtration chromatography
0.116439514.11087738.html.plaintext.txt	141	One major peak 1 several minor protein peaks present chromatogram
0.116439514.11087738.html.plaintext.txt	142	Immunoblot analysis showed peak 1 immunoreactive antibodies PrP
0.116439514.11087738.html.plaintext.txt	143	Aliquots peak used sequence analysis enzymatic digestion endoproteinase Lys C
0.116439514.11087738.html.plaintext.txt	144	Amyloid cores isolated cerebral cortex procedure combining buffer extraction sieving collagenase digestion sucrose gradient fractionation
0.116439514.11087738.html.plaintext.txt	145	As shown light electron microscopic analysis amyloid cores main component final preparations minor contaminants included lipofuscin granules small microvessel fragments
0.116439514.11087738.html.plaintext.txt	146	Proteins extracted amyloid plaque cores formic acid fractionated Sephadex G 100 column
0.116439514.11087738.html.plaintext.txt	147	Gel filtration yielded two major peaks void volume fraction 1 low molecular weight peak fraction 5 present broad band centered 7 kDa TricineSDS PAGE minigels
0.116439514.11087738.html.plaintext.txt	148	In addition minor intermediary peaks fractions 2 4 observed chromatograms data shown
0.116439514.11087738.html.plaintext.txt	149	Immunoblot analysis fractions obtained gel filtration showed 7 kDa band immunoreactive antibodies PrP residues 90 102 109 112 127 147 unreactive antibodies residues 58 71 151 165 suggesting corresponded internal fragment molecule Fig
0.116439514.11087738.html.plaintext.txt	150	Further purification fraction 5 HPLC reverse phase C4 column yielded one major several minor peaks Fig
0.116439514.11087738.html.plaintext.txt	151	Immunoblot analysis showed major peak Fig
0.116439514.11087738.html.plaintext.txt	152	2D peak 1 immunoreactive antibodies PrP
0.116439514.11087738.html.plaintext.txt	153	Amino acid sequencing revealed peak 1 composed PrP fragment ragged N terminus major signals corresponding residues 88 90
0.116439514.11087738.html.plaintext.txt	154	Peak 1 digested endoproteinase Lys C enzymatic digest fractionated HPLC reverse phase C18 column peptides subjected microsequencing laser desorption mass spectrometry
0.116439514.11087738.html.plaintext.txt	155	positions 106107 110111 resulting three peptides predicted basis molecular weight antigenic profile N terminal sequence analysis known resistance cleavage Lys Pro bonds positions 101102 104105 PrP
0.116439514.11087738.html.plaintext.txt	156	Microsequencing mass spectrometry HPLC purified peptides revealed spectrum N termini spanning residues 85 95 although Gly88 Gly90 Gly92 predominant components Fig
0.116439514.11087738.html.plaintext.txt	157	Moreover C terminus heterogeneous corresponding Arg148 Glu152 Asn153 Fig
0.116439514.11087738.html.plaintext.txt	158	Although patient heterozygous Ala Val mutation codon 117 MetVal polymorphism codon 129 Val found positions Fig
0.116439514.11087738.html.plaintext.txt	159	View larger version 40K Fig
0.116439514.11087738.html.plaintext.txt	160	Mass spectrometric analysis N C terminal fragments amyloid protein
0.116439514.11087738.html.plaintext.txt	161	The amyloid fragment digested endoproteinase Lys C analysis isolated peptides matrix assisted laser desorptionionization mass spectrometry revealed spectrum N termini spanning every PrP residue 85 95 106 A B heterogeneous C terminus predicted peptides spanning PrP residues His111 Arg148 Glu152 Asn153 Val position 129 C
0.116439514.11087738.html.plaintext.txt	162	Predicted actual molecular masses component listed
0.116439514.11087738.html.plaintext.txt	163	The presence one four formyl molecules indicated b respectively
0.116439514.11087738.html.plaintext.txt	164	View larger version 53K Fig
0.116439514.11087738.html.plaintext.txt	165	Amino acid sequence analysis amyloid peptide
0.116439514.11087738.html.plaintext.txt	166	PrP peptides obtained enzymatic digestion 7 kDa amyloid protein peak 1 Fig
0.116439514.11087738.html.plaintext.txt	167	2D subjected automated microsequence analysis
0.116439514.11087738.html.plaintext.txt	168	A shows HPLC analysis PTH derivatives released cycles 6 8 sequencing C terminal portion amyloid protein
0.116439514.11087738.html.plaintext.txt	169	These cycles equivalent codons 116 117 118 respectively yielded Ala Val Ala
0.116439514.11087738.html.plaintext.txt	170	B shows HPLC analysis PTH derivatives released cycles 18 20
0.116439514.11087738.html.plaintext.txt	171	These cycles equivalent codons 128 130 respectively yielded Tyr Val Leu
0.116439514.11087738.html.plaintext.txt	172	No signal corresponding Met arrowhead found position 129 amyloid peptide
0.116439514.11087738.html.plaintext.txt	173	In addition 7 kDa amyloid peptide fraction 5 obtained gel filtration chromatography also contained N C terminal PrP fragments corresponding residues 23 41 191 205 217 228
0.116439514.11087738.html.plaintext.txt	174	To investigate whether fragments could contribute amyloid fibril formation compared fibrillogenic properties homologous synthetic peptides synthetic amyloid peptide spanning residues 85 148
0.116439514.11087738.html.plaintext.txt	175	The peptides incubated deionized water 20 mM Tris pH 7
0.116439514.11087738.html.plaintext.txt	176	0 1 24 72 168 h concentration 1 5 10 mgml analyzed fluorescence microscopy following thioflavine S staining electron microscopy negative staining
0.116439514.11087738.html.plaintext.txt	177	The peptide PrP 85 148 formed dense networks straight unbranched 13 nm diameter fibrils 1 h incubation 37 degrees C concentration 1 mgml Fig
0.116439514.11087738.html.plaintext.txt	178	Under conditions peptide PrP 191 205 also formed fibrillary structures although morphologically different narrow less regular size diameter range 4
0.116439514.11087738.html.plaintext.txt	179	5 10 nm length 100 nm 1 2 microm Fig
0.116439514.11087738.html.plaintext.txt	180	The PrP 85 148 PrP 191 205 aggregates exhibited fluorescence thioflavine S staining
0.116439514.11087738.html.plaintext.txt	181	Conversely peptides PrP 23 41 PrP 217 228 generate amyloid like fibrils vitro even highest concentration 1 week
0.116439514.11087738.html.plaintext.txt	182	View larger version 160K Fig
0.116439514.11087738.html.plaintext.txt	183	Electron micrographs negatively stained fibrils aqueous solution synthetic peptides PrP 85 148 A PrP 191 205 B
0.116439514.11087738.html.plaintext.txt	184	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.116439514.11087738.html.plaintext.txt	185	Previous studies showed common feature GSS patients different PRNP mutations presence low molecular weight N C terminal truncated PrP fragments 9 32 33
0.116439514.11087738.html.plaintext.txt	186	These fragments detected unprocessed brain homogenates although prominent PK digestion relative abundance dependent upon amyloid burden 32
0.116439514.11087738.html.plaintext.txt	187	This suggests generated vivo distinct proteolytic pathway PrP species associated mutant GSS genotypes
0.116439514.11087738.html.plaintext.txt	188	Noteworthy GSS patients different PRNP mutations show variation molecular mass internal PrP fragments ranging 7 15 kDa 9
0.116439514.11087738.html.plaintext.txt	189	In patient found 7 kDa peptide physicochemical properties PrPres species found prion diseases
0.116439514.11087738.html.plaintext.txt	190	insolubility nondenaturing detergents resistance PK digestion 16
0.116439514.11087738.html.plaintext.txt	191	This variance previous report brain tissue GSS A117V patients contains little protease resistant PrP 34
0.116439514.11087738.html.plaintext.txt	192	Notably degree protease resistance peptide lower GSS mutant proteins since unlike analogous fragments patients F198S Q217R PrP variants completely degraded presence SDS
0.116439514.11087738.html.plaintext.txt	193	The analysis PrP extracted amyloid plaque cores showed amyloid protein corresponded 7 kDa fragment spanning residues 85 153
0.116439514.11087738.html.plaintext.txt	194	Similar previous studies GSS F198S Q217R fragment derived mutant allele since Val found position 117 129 18
0.116439514.11087738.html.plaintext.txt	195	This finding consistent observation detergent soluble fraction total brain homogenates contained 60 full length PrP protease sensitive whereas remainder full length molecules well N C terminal truncated fragments 16 17 7 kDa partitioned insoluble fraction
0.116439514.11087738.html.plaintext.txt	196	Mass spectrometric analysis revealed amyloid peptide ragged N C termini particular N terminus remarkably heterogeneous starting position residue 85 95
0.116439514.11087738.html.plaintext.txt	197	The amyloid fraction also contained peptides corresponding 19 N terminal amino acids full length PrP two C terminal fragments comprising residues 191 205 217 228
0.116439514.11087738.html.plaintext.txt	198	This finding consistent observation periphery amyloid plaque cores strongly immunoreactive antibodies N C terminal domains
0.116439514.11087738.html.plaintext.txt	199	The copurification small peptides larger amyloid protein likely due insufficient resolution gel filtration column within molecular weight range alternatively peptides could bound amyloid protein
0.116439514.11087738.html.plaintext.txt	200	Collectively data suggest GSS A117V mutant PrP least partially degraded proteases extracellular compartment formation major amyloid peptide whose size sequence similar found patients different mutations
0.116439514.11087738.html.plaintext.txt	201	Other fragments generated partial degradation amyloid precursor protein contribute plaque formation may also participate amyloidogenesis since found peptide comprising residues 191 205 able assemble amyloid like fibrils vitro
0.116439514.11087738.html.plaintext.txt	202	Studies cell free translation systems containing endoplasmic reticulum derived microsomal membranes revealed PrP may exist multiple topological forms including secretory form fully translocated endoplasmic reticulum lumen two transmembrane forms opposite membrane orientation 35 37
0.116439514.11087738.html.plaintext.txt	203	A specific transmembrane form found increased transgenic mice expressing A117V mutation detected brain tissue patients GSS A117V 34
0.116439514.11087738.html.plaintext.txt	204	This form could recognized limited proteolysis brain homogenates using PK low temperature absence ionic detergents conversely protease resistant PrP peptides found conditions used detect PrPres prion diseases
0.116439514.11087738.html.plaintext.txt	205	Based observations proposed transmembrane form PrP rather PrPres plays central role neuropathological changes observed GSS A117V 34 well prion diseases 38
0.116439514.11087738.html.plaintext.txt	206	In present study found remarkable accumulation PrP amyloid brain tissue immunohistochemistry substantial amounts PK resistant low molecular weight PrP peptide brain tissue homogenates purified amyloid fractions Western blot analysis
0.116439514.11087738.html.plaintext.txt	207	Whether protease resistant PrP peptide originates transmembrane glycosylphosphatidylinositol anchored secreted forms PrP investigated
0.116439514.11087738.html.plaintext.txt	208	In conclusion data present previous studies GSS patients different PRNP mutations indicate minimal PrP segment essential amyloidogenesis N C terminal truncated fragment spanning residues 88 146 Fig
0.116439514.11087738.html.plaintext.txt	209	The major part fragment corresponds end flexible N terminal domain PrPC 39 thought undergo profound conformational change conversion normal protein disease specific species
0.116439514.11087738.html.plaintext.txt	210	The C terminus amyloid peptides similar truncated PrP found patient carrying amber mutation PRNP codon 145 40 41
0.116439514.11087738.html.plaintext.txt	211	The conformational plasticity region tendency adopt sheet secondary structure supported studies synthetic peptides 42 44
0.116439514.11087738.html.plaintext.txt	212	Interestingly GSS amyloid peptides derived PrP region essential disease transmissibility Fig
0.116439514.11087738.html.plaintext.txt	213	Early studies determined protease resistant core PrPSc scrapie infected brains N terminally truncated near residue 90 transmit disease 45
0.116439514.11087738.html.plaintext.txt	214	Propagation transmissibility pathologic process also sustained redacted version PrP lacking residues 23 88 141 176 46 47
0.116439514.11087738.html.plaintext.txt	215	Recently Kaneko co workers 48 addressed question whether PrP fragment similar GSS amyloid peptide may initiate prion disease
0.116439514.11087738.html.plaintext.txt	216	They used synthetic peptide homologous mouse PrP residues 89 143
0.116439514.11087738.html.plaintext.txt	217	human residues 90 144 P101L substitution corresponding GSS linked P102L mutation
0.116439514.11087738.html.plaintext.txt	218	Intracerebral inoculation sheet rich form peptide transgenic mice expressing low levels P101L mutation resulted neurologic dysfunction neuropathological changes consistent GSS
0.116439514.11087738.html.plaintext.txt	219	Conversely larger doses non form peptide failed induce changes emphasizing importance protein conformation disease initiation propagation
0.116439514.11087738.html.plaintext.txt	220	Indeed although 7 kDa PrP amyloid fragment component minimal PrP sequence required disease transmissibility unlikely peptide per se might support efficient interaction PrPC PrPC PrPSc conversion due insoluble sheet secondary structure aggregation state
0.116439514.11087738.html.plaintext.txt	221	View larger version 40K Fig
0.116439514.11087738.html.plaintext.txt	222	Schematic representation full length PrP amyloid peptides isolated GSS brains partially deleted PrP sequence supports prion propagation
0.116439514.11087738.html.plaintext.txt	223	The top diagram illustrates polypeptide chain mature human PrP octapeptide repeat region common MetVal polymorphism codon 129 mutations A117V F198S Q217R associated GSS
0.116439514.11087738.html.plaintext.txt	224	The normal protein composed two structurally distinct moieties flexible N terminal segment residues 23 125 globular domain residues 126 231 three helices black areas two stranded antiparallel sheets arrows
0.116439514.11087738.html.plaintext.txt	225	The first four PrP fragments correspond amyloid peptides isolated four GSS patients F198S Q217R A117V present case mutation
0.116439514.11087738.html.plaintext.txt	226	These patients MetVal heterozygous codon 129 Val129 encoded mutant PRNP allele
0.116439514.11087738.html.plaintext.txt	227	The diagrams indicate amino acid residue position 129 major N C terminal signals obtained protein sequence analysis
0.116439514.11087738.html.plaintext.txt	228	Although A117V mutation within amyloid fragment amyloid peptides originated form mutant molecules deduced codon 129 polymorphism
0.116439514.11087738.html.plaintext.txt	229	The last diagram illustrates redacted version PrP lacking residues 23 88 141 176 sufficient support prion disease
0.116439514.11087738.html.plaintext.txt	230	Kascsak Institute Basic Research Developmental Disabilities Staten Island NY donating monoclonal antibody 3F4
0.116439514.11087738.html.plaintext.txt	231	This work supported Italian Ministry Health Department Social Services European Community Grant BMH4 CT98 6015 National Institutes Health Grants ARO2594 B
0.116439514.11087738.html.plaintext.txt	232	The costs publication article defrayed part payment page charges
0.116439514.11087738.html.plaintext.txt	233	The article must therefore hereby marked advertisement accordance 18 U
0.116439514.11087738.html.plaintext.txt	234	Section 1734 solely indicate fact
0.116439514.11087738.html.plaintext.txt	235	To correspondence addressed Istituto Nazionale Neurologico Carlo Besta via Celoria 11 20133 Milano Italy
0.116439514.11087738.html.plaintext.txt	236	3902 2394384 Fax 3902 70638217 E mail ftagliaviniistituto besta
0.116439514.11087738.html.plaintext.txt	237	Published JBC Papers Press November 21 2000 DOI 10
0.116439514.11087738.html.plaintext.txt	238	The abbreviations used GSS Gerstmann Straussler Scheinker disease PrP prion protein PRNP prion protein gene PrPC normal cellular form prion protein PrPSc disease specific isoform prion protein PrPres protease resistant core PrPSc CJD Creutzfeldt Jakob disease PK proteinase K PAGE polyacrylamide gel electrophoresis HPLC high performance liquid chromatography Tricine N 2 hydroxy 11 bishydroxymethylethylglycine PTH phenylthiohydantoin
0.116439514.11087738.html.plaintext.txt	239	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1
0.116439514.11087738.html.plaintext.txt	240	1989 Nature 338 342 345CrossRefMedline Order article via Infotrieve 4
0.116439514.11087738.html.plaintext.txt	241	1991 Neurology 41 681 684Abstract 6
0.116439514.11087738.html.plaintext.txt	242	1 64 67Medline Order article via Infotrieve 7
0.116439514.11087738.html.plaintext.txt	243	1 68 71Medline Order article via Infotrieve 8
0.116439514.11087738.html.plaintext.txt	244	191 709 714CrossRefMedline Order article via Infotrieve 9
0.116439514.11087738.html.plaintext.txt	245	57 979 988Medline Order article via Infotrieve 10
0.116439514.11087738.html.plaintext.txt	246	24 35 40Medline Order article via Infotrieve 12
0.116439514.11087738.html.plaintext.txt	247	1989 Neurology 39 1453 1461Abstract 13
0.116439514.11087738.html.plaintext.txt	248	6 127 145Medline Order article via Infotrieve 15
0.116439514.11087738.html.plaintext.txt	249	97 145 150AbstractFree Full Text 40
0.116439514.11087738.html.plaintext.txt	250	192 525 531CrossRefMedline Order article via Infotrieve 41
0.116439514.11087738.html.plaintext.txt	251	93 744 748AbstractFree Full Text 42
0.116439514.11087738.html.plaintext.txt	252	269 7859 7862AbstractFree Full Text 44
0.116439514.11087738.html.plaintext.txt	253	250 514 526CrossRefMedline Order article via Infotrieve 45
0.116439514.11087738.html.plaintext.txt	254	1984 Cell 38 127 134Medline Order article via Infotrieve 46
0.116439514.11087738.html.plaintext.txt	255	93 15457 15462AbstractFree Full Text 47
0.116439514.11087738.html.plaintext.txt	256	1999 Cell 96 869 878Medline Order article via Infotrieve 48
0.116439514.11087738.html.plaintext.txt	257	295 997 1007CrossRefMedline Order article via Infotrieve
0.116439514.11087738.html.plaintext.txt	258	Copyright 2001 The American Society Biochemistry Molecular Biology Inc
0.11330524.10842180.html.plaintext.txt	0	Doppel Is N Glycosylated Glycosylphosphatidylinositol anchored Protein EXPRESSION IN TESTIS AND ECTOPIC PRODUCTION IN THE BRAINS OF Prnp00 MICE PREDISPOSED TO PURKINJE CELL LOSS Gregory L
0.11330524.10842180.html.plaintext.txt	1	Silvermanabc Kefeng Qina Richard C
0.11330524.10842180.html.plaintext.txt	2	Moorede Ying Yangf Peter Mastrangeloa Patrick Tremblayd Stanley B
0.11330524.10842180.html.plaintext.txt	3	Cohenhijk David Westawayabl
0.11330524.10842180.html.plaintext.txt	4	From Centre Research Neurodegenerative Diseases b Department Laboratory Medicine Pathobiology f Mass Spectrometry Laboratory Molecular Medicine Research Centre University Toronto Toronto Ontario M5S 3H2 Canada d Institute Neurodegenerative Diseases Departments g Neurology h Biochemistry Biophysics Cellular Molecular Pharmacology j Pharmaceutical Chemistry k Medicine University California San Francisco California 94143 0518
0.11330524.10842180.html.plaintext.txt	5	Received publication May 8 2000
0.11330524.10842180.html.plaintext.txt	6	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.11330524.10842180.html.plaintext.txt	7	The Prnd gene encodes homolog cellular prion protein PrPC called doppel Dpl
0.11330524.10842180.html.plaintext.txt	8	Up regulation Prnd mRNA two distinct lines PrP gene ablated Prnp00 mice designated Rcm0 Ngsk associated death Purkinje cells
0.11330524.10842180.html.plaintext.txt	9	Using recombinant Dpl expressed Escherichia coli mouse neuroblastoma cells demonstrate wild type wt Dpl like PrPC adopts predominantly helical conformation forms intramolecular disulfide bonds two N linked oligosaccharides presented cell surface via glycosylphosphatidylinositol anchor
0.11330524.10842180.html.plaintext.txt	10	Dpl protein detected testis wt mice
0.11330524.10842180.html.plaintext.txt	11	Using Triton X 114 phase partitioning enrich glycosylphosphatidylinositol anchored proteins Dpl detected brain samples Rcm0 Prnp00 mice absent equivalent samples wt mice ZrchI Prnp00 mice indicating ectopic expression protein may cause cerebellar pathology Rcm0 mice
0.11330524.10842180.html.plaintext.txt	12	Biochemical structural similarities PrPC Dpl documented parallel observation ataxic Ngsk Prnp00 mice rescued overexpression wild type PrP transgenes suggest cell surface PrPC antagonize toxic effect Dpl expressed central nervous system
0.11330524.10842180.html.plaintext.txt	13	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.11330524.10842180.html.plaintext.txt	14	The prion protein gene Prnp1 encodes PrPSc major structural component etiological agent disorders scrapie Creutzfeldt Jakob disease
0.11330524.10842180.html.plaintext.txt	15	In uninfected animals Prnp encodes cellular protein denoted PrPC thought converted PrPSc posttranslational mechanism course prion infections
0.11330524.10842180.html.plaintext.txt	16	Although Prnp conserved mammalian species ZrchI Npu lines Prnp00 gene ablated mice remain healthy throughout development 1 3 may indicate PrPC serves function apparent laboratory setting perhaps molecules fulfill overlapping function
0.11330524.10842180.html.plaintext.txt	17	An insight issue emerged large scale sequencing 4
0.11330524.10842180.html.plaintext.txt	18	Although Prnp originally considered unique within mammalian genome recently shown paralog 5
0.11330524.10842180.html.plaintext.txt	19	The mouse gene Prnd located 16 kilobases downstream Prnp encodes 179 amino acid Dpl protein
0.11330524.10842180.html.plaintext.txt	20	Corresponding Dpl coding sequences located downstream Prnp humans rats likely mammals
0.11330524.10842180.html.plaintext.txt	21	Dpl approximately 25 sequence identity C terminal two thirds PrPC predicted contain three helices two disulfide bonds notably lacking octapeptide repeat domain like one present N terminus PrPC 5
0.11330524.10842180.html.plaintext.txt	22	Unlike Prnp abundant Prnd mRNAs absent brains wild type wt animals although species 1
0.11330524.10842180.html.plaintext.txt	23	7 kilobases present high levels heart testis 5
0.11330524.10842180.html.plaintext.txt	24	Interestingly however inappropriate expression Prnd mRNA central nervous system associated neurodegenerative syndrome
0.11330524.10842180.html.plaintext.txt	25	The Rcm0 Ngsk lines Prnp00 mice display normal early development develop widespread loss cerebellar Purkinje cells around 70 weeks age accompanied progressive ataxia 5 6
0.11330524.10842180.html.plaintext.txt	26	These mice differ asymptomatic Prnp00 mice carry chromosomal deletions extend beyond Prnp open reading frame intron 2 5 end extending 3 untranslated region Prnp mRNA encoded exon 3 3 end
0.11330524.10842180.html.plaintext.txt	27	These deletions eliminate Prnp exon 3 splice acceptor site result generation high levels Prnd transcripts brain unusual mechanism involving exon skipping intergenic splicing 5
0.11330524.10842180.html.plaintext.txt	28	Although possible long range perturbations chromatin structure underlie ataxic phenotype Rcm0 Ngsk lines Prnp00 mice parsimonious interpretation available data Dpl overexpression toxic Purkinje cells
0.11330524.10842180.html.plaintext.txt	29	Finally noteworthy disease Ngsk Prnp00 mice abrogated reintroduction wt Prnp transgene 7 providing genetic evidence interaction PrPC molecules cause Purkinje cell loss
0.11330524.10842180.html.plaintext.txt	30	In work sought confirmation previous predictions regarding biochemical structural properties Dpl protein
0.11330524.10842180.html.plaintext.txt	31	We demonstrate recombinant Dpl refolded standard conditions adopts predominantly helical conformation Dpl expressed mouse neuroblastoma cells possesses two N linked oligosaccharides attached cell surface via GPI anchor
0.11330524.10842180.html.plaintext.txt	32	These findings show Dpl PrPC resemble one another respect post translational modifications subcellular localization
0.11330524.10842180.html.plaintext.txt	33	We also report Dpl protein present brains Rcm0 mice undetectable brains wt FVBN mice ZrchI line PrP knockout mice
0.11330524.10842180.html.plaintext.txt	34	Our findings discussed context transgene rescue experiments indicating interactions Dpl PrPC
0.11330524.10842180.html.plaintext.txt	35	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.11330524.10842180.html.plaintext.txt	36	Expression Purification Refolding Mouse Dpl 27 154 The DNA fragment coding mouse Dpl MoDpl 27 154 amplified polymerase chain reaction cosmid ILnJ 4 using oligonucleotide primers 1 N terminal primer 5 GGGGCATATGTCTAGGGGCATAAAGCACAGG 3 2 C terminal primer 5 GGGGGATCCTATCACCTTTCCAGCCAGAAATCGCA 3
0.11330524.10842180.html.plaintext.txt	37	The amplified gene cloned plasmid pRBI PDI T7 via NdeI BamHI restriction enzyme sites
0.11330524.10842180.html.plaintext.txt	38	This expression plasmid named pMoDpl27 154
0.11330524.10842180.html.plaintext.txt	39	In plasmid mouse Dpl gene control T7 promoterlac operator sequence 8 9
0.11330524.10842180.html.plaintext.txt	40	According N end rule bacteria 10 introduced Ser N terminus MoDpl 27 154 minimize proteolytic degradation cytoplasm
0.11330524.10842180.html.plaintext.txt	41	The recombinant MoDpl 27 154 consists 130 amino acid residues correct gene sequence verified DNA sequencing
0.11330524.10842180.html.plaintext.txt	42	Cells Escherichia coli BL21 DE3 including pMoDpl27 154 grown 37 degrees C 1 liter LB medium containing ampicillin 100 microgml
0.11330524.10842180.html.plaintext.txt	43	0 IPTG added final concentration 1 mM culture incubated 37 degrees C another 16 h
0.11330524.10842180.html.plaintext.txt	44	Cells harvested centrifugation 3000 x g 10 min suspended 20 ml suspension buffer 50 mM Tris HCl pH 8
0.11330524.10842180.html.plaintext.txt	45	4 mgml RNase A 1 mgml lysozyme 1 mM phenylmethylsulfonyl fluoride shaken 37 degrees C 2 h room temperature 1 h
0.11330524.10842180.html.plaintext.txt	46	The lysate centrifuged 4 degrees C 39000 x g 1 h
0.11330524.10842180.html.plaintext.txt	47	The insoluble inclusion bodies washed twice 10 ml wash buffer 20 mM Tris HCl pH 8
0.11330524.10842180.html.plaintext.txt	48	5 Triton X 100 vv 1 mM EDTA 1 mini complete protease inhibitor mixture tablet EDTA free Roche Molecular Biochemicals solubilized 10 ml dissolve buffer 10 mM Tris HCl pH 8
0.11330524.10842180.html.plaintext.txt	49	0 50 mM DTT 1 mM EDTA 8 M urea 1 mini complete protease inhibitor mixture tablet EDTA free
0.11330524.10842180.html.plaintext.txt	50	After centrifugation 39000 x g 22 degrees C 1 h 3 ml supernatant applied SP Sepharose column 20 ml Amersham Pharmacia Biotech equilibrated 10 mM MOPS NaOH pH 7
0.11330524.10842180.html.plaintext.txt	51	0 5 mM DTT 1 mM EDTA 8 M urea using BioLogic HR chromatography system Bio Rad
0.11330524.10842180.html.plaintext.txt	52	The isocratic rate 1 mlmin fractions collected 1
0.11330524.10842180.html.plaintext.txt	53	MoDpl 27 154 eluted linear NaCl gradient 0 0
0.11330524.10842180.html.plaintext.txt	54	Fractions containing MoDpl 27 154 pooled diluted 50 mM Tris HCl pH 8
0.11330524.10842180.html.plaintext.txt	55	7 8 M urea protein concentration 0
0.11330524.10842180.html.plaintext.txt	56	CuSO4 added final concentration 1 microM solution stirred 2 h room temperature
0.11330524.10842180.html.plaintext.txt	57	The oxidation quenched addition 1 mM EDTA
0.11330524.10842180.html.plaintext.txt	58	The solution dialyzed double distilled H2O concentrated Centriplus 3 kDa molecular mass cut concentrators Amicon 1 mgml stored 20 degrees C
0.11330524.10842180.html.plaintext.txt	59	Recombinant mouse PrP MoPrP 23 231 prepared described previously 11
0.11330524.10842180.html.plaintext.txt	60	Electrophoretic Analyses N terminal Amino Acid Sequencing Proteins boiled gel loading buffer 5 min electrophoresed 10 20 Tricine gels stained Coomassie Blue
0.11330524.10842180.html.plaintext.txt	61	For N terminal amino acid sequencing protein electrophoresed 10 20 Tricine gels transferred PVDF membrane stained Coomassie Blue
0.11330524.10842180.html.plaintext.txt	62	The membrane sliced individual bands sequenced using Porton Gas phase Microsequencer model 2090 line phenylthiohydantoin analysis
0.11330524.10842180.html.plaintext.txt	63	Amino Acid Analysis Determination Protein Concentration The amino acid analysis performed Waters Pico Tag system calibrated triplicate using collection derivatized amino acid standards
0.11330524.10842180.html.plaintext.txt	64	Dried MoDpl 27 154 hydrolyzed using 6 M HCl 1 phenol 110 degrees C 24 h
0.11330524.10842180.html.plaintext.txt	65	After hydrolysis excess HCl removed hydrolysis tube vacuum sample derivatized dissolved sample diluent pH 7
0.11330524.10842180.html.plaintext.txt	66	4 aliquot injected Waters Pico Tag column running Waters Pico Tag gradient column temperature 33 degrees C
0.11330524.10842180.html.plaintext.txt	67	For tabulation individual amino acids yields expressed percentage weight percentage content molecular weight correction loss one water molecule per residue
0.11330524.10842180.html.plaintext.txt	68	S Carbamidomethylation Cysteines MoDpl 27 154 1
0.11330524.10842180.html.plaintext.txt	69	2 mgml 50 microl S carbamidomethylation buffer 0
0.11330524.10842180.html.plaintext.txt	70	0 1 mM EDTA 6 M guanidine hydrochloride incubated without 10 mM dithiothreitol DTT room temperature 1 h
0.11330524.10842180.html.plaintext.txt	71	The reduced non reduced MoDpl 27 154 incubated 50 mM iodoacetamide IAM room temperature dark 30 min
0.11330524.10842180.html.plaintext.txt	72	Iodoacetamide reacts free SH group cysteine yield carbamidomethyl cysteine concomitant increase molecular mass 57 Da
0.11330524.10842180.html.plaintext.txt	73	1 microl reduced non reduced MoDpl 27 154 treated IAM used matrix assisted laser desorptionionization mass spectrometric MALDI MS analysis without purification
0.11330524.10842180.html.plaintext.txt	74	Trypsin Digestion MoDpl 27 154 Trypsin digestion carried MoDpl 27 154 1 mgml 20 microl 100 mM ammonium bicarbonate buffer pH 8
0.11330524.10842180.html.plaintext.txt	75	1 microl modified trypsin sequencing grade Promega solution 2 mgml 50 mM acetic acid added yield final enzyme protein ratio 110
0.11330524.10842180.html.plaintext.txt	76	After incubation 37 degrees C 2 h 2 microl 1 N HCl added bring mixture pH 3
0.11330524.10842180.html.plaintext.txt	77	One half sample 10 microl moved another tube mixed 2 microl 0
0.11330524.10842180.html.plaintext.txt	78	1 M tris 2 carboxyethylphosphin Pierce 0
0.11330524.10842180.html.plaintext.txt	79	The mixture incubated 37 degrees C 30 min reduction disulfide bond containing tryptic peptides
0.11330524.10842180.html.plaintext.txt	80	1 microl aliquots reduced non reduced tryptic peptide mixtures used MALDI MS analysis without purification
0.11330524.10842180.html.plaintext.txt	81	Mass Spectrometric Molecular Weight Determination Peptide Mapping MALDI time flight MS analyses carried using Voyager DE STR mass spectrometer Perseptive Biosystems Inc
0.11330524.10842180.html.plaintext.txt	82	equipped pulsed UV nitrogen laser 337 nm 3 ns pulse dual microchannel plate detector
0.11330524.10842180.html.plaintext.txt	83	For molecular mass determination full length MoDpl 27 154 protein spectra acquired linear DE mode acceleration voltage set 25 kV grid voltage 95 acceleration voltage guide wire voltage 0
0.11330524.10842180.html.plaintext.txt	84	150 delay time 320 ns low mass gate set 1000 Da
0.11330524.10842180.html.plaintext.txt	85	The mass charge ratio calibrated molecular mass mixture proteins mass 5734
0.11330524.10842180.html.plaintext.txt	86	For analysis tryptic peptides spectra acquired reflectron DE mode acceleration voltage set 20 kV grid voltage 72 acceleration voltage guide wire voltage 0
0.11330524.10842180.html.plaintext.txt	87	050 delay time 200 ns low mass gate 250 Da
0.11330524.10842180.html.plaintext.txt	88	The mass charge ratio calibrated mass mixture standard peptides mass 904
0.11330524.10842180.html.plaintext.txt	89	Saturated cyano 4 hydroxycinnamic acid 70 acetonitrile containing 0
0.11330524.10842180.html.plaintext.txt	90	1 trifluoroacetic acid used matrix analysis tryptic peptides saturated sinapinic acid 50 acetonitrile containing 0
0.11330524.10842180.html.plaintext.txt	91	1 trifluoroacetic acid used matrix protein analysis
0.11330524.10842180.html.plaintext.txt	92	1 microl solution MoDpl 27 154 reduced non reduced S carbamidomethyl MoDpl 27 154 reduced non reduced tryptic peptide mixture applied MALDI plate followed 1 microl saturated matrix solution
0.11330524.10842180.html.plaintext.txt	93	Spectra recorded evaporation solvent processed using GRAMS software data collection analysis
0.11330524.10842180.html.plaintext.txt	94	Predicted masses calculated ExPASy Peptide Mass program
0.11330524.10842180.html.plaintext.txt	95	Circular Dichroism Far UV circular dichroism CD measurements performed Jasco J 715 spectropolarimeter
0.11330524.10842180.html.plaintext.txt	96	Using cell path length 1 mm scans conducted 190 250 nm scan speed 20 nmmin sensitivity 50 millidegrees
0.11330524.10842180.html.plaintext.txt	97	All CD spectrum measurements performed room temperature 20 mM phosphate buffer PB pH 7
0.11330524.10842180.html.plaintext.txt	98	Spectra subject curve smoothing noted converted mean residue ellipticities degrees cm2dmol based protein concentration determined amino acid analysis using Pico Tag system
0.11330524.10842180.html.plaintext.txt	99	Antibodies The anti Dpl rabbit polyclonal Ab D7177 raised synthetic Dpl 2 peptide described previously 5
0.11330524.10842180.html.plaintext.txt	100	Cell Lines The mouse neuroblastoma cell line N2a obtained commercially ATCC used establish cell lines
0.11330524.10842180.html.plaintext.txt	101	The cDNA mouse Dpl cloned mammalian expression vector pcDNA3
0.11330524.10842180.html.plaintext.txt	102	0 Invitrogen used establish stably transfected line Dpl expressing cells called Dpl 3 described previously 5
0.11330524.10842180.html.plaintext.txt	103	The Dpl 7 cell line expresses Dpl mRNA protein assayed Northern Western blotting respectively 5 untransfected N2a cells used negative controls
0.11330524.10842180.html.plaintext.txt	104	Preparation Cell Lysates Cells grown 80 90 confluence 10 cm2 dishes Dulbeccos modified Eagles medium supplemented 10 fetal bovine serum
0.11330524.10842180.html.plaintext.txt	105	Medium Dpl 3 Dpl 7 cultures additionally supplemented 0
0.11330524.10842180.html.plaintext.txt	106	3 mgml G418 Life Technologies
0.11330524.10842180.html.plaintext.txt	107	Cells washed three times HBSS scraped HBSS pelleted 1000 x g 4 degrees C resuspended cell lysis buffer 0
0.11330524.10842180.html.plaintext.txt	108	5 sodium deoxycholate 150 mM NaCl 20 mM Tris HCl pH 7
0.11330524.10842180.html.plaintext.txt	109	4 containing one mini complete protease inhibitor tablet
0.11330524.10842180.html.plaintext.txt	110	Cells disrupted agitating 10 min 4 degrees C centrifuging 20000 x g 10 min 4 degrees C remove insoluble debris
0.11330524.10842180.html.plaintext.txt	111	Cleared supernatant transferred new tube stored 80 degrees C needed
0.11330524.10842180.html.plaintext.txt	112	Preparation Tissue Homogenates Ten percent wv homogenates tissues prepared phosphate buffered saline pH 7
0.11330524.10842180.html.plaintext.txt	113	4 containing mini complete protease inhibitor tablet ice using Dounce homogenizer
0.11330524.10842180.html.plaintext.txt	114	Homogenates spun 3000 x g 10 min 4 degrees C cleared supernatant aliquoted stored 80 degrees C needed
0.11330524.10842180.html.plaintext.txt	115	The concentration total protein sample determined using Bradford assay per manufacturers instructions Bio Rad
0.11330524.10842180.html.plaintext.txt	116	PNGase F Digestion Aliquots cell lysate tissue homogenates thawed 0
0.11330524.10842180.html.plaintext.txt	117	1 volume 10 x denaturing buffer 5 SDS 10 mercaptoethanol added sample tubes boiled 10 min
0.11330524.10842180.html.plaintext.txt	118	To sample following added 0
0.11330524.10842180.html.plaintext.txt	119	1 volume 10 Nonidet P 40 0
0.11330524.10842180.html.plaintext.txt	120	5 M sodium phosphate buffer pH 7
0.11330524.10842180.html.plaintext.txt	121	2 volume PNGase F 1 unit microl 50 microM sodium phosphate buffer pH 7
0.11330524.10842180.html.plaintext.txt	122	5 New England Biolabs added samples except used negative controls 0
0.11330524.10842180.html.plaintext.txt	123	2 volume 50 mM sodium phosphate buffer pH 7
0.11330524.10842180.html.plaintext.txt	124	Samples incubated 0 15 30 45 60 120 min 37 degrees C gentle shaking
0.11330524.10842180.html.plaintext.txt	125	25 volume 4 x Laemmli buffer added sample following incubation samples analyzed Western blotting
0.11330524.10842180.html.plaintext.txt	126	PIPLC Incubation Dpl 3 Dpl 7 negative control cell lines grown 80 90 confluence 10 cm2 dish noted
0.11330524.10842180.html.plaintext.txt	127	Cells washed three times HBSS incubated serum free Opti MEM Life Technologies without 0
0.11330524.10842180.html.plaintext.txt	128	2 unitsml PIPLC Molecular Probes 1 h 37 degrees C
0.11330524.10842180.html.plaintext.txt	129	Cell medium recovered transferred tube containing 0
0.11330524.10842180.html.plaintext.txt	130	1 volume 10 x TNE 500 mM Tris HCl pH 7
0.11330524.10842180.html.plaintext.txt	131	Recovered medium centrifuged 2500 x g 5 min 4 degrees C remove cellular debris
0.11330524.10842180.html.plaintext.txt	132	The cleared medium concentrated using 10 kDa molecular mass cut Centricon tube Amicon methanol precipitated
0.11330524.10842180.html.plaintext.txt	133	Precipitated proteins resuspended 1 x Laemmli buffer stored 80 degrees C later analysis
0.11330524.10842180.html.plaintext.txt	134	After removal medium cells washed three times HBSS scraped 5 ml HBSS pelleted 1000 x g 5 min 4 degrees C
0.11330524.10842180.html.plaintext.txt	135	The supernatant removed cell pellet resuspended cell lysis buffer transferred clean microcentrifuge tube
0.11330524.10842180.html.plaintext.txt	136	Cells disrupted agitating 10 min 4 degrees C centrifuging 20000 x g 10 min 4 degrees C remove insoluble debris
0.11330524.10842180.html.plaintext.txt	137	Cleared supernatant transferred new tube 0
0.11330524.10842180.html.plaintext.txt	138	25 volume 4 x Laemmli buffer added samples analyzed Western blotting
0.11330524.10842180.html.plaintext.txt	139	Triton X 114 Phase Partitioning Prior conducting Triton X 114 phase partitioning stock solutions prepared follows
0.11330524.10842180.html.plaintext.txt	140	A 3 vv aqueous solution Triton X 114 thoroughly mixed 4 degrees C solubilize detergent incubated overnight 37 degrees C induce phase transition
0.11330524.10842180.html.plaintext.txt	141	The upper aqueous phase discarded lower detergent phase mixed 0
0.11330524.10842180.html.plaintext.txt	142	1 volume 10 x TNE create Triton X 114 stock
0.11330524.10842180.html.plaintext.txt	143	The hydrophobicity cellular proteins determined harvesting cells described resuspending cell pellet 1 x TNE containing 0
0.11330524.10842180.html.plaintext.txt	144	25 volume Triton X 114 stock
0.11330524.10842180.html.plaintext.txt	145	Recovered medium first cleared concentrated methanol precipitated described proteins resuspended 1 x TNE containing 0
0.11330524.10842180.html.plaintext.txt	146	25 volume Triton X 114 stock
0.11330524.10842180.html.plaintext.txt	147	All samples cooled 4 degrees C centrifuged 3000 x g 10 min 4 degrees C remove insoluble aggregates
0.11330524.10842180.html.plaintext.txt	148	Supernatant transferred clean microcentrifuge tube heated 37 degrees C 10 min induce phase transition centrifuged 3000 x g 10 min pellet detergent protein micelles
0.11330524.10842180.html.plaintext.txt	149	The upper aqueous phase transferred new tube mixed 0
0.11330524.10842180.html.plaintext.txt	150	25 volume Triton X 114 stock 4 degrees C heated 37 degrees C induce phase transition
0.11330524.10842180.html.plaintext.txt	151	This repartitioning aqueous phase repeated two times resulting generation four separate detergent phases single aqueous phase
0.11330524.10842180.html.plaintext.txt	152	Detergent phases one two three pooled single tube
0.11330524.10842180.html.plaintext.txt	153	All samples precipitated adding 5 10 volumes methanol incubating overnight 20 degrees C centrifuging 3000 x g 30 min 4 degrees C
0.11330524.10842180.html.plaintext.txt	154	Samples resuspended 1 x Laemmli buffer analyzed Western blotting
0.11330524.10842180.html.plaintext.txt	155	Triton X 114 phase partitioning mouse tissue homogenates conducted follows
0.11330524.10842180.html.plaintext.txt	156	Volumes 10 wv tissue homogenate corresponding 50 microg total protein thawed mixed 14 1 x TNE containing 0
0.11330524.10842180.html.plaintext.txt	157	25 volume Triton X 114 stock
0.11330524.10842180.html.plaintext.txt	158	Samples mixed 4 degrees C partitioned described
0.11330524.10842180.html.plaintext.txt	159	Western Blotting Prior fractionation SDS PAGE samples boiled 5 min centrifuged 20000 x g 5 min
0.11330524.10842180.html.plaintext.txt	160	Samples loaded onto 10 20 Tricine gradient gels Novex electrophoresed 125 V approximately 90 min
0.11330524.10842180.html.plaintext.txt	161	2 microm nitrocellulose Schleicher Schuell 60 min 100 V 20 mM Tris buffer pH 8
0.11330524.10842180.html.plaintext.txt	162	5 containing 150 mM glycine 20 wv methanol 0
0.11330524.10842180.html.plaintext.txt	163	Blots blocked 5 wv milk powder Tris buffered saline pH 7
0.11330524.10842180.html.plaintext.txt	164	4 3 h room temperature probed D7177 Ab concentration 11250 0
0.11330524.10842180.html.plaintext.txt	165	5 wv milk powder Tris buffered saline pH 7
0.11330524.10842180.html.plaintext.txt	166	Where D7177 Ab preincubated immunogenic Dpl 2 peptide 20 microg peptide added antibody incubated gentle shaking room temperature 3 h prior use
0.11330524.10842180.html.plaintext.txt	167	The secondary Ab used goat anti rabbit HRP conjugated antisera Bio Rad
0.11330524.10842180.html.plaintext.txt	168	Blots visualized using ECL ECL Plus detection reagents Amersham Pharmacia Biotech per manufacturers instructions exposed X Omat AR film Eastman Kodak Co
0.11330524.10842180.html.plaintext.txt	169	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.11330524.10842180.html.plaintext.txt	170	Expression Authentication Recombinant MoDpl 27 154 Dpl predicted contain N C terminal signal peptides directing expression secretory pathway addition glycolipid anchor respectively Ref
0.11330524.10842180.html.plaintext.txt	171	Accordingly expression cassette constructed omitting signal peptide regions MoDpl 27 154 Fig
0.11330524.10842180.html.plaintext.txt	172	1 amplifying DNA ILnJ 4 cosmid clone 12
0.11330524.10842180.html.plaintext.txt	173	The N terminus reading frame modified addition methionine
0.11330524.10842180.html.plaintext.txt	174	Since wild type N terminal Arg predicted destabilizing residue E
0.11330524.10842180.html.plaintext.txt	175	coli according N end rule 10 Ser residue also introduced
0.11330524.10842180.html.plaintext.txt	176	Electrophoretic analysis purified MoDpl 27 154 demonstrated single species 14
0.11330524.10842180.html.plaintext.txt	177	9 kDa data shown Edman degradation yielded anticipated N terminal sequence SRGIKHRF
0.11330524.10842180.html.plaintext.txt	178	MALDI MS molecular mass analysis MoDpl 27 154 showed single charged protein signal MH mz 14917
0.11330524.10842180.html.plaintext.txt	179	2A excellent agreement calculated molecular mass 14916
0.11330524.10842180.html.plaintext.txt	180	The strong signal present analysis Fig
0.11330524.10842180.html.plaintext.txt	181	2A double charged protein signal mz 7458
0.11330524.10842180.html.plaintext.txt	182	9 Da underscoring purity protein sample
0.11330524.10842180.html.plaintext.txt	183	Finally detailed masses tryptic peptides derived recombinant protein also close accord predicted nucleotide sequence Prnd Table I
0.11330524.10842180.html.plaintext.txt	184	View larger version 7K Fig
0.11330524.10842180.html.plaintext.txt	185	Predicted structural features Dpl
0.11330524.10842180.html.plaintext.txt	186	Figure diagram mouse Dpl protein predicted post translational modifications
0.11330524.10842180.html.plaintext.txt	187	Shaded residues 1 27 represent cleaved N terminal signal sequence shaded residues 155 179 represent C terminal domain thought removed upon attachment GPI anchor residue 155
0.11330524.10842180.html.plaintext.txt	188	Two N linked glycosylation sites two disulfide bonds predicted computer modeling indicated
0.11330524.10842180.html.plaintext.txt	189	The coordinates synthetic Dpl 2 peptide used raise D7177 antibody also indicated
0.11330524.10842180.html.plaintext.txt	190	View table Table I MALDI MS peptide mapping analysis tryptic peptides disulfide linked peptides full length protein MoDpl 27 154
0.11330524.10842180.html.plaintext.txt	191	View larger version 17K Fig
0.11330524.10842180.html.plaintext.txt	192	MALDI mass spectra MoDpl 27 154 determination two disulfide bonds
0.11330524.10842180.html.plaintext.txt	193	A MALDI mass spectrum purified recombinant MoDpl 27 154
0.11330524.10842180.html.plaintext.txt	194	B S carbamidomethylation cysteine MoDpl 27 154
0.11330524.10842180.html.plaintext.txt	195	Mass spectrum non reduced MoDpl 27 154 incubated IAM
0.11330524.10842180.html.plaintext.txt	196	0 1 mM EDTA 6 M guanidine hydrochloride incubated without DTT room temperature 1 h
0.11330524.10842180.html.plaintext.txt	197	The non reduced MoDpl 27 154 incubated 50 mM IAM room temperature dark 30 min
0.11330524.10842180.html.plaintext.txt	198	C mass spectrum reduced MoDpl 27 154 incubated IAM
0.11330524.10842180.html.plaintext.txt	199	0 1 microM EDTA 6 M guanidine hydrochloride incubated 10 microM DTT room temperature 1 h
0.11330524.10842180.html.plaintext.txt	200	The reduced MoDpl 27 154 incubated 50 mM IAM room temperature dark 30 min
0.11330524.10842180.html.plaintext.txt	201	Disulfide Bonds MoDpl 27 154 Our preparation scheme MoDpl 27 154 included exposure 1 microM CuII favor formation intramolecular disulfide bond bonds
0.11330524.10842180.html.plaintext.txt	202	Whereas PrPC single disulfide bond according computer modeling studies four Cys residues C terminus Dpl residues 95 109 143 148 predicted participate two disulfide bonds 5
0.11330524.10842180.html.plaintext.txt	203	We therefore employed S carbamidomethylation method previously used analyze PrP 23 231 11 titrate number free cysteines MoDpl 27 154 prepared standard oxidation refolding regimen
0.11330524.10842180.html.plaintext.txt	204	After incubation 6 M guanidine hydrochloride presence absence DTT pH 8
0.11330524.10842180.html.plaintext.txt	205	0 MoDpl 27 154 incubated IAM S carbamidomethylation cysteines analyzed MALDI time flight MS
0.11330524.10842180.html.plaintext.txt	206	non reduced treated IAM exhibit significant change mass starting material mass 14916
0.11330524.10842180.html.plaintext.txt	207	9 IAM treated material mass 14918
0.11330524.10842180.html.plaintext.txt	208	4 Da well within error 0
0.11330524.10842180.html.plaintext.txt	209	5 Da type analysis Fig
0.11330524.10842180.html.plaintext.txt	210	This indicates absence free cysteines
0.11330524.10842180.html.plaintext.txt	211	After reduction DTT carbamidomethylated MoDpl 27 154 increased mass 231 units 15149
0.11330524.10842180.html.plaintext.txt	212	2C consistent addition four adducts predicted mass 15144
0.11330524.10842180.html.plaintext.txt	213	These data compatible 2 disulfide bridges per MoDpl 27 154 molecule
0.11330524.10842180.html.plaintext.txt	214	Secondary Structure Disulfide Bonds MoDpl 27 154 A solution MoDpl 27 154 20 mM PB pH 7
0.11330524.10842180.html.plaintext.txt	215	0 examined far UV circular dichroism CD using mouse PrP 23 231 produced similar refolding regimen control 9 11
0.11330524.10842180.html.plaintext.txt	216	The Dpl 27 154 sample exhibited CD spectrum indicative high helical content MoPrP 23 231 minima 208 222 nm maximum 192 nm Fig
0.11330524.10842180.html.plaintext.txt	217	Standard deconvolution algorithms indicated helical content Dpl 27 154 28 35 sheet estimated 15
0.11330524.10842180.html.plaintext.txt	218	These data compatible prediction Dpl three helices analogous present mouse PrPC could short sheet region like PrPC 5 13 15
0.11330524.10842180.html.plaintext.txt	219	View larger version 16K Fig
0.11330524.10842180.html.plaintext.txt	220	CD spectrum 10 microM MoDpl 27 154 measured 20 mM PB pH 7
0.11330524.10842180.html.plaintext.txt	221	0 solid line room temperature
0.11330524.10842180.html.plaintext.txt	222	The dashed line represents spectrum mouse PrP 23 231 prepared purified similar method
0.11330524.10842180.html.plaintext.txt	223	Tryptic peptides Dpl see Table I Figs
0.11330524.10842180.html.plaintext.txt	224	4 5 analyzed mass spectroscopy ascertain connectivity disulfide linkages
0.11330524.10842180.html.plaintext.txt	225	Mass spectra tryptic digests native reduced MoDpl 27 154 samples presented Fig
0.11330524.10842180.html.plaintext.txt	226	As predicted analysis IAM four signals present reduced sample either absent present considerably lower levels native sample see also Fig
0.11330524.10842180.html.plaintext.txt	227	These tryptic peptides 12 T12 mz 2953
0.11330524.10842180.html.plaintext.txt	228	Parenthetically T12 peptide propensity form Na adducts secondary tertiary peaks immediately right signal 2953
0.11330524.10842180.html.plaintext.txt	229	9 conditions analysis although significance phenomenon currently unclear
0.11330524.10842180.html.plaintext.txt	230	Conversely additional signals high mass charge ratios large peak heights present un reduced native sample
0.11330524.10842180.html.plaintext.txt	231	The peak largest amplitude analysis detected mz 2920
0.11330524.10842180.html.plaintext.txt	232	0 Da assignable T13 S S T19 Fig
0.11330524.10842180.html.plaintext.txt	233	This indicates disulfide bond residues 109 143 exactly analogous PrPC disulfide bond residues 178 213 linking helices B C
0.11330524.10842180.html.plaintext.txt	234	A strong signal also detected mz 4058
0.11330524.10842180.html.plaintext.txt	235	6 Da assignable T12 S S T20 indicating Cys95 Cys148 connectivity
0.11330524.10842180.html.plaintext.txt	236	However also observed signals small amplitudes indicative two disulfide bond connectivities predicted computer modeling Table I Fig
0.11330524.10842180.html.plaintext.txt	237	4A dashed line tryptic peptide maps Fig
0.11330524.10842180.html.plaintext.txt	238	4 Da possibly corresponding Cys143 Cys148 bond predicted mass T19 S S T20 di peptide 1755
0.11330524.10842180.html.plaintext.txt	239	0 Da although peptide indicative reciprocal connectivity T12 T13 detected predicted mass 5223
0.11330524.10842180.html.plaintext.txt	240	Second smaller signal mz 3375
0.11330524.10842180.html.plaintext.txt	241	6 Da assignable T13 S S T20 predicted mass 3375
0.11330524.10842180.html.plaintext.txt	242	7 Da although signal indicating reciprocal connectivity T12 S S T19 predicted mass 3603
0.11330524.10842180.html.plaintext.txt	243	We conclude although MoDpl 27 154 molecules prepared standard oxidative refolding scheme contain Cys109 Cys143 Cys95 Cys148 linkages predicted computer modeling 5 lower abundance species connectivities free sulfhydryl groups detected particular conditions proteolysis mass spectrometric analysis
0.11330524.10842180.html.plaintext.txt	244	View larger version 21K Fig
0.11330524.10842180.html.plaintext.txt	245	MALDI mass spectrometric disulfide bond mapping MoDpl 27 154
0.11330524.10842180.html.plaintext.txt	246	A MALDI mass spectra peptides tryptic digestion without reduction T20 1106
0.11330524.10842180.html.plaintext.txt	247	B MALDI mass spectra peptides tryptic digestion reduction tris 2 carboxyethylphosphin
0.11330524.10842180.html.plaintext.txt	248	Note secondary tertiary peaks adjacent T12 mass predicted Na adducts
0.11330524.10842180.html.plaintext.txt	249	View larger version 29K Fig
0.11330524.10842180.html.plaintext.txt	250	Tryptic peptides MoDpl 27 154
0.11330524.10842180.html.plaintext.txt	251	A amino acid sequence tryptic peptide mapping MoDpl 27 154
0.11330524.10842180.html.plaintext.txt	252	Trypsin cleavage sites T Cys C residues shown
0.11330524.10842180.html.plaintext.txt	253	B connectivity disulfide linkages
0.11330524.10842180.html.plaintext.txt	254	The top panel indicates disulfide linkages tryptic fragments deduced prior computer modeling Dpl structure
0.11330524.10842180.html.plaintext.txt	255	The connection Cys109 Cys143 analogous found PrPC
0.11330524.10842180.html.plaintext.txt	256	The lower two panels tryptic peptides denoted dashed lines indicate connectivities detected low levels mass spectrometric analysis see also Fig
0.11330524.10842180.html.plaintext.txt	257	Dpl Has Two N Linked Glycosylation Sites Previous experiments involving immunoblots Dpl 3 cell lysates showed heterodisperse signal 32 41 kDa blotted D7177 Ab
0.11330524.10842180.html.plaintext.txt	258	This signal reduced single band 17 kDa cell lysates incubated PNGase F prior blotting indicating Dpl heavily glycosylated 5
0.11330524.10842180.html.plaintext.txt	259	When Dpl cell lysates incubated PNGase F different periods time possible identify single intermediate form Dpl 27 kDa presumably representing monoglycosylated protein Fig
0.11330524.10842180.html.plaintext.txt	260	Prolonged incubations PNGase F reduce Dpl beyond 17 kDa
0.11330524.10842180.html.plaintext.txt	261	These results indicate presence two N linked glycosylation sites within Dpl predicted previously 5
0.11330524.10842180.html.plaintext.txt	262	View larger version 44K Fig
0.11330524.10842180.html.plaintext.txt	263	Time course PNGase F digestion Dpl
0.11330524.10842180.html.plaintext.txt	264	Aliquots Dpl cell lysate digested PNGase F 0 15 30 45 60 120 min indicated figure legend
0.11330524.10842180.html.plaintext.txt	265	D diglycosylated Dpl M monoglycosylated Dpl U unglycosylated Dpl
0.11330524.10842180.html.plaintext.txt	266	Dpl Is GPI anchored Cell Surface Protein Analysis translated protein sequence Prnd failed reveal classical GPI recognition sequence 5 although hydrophobic C terminal extension broadly compatible notion
0.11330524.10842180.html.plaintext.txt	267	Resolution issue deemed importance bears upon biological site action Dpl
0.11330524.10842180.html.plaintext.txt	268	Since D7177 Ab exhibits cross reactivity protein species correspond Dpl Ref
0.11330524.10842180.html.plaintext.txt	269	5 paper considered unsuitable immunohistochemical studies cell cultures using GPI anchor cleaving enzyme PIPLC 16
0.11330524.10842180.html.plaintext.txt	270	Instead sought direct biochemical evidence GPI anchor
0.11330524.10842180.html.plaintext.txt	271	7A shows immunoblot cell lysates medium Dpl expressing neuroblastoma cell line Dpl 3
0.11330524.10842180.html.plaintext.txt	272	When monolayer intact Dpl 3 cells incubated enzyme PIPLC prior collection lysis Dpl present recovered medium absent cell lysate
0.11330524.10842180.html.plaintext.txt	273	These results contrast obtained non PIPLC treated Dpl expressing cells Western blotted
0.11330524.10842180.html.plaintext.txt	274	In case Dpl detected cell lysate present recovered medium
0.11330524.10842180.html.plaintext.txt	275	Dpl observed pellet supernatant fractions PIPLC non PIPLC treated Dpl 7 cells used negative controls data shown
0.11330524.10842180.html.plaintext.txt	276	View larger version 29K Fig
0.11330524.10842180.html.plaintext.txt	277	Detection Dpl PIPLC treatment determination relative hydrophobicity Triton X 114 phase partitioning
0.11330524.10842180.html.plaintext.txt	278	A Dpl 3 cells incubated without PIPLC indicated figure legend
0.11330524.10842180.html.plaintext.txt	279	When cells untreated Dpl detectable cell lysate medium
0.11330524.10842180.html.plaintext.txt	280	In PIPLC treated samples Dpl detectable recovered medium cell lysate
0.11330524.10842180.html.plaintext.txt	281	B Dpl 3 cells incubated without PIPLC
0.11330524.10842180.html.plaintext.txt	282	Cell lysates recovered medium subjected repeated Triton X 114 phase partitioning
0.11330524.10842180.html.plaintext.txt	283	Detergent phases 1 3 Dt 1 3 combined detergent phase 4 Dt 4 kept separate internal control pipetting error
0.11330524.10842180.html.plaintext.txt	284	The detergent phases aqueous phase Aq analyzed SDS PAGE
0.11330524.10842180.html.plaintext.txt	285	Lanes 1 3 Triton X 114 fractions untreated Dpl 3 cells lanes 4 6 Triton X 114 fractions PIPLC treated Dpl 3 cells lanes 7 9 Triton X 114 fractions recovered medium PIPLC treated cell
0.11330524.10842180.html.plaintext.txt	286	Dpl present lanes 1 9
0.11330524.10842180.html.plaintext.txt	287	Triton X 114 phase partitioning PIPLC treated non treated Dpl 3 cells medium used another means confirming presence Dpls GPI anchor
0.11330524.10842180.html.plaintext.txt	288	When untreated cell lysates subjected Triton X 114 phase partitioning prior immunoblotting Dpl detected pooled detergent phases 1 3 present either detergent phase 4 included internal negative control aqueous phase Fig
0.11330524.10842180.html.plaintext.txt	289	When recovered medium PIPLC treated Dpl 3 cells subjected Triton X 114 phase partitioning Dpl found shifted detergent phase aqueous phase
0.11330524.10842180.html.plaintext.txt	290	Together results indicate Dpl protein present cell surface attached via GPI anchor
0.11330524.10842180.html.plaintext.txt	291	Detection Dpl Mouse Tissue Samples Homogenates testis brain wt FVBN mice incubated without PNGase F 3 h prior Western blotting
0.11330524.10842180.html.plaintext.txt	292	When samples electrophoresed probed D7177 Ab Dpl could observed testis samples detected within brain samples Fig
0.11330524.10842180.html.plaintext.txt	293	Untreated testis contained heterodisperse signal 29 37 kDa PNGase F treated testis displayed single band 17 kDa corresponded unglycosylated Dpl protein
0.11330524.10842180.html.plaintext.txt	294	These signals observed blots probed D7177 preincubated Dpl 2 peptide blots probed pre immune sera data shown
0.11330524.10842180.html.plaintext.txt	295	View larger version 32K Fig
0.11330524.10842180.html.plaintext.txt	296	Western blot wt FVBN testes brain homogenates
0.11330524.10842180.html.plaintext.txt	297	A testes brain homogenates prepared adult wt FVBN mice
0.11330524.10842180.html.plaintext.txt	298	Lanes 1 3 represent untreated tissue homogenates whereas lanes 2 4 incubated PNGase F prior SDS PAGE analysis
0.11330524.10842180.html.plaintext.txt	299	Diglycosylated Dpl present lane 1 unglycosylated Dpl seen lane 2
0.11330524.10842180.html.plaintext.txt	300	Dpl detectable lanes 3 4
0.11330524.10842180.html.plaintext.txt	301	B brain homogenates wt FVBN ZrchI Rcm0 mice subjected Triton X 114 phase partitioning enrich samples Dpl protein
0.11330524.10842180.html.plaintext.txt	302	Samples split loaded identical SDS PAGE gels
0.11330524.10842180.html.plaintext.txt	303	The blot left hand panel probed D7177 Ab alone blot right hand panel probed D7177 Ab preincubated Dpl 2 peptide
0.11330524.10842180.html.plaintext.txt	304	Left hand panel lane 1 detergent phases 1 3 wt FVBN testes positive control lane 2 detergent phases 1 3 wt FVBN brain lane 3 detergent phases 1 3 ZrchI brain lane 4 detergent phases 1 3 Rcm0 brain lane 5 aqueous phase wt FVBN testes negative control
0.11330524.10842180.html.plaintext.txt	305	Dpl detectable lanes 1 lane 4 indicated arrowhead
0.11330524.10842180.html.plaintext.txt	306	Right hand panel lane 6 detergent phases 1 3 wt FVBN testes lane 7 detergent phases 1 3 wt FVBN brain lane 8 detergent phases 1 3 ZrchI brain lane 9 detergent phases 1 3 Rcm0 brain lane 10 aqueous phase wt FVBN testes
0.11330524.10842180.html.plaintext.txt	307	The signals corresponding Dpl protein left hand panel present
0.11330524.10842180.html.plaintext.txt	308	As Prnd mRNA levels low central nervous system wt FVBN C57BL6 mice 5
0.11330524.10842180.html.plaintext.txt	309	undetectable standard Northern blotting procedures Triton X 114 phase partitioning used enrich Dpl thereby enhance possibility detecting Dpl protein brain samples
0.11330524.10842180.html.plaintext.txt	310	As Dpl intact GPI anchor partitioned within detergent phase Fig
0.11330524.10842180.html.plaintext.txt	311	7B tissue homogenates subjected repetitive partitioning detergent fractions 1 3 pooled used Western blot analysis
0.11330524.10842180.html.plaintext.txt	312	When partitioned brain extracts Rcm0 ZrchI wt FVBN mice using asymptomatic animals case Rcm0 knock line probed D7177 30 33 kDa signal corresponding Dpl could detected brains Rcm0 mice well detergent phases 1 3 testis wt animals
0.11330524.10842180.html.plaintext.txt	313	A comparable signal absent similarly processed brain samples ZrchI wt FVBN mice well aqueous phase testis homogenates included negative control Fig
0.11330524.10842180.html.plaintext.txt	314	A duplicate blot probed D7177 Ab preincubated synthetic Dpl peptide competitor confirmed signals attributed Dpl within wt testis Rcm0 brain due cross reactivity antibody nonspecific antigen Fig
0.11330524.10842180.html.plaintext.txt	315	These results indicate although Dpl protein present testis wt FVBN mice present brains Rcm0 mice suggested prior Northern blot polymerase chain reaction analysis reverse transcriptase synthesized cDNA 5
0.11330524.10842180.html.plaintext.txt	316	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.11330524.10842180.html.plaintext.txt	317	Features MoDpl 27 154 Expressed E
0.11330524.10842180.html.plaintext.txt	318	coli Although number difficulties encountered expressing PrPC E
0.11330524.10842180.html.plaintext.txt	319	coli 17 18 experiments demonstrate feasibility expressing Dpl system
0.11330524.10842180.html.plaintext.txt	320	Dpl produced standard folding paradigm adopts helix rich conformation feature shares common full length PrPC demonstrated side side CD spectral analyses Fig
0.11330524.10842180.html.plaintext.txt	321	However since Dpl likely contains two rather one intramolecular disulfide bond novel re folding protocols may need developed obtain stoichiometric formation two disulfide bridges without accruing molecules extraneous connectivities
0.11330524.10842180.html.plaintext.txt	322	Although tryptic dipeptides containing Cys95 Cys148 Cys109 Cys143 disulfide bonds predicted computer modeling species highest peak heights mass spectrometric analyses re folded MoDpl 27 154 Fig
0.11330524.10842180.html.plaintext.txt	323	4A tryptic peptides indicative alternative connectivities present low levels
0.11330524.10842180.html.plaintext.txt	324	In particular Cys148 located tryptic peptide 20 tendency form linkages Cys143 Cys109
0.11330524.10842180.html.plaintext.txt	325	Whether alternative disulfide linkages represented T13 S S T20 T19 S S T20 di peptides low levels free T13 T20 peptides represent interchange occurring refolding conditions proteolysis mass spectrometric analysis non reduced samples remains determined
0.11330524.10842180.html.plaintext.txt	326	Nonetheless two implications current findings future studies
0.11330524.10842180.html.plaintext.txt	327	First figure helical content Dpl 27 154 may underestimate true value would consistent Dpl lacking unstructured N terminal region present PrP
0.11330524.10842180.html.plaintext.txt	328	Second experiments verify Cys95 Cys148 Cys109 Cys143 disulfide bonds Dpl purified mouse tissue samples would appear prudent embarking upon high resolution structural studies Dpl polypeptides refolded vitro
0.11330524.10842180.html.plaintext.txt	329	Glycobiology Dpl Mouse PrP two consensus Asn linked glycosylation sites form N X T occurring residues 181 196
0.11330524.10842180.html.plaintext.txt	330	Although first site conserved mouse Dpl predicted occur residue 111 helix B region second non conserved N V T Asn linked glycosylation site predicted residue 99
0.11330524.10842180.html.plaintext.txt	331	Our data compatible prediction mature Dpl glycosylated two sites Fig
0.11330524.10842180.html.plaintext.txt	332	6 although studies required demonstrate involve carbohydrate adducts residues 99 111
0.11330524.10842180.html.plaintext.txt	333	The Dpl oligosaccharide side chains resistant digestion endoglycosidase H2 sensitive PNGase F indicating Dpl processed ER Golgi expected
0.11330524.10842180.html.plaintext.txt	334	PrPC attached cell surface via GPI anchor 16 data confirm also case Dpl even though lacks GPI addition signal peptide closely related PrP
0.11330524.10842180.html.plaintext.txt	335	The shift Dpl protein cell lysate recovered medium incubation live cells PIPLC provides biochemical evidence Dpl N2a cells exposed cell surface modified addition GPI anchor
0.11330524.10842180.html.plaintext.txt	336	Triton X 114 phase partitioning used additional means verifying conclusion
0.11330524.10842180.html.plaintext.txt	337	Proteins intact GPI anchor normally partition detergent phase treatment PIPLC removes hydrophobic diacylglycerol moiety anchor results recovery treated proteins aqueous phase 19 20
0.11330524.10842180.html.plaintext.txt	338	Using experimental paradigm Dpl found shift detergent phase aqueous phase PIPLC treatment
0.11330524.10842180.html.plaintext.txt	339	Although attachment sites GPI anchors often correspond Asp Ser residues 21 Ser231 case PrPC addition amino acid residues without precedent
0.11330524.10842180.html.plaintext.txt	340	Indeed GPI anchor signal peptides somewhat degenerate addition occur variety different small amino acids including alanine aspartate asparagine glycine serine 22 23
0.11330524.10842180.html.plaintext.txt	341	In case Dpl prior computer modeling predicts addition Gly155 5
0.11330524.10842180.html.plaintext.txt	342	It also noteworthy even case PrP conservation Ser231 ubiquitous thus rabbit PrPC lacks serine position 231 GPI attachment thought occur adjacent glycine 24
0.11330524.10842180.html.plaintext.txt	343	Dpl Physiology Dpl appear present brains adult wt animals associated neurodegeneration expressed ectopically location see
0.11330524.10842180.html.plaintext.txt	344	It therefore reasonable anticipate although Dpl may play role initial development brain principal physiological function likely lies within tissues
0.11330524.10842180.html.plaintext.txt	345	Northern Western blot data indicate Dpl expressed high levels testes adult wt mice Fig
0.11330524.10842180.html.plaintext.txt	346	8 also present heart 5
0.11330524.10842180.html.plaintext.txt	347	We anticipate experiments determine temporal spatial expression patterns Prnd ablate Prnd coding region required obtain definitive insights normal function novel PrP like protein
0.11330524.10842180.html.plaintext.txt	348	Nonetheless experiments reported interpreted indicate Dpl biogenesis modulated perhaps tissue specific manner
0.11330524.10842180.html.plaintext.txt	349	For example Asn linked side chains associated ectopic expression brain appear different observed testis N2a cells indicated 30 33 27 39 kDa species detected Western blotting
0.11330524.10842180.html.plaintext.txt	350	Second although Prnd mRNA detected testis wt mice brains asymptomatic Rcm0 mice Northern analysis 5 Dpl protein abundant former location latter Fig
0.11330524.10842180.html.plaintext.txt	351	This suggests Dpl protein expressed central nervous system unstable translation Dpl chimeric mRNA brains Rcm0 mice may less efficient translation Prnd mRNA containing 5 untranslated region encoded Prnd exons 1A 1B 5
0.11330524.10842180.html.plaintext.txt	352	Dpl PrPC Pathways Neuronal Death Prior analyses Rcm0 Ngsk Prnp00 mice attributed cerebellar ataxia present mice Prnp00 lines Zrch I Npu organization residual Prnp gene favoring overexpression Prnd mRNA 5
0.11330524.10842180.html.plaintext.txt	353	This correlation extends fifth Prnp00 line designated ZrchII 25
0.11330524.10842180.html.plaintext.txt	354	Although experiments express Dpl control heterologous promoter required cement relationship results presented lend additional support hypothesis begin suggest type events may initiate neuronal death
0.11330524.10842180.html.plaintext.txt	355	Thus Dpl protein detected central nervous system Rcm0 mice brains wt ZrchI mice
0.11330524.10842180.html.plaintext.txt	356	Further demonstrate Dpl possesses two N linked oligosaccharides attached cell surface via GPI anchor
0.11330524.10842180.html.plaintext.txt	357	Thus Dpl resembles PrPC regard amino acid sequence also respect synthesis secretory pathway certain post translational modifications subcellular localization external face plasma membrane
0.11330524.10842180.html.plaintext.txt	358	It likely Dpls GPI anchor directs caveolae like membrane domains 26 27 although remains established experimentally
0.11330524.10842180.html.plaintext.txt	359	The biochemical similarities Dpl PrPC germane observation Purkinje cell death Ngsk mice abrogated overexpression wt PrPC encoded Tg4053 transgene array 7
0.11330524.10842180.html.plaintext.txt	360	Notably similarities suggest PrPC virtue C terminal domain structurally similar Dpl antagonize deleterious activity associated ectopic expression Dpl central nervous system neurons
0.11330524.10842180.html.plaintext.txt	361	One mechanism would Dpl binds another cell surface molecule initiate signal leading cell death whereas PrPC overexpressed competes binding site without initiating signal transduction event
0.11330524.10842180.html.plaintext.txt	362	This type model proposed Schmerling et al
0.11330524.10842180.html.plaintext.txt	363	28 account pathogenic properties internally deleted PrP molecules first discussed context putative PrP ligand denoted PrPL
0.11330524.10842180.html.plaintext.txt	364	These workers noted although ZrchI Prnp00 mice exhibit normal development introduction Prnp transgenes encoding PrP molecule amino acids 32 121 PrP32 121 32 134 PrP32 134 deleted caused mice develop ataxia cerebellar granule cell degeneration 28
0.11330524.10842180.html.plaintext.txt	365	Our data speak hypothetical PrP ligand PrPL Dpl resembles PrPC minus conserved N terminal CuII binding domain suggest expression 32 121 32 134 Dpl like versions PrPC ZrchI mice may activate Dpl dependent pathway neurotoxicity pathogenic consequences somewhat akin observed Rcm0 Ngsk mice 25
0.11330524.10842180.html.plaintext.txt	366	Here partially analogous case Ngsk mice pathology could abrogated ZrchI mice expressing N terminally deleted PrP reintroduction single copy Prnp encoding full length wt PrPC 28 suggestive competitive inhibition
0.11330524.10842180.html.plaintext.txt	367	Identification receptor Dpl affinity PrPC therefore comprises one line future research potential yield insights physiological pathogenic attributes proteins
0.11330524.10842180.html.plaintext.txt	368	We thank Paul Mathews Doug Lee Robert Strome Chris Stenland useful discussions Rudi Glockshuber pRBI PDI T7 plasmid
0.11330524.10842180.html.plaintext.txt	369	This work supported part grants National Institutes Health S
0.11330524.10842180.html.plaintext.txt	370	grants Medical Research Council Canada Health Canada Alzheimer Society Ontario D
0.11330524.10842180.html.plaintext.txt	371	The costs publication article defrayed part payment page charges
0.11330524.10842180.html.plaintext.txt	372	The article must therefore hereby marked advertisement accordance 18 U
0.11330524.10842180.html.plaintext.txt	373	Section 1734 solely indicate fact
0.11330524.10842180.html.plaintext.txt	374	c Supported Ontario Student Opportunity Trust Fund award
0.11330524.10842180.html.plaintext.txt	375	e Supported Human Frontier Science Program long term fellowship award
0.11330524.10842180.html.plaintext.txt	376	l To correspondence addressed Centre Research Neurodegenerative Diseases Tanz Neuroscience Bldg
0.11330524.10842180.html.plaintext.txt	377	Toronto Ontario M5S 3H2 Canada
0.11330524.10842180.html.plaintext.txt	378	416 978 1556 Fax 416 978 1878 E mail david
0.11330524.10842180.html.plaintext.txt	379	Published JBC Papers Press June 6 2000 DOI 10
0.11330524.10842180.html.plaintext.txt	380	The abbreviations used Prnp mouse prion protein gene PrPC cellular isoform prion protein PrPSc scrapie isoform prion protein Dpl doppel downstream prion protein like MoDpl mouse doppel protein Prnd mouse Dpl gene Prn mouse prion gene complex comprised Prnp Prnd PNGase F N glycosidase F PIPLC phosphatidylinositol specific phospholipase C GPI glycosylphosphatidylinositol Ab antibody HBSS Hanks balanced saline solution wt wild type PAGE polyacrylamide gel electrophoresis MOPS 4 morpholinepropanesulfonic acid MALDI matrix assisted laser desorptionionization MS mass spectrometric Tricine N 2 hydroxy 11 bishydroxymethylethylglycine DTT dithiothreitol PB phosphate buffer IAM iodoacetamide
0.11330524.10842180.html.plaintext.txt	381	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1
0.11330524.10842180.html.plaintext.txt	382	1992 Nature 356 577 582CrossRefMedline Order article via Infotrieve 2
0.11330524.10842180.html.plaintext.txt	383	1993 Cell 73 1339 1347Medline Order article via Infotrieve 3
0.11330524.10842180.html.plaintext.txt	384	8 121 127Medline Order article via Infotrieve 4
0.11330524.10842180.html.plaintext.txt	385	8 1022 1037AbstractFree Full Text 5
0.11330524.10842180.html.plaintext.txt	386	292 797 817CrossRefMedline Order article via Infotrieve 6
0.11330524.10842180.html.plaintext.txt	387	1996 Nature 380 528 531CrossRefMedline Order article via Infotrieve 7
0.11330524.10842180.html.plaintext.txt	388	79 689 697Medline Order article via Infotrieve 8
0.11330524.10842180.html.plaintext.txt	389	1995 Biochemistry 34 8281 8293Medline Order article via Infotrieve 9
0.11330524.10842180.html.plaintext.txt	390	413 277 281CrossRefMedline Order article via Infotrieve 10
0.11330524.10842180.html.plaintext.txt	391	1991 Science 254 1374 1377Medline Order article via Infotrieve 11
0.11330524.10842180.html.plaintext.txt	392	Chem 275 19121 19131AbstractFree Full Text 12
0.11330524.10842180.html.plaintext.txt	393	1991 Neuron 7 59 68Medline Order article via Infotrieve 13
0.11330524.10842180.html.plaintext.txt	394	1996 Nature 382 180 182CrossRefMedline Order article via Infotrieve 14
0.11330524.10842180.html.plaintext.txt	395	94 13452 13457AbstractFree Full Text 15
0.11330524.10842180.html.plaintext.txt	396	94 10086 10091AbstractFree Full Text 16
0.11330524.10842180.html.plaintext.txt	397	1987 Cell 51 229 240Medline Order article via Infotrieve 17
0.11330524.10842180.html.plaintext.txt	398	261 614 619CrossRefMedline Order article via Infotrieve 18
0.11330524.10842180.html.plaintext.txt	399	1996 Biochemistry 35 5528 5537CrossRefMedline Order article via Infotrieve 19
0.11330524.10842180.html.plaintext.txt	400	256 1604 1607AbstractFree Full Text 20
0.11330524.10842180.html.plaintext.txt	401	Acta 1328 185 196Medline Order article via Infotrieve 22
0.11330524.10842180.html.plaintext.txt	402	266 1250 1257AbstractFree Full Text 23
0.11330524.10842180.html.plaintext.txt	403	184 215 219CrossRefMedline Order article via Infotrieve 25
0.11330524.10842180.html.plaintext.txt	404	1999 Science 286 914 915Free Full Text 26
0.11330524.10842180.html.plaintext.txt	405	93 14945 14949AbstractFree Full Text 27
0.11330524.10842180.html.plaintext.txt	406	94 2333 2338AbstractFree Full Text 28
0.11330524.10842180.html.plaintext.txt	407	1998 Cell 93 203 214Medline Order article via Infotrieve
0.11330524.10842180.html.plaintext.txt	408	Copyright 2000 The American Society Biochemistry Molecular Biology Inc
0.11211797.15483267.html.plaintext.txt	0	Identification putative atypical scrapie sheep Portugal Leonor Orge12 Alexandre Galo1 Carla Machado1 Carla Lima1 Cristina Ochoa1 Joao Silva1 Manuel Ramos1 J
0.11211797.15483267.html.plaintext.txt	1	1 Laboratorio Nacional de Investigacao Veterinaria Lisboa Portugal 2 Instituto Gulbenkian de Ciencia Rua da Quinta Grande 6 2780 156 Oeiras Portugal 3 Laboratorio de Microbiologia Faculdade de Medicina Universidade de Lisboa Lisboa Portugal
0.11211797.15483267.html.plaintext.txt	2	ABSTRACT Top ABSTRACT MAIN TEXT REFERENCES Experimental transmission bovine spongiform encephalopathy sheep prompted implementation surveillance plan scrapie small ruminants European Union member states
0.11211797.15483267.html.plaintext.txt	3	Since start 30 000 animals tested first seven cases sheep detectable PrPres deposition central nervous system identified Portugal
0.11211797.15483267.html.plaintext.txt	4	Notably pattern PrPres distribution brainstem different previously described scrapie consistent seven animals
0.11211797.15483267.html.plaintext.txt	5	Moreover profile electrophoretic mobility PrPres proteinase K treatment equivalent cases analysed distinct observed scrapie
0.11211797.15483267.html.plaintext.txt	6	Notably four animals genotypes rarely associated scrapie including one animal homozygous A136R154R171
0.11211797.15483267.html.plaintext.txt	7	There cases found exhibit vacuolation pattern PrPres distribution PrPres electrophoretic mobility corresponding scrapie
0.11211797.15483267.html.plaintext.txt	8	These data reveal putative atypical scrapie strain Portugal linked specific Prnp genotypes
0.11211797.15483267.html.plaintext.txt	9	MAIN TEXT Top ABSTRACT MAIN TEXT REFERENCES Scrapie affects sheep goats common natural form group diseases designated transmissible spongiform encephalopathies include Creutzfeldt Jakob disease CJD humans bovine spongiform encephalopathy BSE
0.11211797.15483267.html.plaintext.txt	10	Scrapie endemic several European Union EU countries recognized disease identity 250 years McGowan 1922
0.11211797.15483267.html.plaintext.txt	11	To date apparent clinical epidemiological data linking scrapie human disease
0.11211797.15483267.html.plaintext.txt	12	However since shown sheep could experimentally infected BSE Foster et al
0.11211797.15483267.html.plaintext.txt	13	1993 possibility raised BSE could accidentally introduced species
0.11211797.15483267.html.plaintext.txt	14	This would constitute grave problem terms public health since contrast scrapie BSE directly linked new form CJD Bruce et al
0.11211797.15483267.html.plaintext.txt	15	Furthermore proposed like scrapie BSE sheep could naturally transmitted thus become endemic Foster et al
0.11211797.15483267.html.plaintext.txt	16	Clinically diseases indistinguishable Foster et al
0.11211797.15483267.html.plaintext.txt	17	These possibilities prompted EU implement surveillance scheme scrapie small ruminants
0.11211797.15483267.html.plaintext.txt	18	In Portugal despite completion previous scrapie surveillance plans clinical histopathological levels yet scrapie cases diagnosed
0.11211797.15483267.html.plaintext.txt	19	The absence scrapie Portugal cannot attributed genetic basis possibility suggested subclinical forms scrapie strains present Orge et al
0.11211797.15483267.html.plaintext.txt	20	In study result EU active scrapie surveillance plan identified first cases sheep detectable PrPres deposition central nervous system CNS Portugal
0.11211797.15483267.html.plaintext.txt	21	Since implementation 2002 according EU regulation 9992001 subsequent alterations February 2004 total 30 269 sheep 18 months age screened presence PrPres brainstem Bio Rad rapid test done according manufacturers instructions
0.11211797.15483267.html.plaintext.txt	22	All cases tested positive rapid test selected human consumption
0.11211797.15483267.html.plaintext.txt	23	These cases analysed presence vacuolation histopathology deposition PrPres immunohistochemistry analysis PrPres electrophoretic profile Western immunoblotting Prnp codons 136 154 171 genotypes also determined
0.11211797.15483267.html.plaintext.txt	24	Brainstems divided sagittally one half frozen rapid test analysis Western immunoblotting DNA extraction half fixed 10 saline formalin processed routine paraffin histology
0.11211797.15483267.html.plaintext.txt	25	For immunohistochemistry three anti PrP monoclonal antibodies 2G11 Institute Pourquier Farmoquil SAF84 SPI bio L42 RIDA R Biopharm used three confirmatory independent assays essentially previously described Orge et al
0.11211797.15483267.html.plaintext.txt	26	For 2G11 sections pretreated formic acid followed autoclaving
0.11211797.15483267.html.plaintext.txt	27	In case SAF84 L42 sections addition formic acid treatment pretreated proteinase K described previously Bencsik et al
0.11211797.15483267.html.plaintext.txt	28	The specificity PrPres immunolabelling controlled using sections known scrapie positive kindly supplied Veterinary Laboratory Agency VLA archive scrapie negative cases
0.11211797.15483267.html.plaintext.txt	29	For Western immunoblotting analysis PrPres frozen brainstem tissue processed according new protocol Bio Rad developed ovine tissues
0.11211797.15483267.html.plaintext.txt	30	For Prnp genotyping genomic DNA extracted frozen brainstem tissue subjected PCR Prnp specific primers upper lower primers 321 340 572 590 nt respectively according GenBank accession
0.11211797.15483267.html.plaintext.txt	31	AF180389 yield amplicon encompassed codons 136 154 171
0.11211797.15483267.html.plaintext.txt	32	PCR products submitted automated cycle sequencing orientations using ABI Prism 377 DNA sequencer Perkin Elmer
0.11211797.15483267.html.plaintext.txt	33	As result rapid test screening seven sheep slaughtered human consumption tested positive presence PrPres Table 1 confirmed deposition PrPres brainstem level obex us VLA despite absence obvious vacuolation
0.11211797.15483267.html.plaintext.txt	34	All cases showed granular PrPres deposition neuropil spinal tract nucleus trigeminal nerve STN V Fig
0.11211797.15483267.html.plaintext.txt	35	Remarkably PrPres deposition could detected neuropil dorsal vagal nucleus DVN Fig
0.11211797.15483267.html.plaintext.txt	36	1a d g j neuronal nucleus always associated PrPres deposition scrapie
0.11211797.15483267.html.plaintext.txt	37	In three sheep Table 1 cases 4 6 7 focal granular immunostaining neuropil nucleus solitary tract NST also observed Fig
0.11211797.15483267.html.plaintext.txt	38	This distribution unusual consistent absence detectable PrPres DVN deposition STN V
0.11211797.15483267.html.plaintext.txt	39	In scrapie extensively reported DVN first CNS nucleus show vacuolation PrPres deposition Andreoletti et al
0.11211797.15483267.html.plaintext.txt	40	1997 hence elected nucleus used routine diagnosis
0.11211797.15483267.html.plaintext.txt	41	Thus distribution PrPres deposition obtained three different anti PrP specific antibodies atypical seven cases reported
0.11211797.15483267.html.plaintext.txt	42	Recently scrapie cases reported also diverged phenotypically typical scrapie Benestad et al
0.11211797.15483267.html.plaintext.txt	43	In particular several atypical scrapie cases reported Norway PrPres deposition observed cerebellum midbrain cerebral cortex PrPres could detected obex region Benestad et al
0.11211797.15483267.html.plaintext.txt	44	In cases designated Nor98 although inconsistently PrPres deposition also detected STN V
0.11211797.15483267.html.plaintext.txt	45	These findings consistent described PrPres could detected DVN
0.11211797.15483267.html.plaintext.txt	46	Summary atypical scrapie cases identified
0.11211797.15483267.html.plaintext.txt	47	Sparse marked staining IHC immunohistochemistry STN V spinal tract nucleus trigeminal nerve NST nucleus solitary tract
0.11211797.15483267.html.plaintext.txt	48	View larger version 115K Fig
0.11211797.15483267.html.plaintext.txt	49	PrPres immunohistochemistry brainstem level obex
0.11211797.15483267.html.plaintext.txt	50	Numbers identify cases specified Table 1
0.11211797.15483267.html.plaintext.txt	51	No immunostaining specific PrPres detected DVN d g j
0.11211797.15483267.html.plaintext.txt	52	Marked granular PrPres deposition STN V b e h
0.11211797.15483267.html.plaintext.txt	53	Sparse granular PrPres deposition STN V k NST c f
0.11211797.15483267.html.plaintext.txt	54	Antibodies used follows 2G11 case 4 negative positive controls SAF84 case 6 L42 case 5 7
0.11211797.15483267.html.plaintext.txt	55	The NST available positive control section
0.11211797.15483267.html.plaintext.txt	56	Specific PrPres signal visualized StreptABC alkaline phosphatase New Fuchsin system DAKO tissue sections counterstained Mayers Haematoxylin
0.11211797.15483267.html.plaintext.txt	57	We next sought evaluate electrophoretic profile PrPres cases reported
0.11211797.15483267.html.plaintext.txt	58	Frozen brainstem tissue pretreated proteinase K subjected SDS PAGE followed immunoblotting detection PrPres Fig
0.11211797.15483267.html.plaintext.txt	59	We analysed four seven cases sufficient frozen brainstem tissue available
0.11211797.15483267.html.plaintext.txt	60	This analysis revealed profile PrPres electrophoretic mobility equivalent cases ranged 30 12 kDa
0.11211797.15483267.html.plaintext.txt	61	This result consistent observation seven cases presented pattern PrPres distribution brainstem
0.11211797.15483267.html.plaintext.txt	62	Moreover coherent putative atypical form scrapie PrPres electrophoretic mobility cases analysed ranged 30 12 kDa clearly distinct usually observed scrapie ranges 30 19 kDa Fig
0.11211797.15483267.html.plaintext.txt	63	1999 BSE experimentally inoculated sheep ranges 29 18 4 kDa Stack et al
0.11211797.15483267.html.plaintext.txt	64	Significantly PrPres electrophoretic profile described range pattern described Nor98 Benestad et al
0.11211797.15483267.html.plaintext.txt	65	View larger version 73K Fig
0.11211797.15483267.html.plaintext.txt	66	Comparison PrPres electrophoretic profiles cases 2 5 6 7 Western blot detection proteinase K treatment
0.11211797.15483267.html.plaintext.txt	67	Numbers refer cases Table 1
0.11211797.15483267.html.plaintext.txt	68	Duplication cases 2 6 represent two independently prepared samples
0.11211797.15483267.html.plaintext.txt	69	b Comparison PrPres electrophoretic profiles Western blot detection proteinase K treatment case 7 known scrapie case Scr kindly provided VLA archive
0.11211797.15483267.html.plaintext.txt	70	A known scrapie negative sample used negative control neg
0.11211797.15483267.html.plaintext.txt	71	Notably four seven cases reported genotypes rarely associated scrapie including one animal homozygous ARR Table 1
0.11211797.15483267.html.plaintext.txt	72	Susceptibility clinically apparent scrapie determined polymorphisms Prnp particularly codons 136 A V T 154 R H 171 Q R H K
0.11211797.15483267.html.plaintext.txt	73	Genotypes VRQ ARQ alleles linked higher susceptibility scrapie whereas genotypes AHQ ARR alleles linked lower susceptibility increased resistance scrapie Billinis et al
0.11211797.15483267.html.plaintext.txt	74	Under experimental conditions polymorphisms Prnp also shown influence transmission BSE sheep allele ARQ associated shorter incubation period ARR increased resistance Foster et al
0.11211797.15483267.html.plaintext.txt	75	However successful transmission BSE intracerebral route homozygous ARR sheep reported recently Houston et al
0.11211797.15483267.html.plaintext.txt	76	2003 recently reported scrapie cases Europe Buschmann et al
0.11211797.15483267.html.plaintext.txt	77	2004 cases reported also considered atypical
0.11211797.15483267.html.plaintext.txt	78	Thus far cases sheep PrPres deposition CNS identified Portugal sheep apparent clinical disease came flocks dispersed throughout country
0.11211797.15483267.html.plaintext.txt	79	Notably 30 269 sheep tested none showed pattern PrPres deposition coherent typical scrapie
0.11211797.15483267.html.plaintext.txt	80	This finding consistent fact date clinical scrapie diagnosed Portugal
0.11211797.15483267.html.plaintext.txt	81	Thus clear cases described study represent endemic form prion disease sheep previously identified linked specific Prnp genotypes represent recently acquired new form scrapie
0.11211797.15483267.html.plaintext.txt	82	In order gain insight epidemiological public health relevance apparent atypical scrapie extremely important show transmissible assess constitutes new scrapie strain like Nor98
0.11211797.15483267.html.plaintext.txt	83	The occurrence putative atypical scrapie strain independently Prnp genotype may significance current EU sheep breeding programmes selection non susceptible haplotypes
0.11211797.15483267.html.plaintext.txt	84	Furthermore given recent BSE epidemic Portugal Donnelly et al
0.11211797.15483267.html.plaintext.txt	85	1999 thus geographical risk transmission BSE sheep possible link BSE cannot excluded
0.11211797.15483267.html.plaintext.txt	86	Although cannot rule possibility adaptation BSE sheep following natural transmission fact PrPres electrophoretic profile described putative atypical scrapie strain distinct observed BSE experimentally infected sheep makes link less probable
0.11211797.15483267.html.plaintext.txt	87	ACKNOWLEDGEMENTS We would like thank Marion Simmons VLA collaborative efforts confirming PrPres deposition
0.11211797.15483267.html.plaintext.txt	88	We would also like thank Paula Tavares Paula Almeida Ana Belo rapid test screening Alice Santos Fatima Falcao Clauacutedia Capela technical assistance
0.11211797.15483267.html.plaintext.txt	89	Finally would like thank Bio Rad team particular Jean Marc Bilheude providing new Bio Rad Western blot protocol
0.11211797.15483267.html.plaintext.txt	90	REFERENCES Top ABSTRACT MAIN TEXT REFERENCES Andreoletti O
0.11211797.15483267.html.plaintext.txt	91	Early accumulation PrPSc gut associated lymphoid nervous tissues susceptible sheep Romanov flock natural scrapie
0.11211797.15483267.html.plaintext.txt	92	Autonomic nervous system innervation lymphoid territories spleen possible involvement noradrenergic neurons prion neuroinvasion natural scrapie
0.11211797.15483267.html.plaintext.txt	93	Cases scrapie unusual features Norway designation new type Nor98
0.11211797.15483267.html.plaintext.txt	94	Prion protein gene polymorphisms healthy scrapie affected sheep Greece
0.11211797.15483267.html.plaintext.txt	95	Transmissions mice indicate new variant CJD caused BSE agent
0.11211797.15483267.html.plaintext.txt	96	Atypical scrapie cases Germany France identified discrepant reaction patterns BSE rapid tests
0.11211797.15483267.html.plaintext.txt	97	Molecular analysis prion strain variation aetiology new variant CJD
0.11211797.15483267.html.plaintext.txt	98	BSE Portugal anticipating decline epidemic
0.11211797.15483267.html.plaintext.txt	99	J Epidemiol Biostat 4 277 283
0.11211797.15483267.html.plaintext.txt	100	Transmission bovine spongiform encephalopathy sheep goats
0.11211797.15483267.html.plaintext.txt	101	Clinical signs histopathology genetics experimental transmission BSE natural scrapie sheep goats
0.11211797.15483267.html.plaintext.txt	102	Amino acid polymorphisms PrP gene Mongolian sheep
0.11211797.15483267.html.plaintext.txt	103	A comparative study immunohistochemical methods detecting abnormal prion protein monoclonal polyclonal antibodies
0.11211797.15483267.html.plaintext.txt	104	Molecular analysis ovine prion protein identifies similarities BSE experimental isolate natural scrapie CH1641
0.11211797.15483267.html.plaintext.txt	105	Prion diseases BSE sheep bred resistance infection
0.11211797.15483267.html.plaintext.txt	106	PrP genetics sheep applications scrapie BSE
0.11211797.15483267.html.plaintext.txt	107	Trends Microbiol 5 331 334
0.11211797.15483267.html.plaintext.txt	108	Distinction scrapie phenotypes sheep lesion profiling
0.11211797.15483267.html.plaintext.txt	109	Similarity lesion profile BSE Portuguese cattle described British cattle
0.11211797.15483267.html.plaintext.txt	110	Scrapie genetic susceptibility Portuguese sheep breeds
0.11211797.15483267.html.plaintext.txt	111	Immunohistochemical detection PrP medulla oblongata sheep spectrum staining normal scrapie affected sheep
0.11211797.15483267.html.plaintext.txt	112	Differentiation prion protein glycoforms naturally occurring sheep scrapie sheep passaged scrapie strains CH1641 SSBP1 bovine spongiform encephalopathy BSE cases Romney Cheviot breed sheep experimentally inoculated BSE using two monoclonal antibodies
0.11211797.15483267.html.plaintext.txt	113	Acta Neuropathol Berl 104 279 286
0.11211797.15483267.html.plaintext.txt	114	Immunohistochemical detection localization prion protein brain tissue sheep natural scrapie
0.11211797.15483267.html.plaintext.txt	115	Neuropathology scrapie study distribution patterns brain lesions 222 cases natural scrapie sheep 1982 1991
0.11211797.15483267.html.plaintext.txt	116	Received 30 April 2004 accepted 24 July 2004
0.12702371.14570892.html.plaintext.txt	0	Primary Cultured Neurons Devoid Cellular Prion Display Lower Responsiveness Staurosporine Control p53 Both Transcriptional Post transcriptional Levels Erwan Paitel Claire Sunyach Cristine Alves da Costa Jean Christophe Bourdon Bruno Vincent Frederic Checler
0.12702371.14570892.html.plaintext.txt	1	From Institut de Pharmacologie Moleculaire et Cellulaire du CNRS UMR6097 06560 Valbonne France Ninewells Hospital Medical School Dundee DD1 9SY Scotland United Kingdom
0.12702371.14570892.html.plaintext.txt	2	Received publication September 22 2003
0.12702371.14570892.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES We assessed contribution cellular prion protein PrPc control neuronal apoptosis examining cell death human cells murine primary cultured neurons
0.12702371.14570892.html.plaintext.txt	4	We first confirmed previous finding staurosporine induced caspase activation increased PrPc overexpression HEK293 cells
0.12702371.14570892.html.plaintext.txt	5	We show phenotype fully dependent p53 control p53 activity PrPc occurs transcriptional post transcriptional levels human cells
0.12702371.14570892.html.plaintext.txt	6	Of interest demonstrate neuronal endogenous PrPc also controls p53 dependent pro apoptotic phenotype
0.12702371.14570892.html.plaintext.txt	7	Thus DNA fragmentation TUNEL terminal deoxynucleotidyltransferase mediated dUTP nick end labeling positive cells lower primary cultured neurons derived Zrch 1 mice embryos PrPc abrogated wild type neurons
0.12702371.14570892.html.plaintext.txt	8	PrPc knock neurons also displayed drastically diminished caspase 3 like activity immunoreactivity together reduced p53 expression transcriptional activity phenotype complemented part PrPc transfection
0.12702371.14570892.html.plaintext.txt	9	Interestingly p53 expression also reduced brain adult Prnp mice
0.12702371.14570892.html.plaintext.txt	10	Neuronal PrPc likely controls p53 post transcriptional level deletion cellular prion protein accompanied higher Mdm2 like immunoreactivity reduced phosphorylated p38 MAPK expression
0.12702371.14570892.html.plaintext.txt	11	We therefore propose physiological function endogenous cellular prion could regulate p53 dependent caspase 3 mediated neuronal cell death
0.12702371.14570892.html.plaintext.txt	12	This phenotype likely occurs regulation p53 promoter transactivation well downstream controlling p53 stability via Mdm2 expression
0.12702371.14570892.html.plaintext.txt	13	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Prion related pathologies better understood diseases either sporadic infectious origin always fatal outcome 1 2
0.12702371.14570892.html.plaintext.txt	14	These pathologies conventional first appear caused mainly unique protein bears potential transmissibility infectious cases diseases
0.12702371.14570892.html.plaintext.txt	15	It widely admitted transmission occurs independently accompanying nucleic acid viral particles 1 3
0.12702371.14570892.html.plaintext.txt	16	Second interest demonstration scrapie also called PrPres1 highly protease resistant conformer ubiquitous protein counterpart referred cellular prion protein PrPc 4 5
0.12702371.14570892.html.plaintext.txt	17	Another striking aspect host PrPc seems act substratum scrapie demonstrated fact animals deficient endogenous PrPc highly infectious scrapie rich inoculates fail transmit disease 6 7
0.12702371.14570892.html.plaintext.txt	18	This observation fully understood molecular level mechanisms PrPc converted scrapie remain matter speculation
0.12702371.14570892.html.plaintext.txt	19	Furthermore explain sporadic cases characterized late stages spontaneous deposition PrPres absence exogenous pathogenic species
0.12702371.14570892.html.plaintext.txt	20	Some clues understand PrP related pathologies might come better knowledge PrPc physiology putative dysfunctions responsible disease
0.12702371.14570892.html.plaintext.txt	21	In respect interesting discussion revolving around cell death ongoing opening new field investigation
0.12702371.14570892.html.plaintext.txt	22	It clear apoptosis accompanies late stages disease
0.12702371.14570892.html.plaintext.txt	23	Following idea several groups set investigate putative role PrPc control cell death
0.12702371.14570892.html.plaintext.txt	24	From theoretical point view PrP could antiapoptotic disease could result abolition function
0.12702371.14570892.html.plaintext.txt	25	Alternatively PrPc related pathologies could due exacerbation proapoptotic physiological phenotype associated PrPc
0.12702371.14570892.html.plaintext.txt	26	Studies carried distinct cell types various methodologies approaches led somewhat opposite conclusions 8 12
0.12702371.14570892.html.plaintext.txt	27	Our previous studies shown overexpression PrPc human embryonic kidney cells HEK293 TSM1 neurons well inducible cell line Rov9 leads increased susceptibility apoptotic stimuli reflected mainly enhanced caspase 3 activity 13 14
0.12702371.14570892.html.plaintext.txt	28	We demonstrated TSM1 neurons PrPc induced caspase 3 activation associated regulation p53 expression transcriptional activity 14
0.12702371.14570892.html.plaintext.txt	29	This appears due Mdm2 related post transcriptional modification p53 14
0.12702371.14570892.html.plaintext.txt	30	In present study first establish HEK293 PrPc related increased cell death fully dependent p53 activity
0.12702371.14570892.html.plaintext.txt	31	Moreover demonstrate p53 deletion fibroblasts fully abolishes PrPc induced caspase 3 p53 transcriptional activities
0.12702371.14570892.html.plaintext.txt	32	We also show addition previously described post transcriptional control p53 14 PrPc also enhances transactivation p53 promoter
0.12702371.14570892.html.plaintext.txt	33	Because TSM1 neurons stably overexpressed PrPc also important confirm p53 dependent function endogenous PrPc
0.12702371.14570892.html.plaintext.txt	34	We therefore examined physiological contribution cellular PrPc control neuronal cell death comparing primary cultured neurons derived mice harboring Prnp devoid Prnp Zrch 1 mice 15 endogenous PrPc
0.12702371.14570892.html.plaintext.txt	35	We show neurons derived Zrch 1 mice embryos less sensitive staurosporine display lower DNA fragmentation caspase 3 p53 activities expression higher Mdm2 like immunoreactivity
0.12702371.14570892.html.plaintext.txt	36	We demonstrate endogenous PrPc controls neuronal cell death via Mdm2 regulated p53 dependent caspase 3 activation non immortalized neurons
0.12702371.14570892.html.plaintext.txt	37	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Primary Cultured Neurons 3F4 HEK293 Cells p53 deficient Fibroblasts Primary cultured neurons prepared cerebral hemispheres 14 day old PrPc PrPc mouse embryos described 16
0.12702371.14570892.html.plaintext.txt	38	Briefly cells mechanically dissociated pipette Hams F12 medium Invitrogen supplemented 10 fetal calf serum 0
0.12702371.14570892.html.plaintext.txt	39	Dissociated cells plated density 106 cells 35 mm dishes pre coated 10 microgml polylysine Sigma grown humidified atmosphere 5 CO2 95 air
0.12702371.14570892.html.plaintext.txt	40	Transfection 3F4 PrPc primary cultured neurons performed Superfect Qiagen
0.12702371.14570892.html.plaintext.txt	41	3F4 HEK293 cells described previously 13
0.12702371.14570892.html.plaintext.txt	42	Mouse embryonic fibroblasts devoid p53 obtained described 17 p53 mice established previously 18
0.12702371.14570892.html.plaintext.txt	43	Western Blot Analyses Cells scraped homogenized lysis buffer 50 mM Tris HCl pH 7
0.12702371.14570892.html.plaintext.txt	44	5 150 mM NaCl 5 mM EDTA containing 0
0.12702371.14570892.html.plaintext.txt	45	Equal amounts protein 50 microg determined Bradford method 19 separated 12 SDS PAGE analyzed p53 active caspase 3 Mdm2 phospho P38 PrPc immunoreactivities Western blot hybridization anti p53 mouse monoclonal Pab24 Santa Cruz Biotechnologies anti active caspase 3 rabbit polyclonal R D Systems mouse monoclonal anti Mdm2 20 anti phospho P38 Promega anti PrPc SAF32 21 respectively
0.12702371.14570892.html.plaintext.txt	46	Flow Cytometry TUNEL Analysis Cells grown 6 well plates incubated 15 h 37 degrees C presence absence staurosporine 0
0.12702371.14570892.html.plaintext.txt	47	5 microM Sigma rinsed PBS suspended 750 microl buffer Tris 20 mM tri natrium citrate 0
0.12702371.14570892.html.plaintext.txt	48	05 containing 50 microgml propidium iodide
0.12702371.14570892.html.plaintext.txt	49	Cells left overnight 4 degrees C propidium iodide fluorescence individual nuclei measured described previously 14
0.12702371.14570892.html.plaintext.txt	50	For DNA nick end labeling cells fixed 20 min 1 paraformaldehyde phosphate buffered saline rinsed phosphate buffered saline left overnight 70 ethanol processed dUTP nick end labeling TUNEL technique according manufacturers recommendations kit Roche Applied Science
0.12702371.14570892.html.plaintext.txt	51	Staining assessed peroxidase conjugated antibody revealed diaminobenzidine substrate
0.12702371.14570892.html.plaintext.txt	52	Caspase 3 like Activity Assay Cells cultured 6 well plates 15 h 37 degrees C absence presence staurosporine 0
0.12702371.14570892.html.plaintext.txt	53	5 microM cases cells preincubated 24 h Ac DEVD al 100 microM
0.12702371.14570892.html.plaintext.txt	54	Cells rinsed gently scraped pelleted centrifugation resuspended 40 microl lysis buffer analyzed detailed previously 22
0.12702371.14570892.html.plaintext.txt	55	p53 Transcriptional Activity Its Promoter Transactivation One microg PG13 luciferase p53 gene reporter construct described previously 23 co transfected 1 microg galactosidase coding vector normalize transfections efficiencies 3F4 PrPc HEK293 cells PrP PrP primary cultured neurons
0.12702371.14570892.html.plaintext.txt	56	Forty eight hours transfection luciferase galactosidase activities measured according previously described procedures 23
0.12702371.14570892.html.plaintext.txt	57	Mouse p53 promoter cloned described 24 except p53 promoter region cloned upstream luciferase instead chloramphenicol acetyltransferase
0.12702371.14570892.html.plaintext.txt	58	The construct lacking p53 sequence used control
0.12702371.14570892.html.plaintext.txt	59	Statistical Analysis Statistical analysis performed Prism software Graphpad Software San Diego CA using Newman Keuls multiple comparison test one way analysis variance unpaired Students test pairwise comparisons
0.12702371.14570892.html.plaintext.txt	60	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES PrPc induced Apoptotic Phenotype Is Fully Dependent p53 Human Cells Fibroblasts We established previously PrPc drastically potentiates staurosporine induced caspase activation neuronal TSM1 cells 14
0.12702371.14570892.html.plaintext.txt	61	This phenotype antagonized depletion endogenous p53 using antisense approach 14
0.12702371.14570892.html.plaintext.txt	62	Using pharmacological approach established potent selective p53 inhibitor pifithrin completely abolishes p53 transcriptional activity human HEK293 cells Fig
0.12702371.14570892.html.plaintext.txt	63	Furthermore pifithrin inactive analog Fig
0.12702371.14570892.html.plaintext.txt	64	1A fully inhibits PrPc dependent increase staurosporine induced caspase activation
0.12702371.14570892.html.plaintext.txt	65	View larger version 17K FIG
0.12702371.14570892.html.plaintext.txt	66	Effect pifithrin staurosporine induced caspase 3 activity mock transfected 3F4 PrPc expressing HEK293 cells
0.12702371.14570892.html.plaintext.txt	67	A mock 3F4 PrPc transfected HEK293 cells treated 16 h 2 microM staurosporine absence CT control presence 1 microM pifithrin PFT inactive precursor analog PC caspase 3 activity measured described Materials Methods
0.12702371.14570892.html.plaintext.txt	68	Bars means plus minus S
0.12702371.14570892.html.plaintext.txt	69	three independent determinations
0.12702371.14570892.html.plaintext.txt	70	B identical treatment conditions pifithrin fully abolishes p53 transcriptional activity measured described Materials Methods
0.12702371.14570892.html.plaintext.txt	71	We previously documented fact PrPc increases p38 like immunoreactivity controls Mdm2 dependent p53 metabolic stability TSM1 cells 14
0.12702371.14570892.html.plaintext.txt	72	Here show besides post transcriptional effect PrPc also exerts transcriptional control p53
0.12702371.14570892.html.plaintext.txt	73	Thus 3F4 HEK293 cells display significantly higher p53 promoter transactivation mock transfected cells indicated luciferase reporter activity Fig
0.12702371.14570892.html.plaintext.txt	74	View larger version 14K FIG
0.12702371.14570892.html.plaintext.txt	75	PrPc expression increases p53 promoter transactivation
0.12702371.14570892.html.plaintext.txt	76	Transactivation p53 promoter measured described Materials Methods mock transfected 3F4 PrPc expressing HEK293 cells
0.12702371.14570892.html.plaintext.txt	77	Bars means plus minus S
0.12702371.14570892.html.plaintext.txt	78	luciferase activities control luciferase activity subtracted measured 12 independent determinations
0.12702371.14570892.html.plaintext.txt	79	We previously established link p53 PrPc induced phenotype using fibroblasts p53 gene harbors loss function mutation
0.12702371.14570892.html.plaintext.txt	80	To confirm finding preclude possibility refoldingrestoration p53 activity chaperoning mutated p53 25 switched fibroblastic cell line p53 invalidated examined phenotype triggered overexpression PrPc
0.12702371.14570892.html.plaintext.txt	81	In absence p53 important staurosporine induced caspase 3 activation Fig
0.12702371.14570892.html.plaintext.txt	82	Interestingly p53 independent caspase activity enhanced PrPc Fig
0.12702371.14570892.html.plaintext.txt	83	3B whereas combination PrPc expression p53 complementation led additional increase caspase 3 activity Fig
0.12702371.14570892.html.plaintext.txt	84	Finally co transfection PrPc p53 cDNA drastically potentiated p53 transcriptional activity exhibited p53 cDNA transfection alone Fig
0.12702371.14570892.html.plaintext.txt	85	Altogether data combined observed pifithrin inhibition clearly indicate PrPc proapoptotic phenotype completely dependent p53 latter controlled PrPc transcriptional Fig
0.12702371.14570892.html.plaintext.txt	86	2 post transcriptional 14 levels human neuronal cells
0.12702371.14570892.html.plaintext.txt	87	View larger version 18K FIG
0.12702371.14570892.html.plaintext.txt	88	Effect PrPc transfection caspase 3 p53 transcriptional activities p53 deficient fibroblasts
0.12702371.14570892.html.plaintext.txt	89	A p53 transcriptional activity monitored described Materials Methods transient transfections p53 knock fibroblasts empty pcDNA3 vector 3F4MoPrPc PrPc p53 cDNA p53 alone combination PrPcp53
0.12702371.14570892.html.plaintext.txt	90	In B caspase 3 activity measured identical transient transfection indicated cDNA p53 deficient fibroblasts treated staurosporine
0.12702371.14570892.html.plaintext.txt	91	Bars represent means six determinations plus minus S
0.12702371.14570892.html.plaintext.txt	92	PrP Primary Cultured Neurons Display Lower Susceptibility Staurosporine Our previous statements based several cell lines overexpressing PrPc
0.12702371.14570892.html.plaintext.txt	93	It therefore important assess contribution endogenous PrPc
0.12702371.14570892.html.plaintext.txt	94	We thus measured staurosporine susceptibility primary cultured neurons Zrch 1 mice embryos Prnp gene disrupted 15
0.12702371.14570892.html.plaintext.txt	95	As expected neurons display PrPc like immunoreactivity Fig
0.12702371.14570892.html.plaintext.txt	96	That PrP neurons exhibit lower staurosporine induced responses evidenced TUNEL Fig
0.12702371.14570892.html.plaintext.txt	97	4 B C DNA fragmentation Table I analyses
0.12702371.14570892.html.plaintext.txt	98	Clearly staurosporine induced increase number apoptotic nuclei observed PrP neurons drastically lowered neurons devoid PrPc Fig
0.12702371.14570892.html.plaintext.txt	99	This lower staurosporine susceptibility exhibited PrP primary cultured neurons accompanied lowered caspase 3 like immunoreactivity Fig
0.12702371.14570892.html.plaintext.txt	100	It noteworthy effect staurosporine dose dependent PrP PrP cells another apoptotic effector ceramide C2 Fig
0.12702371.14570892.html.plaintext.txt	101	However effect triggered pharmacological agents always remains lower PrP neurons PrP neurons
0.12702371.14570892.html.plaintext.txt	102	View larger version 62K FIG
0.12702371.14570892.html.plaintext.txt	103	TUNEL positive neurons lower PrP wild type primary cultured neurons
0.12702371.14570892.html.plaintext.txt	104	A endogenous PrPc like immunoreactivity visualized PrP PrP neurons described Materials Methods
0.12702371.14570892.html.plaintext.txt	105	In B TUNEL labeling measured absence presence staurosporine indicated neurons
0.12702371.14570892.html.plaintext.txt	106	Cell death visualized black precipitates quantified C detailed Materials Methods
0.12702371.14570892.html.plaintext.txt	107	View table TABLE I Basal staurosporine stimulated propidium iodide incorporation measured indicated cell lines flow cytometry analysis
0.12702371.14570892.html.plaintext.txt	108	Data means three independent experiments
0.12702371.14570892.html.plaintext.txt	109	View larger version 25K FIG
0.12702371.14570892.html.plaintext.txt	110	Depletion endogenous PrPc lowers responsiveness primary cultured neurons staurosporine ceramide C2
0.12702371.14570892.html.plaintext.txt	111	Primary cultured neurons obtained 14 day old mouse embryos wild type mice PrP Zrch 1 mice Prnp gene deleted PrP cultured described Materials Methods
0.12702371.14570892.html.plaintext.txt	112	Caspase 3 like immunoreactivity A activity B measured indicated cell lines control staurosporine Sts stimulated conditions
0.12702371.14570892.html.plaintext.txt	113	The bars B correspond Ac DEVD al sensitive Ac DEVD 7AMC hydrolyzing activity means plus minus S
0.12702371.14570892.html.plaintext.txt	114	four experiments duplicate determinations
0.12702371.14570892.html.plaintext.txt	115	C D PrP PrP cultured neurons incubated increasing concentrations staurosporine C ceramide C2 D caspase 3 measured described
0.12702371.14570892.html.plaintext.txt	116	The bars show percent control corresponding caspase activity recovered untreated PrP neurons represent means plus minus S
0.12702371.14570892.html.plaintext.txt	117	three independent experiments
0.12702371.14570892.html.plaintext.txt	118	PrPc Complementation Partially Restores Staurosporine induced Caspase 3 Activation PrP Primary Cultured Neurons Transient transfection PrP neurons 3F4MoPrPc cDNA led enhanced PrPc like immunoreactivity Fig
0.12702371.14570892.html.plaintext.txt	119	The treatment mock transfected PrP neurons staurosporine increases caspase 3 like immunoreactivity phenotype drastically enhanced 3F4MoPrPc transfected primary cultured neurons Fig
0.12702371.14570892.html.plaintext.txt	120	Accordingly accompanied consistent elevation staurosporine induced caspase activation upon 3F4MoPrP transfection PrP neurons Fig
0.12702371.14570892.html.plaintext.txt	121	These data indicate primary cultured neurons transfectable 3F4MoPrPc overexpression cells mimics potentiates staurosporine stimulated caspase activation phenotype observed untransfected primary cultured neurons see Fig
0.12702371.14570892.html.plaintext.txt	122	View larger version 34K FIG
0.12702371.14570892.html.plaintext.txt	123	PrPc cDNA transfection increases staurosporine induced caspase activity immunoreactivity PrP neurons
0.12702371.14570892.html.plaintext.txt	124	After transient transfection wild type primary cultured neurons PrP 3F4MoPrPc cDNA empty vector pcDNA3 PrPc caspase 3 like casp
0.12702371.14570892.html.plaintext.txt	125	3 immunoreactivities A caspase activity B measured control staurosporine stimulated conditions see Materials Methods details
0.12702371.14570892.html.plaintext.txt	126	Experiments B correspond three independent transfections 3F4MoPrPc cDNA
0.12702371.14570892.html.plaintext.txt	127	We took advantage feature examine whether lowering caspase activation observed PrP primary cultured neurons could rescued even partially 3F4MoPrPc overexpression
0.12702371.14570892.html.plaintext.txt	128	7A shows PrPc like immunoreactivity detectable 3F4MoPrPc transfected PrP neurons
0.12702371.14570892.html.plaintext.txt	129	This accompanied partial reproducible recovery staurosporine induced caspase activation responsiveness displayed PrP neurons Fig
0.12702371.14570892.html.plaintext.txt	130	Thus although mock transfected PrP display 54 responsiveness PrP neurons staurosporine three distinct 3F4MoPrP transfections PrP neurons consistently restored staurosporine induced caspase 3 activation 81 control
0.12702371.14570892.html.plaintext.txt	131	This incomplete rescue apparent agreement relatively low efficiency 3F4MoPrP cDNA transfection illustrated expression exogenous PrPc PrP primary cultured neurons agrees well data described
0.12702371.14570892.html.plaintext.txt	132	View larger version 29K FIG
0.12702371.14570892.html.plaintext.txt	133	PrPc cDNA transfection partially restores staurosporine induced caspase activation PrP neurons
0.12702371.14570892.html.plaintext.txt	134	Transient transfection PrPc cDNA PrP neurons increases PrPc immunoreactivity A partially restores staurosporine induced caspase activation B
0.12702371.14570892.html.plaintext.txt	135	Bars correspond staurosporine induced increase caspase 3 activity expressed percent control corresponding staurosporine stimulation wild type PrP neurons transiently transfected empty pcDNA3 vector means three independent transfections 3F4MoPrPc cDNA
0.12702371.14570892.html.plaintext.txt	136	PrP Neurons Display Lower p53 Expression Activity We examined putative modulation tumor suppressor oncogene p53 endogenous PrPc
0.12702371.14570892.html.plaintext.txt	137	Primary cultured neurons devoid endogenous PrPc content display decreased p53 immunoreactivity Fig
0.12702371.14570892.html.plaintext.txt	138	8A transcriptional activity Fig
0.12702371.14570892.html.plaintext.txt	139	8B thereby demonstrating endogenous PrPc controls p53 expression activity
0.12702371.14570892.html.plaintext.txt	140	Of greatest interest observation p53 expression 1 month old mouse brain drastically lower PrP wild type mice Fig
0.12702371.14570892.html.plaintext.txt	141	8C indicating PrPc also controls p53 expression vivo
0.12702371.14570892.html.plaintext.txt	142	View larger version 28K FIG
0.12702371.14570892.html.plaintext.txt	143	Endogenous PrPc modulates p53 like immunoreactivity transcriptional activity
0.12702371.14570892.html.plaintext.txt	144	p53 like immunoreactivity A C transcriptional activity B monitored described Materials Methods PrP PrP primary cultured neurons A B adult mouse brain homogenate C
0.12702371.14570892.html.plaintext.txt	145	Bars represent means plus minus S
0.12702371.14570892.html.plaintext.txt	146	4 6 independent experiments triplicate determinations
0.12702371.14570892.html.plaintext.txt	147	Mdm2 like immunoreactivity D phosphorylated p38 MAPK E measured PrP PrP primary cultured neurons detailed Materials Methods
0.12702371.14570892.html.plaintext.txt	148	PrPc Controls Post transcriptional Modulators p53 Activity We searched post transcriptional modulators p53 activity would control endogenous PrP primary cultured neurons
0.12702371.14570892.html.plaintext.txt	149	Mdm2 recently shown decrease p53 metabolic stability thereby lowering activity 20
0.12702371.14570892.html.plaintext.txt	150	We demonstrate Mdm2 immunoreactivity higher PrP wild type neurons Fig
0.12702371.14570892.html.plaintext.txt	151	8D phenotype completely opposite observed p53 immunoreactivity see Fig
0.12702371.14570892.html.plaintext.txt	152	As p38 mitogen activated protein kinase p38 MAPK reported regulate p53 activity via upstream Mdm2 expression 26 also examined endogenous levels active phosphorylated counterpart p38 MAPK
0.12702371.14570892.html.plaintext.txt	153	Active p38 immunoreactivity higher wild type PrP neurons Fig
0.12702371.14570892.html.plaintext.txt	154	8E suggesting PrPc also controls p38 phosphorylation endogenous levels
0.12702371.14570892.html.plaintext.txt	155	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Spongiform encephalopathies comprise group several transmissible diseases known long time affect animals always characterized late stages neurodegenerescence ultimately death 1 27 30
0.12702371.14570892.html.plaintext.txt	156	These pathologies became higher interest appeared diseases could also affect human beings leading logical suspicion human pathology could transmitted animals therefore mankind facing novel public health problem unforeseeable consequences
0.12702371.14570892.html.plaintext.txt	157	The boost interest novel intriguing type pathology focused mainly better knowledge 33 35 kDa sialoglycosylated glycosylphosphatidylinositol anchored polypeptide called prion appears main actor disease
0.12702371.14570892.html.plaintext.txt	158	Interestingly demonstrated pathogenic agent least clearly main component protein called scrapie PrPres primary sequence ubiquitous counterpart cellular prion PrPc 1
0.12702371.14570892.html.plaintext.txt	159	However PrPres displays sheet enriched structure renders highly resistant proteolysis prone aggregation 1
0.12702371.14570892.html.plaintext.txt	160	How PrPres acquires pathological conformation yet established infectious inoculates mimicking disease require endogenous PrPc propagate fully innocuous mice engineered abrogate endogenous PrPc protein content 6
0.12702371.14570892.html.plaintext.txt	161	Also yet fully understood molecular determinants initiate pathogenic process sporadic encephalopathies
0.12702371.14570892.html.plaintext.txt	162	A better understanding sporadic cases would likely come better knowledge physiological function PrPc putative dysfunction takes place diseases occur
0.12702371.14570892.html.plaintext.txt	163	Few things really known concerning physiological function PrPc several lines evidence indicate PrPc could modulate cell death
0.12702371.14570892.html.plaintext.txt	164	PrP mutations could trigger caspase activation 31 murine scrapie appears associated cell death 32
0.12702371.14570892.html.plaintext.txt	165	Furthermore prion infection impairs cellular response oxidative stress inducers 33 triggers apoptosis hypothalamic neuronal cell line 34
0.12702371.14570892.html.plaintext.txt	166	Altogether data suggest ability PrPc modulate cell death whether due exacerbation proapoptotic function alternatively alteration antiapoptotic phenotype could envisioned
0.12702371.14570892.html.plaintext.txt	167	The literature field really solve debate opposing data supporting possibilities
0.12702371.14570892.html.plaintext.txt	168	8 shown serum deprivation induced cell death exacerbated hippocampal neurons prepared Prnp mice
0.12702371.14570892.html.plaintext.txt	169	On hand PrPc also appears protect human neurons cell death triggered overexpression proapoptotic oncogene Bax 9
0.12702371.14570892.html.plaintext.txt	170	Finally recent paper indicates PrPc could cellular mediator protecting retinal tissue anisomycin induced apoptosis 10
0.12702371.14570892.html.plaintext.txt	171	From data one expect drastic deleterious effect PrPc deletion due abrogation antiapoptotic phenotype
0.12702371.14570892.html.plaintext.txt	172	This seems case PrPc deficient mice safe healthy apparently develop behave normally 15
0.12702371.14570892.html.plaintext.txt	173	Furthermore recent article indicates post natal deletion PrPc alters excitability CA1 hippocampal neurons induce neurodegeneration adulthood 12
0.12702371.14570892.html.plaintext.txt	174	We previously established overexpression PrPc enhances staurosporine induced cell toxicity DNA fragmentation activates caspase 3 stably transfected HEK293 TSM1 neurons inducible Rov9 cell lines 13 14
0.12702371.14570892.html.plaintext.txt	175	Furthermore showed PrPc induced caspase 3 activation mediated Mdm2 regulated p53 dependent pathway TSM1 neurons 14
0.12702371.14570892.html.plaintext.txt	176	These data fully agreement previous work demonstrating transgenic mice overexpressing wild type PrPc could exhibit severe neurodegeneration 11
0.12702371.14570892.html.plaintext.txt	177	However could argued PrPc related phenotype could cases due overexpression protein
0.12702371.14570892.html.plaintext.txt	178	In line hypothesis recent study nicely established N2A murine neuroblastoma cells neurotoxicity neurodegeneration could associated cytosolic accumulation PrPc 35
0.12702371.14570892.html.plaintext.txt	179	These data fully agreed demonstration manipulation cytosolic PrPc concentration could indeed affect cell death
0.12702371.14570892.html.plaintext.txt	180	Thus proteasomal inhibition leads increased PrPc like immunoreactivity accompanied drastic potentiation caspase activation HEK293 cells 13
0.12702371.14570892.html.plaintext.txt	181	Conversely depletion cellular PrPc immunosequestration membrane precludes PrPc induced proapoptotic phenotype 13
0.12702371.14570892.html.plaintext.txt	182	The present study first confirms overexpression PrPc enhances staurosporine stimulated caspase 3 activity demonstrates first time HEK293 cells PrPc related phenotypes p53 dependent
0.12702371.14570892.html.plaintext.txt	183	These data fully reinforced observation PrPc inactive p53 deficient fibroblasts
0.12702371.14570892.html.plaintext.txt	184	Interestingly established besides post transcriptional modulation p53 PrPc also enhances p53 promoter transactivation
0.12702371.14570892.html.plaintext.txt	185	It important establish p53 dependent PrPc related phenotype solely due artifactual perturbation cell physiology caused overexpression protein
0.12702371.14570892.html.plaintext.txt	186	In context examined contribution endogenous PrPc apoptotic response monitoring cell death primary cultured neurons derived mice embryos Prnp gene abrogated Zrch 1
0.12702371.14570892.html.plaintext.txt	187	Our data show deletion PrPc led phenotype fully opposite PrP overexpression
0.12702371.14570892.html.plaintext.txt	188	Prnp neurons indeed less sensitive staurosporine monitored TUNEL positive cells DNA fragmentation caspase activity immunoreactivity
0.12702371.14570892.html.plaintext.txt	189	Furthermore phenotype appears linked drastic reduction p53 activity immunoreactivity
0.12702371.14570892.html.plaintext.txt	190	Finally p53 activator p38 MAPK inhibitor Mdm2 immunoreactivities reduced
0.12702371.14570892.html.plaintext.txt	191	This indicates PrPc likely controls p53 least part post transcriptional level demonstrated TSM1 neurons overexpression approach 13
0.12702371.14570892.html.plaintext.txt	192	Therefore current study demonstrates PrPc controls caspase activity p53 dependent Mdm2 regulated process proapoptotic phenotype caused artifactually overexpression protein
0.12702371.14570892.html.plaintext.txt	193	We recently established Alzheimers disease presenilin 2 protein mutated mainly contributes Alzheimers disease related pathologies also controls cell death response staurosporine identical p53 dependent mechanism 36
0.12702371.14570892.html.plaintext.txt	194	This observation together demonstration similar proteolytic dysfunctions occur Alzheimers prion diseases suggests several common features could link apparently distinct neurodegenerative diseases 37
0.12702371.14570892.html.plaintext.txt	195	This also true one considers Parkinsons disease pathology synuclein anti apoptotic physiological phenotype 22 associated p53 regulation abolished 60H dopamine toxin associated pathology 38
0.12702371.14570892.html.plaintext.txt	196	Altogether observations suggest envisioning p53 molecular target therapeutic strategies various neurodegenerative pathologies
0.12702371.14570892.html.plaintext.txt	197	FOOTNOTES This work supported CNRS INSERM Groupement dInteret Scientifique Infections Prions
0.12702371.14570892.html.plaintext.txt	198	The costs publication article defrayed part payment page charges
0.12702371.14570892.html.plaintext.txt	199	This article must therefore hereby marked advertisement accordance 18 U
0.12702371.14570892.html.plaintext.txt	200	Section 1734 solely indicate fact
0.12702371.14570892.html.plaintext.txt	201	These two authors contributed equally work
0.12702371.14570892.html.plaintext.txt	202	To correspondence addressed Institut de Pharmacologie Moleculaire et Cellulaire UMR6097 du CNRS 660 route des Lucioles Sophia Antipolis 06560 Valbonne France
0.12702371.14570892.html.plaintext.txt	203	33 4 93 95 77 60 Fax 33 4 93 95 77 08 E mail checleratipmc
0.12702371.14570892.html.plaintext.txt	204	1 The abbreviations used PrP prion protein TUNEL terminal deoxynucleotidyltransferase mediated dUTP nick end labeling HEK293 cells human embryonic kidney cells MAPK mitogen activated protein kinase
0.12702371.14570892.html.plaintext.txt	205	ACKNOWLEDGMENTS We grateful Pr
0.12702371.14570892.html.plaintext.txt	206	Weissmann Imperial College London UK providing Prnp Zrch 1 mice
0.12702371.14570892.html.plaintext.txt	207	PG13 luciferase cDNA generously provided Dr
0.12702371.14570892.html.plaintext.txt	208	Vogelstein Howard Hughes Medical Institute Baltimore
0.12702371.14570892.html.plaintext.txt	209	Moshe Oren Weizmann Institute Science Rehovot Israel kind gift mouse p53 promoter luciferase
0.12702371.14570892.html.plaintext.txt	210	Grassi CEA Saclay France providing SAF32 monoclonals Dr
0.12702371.14570892.html.plaintext.txt	211	Fahraeus gift anti Mdm2
0.12702371.14570892.html.plaintext.txt	212	Mattson NIA Baltimore providing us pifithrin inactive analog
0.12702371.14570892.html.plaintext.txt	213	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Prusiner S
0.12702371.14570892.html.plaintext.txt	214	95 13363 13383AbstractFree Full Text Aguzzi A
0.12702371.14570892.html.plaintext.txt	215	2 118 126CrossRefMedline Order article via Infotrieve Weissmann C
0.12702371.14570892.html.plaintext.txt	216	62 153 166Medline Order article via Infotrieve Prusiner S
0.12702371.14570892.html.plaintext.txt	217	21 482 487CrossRefMedline Order article via Infotrieve Ghetti B
0.12702371.14570892.html.plaintext.txt	218	6 127 145Medline Order article via Infotrieve Bueler H
0.12702371.14570892.html.plaintext.txt	219	1993 Cell 73 1339 1347CrossRefMedline Order article via Infotrieve Brandner S
0.12702371.14570892.html.plaintext.txt	220	1996 Nature 379 339 343CrossRefMedline Order article via Infotrieve Kuwahara C
0.12702371.14570892.html.plaintext.txt	221	1999 Nature 400 225 226CrossRefMedline Order article via Infotrieve Bounhar Y
0.12702371.14570892.html.plaintext.txt	222	276 39145 39149AbstractFree Full Text Chiarini L
0.12702371.14570892.html.plaintext.txt	223	21 3317 3326AbstractFree Full Text Westaway D
0.12702371.14570892.html.plaintext.txt	224	1994 Cell 76 117 129CrossRefMedline Order article via Infotrieve Mallucci G
0.12702371.14570892.html.plaintext.txt	225	21 202 210AbstractFree Full Text Paitel E
0.12702371.14570892.html.plaintext.txt	226	83 1208 1214CrossRefMedline Order article via Infotrieve Paitel E
0.12702371.14570892.html.plaintext.txt	227	278 10061 10066AbstractFree Full Text Bueler H
0.12702371.14570892.html.plaintext.txt	228	1992 Nature 356 577 582CrossRefMedline Order article via Infotrieve Vincent B
0.12702371.14570892.html.plaintext.txt	229	16 5049 5059AbstractFree Full Text Macleod K
0.12702371.14570892.html.plaintext.txt	230	1992 Nature 356 215 221CrossRefMedline Order article via Infotrieve Bradford M
0.12702371.14570892.html.plaintext.txt	231	72 248 259CrossRefMedline Order article via Infotrieve Yin Y
0.12702371.14570892.html.plaintext.txt	232	4 462 467CrossRefMedline Order article via Infotrieve Demart S
0.12702371.14570892.html.plaintext.txt	233	265 652 657CrossRefMedline Order article via Infotrieve Alves da Costa C
0.12702371.14570892.html.plaintext.txt	234	275 24065 24069AbstractFree Full Text El Deiry W
0.12702371.14570892.html.plaintext.txt	235	1 45 49CrossRefMedline Order article via Infotrieve Ginsberg D
0.12702371.14570892.html.plaintext.txt	236	1990 Oncogene 5 1285 1290Medline Order article via Infotrieve Bykov V
0.12702371.14570892.html.plaintext.txt	237	8 282 288CrossRefMedline Order article via Infotrieve Zhu Y
0.12702371.14570892.html.plaintext.txt	238	277 22909 22914AbstractFree Full Text Chesebro B
0.12702371.14570892.html.plaintext.txt	239	1999 Neuron 24 503 506CrossRefMedline Order article via Infotrieve Aguzzi A
0.12702371.14570892.html.plaintext.txt	240	7 289 290CrossRefMedline Order article via Infotrieve Martins V
0.12702371.14570892.html.plaintext.txt	241	123 1637 1647CrossRefMedline Order article via Infotrieve Jamieson E
0.12702371.14570892.html.plaintext.txt	242	2001 NeuroReport 12 3567 3572CrossRefMedline Order article via Infotrieve Siso S
0.12702371.14570892.html.plaintext.txt	243	103 615 626CrossRefMedline Order article via Infotrieve Milhavet O
0.12702371.14570892.html.plaintext.txt	244	38 328 339CrossRefMedline Order article via Infotrieve Schatzl H
0.12702371.14570892.html.plaintext.txt	245	2002 Science 298 1781 1785AbstractFree Full Text Alves da Costa C
0.12702371.14570892.html.plaintext.txt	246	99 4043 4048AbstractFree Full Text Checler F
0.12702371.14570892.html.plaintext.txt	247	25 616 620CrossRefMedline Order article via Infotrieve Alves da Costa C
0.12702371.14570892.html.plaintext.txt	248	277 50980 50984AbstractFree Full Text This Article Abstract Full Text PDF All Versions Article 2791612 recent M310453200v1 Purchase Article View Shopping Cart Alert article cited Alert correction posted Citation Map Services Email article friend Similar articles journal Similar articles PubMed Alert new issues journal Download citation manager Copyright Permissions Google Scholar Articles Paitel E
0.12702371.14570892.html.plaintext.txt	249	Articles citing Article PubMed PubMed Citation Articles Paitel E
0.12702371.14570892.html.plaintext.txt	250	HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular Cellular Proteomics Journal Lipid Research Biochemistry Molecular Biology Education Copyright 2004 American Society Biochemistry Molecular Biology
0.18159729.11961279.html.plaintext.txt	0	Mutant prion protein acquires resistance protease mouse neuroblastoma cells C
0.18159729.11961279.html.plaintext.txt	1	Institut fur Neuropathologie Universitat Gottingen Robert Koch Str
0.18159729.11961279.html.plaintext.txt	2	40 D 37075 Gottingen Germany1 Institut fur Neuropathologie Ludwig Maximilians Universitat Munchen Marchioninistr
0.18159729.11961279.html.plaintext.txt	3	Authors correspondence Hans Kretzschmar Otto Windl
0.18159729.11961279.html.plaintext.txt	4	uni u d muenchen
0.18159729.11961279.html.plaintext.txt	5	Abstract Top Abstract Introduction Methods Results Discussion References Conversion cellular isoform prion protein PrPC pathogenic isoform PrPSc thought causative event prion diseases
0.18159729.11961279.html.plaintext.txt	6	Biochemically PrPSc differs PrPC partial resistance proteinase K PK
0.18159729.11961279.html.plaintext.txt	7	The amino acid sequence AGAAAAGA comprising residues 112 119 murine PrPC shown amyloidogenic evolutionarily conserved
0.18159729.11961279.html.plaintext.txt	8	To assess effect mutations around hydrophobic sequence protease resistance sequence replaced either alanines glycines third mutant large part surrounding region removed
0.18159729.11961279.html.plaintext.txt	9	The PrP mutant carrying substitutions glycines alanines showed PK resistance aberrant proteolytic processing
0.18159729.11961279.html.plaintext.txt	10	Tetracycline induced expression mutant indicated resistance protease acquired concurrent synthesis protein
0.18159729.11961279.html.plaintext.txt	11	These findings indicate mutations central hydrophobic region lead immediate alterations PrP structure processing
0.18159729.11961279.html.plaintext.txt	12	Introduction Top Abstract Introduction Methods Results Discussion References Prion diseases transmissible spongiform encephalopathies fatal neurodegenerative diseases include Creutzfeldt Jakob disease kuru Gerstmann Straussler Scheinker syndrome fatal familial insomnia humans scrapie sheep bovine spongiform encephalopathy cattle Prusiner et al
0.18159729.11961279.html.plaintext.txt	13	Prion diseases acquired inherited idiopathic origin
0.18159729.11961279.html.plaintext.txt	14	Inherited forms show autosomal dominant trait linked point insertional mutations PrP gene PRNP humans Prnp mice encoding prion protein PrP Prusiner DeArmond 1994
0.18159729.11961279.html.plaintext.txt	15	Prion diseases characterized accumulation proteinase K PK resistant isoform PrPSc cellular protease sensitive prion protein PrPC
0.18159729.11961279.html.plaintext.txt	16	PrPC neuronal glycoprotein anchored plasma membrane glycosylphosphatidylinositol GPI moiety
0.18159729.11961279.html.plaintext.txt	17	The function PrPC copper binding protein Brown et al
0.18159729.11961279.html.plaintext.txt	18	1997a still clearly understood
0.18159729.11961279.html.plaintext.txt	19	Recent data point function synaptic interaction Herms et al
0.18159729.11961279.html.plaintext.txt	20	1999 resistance neurons oxidative stress Brown et al
0.18159729.11961279.html.plaintext.txt	21	1997b signal transduction Mouillet Richard et al
0.18159729.11961279.html.plaintext.txt	22	Studies investigating PrPC metabolism demonstrated PrPC turns half life 3 6 h mouse neuroblastoma cells Borchelt et al
0.18159729.11961279.html.plaintext.txt	23	Chicken PrPC shown recycle plasma membrane endosomal compartment Shyng et al
0.18159729.11961279.html.plaintext.txt	24	During normal processing PrPC cleaved central hydrophobic region yielding C terminal GPI anchored fragment identified brain tissue cultured cells Chen et al
0.18159729.11961279.html.plaintext.txt	25	PrPSc derived PrPC post translational process seems involve species specific molecular interactions two isoforms
0.18159729.11961279.html.plaintext.txt	26	PrPC necessary infectivity pathology demonstrated experiments showing complete resistance Prnp knockout mice infection prions Brandner et al
0.18159729.11961279.html.plaintext.txt	27	PrPC rich helices PrPSc exhibits greater content sheets Caughey et al
0.18159729.11961279.html.plaintext.txt	28	The nuclear magnetic resonance structure full length recombinant PrPC revealed region comprising amino acids 121 231 contains high level secondary structure including three helices two stranded antiparallel sheet whereas N terminus highly flexible Hornemann et al
0.18159729.11961279.html.plaintext.txt	29	Copper binding seems confer distinct structure N terminus Viles et al
0.18159729.11961279.html.plaintext.txt	30	Synthesized peptides homologous residues 109 122 106 126 form sheets spontaneously Forloni et al
0.18159729.11961279.html.plaintext.txt	31	1992 internal sequence AGAAAAGA residues 112 119 displaying highest tendency form amyloid Gasset et al
0.18159729.11961279.html.plaintext.txt	32	Peptides containing AGAAAAGA motif toxic neurons culture whereby sequence AGAAAAGA found necessary sufficient neurotoxic effect Brown 2000a Forloni et al
0.18159729.11961279.html.plaintext.txt	33	A recent study using vitro conversion assays PrPC PK resistant PrPSc indicates synthetic peptides derived central part PrPC amino acids 106 141 inhibitory effect conversion Chabry et al
0.18159729.11961279.html.plaintext.txt	34	The presence residues 119 120 two last residues within motif AGAAAAGA seems crucial inhibitory effect arguing involvement intermolecular interaction leads PK resistant PrP
0.18159729.11961279.html.plaintext.txt	35	Mutant PrP molecules carrying deletions amino acids 108 121 114 121 convertible PrPSc overexpressed scrapie infected neuroblastoma cells Holscher et al
0.18159729.11961279.html.plaintext.txt	36	The central hydrophobic region spanning sequence AGAAAAGA therefore plays important role conversion process
0.18159729.11961279.html.plaintext.txt	37	For insight function region decided establish cell culture model
0.18159729.11961279.html.plaintext.txt	38	To develop system expressed PrP molecules carrying mutations around hydrophobic sequence murine neuroblastoma cells analysed mutant proteins proteolytic processing resistance protease
0.18159729.11961279.html.plaintext.txt	39	We report one mutant PrP molecules acquired protease resistance comparison wild type PrP
0.18159729.11961279.html.plaintext.txt	40	Methods Top Abstract Introduction Methods Results Discussion References Reagents antibodies
0.18159729.11961279.html.plaintext.txt	41	DNA modifying enzymes purchased Promega dideoxy sequencing reagents Amersham
0.18159729.11961279.html.plaintext.txt	42	Cell culture reagents obtained Biochrom KG
0.18159729.11961279.html.plaintext.txt	43	N Glycosidase F PNGase F purchased New England BioLabs
0.18159729.11961279.html.plaintext.txt	44	All reagents Sigma
0.18159729.11961279.html.plaintext.txt	45	The following PrP specific antibodies used mouse mAb 3B5 directed amino acids 68 84 human PrP Krasemann et al
0.18159729.11961279.html.plaintext.txt	46	1996 mAb 6H4 directed amino acids 155 163 bovine PrP Korth et al
0.18159729.11961279.html.plaintext.txt	47	1997 mAb 13A5 directed epitope Syrian hamster PrP Rogers et al
0.18159729.11961279.html.plaintext.txt	48	1991 polyclonal antibody Kan72 directed amino acids 89 103 murine PrP moPrP Holscher et al
0.18159729.11961279.html.plaintext.txt	49	Alkaline phosphatase AP conjugated goat anti mouse antibody Dianova AP conjugated goat anti rabbit antibody Dako
0.18159729.11961279.html.plaintext.txt	50	TRITC coupled goat anti mouse antibody purchased Dianova
0.18159729.11961279.html.plaintext.txt	51	Tissues obtained brain hemispheres tg81 mice Scott et al
0.18159729.11961279.html.plaintext.txt	52	1989 hamster hamster infected scrapie strain 263K
0.18159729.11961279.html.plaintext.txt	53	The murine neuroblastoma cell line Neuro 2a Klebe Ruddle 1969 obtained ATCC
0.18159729.11961279.html.plaintext.txt	54	N2a cells grown DMEM containing 10 foetal calf serum penicillinstreptomycin atmosphere 10 CO2
0.18159729.11961279.html.plaintext.txt	55	The generation plasmid pCI Prnp described previously Windl et al
0.18159729.11961279.html.plaintext.txt	56	The hamster specific 13A5 epitope inserted wild type Prnpa allele via overlap extension OE PCR Higuchi et al
0.18159729.11961279.html.plaintext.txt	57	1988 using outer primers T3 5 AATTAACCCTCACTAAAGGG 3 T7neo 5 TAATACGACTCACTATAGG 3 overlapping primers 13A5up 5 CCAAAATGCATCATGGGCC 3 13A5do 5 CCCATGATGCATTTTGGCA 3
0.18159729.11961279.html.plaintext.txt	58	After cleavage XbaI XhoI PCR product cloned corresponding restriction sites pCI neo Promega give pCI Prnp13A5
0.18159729.11961279.html.plaintext.txt	59	Based pCI Prnp13A5 plasmid pCI PrnpSmaI containing Prnp gene without original SmaI site established
0.18159729.11961279.html.plaintext.txt	60	The following primers used OE PCR SmaIup 5 CCCTGCCCAGGATACCGGC 3 SmaIdo 5 CGGTATCCTGGGCAGGGAAG 3
0.18159729.11961279.html.plaintext.txt	61	Plasmid pCI PrnpSmaI starting point pCI Prnp105 125 pCI PrnpA112 119 pCI PrnpG112 119
0.18159729.11961279.html.plaintext.txt	62	Plasmid pCI Prnp105 125 generated via OE PCR using following overlapping primers 105 125up 5 CCAGCATGTACCCGGGTTTGCTGGGCTTGT 3 105 125do 5 CAGCAAACCCGGGTACATGCTGGGGAGCG 3
0.18159729.11961279.html.plaintext.txt	63	In addition deletion codons 105 125 construct carried new SmaI restriction site changing codons 104 126 silently CCA CCC GGC GGG
0.18159729.11961279.html.plaintext.txt	64	Constructs pCI PrnpA112 119 pCI PrnpG112 119 generated based pCI Prnp105 125
0.18159729.11961279.html.plaintext.txt	65	The primers A112 119up 5ACCAAGGCCCCCCACTACTGCCGCAGCTGCCG CAGCCGCTGCCACATGCTTGAGGTTGGTTTT3 A112 119do 5 AAAACCAACCTCAAGCATGTGGCAGCGGCTGCGGCA GCTGCGGCAGTAGTGGGGGGCCTTGGT3 G112 119up 5 ACCAAGGCCCCCCACTACTCCCCCACCTCCCCCACC CCCTCCCACATGCTTGAGGTTGGTTTT3 G112 119do 5 AAAACCAACCTCAAGCATGTGGGAGGGGGTGGGGGAGGTGGGGGAGTAGTGGGGGGCCT TGGT 3 hybridized resulting fragments cloned SmaI site pCI Prnp105 125 give pCI PrnpA112 119 pCI PrnpG112 119 respectively
0.18159729.11961279.html.plaintext.txt	66	The sequences modified Prnp genes verified DNA sequence analysis
0.18159729.11961279.html.plaintext.txt	67	The plasmid pHA58 carries hygromycin resistance gene control murine pgk 1 promoter
0.18159729.11961279.html.plaintext.txt	68	The construction vector phCMV Prnp described previously Windl et al
0.18159729.11961279.html.plaintext.txt	69	This plasmid originally derived plasmid pUHD 10 3 carries wild type Prnpa allele control transactivator responsive promoter PhCMV 1
0.18159729.11961279.html.plaintext.txt	70	The plasmids pCI Prnp13A5 pCI PrnpG112 119 cleaved XhoI plasmid pUHD 10 3 cleaved EcoRI
0.18159729.11961279.html.plaintext.txt	71	After blunting 5 protruding ends three constructs Klenow fragment DNA polymerase constructs cleaved XbaI
0.18159729.11961279.html.plaintext.txt	72	The inserts excised pCI Prnp13A5 pCI PrnpG112 119 cloned Klenow treated EcoRI site XbaI site pUHD 10 3 produce phCMV Prnp 13A5 phCMV PrnpG112 119
0.18159729.11961279.html.plaintext.txt	73	Construction recombinant cell lines
0.18159729.11961279.html.plaintext.txt	74	N2a cells stably transfected different pCI Prnp constructs using Effectene Superfect Qiagen transfection reagents according manufacturer instructions
0.18159729.11961279.html.plaintext.txt	75	After transfection antibiotic resistant cells selected 400 microgml geniticin G418 polyclonal cell lines obtained 4 weeks
0.18159729.11961279.html.plaintext.txt	76	The level PrP overexpression different cell lines assayed Western blot analysis see
0.18159729.11961279.html.plaintext.txt	77	The use tetracycline inducible expression system required stably double transfected N2a cell lines carrying reverse transactivator first component wild type G112 119 moPrP genes control transactivator responsive promoter second component
0.18159729.11961279.html.plaintext.txt	78	N2a clones expressing first component reverse tetracycline controlled transactivator rtTA established previously Windl et al
0.18159729.11961279.html.plaintext.txt	79	One resulting N2a rtTA clones clone 1 subjected second round transfection co transfection either phCMV Prnp13A5 phCMV PrnpG112 119 combined pHA58 Prnp plasmid hygromycin resistance plasmid 191 mixture using Effectene transfection reagent
0.18159729.11961279.html.plaintext.txt	80	Cells selected presence hygromycin 200 microgml geniticin 200 microgml
0.18159729.11961279.html.plaintext.txt	81	Cells grown 24 well plates fixed 10 paraformaldehyde PBS 10 min methanol 30 min 4 degrees C
0.18159729.11961279.html.plaintext.txt	82	After rinsing PBS cells incubated mouse mAb 3B5 dilution 15 1 h room temperature
0.18159729.11961279.html.plaintext.txt	83	Cells rinsed incubated TRITC conjugated secondary antibody dilution 1200 30 min room temperature
0.18159729.11961279.html.plaintext.txt	84	After rinsing cells embedded PBS examined fluorescence microscope Olympus
0.18159729.11961279.html.plaintext.txt	85	Cells grown 75 cm2 tissue culture flasks lysed 500 microl ice cold lysis buffer containing 50 mM Tris HCl pH 7 5 150 mM sodium chloride 0 5 NP 40 0 5 sodium deoxycholate supplemented 1 mM PMSF
0.18159729.11961279.html.plaintext.txt	86	Brain tissue homogenized 9 vols ice cold lysis buffer
0.18159729.11961279.html.plaintext.txt	87	Where indicated lysates brain homogenates treated PNGase F according manufacturer instructions
0.18159729.11961279.html.plaintext.txt	88	Proteins separated SDS PAGE 12 5 15 acrylamide transferred PVDF membrane processed described elsewhere LeGendre 1990
0.18159729.11961279.html.plaintext.txt	89	For detection PrP fragments membrane incubated one various primary antibodies dilution either 12000 13A5 6H4 Kan72 150 3B5
0.18159729.11961279.html.plaintext.txt	90	This followed incubation AP conjugated goat anti mouse goat anti rabbit antibody diluted 11000
0.18159729.11961279.html.plaintext.txt	91	Immunopositive signals detected using chemiluminescent substrate CDP Star Tropix according manufacturer instructions
0.18159729.11961279.html.plaintext.txt	92	The light signals monitored documented quantified CCD camera system raytest accompanying software DIANA TINA raytest
0.18159729.11961279.html.plaintext.txt	93	Cell lysates treated PK different concentrations 3 3 10 20 50 microgml 10 min 37 degrees C digested 3 3 microgml PK 37 degrees C 0 10 20 40 60 min described previously Lehmann Harris 1996
0.18159729.11961279.html.plaintext.txt	94	Proteolytic digestions terminated adding 2 mM PMSF analysed directly Western blot
0.18159729.11961279.html.plaintext.txt	95	The protease resistance PrP brain tissue scrapie infected hamster analysed digesting homogenized brain PK concentration 20 microgml 1 h 37 degrees C
0.18159729.11961279.html.plaintext.txt	96	Digestion terminated addition 2 mM PMSF
0.18159729.11961279.html.plaintext.txt	97	Proteins brain homogenate methanol precipitated denatured 7 M guanidine hydrochloride methanol precipitated
0.18159729.11961279.html.plaintext.txt	98	The resulting pellet resuspended lysis buffer
0.18159729.11961279.html.plaintext.txt	99	Results Top Abstract Introduction Methods Results Discussion References Overexpression wild type mutant moPrPs N2a cells The wild type moPrP contains highly amyloidogenic sequence AGAAAAGA positions 112 119 central region comprising residues 105 125 Fig
0.18159729.11961279.html.plaintext.txt	100	We generated several mutations sequence motif PrP study fate mutant prion proteins cellular level
0.18159729.11961279.html.plaintext.txt	101	Two mutant moPrPs carried exclusively either glycine alanine residues instead AGAAAAGA sequence designated G112 119 A112 119
0.18159729.11961279.html.plaintext.txt	102	A third mutant form moPrP designated 105 125 deletion central region including AGAAAAGA
0.18159729.11961279.html.plaintext.txt	103	Wild type mutant moPrPs epitopically tagged substituting methionine residue isoleucine position 138 Fig
0.18159729.11961279.html.plaintext.txt	104	The introduction epitope moPrP allowed detection protein mAb 13A5 Rogers et al
0.18159729.11961279.html.plaintext.txt	105	The wild type mutant moPrP genes positioned control strong hCMV promoter stably transfected N2a cells
0.18159729.11961279.html.plaintext.txt	106	View larger version 22K Fig
0.18159729.11961279.html.plaintext.txt	107	Scheme wild type mutant moPrPs
0.18159729.11961279.html.plaintext.txt	108	The coding regions normal moPrP mutant Prnp genes WT 13A5 tagged A112 119 G112 119 105 125 depicted bars
0.18159729.11961279.html.plaintext.txt	109	Numbers indicate amino acid positions CHO indicates N glycosylation sites GPI indicates attachment site glycolipid anchor
0.18159729.11961279.html.plaintext.txt	110	The signal sequence octapeptide repeat region highlighted shaded bars
0.18159729.11961279.html.plaintext.txt	111	The replacement isoleucine I methionine M position 138 creates epitope hamster PrP specific mAb 13A5 Rogers et al
0.18159729.11961279.html.plaintext.txt	112	The hatched box depicts highly amyloidogenic region AGAAAAGA amino acid changes A112 119 G112 119 recorded
0.18159729.11961279.html.plaintext.txt	113	In order determine whether mutant PrP molecules expressed delivered cell surface performed immunofluorescence microscopy stably transfected polyclonal lines N2a cells
0.18159729.11961279.html.plaintext.txt	114	Only overexpressed exogenous PrP Fig
0.18159729.11961279.html.plaintext.txt	115	2a d endogenous PrP untransfected N2a cells Fig
0.18159729.11961279.html.plaintext.txt	116	Overexpressed wild type 105 125 G112 119 A112 119 moPrPs detected surface intact cells
0.18159729.11961279.html.plaintext.txt	117	The staining pattern around cell periphery similar permeabilization data shown
0.18159729.11961279.html.plaintext.txt	118	View larger version 36K Fig
0.18159729.11961279.html.plaintext.txt	119	Overexpression wild type 105 125 G112 119 A112 119 moPrPs
0.18159729.11961279.html.plaintext.txt	120	e N2a cell lines overexpressing wild type WT A112 119 b G112 119 c 105 125 moPrP d well normal N2a cells e labelled mouse mAb 3B5 stained fluorescein coupled secondary antibody
0.18159729.11961279.html.plaintext.txt	121	Cells observed immunofluorescence microscopy
0.18159729.11961279.html.plaintext.txt	122	The exposure time chosen detect overexpressed exogenous PrP
0.18159729.11961279.html.plaintext.txt	123	f Lysates stably transfected N2a cell lines overexpressing wild type lane 1 mutant lanes 2 4 moPrPs analysed immunoblotting mouse mAb 3B5
0.18159729.11961279.html.plaintext.txt	124	Equal amounts 100 microg protein loaded lanes polyacrylamide gel
0.18159729.11961279.html.plaintext.txt	125	Positions marker proteins indicated
0.18159729.11961279.html.plaintext.txt	126	The size glycosylation pattern mutant proteins examined Western blot Fig
0.18159729.11961279.html.plaintext.txt	127	All four recombinant PrP molecules migrated series three bands represent un mono diglycosylated forms proteins
0.18159729.11961279.html.plaintext.txt	128	Wild type G112 119 A112 119 moPrPs Fig
0.18159729.11961279.html.plaintext.txt	129	2f lanes 1 3 size PrPC sources whereas 105 125 protein bands shifted lower molecular mass Fig
0.18159729.11961279.html.plaintext.txt	130	The levels expression A112 119 G112 119 105 125 wild type moPrPs stably transfected N2a cell lines comparable much higher expression endogenous moPrP normal N2a cells see Fig
0.18159729.11961279.html.plaintext.txt	131	View larger version 34K Fig
0.18159729.11961279.html.plaintext.txt	132	Characterization proteolytic fragments wild type WT 105 125 G112 119 A112 119 moPrPs
0.18159729.11961279.html.plaintext.txt	133	b Brain homogenates normal hamster tg81 mice lanes 1 2 lysates N2a cell lines overexpressing recombinant moPrP lanes 3 6 b lanes 1 4 well normal N2a cells lane 7 b lane 5 treated PNGase F 3 h
0.18159729.11961279.html.plaintext.txt	134	Equal amounts 100 microg deglycosylated proteins subjected immunoblotting monoclonal antibodies 13A5 6H4 b
0.18159729.11961279.html.plaintext.txt	135	The positions full length PrP C terminal fragment C1 indicated left positions marker proteins indicated right
0.18159729.11961279.html.plaintext.txt	136	c Quantification immunopositive signals C terminal fragment C1 compared amount full length PrP different mutants following staining antibody 6H4
0.18159729.11961279.html.plaintext.txt	137	The ratio C1 fragment full length PrP determined lane means calculated
0.18159729.11961279.html.plaintext.txt	138	Bars indicate standard deviations based three experiments
0.18159729.11961279.html.plaintext.txt	139	Examination PrP specific fragments following deglycosylation The sugar moieties wild type PrPC N linked cleaved respective asparagines PNGase F giving rise protein 27 kDa Haraguchi et al
0.18159729.11961279.html.plaintext.txt	140	In order study PrP specific fragments mutant moPrPs following deglycosylation performed Western blot analysis different antibodies
0.18159729.11961279.html.plaintext.txt	141	Mouse mAb 13A5 immunoreacted 13A5 tagged wild type 105 125 G112 119 A112 119 moPrPs Fig
0.18159729.11961279.html.plaintext.txt	142	3a lanes 3 6 well hamster PrP normal hamster tg81 mice Fig
0.18159729.11961279.html.plaintext.txt	143	3a lanes 1 2 could detect untagged endogenous PrP normal N2a cells Fig
0.18159729.11961279.html.plaintext.txt	144	mAb 6H4 reacted normal moPrP also failed detect endogenous PrP Fig
0.18159729.11961279.html.plaintext.txt	145	3b lane 5 due low level expression
0.18159729.11961279.html.plaintext.txt	146	Treatment cell lysates PNGase F reduced heterogeneity PrP specific bands 13A5 tagged wild type G112 119 A112 119 moPrPs fragment 27 kDa indicated PrP Fig
0.18159729.11961279.html.plaintext.txt	147	3a lanes 3 5 b lanes 1 3 consistent molecular mass full length deglycosylated PrP containing GPI anchor
0.18159729.11961279.html.plaintext.txt	148	105 125 moPrP showed expected difference molecular mass 2 3 kDa comparison wild type moPrP Fig
0.18159729.11961279.html.plaintext.txt	149	A prominent band 18 kDa designated C1 recognized mAbs 13A5 6H4 blots wild type A112 119 moPrPs Fig
0.18159729.11961279.html.plaintext.txt	150	3a 13A5 lanes 3 4 b 6H4 lanes 1 2
0.18159729.11961279.html.plaintext.txt	151	It corresponded size major C terminal fragment PrPC hamster tg81 mice Fig
0.18159729.11961279.html.plaintext.txt	152	The PrP specific fragment 18 kDa detectable weakly detectable antibodies blots 105 125 G112 119 moPrPs Fig
0.18159729.11961279.html.plaintext.txt	153	3a lanes 5 6 b lanes 3 4 c
0.18159729.11961279.html.plaintext.txt	154	This finding highly significant reproducible
0.18159729.11961279.html.plaintext.txt	155	These experiments showed mutants carried N linked glycosylation amount potentially proteolytic fragment C1 dependent mutation introduced
0.18159729.11961279.html.plaintext.txt	156	G112 119 moPrP resistant protease In order test mutant moPrPs protease resistance lysates digested 10 min 3 3 microgml PK treated PNGase F simplify evaluation
0.18159729.11961279.html.plaintext.txt	157	Wild type A112 119 endogenous moPrPs well PrP tg81 mice completely degraded conditions Fig
0.18159729.11961279.html.plaintext.txt	158	4a lanes 2 8 10 12 mutant G112 119 moPrP gave clear protease resistant signal migrated 22 kDa range Fig
0.18159729.11961279.html.plaintext.txt	159	View larger version 63K Fig
0.18159729.11961279.html.plaintext.txt	160	Protease resistance mutant moPrPs
0.18159729.11961279.html.plaintext.txt	161	Protein lysates N2a cell lines overexpressing recombinant moPrP lanes 1 8 lysate normal N2a cells lanes 9 10 lysate brain homogenate tg81 mice lanes 11 12 treated PK 3 3 microgml 37 degrees C 10 min left undigested
0.18159729.11961279.html.plaintext.txt	162	All lysates incubated PNGase F 3 h equal amounts protein 100 microg analysed Western blot using rabbit polyclonal antiserum Kan72
0.18159729.11961279.html.plaintext.txt	163	b Equal amounts 100 microg lysates N2a cells overexpressing wild type moPrP lanes 1 5 G112 119 moPrP lanes 6 10 digested 37 degrees C 0 10 20 40 60 min PK 3 3 microgml
0.18159729.11961279.html.plaintext.txt	164	An equivalent amount brain homogenate hamster scrapie left undigested lane 11 treated PK 20 microgml 37 degrees C 60 min lane 12
0.18159729.11961279.html.plaintext.txt	165	Positions marker proteins indicated
0.18159729.11961279.html.plaintext.txt	166	To assess extent protease resistance G112 119 subjected lysates G112 119 wild type moPrPs digestion 3 3 microgml PK 10 20 40 60 min 37 degrees C
0.18159729.11961279.html.plaintext.txt	167	In contrast complete degradation wild type moPrP Fig
0.18159729.11961279.html.plaintext.txt	168	4b lanes 2 5 significant amounts immunoreactive G112 119 moPrP remained 10 20 min Fig
0.18159729.11961279.html.plaintext.txt	169	Comparison protease resistant core hamster PrPSc Fig
0.18159729.11961279.html.plaintext.txt	170	4b lane 12 showed fragments hamster PrPSc G112 119 moPrP remaining proteinase digestion migrated similar size range faster respective untreated samples Fig
0.18159729.11961279.html.plaintext.txt	171	4b compare lanes 6 7 well lanes 11 12
0.18159729.11961279.html.plaintext.txt	172	Doxycycline induced expression wild type G112 119 moPrPs The protease resistance G112 119 moPrP examined reverse tetracycline inducible expression system
0.18159729.11961279.html.plaintext.txt	173	The two stably transfected cell lines rtTA wild type rtTA G112 119 displayed inducibility Fig
0.18159729.11961279.html.plaintext.txt	174	5a compare lane 2 lane 3 lane 4 lane 5 tested background expression induction overexpression induction doxycycline
0.18159729.11961279.html.plaintext.txt	175	The level expression increased 2 3 fold induction 2 microgml doxycycline medium 20 h
0.18159729.11961279.html.plaintext.txt	176	Comparison amount wild type G112 119 moPrP uninduced state level endogenous PrP untransfected N2a cells shows background wild type G112 119 moPrPs Fig
0.18159729.11961279.html.plaintext.txt	177	View larger version 37K Fig
0.18159729.11961279.html.plaintext.txt	178	Doxycycline induced overexpression wild type G112 119 moPrPs
0.18159729.11961279.html.plaintext.txt	179	Stably double transfected N2a cell lines tested induction doxycycline 2 microgml medium 20 h
0.18159729.11961279.html.plaintext.txt	180	Expression wild type lanes 2 3 G112 119 lanes 4 5 moPrPs analysed Western blot mAb 3B5
0.18159729.11961279.html.plaintext.txt	181	A cell lysate normal N2a cells added control lane 1
0.18159729.11961279.html.plaintext.txt	182	Equal amounts 100 microg protein loaded lanes
0.18159729.11961279.html.plaintext.txt	183	b Protein lysates stably double transfected N2a cell lines expressing wild type lanes 7 10 G112 119 lanes 1 4 protein lysates normal N2a cells endogenous lanes 5 6 treated PK 3 3 microgml 37 degrees C 10 min left untreated indicated lanes 1 2 7 8 lanes 3 4 9 10 induction doxycycline Dox 2 microgml medium 20 h
0.18159729.11961279.html.plaintext.txt	184	Equal amounts 100 microg protein subjected immunoblotting using Kan72 antiserum
0.18159729.11961279.html.plaintext.txt	185	c Proteins lysates cells expressing wild type lanes 6 8 G112 119 lanes 1 5 moPrPs induction doxycycline 2 microgml medium treated PK different concentrations 3 3 10 20 50 microgml 37 degrees C 10 min lanes 2 5 7 8 left undigested lanes 1 6
0.18159729.11961279.html.plaintext.txt	186	Equal amounts 100 microg protein analysed Western blot rabbit polyclonal antiserum Kan72
0.18159729.11961279.html.plaintext.txt	187	Positions marker proteins indicated
0.18159729.11961279.html.plaintext.txt	188	In order examine whether G112 119 became protease resistant tetracycline inducible system performed digestion 3 3 microgml PK 10 min lysates cells induction 20 h 2 microgml doxycycline
0.18159729.11961279.html.plaintext.txt	189	In contrast complete degradation wild type Fig
0.18159729.11961279.html.plaintext.txt	190	5b lanes 8 10 endogenous Fig
0.18159729.11961279.html.plaintext.txt	191	5b lane 6 moPrP found protease resistant G112 119 moPrP induced well uninduced state Fig
0.18159729.11961279.html.plaintext.txt	192	The amount protease resistant G112 119 moPrP correlated amount total G112 119 moPrP induction Fig
0.18159729.11961279.html.plaintext.txt	193	5b lanes 1 2 well induction Fig
0.18159729.11961279.html.plaintext.txt	194	5b lanes 3 4 50 total G112 119 moPrP expression states
0.18159729.11961279.html.plaintext.txt	195	The clear increase amount protease resistant PrP therefore acquired within 20 h induction
0.18159729.11961279.html.plaintext.txt	196	In induced state G112 119 moPrP showed clear shift diglycosylated monoglycosylated unglycosylated bands digestion PK Fig
0.18159729.11961279.html.plaintext.txt	197	5b lane 4 compared three full length bands digestion Fig
0.18159729.11961279.html.plaintext.txt	198	Treatment G112 119 moPrP induced state 3 3 microgml PK different lengths time yielded protease resistant G112 119 moPrP digestion 10 20 min data shown corresponded results permanently expressed mutant moPrPs control hCMV promoter
0.18159729.11961279.html.plaintext.txt	199	The high level expression wild type G112 119 moPrPs induced state gave us reason test extent resistance PK higher concentrations
0.18159729.11961279.html.plaintext.txt	200	After induction 20 h 2 microgml doxycycline treated lysates N2a cell lines rtTA G112 119 rtTA wild type PK concentrations 3 3 10 20 50 microgml 10 min Fig
0.18159729.11961279.html.plaintext.txt	201	Wild type moPrP degraded completely Fig
0.18159729.11961279.html.plaintext.txt	202	5c lanes 7 8 whereas immunoreactive G112 119 moPrP still remained digestion 10 microgml PK Fig
0.18159729.11961279.html.plaintext.txt	203	The amount still 12 full length G112 119 moPrP Fig
0.18159729.11961279.html.plaintext.txt	204	5c compare lane 3 lane 1
0.18159729.11961279.html.plaintext.txt	205	By employing permanent inducible expression system could show acquisition protease resistance intrinsic property G112 119 moPrP N2a cells
0.18159729.11961279.html.plaintext.txt	206	Discussion Top Abstract Introduction Methods Results Discussion References Three different mutants PrP overexpressed N2a cells analysed alongside normal N2a cells N2a cells overexpressing wild type PrP
0.18159729.11961279.html.plaintext.txt	207	The three mutations positioned central evolutionarily highly conserved domain protein order reveal consequences changing deleting highly amyloidogenic palindrome AGAAAAGA residues 112 119 moPrP Gasset et al
0.18159729.11961279.html.plaintext.txt	208	By immunofluorescence analysis showed mutant prion proteins transported large extent cell surface wild type protein
0.18159729.11961279.html.plaintext.txt	209	Most mutant PrPs far stably overexpressed cells reach cell surface notable exception proteins mutated first N glycosylation site Lehmann Harris 1997
0.18159729.11961279.html.plaintext.txt	210	In mutant proteins presented glycosylation sites used
0.18159729.11961279.html.plaintext.txt	211	Therefore find indication defect post translational transport mutant PrPs cell surface whereas pathogenic human mutations P102L D178N F197 well insertional mutation nine additional octapeptides shown effect delivery molecules cell surface Ivanova et al
0.18159729.11961279.html.plaintext.txt	212	A certain amount normal PrPC cleaved physiologically identifiable presence C terminal fragment Chen et al
0.18159729.11961279.html.plaintext.txt	213	It amount C terminal fragment relative full length PrP altered substantially two mutant PrPs presented
0.18159729.11961279.html.plaintext.txt	214	It easily conceivable might consequence extensive deletion mutant 105 125 moPrP residues N C terminal putative cleavage site residue 110 111 removed Chen et al
0.18159729.11961279.html.plaintext.txt	215	The strongly inhibitory effect mutant G112 119 efficacy cellular cleavage probably determined directly mutation induced alteration protein conformation several possible explanations proteolytic processing influenced altered structure G112 119 moPrP mutated residues might poor substrate putative cleaving enzyme ii structure whole protein might changed cleavage site might less accessible iii due mutation introduced protein might distributed cell surface different manner therefore infrequent contact processing enzyme
0.18159729.11961279.html.plaintext.txt	216	Analysis protease resistance various PrP mutants showed G112 119 moPrP displayed resistance PK digestion concentration 3 3 microgml 10 min 37 degrees C
0.18159729.11961279.html.plaintext.txt	217	These conditions much milder used detection PrPSc brain homogenates diseased animals humans e
0.18159729.11961279.html.plaintext.txt	218	20 microgml 30 min 37 degrees C Bueler et al
0.18159729.11961279.html.plaintext.txt	219	1994 used Lehmann Harris 1997 analysis Prnp genes carrying human pathogenic mutations
0.18159729.11961279.html.plaintext.txt	220	In latter study authors found conditions introduction human pathogenic mutations P102L D178N T183A E200K insertion six additional octapeptides ORF Prnp respective locations P101L D177N T183A E199K rendered mutated proteins resistant PK concentration
0.18159729.11961279.html.plaintext.txt	221	The PK resistance always accompanied enhanced detergent insolubility mutated proteins Daude et al
0.18159729.11961279.html.plaintext.txt	222	1997 Lehmann Harris 1997
0.18159729.11961279.html.plaintext.txt	223	Similar PK resistance reported pathogenic mutations groups Priola Chesebro 1998 Singh et al
0.18159729.11961279.html.plaintext.txt	224	1997 large low concentration PK dependence results cell type used Petersen et al
0.18159729.11961279.html.plaintext.txt	225	1996 Priola Chesebro 1998 lack demonstrable infectivity resulting type protease resistance leave open whether generated protease resistant PrP low concentration PrPSc unrelated infectivity
0.18159729.11961279.html.plaintext.txt	226	We could show extent protease resistance mutant G112 119 moPrP slightly higher standard conditions 3 3 microgml 10 min 37 degrees C still much lower resistance PrPSc infected animals infected tissue culture Holscher et al
0.18159729.11961279.html.plaintext.txt	227	Yet protease resistance intrinsic property G112 119 moPrP N2a cells chance event particular N2a cell clone confirmed protease resistance particular mutant expressing different expression system doxycycline inducible expression system
0.18159729.11961279.html.plaintext.txt	228	So far system used express wild type PrP genes transgenic animals N2a cells Tremblay et al
0.18159729.11961279.html.plaintext.txt	229	The mutant G112 119 moPrP showed concurrent increase amount protease resistant PrP induction expression doxycycline indicating acquisition protease resistance occurs soon biosynthesis mutant protein
0.18159729.11961279.html.plaintext.txt	230	These findings two general meanings conversion certain mutant PrP molecules protease resistant isoforms
0.18159729.11961279.html.plaintext.txt	231	The acquisition mild form protease resistance mutant prion proteins tissue culture restricted mutations known cause inherited prion diseases humans
0.18159729.11961279.html.plaintext.txt	232	This might point fact many probably devastating pathogenic mutations possible PrP might exist living animals interfere evolutionary success respective carrier
0.18159729.11961279.html.plaintext.txt	233	A recent study using peptides randomized hydrophobic domain supports argument author showed peptides toxic neurotoxic fragment 106 126 Brown 2000a
0.18159729.11961279.html.plaintext.txt	234	ii Changes central hydrophobic region immediate consequences structure processing PrP
0.18159729.11961279.html.plaintext.txt	235	This line studies mutants domain used different experimental set ups Hegde et al
0.18159729.11961279.html.plaintext.txt	236	Recently alternative topological variant PrP called CtmPrP proposed key factor development neurodegeneration prion diseases Hegde et al
0.18159729.11961279.html.plaintext.txt	237	The fragment size generated CtmPrP mild PK digestion found smaller PK resistant PrPSc
0.18159729.11961279.html.plaintext.txt	238	The general importance CtmPrP pathogenesis prion diseases remains controversial Stewart Harris 2001
0.18159729.11961279.html.plaintext.txt	239	Structural data full length recombinant PrP define N terminal half protein residues 23 120 moPrP residues 23 124 hamster PrP flexibly disordered random coil Donne et al
0.18159729.11961279.html.plaintext.txt	240	Copper binding seems confer distinctive structure N terminal octapeptide repeats Viles et al
0.18159729.11961279.html.plaintext.txt	241	1999 motif AGAAAAGA positioned hydrophobic C terminus unstructured part PrP recent refinement structure Liu et al
0.18159729.11961279.html.plaintext.txt	242	1999 confirmed adopt regular secondary structure
0.18159729.11961279.html.plaintext.txt	243	Yet latter authors found indications multiple discrete conformations hydrophobic domain might imply region metastable could therefore play essential role formation PrPSc
0.18159729.11961279.html.plaintext.txt	244	It suggested PrPSc interacts recombinant PrPC amino acid residues 112 119 mouse sequence Brown 2000b might indicate sequence encompassing residues 112 119 special importance conversion PrPC PrPSc
0.18159729.11961279.html.plaintext.txt	245	Copper ions reversibly induce PrPC become protease resistant Quaglio et al
0.18159729.11961279.html.plaintext.txt	246	2001 remains seen way binding copper N terminal repeats concomitant adoption structure influences structural transitions potentially take place C terminal hydrophobic domain N terminus
0.18159729.11961279.html.plaintext.txt	247	Our data demonstrate certain mutation hydrophobic region induces ready formation PK resistant PrP
0.18159729.11961279.html.plaintext.txt	248	Therefore hypothesized mutation stabilizes conformation shares features infectious form PrP
0.18159729.11961279.html.plaintext.txt	249	Whether prion infectivity generated de novo tissue culture tested future using infectivity assays transgenic animals
0.18159729.11961279.html.plaintext.txt	250	Acknowledgments We thank Stanley B
0.18159729.11961279.html.plaintext.txt	251	Prusiner antibody 13A5 tg81 mice Bruno Oesch antibody 6H4 Alexander Buerkle antibody Kan72
0.18159729.11961279.html.plaintext.txt	252	We also thank Martin Groschup providing brain hamsters hamsters infected scrapie strain 263K B
0.18159729.11961279.html.plaintext.txt	253	Zevnik gift plasmid pHA58 H
0.18159729.11961279.html.plaintext.txt	254	Bujard generous gifts plasmids pUHG 172 1 pUHD 10 3
0.18159729.11961279.html.plaintext.txt	255	We indebted Connex GmbH Martinsried Germany use S2 facility
0.18159729.11961279.html.plaintext.txt	256	This work supported grants European Commission grants
0.18159729.11961279.html.plaintext.txt	257	BMH4 CT98 6040 ERBFMH4 CT98 6040
0.18159729.11961279.html.plaintext.txt	258	Footnotes b Present address Department Neuropathology Oxford UK
0.18159729.11961279.html.plaintext.txt	259	References Top Abstract Introduction Methods Results Discussion References Borchelt D
0.18159729.11961279.html.plaintext.txt	260	Scrapie cellular prion proteins differ kinetics synthesis topology cultured cells
0.18159729.11961279.html.plaintext.txt	261	Journal Cell Biology 110 743 752
0.18159729.11961279.html.plaintext.txt	262	Normal host prion protein necessary scrapie induced neurotoxicity
0.18159729.11961279.html.plaintext.txt	263	Prion protein peptides optimal toxicity peptide blockade toxicity
0.18159729.11961279.html.plaintext.txt	264	Molecular Cellular Neurosciences 15 66 78
0.18159729.11961279.html.plaintext.txt	265	PrPSc like prion protein peptide inhibits function cellular prion protein
0.18159729.11961279.html.plaintext.txt	266	Biochemical Journal 352 511 518
0.18159729.11961279.html.plaintext.txt	267	Role microglia host prion protein neurotoxicity prion protein fragment
0.18159729.11961279.html.plaintext.txt	268	The cellular prion protein binds copper vivo
0.18159729.11961279.html.plaintext.txt	269	Prion protein deficient cells show altered response oxidative stress due decreased SOD 1 activity
0.18159729.11961279.html.plaintext.txt	270	Experimental Neurology 146 104 112
0.18159729.11961279.html.plaintext.txt	271	Mice devoid PrP resistant scrapie
0.18159729.11961279.html.plaintext.txt	272	High prion PrPSc levels delayed onset disease scrapie inoculated mice heterozygous disrupted PrP gene
0.18159729.11961279.html.plaintext.txt	273	Prion protein biosynthesis scrapie infected uninfected neuroblastoma cells
0.18159729.11961279.html.plaintext.txt	274	Journal Virology 63 175 181
0.18159729.11961279.html.plaintext.txt	275	Secondary structure analysis scrapie associated protein PrP27 30 water infrared spectroscopy
0.18159729.11961279.html.plaintext.txt	276	Specific inhibition vitro formation protease resistant prion protein synthetic peptides
0.18159729.11961279.html.plaintext.txt	277	Journal Biological Chemistry 273 13203 13207
0.18159729.11961279.html.plaintext.txt	278	Truncated forms human prion protein normal brain prion diseases
0.18159729.11961279.html.plaintext.txt	279	Journal Biological Chemistry 270 19173 19180
0.18159729.11961279.html.plaintext.txt	280	Identification intermediate steps conversion mutant prion protein scrapie like form cultured cells
0.18159729.11961279.html.plaintext.txt	281	Journal Biological Chemistry 272 11604 11612
0.18159729.11961279.html.plaintext.txt	282	Structure recombinant full length hamster prion protein PrP29 231 N terminus highly flexible
0.18159729.11961279.html.plaintext.txt	283	Proceedings National Academy Sciences USA 94 13452 13457
0.18159729.11961279.html.plaintext.txt	284	Neurotoxicity prion protein fragment
0.18159729.11961279.html.plaintext.txt	285	Predicted helical regions prion protein synthesized peptides form amyloid
0.18159729.11961279.html.plaintext.txt	286	Proceedings National Academy Sciences USA 89 10940 10944
0.18159729.11961279.html.plaintext.txt	287	Asparagine linked glycosylation scrapie cellular prion proteins
0.18159729.11961279.html.plaintext.txt	288	Archives Biochemistry Biophysics 274 1 13
0.18159729.11961279.html.plaintext.txt	289	Processing cellular prion protein identification N C terminal cleavage sites
0.18159729.11961279.html.plaintext.txt	290	A transmembrane form prion protein neurodegenerative disease
0.18159729.11961279.html.plaintext.txt	291	Transmissible genetic prion diseases share common pathway neurodegeneration
0.18159729.11961279.html.plaintext.txt	292	Evidence presynaptic location function prion protein
0.18159729.11961279.html.plaintext.txt	293	Journal Neuroscience 19 8866 8875
0.18159729.11961279.html.plaintext.txt	294	A general method vitro preparation specific mutagenesis DNA fragments study protein DNA interactions
0.18159729.11961279.html.plaintext.txt	295	Nucleic Acids Research 16 7351 7367
0.18159729.11961279.html.plaintext.txt	296	Overexpression nonconvertible PrPc114 121 scrapie infected mouse neuroblastoma cells leads trans dominant inhibition wild type PrPSc accumulation
0.18159729.11961279.html.plaintext.txt	297	Journal Virology 72 1153 1159
0.18159729.11961279.html.plaintext.txt	298	Recombinant full length murine prion protein mPrP23 231 purification spectroscopic characterization
0.18159729.11961279.html.plaintext.txt	299	Mutant prion proteins partially retained endoplasmic reticulum
0.18159729.11961279.html.plaintext.txt	300	Journal Biological Chemistry 276 42409 42421
0.18159729.11961279.html.plaintext.txt	301	Endogenous proteolytic cleavage normal disease associated isoforms human prion protein neural non neural tissues
0.18159729.11961279.html.plaintext.txt	302	American Journal Pathology 153 1561 1572
0.18159729.11961279.html.plaintext.txt	303	Neuroblastoma cell culture analysis differentiating stem cell system
0.18159729.11961279.html.plaintext.txt	304	Journal Cell Biology 43 69a
0.18159729.11961279.html.plaintext.txt	305	Prion PrPSc specific epitope defined monoclonal antibody
0.18159729.11961279.html.plaintext.txt	306	Generation monoclonal antibodies human prion proteins PrP00 mice
0.18159729.11961279.html.plaintext.txt	307	Immobilon P transfer membrane applications utility protein biochemical analysis
0.18159729.11961279.html.plaintext.txt	308	Mutant infectious prion proteins display common biochemical properties cultured cells
0.18159729.11961279.html.plaintext.txt	309	Journal Biological Chemistry 271 1633 1637
0.18159729.11961279.html.plaintext.txt	310	Blockade glycosylation promotes acquisition scrapie like properties prion protein cultured cells
0.18159729.11961279.html.plaintext.txt	311	Journal Biological Chemistry 272 21479 21487
0.18159729.11961279.html.plaintext.txt	312	Solution structure Syrian hamster prion protein rPrP90 231
0.18159729.11961279.html.plaintext.txt	313	Signal transduction prion protein
0.18159729.11961279.html.plaintext.txt	314	Recombinant scrapie like prion protein 106 amino acids soluble
0.18159729.11961279.html.plaintext.txt	315	Proceedings National Academy Sciences USA 93 15457 15462
0.18159729.11961279.html.plaintext.txt	316	Purification properties cellular prion protein Syrian hamster brain
0.18159729.11961279.html.plaintext.txt	317	Conversion helices sheets features formation scrapie prion proteins
0.18159729.11961279.html.plaintext.txt	318	Proceedings National Academy Sciences USA 90 10962 10966
0.18159729.11961279.html.plaintext.txt	319	Effect D178N mutation codon 129 polymorphism metabolism prion protein
0.18159729.11961279.html.plaintext.txt	320	Journal Biological Chemistry 271 12661 12668
0.18159729.11961279.html.plaintext.txt	321	Abnormal properties prion protein insertional mutations different cell types
0.18159729.11961279.html.plaintext.txt	322	Journal Biological Chemistry 273 11980 11985
0.18159729.11961279.html.plaintext.txt	323	Prion diseases neurodegeneration
0.18159729.11961279.html.plaintext.txt	324	Annual Review Neuroscience 17 311 339
0.18159729.11961279.html.plaintext.txt	325	Prion diseases humans animals
0.18159729.11961279.html.plaintext.txt	326	Seminars Virology 7 159 173
0.18159729.11961279.html.plaintext.txt	327	Copper converts cellular prion protein protease resistant species distinct scrapie isoform
0.18159729.11961279.html.plaintext.txt	328	Journal Biological Chemistry 276 11432 11438
0.18159729.11961279.html.plaintext.txt	329	NMR structure mouse prion protein domain PrP121 231
0.18159729.11961279.html.plaintext.txt	330	NMR characterization full length recombinant murine prion protein mPrP23 231
0.18159729.11961279.html.plaintext.txt	331	Epitope mapping Syrian hamster prion protein utilizing chimeric mutant genes vaccinia virus expression system
0.18159729.11961279.html.plaintext.txt	332	Journal Immunology 147 3568 3574
0.18159729.11961279.html.plaintext.txt	333	Conformational transitions dissociation unfolding scrapie amyloid prion protein
0.18159729.11961279.html.plaintext.txt	334	Journal Biological Chemistry 268 20276 20284
0.18159729.11961279.html.plaintext.txt	335	Transgenic mice expressing hamster prion protein produce species specific scrapie infectivity amyloid plaques
0.18159729.11961279.html.plaintext.txt	336	A prion protein cycles cell surface endocytic compartment cultured neuroblastoma cells
0.18159729.11961279.html.plaintext.txt	337	Journal Biological Chemistry 268 15922 15928
0.18159729.11961279.html.plaintext.txt	338	Prion protein aggregation reverted low temperature transfected cells carrying prion protein gene mutation
0.18159729.11961279.html.plaintext.txt	339	Journal Biological Chemistry 272 28461 28470
0.18159729.11961279.html.plaintext.txt	340	Most pathogenic mutations alter membrane topology prion protein
0.18159729.11961279.html.plaintext.txt	341	Journal Biological Chemistry 276 2212 2220
0.18159729.11961279.html.plaintext.txt	342	Doxycycline control prion protein transgene expression modulates prion disease mice
0.18159729.11961279.html.plaintext.txt	343	Proceedings National Academy Sciences USA 95 12580 12585
0.18159729.11961279.html.plaintext.txt	344	Copper binding prion protein structural implications four identical cooperative binding sites
0.18159729.11961279.html.plaintext.txt	345	Proceedings National Academy Sciences USA 96 2042 2047
0.18159729.11961279.html.plaintext.txt	346	Construction characterization murine neuroblastoma cell clones allowing inducible high expression prion protein
0.18159729.11961279.html.plaintext.txt	347	Journal General Virology 80 15 21
0.18159729.11961279.html.plaintext.txt	348	Received 10 August 2001 accepted 14 December 2001
0.18159729.11961279.html.plaintext.txt	349	This Article Abstract Full Text PDF Alert article cited Alert correction posted Citation Map Services Email article friend Similar articles journal Similar articles PubMed Alert new issues journal Download citation manager Google Scholar Articles Wegner C
0.18159729.11961279.html.plaintext.txt	350	Articles citing Article PubMed PubMed Citation Articles Wegner C
0.18159729.11961279.html.plaintext.txt	351	Agricola Articles Wegner C
0.18159729.11961279.html.plaintext.txt	352	HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL J MED MICROBIOL ALL SGM JOURNALS
0.11076246.11262410.html.plaintext.txt	0	Repression Dpp Targets Binding Brinker Mad Sites Heidi Kirkpatrick Kirby Johnson Allen Laughon
0.11076246.11262410.html.plaintext.txt	1	From Laboratory Genetics University Wisconsin Madison Wisconsin 53706
0.11076246.11262410.html.plaintext.txt	2	Received publication February 13 2001 revised form March 20 2001
0.11076246.11262410.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.11076246.11262410.html.plaintext.txt	4	Signaling decapentaplegic Dpp Drosophila member transforming growth factor TGF superfamily growth factors recently shown activate targets vestigial vg indirectly negative regulation brinker brk
0.11076246.11262410.html.plaintext.txt	5	Here show Brk protein functions repressor binding Dpp response elements
0.11076246.11262410.html.plaintext.txt	6	The Brk DNA binding activity localized amino terminal region containing putative homeodomain
0.11076246.11262410.html.plaintext.txt	7	Brk bound Dpp response element Ultrabithorax Ubx midgut enhancer sequence overlaps binding site Smad protein Mothers Against Dpp Mad
0.11076246.11262410.html.plaintext.txt	8	Furthermore Brk able compete Mad occupancy binding site
0.11076246.11262410.html.plaintext.txt	9	This recognition overlapping binding sites provides potential explanation GC rich Mad binding site consensus differs Smad3Smad4 binding site consensus
0.11076246.11262410.html.plaintext.txt	10	We also found Dpp response element Ubx sensitive vg quadrant enhancer repression Brk
0.11076246.11262410.html.plaintext.txt	11	This difference correlates short range activation Ubx Dpp visceral mesoderm whereas vg exhibits long range response Dpp wing imaginal disc indicating Brk binding sites may play critical role limiting thresholds activation Dpp
0.11076246.11262410.html.plaintext.txt	12	Finally provide evidence Brk capable functioning active repressor
0.11076246.11262410.html.plaintext.txt	13	Thus whereas Brk Mad compete regulation Ubx vg Brk may regulate Dpp targets without direct involvement Mad
0.11076246.11262410.html.plaintext.txt	14	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.11076246.11262410.html.plaintext.txt	15	Members transforming growth factor TGF superfamily growth factors perform multitude functions regulating cell growth differentiation 1 4
0.11076246.11262410.html.plaintext.txt	16	The nuclear effectors pathways Smad transcription factors 5
0.11076246.11262410.html.plaintext.txt	17	The activinTGF pathways trigger activation Smad2 Smad3 whereas bone morphogenetic protein BMP1 pathways utilize Smad1 Smad5 Smad8
0.11076246.11262410.html.plaintext.txt	18	Each receptor activated Smads phosphorylated response signaling leading assembly complexes Smad4 translocation nucleus association cofactors results regulation target genes 6 9
0.11076246.11262410.html.plaintext.txt	19	Signaling Drosophila TGF family member Decapentaplegic Dpp plays important role patterning dorsal ventral axis visceral mesoderm endoderm wing leg eye 10 16
0.11076246.11262410.html.plaintext.txt	20	An important feature Dpp signaling ability trigger activation target genes different thresholds allowing cells interpret position along Dpp gradient 12 17
0.11076246.11262410.html.plaintext.txt	21	The best understood example primoridia wing spalt sal optomotor blind omb vestigial vg expressed progressively wider patterns response postulated gradient extracellular Dpp protein 18 22
0.11076246.11262410.html.plaintext.txt	22	This graded Dpp activity emanates strip Dpp expressing cells bisects wing imaginal disc 23
0.11076246.11262410.html.plaintext.txt	23	Dpp signaling triggers phosphorylation founding member Smad family Mothers Against Dpp Mad 24 27
0.11076246.11262410.html.plaintext.txt	24	Activated Mad associates Smad4 homolog Medea 28 31 directly regulates target genes vg Ubx tinman tin 32 34
0.11076246.11262410.html.plaintext.txt	25	Mad binds GC rich sites consensus sequence GCCGNCGC 32 whereas vertebrate Smad3 Smad4 bind preferably two three tandem copies 4 bp Smad box sequence GTCT 35 36
0.11076246.11262410.html.plaintext.txt	26	The Mad consensus bears limited resemblance inverted pair Smad boxes clear two sequences differ
0.11076246.11262410.html.plaintext.txt	27	The Mad consensus may extend vertebrate BMP responsive Smads Smad1 acts Mad like site activate Smad6 gene 37 38
0.11076246.11262410.html.plaintext.txt	28	One possibility Mad consensus reflects involvement cofactor consistent general dependence Smads cofactors 39 40
0.11076246.11262410.html.plaintext.txt	29	An unexpected twist Dpp regulatory cascade came light discovery brinker brk gene negatively regulated Dpp turn functions negative regulator Dpp targets 41 44
0.11076246.11262410.html.plaintext.txt	30	In wing imaginal disc Dpp targets sal omb vg expressed ectopically brk clones
0.11076246.11262410.html.plaintext.txt	31	Ectopic expression genes occurs even cells brk clone overlaps clone mutant Mad Dpp receptor thickveins tkv
0.11076246.11262410.html.plaintext.txt	32	These results revealed Dpp activates targets indirectly repression brk recently shown occur conjunction Mad cofactor Schnurri 45 46
0.11076246.11262410.html.plaintext.txt	33	However Dpp response elements vg Ubx tin shown dependent Mad binding sites ability direct Dpp dependent reporter expression 32 34
0.11076246.11262410.html.plaintext.txt	34	Together observations suggest Dpp activates targets two distinct mechanisms 1 direct activation Smads 2 indirect activation repression brk
0.11076246.11262410.html.plaintext.txt	35	The Brk protein contains potential homeodomain localized nucleus 43 consistent functioning repressor
0.11076246.11262410.html.plaintext.txt	36	Brk antagonized BMP2 signaling expressed ectopically Xenopus embryos suggesting may conserved feature DppBMP pathways 41
0.11076246.11262410.html.plaintext.txt	37	Here report Brk protein binds represses Dpp response elements vg Ubx
0.11076246.11262410.html.plaintext.txt	38	We show previously identified Mad site actually composite Mad Brk site show Mad Brk capable competing binding site
0.11076246.11262410.html.plaintext.txt	39	These observations suggest explanation Mad binding site consensus differs Smad3 Smad4
0.11076246.11262410.html.plaintext.txt	40	In addition found Dpp response element Ubx sensitive Brk repression element vg quadrant enhancer
0.11076246.11262410.html.plaintext.txt	41	These results correlate respective short long range thresholds Ubx vg indicate Brk binding sites may play important role setting thresholds activation Dpp
0.11076246.11262410.html.plaintext.txt	42	Our results concur recent reports Brk functions DNA binding repressor 47 49
0.11076246.11262410.html.plaintext.txt	43	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.11076246.11262410.html.plaintext.txt	44	Plasmids All reporter plasmids based vector hsplacCasper 50
0.11076246.11262410.html.plaintext.txt	45	Carroll contained two tandem copies core Dpp response element TAGCCTGCCGTCGCGATTCGACAACTTTGGCCGGCACGTTGGCGAGTGTGCCATGCATGCTGATGA separated 25 bp linker inserted BamHI sites hsplacCasper
0.11076246.11262410.html.plaintext.txt	46	The 2 x Ubx lacZ reporter described Figs
0.11076246.11262410.html.plaintext.txt	47	1 4 contained two tandem copies core Dpp response element AATTGGACTGGCGTCAGCGCCGGCGCTG inserted EcoRI KpnI sites hsplacCasper
0.11076246.11262410.html.plaintext.txt	48	The 2 x UbxM11 2 x UbxM13 plasmids described Fig
0.11076246.11262410.html.plaintext.txt	49	4 identical 2 x Ubx except base substitutions indicated Fig
0.11076246.11262410.html.plaintext.txt	50	4 x Suh lacZ gift C
0.11076246.11262410.html.plaintext.txt	51	Carroll contained synthetic sequence AATTGTTCTCACGGATCCAAAGGTTCTCACGAGATCTGTTCTCACGGATCCAAAGGTTCTCACGGAATTCGGATC inserted EcoRI KpnI sites hsplacCasper
0.11076246.11262410.html.plaintext.txt	52	6 x Brk4 x Suh lacZ derived 4 x Suh lacZ insertion EcoRI KpnI sites synthetic sequence AATTAGCACCGGCGCTGTACAGCGCCGGCGCTAATTAGCGCCGGCGCTGTAC
0.11076246.11262410.html.plaintext.txt	53	Effector plasmids activated Tkv Brk Smad3 Smad4 activated ActR1B SuH activated Notch based actin5C promoter vector pPacPL
0.11076246.11262410.html.plaintext.txt	54	Effector plasmids Mad Med gift R
0.11076246.11262410.html.plaintext.txt	55	Padgett 27 based metallothionine promoter vector pMK33
0.11076246.11262410.html.plaintext.txt	56	pPac Brk generated cloning 3
0.11076246.11262410.html.plaintext.txt	57	Rushlow BamHI NotI sites pPacPL
0.11076246.11262410.html.plaintext.txt	58	In addition Brk coding region resulting plasmid contains 500 bp 5 untranslated region UTR 800 bp 3 UTR
0.11076246.11262410.html.plaintext.txt	59	The pPacSuH pPacNact plasmids gift T
0.11076246.11262410.html.plaintext.txt	60	To create MBP Brk fusion protein polymerase chain reaction used position EcoRI site 3 bp upstream Brk initiator ATG
0.11076246.11262410.html.plaintext.txt	61	The resulting clone used create MBP Brk insertion EcoRI HindII sites pMAL2C
0.11076246.11262410.html.plaintext.txt	62	MBP BrkHD generated deleting sequences PstI site 517 bp downstream Brk ATG HindII site 3 end cDNA
0.11076246.11262410.html.plaintext.txt	63	Transfections Reporter Assays Transfections Drosophila S2 cells carried described previously 36
0.11076246.11262410.html.plaintext.txt	64	A chemiluminescent galactosidase assay performed cell extracts using GalactoStar assay system Tropix Inc
0.11076246.11262410.html.plaintext.txt	65	according suppliers instructions
0.11076246.11262410.html.plaintext.txt	66	For sets transfections involving use cDNAs cloned pMK33 metallothionine promoter vector CuSO4 added cultures 24 h transfection final concentration 0
0.11076246.11262410.html.plaintext.txt	67	calculated results triplicate assays
0.11076246.11262410.html.plaintext.txt	68	Purification Fusion Proteins Band Shift Assays MBP Brk fusion proteins expressed affinity purified using amylose agarose used band shift assays previously described 36 modification binding buffer 3 Ficoll 20 mM Tris pH 7
0.11076246.11262410.html.plaintext.txt	69	1 M NaCl 1 mM dithiothreitol 0
0.11076246.11262410.html.plaintext.txt	70	5 mgml bovine serum albumin 0
0.11076246.11262410.html.plaintext.txt	71	02 green food coloring increase reaction volume 50 microl 5 microl loaded use smaller format 10 x 8 x 0
0.11076246.11262410.html.plaintext.txt	72	Purification MBP BrkHD used band shift assay shown Fig
0.11076246.11262410.html.plaintext.txt	73	1C included additional step incubating affinity immobilized protein 5 microgml RNase A 125 unitsml exonuclease III 12
0.11076246.11262410.html.plaintext.txt	74	5 unitsml DNase I 1 h room temperature means reducing contaminating nucleic acid
0.11076246.11262410.html.plaintext.txt	75	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.11076246.11262410.html.plaintext.txt	76	Brinker Represses Dpp Response Elements Dpp activates expression vg cells Drosophila wing imaginal disc quadrant enhancer located within vg fourth intron 22
0.11076246.11262410.html.plaintext.txt	77	The quadrant enhancer contains two Mad binding sites contribute Dpp responsive expression 32 51
0.11076246.11262410.html.plaintext.txt	78	Two copies 60 bp fragment containing adjacent sites referred 2 x MD2 sufficient activate lacZ reporter essentially normal quadrant pattern
0.11076246.11262410.html.plaintext.txt	79	2 It previously shown clones homozygous mutant brkbrk cells wing imaginal discs brk heterozygous larvae express vg ectopically occur outside wing primordia 43 demonstrating brk normally prevents vg expression extending hinge notum regions surround wing proper
0.11076246.11262410.html.plaintext.txt	80	Limitation 2 x MD2 lacZ expression wing primordia suggests brk might repress MD2 element although also possible control indirect means intermediate wing specific transcription factor Scalloped Drifter 51 52
0.11076246.11262410.html.plaintext.txt	81	To determine whether Brk represses MD2 element cotransfected Drosophila S2 cells 2 x MD2 lacZ reporter varying amounts effector plasmids express brk Mad Med activated version type I Dpp receptor thickveins tkvQD Fig
0.11076246.11262410.html.plaintext.txt	82	Reporter expression induced 4 fold expression Mad Med tkVQD blocked cotransfecting 10 ng pPac brk plasmid
0.11076246.11262410.html.plaintext.txt	83	This result shows Brk capable repressing vg small Smad responsive target element
0.11076246.11262410.html.plaintext.txt	84	View larger version 51K Fig
0.11076246.11262410.html.plaintext.txt	85	Brk differentially represses binds Dpp response elements vg Ubx
0.11076246.11262410.html.plaintext.txt	86	A galactosidase reporter assays showing vg lacZ Ubx lacZ reporters repressed Brk Drosophila S2 cells
0.11076246.11262410.html.plaintext.txt	87	indicates 10 ng effector plasmids Mad Med activated Tkv
0.11076246.11262410.html.plaintext.txt	88	B diagrams full length Brk truncated BrkHD Brinker proteins showing positions putative homeodomain HD PMDLS motif intervals enriched glutamine Q histidine H alanine A adapted Ref
0.11076246.11262410.html.plaintext.txt	89	C band shift assays showing binding MBP Brk MBP BrkHD MBP MadNL Ubx vg DNA probes
0.11076246.11262410.html.plaintext.txt	90	Probe sequences shown Fig
0.11076246.11262410.html.plaintext.txt	91	Indicated amounts protein preparation included 50 microl binding reactions together 1011 M indicated probe
0.11076246.11262410.html.plaintext.txt	92	Arrows indicate bound free DNA complexes
0.11076246.11262410.html.plaintext.txt	93	D band shift assay showing competition unlabeled Ubx vg probes binding labeled Ubx probe MBP Brk
0.11076246.11262410.html.plaintext.txt	94	Each 50 microl binding reaction contained 3 ng MBP Brk protein preparation 1011 M labeled Ubx probe
0.11076246.11262410.html.plaintext.txt	95	Expression vg throughout wing primordia distance source Dpp may reflect relatively low sensitivity brk
0.11076246.11262410.html.plaintext.txt	96	In contrast Ubx responds Dpp visceral mesoderm cells actually express Dpp
0.11076246.11262410.html.plaintext.txt	97	We tested whether Brk contributes short range Dpp responsiveness Ubx determining whether Brk could repress Ubx midgut enhancer element 53 S2 cells
0.11076246.11262410.html.plaintext.txt	98	A lacZ reporter driven two copies 30 bp fragment Dpp response element Ubx co transfected combinations effector plasmids expressing Mad Med tkvQD Brk Fig
0.11076246.11262410.html.plaintext.txt	99	The 2 x Ubx lacZ reporter behaved much like 2 x MD2 lacZ response Mad Med tkvQD required 0
0.11076246.11262410.html.plaintext.txt	100	08 ng pPac brk repressed
0.11076246.11262410.html.plaintext.txt	101	Thus transient transfection system Ubx element 100 fold sensitive vg MD2 repression Brk
0.11076246.11262410.html.plaintext.txt	102	This result fits expectation Brk affects target gene sensitivity Dpp
0.11076246.11262410.html.plaintext.txt	103	Brinker Binds Dpp Response Elements Two bacterially produced Brk fusion proteins generated tested means band shift assay ability bind DNA Ubx Dpp response element
0.11076246.11262410.html.plaintext.txt	104	MBP Brk fusion full length Brk C terminus maltose binding protein whereas MBP BrkHD contained amino terminal fragment harboring putative homeodomain Fig
0.11076246.11262410.html.plaintext.txt	105	Both prepared bacterial lysates affinity purification amylose beads
0.11076246.11262410.html.plaintext.txt	106	Despite inclusion protease inhibitor mixture purification fractionation SDS polyacrylamide gel showed major protein preparations 52 kDa degradation product minor amounts larger apparent primary products data shown
0.11076246.11262410.html.plaintext.txt	107	This 52 kDa size suggests fusion proteins susceptible cleavage C terminal putative homeodomain
0.11076246.11262410.html.plaintext.txt	108	Consistent interpretation preparations bound Ubx DNA probe Fig
0.11076246.11262410.html.plaintext.txt	109	1C probe sequence given Fig
0.11076246.11262410.html.plaintext.txt	110	2A whereas non fused MBP lacked detectable binding activity shown
0.11076246.11262410.html.plaintext.txt	111	Approximately 4 ng either preparation sufficient shift half Ubx probe
0.11076246.11262410.html.plaintext.txt	112	This corresponds dissociation constant 109 M value range commonly observed homeodomain DNA interactions 54
0.11076246.11262410.html.plaintext.txt	113	Both Brk fusion protein preparations yielded multiple shifted bands indicating binding occurred one site
0.11076246.11262410.html.plaintext.txt	114	In parallel MBP BrkHD preparation tested binding vg probe comprising MD2 element Fig
0.11076246.11262410.html.plaintext.txt	115	1C right panel probe sequence given Fig
0.11076246.11262410.html.plaintext.txt	116	Forty ng MBP BrkHD required shift half vg probe ten times amount needed shift half Ubx probe
0.11076246.11262410.html.plaintext.txt	117	As second means measuring relative affinities MBP Brk Ubx vg sequences unlabeled preparations Ubx vg double stranded oligos used compete binding labeled Ubx probe low concentration MBP Brk Fig
0.11076246.11262410.html.plaintext.txt	118	A 50 reduction binding probe observed 10 fold excess Ubx competitor 300 fold excess vg competitor
0.11076246.11262410.html.plaintext.txt	119	Thus determined either method low affinity Brk vg probe relative Ubx probe correlates lower relative sensitivity vg MD2 element repression Brk transfected cell reporter assay
0.11076246.11262410.html.plaintext.txt	120	In contrast Mad fusion protein MBP MadNL MH1 domain linker bound Ubx vg probes approximately equal affinities Fig
0.11076246.11262410.html.plaintext.txt	121	Together results suggest differences Dpp response thresholds Ubx vg may primarily function differential affinity Brk rather Mad
0.11076246.11262410.html.plaintext.txt	122	View larger version 34K Fig
0.11076246.11262410.html.plaintext.txt	123	Brk binds GGCGCT motif overlaps Mad binding site
0.11076246.11262410.html.plaintext.txt	124	A left shown alignment Mad binding sites within Dpp response elements vg Ubx sequence band shift probe containing one copy putative Brk binding site GGCGCT capital letters
0.11076246.11262410.html.plaintext.txt	125	Dotted arrows mark degenerate Smad boxes solid arrows mark putative Brk sites Ubx
0.11076246.11262410.html.plaintext.txt	126	To right band shift assay showing binding MBP Brk GGCGCT probe
0.11076246.11262410.html.plaintext.txt	127	The indicated amounts protein per 50 microl binding reaction probe concentration 1011 M
0.11076246.11262410.html.plaintext.txt	128	Arrows indicate bound free DNA complexes
0.11076246.11262410.html.plaintext.txt	129	B example competition band shift assay showing GGCGCT competitor 20 fold effective M1 competitor M1 sequence differs single G A substitution
0.11076246.11262410.html.plaintext.txt	130	Each 50 microl binding reaction contained indicated concentration unlabeled competitor DNA along 3 ng MBP Brk protein preparation 1011 M labeled GGCGCT probe
0.11076246.11262410.html.plaintext.txt	131	C results competition band shift assays comparing affinity MBP Brk GGCGCT probe wildtype series single base pair substitutions M1 M9
0.11076246.11262410.html.plaintext.txt	132	Assays performed parallel described B
0.11076246.11262410.html.plaintext.txt	133	Ratios boundfree probe calculated measurements made phosphorimager
0.11076246.11262410.html.plaintext.txt	134	Relative binding affinities derived competitor concentrations reduce boundfree ratio labeled probe 50
0.11076246.11262410.html.plaintext.txt	135	The resulting values used calculate fold reduction binding affinity mutant competitor relative GGCGCT WT competitor
0.11076246.11262410.html.plaintext.txt	136	The Ubx Element Contains Overlapping Binding Sites Mad Brinker Binding MBP Brk Ubx vg probes generated multiple bands possibly indicating Brk bound one site
0.11076246.11262410.html.plaintext.txt	137	The Ubx element contains inverted repeat GGCGCT Fig
0.11076246.11262410.html.plaintext.txt	138	2A solid arrows overlaps previously identified Mad binding site boxed
0.11076246.11262410.html.plaintext.txt	139	Whereas Mad site embedded repeat resembles vg Mad site repeat whole matched 7 12 positions vg
0.11076246.11262410.html.plaintext.txt	140	We tested MBP Brk ability bind one copy sequence DNA probe otherwise divergent sequence Ubx element Fig
0.11076246.11262410.html.plaintext.txt	141	MBP Brk bound GGCGCT probe affinity similar affinity Ubx probe Fig
0.11076246.11262410.html.plaintext.txt	142	2A right panel yielded single major shifted band position lower band observed Ubx probe
0.11076246.11262410.html.plaintext.txt	143	Although two weak upper bands also observed GGCGCT probe overall results consistent high affinity interaction MBP Brk one site GGCGCT probe
0.11076246.11262410.html.plaintext.txt	144	To investigate specificity Brk GGCGCT sequence effects single base pair substitutions determined
0.11076246.11262410.html.plaintext.txt	145	This done measuring ability unlabeled wildtype GGCGCT mutant DNAs compete labeled GGCGCT probe
0.11076246.11262410.html.plaintext.txt	146	2B shows gel comparing ability GGCGCT AGCGCT mutant M1 probes compete away binding MBP Brk labeled GGCGCT probe
0.11076246.11262410.html.plaintext.txt	147	Note M1 competitor tested 10 fold higher concentration range GGCGCT competitor
0.11076246.11262410.html.plaintext.txt	148	Measurements bound free probe DNA gel parallel band shift assays using eight mutant competitors used generate binding curves shown Fig
0.11076246.11262410.html.plaintext.txt	149	The concentration competitor resulting ordinate value 0
0.11076246.11262410.html.plaintext.txt	150	5 provides relative measure affinity competitor DNA
0.11076246.11262410.html.plaintext.txt	151	The results tabulated graph Fig
0.11076246.11262410.html.plaintext.txt	152	In five mutants exhibited 20 fold reduction binding affinity whereas least critical position contributed much 3 fold binding affinity
0.11076246.11262410.html.plaintext.txt	153	These results indicate Brk makes base specific contacts across entire GGCGCT sequence
0.11076246.11262410.html.plaintext.txt	154	The GGCGCT repeat Ubx element overlaps Mad binding site modeled consisting two degenerate Smad boxes Fig
0.11076246.11262410.html.plaintext.txt	155	2A suggesting Brk may compete Mad binding
0.11076246.11262410.html.plaintext.txt	156	This could determined unequivocally using Ubx probe MBP Mad MBP Brk complexes nearly identical mobilities band shift assay
0.11076246.11262410.html.plaintext.txt	157	However GGCGCT probe formed complex MBP Mad easily resolved main complex formed MBP Brk probe clear formation MBP Brk complexes correlated reduced binding MBP Mad Fig
0.11076246.11262410.html.plaintext.txt	158	In contrast amount MBP Brk reduce binding MBP Mad M7 probe Fig
0.11076246.11262410.html.plaintext.txt	159	3 evidence MBP Brk reduced level MBP Mad binding competition rather sequence independent inhibition
0.11076246.11262410.html.plaintext.txt	160	View larger version 56K Fig
0.11076246.11262410.html.plaintext.txt	161	Brk competes Mad binding Ubx Dpp response element
0.11076246.11262410.html.plaintext.txt	162	Shown two band shift assays demonstrating 3 ng MBP Brk preparation competes effectively binding MBP MadNL GGCGCT probe compete effectively binding M7 probe
0.11076246.11262410.html.plaintext.txt	163	Probe sequences shown Fig
0.11076246.11262410.html.plaintext.txt	164	Indicated nanogram amounts protein included 50 microl binding reactions together 1011 M indicated probe
0.11076246.11262410.html.plaintext.txt	165	Arrows indicate bound free DNA complexes
0.11076246.11262410.html.plaintext.txt	166	Repression Brinker Is Disrupted Mutation Its Binding Sites To determine whether Brk binding sites identified using band shift assay actually required repression Ubx element mutated disrupt Brk binding
0.11076246.11262410.html.plaintext.txt	167	Each three GGCGCT sequences changed GTCG GGCGA Fig
0.11076246.11262410.html.plaintext.txt	168	4A top dramatically reduce Brk binding still allow Mad bind Fig
0.11076246.11262410.html.plaintext.txt	169	Introduction triple substitutions 2 x Ubx lacZ reporter resulted 100 fold decrease sensitivity repression cotransfected pPac Brk Fig
0.11076246.11262410.html.plaintext.txt	170	08 ng pPac Brk top panel 10 ng lower two panels
0.11076246.11262410.html.plaintext.txt	171	These results demonstrate Brk binding sites required repression confirm sequence specificity characterized band shift experiments also observed cells
0.11076246.11262410.html.plaintext.txt	172	View larger version 63K Fig
0.11076246.11262410.html.plaintext.txt	173	Weakened Brk binding vitro correlates disrupted repression Ubx
0.11076246.11262410.html.plaintext.txt	174	A band shift assay showing effects multiple base substitutions Brk binding affinity
0.11076246.11262410.html.plaintext.txt	175	The base substitutions contained UbxM11 UbxM13 probes shown images band shift assays comparing probes wild type Ubx probe binding MBP Brk upper gel MBP MadNL lower gel
0.11076246.11262410.html.plaintext.txt	176	The indicated amounts protein per 50 microl binding reaction probe concentration 1011 M
0.11076246.11262410.html.plaintext.txt	177	Both mutants reduced MBP Brk binding affinity whereas M13 effect MBP MadNL binding
0.11076246.11262410.html.plaintext.txt	178	Compared wild type M13 binding MBP MadNL M11 yielded similar boundfree ratio 300 ng protein greatly reduced ratios 10 100 ng
0.11076246.11262410.html.plaintext.txt	179	The mechanism responsible apparently cooperative effect remains determined
0.11076246.11262410.html.plaintext.txt	180	B reporter assays showing two copies UbxM11 UbxM13 exhibited 100 fold reduced sensitivity co expressed Brk relative two copies wild type Ubx sequence
0.11076246.11262410.html.plaintext.txt	181	10 ng Mad Med activated Tkv effector plasmids
0.11076246.11262410.html.plaintext.txt	182	Brinker Is Capable Active Repression The overlap Mad Brk binding sites Ubx midgut element suggests Brk might repress Dpp targets simply competing Mad occupancy enhancer element
0.11076246.11262410.html.plaintext.txt	183	However repressors generally function quenching activating potential transcription factors bound nearby means long range interfering effects general transcription machinery 55
0.11076246.11262410.html.plaintext.txt	184	To determine whether Brk capable functioning active repressor positioned Brk binding sites adjacent sites unrelated Notch responsive activator Suppressor Hairless SuH monitored reporter expression response cotransfected Brk SuH activated Notch effector plasmids Fig
0.11076246.11262410.html.plaintext.txt	185	Brk completely prevented activation SuH whereas control reporter containing SuH sites repressed 2 4 fold effect may caused presence single Brk binding site adjacent hsp70 TATA box
0.11076246.11262410.html.plaintext.txt	186	Given ability Brk function generic active repressor reasonable speculate Brk might control subset Dpp targets without direct involvement Mad
0.11076246.11262410.html.plaintext.txt	187	View larger version 20K Fig
0.11076246.11262410.html.plaintext.txt	188	Brk function active repressor
0.11076246.11262410.html.plaintext.txt	189	Shown reporter assays demonstrating Brk effectively repress activation SuH non overlapping binding sites 6 x Brk 4 x Suh lacZ
0.11076246.11262410.html.plaintext.txt	190	In comparison 4 x Suh lacZ control plasmid lacking Brk binding sites less sensitive Brk although still exhibits 2 4 fold repression
0.11076246.11262410.html.plaintext.txt	191	The basis basal response Brk clear however note hsp70 promoter sequence contained hsplacCasper reporter vector apparent Brk site GGCGCT located 5 bp upstream TATAAA sequence
0.11076246.11262410.html.plaintext.txt	192	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.11076246.11262410.html.plaintext.txt	193	We shown Brk acts two Dpp targets binding functional Mad sites
0.11076246.11262410.html.plaintext.txt	194	Mutational analysis indicates Brk Mad compete binding overlapping sites sequence specificity Brk distinct Smads
0.11076246.11262410.html.plaintext.txt	195	Thus able identify mutations disrupt Brk repression Ubx little effect activation Mad
0.11076246.11262410.html.plaintext.txt	196	This consistent results previous experiments demonstrated Mad sites required activation several Dpp targets 32 34
0.11076246.11262410.html.plaintext.txt	197	The overlap Brk sites may explain Mad binding site consensus differs consensus identified Smad3 Smad4 Fig
0.11076246.11262410.html.plaintext.txt	198	The Mad consensus aligns perfectly inverted pair GGCGCT Brk binding sites occur Ubx element Fig
0.11076246.11262410.html.plaintext.txt	199	It also apparent Mad consensus modeled pair degenerate Smad boxes align pair Smad boxes arranged AGAC GTCT orientation inverted comparison Smad3 Smad4 consensus GTCT AGAC
0.11076246.11262410.html.plaintext.txt	200	These alignments suggest Mad consensus reflects dual utilization Brk Mad Med complexes
0.11076246.11262410.html.plaintext.txt	201	Whereas Mad Med complexes also recognize Smad3Smad4 consensus Brk
0.11076246.11262410.html.plaintext.txt	202	3 In contrast competition Mad Brk binding GCCGNCGC type sites places targets control positive negative branches Dpp pathway
0.11076246.11262410.html.plaintext.txt	203	Such dual control may important generating target response thresholds span wide range Dpp levels
0.11076246.11262410.html.plaintext.txt	204	Smad1 activation human Smad6 promoter Mad like binding site 37 suggests vertebrate Brk homolog might compete Smad1 Smad5 Smad8 regulation certain BMP targets
0.11076246.11262410.html.plaintext.txt	205	View larger version 11K Fig
0.11076246.11262410.html.plaintext.txt	206	Model overlap Brk Mad binding sites
0.11076246.11262410.html.plaintext.txt	207	The optimal arrangement inverted Smad boxes determined binding Smad1 Smad3 Smad4 aligned inverted arrangement similar Mad binding site consensus Brk sites Ubx midgut enhancer
0.11076246.11262410.html.plaintext.txt	208	Bases match Mad consensus boxed
0.11076246.11262410.html.plaintext.txt	209	Arrows first two lines mark Smad boxes bottom line inverted Brk binding sites
0.11076246.11262410.html.plaintext.txt	210	How requirement Mad binding sites certain Dpp targets reconciled experiments showing Dpp targets including vg become independent Dpp signaling cells lacking functional brk If Brk alone acts sites mutations disrupt Brk binding result elevated ectopic expression rather reduction
0.11076246.11262410.html.plaintext.txt	211	The conclusion Mad acts Dpp targets indirectly Brk based assumption Dpp signaling blocked completely brk cells also mutant tkv7 Mad1
0.11076246.11262410.html.plaintext.txt	212	However type I Dpp receptor encoded saxophone normally insufficient absence tkv provides low level signaling response Dpp 56 may become adequate target response thresholds reduced absence Brk
0.11076246.11262410.html.plaintext.txt	213	Similarly whereas hypomorphic activity Mad1
0.11076246.11262410.html.plaintext.txt	214	2 allele normally inadequate may suffice absence Brk
0.11076246.11262410.html.plaintext.txt	215	Thus low level Dpp signaling could still required even without Brk
0.11076246.11262410.html.plaintext.txt	216	Whereas convergent target specificity intertwines Brk Mad function active repressor Brk also capable functioning independently Mad
0.11076246.11262410.html.plaintext.txt	217	Thus whereas Dpp targets subject competition Mad Brk others may respond Mad Med indirectly cascading affects expression brk
0.11076246.11262410.html.plaintext.txt	218	The Dpp response elements genes may contain Brk binding sites arranged way precludes binding MadMed complexes elements may simply lack nearby binding sites MadMed cofactors
0.11076246.11262410.html.plaintext.txt	219	We thank Christine Rushlow Angela Hudson Craig Nelson Trisha Wittkopp Sean Carroll Richard Padgett generously providing plasmids used study
0.11076246.11262410.html.plaintext.txt	220	This work supported grant National Science Foundation A
0.11076246.11262410.html.plaintext.txt	221	The costs publication article defrayed part payment page charges
0.11076246.11262410.html.plaintext.txt	222	The article must therefore hereby marked advertisement accordance 18 U
0.11076246.11262410.html.plaintext.txt	223	Section 1734 solely indicate fact
0.11076246.11262410.html.plaintext.txt	224	Pharmacology University Wisconsin Medical Sciences Center 1300 University Ave
0.11076246.11262410.html.plaintext.txt	225	To correspondence addressed
0.11076246.11262410.html.plaintext.txt	226	608 262 2456 Fax 608 262 2976 E mail alaughonfacstaff
0.11076246.11262410.html.plaintext.txt	227	Published JBC Papers Press March 21 2001 DOI 10
0.11076246.11262410.html.plaintext.txt	228	Carroll personal communication
0.11076246.11262410.html.plaintext.txt	229	The abbreviations used BMP bone morphogenetic protein bp base pairs MBP maltose binding protein Dpp decapentaplegic Mad Mothers Against Dpp Brk Brinker UTR untranslated region
0.11076246.11262410.html.plaintext.txt	230	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1
0.11076246.11262410.html.plaintext.txt	231	6 432 438CrossRefMedline Order article via Infotrieve 2
0.11076246.11262410.html.plaintext.txt	232	12 2445 2462Free Full Text 3
0.11076246.11262410.html.plaintext.txt	233	2000 Cell 103 295 309Medline Order article via Infotrieve 4
0.11076246.11262410.html.plaintext.txt	234	2000 Nature 403 385 389CrossRefMedline Order article via Infotrieve 5
0.11076246.11262410.html.plaintext.txt	235	67 753 791CrossRefMedline Order article via Infotrieve 6
0.11076246.11262410.html.plaintext.txt	236	19 1745 1754AbstractFree Full Text 7
0.11076246.11262410.html.plaintext.txt	237	2000 Cell 100 189 192Medline Order article via Infotrieve 8
0.11076246.11262410.html.plaintext.txt	238	267 6954 6967AbstractFree Full Text 9
0.11076246.11262410.html.plaintext.txt	239	75 115 157Medline Order article via Infotrieve 10
0.11076246.11262410.html.plaintext.txt	240	1982 Cell 28 451 461Medline Order article via Infotrieve 11
0.11076246.11262410.html.plaintext.txt	241	1992 Cell 71 451 461Medline Order article via Infotrieve 13
0.11076246.11262410.html.plaintext.txt	242	1990 Cell 62 261 268Medline Order article via Infotrieve 14
0.11076246.11262410.html.plaintext.txt	243	1990 Development 110 1041 1050Abstract 15
0.11076246.11262410.html.plaintext.txt	244	15 396 402CrossRefMedline Order article via Infotrieve 16
0.11076246.11262410.html.plaintext.txt	245	210 251 268CrossRefMedline Order article via Infotrieve 17
0.11076246.11262410.html.plaintext.txt	246	1993 Development 117 807 822AbstractFree Full Text 18
0.11076246.11262410.html.plaintext.txt	247	1995 Development 121 2265 2278AbstractFree Full Text 20
0.11076246.11262410.html.plaintext.txt	248	1996 Cell 85 357 368Medline Order article via Infotrieve 21
0.11076246.11262410.html.plaintext.txt	249	1996 Nature 381 387 393CrossRefMedline Order article via Infotrieve 22
0.11076246.11262410.html.plaintext.txt	250	1996 Nature 382 133 138CrossRefMedline Order article via Infotrieve 23
0.11076246.11262410.html.plaintext.txt	251	159 276 287CrossRefMedline Order article via Infotrieve 24
0.11076246.11262410.html.plaintext.txt	252	1995 Genetics 139 241 254AbstractFree Full Text 25
0.11076246.11262410.html.plaintext.txt	253	1995 Genetics 139 1347 1358AbstractFree Full Text 26
0.11076246.11262410.html.plaintext.txt	254	1996 Development 122 2099 2108AbstractFree Full Text 27
0.11076246.11262410.html.plaintext.txt	255	238 595 598CrossRefMedline Order article via Infotrieve 28
0.11076246.11262410.html.plaintext.txt	256	785 318 320Medline Order article via Infotrieve 29
0.11076246.11262410.html.plaintext.txt	257	1998 Development 125 1519 1528AbstractFree Full Text 30
0.11076246.11262410.html.plaintext.txt	258	1998 Development 125 1407 1420AbstractFree Full Text 31
0.11076246.11262410.html.plaintext.txt	259	Cell 9 2145 2156AbstractFree Full Text 32
0.11076246.11262410.html.plaintext.txt	260	1997 Nature 388 304 308CrossRefMedline Order article via Infotrieve 33
0.11076246.11262410.html.plaintext.txt	261	12 2022 2035AbstractFree Full Text 34
0.11076246.11262410.html.plaintext.txt	262	12 2354 2370AbstractFree Full Text 35
0.11076246.11262410.html.plaintext.txt	263	Cell 1 611 617Medline Order article via Infotrieve 36
0.11076246.11262410.html.plaintext.txt	264	274 20709 20716AbstractFree Full Text 37
0.11076246.11262410.html.plaintext.txt	265	275 6075 6079AbstractFree Full Text 38
0.11076246.11262410.html.plaintext.txt	266	Cell 11 555 565AbstractFree Full Text 39
0.11076246.11262410.html.plaintext.txt	267	14 627 644Free Full Text 40
0.11076246.11262410.html.plaintext.txt	268	12 235 243CrossRefMedline Order article via Infotrieve 41
0.11076246.11262410.html.plaintext.txt	269	1999 Nature 398 242 246CrossRefMedline Order article via Infotrieve 42
0.11076246.11262410.html.plaintext.txt	270	1999 Cell 96 563 573Medline Order article via Infotrieve 43
0.11076246.11262410.html.plaintext.txt	271	1999 Cell 96 553 562Medline Order article via Infotrieve 44
0.11076246.11262410.html.plaintext.txt	272	1999 Development 126 3323 3334AbstractFree Full Text 45
0.11076246.11262410.html.plaintext.txt	273	2 745 749CrossRefMedline Order article via Infotrieve 46
0.11076246.11262410.html.plaintext.txt	274	227 388 402CrossRefMedline Order article via Infotrieve 47
0.11076246.11262410.html.plaintext.txt	275	19 6162 6172AbstractFree Full Text 48
0.11076246.11262410.html.plaintext.txt	276	15 261 266AbstractFree Full Text 49
0.11076246.11262410.html.plaintext.txt	277	15 340 351AbstractFree Full Text 50
0.11076246.11262410.html.plaintext.txt	278	2000 Development 127 3173 3183AbstractFree Full Text 52
0.11076246.11262410.html.plaintext.txt	279	12 3815 3820AbstractFree Full Text 53
0.11076246.11262410.html.plaintext.txt	280	1994 Cell 78 211 223Medline Order article via Infotrieve 55
0.11076246.11262410.html.plaintext.txt	281	1999 Science 284 606 609AbstractFree Full Text 56
0.11076246.11262410.html.plaintext.txt	282	1998 Development 125 397 3987
0.11076246.11262410.html.plaintext.txt	283	Copyright 2001 The American Society Biochemistry Molecular Biology Inc
0.11612061.12538578.html.plaintext.txt	0	The Mad Myc Basic Domains Are Functionally Equivalent Mikhail A
0.11612061.12538578.html.plaintext.txt	1	Nikiforov Nikita Popov Iulia Kotenko Marie Henriksson Michael D
0.11612061.12538578.html.plaintext.txt	2	From Department Molecular Biology Princeton University Princeton New Jersey 08544 Microbiology Tumorbiology Center Karolinska Institutet SE 171 77 Stockholm Sweden
0.11612061.12538578.html.plaintext.txt	3	Received publication December 3 2002 revised form January 17 2003
0.11612061.12538578.html.plaintext.txt	4	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.11612061.12538578.html.plaintext.txt	5	The MycMaxMad family transcription factors plays fundamental role regulation cell proliferation oncogenic transformation cell differentiation
0.11612061.12538578.html.plaintext.txt	6	However remains unclear whether different heterodimers MycMax MadMax recognize different target genes vivo
0.11612061.12538578.html.plaintext.txt	7	We show chromatin immunoprecipitation Myc target genes also recognized Mad1 differentiated HL60 cells
0.11612061.12538578.html.plaintext.txt	8	We also substituted complete basic region Myc corresponding region Mad
0.11612061.12538578.html.plaintext.txt	9	Wild type c Myc compared c MycMad BR oncogenic transformation regulation cell proliferation induction apoptosis activation chromosomal gene expression direct binding chromosomal sites chromatin immunoprecipitation
0.11612061.12538578.html.plaintext.txt	10	We find wild type c Myc c MycMadBR proteins indistinguishable biological activity target gene recognition vivo
0.11612061.12538578.html.plaintext.txt	11	These data consistent model Myc Mad regulate common set target genes
0.11612061.12538578.html.plaintext.txt	12	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.11612061.12538578.html.plaintext.txt	13	The c myc gene encodes transcription factor c Myc dimerizes Max serve master regulator cell growth cell division cell differentiation metazoans reviewed Ref
0.11612061.12538578.html.plaintext.txt	14	Mutations disrupt regulated expression c myc related N myc L myc genes common causative lesions many human animal cancers 2
0.11612061.12538578.html.plaintext.txt	15	In addition prominent link cancer myc also required timely progression cell cycle essential downstream effector mitogenic signals 3 5
0.11612061.12538578.html.plaintext.txt	16	The Myc family proteins function transactivators assayed reporter constructs containing consensus binding sites Myc N terminus tethered DNA heterologous DNA binding domain 6 7
0.11612061.12538578.html.plaintext.txt	17	Recognition specific chromosomal targets primarily involves basic region forms extended helix helix 1 Max homodimer crystal structure 8 9
0.11612061.12538578.html.plaintext.txt	18	MycMax heterodimers recognize preferred consensus site ACCACGTGGT although related sites also bound varying affinity 10 12
0.11612061.12538578.html.plaintext.txt	19	The helix loop helix leucine zipper domains dictate highly specific dimerization Myc Max prevents dimerization numerous transcription factors related HLH1 andor leucine zipper motifs 13
0.11612061.12538578.html.plaintext.txt	20	An increasing number cellular targets MycMax heterodimers defined 14 compelling evidence Myc protein cross linked target sites vivo using chromatin immunoprecipitation 15 18
0.11612061.12538578.html.plaintext.txt	21	More recently Max superfamily extended include Mad Mxi proteins form alternate heterodimers Max reviewed Ref
0.11612061.12538578.html.plaintext.txt	22	Unlike Myc MadMxi proteins function repressors transcription inhibitors cell proliferation oncogenic transformation 20 22
0.11612061.12538578.html.plaintext.txt	23	MadMax heterodimers recognize consensus binding sites vitro indistinguishable recognized MycMax suggesting alternate Max complexes may activate repress common target genes
0.11612061.12538578.html.plaintext.txt	24	Although appealing model remains limited evidence support
0.11612061.12538578.html.plaintext.txt	25	Whereas Myc protein expressed proliferating cells Mad protein expression restricted primarily found terminally differentiated cells 23 26
0.11612061.12538578.html.plaintext.txt	26	Thus mitogen deprived cells Myc levels low evidence Mad supplants Myc repress target genes
0.11612061.12538578.html.plaintext.txt	27	Some specific gene promoters tert cyclinD2 shown bind Mad1 protein vivo using HL60 cells differentiate express high enough levels Mad protein cross link 16 18
0.11612061.12538578.html.plaintext.txt	28	In undifferentiated cells express Myc rather Mad Myc bound promoters suggesting Myc Mad bind sequentially common promoters
0.11612061.12538578.html.plaintext.txt	29	However isolated examples far promoters examined
0.11612061.12538578.html.plaintext.txt	30	Further support antagonistic functions Myc MadMxi comes mouse gene knockout experiments Mad Mxi knockouts exhibit minor hyperproliferative disorders occasional tumors suggesting genes function tumor suppressors 27 29
0.11612061.12538578.html.plaintext.txt	31	However homozygous mutations mad mxi genes found human animal cancers establish direct role proteins tumor suppressors
0.11612061.12538578.html.plaintext.txt	32	Previous studies compared Myc MxiMad binding cellular promoters either introduction MadMxi1 specific amino acid substitutions Myc basic region complete substitution Mad1 basicHLHLZ region Myc 30 31
0.11612061.12538578.html.plaintext.txt	33	Since basic region responsible dimerized Max recognition DNA sequence elements chromosomal sites suggested mutants would offer insight Myc versus MadMxi target gene recognition biological function
0.11612061.12538578.html.plaintext.txt	34	One study noted substantial decrease transforming activity MycMxi1 BR exchange mutants shift spectrum genes regulated human fibroblasts 30
0.11612061.12538578.html.plaintext.txt	35	From suggested biological activities Myc Mxi1 involve regulation common distinct sets target genes governing diverse biological processes
0.11612061.12538578.html.plaintext.txt	36	A second study complete BHLHLZ exchange came different conclusion DNA binding activity target gene regulation terms cell proliferation similar Myc Mad1 proteins induction apoptosis substantially different 31
0.11612061.12538578.html.plaintext.txt	37	We interested comparison target gene regulation biological activities Myc MadMxi basic regions
0.11612061.12538578.html.plaintext.txt	38	In particular noted MadMxi1 proteins lacked conserved basic residues N terminal half basic region common three Myc family proteins MadMxi proteins several highly conserved basic amino acids farther toward N terminus found Myc proteins
0.11612061.12538578.html.plaintext.txt	39	To assess basic region MadMxi1 proteins constructed hybrid Myc protein entire basic region Myc exchanged corresponding region Mad1 retaining Myc HLHLZ domain
0.11612061.12538578.html.plaintext.txt	40	We find MycMad BR hybrid protein ability oncogenically transform cells induce apoptosis regulate cellular promoters indistinguishable Myc family proteins
0.11612061.12538578.html.plaintext.txt	41	We also showed Mad1 protein bind several additional Myc target genes vivo
0.11612061.12538578.html.plaintext.txt	42	Therefore conclude inherent structural difference Myc MadMxi1 basic regions would promote regulation distinct sets cellular target genes
0.11612061.12538578.html.plaintext.txt	43	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.11612061.12538578.html.plaintext.txt	44	Vectors Expression plasmids created standard methods retroviral expression vector pLXSH verified sequence analysis
0.11612061.12538578.html.plaintext.txt	45	Details individual constructs available upon request
0.11612061.12538578.html.plaintext.txt	46	Cell Culture Retroviral Infection The human promyelocytic leukemia cell line HL60 grown RPMI 1640 medium containing 10 fetal calf serum 2 mM L glutamine
0.11612061.12538578.html.plaintext.txt	47	To induce cell differentiation cells density 0
0.11612061.12538578.html.plaintext.txt	48	4 x 106 cellsml treated 1
0.11612061.12538578.html.plaintext.txt	49	Normal human fibroblasts IMR90 rat c myc null fibroblasts HO15
0.11612061.12538578.html.plaintext.txt	50	19 cells retroviral producer PhoeNX cells cultured Dulbeccos modified Eagles medium supplemented 10 fetal calf serum
0.11612061.12538578.html.plaintext.txt	51	19 IMR90 cells performed according published protocols 32 using PhoeNX cells
0.11612061.12538578.html.plaintext.txt	52	PhoeNX cells transfected via calcium phosphate method
0.11612061.12538578.html.plaintext.txt	53	To obtain transduced cell population cells transduced LXSH based retroviruses selected resistance hygromycin 150 microgml 7 days
0.11612061.12538578.html.plaintext.txt	54	Fluorescence activated Cell Sorter To induce apoptosis 106 cells incubated Dulbeccos modified Eagles medium supplemented 0
0.11612061.12538578.html.plaintext.txt	55	Floating adherent cells harvested 48 h starvation
0.11612061.12538578.html.plaintext.txt	56	The cells pelleted pellet resuspended 500 microl phosphate buffered saline 0
0.11612061.12538578.html.plaintext.txt	57	5 fetal calf serum fixed 70 ethanol 20 degrees C overnight
0.11612061.12538578.html.plaintext.txt	58	The fixed cells pelleted resuspended 500 microl phosphate buffered saline 0
0.11612061.12538578.html.plaintext.txt	59	5 fetal calf serum equal volume DNA extraction buffer 192 ml 0
0.11612061.12538578.html.plaintext.txt	60	8 added sample followed incubation 5 min room temperature
0.11612061.12538578.html.plaintext.txt	61	The cells pelleted resuspended 800 microl phosphate buffered saline 0
0.11612061.12538578.html.plaintext.txt	62	5 fetal calf serum supplemented 8 microl propidium iodide 1 mgml 20 mM sodium citrate 4 microl RNase A DNase free 10 mgml 1 ml total volume
0.11612061.12538578.html.plaintext.txt	63	The cells incubated 30 min 37 degrees C analyzed BD Biosciences FACScan fluorescence activated cells sorter
0.11612061.12538578.html.plaintext.txt	64	Chromatin Immunoprecipitation Chromatin immunoprecipitation assay logarithmically growing differentiating HL60 cells performed according Xu et al
0.11612061.12538578.html.plaintext.txt	65	Conditions chromatin immunoprecipitation assay HO15
0.11612061.12538578.html.plaintext.txt	66	19 cells described previously 33
0.11612061.12538578.html.plaintext.txt	67	The following sets primers used rat nm23 specific primers NM23a 5 GGTCGTTCTCGTCTCTGCTC 3 NM23b 5 TTCTGCTCGAATCGCTTGAT 3 rat mSHMT specific primers RmSHMT1 5 CTGGATGACCAGTGGAAAGG 3 RmSHMT2 5 GACCCTTGCGTGATGAAAGT 3 rat nucleolin specific primers NUCLa 5 CTGGGAGGGCGATGTAGAGT 3 NUCLb 5 GGAAGGGGGTTATCTCGAAG 3 rat glucokinase specific primers GLUa 5 TGCCCGATTTTCATCTTCTT 3 GLUb 5 CCAAGGACTTCCGCACTAAC 3 hsp60 specific primers HSPa 5 GGCTGGGGATAAGTCTGTCA 3 HSPb 5 GACGGTGCAAAACCCTCTAA 3 human mSHMT specific primers SC 25 5 CGAGTTGCGATGCTGTACTTCTCT 3 SC 26 5 GCTCGGTTGCATCATCTGCA 3 human cad specific primers hCAD CPs 5 CCAGTTCCCATTGGTGTTGTTGCC 3 hCAD CPa 5 GAGAGGCGCATCACAGAGTGGGATAA 3 human hsp60 specific primers hHSP60 CPs 5 CTCCGCCTCAGACTCGTACT 3 hHSP60 CPa 5 AGAGGAGGAAGGCCCACTC 3 human cdk4 specific primers hCDK4 CPa 5 CTCTGGGTGGCCTAGGTTG 3 hCDK4 CPb 5 TAGAGAGGCCCCCTCACC 3
0.11612061.12538578.html.plaintext.txt	68	To normalize samples amount nonspecific DNA amplified region promoter rat pcna gene PCNa 5 CGAAGCACCCAGGTAAGTGT 3 PCNb 5 ATCGTATCCGTGGTTTGAGC 3 third intron human globin gene SC 46 5 ATCTTCC TCCCACAGCTCCT 3 SC 47 5 TTTGCAGCCTCACCTTCTTT 3
0.11612061.12538578.html.plaintext.txt	69	One primers pair end labeled 32PATP
0.11612061.12538578.html.plaintext.txt	70	Amplification performed T3 Thermocycler Biometra 31 cycles 94 degrees C 45 60 degrees C 45 72 degrees C 60 followed final extension step 72 degrees C 5 min
0.11612061.12538578.html.plaintext.txt	71	The optimal number cycles exponential amplification determined kinetic analysis
0.11612061.12538578.html.plaintext.txt	72	PCR products resolved 4 6 polyacrylamide gel
0.11612061.12538578.html.plaintext.txt	73	PCR products quantitated normalized using Amersham Biosciences phosphorimaging system
0.11612061.12538578.html.plaintext.txt	74	Reverse Transcription PCR Total RNA isolated infected cells using TRIzol reagent Invitrogen
0.11612061.12538578.html.plaintext.txt	75	Reverse transcription 1 3 microg RNA performed using SuperScriptTM first strand synthesis system Invitrogen according manufacturers instructions
0.11612061.12538578.html.plaintext.txt	76	PCR performed cDNA using previously described oligonucleotide sets 33 34
0.11612061.12538578.html.plaintext.txt	77	For quantitative analysis PCR products one oligonucleotides pair end labeled 32PATP
0.11612061.12538578.html.plaintext.txt	78	Amplification performed T3 Thermocycler Biometra various number cycles 94 degrees C 45 60 degrees C 45 72 degrees C 60 followed final extension step 72 degrees C 5 min
0.11612061.12538578.html.plaintext.txt	79	The optimal number cycles exponential amplification determined kinetic analysis
0.11612061.12538578.html.plaintext.txt	80	All quantitative PCR tests repeated least two times
0.11612061.12538578.html.plaintext.txt	81	PCR products resolved 6 polyacrylamide gel quantitated using Amersham Biosciences phosphorimaging system
0.11612061.12538578.html.plaintext.txt	82	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.11612061.12538578.html.plaintext.txt	83	Mad Binds Myc Target Genes Vivo To explore binding Mad1 protein vivo took advantage HL60 cells produce Mad1 protein induced differentiate Me2SO
0.11612061.12538578.html.plaintext.txt	84	We analyzed binding Mad1 protein number chromosomal Myc targets vivo chromatin immunoprecipitation Fig
0.11612061.12538578.html.plaintext.txt	85	We found Mad1 protein could efficiently cross linked cad cdk4 hsp60 mSHMT Id2 promoters differentiated HL60 cells Mad1 expression induced cells inducing differentiation Mad1 expressed
0.11612061.12538578.html.plaintext.txt	86	All genes shown previously bind Myc several different cell types
0.11612061.12538578.html.plaintext.txt	87	Nonspecific PCR amplification DNA globin gene bind Myc served negative control normalization
0.11612061.12538578.html.plaintext.txt	88	These data add previous demonstration Myc Mad1 bind promoters tert cyclinD2 logarithmically growing differentiated cells respectively 16 18
0.11612061.12538578.html.plaintext.txt	89	View larger version 27K Fig
0.11612061.12538578.html.plaintext.txt	90	Mad1 binds promoter Myc responsive genes
0.11612061.12538578.html.plaintext.txt	91	Logarithmically growing expressing Mad1 Me2SO DMSO treated differentiated HL60 cells expressing Mad1 cross linked lysed chromatin immunoprecipitated Mad1 specific antibodies followed reversal cross linking DNA isolation
0.11612061.12538578.html.plaintext.txt	92	Isolated DNA used PCR radiolabeled oligonucleotides flanking Myc binding sites promoter genes indicated right side
0.11612061.12538578.html.plaintext.txt	93	For negative control PCR carried oligonucleotides complementary third intron human globin gene
0.11612061.12538578.html.plaintext.txt	94	Quantitation PCR products performed using Amersham Biosciences phosphorimaging system
0.11612061.12538578.html.plaintext.txt	95	Numbers panel indicate fold difference signal intensity determined dividing PCR signal DMSO column corresponding signal Log column ratio signals globin
0.11612061.12538578.html.plaintext.txt	96	Exchange Myc Mad Basic Regions Different antibodies used Myc Mad1 chromatin immunoprecipitation therefore cannot determine whether binding cellular targets quantitatively equal two proteins
0.11612061.12538578.html.plaintext.txt	97	To dissect contribution basic DNA recognition domain alone decided test DNA binding activity Myc Mad basic regions functional assays
0.11612061.12538578.html.plaintext.txt	98	A comparison basic regions Myc MadMxi families shown Fig
0.11612061.12538578.html.plaintext.txt	99	Both protein families bipartite basic region extends 20 25 amino acids N terminal helix 1
0.11612061.12538578.html.plaintext.txt	100	The crystal structure gene family MaxMax homodimers proximal basic residues helical structure defined base contacts 8 9
0.11612061.12538578.html.plaintext.txt	101	However phosphorylation serine 11 Max inhibits DNA binding activity 35 indicating amino acids distal basic region dramatically influence function
0.11612061.12538578.html.plaintext.txt	102	Both Myc MadMxi 6 basic residues proximal helix 1 however MadMxi basic region extends 19 amino acids whereas Myc basic region extends 13 amino acids
0.11612061.12538578.html.plaintext.txt	103	The Myc MadMxi basic regions bounded proline glycine likely positions domain boundary
0.11612061.12538578.html.plaintext.txt	104	Given structural considerations decided test Mad basic region function exchanging 24 amino acids mouse c Myc 21 amino acids mouse Mad1 using N terminal proline one boundary invariant leucine helix 1 C terminal boundary
0.11612061.12538578.html.plaintext.txt	105	Within domain exchanged 9 25 amino acids identical conservative substitutions
0.11612061.12538578.html.plaintext.txt	106	View larger version 36K Fig
0.11612061.12538578.html.plaintext.txt	107	Schematic representation wild type Myc Mad1 Myc Mad1 basic region
0.11612061.12538578.html.plaintext.txt	108	The shaded region MycMad BR line represents extended basic region Mad exchanged c Myc protein
0.11612061.12538578.html.plaintext.txt	109	Basic residues indicated bold
0.11612061.12538578.html.plaintext.txt	110	Ectopic transient expression WT c Myc MycMad BR gave equivalent levels protein equivalent binding E box elements electrophoretic mobility shift assay data shown
0.11612061.12538578.html.plaintext.txt	111	To assess ability two proteins promote cell proliferation reconstituted Myc null rat fibroblasts Myc protein established expressed similar levels Fig
0.11612061.12538578.html.plaintext.txt	112	We examined cell morphology Fig
0.11612061.12538578.html.plaintext.txt	113	Both WT c Myc MycMad BR fully rescued growth defect Myc null fibroblasts giving doubling times 18 19 h respectively equivalent doubling time 18 h parental cells WT c myc genes
0.11612061.12538578.html.plaintext.txt	114	In contrast Myc null fibroblasts doubling time 45 h
0.11612061.12538578.html.plaintext.txt	115	We also tested relative fraction cells phase cell cycle propidium iodide staining Fig
0.11612061.12538578.html.plaintext.txt	116	When compared pronounced accumulation cells G1 Myc null cells 69 c Myc MycMad BR equivalent reduction G1 fraction 52 50 respectively
0.11612061.12538578.html.plaintext.txt	117	Cells reconstituted c Myc MycMad BR similar increases S phase cells 20 21 respectively compared myc null cells 11
0.11612061.12538578.html.plaintext.txt	118	Thus Myc MycMad BR proteins rescue cell cycle defect Myc null cells equivalent extent
0.11612061.12538578.html.plaintext.txt	119	View larger version 61K Fig
0.11612061.12538578.html.plaintext.txt	120	Phenotypes wild type Myc MycMad BR cell growth primary cell transformation
0.11612061.12538578.html.plaintext.txt	121	A expression Myc MycMad BR proteins stably reconstituted HO15
0.11612061.12538578.html.plaintext.txt	122	Equal amounts nuclear extract immunoprecipitated IP anti FLAG antibody probed anti Myc N262 Santa Cruz Biotechnology
0.11612061.12538578.html.plaintext.txt	123	B colony size morphology HO15
0.11612061.12538578.html.plaintext.txt	124	19 cells infected empty vector Myc MycMad BR expressing vectors
0.11612061.12538578.html.plaintext.txt	125	C doubling times Myc null cells reconstituted indicated Myc derived proteins
0.11612061.12538578.html.plaintext.txt	126	D oncogenic activity Myc MycMad BR primary rat embryo cells
0.11612061.12538578.html.plaintext.txt	127	Constructs expressing Myc MycMad BR cotransfected H rasG12V early passage rat embryo fibroblasts foci scored 18 days
0.11612061.12538578.html.plaintext.txt	128	The data average three experiments
0.11612061.12538578.html.plaintext.txt	129	View larger version 32K Fig
0.11612061.12538578.html.plaintext.txt	130	Wild type Myc MycMad BR induce apoptosis Myc null cells
0.11612061.12538578.html.plaintext.txt	131	A representative flow cytometry profiles HO15
0.11612061.12538578.html.plaintext.txt	132	19 cells infected indicated expression constructs following normal growth 10 serum serum starvation 0
0.11612061.12538578.html.plaintext.txt	133	Both floating adherent cells harvested analyzed flow cytometry determine percentage apoptotic cells
0.11612061.12538578.html.plaintext.txt	134	M1 M2 M3 M4 represent gating sub G1 G1 S G2M populations respectively
0.11612061.12538578.html.plaintext.txt	135	B quantitation fraction within gate panel A
0.11612061.12538578.html.plaintext.txt	136	To compare oncogenic activity MycMad BR WT c Myc tested construct focus formation primary rat embryo cells cooperation H rasG12V oncogene
0.11612061.12538578.html.plaintext.txt	137	Both WT c Myc MycMad BR induced equivalent numbers foci 15dish Fig
0.11612061.12538578.html.plaintext.txt	138	Similar results obtained three independent assays
0.11612061.12538578.html.plaintext.txt	139	The morphology foci indistinguishable WT exchange mutant data shown
0.11612061.12538578.html.plaintext.txt	140	We conclude Mad basic region equivalent biological function c Myc
0.11612061.12538578.html.plaintext.txt	141	Since proliferative oncogenic activities c Myc presumably manifestation complex sets target genes regulates infer critical functional targets recognized c Myc basic domain also recognized Mad basic domain
0.11612061.12538578.html.plaintext.txt	142	Myc MycMad BR Induce Equivalent Apoptosis As final test biological activity examined induction apoptosis Myc MycMad BR proteins
0.11612061.12538578.html.plaintext.txt	143	The Myc null cells reconstituted protein using long terminal repeat driven reconstitution vector sustained expression serum survival factors withdrawn
0.11612061.12538578.html.plaintext.txt	144	This constitutive Myc expression induces apoptosis unlike parental Rat1 thioguanine resistant TGR subclone cells Myc regulated upon serum withdrawal
0.11612061.12538578.html.plaintext.txt	145	As reported previously Myc null cells detectable apoptosis starved 0
0.11612061.12538578.html.plaintext.txt	146	1 serum 24 48 h whereas cells reconstituted constitutively expressed WT c Myc protein exhibit substantial amount apoptosis 23 measured appearance floating cells sub G1 DNA content Fig
0.11612061.12538578.html.plaintext.txt	147	Notably difference fraction cells activated apoptotic death program WT c Myc compared MycMad BR 20 Fig
0.11612061.12538578.html.plaintext.txt	148	Therefore basic region Mad capable activating apoptotic pathway WT c Myc protein
0.11612061.12538578.html.plaintext.txt	149	Myc Mad Basic Regions Recognize Equivalent Chromosomal Targets The data support model Myc Mad basic region recognize equivalent set chromosomal target genes
0.11612061.12538578.html.plaintext.txt	150	To address question directly analyzed expression several target genes reconstituted Myc null fibroblasts Fig
0.11612061.12538578.html.plaintext.txt	151	The expression five different c Myc target genes hsp60 nm23 nucleolin mSHMT cad analyzed reverse transcription PCR genes exhibited equivalent induction response WT c Myc MycMad BR
0.11612061.12538578.html.plaintext.txt	152	In case target gene expression stimulated ectopic Myc expression level Myc null cells Fig
0.11612061.12538578.html.plaintext.txt	153	gapdh levels unchanged ectopic Myc expression used negative control
0.11612061.12538578.html.plaintext.txt	154	A much sensitive assay activation chromosomal targets c Myc activation tert gene primary human fibroblasts 36
0.11612061.12538578.html.plaintext.txt	155	The tert gene tightly suppressed primary cells activated ectopic Myc expression recruitment TRRAP containing chromatin modifying complexes 33
0.11612061.12538578.html.plaintext.txt	156	We found WT c Myc MycMad BR activated endogenous tert gene extent Fig
0.11612061.12538578.html.plaintext.txt	157	View larger version 60K Fig
0.11612061.12538578.html.plaintext.txt	158	Myc MycMad BR bind activate cellular targets
0.11612061.12538578.html.plaintext.txt	159	A wild type Myc MycMad BR regulate set genes
0.11612061.12538578.html.plaintext.txt	160	Quantitative PCR performed cDNA synthesized total RNA isolated cells expressing empty vector Myc MycMad BR proteins using radiolabeled oligonucleotides specific rat genes shown right
0.11612061.12538578.html.plaintext.txt	161	Quantitation PCR products performed using Amersham Biosciences phosphorimaging system
0.11612061.12538578.html.plaintext.txt	162	Numbers panel indicate fold induction determined dividing hsp60 nm23 nucleolin mSHMT cad gapdh specific signal corresponding gapdh specific signal ratio signals vector lane
0.11612061.12538578.html.plaintext.txt	163	B wild type Myc MycMad BR bind equivalently chromosomal sites rat fibroblasts
0.11612061.12538578.html.plaintext.txt	164	19 cells expressing empty vector vector WT c Myc indicated Myc MycMad BR cross linked lysed chromatin immunoprecipitated c Myc specific M Gal4 specific G antibodies followed reversal cross linking DNA isolation
0.11612061.12538578.html.plaintext.txt	165	Isolated DNA used PCR radiolabeled oligonucleotides flanking Myc binding sites promoter genes indicated right side
0.11612061.12538578.html.plaintext.txt	166	For negative controls two types PCR performed
0.11612061.12538578.html.plaintext.txt	167	The first used oligonucleotides flanking CACGTG sites interact c Myc promoter rat glucokinase gene GLU
0.11612061.12538578.html.plaintext.txt	168	Another PCR performed oligonucleotides flanking DNA region containing CACGTG sites rat pcna gene
0.11612061.12538578.html.plaintext.txt	169	Quantitation PCR products performed using Amersham Biosciences phosphorimaging system
0.11612061.12538578.html.plaintext.txt	170	Numbers panel indicate fold difference signal intensity determined dividing given PCR signal corresponding pcna specific signal ratio signals Gal4 lane
0.11612061.12538578.html.plaintext.txt	171	As definitive test vivo function basic region assayed direct binding different proteins chromosomal sites chromatin immunoprecipitation
0.11612061.12538578.html.plaintext.txt	172	We analyzed binding Myc proteins chromosomal promoters reconstituted Myc null cells cells lack Myc protein controls
0.11612061.12538578.html.plaintext.txt	173	Formaldehyde cross linked chromatin immunoprecipitated anti Myc antiserum control anti GAL4 antiserum immunoprecipitated DNA analyzed presence four target genes hsp60 nm23 nucleolin mshmt
0.11612061.12538578.html.plaintext.txt	174	For comparison analyzed CACGTG site glucokinase gene bind Myc also pcna gene lacks Myc binding sites Fig
0.11612061.12538578.html.plaintext.txt	175	There reproducible enrichment 4 11 fold Myc target gene sequences anti Myc immunoprecipitations Myc reconstituted cells compared signal control anti GAL4 antiserum
0.11612061.12538578.html.plaintext.txt	176	No similar enrichment observed two genes bind Myc vivo
0.11612061.12538578.html.plaintext.txt	177	Most significantly binding MycMad BR protein chromosomal promoters indistinguishable WT c Myc
0.11612061.12538578.html.plaintext.txt	178	The small differences signal c Myc MycMad BR specific experiment shown found reproducibly signals different genes consistently higher one protein versus
0.11612061.12538578.html.plaintext.txt	179	No significant enrichment gene sequences observed anti Myc antiserum original Myc null cells compared anti GAL4 control
0.11612061.12538578.html.plaintext.txt	180	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES
0.11612061.12538578.html.plaintext.txt	181	In study conducted thorough analysis DNA recognition properties Myc Mad1 basic regions
0.11612061.12538578.html.plaintext.txt	182	We conclude measurable difference DNA site recognition vivo Myc Mad1 basic regions therefore two domains recognize equivalent sets target genes
0.11612061.12538578.html.plaintext.txt	183	The precise fusion proteins analyzed resulting biological activities differ significantly two previous reports 30 31 addressed similar questions
0.11612061.12538578.html.plaintext.txt	184	It informative compare contrast study understand precise contribution basic region target gene selection MycMaxMad family proteins
0.11612061.12538578.html.plaintext.txt	185	Our conclusions differ significantly previous study OHagan et al
0.11612061.12538578.html.plaintext.txt	186	30 attempted create Mxi like basic region within Myc mutation 2 4 amino acids Myc basic region found corresponding positions Mxi Mad proteins
0.11612061.12538578.html.plaintext.txt	187	The disruptive mutation study R357S numbered human c Myc initiation methionine changes one basic amino acids Myc non basic residue
0.11612061.12538578.html.plaintext.txt	188	It seems quite possible target gene recognition Myc dependent extended set basic amino acids within region thus mutation debilitates Myc function
0.11612061.12538578.html.plaintext.txt	189	The basic region exchange used study included two additional basic amino acids farther toward N terminus
0.11612061.12538578.html.plaintext.txt	190	We speculate amino acids provide important nonspecific DNA interactions phosphate backbone increase target gene recognition vivo
0.11612061.12538578.html.plaintext.txt	191	It also possible conformational aspects Mad1 basic region preserved extended MadMyc exchange
0.11612061.12538578.html.plaintext.txt	192	This interpretation supported partial restoration transforming activity MycR357SV361E double mutant exchanges two positions Myc basic region corresponding residues Mxi1 Mad1 30
0.11612061.12538578.html.plaintext.txt	193	The indistinguishable transforming proliferative activity Myc MycMad BR exchange mutant study argues basic regions Myc Mad1 recognize critical target genes vivo
0.11612061.12538578.html.plaintext.txt	194	Our findings also contrast recent report Myc Mad1 BHLHLZ domains differ apoptotic potential proliferative activity 31
0.11612061.12538578.html.plaintext.txt	195	We find c Myc MycMad BR proteins induce indistinguishable levels apoptosis implying two proteins activate repress target genes promote apoptosis absence survival factors
0.11612061.12538578.html.plaintext.txt	196	The simplest explanation differences two studies potential contribution HLHLZ domain biological activity since study exchanged extended basic region entire DNA bindingMax dimerization domain
0.11612061.12538578.html.plaintext.txt	197	Structural studies imply helix 1 loop domains affect DNA binding activity 37 38 although differences DNA binding WT c Myc Mad bHZ exchange found using vitro assays 31
0.11612061.12538578.html.plaintext.txt	198	Of interest reported differences protein interactions HLHLZ domains Myc bind Miz1 Mad1 cannot 39
0.11612061.12538578.html.plaintext.txt	199	We also note significant difference ability previously described bHZ exchange protein rescue growth defect Myc null cells
0.11612061.12538578.html.plaintext.txt	200	We find indistinguishable cell doubling times Myc MycMad BR whereas growth rate MycMadbHZ exchange less WT c Myc 31
0.11612061.12538578.html.plaintext.txt	201	Even greater differences found rescue cell cycle defect
0.11612061.12538578.html.plaintext.txt	202	In MycMadbHZ study 48 cells G1 MycMadbHZ exchange compared 58 Myc null cells 28 29 Myc reconstituted parental Rat1 cells 31
0.11612061.12538578.html.plaintext.txt	203	Similarly S phase fraction 25 Myc null 43 WT c Myc 37 MycMadbHZ
0.11612061.12538578.html.plaintext.txt	204	In contrast find indistinguishable profiles G1 S G2M Myc MycMad BR similar results cell doubling time
0.11612061.12538578.html.plaintext.txt	205	Thus MycMadbHZ exchange protein rescues part growth defect Myc null cells
0.11612061.12538578.html.plaintext.txt	206	These differences study bHZ exchange study may attributable specific protein protein interactions HLH andor LZ domains rather differences target gene recognition
0.11612061.12538578.html.plaintext.txt	207	It also possible defect apoptosis noted MycMadbHZ mutant coupled defect cell cycle rescue
0.11612061.12538578.html.plaintext.txt	208	The important question remains unresolved whether Myc MadMxi regulate target genes normal developmental conditions
0.11612061.12538578.html.plaintext.txt	209	Our study provides extensive evidence date direct binding Myc Mad1 target genes vivo
0.11612061.12538578.html.plaintext.txt	210	Since endogenous Myc MadMxi proteins differ antibody reactivity impossible provide accurate quantitative assessment relative binding efficiency protein individual targets also difficult assess activity protein binding occurred
0.11612061.12538578.html.plaintext.txt	211	However differentiating HL60 cells studied Mad1 binds Myc target genes tested differentiatedgrowth arrest conditions Mad1 induced
0.11612061.12538578.html.plaintext.txt	212	Our data support model MycMax MadMax heterodimers recognize equivalent target genes vivo
0.11612061.12538578.html.plaintext.txt	213	The primary biological difference complexes precise regulation recruitment nuclear cofactors
0.11612061.12538578.html.plaintext.txt	214	activators versus repressors reviewed Ref
0.11612061.12538578.html.plaintext.txt	215	MadMxi family proteins mainly expressed distinct stages development differentiation almost associated growth arrest
0.11612061.12538578.html.plaintext.txt	216	An exception nearly ubiquitous expression Mxi1 S phase specific expression Mad3
0.11612061.12538578.html.plaintext.txt	217	In addition Mxi1 deficient primary cells higher colony forming ability plated low density suggesting enhanced proliferative capacity 27
0.11612061.12538578.html.plaintext.txt	218	In contrast Myc proteins expressed dividing cells repressed virtually growth arrest conditions
0.11612061.12538578.html.plaintext.txt	219	Thus many cells target genes regulated non dividing cells absence Myc activation active repression MadMxi
0.11612061.12538578.html.plaintext.txt	220	Furthermore note Myc target genes still expressed basally even complete absence Myc Myc null fibroblasts 33 40
0.11612061.12538578.html.plaintext.txt	221	This Myc independent target gene expression likely due promoter elements bind nuclear factors Myc dependent induction targets usually quite modest 3 fold log phase cells 33 40
0.11612061.12538578.html.plaintext.txt	222	One factor potential role system Mnt simultaneously expressed dividing cells Myc
0.11612061.12538578.html.plaintext.txt	223	Mnt bind Sin3A corepressor block Myc function 41 MntMax complexes significantly abundant MycMax complexes nuclear extracts 26 42
0.11612061.12538578.html.plaintext.txt	224	It known whether MntMax heterodimers constitutively repress Myc target genes act regulate expression Myc repressed
0.11612061.12538578.html.plaintext.txt	225	Moreover induction MadMxi conditions Myc already regulated may recruit additional repressive cofactors shut target gene promoters level basal transcription
0.11612061.12538578.html.plaintext.txt	226	Yet another complication system upstream stimulatory factor USF transcription factor shown bind many MycMax binding sites conditions Myc expressed 43
0.11612061.12538578.html.plaintext.txt	227	Our data consistent model Myc target genes suppressed MadMxi latter proteins induced development andor differentiation
0.11612061.12538578.html.plaintext.txt	228	This work supported grants NCI National Institutes Health M
0.11612061.12538578.html.plaintext.txt	229	Leukemia Lymphoma Society Special Fellow award M
0.11612061.12538578.html.plaintext.txt	230	This work also supported grant Swedish Research Council M
0.11612061.12538578.html.plaintext.txt	231	The costs publication article defrayed part payment page charges
0.11612061.12538578.html.plaintext.txt	232	The article must therefore hereby marked advertisement accordance 18 U
0.11612061.12538578.html.plaintext.txt	233	Section 1734 solely indicate fact
0.11612061.12538578.html.plaintext.txt	234	To correspondence addressed
0.11612061.12538578.html.plaintext.txt	235	609 258 5956 Fax 609 258 4575 E mail mcolemolbio
0.11612061.12538578.html.plaintext.txt	236	Published JBC Papers Press January 21 2003 DOI 10
0.11612061.12538578.html.plaintext.txt	237	The abbreviations used HLH helix loop helix LZ leucine zipper B basic PCNA proliferating cell nuclear antigen SHMT serine hydroxymethyltransferase mSHMT mitochondrial SHMT WT wild type CAD carbamoyl phosphate synthase aspartate transcarbamylase dihydroorotase GAPDH glyceraldehyde 3 phosphate dehydrogenase bHZ basic helix loop helix leucine zipper
0.11612061.12538578.html.plaintext.txt	238	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1
0.11612061.12538578.html.plaintext.txt	239	16 653 699CrossRefMedline Order article via Infotrieve 2
0.11612061.12538578.html.plaintext.txt	240	20 361 385CrossRefMedline Order article via Infotrieve 3
0.11612061.12538578.html.plaintext.txt	241	2001 Nature 414 768 773CrossRefMedline Order article via Infotrieve 4
0.11612061.12538578.html.plaintext.txt	242	1997 Cell Growth Differ
0.11612061.12538578.html.plaintext.txt	243	2001 Immunity 14 45 55Medline Order article via Infotrieve 6
0.11612061.12538578.html.plaintext.txt	244	10 5914 5920Medline Order article via Infotrieve 7
0.11612061.12538578.html.plaintext.txt	245	1992 Nature 359 426 429CrossRefMedline Order article via Infotrieve 8
0.11612061.12538578.html.plaintext.txt	246	1993 Nature 363 38 45CrossRefMedline Order article via Infotrieve 9
0.11612061.12538578.html.plaintext.txt	247	1997 Structure 5 509 520Medline Order article via Infotrieve 10
0.11612061.12538578.html.plaintext.txt	248	1990 Science 250 1149 1151Medline Order article via Infotrieve 11
0.11612061.12538578.html.plaintext.txt	249	1992 Oncogene 7 775 779Medline Order article via Infotrieve 13
0.11612061.12538578.html.plaintext.txt	250	1993 Oncogene 8 125 132Medline Order article via Infotrieve 14
0.11612061.12538578.html.plaintext.txt	251	95 13887 13892AbstractFree Full Text 16
0.11612061.12538578.html.plaintext.txt	252	15 2042 2047AbstractFree Full Text 17
0.11612061.12538578.html.plaintext.txt	253	15 2069 2082AbstractFree Full Text 18
0.11612061.12538578.html.plaintext.txt	254	98 3826 3831AbstractFree Full Text 19
0.11612061.12538578.html.plaintext.txt	255	21 691 702Free Full Text 20
0.11612061.12538578.html.plaintext.txt	256	1995 Cell 80 777 786Medline Order article via Infotrieve 22
0.11612061.12538578.html.plaintext.txt	257	1995 Cell 80 767 776Medline Order article via Infotrieve 23
0.11612061.12538578.html.plaintext.txt	258	1995 Oncogene 11 2487 2501Medline Order article via Infotrieve 25
0.11612061.12538578.html.plaintext.txt	259	1998 Oncogene 16 967 977CrossRefMedline Order article via Infotrieve 26
0.11612061.12538578.html.plaintext.txt	260	10 785 796AbstractFree Full Text 30
0.11612061.12538578.html.plaintext.txt	261	24 113 119CrossRefMedline Order article via Infotrieve 31
0.11612061.12538578.html.plaintext.txt	262	99 10429 10434AbstractFree Full Text 32
0.11612061.12538578.html.plaintext.txt	263	90 8392 8396AbstractFree Full Text 33
0.11612061.12538578.html.plaintext.txt	264	22 5054 5063AbstractFree Full Text 34
0.11612061.12538578.html.plaintext.txt	265	22 5793 5800AbstractFree Full Text 35
0.11612061.12538578.html.plaintext.txt	266	12 1769 1774AbstractFree Full Text 37
0.11612061.12538578.html.plaintext.txt	267	7 245 251CrossRefMedline Order article via Infotrieve 38
0.11612061.12538578.html.plaintext.txt	268	1992 Science 256 1027 1030Medline Order article via Infotrieve 39
0.11612061.12538578.html.plaintext.txt	269	3 392 399CrossRefMedline Order article via Infotrieve 40
0.11612061.12538578.html.plaintext.txt	270	12 3797 3802AbstractFree Full Text 41
0.11612061.12538578.html.plaintext.txt	271	16 2892 2906AbstractFree Full Text 43
0.11612061.12538578.html.plaintext.txt	272	Copyright 2003 The American Society Biochemistry Molecular Biology Inc
0.13729805.15123682.html.plaintext.txt	0	The Residue 129 Polymorphism Human Prion Protein Does Not Confer Susceptibility Creutzfeldt Jakob Disease Altering Structure Global Stability PrPC Laszlo L
0.13729805.15123682.html.plaintext.txt	1	Trevitt Samantha Jones Mark Batchelor Daljit Bhelt Kanella Prodromidou Anthony R
0.13729805.15123682.html.plaintext.txt	2	From Medical Research Council Prion Unit Department Neurodegenerative Disease Institute Neurology University College London Queen Square London WC1N 3BG United Kingdom Krebs Institute Biomolecular Research Department Molecular Biology Biotechnology University Sheffield Sheffield S10 2TN United Kingdom
0.13729805.15123682.html.plaintext.txt	3	Received publication December 16 2003 revised form March 24 2004
0.13729805.15123682.html.plaintext.txt	4	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES There two common forms prion protein PrP humans either methionine valine position 129
0.13729805.15123682.html.plaintext.txt	5	This polymorphism powerful determinant genetic susceptibility humans toward sporadic acquired forms prion disease restricts propagation particular prion strains
0.13729805.15123682.html.plaintext.txt	6	Despite key role information effect mutation structure stability folding dynamics cellular form PrP PrPC
0.13729805.15123682.html.plaintext.txt	7	Here show mutation measurable effect folding dynamics stability PrPC
0.13729805.15123682.html.plaintext.txt	8	Our data indicate 129MV polymorphism affect prion propagation effect PrPC rather influence likely downstream disease mechanism
0.13729805.15123682.html.plaintext.txt	9	We infer MV effect mediated conformation stability disease related PrP PrPSc intermediates kinetics formation
0.13729805.15123682.html.plaintext.txt	10	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The prion diseases group fatal neurodegenerative diseases include scrapie sheep goats bovine spongiform encephalopathy BSE1 cattle Creutzfeldt Jakob disease CJD Gerstmann Straussler Scheinker disease fatal familial insomnia FFI kuru humans
0.13729805.15123682.html.plaintext.txt	11	The human diseases may inherited arise sporadically acquired exposure infectious prions 1 2
0.13729805.15123682.html.plaintext.txt	12	Although rare humans intense interest focused diseases unique biology occurrence variant CJD new form human prion disease experimental evidence caused BSE like prion strain 3 5
0.13729805.15123682.html.plaintext.txt	13	According protein hypothesis 6 prions composed principally entirely abnormal isoforms host encoded prion protein PrP 7
0.13729805.15123682.html.plaintext.txt	14	The disease related isoform PrPSc derived normal cellular precursor PrPC post translational process involves conformational change
0.13729805.15123682.html.plaintext.txt	15	PrPSc distinguished biochemically PrPC partial protease resistance detergent insolubility
0.13729805.15123682.html.plaintext.txt	16	Although precise molecular events involved conversion remain ill defined molecular genetic vitro studies support hypothesis sort direct interaction PrPSc either PrPC less organized state occurs
0.13729805.15123682.html.plaintext.txt	17	This interaction results PrPSc conformation imposed upon substrate protein process conversion favored sequence complementarity 8 13
0.13729805.15123682.html.plaintext.txt	18	A key piece evidence supporting protein hypothesis general finding large majority cases sporadic CJD homozygous respect common polymorphism position 129 human prion protein either methionine valine encoded 49 UK population homozygous respect polymorphism 9
0.13729805.15123682.html.plaintext.txt	19	Elderly survivors kuru epidemic acquired prion disease largely restricted Fore linguistic group Papua New Guinea Highlands transmitted endocannibalistic feasts multiple exposures mortuary feasts marked contrast younger unexposed Fore predominantly PRNP 129 heterozygotes
0.13729805.15123682.html.plaintext.txt	20	Kuru imposed strong balancing selection Fore essentially eliminating PRNP 129 homozygotes
0.13729805.15123682.html.plaintext.txt	21	World wide PRNP haplotype diversity coding allele frequencies suggested strong balancing selection locus occurred evolution modern humans 14
0.13729805.15123682.html.plaintext.txt	22	This polymorphism crucial etiology neuropathology prion disease date individuals homozygous methionine MetMet succumbed variant CJD 3 15 16 iatrogenic CJD occurs predominately homozygotes excess valine homozygotes cases related exposure contaminated human pituitary hormones 17
0.13729805.15123682.html.plaintext.txt	23	The importance sequence homology emphasized observation families inherited prion diseases age onset significantly later individuals heterozygous polymorphism 18 21
0.13729805.15123682.html.plaintext.txt	24	Thus heterozygosity respect polymorphism appears confer substantial resistance prion disease
0.13729805.15123682.html.plaintext.txt	25	Perhaps fundamentally polymorphism also associated propagation distinct human prion isolates strains seen different CJD phenotypes
0.13729805.15123682.html.plaintext.txt	26	Prion strains distinguished biological properties distinct incubation periods clinical features pattern neuropathological targeting experimental animals
0.13729805.15123682.html.plaintext.txt	27	It apparent human prion strains associated different biochemical features PrPSc differences PrPSc conformation glycosylation serially propagated transgenic mice expressing human PrP 3 5
0.13729805.15123682.html.plaintext.txt	28	The residue 129 HuPrP polymorphism appears able affect generation strain specific PrPSc conformers inference phenotype human prion disease 22 23
0.13729805.15123682.html.plaintext.txt	29	Such phenotypic effects polymorphism also seen inherited prion disease associated D178N mutation PRNP mutation may result phenotype CJD fatal familial insomnia depending 129 genotype mutant allele 24
0.13729805.15123682.html.plaintext.txt	30	Further multiple distinct molecular forms human PrPSc identified molecular strain typing studies 5 22 25 26
0.13729805.15123682.html.plaintext.txt	31	These thought represent distinct conformational states PrPSc differ either fold individual polypeptide chains manner chains packed multimolecular complex
0.13729805.15123682.html.plaintext.txt	32	These states manifested molecular level response cleavage proteinase K subsequent sizing resistant segment polypeptide chain SDS polyacrylamide gel electrophoresis b ratio diglycosylated monoglycosylated unglycosylated forms found protease resistant PrPSc material
0.13729805.15123682.html.plaintext.txt	33	These PrPSc types associated distinct clinico pathological phenotypes affected patients
0.13729805.15123682.html.plaintext.txt	34	Types 1 3 associated classical CJD whereas variant CJD associated type 4 strain 5
0.13729805.15123682.html.plaintext.txt	35	The propagation strain types highly dependent upon codon 129 genotype hence primary structure prion protein
0.13729805.15123682.html.plaintext.txt	36	For instance type 1 strain seen methionine homozygotes whereas type 3 strain seen genetic background
0.13729805.15123682.html.plaintext.txt	37	Most strikingly variant CJD seen date homozygous MM individuals
0.13729805.15123682.html.plaintext.txt	38	This polymorphism thus fundamental prion disease humans therefore understanding influence PrP folding may provide strong clues molecular mechanisms underlie prion propagation
0.13729805.15123682.html.plaintext.txt	39	Current theories concentrate differing abilities methionine valine accommodated within sheet structure thermodynamic stabilities forms PrPC thought affect propensity PrPC convert PrPSc 17 27 28
0.13729805.15123682.html.plaintext.txt	40	As first step characterizing polymorphism effect three dimensional structure valine form PrPC determined
0.13729805.15123682.html.plaintext.txt	41	Here describe influence polymorphism fold stability solution dynamics unfolding characteristics normal cellular form prion protein PrPC
0.13729805.15123682.html.plaintext.txt	42	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Plasmid Preparation Protein Expression Purification The open reading frame human PrP gene PRNP containing methionine residue 129 amplified PCR using oligonucleotide primers designed create unique N terminal BamHI site C terminal HindIII site directional cloning fragment expression vector pTrcHisB Invitrogen Corp
0.13729805.15123682.html.plaintext.txt	43	The primer corresponding N terminal region PRNP expressed designed mutate glycine codon 90 methionine incorporate thrombin cleavage site C terminal primer replacing methionine residue 232 stop codon
0.13729805.15123682.html.plaintext.txt	44	Standard protocols site directed mutagenesis used create another construct valine position 129
0.13729805.15123682.html.plaintext.txt	45	The ligated pTrcHisBPRNP construct used transform Escherichia coli host strain BL21DE3 Novagen genotype F ompT hsdSB rB mB gal dcm DE3 plated onto Luria Bertoni LB agar plates containing 100 microgml carbenicillin
0.13729805.15123682.html.plaintext.txt	46	Following sequence verification clones contained correct construct cultures grown purification using modification protocols previously described 29
0.13729805.15123682.html.plaintext.txt	47	For cleavage fusion protein thrombin used 0
0.13729805.15123682.html.plaintext.txt	48	1 unit thrombin Novagene per 1 mg protein 16 h room temperature
0.13729805.15123682.html.plaintext.txt	49	Protein concentrations determined UV absorption using calculated molar extinction 19893 M 1 cm 1 280 nm
0.13729805.15123682.html.plaintext.txt	50	NMR Sample Preparation NMR Spectroscopy Uniformly 15N 13C15N labeled HuPrP129V HuPrP129M samples expressed E
0.13729805.15123682.html.plaintext.txt	51	coli using EMBL minimal medium recipe 13C6 glucose 15NH42SO4 sole carbon nitrogen sources respectively purified described 29
0.13729805.15123682.html.plaintext.txt	52	To ensure proteins free paramagnetic metal ions unfolded 6 M guanidine hydrochloride 100 mM EDTA pH 8
0.13729805.15123682.html.plaintext.txt	53	0 dialyzed 20 mM sodium acetate d3 3 mM sodium azide pH 5
0.13729805.15123682.html.plaintext.txt	54	NMR spectra acquired 303 K 0
0.13729805.15123682.html.plaintext.txt	55	2 mM15N 13C15N labeled samples 20 mM sodium acetate d3 3 mM sodium azide pH 5
0.13729805.15123682.html.plaintext.txt	56	55 either 90 H2O plus 10 D2O 99
0.13729805.15123682.html.plaintext.txt	57	9 D2O using Bruker DRX 500 DRX 600 spectrometers equipped 5 mm 13C15N1H triple resonance probes
0.13729805.15123682.html.plaintext.txt	58	Proton chemical shifts referenced TSP
0.13729805.15123682.html.plaintext.txt	59	15N 13C chemical shifts calculated relative TSP using gyromagnetic ratios 15N 13C 1H 15N1H 0
0.13729805.15123682.html.plaintext.txt	60	NMR data processed analyzed Silicon Graphics Workstations using Felix 2000 software kindly donated Accelrys San Diego
0.13729805.15123682.html.plaintext.txt	61	Assignments Structure Calculations Backbone resonances HN N C C C HuPrP129V HuPrP129M assigned using standard suite triple resonance NMR experiments 30 33
0.13729805.15123682.html.plaintext.txt	62	Almost complete backbone assignments determined exceptions amide protons nitrogens residues 167 169 171 175 resonances detected
0.13729805.15123682.html.plaintext.txt	63	As discussed residues occupy loop region strand II helix II undergoing conformational exchange resulting line broadening NMR signals
0.13729805.15123682.html.plaintext.txt	64	Side chain 13C 1H resonances determined three dimensional 15N separated total correlation spectroscopy HSQC 34 three dimensional 13C separated HCCH CCH total correlation spectroscopy 35 experiments confirmed using space connectivities NOE spectroscopy spectra
0.13729805.15123682.html.plaintext.txt	65	Aromatic ring protons determined analysis space connectivities NOE spectroscopy spectra
0.13729805.15123682.html.plaintext.txt	66	NOE distance constraints derived three dimensional 15N 13C separated NOE spectroscopy spectra 100 ms mixing times 36 37 assigned using house macros UNIX scripts
0.13729805.15123682.html.plaintext.txt	67	NOEs calibrated basis survey covalently fixed distances divided three groups upper bounds 5 3
0.13729805.15123682.html.plaintext.txt	68	JHNHA coupling constants obtained three dimensional HNHA spectra 38
0.13729805.15123682.html.plaintext.txt	69	Backbone angle constraints obtained using program TALOS 39
0.13729805.15123682.html.plaintext.txt	70	Only residues classified program good included restraints implemented bounds plus minus 1
0.13729805.15123682.html.plaintext.txt	71	5 average S
0.13729805.15123682.html.plaintext.txt	72	respectively dihedral angles predicted TALOS
0.13729805.15123682.html.plaintext.txt	73	Hydrogen bond restraints included slowly exchanging backbone amide resonances see implemented two NOE constraints dN O 2
0.13729805.15123682.html.plaintext.txt	74	Three hydrogen bond restraints used short anti parallel sheet
0.13729805.15123682.html.plaintext.txt	75	These hydrogen bonds determined basis slow amide exchange observed interstrand NOE connectivities
0.13729805.15123682.html.plaintext.txt	76	Structure calculations carried C terminal domain residues 125 231 N C terminal domains residues 91 231 HuPrP129V using standard NMR anneal refine scripts provided within CNS 40
0.13729805.15123682.html.plaintext.txt	77	One hundred structures calculated randomized starting coordinates lowest energy 20 structures refined chosen represent available structural ensemble
0.13729805.15123682.html.plaintext.txt	78	Amide Exchange Hydrogen deuterium exchange rates kex determined diluting 1 mM15N 13C15N labeled HuPrP samples equal volume 20 mM sodium acetate d3 3 mM sodium azide pH 5
0.13729805.15123682.html.plaintext.txt	79	55 dissolved 100 D2O acquiring series 1H15N HSQC spectra 303 K
0.13729805.15123682.html.plaintext.txt	80	The decay curves 1H15N HSQC cross peaks fitted single exponential decays offset protection factors kexkint observable amides determined using intrinsic exchange rates kint 41
0.13729805.15123682.html.plaintext.txt	81	Acquisition first experiment began approximately 5 min mixing setting lower limit detection protection factors approximately 50
0.13729805.15123682.html.plaintext.txt	82	Spin Relaxation Measurements Spin relaxation measurements T1 T2 15N1H NOEs acquired 1 mM 15N labeled HuPrP129V HuPrP129M samples described Ref
0.13729805.15123682.html.plaintext.txt	83	The T1 data obtained using 15N relaxation delays 31 65 144 242 373 573 731 1400 ms
0.13729805.15123682.html.plaintext.txt	84	The T2 data obtained using 15N relaxation delays 16 31 47 62 78 94 125 296 ms
0.13729805.15123682.html.plaintext.txt	85	For 15N1H NOE measurement two two dimensional spectra acquired interleaved manner relaxation delay 3
0.13729805.15123682.html.plaintext.txt	86	Spectra collected acquisition times 164 t2 87
0.13729805.15123682.html.plaintext.txt	87	3 ms t1 using 24 64 scans per complex t1 increment
0.13729805.15123682.html.plaintext.txt	88	Equilibrium Denaturation Data The amide CD absorption 7 microM HuPrP dissolved 20 mM sodium acetate d3 2 mM sodium azide pH 5
0.13729805.15123682.html.plaintext.txt	89	55 55 vv D2O recorded varying concentrations guanidine hydrochloride 222 nm Jasco J715 spectropolarimeter 1 cm light path bandwidth 10 nm 4 integration time
0.13729805.15123682.html.plaintext.txt	90	These sample conditions chosen match conditions used amide exchange experiments described
0.13729805.15123682.html.plaintext.txt	91	The ellipticity signal converted proportion molecules native state N according relationship N UN U U N ellipticity signals unfolded native states respectively
0.13729805.15123682.html.plaintext.txt	92	Data fitted function
0.13729805.15123682.html.plaintext.txt	93	m represents sensitivity unfolding transition denaturant D denaturant activity 43
0.13729805.15123682.html.plaintext.txt	94	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Three dimensional Structure HuPrP129V The molecule used paper comprises residues 91 231 protein HuPrP129V HuPrP129M
0.13729805.15123682.html.plaintext.txt	95	This length construct chosen since corresponds fragment PrP associated prion propagation 1 2 44
0.13729805.15123682.html.plaintext.txt	96	The protein consists N terminal flexible disordered tail residues 91 124 contains high affinity transition metal binding site 45 folded globular domain consisting residues 125 231
0.13729805.15123682.html.plaintext.txt	97	This domain consists three helices encompassing residues 144 154 helix I 173 192 helix II 200 226 helix III short anti parallel sheet made residues 129 131 161 163
0.13729805.15123682.html.plaintext.txt	98	A single disulfide bond links helices II III holds core protein together
0.13729805.15123682.html.plaintext.txt	99	The polymorphism situated within first strand sheet Fig
0.13729805.15123682.html.plaintext.txt	100	View larger version 33K FIG
0.13729805.15123682.html.plaintext.txt	101	Three dimensional structure folded C terminal domain residues 125 228 displayed HuPrP129V
0.13729805.15123682.html.plaintext.txt	102	A backbone ensemble 20 lowest energy structures
0.13729805.15123682.html.plaintext.txt	103	B ribbon representation average NMR structure helices colored red strands colored cyan
0.13729805.15123682.html.plaintext.txt	104	The disulfide bond linking side chains Cys179 Cys214 shown yellow dashed line C positions residues
0.13729805.15123682.html.plaintext.txt	105	The carbon position residue 129 marked space filled sphere
0.13729805.15123682.html.plaintext.txt	106	This figure structural figures prepared using MidasPlus 58 59
0.13729805.15123682.html.plaintext.txt	107	Structure calculations carried C terminal domain residues 125 231 N C terminal domains residues 91 231 HuPrP129V
0.13729805.15123682.html.plaintext.txt	108	A number medium range NOE connectivities observed within N terminus protein residues 91 124 however define secondary structure point supported lack 13C chemical shift perturbation away random coil values
0.13729805.15123682.html.plaintext.txt	109	This result consistent relatively slow spin relaxation NMR signals region indicative predominantly unstructured peptide
0.13729805.15123682.html.plaintext.txt	110	Within C terminal domain protein secondary structure elements well defined reflected r
0.13729805.15123682.html.plaintext.txt	111	deviations mean structure 0
0.13729805.15123682.html.plaintext.txt	112	70 A backbone heavy atoms 1
0.13729805.15123682.html.plaintext.txt	113	0 A heavy atoms Table I
0.13729805.15123682.html.plaintext.txt	114	Regions level definition falls associated loop connecting strand 2 sheet helix 2 residues 167 171 loop connects helices II III residues 194 199 C terminus helix 3 residues 224 226 Fig
0.13729805.15123682.html.plaintext.txt	115	The loop comprising residues 167 171 characterized extensive line broadening NMR signals
0.13729805.15123682.html.plaintext.txt	116	This reported number prion proteins different species due conformational exchange two backbone conformations millisecond time scale results broadening NMR signals
0.13729805.15123682.html.plaintext.txt	117	The lack definition observed within NMR ensemble region protein thus due lack constraints well conformational averaging
0.13729805.15123682.html.plaintext.txt	118	The increased disorder seen less defined regions however appears due conformational equilibria faster time scale discussed later
0.13729805.15123682.html.plaintext.txt	119	View table TABLE I HuPrP129V structural statistics Ensemble 20 lowest energy structures 100 calculated
0.13729805.15123682.html.plaintext.txt	120	deviations bond lengths bond improper angles ideal CNS values 0
0.13729805.15123682.html.plaintext.txt	121	Overall three dimensional structure HuPrP129V derived tertiary fold previously determined structures mouse 46 hamster 47 bovine 48 ovine 49 prion proteins human protein containing pathogenic mutation E200K 50
0.13729805.15123682.html.plaintext.txt	122	They also closely resemble NMR crystal structures HuPrP129M 51 52 Fig
0.13729805.15123682.html.plaintext.txt	123	deviations backbone heavy atoms within structured regions less 1
0.13729805.15123682.html.plaintext.txt	124	2 A NMR structures two polymorphs less 0
0.13729805.15123682.html.plaintext.txt	125	75 A HuPrP129V HuPrP129M crystal structures within uncertainty derived structures
0.13729805.15123682.html.plaintext.txt	126	Indeed coincide remarkably well given differences solution conditions samples
0.13729805.15123682.html.plaintext.txt	127	Regions local differences occur associated highest sequence variation different species different HuPrP mutants
0.13729805.15123682.html.plaintext.txt	128	These regions comprise loop 167 171 C termini helices II III regions greatest conformational variability also observed discussed
0.13729805.15123682.html.plaintext.txt	129	Therefore degree structural definition regions protein rather limited
0.13729805.15123682.html.plaintext.txt	130	View larger version 29K FIG
0.13729805.15123682.html.plaintext.txt	131	Comparison secondary structure side chain packing residue 129 HuPrP129V yellow HuPrP129M red NMR structure 51 HuPrP129M crystal structure green 52 sheep prion protein crystal structure blue 49
0.13729805.15123682.html.plaintext.txt	132	Coordinates huPrP129M NMR crystal structures obtained Protein Data Bank accession codes 1QM0 PDB
0.13729805.15123682.html.plaintext.txt	133	pdb respectively whereas coordinates sheep prion protein kindly provided G
0.13729805.15123682.html.plaintext.txt	134	Dodson advance publication
0.13729805.15123682.html.plaintext.txt	135	A superposition secondary structure elements
0.13729805.15123682.html.plaintext.txt	136	The position residue 129 marked sphere
0.13729805.15123682.html.plaintext.txt	137	Residues 187 195 removed backbone trace HuPrP129M crystal structure since region perturbed three dimensional domain swapped dimer
0.13729805.15123682.html.plaintext.txt	138	B comparison side chain packing hydrogen bonding surrounding residue 129 polymorphism
0.13729805.15123682.html.plaintext.txt	139	Backbone traces residues 127 131 160 165 176 180 shown together side chains Tyr128 MetVal129 Arg164 Asp178
0.13729805.15123682.html.plaintext.txt	140	The site surrounding polymorphism better defined allowing detailed examination effect methionine valine substitution position 129 Fig
0.13729805.15123682.html.plaintext.txt	141	For compared HuPrP129V NMR structure high resolution crystal structures human 52 sheep prion protein 49 well HuPrP129M NMR structure contain methionine position 129
0.13729805.15123682.html.plaintext.txt	142	Overall region surrounding polymorphism remarkably similar two forms Fig
0.13729805.15123682.html.plaintext.txt	143	The methionine valine side chains well defined NMR structure ensemble occupy similar spatial regions significant deformation residues surrounding polymorphism site either residue
0.13729805.15123682.html.plaintext.txt	144	This particular interest since D178N mutation associated clinico pathological phenotype FFI residue 129 methionine CJD valine
0.13729805.15123682.html.plaintext.txt	145	It proposed side chains residues 129 178 interact via hydrogen bonds side chains Tyr128 Arg164 Asp178 24 53 although averaged NMR structure HuPrP129M side chain Arg164 position accomplish 51
0.13729805.15123682.html.plaintext.txt	146	The side chains residues well defined HuPrP129V NMR structure NOEs backbone side chain resonances residues 128 129 164 178 observed
0.13729805.15123682.html.plaintext.txt	147	From distribution conformations within NMR ensemble possible determine unambiguously whether side chains Tyr128 Arg164 Asp178 hydrogen bonded residues sufficiently close individual members ensemble hydrogen bonding present
0.13729805.15123682.html.plaintext.txt	148	Hence close association side chains residues 128 164 178 maintained polymorphs appear significant disruption hydrogen bonding network surrounding residue 129 Fig
0.13729805.15123682.html.plaintext.txt	149	This conclusion supported amide exchange chemical shift data described
0.13729805.15123682.html.plaintext.txt	150	Thus effect residue 129 D178N mutation appear resolvable examination structure surrounding polymorphism
0.13729805.15123682.html.plaintext.txt	151	Fold Stability Partially Unfolded Species Populated HuPrP Polymorphs Although three dimensional structures HuPrP polymorphs appear similar entirely possible either may access varying degrees alternatively folded states involved disease process
0.13729805.15123682.html.plaintext.txt	152	To assess folding behavior species determined detail
0.13729805.15123682.html.plaintext.txt	153	First equilibrium unfolding behavior polymorphs examined equilibrium denaturation profiles species shown Fig
0.13729805.15123682.html.plaintext.txt	154	The amide aromatic CD curves show molecules denature single co operative transition without formation populated intermediate species equilibrium unfolding
0.13729805.15123682.html.plaintext.txt	155	The equilibrium constant native unfolded states derived unfolding curves proteins within error 5000
0.13729805.15123682.html.plaintext.txt	156	This finding similar obtained methionine mouse prion protein substituted valine 54
0.13729805.15123682.html.plaintext.txt	157	View larger version 18K FIG
0.13729805.15123682.html.plaintext.txt	158	A equilibrium denaturation curves HuPrP129V HuPrP129M measured amide CD absorption 222 nm
0.13729805.15123682.html.plaintext.txt	159	The lines superimposed upon data fits Equation 1
0.13729805.15123682.html.plaintext.txt	160	B amide protection factors kexkint HuPrP129M HuPrP129V residues measurable protection
0.13729805.15123682.html.plaintext.txt	161	Those additional residues appear protected HuPrP129V due peak overlap HuPrP129M precluded measurement peaks
0.13729805.15123682.html.plaintext.txt	162	The protection factor corresponding equilibrium constant native N unfolded U states protein plotted dashed line log10KNU
0.13729805.15123682.html.plaintext.txt	163	Regions highest protection surround disulfide bond links helices II III forms core residual structure believed unfolded state protein
0.13729805.15123682.html.plaintext.txt	164	C chemical shift differences C nuclei HuPrP129V HuPrP129M pH 5
0.13729805.15123682.html.plaintext.txt	165	Regions secondary structure HuPrP denoted arrows strands cylinders helices
0.13729805.15123682.html.plaintext.txt	166	The chemical shift differences residue 129 corrected intrinsic chemical shift differences methionine valine extended strand 60
0.13729805.15123682.html.plaintext.txt	167	Although indicates proteins overall stability folded state residue 129 polymorphism appear acting prion disease altering fold stability PrPC exclude possibility folding intermediates transiently populated folding process present differing degrees forms protein
0.13729805.15123682.html.plaintext.txt	168	To investigate rates hydrogendeuterium exchange backbone amide resonances determined used identify regions protein remain hydrogen bonded protein becomes unfolded Fig
0.13729805.15123682.html.plaintext.txt	169	The observed amide exchange protection data shows stabilities secondary structure elements similar polymorphs
0.13729805.15123682.html.plaintext.txt	170	The regions highest stability within forms protein located three helical regions protein associate form core molecule
0.13729805.15123682.html.plaintext.txt	171	For forms PrPC protection factors show stability secondary structure elements equivalent equilibrium constant native unfolded states protein
0.13729805.15123682.html.plaintext.txt	172	The regions protein case region centered around disulfide bond links helices 2 3 first strand sheet polymorphism resides
0.13729805.15123682.html.plaintext.txt	173	The former displays anomalously high protection factors due residual local structure unfolded state protein 55
0.13729805.15123682.html.plaintext.txt	174	The latter region however displays protection factors detectable limit 50 conditions present experiment
0.13729805.15123682.html.plaintext.txt	175	However protection factors residues 161 163 strand sheet exhibit similar protection factors forms PrPC
0.13729805.15123682.html.plaintext.txt	176	Thus although say substitution valine methionine significantly increased stability hydrogen bonds surrounding residue 129 level protection observable 50 appear significantly affected stability hydrogen bonds associated opposite side sheet
0.13729805.15123682.html.plaintext.txt	177	We therefore conclude forms HuPrP significantly populated species either folding intermediates alternatively folded states three helical second strand core protein disrupted effect polymorphism PrPC likely outside core region
0.13729805.15123682.html.plaintext.txt	178	Some secondary structure elements protein show little protection exchange
0.13729805.15123682.html.plaintext.txt	179	For example C terminal regions helix II residues 186 194 helix III residues 219 226 first strand sheet exhibit protection factors detectable limit consistent significant level conformational flexibility regions protein
0.13729805.15123682.html.plaintext.txt	180	In case sheet conclusion supported weak broadened 1H15N HSQC signals observed region residues 129 131 161 164 whereas helical regions although downfield shifted C chemical shifts characteristic helical structure observed downfield shift reduced consistent regions equilibrium unfolded structures data shown
0.13729805.15123682.html.plaintext.txt	181	The higher conformational variability C termini helices comparison core protein supported small chemical shift differences M V polymorphs
0.13729805.15123682.html.plaintext.txt	182	These chemical shift differences small lie outside uncertainty measurement
0.13729805.15123682.html.plaintext.txt	183	The changes C chemical shifts indicate slight stabilization C terminus helix III destabilization C terminus Helix II HuPrP129V compared HuPrP129M
0.13729805.15123682.html.plaintext.txt	184	In previous studies chemical shift differences regions protein different PrP constructs variously ascribed small pH differences samples transient interactions folded domain unstructured N terminus protein 51 56
0.13729805.15123682.html.plaintext.txt	185	The chemical shift differences observed lie outside caused uncertainty precise pH solutions indicate difference distribution stability throughout molecule implying possible role polymorphism
0.13729805.15123682.html.plaintext.txt	186	Chemical shift changes immediately adjacent polymorphism however harder interpret since inevitably changes associated change chemical composition
0.13729805.15123682.html.plaintext.txt	187	Indeed sequence surrounding residue cause change C chemical shift order plus minus 0
0.13729805.15123682.html.plaintext.txt	188	3 ppm unfolded proteins larger chemical shift changes observed adjacent polymorphism 57
0.13729805.15123682.html.plaintext.txt	189	Any changes conformation reported chemical shift perturbations small since affect observed structure stability protein reflect small changes population distribution structural ensemble fall within resolution solution structure
0.13729805.15123682.html.plaintext.txt	190	Spin Relaxation Measurements In order characterize conformational dynamics polymorphs particular regions low amide protection conformational variability constructs probed using 15N spin relaxation measurements Fig
0.13729805.15123682.html.plaintext.txt	191	4 provide information flexibility within protein
0.13729805.15123682.html.plaintext.txt	192	The steady state 15N1H NOEs longitudinal transverse relaxation times T1 15N T2 15N folded well defined regions HuPrP129V characteristic globular protein size
0.13729805.15123682.html.plaintext.txt	193	In particular residues within sheet region polymorphism resides exhibit dynamic properties significantly different rest protein despite low amide protection factors broadened 15N1H HSQC signals
0.13729805.15123682.html.plaintext.txt	194	Residues 190 199 however link helices II III display smaller still positive 15N1H NOE values slightly increased T2 values indicating residues indeed relatively flexible structured parts protein resulting decreased definition NMR structure ensemble region
0.13729805.15123682.html.plaintext.txt	195	The degree flexibility region still significantly less N C termini protein residues 91 124 227 231 display large negative 15N1H NOE values indicative molecular motions subnanosecond time scale consistent previous observations unstructured
0.13729805.15123682.html.plaintext.txt	196	The increased flexibility within C terminus helix III appears extend residue 220 consistent lack amide exchange reduced downfield C chemical shifts
0.13729805.15123682.html.plaintext.txt	197	View larger version 24K FIG
0.13729805.15123682.html.plaintext.txt	198	Dynamics data used assess mobility globular region HuPrP129V HuPrP129M
0.13729805.15123682.html.plaintext.txt	199	Regions secondary structure denoted arrows strands cylinders helices top panel
0.13729805.15123682.html.plaintext.txt	200	Top longitudinal 15N spin relaxation times T1
0.13729805.15123682.html.plaintext.txt	201	Middle transverse 15N spin relaxation times T2
0.13729805.15123682.html.plaintext.txt	202	Bottom steady state 15N1H NOE data
0.13729805.15123682.html.plaintext.txt	203	Overall spin relaxation properties polymorphs similar
0.13729805.15123682.html.plaintext.txt	204	In particular region surrounding residue 129 polymorphism shows remarkably little difference spin relaxation values constructs slight changes 15N1H NOE HuPrP129V suggestive slight increase conformational mobility surrounding polymorphism
0.13729805.15123682.html.plaintext.txt	205	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES This study set compare conformation stability methionine valine forms human PrPC stimulated dramatic effect codon 129 variations susceptibility phenotype human prion disease
0.13729805.15123682.html.plaintext.txt	206	Individuals MV genotype highly protected developing sporadic acquired prion disease
0.13729805.15123682.html.plaintext.txt	207	This effect explained principle molecular complementarity combined gene dosage effect
0.13729805.15123682.html.plaintext.txt	208	In words spontaneous conversion PrPC PrPSc identical molecules recruited propagation process due structural complementarity homozygote double dose available substrate hence probability initiation andor rate propagation enhanced
0.13729805.15123682.html.plaintext.txt	209	The arguments establish general point residue 129 polymorphism confers different molecular properties prion protein properties strongly influence susceptibility disease conformation PrPSc
0.13729805.15123682.html.plaintext.txt	210	It follows understanding mechanism underlying methioninevaline effect would provide valuable insights process cellular conformation protein converted disease related PrPSc state
0.13729805.15123682.html.plaintext.txt	211	To end addressed question whether influence M V residues position results changes conformation stability PrPC
0.13729805.15123682.html.plaintext.txt	212	Our results establish close similarity valine methionine forms protein PrPC conformation
0.13729805.15123682.html.plaintext.txt	213	No obvious effect side chain packing dynamics region surrounding mutation discernible structural ensemble calculated NOE derived constraints chemical shift data region also show remarkably little difference two sequences
0.13729805.15123682.html.plaintext.txt	214	In addition polymorphism affect global stability molecule evidenced lack effect denaturant induced unfolding transition hydrogen exchange behavior
0.13729805.15123682.html.plaintext.txt	215	The latter measurements also probe propensity local regions protein unfold protein adopt less stable alternative conformations
0.13729805.15123682.html.plaintext.txt	216	In respects also methionine valine forms behave identically
0.13729805.15123682.html.plaintext.txt	217	From observations seems likely influence residue 129 prion disease results effect conformational properties PrPSc type 1 type 4 conformations formed methionine variant whereas type 3 favored valine type 2 conformation formed equally well either
0.13729805.15123682.html.plaintext.txt	218	FOOTNOTES This work funded Medical Research Council
0.13729805.15123682.html.plaintext.txt	219	The costs publication article defrayed part payment page charges
0.13729805.15123682.html.plaintext.txt	220	This article must therefore hereby marked advertisement accordance 18 U
0.13729805.15123682.html.plaintext.txt	221	Section 1734 solely indicate fact
0.13729805.15123682.html.plaintext.txt	222	To correspondence addressed
0.13729805.15123682.html.plaintext.txt	223	44 207 837 4888 Fax 44 207 837 8047 E mail j
0.13729805.15123682.html.plaintext.txt	224	1 The abbreviations used BSE bovine spongiform encephalopathy CJD Creutzfeldt Jakob disease FFI fatal familial insomnia PrP prion protein PrPC cellular PrP isoform PrPSc pathogenic scrapie PrP isoform HuPrP human PRP HuPrP129MV methioninevaline forms human prion protein residues 91 231 HSQC heteronuclear single quantum coherence NOE nuclear Overhauser effect TSP sodium 3 trimethylsilyl 2233 2H4 propionate r
0.13729805.15123682.html.plaintext.txt	225	ACKNOWLEDGMENTS We grateful Ray Young assistance preparation figures manuscript Guy Dodson access presubmission manuscript
0.13729805.15123682.html.plaintext.txt	226	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Prusiner S
0.13729805.15123682.html.plaintext.txt	227	95 13363 13383AbstractFree Full Text Collinge J
0.13729805.15123682.html.plaintext.txt	228	24 519 550CrossRefMedline Order article via Infotrieve Hill A
0.13729805.15123682.html.plaintext.txt	229	1997 Nature 389 448 450CrossRefMedline Order article via Infotrieve Bruce M
0.13729805.15123682.html.plaintext.txt	230	1997 Nature 389 498 501CrossRefMedline Order article via Infotrieve Collinge J
0.13729805.15123682.html.plaintext.txt	231	1996 Nature 383 685 690CrossRefMedline Order article via Infotrieve Griffith J
0.13729805.15123682.html.plaintext.txt	232	1967 Nature 215 1043 1044Medline Order article via Infotrieve Prusiner S
0.13729805.15123682.html.plaintext.txt	233	1982 Science 216 136 144Medline Order article via Infotrieve Prusiner S
0.13729805.15123682.html.plaintext.txt	234	1990 Cell 63 673 686Medline Order article via Infotrieve Palmer M
0.13729805.15123682.html.plaintext.txt	235	1991 Nature 352 340 342CrossRefMedline Order article via Infotrieve Kocisko D
0.13729805.15123682.html.plaintext.txt	236	1994 Nature 370 471 474CrossRefMedline Order article via Infotrieve Bessen R
0.13729805.15123682.html.plaintext.txt	237	1995 Nature 375 698 700CrossRefMedline Order article via Infotrieve Kocisko D
0.13729805.15123682.html.plaintext.txt	238	92 3923 3927AbstractFree Full Text Collinge J
0.13729805.15123682.html.plaintext.txt	239	1995 Nature 378 779 783CrossRefMedline Order article via Infotrieve Mead S
0.13729805.15123682.html.plaintext.txt	240	2003 Science 300 640 643AbstractFree Full Text Collinge J
0.13729805.15123682.html.plaintext.txt	241	1999 Lancet 353 183 189CrossRefMedline Order article via Infotrieve Collinge J
0.13729805.15123682.html.plaintext.txt	242	1991 Lancet 337 1441 1442CrossRefMedline Order article via Infotrieve Baker H
0.13729805.15123682.html.plaintext.txt	243	1991 Lancet 337 1286 Collinge J
0.13729805.15123682.html.plaintext.txt	244	1992 Brain 115 687 710Abstract Poulter M
0.13729805.15123682.html.plaintext.txt	245	1992 Brain 115 675 685Abstract Dlouhy S
0.13729805.15123682.html.plaintext.txt	246	1 64 67Medline Order article via Infotrieve Wadsworth J
0.13729805.15123682.html.plaintext.txt	247	1 55 59CrossRefMedline Order article via Infotrieve Asante E
0.13729805.15123682.html.plaintext.txt	248	21 6358 6366AbstractFree Full Text Goldfarb L
0.13729805.15123682.html.plaintext.txt	249	1992 Science 258 806 808Medline Order article via Infotrieve Parchi P
0.13729805.15123682.html.plaintext.txt	250	2003 Brain 126 1333 1346AbstractFree Full Text Kim C
0.13729805.15123682.html.plaintext.txt	251	1993 Nature 362 267 270CrossRefMedline Order article via Infotrieve Jackson G
0.13729805.15123682.html.plaintext.txt	252	1999 Science 283 1935 1937AbstractFree Full Text Jackson G
0.13729805.15123682.html.plaintext.txt	253	Acta 1431 1 13Medline Order article via Infotrieve Bax A
0.13729805.15123682.html.plaintext.txt	254	NMR 1 99 104Medline Order article via Infotrieve Wittekind M
0.13729805.15123682.html.plaintext.txt	255	B 101 201 205CrossRef Muhandiram D
0.13729805.15123682.html.plaintext.txt	256	B 103 203 216CrossRef Kay L
0.13729805.15123682.html.plaintext.txt	257	A 109 129 133CrossRef Whitehead B
0.13729805.15123682.html.plaintext.txt	258	NMR 9 313 316CrossRef Bax A
0.13729805.15123682.html.plaintext.txt	259	115 12593 12594 Schleucher J
0.13729805.15123682.html.plaintext.txt	260	NMR 4 301 306Medline Order article via Infotrieve Vuister G
0.13729805.15123682.html.plaintext.txt	261	NMR 13 289 302CrossRefMedline Order article via Infotrieve Brunger A
0.13729805.15123682.html.plaintext.txt	262	54 905 921CrossRefMedline Order article via Infotrieve Bai Y
0.13729805.15123682.html.plaintext.txt	263	1993 Proteins 17 75 86Medline Order article via Infotrieve Tjandra N
0.13729805.15123682.html.plaintext.txt	264	253 771 786CrossRefMedline Order article via Infotrieve Fischer M
0.13729805.15123682.html.plaintext.txt	265	15 1255 1264Abstract Jackson G
0.13729805.15123682.html.plaintext.txt	266	98 8531 8535AbstractFree Full Text Riek R
0.13729805.15123682.html.plaintext.txt	267	1996 Nature 382 180 182CrossRefMedline Order article via Infotrieve James T
0.13729805.15123682.html.plaintext.txt	268	94 10086 10091AbstractFree Full Text Garcia F
0.13729805.15123682.html.plaintext.txt	269	97 8334 8339AbstractFree Full Text Haire L
0.13729805.15123682.html.plaintext.txt	270	336 1175 1183CrossRefMedline Order article via Infotrieve Zhang Y
0.13729805.15123682.html.plaintext.txt	271	275 33650 33654AbstractFree Full Text Zahn R
0.13729805.15123682.html.plaintext.txt	272	97 145 150AbstractFree Full Text Knaus K
0.13729805.15123682.html.plaintext.txt	273	8 770 774CrossRefMedline Order article via Infotrieve Riek R
0.13729805.15123682.html.plaintext.txt	274	95 11667 11672AbstractFree Full Text Liemann S
0.13729805.15123682.html.plaintext.txt	275	1999 Biochemistry 38 3258 3267CrossRefMedline Order article via Infotrieve Hosszu L
0.13729805.15123682.html.plaintext.txt	276	6 740 743CrossRefMedline Order article via Infotrieve Donne D
0.13729805.15123682.html.plaintext.txt	277	94 13452 13457AbstractFree Full Text Peti W
0.13729805.15123682.html.plaintext.txt	278	NMR 19 153 165CrossRefMedline Order article via Infotrieve Ferrin T
0.13729805.15123682.html.plaintext.txt	279	Graphics 9 27 32CrossRefMedline Order article via Infotrieve Ferrin T
0.13729805.15123682.html.plaintext.txt	280	Graphics 6 13 17CrossRef Wishart D
0.13729805.15123682.html.plaintext.txt	281	222 311 333Medline Order article via Infotrieve Laskowski R
0.3283119.15342797.html.plaintext.txt	0	Evolution Vertebrate Genes Related Prion Shadoo Proteins Clues Comparative Genomic Analysis Marko Premzl Jill E
0.3283119.15342797.html.plaintext.txt	1	Jermiin Tatjana Simonic Jennifer A
0.3283119.15342797.html.plaintext.txt	2	Computational Proteomics Group John Curtin School Medical Research Australian National University Canberra Australia School Biological Sciences Biological Informatics Technology Centre University Sydney NSW Australia Dipartimento di Patologia Animale Igiene e Sanita Pubblica Veterinaria Sezione di Biochimica e Fisiologia Veterinaria Universita di Milano Milan Italy Comparative Genomics Group Research School Biological Sciences Australian National University Canberra Australia
0.3283119.15342797.html.plaintext.txt	3	Abstract TOP Abstract Introduction Methods Materials Results Discussion Conclusions Supplementary Material Acknowledgements References Recent findings new genes fish related prion protein PrP gene PRNP including recent report SPRN coding Shadoo Sho protein found also mammals raise issues function evolution
0.3283119.15342797.html.plaintext.txt	4	Here report additional novel fish genes found public databases including duplicated SPRN gene SPRNB Fugu Tetraodon carp zebrafish encoding Sho2 protein use comparative genomic analysis analyze evolutionary relationships infer evolutionary trajectories complete data set
0.3283119.15342797.html.plaintext.txt	5	Phylogenetic footprinting performed aligned human mouse Fugu SPRN genes define candidate regulatory promoter regions detected 16 conserved motifs three known transcription factor binding sites receptor transcription factors specific associated expression brain
0.3283119.15342797.html.plaintext.txt	6	This result homology based VISTA global genomic alignment protein sequence alignment phylogenetics context dependent genomic context relative gene order orientation criteria indicate fish mammalian SPRN genes orthologous suggest strongly conserved basic function brain
0.3283119.15342797.html.plaintext.txt	7	Whereas tetrapod PRNPs share context analogous stPrP 2 coding gene fish sequences diverged suggesting tetrapod fish genes likely significantly different functions
0.3283119.15342797.html.plaintext.txt	8	Phylogenetic analysis predicts SPRNSPRNB duplication occurred divergence fish tetrapods whereas stPrP 1 stPrP 2 occurred fish
0.3283119.15342797.html.plaintext.txt	9	Whereas Sho appears conserved function vertebrate brain PrP seems adaptive role fine tuned lineage specific fashion
0.3283119.15342797.html.plaintext.txt	10	An evolutionary model consistent findings literature knowledge proposed ancestral prevertebrate SPRN like gene leading vertebrate PrP related Sho related genes
0.3283119.15342797.html.plaintext.txt	11	This provides new framework exploring evolution unusual family proteins searching members fish branches intermediate vertebrate groups
0.3283119.15342797.html.plaintext.txt	12	Key Words comparative genomics conserved contiguity phylogenetic analysis repeats regulatory sequences phylogenetic footprinting
0.3283119.15342797.html.plaintext.txt	13	Introduction TOP Abstract Introduction Methods Materials Results Discussion Conclusions Supplementary Material Acknowledgements References The mammalian PRNP gene Lee et al
0.3283119.15342797.html.plaintext.txt	14	1999 encodes prion protein PrP whose aberrant metabolism hallmark prion diseases Prusiner 1998
0.3283119.15342797.html.plaintext.txt	15	Physiologically PrP exhibits environment dependent conformational flexibility one isoform PrPC undergoing refolding compact amyloidogenic isoform PrPSc prion disease pathogenesis
0.3283119.15342797.html.plaintext.txt	16	Both isoforms encoded PRNP gene
0.3283119.15342797.html.plaintext.txt	17	PrP mutations determine disposition resistance human familial infectious forms prion diseases determine phenotype human mouse sheep Prusiner Scott 1997
0.3283119.15342797.html.plaintext.txt	18	The normal functions PrPs still unknown although evidence bewildering number functions often contradictory presented Aguzzi Hardt 2003
0.3283119.15342797.html.plaintext.txt	19	The first gene distal PRNP eutherian mammals PRND encodes doppel Dpl protein Moore et al
0.3283119.15342797.html.plaintext.txt	20	1999 thought arisen duplication PRNP Mastrangelo Westaway 2001
0.3283119.15342797.html.plaintext.txt	21	The next neighbor gene PRND detected far humans present mouse related PRNT gene Makrinou Collinge Antoniou 2002 seems pseudogene arisen duplication PRND
0.3283119.15342797.html.plaintext.txt	22	The complexity mammalian PRNP locus conundrum PrP function provided impetus searching publicly available genomic sequence databases human Lander et al
0.3283119.15342797.html.plaintext.txt	23	2001 model vertebrates Aparicio et al
0.3283119.15342797.html.plaintext.txt	24	2002 discover PrP paralogs silico
0.3283119.15342797.html.plaintext.txt	25	As paralog genes may functions related PrP characterization may illuminate functions reveal basis PrPs disease associations
0.3283119.15342797.html.plaintext.txt	26	The paralogs may indicated potential drug targets Lander et al
0.3283119.15342797.html.plaintext.txt	27	Using comparative genomics approach recently manually annotated new gene SPRN paralog PRNP Premzl et al
0.3283119.15342797.html.plaintext.txt	28	SPRN detected mammals human mouse rat fish Fugu Tetraodon zebrafish
0.3283119.15342797.html.plaintext.txt	29	It encodes Shadoo Sho protein better conserved mammals fish PRNP fig
0.3283119.15342797.html.plaintext.txt	30	View larger version 20K FIG
0.3283119.15342797.html.plaintext.txt	31	Overall structures prion proteins PrPs PrP related proteins fish stPrP 2 stPrP 1 stPrP 3 PrP like protein Shadoo Sho proteins
0.3283119.15342797.html.plaintext.txt	32	Numbers indicate first residue section last one protein
0.3283119.15342797.html.plaintext.txt	33	S signal sequence B basic region R repeats low complexity region PGH Pro Gly His rich RG Arg Gly rich H hydrophobic region N N glycosylation site S S disulphide bond GPI glycophosphatidylinositol anchor
0.3283119.15342797.html.plaintext.txt	34	A F Numbers refer human E numbers refer Fugu G H numbers refer zebrafish
0.3283119.15342797.html.plaintext.txt	35	Several genes encoding proteins homology PrP also described recently fish table 1 PrP like protein Fugu Tetraodon zebrafish Suzuki et al
0.3283119.15342797.html.plaintext.txt	36	2002 protein Fugu Tetraodon named PrP461 Rivera Milla Stuermer Malaga Trillo 2003 stPrP 1 Oidtmann et al
0.3283119.15342797.html.plaintext.txt	37	2003 stPrP 2 Fugu stPrP salmon Oidtmann et al
0.3283119.15342797.html.plaintext.txt	38	In contrast Shos new fish proteins well conserved among major fish lineages among mammalian vertebrate PrPs frog reptile bird
0.3283119.15342797.html.plaintext.txt	39	View table Table 1 Summary Vertebrate Proteins Genes Related PrP Dpl Sho
0.3283119.15342797.html.plaintext.txt	40	However despite divergence amino acid sequences many overall protein features peculiar proteins conserved features summarized figure 1
0.3283119.15342797.html.plaintext.txt	41	First proteins extracellular predicted GPI anchored exception divergent PrP like proteins also actually potentially N glycosylated
0.3283119.15342797.html.plaintext.txt	42	In addition PrPs stPrPs predicted contain disulfide bond
0.3283119.15342797.html.plaintext.txt	43	Next mature proteins basic regions except frog PrP repeats
0.3283119.15342797.html.plaintext.txt	44	The characteristic feature PrPs fish proteins related PrP middle stretch hydrophobic amino acids mammals essential pathogenic PrP isotype conversion Prusiner 1998
0.3283119.15342797.html.plaintext.txt	45	Sho protein shares PrPs unique property middle non membrane spanning hydrophobic region fig
0.3283119.15342797.html.plaintext.txt	46	In contrast Dpl sequence lacks repeat hydrophobic regions shows homology C terminal folded domain PrP
0.3283119.15342797.html.plaintext.txt	47	In addition serious problem transmission prion disease among mammals humans recent bovine spongiform encephalopathy BSE crisis arising feeding contaminated mammal derived proteins cows new findings PrP homologs fish raise new issues possibility spread prion disease farmed fish mammals vice versa meat bone meal feedstuff derived farm animals
0.3283119.15342797.html.plaintext.txt	48	Hence understanding evolution fish proteins definition functions appear critical timely defining function dysfunction mammalian PrPs means understanding transmissibility infectious prion disease
0.3283119.15342797.html.plaintext.txt	49	Genes different species defined orthologous derivation common ancestor generally lie genomic context perform function property basis prediction gene function newly sequenced genomes OBrien et al
0.3283119.15342797.html.plaintext.txt	50	Although comparative genomics approach powerful tool understanding biological function appropriate evolutionary distance species comparison depends biological question addressed Frazer et al
0.3283119.15342797.html.plaintext.txt	51	For example comparative study custom sequenced genomic data four yeast species diverged 5 20 MYA allowed complete analysis gene identification determination gene structures estimate rapidslow evolutionary changes detection regulatory elements detection combinatorial control expression identification key regulatory elements determining gene activity Kellis et al
0.3283119.15342797.html.plaintext.txt	52	However limitations depth extent possible mammalian comparative genomic analysis parallel availability eutherian marsupial monotreme lineage representatives OBrien Eizirik Murphy 2001 Graves Westerman 2002
0.3283119.15342797.html.plaintext.txt	53	The comprehensive targeted comparative genomic analysis reported date included 13 vertebrate species one human eight mammals one bird three fish allowed identification conserved coding noncoding sequences well insight genome dynamics Thomas et al
0.3283119.15342797.html.plaintext.txt	54	The aim work analyze evolutionary relationships among mammalian PRNP fish genes encoding proteins related PrP also relationships SPRN mammals fish means comparative genomic analysis
0.3283119.15342797.html.plaintext.txt	55	This analysis comprises homology nonhomology criteria assessing gene orthology Eisen Wu 2002
0.3283119.15342797.html.plaintext.txt	56	Apart identification gene similarity homology criteria tested whether homologous rearrangement events occurred intergenic regions nonhomology criteria
0.3283119.15342797.html.plaintext.txt	57	Conserved order transcription orientation respect adjacent gene genes also dubbed conserved contiguity implies rearrangement intergenic regions genes share common evolutionary history
0.3283119.15342797.html.plaintext.txt	58	This suggested strong indication orthology Comparative Genome Organization Workshop 1996 Gilligan Brenner Venkatesh 2002
0.3283119.15342797.html.plaintext.txt	59	Our analysis based sequence data available public databases
0.3283119.15342797.html.plaintext.txt	60	Apart human two vertebrate genome sequences available draft form mouse Waterston et al
0.3283119.15342797.html.plaintext.txt	61	2002 tiger pufferfish Fugu rubripes Aparicio et al
0.3283119.15342797.html.plaintext.txt	62	Substantial data rat genome also available httpwww
0.3283119.15342797.html.plaintext.txt	63	Rodents separated human 75 Myr independent evolution mouse rat separated 30 Myr major mammalian models genetic immunological research physiological research respectively
0.3283119.15342797.html.plaintext.txt	64	Data recently reported dog genome 1
0.3283119.15342797.html.plaintext.txt	65	5x sequence coverage Kirkness et al
0.3283119.15342797.html.plaintext.txt	66	2003 yet available searchable form
0.3283119.15342797.html.plaintext.txt	67	Fish root vertebrate diversification extant fish separated mammals 450 Myr independent evolution
0.3283119.15342797.html.plaintext.txt	68	The compact vertebrate genome Fugu rubripes proposed tool discovery vertebrate genes regulatory elements Brenner et al
0.3283119.15342797.html.plaintext.txt	69	1993 indeed draft genome sequence showed significant conservation protein coding genes intron exon structures gene arrangement human Aparicio et al
0.3283119.15342797.html.plaintext.txt	70	Partial genomic sequence information also available green pufferfish Tetraodon nigroviridis httpwww
0.3283119.15342797.html.plaintext.txt	71	fr diverged Fugu 20 30 MYA also zebrafish Danio rerio httpwww
0.3283119.15342797.html.plaintext.txt	72	org diverged 100 150 MYA pufferfish popular experimental model developmental studies
0.3283119.15342797.html.plaintext.txt	73	The availability genome information led increased recent interest zebrafish model system human disease Ward Lieschke 2002
0.3283119.15342797.html.plaintext.txt	74	Here compare genomic sequences including adjacent genes protein alignments phylogenetic analysis mammalian PRNP related fish genes SPRN genes mammals fish together adjacent genes
0.3283119.15342797.html.plaintext.txt	75	We provide detailed descriptions mammalian PRNP PRND PRNT SPRN genes performed phylogenetic footprinting aligned human mouse Fugu SPRN genes define possible regulatory regions transcription factor binding sites
0.3283119.15342797.html.plaintext.txt	76	We present evidence novel fish genes related PrP identified public databases stPrP 2 Tetraodon stPrP 3 zebrafish
0.3283119.15342797.html.plaintext.txt	77	We derived SPRN sequence coding Sho experimentally Tetraodon Fugu Tetraodon carp zebrafish found silico duplicated SPRN gene SPRNB encoding related Shadoo2 protein Sho2
0.3283119.15342797.html.plaintext.txt	78	We assessed orthology mammalian PRNP fish genes related PrP mammalian SPRN homologous fish genes respectively inferred evolutionary patterns mammalian PRNP SPRN genes
0.3283119.15342797.html.plaintext.txt	79	We developed evolutionary model consistent various findings well information available literature propose framework investigating gaps knowledge genes particularly fish tetrapod lineages
0.3283119.15342797.html.plaintext.txt	80	Methods Materials TOP Abstract Introduction Methods Materials Results Discussion Conclusions Supplementary Material Acknowledgements References Public Databases Searches Search Tools Public databases searched find genes genomic environments Ensembl database httpwww
0.3283119.15342797.html.plaintext.txt	81	gov Genoscope httpwww
0.3283119.15342797.html.plaintext.txt	82	Detection PRNP Genes Genomic Environment Human Mouse Rat The PRNP genes human chr20p13 4614996 4630236 bp mouse Chr2F3 132911892 132940089 bp rat Chr3Q36 112889678 112890442 bp found key word search Ensembl human version 12
0.3283119.15342797.html.plaintext.txt	83	1 Ensembl rat version 11
0.3283119.15342797.html.plaintext.txt	84	1 genome databases respectively
0.3283119.15342797.html.plaintext.txt	85	The local genomic environment also evident interactive web genome browser annotation genomic sequence
0.3283119.15342797.html.plaintext.txt	86	Detection Fugu stPrP 1 Coding Gene stPrP 2 Coding Genes Their Genomic Context We identified stPrP 1 coding gene stPrP 2 coding gene sequences local genomic context Fugu interactive Ensembl genome browser version 12
0.3283119.15342797.html.plaintext.txt	87	1 using sequences open reading frame ORFs search query GenBank accession numbers AY141106 AY188583 respectively servers BlastN Altschul et al
0.3283119.15342797.html.plaintext.txt	88	The local genomic environment annotation genomic sequence also evident Web service
0.3283119.15342797.html.plaintext.txt	89	The genes encoding stPrP 1 stPrP 2 located scaffold96 scaffold155 respectively
0.3283119.15342797.html.plaintext.txt	90	Identification Tetraodon Sequences Containing PrP like stPrP 2 Coding Genes We identified genomic contig FSCONTIG42382 containing Tetraodon PrP like stPrP 2 coding genes using sequence Tetraodon PrP like ORF Suzuki et al
0.3283119.15342797.html.plaintext.txt	91	2002 search query BlastN program provided Genoscope Web service
0.3283119.15342797.html.plaintext.txt	92	We identified overlapping genomic clone FSCONTIG42381 using terminal 200 bp FSCONTIG42382 search query
0.3283119.15342797.html.plaintext.txt	93	In addition two overlapping clones FSCONTIG248951 FSCONTIG312861 identified using strategy
0.3283119.15342797.html.plaintext.txt	94	Sequences contigs merged virtual contig Tetraodon virtual contig 1 length 22249 bp
0.3283119.15342797.html.plaintext.txt	95	We verified assembly using PiPMaker program Schwartz et al
0.3283119.15342797.html.plaintext.txt	96	2000 alignment orthologous Fugu genomic sequence
0.3283119.15342797.html.plaintext.txt	97	The sequence also annotated using NIX interactive Web tool Williams Woollard Hingamp 1998 httpwww
0.3283119.15342797.html.plaintext.txt	98	The TestPrP 2 accession number BN000527
0.3283119.15342797.html.plaintext.txt	99	Identification Zebrafish Coding Sequence stPrP 1 C Terminal Only stPrP 3 To identify zebrafish stPrP 1 coding gene used nucleotide sequence Fugu stPrP 1 ORF search query BlastN Web service Ensembl zebrafish interactive genome database version 14
0.3283119.15342797.html.plaintext.txt	100	We detected coding sequence C terminal part protein chromosome fragment ctg10456
0.3283119.15342797.html.plaintext.txt	101	1 detected complete gene genomic context chr10 11350000 11390000 bp
0.3283119.15342797.html.plaintext.txt	102	Genomic sequence containing zebrafish stPrP 3 gene assembly234 NA3274
0.3283119.15342797.html.plaintext.txt	103	1 identified using Fugu stPrP 2 coding sequence search query BlastN Web service Ensembl zebrafish genome DB
0.3283119.15342797.html.plaintext.txt	104	The local genomic environment annotation evident interactive genome browser
0.3283119.15342797.html.plaintext.txt	105	The ZePrP 3 accession number BN000526
0.3283119.15342797.html.plaintext.txt	106	Detection SPRN Genes Genomic Environment Human Mouse Rat Fugu Zebrafish We described recently identification SPRN gene human mouse rat Fugu zebrafish Premzl et al
0.3283119.15342797.html.plaintext.txt	107	We used identical approach extract SPRN gene sequences local genomic environment Ensembl databases
0.3283119.15342797.html.plaintext.txt	108	The SPRN accession numbers BN000518 human BN000519 mouse BN000520 rat BN000521 Fugu
0.3283119.15342797.html.plaintext.txt	109	Identification Tetraodon Genomic Sequence Containing SPRN Gene Cloning Sho Coding Sequence Genomic contig FS CONTIG41441 identified Genoscope database described Premzl et al
0.3283119.15342797.html.plaintext.txt	110	By using terminal 200 bp sequence search query BlastN program Web service identified overlapping clone FSCONTIG310291
0.3283119.15342797.html.plaintext.txt	111	Using strategy next overlapping clone FSCONTIG374291 identified
0.3283119.15342797.html.plaintext.txt	112	These sequences assembled virtual contig 19029 bp Tetraodon virtual contig 2 used 10 kb sequence containing SPRN gene virtual contig analyses
0.3283119.15342797.html.plaintext.txt	113	We verified assembly using PiPMaker program align orthologous Fugu genomic sequence annotated using NIX interactive Web tool
0.3283119.15342797.html.plaintext.txt	114	As low quality FSCONTIG41441 sequence allow translation Sho ORF used sequence design primers 5 CTAAGACATCCGCCATGACACG 3 5 AGCATCTGCTGCACATCCACAC 3 flanking Sho ORF using MacVector version 7
0.3283119.15342797.html.plaintext.txt	115	0 program Oxford Molecular Group 2000
0.3283119.15342797.html.plaintext.txt	116	DNA extracted Tetraodon cells using standard procedures Sambrook Fritsch Maniatis 1989 used template PCR amplification using FastStart Taq polymerase Roche according PCR procedure using GC RICH solution
0.3283119.15342797.html.plaintext.txt	117	The PCR product cloned using TOPO cloning kit Invitrogen
0.3283119.15342797.html.plaintext.txt	118	The cloned fragment sequenced using universal primers M13 forward M13 reverse BigDye Terminator version 3
0.3283119.15342797.html.plaintext.txt	119	1 Cycle Sequencing Kit Applied Biosystems
0.3283119.15342797.html.plaintext.txt	120	Products cycle sequencing reactions run ABI3730 DNA sequencer Applied Biosystems
0.3283119.15342797.html.plaintext.txt	121	The TeSPRN accession number AJ717305
0.3283119.15342797.html.plaintext.txt	122	Identification Sho2 Coding Sequences Zebrafish Fugu Tetraodon Carp Zebrafish genomic sequence containing Sho2 ctg10456 coding sequence identified using zebrafish Sho ORF sequence search query BlastN program available Ensembl version 14
0.3283119.15342797.html.plaintext.txt	123	Genomic sequence containing Fugu gene encoding Sho2 scaffold96 identified using zebrafish Sho2 coding sequence search query BlastN program available Ensembl version 12
0.3283119.15342797.html.plaintext.txt	124	The Tetraodon genomic contig FSCONTIG414641 containing Sho2 coding sequence identified using Fugu Sho2 ORF sequence BlastN search tool Genoscope database
0.3283119.15342797.html.plaintext.txt	125	The express sequence tag EST CA964511 containing ORF carp Sho2 detected BlastN search NCBI estothers database using zebrafish Sho2 coding sequence search query
0.3283119.15342797.html.plaintext.txt	126	Local genomic environment annotation provided Ensembl genome browser Fugu SPRNB zebrafish sprnb
0.3283119.15342797.html.plaintext.txt	127	The SPRNB accession numbers BN000522 Fugu BN000523 zebrafish BN000524 carp BN000525 Tetraodon
0.3283119.15342797.html.plaintext.txt	128	Interspersed Elements Analysis We determined relative content repetitive elements interspersed repeats small RNA satellites simple repeats low complexity sequence human PRNP PRND PRNT SPRN genes mouse Prnp Prnd Sprn genes using RepeatMasker program Web server httpftp
0.3283119.15342797.html.plaintext.txt	129	html high sensitivity slow option
0.3283119.15342797.html.plaintext.txt	130	The genomic coordinates database source genes given Supplementary Material table S1 Ensembl databases listed
0.3283119.15342797.html.plaintext.txt	131	Content distribution interspersed repeats human mouse rat genomic sequences also determined using RepeatMasker
0.3283119.15342797.html.plaintext.txt	132	Interspersed repeats masked genomic sequences used VISTA alignments
0.3283119.15342797.html.plaintext.txt	133	VISTA Global Alignments We used VISTA Web server Mayor et al
0.3283119.15342797.html.plaintext.txt	134	govVISTA align genomic sequences two silico experiments
0.3283119.15342797.html.plaintext.txt	135	In first experiment aligned human chr20 4558866 4938939 bp mouse chr2 132862228 133103751 bp rat chr3 112821949 113040637 bp Fugu chrscaffold155 247572 271811 bp Tetraodon Tetraodon virtual contig 1 see genomic sequences containing either PRNP stPrP 2 gene whole upstream intergenic sequence adjacent genes gene PrP like protein fishes PRND mammals PRNT human RASSF2 SLC23A1 mammals fishes
0.3283119.15342797.html.plaintext.txt	136	In second experiment aligned human chr10 134322741 134374165 bp mouse chr7 130335510 130371625 bp rat chr1 199669758 199704156 bp zebrafish assembly203 4494411 4519077 bp Fugu chrscaffold28 384496 394338 bp Tetraodon Tetraodon virtual contig 2 see genomic sequences containing SPRN gene whole upstream intergenic region adjacent genes gene encoding GTP binding protein species amine oxidase AO coding gene mammals pufferfish long chain fatty acyl elongase coding gene zebrafish
0.3283119.15342797.html.plaintext.txt	137	Before submission VISTA transposable elements mammalian sequences masked using RepeatMasker
0.3283119.15342797.html.plaintext.txt	138	Human sequence annotation always used base sequence
0.3283119.15342797.html.plaintext.txt	139	Pairwise sequence comparisons calculated threshold 50 identity 50 bp window
0.3283119.15342797.html.plaintext.txt	140	The minimum identity shown VISTA plots 30
0.3283119.15342797.html.plaintext.txt	141	PiPMaker Local Alignments Pairwise alignments Fugu Tetraodon genomic sequences containing stPrP 2 coding gene SPRNA see human chr20 4657104 4708670 bp mouse chr2 132957930 132998136 bp genomic sequences bordered PRND RASSF2 genes performed using default settings PiPMaker program available Web service Schwartz et al
0.3283119.15342797.html.plaintext.txt	142	Results presented dot plots
0.3283119.15342797.html.plaintext.txt	143	Phylogenetic Footprinting Promoter Analysis Phylogenetic footprinting human mouse Fugu genomic sequences containing SPRNSprn gene performed using FootPrinter program Web service Blanchette Tompa 2002 httpabstract
0.3283119.15342797.html.plaintext.txt	144	edublanchemFootPrinterWebFootPrinterInput
0.3283119.15342797.html.plaintext.txt	145	We used sequence upstream Sho ORF whole intergenic region experiment
0.3283119.15342797.html.plaintext.txt	146	The orthologous rat Tetraodon zebrafish sequence data used analysis gaps sequence rat zebrafish low quality Tetraodon
0.3283119.15342797.html.plaintext.txt	147	We used conservative approach analysis accepting motifs detected three species setting low parsimony scores score 0 6 bp 7 bp motifs score 1 8 bp 9 bp motifs score 2 10 bp 11 bp 12 bp motifs
0.3283119.15342797.html.plaintext.txt	148	A 13 bp motif score 2 identified inspection 12 bp motif sequences
0.3283119.15342797.html.plaintext.txt	149	Potential transcription factor binding sites human mouse genomic sequences analyzed using MatInspector program available Web service Quandt et al
0.3283119.15342797.html.plaintext.txt	150	Again used conservative approach analysis motifs identified core similarity 1 matrix similarity score optimized matrix similarity score
0.3283119.15342797.html.plaintext.txt	151	Motifs predicting transcription factor binding sites deposited TRANSFAC database Wingender et al
0.3283119.15342797.html.plaintext.txt	152	Alignment Phylogenetic Analysis PrP Related Sho Proteins Amino acid sequences 11 PrP PrP related proteins details figure S3 Supplementary Material online 10 ShoSho2 proteins details figure S4 Supplementary Material online obtained GenBank described study
0.3283119.15342797.html.plaintext.txt	153	The sequences two protein sets aligned independently using ClustalW Thompson Higgins Gibson 1994 result subsequently refined using genetic data environment GDE Smith et al
0.3283119.15342797.html.plaintext.txt	154	From PrP Sho alignments 118 149 sites respectively chosen phylogenetic analyses using maximum likelihood program package MOLPHY Adachi Hasegawa 1996
0.3283119.15342797.html.plaintext.txt	155	The two alignments analyzed using ProtML Adachi Hasegawa 1996 JTT F model amino acid substitution
0.3283119.15342797.html.plaintext.txt	156	Initially every possible tree assessed produce set 2000 near optimal trees using jfen 2000 option
0.3283119.15342797.html.plaintext.txt	157	This set trees analyzed rigorously without nearest neighbor interchanges using jfu jfRu options
0.3283119.15342797.html.plaintext.txt	158	Local bootstrap probabilities LBP estimated using resampling estimated log likelihood method internal edges tree examined
0.3283119.15342797.html.plaintext.txt	159	Trees compared statistically using Kishino Hasegawa test Kishino Hasegawa 1989 topological model uncertainty Wolf et al
0.3283119.15342797.html.plaintext.txt	160	2000 considered using model averaging Jermiin et al
0.3283119.15342797.html.plaintext.txt	161	1997 considered used class V weighting scheme 0
0.3283119.15342797.html.plaintext.txt	162	05 produce 1 majority rule consensus tree 2 relative likelihood scores RLS internal edges inferred phylogeny
0.3283119.15342797.html.plaintext.txt	163	Analysis Software The Lasergene DNASTAR Madison Wis
0.3283119.15342797.html.plaintext.txt	164	Vector NTI InforMax Frederick Md
0.3283119.15342797.html.plaintext.txt	165	software packages used basic handling analyses nucleotide sequence protein data
0.3283119.15342797.html.plaintext.txt	166	Signal peptide cleavage sites predicted using SignalP program Nielsen et al
0.3283119.15342797.html.plaintext.txt	167	dkservicesSignalP GPI anchor sites predicted using bigPI predictor program Eisenhaber Bork Eisenhaber 1999 httpmendel
0.3283119.15342797.html.plaintext.txt	168	html available Web services
0.3283119.15342797.html.plaintext.txt	169	Other figures drawn using Microsoft PowerPoint Adobe Illustrator
0.3283119.15342797.html.plaintext.txt	170	Results Discussion TOP Abstract Introduction Methods Materials Results Discussion Conclusions Supplementary Material Acknowledgements References Genomic Environments PRNP SPRN Related Genes Sequence comparison multistep process Frazer et al
0.3283119.15342797.html.plaintext.txt	171	We found extracted genomic sequences public databases
0.3283119.15342797.html.plaintext.txt	172	We annotated reference sequence aligned sequences identified conserved segments
0.3283119.15342797.html.plaintext.txt	173	Identification Genomic Sequences Containing PRNP Mammals Related Genes Fish Using Ensembl interactive genome browsers human mouse rat Fugu zebrafish httpwww
0.3283119.15342797.html.plaintext.txt	174	org found genes extracted local contexts
0.3283119.15342797.html.plaintext.txt	175	Genomic sequence Tetraodon containing stPrP 2 PrP like proteins derived detecting overlapping genomic clones Genoscope database httpwww
0.3283119.15342797.html.plaintext.txt	176	fr assembling virtual genomic contig Tetraodon virtual contig 1 see
0.3283119.15342797.html.plaintext.txt	177	In figure 2 present gene order relative orientation local genomic regions mammalian PRNP genes fish genes encoding stPrP 1 stPrP 2 stPrP 3 PrP like proteins
0.3283119.15342797.html.plaintext.txt	178	In mammals genes adjacent PRNP PRND RASSF2 SLC23A1
0.3283119.15342797.html.plaintext.txt	179	The PRNT gene present humans rodents fig
0.3283119.15342797.html.plaintext.txt	180	In pufferfish genes encoding stPrP 2 PrP like proteins also adjacent Rassf2 coding Slc23a1 coding genes fig
0.3283119.15342797.html.plaintext.txt	181	The stPrP 2 coding gene position relative orientation respect adjacent genes mammalian PRNP suggesting evolutionary relationship
0.3283119.15342797.html.plaintext.txt	182	View larger version 12K FIG
0.3283119.15342797.html.plaintext.txt	183	Overview genomic contexts PRNP gene coding prion protein PrP mammals stPrP 1 stPrP 2 Sho2 PrP like protein coding genes fish
0.3283119.15342797.html.plaintext.txt	184	Figure approximately scale shown rulers
0.3283119.15342797.html.plaintext.txt	185	PRND Doppel PRNT PRNT gene RASSF2 Ras association domain family 2 SLC23A1 Solute carrier 23 member 2 KCNIP3 calsenilin SPRNB Shadoo2 TA PPC2 T cell activation protein phosphatase 2C EPI 64 Epi64 protein slk STE20 like kinase
0.3283119.15342797.html.plaintext.txt	186	For ruler B gene sizes intergenic distances refer mouse ruler C gene sizes intergenic distances refer Fugu
0.3283119.15342797.html.plaintext.txt	187	Genomic coordinates DB information genomic sequences roughly correspond used cross species Vista analysis given Materials Methods
0.3283119.15342797.html.plaintext.txt	188	In contrast stPrP 1 coding genes Fugu zebrafish located different genomic environments fig
0.3283119.15342797.html.plaintext.txt	189	In Fugu genome stPrP 1 flanked distally TA PPC2 T cell activation protein phosphatase 2C EPI 64 epi64 protein
0.3283119.15342797.html.plaintext.txt	190	Proximally arranged head head gene appears homolog SPRNB gene SPRN recently discovered encoding protein Shadoo Sho Premzl et al
0.3283119.15342797.html.plaintext.txt	191	2003 SPRNB turn flanked KCNIP3 calsenilin see also
0.3283119.15342797.html.plaintext.txt	192	In zebrafish genome detected stPrP 1 adjacent sprnb also head head flanked interestingly rassf2 gene proximally slk gene STE20 like kinase distally
0.3283119.15342797.html.plaintext.txt	193	different genomic environment Fugu
0.3283119.15342797.html.plaintext.txt	194	The proximity fish two genes stPrP 1 SPRNBsprnb interesting suggesting evolutionary possible functional link stPrP 1 Sho2 proteins
0.3283119.15342797.html.plaintext.txt	195	We found SPRNB gene mammalian sequence databases
0.3283119.15342797.html.plaintext.txt	196	There several possible explanations example gene lost mammalian lineage diverged searches cannot recognize
0.3283119.15342797.html.plaintext.txt	197	The obvious possibility gene duplicated divergence mammals fish consistent phylogenetic results present later
0.3283119.15342797.html.plaintext.txt	198	We found another stPrP like gene call stPrP 3 zebrafish Ensembl genomic contig NA3274
0.3283119.15342797.html.plaintext.txt	199	Its proximal flanking gene unknown distal flanking genes code green cone photoreceptor gcp annexin a6 anxa6
0.3283119.15342797.html.plaintext.txt	200	We observe major differences PrP related genes mammalian fish genomes
0.3283119.15342797.html.plaintext.txt	201	First neither PRND PRNT genes detected fish
0.3283119.15342797.html.plaintext.txt	202	Although similarity position orientation PRNT human PrP like gene pufferfish might suggest orthology sequence comparison shows similarity
0.3283119.15342797.html.plaintext.txt	203	Obversely PrP like protein coding genes found mammals
0.3283119.15342797.html.plaintext.txt	204	2002 correctly noted genes encoding Rassf2 Slc23a1 proximity PrP like protein coding gene Fugu reported different gene order relative gene orientation
0.3283119.15342797.html.plaintext.txt	205	Rivera Milla Stuermer Malaga Trillo 2003 stated genomic environments around Fugu genes encoding PrP461 PrP like proteins seemed undergone multiple chromosomal rearrangements present supporting data
0.3283119.15342797.html.plaintext.txt	206	In Fugu genomic data Oidtmann et al
0.3283119.15342797.html.plaintext.txt	207	2003 found stPrP 1 coding gene scaffold96 stPrP 2 coding gene scaffold155 adjacent PrP like protein coding gene concluded unlikely ancestors stPrP 1 stPrP 2 genes evolved directly present mammalian forms PRNP PRND
0.3283119.15342797.html.plaintext.txt	208	As supported later phylogenetic analysis suggest stPrP 2 shares ancestor fish gene encoding stPrP 1 gene duplication giving rise stPrP 1 stPrP 2 occurred evolutionary separation fish mammals
0.3283119.15342797.html.plaintext.txt	209	Although stPrP 2 pufferfish PRNP mammals share proximity Rassf2 coding Slc23a1 coding genes likely orthologous sequences diverged greatly may evolved significantly different functions
0.3283119.15342797.html.plaintext.txt	210	The relaxation conserved contiguity sites different genes distal PRNP stPrP 2
0.3283119.15342797.html.plaintext.txt	211	PRND PrP like genes suggests independent duplications producing PRNP PRND stPrP 2 PrP like genes
0.3283119.15342797.html.plaintext.txt	212	As shown figure 1 C terminal regions PrP stPrP 2 proteins similar features present PrP like protein sequences hence function PrP like protein likely different stPrP 2
0.3283119.15342797.html.plaintext.txt	213	Identification Genomic Sequences Containing SPRN Mammals Fish We recently characterized genomic environment SPRN gene human mouse rat Fugu zebrafish genomes Premzl et al
0.3283119.15342797.html.plaintext.txt	214	2003 summarized figure 3 together Tetraodon
0.3283119.15342797.html.plaintext.txt	215	Interestingly recently detected apparent duplication SPRN gene human 140 kb downstream genomic data L
0.3283119.15342797.html.plaintext.txt	216	We obtained Tetraodon SPRNA context finding overlapping genomic sequence reads Genoscope database httpwww
0.3283119.15342797.html.plaintext.txt	217	fr assembling virtual genomic contig Tetraodon virtual contig 2 see
0.3283119.15342797.html.plaintext.txt	218	The fish gene labeled SPRNA differentiate related gene fish SPRNB reported paper
0.3283119.15342797.html.plaintext.txt	219	Genes adjacent SPRN mammals SPRNA pufferfish encoding GTP binding protein GTP AO gene order relative orientation conserved two vertebrate clades implying orthology
0.3283119.15342797.html.plaintext.txt	220	However zebrafish although found GTP binding protein gene adjacent sprna tail tail orientation proximal adjacent gene long chain fatty acyl elongase fae coding gene rather AO homologous gene
0.3283119.15342797.html.plaintext.txt	221	Because next proximal genes known assembly clear whether AO encoding gene present
0.3283119.15342797.html.plaintext.txt	222	View larger version 8K FIG
0.3283119.15342797.html.plaintext.txt	223	Overview local genomic contexts SPRN gene coding Shadoo protein mammals fish
0.3283119.15342797.html.plaintext.txt	224	AO Amine oxidase GTP GTP binding protein FAE long chain fatty acyl elongase
0.3283119.15342797.html.plaintext.txt	225	Figure approximately scale shown rulers
0.3283119.15342797.html.plaintext.txt	226	For ruler D gene sizes intergenic distances refer Fugu
0.3283119.15342797.html.plaintext.txt	227	Genomic coordinates DB information genomic sequences roughly correspond used cross species Vista analysis given Materials Methods
0.3283119.15342797.html.plaintext.txt	228	Identification Annotation Tetraodon Genomic Context Containing stPrP 2 coding Gene SPRN We assembled annotated Tetraodon genomic sequences silico
0.3283119.15342797.html.plaintext.txt	229	First extracted 22249 bp genomic sequence containing stPrP 2 coding gene neighbor genes FSCONTIG42382 FSCONTIG42381 FSCONTIG248951 FSCONTIG312861 Genoscope assembled Tetraodon virtual contig 1
0.3283119.15342797.html.plaintext.txt	230	To verify assembly assess validity comparative genomic analysis aligned orthologous Fugu genomic sequence using PiPMaker program Schwartz et al
0.3283119.15342797.html.plaintext.txt	231	2000 able compare complete incomplete sequences
0.3283119.15342797.html.plaintext.txt	232	The dot plot Fugu chrscaffold155 247572 271811 bp Ensembl Tetraodon genomic sequences given figure S1A Supplementary Material online
0.3283119.15342797.html.plaintext.txt	233	Among four genes genomic fragment exon intron structure known comparison genomic cDNA sequences PrP like protein coding gene
0.3283119.15342797.html.plaintext.txt	234	The single exon ORF stPrP 2 coding gene GenScan predictions Rassf2 coding gene Slc23a1 coding gene exons also shown
0.3283119.15342797.html.plaintext.txt	235	The dot plot indicates Tetraodon virtual contig 1 assembled order consistent Fugu genomic sequence conclude assembly correct valid comparative analysis
0.3283119.15342797.html.plaintext.txt	236	Additionally deduced Tetraodon stPrP 2 amino acid sequence genomic sequence information see later figure S3 Supplementary Material online
0.3283119.15342797.html.plaintext.txt	237	Second identified 19029 bp Tetraodon genomic sequence FSCONTIG41441 FSCONTIG310291 FSCONTIG374291 Genoscope containing SPRNA gene adjacent genes merged Tetraodon virtual contig 2
0.3283119.15342797.html.plaintext.txt	238	The dot plot 10 kb sequence aligned orthologous Fugu genomic sequence chrscaffold28 384496 394338 bp Ensembl shown figure S1B Supplementary Material online shows GenScan exon predictions single exon Sho ORF genes encoding AO GTP binding protein
0.3283119.15342797.html.plaintext.txt	239	The dot plot shows consistent patterns aligned sequences suggesting correct assembly second virtual Tetraodon contig suitability computational cross species comparisons
0.3283119.15342797.html.plaintext.txt	240	Conservation sequence proximal 4
0.3283119.15342797.html.plaintext.txt	241	5 kb distal 6 kb GTP binding protein coding gene may denote exons recognized GenScan prediction Guigo et al
0.3283119.15342797.html.plaintext.txt	242	2003 see also figure S2 Supplementary Material online
0.3283119.15342797.html.plaintext.txt	243	Comparative Genomic Analysis PRNP SPRN Genomic Regions Genomic sequence annotation comprises gene order relative transcriptional orientation gene structure distribution repeat elements distribution GC islands
0.3283119.15342797.html.plaintext.txt	244	The information human base reference sequences study mouse genomes provided interactive Ensembl genome browsers httpwww
0.3283119.15342797.html.plaintext.txt	245	An extensive collection transcripts available two species rat Fugu zebrafish genome annotations httpwww
0.3283119.15342797.html.plaintext.txt	246	org much less comprehensive
0.3283119.15342797.html.plaintext.txt	247	There major differences genomes homeothermic poikilothermic species example GC compositional heterogeneity poikilothermic animals less pronounced Aparicio et al
0.3283119.15342797.html.plaintext.txt	248	In addition depth fish transposable element analysis less primates rodents Aparicio et al
0.3283119.15342797.html.plaintext.txt	249	In following section compare annotations human mouse PRNP PRND PRNT SPRN genes local genomic contexts
0.3283119.15342797.html.plaintext.txt	250	Gene Structure Gene Features Gene Density CpG Islands Genomic location gene structure gene size GC content features exons introns human mouse PRNP PRND PRNT SPRN genes summarized table S1 Supplementary Material online
0.3283119.15342797.html.plaintext.txt	251	We found gene density GC content much higher SPRN genomic environment PRNP environment mammals analyzed figs
0.3283119.15342797.html.plaintext.txt	252	2 3 see also tables S2 S3 Supplementary Material online
0.3283119.15342797.html.plaintext.txt	253	There five genes 380074 bp human PRNP local genomic environment 45
0.3283119.15342797.html.plaintext.txt	254	02 GC rich compared three genes 51425 bp human SPRN gene context 50
0.3283119.15342797.html.plaintext.txt	255	In four genes PRNP PRND PRNT SPRN ORF contained single coding exon
0.3283119.15342797.html.plaintext.txt	256	Their gene lengths correlate inversely GC content GC content also higher exons comparing exon 1intron 1 pairs relevant exon 2 intron 2 pairs
0.3283119.15342797.html.plaintext.txt	257	The GC content human mouse SPRN genes 66 58 respectively much higher PRNP 42 45 PRND 46 47 PRNT 43 human
0.3283119.15342797.html.plaintext.txt	258	For reference mammalian GC content known vary genome wide different scales example average GC content human genome 41 ranging 36 47 large scale 10 Mb 33 59 small scale 300 kb Lander et al
0.3283119.15342797.html.plaintext.txt	259	2001 similar values reported mouse genome Waterston et al
0.3283119.15342797.html.plaintext.txt	260	An analysis CpG islands human mouse genomic contexts PRNP PRND PRNT SPRN using cpgplot program Larsen et al
0.3283119.15342797.html.plaintext.txt	261	1992 results shown showed islands associated PRNP SPRN promoter regions PRND shown Comincini et al
0.3283119.15342797.html.plaintext.txt	262	Distribution Transposable Elements PRNP SPRN Genes The role repeats genome controversial
0.3283119.15342797.html.plaintext.txt	263	Although often considered junk recognized active elements reshaped genomes e
0.3283119.15342797.html.plaintext.txt	264	creating new modified reshuffled genes
0.3283119.15342797.html.plaintext.txt	265	Passive elements excellent markers mutation selection analyses Lander et al
0.3283119.15342797.html.plaintext.txt	266	Differences repeat content distribution denote differences genegenome dynamics Thomas et al
0.3283119.15342797.html.plaintext.txt	267	Discernable interspersed repeats reported comprise approximately 45 human genome Lander et al
0.3283119.15342797.html.plaintext.txt	268	5 mouse genome Waterston et al
0.3283119.15342797.html.plaintext.txt	269	The lower content mouse thought caused higher nucleotide substitution rate mouse 4
0.3283119.15342797.html.plaintext.txt	270	2 x 10 9 makes older elements difficult identify
0.3283119.15342797.html.plaintext.txt	271	The depth repeat analysis using RepeatMasker program httpftp
0.3283119.15342797.html.plaintext.txt	272	html 150 200 100 120 MYA human mouse elements respectively Waterston et al
0.3283119.15342797.html.plaintext.txt	273	Our analysis distribution interspersed repeat elements local genomic environments human mouse rat PRNP SPRN genes shows transposable repeats human mouse rat regions given tables S2 S3 Supplementary Material online
0.3283119.15342797.html.plaintext.txt	274	There interspersed elements SPRN genomic environment PRNP human rat fewer mouse
0.3283119.15342797.html.plaintext.txt	275	At single gene level however observe striking differences transposable element content distribution summarized table 2 human mouse PRNP PRND PRNT SPRN genes
0.3283119.15342797.html.plaintext.txt	276	For detailed analysis repeat distribution eutherian PRNP PRND genes see Lee et al
0.3283119.15342797.html.plaintext.txt	277	The repeat content four genes correlates length inversely GC content thus PRNP repeats
0.3283119.15342797.html.plaintext.txt	278	1999 suggested gene expanded independently lineages since mammalian radiation numerous insertions
0.3283119.15342797.html.plaintext.txt	279	Strikingly contrast SPRN shortest gene highest GC content devoid transposable elements
0.3283119.15342797.html.plaintext.txt	280	View table Table 2 Summary Transposable Element Content Human Mouse PRNP PRND PRNT SPRN Genes
0.3283119.15342797.html.plaintext.txt	281	The frequency fixation transposable elements known vary genome wide
0.3283119.15342797.html.plaintext.txt	282	At two extremes human Hox gene clusters contain less 2 repeats approximately 100 kb whereas human Xp11 accumulated 89 transposable elements 525 kb region Lander et al
0.3283119.15342797.html.plaintext.txt	283	There also strong correlation divergence noncoding DNA amount repetitive DNA Chiaromonte et al
0.3283119.15342797.html.plaintext.txt	284	2001 flexible genomic regions accumulate many changes whereas rigid regions accumulate fewer
0.3283119.15342797.html.plaintext.txt	285	Rigidity sequence may reflect strong selection large number gene regulatory elements Lander et al
0.3283119.15342797.html.plaintext.txt	286	2001 alternatively may determined local genomic mutation rate Chiaromonte et al
0.3283119.15342797.html.plaintext.txt	287	We suggest fact SPRN lacks repeats local genomic environment indication strong purifying functionally driven selection acting gene
0.3283119.15342797.html.plaintext.txt	288	Conversely PRNPs flexibility promiscuity accepting repeat insertions suggests relaxed evolutionary history gene
0.3283119.15342797.html.plaintext.txt	289	Alignment Genomic Sequences Orthologous genes usually aligned recognized comparative genomic analysis closely related species
0.3283119.15342797.html.plaintext.txt	290	Between evolutionarily distant species mammals fish coding regions primarily recognizable Frazer et al
0.3283119.15342797.html.plaintext.txt	291	However rapid divergence nucleotide sequence indels gene loss acquisition occurred sequences cannot readily aligned orthologs recognized Kellis et al
0.3283119.15342797.html.plaintext.txt	292	Indeed analysis Thomas et al
0.3283119.15342797.html.plaintext.txt	293	2003 showed almost one third human coding sequence align fish corresponding genomic region
0.3283119.15342797.html.plaintext.txt	294	To detect highly diverged orthologous sequences two long contiguous sequences global alignments advantage Frazer et al
0.3283119.15342797.html.plaintext.txt	295	We used VISTA global alignment tool Mayor et al
0.3283119.15342797.html.plaintext.txt	296	2000 purpose detect conserved orthologous elements mammalian fish genomic sequences
0.3283119.15342797.html.plaintext.txt	297	Cross species VISTA analysis genomic fragments containing mammalian PRNP fish stPrP 2 coding PrP like protein coding genes shown figure 4 similar analysis mammalian fish SPRN genes figure S2 Supplementary Material online
0.3283119.15342797.html.plaintext.txt	298	Description genomic context coordinates given Materials Methods
0.3283119.15342797.html.plaintext.txt	299	View larger version 93K FIG
0.3283119.15342797.html.plaintext.txt	300	VISTA plot showing peaks similarity pairwise sequence alignments 1 human versus mouse 2 human versus rat 3 human versus Fugu 4 human versus Tetraodon
0.3283119.15342797.html.plaintext.txt	301	PRNP prion protein coding gene PRND doppel coding gene PRNT PRNT gene RASSF2 ras association domain family 2 coding gene SLC23A1 solute carrier 23 member 2 coding gene
0.3283119.15342797.html.plaintext.txt	302	Peaks shown relative position reference human sequence horizontal axis percent identities 30 100 indicated vertical axis
0.3283119.15342797.html.plaintext.txt	303	For reference sequence direction gene transcription indicated horizontal arrow blue rectangles denote coding exons light blue rectangles indicate 5 3 untranslated regions
0.3283119.15342797.html.plaintext.txt	304	Pink noncoding UTR light blue coding blue sequence peaks fitting criteria conserved elements 50 50 bp indicated
0.3283119.15342797.html.plaintext.txt	305	Genomic coordinates given Materials Methods
0.3283119.15342797.html.plaintext.txt	306	VISTA Plots Genomic Regions PRNP PRND PRNT We observe substantial conservation coding noncoding sequences PRNP PRND RASSF2 SLC23A1 genes human rodents conservation high exons highly conserved regions introns well
0.3283119.15342797.html.plaintext.txt	307	For PRNP gene results agree Lee et al
0.3283119.15342797.html.plaintext.txt	308	For PRND gene note highest conservation coding exon 2 exons 1 3 seem less conserved
0.3283119.15342797.html.plaintext.txt	309	An intergenic exon mouse 85944 86046 bp mouse sequence align corresponding human region
0.3283119.15342797.html.plaintext.txt	310	The human rodent RASSF2 SLC23A1 genes align extensively
0.3283119.15342797.html.plaintext.txt	311	We observe conservation rodents human PRNT gene region differs genes shown plot
0.3283119.15342797.html.plaintext.txt	312	There almost conservation rat human none exons conservation human mouse appears poor
0.3283119.15342797.html.plaintext.txt	313	In contrast human rodent comparison VISTA plot figure 4 detects conservation mammalian PRNP fish stPrP 2 coding PrP like protein coding genes
0.3283119.15342797.html.plaintext.txt	314	Neither homology criteria nonhomology criteria gene orthology fulfilled
0.3283119.15342797.html.plaintext.txt	315	First coding exons genes align indicating divergence mammalian PRNP fish stPrP 2 coding genes beyond detectable conservation
0.3283119.15342797.html.plaintext.txt	316	Second clear evidence deletion translocation duplication events local genomic sequence since divergence mammals fish PRND gene PRNT gene human exists mammals fish whereas PrP like protein coding gene present fish
0.3283119.15342797.html.plaintext.txt	317	The adjacent RASSF2 SLC23A1 genes align fish orthologs exons
0.3283119.15342797.html.plaintext.txt	318	PipMaker Analysis PRNT To test Vista observation PRNT gene aligned human chr20 4657104 4708670 bp Ensembl mouse chr2 132957930 132998136 bp Ensembl genomic sequence regions PRND RASSF2 genes using PipMaker program
0.3283119.15342797.html.plaintext.txt	319	The dot plot results presented figure 5 like Vista results show conservation PRNT gene exons human mouse
0.3283119.15342797.html.plaintext.txt	320	View larger version 6K FIG
0.3283119.15342797.html.plaintext.txt	321	Analysis human mouse conservation genomic region human PRNT gene
0.3283119.15342797.html.plaintext.txt	322	PipMaker dot plot human chr20 4657104 4708670 bp Ensembl mouse chr2 132957930 132998136 bp Ensembl genomic sequence PRND RASSF2 genes
0.3283119.15342797.html.plaintext.txt	323	Human sequence along horizontal axis
0.3283119.15342797.html.plaintext.txt	324	When translated exon 2 human PRNT gene detected two potential ORFs encoding 60 94 residues also several smaller ORFs shown
0.3283119.15342797.html.plaintext.txt	325	Makrinou Collinge Antoniou 2002 reported expression PRNT gene exclusively testis PRND gene noted 50 similarity 42 identity potential 94 residue protein human Dpl
0.3283119.15342797.html.plaintext.txt	326	The absence long ORF apparently recent origin suggest human PRNT pseudogene arising originally duplication PRND
0.3283119.15342797.html.plaintext.txt	327	Pseudogenes often remnants duplicate genes arising either tandem duplication retrotransposition processed mRNA
0.3283119.15342797.html.plaintext.txt	328	Although sequences show similarities coding regions known proteins acquired many stop codons frame shifts longer code full length protein
0.3283119.15342797.html.plaintext.txt	329	They usually transcribed occasionally resurrected response new organismal need Harrison Gerstein 2002 acquire additional functions specific regulatory role Hirotsune et al
0.3283119.15342797.html.plaintext.txt	330	Also intron PRNT gene detected processed pseudogene sequence high homology mRNA isopentenyl diphosphate delta isomerase 1 disrupted Alu insertion
0.3283119.15342797.html.plaintext.txt	331	It likely PRNT gene appeared human lineage evolutionary split rodents
0.3283119.15342797.html.plaintext.txt	332	This consistent position PRNP genomic context chromosome 20 highly recombinogenic region may fostered recent duplication PRND create human specific PRNT gene
0.3283119.15342797.html.plaintext.txt	333	However also possible PRND duplication ancient PRNT survives pseudogene mammalian lineages well human deleted rodents
0.3283119.15342797.html.plaintext.txt	334	VISTA Plot SPRN Genomic Region Alignment mammalian fish genomic regions containing SPRN adjacent genes shows conservation three genes figure S2 Supplementary Material online
0.3283119.15342797.html.plaintext.txt	335	Notably coding exon sequence SPRN aligns five pairwise alignments
0.3283119.15342797.html.plaintext.txt	336	We note several conservation peaks distal SPRN promoter mammals fish human sequence positions approximately 48 48
0.3283119.15342797.html.plaintext.txt	337	5 50 kb detailed analysis regulatory region given
0.3283119.15342797.html.plaintext.txt	338	The coding exons GTP binding protein gene mostly conserved mammals fish
0.3283119.15342797.html.plaintext.txt	339	The large gap alignment approximately 24
0.3283119.15342797.html.plaintext.txt	340	5 39 kb human sequence caused insertion LINE elements human sequence two complete elements antisense orientation two truncated human LINEL1 elements
0.3283119.15342797.html.plaintext.txt	341	L1s young transposable elements actively amplified past 40 Myr primate evolution evolutionary divergence human rodents
0.3283119.15342797.html.plaintext.txt	342	The distal end GTP binding protein gene overlaps distal end SPRN gene human mouse sequence functional significance unclear
0.3283119.15342797.html.plaintext.txt	343	A examples antiparallel overlapping untranslated exons functional genes reported Miyajima et al
0.3283119.15342797.html.plaintext.txt	344	1989 Batshake Sundelin 1996 Dan et al
0.3283119.15342797.html.plaintext.txt	345	There four polyadenylation signals human GTP binding protein coding gene resulting alternative transcription noncoding part 3 terminal exon
0.3283119.15342797.html.plaintext.txt	346	All four sites differ one position canonical consensus polyadenylation signals AAUAAA AUUAAA sequence first 41227 41232 bp AK095872 BC00409 BC000920 transcripts second 41262 41267 bp BC026725 transcript third 41321 41326 bp BC035721 transcript signals GTTAAA
0.3283119.15342797.html.plaintext.txt	347	The distal fourth signal sequence overlaps 3 end SPRN gene AATCAA 42068 42072 bp cDNAs AK074976 NM138384
0.3283119.15342797.html.plaintext.txt	348	Untranslated gene fragments may contain regulatory sequences affect mRNA stability translation efficiency choice alternate polyadenylation sites may strongly affect expression gene Beaudoing Gautheret 2001
0.3283119.15342797.html.plaintext.txt	349	The sequence polyadenylation signal site SPRN canonical consensus AATAAA 41454 41449 bp BC040198 transcript
0.3283119.15342797.html.plaintext.txt	350	The exons third gene encoding AO conserved mammals pufferfish zebrafish
0.3283119.15342797.html.plaintext.txt	351	In zebrafish sequence third gene long chain fatty acyl synthetase fig
0.3283119.15342797.html.plaintext.txt	352	As zebrafish contig contain next proximal gene clear whether synthetase gene merely inserted AO coding gene found another contig another location
0.3283119.15342797.html.plaintext.txt	353	Conservation SPRN coding exon mammals fish satisfies homology criteria gene orthology
0.3283119.15342797.html.plaintext.txt	354	Next conserved gene order relative transcription orientation SPRN adjacent gene encoding GTP binding protein including also AO coding gene pufferfish mammals fish indicates rearrangement occurred genomic fragment evolutionary divergence fish mammals 450 MYA
0.3283119.15342797.html.plaintext.txt	355	Thus conclude SPRN gene likely orthologous mammals fish
0.3283119.15342797.html.plaintext.txt	356	Phylogenetic Footprinting SPRN Gene Phylogenetic footprinting method identifying regulatory elements single gene comparing orthologous sequences several species Blanchette Tompa 2002
0.3283119.15342797.html.plaintext.txt	357	The basic assumption functional regions including regulatory elements greater selective pressure conserved species nonfunctional regions
0.3283119.15342797.html.plaintext.txt	358	However regulatory elements may quite short 5 20 bp difficult recognize nonfunctional background noise
0.3283119.15342797.html.plaintext.txt	359	We used program Footprinter Blanchette Tompa 2002 httpabstract
0.3283119.15342797.html.plaintext.txt	360	edublanchemFootPrinterWebFootPrinterInput
0.3283119.15342797.html.plaintext.txt	361	pl identify elements conserved human mouse Fugu SPRN genes
0.3283119.15342797.html.plaintext.txt	362	The program reports sets conserved motifs taking account phylogenetic tree relating input species
0.3283119.15342797.html.plaintext.txt	363	As shown table 3 identified 16 conserved motifs upstream SPRN ORF intron exon 1 upstream promoter
0.3283119.15342797.html.plaintext.txt	364	In human mouse five motifs detected upstream promoter one exon 1 10 intron shown figure 6
0.3283119.15342797.html.plaintext.txt	365	Although set motifs contains candidates regulatory regions SPRN gene may also contain false positives
0.3283119.15342797.html.plaintext.txt	366	Also Footprinter may miss motifs present single species
0.3283119.15342797.html.plaintext.txt	367	false negatives motifs shorter 6 bp multiple species motifs containing indels motifs fail meet statistical significance dimers variable internal sequences Blanchette Tompa 2002
0.3283119.15342797.html.plaintext.txt	368	We next checked whether known transcription factor binding sites among detected motifs using MatInspector program Quandt et al
0.3283119.15342797.html.plaintext.txt	369	de human mouse sequences
0.3283119.15342797.html.plaintext.txt	370	This program predicts transcription factor binding sites deposited TRANSFAC database Wingender et al
0.3283119.15342797.html.plaintext.txt	371	We detected 155 159 likely transcription factor binding sites human mouse sequences respectively 69 82 intron 11 14 exon 1 75 62 upstream promoter full lists human mouse given tables S4 S5 respectively Supplementary Material online
0.3283119.15342797.html.plaintext.txt	372	View table Table 3 Conserved Motifs Human Mouse Fugu SPRN Gene Identified Phylogenetic Footprinting
0.3283119.15342797.html.plaintext.txt	373	View larger version 6K FIG
0.3283119.15342797.html.plaintext.txt	374	Potential regulatory motifs human SPRN mouse Sprn genes identified phylogenetic footprinting
0.3283119.15342797.html.plaintext.txt	375	Motifs 4 14 16 labeled asterisk denote potential nurr1 ATF6 activating transcription factor 6 MAZR MYC associated zinc finger protein related transcription factor binding sites respectively
0.3283119.15342797.html.plaintext.txt	376	This combined analysis showed three motifs detected phylogenetic footprinting correspond predicted transcription factor binding sites significantly note elements present relative order human mouse sequences
0.3283119.15342797.html.plaintext.txt	377	All three motifs detected SPRN intron note intron free transposable elements presence motifs suggests intron may play important role gene regulation
0.3283119.15342797.html.plaintext.txt	378	Motif 4 denotes binding site nurr1 nuclear receptor expressed brain known play important role coordinate neuroendocrine regulation activity hypothalamicpituitaryadrenal axis Murphy Conneely 1997
0.3283119.15342797.html.plaintext.txt	379	It also critical dopaminergic neuron development activating tyrosine hydroxylase transcription cell context dependent manner Kim et al
0.3283119.15342797.html.plaintext.txt	380	Aberrations dopaminergic system associated Parkinson disease schizophrenia
0.3283119.15342797.html.plaintext.txt	381	Motif 14 corresponds activating transcription factor 6 ATF6 binding site
0.3283119.15342797.html.plaintext.txt	382	ATF6 member basic leucine zipper family
0.3283119.15342797.html.plaintext.txt	383	It involved induction endoplasmic reticulum ER stress response transcription genes encoding molecular chaperones folding enzymes located ER upregulated
0.3283119.15342797.html.plaintext.txt	384	Some genes pathway directly activated ATF6 binding sites
0.3283119.15342797.html.plaintext.txt	385	Upstream ATF6 ER stress response IRE1 Wang et al
0.3283119.15342797.html.plaintext.txt	386	Remarkably ER stress response pathway involved familial Alzheimer disease FAD pathogenesis
0.3283119.15342797.html.plaintext.txt	387	FAD linked PS1 mutants attenuate autophosphorylation IRE1 lead impaired induction ER stress response
0.3283119.15342797.html.plaintext.txt	388	These mutants also attenuate ATF6 signaling pathway Kudo et al
0.3283119.15342797.html.plaintext.txt	389	We already shown predominant expression mammalian SPRN brain Premzl et al
0.3283119.15342797.html.plaintext.txt	390	These new findings conserved clustered nurr1 ATF6 transcription factor binding site motifs human mouse introns suggestive Shos brain specific function targets experimental analysis
0.3283119.15342797.html.plaintext.txt	391	Finally part third conserved motif 16 binds MYC associated zinc finger protein related transcription factor MAZR
0.3283119.15342797.html.plaintext.txt	392	MAZR interacts Bach2 B cell neuron specific transcription repressor Kobayashi et al
0.3283119.15342797.html.plaintext.txt	393	Protein Alignment Phylogenetic Analysis As already discussed genomic sequences summarized figures 1 3 table 1 expanded data set fish proteins related PrP
0.3283119.15342797.html.plaintext.txt	394	First deduced sequence 395 amino acids Tetraodon stPrP 2 protein assembled genomic sequence
0.3283119.15342797.html.plaintext.txt	395	Second translated zebrafish stPrP 3 coding sequence Ensembl genomic contig NA3274
0.3283119.15342797.html.plaintext.txt	396	1 protein 561 amino acids
0.3283119.15342797.html.plaintext.txt	397	Third based incomplete genomic sequence assembled cloned sequenced Tetraodon Sho ORF deduced 155 residue protein thus adding third fish Sho sequence zebrafish Fugu previously reported Premzl et al
0.3283119.15342797.html.plaintext.txt	398	Last already discussed identified new Sho related class Shadoo2 Sho2 sequences public databases
0.3283119.15342797.html.plaintext.txt	399	We able deduce Sho2 protein sequences 150 150 135 amino acids respectively genomic information Fugu scaffold96 Ensembl Tetraodon FSCONTIG414641 Genoscope zebrafish ctg10456 Ensembl
0.3283119.15342797.html.plaintext.txt	400	Carp Sho2 conceptually translated EST data CA964511 NCBI give protein 145 amino acids
0.3283119.15342797.html.plaintext.txt	401	As described Materials Methods amino acid sequences 11 PrP related proteins human chicken turtle Xenopus Fugu Tetraodon zebrafish 10 Sho Sho2 proteins human mouse rat Fugu Tetraodon zebrafish carp aligned independently using ClustalW Thompson Higgins Gibson 1994
0.3283119.15342797.html.plaintext.txt	402	After refinement alignments using GDE Smith et al
0.3283119.15342797.html.plaintext.txt	403	1994 assessed alignments chose 118 149 sites PrP related ShoSho2 proteins respectively phylogenetic analyses using maximum likelihood program MOLPHY Adachi Hasegawa 1996
0.3283119.15342797.html.plaintext.txt	404	The alignments shown figures S3 S4 Supplementary Material online
0.3283119.15342797.html.plaintext.txt	405	The analysis PrP related sequence set identified single likely tree shown figure 7 281 near optimal trees none differed significantly likely tree
0.3283119.15342797.html.plaintext.txt	406	65 implying every site alignment figure S3 Supplementary Material online changed average 5
0.3283119.15342797.html.plaintext.txt	407	65 times turn implies interpretation tree must done caution also reflected several low LBP RLS values fig
0.3283119.15342797.html.plaintext.txt	408	However fact found 282 good trees
0.3283119.15342797.html.plaintext.txt	409	likely tree near optimal trees 34459425 possible trees places result better light
0.3283119.15342797.html.plaintext.txt	410	View larger version 9K FIG
0.3283119.15342797.html.plaintext.txt	411	The likely tree based phylogenetic analysis PrP related proteins alignment figure S3 Supplementary Material online
0.3283119.15342797.html.plaintext.txt	412	Local bootstrap probabilities LBP listed edges relative likelihood scores RLS listed edges
0.3283119.15342797.html.plaintext.txt	413	The error bar bottom corresponds 1
0.3283119.15342797.html.plaintext.txt	414	The likely tree groups human chicken turtle frog sequences together exclusion fish sequences expected known phylogeny
0.3283119.15342797.html.plaintext.txt	415	Although inferred evolutionary relationship among higher vertebrates human PrP distantly related birds reptiles frog likely tree significantly different others consistent current view tetrapod evolution
0.3283119.15342797.html.plaintext.txt	416	PrPHu PrPFr changed
0.3283119.15342797.html.plaintext.txt	417	The divergence amino acid sequence fish proteins related PrP PrPs higher vertebrates suggests orthology proteins
0.3283119.15342797.html.plaintext.txt	418	The clustering pattern stPrPs also indicates genes coding proteins duplicated fish evolutionary split tetrapods
0.3283119.15342797.html.plaintext.txt	419	The analysis Shadoo proteins identified single likely tree shown figure 8 48 near optimal trees none differed significantly likely tree
0.3283119.15342797.html.plaintext.txt	420	77 implying every site alignment figure S4 Supplementary Material online changed average 4
0.3283119.15342797.html.plaintext.txt	421	Again implies caution must applied interpretation tree need reflected also low LBP RLS values fig
0.3283119.15342797.html.plaintext.txt	422	However note found 49 good trees
0.3283119.15342797.html.plaintext.txt	423	likely tree near optimal trees 2027025 possible trees setting result better light
0.3283119.15342797.html.plaintext.txt	424	View larger version 9K FIG
0.3283119.15342797.html.plaintext.txt	425	The likely tree consensus tree based phylogenetic analysis ShoSho2 proteins alignment figure S4 Supplementary Material online
0.3283119.15342797.html.plaintext.txt	426	Local bootstrap probabilities LBP listed edges relative likelihood scores RLS listed edges
0.3283119.15342797.html.plaintext.txt	427	The error bar bottom corresponds 1
0.3283119.15342797.html.plaintext.txt	428	The Shadoo tree indicates Shos Shos2s lie two separate branches implying two genes duplicated divergence fish tetrapods
0.3283119.15342797.html.plaintext.txt	429	Most importantly fish Shos cluster mammalian homologs rather fish Sho2 paralogs
0.3283119.15342797.html.plaintext.txt	430	This clustering pattern strongly suggests orthology mammalian fish Shadoos inference previously made basis sequence conservation Premzl et al
0.3283119.15342797.html.plaintext.txt	431	As noted previously conserved genomic context failure detect SPRNB mammalian genomes suggests either SPRNB gene lost fish mammals highly diverged yet found
0.3283119.15342797.html.plaintext.txt	432	It established gene duplication occurred several fish lineages many duplicated fish genes one homolog mammals Taylor et al
0.3283119.15342797.html.plaintext.txt	433	Two fates duplicated genes proposed
0.3283119.15342797.html.plaintext.txt	434	The classical model neofunctionalization predicts one duplicate loci retains original function whereas duplicate fixed rare beneficial mutations occur Ohno 1970
0.3283119.15342797.html.plaintext.txt	435	This model fits current knowledge Shos Sho2s Sho2 duplicate either deleted mammals tetrapods highly diverged neofunctionalization mammalian ortholog recognizable
0.3283119.15342797.html.plaintext.txt	436	The alternative model proposes duplicates preserved subfunctionalization proteins encoded duplicates complement functionally Force et al
0.3283119.15342797.html.plaintext.txt	437	This model fits fish stPrPs sequences similar dissimilar tetrapod PrPs
0.3283119.15342797.html.plaintext.txt	438	Protein Sequence Features We introduced previously model structures mature Sho PrP PrP related proteins useful basis discussing conserved highly variable regions sequences Premzl et al
0.3283119.15342797.html.plaintext.txt	439	The model consists four regions basic region 1 shows tendency insertion repeat sequence region 2 hydrophobic region 3 C terminal region 4
0.3283119.15342797.html.plaintext.txt	440	Figure 1 figures S3 S4 Supplementary Material online show model represents quite dynamic structural scaffold substantial differences presence lengths sequence compositions regions insertions among complete ShoPrP set particularly taking account numerous fish proteins
0.3283119.15342797.html.plaintext.txt	441	As already compared sequence features proteins figure 1 except ones newly reported TestPrP 2 ZestPrP 3 TeSho FuSho2 TeSho2 CaSho2 ZeSho2 see table 1 confine attention largely new proteins
0.3283119.15342797.html.plaintext.txt	442	Fish proteins known stPrP set FustPrP 2 424 residues TestPrP 2 395 residues FustPrP 1 461 residues ZestPrP 3 561 residues much longer tetrapod PrPs frog 216 residues turtle 270 residues chicken 273 residues human 253 residues fish PrP like proteins 170 190 residues show significant sequence heterogeneity among especially seemingly free format low complexity repeats large insertion region 2 large insertions within region 4
0.3283119.15342797.html.plaintext.txt	443	Most difference length TestPrP 2 FustPrP 2 large insertion region 2 whereas large ZestPrP 3 protein shows increases approximately 90 approximately 45 residues region 2 insertion region 4 respectively compared stPrP 2s
0.3283119.15342797.html.plaintext.txt	444	More useful alignment analysis requires better knowledge number stPrP proteins individual fish variation among major fish lineages see also Protein Alignment Phylogenetic Analysis
0.3283119.15342797.html.plaintext.txt	445	As shown figure 1 new stPrPs also predicted N terminal C terminal signal sequences extracellular export GPI anchor attachment respectively Premzl et al
0.3283119.15342797.html.plaintext.txt	446	2003 Materials Methods also one disulfide bridge three N glycosylation sites
0.3283119.15342797.html.plaintext.txt	447	The main significantly conserved feature among PrP related proteins hydrophobic region 3 residues 112 131 HuPrP also subsequent sequence region 4 residue 160 HuPrP
0.3283119.15342797.html.plaintext.txt	448	Interestingly includes beginning sequence shown folded NMR structures L125 R228 HuPrP Zahn et al
0.3283119.15342797.html.plaintext.txt	449	2000 includes first unusual highly hydrophilic helix D144 M154 HuPrP first part antiparallel ss sheet Y128 G131 HuPrP
0.3283119.15342797.html.plaintext.txt	450	This segment also includes region residues 119 138 HuPrP implicated PrPC dimerization site potential binding site PrPC PrPSc complex formation Horiuchi Caughey 1999 Zuegg Gready 2000
0.3283119.15342797.html.plaintext.txt	451	We note repetitive insertion region fish PrP like proteins
0.3283119.15342797.html.plaintext.txt	452	Compared PrP related proteins conservation features including length much higher ShoSho2 set
0.3283119.15342797.html.plaintext.txt	453	We previously noted high conservation identity 81 96 among mammalian Shos human mouse rat good conservation particularly zebrafish fish mammalian sequences slightly beyond end hydrophobic sequence identity 41 53 zebrafish 1 78 Premzl et al
0.3283119.15342797.html.plaintext.txt	454	The fish proteins similar length FuSho 146 residues TeSho 149 residues ZeSho 131 residues FuSho2 150 residues TeSho2 150 residues ZeSho2 136 residues CaSho2 145 residues
0.3283119.15342797.html.plaintext.txt	455	There insertion Fugu Tetraodon Sho basic repeats present Shos
0.3283119.15342797.html.plaintext.txt	456	Of note however Sho2 sequence region different Shos Sho basic region N terminal hydrophobic region missing Sho2s
0.3283119.15342797.html.plaintext.txt	457	Although local regions sequence conservation including around N glycosylation site conserved Shos Sho2s C terminal regions fish Shos Sho2s quite diverged also sequence region diverged fish tetrapod Shos see
0.3283119.15342797.html.plaintext.txt	458	Model Evolution PRNP Related SPRN Related Genes In paper reporting finding fish PrP like protein coding genes Suzuki et al
0.3283119.15342797.html.plaintext.txt	459	2002 made initial suggestion evolutionary link fish PrP like protein coding genes tetrapod PRNP genes
0.3283119.15342797.html.plaintext.txt	460	This based weak homology encode extracellular GPI anchored proteins repeats unusual internal hydrophobic region see figure 1 context based conservation genes encoding Rassf2 Slc23a1 genomic contexts criteria
0.3283119.15342797.html.plaintext.txt	461	2003 stPrP 2 coding gene proximal PrP like protein coding gene Fugu somewhat strengthened homology argument evolutionary relationship tetrapod PRNPs fish gene C terminal regions proteins similar whereas PrP like proteins quite different see figure 1
0.3283119.15342797.html.plaintext.txt	462	However finding weakened context based argument
0.3283119.15342797.html.plaintext.txt	463	Although orientation stPrP 2 gene mammalian PRNP two genes separated Rassf2 coding gene different genes PrP like gene PRND different orientations fig
0.3283119.15342797.html.plaintext.txt	464	We suggested previously could accounted independent duplications
0.3283119.15342797.html.plaintext.txt	465	2003 also reported another fish gene stPrP 1 another genomic context
0.3283119.15342797.html.plaintext.txt	466	In earlier paper Premzl et al
0.3283119.15342797.html.plaintext.txt	467	2003 reporting finding SPRN gene fish mammals provided clear evidence homology context based suggested direct evolutionary relationship
0.3283119.15342797.html.plaintext.txt	468	However stage evidence evolutionary link Sho PrP proteins although overall structural features intriguingly similar
0.3283119.15342797.html.plaintext.txt	469	In paper applied several methods homology based VISTA genomic global alignment promoter region footprinting protein sequence alignment phylogenetics context based genomic context relative gene order orientation analysis see whether definitive statements made relationships fish tetrapod genes
0.3283119.15342797.html.plaintext.txt	470	We also included analyses sequences several relevant new genes found fish
0.3283119.15342797.html.plaintext.txt	471	It clear fish contain plethora genes similarities PRNP SPRN quite diverged sequences even among fish lineages available us
0.3283119.15342797.html.plaintext.txt	472	Also data SPRN PRND genes tetrapods mammals lacking
0.3283119.15342797.html.plaintext.txt	473	Remarkably genes ORF contained within single exon
0.3283119.15342797.html.plaintext.txt	474	Hence although make firm conclusions others tentative await correction current draft data Fugu Tetraodon zebrafish genomes well availability data tetrapod lineages mammals
0.3283119.15342797.html.plaintext.txt	475	amphibians reptiles birds marsupials monotremes
0.3283119.15342797.html.plaintext.txt	476	Considering first issues PrP related genes VISTA analysis global alignment genomic environment show conservation mammalian PRNP fish stPrP 2 PrP like protein coding genes although adjacent Rassf2 Slc23a1 coding genes align fish orthologs exons
0.3283119.15342797.html.plaintext.txt	477	There clear evidence rearrangements genomic region PRND gene PRNT gene human exists mammals fish PrP like protein coding gene far reported fish
0.3283119.15342797.html.plaintext.txt	478	It thus seems clear PRNP stPrP 2 coding genes diverged greatly since last shared common ancestor
0.3283119.15342797.html.plaintext.txt	479	There basis suggesting functional homology genes likely evolved significantly different functions
0.3283119.15342797.html.plaintext.txt	480	Second phylogenetic analysis suggests gene duplication giving rise stPrP 1stPrP 3 stPrP 2 likely occurred evolutionary separation fish mammals
0.3283119.15342797.html.plaintext.txt	481	The clustering fish stPrPs separately tetrapod PrPs figure 7 indicative divergence amino acid sequence fish higher vertebrate proteins likely different functions
0.3283119.15342797.html.plaintext.txt	482	Remarkably found new SPRN related gene SPRNB adjacent stPrP 1 coding gene Fugu zebrafish
0.3283119.15342797.html.plaintext.txt	483	As current data indicate genomic contexts genes fig
0.3283119.15342797.html.plaintext.txt	484	2 different caution interpreting results necessary
0.3283119.15342797.html.plaintext.txt	485	However seems unlikely accidental two genes found together twice
0.3283119.15342797.html.plaintext.txt	486	Hence findings provide first hint evolutionary link SPRN PRNP families
0.3283119.15342797.html.plaintext.txt	487	The fact two genes code unique hydrophobic segment reported initially Premzl et al
0.3283119.15342797.html.plaintext.txt	488	2003 evidence protein level evolutionary link
0.3283119.15342797.html.plaintext.txt	489	Considering SPRNSPRNB genes quite different picture emerges
0.3283119.15342797.html.plaintext.txt	490	All evidence suggests mammalian fish SPRNsprn genes likely orthologous directly descended common ancestor preserved function
0.3283119.15342797.html.plaintext.txt	491	VISTA analysis shows SPRN gene aligns cross species analysis together adjacent genes whereas protein sequence alignment phylogenetic tree analysis also indicate conservation mammalian fish Shos
0.3283119.15342797.html.plaintext.txt	492	Phylogenetic analysis shows Shos Sho2s lying two separate branches fig
0.3283119.15342797.html.plaintext.txt	493	8 implying two genes duplicated divergence fish tetrapods
0.3283119.15342797.html.plaintext.txt	494	We present evolutionary model consistent various findings figure 9 basis discussion future investigation
0.3283119.15342797.html.plaintext.txt	495	The model proposes ancestral gene leading PrP related Sho related encoding genes SPRN like gene
0.3283119.15342797.html.plaintext.txt	496	First ancient prevertebrate duplication produced SPRNA SPRNB genes within environment may contained AO binding protein GTP binding protein encoding genes proximally Rassf2 Slc23a1 encoding genes distally
0.3283119.15342797.html.plaintext.txt	497	The model proposes separation SPRN SPRNB genes translocation half gene cluster
0.3283119.15342797.html.plaintext.txt	498	The subsequent history two branches suggests genomic environment containing SPRNB gene highly recombinogenic whereas containing SPRNA gene stable leading currently known fish mammal Sho orthologs
0.3283119.15342797.html.plaintext.txt	499	The stability gene suggests orthologous SPRN genes coding Sho protein found tetrapod lineages
0.3283119.15342797.html.plaintext.txt	500	A duplication SPRNB gene proposed still divergence fish tetrapods duplicate genes acquiring additional C terminal coding sequence produce SPRNB1 SPRNB2 protogenes completed C terminal domain tetrapod PrP fish stPrP 1 2 3 proteins fig
0.3283119.15342797.html.plaintext.txt	501	View larger version 14K FIG
0.3283119.15342797.html.plaintext.txt	502	An evolutionary model origin Sho related PrP related coding genes consistent current data vertebrates
0.3283119.15342797.html.plaintext.txt	503	As shown figure 9 acquisition additional sequence form complete C terminal domain stage necessary explain subsequent gene evolution steps
0.3283119.15342797.html.plaintext.txt	504	It intriguing model predicts C terminal domain sequence genes evolved SPRNB1 SPRNB2 truncated replaced least three times leading PrP like protein Sho2 SPRNB coding genes fish PRNT gene human
0.3283119.15342797.html.plaintext.txt	505	Figure 9 shows SPRNB2 translocated ancestor stage separate contexts consistent known fish stPrP 1 stPrP 2 gene contexts fig
0.3283119.15342797.html.plaintext.txt	506	However genes descendent SPRNB2 reported tetrapods certain translocation occurred separation fish tetrapods
0.3283119.15342797.html.plaintext.txt	507	After divergence fish tetrapods model proposes independent duplications SPRNB1 SPRNB2 protogenes
0.3283119.15342797.html.plaintext.txt	508	In tetrapod lineage gene duplication SPRNB1 produced gene cluster containing PRNP PRND genes together Rassf2 Slc23a1 coding genes
0.3283119.15342797.html.plaintext.txt	509	The timing duplication unclear known genes limited PRNPs frogs reptiles birds mammals PRND mammals
0.3283119.15342797.html.plaintext.txt	510	As noted elsewhere paper known stage SPRNB2 gene deleted tetrapod evolution whether simply diverged beyond levels currently detectable mammals
0.3283119.15342797.html.plaintext.txt	511	The model allows ancient origin PRNT necessary simply explain existing minimal data
0.3283119.15342797.html.plaintext.txt	512	absent rodents present human
0.3283119.15342797.html.plaintext.txt	513	In fish branch initial duplications SPRNB1 protogene produce stPrP 2 PrP like protein coding genes duplications SPRNB2 protogene produce SPRNB Sho2 coding gene observed stPrP 1 coding gene proposed
0.3283119.15342797.html.plaintext.txt	514	As drawn figure 9 gene clusters already separated
0.3283119.15342797.html.plaintext.txt	515	If separation occurred duplications translocation SPRNB stPrP 1 fragment might conveniently explain different contexts observed Fugu zebrafish
0.3283119.15342797.html.plaintext.txt	516	The additional complexity plethora genes fish consistent existing knowledge higher rate gene duplication fish fact many duplicated fish genes one homolog mammals Taylor et al
0.3283119.15342797.html.plaintext.txt	517	Dynamics Mammalian PRNP SPRN Genes We observed interesting differences mammalian SPRN PRNP gene characteristics offer insights genes evolving
0.3283119.15342797.html.plaintext.txt	518	First although SPRN PRNP local genomic environments covering several genes VISTA analyses figure 4 figure S2 Supplementary Material online found percentage repetitive elements comparable tables S2 S3 Supplementary Material online single gene level picture strikingly different
0.3283119.15342797.html.plaintext.txt	519	The SPRN gene transposable elements whereas PRNP PRND 46 24 respectively human introns table 2
0.3283119.15342797.html.plaintext.txt	520	Consistent picture gene dynamics brain specific SPRN gene evolved conservatively fish mammals Sho predicted conserved basic function vertebrate brain
0.3283119.15342797.html.plaintext.txt	521	By contrast shown PRNP gene undergone major rapid changes several levels comparison align sequences fish stPrP 2 coding genes fig
0.3283119.15342797.html.plaintext.txt	522	4 sequence subsequence composition Strumbo et al
0.3283119.15342797.html.plaintext.txt	523	2001 tetrapod PrPs frog reptile bird mammal show significant differences number exons size introns varies significantly mammals Lee et al
0.3283119.15342797.html.plaintext.txt	524	1998 Makrinou Collinge Antoniou 2002 table 2
0.3283119.15342797.html.plaintext.txt	525	These features characteristic genes evolving relaxed evolutionary constraints typical proteins rapidly evolving function Harrison Gerstein 2002 Kitami Nadeau 2002
0.3283119.15342797.html.plaintext.txt	526	What functions yet elucidated
0.3283119.15342797.html.plaintext.txt	527	Despite extensive study functions mammalian PrP remain elusive Aguzzi Hardt 2003 functional studies tissue expression profiles tetrapod PrPs reported
0.3283119.15342797.html.plaintext.txt	528	Conclusions TOP Abstract Introduction Methods Materials Results Discussion Conclusions Supplementary Material Acknowledgements References Evolution broadly viewed interplay conservation change enables perpetuation life whereas maintenance organization requires conservation variation allows adaptation Radman Matic Taddei 1999
0.3283119.15342797.html.plaintext.txt	529	In context suggest PrP Sho two components complex brain system distinct evolutionary histories functional roles
0.3283119.15342797.html.plaintext.txt	530	Whereas conserved Sho appears conserved role vertebrate brain maintenance relaxed evolution PrP may fine tuned adaptive role vertebrate brain lineage specific fashion
0.3283119.15342797.html.plaintext.txt	531	The intriguing similarities overall structures PrP Sho taken together new model ancient common evolutionary origin reinforce earlier suggestion Premzl et al
0.3283119.15342797.html.plaintext.txt	532	2003 functions may partly overlapping
0.3283119.15342797.html.plaintext.txt	533	However fact model highlights lineage specific PrP related genes encoding PrP like protein stPrP 1 Sho2 fish Dpl mammals suggests PRNP stPrP 2 genes may developed lineage specific functions coevolution genes
0.3283119.15342797.html.plaintext.txt	534	It possible PrPs functions vertebrate evolution coevolving several varied partners acquired lost range relatively weak subtle useful functions
0.3283119.15342797.html.plaintext.txt	535	In sense PrP dispensable Hirsh Fraser 2001 allows remarkable adaptation
0.3283119.15342797.html.plaintext.txt	536	Supplementary Material TOP Abstract Introduction Methods Materials Results Discussion Conclusions Supplementary Material Acknowledgements References FigureS1caption
0.3283119.15342797.html.plaintext.txt	537	PipMaker dot plots genomic fragments containing stPrP 2 coding PrP like protein coding SPRNA genes Fugu Tetraodon
0.3283119.15342797.html.plaintext.txt	538	VISTA plot SPRN showing peaks similarity human versus mouse human versus rat human versus Fugu human versus Tetraodon human versus zebrafish
0.3283119.15342797.html.plaintext.txt	539	Alignment 11 PrP related proteins used study
0.3283119.15342797.html.plaintext.txt	540	Alignment 10 ShoSho2 proteins used study
0.3283119.15342797.html.plaintext.txt	541	PRNP PRND PRNT SPRN genes human mouse
0.3283119.15342797.html.plaintext.txt	542	Repetitive elements human mouse rat PRNP SPRN genes respectively
0.3283119.15342797.html.plaintext.txt	543	MatInspector analysis human SPRN regulatory regions
0.3283119.15342797.html.plaintext.txt	544	MatInspector analysis mouse Sprn regulatory regions
0.3283119.15342797.html.plaintext.txt	545	Acknowledgements TOP Abstract Introduction Methods Materials Results Discussion Conclusions Supplementary Material Acknowledgements References J
0.3283119.15342797.html.plaintext.txt	546	supported ANU IAS block grant J
0.3283119.15342797.html.plaintext.txt	547	also grant Australian Research Council
0.3283119.15342797.html.plaintext.txt	548	supported EC grant QLK5 2002 00866 FIRST
0.3283119.15342797.html.plaintext.txt	549	We thank DNASTAR extended trial Lasergene software
0.3283119.15342797.html.plaintext.txt	550	Frances Shannon JCSMR ANU Professor M
0.3283119.15342797.html.plaintext.txt	551	Radman Faculte de Medecine Necker Enfants Malades Universite Paris V helpful discussions
0.3283119.15342797.html.plaintext.txt	552	Tetraodon cells kindly supplied Dr
0.3283119.15342797.html.plaintext.txt	553	Frank Grutzner Research School Biological Sciences ANU
0.3283119.15342797.html.plaintext.txt	554	This research paper 006 Sydney University Biological Informatics Technology Centre
0.3283119.15342797.html.plaintext.txt	555	Footnotes Takashi Gojobori Associate Editor
0.3283119.15342797.html.plaintext.txt	556	References TOP Abstract Introduction Methods Materials Results Discussion Conclusions Supplementary Material Acknowledgements References
0.3283119.15342797.html.plaintext.txt	557	3 Programs molecular phylogenetics based maximum likelihood
0.3283119.15342797.html.plaintext.txt	558	The Institute Statistical Mathematics Tokyo Japan
0.3283119.15342797.html.plaintext.txt	559	Dangerous liaisons microbe prion protein
0.3283119.15342797.html.plaintext.txt	560	Basic local alignment search tool
0.3283119.15342797.html.plaintext.txt	561	Whole genome shotgun assembly analysis genome Fugu rubripes
0.3283119.15342797.html.plaintext.txt	562	The mouse genes EP1 prostanoid receptor PKN protein kinase overlap
0.3283119.15342797.html.plaintext.txt	563	Identification alternate polyadenylation sites analysis tissue distribution using EST data
0.3283119.15342797.html.plaintext.txt	564	Discovery regulatory elements computational method phylogenetic footprinting
0.3283119.15342797.html.plaintext.txt	565	Characterization pufferfish Fugu genome compact model vertebrate genome
0.3283119.15342797.html.plaintext.txt	566	Association divergence interspersed repeats mammalian noncoding genomic DNA
0.3283119.15342797.html.plaintext.txt	567	Genomic organization comparative analysis genetic polymorphisms bovine ovine prion Doppel genes PRND
0.3283119.15342797.html.plaintext.txt	568	Comparative Genome Organization Workshop
0.3283119.15342797.html.plaintext.txt	569	Comparative genome organization vertebrates
0.3283119.15342797.html.plaintext.txt	570	Overlapping MINK CHRNE gene loci course mammalian evolution
0.3283119.15342797.html.plaintext.txt	571	Phylogenetic analysis gene functional predictions phylogenomics action
0.3283119.15342797.html.plaintext.txt	572	Prediction potential GPI modification sites proprotein sequences
0.3283119.15342797.html.plaintext.txt	573	Preservation duplicate genes complementary degenerative mutations
0.3283119.15342797.html.plaintext.txt	574	Cross species sequence comparisons review methods available resources
0.3283119.15342797.html.plaintext.txt	575	Fugu human sequence comparison identifies novel human genes conserved non coding sequences
0.3283119.15342797.html.plaintext.txt	576	Marsupial genetics genomics
0.3283119.15342797.html.plaintext.txt	577	Comparison mouse human genomes followed experimental verification yields estimated 1019 additional genes
0.3283119.15342797.html.plaintext.txt	578	A prion like protein chicken brain copurifies acetylcholine receptor inducing activity
0.3283119.15342797.html.plaintext.txt	579	Studying genomes aeons protein families pseudogenes proteome evolution
0.3283119.15342797.html.plaintext.txt	580	An expressed pseudogene regulates messenger RNA stability homologous coding gene
0.3283119.15342797.html.plaintext.txt	581	Protein dispensability rate evolution
0.3283119.15342797.html.plaintext.txt	582	Specific binding normal prion protein scrapie form via localized domain initiates conversion protease resistant state
0.3283119.15342797.html.plaintext.txt	583	Majority rule consensus phylogenetic trees obtained maximum likelihood analysis
0.3283119.15342797.html.plaintext.txt	584	Sequencing comparison yeast species identify genes regulatory elements
0.3283119.15342797.html.plaintext.txt	585	Orphan nuclear receptor Nurr1 directly transactivates promoter activity tyrosine hydroxylase gene cell specific manner
0.3283119.15342797.html.plaintext.txt	586	The dog genome survey sequencing comparative analysis
0.3283119.15342797.html.plaintext.txt	587	Evaluation maximum likelihood estimate evolutionary tree topologies DNA sequence data branching order Hominoidea
0.3283119.15342797.html.plaintext.txt	588	Biochemical networking contributes genetic buffering human mouse metabolic pathways gene duplication
0.3283119.15342797.html.plaintext.txt	589	A combinatorial code gene expression generated transcription factor Bach2 MAZR MAZ related factor BTBPOZ domain
0.3283119.15342797.html.plaintext.txt	590	Molecular cloning human prion protein cDNA
0.3283119.15342797.html.plaintext.txt	591	The unfolded protein response involved pathology Alzheimers disease
0.3283119.15342797.html.plaintext.txt	592	Initial sequencing analysis human genome
0.3283119.15342797.html.plaintext.txt	593	CpG islands gene markers human genome
0.3283119.15342797.html.plaintext.txt	594	Complete genomic sequence analysis prion protein gene region three mammalian species
0.3283119.15342797.html.plaintext.txt	595	Genomic characterization human prion protein PrP gene locus
0.3283119.15342797.html.plaintext.txt	596	The prion gene complex encoding PrPC Doppel insights mutational analysis
0.3283119.15342797.html.plaintext.txt	597	VISTA visualizing global DNA sequence alignments arbitrary length
0.3283119.15342797.html.plaintext.txt	598	Bioinformatics 161046 1047
0.3283119.15342797.html.plaintext.txt	599	Two erbA homologs encoding proteins different T3 binding capacities transcribed opposite DNA strands genetic locus
0.3283119.15342797.html.plaintext.txt	600	Ataxia prion protein PrP deficient mice associated upregulation novel PrP like protein doppel
0.3283119.15342797.html.plaintext.txt	601	Neuroendocrine regulation hypothalamic pituitary adrenal axis nurr1nur77 subfamily nuclear receptors
0.3283119.15342797.html.plaintext.txt	602	Identification prokaryotic eukaryotic signal peptides prediction cleavage sites
0.3283119.15342797.html.plaintext.txt	603	The promise comparative genomics mammals
0.3283119.15342797.html.plaintext.txt	604	Science 286458 462 479 481
0.3283119.15342797.html.plaintext.txt	605	On choosing mammalian genomes sequencing
0.3283119.15342797.html.plaintext.txt	606	Springer Verlag Heidelberg Germany
0.3283119.15342797.html.plaintext.txt	607	Identification cDNAs Japanese pufferfish Fugu rubripes Atlantic salmon Salmo salar coding homologs tetrapod prion proteins
0.3283119.15342797.html.plaintext.txt	608	Shadoo new protein highly conserved fish mammals similarity prion protein
0.3283119.15342797.html.plaintext.txt	609	MatInd MatInspector new fast versatile tools detection consensus matches nucleotide sequence data
0.3283119.15342797.html.plaintext.txt	610	An evolutionary basis scrapie disease identification fish prion mRNA
0.3283119.15342797.html.plaintext.txt	611	Molecular cloning laboratory manual 2nd edition
0.3283119.15342797.html.plaintext.txt	612	Cold Spring Harbor Laboratory Cold Spring Harbor New York
0.3283119.15342797.html.plaintext.txt	613	PipMaker Web server aligning two genomic DNA sequences
0.3283119.15342797.html.plaintext.txt	614	cDNA cloning turtle prion protein
0.3283119.15342797.html.plaintext.txt	615	The genetic data environment expandable GUI multiple sequence analysis
0.3283119.15342797.html.plaintext.txt	616	Molecular cloning cDNA coding Xenopus laevis prion protein
0.3283119.15342797.html.plaintext.txt	617	cDNA sequence tissue expression Fugu rubripes prion protein like candidate teleost orthologue tetrapod PrPs
0.3283119.15342797.html.plaintext.txt	618	Genome duplication trait shared 22000 species ray finned fish
0.3283119.15342797.html.plaintext.txt	619	Comparative analyses multi species sequences targeted genomic regions
0.3283119.15342797.html.plaintext.txt	620	CLUSTAL W improving sensitivity progressive multiple sequence alignment sequence weighting position specific gap penalties weight matrix choice
0.3283119.15342797.html.plaintext.txt	621	Activation ATF6 ATF6 DNA binding site endoplasmic reticulum stress response
0.3283119.15342797.html.plaintext.txt	622	The zebrafish model system human disease
0.3283119.15342797.html.plaintext.txt	623	Initial sequencing comparative analysis mouse genome
0.3283119.15342797.html.plaintext.txt	624	NIX nucleotide identification system HGMP RC
0.3283119.15342797.html.plaintext.txt	625	TRANSFAC database transcription factors DNA binding sites
0.3283119.15342797.html.plaintext.txt	626	TrExML maximum likelihood approach extensive tree space exploration
0.3283119.15342797.html.plaintext.txt	627	NMR solution structure human prion protein
0.3283119.15342797.html.plaintext.txt	628	Molecular dynamics simulation human prion protein including N linked oligosaccharides GPI anchor
0.3283119.15342797.html.plaintext.txt	629	Accepted publication August 3 2004
0.26525193.15987701.html.plaintext.txt	0	The prion gene associated human long term memory Andreas Papassotiropoulos1 M
0.26525193.15987701.html.plaintext.txt	1	Axel Wollmer1 Adriano Aguzzi2 Christoph Hock1 Roger M
0.26525193.15987701.html.plaintext.txt	2	1Division Psychiatry Research University Zurich 8032 Zurich Switzerland 2Institute Neuropathology University Hospital Zurich Zurich Switzerland
0.26525193.15987701.html.plaintext.txt	3	To correspondence addressed Division Psychiatry Research University Zurich Lenggstr
0.26525193.15987701.html.plaintext.txt	4	31 PO Box 1931 8032 Zurich Switzerland
0.26525193.15987701.html.plaintext.txt	5	Tel 41 13842644 Fax 41 13842686 Email papasatbli
0.26525193.15987701.html.plaintext.txt	6	Received May 2 2005 Accepted June 23 2005
0.26525193.15987701.html.plaintext.txt	7	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Human cognitive processes highly variable across individuals influenced genetic environmental factors
0.26525193.15987701.html.plaintext.txt	8	Although genetic variations affect short term memory humans unknown whether genetic variability also impact long term memory
0.26525193.15987701.html.plaintext.txt	9	Because prion like conformational changes may involved induction long lasting synaptic plasticity examined impact single nucleotide polymorphisms SNPs prion protein gene PRNP long term memory healthy young humans
0.26525193.15987701.html.plaintext.txt	10	SNPs genomic region PRNP associated better long term memory performance two independent populations different educational background
0.26525193.15987701.html.plaintext.txt	11	Among examined PRNP SNPs common Met129Val polymorphism yielded highest effect size
0.26525193.15987701.html.plaintext.txt	12	Twenty four hours word list learning task carriers either 129MM 129MV genotype recalled 17 information 129VV carriers short term memory unaffected
0.26525193.15987701.html.plaintext.txt	13	These results suggest role prion protein formation long term memory humans
0.26525193.15987701.html.plaintext.txt	14	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Human memory heritable polygenic behavioral trait
0.26525193.15987701.html.plaintext.txt	15	Converging evidence twin studies suggests 50 interindividual variability memory capacity attributable genetic factors 12
0.26525193.15987701.html.plaintext.txt	16	However little known identity underlying genes whether different parts cognitive ability short term long term memory share common genetic factors genetically distinct
0.26525193.15987701.html.plaintext.txt	17	Recently naturally occurring functionally relevant genetic variations single nucleotide polymorphisms SNPs genes encoding serotonin 2a receptor HTR2A brain derived neurotrophic factor BDNF found influence medial temporal lobe MTL dependent short term memory capacity healthy human subjects 34
0.26525193.15987701.html.plaintext.txt	18	In contrast short term memory long term memory
0.26525193.15987701.html.plaintext.txt	19	ability retain information several hours days even years depends de novo protein synthesis long term changes molecular components neuronal synapse 5
0.26525193.15987701.html.plaintext.txt	20	However little known cell biology molecular mechanisms initiate maintain structural changes
0.26525193.15987701.html.plaintext.txt	21	Recent experiments yeast Aplysia suggest prion like protein switch might help maintain long term synaptic changes required formation long term memory
0.26525193.15987701.html.plaintext.txt	22	Specifically shown neuronal isoform cytoplasmic polyadenylation element binding protein CPEB regulates local protein synthesis stabilizes synapse specific long term facilitation Aplysia 6
0.26525193.15987701.html.plaintext.txt	23	In addition Aplysia CPEB prion like properties expressed yeast self perpetuating prion like form CPEB capacity activate translationally dormant mRNA 7
0.26525193.15987701.html.plaintext.txt	24	These studies led radically new notion prion like conformational changes may key event maintenance structural synaptic changes underlying long term memory
0.26525193.15987701.html.plaintext.txt	25	If conversion proteins self perpetuating state represents mechanism long term memory storage genes encoding proteins prion like properties excellent candidates association human long term memory capacity
0.26525193.15987701.html.plaintext.txt	26	In humans protein well characterized prion properties prion protein PrP encoded PRNP gene short arm chromosome 20
0.26525193.15987701.html.plaintext.txt	27	PRNP polymorphic intronic 5 3 UTR SNPs well common methioninevaline polymorphism codon 129 M129V modulates folding behavior protein 89 controls susceptibility prion diseases 10
0.26525193.15987701.html.plaintext.txt	28	Human genetic variation often organized population specific haplotype blocks
0.26525193.15987701.html.plaintext.txt	29	areas genome substantial correlations among neighboring alleles 11
0.26525193.15987701.html.plaintext.txt	30	In populations Caucasian origin genetic variability PRNP represented haplotype block spanning 25 kb including M129V SNP www
0.26525193.15987701.html.plaintext.txt	31	On basis recent experimental observations related mechanisms long term memory formation 67 hypothesized human genetic variability PRNP might related long term memory therefore investigated influence polymorphic sites within PRNP memory capacity 354 healthy young subjects Table 1
0.26525193.15987701.html.plaintext.txt	32	Demographic behavioral data study population RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Influence PRNP SNPs human long term memory All investigated SNPs genomic region PRNP n3 significantly associated long term memory performance free recall 24 h learning logistic regression analysis Fig
0.26525193.15987701.html.plaintext.txt	33	1 whereas none associated short term memory free recall immediately 5 min learning
0.26525193.15987701.html.plaintext.txt	34	The M129V polymorphism displayed highest level significance P0
0.26525193.15987701.html.plaintext.txt	35	To improve estimation type I statistical error performed permutation analysis used Monte Carlo simulations addition logistic regression analysis
0.26525193.15987701.html.plaintext.txt	36	The association remained significant 50 000 permutations Monte Carlo simulations 100 000 random samplings P0
0.26525193.15987701.html.plaintext.txt	37	Although three PRNP SNPs tightly linked For multi locus linkage disequilibrium LD P0
0.26525193.15987701.html.plaintext.txt	38	00001 extended haplotype analysis increase significance
0.26525193.15987701.html.plaintext.txt	39	In addition 5 UTR SNPs failed show association long term memory performance statistically controlled effect M129V polymorphism
0.26525193.15987701.html.plaintext.txt	40	Conversely significant effect M129V polymorphism affected controlled 5 UTR SNPs
0.26525193.15987701.html.plaintext.txt	41	Therefore conclude M129V polymorphism accounted fully association PRNP region long term memory
0.26525193.15987701.html.plaintext.txt	42	The significant effect M129V polymorphism long term memory performance present academic group n240 P0
0.26525193.15987701.html.plaintext.txt	43	006 non academic group n114 P0
0.26525193.15987701.html.plaintext.txt	44	Analysis covariance showed subjects homozygous heterozygous 129M variant exhibited 17 better memory performance 24 h recall valine homozygotes Fig
0.26525193.15987701.html.plaintext.txt	45	Importantly values 24 h recall performance genotype strata normally distributed P 0
0.26525193.15987701.html.plaintext.txt	46	Forward backward logistic regression analyses entire sample revealed besides M129V polymorphism 5 min delayed recall performance gender significantly influenced long term memory performance Table 2
0.26525193.15987701.html.plaintext.txt	47	Exclusion covariates regression model influence effect M129V polymorphism long term memory
0.26525193.15987701.html.plaintext.txt	48	Importantly immediate 5 min delayed recall affected M129V polymorphism Table 3 indicating genotype dependent differences 24 h recall unlikely caused confounding factors motivation attention
0.26525193.15987701.html.plaintext.txt	49	View larger version 14K Figure 1 Genomic structure association findings chromosomal region harboring prion protein gene
0.26525193.15987701.html.plaintext.txt	50	PRNP PRND encoding prion protein Doppel respectively located short arm chromosome 20 4660 4700 kb NCBI Map Viewer httpwww
0.26525193.15987701.html.plaintext.txt	51	SNPs hCV2969384 hCV2969397 Celera database httpmyscience
0.26525193.15987701.html.plaintext.txt	52	jsp G C A G transitions respectively located within PRNP
0.26525193.15987701.html.plaintext.txt	53	SNP rs1029273 dbSNP httpwww
0.26525193.15987701.html.plaintext.txt	54	html T C transition 25 kb 5 PRNP
0.26525193.15987701.html.plaintext.txt	55	The methionine valine substitution codon 129 PRNP M129V caused common A G transition rs1799990 threonine methionine substitution codon 174 PRND T174M caused common C T transition rs2245220
0.26525193.15987701.html.plaintext.txt	56	All PRNP SNPs significantly P0
0.26525193.15987701.html.plaintext.txt	57	01 associated long term memory performance M129V underlined yielding significant result
0.26525193.15987701.html.plaintext.txt	58	T174M rs1029273 failed reach significant levels association
0.26525193.15987701.html.plaintext.txt	59	Significances obtained forward backward logistic regression analyses controlled age gender education 5 min free recall performance
0.26525193.15987701.html.plaintext.txt	60	Long term memory performance median split served dependent binary variable
0.26525193.15987701.html.plaintext.txt	61	View table Figure 2 Better long term memory performance 129MM 129MV carriers
0.26525193.15987701.html.plaintext.txt	62	The figure shows cumulative percentage study subjects increasing long term memory performance number freely recalled words 24 h presentation word list
0.26525193.15987701.html.plaintext.txt	63	The curves 129MM carriers n159 129MV carriers n151 essentially identical
0.26525193.15987701.html.plaintext.txt	64	129VV carriers n44 significantly P0
0.26525193.15987701.html.plaintext.txt	65	001 lower long term memory performance 129MM 129MV carriers indicated left shift corresponding curve
0.26525193.15987701.html.plaintext.txt	66	Influence PRNP adjacent polymorphisms long term memory 24 h free recall words entire sample two subsamples Exclusion nearby genomic loci Next investigated whether observed association M129V SNP long term memory due linkage disequilibrium nearby genetic variation
0.26525193.15987701.html.plaintext.txt	67	In 3 flanking region PRNP analyzed T174M substitution PRND gene located 25 kb 3 M129V SNP encodes PrP homologue doppel Fig
0.26525193.15987701.html.plaintext.txt	68	Twenty five kilobases 5 M129V SNP analyzed SNP rs1029273 previously shown confer susceptibility sporadic Creutzfeldt Jakob disease CJD independently M129V polymorphism 12
0.26525193.15987701.html.plaintext.txt	69	Consistent existing data populations Caucasian origin www
0.26525193.15987701.html.plaintext.txt	70	com three PRNP SNPs 5 flanking SNP rs1029273 part haplotype block study population multi allelic D0
0.26525193.15987701.html.plaintext.txt	71	000001 PRNP SNPs exerting highest LD values
0.26525193.15987701.html.plaintext.txt	72	The T174M SNP PRND part haplotype D0
0.26525193.15987701.html.plaintext.txt	73	Of note none examined SNPs deviated Hardy Weinberg equilibrium P0
0.26525193.15987701.html.plaintext.txt	74	Neither T174M rs102973 showed significant association long term memory performance Fig
0.26525193.15987701.html.plaintext.txt	75	Therefore conclude codon 129 polymorphism fully accounts association PRNP locus long term memory
0.26525193.15987701.html.plaintext.txt	76	Exclusion non random genetic heterogeneity Association studies outbred populations present one may prone false positivity non random genetic heterogeneity within study sample
0.26525193.15987701.html.plaintext.txt	77	population structure lead spurious associations candidate marker phenotype 13
0.26525193.15987701.html.plaintext.txt	78	Therefore calculated structure genetic heterogeneity study population genotyping subject 318 SNPs located genic non genic regions distributed autosomes
0.26525193.15987701.html.plaintext.txt	79	Structured association analysis 14 revealed low allele frequency divergence population Kullback Leibler distance0
0.26525193.15987701.html.plaintext.txt	80	The individual genetic background values normally distributed P0
0.26525193.15987701.html.plaintext.txt	81	Ten subjects identified outliers
0.26525193.15987701.html.plaintext.txt	82	beyond 25 75 limits normal distribution curve
0.26525193.15987701.html.plaintext.txt	83	Importantly findings remained unchanged exclusion subjects statistical analyses
0.26525193.15987701.html.plaintext.txt	84	In addition included subjects genetic background value covariate analysis
0.26525193.15987701.html.plaintext.txt	85	Again results remained unchanged
0.26525193.15987701.html.plaintext.txt	86	Therefore conclude significant association M129V SNP long term memory independent observed genetic heterogeneity levels population
0.26525193.15987701.html.plaintext.txt	87	View larger version 20K Figure 3 Genetic structure study population estimates ancestry study subjects priori assumption K2 discrete subpopulations
0.26525193.15987701.html.plaintext.txt	88	The histograms show number individuals distinct proportions ancestry subpopulation 1
0.26525193.15987701.html.plaintext.txt	89	Using 318 unlinked SNPs structured association analysis revealed low allele frequency divergence among populations Kullback Leibler distance0
0.26525193.15987701.html.plaintext.txt	90	The superimposed curve indicates normal distribution data P0
0.26525193.15987701.html.plaintext.txt	91	Ten subjects identified outliers
0.26525193.15987701.html.plaintext.txt	92	outside 25 75 limits normal distribution curve
0.26525193.15987701.html.plaintext.txt	93	Identical results obtained priori assumption 3K6 discrete subpopulations
0.26525193.15987701.html.plaintext.txt	94	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The present study shows PRNP genetically associated human long term memory performance
0.26525193.15987701.html.plaintext.txt	95	SNP mapping within PRNP locus extended haplotype analysis revealed observed association caused M129V SNP PRNP
0.26525193.15987701.html.plaintext.txt	96	Other possibilities adjacent genomic loci population structure sampling bias excluded
0.26525193.15987701.html.plaintext.txt	97	Although mechanistical explanations genetic association findings rather speculative must therefore treated caution results raise question nature observed association
0.26525193.15987701.html.plaintext.txt	98	In vitro experiments suggest 129M allele results higher propensity prion protein form beta sheet rich oligomers 9
0.26525193.15987701.html.plaintext.txt	99	Recently transgenic mice expressing human PrP methionine 129 valine 129 presented variant CJD related phenotype 15
0.26525193.15987701.html.plaintext.txt	100	These findings indicate 129M allele may facilitate self perpetuating conformational changes human prion protein
0.26525193.15987701.html.plaintext.txt	101	Interestingly results demonstrate beneficial effect 129M allele long term memory healthy young subjects therefore support hypothesis prion based mechanism involved formation long term memory
0.26525193.15987701.html.plaintext.txt	102	Is association PRNP locus human long term memory related susceptibility prion diseases In humans mammalian species 16 PRNP displays common methioninevaline polymorphism codon 129
0.26525193.15987701.html.plaintext.txt	103	Approximately 40 population heterozygous polymorphism line reports middle European populations 17
0.26525193.15987701.html.plaintext.txt	104	However 129MM 129VV homozygotes heavily represented sporadic CJD iatrogenic CJD 10
0.26525193.15987701.html.plaintext.txt	105	In addition victims variant CJD thought result infection bovine prions found 129MM homozygotes 18
0.26525193.15987701.html.plaintext.txt	106	Therefore 129MV heterozygosity appears protective prion infection 1019
0.26525193.15987701.html.plaintext.txt	107	We observed methionine allele correlated dominantly better long term memory unable discern difference 129MM 129MV subgroups
0.26525193.15987701.html.plaintext.txt	108	Therefore association PRNP locus human long term memory seems unrelated susceptibility prion diseases
0.26525193.15987701.html.plaintext.txt	109	Although prions originally described transmissible pathogens 20 induction self perpetuating conformational change within populations cellular proteins always need deleterious 21
0.26525193.15987701.html.plaintext.txt	110	For example Podospora anserina prion Het S may confer selection advantage host 22
0.26525193.15987701.html.plaintext.txt	111	Also Sup35 translational termination factor may act useful evolutionary buffer infected yeast 23
0.26525193.15987701.html.plaintext.txt	112	Finally CPEB protein involved maintenance long term synaptic changes 6 shown possess prion like properties expressed yeast 7
0.26525193.15987701.html.plaintext.txt	113	One might therefore speculate impact PrP variants long term memory healthy humans related physiologically occurring conformational changes 24
0.26525193.15987701.html.plaintext.txt	114	Taken together human prion protein genetically associated long term memory
0.26525193.15987701.html.plaintext.txt	115	Further evaluation biological consequences M129V polymorphism neurons help elucidate molecular mechanisms underlying association
0.26525193.15987701.html.plaintext.txt	116	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Study subjects memory testing Memory testing genotyping done total 354 healthy young Swiss subjects 244 females 110 males mean age 23 plus minus 0
0.26525193.15987701.html.plaintext.txt	117	This population consisted two independently recruited tested groups 240 university students 114 non academic employeestrainees Table 1
0.26525193.15987701.html.plaintext.txt	118	After complete description study subjects written informed consent obtained
0.26525193.15987701.html.plaintext.txt	119	The ethics committee Canton Zurich Switzerland approved study protocol
0.26525193.15987701.html.plaintext.txt	120	Memory capacity tested two consecutive days
0.26525193.15987701.html.plaintext.txt	121	On first day subjects viewed six series five semantically unrelated nouns presented rate one word per second instruction learn words immediate free recall series
0.26525193.15987701.html.plaintext.txt	122	In addition subjects underwent unexpected delayed free recall test learned words 5 min 24 h
0.26525193.15987701.html.plaintext.txt	123	Both delayed recall tests reflect episodic memory 25
0.26525193.15987701.html.plaintext.txt	124	In contrast 5 min recall 24 h recall additionally requires long term synaptic changes 5
0.26525193.15987701.html.plaintext.txt	125	To control type I statistical error effects educational level memory recruited two independent populations either university students academic group non academic employeestrainees non academic group
0.26525193.15987701.html.plaintext.txt	126	Blood collection genotyping We collected 18 ml blood 2x9 Monovette tubes EDTA Sarstedt Germany donor venous puncture
0.26525193.15987701.html.plaintext.txt	127	Genomic DNA extracted using QIAamp DNA blood maxi kit Qiagen
0.26525193.15987701.html.plaintext.txt	128	Genotyping PRNP SNPs done AmplifluorTM method following primers
0.26525193.15987701.html.plaintext.txt	129	For M129V SNP primers 5 GAA GGT GAC CAA GTT CAT GCT CAT GGC ACT TCC CAG CAT 3 A allele 5 GAA GGT CGG AGT CAA CGG ATT GCT CAT GGC ACT TCC CAG CAC 3 G allele 5 TGG GGG GCC TTG GCG GCT A 3 common used
0.26525193.15987701.html.plaintext.txt	130	Primers SNP hCV2969397 5 GAA GGT GAC CAA GTT CAT GCT TAG TAA TAA ACA GGT ATT GAC CAT TAC CA 3 T allele 5 GAA GGT CGG AGT CAA CGG ATT GTA ATA AAC AGG TAT TGA CCA TTA CCG 3 C allele 5 GTC CTC TGG CAT ATT TCA AGA TAT CCT AT 3 common
0.26525193.15987701.html.plaintext.txt	131	Primers SNP hCV2969384 5 GAA GGT GAC CAA GTT CAT GCT CCC ACC CTC TGT TCT CCA GG 3 C allele 5 GAA GGT CGG AGT CAA CGG ATT CCC ACC CTC TGT TCT CCA GC 3 G allele 5 GCA GAC CTG CAG CTC CTC TCT 3 common
0.26525193.15987701.html.plaintext.txt	132	The T174M SNP PRND rs1029273 genotyped PyrosequencingTM PSQTM 96 machine
0.26525193.15987701.html.plaintext.txt	133	Primers T174M 5 ATT GCG AGT TTT GGT TGG AG 3 forward 5 GTC ACT TGC CAG GAT TTG CT 3 reverse 5 biotinylated 5 GGC TTT GAT CTG GCT C 3 sequencing primer
0.26525193.15987701.html.plaintext.txt	134	Primers rs1029273 5 AAC CAG AAA CAT GGG GTG TT 3 forward 5 CCT GGC TTT TAC AAA GAA CCT C 3 reverse 5 biotinylated 5 GGT GTT AAA TCA ATT ACA GG 3sequencing primer
0.26525193.15987701.html.plaintext.txt	135	To analyze genetic structure population used 318 SNPs located genic non genic regions distributed autosomes
0.26525193.15987701.html.plaintext.txt	136	Please contact authors detailed list examined SNPs
0.26525193.15987701.html.plaintext.txt	137	Statistics Analysis linkage disequilibrium haplotype reconstruction done PowerMarker version 3
0.26525193.15987701.html.plaintext.txt	138	Forward backward logistic regression analyses multifactorial analyses covariance done simultaneous assessment influence age gender education PRNP PRND genotype effect immediate 5 min 24 h delayed free recall performance
0.26525193.15987701.html.plaintext.txt	139	To improve estimation type I statistical error performed permutation analysis 50 000 permutations used Monte Carlo simulations 100 000 random samplings addition logistic regression analysis
0.26525193.15987701.html.plaintext.txt	140	ACKNOWLEDGEMENTS This work supported grants Swiss National Science Foundation A
0.26525193.15987701.html.plaintext.txt	141	PP00B 106708 Helmut Horten Stiftung D
0.26525193.15987701.html.plaintext.txt	142	Olga Mayenfisch Stiftung A
0.26525193.15987701.html.plaintext.txt	143	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Bouchard T
0.26525193.15987701.html.plaintext.txt	144	1981 Familial studies intelligence review
0.26525193.15987701.html.plaintext.txt	145	1997 Substantial genetic influence cognitive abilities twins 80 years old
0.26525193.15987701.html.plaintext.txt	146	2003 A functional genetic variation 5 HT2a receptor affects human memory
0.26525193.15987701.html.plaintext.txt	147	2003 The BDNF val66met polymorphism affects activity dependent secretion BDNF human memory hippocampal function
0.26525193.15987701.html.plaintext.txt	148	2001 The molecular biology memory storage dialogue genes synapses
0.26525193.15987701.html.plaintext.txt	149	2003 A neuronal isoform CPEB regulates local protein synthesis stabilizes synapse specific long term facilitation aplysia
0.26525193.15987701.html.plaintext.txt	150	2003 A neuronal isoform aplysia CPEB prion like properties
0.26525193.15987701.html.plaintext.txt	151	2001 Biochemical structural studies prion protein polymorphism
0.26525193.15987701.html.plaintext.txt	152	2004 Methionine 129 variant human prion protein oligomerizes rapidly valine 129 variant implications disease susceptibility Creutzfeldt Jakob disease
0.26525193.15987701.html.plaintext.txt	153	1991 Homozygous prion protein genotype predisposes sporadic Creutzfeldt Jakob disease
0.26525193.15987701.html.plaintext.txt	154	2001 Linkage disequilibrium human genome
0.26525193.15987701.html.plaintext.txt	155	2001 Sporadic variant Creutzfeldt Jakob disease associated polymorphisms upstream PRNP exon 1
0.26525193.15987701.html.plaintext.txt	156	2004 Assessing impact population stratification genetic association studies
0.26525193.15987701.html.plaintext.txt	157	1999 Use unlinked genetic markers detect population stratification association studies
0.26525193.15987701.html.plaintext.txt	158	2004 Human prion protein valine 129 prevents expression variant CJD phenotype
0.26525193.15987701.html.plaintext.txt	159	1995 Prion protein gene variation among primates
0.26525193.15987701.html.plaintext.txt	160	1999 Genotyping prion protein gene codon 129
0.26525193.15987701.html.plaintext.txt	161	2003 Deaths variant Creutzfeldt Jakob disease UK
0.26525193.15987701.html.plaintext.txt	162	1997 Prion research next frontiers
0.26525193.15987701.html.plaintext.txt	163	1982 Novel proteinaceous infectious particles cause scrapie
0.26525193.15987701.html.plaintext.txt	164	2004 Mammalian prion biology one century evolving concepts
0.26525193.15987701.html.plaintext.txt	165	2003 Domain organization structure function relationship HET prion protein Podospora anserina
0.26525193.15987701.html.plaintext.txt	166	2000 A yeast prion provides mechanism genetic variation phenotypic diversity
0.26525193.15987701.html.plaintext.txt	167	1998 Prion proteins memory molecules hypothesis
0.26525193.15987701.html.plaintext.txt	168	Neuroscience 86 1037 1043
0.26525193.15987701.html.plaintext.txt	169	1995 Retrograde amnesia memory consolidation neurobiological perspective
0.26525193.15987701.html.plaintext.txt	170	This Article Abstract Full Text PDF All Versions Article 14152241 recent ddi228v1 Alert article cited Alert correction posted Services Email article friend Similar articles journal Similar articles ISI Web Science Similar articles PubMed Alert new issues journal Add My Personal Archive Download citation manager Search citing articles ISI Web Science 1 Request Permissions Google Scholar Articles Papassotiropoulos A
0.26525193.15987701.html.plaintext.txt	171	PubMed PubMed Citation Articles Papassotiropoulos A
0.26525193.15987701.html.plaintext.txt	172	Online ISSN 1460 2083 Print ISSN 0964 6906 Copyright 2006 Oxford University Press Oxford Journals Oxford University Press Site Map Terms Conditions Privacy Policy Frequently Asked Questions Other Oxford University Press sites Oxford University Press American National Biography Booksellers Information Service Childrens Fiction Poetry Childrens Reference Corporate Special Sales Dictionaries Dictionary National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights Permissions Science School Books Social Sciences Very Short Introductions Worlds Classics
0.10508279.15131108.html.plaintext.txt	0	Methionine 129 Variant Human Prion Protein Oligomerizes More Rapidly Valine 129 Variant IMPLICATIONS FOR DISEASE SUSCEPTIBILITY TO CREUTZFELDT JAKOB DISEASE Abdessamad Tahiri Alaoui Andrew C
0.10508279.15131108.html.plaintext.txt	1	Gill Petra Disterer William James
0.10508279.15131108.html.plaintext.txt	2	From Sir William Dunn School Pathology University Oxford South Parks Road Oxford OX1 3RE United Kingdom Institute Animal Health Compton Berkshire Newbury RG20 7NN United Kingdom
0.10508279.15131108.html.plaintext.txt	3	Received publication February 17 2004 revised form May 4 2004
0.10508279.15131108.html.plaintext.txt	4	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES The human PrP gene PRNP two common alleles encode either methionine valine codon 129
0.10508279.15131108.html.plaintext.txt	5	This polymorphism modulates disease susceptibility phenotype human transmissible spongiform encyphalopathies molecular mechanism effects mediated remains unclear
0.10508279.15131108.html.plaintext.txt	6	Here compared misfolding pathway leads formation sheet rich oligomeric isoforms methionine 129 variant PrP valine 129 variant
0.10508279.15131108.html.plaintext.txt	7	We provide evidence differences folding behavior two variants early stages oligomer formation
0.10508279.15131108.html.plaintext.txt	8	We show Met129 higher propensity form sheet rich oligomers whereas Val129 higher tendency fold helical rich monomers
0.10508279.15131108.html.plaintext.txt	9	An equimolar mixture variants displayed intermidate folding behavior
0.10508279.15131108.html.plaintext.txt	10	We show oligomers variants initially mixture rich conformers evolve time increasingly homogeneous rich form
0.10508279.15131108.html.plaintext.txt	11	This maturation process involves change proteinase K resistance occurs rapidly Met129 form Val129 form
0.10508279.15131108.html.plaintext.txt	12	Although involvement rich oligomers prion pathogenesis speculative misfolding behavior could part explain higher susceptibility individuals methionine homozygote sporadic variant Creutzfeldt Jakob disease
0.10508279.15131108.html.plaintext.txt	13	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES The transmissible spongiform encephalopathies group fatal neurodegenerative disorders affect humans animals believed caused novel class infectious pathogen prion 1 2
0.10508279.15131108.html.plaintext.txt	14	These diseases attracted considerable interest unique biology also appearance new variant Creutzfeldt Jakob disease vCJD1 3 appears caused dietary exposure causative agent bovine spongiform encephalopathy 4 5
0.10508279.15131108.html.plaintext.txt	15	At heart disease pathogenesis lies poorly understood structural rearrangement PrP host encoded glycoprotein nervous lymphoid systems
0.10508279.15131108.html.plaintext.txt	16	The normal cellular form prion protein PrPC undergoes conversion leads accumulation abnormal conformationally altered isoform PrPSc
0.10508279.15131108.html.plaintext.txt	17	According protein hypothesis prion propagation PrPSc principal sole component transmissible prions 6
0.10508279.15131108.html.plaintext.txt	18	PrPSc differs PrPC increased sheet content increased resistance proteinase K oligomeric rather monomeric state 7
0.10508279.15131108.html.plaintext.txt	19	The human PrP gene PRNP exists two major allelic forms encode either methionine valine codon 129 allele frequencies 0
0.10508279.15131108.html.plaintext.txt	20	37 western European American populations respectively 8 9
0.10508279.15131108.html.plaintext.txt	21	This polymorphism key determinant susceptibility sporadic 10 acquired 8 11 prion diseases may affect age onset 12 14
0.10508279.15131108.html.plaintext.txt	22	Based analysis 300 sporadic CJD subjects Parchi et al
0.10508279.15131108.html.plaintext.txt	23	14 identified six distinct clinicopathological variants sCJD appeared specified largely genotype codon 129 physiochemical properties PrPSc
0.10508279.15131108.html.plaintext.txt	24	More recently extensive analysis included metal ion dependent conformation PrPSc large number sCJD cases showed PrPSc types associated residue encoded codon 129 duration illness neuropathological phenotype 15
0.10508279.15131108.html.plaintext.txt	25	PrPSc types 1 4 far detected Met129 homozygotes type 4 uniquely associated vCJD type 3 cases containing Val129 allele type 2 PRNP codon 129 genotype 16
0.10508279.15131108.html.plaintext.txt	26	The codon 129 polymorphism seemed modulate pattern neuropathology extent lesions sCJD shown study involved 70 patients died France 1994 1998 17
0.10508279.15131108.html.plaintext.txt	27	Codon 129 polymorphism also epistatic effects phenotypic effects mutations elsewhere prion gene
0.10508279.15131108.html.plaintext.txt	28	For example Asp178 Gln mutation combined methionine position 129 results fatal familial insomnia 18
0.10508279.15131108.html.plaintext.txt	29	In contrast mutation valine encoded position 129 results familial CJD 19
0.10508279.15131108.html.plaintext.txt	30	Similarly Val129 homozygotes association Phe198 Ser mutation predispose patients Indiana kindred variant Gerstmann Straussler Scheinker disease 20
0.10508279.15131108.html.plaintext.txt	31	Furthermore increased prevalence genotype ValVal polymorphic site 129 described patients early onset Alzheimers disease 21 shift cognitive decline toward early age carriers PRNP129 ValVal reported recently 22
0.10508279.15131108.html.plaintext.txt	32	Despite clear importance polymorphism codon 129 PRNP gene link disease susceptibility pathogenesis molecular mechanisms effects mediated remain unclear
0.10508279.15131108.html.plaintext.txt	33	The vitro thermodynamic stability recombinant PrP affected Met129 Val mutation substitutions related inherited human prion diseases 23
0.10508279.15131108.html.plaintext.txt	34	Structural studies however shown evidence hydrogen bonding residues 128 178 might provide structural basis highly specific influence polymorphism position 129 disease phenotype segregates Asp178 Gln 24
0.10508279.15131108.html.plaintext.txt	35	Molecular dynamic simulations low pH induced conformational conversion PrP provided clues role residue 129 25
0.10508279.15131108.html.plaintext.txt	36	In simulations Met129 seems interact Val122 leading recruitment N proximal residues expanding sheet
0.10508279.15131108.html.plaintext.txt	37	As complementary approach chosen study folding properties two PrP allelomorphs experimentally examining misfolding pathway leads formation sheet rich oligomeric isoforms 26
0.10508279.15131108.html.plaintext.txt	38	We show PrP Met129 higher propensity form sheet rich oligomers whereas PrP Val129 higher tendency fold helical rich monomers
0.10508279.15131108.html.plaintext.txt	39	We also provide evidence dynamics maturation oligomers differ two variants
0.10508279.15131108.html.plaintext.txt	40	The maturation process occurs time expense helical like monomers faster rate PrP Met129 PrP Val129
0.10508279.15131108.html.plaintext.txt	41	Once oligomers either allelomorph formed show similar proteinase K resistance change throughout oligomer maturation process
0.10508279.15131108.html.plaintext.txt	42	The observed differences misfolding PrP Met129 PrP Val129 could explain high susceptibility individuals methionine homozygote sporadic well variant CJD
0.10508279.15131108.html.plaintext.txt	43	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Cloning PrP Genes Protein Purification Genomic DNA encoding methioninevaline codon 129 PRNP gene 18 extracted blood heterozygote individual using standard phenolchloroform methods
0.10508279.15131108.html.plaintext.txt	44	The fragment PRNP gene spanning codon 90 231 amplified oligonucleotide primers 5 cgggatcccatgcaaggaggtggcacccacagtcagtggaacaagccg 3 5 cccaagcttcatgctcgatcctctctggtaataggcctgag 3 100 microl PCR buffer contained 300 ng DNA 2 units Taq DNA polymerase 200 microM concentration dNTP 0
0.10508279.15131108.html.plaintext.txt	45	2 microM concentration primer 3
0.10508279.15131108.html.plaintext.txt	46	5 microM MgCl2 10 mM Tris HCl pH 9
0.10508279.15131108.html.plaintext.txt	47	The following PCR conditions used initial denaturation 95 degrees C 3 min followed 25 cycles denaturation 95 degrees C 1 min annealing 55 degrees C 1 min extension 72 degrees C 1 min final elongation 72 degrees C 8 min
0.10508279.15131108.html.plaintext.txt	48	Restriction sites BamHI HindIII including extra nucleotides efficient cleavage close ends introduced primers
0.10508279.15131108.html.plaintext.txt	49	The PCR fragment cloned pTrcHis2B vector incorporated C terminal His tag Invitrogen Paisley UK according manufacturers instructions
0.10508279.15131108.html.plaintext.txt	50	The identity human PrP clones confirmed sequencing BigDye Terminator v3
0.10508279.15131108.html.plaintext.txt	51	0 ABI Prism 3100 Genetic Analyzer Applied Biosystems
0.10508279.15131108.html.plaintext.txt	52	The clones corresponding PrP90 231 Met129 Val129 identified comparison human PrP clones available databases GenBankTM accession numbers M13667 GenBank P04156 GenBank
0.10508279.15131108.html.plaintext.txt	53	Escherchia coli expression purification recombinant human PrP performed described previously 27 except buffer used solubilize inclusion bodies contain dithiothreitol
0.10508279.15131108.html.plaintext.txt	54	Stocks highly purified proteins stored 6 M guanidine hydrochloride 50 mM Tris HCl pH 7
0.10508279.15131108.html.plaintext.txt	55	Oligomer Formation HPLC Gel Filtration Dialysis Methods Rapid refolding proteins oligomeric isoforms carried concentrations 10 30 mgml
0.10508279.15131108.html.plaintext.txt	56	PrP Met129 PrP Val129 denatured 6 M guanidine hydrochloride 50 mM Tris HCl pH 7
0.10508279.15131108.html.plaintext.txt	57	2 injected 100 microl onto size exclusion chromatography SEC column TSK Gel SWXL G3000 HPLC column 7
0.10508279.15131108.html.plaintext.txt	58	8 x 300 mm Phenomenex Macclesfield UK equilibrated 20 mM sodium acetate 0
0.10508279.15131108.html.plaintext.txt	59	This rapid oligomer formation SEC HPLC corresponded time 0 opposed time course analysis oligomer formation dialysis
0.10508279.15131108.html.plaintext.txt	60	This time course analysis oligomer formation carried follows
0.10508279.15131108.html.plaintext.txt	61	1 ml 6 M guanidine hydrochloride denatured proteins 10 30 mgml dialyzed room temperature 2 liters 20 mM sodium acetate 0
0.10508279.15131108.html.plaintext.txt	62	7 2 M urea use Slide A Lyser dialysis cassette Perbio Science UK Ltd
0.10508279.15131108.html.plaintext.txt	63	Tattenhall UK 10 kDa cutoff
0.10508279.15131108.html.plaintext.txt	64	Aliquots withdrawn carefully shaking cassette ensure homogeneity 30 min 2 4 24 h analyzed SEC described
0.10508279.15131108.html.plaintext.txt	65	Protein peaks manually collected subsequent analysis
0.10508279.15131108.html.plaintext.txt	66	Circular dichroism carried described previously 28 assess secondary structure protein
0.10508279.15131108.html.plaintext.txt	67	Analytical Reversed phase HPLC Protein fractions collected SEC analysis kept SEC elution buffer room temperature analyzed 2 12 30 110 140 200 300 days analytical reversed phase RP HPLC Sephasil C4 5 microm 4
0.10508279.15131108.html.plaintext.txt	68	6 x 250 mm Amersham Biosciences Little Chalfont UK
0.10508279.15131108.html.plaintext.txt	69	Proteins eluted linear gradient H2O 0
0.10508279.15131108.html.plaintext.txt	70	1 trifluoroacetic acid 95 acetonitrile 0
0.10508279.15131108.html.plaintext.txt	71	09 trifluoroacetic acid 25 min
0.10508279.15131108.html.plaintext.txt	72	All HPLC separations performed room temperature flow rate 1 mlmin means PerkinElmer Life Sciences HPLC system composed Binary LC pump 250 diode array detector 235C controlled Total Chrome software version 6
0.10508279.15131108.html.plaintext.txt	73	2 PerkinElmer Life Sciences Seer Green UK PE Nelson 600 series link
0.10508279.15131108.html.plaintext.txt	74	The eluent monitored UV absorption 280 nm
0.10508279.15131108.html.plaintext.txt	75	Proteinase K Digestion Recombinant human PrP collected SEC HPLC subjected proteinase K digestion 2 12 140 days maturation oligomers
0.10508279.15131108.html.plaintext.txt	76	The solution incubated 37 degrees C ratio 124 PK protein 20 mM sodium acetate 0
0.10508279.15131108.html.plaintext.txt	77	Aliquots digests taken 15 30 60 min snap frozen analysis SDS PAGE mass spectrometry
0.10508279.15131108.html.plaintext.txt	78	On line Capillary HPLC Nanospray Mass Spectrometry Mass spectrometry carried Quattro II tandem quadrupole mass spectrometer Micromass UK Ltd
0.10508279.15131108.html.plaintext.txt	79	Altrincham UK equipped line capillary HPLC detailed Ref
0.10508279.15131108.html.plaintext.txt	80	Briefly capillary HPLC 180 microm inner diameter packed 3
0.10508279.15131108.html.plaintext.txt	81	5 microm Jupiter C18 resin Phenomenex Macclesfield UK
0.10508279.15131108.html.plaintext.txt	82	A flow rate 1 microlmin used proteins eluted gradient 0 70 solvent A B solvent A 955 wateracetonitrile 0
0.10508279.15131108.html.plaintext.txt	83	05 trifluoroacetic acid solvent B 955 wateracetonitrile 0
0.10508279.15131108.html.plaintext.txt	84	The eluent passed directly mass spectrometer operated continuous flow nanospray mode
0.10508279.15131108.html.plaintext.txt	85	Full scan mass spectra mz 300 2100 acquired every 5
0.10508279.15131108.html.plaintext.txt	86	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Characterization Recombinant Human PrP Met129 PrP Val129 Recombinant human prion protein variants HuPrP90 231 Met129 HuPrP90 231 Val129 purified homogeneity immobilized metal affinity chromatography see supplementary Fig
0.10508279.15131108.html.plaintext.txt	87	Purified proteins analyzed mass spectrometry confirm purity identity
0.10508279.15131108.html.plaintext.txt	88	Omitting dithiothreitol buffer used solubilize inclusion bodies allowing disulfide bond form oxidizing environment immobilized metal affinity chromatography found yield fully oxidized protein see supplementary Fig
0.10508279.15131108.html.plaintext.txt	89	1 characteristics PrPC monomeric state high helical content proteinase K sensitivity
0.10508279.15131108.html.plaintext.txt	90	All studies presented paper performed proteins included C terminal His tag
0.10508279.15131108.html.plaintext.txt	91	PrP Met129 Has Intrinsically Higher Propensity Oligomerize PrP Val129 To assess effect codon 129 polymorphic residue formation non native isoforms protein variants denatured 6 M guanidine hydrochloride 50 mM Tris HCl pH 7
0.10508279.15131108.html.plaintext.txt	92	2 allowed fold conditions favoring formation oligomer species 26
0.10508279.15131108.html.plaintext.txt	93	To dissect vitro folding pathway prion protein misfolding used SEC dialysis CD
0.10508279.15131108.html.plaintext.txt	94	The denatured proteins 30 mgml injected onto SEC column previously equilibrated 20 mM sodium acetate 0
0.10508279.15131108.html.plaintext.txt	95	02 sodium azide eluted buffer
0.10508279.15131108.html.plaintext.txt	96	The elution profile Met129 variant shows two major peaks one minor peak Fig
0.10508279.15131108.html.plaintext.txt	97	Peak I terminology given Baskakov et al
0.10508279.15131108.html.plaintext.txt	98	68 min corresponded high molecular weight aggregates Fig
0.10508279.15131108.html.plaintext.txt	99	54 min corresponded oligomeric isoform peak III eluted 9
0.10508279.15131108.html.plaintext.txt	100	08 min similar retention time monomeric protein Fig
0.10508279.15131108.html.plaintext.txt	101	The elution profile Val129 variant shows three peaks different proportions peak II eluting shoulder peak I Fig
0.10508279.15131108.html.plaintext.txt	102	To mimic heterozygote situation individual carries alleles analyzed folding behavior 11 mixture Met129 Val129 Fig
0.10508279.15131108.html.plaintext.txt	103	The elution profile equimolar mixture showed three peaks seen Fig
0.10508279.15131108.html.plaintext.txt	104	Integration peaks Fig
0.10508279.15131108.html.plaintext.txt	105	1 A B revealed less 2 Val129 variant formed oligomers rapid refolding conditions within first 10 min SEC elution compared 70 case Met129 Fig
0.10508279.15131108.html.plaintext.txt	106	In addition percentage monomeric population formed within 10 min calculated 66 Val129 variant 24 Met129 variant Fig
0.10508279.15131108.html.plaintext.txt	107	Integration peaks equimolar mixture showed percentage oligomeric form reduced 44 corresponding 30 reduction amount oligomers compared situation Met129 alone Fig
0.10508279.15131108.html.plaintext.txt	108	Also amount monomeric population mixture 11 increased 17 compared Met129 alone Fig
0.10508279.15131108.html.plaintext.txt	109	The monomeric forms Met129 Val129 variants yielded CD spectra two minima 208 222 nm indicative predominantly helical conformation data shown
0.10508279.15131108.html.plaintext.txt	110	The CD spectra protein peak II PrP Met129 peaks I II PrP Val129 give clear information protein conformations suggested fractions composed mixture helical sheet forms
0.10508279.15131108.html.plaintext.txt	111	View larger version 29K FIG
0.10508279.15131108.html.plaintext.txt	112	Rapid refolding recHuPrP90 231 C terminal His tag denaturedunfolded state SEC HPLC conditions favored oligomers formation
0.10508279.15131108.html.plaintext.txt	113	recHuPrP90 231 Met129 A recHuPrP90 231 Val129 B equimolar mixture 11 Met129 Val129 6 M guanidine hydrochloride 50 mM Tris HCl pH 7
0.10508279.15131108.html.plaintext.txt	114	2 30 mgml C injected onto SEC eluted equilibration buffer 20 mM sodium acetate 0
0.10508279.15131108.html.plaintext.txt	115	D areas peaks analyzed using Total Chrome software 6
0.10508279.15131108.html.plaintext.txt	116	2 data used construct plot allowing direct comparison proportions peaks eluted SEC Met129 Val129 variants
0.10508279.15131108.html.plaintext.txt	117	To investigate formation evolution oligomers eluted peak II detail used slower dialysis method refolding allowed analysis different times initiation refolding
0.10508279.15131108.html.plaintext.txt	118	Two protein concentrations 30 10 mgml analyzed parallel
0.10508279.15131108.html.plaintext.txt	119	The composition dialysis buffer used SEC elution buffer except maximize formation oligomers urea concentration increased 2 M 28
0.10508279.15131108.html.plaintext.txt	120	After 30 min refolding 30 mgml allelomorphs adopted predominately oligomeric forms peak II virtually monomeric protein present peak III elution profile change course experiment Fig
0.10508279.15131108.html.plaintext.txt	121	Similar results obtained mixture 11 Met129 Val129 data shown
0.10508279.15131108.html.plaintext.txt	122	The CD spectra oligomers collected 30 min 1 h showed population dominated sheet rich structures contained helical rich protein Fig
0.10508279.15131108.html.plaintext.txt	123	However 4 h CD spectra protein contained peak II allelomorphs typical proteins possessing high amounts sheet spectra remained constant thereafter
0.10508279.15131108.html.plaintext.txt	124	View larger version 23K FIG
0.10508279.15131108.html.plaintext.txt	125	SEC profiles fractions recHuPrP90 231 time course refolding oligomer isoforms using dialysis method
0.10508279.15131108.html.plaintext.txt	126	A B chromatograms recHuPrP90 231 Met129 Val129 30 10 mgml respectively
0.10508279.15131108.html.plaintext.txt	127	Proteins 6 M guanidine hydrochloride 50 mM Tris HCl pH 7
0.10508279.15131108.html.plaintext.txt	128	2 dialyzed 20 mM sodium acetate 0
0.10508279.15131108.html.plaintext.txt	129	7 2 M urea aliquots withdrawn dialysis cassette indicated time injected onto SEC previously equilibrated 20 mM sodium acetate 0
0.10508279.15131108.html.plaintext.txt	130	C D CD spectra Met129 Val129 respectively recorded indicated times manual collection oligomer fraction eluted peak II samples A
0.10508279.15131108.html.plaintext.txt	131	In contrast 10 mgml Fig
0.10508279.15131108.html.plaintext.txt	132	2B kinetics oligomerization PrP Met129 significantly different PrP Val129
0.10508279.15131108.html.plaintext.txt	133	The disappearance aggregated proteins peak I occurred rapidly Met129 variant Val129 variant suggests oligomer promoting conditions aggregated material PrP Met129 higher propensity convert oligomer aggregated protein PrP Val129
0.10508279.15131108.html.plaintext.txt	134	To test took aggregated proteins peak I PrP Met129 PP Val129 SEC time 0 monitored evolution time re injecting onto SEC
0.10508279.15131108.html.plaintext.txt	135	Time course comparison two allelomorphes clearly demonstrated higher propensity Met129 variant oligomerize Val129 variant see supplementary Fig
0.10508279.15131108.html.plaintext.txt	136	Virtually aggregated PrP Met129 converted oligomeric isoforms period 12 days whereas substantial amount PrP Val129 remained aggregates
0.10508279.15131108.html.plaintext.txt	137	To investigate behavior monomeric species peak III oligomeric promoting conditions compared rate oligomerization Met129 variant Val129 variant collected SEC time 0
0.10508279.15131108.html.plaintext.txt	138	Time course comparison two allelomorphs clearly revealed monomeric Met129 higher propensity oligomerize monomeric Val129
0.10508279.15131108.html.plaintext.txt	139	This difference oligomerization rates apparent 2 days incubation room temperature see supplementary Fig
0.10508279.15131108.html.plaintext.txt	140	From data conclude conditions Met129 variant intrinsically higher propensity form oligomer isoforms Val129
0.10508279.15131108.html.plaintext.txt	141	The high oligomerization propensity methionine variant becomes even apparent highest protein concentration rapid refolding conditions
0.10508279.15131108.html.plaintext.txt	142	Since true denatured aggregated natively folded monomeric protein higher propensity oligomerization clearly independent starting state protein
0.10508279.15131108.html.plaintext.txt	143	The Oligomers Both Met129 Val129 Variants Are Conformationally Heterogeneous Show Different Kinetics Maturation It shown oligomeric isoforms mouse Syrian hamster PrP formed populations structurally heterogeneous proteins 26
0.10508279.15131108.html.plaintext.txt	144	RP HPLC analysis showed reduced forms recombinant mouse PrP existed multiple sheet rich isoforms distinct retention times 30 31
0.10508279.15131108.html.plaintext.txt	145	Accordingly used RP HPLC investigate effect residue encoded codon 129 composition oligomer population eluted SEC peak II
0.10508279.15131108.html.plaintext.txt	146	Aliquots fraction incubated room temperature SEC elution buffer 20 mM sodium acetate 0
0.10508279.15131108.html.plaintext.txt	147	02 sodium azide analyzed various times Fig
0.10508279.15131108.html.plaintext.txt	148	After 2 days incubation RP chromatogram PrP Met129 showed two peaks distinct retention times Fig
0.10508279.15131108.html.plaintext.txt	149	3A however PrP Val129 one major peak observed Fig
0.10508279.15131108.html.plaintext.txt	150	A second peak could seen 12 days incubation
0.10508279.15131108.html.plaintext.txt	151	The two peaks designated IIa IIb shorter longer retention times respectively
0.10508279.15131108.html.plaintext.txt	152	To rule possibility two peaks represented unexpected modification proteins analyzed mass spectrometry Fig
0.10508279.15131108.html.plaintext.txt	153	The deconvoluted mass spectra PrP Met129 IIa PrP Met129 IIb demonstrate represent proteins molecular mass Fig
0.10508279.15131108.html.plaintext.txt	154	Similarly deconvoluted mass spectra PrP Val129 IIa PrP Val129 IIb showed also represented proteins similar molecular masses Fig
0.10508279.15131108.html.plaintext.txt	155	From analyses infer covalent differences evident two peaks observed RP HPLC represent different conformations different amounts hydrophobic residues exposed protein surface
0.10508279.15131108.html.plaintext.txt	156	View larger version 20K FIG
0.10508279.15131108.html.plaintext.txt	157	Time course analysis RP HPLC oligomeric rec HuPrP90 231
0.10508279.15131108.html.plaintext.txt	158	Aliquots recHuPrP90 231 Met129 A recHuPrP90 231 Val129 B refolded dialysis oligomer isoforms 4 h fractionated SEC see Fig
0.10508279.15131108.html.plaintext.txt	159	2A incubated room temperature SEC elution buffer 20 mM sodium acetate 0
0.10508279.15131108.html.plaintext.txt	160	02 sodium azide anlalyzed reversed phase HPLC indicated times
0.10508279.15131108.html.plaintext.txt	161	The elution done linear gradient H O 0
0.10508279.15131108.html.plaintext.txt	162	1 trifluoroacetic acid 95 acetonitrile 0
0.10508279.15131108.html.plaintext.txt	163	09 trifluoroacetic 2acid 25 min
0.10508279.15131108.html.plaintext.txt	164	For direct comparison retention times monomeric helical denatured 6 M guanidine hydrochloride PrPs analyzed RP HPLC conditions
0.10508279.15131108.html.plaintext.txt	165	View larger version 35K FIG
0.10508279.15131108.html.plaintext.txt	166	Nanospray mass spectrometry analysis peaks IIa IIb 12 days oligomerization
0.10508279.15131108.html.plaintext.txt	167	Peaks IIa IIb resolved reversed phase HPLC oligomerization Met129 Val129 manually collected immediately subjected mass spectrometry analysis
0.10508279.15131108.html.plaintext.txt	168	A B electrospray mass spectra deconvoluted see insets mass spectra peaks IIa IIb respectively Met129 oligomer
0.10508279.15131108.html.plaintext.txt	169	C D electrospray mass spectra deconvoluted see insets mass spectra peaks IIa IIb respectively Val129 oligomer
0.10508279.15131108.html.plaintext.txt	170	Two important observations clearly made reversed phase chromatograms
0.10508279.15131108.html.plaintext.txt	171	First proportions two forms PrP Met129 PrP Val129 different proportion protein eluting peak IIa higher PrP Met129 12 days incubation Fig
0.10508279.15131108.html.plaintext.txt	172	3 A versus B PrP Val129 protein eluted peak IIb
0.10508279.15131108.html.plaintext.txt	173	Second proportions two peaks changed time different rates Met129 Val129 variants
0.10508279.15131108.html.plaintext.txt	174	In particular proportion protein eluting peak IIb decreased higher rate oligomer PrP Met129 Fig
0.10508279.15131108.html.plaintext.txt	175	3A oligomer PrP Val129 Fig
0.10508279.15131108.html.plaintext.txt	176	Peak IIb oligomer allelomorphs seemed retention time similar corresponding helical monomers
0.10508279.15131108.html.plaintext.txt	177	Because RP HPLC uses differences hydrophobic properties achieve separation bio molecules concluded protein population present highly retained peak IIb surface exposed hydrophobic residues protein population present peak IIa
0.10508279.15131108.html.plaintext.txt	178	Furthermore protein population present peak IIb appears undergo conversion become recruited population eluted peak IIa
0.10508279.15131108.html.plaintext.txt	179	Over time conversion seemed occur much quicker PrP Met129 PrP Val129 Fig
0.10508279.15131108.html.plaintext.txt	180	Because long storage time allelomorphs SEC elution buffer room temperature used mass spectrometry assess integrity samples see supplementary Fig
0.10508279.15131108.html.plaintext.txt	181	After 2 12 days oligomerization allelomorphs molecular masses matched predicted amino acid sequences
0.10508279.15131108.html.plaintext.txt	182	However 30 days oligomerization deconvoluted mass spectra variants showed additional species molecular mass corresponded cleavage N terminal two residues proteins see supplementary Fig
0.10508279.15131108.html.plaintext.txt	183	The two variants showed level cleavage increased time yield 300 days later proteins completely lacking two residues N terminus see supplementary Fig
0.10508279.15131108.html.plaintext.txt	184	The cleavage occurred peptide bond linking aspartyl residue prolyl residue Fig
0.10508279.15131108.html.plaintext.txt	185	The lability Asp Pro bonds acidic conditions reported previously 32 provides simple explanation observation
0.10508279.15131108.html.plaintext.txt	186	The cleavage occurred rate Met129 Val129 variants region N terminus PK sensitive see therefore unlikely impact differences observed oligomerization two allelomorphs
0.10508279.15131108.html.plaintext.txt	187	View larger version 45K FIG
0.10508279.15131108.html.plaintext.txt	188	Nanospray mass spectrometry SDS PAGE analysis proteinase K digests oligomeric recHuPrP90 231
0.10508279.15131108.html.plaintext.txt	189	A deconvoluted mass spectrum polypeptides eluting 23
0.10508279.15131108.html.plaintext.txt	190	35 min C 18 reversed phase capillary HPLC see inset Met129 oligomers
0.10508279.15131108.html.plaintext.txt	191	These correspond residues 117 225 12678 Da 117 232 13488 Da 117 244 14840 Da
0.10508279.15131108.html.plaintext.txt	192	B deconvoluted mass spectrum polypeptides eluting 22
0.10508279.15131108.html.plaintext.txt	193	90 min see inset Val129 oligomers
0.10508279.15131108.html.plaintext.txt	194	These correspond residues 117 225 12 646 Da 117 232 13456 Da 117 244 14808 Da
0.10508279.15131108.html.plaintext.txt	195	C deconvoluted mass spectrum polypeptides eluting 21
0.10508279.15131108.html.plaintext.txt	196	33 min see inset A Met129 oligomers
0.10508279.15131108.html.plaintext.txt	197	These correspond residues 135 222 10752 Da 135 225 11114 Da 135 232 11924 Da 135 244 13276
0.10508279.15131108.html.plaintext.txt	198	D deconvoluted mass spectrum polypeptides eluted 21
0.10508279.15131108.html.plaintext.txt	199	55 min see inset B Val129 oligomers
0.10508279.15131108.html.plaintext.txt	200	These correspond residues 135 222 10752 Da 135 225 11114 Da 135 232 11924 Da 135 244 13276 Da
0.10508279.15131108.html.plaintext.txt	201	E Coomassie stained SDS PAGE limited proteinase K digests Met129 Val129 2 12 140 days oligomerization
0.10508279.15131108.html.plaintext.txt	202	The digestion carried 37 degrees C indicated incubation times ratio 124 PK protein
0.10508279.15131108.html.plaintext.txt	203	F PK resistant fragments identified mass spectrometry overlaid amino acid sequence human PrP MetVal129
0.10508279.15131108.html.plaintext.txt	204	The residues introduced recombinant HuPrP cloning purification purposes indicated green N terminus blue C terminus
0.10508279.15131108.html.plaintext.txt	205	The Oligomers Met129 Val129 Show Similar Proteinase K Resistance Limited PK digestion used widely distinguish disease isoform PrPSc PrPC well probe differences PrPSc strains 33 34
0.10508279.15131108.html.plaintext.txt	206	We therefore used limited PK digestion combination line capillary HPLC mass spectrometry probe differences Met129 Val129 variants oligomerization
0.10508279.15131108.html.plaintext.txt	207	After treatment 60 min 124 ratio PK protein capillary HPLC mass spectrometry demonstrated digestion oligomers allelomorphs yielded range short peptides eluted 20 min insets Fig
0.10508279.15131108.html.plaintext.txt	208	5 A B liberated N C terminal His tag regions protein
0.10508279.15131108.html.plaintext.txt	209	The central C terminal domains remained intact eluted 20 min two peaks reversed phase column insets Fig
0.10508279.15131108.html.plaintext.txt	210	These polypeptides separated two peaks started either residues 117 135 respectively result differential cleavage within hydrophobic region Fig
0.10508279.15131108.html.plaintext.txt	211	Comparison deconvoluted mass spectra polypeptides starting 117 PrP Met129 Fig
0.10508279.15131108.html.plaintext.txt	212	5B oligomers showed three major PK resistant cores matching cleavage sites variant
0.10508279.15131108.html.plaintext.txt	213	The differences masses 32 Da PK resistant fragments due presence methionine valine position 129
0.10508279.15131108.html.plaintext.txt	214	Similarly comparison deconvoluted mass spectra polypeptides started 135 PrP Met129 Fig
0.10508279.15131108.html.plaintext.txt	215	5D oligomers revealed four major PK resistant polypeptides identical molecular masses Met129 Val129
0.10508279.15131108.html.plaintext.txt	216	Most C terminal His tag remained PK sensitive Fig
0.10508279.15131108.html.plaintext.txt	217	5F oligomerization indicating unlikely interfere oligomerization process
0.10508279.15131108.html.plaintext.txt	218	SDS PAGE separation PK digests various times oligomerization Fig
0.10508279.15131108.html.plaintext.txt	219	5E provided additional evidence oligomers PrP Met129 PrP Val129 similar PK resistant properties
0.10508279.15131108.html.plaintext.txt	220	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES In work show polymorphism codon 129 affects kinetics oligomerization leads non native isoforms human prion protein
0.10508279.15131108.html.plaintext.txt	221	Starting unfolded state forced rapidly adopt oligomeric form low pH high protein concentration Met129 variant clearly exhibited preference oligomeric state whereas Val129 variant favored helical rich monomeric state
0.10508279.15131108.html.plaintext.txt	222	The apparent molecular mass oligomers PrP variants estimated around 400 kDa close reported previously 26
0.10508279.15131108.html.plaintext.txt	223	We ruled possibility denatured starting protein contained oligomeric forms PrP SEC analysis denaturing conditions using 6 M guanidine hydrochloride 50 mM Tris HCl pH 7
0.10508279.15131108.html.plaintext.txt	224	Indeed chromatograms showed monomeric population PrP variants see supplementary Fig
0.10508279.15131108.html.plaintext.txt	225	How residue 129 influence folding behavior The first clue derived solution structure human PrP determined NMR 35
0.10508279.15131108.html.plaintext.txt	226	Residue 129 lies within first strand residues 128 131 human PrP
0.10508279.15131108.html.plaintext.txt	227	36 proposed short sheet might nucleation site conformational transition PrPC PrPSc could include loops connecting sheet first helix
0.10508279.15131108.html.plaintext.txt	228	Prion peptide models also indicated possible involvement region containing first strand conformational switch PrP 37 38
0.10508279.15131108.html.plaintext.txt	229	To knowledge published structure Val129 variant human PrP however molecular dynamic simulations Syrian hamster PrP90 231 neutral pH showed valine residue present position 129 instead methionine residue proportion protein three stranded antiparallel sheet structure increased 0 23 39
0.10508279.15131108.html.plaintext.txt	230	The three strands spanned residues 115 116 119 122 129 130 without affecting thermodynamic stability PrP demonstrated experimentally 23
0.10508279.15131108.html.plaintext.txt	231	Molecular dynamic simulations Syrian hamster PrP109 219 low pH revealed regions around strand 1 strand 2 potential sites conversion structures 25
0.10508279.15131108.html.plaintext.txt	232	In particular first strand served structural nucleus formation new propagation existing like structures 25
0.10508279.15131108.html.plaintext.txt	233	The interactions Met129 Val122 Tyr128 Tyr162 illustrated role tertiary interactions side chains nucleating secondary structure formation observed helix formation barnase 40
0.10508279.15131108.html.plaintext.txt	234	Our experimental data show conditions favor rapid formation oligomers SEC used partition protein folded aggregated monomeric oligomeric states differences folding Met129 Val129 variants become clear
0.10508279.15131108.html.plaintext.txt	235	It shown folding recombinant murine prion protein helix rich conformation extremely rapid 41 kinetic control 28
0.10508279.15131108.html.plaintext.txt	236	We show work propensity recombinant human prion protein fold monomeric helical rich population increased residue 129 occupied valine
0.10508279.15131108.html.plaintext.txt	237	However position occupied methionine tendency oligomerization observed comparatively little monomeric helical rich population
0.10508279.15131108.html.plaintext.txt	238	These differences folding behavior explained fundamental event protein folding driven small number specific residues involved formation well defined specific nucleus allows rest structure coalesce efficiently around 42 43
0.10508279.15131108.html.plaintext.txt	239	The high sheet propensity valine residues compared methionine residues 44 45 makes PrP valine present residue 129 favorable adopt native local sheet would temporarily stabilize Val129 allelomorph monomeric helical PrP
0.10508279.15131108.html.plaintext.txt	240	Differences oligomers formed Met129 Val129 could seen explored hydrophobicity oligomers evolved time
0.10508279.15131108.html.plaintext.txt	241	These differences consistent early events observed rapid misfolding process
0.10508279.15131108.html.plaintext.txt	242	That proportion oligomer subunits hydrophobic properties resembling monomer higher PrP Val129 PrP Met129
0.10508279.15131108.html.plaintext.txt	243	Over course several weeks incubation oligomerization process variants occurred expense helical like population became substrate oligomer recruitment 28 46
0.10508279.15131108.html.plaintext.txt	244	The presence helical like species oligomer reflected heterogeneous nature nonnative form PrP
0.10508279.15131108.html.plaintext.txt	245	This finding consistent previously published supra molecular electrospray ionization mass spectrometry results 26
0.10508279.15131108.html.plaintext.txt	246	On basis observations propose model Fig
0.10508279.15131108.html.plaintext.txt	247	6 depicts formation non native oligomers vitro
0.10508279.15131108.html.plaintext.txt	248	Under appropriate conditions low pH high protein concentration acquisition non native form happen either denatured aggregated native forms involves two steps rapid oligomerization phase followed slow maturation phase characterized structural rearrangement oligomers
0.10508279.15131108.html.plaintext.txt	249	The presence methionine codon 129 affects kinetics oligomerization maturation phase
0.10508279.15131108.html.plaintext.txt	250	View larger version 31K FIG
0.10508279.15131108.html.plaintext.txt	251	Schematic model illustrating vitro formation maturation oligomer isoforms recHuPrP90 231 Met129 Val129
0.10508279.15131108.html.plaintext.txt	252	Under appropriate conditions low pH high protein concentration acquisition non native form happen either denatured aggregated native forms involves two steps rapid oligomerization phase followed slow maturation phase characterized structural rearrangement oligomers
0.10508279.15131108.html.plaintext.txt	253	The presence methionine codon 129 affects kinetics oligomerization maturation phase
0.10508279.15131108.html.plaintext.txt	254	A hallmark disease isoform PrPSc partial resistance proteinase K digestion compared normal cellular PrP
0.10508279.15131108.html.plaintext.txt	255	This property also used probe differences PrPSc conformations
0.10508279.15131108.html.plaintext.txt	256	We found oligomers allelomorphs formed show similar proteinase K resistance change throughout oligomer maturation process
0.10508279.15131108.html.plaintext.txt	257	This indicates one relies solely PK digestion investigate PrP conformations one could miss detection dynamic conformational changes influenced polymorphism codon 129 human PrP disease pathogenesis
0.10508279.15131108.html.plaintext.txt	258	A similar PK cleavage site starting residue 117 protease resistant core oligomers human PrP variants reported recombinant mouse PrP23 231 47
0.10508279.15131108.html.plaintext.txt	259	It important emphasize PK cleavage site termini around codon 90 found authentic PrPSc 48
0.10508279.15131108.html.plaintext.txt	260	It reported two mutations synuclein linked early onset Parkinsons disease accelerate oligomerization fibrilization suggesting formation nonfibrillar oligomer likely critical disease pathogenesis 49
0.10508279.15131108.html.plaintext.txt	261	There evidence far oligomers exist vivo directly cause prion diseases either alone help factors
0.10508279.15131108.html.plaintext.txt	262	The high affinity newly reported ligands isolated laboratory 50 51 would help investigating presence vivo oligomers
0.10508279.15131108.html.plaintext.txt	263	The observed differences misfolding behavior Met129 Val129 variants could provide kinetic explanation observed high susceptibility individuals methionine homozygote sporadic well variant CJD
0.10508279.15131108.html.plaintext.txt	264	The attempt model heterozygote situation mixing Met129Val129 11 allowing rapid refolding occur yielded promising results amount oligomers formed reduced 30 compared homozoygote like situation Met129 alone indicating certain degree inhibition oligomerization heterozygote
0.10508279.15131108.html.plaintext.txt	265	Phylogenetically methionine ancestral amino acid codon 129 52 Val129 mutation found humans
0.10508279.15131108.html.plaintext.txt	266	Worldwide PRNP haplotype diversity coding allele frequencies suggest strong balancing selection locus occurred evolution modern human made heterozygosity PRNP significant selective advantage 53
0.10508279.15131108.html.plaintext.txt	267	Our data could provide mechanism based prion protein folding properties additional selective pressure particularly Met129 homozygosity
0.10508279.15131108.html.plaintext.txt	268	FOOTNOTES The costs publication article defrayed part payment page charges
0.10508279.15131108.html.plaintext.txt	269	This article must therefore hereby marked advertisement accordance 18 U
0.10508279.15131108.html.plaintext.txt	270	Section 1734 solely indicate fact
0.10508279.15131108.html.plaintext.txt	271	The line version article available httpwww
0.10508279.15131108.html.plaintext.txt	272	org contains supplemental Figs
0.10508279.15131108.html.plaintext.txt	273	Fellow Brasenose College Oxford supported BBSRC UK
0.10508279.15131108.html.plaintext.txt	274	University Research Lecturer supported Biotechnology Biological Sciences Research Council BBSRC UK
0.10508279.15131108.html.plaintext.txt	275	To correspondence addressed
0.10508279.15131108.html.plaintext.txt	276	44 1865 275545 Fax 44 1865 285756 E mail abdou
0.10508279.15131108.html.plaintext.txt	277	1 The abbreviations used vCJD variant CJD CJD Creutzfeldt Jakob disease HPLC high performance liquid chromatography SEC size exclusion chromatography RP reversed phase PK proteinase K
0.10508279.15131108.html.plaintext.txt	278	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Prusiner S
0.10508279.15131108.html.plaintext.txt	279	21 482 487CrossRefMedline Order article via Infotrieve Weissmann C
0.10508279.15131108.html.plaintext.txt	280	389 3 11CrossRefMedline Order article via Infotrieve Will R
0.10508279.15131108.html.plaintext.txt	281	1996 Lancet 347 921 925Medline Order article via Infotrieve Bruce M
0.10508279.15131108.html.plaintext.txt	282	1997 Nature 389 498 501CrossRefMedline Order article via Infotrieve Hill A
0.10508279.15131108.html.plaintext.txt	283	1997 Nature 389 448 450 526CrossRefMedline Order article via Infotrieve Prusiner S
0.10508279.15131108.html.plaintext.txt	284	1991 Science 252 1515 1522Medline Order article via Infotrieve Prusiner S
0.10508279.15131108.html.plaintext.txt	285	95 13363 13383AbstractFree Full Text Collinge J
0.10508279.15131108.html.plaintext.txt	286	1991 Lancet 337 1441 1442CrossRefMedline Order article via Infotrieve Windl O
0.10508279.15131108.html.plaintext.txt	287	98 259 264CrossRefMedline Order article via Infotrieve Palmer M
0.10508279.15131108.html.plaintext.txt	288	1991 Nature 352 340 342CrossRefMedline Order article via Infotrieve Brown P
0.10508279.15131108.html.plaintext.txt	289	1994 Neurology 44 291 293Abstract Baker H
0.10508279.15131108.html.plaintext.txt	290	1991 Lancet 337 1286 Cervenakova L
0.10508279.15131108.html.plaintext.txt	291	95 13239 13241AbstractFree Full Text Parchi P
0.10508279.15131108.html.plaintext.txt	292	CO2 W 1346AbstractFree Full Text Collinge J
0.10508279.15131108.html.plaintext.txt	293	1996 Nature 383 685 690CrossRefMedline Order article via Infotrieve Hauw J
0.10508279.15131108.html.plaintext.txt	294	2000 Neurology 54 1641 1646AbstractFree Full Text Goldfarb L
0.10508279.15131108.html.plaintext.txt	295	1992 Science 258 806 808Medline Order article via Infotrieve Goldfarb L
0.10508279.15131108.html.plaintext.txt	296	1991 Lancet 337 425Medline Order article via Infotrieve Dlouhy S
0.10508279.15131108.html.plaintext.txt	297	1 64 67Medline Order article via Infotrieve Dermaut B
0.10508279.15131108.html.plaintext.txt	298	53 409 412CrossRefMedline Order article via Infotrieve Croes E
0.10508279.15131108.html.plaintext.txt	299	54 275 276CrossRefMedline Order article via Infotrieve Liemann S
0.10508279.15131108.html.plaintext.txt	300	1999 Biochemistry 38 3258 3267CrossRefMedline Order article via Infotrieve Riek R
0.10508279.15131108.html.plaintext.txt	301	95 11667 11672AbstractFree Full Text Alonso D
0.10508279.15131108.html.plaintext.txt	302	98 2985 2989AbstractFree Full Text Baskakov I
0.10508279.15131108.html.plaintext.txt	303	277 21140 21148AbstractFree Full Text Jackson G
0.10508279.15131108.html.plaintext.txt	304	Acta 1431 1 13Medline Order article via Infotrieve Baskakov I
0.10508279.15131108.html.plaintext.txt	305	276 19687 19690AbstractFree Full Text Gill A
0.10508279.15131108.html.plaintext.txt	306	19 5324 5331AbstractFree Full Text Lu B
0.10508279.15131108.html.plaintext.txt	307	268 3767 3773AbstractFree Full Text Lu B
0.10508279.15131108.html.plaintext.txt	308	2001 Biochemistry 40 13390 13396CrossRefMedline Order article via Infotrieve Landon M
0.10508279.15131108.html.plaintext.txt	309	47 145 149Medline Order article via Infotrieve Safar J
0.10508279.15131108.html.plaintext.txt	310	4 1157 1165CrossRefMedline Order article via Infotrieve Bessen R
0.10508279.15131108.html.plaintext.txt	311	68 7859 7868Abstract Zahn R
0.10508279.15131108.html.plaintext.txt	312	97 145 150AbstractFree Full Text Riek R
0.10508279.15131108.html.plaintext.txt	313	1996 Nature 382 180 182CrossRefMedline Order article via Infotrieve Nguyen J
0.10508279.15131108.html.plaintext.txt	314	1995 Biochemistry 34 4186 4192Medline Order article via Infotrieve Tahiri Alaoui A
0.10508279.15131108.html.plaintext.txt	315	12 600 608AbstractFree Full Text Santini S
0.10508279.15131108.html.plaintext.txt	316	2003 Proteins 51 258 265CrossRefMedline Order article via Infotrieve Wong K
0.10508279.15131108.html.plaintext.txt	317	296 1257 1282CrossRefMedline Order article via Infotrieve Wildegger G
0.10508279.15131108.html.plaintext.txt	318	6 550 553CrossRefMedline Order article via Infotrieve Matouschek A
0.10508279.15131108.html.plaintext.txt	319	1989 Nature 340 122 126CrossRefMedline Order article via Infotrieve Vendruscolo M
0.10508279.15131108.html.plaintext.txt	320	2001 Nature 409 641 645CrossRefMedline Order article via Infotrieve Kim C
0.10508279.15131108.html.plaintext.txt	321	1993 Nature 362 267 270CrossRefMedline Order article via Infotrieve Fasman G
0.10508279.15131108.html.plaintext.txt	322	14 295 299CrossRefMedline Order article via Infotrieve Baskakov I
0.10508279.15131108.html.plaintext.txt	323	2000 Biochemistry 39 2792 2804CrossRefMedline Order article via Infotrieve Qin K
0.10508279.15131108.html.plaintext.txt	324	275 19121 19131AbstractFree Full Text Oesch B
0.10508279.15131108.html.plaintext.txt	325	1985 Cell 40 735 746Medline Order article via Infotrieve Conway K
0.10508279.15131108.html.plaintext.txt	326	97 571 576AbstractFree Full Text Sayer N
0.10508279.15131108.html.plaintext.txt	327	279 13102 13109AbstractFree Full Text Rhie A
0.10508279.15131108.html.plaintext.txt	328	278 39697 39705AbstractFree Full Text Schatzl H
0.10508279.15131108.html.plaintext.txt	329	245 362 374CrossRefMedline Order article via Infotrieve Mead S
0.10508279.15131108.html.plaintext.txt	330	2003 Science 300 640 643AbstractFree Full Text
0.18022668.14573822.html.plaintext.txt	0	Transmission murine scrapie P101L transgenic mice Rona M
0.18022668.14573822.html.plaintext.txt	1	Barron1 Val Thomson1 Declan King1 Jane Shaw1 David W
0.18022668.14573822.html.plaintext.txt	2	1 Neuropathogenesis Unit Institute Animal Health Ogston Building West Mains Road Edinburgh EH9 3JF UK 2 Sir Alastair Currie Cancer Research UK Laboratories Molecular Medicine Centre Western General Hospital Edinburgh UK
0.18022668.14573822.html.plaintext.txt	3	Correspondence Rona Barron rona
0.18022668.14573822.html.plaintext.txt	4	ABSTRACT Top ABSTRACT INTRODUCTION METHODS RESULTS AND DISCUSSION REFERENCES The PrP protein central transmissible spongiform encephalopathies TSEs amino acid sequence protein host influence incubation time disease targeting disease pathology
0.18022668.14573822.html.plaintext.txt	5	The N terminus murine PrP proposed important replication TSE agents mutations deletions region alter efficiency agent replication
0.18022668.14573822.html.plaintext.txt	6	To address hypothesis investigate mechanisms host PrP sequence controls outcome disease assessed influence single amino acid alteration N terminal region murine PrP P101L transmission TSE agents mice
0.18022668.14573822.html.plaintext.txt	7	Mice homozygous mutation 101LL inoculated TSE strains 139A 79A derived mice carrying Prnpa allele 79V 301V derived mice carrying Prnpb allele
0.18022668.14573822.html.plaintext.txt	8	Incubation times 101LL mice extended four strains agent compared corresponding mouse genotype infectivity derived
0.18022668.14573822.html.plaintext.txt	9	However degree incubation period increased showed considerable variation strain agent
0.18022668.14573822.html.plaintext.txt	10	Moreover presence single amino acid alteration resulted 70 day reduction incubation time 301V strain Prnpa mice
0.18022668.14573822.html.plaintext.txt	11	The effect 101L mutation murine scrapie incubation time appears therefore strain specific
0.18022668.14573822.html.plaintext.txt	12	Present address Scottish Crop Research Institute Invergowrie Dundee UK
0.18022668.14573822.html.plaintext.txt	13	INTRODUCTION Top ABSTRACT INTRODUCTION METHODS RESULTS AND DISCUSSION REFERENCES The transmissible spongiform encephalopathies TSEs group fatal neurodegenerative diseases include scrapie sheep bovine spongiform encephalopathy BSE cattle Creutzfeldt Jacob disease CJD humans
0.18022668.14573822.html.plaintext.txt	14	These diseases thought caused conversion normal cellular glycoprotein PrPC abnormal disease associated form PrPSc Prusiner 1996
0.18022668.14573822.html.plaintext.txt	15	As name indicates TSE diseases transmissible many different TSE agents transmitted maintained laboratory mice Bruce 1993 Bruce et al
0.18022668.14573822.html.plaintext.txt	16	Mouse passaged TSE strains readily studied laboratory identical genetic background inbred strains laboratory mice allows direct comparison different TSE agents individual strain mouse Bruce et al
0.18022668.14573822.html.plaintext.txt	17	The murine Prnp gene encodes PrP protein appears major factor controlling incubation time TSE disease mice Carlson et al
0.18022668.14573822.html.plaintext.txt	18	Mice lack PrP protein PrP null mice develop disease inoculated TSE infectivity Bueler et al
0.18022668.14573822.html.plaintext.txt	19	Transgenic mice containing multiple copies Prnp gene express elevated levels PrP protein show reduced incubation times TSE infectivity compared wild type mice Scott et al
0.18022668.14573822.html.plaintext.txt	20	This gene dosage effect also evident transgenic mice containing one copy PrP gene express reduced levels PrP protein show prolonged TSE incubation times Manson et al
0.18022668.14573822.html.plaintext.txt	21	Different lines inbred mice show altered incubation times TSE agent linked two naturally occurring polymorphisms found mouse PrP protein amino acids 108 189 Westaway et al
0.18022668.14573822.html.plaintext.txt	22	Mice encoding 108L189T PrP C57BL 129Ola contain murine Prnpa gene mice encoding 108F189V VM contain murine Prnpb gene
0.18022668.14573822.html.plaintext.txt	23	In general strains passaged Prnpa mice maintain shortened incubation times Prnpa mice show prolonged incubation times Prnpb mice vice versa
0.18022668.14573822.html.plaintext.txt	24	However strains passaged Prnpb mice e
0.18022668.14573822.html.plaintext.txt	25	79V show shorter incubation times Prnpa mice Bruce 1993
0.18022668.14573822.html.plaintext.txt	26	The different genetic backgrounds various inbred lines mice complicated studies effects polymorphisms
0.18022668.14573822.html.plaintext.txt	27	However introduction 108F189V polymorphisms Prnpa allele murine PrP gene targeting Prnpa108F189V established indeed 108189 polymorphisms exert major control scrapie incubation time wild type mice Moore et al
0.18022668.14573822.html.plaintext.txt	28	The influence amino acid substitutions murine Prnp gene incubation time disease demonstrated previously
0.18022668.14573822.html.plaintext.txt	29	The substitution leucine proline amino acid 101 101L murine Prnpa allele gene targeting Prnpa101L shown shorten TSE incubation times P102L GSS humans 263K hamsters SSBP1 sheep compared wild type 101P mice
0.18022668.14573822.html.plaintext.txt	30	Conversely second human TSE agent variant CJD vCJD displayed prolonged incubation times Prnpa101L 101LL mice compared wild type mice Barron et al
0.18022668.14573822.html.plaintext.txt	31	Furthermore challenged mouse passaged scrapie strains ME7 derived mice carrying Prnpa gene 22A derived mice carrying Prnpb gene 101LL mice also displayed increased incubation times compared mice homozygous either Prnpa Prnpb alleles Barron et al
0.18022668.14573822.html.plaintext.txt	32	Transgenic mice overexpressing murine PrP containing methionine substitution position 108 also shown produce lengthening scrapie incubation time compared mice overexpressing wild type gene however effect mutation transgene copy number cannot readily separated experiments Supattapone et al
0.18022668.14573822.html.plaintext.txt	33	The mechanism polymorphisms mutations murine PrP control incubation time yet established
0.18022668.14573822.html.plaintext.txt	34	Amino acids 101 108 located N terminal region PrP amino acids 21 121 described NMR structural studies discernible secondary structure Donne et al
0.18022668.14573822.html.plaintext.txt	35	However despite apparent lack structure region PrP contains octapeptide repeat sequences shown bind copper therefore may influence structure function normal protein Brown et al
0.18022668.14573822.html.plaintext.txt	36	1997 Brown Harris 2002
0.18022668.14573822.html.plaintext.txt	37	Deletion studies shown also removing sections N terminal region cause increased incubation times reduced efficiency disease propagation mice Flechsig et al
0.18022668.14573822.html.plaintext.txt	38	2001 reduce efficiency PrPC conversion cell free conversion assays Lawson et al
0.18022668.14573822.html.plaintext.txt	39	Due close proximity amino acids 101 108 possible similar mechanisms operating changes positions murine PrP control scrapie incubation time mice
0.18022668.14573822.html.plaintext.txt	40	In order investigate role region PrP influencing TSE disease transmission inoculated 101LL mice four mouse passaged TSE strains derived Prnpa Prnpb mice compared disease profile 101LL mice Prnpa Prnpb mice genetic background
0.18022668.14573822.html.plaintext.txt	41	METHODS Top ABSTRACT INTRODUCTION METHODS RESULTS AND DISCUSSION REFERENCES Preparation inoculum
0.18022668.14573822.html.plaintext.txt	42	Each inoculum prepared one mouse brain terminal TSE disease 139A 79A 79V 301V mouse scrapie
0.18022668.14573822.html.plaintext.txt	43	139A 79A prepared C57BL mice Prnpa 79V 301V prepared VM mice Prnpb
0.18022668.14573822.html.plaintext.txt	44	A 1 homogenate sample prepared normal saline prior use inoculum
0.18022668.14573822.html.plaintext.txt	45	Groups wild type FVFV Moore et al
0.18022668.14573822.html.plaintext.txt	46	1998 101LL transgenic mice Manson et al
0.18022668.14573822.html.plaintext.txt	47	1999 inoculated intracerebrally 20 microl inoculum fluothane anaesthesia
0.18022668.14573822.html.plaintext.txt	48	Scoring clinical TSE disease
0.18022668.14573822.html.plaintext.txt	49	The presence clinical TSE disease assessed described Dickinson et al
0.18022668.14573822.html.plaintext.txt	50	Incubation times calculated interval inoculation cull due terminal TSE disease
0.18022668.14573822.html.plaintext.txt	51	Mice killed cervical dislocation terminal stage disease termination experiment 600 700 days due intercurrent illness
0.18022668.14573822.html.plaintext.txt	52	Half brains fixed 10 formol saline 48 h followed decontamination 98 formic acid 1 h
0.18022668.14573822.html.plaintext.txt	53	The remaining half brain frozen 70 degrees C Western blot analysis
0.18022668.14573822.html.plaintext.txt	54	Fixed brain tissue dehydrated alcohol impregnated wax 7 h automated processing cycle
0.18022668.14573822.html.plaintext.txt	55	Sections cut coronally four levels mounted Superfrost slides
0.18022668.14573822.html.plaintext.txt	56	Sections haematoxylin eosin stained scored vacuolar degeneration scale 0 5 nine standard grey matter areas three standard white matter areas described previously Fraser Dickinson 1967
0.18022668.14573822.html.plaintext.txt	57	Mean scores produced minimum six mice plotted standard error mean SEM scoring areas give lesion profile strain agent
0.18022668.14573822.html.plaintext.txt	58	For detection PrPSc transgenic wild type mice 10 wv homogenates frozen brain tissue prepared NP40 buffer 0 5 vv NP40 0 5 wv sodium deoxycholate 150 mM NaCl 50 mM TrisHCl pH 7 5
0.18022668.14573822.html.plaintext.txt	59	Homogenates centrifuged 10 000 g 15 min 4 degrees C remove cellular debris
0.18022668.14573822.html.plaintext.txt	60	Clarified supernates 100 mg wet weight ml 1 incubated without Proteinase K 20 microg ml 1 1 h 37 degrees C reaction terminated addition PMSF
0.18022668.14573822.html.plaintext.txt	61	Samples mixed 2x sample buffer Novex Invitrogen 10 mg ml 1 final concentration incubated 90 degrees C 20 min
0.18022668.14573822.html.plaintext.txt	62	Total protein estimates performed effect mutation PrPSc levels unknown
0.18022668.14573822.html.plaintext.txt	63	Samples therefore loaded wet weight tissue equivalents
0.18022668.14573822.html.plaintext.txt	64	Twenty microl sample approximately 200 microg wet weight tissue separated 12 Novex Trisglycine acrylamide gels Invitrogen
0.18022668.14573822.html.plaintext.txt	65	Proteins transferred onto PVDF membrane electroblotting incubated 2 h room temperature mAbs 8H4 7A12 Zanusso et al
0.18022668.14573822.html.plaintext.txt	66	1998 50 ng microl 1 concentration
0.18022668.14573822.html.plaintext.txt	67	Proteins visualized horseradish peroxidase HRP conjugated rabbit anti mouse secondary antibody Jackson ImmunoResearch chemiluminescence detection kit Roche Diagnostics
0.18022668.14573822.html.plaintext.txt	68	Membranes exposed X ray film periods ranging 10 10 min
0.18022668.14573822.html.plaintext.txt	69	All P101L transgenic mice genotyped termination experiments confirm genotype
0.18022668.14573822.html.plaintext.txt	70	A 765 bp fragment containing Prnp ORF generated using 5 primer 5 ATGGCGAACCTTGGCTACTGGCTG 3 position 107 130 GenBank acc
0.18022668.14573822.html.plaintext.txt	71	M18070 3 primer 5 TCATCCCACGATCAGGAAGATGAG 3 position 871 848 GenBank acc
0.18022668.14573822.html.plaintext.txt	72	Cycle conditions 94 degrees C 3 min followed 30 cycles 30 94 degrees C 30 62 degrees C 1 min 72 degrees C
0.18022668.14573822.html.plaintext.txt	73	This followed final 10 min 72 degrees C Biometra Triblock
0.18022668.14573822.html.plaintext.txt	74	The presence absence DdeI site within PCR product provided marker codon 101P L alteration
0.18022668.14573822.html.plaintext.txt	75	RESULTS AND DISCUSSION Top ABSTRACT INTRODUCTION METHODS RESULTS AND DISCUSSION REFERENCES The 101L mutation alters murine scrapie incubation times Transgenic mice homozygous 101 leucine mutation 101LL wild type mice 101PP inoculated infectivity three sources murine scrapie 139A 79A 79V one source mouse passaged BSE 301V
0.18022668.14573822.html.plaintext.txt	76	TSE strains 139A 79A derived mice homozygous Prnpa whereas 79V 301V derived mice homozygous Prnpb
0.18022668.14573822.html.plaintext.txt	77	The incubation times obtained transmission shown Table 1 Fig
0.18022668.14573822.html.plaintext.txt	78	The analysis results complex due transmission TSE strains derived Prnpa Prnpb mice
0.18022668.14573822.html.plaintext.txt	79	Incubation times produced Prnpa derived strains 101LL mice could directly compared homologous transmission Prnpa mice 101L mutation introduced Prnpa gene gene targeting
0.18022668.14573822.html.plaintext.txt	80	This comparison would reveal specific effect 101L mutation TSE disease progression
0.18022668.14573822.html.plaintext.txt	81	In addition comparison 101LL mice Prnpa108F189V mice also contain mutations Prnpa gene would demonstrate whether 101L 108F189V mutations influenced incubation time similar manner
0.18022668.14573822.html.plaintext.txt	82	However Prnpb derived strains effects seen 101LL mice likely due combined presence 108L189T 101L
0.18022668.14573822.html.plaintext.txt	83	The interpretation Prnpb strain data therefore depends whether 101LL incubation times compared homologous strain transmission Prnpb mice heterologous strain transmission Prnpa mice
0.18022668.14573822.html.plaintext.txt	84	Comparison 101LL mice Prnpb mice shows effect three amino acid changes host PrP 108 189 101 transmission homologous strains agent whereas comparison Prnpa mice examines precise effect 101L mutation transmission non homologous strains agent
0.18022668.14573822.html.plaintext.txt	85	The following interpretation results aims address points
0.18022668.14573822.html.plaintext.txt	86	Transmission murine scrapie strains Prnpa101L Prnpa108F189V mice
0.18022668.14573822.html.plaintext.txt	87	View larger version 19K Fig
0.18022668.14573822.html.plaintext.txt	88	Transmission murine scrapie strains Prnpa101L Prnpa108F189V mice
0.18022668.14573822.html.plaintext.txt	89	Incubation times plus minus SEM six mouse passaged TSE agents Prnpa mice white bars Prnpa101L mice grey bars Prnpa108F189V mice black bars
0.18022668.14573822.html.plaintext.txt	90	No incubation time data available Prnpa108F189V mice infected 79V
0.18022668.14573822.html.plaintext.txt	91	All incidence disease 100 except 101LL79V 1415 101LL22A 916
0.18022668.14573822.html.plaintext.txt	92	ME7 22A 101LL incubation times taken Manson et al
0.18022668.14573822.html.plaintext.txt	93	When inoculated 139A 79A 101LL mice produced extended incubation times approximately double obtained Prnpa mice
0.18022668.14573822.html.plaintext.txt	94	This observation similar obtained previously ME7 Manson et al
0.18022668.14573822.html.plaintext.txt	95	In order assess whether mechanism control incubation time could similar 108F189V polymorphisms compared incubation times agents Prnpa108F189V mice genetic background 101LL mice
0.18022668.14573822.html.plaintext.txt	96	The results showed 79A 139A incubation times increased 101LL Prnpa108F189V mice compared Prnpa mice Table 1 Fig
0.18022668.14573822.html.plaintext.txt	97	However degree incubation times extended varied strain agent
0.18022668.14573822.html.plaintext.txt	98	With 79A strain agent 108F189V alterations lead prolonged incubation time 101L mutation whereas opposite true 139A strain
0.18022668.14573822.html.plaintext.txt	99	This suggested interaction strain agent control incubation time differs 108F189V 101L
0.18022668.14573822.html.plaintext.txt	100	For strains derived mice homozygous Prnpb allele situation complex
0.18022668.14573822.html.plaintext.txt	101	Incubation times 79V reduced Prnpa mice 234 days compared expected homologous transmission VM Prnpb mice 270 days Bruce 1993 data available transmission 79V Prnpa108F189V mice
0.18022668.14573822.html.plaintext.txt	102	However incubation time 101LL mice found extended 100 days respect Prnpa Prnpb genotypes 377 days
0.18022668.14573822.html.plaintext.txt	103	With 301V incubation times Prnpa 101LL mice extended respect Prnpa108F189V mice degree incubation times increased greater Prnpa 101LL mice 70 day difference
0.18022668.14573822.html.plaintext.txt	104	These results also differed obtained previously 22A also Prnpb derived incubation times Prnpa 101LL mice increased approximately degree compared Prnpa108F189V mice Table 1 Fig
0.18022668.14573822.html.plaintext.txt	105	However transmissions Prnpb strains agent 101LL mice observed effects due three amino acid changes host PrP 108 189 101
0.18022668.14573822.html.plaintext.txt	106	To truly examine effect 101L mutation Prnpb derived strains agent would require mutation expressed allele possibility combinatory compensatory mechanisms 101L 108L alterations cannot ignored infection Prnpb strains Vorberg et al
0.18022668.14573822.html.plaintext.txt	107	However effect Prnpb strains Prnpa 101LL mice differ one amino acid unpredictable
0.18022668.14573822.html.plaintext.txt	108	While 79V strain showed lengthening Prnpa incubation time presence 101L mutation reduction Prnpa incubation time observed 101LL mice inoculated 301V strain
0.18022668.14573822.html.plaintext.txt	109	These results particularly produced 301V strain indicate control incubation time 101L mutation different 108189 polymorphisms
0.18022668.14573822.html.plaintext.txt	110	While present results unable separate effect 108F 189V currently addressing issue two lines gene targeted mice homozygous either Prnpa108F189T Prnpa108L189V alleles
0.18022668.14573822.html.plaintext.txt	111	101L mutation affect PrPSc production It observed previously brain tissue 101LL mice infected ME7 contained lower levels protease resistant PrP terminal stage disease wild type mice Manson et al
0.18022668.14573822.html.plaintext.txt	112	To determine whether 101L mutation host PrP gene influenced level protease resistant PrP produced strains mouse scrapie brain homogenates prepared 101LL wild type Prnpa mice infected Prnpa strains 139A 79A Prnpb strains 22A 79V 301V analysed Western blotting mAbs 7A12 8H4
0.18022668.14573822.html.plaintext.txt	113	Preliminary analysis focused three mice genotype strain agent assess whether levels PrPSc brain consistent varied animals
0.18022668.14573822.html.plaintext.txt	114	For transmissions similar levels PrPSc observed three mice group except transmission 22A 101LL mice data shown
0.18022668.14573822.html.plaintext.txt	115	Comparison 101LL Prnpa mice inoculated Prnpa strains showed heterologous transmissions 101LL mice produced levels PrPSc identical seen homologous transmission Prnpa mice despite difference incubation times Table 1 Fig
0.18022668.14573822.html.plaintext.txt	116	Similarly transmission 79V 301V produced PrPSc levels 101LL Prnpa mice despite heterologous transmission presence three two PrP amino acid differences respectively
0.18022668.14573822.html.plaintext.txt	117	The difference seen 101LL Prnpa mice 79V blot appears examination lanes without proteinase K treatment due protein loadings Fig
0.18022668.14573822.html.plaintext.txt	118	2a lanes 5 8 protein concentrations calculated wet weight tissue
0.18022668.14573822.html.plaintext.txt	119	Previous analysis shown PrPSc levels mice similar data shown
0.18022668.14573822.html.plaintext.txt	120	However heterologous challenge 101LL mice Prnpb strain 22A show degree variation level PrPSc present
0.18022668.14573822.html.plaintext.txt	121	Of three animals examined one showed similar levels found inoculation Prnpa mice others contained much lower levels Fig
0.18022668.14573822.html.plaintext.txt	122	The presence 101L mutation therefore affect level PrPSc produced strains agent alter PrPSc levels strains independent Prnp genotype source infectivity found 22A previously ME7 Manson et al
0.18022668.14573822.html.plaintext.txt	123	View larger version 63K Fig
0.18022668.14573822.html.plaintext.txt	124	Western blot analysis brain homogenates presence PrPSc using mAb 7A12
0.18022668.14573822.html.plaintext.txt	125	Lanes 1 4 79A lanes 5 8 79V lanes 9 12 139A
0.18022668.14573822.html.plaintext.txt	126	b Lanes 1 4 301V lanes 5 10 22A
0.18022668.14573822.html.plaintext.txt	127	P represents 101PP mice L represents 101LL mice
0.18022668.14573822.html.plaintext.txt	128	Samples lanes 7 10 show two 101LL mice differing levels PrPSc
0.18022668.14573822.html.plaintext.txt	129	All samples incubated either even lanes without odd lanes proteinase K 20 microg ml 1 prior electrophoresis
0.18022668.14573822.html.plaintext.txt	130	Targeting vacuolation The effect 101L mutation host PrP targeting pathology assessed comparing degree vacuolation mice carrying 101L mutation mice carrying wild type 101P PrP Prnpa
0.18022668.14573822.html.plaintext.txt	131	The degree vacuolation specific brain areas characteristic individual mouse passaged scrapie strains
0.18022668.14573822.html.plaintext.txt	132	Vacuolation scored scale 0 5 nine grey matter three white matter areas average scores plus minus SEM plotted give lesion profile essentially fingerprint strain Fraser Dickinson 1967
0.18022668.14573822.html.plaintext.txt	133	Lesion profiles produced strain mouse scrapie comparing mean vacuolation scores 101LL Prnpa mice displaying clinical pathological signs TSE disease Fig
0.18022668.14573822.html.plaintext.txt	134	The heterologous transmission 101LL mice Prnpa derived strains 139A 79A produced significant variation targeting vacuolation compared corresponding homologous transmission Prnpa mice
0.18022668.14573822.html.plaintext.txt	135	The 139A 79A Prnpa derived mouse scrapie strains share common lineage produce identical lesion profiles wild type mice Prnp genotypes
0.18022668.14573822.html.plaintext.txt	136	These strains however distinguished incubation times Prnpb Prnpa108F189V mice Table 1 Fig
0.18022668.14573822.html.plaintext.txt	137	Both strains displayed increased levels vacuolation areas 1 dorsal medulla 3 superior colliculus 4 hypothalamus 7 septum decreased levels vacuolation white matter regions 1 cerebellar white matter 2 midbrain white matter 3 cerebral peduncle 101LL mice
0.18022668.14573822.html.plaintext.txt	138	The change vacuolar profile incubation time two related strains 101LL mice appears identical Figs 1 3 Table 1 indicating similar interaction strain 101L mutation PrP
0.18022668.14573822.html.plaintext.txt	139	Heterologous challenges Prnpb derived strains 79V 22A 301V produced less variability Prnpa 101LL mice despite differing source infectivity two three PrP amino acids respectively
0.18022668.14573822.html.plaintext.txt	140	Identical lesion profiles obtained 101LL Prnpa mice challenged 301V although 79V showed reduced levels vacuolation areas 6 9 hippocampus septum cerebral cortex forebrain cerebral cortex 101LL brain overall pattern Prnpa mice
0.18022668.14573822.html.plaintext.txt	141	The 22A strain showed slightly variability due altered levels vacuolation areas 4 hypothalamus 7 septum 8 cerebral cortex areas grey white matter showed identical targeting vacuolation lines mice
0.18022668.14573822.html.plaintext.txt	142	The 101L mutation therefore exerts strain specific effect vacuolar targeting ranging little alteration heterologous challenges differing three amino acids 108L 189T 101L major alterations heterologous challenges differing one amino acid 101L also observed previously ME7 Manson et al
0.18022668.14573822.html.plaintext.txt	143	View larger version 19K Fig
0.18022668.14573822.html.plaintext.txt	144	The extent vacuolar change brain scored scale 0 5 nine areas grey matter three areas white matter mean scores calculated minimum six animals shown graphically error bars represent plus minus SEM
0.18022668.14573822.html.plaintext.txt	145	Grey matter scoring areas 1 dorsal medulla 2 cerebellar cortex 3 superior colliculus 4 hypothalamus 5 medial thalamus 6 hippocampus 7 septum 8 cerebral cortex 9 forebrain cerebral cortex
0.18022668.14573822.html.plaintext.txt	146	White matter scoring areas 1 cerebellar white matter 2 midbrain white matter 3 cerebral peduncle
0.18022668.14573822.html.plaintext.txt	147	Separate profiles shown mouse TSE strain 79A b 139A c 79V d 301V e 22A
0.18022668.14573822.html.plaintext.txt	148	Conclusions Transmission TSE disease thought efficient identical PrP sequences present donor recipient infectivity
0.18022668.14573822.html.plaintext.txt	149	The differences PrP sequence species thought reduce efficiency conversion PrPC PrPSc result low transmission frequencies long incubation periods
0.18022668.14573822.html.plaintext.txt	150	However TSE infectivity human hamster sheep brain tissue previously transmitted 101LL mice reduced incubation times compared wild type mice despite lack PrP sequence identity species Barron et al
0.18022668.14573822.html.plaintext.txt	151	The PrP sequence C57BL mice Prnpa ME7 139A 79A propagated differs 101LL mice one amino acid 101P yet incubation times 101LL mice 2 fold greater wild type mice
0.18022668.14573822.html.plaintext.txt	152	The PrP sequence VM mice Prnpb 79V 301V 22A propagated differs 101LL mice three residues 101P 108F 189V however effect case far less predictable
0.18022668.14573822.html.plaintext.txt	153	With Prnpb derived strains incubation times observed 101LL mice also extended compared Prnpb mice found shorter 301V longer 79V 22A compared Prnpa mice
0.18022668.14573822.html.plaintext.txt	154	Thus within mouse species presence 101L alteration prolongs scrapie incubation time normally observed donor genotype
0.18022668.14573822.html.plaintext.txt	155	However agents species effect 101L mutation appears cases facilitate transmission disease perhaps indicating 101L mutation allows efficient adaptation agent mice
0.18022668.14573822.html.plaintext.txt	156	The effect 101L mutation murine scrapie incubation times largely parallels effect 108189 polymorphisms murine PrP incubation times extended 101LL mice compared homologous transmission either Prnpa Prnpb mice
0.18022668.14573822.html.plaintext.txt	157	However degree incubation times affected 101L distinct 108189 also unpredictable Prnpb derived strains
0.18022668.14573822.html.plaintext.txt	158	Specific differences 101L 108189 also evident Prnpa derived strains
0.18022668.14573822.html.plaintext.txt	159	The related strains 139A 79A produce almost identical incubation times lesion profiles Prnpa mice distinguished incubation times Prnpb Prnpa108F189V mice 79A incubation time approximately 140 days longer 139A Table 1 Fig
0.18022668.14573822.html.plaintext.txt	160	On inoculation 101LL mice 139A 79A strains agent produced almost identical incubation times alterations lesion profile Table 1 Figs 1 3 proving 101L mutation alters disease profile agents manner indeed distinct 108189
0.18022668.14573822.html.plaintext.txt	161	Future experiments involving mice expressing Prnpa108F189T allow us examine influence L108F alone TSE disease progression directly compare effect L108F P101L alterations
0.18022668.14573822.html.plaintext.txt	162	These experiments may reveal mutations unstructured N terminal region PrP dramatic effects disease phenotype
0.18022668.14573822.html.plaintext.txt	163	Other mutations N terminal region murine PrP also shown affect incubation times murine scrapie strains
0.18022668.14573822.html.plaintext.txt	164	The introduction methionine positions 108 111 murine PrP create epitope mAb 3F4 increased incubation times four mouse passaged scrapie strains transgenic mice overexpressing Prnpa108M111M compared mice overexpressing Prnpa Supattapone et al
0.18022668.14573822.html.plaintext.txt	165	The mutations caused prolonged incubation times ranging 1 6 2 8 fold scrapie strains investigated independent Prnp genotype strain derived
0.18022668.14573822.html.plaintext.txt	166	Although precise effects 108M111M mutations difficult quantify experiments due differences Prnp gene copy number genetic background control mutant mice results suggested mutations region PrP may extend TSE incubation times mouse passaged TSE isolates
0.18022668.14573822.html.plaintext.txt	167	However experiment incubation times 301V extended Prnpa108M111M mice compared transgenic mice overexpressing Prnpa
0.18022668.14573822.html.plaintext.txt	168	This observed 101LL mice shortening 301V incubation time occurred respect wild type Prnpa mice
0.18022668.14573822.html.plaintext.txt	169	These observations indicate effect incubation time introducing 3F4 epitope distinct caused presence 101L murine PrP
0.18022668.14573822.html.plaintext.txt	170	The shorter incubation time 301V Prnpb mouse passaged BSE 101LL mice compared wild type Prnpa mice complete contrast previous experiments shown longer incubation times 101LL mice inoculated vCJD 101PP mice Barron et al
0.18022668.14573822.html.plaintext.txt	171	Strain characteristics particular TSE agent show remain remarkably consistent transmission several different species Bruce et al
0.18022668.14573822.html.plaintext.txt	172	However vCJD thought human passaged BSE produced increased incubation times altered lesion profiles 101LL mice compared wild type mice Barron et al
0.18022668.14573822.html.plaintext.txt	173	2001 BSE transmitted Prnpb mouse 301V produced shortened incubation times Table 1 Fig
0.18022668.14573822.html.plaintext.txt	174	1 unaltered lesion profiles 101LL mice compared wild type mice Fig
0.18022668.14573822.html.plaintext.txt	175	Adaptation mouse strain agent therefore increases efficiency transmission 101LL mice even presence three polymorphisms murine PrP may way related human TSE agent alone transmits efficiently wild type mice Bruce et al
0.18022668.14573822.html.plaintext.txt	176	These issues currently addressed transmitting subpassinging human TSE isolates P101L mice unpublished data
0.18022668.14573822.html.plaintext.txt	177	The interaction different strains TSE agent host PrP complex process alterations host PrP protein dramatic effect TSE disease progression
0.18022668.14573822.html.plaintext.txt	178	If infectious process dependent interaction PrP molecules unclear 101LL mice Prnpb derived strains behave unpredictable manner Prnpa derived strains
0.18022668.14573822.html.plaintext.txt	179	It may due presence three amino acid changes 101LL host Prnpb line agent propagated
0.18022668.14573822.html.plaintext.txt	180	It also possible Prnpb strains diverse PrPSc conformations Prnpa strains examined
0.18022668.14573822.html.plaintext.txt	181	Alternatively direct interaction PrPC PrPSc may define infectious process
0.18022668.14573822.html.plaintext.txt	182	Other molecules may involved process interaction PrPC may define importance PrP sequence transmission disease Kaneko et al
0.18022668.14573822.html.plaintext.txt	183	We aim define nature interaction N terminus host PrP infectious agent study mutations region PrP
0.18022668.14573822.html.plaintext.txt	184	ACKNOWLEDGEMENTS The authors would like thank Man Sun Sy 7A12 8H4 antibodies A
0.18022668.14573822.html.plaintext.txt	185	Lui lesion profile analysis A
0.18022668.14573822.html.plaintext.txt	186	Mack tissue processing sectioning S
0.18022668.14573822.html.plaintext.txt	187	Murdoch care scoring animals W
0.18022668.14573822.html.plaintext.txt	188	Goldmann review comment manuscript
0.18022668.14573822.html.plaintext.txt	189	This work supported grant BBSRC
0.18022668.14573822.html.plaintext.txt	190	REFERENCES Top ABSTRACT INTRODUCTION METHODS RESULTS AND DISCUSSION REFERENCES Barron R
0.18022668.14573822.html.plaintext.txt	191	Changing single amino acid N terminus murine PrP alters TSE incubation time across three species barriers
0.18022668.14573822.html.plaintext.txt	192	The prion protein copper connection pp
0.18022668.14573822.html.plaintext.txt	193	The cellular prion protein binds copper vivo
0.18022668.14573822.html.plaintext.txt	194	Scrapie strain variation mutation
0.18022668.14573822.html.plaintext.txt	195	The disease characteristics different strains scrapie Sinc congenic mouse lines implications nature agent host control pathogenesis
0.18022668.14573822.html.plaintext.txt	196	Transmissions mice indicate new variant CJD caused BSE agent
0.18022668.14573822.html.plaintext.txt	197	Strain characterization natural sheep scrapie comparison BSE
0.18022668.14573822.html.plaintext.txt	198	Mice devoid PrP resistant scrapie
0.18022668.14573822.html.plaintext.txt	199	Genetics polymorphism mouse prion gene complex control scrapie incubation time
0.18022668.14573822.html.plaintext.txt	200	Prion isolate specified allotypic interactions cellular scrapie prion proteins congenic transgenic mice
0.18022668.14573822.html.plaintext.txt	201	Proc Natl Acad Sci U S A 91 5690 5694
0.18022668.14573822.html.plaintext.txt	202	Identification gene controls incubation period strains scrapie agent mice
0.18022668.14573822.html.plaintext.txt	203	Structure recombinant full length hamster prion protein PrP29 231 N terminus highly flexible
0.18022668.14573822.html.plaintext.txt	204	Proc Natl Acad Sci U S A 94 13452 13457
0.18022668.14573822.html.plaintext.txt	205	Prion protein devoid octapeptide repeat region restores susceptibility scrapie PrP knockout mice
0.18022668.14573822.html.plaintext.txt	206	Distribution experimentally induced scrapie lesions brain
0.18022668.14573822.html.plaintext.txt	207	Recombinant full length murine prion protein mPrP23 231 purification spectroscopic characterization
0.18022668.14573822.html.plaintext.txt	208	Evidence protein X binding discontinuous epitope cellular prion protein scrapie prion propagation
0.18022668.14573822.html.plaintext.txt	209	Proc Natl Acad Sci U S A 94 10069 10074
0.18022668.14573822.html.plaintext.txt	210	N terminal truncation prion protein affects formation conformation abnormal protease resistant prion protein generated vitro
0.18022668.14573822.html.plaintext.txt	211	J Biol Chem 276 35265 35271
0.18022668.14573822.html.plaintext.txt	212	Identification multiple quantitative trait loci linked prion disease incubation period mice
0.18022668.14573822.html.plaintext.txt	213	Proc Natl Acad Sci U S A 98 6279 6283
0.18022668.14573822.html.plaintext.txt	214	Genetic environmental factors modify bovine spongiform encephalopathy incubation period mice
0.18022668.14573822.html.plaintext.txt	215	Proc Natl Acad Sci U S A 98 7402 7407
0.18022668.14573822.html.plaintext.txt	216	129Ola mice carrying null mutation PrP abolishes messenger RNA production developmentally normal
0.18022668.14573822.html.plaintext.txt	217	PrP gene dosage determines timing final intensity distribution lesions scrapie pathology
0.18022668.14573822.html.plaintext.txt	218	Neurodegeneration 3 331 340
0.18022668.14573822.html.plaintext.txt	219	A single amino acid alteration 101L introduced murine PrP dramatically alters incubation time transmissible spongiform encephalopathy
0.18022668.14573822.html.plaintext.txt	220	Mice gene targetted prion protein alterations show Prnp Sinc Prni congruent
0.18022668.14573822.html.plaintext.txt	221	Molecular biology pathogenesis prion diseases
0.18022668.14573822.html.plaintext.txt	222	Trends Biochem Sci 21 482 487
0.18022668.14573822.html.plaintext.txt	223	Transgenic mice expressing hamster prion protein produce species specific scrapie infectivity amyloid plaques
0.18022668.14573822.html.plaintext.txt	224	Quantitative trait loci affecting prion incubation time mice
0.18022668.14573822.html.plaintext.txt	225	Identification two prion protein regions modify scrapie incubation time
0.18022668.14573822.html.plaintext.txt	226	Transmission human prion diseases rodents
0.18022668.14573822.html.plaintext.txt	227	Prion propagation mice expressing human chimeric PrP transgenes implicates interaction cellular PrP another protein
0.18022668.14573822.html.plaintext.txt	228	Multiple amino acid residues within rabbit prion protein inhibit formation abnormal isoform
0.18022668.14573822.html.plaintext.txt	229	Distinct prion proteins short long scrapie incubation period mice
0.18022668.14573822.html.plaintext.txt	230	Paradoxical shortening scrapie incubation times expression prion protein transgenes derived long incubation period mice
0.18022668.14573822.html.plaintext.txt	231	Degeneration skeletal muscle peripheral nerves central nervous system transgenic mice overexpressing wild type prion proteins
0.18022668.14573822.html.plaintext.txt	232	NMR solution structure human prion protein
0.18022668.14573822.html.plaintext.txt	233	Proc Natl Acad Sci U S A 97 145 150
0.18022668.14573822.html.plaintext.txt	234	Prion protein expression different species analysis panel new mAbs
0.18022668.14573822.html.plaintext.txt	235	Proc Natl Acad Sci U S A 95 8812 8816
0.18022668.14573822.html.plaintext.txt	236	Received 6 February 2003 accepted 16 July 2003
0.18326303.15105552.html.plaintext.txt	0	Polymorphisms prion precursor functional gene pseudogene associated susceptibility chronic wasting disease white tailed deer Katherine I
0.18326303.15105552.html.plaintext.txt	1	1 US Department Agriculture Agricultural Research Service Animal Disease Research Unit 3003 ADBF Pullman WA 99164 USA 2 Department Veterinary Microbiology Pathology Washington State University Pullman WA USA 3 Colorado State Veterinary Diagnostic Laboratory College Veterinary Medicine Colorado State University Fort Collins CO USA
0.18326303.15105552.html.plaintext.txt	2	ABSTRACT Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Chronic wasting disease CWD status PrP genotypes determined group 133 wild white tailed deer 780 acre enclosure western Nebraska USA
0.18326303.15105552.html.plaintext.txt	3	Approximately half deer tested showed evidence PrPd brainstem lymphoid tissues
0.18326303.15105552.html.plaintext.txt	4	Four PRNP alleles encoding amino acid substitutions identified substitutions residues 95 QH 96 GS 116 AG serine S residue 138
0.18326303.15105552.html.plaintext.txt	5	In addition processed pseudogene two alleles encoding five six copies octapeptide repeat identified 26 deer
0.18326303.15105552.html.plaintext.txt	6	Both alleles encoded asparagine N residue 138
0.18326303.15105552.html.plaintext.txt	7	The functional gene alleles sorted five major diploid genotypes four rare genotypes
0.18326303.15105552.html.plaintext.txt	8	Although five major diploid genotypes found deer CWD unaffected deer less likely allele QGAS likely QSAS compared CWD affected deer
0.18326303.15105552.html.plaintext.txt	9	Late stage disease PrPd brainstem noted deer less 1 year age although single genotype associated rapid neuroinvasion
0.18326303.15105552.html.plaintext.txt	10	Early stage disease PrPd distribution limited lymphoid system observed deer estimated 5 years old suggesting infected adults incubation time might extremely long individuals
0.18326303.15105552.html.plaintext.txt	11	The pseudogene found deer major PRNP genotypes correlated CWD status
0.18326303.15105552.html.plaintext.txt	12	The large number susceptible genotypes possibility adult adult transmission suggest much white tailed deer population may risk disease following exposure CWD despite association specific genotypes CWD noted
0.18326303.15105552.html.plaintext.txt	13	INTRODUCTION Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Chronic wasting disease CWD transmissible spongiform encephalopathy TSE North American cervid ruminants
0.18326303.15105552.html.plaintext.txt	14	CWD reported low incidence farm raised free ranging white tailed deer Odocoileus virginianus mule deer O
0.18326303.15105552.html.plaintext.txt	15	2000 Rocky Mountain elk Cervus elaphus Spraker et al
0.18326303.15105552.html.plaintext.txt	16	1997 Williams Young 1980 several US states Canadian provinces
0.18326303.15105552.html.plaintext.txt	17	Other naturally occurring North American TSEs include geographically widespread scrapie sheep Wineland et al
0.18326303.15105552.html.plaintext.txt	18	1998 low numbers scrapie infected goats Valdez et al
0.18326303.15105552.html.plaintext.txt	19	2003 rare epidemic outbreaks transmissible mink encephalopathy farm raised mink Hartsough Burger 1965
0.18326303.15105552.html.plaintext.txt	20	The TSEs diverse family fatal neurodegenerative diseases characterized accumulation PrPd abnormal disease specific isoform Prusiner 1982 normal host protein PrPc Basler et al
0.18326303.15105552.html.plaintext.txt	21	Transmission pathogenesis TSEs appear involve novel mechanism PrPd major protein component tissue extracts infected animals catalyses conversion PrPc pathogenic PrPd molecule series aggregation post translational secondary changes Caughey et al
0.18326303.15105552.html.plaintext.txt	22	1990 Horiuchi Caughey 1999 Safar et al
0.18326303.15105552.html.plaintext.txt	23	The protein model supported experiments demonstrating expression PrPc host necessary prerequisite disease Bueler et al
0.18326303.15105552.html.plaintext.txt	24	1993 primary amino acid sequence PrPc associated relative susceptibility natural TSE infection species
0.18326303.15105552.html.plaintext.txt	25	Residues 136 154 171 alone combination control relative susceptibility incubation time sheep Belt et al
0.18326303.15105552.html.plaintext.txt	26	Predisposing genotypes elk CWD ORourke et al
0.18326303.15105552.html.plaintext.txt	27	1999 humans iatrogenic sporadic variant Creutzfeldt Jakob disease Collinge et al
0.18326303.15105552.html.plaintext.txt	28	1991 associated mutations single site elk codon 132 corresponding human codon 129
0.18326303.15105552.html.plaintext.txt	29	Genetic analysis susceptible predisposing prion protein precursor gene PRNP alleles mule deer complicated nearly universal presence unexpressed processed pseudogene PRNP exon 3 encodes polymorphic open reading frame ORF Brayton et al
0.18326303.15105552.html.plaintext.txt	30	In study examined PRNP functional gene pseudogene alleles herd white tailed deer high prevalence naturally occurring CWD investigate possibility predisposing genotypes species
0.18326303.15105552.html.plaintext.txt	31	METHODS Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Animals
0.18326303.15105552.html.plaintext.txt	32	Tissues collected white tailed deer ranch Sioux county northwest corner Nebraska USA within CWD endemic area
0.18326303.15105552.html.plaintext.txt	33	In 1992 area pine covered steep hills containing many deep ravines enclosed 3 m net barbed wire fence
0.18326303.15105552.html.plaintext.txt	34	An estimated 20 30 free ranging white tailed deer smaller number mule deer inadvertently fenced enclosure
0.18326303.15105552.html.plaintext.txt	35	This herd allowed multiply population high 300 head next 10 years
0.18326303.15105552.html.plaintext.txt	36	Food plots creep feeders trace minerals hay used supplement deer enclosure
0.18326303.15105552.html.plaintext.txt	37	Some losses enzootic haemorrhagic disease deer enclosure coincided similar losses deer outside fence
0.18326303.15105552.html.plaintext.txt	38	No deer poor body condition symptoms suggestive CWD noted
0.18326303.15105552.html.plaintext.txt	39	From 1992 2001 animals removed guided hunts met State Nebraska Game Parks Division season permit requirements
0.18326303.15105552.html.plaintext.txt	40	A group bull elk placed deer enclosure 1998 harvested hunters moved adjacent pasture
0.18326303.15105552.html.plaintext.txt	41	In 2001 CWD surveillance initiated positive deer found first group sampled
0.18326303.15105552.html.plaintext.txt	42	The entire enclosure several acres perimeter depopulated early 2002 agreement property owner Nebraska Game Parks Commission
0.18326303.15105552.html.plaintext.txt	43	All deer n172 removed within fenced area
0.18326303.15105552.html.plaintext.txt	44	Thirty nine animals excluded study submission lacked either complete tissue set formalin fixed brain tonsil retropharyngeal lymph node CWD status determination frozen tissue sample suitable genetic analysis
0.18326303.15105552.html.plaintext.txt	45	Diagnostic testing performed Colorado State Veterinary Diagnostic Laboratory Wyoming Veterinary Diagnostic Laboratory
0.18326303.15105552.html.plaintext.txt	46	All animals good body condition killed
0.18326303.15105552.html.plaintext.txt	47	Most deer killed late winter January March 2002
0.18326303.15105552.html.plaintext.txt	48	White tailed deer breed seasonally fawns 7 10 months age herd depopulated
0.18326303.15105552.html.plaintext.txt	49	Age estimated tooth eruption 36 88 adult animals remaining 52 recorded adult
0.18326303.15105552.html.plaintext.txt	50	DNA extracted frozen brain tissue using commercial kit Q Biogene following manufacturers instructions
0.18326303.15105552.html.plaintext.txt	51	Primer pairs specific amplification PRNP PRNP derived corresponding sequences mule deer GenBank accession nos AY330343 AY371694
0.18326303.15105552.html.plaintext.txt	52	Intron exon borders derived sequences bovine PRNP cDNA genomic DNA GenBank accession nos AB001468 AJ298878 cDNA mule deer K
0.18326303.15105552.html.plaintext.txt	53	PCR amplification performed using universal prion primer pair amplifying 800 bp fragment including entire ORF exon 3 PRNP PRNP forward primer 247 5 atggtgaaaagccacataggcag 3 beginning initiation site PrP translation reverse primer 224 5 agaagataatgaaaacaggaag 3 beginning 8 bp termination codon primer pair specific functional gene forward primer 223 5 acaccctctttattttgcag 3 intron 2 reverse primer 224 yielding 830 bp product two primer pairs specific pseudogene forward primer 379 5 aagaaaattcctgagagagcat 3 containing pseudogene flanking repeat sequence adjacent 8 bp exon 1 forward primer 369 5 caaccaagtcgaagcatct 3 exon 2 reverse primer 224 used cases
0.18326303.15105552.html.plaintext.txt	54	Amplification DNA deer PRNP yielded product 950 974 bp primers 379224 875 899 bp primers 369224 depending octapeptide repeat number
0.18326303.15105552.html.plaintext.txt	55	Although primers 369224 annealed PRNP PRNP intervening intron PRNP deleted PRNP precluded efficient amplification functional gene therefore primer pair selectively amplified PRNP conditions used
0.18326303.15105552.html.plaintext.txt	56	All PCR reactions follows 95 degrees C 5 min followed 30 cycles denaturation 95 degrees C 30 annealing 54 degrees C 30 extension 72 degrees C 59 followed extension cycle 72 degrees C 7 min standard buffer conditions 2 5 mM MgCl2 Qiagen
0.18326303.15105552.html.plaintext.txt	57	PCR products analysed 1 agarose ethidium bromide stained gels
0.18326303.15105552.html.plaintext.txt	58	PRNP amplification reactions scored presence absence pseudogene specific band
0.18326303.15105552.html.plaintext.txt	59	PCR products purified ExoSAP USB Corporation remove unincorporated dNTPs primers sequenced ABI Prism 377 DNA Sequencer Big Dye Terminator chemistry PE Applied Biosystems using forward primer 245 5 gccaaccgctatccacctca 3 reverse primer 12 5 ggtggtgactgtgtgttgcttga 3 Amplicon Express
0.18326303.15105552.html.plaintext.txt	60	PCR products cloned sequencing PRNP allele PRNP products using TOPO TA cloning system Invitrogen according manufacturers instructions sequenced primers T3 T7 MWG Biotech
0.18326303.15105552.html.plaintext.txt	61	In study PRNP alleles identified deduced amino acids positions 95 glutamine Q histidine H 96 glycine G serine S 116 alanine A glycine G 138 serine S asparagine N sites three coding changes functional gene PRNPPRNP marker codon 138 Odocoileus spp
0.18326303.15105552.html.plaintext.txt	62	PRNP alleles identified number octanonapeptide repeat units five six
0.18326303.15105552.html.plaintext.txt	63	CWD diagnosed monoclonal antibody immunohistochemistry described previously Spraker et al
0.18326303.15105552.html.plaintext.txt	64	Deer considered CWD positive PrPd detected dorsal motor nucleus vagus nerve DMNV tonsil retropharyngeal lymph node
0.18326303.15105552.html.plaintext.txt	65	Animals considered early disease tonsil retropharyngeal node positive immunostaining evident DMNV Spraker et al
0.18326303.15105552.html.plaintext.txt	66	Animals considered late disease PrPd detected brain well lymphoid tissue
0.18326303.15105552.html.plaintext.txt	67	Deer detectable PrPd brain nodes considered No PrPd
0.18326303.15105552.html.plaintext.txt	68	These animals considered CWD free long undefined incubation period infection accumulation detectable PrPd
0.18326303.15105552.html.plaintext.txt	69	Frequencies CWD associated specific PRNP alleles assessed 2 analysis contingency tables using Yates continuity correction appropriate comparisons single degree freedom
0.18326303.15105552.html.plaintext.txt	70	Confidence intervals calculated odds ratios CWD major genotypes detected study population using presumed wild type genotype QGAS QGAS reference genotype Armitage Berry 1994
0.18326303.15105552.html.plaintext.txt	71	RESULTS Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES PRNP alleles The ORF PRNP determined DNA sequence analysis PCR products generated using primer pair specific functional gene
0.18326303.15105552.html.plaintext.txt	72	Alleles confirmed sequence analysis cloned amplicons
0.18326303.15105552.html.plaintext.txt	73	The previously reported polymorphisms codons 95 caacat QH 96 ggtagt GS Raymond et al
0.18326303.15105552.html.plaintext.txt	74	2003 116 gcagga AG Heaton et al
0.18326303.15105552.html.plaintext.txt	75	Silent changes cgccgt codon 51 aacaat codon 146 ggtgga codon 81 identified small number animals
0.18326303.15105552.html.plaintext.txt	76	The frequencies functional gene alleles QGAS QSAS QGGS HGAS shown Table 1
0.18326303.15105552.html.plaintext.txt	77	The common alleles QGAS QSAS represented nearly 90 total frequencies 0 50 0 36 respectively
0.18326303.15105552.html.plaintext.txt	78	Alleles QGGS HGAS rare frequencies 0 13 0 011
0.18326303.15105552.html.plaintext.txt	79	All functional gene alleles encoded five octanonapeptide repeat units nonapeptides PQHGGGGWGQ flanking three octapeptides PHGGGWGQ
0.18326303.15105552.html.plaintext.txt	80	PrP functional pseudogene allelic frequencies 133 white tailed deer herd high prevalence CWD
0.18326303.15105552.html.plaintext.txt	81	PRNP alleles The cervid prion pseudogene PRNP bears hallmarks processed pseudogene lacking introns flanked direct repeats Mighell et al
0.18326303.15105552.html.plaintext.txt	82	The white tailed deer PRNP amplified using two pseudogene specific primer pairs forward primer 379 incorporating 5 pseudogene repeat Fig
0.18326303.15105552.html.plaintext.txt	83	1 5 end truncated exon 1 forward primer 369 exon 2 paired 3 universal prion reverse primer end ORF
0.18326303.15105552.html.plaintext.txt	84	Products evaluated agarose gel electrophoresis Fig
0.18326303.15105552.html.plaintext.txt	85	2 amplicons sequenced directly TOPO cloning
0.18326303.15105552.html.plaintext.txt	86	Of 133 samples 35 26 yielded amplification product pseudogene specific primers
0.18326303.15105552.html.plaintext.txt	87	Sequence analysis TOPO cloned products demonstrated organization PRNP white tailed deer GenBank accession
0.18326303.15105552.html.plaintext.txt	88	AY425673 similar mule deer GenBank accession
0.18326303.15105552.html.plaintext.txt	89	AY371694 containing truncated exon 1 contiguous exon 2 exon 3 sequences Fig
0.18326303.15105552.html.plaintext.txt	90	The 5 sequence flanking pseudogene identical mule deer 5 aagaaaattcctgaga 3
0.18326303.15105552.html.plaintext.txt	91	This sequence identified 5 end white tailed deer pseudogene
0.18326303.15105552.html.plaintext.txt	92	Because similarity mule deer pseudogene likely flanking sequence part repeat also found 3 terminus pseudogene
0.18326303.15105552.html.plaintext.txt	93	The PRNP sequence white tailed deer identical common allele mule deer lacked heterogeneity mule deer PRNP Brayton et al
0.18326303.15105552.html.plaintext.txt	94	No single base pair changes identified among white tailed deer PRNP sequences
0.18326303.15105552.html.plaintext.txt	95	Variation observed octapeptide repeat number pseudogene either five n29 deer six n6 deer repeat units observed
0.18326303.15105552.html.plaintext.txt	96	The longer allele 24 bp insertion second repeat unit five repeat units identical shorter pseudogene allele functional gene
0.18326303.15105552.html.plaintext.txt	97	All functional gene alleles encoded serine S codon 138 pseudogene alleles encoded asparagine N observed mule deer
0.18326303.15105552.html.plaintext.txt	98	View larger version 11K Fig
0.18326303.15105552.html.plaintext.txt	99	Organization cervid functional PRNP gene cervid prion pseudogene PRNP drawn scale
0.18326303.15105552.html.plaintext.txt	100	A The functional gene includes three exons intervening introns
0.18326303.15105552.html.plaintext.txt	101	The entire ORF shown grey found exon 3 encodes five octanonapeptide repeat units serine S codon 138 alleles
0.18326303.15105552.html.plaintext.txt	102	B The cervid pseudogene contains classic hallmarks processed retrotransposon lacking introns flanked direct repeat R 3 repeat inferred similarity mule deer pseudogene
0.18326303.15105552.html.plaintext.txt	103	The pseudogene encodes either five octanonapeptide repeat units identical functional gene six repeat units additional 24 bp repeat unit inserted second unit
0.18326303.15105552.html.plaintext.txt	104	Both PRNP alleles encode asparagine N codon 138
0.18326303.15105552.html.plaintext.txt	105	View larger version 25K Fig
0.18326303.15105552.html.plaintext.txt	106	Amplification genomic DNA primers specific functional gene PRNP lanes b d f primers 223224 cervid pseudogene PRNP lanes c e g primers 379224 deer 115 261 lanes b c pseudogene encoding six octapeptide repeats upper arrow deer 115 1 lanes d e pseudogene encoding five octapeptide repeats lower arrow deer 115 84 lanes f g pseudogene
0.18326303.15105552.html.plaintext.txt	107	Molecular mass markers lane 1100 1000 900 800 700 600 bp
0.18326303.15105552.html.plaintext.txt	108	CWD adult deer fawns A hundred thirty three white tailed deer study killed CWD diagnosed deer within fenced area
0.18326303.15105552.html.plaintext.txt	109	Paired samples formalin fixed tissue CWD diagnosis frozen tissue DNA sequence analysis collected
0.18326303.15105552.html.plaintext.txt	110	Fifty per cent 67133 deer diagnosed CWD Table 2 using immunohistochemical assay PrPd formalin fixed paraffin embedded brain lymphoid tissues
0.18326303.15105552.html.plaintext.txt	111	Five CWD positive deer fawns less 1 year age
0.18326303.15105552.html.plaintext.txt	112	Early CWD PrPd detected tonsil retropharyngeal node brain diagnosed 14 deer 12 adults ranging 1 5 5 years age two fawns
0.18326303.15105552.html.plaintext.txt	113	Late CWD PrPd detectable brain well lymphoid tissues diagnosed 53 deer 50 adults ranging age 1 5 7 years age three fawns
0.18326303.15105552.html.plaintext.txt	114	None CWD positive deer showed clinical signs disease weight loss hypersalivation disorientation gross changes consistent CWD serous atrophy fat necropsy
0.18326303.15105552.html.plaintext.txt	115	PRNP disease status white tailed deer early late CWD
0.18326303.15105552.html.plaintext.txt	116	A hundred thirty three white tailed deer evaluated diploid functional PRNP genotype presence cervid prion pseudogene PRNP CWD status
0.18326303.15105552.html.plaintext.txt	117	Diploid genotypes deer varying age disease status Diploid genotypes CWD status 133 deer study shown Table 2
0.18326303.15105552.html.plaintext.txt	118	Nine 10 potential diploid genotypes identified herd lacking deer homozygous rare HGAS allele
0.18326303.15105552.html.plaintext.txt	119	CWD diagnosed deer three commonly occurring genotypes QGAS QGAS QGAS QSAS QGAS QGGS three less common genotypes QSAS QGGS QSAS QSAS QGGS HGAS
0.18326303.15105552.html.plaintext.txt	120	Late stage disease seen fawns adults genotypes QGAS QSAS QGAS QGGS
0.18326303.15105552.html.plaintext.txt	121	Adult deer early disease identified three genotypes QGAS QGAS QGAS QSAS QSAS QGGS
0.18326303.15105552.html.plaintext.txt	122	Deer homozygous two major alleles QGAS QSAS found CWD population although one fawn one adult homozygous QSAS identified
0.18326303.15105552.html.plaintext.txt	123	The frequencies CWD differed among deer five major diploid genotypes
0.18326303.15105552.html.plaintext.txt	124	first five rows Table 2 212 2 4 df P0 016
0.18326303.15105552.html.plaintext.txt	125	The genotypes rare meaningful analysis
0.18326303.15105552.html.plaintext.txt	126	The strongest association detected CWD occurrence carriage QGAS allele 211 3 1 df P 0 001
0.18326303.15105552.html.plaintext.txt	127	Deer either haploid 26 52 1 df P0 01 diploid 29 36 1 df P 0 01 QGAS allele frequently affected CWD compared deer lacking allele
0.18326303.15105552.html.plaintext.txt	128	Correspondingly negative association observed CWD carriage one two QSAS alleles 26 98 2 df P 0 05
0.18326303.15105552.html.plaintext.txt	129	No association detected carriage PRNP pseudogene allele CWD 20 003 P 0 05
0.18326303.15105552.html.plaintext.txt	130	Sample sizes small analysis genotypes
0.18326303.15105552.html.plaintext.txt	131	Odds ratios 95 confidence intervals CI occurrence CWD frequently occurring diploid genotypes using presumed wild type allele QGAS homozygous deer reference group shown Table 2
0.18326303.15105552.html.plaintext.txt	132	In spite small sample size 95 CI showed decrease odds ratio deer QSAS allele lacking QGAS allele compared deer presumed wild type QGAS homozygous genotype
0.18326303.15105552.html.plaintext.txt	133	Homozygous QSAS deer lower odds ratio 0 089 95 CI 0 016 0 502 heterozygous QSAS QGGS deer 0 167 CI 0 035 0 789
0.18326303.15105552.html.plaintext.txt	134	The presence QGAS allele resulted similar odds ratios heterozygous QSAS 0 564 95 CI 0 212 1 501 QGGS 0 444 95 CI 0 133 1 489 deer
0.18326303.15105552.html.plaintext.txt	135	DISCUSSION Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Relative genetic susceptibility TSEs based supposition variation critical residues PrPc increases efficiency conversion PrPd isoform
0.18326303.15105552.html.plaintext.txt	136	The post translational change PrPc PrPd thought two step process PrPcPrPd aggregation Horiuchi Caughey 1999 followed conversion PrPc sheet enriched protease resistant protein Cohen Prusiner 1998
0.18326303.15105552.html.plaintext.txt	137	Amino acid substitutions contribute efficiency aggregation step stability disease associated isoform Supattapone et al
0.18326303.15105552.html.plaintext.txt	138	2001 expected associated increased susceptibility decreased incubation time
0.18326303.15105552.html.plaintext.txt	139	In ruminant herbivores naturally occurring TSEs susceptibility natural challenge estimated proportion affected unaffected animals genotype populations presumed uniform exposure disease causing agent
0.18326303.15105552.html.plaintext.txt	140	The low prevalence CWD free ranging populations deer elk complicate similar analysis genetic susceptibility CWD
0.18326303.15105552.html.plaintext.txt	141	We identified group wild deer confined single large area CWD diagnosed approximately 50 animals
0.18326303.15105552.html.plaintext.txt	142	Examination relationship CWD PRNP genotype conditions heavy natural challenge performed identify susceptible predisposing genotypes
0.18326303.15105552.html.plaintext.txt	143	The ORF PRNP gene variable group deer reported previously free ranging elk ORourke et al
0.18326303.15105552.html.plaintext.txt	144	1999 mule deer Brayton et al
0.18326303.15105552.html.plaintext.txt	145	2004 duplicated cervid prion pseudogene PRNP described previously mule deer Brayton et al
0.18326303.15105552.html.plaintext.txt	146	The presumed wild type allele QGAS three alleles coding changes codons 95 H 96 S 116 G identified functional gene
0.18326303.15105552.html.plaintext.txt	147	In addition coding change codon 138 distinguished PRNP 138S PRNP 138N sample set
0.18326303.15105552.html.plaintext.txt	148	Both location potential charge shift three amino acid replacements functional gene interest
0.18326303.15105552.html.plaintext.txt	149	The HQ polymorphism position 95 results substitution neutral polar residue commonly reported deduced amino acid sequences PRNP gene among within large number species Schatzl et al
0.18326303.15105552.html.plaintext.txt	150	Residue 96 encoding G S adjacent final octapeptide repeat region poorly conserved among mammalian species examined insertions single base changes reported Van Rheede et al
0.18326303.15105552.html.plaintext.txt	151	Although evidence resistance disease deer major genotypes study deer lacking QGAS allele carrying one two copies allele encoding 96S QSAS less likely found CWD population deer QGAS allele one chromosomes
0.18326303.15105552.html.plaintext.txt	152	This finding consistent data deer Wisconsin Johnson et al
0.18326303.15105552.html.plaintext.txt	153	2003 although study universal prion primers used functional genotype could determined animals data shown
0.18326303.15105552.html.plaintext.txt	154	The sample sizes studies relatively small 26 Wisconsin 67 study
0.18326303.15105552.html.plaintext.txt	155	If larger sample sizes support observations however pattern genetic susceptibility white tailed deer would similar observed Rocky Mountain elk predisposing genotype reported ORourke et al
0.18326303.15105552.html.plaintext.txt	156	1999 although major genotypes susceptible CWD Spraker et al
0.18326303.15105552.html.plaintext.txt	157	In contrast PRNP polymorphisms sheep result lack disease virtually sheep resistant genotypes Belt et al
0.18326303.15105552.html.plaintext.txt	158	1992 1994 1997 ORourke et al
0.18326303.15105552.html.plaintext.txt	159	The polymorphism codon 116 functional gene interest
0.18326303.15105552.html.plaintext.txt	160	The alanine A residue position conserved across large number eutherian orders Van Rheede et al
0.18326303.15105552.html.plaintext.txt	161	2003 previously reported variant tenrec insectivorous mammal found island Madagascar
0.18326303.15105552.html.plaintext.txt	162	Residue 116 human 113 potential membrane spanning domain Hegde et al
0.18326303.15105552.html.plaintext.txt	163	1998 PrPc immediately adjacent proposed cleavage site cytosolically derived protease protected proteolysis insertion membrane endoplasmic reticulum Hegde et al
0.18326303.15105552.html.plaintext.txt	164	The AG mutation residue 116 white tailed deer results replacement hydrophobic aliphatic residue polar residue may affect intracellular processing transport PrP precursor
0.18326303.15105552.html.plaintext.txt	165	However study 116G allele found 13 CWD positive heterozygous deer demonstrating allele provide protection conditions
0.18326303.15105552.html.plaintext.txt	166	Two 116G homozygous animals identified one adult one fawn arguing early lethal effect mutation
0.18326303.15105552.html.plaintext.txt	167	Neither homozygous deer detectable PrPd neurodegenerative changes
0.18326303.15105552.html.plaintext.txt	168	The cervid prion pseudogene white tailed deer study appeared low frequency comparison pseudogene O
0.18326303.15105552.html.plaintext.txt	169	hemionus mule deer Brayton et al
0.18326303.15105552.html.plaintext.txt	170	2004 black tailed deer subspecies O
0.18326303.15105552.html.plaintext.txt	171	PRNP characterized polymorphism detected functional gene heterogeneity limited variable octapeptide repeat number
0.18326303.15105552.html.plaintext.txt	172	The low frequency lack heterogeneity white tailed deer pseudogene could due inbreeding within confined herd polymorphisms primer binding sites resulting detection limited subset alleles relatively recent introduction pseudogene genome white tailed deer
0.18326303.15105552.html.plaintext.txt	173	Although founder group study herd estimated fewer 20 animals loss heterogeneity pseudogene due inbreeding unlikely explanation functional alleles identified Wisconsin Johnson et al
0.18326303.15105552.html.plaintext.txt	174	2003 Mississippi unpublished data Wyoming Heaton et al
0.18326303.15105552.html.plaintext.txt	175	2003 groups represented herd
0.18326303.15105552.html.plaintext.txt	176	Furthermore using 138N polymorphism marker PNRP Wisconsin Wyoming studies pseudogene frequencies similar among groups
0.18326303.15105552.html.plaintext.txt	177	Polymorphisms PCR primer binding sites cannot ruled
0.18326303.15105552.html.plaintext.txt	178	However pseudogene detected two primer pairs deer 138N mutation detected universal prion primer pair suggesting failure amplify novel PRNP allele likely
0.18326303.15105552.html.plaintext.txt	179	The third explanation appearance pseudogene O
0.18326303.15105552.html.plaintext.txt	180	hemionus mule deer black tailed deer divergence white tailed deer limited relatively recent introgression white tailed deer genome hybridization ancestral sympatric populations
0.18326303.15105552.html.plaintext.txt	181	Although evolution taxonomy dozens subspecies white tailed black tailed deer Americas complex examination mitochondrial DNA Y linked genes supports model white tailed deer black tailed deer diverged North American continent Pleistocene subsequent hybridization sympatric populations resulting appearance mule deer reviewed Geist Francis 1999
0.18326303.15105552.html.plaintext.txt	182	Subsequent hybridization mule deer white tailed deer probably occurred continues occur infrequently low level introgressive hybridization maternal DNA mule deer black tailed deer white tailed deer populations within limited geographic areas Cronin 1991
0.18326303.15105552.html.plaintext.txt	183	The PRNP alleles study previous study mule deer Brayton et al
0.18326303.15105552.html.plaintext.txt	184	2004 invariably encoded 138N expansion octapeptide repeat number observed deer
0.18326303.15105552.html.plaintext.txt	185	These changes seen functional gene leaving unresolved question whether changes occurred ancestral functional gene duplication event processed pseudogene duplication
0.18326303.15105552.html.plaintext.txt	186	The substitution N S prion protein common within among species functional alleles encoding 138N common fallow deer Dama dama reindeer Rangifer tarandus unpublished data
0.18326303.15105552.html.plaintext.txt	187	Likewise variable octapeptide repeat number common breeds cattle
0.18326303.15105552.html.plaintext.txt	188	There several dozen subspecies Odocoileus Americas genetic examination additional populations demonstrate whether changes noted pseudogene study characteristic processed pseudogene found functional alleles well
0.18326303.15105552.html.plaintext.txt	189	No evidence pseudogene found small populations New World moose Alces alces holoarctic reindeer Old World Rocky Mountain elk C
0.18326303.15105552.html.plaintext.txt	190	elaphus captive Asian fallow deer unpublished data
0.18326303.15105552.html.plaintext.txt	191	If PRNP arose evolutionary radiation Odocoileus species New World pseudogene likely found distantly related members order Artiodactyla sheep cattle goats
0.18326303.15105552.html.plaintext.txt	192	Novel pseudogenes may yet found populations domestic livestock judicious selection primer pairs optimized pseudogene discovery
0.18326303.15105552.html.plaintext.txt	193	However processed pseudogenes typically transcribed translated Mighell et al
0.18326303.15105552.html.plaintext.txt	194	2000 therefore expected affect susceptibility protein based disorder
0.18326303.15105552.html.plaintext.txt	195	All major PRNP diploid genotypes represented CWD group study
0.18326303.15105552.html.plaintext.txt	196	We addressed possibility genetically controlled differences incubation time period infection accumulation detectable PrPd brain examining fawns animals 1 year age late disease PrPd brain
0.18326303.15105552.html.plaintext.txt	197	Using crude measure identified three fawns QGAS QSAS QGAS QGGS genotypes late disease demonstrating extremely rapid course animals
0.18326303.15105552.html.plaintext.txt	198	PrPd thought accumulate first lymphoid tissues alimentary tract Sigurdson et al
0.18326303.15105552.html.plaintext.txt	199	1999 subsequent neuroinvasion transport splenic vagus nerves brain
0.18326303.15105552.html.plaintext.txt	200	In experimental rodent models incubation time neuroinvasion rate associated number variables including PRNP polymorphisms Dickinson Outram 1973 innervation PrPc production lymphoid tissues Mabbott et al
0.18326303.15105552.html.plaintext.txt	201	2001 route infection Bartz et al
0.18326303.15105552.html.plaintext.txt	202	Transgenic mice cervid PRNP genes may appropriate laboratory model examining extremely rapid neuroinvasion seen genotypes
0.18326303.15105552.html.plaintext.txt	203	CWD mule deer typically associated weight loss ataxia hypersalivation polyuria polydipsia Williams Miller 2002 similar signs reported captive white tailed deer held research settings M
0.18326303.15105552.html.plaintext.txt	204	Miller personal communication
0.18326303.15105552.html.plaintext.txt	205	In spite infection rate nearly 50 herd clinical evidence CWD noted live deer property owner hunters necropsy
0.18326303.15105552.html.plaintext.txt	206	Losses intercurrent viral diseases extensive years terrain provided adequate cover sick animals evade detection prior death possibly masking presence TSE herd
0.18326303.15105552.html.plaintext.txt	207	Alternately clinical course white tailed deer may acute described mule deer due differences biology cervid host strain TSE agent herd dose disease causing agent confined facility
0.18326303.15105552.html.plaintext.txt	208	Additional observations clinical CWD white tailed deer held captive settings necessary address spectrum phenotypes TSE infection cervids
0.18326303.15105552.html.plaintext.txt	209	PRNP alleles diploid genotypes white tailed deer CWD identify associated CWD susceptibility
0.18326303.15105552.html.plaintext.txt	210	In contrast disease resistance considerably challenging define free ranging populations several reasons
0.18326303.15105552.html.plaintext.txt	211	First equivalent exposure disease causing agent cannot demonstrated across population
0.18326303.15105552.html.plaintext.txt	212	Although deer study removed single fenced area likely herd spent part year small maternally related groups congregating feed plots natural watering areas
0.18326303.15105552.html.plaintext.txt	213	CWD transmission routes known relative efficiency transmission deer deer contact shared feed water sources cannot determined
0.18326303.15105552.html.plaintext.txt	214	Microsatellite analysis DNA affected animals needs performed determine whether maternal contact increases probability infection
0.18326303.15105552.html.plaintext.txt	215	Secondly alleles relatively rare additional study populations endemic areas selectively bred captive white tailed deer needed increase sample size genotypes
0.18326303.15105552.html.plaintext.txt	216	Thirdly interval infection accumulation detectable PrPd levels known
0.18326303.15105552.html.plaintext.txt	217	CWD diagnosed deer 8 10 months age herd establishing minimum incubation period
0.18326303.15105552.html.plaintext.txt	218	The maximum incubation period cannot identified infection times occur outside perinatal period Miller Williams 2003
0.18326303.15105552.html.plaintext.txt	219	Some older adult deer detectable PrPd restricted lymphoid tissue
0.18326303.15105552.html.plaintext.txt	220	If temporal pattern PrPd accumulation white tailed deer similar sheep Hadlow et al
0.18326303.15105552.html.plaintext.txt	221	1982 experimentally infected mule deer Sigurdson et al
0.18326303.15105552.html.plaintext.txt	222	1999 observation indicates white tailed deer infected adults reported mule deer Miller Williams 2003 incubation period long 5 years
0.18326303.15105552.html.plaintext.txt	223	Failure detect PrPd deer less likely due genetic differences termination entire herd regulatory reasons deer early stage disease PrPd detectable
0.18326303.15105552.html.plaintext.txt	224	Long term observations heavily exposed herds direct oral challenge captive deer needed establish relative disease resistance deer rare genotypes
0.18326303.15105552.html.plaintext.txt	225	However presence relatively resistant rare genotype may confer selective advantage sufficient reduce prevalence CWD free ranging herds
0.18326303.15105552.html.plaintext.txt	226	ACKNOWLEDGEMENTS Roger Sahara Nebraska Department Agriculture provided information origin animals study
0.18326303.15105552.html.plaintext.txt	227	Tissues collected Nebraska Game Parks NGP Commission data age sex provided B
0.18326303.15105552.html.plaintext.txt	228	CWD diagnostic testing performed T
0.18326303.15105552.html.plaintext.txt	229	Spraker Colorado Veterinary Diagnostic Laboratory E
0.18326303.15105552.html.plaintext.txt	230	Williams Wyoming Veterinary Diagnostic Laboratory
0.18326303.15105552.html.plaintext.txt	231	Excellent technical assistance provided A
0.18326303.15105552.html.plaintext.txt	232	Miller provided helpful discussions
0.18326303.15105552.html.plaintext.txt	233	We grateful Rich Edwards family cooperation completion study
0.18326303.15105552.html.plaintext.txt	234	This work supported grant Agricultural Research Service US Department Agriculture CWU 5348 32000 011 00D
0.18326303.15105552.html.plaintext.txt	235	REFERENCES Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Armitage P
0.18326303.15105552.html.plaintext.txt	236	Statistical Methods Medical Research 3rd edn
0.18326303.15105552.html.plaintext.txt	237	Rapid prion neuroinvasion following tongue infection
0.18326303.15105552.html.plaintext.txt	238	Scrapie cellular PrP isoforms encoded chromosomal gene
0.18326303.15105552.html.plaintext.txt	239	Identification five allelic variants sheep PrP gene association natural scrapie
0.18326303.15105552.html.plaintext.txt	240	PrP genotype contributes determining survival times sheep natural scrapie
0.18326303.15105552.html.plaintext.txt	241	A processed pseudogene contributes apparent mule deer prion gene heterogeneity
0.18326303.15105552.html.plaintext.txt	242	Mice devoid PrP resistant scrapie
0.18326303.15105552.html.plaintext.txt	243	Normal scrapie associated forms prion protein differ sensitivities phospholipase proteases intact neuroblastoma cells
0.18326303.15105552.html.plaintext.txt	244	Different allelic effects codon 136 171 prion protein gene sheep natural scrapie
0.18326303.15105552.html.plaintext.txt	245	Pathologic conformations prion proteins
0.18326303.15105552.html.plaintext.txt	246	Annu Rev Biochem 67 793 819
0.18326303.15105552.html.plaintext.txt	247	Genetic predisposition iatrogenic Creutzfeldt Jakob disease
0.18326303.15105552.html.plaintext.txt	248	Prion protein gene analysis new variant cases Creutzfeldt Jakob disease
0.18326303.15105552.html.plaintext.txt	249	Mitochondrial nuclear genetic relationships deer Odocoileus spp western North America
0.18326303.15105552.html.plaintext.txt	250	Differences access central nervous system ME7 scrapie agent two strains mice
0.18326303.15105552.html.plaintext.txt	251	Chanhassen MN Northword Press
0.18326303.15105552.html.plaintext.txt	252	Sympathetic innervation lymphoreticular organs rate limiting prion neuroinvasion
0.18326303.15105552.html.plaintext.txt	253	PrP genotype agent effects scrapie change allelic interaction different isolates agent sheep natural host scrapie
0.18326303.15105552.html.plaintext.txt	254	PrP genotypes Sip gene Cheviot sheep form basis scrapie strain typing sheep
0.18326303.15105552.html.plaintext.txt	255	Ann N Y Acad Sci 724 296 299
0.18326303.15105552.html.plaintext.txt	256	Natural infection Suffolk sheep scrapie virus
0.18326303.15105552.html.plaintext.txt	257	Epizootiologic clinical observations
0.18326303.15105552.html.plaintext.txt	258	Prion gene sequence variation within diverse groups US sheep beef cattle deer
0.18326303.15105552.html.plaintext.txt	259	A transmembrane form prion protein neurodegenerative disease
0.18326303.15105552.html.plaintext.txt	260	Specific binding normal prion protein scrapie form via localized domain initiates conversion protease resistant state
0.18326303.15105552.html.plaintext.txt	261	Natural scrapie British sheep breeds ages PrP gene polymorphisms
0.18326303.15105552.html.plaintext.txt	262	The association codon 136 PrP gene variant occurrence natural scrapie
0.18326303.15105552.html.plaintext.txt	263	Natural scrapie PrP genotype case control studies British sheep
0.18326303.15105552.html.plaintext.txt	264	Prion protein gene heterogeneity free ranging white tailed deer within chronic wasting disease affected region Wisconsin
0.18326303.15105552.html.plaintext.txt	265	Temporary inactivation follicular dendritic cells delays neuroinvasion scrapie
0.18326303.15105552.html.plaintext.txt	266	Horizontal prion transmission mule deer
0.18326303.15105552.html.plaintext.txt	267	Epizootiology chronic wasting disease free ranging cervids Colorado Wyoming
0.18326303.15105552.html.plaintext.txt	268	PrP genotypes experimental scrapie orally inoculated Suffolk sheep United States
0.18326303.15105552.html.plaintext.txt	269	PrP genotypes captive free ranging Rocky Mountain elk Cervus elaphus nelsoni chronic wasting disease
0.18326303.15105552.html.plaintext.txt	270	Homozygous prion protein genotype predisposes sporadic Creutzfeldt Jakob disease
0.18326303.15105552.html.plaintext.txt	271	Novel proteinaceous infectious particles cause scrapie
0.18326303.15105552.html.plaintext.txt	272	Evidence molecular barrier limiting susceptibility humans cattle sheep chronic wasting disease
0.18326303.15105552.html.plaintext.txt	273	Scrapie amyloid prion protein conformational characteristics aggregated molten globule folding intermediate
0.18326303.15105552.html.plaintext.txt	274	Prion protein gene variation among primates
0.18326303.15105552.html.plaintext.txt	275	Oral transmission early lymphoid tropism chronic wasting disease PrPres mule deer fawns Odocoileus hemionus
0.18326303.15105552.html.plaintext.txt	276	Spongiform encephalopathy free ranging mule deer Odocoileus hemionus white tailed deer Odocoileus virginianus Rocky Mountain elk Cervus elaphus nelsoni northcentral Colorado
0.18326303.15105552.html.plaintext.txt	277	Validation monoclonal antibody F9997
0.18326303.15105552.html.plaintext.txt	278	1 immunohistochemical staining brain tonsil mule deer Odocoileus hemionus chronic wasting disease
0.18326303.15105552.html.plaintext.txt	279	Comparison histological lesions immunohistochemical staining proteinase resistant prion protein naturally occurring spongiform encephalopathy free ranging mule deer Odocoileus hemionus chronic wasting disease captive mule deer
0.18326303.15105552.html.plaintext.txt	280	Variable patterns PrP CWD distribution obex cranial lymphoid tissues Rocky Mountain elk nonclinical chronic wasting disease
0.18326303.15105552.html.plaintext.txt	281	Identification two prion protein regions modify scrapie incubation time
0.18326303.15105552.html.plaintext.txt	282	Immunohistochemical detection distribution prion protein goat natural scrapie
0.18326303.15105552.html.plaintext.txt	283	J Vet Diagn Invest 15 157 162
0.18326303.15105552.html.plaintext.txt	284	Molecular evolution mammalian prion protein
0.18326303.15105552.html.plaintext.txt	285	Homozygosity prion protein alleles encoding glutamine 171 renders sheep susceptible natural scrapie
0.18326303.15105552.html.plaintext.txt	286	Chronic wasting disease captive mule deer spongiform encephalopathy
0.18326303.15105552.html.plaintext.txt	287	Chronic wasting disease deer elk North America
0.18326303.15105552.html.plaintext.txt	288	Rev Sci Tech Off Int Epozoot 21 305 316
0.18326303.15105552.html.plaintext.txt	289	Epidemiologic analysis reported scrapie sheep United States 1117 cases 1947 1992
0.18326303.15105552.html.plaintext.txt	290	J Am Vet Med Assoc 212 713 718
0.18326303.15105552.html.plaintext.txt	291	Analysis 27 mammalian 9 avian PrPs reveals high conservation flexible regions prion protein
0.18326303.15105552.html.plaintext.txt	292	Received 5 November 2003 accepted 23 December 2003
0.10246989.15269177.html.plaintext.txt	0	A Drosophila model early onset torsion dystonia suggests impairment TGF ss signaling Young Ho Koh Kimberly Rehfeld Barry Ganetzky
0.10246989.15269177.html.plaintext.txt	1	Laboratory Genetics 445 Henry Mall University Wisconsin Madison Madison WI 53706 USA
0.10246989.15269177.html.plaintext.txt	2	Received May 3 2004 Revised June 23 2004 Accepted July 1 2004
0.10246989.15269177.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS Expression DeltaE HtorA
0.10246989.15269177.html.plaintext.txt	4	DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES To investigate cellular molecular etiology early onset torsion dystonia established Drosophila model disorder
0.10246989.15269177.html.plaintext.txt	5	Expression mutant human torsinA deleted single glutamic acid residue E HtorA normal HtorA elicits locomotor defects Drosophila
0.10246989.15269177.html.plaintext.txt	6	As mammalian systems E HtorA flies forms protein accumulations localize synaptic membranes nuclei endosomes
0.10246989.15269177.html.plaintext.txt	7	Various morphological defects neuromuscular junction larvae expressing E HtorA observed EM level resemble recently reported mutants defects TGF ss signaling
0.10246989.15269177.html.plaintext.txt	8	These results together distribution patterns localizations E HtorA accumulations suggested E HtorA could interfere aspect TGF ss signaling synapses endosomes nuclei
0.10246989.15269177.html.plaintext.txt	9	Consistent possibility neuronal overexpression Drosophila human Smad2 downstream effector TGF ss pathway suppressed behavioral ultrastructural defects E HtorA flies
0.10246989.15269177.html.plaintext.txt	10	These results raise possibility defect TGF ss signaling might also underlie early onset torsion dystonia humans
0.10246989.15269177.html.plaintext.txt	11	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS Expression DeltaE HtorA
0.10246989.15269177.html.plaintext.txt	12	DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES Dystonia third common movement disorder humans characterized sustained involuntary muscle contractions resulting severe twisting movements abnormal postures
0.10246989.15269177.html.plaintext.txt	13	Although number heritable forms dystonia common severe form early onset torsion dystonia neurological disorder affecting central nervous system
0.10246989.15269177.html.plaintext.txt	14	It inherited autosomal dominant fashion variable penetrance
0.10246989.15269177.html.plaintext.txt	15	About 30 40 heterozygotes manifest disease onset 1 28 years age 1 3
0.10246989.15269177.html.plaintext.txt	16	Although cellular molecular etiology torsion dystonia unknown associated obvious neurodegeneration 45
0.10246989.15269177.html.plaintext.txt	17	Recently form dystonia linked DYT1 gene 6
0.10246989.15269177.html.plaintext.txt	18	The causative mutation 3 bp deletion results deletion glutamic acid E302303 residue near C terminus encoded protein Torsin A HtorA
0.10246989.15269177.html.plaintext.txt	19	Another study patient early onset dystonia early onset Parkinson disease myoclonic features revealed presence 18 bp deletion mutation DYT1 gene resulted deletion six amino acids F323 Y328 HtorA 7
0.10246989.15269177.html.plaintext.txt	20	Sequence comparisons demonstrate HtorA member HSP100Clp family ATP dependent chaperones functions assembly disassembly operation variety protein complexes including involved many types vesicular transport 8
0.10246989.15269177.html.plaintext.txt	21	Immunolocalization HtorA expressed transfected cell lines suggests lumenally oriented protein localized intracellular membranes endoplasmic reticulum ER
0.10246989.15269177.html.plaintext.txt	22	E HtorA found large spheroid intracellular structures colocalize ER markers 9
0.10246989.15269177.html.plaintext.txt	23	At EM level reported E TorsinA found membrane whorls may derive ER 10
0.10246989.15269177.html.plaintext.txt	24	In addition HtorA localized Lewy bodies postmortem Parkinson disease patients 1112
0.10246989.15269177.html.plaintext.txt	25	Expression normal HtorA cultured cells resulted colocalization various heat shock proteins suppressed synuclein aggregation
0.10246989.15269177.html.plaintext.txt	26	However expression E HtorA suppress synuclein aggregation 13
0.10246989.15269177.html.plaintext.txt	27	Similarly expression normal HtorA suppressed polyglutamine induced protein aggregation Caenorhabditis elegans 14
0.10246989.15269177.html.plaintext.txt	28	These observations suggest HtorA could function chaperone involved folding processing secreted membrane proteins
0.10246989.15269177.html.plaintext.txt	29	The effects E mutation HtorA functions unknown although dominant phenotype together observations suggests mutant protein dominant negative gain function mode action
0.10246989.15269177.html.plaintext.txt	30	The basis variable penetrance early onset torsion dystonia caused E HtorA still unclear
0.10246989.15269177.html.plaintext.txt	31	A second hit model genetic mutations environmental factors increase susceptibilities individuals heterozygous E HtorA mutation proposed 91516
0.10246989.15269177.html.plaintext.txt	32	As Drosophila offers many experimental advantages genetic molecular studies basic molecular components neuronal signaling mechanisms evolutionarily conserved 17 19 increasingly used model system study human neurological disorders
0.10246989.15269177.html.plaintext.txt	33	Here established Drosophila model early onset torsion dystonia may increase understanding molecular cellular mechanisms responsible disorder
0.10246989.15269177.html.plaintext.txt	34	Several lines evidences study suggest behavioral ultrastructural abnormalities observed E HtorA expressing flies involve impaired TGF ss signaling
0.10246989.15269177.html.plaintext.txt	35	Therefore propose defect TGF ss signaling may also contribute etiology early onset torsion dystonia humans
0.10246989.15269177.html.plaintext.txt	36	RESULTS TOP ABSTRACT INTRODUCTION RESULTS Expression DeltaE HtorA
0.10246989.15269177.html.plaintext.txt	37	DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES Transgenic expression human TorsinA Drosophila To develop model early onset torsion dystonia Drosophila used Gal4UAS system 20 express human cDNAs encoding wild type WT F323 Y328 FY 7 E302303 E 6 mutant forms HtorA transgenic flies
0.10246989.15269177.html.plaintext.txt	38	We used C155 Gal4 driver 21 34 dihydroxyphenylalanine L decarboxylase Ddc Gal4 driver 22 respectively drive expression constructs either pan neuronally specifically dopaminergic neurons
0.10246989.15269177.html.plaintext.txt	39	To characterize anti HtorA antiserum various UAS HtorA transgenic flies expression WT HtorA proteins Ddc Gal4 drivers examined using goat anti HtorA antiserum Fig
0.10246989.15269177.html.plaintext.txt	40	Strong immunolabeling observed dopaminergic neurons ventral nerve cords Fig
0.10246989.15269177.html.plaintext.txt	41	No staining observed larvae carrying driver Ddc Gal4 alone Fig
0.10246989.15269177.html.plaintext.txt	42	Preincubation anti HtorA antiserum HtorA peptides also eliminated staining Fig
0.10246989.15269177.html.plaintext.txt	43	View larger version 125K Figure 1
0.10246989.15269177.html.plaintext.txt	44	Expression human TorsinA Drosophila
0.10246989.15269177.html.plaintext.txt	45	Confocal images ventral nerve cords expressing WT HtorA dopaminergic neurons third instar larvae stained anti HtorA antibodies
0.10246989.15269177.html.plaintext.txt	46	A1 Ddc Gal4UAS WT HtorA expressing A2 control genetic backgrounds Ddc Gal4 stained anti HtorA antibodies
0.10246989.15269177.html.plaintext.txt	47	A3 Ddc Gal4UAS WT HtorA stained anti HtorA antibodies previously incubated HtorA pepetides demonstrate specificities immunostaining
0.10246989.15269177.html.plaintext.txt	48	B C Confocal images single dopaminergic neurons larval ventral nerve cords expressing different HtorA constructs stained anti HtorA antibodies
0.10246989.15269177.html.plaintext.txt	49	Two independent lines examined construct B B2 WT C C2 FY D D2 E
0.10246989.15269177.html.plaintext.txt	50	Note presence distinct protein clusters cells expressing E HtorA
0.10246989.15269177.html.plaintext.txt	51	Bar 60 mm A1 A3 5 microm B D2
0.10246989.15269177.html.plaintext.txt	52	Examples WT mutant HtorA expression individual dopaminergic neurons ventral nerve cord shown Figure 1B D
0.10246989.15269177.html.plaintext.txt	53	Comparable levels expression observed different HtorA constructs two independent transgenic lines construct Fig
0.10246989.15269177.html.plaintext.txt	54	A striking difference apparent immunolocalization patterns E HtorA compared WT FY HtorA Fig
0.10246989.15269177.html.plaintext.txt	55	WT FY HtorA distributed diffusely throughout cytoplasm Fig
0.10246989.15269177.html.plaintext.txt	56	1B C whereas E HtorA formed distinct cytoplasmic clusters aggregates localized proximity nuclear membrane plasma membrane Fig
0.10246989.15269177.html.plaintext.txt	57	The E HtorA clusters observed using two independent anti HtorA antisera Supplementary Material Fig
0.10246989.15269177.html.plaintext.txt	58	These distribution patterns similar reported expression WT mutant HtorA transfected human cells cultured vitro 1023
0.10246989.15269177.html.plaintext.txt	59	Thus aberrant localization E HtorA clusters recapitulated expressed vivo Drosophila
0.10246989.15269177.html.plaintext.txt	60	When expression WT FY E HtorA constructs driven postsynaptically muscle specific C57 Gal4 driver 24 proteins showed distribution patterns similar neurons Fig
0.10246989.15269177.html.plaintext.txt	61	WT FY HtorA proteins localized diffusely muscle sarcoplasm
0.10246989.15269177.html.plaintext.txt	62	In contrast E HtorA protein formed protein clusters
0.10246989.15269177.html.plaintext.txt	63	Western blot analysis larval body wall muscle extracts revealed one strong band size 40 kDa Supplementary Material Fig
0.10246989.15269177.html.plaintext.txt	64	Comparable levels expression found WT mutant forms HtorA
0.10246989.15269177.html.plaintext.txt	65	Compared either WT E HtorA 18 bp HtorA moved faster consistent smaller size Supplementary Material Fig
0.10246989.15269177.html.plaintext.txt	66	Similar results reported human cell culture experiments 23
0.10246989.15269177.html.plaintext.txt	67	View larger version 97K Figure 3
0.10246989.15269177.html.plaintext.txt	68	Immunolocalization E HtorA protein clusters synaptic boutons within neurons A B Two sets three consecutive Z series confocal slices 0
0.10246989.15269177.html.plaintext.txt	69	3 microm intervals type Ib glutamatergic boutons labeled anti HRP blue anti DLG green anti HtorA red antisera
0.10246989.15269177.html.plaintext.txt	70	White arrowheads point E HtorA clusters localized near synapses within SSR
0.10246989.15269177.html.plaintext.txt	71	E HtorA proteins expressed muscles
0.10246989.15269177.html.plaintext.txt	72	C1 C3 Confocal images neuronal cell soma expressing E HtorA neurons larval ventral nerve cord stained C1 anti HtorA antisera red C2 anti HRS antisera green
0.10246989.15269177.html.plaintext.txt	73	Note colocalizations indicated yellow colors white arrowheads E HtorA clusters anti HRS signal specific marker endosomes clearly seen superimposed image C3 inset
0.10246989.15269177.html.plaintext.txt	74	D Confocal image larval nerve bundles
0.10246989.15269177.html.plaintext.txt	75	Again note overlap subset E HtorA clusters endosomal markers
0.10246989.15269177.html.plaintext.txt	76	Bar 5 microm A B 10 microm C D
0.10246989.15269177.html.plaintext.txt	77	Expression E HtorA Drosophila results behavioral abnormalities TOP ABSTRACT INTRODUCTION RESULTS Expression DeltaE HtorA
0.10246989.15269177.html.plaintext.txt	78	DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES Expression WT FY E HtorA neurons adult CNS gave results similar observed larvae
0.10246989.15269177.html.plaintext.txt	79	WT FY HtorA proteins distributed broadly throughout cytoplasm adult neurons whereas E HtorA forms dense accumulations cluster around membranes Supplementary Material Fig
0.10246989.15269177.html.plaintext.txt	80	Transgenic flies expressing WT mutant forms HtorA showed normal life spans raised 25 degrees C Supplementary Material Fig
0.10246989.15269177.html.plaintext.txt	81	S4 30 degrees C data shown manifest overt behavioral deficits conditions whether expression dopaminergic neurons neurons muscles
0.10246989.15269177.html.plaintext.txt	82	Similar observations reported Muraro Moffat 9th European Drosophila neurobiology meeting abstract 2002
0.10246989.15269177.html.plaintext.txt	83	These data suggested presence clusters E HtorA proteins neurons muscles might sufficient induce behavioral abnormalities
0.10246989.15269177.html.plaintext.txt	84	To explain 30 40 penetrance E HtorA mutation humans second hit model proposed according environmental factors genetic mutations required evoke severe behavioral abnormalities 91516
0.10246989.15269177.html.plaintext.txt	85	Therefore hypothesized another factor may required induce behavioral defects flies expressing E HtorA
0.10246989.15269177.html.plaintext.txt	86	In previous studies found number mutants Drosophila defects neuronal membrane excitability synaptic transmission behave normally room temperature 20 25 degrees C show severe locomotor defects paralysis seizures placed elevated temperatures 25
0.10246989.15269177.html.plaintext.txt	87	Therefore tested whether exposing HtorA expressing flies 38 degrees C uncovered latent behavioral defects Fig
0.10246989.15269177.html.plaintext.txt	88	We monitored flies 38 degrees C period 10 min counted number flies remaining active sides top vial versus remaining bottom time point
0.10246989.15269177.html.plaintext.txt	89	View larger version 66K Figure 2
0.10246989.15269177.html.plaintext.txt	90	Impaired locomotor behaviors HtorA expressing flies
0.10246989.15269177.html.plaintext.txt	91	Flies different ages expressing WT E HtorA control various Gal4 drivers placed vials 38 degrees C behavior monitored 10 min
0.10246989.15269177.html.plaintext.txt	92	The number actively walking climbing flies plotted time point
0.10246989.15269177.html.plaintext.txt	93	Time points showing significant difference P 0
0.10246989.15269177.html.plaintext.txt	94	05 determined test analysis marked asterisk
0.10246989.15269177.html.plaintext.txt	95	A C155 pan neuronal driver B Ddc dopaminergic neuronal Gal4 driver C C57 muscle driver D Tubulin ubiquitous Gal4 drivers
0.10246989.15269177.html.plaintext.txt	96	Thirteen groups C155 15 groups C155UAS WT HtorA 15 groups C155UAS E HtorA 13 groups DdcGal4 11 groups Ddc Gal4UAS WT HtorA 10 groups DdcGal4UAS E HtorA 12 groups C57 15 groups C57UAS WT HtorA 14 groups UAS E HtorAC57 12 groups TubGal4 12 groups TubGal4UAS WT HtorA 12 groups UAS E HtorA TubGal4 collected three different independent crosses tested
0.10246989.15269177.html.plaintext.txt	97	Flies expressing E HtorA pan neural pattern showed striking differences behavior compared control flies expressing WT HtorA abnormalities became even pronounced age Fig
0.10246989.15269177.html.plaintext.txt	98	Impaired locomotor control 38 degrees C already apparent 3 day old E HtorA flies compared controls
0.10246989.15269177.html.plaintext.txt	99	By 6 days age 90 E HtorA expressing flies became severely incapacitated within 1 min exposure 38 degrees C exhibiting convulsive like leg wing movements suggestive aberrant muscle contractions twisting movements seen torsion dystonia patients whereas majority WT HtorA expressing flies control flies aged 12 days retained locomotor control conditions Supplementary Material Movie A B
0.10246989.15269177.html.plaintext.txt	100	Ubiquitous expression using Tubulin Gal4 driver produced similar results Fig
0.10246989.15269177.html.plaintext.txt	101	We observed similar somewhat less extreme phenotype E HtorA expressed specifically dopaminergic neurons Fig
0.10246989.15269177.html.plaintext.txt	102	It necessary age E HtorA expressing flies least 12 days 90 100 lost locomotor control 38 degrees C
0.10246989.15269177.html.plaintext.txt	103	The weaker phenotype flies expressing E HtorA dopaminergic neurons compared pan neurally expressing flies suggests early onset severe phenotype requires E HtorA expression multiple types neurons may include motor neurons
0.10246989.15269177.html.plaintext.txt	104	Postsynaptic expression E HtorA muscles also resulted age temperature dependent loss locomotor control 90 100 E HtorA expressing flies remaining bottom vials 38 degrees C 9 days age Fig
0.10246989.15269177.html.plaintext.txt	105	In summary expression E HtorA Drosophila either neurons muscles cause severe motor impairments function age environmental conditions severity age onset phenotype vary depending spatial pattern expression
0.10246989.15269177.html.plaintext.txt	106	E HtorA clusters distinct subcellular localization To investigate E HtorA protein clusters might contribute observed behavioral defects examined subcellular distribution patterns clusters well characterized type I glutamatergic synapses larval neuromuscular junction NMJ
0.10246989.15269177.html.plaintext.txt	107	At type I glutamatergic synapses found least postsynaptic E HtorA clusters localized near synaptic boutons association subsynaptic reticulum SSR
0.10246989.15269177.html.plaintext.txt	108	This illustrated Figure 3A B shows three consecutive confocal slices two sets synaptic boutons labeled specific antibodies presynaptic membranes anti HRP well SSR anti DLG
0.10246989.15269177.html.plaintext.txt	109	Cell bodies motor neurons ventral nerve cords larvae expressing E HtorA pan neural pattern contained HtorA clusters whose subcellular location partially overlapped endosomes marked anti HRS antibodies Fig
0.10246989.15269177.html.plaintext.txt	110	We also observed overlap HtorA clusters endosomes motor neuron nerve bundles Fig
0.10246989.15269177.html.plaintext.txt	111	3D muscles data shown
0.10246989.15269177.html.plaintext.txt	112	In contrast overlap observed WT 18 bp HtorA proteins endosomal markers detected anti HRA antiserum data shown
0.10246989.15269177.html.plaintext.txt	113	We examined localization E HtorA clusters higher resolution using silver enhanced immuno EM analysis Fig
0.10246989.15269177.html.plaintext.txt	114	In E HtorA expressing flies silver enhanced immunogold particles observed associated various cellular membranes nerve terminals cell bodies
0.10246989.15269177.html.plaintext.txt	115	Examples immunogold particles localized synapse within SSR outer periphery nucleus adjacent mitochondria inside lumen single double membrane endosomes shown Figure 4A C
0.10246989.15269177.html.plaintext.txt	116	In control experiments larvae express E HtorA incubated anti HtorA antibodies larvae express E HtorA incubated absence anti HtorA antibodies observed fewer 10 total particles seen experimental analysis confirming specificity silver enhanced anti HtorA particles
0.10246989.15269177.html.plaintext.txt	117	Similar subcellular distribution patterns observed either presynaptic postsynaptic expression E HtorA
0.10246989.15269177.html.plaintext.txt	118	The localization E HtorA clusters synaptic regions nuclei endosomes suggests mutant protein could affect synaptic structure function interfering one signaling pathways synapses nuclei andor endosomes vice versa
0.10246989.15269177.html.plaintext.txt	119	View larger version 134K Figure 4
0.10246989.15269177.html.plaintext.txt	120	Subcellular localization E HtorA immuno EM analysis
0.10246989.15269177.html.plaintext.txt	121	E HtorA expressing larvae dissected incubated anti HtorA antiserum followed addition anti rabbit IgG conjugated 1 nm gold particles processed EM silver enhancement
0.10246989.15269177.html.plaintext.txt	122	Localization detected synaptic densities A A1 within SSR A2 nuclear membranes A3 associated mitochondria B endosomes C1 C2
0.10246989.15269177.html.plaintext.txt	123	In A A1 E HtorA expression control C155 pan neuronal driver
0.10246989.15269177.html.plaintext.txt	124	In remaining panels expression driven C57 muscle driver
0.10246989.15269177.html.plaintext.txt	125	Expression E HtorA induces morphological abnormalities type I glutamatergic synapses To determine whether E HtorA expression resulted structural defects synapses examined type I glutamatergic synapses larval NMJ
0.10246989.15269177.html.plaintext.txt	126	We observe significant differences numbers type I synaptic boutons larvae expressing WT E HtorA neurons WT 88
0.10246989.15269177.html.plaintext.txt	127	However high power confocal microscopy revealed altered morphologies synaptic boutons expressing E HtorA motor neurons muscles Fig
0.10246989.15269177.html.plaintext.txt	128	Synaptic boutons expressing WT HtorA normal smooth rounded appearance Fig
0.10246989.15269177.html.plaintext.txt	129	In contrast synaptic boutons expressing E HtorA noticeably enlarged many abnormal irregular shapes Fig
0.10246989.15269177.html.plaintext.txt	130	View larger version 114K Figure 5
0.10246989.15269177.html.plaintext.txt	131	Altered morphology E HtorA expressing larvae
0.10246989.15269177.html.plaintext.txt	132	NMJs muscle 67 stained anti HRP visualize overall morphology bouton numbers
0.10246989.15269177.html.plaintext.txt	133	No major differences parameters observed comparison A C155 Gal4UAS WT HtorA B C155 Gal4UAS E HtorA C UAS WT HtorAC57 Gal4 D UAS E HtorAC57 Gal4
0.10246989.15269177.html.plaintext.txt	134	However closer examination revealed abnormalities black arrowheads size appearance boutons larvae expressing E HtorA either presynaptically F postsynaptically H compared corresponding controls E G
0.10246989.15269177.html.plaintext.txt	135	Bar 50 microm A D 10 microm E H
0.10246989.15269177.html.plaintext.txt	136	To characterize synaptic defects associated E HtorA expression performed ultrastructural morphometric analysis serial reconstructions obtained two independent samples boutons expressing WT E HtorA presynaptically
0.10246989.15269177.html.plaintext.txt	137	We examined total seven controls 10 WT HtorA nine E HtorA boutons
0.10246989.15269177.html.plaintext.txt	138	There significant difference control synaptic boutons WT HtorA synaptic boutons Table 1
0.10246989.15269177.html.plaintext.txt	139	However length surface area volume E HtorA boutons significantly larger controls WT HtorA boutons Fig
0.10246989.15269177.html.plaintext.txt	140	Ultrastructural analysis synapses type Ib glutamatergic synapses NMJs E HtorA expressing larvae
0.10246989.15269177.html.plaintext.txt	141	A1 A3 Midline cross sections synaptic boutons neuronal expression A1 WT HtorA A2 E HtorA A3 dSmad2 E HtorA simultaneously
0.10246989.15269177.html.plaintext.txt	142	Compared controls larvae expressing E HtorA showed increased bouton size abnormal elongated membrane structures black arrowheads
0.10246989.15269177.html.plaintext.txt	143	Arrows indicate presynaptic dense bodies
0.10246989.15269177.html.plaintext.txt	144	B1 B6 Consecutive images taken serial thin sections synapse larvae expressing WT HtorA neurons
0.10246989.15269177.html.plaintext.txt	145	Synaptic vesicle pools present presynaptic terminals
0.10246989.15269177.html.plaintext.txt	146	Arrows indicate presynaptic dense bodies
0.10246989.15269177.html.plaintext.txt	147	C1 C6 Consecutive images serial thin sections synapses larva expressing E HtorA motorneurons show empty synaptic vesicle pools near synapse indicated asterisk
0.10246989.15269177.html.plaintext.txt	148	D1 D3 Serial EM images show extended membrane structures observed synaptic bouton expressing E HtorA protein neurons
0.10246989.15269177.html.plaintext.txt	149	Arrowheads indicate abnormal extended membrane structures arrow indicates presynaptic dense body
0.10246989.15269177.html.plaintext.txt	150	E1 E4 Free dense bodies indicated arrow heads presynaptic terminals observed neuronal expression E HtorA
0.10246989.15269177.html.plaintext.txt	151	Free dense bodies structures clearly seen higher magnification EM inset
0.10246989.15269177.html.plaintext.txt	152	Mit mitochondria SSR subsynaptic reticulum
0.10246989.15269177.html.plaintext.txt	153	Bar 500 nm A 250 nm B1 E4
0.10246989.15269177.html.plaintext.txt	154	In addition expression E HtorA also caused ultrastructural abnormalities regions synaptic contact Fig
0.10246989.15269177.html.plaintext.txt	155	One defect absence synaptic vesicle pools near synapses
0.10246989.15269177.html.plaintext.txt	156	Synapses WT HtorA boutons always surrounded pool synaptic vesicles regardless whether one presynaptic dense bodies T bars active zones present Fig
0.10246989.15269177.html.plaintext.txt	157	However 12 E HtorA synapses 23183 devoid synaptic vesicle pools surrounded instead discrete clear zone Fig
0.10246989.15269177.html.plaintext.txt	158	A second abnormality observed synaptic regions presence abnormal membrane structures extended within synaptic vesicle pools Fig
0.10246989.15269177.html.plaintext.txt	159	The abnormal membrane structure extended across bouton interconnecting two dense bodies opposite sides
0.10246989.15269177.html.plaintext.txt	160	We observed similar abnormal membrane structures E HtorA boutons examined
0.10246989.15269177.html.plaintext.txt	161	A third presynaptic abnormality presence free dense bodies Fig
0.10246989.15269177.html.plaintext.txt	162	6E clear high magnification inset
0.10246989.15269177.html.plaintext.txt	163	Despite morphological resemblance presynaptic dense bodies structures free presynaptic terminals rather anchored synaptic membrane Table 1
0.10246989.15269177.html.plaintext.txt	164	In addition boutons expressing E HtorA showed significantly increased synaptic density area compared boutons expressing WT HtorA Table 1
0.10246989.15269177.html.plaintext.txt	165	These structural defects synaptic terminals E HtorA expressing boutons may account locomotor defects observed elevated temperatures
0.10246989.15269177.html.plaintext.txt	166	Expression dSmad2 hSmad2 suppresses E HtorA phenotypes The presence free dense bodies presynaptic terminals associated expression E HtorA also recently observed several Drosophila mutant affecting receptors ligands TGF ss signaling pathway 26 28
0.10246989.15269177.html.plaintext.txt	167	The phenotypes identical however mutations wishful thinking wit affects type II BMP receptor causes additional synaptic defects including decrease levels Fasciclin II distinctive detachment synaptic membranes observed larvae expressing E HtorA Fig
0.10246989.15269177.html.plaintext.txt	168	Those observations suggest E HtorA expression might disrupt part TGF ss signaling pathway interfere proper synaptic development
0.10246989.15269177.html.plaintext.txt	169	As E HtorA clusters localized synapses SSR endosomes nuclear periphery possible disrupt trafficking components TGF ss signaling synapses endosomes nuclei
0.10246989.15269177.html.plaintext.txt	170	Mad dSmad2 known transcriptional effectors TGF ss pathway regulates target gene expression control cell proliferation 29 neuronal remodeling metamorphosis 30 synaptic plasticity type I glutamatergic NMJs 2627
0.10246989.15269177.html.plaintext.txt	171	Studies indicate dynamic changes molecular components Smad complexes trafficking receptors endosomes nuclei essential eliciting proper responses 3132
0.10246989.15269177.html.plaintext.txt	172	We hypothesized E HtorA interfered trafficking mothers decapentaplegic Mad Drosophila Smad2 dSmad2 synapses nuclei endosomes
0.10246989.15269177.html.plaintext.txt	173	To explore possibility E HtorA interfered TGF ss pathway examined effect overexpressing Mad dSmad2 E HtorA background
0.10246989.15269177.html.plaintext.txt	174	At behavioral level pan neural expression dSmad2 substantially rescued locomotor defects caused E HtorA 38 degrees C flies remained active controls C155 Gal4 Fig
0.10246989.15269177.html.plaintext.txt	175	However condition Mad overexpression suppress E HtorA behavioral defects
0.10246989.15269177.html.plaintext.txt	176	Pan neural expression dSmad2 alone effect flies compared control background C155 Gal4 Fig
0.10246989.15269177.html.plaintext.txt	177	Although E HtorA behavioral phenotypes suppressed dSmad2 overexpression mutating one copy dSmad2 reduce gene dosage 50 enhance phenotypes Fig
0.10246989.15269177.html.plaintext.txt	178	Expression dSmad2 also rescued E HtorA morphological ultrastructural phenotypes Fig
0.10246989.15269177.html.plaintext.txt	179	The volume surface area length synaptic boutons completely rescued synaptic area
0.10246989.15269177.html.plaintext.txt	180	Other presynaptic abnormalities observed E HtorA animals including synapses empty synaptic vesicle pools presence abnormal extended membrane structures presence free dense bodies eliminated significantly reduced expression dSmad2 Table 1
0.10246989.15269177.html.plaintext.txt	181	Furthermore found expression human Smad2 human homologues dSmad2 33 rescued behavioral abnormalities dSmad2 Fig
0.10246989.15269177.html.plaintext.txt	182	Rescue E HtorA phenotypes expression human Drosophila Smad2 due indirect effect E HtorA expression levels E HtorA remained unaltered appeared backgrounds data shown
0.10246989.15269177.html.plaintext.txt	183	View larger version 49K Figure 7
0.10246989.15269177.html.plaintext.txt	184	Drosophila human Smad2 rescued impaired locomotor control flies expressing E HtorA
0.10246989.15269177.html.plaintext.txt	185	A Flies different ages expressing E HtorA Mad dSmad2 hSmad2 together E HtorA control pan neural Gal4 drivers placed vials 38 degrees C tested described Figure 2
0.10246989.15269177.html.plaintext.txt	186	Note pan neural expression Mad suppress rescue locomotor defects induced E HtorA proteins 38 degrees C
0.10246989.15269177.html.plaintext.txt	187	However dSmad2 hSmad2 rescued behavioral abnormalities
0.10246989.15269177.html.plaintext.txt	188	Time points showing significant increase locomotor activity P 0
0.10246989.15269177.html.plaintext.txt	189	05 determined test analysis marked asterisks
0.10246989.15269177.html.plaintext.txt	190	Fourteen groups C155 Gal4UAS E HtorA 14 groups C155 Gal4UAS MadUAS E HtorA 14 groups C155 Gal4UAS E HtorAUAS dSmad2 12 groups C155 Gal4UAS hSmad2UAS hSmad2UAS E HtorA tested
0.10246989.15269177.html.plaintext.txt	191	B C155 Gal4UAS E HtorA flies C155 Gal4dsmad21UAS E HTorA flies C155 Gal4 flies C155 Gal4UAS dSmad2 flies tested behavioral abnormality
0.10246989.15269177.html.plaintext.txt	192	Overexpression dSmad2 alone induce behavioral change
0.10246989.15269177.html.plaintext.txt	193	A point mutation one copy dSmad2 dsmad21 exacerbate E HtorA overexpression phenotype
0.10246989.15269177.html.plaintext.txt	194	Time points showing significant change locomotor activity P 0
0.10246989.15269177.html.plaintext.txt	195	05 determined test analysis comparing C155 Gal4 flies marked asterisks
0.10246989.15269177.html.plaintext.txt	196	Fourteen groups C155 Gal4UAS E HtorA 14 groups C155 Gal4UAS MadUAS E HtorA 14 groups C155 Gal4UAS E HtorAUAS dSmad2 12 groups C155 Gal4UAS hSmad2UAS hSmad2UAS E HtorA 12 groups C155 Gal4dsmad21UAS E HTorA 12 groups C155 Gal4 12 groups C155 Gal4UAS dSmad2 tested
0.10246989.15269177.html.plaintext.txt	197	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS Expression DeltaE HtorA
0.10246989.15269177.html.plaintext.txt	198	DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES The major goal present investigation develop Drosophila model early onset torsion dystonia
0.10246989.15269177.html.plaintext.txt	199	Our significant finding expression E HtorA WT HtorA either nervous system muscles Drosophila results severely impaired motor behavior
0.10246989.15269177.html.plaintext.txt	200	Affected flies exhibit loss coordination inability stand upright spasmodic activity leg kicking held wings reminiscent uncontrolled muscle contractions characteristic early onset torsion dystonia humans
0.10246989.15269177.html.plaintext.txt	201	Interestingly E HtorA expressing flies manifest behavioral abnormalities upon acute exposure 38 degrees C
0.10246989.15269177.html.plaintext.txt	202	This result consistent proposed second hit model explain 30 40 individuals heterozygous DYT1 mutation develop phenotypic manifestations early onset torsion dystonia 91516
0.10246989.15269177.html.plaintext.txt	203	According model expression mutated E HtorA protein heterozygous individuals predisposes towards disease state making individuals susceptible second hit exposure environmental stress presence another genetic factor triggers complete onset disease
0.10246989.15269177.html.plaintext.txt	204	In fact found several phenotypic abnormalities associated E HtorA expression temperature dependent could underlie observed behavioral defects elevated temperatures
0.10246989.15269177.html.plaintext.txt	205	Similar observed transfected human cells culture 910 found E HtorA forms protein aggregates expressed Drosophila neurons muscles Figs 1 3
0.10246989.15269177.html.plaintext.txt	206	Localization E HtorA protein clusters confocal microscopy level revealed clusters associated synaptic boutons particularly region SSR colocalized endosomal markers Fig
0.10246989.15269177.html.plaintext.txt	207	In addition confirming presence E HtorA SSR association endosomes immuno EM studies demonstrated E HtorA also found associated synaptic densities nuclear envelope Fig
0.10246989.15269177.html.plaintext.txt	208	The subcellular localization E HtorA raises possibility could interfere signal transduction pathway synapses nuclei required proper synaptic development function
0.10246989.15269177.html.plaintext.txt	209	Detailed confocal electron microscopic examination synaptic boutons revealed number structural defects E HtorA expressing larvae Figs 5 6
0.10246989.15269177.html.plaintext.txt	210	The presence free dense bodies particularly intriguing phenotype previously reported mutations perturb TGF ss signaling pathway
0.10246989.15269177.html.plaintext.txt	211	TGF ss signaling pathways regulate many developmental physiological processes vertebrates invertebrates perturbations signaling pathways implicated wide array pathological conditions 34
0.10246989.15269177.html.plaintext.txt	212	Recent studies Drosophila demonstrated proper development plasticity synaptic boutons larval NMJ dependent TGF ss pathway least part wit 2627
0.10246989.15269177.html.plaintext.txt	213	Downregulation TGF ss receptors synaptic terminals via endocytotic internalization appears important mechanism controlling synaptic plasticity 35
0.10246989.15269177.html.plaintext.txt	214	In addition experimental evidence suggests retrograde transport signaling endosomes containing activated TGF ss receptorSmads complexes synaptic terminal membranes cell body might also essential aspect TGF ss signaling mechanism control development function synapses 2736
0.10246989.15269177.html.plaintext.txt	215	The existence known signaling pathway synapse nucleus via endosomal intermediates regulates growth development synapses particular interest context present work E HtorA expression perturbs synaptic development E HtorA protein aggregates found precisely subcellular locations synaptic terminals endosomes nuclei could readily interfere signaling pathway
0.10246989.15269177.html.plaintext.txt	216	This possibility strengthened finding production free dense bodies motor terminals associated E HtorA expression mutations components TGF ss signaling 2627
0.10246989.15269177.html.plaintext.txt	217	To investigate whether phenotypic abnormalities associated E HtorA expression fact dependent perturbing TGF ss signaling asked whether phenotypes could modified overexpression Mad dSmad2 transcriptional effectors TGF ss pathway 26 29
0.10246989.15269177.html.plaintext.txt	218	Remarkably found pan neural overexpression dSmad2 Mad substantially suppressed defects locomotor behavior well synaptic morphology E HtorA animals
0.10246989.15269177.html.plaintext.txt	219	As locomotor defects observed E HtorA flies elevated temperatures bear striking resemblance phenotype torsion dystonia patients possible involvement common mechanisms seem unreasonable
0.10246989.15269177.html.plaintext.txt	220	Moreover variety data demonstrate Drosophila TGF ss signaling important development mammalian nervous system particular plays essential role synaptic development plasticity 3437
0.10246989.15269177.html.plaintext.txt	221	We also showed expression hSmad2 rescues abnormal behaviors dSmad2 flies Fig
0.10246989.15269177.html.plaintext.txt	222	Consequently possibility underlying mechanism early onset torsion dystonia humans involves disruption TGF ss signaling merits investigation
0.10246989.15269177.html.plaintext.txt	223	Early onset torsion dystonia one many severe complex neurobehavioral disorders caused interaction multiple genes combination genetic environmental risk factors 1415
0.10246989.15269177.html.plaintext.txt	224	As significant variation phenotype manifested human patients identification susceptible genes may responsible triggering severe symptoms important seeking adequate treatment 1 5
0.10246989.15269177.html.plaintext.txt	225	In addition examining human patients another strategy find susceptible genes taking advantage established animal model
0.10246989.15269177.html.plaintext.txt	226	As studies reported demonstrate studies Drosophila model early onset torsion dystonia provide unique opportunities obtain additional novel information underlying cellular molecular mechanisms disorder
0.10246989.15269177.html.plaintext.txt	227	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS Expression DeltaE HtorA
0.10246989.15269177.html.plaintext.txt	228	DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES Fly genetics Flies raised standard medium 25 degrees C unless otherwise specified
0.10246989.15269177.html.plaintext.txt	229	Generating human TorsinA transgenic flies
0.10246989.15269177.html.plaintext.txt	230	The WT HtorA open reading frame amplified polymerase chain reaction PCR human fetal brain cDNA library Clontech CA USA
0.10246989.15269177.html.plaintext.txt	231	Amplified PCR products subcloned pBlueScript II KS Stratagene CA USA DNA sequences confirmed
0.10246989.15269177.html.plaintext.txt	232	For generating E302303 forms HtorA Kunkel mutagenesis employed 38
0.10246989.15269177.html.plaintext.txt	233	Briefly GAG primer 5 GTA AGC AGA GTG GCT GAG ATG ACA TTT TTC CCC 3 missing glutamic acid codon amino acid position 302303 indicated asterisk designed
0.10246989.15269177.html.plaintext.txt	234	Single stranded DNAs pBlueScript II KS containing HtorA generated purified annealed GAG primers
0.10246989.15269177.html.plaintext.txt	235	Plasmids containing GAG confirmed DNA sequencing
0.10246989.15269177.html.plaintext.txt	236	For generating 18 bp deletion mutant forms F323 Y328 HtorA three rounds PCR performed using three different overlapping primers 5 CTT TAT CTG AGA AAA CTC TCT CCT CTT TGG GGA AA 3 5 GGT GAA CAC CGT TTT GCA GCC TTT ATC GCC TTT ATC TGA GAA AA 3 5 TCG TAG TAA TAA TCA ATC TTG GTG AAC ACC GTT TT 3
0.10246989.15269177.html.plaintext.txt	237	Final PCR products deleted desired 18 bp confirmed DNA sequencing
0.10246989.15269177.html.plaintext.txt	238	Open reading frames WT E302303 F323 Y328 HtorA cloned pUAST germline transformation vectors
0.10246989.15269177.html.plaintext.txt	239	DNA sequences confirmed typical germline transformation technique procedure followed 19
0.10246989.15269177.html.plaintext.txt	240	Several independent fly lines generated construct
0.10246989.15269177.html.plaintext.txt	241	Similar levels expressions phenotypic properties observed independent isolates
0.10246989.15269177.html.plaintext.txt	242	Expression UAS HtorA constructs driven various Gal4 drivers including pan neuronal C155 Gal4 driver 21 34 dihydroxyphenylalanine L decarboxylase Ddc Gal4 driver 22 muscle specific Gal4 driver 24 Tubulin Gal4 driver 39
0.10246989.15269177.html.plaintext.txt	243	Mad dSmad2 hSmad2 overexpression
0.10246989.15269177.html.plaintext.txt	244	To test suppression Mad hSmad2 dSmad2 UAS Mad UAS hSmad2 33 gifts Dr Stewart Newfeld Arizona State University UAS dSmad2 flies 30 gift Dr Tzumin Lee University Illinois crossed C155 Gal4 UAS E HtorASM6b generate C155 Gal4UAS Mad UAS E HtorA C155UAS hSmad2 UAS E HtorAUAS hSmad2 C155 Gal4 UAS E HtorAUAS dSmad2 flies expressed E HtorA Mad hSamd2 dSmad2 pan neuronally
0.10246989.15269177.html.plaintext.txt	245	UAS dSmad2 flies crossed C155 Gal4 generate flies overexpressing dSamd2 neurons determine effects behavior
0.10246989.15269177.html.plaintext.txt	246	To examine whether compromising TGF ss pathway yielded obvious phenotypes dSmad21FM7c flies gift Dr Tzumin Lee University Illinois crossed C155 Gal4UAS E HtorA flies
0.10246989.15269177.html.plaintext.txt	247	C155 Gal4dSmad21UAS E HtorA flies collected tested locomotor behavior described following text
0.10246989.15269177.html.plaintext.txt	248	For EM analysis UAS dSmad2 females crossed C155 Gal4Y UAS E HtorASM6b kr GFP males separate C155 Gal4 UAS E HtorAUAS dSmad2 larvae identified female larvae lacking GFP expression
0.10246989.15269177.html.plaintext.txt	249	Antibodies immunocytochemistry His tagged human TorsinA recombinant peptides residues 61 332 expressed Escherichia coli M15 carrying pREP4 plasmid Qiagen
0.10246989.15269177.html.plaintext.txt	250	The fusion proteins purified using Ni NTA beads Qiagen SDS PAGE injected rabbits antibody production
0.10246989.15269177.html.plaintext.txt	251	Procedures immunocytochemistry described literature 24
0.10246989.15269177.html.plaintext.txt	252	The following antibodies used 1 anti HRP FITC anti HRP CY5 Jackson Labs Bouins 1 80 2 guinea pig anti hepatocyte growth factor regulated tyrosine kinase substrate HRS 40 Bouins 1 4000 3 mAb anti DLG 41 Bouins 1 200 4 rabbit anti human TorsinA Bouins 1 2000 5 goat anti human TorsinA Santa Cruz Biotechnology Inc
0.10246989.15269177.html.plaintext.txt	253	For blocking experiments Figure 1A3 rabbit goat anti human TorsinA antibodies incubated human TorsinA peptides Santa Cruz Biotechnology Inc
0.10246989.15269177.html.plaintext.txt	254	Donkey anti rabbit Alexa 568 anti guinea pig Alexa 488 anti mouse Alexa 488 used secondary antibodies 1 200 dilutions Molecular Probes OR USA
0.10246989.15269177.html.plaintext.txt	255	Confocal images taken Bio Rad MRC 1024 confocal laser scanning microscope BioRad UK processed using Adobe Photoshop 5
0.10246989.15269177.html.plaintext.txt	256	The number synaptic boutons larval muscles 6 7 segment A2 experimental control larvae counted epi fluorescence microscope
0.10246989.15269177.html.plaintext.txt	257	Two sample tests performed using Minitab software
0.10246989.15269177.html.plaintext.txt	258	Behavioral assays Each group flies tested locomotor abilities consisted five males five females age
0.10246989.15269177.html.plaintext.txt	259	After group flies transferred vial vial placed pre heated 38 degrees C water bath observed continuously 10 min period
0.10246989.15269177.html.plaintext.txt	260	Flies retaining locomotor abilities considered walking sides tops vials rather immobilized remaining bottom time point
0.10246989.15269177.html.plaintext.txt	261	Tested flies collected three different independent crosses raised 30 degrees C accelerate aging
0.10246989.15269177.html.plaintext.txt	262	Genetic backgrounds Gal4 drivers E HtorA expressing flies compared WT HtorA expression flies
0.10246989.15269177.html.plaintext.txt	263	Two sample tests performed using Minitab software
0.10246989.15269177.html.plaintext.txt	264	Silver enhanced anti human TorsinA immuno gold electron microscopy Control experimental larvae dissected Ca2 free saline fixed 0
0.10246989.15269177.html.plaintext.txt	265	005 glutaraldehyde 4 paraformaldehyde 0
0.10246989.15269177.html.plaintext.txt	266	Samples marked processed well
0.10246989.15269177.html.plaintext.txt	267	After washing three times 0
0.10246989.15269177.html.plaintext.txt	268	2 Triton X 100 PBT samples incubated anti human TorsinA antisera diluted 1 1000 overnight 4 degrees C
0.10246989.15269177.html.plaintext.txt	269	Samples washed three times PBT 4 bovine serum albumin 4 normal goat serum prevent non specific binding
0.10246989.15269177.html.plaintext.txt	270	Samples incubated 1 200 diluted 1 nm gold conjugated anti rabbit IgG BBInternational UK diluted 1 200 2 h RT shaking
0.10246989.15269177.html.plaintext.txt	271	After washing three times PBT silver enhancement performed according manufacturers directions 10 min BBInternational UK
0.10246989.15269177.html.plaintext.txt	272	Samples washed H2O 5 min postfixed 1 glutaraldehyde 4 paraformaldehyde 0
0.10246989.15269177.html.plaintext.txt	273	Samples subsequently processed previously described 24
0.10246989.15269177.html.plaintext.txt	274	Two independent controls performed confirm specificity silver enhanced particles
0.10246989.15269177.html.plaintext.txt	275	Larvae express E HtorA antiserum dissected E HtorA expressing larvae incubated without anti HtorA antiserum processed simultaneously experimental samples
0.10246989.15269177.html.plaintext.txt	276	Thin sections 100 nm collected membrane coated one slot grids double stained lead citrate uranyl acetate solution
0.10246989.15269177.html.plaintext.txt	277	Silver enhanced anti HtorA positive particles photographed 25 000x Megaplus digital camera Kodak USA attached Philips CM120 Scanning Transmission Electron Microscope STEM 60 kV
0.10246989.15269177.html.plaintext.txt	278	Transmission electron microscopy The procedure TEM morphometric analysis synaptic boutons previously described 24
0.10246989.15269177.html.plaintext.txt	279	For analysis type Ib glutamatergic synaptic boutons muscles 6 7 segment A2 serially thin sectioned 100 nm
0.10246989.15269177.html.plaintext.txt	280	Thickness thin sections confirmed examining wrinkles thin sections TEM
0.10246989.15269177.html.plaintext.txt	281	Serial images type Ib boutons taken 15 000x Megaplus digital camera Kodak USA attached Philips CM120 STEM 60 kV
0.10246989.15269177.html.plaintext.txt	282	To determine length surface area volume boutons area synapses serial reconstructions synaptic boutons made carefully aligning digital images
0.10246989.15269177.html.plaintext.txt	283	The relevant features synaptic boutons bouton surfaces synaptic densities digitalized using Adobe Photoshop analyzed NIH image software
0.10246989.15269177.html.plaintext.txt	284	Two different samples genotype used morphometric analysis
0.10246989.15269177.html.plaintext.txt	285	Minitab software used perform two sample tests
0.10246989.15269177.html.plaintext.txt	286	SUPPLEMENTARY MATERIAL TOP ABSTRACT INTRODUCTION RESULTS Expression DeltaE HtorA
0.10246989.15269177.html.plaintext.txt	287	DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES Supplementary Material available HMG Online
0.10246989.15269177.html.plaintext.txt	288	ACKNOWLEDGEMENTS We thank Drs Vivian Budnik Michael Gorczyca University Massachusetts Medical School dissection chambers Hugo Bellen Guisy Panetta Baylor college Medicine anti HRS antibodies Developmental Studies Hybridoma Bank University Iowa anti DLG monoclonal antibodies Stuart Newfeld Arizona State University Tzumin Lee University Illinois Urbana providing us UAS Mad UAS hSmad2 UAS dSmad2 dsmad1FM7C flies respectively
0.10246989.15269177.html.plaintext.txt	289	This paper number 3617 Laboratory Genetics
0.10246989.15269177.html.plaintext.txt	290	This work funded postdoctoral fellowship Y
0.10246989.15269177.html.plaintext.txt	291	Dystonia Medical Research Foundation NIH grant NS15390 B
0.10246989.15269177.html.plaintext.txt	292	FOOTNOTES To correspondence addressed
0.10246989.15269177.html.plaintext.txt	293	Tel 1 6082623896 Fax 1 6082622976 Email ganetzkyatwisc
0.10246989.15269177.html.plaintext.txt	294	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS Expression DeltaE HtorA
0.10246989.15269177.html.plaintext.txt	295	DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES Bressman S
0.10246989.15269177.html.plaintext.txt	296	1989 Idiopathic torsion dystonia among Ashkenazi Jews evidence autosomal dominant inheritance
0.10246989.15269177.html.plaintext.txt	297	2002 Diagnostic criteria dystonia DYT1 families
0.10246989.15269177.html.plaintext.txt	298	1995 Genetic analysis idiopathic torsion dystonia Ashkenazi Jews recent descent small founder population
0.10246989.15269177.html.plaintext.txt	299	1998 Functional brain networks DYT1 dystonia
0.10246989.15269177.html.plaintext.txt	300	1988 Primary dystonias review pathology suggestions new directions study
0.10246989.15269177.html.plaintext.txt	301	1997 The early onset torsion dystonia gene DYT1 encodes ATP binding protein
0.10246989.15269177.html.plaintext.txt	302	2001 Novel mutation TOR1A DYT1 gene atypical early onset dystonia polymorphisms dystonia early onset parkinsonism
0.10246989.15269177.html.plaintext.txt	303	1999 AAA class chaperone like ATPases associated assembly operation disassembly protein complexes
0.10246989.15269177.html.plaintext.txt	304	2000 Torsin A torsion dystonia associated mutant forms lumenal glycoproteins exhibit distinct subcellular localizations
0.10246989.15269177.html.plaintext.txt	305	2000 Mutant torsinA responsible early onset torsion dystonia forms membrane inclusions cultured neural cells
0.10246989.15269177.html.plaintext.txt	306	2001 A close association torsinA alpha synuclein Lewy bodies fluorescence resonance energy transfer study
0.10246989.15269177.html.plaintext.txt	307	2000 TorsinA accumulation Lewy bodies sporadic Parkinsons disease
0.10246989.15269177.html.plaintext.txt	308	2002 TorsinA heat shock proteins act molecular chaperones suppression alpha synuclein aggregation
0.10246989.15269177.html.plaintext.txt	309	2003 Suppression polyglutamine induced protein aggregation Caenorhabditis elegans torsin proteins
0.10246989.15269177.html.plaintext.txt	310	2003 Discovering genotypes underlying human phenotypes past successes mendelian disease future approaches complex disease
0.10246989.15269177.html.plaintext.txt	311	2003 Different patterns electrophysiological deficits manifesting non manifesting carriers DYT1 gene mutation
0.10246989.15269177.html.plaintext.txt	312	2003 Human neurodegenerative disease modeling using Drosophila Annu
0.10246989.15269177.html.plaintext.txt	313	2002 Synaptic homeostasis wishful thinking Neuron 33 491 492
0.10246989.15269177.html.plaintext.txt	314	2000 Drosophila larval neuromuscular junction molecular components mechanisms underlying synaptic plasticity
0.10246989.15269177.html.plaintext.txt	315	CO2 7linktypeDOI CrossRefISIMedline
0.10246989.15269177.html.plaintext.txt	316	1993 Targeted gene expression means altering cell fates generating dominant phenotypes
0.10246989.15269177.html.plaintext.txt	317	2002 Chaperone suppression alpha synuclein toxicity Drosophila model Parkinsons disease
0.10246989.15269177.html.plaintext.txt	318	2000 A Drosophila model Parkinsons disease
0.10246989.15269177.html.plaintext.txt	319	2002 Normal localization deltaF323 Y328 mutant torsinA transfected human cells
0.10246989.15269177.html.plaintext.txt	320	1999 Regulation DLG localization synapses CaMKII dependent phosphorylation
0.10246989.15269177.html.plaintext.txt	321	2000 Analysis ion channel dysfunction Drosophila Kidney Int
0.10246989.15269177.html.plaintext.txt	322	2002 wishful thinking encodes BMP type II receptor regulates synaptic growth Drosophila
0.10246989.15269177.html.plaintext.txt	323	2003 The BMP homolog Gbb provides retrograde signal regulates synaptic growth Drosophila neuromuscular junction
0.10246989.15269177.html.plaintext.txt	324	2004 Highwire regulates presynaptic BMP signaling essential synaptic growth
0.10246989.15269177.html.plaintext.txt	325	1999 The Drosophila activin receptor baboon signals dSmad2 controls cell proliferation patterning larval development
0.10246989.15269177.html.plaintext.txt	326	2003 TGF ss signaling activates steroid hormone receptor expression neuronal remodeling Drosophila brain
0.10246989.15269177.html.plaintext.txt	327	2003 Mechanisms TGF ss signaling cell membrane nucleus
0.10246989.15269177.html.plaintext.txt	328	2003 Membranes trafficking signaling animal development
0.10246989.15269177.html.plaintext.txt	329	2001 Transgenic analysis smad family TGF ss signal transducers Drosophila melanogaster suggests new roles new interactions family members
0.10246989.15269177.html.plaintext.txt	330	2003 TGF betaSmad signaling system pathologic correlates
0.10246989.15269177.html.plaintext.txt	331	2002 Unrestricted synaptic growth spinster late endosomal protein implicated TGF ss mediated synaptic growth regulation
0.10246989.15269177.html.plaintext.txt	332	2003 Distinct endocytic pathways regulate TGF ss receptor signaling turnover
0.10246989.15269177.html.plaintext.txt	333	1998 Bone morphogenetic proteins receptors potential functions brain
0.10246989.15269177.html.plaintext.txt	334	CO2 ElinktypeDOI CrossRefISIMedline
0.10246989.15269177.html.plaintext.txt	335	1995 Improved protocol Kunkel mutagenesis Phagemid vectors
0.10246989.15269177.html.plaintext.txt	336	1999 Mosaic analysis repressible cell marker studies gene function neuronal morphogenesis
0.10246989.15269177.html.plaintext.txt	337	2002 Hrs regulates endosome membrane invagination tyrosine kinase receptor signaling Drosophila
0.10246989.15269177.html.plaintext.txt	338	2001 Regulation postsynaptic structure protein localization Rho type guanine nucleotide exchange factor dPix
0.15704574.10841816.html.plaintext.txt	0	NEWS Almost Serendipity Alcoholism Drug Reverses Drug Resistance In Vitro Brian Vastag
0.15704574.10841816.html.plaintext.txt	1	Sometimes science luck open mind count much diligence dedication
0.15704574.10841816.html.plaintext.txt	2	protein structure researchers University Toronto
0.15704574.10841816.html.plaintext.txt	3	View larger version 144K Dr
0.15704574.10841816.html.plaintext.txt	4	Their story starts spicy meal includes fortuitous encounter mislabeled drug ends discovery could open unexpected research agenda
0.15704574.10841816.html.plaintext.txt	5	In issue Journal p
0.15704574.10841816.html.plaintext.txt	6	898 Clarke Loo report disulfiram AntabuseTM inexpensive anti alcoholism drug blocks cancer drug resistance cell cultures
0.15704574.10841816.html.plaintext.txt	7	While still preclinical Toronto work presents entirely new route overcoming one cancer therapy major stumbling blocks
0.15704574.10841816.html.plaintext.txt	8	Drug resistance stymies treatment half cancer patients
0.15704574.10841816.html.plaintext.txt	9	Tumors often shrink initial chemotherapy regrow resistant therapy
0.15704574.10841816.html.plaintext.txt	10	Reversing drug resistance one pseudo Holy Grails medical oncology
0.15704574.10841816.html.plaintext.txt	11	If could get reversed therapeutic index would go dramatically said Tom Anderson M
0.15704574.10841816.html.plaintext.txt	12	helping test anti resistance drug leukemia patients Medical College Wisconsin Milwaukee
0.15704574.10841816.html.plaintext.txt	13	But number reasons finding testing anti resistance agents slow struggle see News Aug
0.15704574.10841816.html.plaintext.txt	14	Evolution equipped cells biologic shields toxins
0.15704574.10841816.html.plaintext.txt	15	A key player defensive scheme P glycoprotein pump straddles cellular membrane expels poisons
0.15704574.10841816.html.plaintext.txt	16	P glycoprotein remarkably catholic ability reject toxic compounds spits molecules shapes sizes including many cancer drugs
0.15704574.10841816.html.plaintext.txt	17	While recent research draws drug resistance tangled skein extending far beyond single pump model clear P glycoprotein plays key role process
0.15704574.10841816.html.plaintext.txt	18	View larger version 57K A hypothetical model P glycoprotein integral plasma membrane protein causes multidrug resistance overexpressed
0.15704574.10841816.html.plaintext.txt	19	Image courtesy Michael Gottesman M
0.15704574.10841816.html.plaintext.txt	20	Seminal work area laboratory Michael Gottesman M
0.15704574.10841816.html.plaintext.txt	21	chief Laboratory Cell Biology National Cancer Institute shows least 50 human tumors overexpress P glycoprotein
0.15704574.10841816.html.plaintext.txt	22	Other research Piet Borst M
0.15704574.10841816.html.plaintext.txt	23	colleagues Netherlands Cancer Institute Amsterdam confirms transgenic mice without P glycoprotein normal lifespans
0.15704574.10841816.html.plaintext.txt	24	These two factors make molecule keen target extensive anti resistance drug development efforts
0.15704574.10841816.html.plaintext.txt	25	Several drug companies along NCI vested bringing anti P glycoprotein drugs market
0.15704574.10841816.html.plaintext.txt	26	Most efforts focus finding drugs bind P glycoprotein cell surface disarm toxin pump
0.15704574.10841816.html.plaintext.txt	27	The drug approved overcoming chemotherapy resistance cyclosporin A works like
0.15704574.10841816.html.plaintext.txt	28	Cyclosporin improves chemotherapy response rates retinoblastoma type eye tumor common children extends cancer free survival times leukemias
0.15704574.10841816.html.plaintext.txt	29	Despite successes cyclosporin immunosuppressive liver toxic properties limit use
0.15704574.10841816.html.plaintext.txt	30	Clarke Loo discovered unlike agents developed via high priced modern drug design disulfiram market half century retails pennies pill impedes P glycoprotein entirely different way
0.15704574.10841816.html.plaintext.txt	31	Said Clarke Antabuse seems block movement protein synthesized cell cell membrane needed function
0.15704574.10841816.html.plaintext.txt	32	If cell membrane chemotherapy drugs get inside damage
0.15704574.10841816.html.plaintext.txt	33	Explaining surprise takes steps back mid 1990s
0.15704574.10841816.html.plaintext.txt	34	Clarke Loo turning attention P glycoprotein similar proteins form fold construction
0.15704574.10841816.html.plaintext.txt	35	The field protein folding gaining followers host diseases including cystic fibrosis sickle cell anemia mad cow disease found mediated misshapen proteins
0.15704574.10841816.html.plaintext.txt	36	One tiny crinkle bend kink protein structure good chance molecular traffic cops shunt cellular junkyard recycling
0.15704574.10841816.html.plaintext.txt	37	This exactly happens protein involved cystic fibrosis
0.15704574.10841816.html.plaintext.txt	38	A close cousin P glycoprotein cystic fibrosis protein also sits cell membrane serving gate channel
0.15704574.10841816.html.plaintext.txt	39	But instead pumping poisons cell cystic fibrosis protein regulates salt levels shuttling chloride ions essentials
0.15704574.10841816.html.plaintext.txt	40	During trip local Indian restaurant Clarke Loo choked bowlfuls curry
0.15704574.10841816.html.plaintext.txt	41	Their noses ran ran napkins piled revelation sorts
0.15704574.10841816.html.plaintext.txt	42	We thought CF patients problem mucous flowing said Clarke
0.15704574.10841816.html.plaintext.txt	43	Then thought active ingredient makes nose run makes mucous flow
0.15704574.10841816.html.plaintext.txt	44	That magical spicy kick capsaicin well known pepper lovers
0.15704574.10841816.html.plaintext.txt	45	Loo wanted sprinkle cystic fibrosis cells
0.15704574.10841816.html.plaintext.txt	46	Loo kept 6 months I kept saying re wasting time recalled Clarke
0.15704574.10841816.html.plaintext.txt	47	He finally experiment
0.15704574.10841816.html.plaintext.txt	48	But lab supply cells expressed defective cystic fibrosis protein
0.15704574.10841816.html.plaintext.txt	49	Fortunately plenty cells engineered make mutant misfolded P glycoprotein
0.15704574.10841816.html.plaintext.txt	50	Like cystic fibrosis protein P glycoprotein misfolded remains trapped inside cells
0.15704574.10841816.html.plaintext.txt	51	We thought would try throwing capsaicin P glycoprotein mutants find optimal concentration said Clarke
0.15704574.10841816.html.plaintext.txt	52	And lo behold misfolded P glycoprotein mutants popped cell surface
0.15704574.10841816.html.plaintext.txt	53	For week thought Wow must cure cystic fibrosis
0.15704574.10841816.html.plaintext.txt	54	When pair acquired cells made mutant cystic fibrosis protein immediately disappointed
0.15704574.10841816.html.plaintext.txt	55	Nothing happened despite researcher visions proteins bobbing cellular surface
0.15704574.10841816.html.plaintext.txt	56	But made important discovery nonetheless misfolded proteins could rescued
0.15704574.10841816.html.plaintext.txt	57	Soon tested cyclosporin raft cancer drugs concluding compounds revived misshapen P glycoprotein findings disclosed 1997 Journal Biological Chemistry
0.15704574.10841816.html.plaintext.txt	58	Although important cystic fibrosis research work directly applicable problem cancer drug resistance
0.15704574.10841816.html.plaintext.txt	59	However led next logical step If mutant P glycoprotein molecules could fixed could normal versions crippled
0.15704574.10841816.html.plaintext.txt	60	The answer published 1999 FASEB Journal article short yes
0.15704574.10841816.html.plaintext.txt	61	But remained big problem drugs Clarke Loo used block P glycoprotein surface migration extremely toxic
0.15704574.10841816.html.plaintext.txt	62	They needed something tolerable
0.15704574.10841816.html.plaintext.txt	63	A search pharmacopeia led bottle disulfiram
0.15704574.10841816.html.plaintext.txt	64	The drug cheap widespread use definite pluses
0.15704574.10841816.html.plaintext.txt	65	But information label really caught eye
0.15704574.10841816.html.plaintext.txt	66	It said disulfiram shuts alcohol metabolic pathway reacting cysteine residues important amino acid building blocks alcohol reducing enzyme
0.15704574.10841816.html.plaintext.txt	67	P glycoprotein also contains key cysteine residues disulfiram disable reasoned
0.15704574.10841816.html.plaintext.txt	68	We thought would react cell surface shut P glycoprotein said Clarke
0.15704574.10841816.html.plaintext.txt	69	But disulfiram doesn work like
0.15704574.10841816.html.plaintext.txt	70	It labeled compound wrong gave try
0.15704574.10841816.html.plaintext.txt	71	When Clarke Loo dosed kidney cell lines disulfiram instead noticed P glycoprotein molecules surfaced
0.15704574.10841816.html.plaintext.txt	72	Further inspection revealed disulfiram reacts molecules form inside cell
0.15704574.10841816.html.plaintext.txt	73	Crumpled broken never migrate cell membrane
0.15704574.10841816.html.plaintext.txt	74	The result cell lines increased sensitivity standard chemotherapy drugs like vinblastine
0.15704574.10841816.html.plaintext.txt	75	Gottesman calls research clever new idea adding The issue course clinically useful It depends much drug need whether inhibiting P glycoprotein folding specific phenomenon
0.15704574.10841816.html.plaintext.txt	76	Disulfiram may interfere key proteins said Gottesman something sorted preclinical clinical studies
0.15704574.10841816.html.plaintext.txt	77	For Clarke future plans include testing disulfiram actual cancer cells overexpress P glycoprotein Loo using kidney cells transfected recombinant form protein performing animal studies see disulfiram really works living system
0.15704574.10841816.html.plaintext.txt	78	Of course someone got whole bunch alcoholics Antabuse volunteer would worthwhile said Clarke tongue somewhat cheek
0.15704574.10841816.html.plaintext.txt	79	We need somebody round test P glycoprotein activity
0.15704574.10841816.html.plaintext.txt	80	Copyright 2000 Oxford University Press unless otherwise stated Oxford University Press Privacy Policy Legal Statement Search All Search JNCI Search Journals Search Cancer Statistics Search PDQ Search PDR Search Calendar
0.09740346.15735256.html.plaintext.txt	0	Blade Runner blackout haemofiltration dialysis times catastrophe Giuseppe Piccoli Alfonso Pacitti Giovanni Mangiarotti Alberto Jeantet Elisabetta Mezza Giuseppe Paolo Segoloni Giorgina Barbara Piccoli
0.09740346.15735256.html.plaintext.txt	1	Chair Nephrology University Turin Italy Email gbpiccoliathotmail
0.09740346.15735256.html.plaintext.txt	2	On 28 September 2003 long blackout occurred Italy lasting 3
0.09740346.15735256.html.plaintext.txt	3	morning largest blackout Italy outside wartime
0.09740346.15735256.html.plaintext.txt	4	A weeks colossal blackout involved USA Canada greatest history since diffusion electricity
0.09740346.15735256.html.plaintext.txt	5	We know small polluted violent planet endangered
0.09740346.15735256.html.plaintext.txt	6	Since 11 September 2001 feel globalization bringing opening markets fear terrorist attacks 1
0.09740346.15735256.html.plaintext.txt	7	The SARS epidemic mad cow disease confronted us new potentially lethal diseases dangers forcing nature order increase food production 2
0.09740346.15735256.html.plaintext.txt	8	Nevertheless daily life lost sense danger
0.09740346.15735256.html.plaintext.txt	9	In case blackouts natural catastrophes one crucial problems risk lack water water contamination
0.09740346.15735256.html.plaintext.txt	10	The water purification distribution systems consume large amount electricity water may available safe long electric blackout
0.09740346.15735256.html.plaintext.txt	11	Dialysis widespread chronic life saving therapy worldwide requires large quantity microbiologically pure controlled water 500 mlmin treatment 120 l standard 4 h treatment 3
0.09740346.15735256.html.plaintext.txt	12	This one impediments diffusion dialysis Third World may also become acute problem particular times even developed countries
0.09740346.15735256.html.plaintext.txt	13	Three years ago flood Turin northern Italy city 900 000 inhabitants
0.09740346.15735256.html.plaintext.txt	14	The aqueduct water polluted areas risk others
0.09740346.15735256.html.plaintext.txt	15	In situation risk massive microbiological toxic metals biological compounds contamination water depuration systems targeted usually low amount contaminants present aqueduct water guarantee water pure enough dialysis
0.09740346.15735256.html.plaintext.txt	16	This true case large depuration systems reverse osmosis employed large dialysis centres water purity problem could endanger hundreds patients within couple days even case home haemodialysis patients whose water treatment system consists small portable osmosis kit water softener
0.09740346.15735256.html.plaintext.txt	17	Our dialysis centre able overcome emergency support dialysis centres Turin policy maintaining haemofiltration HF technique one require water rescue treatment patients poor tolerance conventional dialysis techniques patients acute renal failure hospital mainly intensive care unit ICU
0.09740346.15735256.html.plaintext.txt	18	In recent years technique average employed 3 5 hospital dialysis patients pool 65 70 cases global dialysis population 200 patients 45 55 peritoneal dialysis 18 22 home haemodialysis rest hospital settings
0.09740346.15735256.html.plaintext.txt	19	Due flood week 16 22 October 2000 dialysis centre hospital shifted bicarbonate haemodiafiltration dialysis treatments scheduled 84 outpatients HF 208 HF sessions performed
0.09740346.15735256.html.plaintext.txt	20	Another 45 sessions performed hospitalized patients
0.09740346.15735256.html.plaintext.txt	21	Home haemodialysis patients area treated hospital end flood returned home microbiological metal control water
0.09740346.15735256.html.plaintext.txt	22	Our experience flood taught us HF considered clinical rescue treatment able improve dialysis tolerance small percentage fragile patients also logistical rescue treatment
0.09740346.15735256.html.plaintext.txt	23	Therefore centre chose switch online HF maintain clinical use without rapidly losing practical know least one water independent extracorporeal dialysis technique
0.09740346.15735256.html.plaintext.txt	24	A example use logistical rescue occurred recent eruption Mount Etna volcano
0.09740346.15735256.html.plaintext.txt	25	A daily home haemodialysis patient depending centre living affected area ready switch HF case water purity problems
0.09740346.15735256.html.plaintext.txt	26	During Saturday night recent blackout availability HF allowed us safely treat patient needing dialysis vascular surgery perform slow HF treatments scheduled 12 h three patients ICUs
0.09740346.15735256.html.plaintext.txt	27	While habitat steadily approaches catastrophic panoramas science fiction movies also reconsider natural man made catastrophes almost forgotten last two generations Europeans 12
0.09740346.15735256.html.plaintext.txt	28	No field medicine immune need wise use HF technique often considered slow costly complex least level maintaining practical knowledge management may life saving times emergency 4
0.09740346.15735256.html.plaintext.txt	29	Only history tell becomes new indication HF
0.09740346.15735256.html.plaintext.txt	30	References Top References Howson CP Fineberg HV Bloom BR
0.09740346.15735256.html.plaintext.txt	31	The pursuit global health relevance engagement developed countries
0.09740346.15735256.html.plaintext.txt	32	Lancet 1998 351 586 590CrossRefISIMedline McMichael AJ Beaglehole R
0.09740346.15735256.html.plaintext.txt	33	The changing global context public health
0.09740346.15735256.html.plaintext.txt	34	Lancet 2000 356 495 499CrossRefISIMedline Pontoriero G Pozzoni P Andrulli S Locatelli F
0.09740346.15735256.html.plaintext.txt	35	Nephrol Dial Transplant 2003 18 Suppl 7 21 25 56 McCarthy JT Moran J Posen G et al
0.09740346.15735256.html.plaintext.txt	36	A time rediscovery chronic hemofiltration end stage renal disease
0.09740346.15735256.html.plaintext.txt	37	Semin Dial 2003 16 199 207CrossRefISIMedline This Article Extract FREE Full Text PDF Alert article cited Alert correction posted Services Email article friend Similar articles journal Similar articles ISI Web Science Similar articles PubMed Alert new issues journal Add My Personal Archive Download citation manager Disclaimer Request Permissions Google Scholar Articles Piccoli G
0.09740346.15735256.html.plaintext.txt	38	PubMed PubMed Citation Articles Piccoli G
0.09740346.15735256.html.plaintext.txt	39	Online ISSN 1460 2385 Print ISSN 0931 0509 Copyright 2005 European Renal Association European Dialysis Transplant Assoc Oxford Journals Oxford University Press Site Map Terms Conditions Privacy Policy Frequently Asked Questions Other Oxford University Press sites Oxford University Press American National Biography Booksellers Information Service Childrens Fiction Poetry Childrens Reference Corporate Special Sales Dictionaries Dictionary National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights Permissions Science School Books Social Sciences Very Short Introductions Worlds Classics
0.09964287.10640548.html.plaintext.txt	0	In vitro infection cells monocyticmacrophage lineage bovine leukaemia virus Ana Domenech1 Joaquin Goyache1 Louie Llamesb1 M
0.09964287.10640548.html.plaintext.txt	1	Jesuacutes Paya1 Guillermo Suarez1 Esperanza Gomez Lucia1
0.09964287.10640548.html.plaintext.txt	2	Dpto Patologia Animal I Facultad de Veterinaria Universidad Complutense 28040 Madrid Spain1
0.09964287.10640548.html.plaintext.txt	3	Author correspondence Esperanza Gomez Lucia
0.09964287.10640548.html.plaintext.txt	4	Abstract Top Abstract Introduction Methods Results Discussion References The oncogenic retrovirus bovine leukaemia virus BLV primarily infects B cells
0.09964287.10640548.html.plaintext.txt	5	Most infected animals remain asymptomatic long periods time increase circulating B cells localized tumours observed
0.09964287.10640548.html.plaintext.txt	6	This long clinical latency period may explained cells monocytemacrophage lineage MM becoming infected acting reservoir virus shown retroviruses human immunodeficiency virus 1 feline immunodeficiency virus
0.09964287.10640548.html.plaintext.txt	7	MM cells different stages differentiation HL 60 THP 1 U 937 J774 BGM PM2 primary macrophages sheep cows cultured BLV produced permanently infected donor cells FLKBLV BLV bat2
0.09964287.10640548.html.plaintext.txt	8	Donor cells inhibited multiplying either irradiation treatment mitomycin C
0.09964287.10640548.html.plaintext.txt	9	In experiments supernatant donor cells containing virus used
0.09964287.10640548.html.plaintext.txt	10	In co culture donor cells less differentiated monocytic cells showed severe cellular changes differentiation vacuolization cell lysis membrane blebbing apoptosis frequent phenomenon
0.09964287.10640548.html.plaintext.txt	11	Budding extracellular viruses also observed
0.09964287.10640548.html.plaintext.txt	12	The differentiated macrophage cells although showed less signs infection microscopy complete BLV protein profile seen Western blotting bands corresponding p24CA Gag precursors clearly seen
0.09964287.10640548.html.plaintext.txt	13	In addition gp51SU identified syncytia formation assays
0.09964287.10640548.html.plaintext.txt	14	It concluded MM cells may infected BLV consequences infection differing according type cell
0.09964287.10640548.html.plaintext.txt	15	Introduction Top Abstract Introduction Methods Results Discussion References Enzootic bovine leukaemia infectious disease cows produced lymphotropic retrovirus bovine leukaemia virus BLV experimentally may also infect species Burny et al
0.09964287.10640548.html.plaintext.txt	16	The encounter animal BLV necessarily mean infection
0.09964287.10640548.html.plaintext.txt	17	If animal susceptible BLV persistent infection occurs development immune response
0.09964287.10640548.html.plaintext.txt	18	Bovine leukaemia characterized long incubation period ranging 200 days 7 years animals asymptomatic carriers
0.09964287.10640548.html.plaintext.txt	19	The mechanisms mark end asymptomatic stage unclear
0.09964287.10640548.html.plaintext.txt	20	Some authors suggested real virus latency Radke et al
0.09964287.10640548.html.plaintext.txt	21	1992 expression virus cells detected situ hybridization Heeney et al
0.09964287.10640548.html.plaintext.txt	22	1992 Powers Radke 1992 stimulates antibody production
0.09964287.10640548.html.plaintext.txt	23	Depending evolution disease animals may ascribed one three groups clinically healthy b persistent lymphocytosis c lymphosarcoma localized lymphoid tumours
0.09964287.10640548.html.plaintext.txt	24	The first group includes around 60 infected animals Kettmann et al
0.09964287.10640548.html.plaintext.txt	25	1994 asymptomatic carriers virus even though may suffer relative increase B cells Fossum et al
0.09964287.10640548.html.plaintext.txt	26	These animals identifiable presence specific antibodies cumbersome molecular biology techniques
0.09964287.10640548.html.plaintext.txt	27	In two groups marked increase number B lymphocytes either blood localized lymph nodes tissues Burny et al
0.09964287.10640548.html.plaintext.txt	28	The virus persists mainly peripheral B cells Paul et al
0.09964287.10640548.html.plaintext.txt	29	1977 results presented several authors suggest virus may replicate various sites possibly currently unidentified tissues
0.09964287.10640548.html.plaintext.txt	30	T cells seem decrease number animals persistent lymphocytosis may result BLV infection Meiron et al
0.09964287.10640548.html.plaintext.txt	31	Even though reports indicating convincing evidence T lymphocytes monocytes major reservoir BLV provirus Mirsky et al
0.09964287.10640548.html.plaintext.txt	32	1996 BLV shown able replicate several areas associated presence monocytes macrophages Reinacher et al
0.09964287.10640548.html.plaintext.txt	33	Lagarias Radke 1989 detected viral mRNA monocytic like cells experimentally infected asymptomatic sheep situ hybridization
0.09964287.10640548.html.plaintext.txt	34	1989 observed BLV expression peripheral blood multinucleated cells positive non specific esterase
0.09964287.10640548.html.plaintext.txt	35	cells monocytemacrophage lineage MM obtained infected rabbits
0.09964287.10640548.html.plaintext.txt	36	They concluded circulating monocytes could infected virus act reservoir BLV
0.09964287.10640548.html.plaintext.txt	37	1992 detected proviral DNA circulating monocytes separated FACS infected cows proposed infection monocytes BLV could explain persistence virus animal well continuous antigenic stimulation
0.09964287.10640548.html.plaintext.txt	38	1994 also detected viral RNA PCR monocytes suggested BLV could larger vivo tropism expected initially
0.09964287.10640548.html.plaintext.txt	39	This also agrees previous data reporting human T lymphotropic virus 1 HTLV 1 closely related BLV infect MM cells Hoffman et al
0.09964287.10640548.html.plaintext.txt	40	Some aspects disease progression altered immunological functions could also explained infection MM cells
0.09964287.10640548.html.plaintext.txt	41	1994 suggested expression viral proteins could give rise abnormal expression cellular genes interleukins thus altering normal cell interactions leading expansion B cells
0.09964287.10640548.html.plaintext.txt	42	This supported findings Pyeon et al
0.09964287.10640548.html.plaintext.txt	43	1996 Pyeon Splitter 1998 mainly concerning IL 10 IL 12 cytokines expressed MM cells
0.09964287.10640548.html.plaintext.txt	44	According authors IL 10 mRNA expression increased late stages disease compared non infected animals early stages disease Pyeon et al
0.09964287.10640548.html.plaintext.txt	45	In contrast levels expression IL 12 mRNA lower normal late stages disease even though early stages infection higher non infected animals Pyeon Splitter 1998
0.09964287.10640548.html.plaintext.txt	46	1995 determined production IL 1 TNF increased infected animals stimulating monocytes vitro lipopolysaccharide
0.09964287.10640548.html.plaintext.txt	47	1998 also reported alterations surface antigen expression decreased phagocytic activity MM cells isolated BLV infected cows compared healthy animals
0.09964287.10640548.html.plaintext.txt	48	In paper studied experimental transmission BLV cells persistently infected BLV several MM cells cell lines primary cultures cell contact achieved co cultivation infection filtered supernatants
0.09964287.10640548.html.plaintext.txt	49	Methods Top Abstract Introduction Methods Results Discussion References Cells
0.09964287.10640548.html.plaintext.txt	50	Two cell lines persistently infected BLV used donor cells FLKBLV Van der Maaten Miller 1976 BLV bat2 Graves Ferrer 1976 kindly provided A
0.09964287.10640548.html.plaintext.txt	51	Burny University Brussels Belgium K
0.09964287.10640548.html.plaintext.txt	52	Radke UC Davis CA USA respectively
0.09964287.10640548.html.plaintext.txt	53	MM cells used included following cell lines order increasing degrees differentiation human promyelocytic cell line HL 60 ATCC CCL 240 Collins et al
0.09964287.10640548.html.plaintext.txt	54	1978 human monocytic cell line THP 1 ATCC TIB 202 Tsuchiya et al
0.09964287.10640548.html.plaintext.txt	55	1980 human monocyte like cell line histiocytic origin U 937 ATCC CRL 1593 Sundstrom Nilsson 1976 mouse monocyte macrophage J774 A
0.09964287.10640548.html.plaintext.txt	56	1 ATCC TIB 67 Ralph Nakoinz 1975 African green monkey macrophage like BGM ATCC 03 240 PM2 porcine alveolar macrophage cell line obtained University James Cook Australia
0.09964287.10640548.html.plaintext.txt	57	HL 60 THP 1 U937 J774 grew suspension cells BGM PM2 grew adherent monolayer
0.09964287.10640548.html.plaintext.txt	58	Primary macrophages isolated 40 50 ml heparinized blood sheep cows
0.09964287.10640548.html.plaintext.txt	59	The white layer obtained centrifugation 3500 r
0.09964287.10640548.html.plaintext.txt	60	30 min room temperature treated sterile distilled water 20 lyse remaining red blood cells
0.09964287.10640548.html.plaintext.txt	61	Cells washed twice Hanks balanced solution without Ca2 Mg2 separated Ficoll Paque gradient Pharmacia 2500 r
0.09964287.10640548.html.plaintext.txt	62	30 min room temperature
0.09964287.10640548.html.plaintext.txt	63	White cells washed twice Hanks solution resuspended culture medium 10 foetal calf serum FCS
0.09964287.10640548.html.plaintext.txt	64	The medium containing non adherent cells removed 2 h periodically thereafter replaced fresh medium
0.09964287.10640548.html.plaintext.txt	65	Non specific esterase assayed initially 10 days culture
0.09964287.10640548.html.plaintext.txt	66	All cells study maintained RPMI 1640 medium supplemented 10 heat inactivated FCS Gibco BRL penicillin 100 Uml streptomycin 100 mgml anti PPLO agent Gibco BRL incubated 37 degrees C humidified 5 CO2 atmosphere
0.09964287.10640548.html.plaintext.txt	67	The mitotic activity donor cells irreversibly blocked either incubation cells 100 microgml mitomycin C 30 min 37 degrees C b sublethal irradiation 15000 rads cobalt chamber
0.09964287.10640548.html.plaintext.txt	68	The cells washed several times medium used co cultivation experiments
0.09964287.10640548.html.plaintext.txt	69	For co cultivation 106 treated donor cells mixed 106 recipient cells
0.09964287.10640548.html.plaintext.txt	70	During 3 weeks co cultivation three four culture transfers mitomycin C treated irradiated donor cells usually eliminated mixture judged control flasks treated donor cells leaving recipient cells
0.09964287.10640548.html.plaintext.txt	71	In experiments various MM cells infected filtered 0 45 microm supernatant containing BLV donor cells used co cultivation experiments
0.09964287.10640548.html.plaintext.txt	72	Controls included MM cells without addition treated donor cells FLKBLV BLV bat2 supernatant containing BLV b treated irradiated mitomycin C donor cells c non treated donor cells
0.09964287.10640548.html.plaintext.txt	73	Controls MM cells co cultured non infected donor cells FLK bat cells used cells available
0.09964287.10640548.html.plaintext.txt	74	We named co cultures using three letter combinations
0.09964287.10640548.html.plaintext.txt	75	The first one represents treatment donor cell M mitomycin C R irradiation S supernatant second recipient cell J J774 H HL 60 T THP 1 U U 937 B BGM P PM2 O sheep macrophages C cow macrophages third donor cell line F FLKBLV B BLV bat2
0.09964287.10640548.html.plaintext.txt	76	For purposes brevity MMBLV used refer co cultures
0.09964287.10640548.html.plaintext.txt	77	Electron microscopy studies syncytium induction assays SIA Western blotting tests performed 3 week old co cultures
0.09964287.10640548.html.plaintext.txt	78	Pellets fixed 1 h 2 glutaraldehyde 0 1 M sodium cacodylate 4 degrees C 1 OsO4 buffer 45 min crushed ice
0.09964287.10640548.html.plaintext.txt	79	The samples dehydrated ethanol series stained 1 uranyl acetate 70 ethanol
0.09964287.10640548.html.plaintext.txt	80	The samples embedded Epon Araldite resin polymerized 48 h 60 degrees C
0.09964287.10640548.html.plaintext.txt	81	The ultrathin sections stained uranyl acetate followed lead citrate examined electron microscope JEOL 100B
0.09964287.10640548.html.plaintext.txt	82	The monolayer cells fixed dehydrated stained directly bottle
0.09964287.10640548.html.plaintext.txt	83	Syncytium induction assay SIA
0.09964287.10640548.html.plaintext.txt	84	We followed protocol described previously Domenech et al
0.09964287.10640548.html.plaintext.txt	85	1997 using line CC81 Fischinger et al
0.09964287.10640548.html.plaintext.txt	86	1974 kind donation A
0.09964287.10640548.html.plaintext.txt	87	We used ratio 12 MMBLV CC81 cells
0.09964287.10640548.html.plaintext.txt	88	The mixture incubated 8 well Lab Tek Nunc 3x104 total cells0 4 ml per well 96 well plates 1 5x104 total cells0 2 ml per well 37 degrees C CO2
0.09964287.10640548.html.plaintext.txt	89	After 24 h supernatant aspirated cells air dried Giemsa stained
0.09964287.10640548.html.plaintext.txt	90	Syncytia five nuclei scored 30 fields 200x number syncytia per 100 cells determined compared positive control FLKBLVCC81
0.09964287.10640548.html.plaintext.txt	91	Syncytia inhibition performed similar way incubating MMBLV BLV positive cow serum reference positive serum included AGID Test Rhone Merieux filtered 0 22 microm complement inactivated 1 h 37 degrees C mixing CC81
0.09964287.10640548.html.plaintext.txt	92	The titre serum 144 determined prior test
0.09964287.10640548.html.plaintext.txt	93	Cells centrifuged treated lysis buffer 0 15 M NaCl 0 05 M Tris HCl pH 7 2 1 Triton X 100 1 sodium deoxycholate 0 1 SDS 1 mM PMSF 100 microl6x106 cells 1 h ice Domenech et al
0.09964287.10640548.html.plaintext.txt	94	4 degrees C 1 h samples resolved 12 5 polyacrylamide gels 0 1 SDS Mini Protean II system Bio Rad
0.09964287.10640548.html.plaintext.txt	95	Gels sandwiched two nitrocellulose membranes 0 45 microm pore size proteins passively transferred 24 48 h 4 degrees C
0.09964287.10640548.html.plaintext.txt	96	Membranes blocked 3 BSA PBS 1 h 37 degrees C exposed consecutively 1250 dilution pool sera naturally infected seropositive cows Domenech et al
0.09964287.10640548.html.plaintext.txt	97	1997 18000 dilution rabbit anti bovine IgG labelled peroxidase Sigma
0.09964287.10640548.html.plaintext.txt	98	To precisely localize p24CA gp51SU MAbs proteins kindly provided D
0.09964287.10640548.html.plaintext.txt	99	Portetelle Faculty Agronomy Gembloux Belgium used instead cow sera continuing reaction rabbit anti mouse peroxidase labelled conjugate
0.09964287.10640548.html.plaintext.txt	100	Reactions revealed substrate mixture consisting H2O2 diaminobenzidine
0.09964287.10640548.html.plaintext.txt	101	Results Top Abstract Introduction Methods Results Discussion References BLV infected monocytes macrophages representing different stages differentiation tested signs infection 3 weeks co culture
0.09964287.10640548.html.plaintext.txt	102	Infection followed study several indicative parameters morphological alterations optical microscope alterations production viral proteins Env related proteins SIA Gag related proteins WB
0.09964287.10640548.html.plaintext.txt	103	At time point viability treated donor cells FLKBLV BLV bat2 co cultures almost negligible
0.09964287.10640548.html.plaintext.txt	104	Morphological changes seen electron microscope MMBLV included among others nuclear nucleolar condensation cytoplasmic vacuolization swelling rough endoplasmic reticulum mitochondrial degeneration blebbing cytoplasmic membrane suggesting possibility apoptosis
0.09964287.10640548.html.plaintext.txt	105	Extracellular viral particles evident adherent MM cell lines By electron microscopy viral particles difficult find MMBLV
0.09964287.10640548.html.plaintext.txt	106	They dispersed extracellular spaces usually single particles Fig
0.09964287.10640548.html.plaintext.txt	107	1b phase condensation cell membrane budding cell surface Fig
0.09964287.10640548.html.plaintext.txt	108	Further analysis using colloidal gold labelled anti Ig BLV specific MAbs confirmed extracellular budding particles unequivocally BLV origin L
0.09964287.10640548.html.plaintext.txt	109	Gomez Lucia unpublished results
0.09964287.10640548.html.plaintext.txt	110	Extracellular particles seen frequently adherent MMBLV BGM PM2 followed cells suspension U 937 J774 THP 1
0.09964287.10640548.html.plaintext.txt	111	Viral particles never seen within cytoplasmic vacuoles
0.09964287.10640548.html.plaintext.txt	112	View larger version 189K Fig
0.09964287.10640548.html.plaintext.txt	113	Electron microscope morphological observations
0.09964287.10640548.html.plaintext.txt	114	Isolated viral particle extracellular environment SUB bar 100 nm
0.09964287.10640548.html.plaintext.txt	115	b Extracellular viral particles arrows arranged small groups close plasma membrane budding arrowheads MBB bar 100 nm
0.09964287.10640548.html.plaintext.txt	116	c MJB cell apoptotic nucleus bar 1 microm
0.09964287.10640548.html.plaintext.txt	117	d MUB cell apoptotic nucleus bar 1 microm
0.09964287.10640548.html.plaintext.txt	118	e Intense vacuolization MUB cell close morphologically normal cells bar 1 microm
0.09964287.10640548.html.plaintext.txt	119	f Blebbing plasma membrane SUB cell bar 1 microm
0.09964287.10640548.html.plaintext.txt	120	Monocytic cell lines susceptible morphological alterations As seen optical microscope morphological alterations observed suspended monocytesBLV adherent macrophagesBLV Table 1
0.09964287.10640548.html.plaintext.txt	121	Morphological changes suspended cells included cellular differentiation macrophage adherent stage THP 1 U 937 vacuolization THP 1 J774 development giant cells four eight times normal size THP 1 U 937 J774 cell lysis HL 60
0.09964287.10640548.html.plaintext.txt	122	Thus cells seemed respond differently BLV infection THP 1 U 937 remained mostly viable others HL 60 infection tended lytic
0.09964287.10640548.html.plaintext.txt	123	Morphological changes MMBLV seen optical microscope
0.09964287.10640548.html.plaintext.txt	124	Ultrastructural alterations observed related apoptosis prominent less differentiated cells In co cultures chromatin condensed close nuclear envelope maintaining integrity plasma membrane Fig
0.09964287.10640548.html.plaintext.txt	125	These alterations present suspended monocytesBLV principally U 937 associated changes vacuolization surface blebbing cellular death linked apoptosis Table 2
0.09964287.10640548.html.plaintext.txt	126	The nuclear condensation usually occurred dying cells massive cellular death
0.09964287.10640548.html.plaintext.txt	127	Cell cultures showed nuclear changes suspended monocytes J774 HL 60 THP 1 U 937BLV Table 2
0.09964287.10640548.html.plaintext.txt	128	Apoptosis seen frequently mitomycin C treated co cultures followed incubation supernatant never seen irradiated co cultures
0.09964287.10640548.html.plaintext.txt	129	As also frequently seen MM cells infected supernatant proteins secreted mitomycin C treated cells might induce apoptosis suspected
0.09964287.10640548.html.plaintext.txt	130	No nuclear alterations observed monolayer cells BGM PM2 sheep cow macrophages
0.09964287.10640548.html.plaintext.txt	131	We observe apoptosis alteration control non infected MM cells controls irradiatedmitomycin C treated donor cells
0.09964287.10640548.html.plaintext.txt	132	Morphological changes MMBLV seen electron microscope
0.09964287.10640548.html.plaintext.txt	133	The cytoplasmic alteration frequently seen vacuolization particularly J774
0.09964287.10640548.html.plaintext.txt	134	Vacuoles usually empty generally circular quite big seldom enlarged cell Fig
0.09964287.10640548.html.plaintext.txt	135	In cases vacuoles concentrated area free cellular organelles
0.09964287.10640548.html.plaintext.txt	136	In several samples MM cells co cultivated mitomycin C treated cells MM cells incubated filtered supernatant observed surface blebbing blebs could full vacuoles Fig
0.09964287.10640548.html.plaintext.txt	137	In MMBLV J774 HL 60 U 937 alterations associated apoptosis
0.09964287.10640548.html.plaintext.txt	138	Apoptosis confirmed visualization characteristic ladder pattern genomic DNA fragmentation agarose gels 2 7 days post infection data shown following standard protocol already described Cascales et al
0.09964287.10640548.html.plaintext.txt	139	These bands present co cultures suspended monocytic cells donor cells seen controls
0.09964287.10640548.html.plaintext.txt	140	Other cytoplasmic alterations observed frequently electron microscopy syncytia hypertrophy rough endoplasmic reticulum cisternal swelling degeneration mitochondria tubulo reticular structures associated virus replication areas condensed proteic matter
0.09964287.10640548.html.plaintext.txt	141	Further analysis using BLV specific MAbs colloidal gold labelled anti Ig detected BLV proteins mitochondria areas condensed proteinaceous matter confirmed previous association alterations active virus infection L
0.09964287.10640548.html.plaintext.txt	142	Gomez Lucia unpublished results
0.09964287.10640548.html.plaintext.txt	143	Mitosis almost non existent
0.09964287.10640548.html.plaintext.txt	144	These observations suggested less differentiated monocytes underwent severe morphological changes consequence infection changes evident differentiated cells
0.09964287.10640548.html.plaintext.txt	145	Even though presence budding extracellular virus indicated virus production synthesis viral proteins studied
0.09964287.10640548.html.plaintext.txt	146	Only differentiated cow sheep primary macrophages sustain clear synthesis BLV envelope Gag proteins SIA used determine presence envelope glycoprotein gp51SU plasma membrane
0.09964287.10640548.html.plaintext.txt	147	Positive cases confirmed specific inhibition BLV positive serum titred used 144 dilution
0.09964287.10640548.html.plaintext.txt	148	Cow sheep primary macrophagesBLV positive experiments Table 3
0.09964287.10640548.html.plaintext.txt	149	Syncytia seen co cultures similar observed FLKBLV controls
0.09964287.10640548.html.plaintext.txt	150	syncytia abundant cytoplasm many nuclei sometimes arranged parallel lines
0.09964287.10640548.html.plaintext.txt	151	With MMBLV results weak BGM PM2 unclear J774 THP 1 U 937 clearly negative syncytia include many nuclei difficult identify
0.09964287.10640548.html.plaintext.txt	152	A low number syncytia background seen sheep cow MM cells used controls whereas could seen MM cell controls
0.09964287.10640548.html.plaintext.txt	153	Syncytia induction assay MMBLV
0.09964287.10640548.html.plaintext.txt	154	Cell lysates MMBLV analysed WB using pool cow sera positive BLV
0.09964287.10640548.html.plaintext.txt	155	Reference specific bands identified lysates FLKBLV BLV bat2 apparent molecular masses 25 32 40 50 62 kDa
0.09964287.10640548.html.plaintext.txt	156	These bands recognized MAb p24CA correspond p24CA precursors A
0.09964287.10640548.html.plaintext.txt	157	Burny personal communication
0.09964287.10640548.html.plaintext.txt	158	Four additional bands 28 41 76 89 kDa Domenech et al
0.09964287.10640548.html.plaintext.txt	159	None nine bands seen lysates non BLV infected MM cells
0.09964287.10640548.html.plaintext.txt	160	A complete profile proteins seen cow sheep primary macrophages Fig
0.09964287.10640548.html.plaintext.txt	161	p24CA protein produced largest amounts judged intensity band followed protein giving band 32 kDa
0.09964287.10640548.html.plaintext.txt	162	Some MMBLV expressed Gag precursors p24CA identified MAb p24CA
0.09964287.10640548.html.plaintext.txt	163	Regarding suspended monocytes results variable
0.09964287.10640548.html.plaintext.txt	164	In U 937 p24 observed cases FLKBLV used donor cells MUF SUF RUF co cultures irradiated BLV bat2 RUB nevertheless Gag precursors detected Fig
0.09964287.10640548.html.plaintext.txt	165	The level protein expression lower primary macrophages
0.09964287.10640548.html.plaintext.txt	166	In suspended MMBLV p24CA sporadically detected
0.09964287.10640548.html.plaintext.txt	167	BGM PM2 rendered specific bands possibly low protein concentration due limited amount cells could used lysate data shown
0.09964287.10640548.html.plaintext.txt	168	View larger version 48K Fig
0.09964287.10640548.html.plaintext.txt	169	Western blot lysates three MMBLV show Gag proteins expressed cells 3 weeks co culture
0.09964287.10640548.html.plaintext.txt	170	Lysates sheep macrophagesBLV
0.09964287.10640548.html.plaintext.txt	171	Lanes 1 FLKBLV 2 MOF 3 SOF 4 ROF 5 MOB 6 SOB 7 ROB 8 non infected sheep macrophages
0.09964287.10640548.html.plaintext.txt	172	b Lysates cow macrophagesBLV
0.09964287.10640548.html.plaintext.txt	173	Lanes 1 FLKBLV 2 MCF 3 SCF 4 RCF 5 MCB 6 SCB 7 RCB 8 non infected cow macrophages
0.09964287.10640548.html.plaintext.txt	174	Lanes 1 FLKBLV 2 MUF 3 SUF 4 RUF 5 MUB 6 SUB 7 RUB 8 non infected U 937
0.09964287.10640548.html.plaintext.txt	175	Serum used reaction pool BLV positive cow serum diluted 1250
0.09964287.10640548.html.plaintext.txt	176	The MAb p24 recognized bands molecular mass indicated left
0.09964287.10640548.html.plaintext.txt	177	Discussion Top Abstract Introduction Methods Results Discussion References The recipient MM cells used represent cells varying degrees differentiation least differentiated HL 60 promyelocytic primary macrophages passing THP 1 U 937 J774 suspended cells BGM PM2 macrophage like ascending order differentiation described Methods
0.09964287.10640548.html.plaintext.txt	178	We wanted determine whether stated retroviruses level cell differentiation affected susceptibility infection
0.09964287.10640548.html.plaintext.txt	179	To determine degree infection analysed several indicative parameters extracellular viral particles would mean cell sustaining synthesis structural proteins others necessary replication b morphological alterations seen cells c expression viral proteins would also indicate efficient integration active replication cycle
0.09964287.10640548.html.plaintext.txt	180	Extracellular BLV particles The number viral particles budding activity low
0.09964287.10640548.html.plaintext.txt	181	It proposed retroviruses degree cell infection always coincide larger extracellular presence may also true BLV
0.09964287.10640548.html.plaintext.txt	182	Moreover number budding particles calculated 2 9 per cell Calafat Ressang 1977 lower retroviruses Mussgay Kaaden 1978 Dekegel 1987
0.09964287.10640548.html.plaintext.txt	183	Thus budding activity MMBLV could considered normal
0.09964287.10640548.html.plaintext.txt	184	Budding also depends cell type viral particles seen budding lymphocytes granulocytes peripheral blood Calafat Ressang 1977
0.09964287.10640548.html.plaintext.txt	185	We also observed budding takes place mostly localized areas membrane particles may shed close
0.09964287.10640548.html.plaintext.txt	186	Budding considered indication active infection MM cells cell able sustain stages virus replication
0.09964287.10640548.html.plaintext.txt	187	The absence extracellular viral particles sheep cow macrophagesBLV may indicate apparent restriction virus morphogenesis release vitro conditions described cell types bovine origin mechanism remains elucidated
0.09964287.10640548.html.plaintext.txt	188	This restriction may overcome species primary macrophagesBLV induced high humoral response inoculated rabbits Domenech et al
0.09964287.10640548.html.plaintext.txt	189	Expression BLV proteins MMBLV The protein profile seen WB dependent degree differentiation recipient MM cells
0.09964287.10640548.html.plaintext.txt	190	Suspended monocytes HL 60 THP 1 U 937 J774 incomplete profiles whereas differentiated primary macrophages standard bands
0.09964287.10640548.html.plaintext.txt	191	In sheep cow macrophagesBLV amount viral core protein Gag expressed high intensity bands comparable observed persistently infected cell line FLKBLV Fig
0.09964287.10640548.html.plaintext.txt	192	2 even MMBLV lysates contained two thirds total amount cells FLKBLV
0.09964287.10640548.html.plaintext.txt	193	In addition expression membrane gp51SU high judging SIA values Table 3
0.09964287.10640548.html.plaintext.txt	194	These results indicate primary macrophagesBLV able produce complete BLV protein pattern comparable observed permanently infected cells
0.09964287.10640548.html.plaintext.txt	195	On contrary suspended cellsBLV expressed BLV proteins
0.09964287.10640548.html.plaintext.txt	196	In co cultures p24 seen absence precursors whereas others precursors present p24 observed
0.09964287.10640548.html.plaintext.txt	197	The fact Gag precursors seen absence p24CA may indicate either protease proteolytic route lacking precursors inefficiently cleaved mature proteins
0.09964287.10640548.html.plaintext.txt	198	Morphological alterations infected cells Ultrastructural changes MMBLV resembled described retrovirus infected cells typical programmed cell death apoptosis distinct usual necrosis cytotoxic virus infected cells
0.09964287.10640548.html.plaintext.txt	199	In general cells undergoing apoptosis displayed profound structural changes including blebbing plasma membrane
0.09964287.10640548.html.plaintext.txt	200	This surface blebbing also described infections human immunodeficiency virus HIV Gougeon Montagnier 1993 feline leukaemia virus FeLV Rojko et al
0.09964287.10640548.html.plaintext.txt	201	In HIV suggested surface blebbing may play role direct cell cell spread virus Karimi et al
0.09964287.10640548.html.plaintext.txt	202	The presence apoptosis seems linked virus infection non BLV infected controls MM cells never presented apoptotic bodies
0.09964287.10640548.html.plaintext.txt	203	Neither controls irradiated mitomycin C treated donor cells presented chromatin condensation nuclei
0.09964287.10640548.html.plaintext.txt	204	Moreover apoptosis figures also seen MM cells incubated filtered supernatant FLKBLV BLV bat2 thus apoptosis seem due blocking treatment donor cell lines might promote secretion certain apoptosis inducing proteins consequence virus infection
0.09964287.10640548.html.plaintext.txt	205	Apoptosis related pathogenesis several retroviruses HIV Gougeon Montagnier 1993 Dittmer et al
0.09964287.10640548.html.plaintext.txt	206	1996 simian immunodeficiency virus Dittmer et al
0.09964287.10640548.html.plaintext.txt	207	1996 feline immunodeficiency virus FIV Momoi et al
0.09964287.10640548.html.plaintext.txt	208	It observed vitro cultures U 937 cells infected HIV Malorni et al
0.09964287.10640548.html.plaintext.txt	209	1993 T cells cats infected FIV Momoi et al
0.09964287.10640548.html.plaintext.txt	210	1996 FeLV Rojko et al
0.09964287.10640548.html.plaintext.txt	211	Candidate HIV proteins may modulate apoptosis include surface glycoprotein gp120SU Gougeon Montagnier 1993 regulatory protein Tat Li et al
0.09964287.10640548.html.plaintext.txt	212	HTLV 1 Tax closely related BLV Tax reported different effects regulation apoptosis
0.09964287.10640548.html.plaintext.txt	213	Some authors reported may promote apoptosis Rat 1 cells Yamada et al
0.09964287.10640548.html.plaintext.txt	214	1994 possibly activation c myc c fos Fujita Shiku 1995 whereas others Tsukahara et al
0.09964287.10640548.html.plaintext.txt	215	1999 suggested HTLV 1 Tax may prevent apoptosis
0.09964287.10640548.html.plaintext.txt	216	Regarding BLV early reports describe presence fragmented nuclei infected bovine cells associated virus activity cultures Van der Maaten et al
0.09964287.10640548.html.plaintext.txt	217	1974 Mussgay Kaaden 1978 could termed apoptosis today
0.09964287.10640548.html.plaintext.txt	218	1996 determined BLV infection increase secretion IL 10 mRNA MM cells could lead apoptosis
0.09964287.10640548.html.plaintext.txt	219	Susceptibility apoptosis associated BLV infection seems vary one species another
0.09964287.10640548.html.plaintext.txt	220	B cells lymphocytotic sheep appear protected ex vivo spontaneous programmed cell death Dequiedt et al
0.09964287.10640548.html.plaintext.txt	221	1997 PBMCs persistently lymphocytotic BLV infected cows susceptible ex vivo apoptosis PBMCs uninfected aleukaemic animals Dequiedt et al
0.09964287.10640548.html.plaintext.txt	222	According results primary macrophages uninfected sheep cows infected vitro BLV similarly resistant apoptosis
0.09964287.10640548.html.plaintext.txt	223	The mechanism BLV interferes apoptosis unknown
0.09964287.10640548.html.plaintext.txt	224	It may either direct consequence BLV gene expression result viral cellular factors secreted medium BLV infected cells
0.09964287.10640548.html.plaintext.txt	225	Several authors presented data could argue possible role virus gene expression protection programmed cell death Schwartz Cornil et al
0.09964287.10640548.html.plaintext.txt	226	Favouring second hypothesis Dequiedt et al
0.09964287.10640548.html.plaintext.txt	227	1997 described even strongly attenuated BLVs protected PBMCs apoptosis suggested viral cellular factor might secreted infected cells protects uninfected cells
0.09964287.10640548.html.plaintext.txt	228	Their findings indicated decreased susceptibility cell death infected sheep PBMCs depend total amount viral proteins expressed short term cultures
0.09964287.10640548.html.plaintext.txt	229	Our results suggest co cultures expression BLV proteins complete protected apoptosis agrees data presented Schwartz Cornil et al
0.09964287.10640548.html.plaintext.txt	230	1997 even though secretion apoptosis protecting factor disregarded
0.09964287.10640548.html.plaintext.txt	231	On contrary cells apoptosis seen express complete BLV protein pattern
0.09964287.10640548.html.plaintext.txt	232	Conclusions In view results may conclude MM cells may infected BLV able express viral proteins
0.09964287.10640548.html.plaintext.txt	233	However degree infection seems depend MM cell type
0.09964287.10640548.html.plaintext.txt	234	Thus primary sheep cow macrophages expression level high inferred induction syncytia gp51SU WB Gag proteins
0.09964287.10640548.html.plaintext.txt	235	On hand suspended MM cells less differentiated expression level lower
0.09964287.10640548.html.plaintext.txt	236	If functional protein expression results compared morphological microscopy results appears group cells suspended macrophage like morphological alterations seen infection culminate typical protein profile
0.09964287.10640548.html.plaintext.txt	237	Thus cells may fall one two categories restrictive permissive Narayan Zink 1988
0.09964287.10640548.html.plaintext.txt	238	Restrictive infection would characterized absence gp51SU presence morphological changes related apoptosis
0.09964287.10640548.html.plaintext.txt	239	On hand permissive infection characteristics could include high expression p24CA Gag proteins well membrane associated gp51SU extracellular particles lack apoptosis related morphological alterations infected cells
0.09964287.10640548.html.plaintext.txt	240	According results cells belonging first category restrictive would correspond less differentiated monocytes suspended cells second category permissive would adherent primary macrophages
0.09964287.10640548.html.plaintext.txt	241	This surprising conclusion unlike lentiviruses oncoviruses seem replicate better less differentiated cells
0.09964287.10640548.html.plaintext.txt	242	However presence regulatory genes BLV HTLV may relate two oncoviruses lentiviruses
0.09964287.10640548.html.plaintext.txt	243	Acknowledgments We thank Dr Burny University Brussels Belgium providing FLKBLV CC81 Dr Radke UC Davis CA USA BLV bat2 Dr Essex HSPH MA USA HL 60 THP 1 U 937 Dr Vallejo Centro de Salud Carlos III Spain J774 Dr Lopez Carrascosa CBM Madrid Spain BGM PM2 Dr Portetelle Faculty Agronomy Gembloux Belgium monoclonal antibodies
0.09964287.10640548.html.plaintext.txt	244	We also want express gratitude Junta de Energia Nuclear UCM Madrid donor cells irradiated Ms Vicente Facultad de Veterinaria UCM Madrid help EM preparations Centro de Microscopia Electronica UCM Madrid assistance observations Dr Herrera Centro de Salud Carlos III Spain helpful discussion
0.09964287.10640548.html.plaintext.txt	245	Bruhn gratefully acknowledged
0.09964287.10640548.html.plaintext.txt	246	This work partially supported grant Spanish CICYT PB910863 AGF95 0289 PR 15697 7142
0.09964287.10640548.html.plaintext.txt	247	Footnotes b Present address Gruppe Physiologie und Tierhaltung Institut fur Nutztierwissenschaften Eidgenossische Technische Hochschule ETH Schorenstrasse 16 SLA B38 CH 8603 Schwerzenbach Switzerland
0.09964287.10640548.html.plaintext.txt	248	References Top Abstract Introduction Methods Results Discussion References Burny A
0.09964287.10640548.html.plaintext.txt	249	Bovine leukemia facts hypotheses derived study infectious cancer
0.09964287.10640548.html.plaintext.txt	250	Advances Veterinary Science Comparative Medicine 32 149 170
0.09964287.10640548.html.plaintext.txt	251	Morphogenesis bovine leukemia virus
0.09964287.10640548.html.plaintext.txt	252	Cocaine induced liver injury mice elicits specific changes DNA ploidy induces programmed death hepatocytes
0.09964287.10640548.html.plaintext.txt	253	Terminal differentiation human promyelocytic leukemia cells induced dimethyl sulfoxide polar compounds
0.09964287.10640548.html.plaintext.txt	254	Proceedings National Academy Sciences USA 75 2458 2462
0.09964287.10640548.html.plaintext.txt	255	Morphology bovine leukemia virus
0.09964287.10640548.html.plaintext.txt	256	In Enzootic Bovine Leukosis Bovine Leukosis Virus pp
0.09964287.10640548.html.plaintext.txt	257	Both wild type strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells apoptosis
0.09964287.10640548.html.plaintext.txt	258	Journal Virology 71 630 639
0.09964287.10640548.html.plaintext.txt	259	Bovine leukemia virus induced persistent lymphocytosis cattle correlate increased ex vivo survival B lymphocytes
0.09964287.10640548.html.plaintext.txt	260	Journal Virology 73 1127 1137
0.09964287.10640548.html.plaintext.txt	261	In vitro infection human macrophages human T cell leukemia virus type 1
0.09964287.10640548.html.plaintext.txt	262	T cell apoptosis human immunodeficiency virus type 2 simian immunodeficiency virus infected macaques
0.09964287.10640548.html.plaintext.txt	263	Journal General Virology 77 2433 2436
0.09964287.10640548.html.plaintext.txt	264	Macrophages infected bovine leukemia virus BLV induce humoral response rabbits
0.09964287.10640548.html.plaintext.txt	265	Veterinary Immunology Immunopathology 58 309 320
0.09964287.10640548.html.plaintext.txt	266	Simple quantitative assay xenotropic murine leukemia ecotropic feline leukemia viruses
0.09964287.10640548.html.plaintext.txt	267	Journal Virology 14 177 179
0.09964287.10640548.html.plaintext.txt	268	Detection B T cells lectins antibodies healthy bovine leukemia virus infected cattle
0.09964287.10640548.html.plaintext.txt	269	Veterinary Immunology Immunopathology 18 269 278
0.09964287.10640548.html.plaintext.txt	270	Differences sensitivity induction apoptosis among rat fibroblast cells transformed HTLV I tax gene cellular nuclear oncogenes
0.09964287.10640548.html.plaintext.txt	271	In vitro transmission propagation bovine leukemia virus monolayer cell cultures
0.09964287.10640548.html.plaintext.txt	272	Evidence bovine leukemia virus infection peripheral blood monocytes limited antigen expression bovine lymphoid tissue
0.09964287.10640548.html.plaintext.txt	273	Laboratory Investigation 66 608 617
0.09964287.10640548.html.plaintext.txt	274	Human T cell leukemia virus type I infection monocytes microglial cells primary human cultures
0.09964287.10640548.html.plaintext.txt	275	Proceedings National Academy Sciences USA 89 1784 1788
0.09964287.10640548.html.plaintext.txt	276	Accumulation chlamydial lipopolysaccharide antigen plasma membranes infected cells
0.09964287.10640548.html.plaintext.txt	277	Infection Immunity 57 1780 1785
0.09964287.10640548.html.plaintext.txt	278	Transcriptional activation bovine leukemia virus blood cells experimentally infected asymptomatic sheep latent infections
0.09964287.10640548.html.plaintext.txt	279	Journal Virology 63 2099 2107
0.09964287.10640548.html.plaintext.txt	280	Induction apoptosis uninfected lymphocytes HIV 1 tat protein
0.09964287.10640548.html.plaintext.txt	281	N Acetylcysteine inhibits apoptosis decreases viral particles HIV chronically infected U 937 cells
0.09964287.10640548.html.plaintext.txt	282	Humoral cellular responses calves experimentally infected bovine leukemia virus BLV
0.09964287.10640548.html.plaintext.txt	283	Veterinary Immunology Immunopathology 9 105 114
0.09964287.10640548.html.plaintext.txt	284	The prevalence proviral bovine leukemia virus peripheral blood mononuclear cells two subclinical stages infection
0.09964287.10640548.html.plaintext.txt	285	Journal Virology 70 2178 2183
0.09964287.10640548.html.plaintext.txt	286	Detection apoptosis induced peripheral blood lymphocytes cats infected feline immunodeficiency virus
0.09964287.10640548.html.plaintext.txt	287	Archives Virology 141 1651 1659
0.09964287.10640548.html.plaintext.txt	288	Progress studies etiology serologic diagnosis enzootic bovine leukosis
0.09964287.10640548.html.plaintext.txt	289	Current Topics Microbiology Immunology 79 43 72
0.09964287.10640548.html.plaintext.txt	290	Role macrophages lentivirus infections
0.09964287.10640548.html.plaintext.txt	291	Advances Veterinary Science Comparative Medicine 32 129 147
0.09964287.10640548.html.plaintext.txt	292	Detection bovine leukemia virus B lymphocytes syncytia induction assay
0.09964287.10640548.html.plaintext.txt	293	Journal National Cancer Institute 5 1269 1272
0.09964287.10640548.html.plaintext.txt	294	Activation bovine leukemia virus transcription lymphocytes infected sheep rapid transition early late gene expression
0.09964287.10640548.html.plaintext.txt	295	Journal Virology 66 4769 4777
0.09964287.10640548.html.plaintext.txt	296	Interleukin 12 p40 mRNA expression bovine leukemia virus infected animals increase alymphocytosis decrease persistent lymphocytosis
0.09964287.10640548.html.plaintext.txt	297	Journal Virology 72 6917 6921
0.09964287.10640548.html.plaintext.txt	298	Increased interleukin 10 mRNA expression tumor bearing persistently lymphocytotic animals infected bovine leukemia virus
0.09964287.10640548.html.plaintext.txt	299	Journal Virology 70 5706 5710
0.09964287.10640548.html.plaintext.txt	300	In Encyclopedia Virology pp
0.09964287.10640548.html.plaintext.txt	301	Transcription bovine leukemia virus peripheral blood cells obtained early infection vivo
0.09964287.10640548.html.plaintext.txt	302	Microbial Pathogenesis 12 319 331
0.09964287.10640548.html.plaintext.txt	303	Phagocytosis cytolysis macrophage tumour cloned cell line
0.09964287.10640548.html.plaintext.txt	304	Immunohistological demonstration virus tumor associated antigens tissues experimental spontaneous bovine leukemia virus BLV infection
0.09964287.10640548.html.plaintext.txt	305	Veterinary Immunology Immunopathology 22 223 231
0.09964287.10640548.html.plaintext.txt	306	Lymphocytotoxic strains feline leukemia virus induce apoptosis feline T4 thymic lymphoma cells
0.09964287.10640548.html.plaintext.txt	307	Laboratory Investigation 66 418 426
0.09964287.10640548.html.plaintext.txt	308	In vivo leukocyte tropism bovine leukemia virus sheep cattle
0.09964287.10640548.html.plaintext.txt	309	Journal Virology 68 4589 4596
0.09964287.10640548.html.plaintext.txt	310	Bovine leukaemia virus induced lymphocytosis sheep associated reduction spontaneous B cell apoptosis
0.09964287.10640548.html.plaintext.txt	311	Journal General Virology 78 153 162
0.09964287.10640548.html.plaintext.txt	312	Establishment characterization human histiocytic lymphoma cell line U 937
0.09964287.10640548.html.plaintext.txt	313	International Journal Cancer 17 565 577
0.09964287.10640548.html.plaintext.txt	314	Establishment characterization human acute monocytic leukemia cell line THP 1
0.09964287.10640548.html.plaintext.txt	315	International Journal Cancer 26 171 176
0.09964287.10640548.html.plaintext.txt	316	Induction bcl xL expression human T cell leukemia virus type 1 tax NF B apoptosis resistant T cell transfectants Tax
0.09964287.10640548.html.plaintext.txt	317	Journal Virology 73 7981 7987
0.09964287.10640548.html.plaintext.txt	318	Replication bovine leukemia virus monolayer cell cultures
0.09964287.10640548.html.plaintext.txt	319	In Comparative Leukemia Research
0.09964287.10640548.html.plaintext.txt	320	Replicating type C virus particles monolayer cell cultures tissues cattle lymphosarcoma
0.09964287.10640548.html.plaintext.txt	321	Journal National Cancer Institute 52 491 494
0.09964287.10640548.html.plaintext.txt	322	Effect bovine leukemia virus infection bovine peripheral blood monocyte responsiveness lipopolysaccharide stimulation vitro
0.09964287.10640548.html.plaintext.txt	323	Veterinary Immunology Immunopathology 48 77 88
0.09964287.10640548.html.plaintext.txt	324	Analysis phenotype phagocytic activity monocytesmacrophages cattle infected bovine leukemia virus
0.09964287.10640548.html.plaintext.txt	325	Veterinary Immunology Immunopathology 62 185 195
0.09964287.10640548.html.plaintext.txt	326	Persistent infection rabbits bovine leukemia virus associated development immune dysfunction
0.09964287.10640548.html.plaintext.txt	327	Journal Virology 63 4498 4506
0.09964287.10640548.html.plaintext.txt	328	The human T cell leukemia virus type I tax protein induces apoptosis blocked Bcl 2 protein
0.09964287.10640548.html.plaintext.txt	329	Journal Virology 68 3374 3379
0.09964287.10640548.html.plaintext.txt	330	Received 14 July 1999 accepted 7 October 1999
0.1370075.9300662.html.plaintext.txt	0	Human prion diseases bovine spongiform encephalopathy BSE Human prion diseases bovine spongiform encephalopathy BSE John Collinge
0.1370075.9300662.html.plaintext.txt	1	Prion Disease Group Neurogenetics Unit Imperial College School Medicine St
0.1370075.9300662.html.plaintext.txt	2	Prion diseases transmissible neurodegenerative disorders affect range mammalian species
0.1370075.9300662.html.plaintext.txt	3	In humans inherited sporadic well acquired exposure human prions
0.1370075.9300662.html.plaintext.txt	4	Prions appear composed principally conformational isomer host encoded prion protein propagate recruitment cellular prion protein
0.1370075.9300662.html.plaintext.txt	5	Recent evidence argues prion protein also encode disease phenotypes differences conformation glycosylation
0.1370075.9300662.html.plaintext.txt	6	Such molecular analysis prion strains suggests new variant Creutzfeldt Jakob disease caused BSE exposure
0.1370075.9300662.html.plaintext.txt	7	The novel biology prion propagation may unique rare degenerative brain diseases
0.1370075.9300662.html.plaintext.txt	8	The human prion diseases transmissible spongiform encephalopathies traditionally classified Creutzfeldt Jakob disease CJD Gerstmann Straussler Scheinker disease GSS kuru
0.1370075.9300662.html.plaintext.txt	9	They rare neurodegenerative disorders affecting 1 person per million world wide per annum
0.1370075.9300662.html.plaintext.txt	10	Despite rarity remarkable attention recently focused diseases
0.1370075.9300662.html.plaintext.txt	11	This unique biology concerns epidemic newly recognised bovine prion disease bovine spongiform encephalopathy BSE could pose threat public health dietary exposure infected tissues
0.1370075.9300662.html.plaintext.txt	12	Transmissibility human diseases experimental animals demonstrated transmission intracerebral inoculation brain homogenates chimpanzees first kuru CJD 1966 1968 respectively 1 2
0.1370075.9300662.html.plaintext.txt	13	Transmission GSS followed 1981 3
0.1370075.9300662.html.plaintext.txt	14	The prototypic prion disease scrapie naturally occurring disease sheep goats recognised 200 years 4
0.1370075.9300662.html.plaintext.txt	15	Scrapie demonstrated transmissible inoculation 1936 5 recognition histopathologically kuru CJD resembled scrapie led suggestions diseases may also transmitted inoculation 6 7
0.1370075.9300662.html.plaintext.txt	16	Kuru neurodegenerative condition characterised principally progressive cerebellar ataxia reached epidemic proportions amongst Fore linguistic group Eastern Highlands Papua New Guinea transmitted cannibalism
0.1370075.9300662.html.plaintext.txt	17	Since cessation cannibalism 1950s disease declined cases still occur result long incubation periods condition 8
0.1370075.9300662.html.plaintext.txt	18	Transmission CJD case case occurred number routes involving accidental inoculation human prions result medical procedures
0.1370075.9300662.html.plaintext.txt	19	Such iatrogenic routes include use inadequately sterilised neurosurgical instruments dura mater corneal grafting use human cadaveric pituitary derived growth hormone gonadotrophin
0.1370075.9300662.html.plaintext.txt	20	The epidemiology human prion diseases encompasses three aetiological types prion disease inherited sporadic acquired Table 1
0.1370075.9300662.html.plaintext.txt	21	Inherited cases constitute 15 cases acquired cases kuru iatrogenic CJD rare
0.1370075.9300662.html.plaintext.txt	22	Most human cases sporadic precise aetiology still unclear
0.1370075.9300662.html.plaintext.txt	23	Both human animal prion diseases share common histopathological features
0.1370075.9300662.html.plaintext.txt	24	The classical triad spongiform vacuolation affecting part cerebral grey matter astrocytic proliferation neuronal loss may accompanied deposition amyloid plaques 9
0.1370075.9300662.html.plaintext.txt	25	These plaques composed principally abnormal partially protease resistant isoform host encoded sialoglycoprotein prion protein PrP
0.1370075.9300662.html.plaintext.txt	26	PrP expressed widely much higher levels neuronal cells glycosylphosphatidyl inositol anchored cell surface protein 10
0.1370075.9300662.html.plaintext.txt	27	MOLECULAR GENETICS OF THE HUMAN PRION DISEASES AND A MODEL FOR PRION PROPAGATION
0.1370075.9300662.html.plaintext.txt	28	The transmissible agent prion seems consist principally abnormal isoform prion protein PrP designated PrPSc 11
0.1370075.9300662.html.plaintext.txt	29	PrPSc known derived cellular isoform PrPC post translational mechanism 12 13 evidence mounting change conformational rather covalent 14 15
0.1370075.9300662.html.plaintext.txt	30	While PrPC fully sensitive proteolysis PrPSc accumulates brain disease partially protease resistant
0.1370075.9300662.html.plaintext.txt	31	The human PrP gene PRNP single copy gene located short arm chromosome 20 16 spans 16 kb contains two exons 17 18
0.1370075.9300662.html.plaintext.txt	32	The complete open reading frame 759 nucleotides contained within larger second exon comprises majority 2
0.1370075.9300662.html.plaintext.txt	33	A key advance understanding prion biology identification mutations PRNP familial forms human diseases
0.1370075.9300662.html.plaintext.txt	34	The first mutation identified PRNP family CJD constituted 144 bp insertion coding sequence 19
0.1370075.9300662.html.plaintext.txt	35	A second mutation reported two families GSS genetic linkage confirmed missense variant codon 102 GSS confirming GSS autosomal dominant Mendelian disorder 20
0.1370075.9300662.html.plaintext.txt	36	This genetic variant present normal population rapidly identified numerous unrelated GSS kindreds
0.1370075.9300662.html.plaintext.txt	37	These diseases therefore inherited germline transmissible inoculation biologically unique regard
0.1370075.9300662.html.plaintext.txt	38	The identification one pathogenic PrP gene mutations case neurodegenerative disease allows molecular diagnosis inherited prion disease 21 pre symptomatic testing risk individuals 22 also sub classification according mutation
0.1370075.9300662.html.plaintext.txt	39	Pathogenic mutations reported date human PrP gene consist two groups point mutations within coding sequence resulting amino acid substitutions PrP one case production stop codon resulting expression truncated PrP ii insertions encoding additional integral copies octapeptide repeat present tandem array five copies normal protein Fig
0.1370075.9300662.html.plaintext.txt	40	The availability direct gene markers diseases enabled identification highly atypical cases widened known phenotypic range disorders 23 24
0.1370075.9300662.html.plaintext.txt	41	Remarkable phenotypic variability may present family phenotypes ranging classical CJD atypical dementias extremely long duration lacking typical histological features spongiform encephalopathy 25
0.1370075.9300662.html.plaintext.txt	42	Clinical pathological syndromes human inherited prion diseases reviewed detail elsewhere 26
0.1370075.9300662.html.plaintext.txt	43	Genetic susceptibility also relevant sporadic acquired prion diseases
0.1370075.9300662.html.plaintext.txt	44	There common polymorphism human prion protein either methionine valine present residue 129
0.1370075.9300662.html.plaintext.txt	45	In Caucasians 38 homozygous frequent methionine allele 51 heterozygotes 11 homozygous valine 27
0.1370075.9300662.html.plaintext.txt	46	The large majority sporadic CJD occurs individuals homozygous polymorphism 28 pituitary hormone related iatrogenic CJD cases homozygotes particular excess valine homozygotes 29
0.1370075.9300662.html.plaintext.txt	47	This protective effect PRNP heterozygosity also seen inherited prion diseases age onset disease 1 2 decades later heterozygotes PRNP codon 129 compared homozygotes 30 31
0.1370075.9300662.html.plaintext.txt	48	Although prion diseases transmitted mammalian species inoculation practice difficult typically transmission occurs small proportion inoculated animals prolonged incubation periods primary passage
0.1370075.9300662.html.plaintext.txt	49	On second subsequent passage infectivity animals species incubation periods typically much shortened relatively synchronous compared primary passage inoculated animals succumb disease
0.1370075.9300662.html.plaintext.txt	50	A key component called species barrier degree homology PrP donor recipient species
0.1370075.9300662.html.plaintext.txt	51	Mice transgenic hamster PrP lose species barrier hamster prions 32
0.1370075.9300662.html.plaintext.txt	52	When transgenic mice challenged mouse derived prions infectivity produced fully pathogenic mice hamsters challenge hamster derived prions produced prions fully pathogenic hamsters mice
0.1370075.9300662.html.plaintext.txt	53	The interpretation finding direct interaction PrP molecules occurs stage process prion propagation interaction occurs easily interacting PrP molecules identical
0.1370075.9300662.html.plaintext.txt	54	Such work led idea replication prions may occur PrPSc interacting directly PrPC catalysing conversion PrPC PrPSc 32 33
0.1370075.9300662.html.plaintext.txt	55	Such effect could lead chain reaction conversion leading progressive conversion increasing amounts PrPC PrPSc
0.1370075.9300662.html.plaintext.txt	56	The pathogenic mutations prion protein may result production protein converts spontaneously PrPSc individuals inherited prion diseases
0.1370075.9300662.html.plaintext.txt	57	Such model provides explanation disease simultaneously inherited transmissible
0.1370075.9300662.html.plaintext.txt	58	The finding nearly sporadic CJD occurs homozygotes respect common apparently innocent protein polymorphism lends strong support mechanism 28
0.1370075.9300662.html.plaintext.txt	59	Again prion protein interaction would occur favourably individuals two identical copies prion protein
0.1370075.9300662.html.plaintext.txt	60	Heterozygotes producing two different proteins would somewhat protected internal species barrier
0.1370075.9300662.html.plaintext.txt	61	It possible occasional individuals heterozygous codon 129 develop sporadic CJD prolonged illness although detailed studies required investigate 34
0.1370075.9300662.html.plaintext.txt	62	PrP valine 129 PrP methionine 129 would expected differ slightly propensity conversion PrPSc
0.1370075.9300662.html.plaintext.txt	63	The excess PrP valine 129 homozygotes amongst human pituitary hormone related cases suggests PrP valine 129 may susceptible 29
0.1370075.9300662.html.plaintext.txt	64	Pathogenic mutations reported date human prion protein
0.1370075.9300662.html.plaintext.txt	65	The aetiology sporadic CJD remains unclear
0.1370075.9300662.html.plaintext.txt	66	It speculated cases might arise somatic mutation PRNP spontaneous conversion PrPC PrPSc rare stochastic event
0.1370075.9300662.html.plaintext.txt	67	The alternative hypothesis cases arise result exposure environmental source either human animal prions supported epidemiological evidence 35
0.1370075.9300662.html.plaintext.txt	68	Since transgenic mice expressing extremely high levels wild type hamster murine PrP develop spontaneous neuromuscular disease 36 appears transmissible also suggested cases sporadic CJD may arise result PrP overexpression
0.1370075.9300662.html.plaintext.txt	69	Table 1 Human prion diseases Type Clinical syndromes Aetiology Acquired Kuru Cannibalism Iatrogenic CJD Accidental innoculation human prions Sporadic CJD Somatic PRNP mutation Atypical CJD spontaneous conversion PrPC PrPSc Inherited Familial CJD Germline PRNP mutation GSS FFI Various atypical dementias CJD Creuzfeldt Jakob disease GSS Gerstmann Straussler Scheinker disease FFI fatal familial insomnia PRNP human prion protein gene
0.1370075.9300662.html.plaintext.txt	70	A high resolution structure full length PrP yet reported NMR structure determination mouse PrP fragment spanning residues 121 231 represents important step forward 37
0.1370075.9300662.html.plaintext.txt	71	However structure lacks highly conserved hydrophobic region 106 126 contains several known pathogenic human mutations well N terminal octapeptide repeat region expansion integral numbers repeat elements results group inherited prion diseases
0.1370075.9300662.html.plaintext.txt	72	The conformation repeat region studied circular dichroism appears form extended flexible domain properties similar poly L proline type II helix 38
0.1370075.9300662.html.plaintext.txt	73	It hypothesised may form low specificity binding domain
0.1370075.9300662.html.plaintext.txt	74	Despite wealth evidence indicating central role PrP diseases normal cellular function remains unclear
0.1370075.9300662.html.plaintext.txt	75	Mice homozygous PrP null alleles appear develop behave normally 39
0.1370075.9300662.html.plaintext.txt	76	Such mice completely resistant developing prion disease following inoculation propagate infectivity 40 41
0.1370075.9300662.html.plaintext.txt	77	However electrophysiological studies demonstrated impaired GABAA mediated synaptic inhibition hippocampal brain slices maintained vitro also reduced long term potentiation 42 abnormality independently confirmed different PrP knockout line 43
0.1370075.9300662.html.plaintext.txt	78	However others failed replicate finding albeit using different techniques experimental conditions 44
0.1370075.9300662.html.plaintext.txt	79	That phenotype rescued expression human PrP mice confirmed specificity PrP 45
0.1370075.9300662.html.plaintext.txt	80	These abnormalities synaptic inhibition reminiscent neurophysiological abnormalities seen patients CJD scrapie infected mice 46 raising possibility prion neurodegeneration may least part due loss PrP function rather deleterious effect PrPSc 42
0.1370075.9300662.html.plaintext.txt	81	The relative normality PrP null mice develop progressive neurodegeneration could result effective adaptive changes neurodevelopment
0.1370075.9300662.html.plaintext.txt	82	It possible sequestration PrPC PrPSc prion disease developed nervous system lacking plasticity severe consequences
0.1370075.9300662.html.plaintext.txt	83	Certainly PrPSc appear toxic cells lacking PrPC 47 PrPSc difficult detect cases inherited human prion disease fatal familial insomnia FFI 48 transgenic mice infected experimentally FFI 49 suggesting least cases neurodegeneration may result PrPSc toxicity
0.1370075.9300662.html.plaintext.txt	84	According model gain function implied autosomal dominant mode inheritance could reflect formation PrPSc functionally depletes PrPC dominant negative effect
0.1370075.9300662.html.plaintext.txt	85	Two additional phenotypes described PrP null mice abnormalities circadian rhythms 50 cerebellar Purkinje cell degeneration 51
0.1370075.9300662.html.plaintext.txt	86	Further neurophysiological abnormalities hippocampus PrP null mice including disrupted Ca2 activated K currents abnormal intrinsic properties CA1 pyramidal cells recently reported 52 53
0.1370075.9300662.html.plaintext.txt	87	Creutzfeldt Jakob disease new variant putatively linked BSE
0.1370075.9300662.html.plaintext.txt	88	Extensive epidemiological studies CJD performed number countries obtained broadly similar results 35
0.1370075.9300662.html.plaintext.txt	89	The overall annual incidence studies 1 case per million
0.1370075.9300662.html.plaintext.txt	90	No significant case clustering present respect familial clusters
0.1370075.9300662.html.plaintext.txt	91	Cases distributed apparently random frequency related local population density
0.1370075.9300662.html.plaintext.txt	92	In particular evidence case case spread association local scrapie prevalence
0.1370075.9300662.html.plaintext.txt	93	For instance CJD common Australia New Zealand scrapie free many years UK scrapie endemic
0.1370075.9300662.html.plaintext.txt	94	Numerous case control studies shown consistent associations particular occupational groups dietary components
0.1370075.9300662.html.plaintext.txt	95	The core clinical syndrome CJD rapidly progressive dementia usually myoclonus
0.1370075.9300662.html.plaintext.txt	96	The onset usually 45 75 year age group peak onset 60 65
0.1370075.9300662.html.plaintext.txt	97	Sporadic CJD exceedingly rare individuals age 30
0.1370075.9300662.html.plaintext.txt	98	The clinical progression typically weeks progressing akinetic mutism death often 2 3 months
0.1370075.9300662.html.plaintext.txt	99	Around 70 cases die 6 months
0.1370075.9300662.html.plaintext.txt	100	However late 1995 two cases sporadic CJD reported UK teenagers 54 55
0.1370075.9300662.html.plaintext.txt	101	Only four cases sporadic CJD previously recorded literature teenagers none cases occurred UK
0.1370075.9300662.html.plaintext.txt	102	In addition cases unusual kuru type plaques finding seen 5 CJD cases
0.1370075.9300662.html.plaintext.txt	103	Soon afterwards third young sporadic CJD case occurred 56
0.1370075.9300662.html.plaintext.txt	104	These cases caused considerable concern possibility raised might suggest link BSE
0.1370075.9300662.html.plaintext.txt	105	By March 1996 extremely young onset cases apparent review histology cases showed remarkably consistent unique pattern 57
0.1370075.9300662.html.plaintext.txt	106	These cases named new variant CJD although clear also rather atypical clinical presentation fact cases meet accepted clinical diagnostic criteria probable CJD 57 respects least clinically closely resembled kuru 58
0.1370075.9300662.html.plaintext.txt	107	Extensive studies archival cases CJD prion diseases failed show picture seemed represent arrival new form prion disease UK
0.1370075.9300662.html.plaintext.txt	108	The statistical probability cases occurring chance vanishingly small ascertainment bias seemed unlikely explanation
0.1370075.9300662.html.plaintext.txt	109	It clear new risk factor CJD emerged appeared specific UK
0.1370075.9300662.html.plaintext.txt	110	The UK Government advisory committee spongiform encephalopathy SEAC concluded direct evidence link BSE exposure specified bovine offal SBO prior ban inclusion human foodstuffs 1989 likely explanation
0.1370075.9300662.html.plaintext.txt	111	A case new variant reported France soon 59
0.1370075.9300662.html.plaintext.txt	112	PRNP analysis showed cases available study homozygous methionine codon 129 known novel pathogenic mutations found PRNP coding sequence 60
0.1370075.9300662.html.plaintext.txt	113	Recently transmission BSE three macaques reported production histopathological appearances closely similar unusual pattern pathology seen new variant CJD 61 providing evidence cases may result BSE transmission
0.1370075.9300662.html.plaintext.txt	114	However detailed comparisons transmissions typical CJD cases macaques needed fully evaluate significance finding
0.1370075.9300662.html.plaintext.txt	115	If cases represent transmission BSE humans unclear none pattern unusual occupational dietary exposure BSE possible represent genetically susceptible sub population
0.1370075.9300662.html.plaintext.txt	116	In addition unknown age group particularly affected
0.1370075.9300662.html.plaintext.txt	117	However little known foodstuffs contained high titre bovine offal
0.1370075.9300662.html.plaintext.txt	118	It possible certain foods containing particularly high titres eaten predominately younger people
0.1370075.9300662.html.plaintext.txt	119	It also possible children inherently higher intrinsic susceptibility shorter incubation period following dietary exposure BSE agent
0.1370075.9300662.html.plaintext.txt	120	Possibilities might include example differences gut permeability lymphoreticular system higher PrP expression levels
0.1370075.9300662.html.plaintext.txt	121	Direct experimental evidence new variant CJD may caused BSE provided molecular analysis human prion strains PrPSc typing see
0.1370075.9300662.html.plaintext.txt	122	The identification biochemical marker distinguished new variant CJD previously recognised forms sporadic iatrogenic CJD confirmed novel variant implied caused exposure single novel prion strain type 62
0.1370075.9300662.html.plaintext.txt	123	The lack history iatrogenic exposure humans patients suggested novel animal prion
0.1370075.9300662.html.plaintext.txt	124	The molecular strain characteristics new variant CJD closely resembled seen BSE BSE transmitted mice domestic cat macaque consistent BSE origin new variant CJD 62
0.1370075.9300662.html.plaintext.txt	125	Such PrPSc markers detectable tonsil 63 may allow pre mortem diagnosis new variant CJD without brain biopsy may potentially allow earlier diagnosis
0.1370075.9300662.html.plaintext.txt	126	Experimental transmission studies human prion diseases recently largely involved transmission laboratory primates particular chimpanzees squirrel monkeys
0.1370075.9300662.html.plaintext.txt	127	The extensive experience NIH group reporting 300 successful transmissions recently summarised 64
0.1370075.9300662.html.plaintext.txt	128	However transmission studies primates severely limited expense studies ethical concerns use primates work
0.1370075.9300662.html.plaintext.txt	129	Attempts laboratories transmit human prions rodents fairly unsuccessful occasional transmissions occurring prolonged incubation periods close natural lifespan mice
0.1370075.9300662.html.plaintext.txt	130	Some groups however reported frequent transmissions 65
0.1370075.9300662.html.plaintext.txt	131	Recently transgenic mice become available increased susceptibility human prions
0.1370075.9300662.html.plaintext.txt	132	Mice expressing chimaeric humanmouse PrP susceptible three CJD isolates short incubation periods 66
0.1370075.9300662.html.plaintext.txt	133	It become clear transgenic mice expressing wild type human PrP mouse PrP highly susceptible CJD inoculated mice succumbing short incubation periods usually range 180 220 days 67 68
0.1370075.9300662.html.plaintext.txt	134	Such mice appear lack species barrier human prions used extensive studies transmission characteristics human prion diseases bioassay human prions 68
0.1370075.9300662.html.plaintext.txt	135	Molecular basis prion strains
0.1370075.9300662.html.plaintext.txt	136	A major problem protein hypothesis prion propagation explain existence multiple isolates strains prions
0.1370075.9300662.html.plaintext.txt	137	Such strains distinguished biological properties produce distinct incubation periods patterns neuropathological targeting inbred mouse lines
0.1370075.9300662.html.plaintext.txt	138	As serially propagated inbred mice Prn p genotype cannot encoded differences PrP primary structure
0.1370075.9300662.html.plaintext.txt	139	Furthermore strains re isolated mice passage intermediate species different PrP primary structures 69
0.1370075.9300662.html.plaintext.txt	140	Understanding protein infectious agent could encode phenotypic information considerable biological interest
0.1370075.9300662.html.plaintext.txt	141	Support contention strain specificity encoded PrP alone provided study two distinct strains transmissible mink encephalopathy prions serially propagated hamsters designated hyper HY drowsy DY 70
0.1370075.9300662.html.plaintext.txt	142	These strains distinguished differing physiochemical properties accumulated PrPSc brains affected hamsters 71
0.1370075.9300662.html.plaintext.txt	143	Following limited proteolysis strain specific migration patterns PrPSc polyacrylamide gels seen
0.1370075.9300662.html.plaintext.txt	144	DY PrPSc appears protease sensitive HY PrPSc producing different banding pattern PrPSc Western blots following proteinase K treatment
0.1370075.9300662.html.plaintext.txt	145	This relates different N terminal ends HY DY PrPSc following protease treatment implies differing conformations HY DY PrPSc 72
0.1370075.9300662.html.plaintext.txt	146	Furthermore demonstration strain specific physiochemical properties maintained vitro production protease resistant PrP PrPC mixed HY DY hamster PrPSc supports concept prion strains involve different PrP conformers 73
0.1370075.9300662.html.plaintext.txt	147	Recently several human PrPSc types identified associated different phenotypes CJD 62 74
0.1370075.9300662.html.plaintext.txt	148	The different fragment sizes seen Western blots following treatment proteinase K suggests several different human PrPSc conformations
0.1370075.9300662.html.plaintext.txt	149	However fulfil criteria strains patterns must transmissible animals different species
0.1370075.9300662.html.plaintext.txt	150	Remarkably case PrPSc fragment sizes ratios three PrP glycoforms diglycosylated monoglycosylated unglycosylated PrP maintained passage transgenic mice expressing human PrP 62
0.1370075.9300662.html.plaintext.txt	151	Transmission human prions bovine prions wild type mice results murine PrPSc fragment sizes glycoform ratios correspond original inoculum 62
0.1370075.9300662.html.plaintext.txt	152	New variant CJD associated PrPSc glycoform ratios distinct seen classical CJD
0.1370075.9300662.html.plaintext.txt	153	Similar ratios seen BSE BSE transmitted several species 62
0.1370075.9300662.html.plaintext.txt	154	These data strongly support protein hypothesis infectivity suggest strain variation encoded combination PrP conformation glycosylation
0.1370075.9300662.html.plaintext.txt	155	Transmission PrPSc fragment sizes two different sub types inherited prion disease transgenic mice expressing chimaeric human mouse PrP also reported 75
0.1370075.9300662.html.plaintext.txt	156	As PrP glycosylation thought co translational process different glycoform ratios may represent selection particular PrPC glycoforms PrPSc different conformations
0.1370075.9300662.html.plaintext.txt	157	According hypothesis PrP conformation would primary determinant strain type glycosylation involved secondary process
0.1370075.9300662.html.plaintext.txt	158	However since known different cell types may glycosylate proteins differently PrPSc glycosylation patterns may provide substrate neuropathological targeting distinguishes different prion strains
0.1370075.9300662.html.plaintext.txt	159	Particular PrPSc glycoforms may replicate favourably neuronal populations similar PrP glycoform expressed cell surface
0.1370075.9300662.html.plaintext.txt	160	Such targeting could also explain different incubation periods also discriminate strains targeting critical brain regions regions higher levels PrP expression producing shorter incubation periods
0.1370075.9300662.html.plaintext.txt	161	Such studies may allow new molecular classification human prion diseases likely additional PrPSc types strains identified
0.1370075.9300662.html.plaintext.txt	162	This may well open new avenues epidemiological investigation offer insights causes sporadic CJD
0.1370075.9300662.html.plaintext.txt	163	In addition PrPSc typing applied species already apparent PrP glycoform analysis alone distinguish number mouse passaged scrapie strains 76
0.1370075.9300662.html.plaintext.txt	164	The combination fragment size glycoform analysis allow better resolution might applied instance study BSE transmitted species involved human diet sheep
0.1370075.9300662.html.plaintext.txt	165	It necessary study full range sheep strains determine whether distinguished molecular level BSE possible refined molecular techniques may necessary 77
0.1370075.9300662.html.plaintext.txt	166	Classical strain typing involving mouse transmissions takes 1 2 years applied limited numbers cases
0.1370075.9300662.html.plaintext.txt	167	Molecular strain typing takes days allows large scale screening
0.1370075.9300662.html.plaintext.txt	168	The ability protein encode disease phenotype important implications biology represents non Mendelian form transmission
0.1370075.9300662.html.plaintext.txt	169	It would surprising also intriguing evolution used mechanism proteins range species
0.1370075.9300662.html.plaintext.txt	170	The recent identification prion like mechanisms yeast particularly interesting regard 78 79
0.1370075.9300662.html.plaintext.txt	171	Bovine human species barrier
0.1370075.9300662.html.plaintext.txt	172	As BSE appears transmitted humans key issue extent bovine human species barrier
0.1370075.9300662.html.plaintext.txt	173	Clearly cannot measured directly since would require inoculation humans BSE
0.1370075.9300662.html.plaintext.txt	174	However transgenic models may offer way address issue least part
0.1370075.9300662.html.plaintext.txt	175	The principal determinants species barrier degree homology PrP molecules host inoculum 32 strain agent however BSE appears caused single prion strain 69
0.1370075.9300662.html.plaintext.txt	176	Transgenic mice expressing human PrP competent produce human PrPSc human prions CJD challenge offer opportunity address issue whether possible bovine prions induce production human PrPSc
0.1370075.9300662.html.plaintext.txt	177	To date results reassuring
0.1370075.9300662.html.plaintext.txt	178	Incubation periods BSE unaltered mice expressing human PrP addition mouse PrP mouse PrPSc appeared produced 68
0.1370075.9300662.html.plaintext.txt	179	A potentially revealing experiment challenge mice expressing human PrP BSE 68
0.1370075.9300662.html.plaintext.txt	180	No transmission occurred incubation periods well beyond CJD mice 68 remains seen transmission occur longer incubation periods
0.1370075.9300662.html.plaintext.txt	181	These mice express valine polymorphic codon 129 PRNP studies repeated mice transgenic human PrP methionine 129
0.1370075.9300662.html.plaintext.txt	182	This particular importance given new variant CJD cases seen date methionine 129 homozygotes
0.1370075.9300662.html.plaintext.txt	183	However even presence highly effective species barrier cattle humans exclude degree BSE transmission humans given large numbers people exposed
0.1370075.9300662.html.plaintext.txt	184	Genetic susceptibility may well important regard particular PRNP codon 129 homozygotes would expected considerably higher risk heterozygotes although possible heterozygotes may simply longer incubation periods
0.1370075.9300662.html.plaintext.txt	185	1966 Experimental transmission kuru like syndrome chimpanzees
0.1370075.9300662.html.plaintext.txt	186	1968 Creutzfeldt Jakob disease spongiform encephalopathy transmission chimpanzee
0.1370075.9300662.html.plaintext.txt	187	1981 Creutzfeldt Jakob disease virus isolations Gerstmann Straussler syndrome analysis various forms amyloid plaque deposition virus induced spongiform encephalopathies
0.1370075.9300662.html.plaintext.txt	188	1936 La maladie dite tremblante du mouton est elle inocuable C
0.1370075.9300662.html.plaintext.txt	189	1987 Epidemiology clinical aspects kuru
0.1370075.9300662.html.plaintext.txt	190	McKinley eds Prions Novel infectious pathogens causing scrapie Creutzfeldt Jakob disease
0.1370075.9300662.html.plaintext.txt	191	1987 Neuropathology transmissible spongiform encephalopathies
0.1370075.9300662.html.plaintext.txt	192	McKinley eds Prions Novel infectious pathogens causing scrapie Creutzfeldt Jakob disease
0.1370075.9300662.html.plaintext.txt	193	1992 Glycosylinositol phospholipid anchors prion proteins
0.1370075.9300662.html.plaintext.txt	194	Anderton eds Prion Diseases Humans Animals
0.1370075.9300662.html.plaintext.txt	195	1991 Molecular biology prion diseases
0.1370075.9300662.html.plaintext.txt	196	1990 Scrapie cellular prion proteins differ kinetics synthesis topology cultured cells
0.1370075.9300662.html.plaintext.txt	197	1991 The scrapie associated form PrP made cell surface precursor protease phospholipase sensitive
0.1370075.9300662.html.plaintext.txt	198	1993 Perturbation secondary structure scrapie prion protein conditions alter infectivity
0.1370075.9300662.html.plaintext.txt	199	1993 Conversion alpha helices beta sheets features formation scrapie prion proteins
0.1370075.9300662.html.plaintext.txt	200	1986 Localization human gene homologous PrP gene p arm chromosome 20 detection PrP related antigens normal human brain
0.1370075.9300662.html.plaintext.txt	201	1986 Molecular cloning human prion protein cDNA
0.1370075.9300662.html.plaintext.txt	202	1985 A cellular gene encodes scrapie PrP 27 30 protein
0.1370075.9300662.html.plaintext.txt	203	1989 Insertion prion protein gene familial Creutzfeldt Jakob disease
0.1370075.9300662.html.plaintext.txt	204	1989 Linkage prion protein missense variant Gerstmann Straussler syndrome
0.1370075.9300662.html.plaintext.txt	205	1989 Diagnosis Gerstmann Straussler syndrome familial dementia prion protein gene analysis
0.1370075.9300662.html.plaintext.txt	206	1991 Presymptomatic detection exclusion prion protein gene defects families inherited prion diseases
0.1370075.9300662.html.plaintext.txt	207	1990 Prion dementia without characteristic pathology
0.1370075.9300662.html.plaintext.txt	208	1992 Fatal familial insomnia prion disease mutation codon 178 prion protein gene
0.1370075.9300662.html.plaintext.txt	209	1992 Inherited prion disease 144 base pair gene insertion II Clinical pathological features
0.1370075.9300662.html.plaintext.txt	210	Oxford University Press Oxford pp
0.1370075.9300662.html.plaintext.txt	211	1990 Codon 129 changes prion protein gene Caucasians
0.1370075.9300662.html.plaintext.txt	212	1991 Homozygous prion protein genotype predisposes sporadic Creutzfeldt Jakob disease
0.1370075.9300662.html.plaintext.txt	213	1991 Genetic predisposition iatrogenic Creutzfeldt Jakob disease
0.1370075.9300662.html.plaintext.txt	214	1991 Amino acid polymorphism human prion protein age death inherited prion disease
0.1370075.9300662.html.plaintext.txt	215	1992 Linkage Indiana kindred Gerstmann Straussler Scheinker disease prion protein gene
0.1370075.9300662.html.plaintext.txt	216	1990 Transgenetic studies implicate interactions homologous PrP isoforms scrapie prion replication
0.1370075.9300662.html.plaintext.txt	217	1991 Spongiform encephalopathies
0.1370075.9300662.html.plaintext.txt	218	1987 The epidemiology Creutzfeldt Jakob disease conclusion 15 year investigation France review world literature
0.1370075.9300662.html.plaintext.txt	219	1994 Degeneration skeletal muscle peripheral nerves central nervous system transgenic mice overexpressing wild type prion proteins
0.1370075.9300662.html.plaintext.txt	220	1996 NMR structure mouse prion protein domain PrP 121 231
0.1370075.9300662.html.plaintext.txt	221	1997 Conformational properties prion octa repeat hydrophobic sequences
0.1370075.9300662.html.plaintext.txt	222	1992 Normal development behaviour mice lacking neuronal cell surface PrP protein
0.1370075.9300662.html.plaintext.txt	223	1993 Mice devoid PrP resistant scrapie
0.1370075.9300662.html.plaintext.txt	224	1994 No propagation prions mice devoid PrP
0.1370075.9300662.html.plaintext.txt	225	1994 Prion protein necessary normal synaptic function
0.1370075.9300662.html.plaintext.txt	226	1995 PrP gene dosage long term potentiation
0.1370075.9300662.html.plaintext.txt	227	1996 Mice deficient prion protein exhibit normal neuronal excitability synaptic transmission hippocampus
0.1370075.9300662.html.plaintext.txt	228	1995 Rescue neurophysiological phenotype seen PrP null mice transgene encoding human prion protein
0.1370075.9300662.html.plaintext.txt	229	1994 Scrapie infection transgenic mice leads network intrinsic dysfunction cortical hippocampal neurons
0.1370075.9300662.html.plaintext.txt	230	1996 Normal host prion protein necessary scrapie induced neurotoxicity
0.1370075.9300662.html.plaintext.txt	231	1992 Fatal familial insomnia A second kindred mutation prion protein gene codon 178
0.1370075.9300662.html.plaintext.txt	232	1995 Transmission fatal familial insomnia laboratory animals
0.1370075.9300662.html.plaintext.txt	233	1996 Altered circadian activity rhythms sleep mice devoid prion protein
0.1370075.9300662.html.plaintext.txt	234	1996 Loss cerebellar Purkinje cells aged mice homozygous disrupted PrP gene
0.1370075.9300662.html.plaintext.txt	235	1996 Hippocampal slices prion protein null mice disrupted CA2 activated K currents
0.1370075.9300662.html.plaintext.txt	236	1996 Prion protein null mice abnormal intrinsic properties hippocampal CA1 pyramidal cells
0.1370075.9300662.html.plaintext.txt	237	1995 Sporadic Creutzfeldt Jakob disease 18 year old UK
0.1370075.9300662.html.plaintext.txt	238	1995 Sporadic Creutzfeldt Jakob disease 16 year old UK
0.1370075.9300662.html.plaintext.txt	239	1996 Creutzfeldt Jakob disease young woman
0.1370075.9300662.html.plaintext.txt	240	Report Meeting Physicians Scientists St
0.1370075.9300662.html.plaintext.txt	241	1996 A new variant Creutzfeldt Jakob disease UK
0.1370075.9300662.html.plaintext.txt	242	1996 A new variant prion disease
0.1370075.9300662.html.plaintext.txt	243	1996 New variant Creutzfeldt Jakob disease 26 year old French man
0.1370075.9300662.html.plaintext.txt	244	1996 Prion protein gene analysis new variant cases Creutzfeldt Jakob disease
0.1370075.9300662.html.plaintext.txt	245	1996 BSE transmission macaques
0.1370075.9300662.html.plaintext.txt	246	1996 Molecular analysis prion strain variation aetiology new variant CJD
0.1370075.9300662.html.plaintext.txt	247	1997 Diagnosis new variant Creutzfeldt Jakob disease tonsil biopsy
0.1370075.9300662.html.plaintext.txt	248	1994 Human spongiform encephalopathy National Institutes Health series 300 cases experimentally transmitted disease
0.1370075.9300662.html.plaintext.txt	249	1981 Experimental transmission Creutzfeldt Jakob disease
0.1370075.9300662.html.plaintext.txt	250	1994 Transmission Creutzfeldt Jakob disease humans transgenic mice expressing chimeric human mouse prion protein
0.1370075.9300662.html.plaintext.txt	251	1995 Prion propagation mice expressing human chimeric PrP transgenes implicates interaction cellular PrP another protein
0.1370075.9300662.html.plaintext.txt	252	1995 Unaltered susceptibility BSE transgenic mice expressing human prion protein
0.1370075.9300662.html.plaintext.txt	253	1994 Transmission bovine spongiform encephalopathy scrapie mice Strain variation species barrier
0.1370075.9300662.html.plaintext.txt	254	1975 Comparison scrapie transmissible mink encephalopathy hamsters
0.1370075.9300662.html.plaintext.txt	255	Clinical signs pathology pathogenesis
0.1370075.9300662.html.plaintext.txt	256	1992 Biochemical physical properties prion protein two strains transmissible mink encephalopathy agent
0.1370075.9300662.html.plaintext.txt	257	1994 Distinct PrP properties suggest molecular basis strain variation transmissible mink encephalopathy
0.1370075.9300662.html.plaintext.txt	258	1995 Non genetic propagation strain specific properties scrapie prion protein
0.1370075.9300662.html.plaintext.txt	259	1996 Molecular basis phenotypic variability sporadic Creutzfeldt Jakob disease
0.1370075.9300662.html.plaintext.txt	260	1996 Evidence conformation pathologic isoform prion protein enciphering propagating prion diversity
0.1370075.9300662.html.plaintext.txt	261	1997 Biochemical typing scrapie strains
0.1370075.9300662.html.plaintext.txt	262	1997 Biochemical typing scrapie strains
0.1370075.9300662.html.plaintext.txt	263	1994 URE3 altered URE2 protein Evidence prion analog Saccharomyces cerevisiae
0.1370075.9300662.html.plaintext.txt	264	1994 The SUP35 omnipotent suppressor gene involved maintenance non Mendelian determinant psi yeast Saccharomyces cerevisiae
0.1370075.9300662.html.plaintext.txt	265	1996 New diagnostic tests prion diseases
0.1370075.9300662.html.plaintext.txt	266	Tel 44 171 594 3760 Fax 44 171 706 7094 Email j
0.1370075.9300662.html.plaintext.txt	267	This page maintained OUP admin
0.1370075.9300662.html.plaintext.txt	268	Last updated Fri Sep 12 180923 BST 1997
0.1370075.9300662.html.plaintext.txt	269	Part OUP Journals World Wide Web service
0.1370075.9300662.html.plaintext.txt	270	Copyright Oxford University Press 1997
0.12289999.15269389.html.plaintext.txt	0	Characterization two distinct prion strains derived bovine spongiform encephalopathy transmissions inbred mice Sarah E
0.12289999.15269389.html.plaintext.txt	1	Linehan Melanie Desbruslais Susan Joiner Jennifer Buckell Sebastian Brandner Jonathan D
0.12289999.15269389.html.plaintext.txt	2	MRC Prion Unit Department Neurodegenerative Disease Institute Neurology University College London WC1N 3BG UK
0.12289999.15269389.html.plaintext.txt	3	ABSTRACT Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Distinct prion strains distinguished differences incubation period neuropathology biochemical properties disease associated prion protein PrPSc inoculated mice
0.12289999.15269389.html.plaintext.txt	4	Reliable comparisons mouse prion strain properties achieved passage genetically identical mice host prion protein sequence genetic background known modulate prion disease phenotypes
0.12289999.15269389.html.plaintext.txt	5	While multiple prion strains identified sheep scrapie Creutzfeldt Jakob disease bovine spongiform encephalopathy BSE thought caused single prion strain
0.12289999.15269389.html.plaintext.txt	6	Primary passage BSE prions different lines inbred mice resulted propagation two distinct PrPSc types suggesting two prion strains may isolated
0.12289999.15269389.html.plaintext.txt	7	To investigate isolates subpassaged single line inbred mice SJL confirmed two distinct prion strains identified
0.12289999.15269389.html.plaintext.txt	8	MRC1 characterized short incubation time 110 plus minus 3 days mono glycosylated dominant PrPSc type generalized diffuse pattern PrP immunoreactive deposits MRC2 displayed much longer incubation time 155 plus minus 1 days di glycosylated dominant PrPSc type distinct pattern PrP immunoreactive deposits neuronal loss
0.12289999.15269389.html.plaintext.txt	9	These data indicate crucial involvement host genome modulating prion strain selection propagation mice
0.12289999.15269389.html.plaintext.txt	10	It possible multiple disease phenotypes may also possible BSE prion infection humans animals
0.12289999.15269389.html.plaintext.txt	11	INTRODUCTION Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Prion diseases transmissible spongiform encephalopathies group fatal neurodegenerative disorders include Creutzfeldt Jakob disease CJD humans scrapie bovine spongiform encephalopathy BSE animals
0.12289999.15269389.html.plaintext.txt	12	Prion diseases characterized prolonged incubation periods distinctive neuropathology includes accumulation affected brains abnormal isomer PrPSc host encoded cellular prion protein PrPc
0.12289999.15269389.html.plaintext.txt	13	The conversion PrPc PrPSc involves conformation change resulting increased sheet secondary structure Pan et al
0.12289999.15269389.html.plaintext.txt	14	1993 associated detergent insolubility acquisition partial resistance protease digestion Meyer et al
0.12289999.15269389.html.plaintext.txt	15	According protein hypothesis Griffith 1967 PrPSc principal sole component infectious agent Prusiner 1991
0.12289999.15269389.html.plaintext.txt	16	Multiple prion strains described distinguished incubation periods patterns neuropathology passaged inbred lines mice distinctive phenotypes preserved multiple passage host review see Bruce et al
0.12289999.15269389.html.plaintext.txt	17	The existence prion strains challenges protein hypothesis prion propagation
0.12289999.15269389.html.plaintext.txt	18	However clear prion strains associated biochemical differences PrPSc including differences conformation Hill et al
0.12289999.15269389.html.plaintext.txt	19	1997 2003 Bessen Marsh 1992 1994 Collinge et al
0.12289999.15269389.html.plaintext.txt	20	1999 glycosylation Hill et al
0.12289999.15269389.html.plaintext.txt	21	1996 overall protease resistance Kuczius Groschup 1999
0.12289999.15269389.html.plaintext.txt	22	That strain associated biochemical differences PrPSc fragment sizes glycoform ratios following proteolysis transmitted PrP experimental host argues may responsible encoding strain diversity
0.12289999.15269389.html.plaintext.txt	23	While precise nature molecular basis prion strain diversity unclear prion strains may distinguished differing molecular mass fragments following partial proteinase K digestion differing ratios di mono unglycosylated PrPSc clear
0.12289999.15269389.html.plaintext.txt	24	Using approach described four common PrPSc types humans Collinge et al
0.12289999.15269389.html.plaintext.txt	25	PrPSc types 1 3 seen sporadic iatrogenic CJD type 4 PrPSc exclusively associated variant CJD vCJD associated di glycosylated dominant PrPSc pattern Western blot Collinge et al
0.12289999.15269389.html.plaintext.txt	26	This characteristic glycoform ratio also seen BSE infected cattle brain observations together bioassay data wild type transgenic mice non human primates proved critical establishing link BSE vCJD Hill et al
0.12289999.15269389.html.plaintext.txt	27	This characteristic molecular signature BSE derived prion isolates seen UK cattle BSE cases examined together biological strain typing studies inbred transgenic mice suggests BSE caused single strain agent Hill et al
0.12289999.15269389.html.plaintext.txt	28	1996 Kuczius Groschup 1999 unpublished data
0.12289999.15269389.html.plaintext.txt	29	This molecular pattern additional biological characteristics also maintained transmission hosts domestic cat sheep macaque exotic animals either natural exposure experimental transmission Bruce et al
0.12289999.15269389.html.plaintext.txt	30	Recent data French Italian screening programmes suggest one strain BSE may exist cattle Biacabe et al
0.12289999.15269389.html.plaintext.txt	31	We also shown BSE transmission line transgenic mice expressing human PrP Met 129 TgHuPrP129MPrnp00 35 two distinct molecular phenotypes produced one mirrors vCJD phenotype type 4 PrPSc additional molecular phenotype indistinguishable sporadic CJD PrPSc type 2 Asante et al
0.12289999.15269389.html.plaintext.txt	32	These transgenic mice generated mixed genetic background one possibility different patterns determined background effects individual mice Asante et al
0.12289999.15269389.html.plaintext.txt	33	This interpretation supported demonstration vCJD BSE prions primary passage series inbred lines mice also able produce two distinct molecular phenotypes Western blotting dependent genetic background mice Asante et al
0.12289999.15269389.html.plaintext.txt	34	These data argued two distinct strains propagated cattle BSE
0.12289999.15269389.html.plaintext.txt	35	However since parameters distinguish prion strains incubation time neuropathology PrPSc type also known modulated host genetic background cannot adequately compared primary passage different lines inbred mice Bruce 1993 Moore et al
0.12289999.15269389.html.plaintext.txt	36	We therefore subpassaged mouse adapted BSE prions inbred mouse line determine whether distinctive biological characteristics resulted indicative different strains whether correlated different PrPSc types propagated animals
0.12289999.15269389.html.plaintext.txt	37	METHODS Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Transmission studies
0.12289999.15269389.html.plaintext.txt	38	SJLOlaHsd SJL C57BL6JOlaHsd C57BL6 mice obtained Harlan UK Ltd Bicester UK
0.12289999.15269389.html.plaintext.txt	39	BSE tissues collected strict aseptic conditions using sterile instrumentation specifically transmission studies UK Central Veterinary Laboratory Veterinary Laboratories Agency
0.12289999.15269389.html.plaintext.txt	40	I783 derived single natural BSE affected cow brainstem I038 derived pool five natural BSE affected brainstems
0.12289999.15269389.html.plaintext.txt	41	DNA sequence analysis bovine Prnp gene I783 showed animal homozygous polymorphic repeat sequence R6R6
0.12289999.15269389.html.plaintext.txt	42	These inocula previously used transmission studies Hill et al
0.12289999.15269389.html.plaintext.txt	43	For second passage SJL mice single brain terminally sick mouse primary passage SJL group I783 used produce inoculum I1590 cattle BSE I783SJL mice I1590SJL mice
0.12289999.15269389.html.plaintext.txt	44	For second passage C57BL6 mice single brain subclinically infected mouse primary passage C57BL6 group I038 used produce inoculum I656 cattle BSE I038C57BL6 mice I656C57BL6 mice
0.12289999.15269389.html.plaintext.txt	45	For third passage SJL passaged inoculum generated single mouse brain SJL second passage group I1891 used inoculate group SJL mice cattle BSE I783SJL I1590SJL I1891SJL mice
0.12289999.15269389.html.plaintext.txt	46	To generate C57BL6 passaged BSE inoculum 11 mouse brains second passage pooled generate larger volume homogenate I874
0.12289999.15269389.html.plaintext.txt	47	The inoculum generated way originally intended use survey incubation times inbred lines use large mapping study identify genes influence prion disease incubation time Lloyd et al
0.12289999.15269389.html.plaintext.txt	48	This pool I874 used inoculate SJL mice cattle BSE I038C57BL6 I656C57BL6 I874SJL mice
0.12289999.15269389.html.plaintext.txt	49	All inocula prepared homogenizing brain samples 1 wv PBS using disposable equipment inoculum microbiological containment level 3 laboratory inoculations performed within class I microbiological safety cabinet
0.12289999.15269389.html.plaintext.txt	50	All mice uniquely identified subcutaneous transponder tag
0.12289999.15269389.html.plaintext.txt	51	Disposable cages used throughout lids water bottles also uniquely tagged
0.12289999.15269389.html.plaintext.txt	52	Mice anaesthetized halothaneO2 inoculated intracerebrally right parietal lobe 30 microl inoculum
0.12289999.15269389.html.plaintext.txt	53	Incubation time defined number days inoculation onset clinical signs
0.12289999.15269389.html.plaintext.txt	54	This assessed daily examination neurological signs disease
0.12289999.15269389.html.plaintext.txt	55	Criteria clinical diagnosis prion disease described Carlson et al
0.12289999.15269389.html.plaintext.txt	56	Animals killed soon clinical scrapie confirmed showing signs distress
0.12289999.15269389.html.plaintext.txt	57	Brain homogenates 10 wv PBS prepared proteinase K digested 100 microg proteinase K ml 1 1 h 37 degrees C Western blotted described previously Wadsworth et al
0.12289999.15269389.html.plaintext.txt	58	Blots probed biotinylated anti PrP monoclonal antibody ICSM 35 Asante et al
0.12289999.15269389.html.plaintext.txt	59	2002 conjunction avidin biotin alkaline phosphatase conjugate Dako developed chemiluminescent substrate CDP Star Tropix Inc
0.12289999.15269389.html.plaintext.txt	60	For quantification analysis PrP glycoforms blots developed chemifluorescent substrate AttoPhos Promega visualized Storm 840 PhosphorImager Molecular Dynamics
0.12289999.15269389.html.plaintext.txt	61	Quantification PrPSc glycoforms performed using ImageQuaNT software Molecular Dynamics
0.12289999.15269389.html.plaintext.txt	62	Sodium phosphotungstic acid pre concentration PrPSc performed described previously Wadsworth et al
0.12289999.15269389.html.plaintext.txt	63	Neuropathology immunohistochemistry
0.12289999.15269389.html.plaintext.txt	64	Mouse brains fixed 10 buffered formol saline immersed 98 formic acid 1 h formalin post fixed paraffin wax embedded
0.12289999.15269389.html.plaintext.txt	65	Serial sections 4 microm nominal thickness pre treated TriscitrateEDTA buffer 1 3 mM EDTA 2 1 mM Tris 1 1 mM citrate pH 7 8 antigen retrieval
0.12289999.15269389.html.plaintext.txt	66	PrP deposition visualized using ICSM 35 primary antibody diluted 1 3000 gliosis detected anti glial fibrillary acidic protein rabbit polyclonal antiserum diluted 1 1000 Dako using automated immunostaining system www
0.12289999.15269389.html.plaintext.txt	67	Sections brains examined person blind identity animal genotype
0.12289999.15269389.html.plaintext.txt	68	Sections scored spongiosis neuronal loss gliosis PrPSc deposition
0.12289999.15269389.html.plaintext.txt	69	Photographs taken ImageView digital camera www
0.12289999.15269389.html.plaintext.txt	70	de composed Adobe Photoshop
0.12289999.15269389.html.plaintext.txt	71	RESULTS Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Primary passage BSE SJL C57BL6 mice As part study map prion disease incubation time genes Lloyd et al
0.12289999.15269389.html.plaintext.txt	72	2001 inoculated range inbred mouse lines BSE prions isolate I783
0.12289999.15269389.html.plaintext.txt	73	Coding polymorphisms mouse prion protein gene Prnp known influence incubation time Westaway et al
0.12289999.15269389.html.plaintext.txt	74	1998 therefore mice tested Prnpa Leu 108 Thr 189
0.12289999.15269389.html.plaintext.txt	75	While BSE transmits readily wild type mice nevertheless substantial transmission barrier Wells et al
0.12289999.15269389.html.plaintext.txt	76	2001 results long variable incubation times incomplete attack rate primary passage Hill et al
0.12289999.15269389.html.plaintext.txt	77	2002 Table 1 compared passage mouse adapted prions mice
0.12289999.15269389.html.plaintext.txt	78	Primary passage BSE prions mice usually results di glycosylated dominant PrPSc pattern Western blot closely resembles PrPSc types seen cattle BSE human vCJD type 4 Hill et al
0.12289999.15269389.html.plaintext.txt	79	Most inbred lines tested C57BL6JOlaHsd FVBNHsd NZWOlaHsd SMJ SWROlaHsd corresponded pattern Fig
0.12289999.15269389.html.plaintext.txt	80	1 unpublished data Asante et al
0.12289999.15269389.html.plaintext.txt	81	However two strains SJLOlaHsd RIIISJ produced alternative PrPSc type fragment sizes appeared glycoform ratios different mono glycosylated glycoform dominant Fig
0.12289999.15269389.html.plaintext.txt	82	Passage cattle BSE I783 C57BL6 mice gave reported previously prolonged incubation time 710 plus minus 15 days however passage cattle BSE I783 SJL mice gave much shorter incubation time 196 plus minus 13 days Table 1 Asante et al
0.12289999.15269389.html.plaintext.txt	83	Neuropathological findings unremarkable diffuse PrP staining inbred mouse lines Asante et al
0.12289999.15269389.html.plaintext.txt	84	We also inoculated C57BL6 mice another cattle BSE inoculum I038 Collinge et al
0.12289999.15269389.html.plaintext.txt	85	On Western blots I783 I038 show di glycosylated dominant PrPSc pattern Fig
0.12289999.15269389.html.plaintext.txt	86	1a best knowledge observed UK BSE cattle brain isolates reported date
0.12289999.15269389.html.plaintext.txt	87	C57BL6 mice inoculated I038 show clinical signs disease 012 839 days Table 1 Collinge et al
0.12289999.15269389.html.plaintext.txt	88	However I038 used many transmissions laboratory transmitted efficiently consistent di glycosylated dominant PrPSc pattern Western blots following transmission various lines inbred mice Fig
0.12289999.15269389.html.plaintext.txt	89	BSE transmissions SJL C57BL6 mice
0.12289999.15269389.html.plaintext.txt	90	View larger version 25K Fig
0.12289999.15269389.html.plaintext.txt	91	Western blots proteinase K treated brain homogenates cattle BSE BSE transmission subpassage inbred mice
0.12289999.15269389.html.plaintext.txt	92	Western blots analysed high sensitivity ECL using biotinylated anti PrP monoclonal antibody ICSM 35
0.12289999.15269389.html.plaintext.txt	93	All lanes show PrPSc present 5 10 microl 10 brain homogenate exception lane 2 lane 1 b show PrPSc derived 100 microl 10 brain homogenate following pre concentration sodium phosphotungstic acid
0.12289999.15269389.html.plaintext.txt	94	Lane 1 isolate I038 lane 2 isolate I783
0.12289999.15269389.html.plaintext.txt	95	b Primary transmission BSE prions inbred mice
0.12289999.15269389.html.plaintext.txt	96	Lane 1 transmission BSE isolate I038 C57BL6 mice lanes 2 3 transmission BSE isolate I783 C57BL6 mice lane 2 SJL mice lane 3
0.12289999.15269389.html.plaintext.txt	97	c Secondary passage BSE prions inbred mice
0.12289999.15269389.html.plaintext.txt	98	Lane 1 secondary passage BSE isolate I038 C57BL6 mice lane 2 secondary passage BSE isolate I783 SJL mice
0.12289999.15269389.html.plaintext.txt	99	d Third passage BSE inbred mice
0.12289999.15269389.html.plaintext.txt	100	Lane 1 BSE isolate I038 passaged twice C57BL6 mice passaged SJL mice lane 2 BSE isolate I783 passaged three times SJL mice
0.12289999.15269389.html.plaintext.txt	101	To determine whether two different PrPSc types corresponded distinguishable prion strains completed additional passages could compared host genetic background
0.12289999.15269389.html.plaintext.txt	102	Second passage BSE SJL C57BL6 mice On second passage either SJL C57BL6 mice incubation times groups substantially reduced 100 attack rate Table 1 showing expected adaptation second passage mouse
0.12289999.15269389.html.plaintext.txt	103	It appropriate compare incubation times inocula passage host genetic background effects
0.12289999.15269389.html.plaintext.txt	104	On Western blotting PrPSc type bred true maintaining pattern seen primary passage SJL derived strain giving mono glycosylated dominant pattern C57BL6 derived strain showing di glycosylated dominant pattern Fig
0.12289999.15269389.html.plaintext.txt	105	Third passage BSE SJL C57BL6 mice All third passages carried SJL mice therefore appropriate comparison criteria prion strains incubation time PrPSc type neuropathology
0.12289999.15269389.html.plaintext.txt	106	The incubation time third passage reduced SJL C57BL6 derived BSE suggesting adaptation mouse Table 1
0.12289999.15269389.html.plaintext.txt	107	The incubation times 110 plus minus 3 days SJL derived BSE 155 plus minus 1 days C57BL6 derived BSE highly significantly different P 0 0001 Mann Whitney test
0.12289999.15269389.html.plaintext.txt	108	As inoculation intracerebral brain homogenate terminally affected animals titre effects also evidenced remarkably consistent incubation periods genetic background effects since transmissions inbred SJL mice
0.12289999.15269389.html.plaintext.txt	109	These data therefore consistent propagation two distinct prion strains SJL mice
0.12289999.15269389.html.plaintext.txt	110	Brains groups examined Western blotting
0.12289999.15269389.html.plaintext.txt	111	The PrPSc type observed primary secondary passage faithfully maintained third passage
0.12289999.15269389.html.plaintext.txt	112	The SJL passaged BSE showed mono glycosylated dominant pattern C57BL6 passaged BSE showed di glycosylated dominant pattern Fig
0.12289999.15269389.html.plaintext.txt	113	2 subpassage SJL
0.12289999.15269389.html.plaintext.txt	114	View larger version 18K Fig
0.12289999.15269389.html.plaintext.txt	115	Bar graph showing relative proportions di white mono black unglycosylated grey PrP following partial digestion proteinase K
0.12289999.15269389.html.plaintext.txt	116	Data plotted mean plus minus SEM n5
0.12289999.15269389.html.plaintext.txt	117	Further evidence isolated two distinct mouse prion strains cattle BSE came neuropathological studies SJL brains groups
0.12289999.15269389.html.plaintext.txt	118	For C57BL6 derived BSE group 1 SJL derived BSE group 2 five seven individual brains examined respectively
0.12289999.15269389.html.plaintext.txt	119	Findings consistent within group
0.12289999.15269389.html.plaintext.txt	120	The level distribution spongiosis vacuolation similar groups Fig
0.12289999.15269389.html.plaintext.txt	121	Spongiosis prominent cortex hippocampus thalamus involvement brain stem basal ganglia cerebellum spared
0.12289999.15269389.html.plaintext.txt	122	However consistent differences observed regard neuronal cell loss hippocampus granule cell layer CA1 region dentate gyrus showed significant loss cells C57BL6 derived inoculum remained intact SJL derived BSE Fig
0.12289999.15269389.html.plaintext.txt	123	Patterns PrPSc deposition strikingly different two groups Fig
0.12289999.15269389.html.plaintext.txt	124	For C57BL6 derived BSE group 1 hippocampus thalamus brain stem heavily involved less affected SJL derived BSE group 2
0.12289999.15269389.html.plaintext.txt	125	In group 1 cortex strongly pronounced ribbon PrPSc followed cortical lamination rest cortex mainly negative
0.12289999.15269389.html.plaintext.txt	126	However group 2 cortex uniform distribution diffuse staining PrPSc Fig
0.12289999.15269389.html.plaintext.txt	127	Many plaques found corpus callosum surface brain group 1 seen group 2 Fig
0.12289999.15269389.html.plaintext.txt	128	Differences also observed cerebellum slightly involved group 1 occasional plaques found granular layer
0.12289999.15269389.html.plaintext.txt	129	However group 2 cerebellum exhibited uniform diffuse staining molecular granular layer plaques Fig
0.12289999.15269389.html.plaintext.txt	130	View larger version 144K Fig
0.12289999.15269389.html.plaintext.txt	131	Neuropathological analysis brain SJL mice inoculated BSE following two passages C57BL6 c e SJL b d f mice
0.12289999.15269389.html.plaintext.txt	132	b Haematoxylin eosin H E stained sections hippocampus showing spongiform neurodegeneration
0.12289999.15269389.html.plaintext.txt	133	Arrowheads indicate neuronal loss
0.12289999.15269389.html.plaintext.txt	134	c d PrP immunohistochemistry showing distinct laminar distribution pattern abnormal PrP cortex C57BL6C57BL6SJL passaged BSE c PrP immunoreactivity SJLSJLSJL passaged BSE uniformly distributed d
0.12289999.15269389.html.plaintext.txt	135	The cerebellum former group e mainly shows plaques little diffuse staining latter group f predominantly shows diffuse staining plaques
0.12289999.15269389.html.plaintext.txt	136	Bars 450 microm d 110 microm e f
0.12289999.15269389.html.plaintext.txt	137	View larger version 56K Fig
0.12289999.15269389.html.plaintext.txt	138	Schematic representation spongiosis blue b PrPSc deposition red c d brain SJL mice inoculated BSE following two passages C57BL6 c SJL b d mice
0.12289999.15269389.html.plaintext.txt	139	For PrPSc deposition red represents areas intense staining pink represents areas lighter staining
0.12289999.15269389.html.plaintext.txt	140	DISCUSSION Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Several strains sheep scrapie human CJD described yet BSE UK thought caused single prion strain Bruce et al
0.12289999.15269389.html.plaintext.txt	141	However recent data French Italian cattle suggest one strain BSE may exist Biacabe et al
0.12289999.15269389.html.plaintext.txt	142	Strain typing may carried many ways Safar et al
0.12289999.15269389.html.plaintext.txt	143	2002 strains originally defined classified characteristics passage particular inbred lines mice based incubation time patterns neuropathological targeting recently distinguished PrPSc type Western blots
0.12289999.15269389.html.plaintext.txt	144	A mouse prion strain difference assessed line inbred mouse genetic background known modulate defining features prion strain Bruce 1993 Moore et al
0.12289999.15269389.html.plaintext.txt	145	Based criteria isolated two distinct strains cattle BSE designated MRC1 MRC2 respectively
0.12289999.15269389.html.plaintext.txt	146	MRC1 showed mono glycosylated dominant PrPSc type Western blots
0.12289999.15269389.html.plaintext.txt	147	It derived primary BSE passage SJLOlaHsd mice relatively short incubation time generalized diffuse pattern PrP immunostaining brain
0.12289999.15269389.html.plaintext.txt	148	MRC2 shows di glycosylated dominant PrPSc type Western blots derived primary BSE passage C57BL6JOlaHsd mice relatively long incubation time showed distinctive pattern PrP immunoreactivity neuronal loss
0.12289999.15269389.html.plaintext.txt	149	SJL mice able support MRC1 MRC2 strain patterns
0.12289999.15269389.html.plaintext.txt	150	However important establish whether strains stable passage SJL strains mice
0.12289999.15269389.html.plaintext.txt	151	Both C57BL6 SJL mice share PrP amino acid sequence therefore strain selection must feature genetic loci
0.12289999.15269389.html.plaintext.txt	152	Within limits resolution available Western blotting fragment sizes following proteinase K digestion PrPSc associated strains raising possibility differences related glycosylation gross conformational differences least differentiated proteinase K digestion
0.12289999.15269389.html.plaintext.txt	153	Additional studies required characterize precisely conformation physico chemical properties PrPSc associated prion strains
0.12289999.15269389.html.plaintext.txt	154	Although recent reports suggest alternative strains BSE found cattle previous studies suggested BSE caused single strain agent Bruce et al
0.12289999.15269389.html.plaintext.txt	155	301V 301C represent previously reported independent BSE strains however propagated different strains mice different genetic backgrounds VMDk C57 also two amino acid coding differences PrP therefore strain characteristics cannot directly compared
0.12289999.15269389.html.plaintext.txt	156	It possible MRC2 represents strain 301C however formal comparisons required investigate
0.12289999.15269389.html.plaintext.txt	157	The strain characteristics associated MRC1 resemble seen passage ChandlerRML scrapie strains mice respect incubation time 122 plus minus 1 days histology PrPSc type Western blotting unpublished data
0.12289999.15269389.html.plaintext.txt	158	We confident findings result contamination mouse scrapie transmissions performed accordance rigorous biosafety protocols preparation inocula inoculations care mice
0.12289999.15269389.html.plaintext.txt	159	Disposable equipment used inoculum mouse identified unique transponder
0.12289999.15269389.html.plaintext.txt	160	In addition MRC1 strain also seen primary passage RIIIS mice also primary passage vCJD SJL mice Asante et al
0.12289999.15269389.html.plaintext.txt	161	vCJD caused BSE like prion strain Hill et al
0.12289999.15269389.html.plaintext.txt	162	1996 therefore surprising phenomenon seen vCJD BSE prions strains mice
0.12289999.15269389.html.plaintext.txt	163	Further transmission studies way characterize vCJD derived mouse strains
0.12289999.15269389.html.plaintext.txt	164	A similar bifurcation BSE strain characteristics also observed independent BSE inocula transgenic mice expressing human PrP methionine codon 129 TgHuPrP129MPrnp00 35 Asante et al
0.12289999.15269389.html.plaintext.txt	165	MRC2 MRC1 derived different sources BSE prions I038 I783 respectively
0.12289999.15269389.html.plaintext.txt	166	I038 originated pool five infected cow brainstems
0.12289999.15269389.html.plaintext.txt	167	However extensive transmission studies isolates excluded pooling material five cows source strain variation observe transmissions
0.12289999.15269389.html.plaintext.txt	168	I038 gave classical BSE signature novel phenotype derived I783 originated single cow brain
0.12289999.15269389.html.plaintext.txt	169	I783 used transmissions several inbred lines mice laboratory consistently produces MRC2 strain determined Western blotting C57BL6JOlaHsd FVBNHsd NZWOlaHsd SMJ SWROlaHsd mice
0.12289999.15269389.html.plaintext.txt	170	However also consistently produces MRC1 strain determined Western blotting SJLOlaHsd RIIISJ mice Fig
0.12289999.15269389.html.plaintext.txt	171	DNA sequence analysis bovine Prnp gene I783 confirmed animal homozygous PrP amino acids thereby excluding PrP heterozygosity source strain bifurcation
0.12289999.15269389.html.plaintext.txt	172	I038 independent BSE inocula also shown produce two strains TgHuPrP129MPrnp00 35 transgenic mice mixed genetic background
0.12289999.15269389.html.plaintext.txt	173	We therefore believe prion strain selection mutation feature genetic background mice studies way identify genes involved
0.12289999.15269389.html.plaintext.txt	174	Although recent data suggest one strain BSE may exist cattle Biacabe et al
0.12289999.15269389.html.plaintext.txt	175	2004 study I038 I783 appeared single strain
0.12289999.15269389.html.plaintext.txt	176	However Western blotting unable determine whether mixed population strains already existed either brains whether alternative strains generated de novo mice
0.12289999.15269389.html.plaintext.txt	177	The inbred lines studied date represent small proportion allelic variation exists mouse genome therefore study strains mice particularly derived unrelated strains trapped wild mice may reveal additional BSE derived strains
0.12289999.15269389.html.plaintext.txt	178	The human population exposed BSE much diverse genetic background observed using laboratory strains inbred mice
0.12289999.15269389.html.plaintext.txt	179	Therefore possible BSE infection may revealed type 4 PrPSc associated vCJD clinicopathological phenotype seen date Collinge et al
0.12289999.15269389.html.plaintext.txt	180	2003 future may also present alternative PrPSc types incubation times neuropathology may distinguishable sporadic CJD Hill et al
0.12289999.15269389.html.plaintext.txt	181	2002 represent additional novel phenotypes Collinge 1999
0.12289999.15269389.html.plaintext.txt	182	BSE may also infected sheep flocks UK given genetic diversity sheep breeds also possible breeds BSE propagates strain type indistinguishable natural sheep scrapie
0.12289999.15269389.html.plaintext.txt	183	ACKNOWLEDGEMENTS We thank R
0.12289999.15269389.html.plaintext.txt	184	Hawkins colleagues UK Veterinary Laboratories Agency providing BSE infected material
0.12289999.15269389.html.plaintext.txt	185	We also thank Catherine OMalley Paul Hudson Judy Beake preparation histological slides Dave Moore team animal care Ray Young preparation figures
0.12289999.15269389.html.plaintext.txt	186	This work supported Medical Research Council UK
0.12289999.15269389.html.plaintext.txt	187	REFERENCES Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Asante E
0.12289999.15269389.html.plaintext.txt	188	BSE prions propagate either variant CJD like sporadic CJD like prion strains transgenic mice expressing human prion protein
0.12289999.15269389.html.plaintext.txt	189	Biochemical physical properties prion protein two strains transmissible mink encephalopathy agent
0.12289999.15269389.html.plaintext.txt	190	Distinct PrP properties suggest molecular basis strain variation transmissible mink encephalopathy
0.12289999.15269389.html.plaintext.txt	191	Distinct molecular phenotypes bovine prion diseases
0.12289999.15269389.html.plaintext.txt	192	Scrapie strain variation mutation
0.12289999.15269389.html.plaintext.txt	193	The basis strain variation scrapie
0.12289999.15269389.html.plaintext.txt	194	In Prion Diseases Human Animals pp
0.12289999.15269389.html.plaintext.txt	195	Transmission bovine spongiform encephalopathy scrapie mice strain variation species barrier
0.12289999.15269389.html.plaintext.txt	196	Philos Trans R Soc Lond B Biol Sci 343 405 411
0.12289999.15269389.html.plaintext.txt	197	Transmissions mice indicate new variant CJD caused BSE agent
0.12289999.15269389.html.plaintext.txt	198	Strain characterization natural sheep scrapie comparison BSE
0.12289999.15269389.html.plaintext.txt	199	Linkage prion protein scrapie incubation time genes
0.12289999.15269389.html.plaintext.txt	200	Identification second bovine amyloidotic spongiform encephalopathy molecular similarities sporadic Creutzfeldt Jakob disease
0.12289999.15269389.html.plaintext.txt	201	Proc Natl Acad Sci U S A 101 3065 3070
0.12289999.15269389.html.plaintext.txt	202	Variant Creutzfeldt Jakob disease
0.12289999.15269389.html.plaintext.txt	203	Unaltered susceptibility BSE transgenic mice expressing human prion protein
0.12289999.15269389.html.plaintext.txt	204	Molecular analysis prion strain variation aetiology new variant CJD
0.12289999.15269389.html.plaintext.txt	205	Transmission feline spongiform encephalopathy mice
0.12289999.15269389.html.plaintext.txt	206	The prion strain causes vCJD BSE
0.12289999.15269389.html.plaintext.txt	207	Molecular screening sheep bovine spongiform encephalopathy
0.12289999.15269389.html.plaintext.txt	208	Molecular classification sporadic Creutzfeldt Jakob disease
0.12289999.15269389.html.plaintext.txt	209	Differences proteinase K resistance neuronal deposition abnormal prion proteins characterize bovine spongiform encephalopathy BSE scrapie strains
0.12289999.15269389.html.plaintext.txt	210	Adaptation bovine spongiform encephalopathy agent primates comparison Creutzfeldt Jakob disease implications human health
0.12289999.15269389.html.plaintext.txt	211	Proc Natl Acad Sci U S A 98 4142 4147
0.12289999.15269389.html.plaintext.txt	212	Identification multiple quantitative trait loci linked prion disease incubation period mice
0.12289999.15269389.html.plaintext.txt	213	Proc Natl Acad Sci U S A 98 6279 6283
0.12289999.15269389.html.plaintext.txt	214	Identification genetic loci affecting mouse adapted bovine spongiform encephalopathy incubation time mice
0.12289999.15269389.html.plaintext.txt	215	Separation properties cellular scrapie prion proteins
0.12289999.15269389.html.plaintext.txt	216	Proc Natl Acad Sci U S A 83 2310 2314
0.12289999.15269389.html.plaintext.txt	217	Mice gene targetted prion protein alterations show Prnp Sinc Prni congruent
0.12289999.15269389.html.plaintext.txt	218	Conversion helices sheets features formation scrapie prion proteins
0.12289999.15269389.html.plaintext.txt	219	Proc Natl Acad Sci U S A 90 10962 10966
0.12289999.15269389.html.plaintext.txt	220	A change conformation prions accompanies emergence new prion strain
0.12289999.15269389.html.plaintext.txt	221	Molecular biology prion diseases
0.12289999.15269389.html.plaintext.txt	222	Eight prion strains PrPSc molecules different conformations
0.12289999.15269389.html.plaintext.txt	223	Host transmissible spongiform encephalopathy agent strain control glycosylation PrP
0.12289999.15269389.html.plaintext.txt	224	Biochemical typing scrapie strains
0.12289999.15269389.html.plaintext.txt	225	Evidence conformation pathologic isoform prion protein enciphering propagating prion diversity
0.12289999.15269389.html.plaintext.txt	226	Strain specific prion protein conformation determined metal ions
0.12289999.15269389.html.plaintext.txt	227	Tissue distribution protease resistant prion protein variant CJD using highly sensitive immuno blotting assay
0.12289999.15269389.html.plaintext.txt	228	Preliminary observations pathogenesis experimental bovine spongiform encephalopathy BSE update
0.12289999.15269389.html.plaintext.txt	229	Distinct prion proteins short long scrapie incubation period mice
0.12289999.15269389.html.plaintext.txt	230	Received 9 December 2003 accepted 27 April 2004
0.19237107.15494372.html.plaintext.txt	0	Inhibition PrPSc formation lentiviral gene transfer PrP containing dominant negative mutations Carole Crozet1 Yea Lih Lin2 Clement Mettling2 Chantal Mourton Gilles3 Pierre Corbeau2 Sylvain Lehmann14 Veronique Perrier1
0.19237107.15494372.html.plaintext.txt	1	1 Laboratoire de Biologie des Encephalopathies Spongiformes CNRS UPR 1142 141 rue de la Cardonille 34396 Montpellier CEDEX 5 France 2 Laboratoire Lentivirus et Transfert de Genes Institut de Genetique Humaine CNRS UPR 1142 141 rue de la Cardonille 34396 Montpellier CEDEX 5 France 3 BIO RAD Centre de Pharmacologie et Biotechnologies pour la Sante CNRS UMR 5094 15 avenue C
0.19237107.15494372.html.plaintext.txt	2	Flahault 34060 Montpellier CEDEX 2 France 4 Laboratoire de Biochimie
0.19237107.15494372.html.plaintext.txt	3	Fliche 34295 Montpellier CEDEX 5 France
0.19237107.15494372.html.plaintext.txt	4	Author correspondence e mail vperrieratigh
0.19237107.15494372.html.plaintext.txt	5	Summary Top Summary Introduction Materials Methods Results Discussion References Currently treatment cure transmissible spongiform encephalopathies
0.19237107.15494372.html.plaintext.txt	6	By taking advantage prion resistant polymorphisms Q171R E219K naturally exist sheep humans respectively evaluated therapeutic approach lentiviral gene transfer
0.19237107.15494372.html.plaintext.txt	7	Here show VSV G vesicular stomatitis virus G glycoprotein pseudotyped FIV feline immunodeficiency virus derived vectors carrying mouse Prnp gene mutations inserted able inhibit prion replication chronically prion infected cells
0.19237107.15494372.html.plaintext.txt	8	Because lentiviral tools able transduce post mitotic cells neurons cells lymphoreticular system result might help development gene cell therapy approaches prion disease
0.19237107.15494372.html.plaintext.txt	9	Key words PrP Prion Dominant negative Lentivirus Therapy
0.19237107.15494372.html.plaintext.txt	10	Introduction Top Summary Introduction Materials Methods Results Discussion References Transmissible spongiform encephalopathies TSEs neurodegenerative disorders including Creutzfeldt Jakob disease humans scrapie sheep goats bovine spongiform encephalopathy cattle
0.19237107.15494372.html.plaintext.txt	11	These diseases characterized accumulation abnormal scrapie isoform prion protein called PrPSc brain Prusiner et al
0.19237107.15494372.html.plaintext.txt	12	According prion hypothesis infectious isoform PrPSc trigger autocatalytic conversion normal cellular prion protein PrPC PrPSc Prusiner et al
0.19237107.15494372.html.plaintext.txt	13	However certain cofactors protein X laminin receptor precursor might also play role conversion process Kaneko et al
0.19237107.15494372.html.plaintext.txt	14	Currently treatment available cure TSEs
0.19237107.15494372.html.plaintext.txt	15	A number chemical molecules targeting PrPSc PrPSc replication discovered either serendipitously branched polyamines Supattapone et al
0.19237107.15494372.html.plaintext.txt	16	1999 phtalocyanines porphyrin derivatives Caughey et al
0.19237107.15494372.html.plaintext.txt	17	1998 using rational approach help structure based drug design identification compound 60 Perrier et al
0.19237107.15494372.html.plaintext.txt	18	These molecules able cure scrapie infected cells infectivity however poorly efficient mice clinical symptoms developed
0.19237107.15494372.html.plaintext.txt	19	Because PrPC major cellular requirement propagation infectivity Bueler et al
0.19237107.15494372.html.plaintext.txt	20	1993 represents attractive therapeutic target
0.19237107.15494372.html.plaintext.txt	21	Recent studies conditional Prnp knockout mice showing inhibition PrPC production neurons able prevent stop development disease emphasized importance therapeutic strategies targeting PrPC Mallucci et al
0.19237107.15494372.html.plaintext.txt	22	By taking advantage prion resistant polymorphisms naturally exist sheep humans alternative approach envisaged
0.19237107.15494372.html.plaintext.txt	23	Genotype analyses sheep shown polymorphism present codon 171 ovine Prnp gene correlated disease incidence modulation incubation time
0.19237107.15494372.html.plaintext.txt	24	Sheep carrying polymorphisms QR RR codon 171 PrP protein resistant different isolates scrapie whereas sheep harboring QQ alleles developed prion disease Belt et al
0.19237107.15494372.html.plaintext.txt	25	Human genetic studies revealed gene encoding prion protein large repertoire polymorphisms mutations
0.19237107.15494372.html.plaintext.txt	26	Studies among Japanese population found 12 carried polymorphism EK codon 219 PrP protein whereas remainder carried EE alleles
0.19237107.15494372.html.plaintext.txt	27	Because EK heterozygosity codon 219 reported 85 autopsied cases patients sporadic CJD therefore suggests polymorphism EK protects humans prion diseases Shibuya et al
0.19237107.15494372.html.plaintext.txt	28	introduced Q171R sheep mutation E219K human mutation mouse Prnp gene MoPrPQ167R MoPrPQ218K respectively Kaneko et al
0.19237107.15494372.html.plaintext.txt	29	These mutated PrPs could converted abnormal PrPSc isoform significantly also inhibited formation 3F4 tagged mouse PrPSc molecules co transfection experiments Kaneko et al
0.19237107.15494372.html.plaintext.txt	30	The substitutions Q167R Q218K MoPrP therefore described dominant negative mutants block replication wild type counterparts Kaneko et al
0.19237107.15494372.html.plaintext.txt	31	analyzed dominant negative inhibition effect transgenic mice Perrier et al
0.19237107.15494372.html.plaintext.txt	32	Transgenic mice carrying PrP Q167R Q218K substitutions Prnp background unable replicate propagate prion diseases
0.19237107.15494372.html.plaintext.txt	33	In transgenic mice whose wild type wt Prnp gene re inserted conversion wt PrPC PrPSc dramatically slowed correlated increase incubation time animals
0.19237107.15494372.html.plaintext.txt	34	This dominant negative effect seemed depend particular ratio mutated PrP molecules produced transgene endogenous wt PrP molecules
0.19237107.15494372.html.plaintext.txt	35	These transgenic experiments demonstrate relevance dominant negative mutants directly applicable gene therapy appeared necessary develop vectors vivo delivery
0.19237107.15494372.html.plaintext.txt	36	The lentiviral gene transfer system one appropriate systems could employed
0.19237107.15494372.html.plaintext.txt	37	We used vesicular stomatitis virus G glycoprotein VSV G pseudotyped feline immunodeficiency virus FIV lentiviral vectors evaluate gene transfer therapeutic strategy
0.19237107.15494372.html.plaintext.txt	38	Here show FIV vectors carrying MoPrPQ167R MoPrPQ218K dominant negative mutants able abolish endogenous wt PrPSc replication chronically prion infected N2a5822L cells
0.19237107.15494372.html.plaintext.txt	39	In addition injections virion preparations mice using intracerebral ic intravenous iv routes demonstrate lentiviral vectors transduce cells brain spleen tissues
0.19237107.15494372.html.plaintext.txt	40	Therefore results present advance development gene cell therapy approaches combat prion disease
0.19237107.15494372.html.plaintext.txt	41	Materials Methods Top Summary Introduction Materials Methods Results Discussion References Nomenclature Residue 171 ovine PrP corresponds codon 167 mouse prion protein MoPrP
0.19237107.15494372.html.plaintext.txt	42	Residue 219 human PrP HuPrP corresponds codon 218 MoPrP
0.19237107.15494372.html.plaintext.txt	43	Cell lines description The Prnp cerebellar cells derived Prnp knockout mice kindly provided T
0.19237107.15494372.html.plaintext.txt	44	Prnp cells cultured Dulbeccos modified Eagles medium DMEMF12 containing 10 fetal calf serum FCS 10 Uml penicillin 10 mgml streptomycin 37 degrees C 5 CO2
0.19237107.15494372.html.plaintext.txt	45	The mouse neuroblastoma N2a cell line purchased American Type Culture Collection ATCC CCL 131
0.19237107.15494372.html.plaintext.txt	46	N2a cells stably transfected wild type mouse Prnp cDNA
0.19237107.15494372.html.plaintext.txt	47	N2a58 subclone overexpressing MoPrP proteins chronically infected mouse adapted scrapie strain 22L described Nishida et al
0.19237107.15494372.html.plaintext.txt	48	2000 resulting N2a5822L cells
0.19237107.15494372.html.plaintext.txt	49	Cells cultivated MEM supplemented 10 FCS 300 microgml geneticin 10 Uml penicillin 10 mgml streptomycin 37 degrees C 5 CO2
0.19237107.15494372.html.plaintext.txt	50	Construction lentiviral derived vector carrying PrP mutants Q167R Q218K Mutagenesis performed open reading frame MoPrP using QuikChange site directed mutagenesis kit Stratagene primers containing mutations Q167R 5 GTACTACAGGCCAGTGGATCGGTACAGCAACCAGAACAACT 3 5 GTTGTTCTGGTTGCTGTACCGATCCACTGGCCTGTAGTAC 3 Q218K 5 GATGTGCGTCACCCAGTACAAAAAGGAGTCCCAGGCCTATTA 3 5 TAATAGGCCTGGGACTCCTTTTTGTACTGGGTGACGCACATC 3
0.19237107.15494372.html.plaintext.txt	51	The resulting cDNAs MoPrPQ167R MoPrPQ218K subcloned gene transfer vector used virion production
0.19237107.15494372.html.plaintext.txt	52	This transfer vector derived prototypic FIV 14 Petaluma genome NIH AIDS Research Reference Reagent Program httpwww
0.19237107.15494372.html.plaintext.txt	53	org replacing U3 region 5 LTR cytomegalovirus CMV promoter supporting expression vector cells Lin et al
0.19237107.15494372.html.plaintext.txt	54	Moreover gag gene truncated position 1243 frameshift introduced position 926
0.19237107.15494372.html.plaintext.txt	55	The pol vif orfA env rev genes replaced cloning cassette containing mutated PrP sequences driven phosphoglycerate kinase promoter
0.19237107.15494372.html.plaintext.txt	56	The PrP sequence followed internal ribosome entry sequence IRES enhanced green fluorescent GFP protein marker gene Fig
0.19237107.15494372.html.plaintext.txt	57	View larger version 17K Fig
0.19237107.15494372.html.plaintext.txt	58	Characteristics lentiviral vectors
0.19237107.15494372.html.plaintext.txt	59	The packaging vector derived prototypic FIV 14 Petaluma genome AIDS Research Reference Reagent Program 5 LTR replaced CMV promoter 3 LTR poly A signal
0.19237107.15494372.html.plaintext.txt	60	The transfer vector also obtained FIV 14 Petaluma replacing U3 region 5 LTR CMV promoter order enable expression vector cells
0.19237107.15494372.html.plaintext.txt	61	Moreover gag gene truncated position 1243 frameshift introduced position 926
0.19237107.15494372.html.plaintext.txt	62	The pol vif orfA env rev genes replaced cassette containing mutated PrP sequences driven phosphoglycerate kinase promoter
0.19237107.15494372.html.plaintext.txt	63	The PrP sequence followed IRES sequence enhanced GFP marker gene
0.19237107.15494372.html.plaintext.txt	64	G used pseudotyping contains VSV G envelope gene encodes envelope G protein vesicular stomatitis virus
0.19237107.15494372.html.plaintext.txt	65	PGK phosphoglycerate kinase promoter CTE constitutive transport element cPPT CTS central DNA flap sequence SD splice donor site
0.19237107.15494372.html.plaintext.txt	66	Virion production VSV G pseudotyped FIV lentiviral vectors produced transient transfections HEK293T cells following three plasmids gene transfer vector packaging vector pMD
0.19237107.15494372.html.plaintext.txt	67	The packaging vector also derived FIV 14 Petaluma genome whose 5 LTR replaced CMV promoter 3 LTR replaced poly A signal
0.19237107.15494372.html.plaintext.txt	68	G used pseudotyping contains VSV G envelope gene encodes envelope G protein vesicular stomatitis virus Fig
0.19237107.15494372.html.plaintext.txt	69	HEK293T cells plated density 3
0.19237107.15494372.html.plaintext.txt	70	106 100 mm plates transfected using calcium phosphate method Sambrook et al
0.19237107.15494372.html.plaintext.txt	71	1989 9 microg gene transfer plasmid harboring PrP mutant 15 microg FIV derived packaging plasmid codes virion structural protein 6 microg VSV G envelope plasmid pseudotyping
0.19237107.15494372.html.plaintext.txt	72	After 18 hours medium replaced 10 ml DMEM containing 125 mM Hepesplate
0.19237107.15494372.html.plaintext.txt	73	Virions collected day 2 3
0.19237107.15494372.html.plaintext.txt	74	The virion suspension cleared filtration 0
0.19237107.15494372.html.plaintext.txt	75	45 microM filter concentrated two successive ultra centrifugations 52112 g 90 minutes SW28 Beckman
0.19237107.15494372.html.plaintext.txt	76	Virions resuspended PBS
0.19237107.15494372.html.plaintext.txt	77	The viral titer determined FACS analysis GFP HEK293T cells transduced virion preparations according protocol described Curran et al
0.19237107.15494372.html.plaintext.txt	78	2000 measuring p24 levels virions PetChek Idexx kit IDEXX Laboratories Westbrook Maine USA
0.19237107.15494372.html.plaintext.txt	79	As indication 20 microl virion suspension titer 108 109 transducing unit TUml obtained 100 mm plate HEK293T cells
0.19237107.15494372.html.plaintext.txt	80	In vitro lentivirus transduction Cells transduced multiplicity infection MOI 1 10 1 10 TUs per cell medium supplemented polybrene 8 microgml using 12 well plate containing 105 cellswell
0.19237107.15494372.html.plaintext.txt	81	The plates centrifuged 1200 g 90 minutes 30 degrees C
0.19237107.15494372.html.plaintext.txt	82	At next day medium replaced fresh one
0.19237107.15494372.html.plaintext.txt	83	Immunoblotting PrPC PrPSc Six days transduction Prnp cells lysed lysis buffer 10 mM Tris HCl pH 8
0.19237107.15494372.html.plaintext.txt	84	5 sodium deoxycholate samples analyzed immunoblotting Perrier et al
0.19237107.15494372.html.plaintext.txt	85	PrPC detected SAF32 monoclonal antibody directed 59 89 epitope human PrP
0.19237107.15494372.html.plaintext.txt	86	To detect PrPSc N2a5822L cells cellular lysates collected different times transduction proteinase K PK treated Perrier et al
0.19237107.15494372.html.plaintext.txt	87	Immunoblotting performed SAF mix described elsewhere Perrier et al
0.19237107.15494372.html.plaintext.txt	88	In situ detection GFP PrPC PrPSc Fluorescence GFP protein observed indirect microscopy Leica fixation formaline 3
0.19237107.15494372.html.plaintext.txt	89	Immunocytofluorescence PrPC PrPSc performed previously described Mange et al
0.19237107.15494372.html.plaintext.txt	90	The SAF61 antibody directed the144 156 epitope HuPrP
0.19237107.15494372.html.plaintext.txt	91	Animal models C57Bl6 mice used experiments Charles RiversIFFA CREDO LArbresle France
0.19237107.15494372.html.plaintext.txt	92	They housed independent filtered pressurised enclosure A3 facility according French Ethical Committee guidelines Decree 87 848 European Community Directive 86609EEC
0.19237107.15494372.html.plaintext.txt	93	Injection lentivirus mice Mice deeply anaesthetized mixture 100 microgg ketamine 15 microgg xylazine
0.19237107.15494372.html.plaintext.txt	94	For ic injection lentivirus used 10 microl Hamilton syringe 26 gauge G needle fixed stereotaxic frame connected microinjection pump David Kopf Instruments Tujunga CA
0.19237107.15494372.html.plaintext.txt	95	Five microliters lentiviral preparation expressing ss galactosidase gene 108 TUml injected rate 0
0.19237107.15494372.html.plaintext.txt	96	5 microlminute either ventricle anteroposterior 0 lateral 1 dorsoventral 25 see Fig
0.19237107.15494372.html.plaintext.txt	97	4CD thalamus 1
0.19237107.15494372.html.plaintext.txt	98	One three weeks injections brains removed fixed 2 paraformaldehyde PFA
0.19237107.15494372.html.plaintext.txt	99	For iv injections 100 microl lentiviral preparation expressing ss galactosidase gene 2x108 TUml injected 26G needle mouse
0.19237107.15494372.html.plaintext.txt	100	Five weeks injections spleens removed fixed 2 PFA
0.19237107.15494372.html.plaintext.txt	101	View larger version 90K Fig
0.19237107.15494372.html.plaintext.txt	102	In vivo delivery FIV lentiviral vectors
0.19237107.15494372.html.plaintext.txt	103	A E Brain slices mice intracerebrally injected FIV lentiviral vectors carrying ss galactosidase gene X Gal staining blue coloration 1 week injection
0.19237107.15494372.html.plaintext.txt	104	A B According site injection red arrow blue coloration observed mediodorsal thalamic nucleus
0.19237107.15494372.html.plaintext.txt	105	C E X Gal staining also observed along needle passage C cortex well fibers corpus callosum D wall ventricules E anteroventral thalamic nucleus
0.19237107.15494372.html.plaintext.txt	106	F K After intraventricular injection close immunohistochemical examination using anti ss galactosidase antibody allowed detection ss galactosidase expression red staining 3 weeks injection I cortex J striatum K cerebellum
0.19237107.15494372.html.plaintext.txt	107	No staining observed non injected mice used control
0.19237107.15494372.html.plaintext.txt	108	F cortex G striatum H cerebellum
0.19237107.15494372.html.plaintext.txt	109	L Q Sections spleen liver intravenously injected mice analysed immunocytochemistry
0.19237107.15494372.html.plaintext.txt	110	Positive cells detected vicinity blood vessels M N spleen Q liver P isolated cells liver
0.19237107.15494372.html.plaintext.txt	111	No staining observed non injected mice L spleen O Liver
0.19237107.15494372.html.plaintext.txt	112	Cx cortex Hp hippocampus MDTh mediodorsal thalamic nucleus CC corpus callosum LV lateral ventricule vhc ventral hippocampal commissure AV Th anteroventral thalamic nucleus BV blood vessel
0.19237107.15494372.html.plaintext.txt	113	Scale bars A E 1 mm F N 10 microm
0.19237107.15494372.html.plaintext.txt	114	Detection ss galactosidase expression C57Bl6 mice After short 30 minutes fixation period 2 PFA ss galactosidase staining carried incubating entire brain overnight X Gal solution 37 degrees C
0.19237107.15494372.html.plaintext.txt	115	For immunohistochemical analysis fixation spleen tissue brains performed overnight 0
0.19237107.15494372.html.plaintext.txt	116	The brains subsequently dehydrated graded concentrations alcohol embedded paraffin
0.19237107.15494372.html.plaintext.txt	117	Sections 5 microm collected onto pre treated glass slides Polylysin StarFrost Fisher Scientific
0.19237107.15494372.html.plaintext.txt	118	Slides dewaxed treated proteinase K 20 microgml Roche Boehringer 10 minutes 37 degrees C
0.19237107.15494372.html.plaintext.txt	119	All steps carried room temperature 22 degrees C 24 degrees C
0.19237107.15494372.html.plaintext.txt	120	Endogenous peroxidase activity inhibited 2 H2O2 Merck 0
0.19237107.15494372.html.plaintext.txt	121	Non specific antigenic sites blocked 30 minute incubation 4 normal goat serum
0.19237107.15494372.html.plaintext.txt	122	An anti ss galactosidase monoclonal antibody Chemicon applied overnight
0.19237107.15494372.html.plaintext.txt	123	Brain sections rinsed detection primary antibody using ABC system Vector
0.19237107.15494372.html.plaintext.txt	124	These steps followed rinsing sections 0
0.19237107.15494372.html.plaintext.txt	125	1 M PBS peroxidase finally revealed incubating sections 0
0.19237107.15494372.html.plaintext.txt	126	1 M PBS containing aminoethylcarbazole AEC Dako give red deposits
0.19237107.15494372.html.plaintext.txt	127	The slides weakly counterstained aqueous hematoxylin mounting GelMount
0.19237107.15494372.html.plaintext.txt	128	Images collected Zeiss Axiophot microscope using Nikon DXM1200 camera
0.19237107.15494372.html.plaintext.txt	129	Results Discussion Top Summary Introduction Materials Methods Results Discussion References Lentivirus mediated gene transfer provides potentially useful tool therapeutic strategies transduce dividing non dividing cells neurons stable long term fashion Blomer et al
0.19237107.15494372.html.plaintext.txt	130	This system also allows transfer genes without selection process preventing eventual undesirable clonal effect
0.19237107.15494372.html.plaintext.txt	131	We therefore developed FIV derived vectors evaluate gene transfer therapeutic strategy using inhibitory properties PrP dominant negative mutants prion replication
0.19237107.15494372.html.plaintext.txt	132	We prepared VSV G pseudotyped FIV vectors containing mouse Prnp gene Q167R Q218K mutations generated PCR mutagenesis
0.19237107.15494372.html.plaintext.txt	133	To identify transduced cells measure efficiency transduction gene interest vectors followed IRES sequence reporter gene coding GFP
0.19237107.15494372.html.plaintext.txt	134	Virion particles produced transfecting HEK293T cells three plasmid expression system Fig
0.19237107.15494372.html.plaintext.txt	135	1 gene transfer vector carrying mutated Prnp genes FIV derived packaging plasmid coding structural proteins virions VSV G envelope plasmid determines cellular pseudotyping
0.19237107.15494372.html.plaintext.txt	136	Virions produced culture medium filtrated concentrated successive ultra centrifugations Curran et al
0.19237107.15494372.html.plaintext.txt	137	The viral titers determined counting number GFP positive fluorescent cells using FACS analysis transduction HEK293T cells different dilutions virions
0.19237107.15494372.html.plaintext.txt	138	To evaluate whether viral particles able transduce cellular models efficiently express mutated genes Prnp cerebellar cells derived Prnp knockout mice Kuwahara et al
0.19237107.15494372.html.plaintext.txt	139	1999 transduced virion preparations MOI 10 10 TUcell
0.19237107.15494372.html.plaintext.txt	140	The success gene transfer assessed fluorescence properties GFP Fig
0.19237107.15494372.html.plaintext.txt	141	The transduced Prnp cells expressed MoPrPQ167R MoPrPQ218K proteins demonstrated immunoblotting analysis using SAF32 antibody Fig
0.19237107.15494372.html.plaintext.txt	142	The similar levels PrPC detected agree identical viral titers used transduction
0.19237107.15494372.html.plaintext.txt	143	Furthermore immunofluorescence cells also showed mutated proteins correctly exported cell surface suggests dominant negative mutations affect cellular trafficking PrP protein Fig
0.19237107.15494372.html.plaintext.txt	144	View larger version 78K Fig
0.19237107.15494372.html.plaintext.txt	145	Transduction Prnp cells lentivirus carrying PrP dominant negative mutants MoPrPQ167R MoPrPQ218K
0.19237107.15494372.html.plaintext.txt	146	A Transduction efficacy Prnp cells lentiviral vectors assessed GFP fluorescence
0.19237107.15494372.html.plaintext.txt	147	Images A1 A2 A3 A4 correspond non transduced GFP MoPrPQ167R MoPrPQ218K transduced cells respectively
0.19237107.15494372.html.plaintext.txt	148	B Detection PrPC immunoblotting using SAF32 anti PrP antibody C SAF32 immunocytofluorescence PrPC Prnp cells staining visible C5 non transduced C6 GFP lentiviral transduced cells whereas cells transduced C7 MoPrPQ167R C8 MoPrPQ218K lentivirus exhibit strong rhodamine fluorescence
0.19237107.15494372.html.plaintext.txt	149	C1 C2 C3 C4 correspond Hoechst nuclear staining cells represented figure C5 C6 C7 C8 respectively
0.19237107.15494372.html.plaintext.txt	150	To investigate inhibitory potential lentivirus vectors carrying dominant negative PrP mutants prion infected neuroblastoma cells N2a5822L transduced
0.19237107.15494372.html.plaintext.txt	151	This N2a5822L cell line provides model prion replication constitutively produces high levels PrPSc proteins Nishida et al
0.19237107.15494372.html.plaintext.txt	152	The cells transduced different preparations virions using MOI 1
0.19237107.15494372.html.plaintext.txt	153	By counting number GFP positive cells able determine efficacy transduction 80 Fig
0.19237107.15494372.html.plaintext.txt	154	3A without toxicity cells
0.19237107.15494372.html.plaintext.txt	155	View larger version 64K Fig
0.19237107.15494372.html.plaintext.txt	156	Transduction N2a5822L cells MoPrPQ167R MoPrPQ218K virions
0.19237107.15494372.html.plaintext.txt	157	A GFP analysis transduction N2a5822L cells
0.19237107.15494372.html.plaintext.txt	158	A1 non transduced cells A2 cells transduced GFP vector A3 MoPrPQ167R A4 MoPrPQ218K PrP mutants
0.19237107.15494372.html.plaintext.txt	159	B Inhibition endogenous MoPrPSc levels dominant negative mutants N2a5822L cells
0.19237107.15494372.html.plaintext.txt	160	Proteinase K digested cell lysates analyzed immunoblotting wild type MoPrPSc levels revealed SAF mix
0.19237107.15494372.html.plaintext.txt	161	N2a5822L cells expressing MoPrPQ218K mutant showed strong inhibition PrPSc level day 8 D8 day 12 D12 transduction whereas cells expressing MoPrPQ167R mutants showed slight diminution
0.19237107.15494372.html.plaintext.txt	162	C Kinetic analysis PrPSc inhibition N2a5822L cells western blot analysis 8 12 15 days lanes 1 2 3 respectively transduction
0.19237107.15494372.html.plaintext.txt	163	NT non transduced cells GFP cells transduced virions carrying GFP virions carrying Q167R MoPrPQ167R Q218K MoPrPQ218K
0.19237107.15494372.html.plaintext.txt	164	These results representative several independent experiments
0.19237107.15494372.html.plaintext.txt	165	D Immunofluorescence PrPSc accumulation using SAF61 anti PrP antibody 20 days transduction
0.19237107.15494372.html.plaintext.txt	166	D5 non transduced D6 GFP D7 MoPrPQ167R D8 MoPrPQ218K
0.19237107.15494372.html.plaintext.txt	167	D1 D2 D3 D4 correspond Hoechst nuclear staining cells presented figure D5 D6 D7 D8 respectively
0.19237107.15494372.html.plaintext.txt	168	Transduced N2a5822L cells serially split duplicates cultivated several weeks
0.19237107.15494372.html.plaintext.txt	169	Every four days cellular lysates collected proteinase K treated analyse inhibition kinetic endogenous MoPrPSc levels immunoblotting
0.19237107.15494372.html.plaintext.txt	170	After 8 12 days N2a5822L cells expressing dominant negative MoPrPQ167R MoPrPQ218K mutants showed strong reduction endogenous wt MoPrPSc levels Fig
0.19237107.15494372.html.plaintext.txt	171	After 15 days culture majority PrPSc cleared Fig
0.19237107.15494372.html.plaintext.txt	172	To confirm elimination PrPSc performed SAF61 immunocytofluorescence PrPSc 20 days
0.19237107.15494372.html.plaintext.txt	173	We used standard guanidinium thiocyanate protocol allows PrPSc staining promoting antigen retrieval PrPSc elimination PrPC staining Mange et al
0.19237107.15494372.html.plaintext.txt	174	This method also showed large decrease PrPSc cells containing dominant negative construct Fig
0.19237107.15494372.html.plaintext.txt	175	3D inhibitory effect reproduced three independent experiments data shown
0.19237107.15494372.html.plaintext.txt	176	Generally results show virions harboring PrP dominant negative mutants functional efficient inhibit endogenous wt PrPSc conversion
0.19237107.15494372.html.plaintext.txt	177	These results accordance obtained previous studies Kaneko et al
0.19237107.15494372.html.plaintext.txt	178	2002 showed inhibition wt MoPrPSc formation occur MoPrPQ167R MoPrPQ218K mutants
0.19237107.15494372.html.plaintext.txt	179	In addition lentiviral gene transfer method allowed us amplify inhibitory effect dominant negative mutants scrapie infected cells
0.19237107.15494372.html.plaintext.txt	180	The transient transfections prion infected cells performed Kaneko et al
0.19237107.15494372.html.plaintext.txt	181	1997 resulted minority cells expressing PrP mutants inhibitory effect conversion 3F4 tagged MoPrPC conversion endogenous wild type PrPC PrPSc
0.19237107.15494372.html.plaintext.txt	182	In case majority cells expressed PrP mutants able obtain strong inhibition conversion endogenous wt PrPC PrPSc
0.19237107.15494372.html.plaintext.txt	183	Our results show delivery dominant negative PrP mutants lentiviral vectors provide strong expression transgene also transdominantly inhibit accumulation endogenous wt MoPrPSc chronically scrapie infected N2a5822L cells
0.19237107.15494372.html.plaintext.txt	184	Lentiviral vectors possess ability transduce post mitotic cells differentiated neurons well cells lymphoreticular system prolonged stable manner Aguzzi et al
0.19237107.15494372.html.plaintext.txt	185	2004 Mabbott Bruce 2003 Mangeot et al
0.19237107.15494372.html.plaintext.txt	186	To analyse whether lentiviral vectors potential deliver gene brain peripheric organs performed ic iv injections lentivirus expressing ss galactosidase gene mice
0.19237107.15494372.html.plaintext.txt	187	For ic delivery used stereotaxic frame inject lentiviral preparation right lateral ventricle thalamus adult C57BL6 mice
0.19237107.15494372.html.plaintext.txt	188	ss galactosidase expression assessed direct X Gal staining entire brain
0.19237107.15494372.html.plaintext.txt	189	Following intrathalamic injection observed ss galactosidase activity mainly injection site Fig
0.19237107.15494372.html.plaintext.txt	190	4ABE demonstrated capacity lentivirus transduce neural cells
0.19237107.15494372.html.plaintext.txt	191	Following intraventricular injection X Gal blue coloration limited along syringe trajectory around lateral ventricle Fig
0.19237107.15494372.html.plaintext.txt	192	This probably owing diffusion lentiviral particle whole ventricle
0.19237107.15494372.html.plaintext.txt	193	However close examination brain immunohistochemical analysis allowed us detect ss galactosidase staining area striatum cortex distant sites well area cerebellum Fig
0.19237107.15494372.html.plaintext.txt	194	After systemic lentiviral injections ss galactosidase observed around blood vessels spleen mice dispersed liver cells probably due iv injection Fig
0.19237107.15494372.html.plaintext.txt	195	The spleen localisation vicinity vessels somehow pertinent structures innervated noradrenergic peripheric autonomous nervous system implicated neuroinvasion process Aguzzi et al
0.19237107.15494372.html.plaintext.txt	196	These data showed lentiviral vectors used transduce cells brain spleen
0.19237107.15494372.html.plaintext.txt	197	Because neurons main cells targeted prion disease use lentiviral vectors carrying dominant negative PrP mutants could slow even prevent prion replication least brain area transduced virion particles
0.19237107.15494372.html.plaintext.txt	198	In addition first stages prion diseases characterized increase PrPSc levels lymphoreticular system spleen Lasmezas et al
0.19237107.15494372.html.plaintext.txt	199	Thus lentiviral vectors could useful effectors development gene therapy repeated peripheral injections aim slowing preventing prion replication early stages disease least neuroinvasion
0.19237107.15494372.html.plaintext.txt	200	Moreover gene therapy strategy recently evaluated Marr et al
0.19237107.15494372.html.plaintext.txt	201	alternative therapeutic approach treatment Alzheimers disease Marr et al
0.19237107.15494372.html.plaintext.txt	202	Lentiviral vectors expressing neprilysin major Ass degrading enzyme identified human brain implicated clearance Ass amyloids tested transgenic mouse models amyloidosis
0.19237107.15494372.html.plaintext.txt	203	A single lentiviral injection decreased number size amyloid plaques 45
0.19237107.15494372.html.plaintext.txt	204	Altogether data encouraged us evaluate therapeutic strategies based injections lentivirus carrying dominant negative PrP mutants ic peripheral routes
0.19237107.15494372.html.plaintext.txt	205	Moreover recent promising results neuroprotective cell therapy treatment prompted us consider approach combining cell therapy gene therapy using dominant negative PrP mutants Bachoud Levi et al
0.19237107.15494372.html.plaintext.txt	206	2001 Brustle McKay 1996 Lindvall 2003 Lindvall McKay 2003
0.19237107.15494372.html.plaintext.txt	207	Indeed neural precursors obtained vitro differentiation embryonic stem cells could thus transduced dominant negative PrP virion preparations injection prion infected brain
0.19237107.15494372.html.plaintext.txt	208	The recent description soluble dimeric PrP Meier et al
0.19237107.15494372.html.plaintext.txt	209	2003 RNAi interferences Daude et al
0.19237107.15494372.html.plaintext.txt	210	2003 antagonize prion replication may also engineered lentiviral vectors extend inhibitory effect
0.19237107.15494372.html.plaintext.txt	211	Acknowledgments We grateful Claire Marianni T
0.19237107.15494372.html.plaintext.txt	212	Onodera Prnp cells J
0.19237107.15494372.html.plaintext.txt	213	Grassi anti PrP antibodies AIDS Research Reference Reagent Program FIV F14 Petaluma strain
0.19237107.15494372.html.plaintext.txt	214	financially supported government grants French Ministry Research GIS Infections Prions 2001 project number A62 fellowship International Carrefour Foundation Paris France
0.19237107.15494372.html.plaintext.txt	215	References Top Summary Introduction Materials Methods Results Discussion References
0.19237107.15494372.html.plaintext.txt	216	Immune system peripheral nerves propagation prions CNS
0.19237107.15494372.html.plaintext.txt	217	Motor cognitive improvements patients Huntingtons disease neural transplantation
0.19237107.15494372.html.plaintext.txt	218	Identification five allelic variants sheep PrP gene association natural scrapie
0.19237107.15494372.html.plaintext.txt	219	Autonomic nervous system innervation lymphoid territories spleen possible involvement noradrenergic neurons prion neuroinvasion natural scrapie
0.19237107.15494372.html.plaintext.txt	220	Applications gene therapy CNS
0.19237107.15494372.html.plaintext.txt	221	Highly efficient sustained gene transfer adult neurons lentivirus vector
0.19237107.15494372.html.plaintext.txt	222	PrP genotype contributes determining survival times sheep natural scrapie
0.19237107.15494372.html.plaintext.txt	223	Fetal cell grafts provide long term protection scrapie induced neuronal loss
0.19237107.15494372.html.plaintext.txt	224	Neuronal progenitors tools cell replacement nervous system
0.19237107.15494372.html.plaintext.txt	225	Mice devoid PrP resistant scrapie
0.19237107.15494372.html.plaintext.txt	226	Inhibition protease resistant prion protein formation porphyrins phthalocyanines
0.19237107.15494372.html.plaintext.txt	227	Efficient transduction nondividing cells optimized feline immunodeficiency virus vectors
0.19237107.15494372.html.plaintext.txt	228	Specific inhibition pathological prion protein accumulation small interfering RNAs
0.19237107.15494372.html.plaintext.txt	229	Variant Creutzfeldt jakob disease lymphoid organs brain
0.19237107.15494372.html.plaintext.txt	230	PrP genotype agent effects scrapie change allelic interaction different isolates agent sheep natural host scrapie
0.19237107.15494372.html.plaintext.txt	231	Brain targeting autonomous nervous system lessons prion diseases
0.19237107.15494372.html.plaintext.txt	232	Evidence protein X binding discontinuous epitope cellular prion protein scrapie prion propagation
0.19237107.15494372.html.plaintext.txt	233	Prions prevent neuronal cell line death
0.19237107.15494372.html.plaintext.txt	234	Immune system dependent independent replication scrapie agent
0.19237107.15494372.html.plaintext.txt	235	The 37 kDa67 kDa laminin receptor required PrPSc propagation scrapie infected neuronal cells
0.19237107.15494372.html.plaintext.txt	236	FIV vectors efficient transduction primary human synoviocytes application original model rheumatoid arthritis
0.19237107.15494372.html.plaintext.txt	237	Stem cells cell therapy Parkinsons disease
0.19237107.15494372.html.plaintext.txt	238	Brain repair cell replacement regeneration
0.19237107.15494372.html.plaintext.txt	239	Prion disease bridging spleen nerve gap
0.19237107.15494372.html.plaintext.txt	240	Pathogenesis oral route infection mice scrapie bovine spongiform encephalopathy agents
0.19237107.15494372.html.plaintext.txt	241	Depleting neuronal PrP prion infection prevents disease reverses spongiosis
0.19237107.15494372.html.plaintext.txt	242	Scrapie like prion protein translocated nuclei infected cells independently proteasome inhibition interacts chromatin
0.19237107.15494372.html.plaintext.txt	243	High levels transduction human dendritic cells optimized SIV vectors
0.19237107.15494372.html.plaintext.txt	244	Neprilysin gene transfer reduces human amyloid pathology transgenic mice
0.19237107.15494372.html.plaintext.txt	245	Soluble dimeric prion protein binds PrPSc vivo antagonizes prion disease
0.19237107.15494372.html.plaintext.txt	246	In vivo gene delivery stable transduction nondividing cells lentiviral vector
0.19237107.15494372.html.plaintext.txt	247	Successful transmission three mouse adapted scrapie strains murine neuroblastoma cell lines overexpressing wild type mouse prion protein
0.19237107.15494372.html.plaintext.txt	248	Mimicking dominant negative inhibition prion replication structure based drug design
0.19237107.15494372.html.plaintext.txt	249	Dominant negative inhibition prion replication transgenic mice
0.19237107.15494372.html.plaintext.txt	250	Anti PrP antibodies block PrPSc replication prion infected cell cultures accelerating PrPC degradation
0.19237107.15494372.html.plaintext.txt	251	Positioning follicular dendritic cells within spleen controls prion neuroinvasion
0.19237107.15494372.html.plaintext.txt	252	Transgenetic studies implicate interactions homologous PrP isoforms scrapie prion replication
0.19237107.15494372.html.plaintext.txt	253	Cold Spring Harbor NY Cold Spring Harbor Laboratory Press
0.19237107.15494372.html.plaintext.txt	254	Codon 219 Lys allele PRNP found sporadic Creutzfeldt Jakob disease
0.19237107.15494372.html.plaintext.txt	255	Elimination prions branched polyamines implications therapeutics
0.19237107.15494372.html.plaintext.txt	256	Gene therapy prions JCS 2004 117 2303
0.19237107.15494372.html.plaintext.txt	257	This Article Summary Figures Only Full Text PDF All Versions Article jcs
0.19237107.15494372.html.plaintext.txt	258	01484v1 117235591 recent Alert article cited Alert correction posted Services Email article friend Related articles JCS Similar articles journal Similar articles PubMed Alert new issues journal Download citation manager Google Scholar Articles Crozet C
0.19237107.15494372.html.plaintext.txt	259	Articles citing Article PubMed PubMed Citation Articles Crozet C
0.2039969.11842265.html.plaintext.txt	0	Expression doppel CNS mice modulate transmissible spongiform encephalopathy disease Nadia L
0.2039969.11842265.html.plaintext.txt	1	Tuzi1 Elaine Gall1 David Melton2 Jean C
0.2039969.11842265.html.plaintext.txt	2	Neuropathogenesis Unit Institute Animal Health Ogston Building West Mains Road Edinburgh EH9 3JF UK1 Sir Alastair Currie CRC Laboratories Molecular Medicine Centre University Edinburgh Western General Hospital Edinburgh EH4 2XU UK2
0.2039969.11842265.html.plaintext.txt	3	Author correspondence Jean Manson
0.2039969.11842265.html.plaintext.txt	4	Abstract Top Abstract Introduction Methods Results Discussion References Late onset ataxia reported three independently derived PrP null lines mice attributed overexpression doppel protein CNS mice rather loss PrP
0.2039969.11842265.html.plaintext.txt	5	The central role PrP transmissible spongiform encephalopathies TSEs proximity gene encodes doppel Prnd PrP gene Prnp structural similarity shared PrP doppel led proposition ataxia develops TSE disease could part due doppel
0.2039969.11842265.html.plaintext.txt	6	In order address hypothesis crossed two inbred lines PrP null mice either express RCM express NPU Prnd gene CNS mice expressing two Prnpa108F189V alleles PrP gene
0.2039969.11842265.html.plaintext.txt	7	We found TSE infection influence level expression Prnd CNS terminal stages disease
0.2039969.11842265.html.plaintext.txt	8	Moreover demonstrated level expression Prnd CNS influence incubation period vacuolar pathology amount distribution PrPSc deposition brains TSE infected mice
0.2039969.11842265.html.plaintext.txt	9	Doppel therefore apparent influence outcome TSE disease transgenic mice suggesting unlikely involved naturally occurring TSE diseases species
0.2039969.11842265.html.plaintext.txt	10	Introduction Top Abstract Introduction Methods Results Discussion References The transmissible spongiform encephalopathies TSEs group fatal neurodegenerative diseases affect animals humans
0.2039969.11842265.html.plaintext.txt	11	The PrP protein plays central role diseases demonstrated resistance PrP null mice TSE disease Bueler et al
0.2039969.11842265.html.plaintext.txt	12	During course disease PrP converted normal cellular protease sensitive form PrPC attached cell membrane glycophosphatidylinositol GPI anchor disease associated form PrPSc resistant proteases accumulates around cells CNS
0.2039969.11842265.html.plaintext.txt	13	To elucidate role PrP TSE disease normal function PrP number lines PrP null PrP mice generated
0.2039969.11842265.html.plaintext.txt	14	The first two lines PrP mice produced ZrchI NPU developed reproduced normally Bueler et al
0.2039969.11842265.html.plaintext.txt	15	However subtle phenotypic alterations altered circadian rhythm Tobler et al
0.2039969.11842265.html.plaintext.txt	16	1996 electrophysiological defects Collinge et al
0.2039969.11842265.html.plaintext.txt	17	1994 alterations copper binding superoxide dismutase activity CNS Brown et al
0.2039969.11842265.html.plaintext.txt	18	1997 subsequently attributed loss PrP mice
0.2039969.11842265.html.plaintext.txt	19	Three lines PrP null mice Nsgk Rcm0 Zrch II since reported
0.2039969.11842265.html.plaintext.txt	20	These lines present ataxic phenotype Purkinje cell loss approximately 50 70 weeks age Moore et al
0.2039969.11842265.html.plaintext.txt	21	A recent study investigating cause ataxia mice mapped gene 16 kb downstream murine Prnp gene PrP termed Prnd
0.2039969.11842265.html.plaintext.txt	22	This gene encodes PrP like protein named doppel Dpl
0.2039969.11842265.html.plaintext.txt	23	This gene found expressed CNS PrP null mice went develop ataxic phenotype Prnd expression detected CNS ZrchI Moore et al
0.2039969.11842265.html.plaintext.txt	24	Manson unpublished observation
0.2039969.11842265.html.plaintext.txt	25	It suggested overexpression Dpl Prnp mice causes Purkinje cell loss ataxia ataxia prevented expressing wild type PrP Nishida et al
0.2039969.11842265.html.plaintext.txt	26	Furthermore recent study reported reducing amount Prnd mRNA onset ataxia delayed 6 months Rossi et al
0.2039969.11842265.html.plaintext.txt	27	Dpl PrP 25 amino acid sequence identity Moore et al
0.2039969.11842265.html.plaintext.txt	28	1999 Dpl shown anchored cell surface via GPI anchor Silverman et al
0.2039969.11842265.html.plaintext.txt	29	2000 PrP Stahl et al
0.2039969.11842265.html.plaintext.txt	30	Detailed analysis recombinant Dpl shown protein similar PrP structure topology Mo et al
0.2039969.11842265.html.plaintext.txt	31	However Dpl lacks octapeptide repeats conserved amino acid region 106 126 found N terminus PrP thus resembles truncated form PrP
0.2039969.11842265.html.plaintext.txt	32	Indeed transgenic mice expressing truncated versions PrP lack octapeptide repeats amino acid region 106 126 d32 121 d32 134 PrP hence resemble Dpl reported develop spontaneous behavioural disorders young age including ataxia Shmerling et al
0.2039969.11842265.html.plaintext.txt	33	It suggested structural similarity PrP Dpl may result two proteins competing binding ligand PrPL Weissmann Aguzzi 1999
0.2039969.11842265.html.plaintext.txt	34	It also proposed binding PrP PrPL generates survival signal however binding Dpl truncated forms PrP PrPL would result survival signal generated resulting Purkinje cell death ataxia
0.2039969.11842265.html.plaintext.txt	35	Since PrP central role TSE disease Prnp Prnd genes close proximity proteins share structural similarity proposed Dpl might also play role TSE disease
0.2039969.11842265.html.plaintext.txt	36	A number studies investigated whether evidence involve Dpl altered susceptibility TSE diseases humans
0.2039969.11842265.html.plaintext.txt	37	The human Dpl gene PRND sequenced control individuals patients CJD
0.2039969.11842265.html.plaintext.txt	38	Although four polymorphisms within coding region PRND found two studies apparent association polymorphisms human TSE diseases Mead et al
0.2039969.11842265.html.plaintext.txt	39	In study grafts Dpl deficient cells implanted brains adult PrP null mice
0.2039969.11842265.html.plaintext.txt	40	When grafts inoculated RML isolate TSE agent classical signs TSE pathology observed grafts demonstrating absence Dpl grafts lead absence TSE disease pathology Behrens et al
0.2039969.11842265.html.plaintext.txt	41	However rather absolute requirement TSE disease Dpl may capable modulating outcome TSEs resulting alterations incubation time targeting intensity pathological lesions brain
0.2039969.11842265.html.plaintext.txt	42	In order therefore investigate hypothesis crossed two inbred lines PrP null mice either express Rcm0 express NPU Prnd gene CNS mice expressing two copies Prnpa108F189V allele Moore et al
0.2039969.11842265.html.plaintext.txt	43	1998 PrP gene BB mice
0.2039969.11842265.html.plaintext.txt	44	This PrP targeted line transgenic mice chosen relatively short incubation period observed BB mice challenged TSE agent 301V
0.2039969.11842265.html.plaintext.txt	45	Critically three lines mice share identical genetic background 129Ola thereby removing effects due non specific genetic differences
0.2039969.11842265.html.plaintext.txt	46	We inoculated lines mice BORCM BONPU mouse passaged 301V strain BSE
0.2039969.11842265.html.plaintext.txt	47	We compared level Prnd expression infected uninfected mice line establish whether Prnd expression altered CNS TSE infection
0.2039969.11842265.html.plaintext.txt	48	We also investigated whether Prnd expression CNS modulate TSE disease comparing incubation times pathological lesions CNS two lines TSE infected mice
0.2039969.11842265.html.plaintext.txt	49	Methods Top Abstract Introduction Methods Results Discussion References Generation mouse lines
0.2039969.11842265.html.plaintext.txt	50	The gene targeted transgenic mice termed BB polymorphisms 108 189 altered L108T189 F108V189 Prnpa108F189V Moore et al
0.2039969.11842265.html.plaintext.txt	51	1998 crossed two lines PrP null mice either NPU Manson et al
0.2039969.11842265.html.plaintext.txt	52	The F1 mice generated termed BONPU BORCM respectively
0.2039969.11842265.html.plaintext.txt	53	BONPU BORCM mice inoculated halothane anaesthesia intracerebrally
0.2039969.11842265.html.plaintext.txt	54	20 microl 1 brain homogenate PBS prepared brains VM mice terminally infected 301V strain TSE
0.2039969.11842265.html.plaintext.txt	55	A group BB mice also inoculated controls targeting CNS pathology 301V
0.2039969.11842265.html.plaintext.txt	56	Signs TSE illness scored previously described Fraser Dickinson 1968
0.2039969.11842265.html.plaintext.txt	57	Incubation times calculated time interval inoculation terminal illness
0.2039969.11842265.html.plaintext.txt	58	A control group BORCM BONPU mice inoculated
0.2039969.11842265.html.plaintext.txt	59	route 20 microl 1 brain homogenate prepared normal non TSE challenged mouse brain
0.2039969.11842265.html.plaintext.txt	60	Mice killed cervical dislocation brains removed fixed 10 formal saline
0.2039969.11842265.html.plaintext.txt	61	Haematoxylin eosin stained coronal sections 6 microm scored vacuolation scale 0 5 nine standard grey matter areas three white matter areas described previously Fraser Dickinson 1967 1968
0.2039969.11842265.html.plaintext.txt	62	Following fixation formal saline brains treated formic acid 98 90 min placed fresh formal saline minimum 24 h
0.2039969.11842265.html.plaintext.txt	63	The brains trimmed dehydrated alcohol impregnated wax cycle lasting approx
0.2039969.11842265.html.plaintext.txt	64	Sections 6 microm mounted Superfrost plus glass slides air dried room temperature overnight 2 days 37 degrees C
0.2039969.11842265.html.plaintext.txt	65	Sections immunostained using mouse monoclonal antibody 6H4 Prionics AG described
0.2039969.11842265.html.plaintext.txt	66	Briefly sections de waxed rehydrated prior autoclaving 121 degrees C 15 min followed treatment 98 formic acid 5 min
0.2039969.11842265.html.plaintext.txt	67	Endogenous peroxidases inhibited using methanol 1 hydrogen peroxide
0.2039969.11842265.html.plaintext.txt	68	Sections incubated 5 normal rabbit serum prior addition primary antibody
0.2039969.11842265.html.plaintext.txt	69	To test slide 11000 dilution primary antibody added left incubate overnight room temperature
0.2039969.11842265.html.plaintext.txt	70	The biotinylated rabbit anti mouse secondary antibody Jackson ImmunoResearch Laboratories USA added 1400 dilution bound antibody visualized using ABC kit Elite diaminobenzidine tetrahydrochloride
0.2039969.11842265.html.plaintext.txt	71	Sections counterstained lightly haematoxylin
0.2039969.11842265.html.plaintext.txt	72	Normal mouse serum place primary antibody used control
0.2039969.11842265.html.plaintext.txt	73	All washes done using buffer consisting PBS 0 1 BSA
0.2039969.11842265.html.plaintext.txt	74	Total RNA isolated terminal brains using RNAzol B based guanidinium thiocyanate phenol chloroform extraction method Chomczynski Sacchi 1987
0.2039969.11842265.html.plaintext.txt	75	Total RNA 50 microg separated 1 0 agarose formaldehyde denaturing gel transferred Hybond N Amersham Pharmacia capillary transfer overnight
0.2039969.11842265.html.plaintext.txt	76	RNA fixed membrane baking 80 degrees C 2 h probing Prnd transcript using 32P labelled 540 bp PCR fragment generated Dpl ORF Moore et al
0.2039969.11842265.html.plaintext.txt	77	Membranes hybridized overnight using ULTRAhyb Ambion washed according manufacturer instructions
0.2039969.11842265.html.plaintext.txt	78	A 936 bp KpnI EcoRI fragment Prnp exon 3 used generate PrP probe
0.2039969.11842265.html.plaintext.txt	79	Prior probing membrane correct loading membranes stripped adding 0 1 SDS heated 100 degrees C shaken cool
0.2039969.11842265.html.plaintext.txt	80	The stripped membrane hybridized probed 32P labelled murine B actin probe GenBank acc
0.2039969.11842265.html.plaintext.txt	81	BE689156 isolated restriction enzymes EcoRI NotI
0.2039969.11842265.html.plaintext.txt	82	Results Top Abstract Introduction Methods Results Discussion References Northern blot analysis BORCM BONPU mice The levels Prnd Prnp mRNA determined Northern blot analysis total RNA prepared three 301V
0.2039969.11842265.html.plaintext.txt	83	challenged terminal brains BORCM BONPU mice one normal brain challenged controls
0.2039969.11842265.html.plaintext.txt	84	This revealed two RNA species approximately 3 5 2 0 kb 301V infected normal brain challenged BORCM mice Fig
0.2039969.11842265.html.plaintext.txt	85	No difference levels mRNA detected TSE infected uninfected BORCM mice
0.2039969.11842265.html.plaintext.txt	86	Prnd mRNA detected brains BONPU mice infected 301V challenged normal brain homogenate
0.2039969.11842265.html.plaintext.txt	87	When Northern blot hybridized Prnp probe one mRNA species approximately 2 1 kb detected brains animals Fig
0.2039969.11842265.html.plaintext.txt	88	The amount mRNA loaded visualized hybridizing membrane murine actin probe Fig
0.2039969.11842265.html.plaintext.txt	89	These results confirm Prnd mRNA expressed presence Prnp transcript level Prnp mRNA affected expression Prnd mRNA
0.2039969.11842265.html.plaintext.txt	90	Thus evidence experiments expression Prnd gene altered CNS animals infected TSE disease
0.2039969.11842265.html.plaintext.txt	91	View larger version 84K Fig
0.2039969.11842265.html.plaintext.txt	92	Doppel PrP mRNA expression 301V challenged BONPU BORCM mouse brains
0.2039969.11842265.html.plaintext.txt	93	Northern blot analysis 50 microg total RNA prepared terminal brains 301V challenged BONPU lanes 3 5 BORCM lanes 6 8 normal brain challenged BONPU lane 2 BORCM lane 1 mice
0.2039969.11842265.html.plaintext.txt	94	A radiolabelled probe ORF Dpl used detect presence Prnd mRNA
0.2039969.11842265.html.plaintext.txt	95	b A radiolabelled probe murine Prnp exon 3 used detect Prnp mRNA c stripped membrane probed actin mRNA
0.2039969.11842265.html.plaintext.txt	96	Prnd expression influence incubation time Despite major differences expression Prnd brains BORCM BONPU mice essentially difference incubation time disease following
0.2039969.11842265.html.plaintext.txt	97	challenge 301V strain TSE Table 1
0.2039969.11842265.html.plaintext.txt	98	The BONPU mice succumbed disease 195 days plus minus 0 9 SEM BORCM mice 191 days plus minus 1 6 SEM
0.2039969.11842265.html.plaintext.txt	99	Thus Prnd expression CNS apparently influence incubation time TSE disease mice
0.2039969.11842265.html.plaintext.txt	100	The incubation times BORCM BONPU mice longer homozygous BB mice reflecting effect gene dosage Prnp incubation time Manson et al
0.2039969.11842265.html.plaintext.txt	101	1994b since BB mice possess two functional PrP alleles whereas BONPU BORCM mice possess one
0.2039969.11842265.html.plaintext.txt	102	Pathological lesions CNS affected expression Prnd Lesion profile analysis revealed extensive vacuolation superior colliculus thalamus cortex forebrain BORCM BONPU Fig
0.2039969.11842265.html.plaintext.txt	103	A high degree vacuolation also observed cochlear nucleus Fig
0.2039969.11842265.html.plaintext.txt	104	3 cortex CA1 region hippocampus Fig
0.2039969.11842265.html.plaintext.txt	105	Although variation amount vacuolation observed different brains within group animals difference overall pattern extent vacuolation observed BORCM BONPU groups mice Fig
0.2039969.11842265.html.plaintext.txt	106	The pattern vacuolation observed BB mice similar BORCM BONPU mice degree vacuolation lower areas brain
0.2039969.11842265.html.plaintext.txt	107	This could due difference expression levels PrP since BB mice possess two PrP108F189V alleles whereas BORCM BONPU mice possess one
0.2039969.11842265.html.plaintext.txt	108	Thus expression Prnd CNS influence either targeting amount vacuolar pathology detected CNS terminal stage TSE disease
0.2039969.11842265.html.plaintext.txt	109	View larger version 17K Fig
0.2039969.11842265.html.plaintext.txt	110	Analysis brain vacuolation lesion profiling
0.2039969.11842265.html.plaintext.txt	111	BORCM BONPU BB transgenic mice challenged TSE agent 301V via
0.2039969.11842265.html.plaintext.txt	112	Animals culled brains removed terminal stages disease
0.2039969.11842265.html.plaintext.txt	113	Nine grey matter 1 9 three white matter areas 10 12 terminal brains scored semi quantitatively vacuolation
0.2039969.11842265.html.plaintext.txt	114	Lesion profiles constructed scoring 14 23 brains group scale 0 5
0.2039969.11842265.html.plaintext.txt	115	The mean scores brain area shown error bars plus minus SEM
0.2039969.11842265.html.plaintext.txt	116	Lesion profile scoring areas 1 dorsal medulla 2 cerebellar cortex 3 superior colliculus 4 hypothalamus 5 medial thalamus 6 hippocampus 7 septum 8 thalamic cortex 9 forebrain cortex 10 cerebellar white matter 11 mesencephalic tegmentum 12 pyramidal tract
0.2039969.11842265.html.plaintext.txt	117	View larger version 83K Fig
0.2039969.11842265.html.plaintext.txt	118	Vacuolar change cochlear nucleus
0.2039969.11842265.html.plaintext.txt	119	Vacuolar change cochlear nucleus 301V terminal brains BONPU BORCM b mice
0.2039969.11842265.html.plaintext.txt	120	Coronal sections stained haematoxylin eosin
0.2039969.11842265.html.plaintext.txt	121	Magnification bar 100 microm
0.2039969.11842265.html.plaintext.txt	122	View larger version 159K Fig
0.2039969.11842265.html.plaintext.txt	123	Neuronal loss vacuolar change CA1 region hippocampus
0.2039969.11842265.html.plaintext.txt	124	Neuronal loss vacuolar change CA1 region hippocampus 301V terminal brains BONPU BORCM b mice normal brain challenged BONPU c BORCM d
0.2039969.11842265.html.plaintext.txt	125	Coronal sections stained haematoxylin eosin
0.2039969.11842265.html.plaintext.txt	126	Expression Prnd effect PrP deposition neuronal loss Severe neuronal loss observed hippocampus particular pyramidal cells CA1 region
0.2039969.11842265.html.plaintext.txt	127	The degree neuronal loss variable animals genotype major differences different lines mice observed Fig
0.2039969.11842265.html.plaintext.txt	128	The extent PrP deposition determined terminal brains BORCM BONPU mice PrP deposition evident CA1 region hippocampus dorsal lateral geniculate nucleus thalamus Fig
0.2039969.11842265.html.plaintext.txt	129	Although variation observed within genotype group major differences BORCM BONPU mice observed patterns PrP deposition seen two lines mice comparable BB mice data shown
0.2039969.11842265.html.plaintext.txt	130	Immunocytochemistry also performed brains animals inoculated normal mouse brain homogenate
0.2039969.11842265.html.plaintext.txt	131	These showed neuronal loss PrP deposition Fig
0.2039969.11842265.html.plaintext.txt	132	Furthermore cross reaction anti PrP antibody Dpl evident since signal detected brain sections normal brain challenged BORCM mice overexpress Dpl CNS Fig
0.2039969.11842265.html.plaintext.txt	133	5 unchallenged RCM PrP null mice data shown
0.2039969.11842265.html.plaintext.txt	134	View larger version 162K Fig
0.2039969.11842265.html.plaintext.txt	135	PrP deposition hippocampus thalamus
0.2039969.11842265.html.plaintext.txt	136	PrP staining 301V terminal brains normal brain challenge controls
0.2039969.11842265.html.plaintext.txt	137	PrP detected coronal sections using monoclonal antibody 6H4 developed immunoperoxidase method lightly counterstained haematoxylin
0.2039969.11842265.html.plaintext.txt	138	c 301V BONPU b e 301V BORCM d normal brain BONPU f normal brain BORCM
0.2039969.11842265.html.plaintext.txt	139	b Dorsal lateral geniculate nucleus thalamus magnification bar 100 microm
0.2039969.11842265.html.plaintext.txt	140	c f CA1 hippocampus magnification bar 50 microm
0.2039969.11842265.html.plaintext.txt	141	Discussion Top Abstract Introduction Methods Results Discussion References PrP central TSE diseases mutations polymorphisms coding region PrP influence outcome TSE disease
0.2039969.11842265.html.plaintext.txt	142	However also clear factors coding region PrP influence TSE phenotype
0.2039969.11842265.html.plaintext.txt	143	The close proximity Prnd gene Prnp gene structural similarity Dpl PrP apparent ability induce ataxia mice overexpressed CNS suggested Dpl ideal candidate influencing TSE disease
0.2039969.11842265.html.plaintext.txt	144	We however found evidence expression Prnd gene altered CNS mice terminally infected TSE
0.2039969.11842265.html.plaintext.txt	145	The brains uninfected 301V infected BORCM mice similar levels Prnd mRNA transcripts whereas evidence Prnd mRNA CNS either infected uninfected BONPU mice
0.2039969.11842265.html.plaintext.txt	146	This suggests expression Dpl mRNA induced CNS terminal stages TSE disease
0.2039969.11842265.html.plaintext.txt	147	This supported finding Prnd mRNA could detected Northern blot analysis terminal brains SV VM mice challenged
0.2039969.11842265.html.plaintext.txt	148	another TSE agent ME7 data shown
0.2039969.11842265.html.plaintext.txt	149	Moreover found evidence different expression levels Prnd CNS transgenic mice alter course TSE disease following
0.2039969.11842265.html.plaintext.txt	150	challenge 301V since difference incubation times terminal pathology mice without Prnd expression CNS
0.2039969.11842265.html.plaintext.txt	151	Dpl normally expressed CNS adult mice expressed periphery
0.2039969.11842265.html.plaintext.txt	152	Dpl mRNA shown present gut endothelial cells brain spleen 6 day old mice highest levels detected testis heart spleen skeletal muscle showing lower levels brain kidney liver lung barely detectable levels 9 week old mice Li et al
0.2039969.11842265.html.plaintext.txt	153	Therefore Dpl may function primarily periphery rather CNS adult mice
0.2039969.11842265.html.plaintext.txt	154	It also reported Ngsk Prnp mice showed evidence demyelination axon loss PNS
0.2039969.11842265.html.plaintext.txt	155	However whether due Dpl overexpression absence PrP unclear Zrch I Prnp mice overexpress Dpl also reported show demyelination sciatic nerve Nishida et al
0.2039969.11842265.html.plaintext.txt	156	Thus Dpl influence outcome TSE disease may achieve events periphery rather CNS
0.2039969.11842265.html.plaintext.txt	157	With TSE diseases natural route infection via periphery events uptake replication infectivity transport CNS likely controlled number different factors
0.2039969.11842265.html.plaintext.txt	158	Experiments currently way address effect Dpl expression CNS TSE disease mice challenged via peripheral route present evidence alterations Dpl expression leading different outcomes TSE disease peripheral routes infection
0.2039969.11842265.html.plaintext.txt	159	However since Prnd expression altered CNS BORCM mice may result alterations peripheral events TSE disease line mice
0.2039969.11842265.html.plaintext.txt	160	In order address issue produced line mice Prnd gene ablated resulting absence Prnd expression throughout mouse
0.2039969.11842265.html.plaintext.txt	161	Inoculation line mice TSE strains
0.2039969.11842265.html.plaintext.txt	162	peripheral routes establish expression Prnd influences aspect TSE disease mice
0.2039969.11842265.html.plaintext.txt	163	This work currently progress
0.2039969.11842265.html.plaintext.txt	164	In summary found evidence expression Prnd altered terminal stages TSE infection Prnd expression CNS influences incubation time TSE disease
0.2039969.11842265.html.plaintext.txt	165	Moreover expression Prnd CNS appear alter either targeting intensity pathological lesions brain animals terminally infected TSE disease
0.2039969.11842265.html.plaintext.txt	166	Thus demonstrated Dpl apparent role play TSE diseases
0.2039969.11842265.html.plaintext.txt	167	However experiments currently way determine whether expression Dpl affect naturally occurring TSE diseases
0.2039969.11842265.html.plaintext.txt	168	Acknowledgments We grateful I
0.2039969.11842265.html.plaintext.txt	169	McConnell staff especially J
0.2039969.11842265.html.plaintext.txt	170	Beaton care clinical scoring mice D
0.2039969.11842265.html.plaintext.txt	171	Mack tissue processing section cutting A
0.2039969.11842265.html.plaintext.txt	172	Boyle lesion profiles Dr L
0.2039969.11842265.html.plaintext.txt	173	Suttie advice ICC analysis
0.2039969.11842265.html.plaintext.txt	174	References Top Abstract Introduction Methods Results Discussion References Behrens A
0.2039969.11842265.html.plaintext.txt	175	Normal neurogenesis scrapie pathogenesis neural grafts lacking prion protein homologue Doppel
0.2039969.11842265.html.plaintext.txt	176	The cellular prion protein binds copper vivo
0.2039969.11842265.html.plaintext.txt	177	Normal development behavior mice lacking neuronal cell surface PrP protein
0.2039969.11842265.html.plaintext.txt	178	Mice devoid PrP resistant scrapie
0.2039969.11842265.html.plaintext.txt	179	Single step method RNA isolation acid guanidinium thiocyanate phenol chloroform extraction
0.2039969.11842265.html.plaintext.txt	180	Analytical Biochemistry 162 156 159
0.2039969.11842265.html.plaintext.txt	181	Prion protein necessary normal synaptic function
0.2039969.11842265.html.plaintext.txt	182	Distribution experimentally inducted scrapie lesions brain
0.2039969.11842265.html.plaintext.txt	183	The sequential development brain lesions scrapie three strains mice
0.2039969.11842265.html.plaintext.txt	184	Journal Comparative Pathology 78 301 311
0.2039969.11842265.html.plaintext.txt	185	Physiological expression gene PrP like protein PrPLPDpl brain endothelial cells ectopic expression neurons PrP deficient mice ataxic due Purkinje cell degeneration
0.2039969.11842265.html.plaintext.txt	186	American Journal Pathology 157 1447 1452
0.2039969.11842265.html.plaintext.txt	187	129Ola mice carrying null mutation PrP abolishes messenger RNA production developmentally normal
0.2039969.11842265.html.plaintext.txt	188	Molecular Neurobiology 8 121 127
0.2039969.11842265.html.plaintext.txt	189	PrP gene dosage determines timing final intensity distribution lesions scrapie pathology
0.2039969.11842265.html.plaintext.txt	190	Examination human prion protein like gene Doppel genetic susceptibility sporadic variant Creutzfeldt Jakob disease
0.2039969.11842265.html.plaintext.txt	191	Neuroscience Letters 290 117 120
0.2039969.11842265.html.plaintext.txt	192	Two different neurodegenerative diseases caused proteins similar structures
0.2039969.11842265.html.plaintext.txt	193	Proceedings National Academy Sciences USA 98 2352 2357
0.2039969.11842265.html.plaintext.txt	194	Double replacement gene targeting production series mouse strains different prion protein gene alterations
0.2039969.11842265.html.plaintext.txt	195	Mice gene targetted prion protein alterations show Prnp Sinc Prni congruent
0.2039969.11842265.html.plaintext.txt	196	Ataxia prion protein PrP deficient mice associated upregulation novel PrP like protein Doppel
0.2039969.11842265.html.plaintext.txt	197	Journal Molecular Biology 292 797 817
0.2039969.11842265.html.plaintext.txt	198	A mouse prion protein transgene rescues mice deficient prion protein gene Purkinje cell degeneration demyelination
0.2039969.11842265.html.plaintext.txt	199	Laboratory Investigation 79 689 697
0.2039969.11842265.html.plaintext.txt	200	First report polymorphisms prion like protein gene PRND implications human prion diseases
0.2039969.11842265.html.plaintext.txt	201	Neuroscience Letters 286 144 148
0.2039969.11842265.html.plaintext.txt	202	Onset ataxia Purkinje cell loss PrP null mice inversely correlated Dpl level brain
0.2039969.11842265.html.plaintext.txt	203	Loss cerebellar Purkinje cells aged mice homozygous disrupted PrP gene
0.2039969.11842265.html.plaintext.txt	204	Expression amino terminally truncated PrP mouse leading ataxia specific cerebellar lesions
0.2039969.11842265.html.plaintext.txt	205	Doppel N glycosylated glycosylphosphatidylinositol anchored protein expression testis ectopic production brains Prnpoo mice predisposed Purkinje cell loss
0.2039969.11842265.html.plaintext.txt	206	Journal Biological Chemistry 275 26834 26841
0.2039969.11842265.html.plaintext.txt	207	Differential release cellular scrapie prion proteins cellular membranes phosphatidylinositol specific phospholipase C
0.2039969.11842265.html.plaintext.txt	208	Altered circadian activity rhythms sleep mice devoid prion protein
0.2039969.11842265.html.plaintext.txt	209	Received 12 September 2001 accepted 23 November 2001
0.12703612.12847133.html.plaintext.txt	0	Rockefeller University Press 0022 1007200371 5
0.12703612.12847133.html.plaintext.txt	1	00 The Journal Experimental Medicine Volume 198 Number 1 1 4 Commentary
0.12703612.12847133.html.plaintext.txt	2	Dangerous Liaisons Microbe Prion Protein Adriano Aguzzi1 Wolf Dietrich Hardt2
0.12703612.12847133.html.plaintext.txt	3	1 Institute Neuropathology Department Pathology University Hospital Zurich CH 8091 Zurich Switzerland 2 Institute Microbiology Department Biology ETH Zurich CH 8092 Zurich Switzerland
0.12703612.12847133.html.plaintext.txt	4	Address correspondence Adriano Aguzzi Institute Neuropathology Department Pathology University Hospital Zurich Schmelzbergstr
0.12703612.12847133.html.plaintext.txt	5	12 CH 8091 Zurich Switzerland
0.12703612.12847133.html.plaintext.txt	6	Phone 41 1 255 2869 Fax 41 1 255 4402 E mail adrianoatpathol
0.12703612.12847133.html.plaintext.txt	7	Arent bugs source continuous amazement Consider example cunningly bacteria conspire shanghai molecular machines mammalian hosts goals
0.12703612.12847133.html.plaintext.txt	8	Besides serving bugs evil intelligence exploitable studying cellular physiology bewildering affinity bacterial toxins crucial host cell proteins taught us many thing cells work
0.12703612.12847133.html.plaintext.txt	9	Perhaps Brucella may help teach us function normal prion protein 1
0.12703612.12847133.html.plaintext.txt	10	Brucella species Gram negative facultative intracellular pathogens
0.12703612.12847133.html.plaintext.txt	11	They invade resist intracellular killing replicate phagocytic nonphagocytic cells 2
0.12703612.12847133.html.plaintext.txt	12	But Brucella initiate replication macrophages The contact bug instructs macrophage internalize mode internalization Fc complement receptors vs
0.12703612.12847133.html.plaintext.txt	13	uptake nonopsonized bugs determines fate bug 2
0.12703612.12847133.html.plaintext.txt	14	Brucella actively modulates engulfment
0.12703612.12847133.html.plaintext.txt	15	It induces peculiar membrane ruffles site contact macrophage slow swimming internalization macropinosome
0.12703612.12847133.html.plaintext.txt	16	Then Brucella takes full control macropinosome
0.12703612.12847133.html.plaintext.txt	17	It inhibits maturation degradative lysosome 3 reprograms acquire endoplasmic reticulum markers mature replicative phagosome bacteria start multiplying Fig
0.12703612.12847133.html.plaintext.txt	18	View larger version 27K Figure 1
0.12703612.12847133.html.plaintext.txt	19	abortus A role Hsp60 PrPC interaction
0.12703612.12847133.html.plaintext.txt	20	abortus transports Hsp60 via VirB type IV system onto surface
0.12703612.12847133.html.plaintext.txt	21	Upon encounter macrophage Hsp60 binds PrPC embedded lipid rafts macrophage surface
0.12703612.12847133.html.plaintext.txt	22	This thought modulate phagocytosis swimming internalization mediate macropinosome formation inhibit lysosome fusion steer macropinosome formation replicative phagosome
0.12703612.12847133.html.plaintext.txt	23	Other hitherto unknown effector proteins traveling via VirB system also involved see text based findings Watarai et al
0.12703612.12847133.html.plaintext.txt	24	For playing tricks Brucella relies set virulence factors including bacterial injection organelle termed VirB type IV secretion system 4 8
0.12703612.12847133.html.plaintext.txt	25	When exposed macrophages vitro virB deficient bugs cannot modulate phagocytosis degraded lysosome
0.12703612.12847133.html.plaintext.txt	26	But VirB system exactly context According Watarai et al
0.12703612.12847133.html.plaintext.txt	27	1 may needed transporting bacterial heat shock protein Hsp60 onto surface bug
0.12703612.12847133.html.plaintext.txt	28	Unexpectedly chaperonin Hsp60 normally hangs cytoplasm deals unfolded proteins 9 turns reside surface wild type Brucella abortus virB mutants
0.12703612.12847133.html.plaintext.txt	29	On macrophage surface Brucella attaches cholesterol rich microdomains called lipid rafts 10 12
0.12703612.12847133.html.plaintext.txt	30	There Hsp60 appears snatch unlikely friend cellular prion protein PrPC encoded Prnp gene resides preferentially rafts
0.12703612.12847133.html.plaintext.txt	31	PrPC apparently recruited macrophages membrane protrusions engulf bacteria subsequently early macropinosome
0.12703612.12847133.html.plaintext.txt	32	abortus modulate phagocytosis phagosome maturation
0.12703612.12847133.html.plaintext.txt	33	This strikingly similar behavior Brucella virB mutants suggests Hsp60 PrPC interaction instrumental actions
0.12703612.12847133.html.plaintext.txt	34	The latter presumption backed animal studies
0.12703612.12847133.html.plaintext.txt	35	Wild type Brucella replicates wild type mice whereas virB mutants 13
0.12703612.12847133.html.plaintext.txt	36	In Watarais 1 experiments wild type VirB deficient bugs avirulent PrPC deficient mice
0.12703612.12847133.html.plaintext.txt	37	Hence Hsp60 PrPC connection important real infections Fig
0.12703612.12847133.html.plaintext.txt	38	So Brucella teach us PrPC The prion infectious agent causing transmissible spongiform encephalopathies 14
0.12703612.12847133.html.plaintext.txt	39	Its known constituent PrPSc conformational isoform PrPC expressed various levels mammalian cells
0.12703612.12847133.html.plaintext.txt	40	The established function PrPC vivo enable transmissible spongiform encephalopathies
0.12703612.12847133.html.plaintext.txt	41	Ablation Prnp abrogates prion replication 15 pathogenesis 16
0.12703612.12847133.html.plaintext.txt	42	However physiological function PrPC remained mysterious
0.12703612.12847133.html.plaintext.txt	43	Prnpoo mice show obvious developmental defect live long happy lives 17
0.12703612.12847133.html.plaintext.txt	44	Subtle changes circadian rhythms 18 alterations hippocampal function 19 22 described Prnpoo mice
0.12703612.12847133.html.plaintext.txt	45	However phenotypes reproduced others 23 none clarified molecular terms
0.12703612.12847133.html.plaintext.txt	46	Biochemically PrPC reported almost everything including opposite everything
0.12703612.12847133.html.plaintext.txt	47	For example PrPC binds copper 24 suggested cuproenzyme others hold finding red herring 25
0.12703612.12847133.html.plaintext.txt	48	PrPC may antiapoptotic properties 26 29 others find sensitizes neurons apoptosis 30
0.12703612.12847133.html.plaintext.txt	49	PrPC peptides might neurotoxic 31 maybe 32
0.12703612.12847133.html.plaintext.txt	50	Prion toxicity might due retrotranslocation PrPC endoplasmic reticulum cytoplasm 33 maybe retrotranslocation occur 34
0.12703612.12847133.html.plaintext.txt	51	Hence unified view PrPC function health disease emerged observations apart fact PrPC dispensable life normal development
0.12703612.12847133.html.plaintext.txt	52	And yet reverse genetics shows PrPC must biological function bind one partners functionally meaningful way
0.12703612.12847133.html.plaintext.txt	53	Transgenic expression amino proximally truncated PrPC mutants causes cerebellar degeneration early death 35
0.12703612.12847133.html.plaintext.txt	54	This phenotype observed Prnpoo mice fully reverted substoichiometric coexpression full length PrPC
0.12703612.12847133.html.plaintext.txt	55	It follows truncated PrP interferes physiological function PrPC effector domain lies amino proximal half
0.12703612.12847133.html.plaintext.txt	56	A similar phenotype elicited overexpression Dpl protein 36 resembles truncated PrPC may therefore represent endogenous PrPC antagonist 37
0.12703612.12847133.html.plaintext.txt	57	Population genetics provides evidence PrPC bestowing prion diseases us
0.12703612.12847133.html.plaintext.txt	58	Protective variations human prion gene arose recently evolution disseminated much efficiently among human populations nonprotective polymorphisms 38
0.12703612.12847133.html.plaintext.txt	59	This provides compelling case role evolutionary fitness similarly globin gene mutations protective malaria
0.12703612.12847133.html.plaintext.txt	60	Selective pressure maintain heterozygosity might come Kuru cannibalism transmitted prion disease prime cause death New Guinea tribes
0.12703612.12847133.html.plaintext.txt	61	One disturbing conclusion cannibalism commonplace among ancestors 38
0.12703612.12847133.html.plaintext.txt	62	Consequently prion diseases exceedingly rare probably ravaged human populations distant past
0.12703612.12847133.html.plaintext.txt	63	What mystifying Prnp null alleles selected despite presumptive evolutionary advantage resistance cannibalism induced prion disease
0.12703612.12847133.html.plaintext.txt	64	At face value resistance PrPC knockout animals B
0.12703612.12847133.html.plaintext.txt	65	abortus infection provides hints usefulness PrPC
0.12703612.12847133.html.plaintext.txt	66	Animals probably dealt Brucella infections long time Brucella resistant individuals disrupted Hsp60 binding domains PrPC edge
0.12703612.12847133.html.plaintext.txt	67	However happened
0.12703612.12847133.html.plaintext.txt	68	So elusive functions partners PrPC Several PrPC binding factors described including laminin receptor precursor protein 39 heparan sulfate 40 N CAM 41 bcl 2 42 yet none interactions linked biological functions
0.12703612.12847133.html.plaintext.txt	69	Could PrPC serve general Hsp60 sensor Hsp60 homologues found bacteria eukaryotic cells induce inflammation immune responses 43 44
0.12703612.12847133.html.plaintext.txt	70	It exciting test whether PrPC involved Hsp60 dependent common danger sensing mechanism detection destructed body cells pathogenic microbes 43 44
0.12703612.12847133.html.plaintext.txt	71	Watarais provocative report hints novel surprising aspects bacterial prion biology
0.12703612.12847133.html.plaintext.txt	72	Many following exciting ramifications deserve studied Hsp60 first B
0.12703612.12847133.html.plaintext.txt	73	abortus protein whose presence outer surface relies type IV secretion system yet seem participate type IV secretion apparatus
0.12703612.12847133.html.plaintext.txt	74	How Hsp60 recognized transported VirB type IV system And retained bacterial surface b What function Hsp60 PrPC complex Is simply slowing initial steps phagocytosis allow sufficient time injection via VirB type IV system manipulation early macropinosome far unidentified effector proteins Or serve anchor assembling whole set host cellular proteins macropinosome membrane c The Hsp60 PrPC interaction clearly insufficient proper macropinosome formation maturation
0.12703612.12847133.html.plaintext.txt	75	Hence function type IV secretion system must go beyond surface exposure Hsp60
0.12703612.12847133.html.plaintext.txt	76	Which effector proteins travel via pathway function d Bacteria often accomplish deeds disrupting specialized cellular functions
0.12703612.12847133.html.plaintext.txt	77	Does Brucella interfere function PrPC If get Answers questions may come analyzing interactions Hsp60 amino terminally truncated versions PrPC
0.12703612.12847133.html.plaintext.txt	78	Many microbial pathogens invade replicate within host cells
0.12703612.12847133.html.plaintext.txt	79	All bugs face death lysosome devised strategies escape fate
0.12703612.12847133.html.plaintext.txt	80	Shigella Listeria lyse vacuole membrane dwell host cell cytoplasm
0.12703612.12847133.html.plaintext.txt	81	Others including Salmonella typhimurium Legionella pneumophila mycobacteria Chlamydia trachomatis certain Escherichia coli strains manipulate endosomelysosome pathway reside type restructured vesicle
0.12703612.12847133.html.plaintext.txt	82	Interestingly bugs mycobacteria 45 C
0.12703612.12847133.html.plaintext.txt	83	trachomatis 46 certain E
0.12703612.12847133.html.plaintext.txt	84	coli strains 47 need like Brucella intact lipid rafts host cell surface reach niche 48
0.12703612.12847133.html.plaintext.txt	85	It exciting test whether Hsp60 PrPC connection involved
0.12703612.12847133.html.plaintext.txt	86	Future work may test whether host cell manipulation via PrPC exception rule
0.12703612.12847133.html.plaintext.txt	87	Submitted May 5 2003 Accepted May 7 2003
0.12703612.12847133.html.plaintext.txt	88	Cellular prion protein promotes Brucella infection macrophages
0.12703612.12847133.html.plaintext.txt	89	AbstractFree Full Text Gorvel J
0.12703612.12847133.html.plaintext.txt	90	Brucella intracellular life invasion intracellular replication
0.12703612.12847133.html.plaintext.txt	91	Brucella suis impaired specific recognition phagosomes lysosomes due phagosomal membrane modifications
0.12703612.12847133.html.plaintext.txt	92	AbstractFree Full Text Comerci D
0.12703612.12847133.html.plaintext.txt	93	Essential role VirB machinery maturation Brucella abortus containing vacuole
0.12703612.12847133.html.plaintext.txt	94	A homologue operon required DNA transfer Agrobacterium required Brucella abortus virulence intracellular multiplication
0.12703612.12847133.html.plaintext.txt	95	AbstractFree Full Text OCallaghan D
0.12703612.12847133.html.plaintext.txt	96	A homologue Agrobacterium tumefaciens VirB Bordetella pertussis Ptl type IV secretion systems essential intracellular survival Brucella suis
0.12703612.12847133.html.plaintext.txt	97	CrossRefMedline Foulongne V
0.12703612.12847133.html.plaintext.txt	98	Identification Brucella suis genes affecting intracellular survival vitro human macrophage infection model signature tagged transposon mutagenesis
0.12703612.12847133.html.plaintext.txt	99	AbstractFree Full Text Sun Y
0.12703612.12847133.html.plaintext.txt	100	virB mediated survival Brucella abortus mice macrophages independent functional inducible nitric oxide synthase NADPH oxidase macrophages
0.12703612.12847133.html.plaintext.txt	101	AbstractFree Full Text Hartl F
0.12703612.12847133.html.plaintext.txt	102	Molecular chaperones cytosol nascent chain folded protein
0.12703612.12847133.html.plaintext.txt	103	AbstractFree Full Text Watarai M
0.12703612.12847133.html.plaintext.txt	104	Modulation Brucella induced macropinocytosis lipid rafts mediates intracellular replication
0.12703612.12847133.html.plaintext.txt	105	Role cholesterol ganglioside GM1 entry short term survival Brucella suis murine macrophages
0.12703612.12847133.html.plaintext.txt	106	AbstractFree Full Text Watarai M
0.12703612.12847133.html.plaintext.txt	107	Macrophage plasma membrane cholesterol contributes Brucella abortus infection mice
0.12703612.12847133.html.plaintext.txt	108	AbstractFree Full Text Hong P
0.12703612.12847133.html.plaintext.txt	109	Identification genes required chronic persistence Brucella abortus mice
0.12703612.12847133.html.plaintext.txt	110	AbstractFree Full Text Prusiner S
0.12703612.12847133.html.plaintext.txt	111	Novel proteinaceous infectious particles cause scrapie
0.12703612.12847133.html.plaintext.txt	112	Mice devoid PrP resistant scrapie
0.12703612.12847133.html.plaintext.txt	113	Normal host prion protein necessary scrapie induced neurotoxicity
0.12703612.12847133.html.plaintext.txt	114	Normal development behaviour mice lacking neuronal cell surface PrP protein
0.12703612.12847133.html.plaintext.txt	115	Altered circadian activity rhythms sleep mice devoid prion protein
0.12703612.12847133.html.plaintext.txt	116	Mossy fibre reorganization hippocampus prion protein null mice
0.12703612.12847133.html.plaintext.txt	117	CrossRefMedline Collinge J
0.12703612.12847133.html.plaintext.txt	118	Prion protein necessary normal synaptic function
0.12703612.12847133.html.plaintext.txt	119	Evidence presynaptic location function prion protein
0.12703612.12847133.html.plaintext.txt	120	AbstractFree Full Text Kretzschmar H
0.12703612.12847133.html.plaintext.txt	121	Function PrPC copper binding protein synapse
0.12703612.12847133.html.plaintext.txt	122	Mice deficient prion protein exhibit normal neuronal excitability synaptic transmission hippocampus
0.12703612.12847133.html.plaintext.txt	123	AbstractFree Full Text Brown D
0.12703612.12847133.html.plaintext.txt	124	The cellular prion protein binds copper vivo
0.12703612.12847133.html.plaintext.txt	125	CrossRefMedline Waggoner D
0.12703612.12847133.html.plaintext.txt	126	Brain copper content cuproenzyme activity vary prion protein expression level
0.12703612.12847133.html.plaintext.txt	127	AbstractFree Full Text Kuwahara C
0.12703612.12847133.html.plaintext.txt	128	Prions prevent neuronal cell line death
0.12703612.12847133.html.plaintext.txt	129	CrossRefMedline Chiarini L
0.12703612.12847133.html.plaintext.txt	130	Cellular prion protein transduces neuroprotective signals
0.12703612.12847133.html.plaintext.txt	131	AbstractFree Full Text Zanata S
0.12703612.12847133.html.plaintext.txt	132	Stress inducible protein 1 cell surface ligand cellular prion triggers neuroprotection
0.12703612.12847133.html.plaintext.txt	133	AbstractFree Full Text Bounhar Y
0.12703612.12847133.html.plaintext.txt	134	Prion protein protects human neurons Bax mediated apoptosis
0.12703612.12847133.html.plaintext.txt	135	AbstractFree Full Text Paitel E
0.12703612.12847133.html.plaintext.txt	136	Cellular prion protein sensitizes neurons apoptotic stimuli Mdm2 regulated p53 dependent caspase 3 like activation
0.12703612.12847133.html.plaintext.txt	137	AbstractFree Full Text Brown D
0.12703612.12847133.html.plaintext.txt	138	Role microglia host protein neurotoxicity prion protein fragment
0.12703612.12847133.html.plaintext.txt	139	Neurotoxicity prion peptide 106 126 confirmed
0.12703612.12847133.html.plaintext.txt	140	Neurotoxicity neurodegeneration PrP accumulates cytosol
0.12703612.12847133.html.plaintext.txt	141	AbstractFree Full Text Drisaldi B
0.12703612.12847133.html.plaintext.txt	142	Mutant PrP delayed exit endoplasmic reticulum neither wild type mutant PrP undergoes retrotranslocation prior proteasomal degradation
0.12703612.12847133.html.plaintext.txt	143	AbstractFree Full Text Shmerling D
0.12703612.12847133.html.plaintext.txt	144	Expression amino terminally truncated PrP mouse leading ataxia specific cerebellar lesions
0.12703612.12847133.html.plaintext.txt	145	Small beautiful antagonizing functions prion protein PrPC homologue Dpl
0.12703612.12847133.html.plaintext.txt	146	Balancing selection prion protein gene consistent prehistoric kurulike epidemics
0.12703612.12847133.html.plaintext.txt	147	AbstractFree Full Text Rieger R
0.12703612.12847133.html.plaintext.txt	148	The human 37 kDa laminin receptor precursor interacts prion protein eukaryotic cells
0.12703612.12847133.html.plaintext.txt	149	Binding protease sensitive form PrP prion protein sulfated glycosaminoglycan congo red
0.12703612.12847133.html.plaintext.txt	150	Binding neural cell adhesion molecules N CAMs cellular prion protein
0.12703612.12847133.html.plaintext.txt	151	CrossRefMedline Kurschner C
0.12703612.12847133.html.plaintext.txt	152	The cellular prion protein PrP selectively binds Bcl 2 yeast two hybrid system identification candidate proteins binding prion protein
0.12703612.12847133.html.plaintext.txt	153	Mycobacterial 65 kD heat shock protein induces release proinflammatory cytokines human monocytic cells
0.12703612.12847133.html.plaintext.txt	154	Danger signals SOS immune system
0.12703612.12847133.html.plaintext.txt	155	CrossRefMedline Gatfield J
0.12703612.12847133.html.plaintext.txt	156	Essential role cholesterol entry mycobacteria macrophages
0.12703612.12847133.html.plaintext.txt	157	AbstractFree Full Text Norkin L
0.12703612.12847133.html.plaintext.txt	158	Association caveolin Chlamydia trachomatis inclusions early late stages infection
0.12703612.12847133.html.plaintext.txt	159	Involvement cellular caveolae bacterial entry mast cells
0.12703612.12847133.html.plaintext.txt	160	AbstractFree Full Text Duncan M
0.12703612.12847133.html.plaintext.txt	161	Microbial entry caveolae variations theme
0.15615378.12759361.html.plaintext.txt	0	Deletion N terminal Residues 23 88 Prion Protein PrP Abrogates Potential Rescue PrP deficient Mice PrP like ProteinDoppel induced Neurodegeneration Ryuichiro Atarashi Noriyuki Nishida Kazuto Shigematsu Shinji Goto Takahito Kondo Suehiro Sakaguchi Shigeru Katamine
0.15615378.12759361.html.plaintext.txt	1	From Departments Molecular Microbiology Immunology Pathology Biochemistry Molecular Biology Disease Institute Atomic Bomb Disease Nagasaki University Graduate School Biomedical Sciences 1 12 4 Sakamoto Nagasaki 852 8523 Japan
0.15615378.12759361.html.plaintext.txt	2	Received publication April 8 2003
0.15615378.12759361.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Accumulating evidence suggested prion protein PrP neuroprotective PrP like proteinDoppel PrPLPDpl neurotoxic
0.15615378.12759361.html.plaintext.txt	4	A line PrP deficient mice Ngsk Prnp00 ectopically expressing PrPLPDpl neurons exhibits late onset ataxia Purkinje cell death prevented transgene encoding wild type mouse PrP
0.15615378.12759361.html.plaintext.txt	5	To elucidate mechanisms neurodegeneration mice introduced five types PrP transgene namely one heterologous hamster two mousehamster chimeric genes two mutants encoded PrP lacking residues 23 88 MHM2
0.15615378.12759361.html.plaintext.txt	6	del23 88 E199K substitution Mo
0.15615378.12759361.html.plaintext.txt	7	del23 88 failed rescue mice Purkinje cell death
0.15615378.12759361.html.plaintext.txt	8	del23 88Ngsk Prnp00 expressed several times PrP wild type Prnp mice PrPLPDpl equivalent level Ngsk Prnp00 mice
0.15615378.12759361.html.plaintext.txt	9	Little difference observed pathology onset ataxia Ngsk Prnp00 MHM2
0.15615378.12759361.html.plaintext.txt	10	No detergent insoluble PrPLPDpl detectable central nervous system Ngsk Prnp00 mice even onset ataxia
0.15615378.12759361.html.plaintext.txt	11	Our findings provide evidence N terminal residues 23 88 PrP containing unique octapeptide repeat region crucial preventing Purkinje cell death Prnp00 mice expressing PrPLPDpl neuron
0.15615378.12759361.html.plaintext.txt	12	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Prion protein PrP1 membrane glycoprotein expressed neuronal cell surface physiological function fully understood
0.15615378.12759361.html.plaintext.txt	13	However complete resistance PrP deficient mice prion infection indicates essential role development prion diseases replication prion 1 2
0.15615378.12759361.html.plaintext.txt	14	In affected brains constitutive structural conversion PrP results accumulation detergent insoluble proteinase K resistant PrP isoform namely PrPSc 3
0.15615378.12759361.html.plaintext.txt	15	Although accumulated PrPSc thought play central role pathogenesis molecular mechanisms neurodegeneration prion diseases remain elucidated
0.15615378.12759361.html.plaintext.txt	16	We previously established line PrP deficient mice designated Ngsk Prnp00 exhibited late onset ataxia cerebellar Purkinje cell degeneration 4 rescued mouse wild type PrP gene Prnp 5
0.15615378.12759361.html.plaintext.txt	17	Subsequently results reproduced two independent lines Rcm0 Zrch II Prnp00 mice 6 7
0.15615378.12759361.html.plaintext.txt	18	In contrast two independent lines Zrch I Edbg Prnp00 never revealed phenotype 8 9
0.15615378.12759361.html.plaintext.txt	19	Recent studies provided evidence ectopic expression PrP like proteinDoppel PrPLPDpl neuron ataxic Prnp00 mouse lines non ataxic lines could explain discrepancy phenotypes 6 10
0.15615378.12759361.html.plaintext.txt	20	Disruption part Prnp intron 2 including splicing acceptor ataxic lines leads unusual intergenic splicing Prnp downstream gene designated Prnd encoding PrPLPDpl
0.15615378.12759361.html.plaintext.txt	21	As consequence PrPLPDpl gene comes control Prnp promoter leading ectopic expression PrPLPDpl neuron
0.15615378.12759361.html.plaintext.txt	22	In physiological situation PrPLPDpl mRNA expressed high level testis heart detectable brain except transient expression brain endothelial cells around 1 week birth 11
0.15615378.12759361.html.plaintext.txt	23	A study using PrPLPDpl deficient mice suggested physiological role PrPLPDpl spermatogenesis 12
0.15615378.12759361.html.plaintext.txt	24	Recent reports demonstrated introduction transgene encoding PrPLPDpl rendered Zrch I Prnp00 mice capable reproducing Purkinje cell degeneration observed Ngsk Prnp00 mice 13
0.15615378.12759361.html.plaintext.txt	25	This direct evidence confirming ectopic expression PrPLPDpl functional loss PrP required neurodegeneration Ngsk Prnp00 mice
0.15615378.12759361.html.plaintext.txt	26	PrPLPDpl glycoprotein expressed cell surface glycosylphosphatidylinositol moiety 14 consists 179 amino acids 23 identity PrP primary structure lacking unique octapeptide repeat region hydrophobic region present N terminal half PrP 10
0.15615378.12759361.html.plaintext.txt	27	An NMR study revealed similarities tertiary structure PrPLPDpl C terminal half PrP composed two short strands three helices 15
0.15615378.12759361.html.plaintext.txt	28	Interestingly expression transgene encoding truncated PrP lacking N terminal residues 32 121 32 134 nonataxic Zrch I Prnp00 mice also resulted severe cerebellar degeneration abrogated reintroduction wild type mouse PrP gene 16
0.15615378.12759361.html.plaintext.txt	29	These results suggested PrPLPDpl N terminal truncated del32 121 32 134 PrP toxic neurons similar mechanisms wild type PrP may neuroprotective function
0.15615378.12759361.html.plaintext.txt	30	In present study elucidate mechanisms Purkinje cell death generated five different transgenic mouse lines expressing respectively heterologous chimeric mutant PrPs Ngsk Prnp00 background
0.15615378.12759361.html.plaintext.txt	31	A transgene encoding PrP lacking N terminal residues 23 88 failed rescue Ngsk Prnp00 mice Purkinje cell degeneration indicating crucial role residues
0.15615378.12759361.html.plaintext.txt	32	The roles PrPLPDpl aggregation impaired metabolism reactive oxygen species brain tissues Ngsk Prnp00 mice also evaluated
0.15615378.12759361.html.plaintext.txt	33	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Mice The mouse PrP Mo
0.15615378.12759361.html.plaintext.txt	34	PrP transgenic Tg mice Ngsk Prnp00 background described previously 5
0.15615378.12759361.html.plaintext.txt	35	In current study introduced five types PrP transgene Ngsk Prnp00 mice mating transgenic mouse lines harboring corresponding transgene Zrch I Prnp00 background 8
0.15615378.12759361.html.plaintext.txt	36	Prusiner University California San Francisco CA kindly provided Tg mouse lines
0.15615378.12759361.html.plaintext.txt	37	The transgenes included Syrian hamster wild type PrP gene SHa two SHamouse chimeric PrP genes MH2M MHM2 MHM2 lacking residues 23 88 MHM2
0.15615378.12759361.html.plaintext.txt	38	PrP gene E199K substitution Mo
0.15615378.12759361.html.plaintext.txt	39	They constructed cosSHa
0.15615378.12759361.html.plaintext.txt	40	vector encompassing entire SHa Prnp locus containing PrPLPDpl locus Prnd 6
0.15615378.12759361.html.plaintext.txt	41	MHM2 PrP two amino acid substitutions Mo
0.15615378.12759361.html.plaintext.txt	42	PrP L108M V111M included epitope recognized 3F4 anti PrP antibody
0.15615378.12759361.html.plaintext.txt	43	MH2M PrP five amino acid substitutions L108M V111M I138M Y154N S169N Mo
0.15615378.12759361.html.plaintext.txt	44	E199K PrP corresponds found patients familial Creutzfeldt Jakob disease 21
0.15615378.12759361.html.plaintext.txt	45	Offspring carrying transgenes identified PCR tail DNA described previously 5
0.15615378.12759361.html.plaintext.txt	46	To distinguish Ngsk Zrch I Prnp00 genotypes Zrch I specific primer pair MP685S 5 AACTTCACCGAGACCGATGT MP215A 5 GAACCCTTTGCCTATGCTAA Ngsk specific primer pair PGK468S 5 CGCTGTTCTCCTCTTCCTCA NEO390A 5 GGTAGCCGGATCAAGCGTAT used PCR
0.15615378.12759361.html.plaintext.txt	47	The F2 offspring carrying transgenes Ngsk Prnp00 background TgNgsk Prnp00 subjected analysis
0.15615378.12759361.html.plaintext.txt	48	Antibodies The anti PrP polyclonal mouse antiserum used described previously 5
0.15615378.12759361.html.plaintext.txt	49	We produced anti PrPLPDpl polyclonal rabbit antiserum using full length 27 155 recombinant mouse PrPLPDpl
0.15615378.12759361.html.plaintext.txt	50	3F4 anti PrP antibody purchased Dako
0.15615378.12759361.html.plaintext.txt	51	SAF mix antibody kind gift Dr
0.15615378.12759361.html.plaintext.txt	52	Horseradish peroxidase conjugated anti mouse IgG anti rabbit IgG antibodies purchased Amersham Biosciences
0.15615378.12759361.html.plaintext.txt	53	Western Blotting Brain homogenates 10 wv prepared lysis buffer containing 150 mM NaCl 50 mM Tris HCl pH 7
0.15615378.12759361.html.plaintext.txt	54	5 sodium deoxycholate 1 mM EDTA protease inhibitor mixture Roche Applied Science
0.15615378.12759361.html.plaintext.txt	55	Postnuclear supernatants collected low speed centrifugation protein concentrations determined using BCA protein assay Pierce
0.15615378.12759361.html.plaintext.txt	56	Samples electrophoresed SDS polyacrylamide gel transferred polyvinylidene difluoride membrane Millipore
0.15615378.12759361.html.plaintext.txt	57	Anti PrP polyclonal mouse antiserum anti PrPLPDpl polyclonal rabbit antiserum used probe immunoreactive bands visualized using ECL system Amersham Biosciences
0.15615378.12759361.html.plaintext.txt	58	PNGase F Digestion PNGase F digestion brain homogenates performed according manufacturers protocol New England Bio labs
0.15615378.12759361.html.plaintext.txt	59	Briefly glycoproteins sample denatured boiling 10 min 0
0.15615378.12759361.html.plaintext.txt	60	volume 10 Nonidet P 40 volume 0
0.15615378.12759361.html.plaintext.txt	61	5 2 microl PNGase F 500 units microl added sample
0.15615378.12759361.html.plaintext.txt	62	After incubation 2 h 37 degrees C samples subjected Western blotting analysis
0.15615378.12759361.html.plaintext.txt	63	Detergent Insolubility PrPLPDpl Postnuclear supernatants diluted 4 mgml protein concentration lysis buffer without Sarcosyl 1 final concentration
0.15615378.12759361.html.plaintext.txt	64	After incubation ice 30 min samples centrifuged 108000 x g 45 min 4 degrees C
0.15615378.12759361.html.plaintext.txt	65	Proteins pellets supernatant analyzed Western blotting
0.15615378.12759361.html.plaintext.txt	66	Immunohistochemistry Deparaffinized sections digested 1 mgml trypsin 15 min 37 degrees C placed 3 H2O2 methanol 30 min room temperature abolish endogenous peroxidase activity
0.15615378.12759361.html.plaintext.txt	67	The tissue sections incubated overnight 4 degrees C anti spot 35 calbindin polyclonal antibody
0.15615378.12759361.html.plaintext.txt	68	To detect spot 35 immunoreactivities used EnVision accordance manufacturers recommendations Dako
0.15615378.12759361.html.plaintext.txt	69	The antibody bound peroxidase revealed 0
0.15615378.12759361.html.plaintext.txt	70	Superoxide Dismutase SOD Glutathione Peroxidase Gpx Activities Brain homogenates prepared phosphate buffered saline containing 1 mM EDTA protease inhibitor mixture Roche Applied Science
0.15615378.12759361.html.plaintext.txt	71	Homogenates centrifuged 10000 x g 10 min supernatants subjected analysis
0.15615378.12759361.html.plaintext.txt	72	The protein concentration supernatants determined using BCA protein assay Pierce
0.15615378.12759361.html.plaintext.txt	73	The total SOD activity measured inhibition reduction rate nitro blue tetrazolium monitored 560 nm using xanthine xanthine oxidase system
0.15615378.12759361.html.plaintext.txt	74	One unit SOD activity defined amount enzyme required inhibit reduction rate nitro blue tetrazolium 50
0.15615378.12759361.html.plaintext.txt	75	The activity expressed unitsmg protein
0.15615378.12759361.html.plaintext.txt	76	To measure Mn SOD activity reaction mixture treated 2 mM potassium cyanide
0.15615378.12759361.html.plaintext.txt	77	To obtain CuZn SOD activity amount Mn SOD activity subtracted total SOD activity
0.15615378.12759361.html.plaintext.txt	78	The Gpx activity measured determining rate NADPH oxidation NADP monitored 340 nm using glutathione reductase NADPH system
0.15615378.12759361.html.plaintext.txt	79	The activity expressed nmolminmg protein
0.15615378.12759361.html.plaintext.txt	80	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Rescue Ngsk Prnp00 Mice Neurodegeneration Mo
0.15615378.12759361.html.plaintext.txt	81	del23 88 PrP Mutants We introduced five types PrP transgene SHa MH2M MHM2 MHM2
0.15615378.12759361.html.plaintext.txt	82	E199K Ngsk Prnp00 evaluated effects phenotype
0.15615378.12759361.html.plaintext.txt	83	All TgNgsk Prnp00 mice developed normally initially showed neurological symptoms
0.15615378.12759361.html.plaintext.txt	84	At 13 months birth however Tg MHM2
0.15615378.12759361.html.plaintext.txt	85	del23 88Ngsk Prnp00 mice well Ngsk Prnp00 mice lacking PrP transgene began exhibit progressive symptoms ataxia tremor gait disturbance Fig
0.15615378.12759361.html.plaintext.txt	86	Analysis hind footprints confirmed ataxic mice could walk straight line length steps shorter wild type mice Fig
0.15615378.12759361.html.plaintext.txt	87	Age onset Ngsk Prnp00 Tg MHM2
0.15615378.12759361.html.plaintext.txt	88	del23 88Ngsk Prnp00 mice 68
0.15615378.12759361.html.plaintext.txt	89	5 weeks mean plus minus S
0.15615378.12759361.html.plaintext.txt	90	The remaining TgNgsk Prnp00 lines never shown neurological symptoms 24 months age indicating SHa MH2M MHM2 MoE199K transgenes MHM2
0.15615378.12759361.html.plaintext.txt	91	del23 88 able rescue Ngsk Prnp00 mice ataxia
0.15615378.12759361.html.plaintext.txt	92	View larger version 21K FIG
0.15615378.12759361.html.plaintext.txt	93	del23 88 PrP failed rescue Ngsk Prnp00 mice ataxia
0.15615378.12759361.html.plaintext.txt	94	A proportions mice without ataxia plotted month birth follows Prnp open triangles n 16 Ngsk Prnp00 open circles n 21 Tg SHaNgsk Prnp00 open diamonds n 14 Tg MH2MNgsk Prnp00 open squares n 12 Tg MHM2Ngsk Prnp00 closed circles n 16 Tg Mo
0.15615378.12759361.html.plaintext.txt	95	E199KNgsk Prnp00 closed diamonds n 14 Tg MHM2
0.15615378.12759361.html.plaintext.txt	96	del23 88Ngsk Prnp00 closed squares n 20
0.15615378.12759361.html.plaintext.txt	97	B footprint analysis Prnp Ngsk Prnp00 Tg MHM2
0.15615378.12759361.html.plaintext.txt	98	del23 88Ngsk Prnp00 mice 24 months
0.15615378.12759361.html.plaintext.txt	99	del23 88Ngsk Prnp00 mice could walk straight length steps shorter Prnp mice
0.15615378.12759361.html.plaintext.txt	100	Immunostaining anti spot 35 calbindin antibody brain sections derived 20 month old Ngsk Prnp00 Tg MHM2
0.15615378.12759361.html.plaintext.txt	101	del23 88Ngsk Prnp00 mice revealed extensive loss Purkinje cells throughout cerebellar vermis Fig
0.15615378.12759361.html.plaintext.txt	102	No difference found extent Purkinje cell loss two mouse lines
0.15615378.12759361.html.plaintext.txt	103	In contrast Tg SHa Tg MH2M Tg MHM2 Tg Mo
0.15615378.12759361.html.plaintext.txt	104	E199KNgsk Prnp00 mice showed Purkinje cell loss Fig
0.15615378.12759361.html.plaintext.txt	105	View larger version 51K FIG
0.15615378.12759361.html.plaintext.txt	106	del23 88Ngsk Prnp00 well Ngsk Prnp00 mice revealed extensive Purkinje cell loss
0.15615378.12759361.html.plaintext.txt	107	Purkinje cells cerebellum sections Prnp A Ngsk Prnp00 B Tg SHaNgsk Prnp00 C Tg MH2MNgsk Prnp00 D Tg MHM2Ngsk Prnp00 E Tg MoE199K Prnp00 F Tg MHM2
0.15615378.12759361.html.plaintext.txt	108	del23 88Ngsk Prnp00 G mice 20 months age stained anti spot 35 calbindin antibodies
0.15615378.12759361.html.plaintext.txt	109	Expression Transgene encoded PrP Brain Tissues TgNgsk Prnp00 Mouse Lines Expression transgene products PrPs brain tissues 4 month old Tg mice examined Western blotting using polyclonal anti PrP mouse serum Fig
0.15615378.12759361.html.plaintext.txt	110	3 SAF mix anti PrP monoclonal antibody data shown
0.15615378.12759361.html.plaintext.txt	111	Two lines Tg MHM2 Tg MHM2
0.15615378.12759361.html.plaintext.txt	112	del23 88Ngsk Prnp00 overexpressed PrP four eight times wild type mice
0.15615378.12759361.html.plaintext.txt	113	The expression levels remaining three Tg SHa Tg MH2M Tg Mo
0.15615378.12759361.html.plaintext.txt	114	E199KNgsk Prnp00 appeared equivalent wild type mice
0.15615378.12759361.html.plaintext.txt	115	View larger version 55K FIG
0.15615378.12759361.html.plaintext.txt	116	PrP expression levels brain tissues wild type Ngsk Prnp00 TgNgsk Prnp00 mice
0.15615378.12759361.html.plaintext.txt	117	PrP expression brain tissues mice line examined Western blot using anti PrP polyclonal mouse antiserum shown
0.15615378.12759361.html.plaintext.txt	118	Each lane contains 60 microg total protein
0.15615378.12759361.html.plaintext.txt	119	4A deglycosylation PNGase F SAF mix visualized two clear bands 18 27 kDa faint band 21 kDa brain homogenates Tg SHa Tg MHM2Ngsk Prnp00 mice 3F4 monoclonal antibody failed detect 18 kDa product Fig
0.15615378.12759361.html.plaintext.txt	120	It demonstrated PrPC undergoes physiological proteolytic cleavage amino acid residues 110111 111112 leading production C terminal fragment C1 23
0.15615378.12759361.html.plaintext.txt	121	Because cleavage occurs within linear 3F4 epitope C1 recognized SAF mix 3F4
0.15615378.12759361.html.plaintext.txt	122	The 18 kDa band thus likely correspond C1
0.15615378.12759361.html.plaintext.txt	123	The remaining 27 21 kDa bands likely full length PrP another C terminal minor product C2 respectively
0.15615378.12759361.html.plaintext.txt	124	del23 88Ngsk Prnp00 mice also expressed 18 kDa band reacted SAF mix 3F4 addition full length product 20 kDa lane 6 Fig
0.15615378.12759361.html.plaintext.txt	125	View larger version 38K FIG
0.15615378.12759361.html.plaintext.txt	126	del23 88 PrP undergoes physiological cleavage leading production C terminal fragment C1
0.15615378.12759361.html.plaintext.txt	127	Western blot analysis using 3F4 A SAF mix B anti PrP monoclonal antibodies brain homogenates Tg SHa Tg MHM2 Tg MHM2
0.15615378.12759361.html.plaintext.txt	128	del23 88Ngsk Prnp00 mice without PNGase F pretreatment reveals proteolytic cleavage PrPs
0.15615378.12759361.html.plaintext.txt	129	The arrowhead B indicates band C1 18 kDa
0.15615378.12759361.html.plaintext.txt	130	Each lane Tg SHaNgsk Prnp00 contains 60 microg total protein whereas Tg MHM2 Tg MHM2
0.15615378.12759361.html.plaintext.txt	131	del23 88Ngsk Prnp00 15 microg total protein
0.15615378.12759361.html.plaintext.txt	132	Expression Levels Detergent Insolubility PrPLPDpl Brain Tissues TgNgsk Prnp00 Mouse Lines PrPLPDpl expression levels brains examined Western blotting polyclonal anti PrPLPDpl rabbit antiserum
0.15615378.12759361.html.plaintext.txt	133	Although brain tissues Prnp mice expressed detectable PrPLPDpl TgNgsk Prnp00 mouse lines exhibited PrPLPDpl expression levels equivalent Ngsk Prnp00 mice Fig
0.15615378.12759361.html.plaintext.txt	134	The expression levels remained stable aging even onset ataxia data shown
0.15615378.12759361.html.plaintext.txt	135	View larger version 38K FIG
0.15615378.12759361.html.plaintext.txt	136	PrPLPDpl expression levels similar among brain tissues wild type Ngsk Prnp00 TgNgsk Prnp00 mouse lines
0.15615378.12759361.html.plaintext.txt	137	PrPLPDpl brain tissues mouse line visualized Western blot analysis using anti PrPLPDpl polyclonal rabbit antiserum
0.15615378.12759361.html.plaintext.txt	138	Each lane contains 60 microg total protein
0.15615378.12759361.html.plaintext.txt	139	Accumulating evidence indicated certain neurodegenerative conditions caused aggregation detergent insoluble proteins PrPSc central nervous system 24
0.15615378.12759361.html.plaintext.txt	140	To evaluate possibility PrPLPDpl aggregation brain tissues examined detergent insolubility PrPLPDpl brains ataxic Ngsk Prnp00 Tg SHaNgsk Prnp00 mice 98 weeks age
0.15615378.12759361.html.plaintext.txt	141	6A PrPLPDpl partially insoluble buffer containing 0
0.15615378.12759361.html.plaintext.txt	142	5 sodium deoxycholate completely solubilized 1 sarcosyl
0.15615378.12759361.html.plaintext.txt	143	The levels Triton X 100 insoluble fraction PrPLPDpl similar Ngsk Prnp00 Tg SHaNgsk Prnp00 mice even 98 weeks age increase aging Fig
0.15615378.12759361.html.plaintext.txt	144	View larger version 36K FIG
0.15615378.12759361.html.plaintext.txt	145	Absence detergent insoluble PrPLPDpl brains Ngsk Prnp00 Tg SHaPrPNgsk Prnp00 mice
0.15615378.12759361.html.plaintext.txt	146	A postnuclear supernatants protein concentration 4 mgml brain homogenates 98 week old Ngsk Prnp00 Tg SHaNgsk Prnp00 mice lysis buffer without 1 sarcosyl centrifuged 108000 x g 45 min
0.15615378.12759361.html.plaintext.txt	147	PrPLPDpl resulting pellets Plt supernatants Sup visualized Western blotting
0.15615378.12759361.html.plaintext.txt	148	B analysis Ngsk Prnp00 mice 12 35 64 98 weeks age shown
0.15615378.12759361.html.plaintext.txt	149	SOD Gpx Activities Brain Tissues Ngsk Prnp00 Mice Are Not Reduced Finally possible involvement regulation anti oxidative enzyme activities neurodegeneration Ngsk Prnp00 mice evaluated
0.15615378.12759361.html.plaintext.txt	150	The activities SOD Gpx brain tissues Ngsk Prnp00 mice 6 months age measured compared two age matched control mouse lines Prnpand Tg Mo
0.15615378.12759361.html.plaintext.txt	151	CuZn SOD activities Prnp Ngsk Prnp00 Tg Mo
0.15615378.12759361.html.plaintext.txt	152	5 unitsmg protein mean plus minus S
0.15615378.12759361.html.plaintext.txt	153	respectively Mn SOD activities 19
0.15615378.12759361.html.plaintext.txt	154	4 unitsmg protein respectively Fig
0.15615378.12759361.html.plaintext.txt	155	There statistically significant difference
0.15615378.12759361.html.plaintext.txt	156	Gpx activities also similar among mouse lines 67
0.15615378.12759361.html.plaintext.txt	157	8 nmolminmg protein respectively Fig
0.15615378.12759361.html.plaintext.txt	158	View larger version 21K FIG
0.15615378.12759361.html.plaintext.txt	159	Activities Cu Zn SOD Mn SOD Gpx reduced brains Ngsk Prnp00 mice
0.15615378.12759361.html.plaintext.txt	160	The activities Cu Zn SOD Mn SOD A Gpx B compared among brain tissues wild type Ngsk Prnp00 Tg Mo
0.15615378.12759361.html.plaintext.txt	161	Three mice line used
0.15615378.12759361.html.plaintext.txt	162	All measurements repeated two three times brain
0.15615378.12759361.html.plaintext.txt	163	Vertical bars indicate standard errors
0.15615378.12759361.html.plaintext.txt	164	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES We previously demonstrated wild type Mo
0.15615378.12759361.html.plaintext.txt	165	PrP potential prevent PrPLPDpl induced neurodegeneration Ngsk Prnp00 mice 5
0.15615378.12759361.html.plaintext.txt	166	The present study showed Mo
0.15615378.12759361.html.plaintext.txt	167	E199K PrP well heterologous hamster hamstermouse chimeric PrPs MHM2
0.15615378.12759361.html.plaintext.txt	168	del23 88 PrP could rescue Ngsk Prnp00 mice Purkinje cell death
0.15615378.12759361.html.plaintext.txt	169	E199K represents E200K substitution human PrP commonly found patients familial Creutzfeldt Jakob disease 21
0.15615378.12759361.html.plaintext.txt	170	E199K strongly indicates mutant retains major aspects normal PrP function thus argues dominant negative role mutant
0.15615378.12759361.html.plaintext.txt	171	The solution structure recombinant human PrP 90 231 E200K reported nearly identical wild type PrP 25
0.15615378.12759361.html.plaintext.txt	172	This finding also supports notion amino acid substitution disrupt structure critical normal function PrP
0.15615378.12759361.html.plaintext.txt	173	Although various hypothetical models proposed precise mechanisms neurodegeneration seen Ngsk Prnp00 mice remain elucidated
0.15615378.12759361.html.plaintext.txt	174	In addition structural similarities PrP PrPLPDpl previous finding recombinant C terminal PrP 121 231 fragment could convert sheet rich structure acidic pH vitro 26 prompted us examine involvement abnormal PrPLPDpl aggregation neurodegeneration
0.15615378.12759361.html.plaintext.txt	175	However failed detect detergent insoluble PrPLPDpl accumulation central nervous system Ngsk Prnp00 mice even onset ataxia
0.15615378.12759361.html.plaintext.txt	176	PrPLPDpl contains two intramolecular disulfide bonds C terminal portion 14 contrast PrP single disulfide bond shown necessary conversion pathogenic isoform PrPSc
0.15615378.12759361.html.plaintext.txt	177	The structures determined intramolecular disulfide bonds may account difference two proteins potential structural conversion
0.15615378.12759361.html.plaintext.txt	178	del23 88 transgene encoded product lacking almost entire unique octapeptide repeat region failed rescue Ngsk Prnp00 mice neurodegeneration
0.15615378.12759361.html.plaintext.txt	179	Little difference observed pathology onset ataxia Ngsk Prnp00 Tg MHM2
0.15615378.12759361.html.plaintext.txt	180	The PrP expression level Tg MHM2
0.15615378.12759361.html.plaintext.txt	181	del23 88Ngsk Prnp00 mice higher Tg SHa Tg MH2MNgsk Prnp00 similar Tg MHM2Ngsk Prnp00 mice
0.15615378.12759361.html.plaintext.txt	182	This strongly indicates N terminal part PrP essential rescue Purkinje cell death
0.15615378.12759361.html.plaintext.txt	183	del23 88 PrP shown retain potential convert pathogenic isoform prion infected cell cultures 27 brain tissues Tg MHM2
0.15615378.12759361.html.plaintext.txt	184	The N terminal region could thus key factor determining whether physiological function maintained likely less important pathogenic structural conversion
0.15615378.12759361.html.plaintext.txt	185	Because unique octapeptide repeat region potential bind copper 28 PrP may function transport metabolism copper neuron 29 31
0.15615378.12759361.html.plaintext.txt	186	Copper involved various aspects reactive oxygen species metabolism 32
0.15615378.12759361.html.plaintext.txt	187	It could thus possible impaired copper transport may result reactive oxygen species accumulation leading cell death
0.15615378.12759361.html.plaintext.txt	188	Indeed reduced activity CuZn SOD brains Zrch I Prnp00 mice reported 33
0.15615378.12759361.html.plaintext.txt	189	However along contradictory reports 34 present study failed show reduced activities CuZn SOD Mn SOD Gpx brains Ngsk Prnp00 mice
0.15615378.12759361.html.plaintext.txt	190	The fact CuZn SOD deficient mice never developed neurological signs ataxia 35 also argues causal relationship reduced activity CuZn SOD Purkinje cell death
0.15615378.12759361.html.plaintext.txt	191	Interestingly Tg mice expressing PrP
0.15615378.12759361.html.plaintext.txt	192	del32 121 32 134 Zrch I Prnp00 background also developed cerebellar cell death wild type Prnp background 16
0.15615378.12759361.html.plaintext.txt	193	The two mutant PrPs lack part hydrophobic region 111 134 addition octapeptide repeat region also absent PrPLPDpl
0.15615378.12759361.html.plaintext.txt	194	The structural similarities PrP
0.15615378.12759361.html.plaintext.txt	195	del32 12132 134 PrPLPDpl strongly suggested common mechanism involved neurodegeneration Tg mice Ngsk Prnp00 mice
0.15615378.12759361.html.plaintext.txt	196	Behrens Aguzzi 36 hypothesized yet unidentified ligand harbors affinities PrP PrPLPDpl N terminus truncated PrPs
0.15615378.12759361.html.plaintext.txt	197	In absence PrP binding putative ligand PrPLPDpl PrP
0.15615378.12759361.html.plaintext.txt	198	del32 12132 134 may trigger apoptotic signal prevent survival signal
0.15615378.12759361.html.plaintext.txt	199	On hand presence PrP binding would impeded much lower affinity
0.15615378.12759361.html.plaintext.txt	200	If case failure MHM2
0.15615378.12759361.html.plaintext.txt	201	del23 88 PrP phenotype rescue suggests residues 23 88 include site critical ligand binding functional transduction ligand signals
0.15615378.12759361.html.plaintext.txt	202	Recent studies demonstrated copper binds octapeptide repeat region also C terminal PrP 91 231121 231 fragments 37 38 PrPLPDpl 39
0.15615378.12759361.html.plaintext.txt	203	Hence copper could one candidate hypothetical ligand acting raise neurotoxic signal prevent survival signal binding PrPLPDpl PrP
0.15615378.12759361.html.plaintext.txt	204	del23 88 PrP well full length PrP underwent proteolytic cleavage leading production C1
0.15615378.12759361.html.plaintext.txt	205	This indicated loss N terminal residues 23 88 affect cleavage C1 necessary phenotype rescue
0.15615378.12759361.html.plaintext.txt	206	It also shown N terminal cleavage product PrP 23 110111 designated N1 released supernatant cultured cells 40
0.15615378.12759361.html.plaintext.txt	207	An intriguing hypothesis N1 may play neuroprotective role outside cells
0.15615378.12759361.html.plaintext.txt	208	For instance may bind copper molecules produce neuroprotective signal
0.15615378.12759361.html.plaintext.txt	209	del23 88 PrP lacking octapeptide repeat region unlikely preserve function
0.15615378.12759361.html.plaintext.txt	210	It would value examine potential N1 rescue Ngsk Prnp00 mice Purkinje cell death
0.15615378.12759361.html.plaintext.txt	211	Another model neurodegeneration evaluated absence PrP might make cerebellar cells vulnerable constitutive weak apoptotic signal transduced PrPLPDpl 36
0.15615378.12759361.html.plaintext.txt	212	PrP could raise anti apoptotic signal independently protect PrPLPDpl induced apoptosis
0.15615378.12759361.html.plaintext.txt	213	Accumulating evidence supported anti apoptotic role PrP
0.15615378.12759361.html.plaintext.txt	214	For instance overexpression PrP protected human primary neurons Bax mediated apoptosis 41
0.15615378.12759361.html.plaintext.txt	215	The protective effect abolished deletion octapeptide repeat region residues 56 88 human PrP
0.15615378.12759361.html.plaintext.txt	216	Serum withdrawal induced apoptosis immortalized hippocampal cells derived Prnp00 mice also prevented overexpressed PrP Bcl 2 42
0.15615378.12759361.html.plaintext.txt	217	43 recently demonstrated evidence peptide capable binding residues 113 128 PrP protected developing retina neurons apoptosis via activation cAMP dependent protein kinase
0.15615378.12759361.html.plaintext.txt	218	The group identified stress inducible protein 1 heat shock protein binds residues 113 128 PrP promotes neuroprotective signal 44
0.15615378.12759361.html.plaintext.txt	219	Interestingly expression PrP
0.15615378.12759361.html.plaintext.txt	220	del32 12132 134 Zrch I Prnp00 mice induced cerebellar neurodegeneration MHM2
0.15615378.12759361.html.plaintext.txt	221	del23 88 PrP preserving residues 113 128
0.15615378.12759361.html.plaintext.txt	222	The absence potential bind stress inducible protein 1 may crucial neurotoxic effects PrP
0.15615378.12759361.html.plaintext.txt	223	del32 12132 134 PrPLPDpl
0.15615378.12759361.html.plaintext.txt	224	In prion diseases constitutive conversion PrP pathogenic isoform PrPSc likely result functional loss normal PrP 45
0.15615378.12759361.html.plaintext.txt	225	If PrPSc mimics neurotoxic role PrPLPDpl PrP
0.15615378.12759361.html.plaintext.txt	226	del32 12132 134 Ngsk Prnp00 mice lacking PrP ectopically expressing PrPLPDpl neurons could valuable model neurodegeneration
0.15615378.12759361.html.plaintext.txt	227	Alternatively also possible mechanisms neurodegeneration mice distinct prion diseases based present finding detergent insoluble PrPLPDpl detectable mouse brain tissues
0.15615378.12759361.html.plaintext.txt	228	Elucidation molecular mechanisms responsible neurodegeneration Ngsk Prnp00 mice would provide new insights understanding pathogenesis prion diseases neurodegenerative conditions well physiological function PrP
0.15615378.12759361.html.plaintext.txt	229	FOOTNOTES This work supported grants Ministry Education Culture Sports Science Technology Japan Ministry Health Labor Welfare Japan
0.15615378.12759361.html.plaintext.txt	230	The costs publication article defrayed part payment page charges
0.15615378.12759361.html.plaintext.txt	231	This article must therefore hereby marked advertisement accordance 18 U
0.15615378.12759361.html.plaintext.txt	232	Section 1734 solely indicate fact
0.15615378.12759361.html.plaintext.txt	233	Research Resident Japan Health Sciences Foundation
0.15615378.12759361.html.plaintext.txt	234	To correspondence addressed
0.15615378.12759361.html.plaintext.txt	235	81 95 849 7059 Fax 81 95 849 7060 E mail ryu ngsatumin
0.15615378.12759361.html.plaintext.txt	236	1 The abbreviations used PrP prion protein PrPLPDpl PrP like proteinDoppel SOD superoxide dismutase Gpx glutathione peroxidase Mo
0.15615378.12759361.html.plaintext.txt	237	ACKNOWLEDGMENTS We grateful Drs
0.15615378.12759361.html.plaintext.txt	238	Prusiner Patrick Tremblay Sylvain Lehmann providing mice reagents
0.15615378.12759361.html.plaintext.txt	239	We thank Nobuhiko Okimura technical support Aimin Li anti PrPLPDpl polyclonal rabbit antiserum Amanda Nishida help preparation manuscript
0.15615378.12759361.html.plaintext.txt	240	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Bueler H
0.15615378.12759361.html.plaintext.txt	241	1993 Cell 73 1339 1347Medline Order article via Infotrieve Sakaguchi S
0.15615378.12759361.html.plaintext.txt	242	69 7586 7592Abstract Prusiner S
0.15615378.12759361.html.plaintext.txt	243	1998 Cell 93 337 348Medline Order article via Infotrieve Sakaguchi S
0.15615378.12759361.html.plaintext.txt	244	1996 Nature 380 528 531CrossRefMedline Order article via Infotrieve Nishida N
0.15615378.12759361.html.plaintext.txt	245	79 689 697Medline Order article via Infotrieve Moore R
0.15615378.12759361.html.plaintext.txt	246	292 797 817CrossRefMedline Order article via Infotrieve Rossi D
0.15615378.12759361.html.plaintext.txt	247	20 694 702AbstractFree Full Text Bueler H
0.15615378.12759361.html.plaintext.txt	248	1992 Nature 356 577 582CrossRefMedline Order article via Infotrieve Manson J
0.15615378.12759361.html.plaintext.txt	249	8 121 127Medline Order article via Infotrieve Li A
0.15615378.12759361.html.plaintext.txt	250	20 553 567CrossRefMedline Order article via Infotrieve Li A
0.15615378.12759361.html.plaintext.txt	251	157 1447 1452AbstractFree Full Text Behrens A
0.15615378.12759361.html.plaintext.txt	252	21 3652 3658AbstractFree Full Text Moore R
0.15615378.12759361.html.plaintext.txt	253	98 15288 15293AbstractFree Full Text Silverman G
0.15615378.12759361.html.plaintext.txt	254	275 26834 26841AbstractFree Full Text Mo H
0.15615378.12759361.html.plaintext.txt	255	98 2352 2357AbstractFree Full Text Shmerling D
0.15615378.12759361.html.plaintext.txt	256	1998 Cell 93 203 214Medline Order article via Infotrieve Scott M
0.15615378.12759361.html.plaintext.txt	257	1989 Cell 59 847 857Medline Order article via Infotrieve Scott M
0.15615378.12759361.html.plaintext.txt	258	1993 Cell 73 979 988Medline Order article via Infotrieve Supattapone S
0.15615378.12759361.html.plaintext.txt	259	1999 Cell 96 869 878Medline Order article via Infotrieve Telling G
0.15615378.12759361.html.plaintext.txt	260	10 1736 1750Abstract Hsiao K
0.15615378.12759361.html.plaintext.txt	261	324 1091 1097Abstract Nishida N
0.15615378.12759361.html.plaintext.txt	262	74 320 325AbstractFree Full Text Chen S
0.15615378.12759361.html.plaintext.txt	263	270 19173 19180AbstractFree Full Text Murphy R
0.15615378.12759361.html.plaintext.txt	264	4 155 174CrossRefMedline Order article via Infotrieve Zhang Y
0.15615378.12759361.html.plaintext.txt	265	275 33650 33654AbstractFree Full Text Hornemann S
0.15615378.12759361.html.plaintext.txt	266	95 6010 6014AbstractFree Full Text Rogers M
0.15615378.12759361.html.plaintext.txt	267	90 3182 3186Abstract Hornshaw M
0.15615378.12759361.html.plaintext.txt	268	207 621 629CrossRefMedline Order article via Infotrieve Brown D
0.15615378.12759361.html.plaintext.txt	269	1997 Nature 390 684 687CrossRefMedline Order article via Infotrieve Herms J
0.15615378.12759361.html.plaintext.txt	270	19 8866 8875AbstractFree Full Text Pauly P
0.15615378.12759361.html.plaintext.txt	271	273 33107 33110AbstractFree Full Text Linder M
0.15615378.12759361.html.plaintext.txt	272	63 797S 811SAbstract Brown D
0.15615378.12759361.html.plaintext.txt	273	334 423 429Medline Order article via Infotrieve Waggoner D
0.15615378.12759361.html.plaintext.txt	274	275 7455 7458AbstractFree Full Text Reaume A
0.15615378.12759361.html.plaintext.txt	275	13 43 47Medline Order article via Infotrieve Behrens A
0.15615378.12759361.html.plaintext.txt	276	25 150 154CrossRefMedline Order article via Infotrieve Cereghetti G
0.15615378.12759361.html.plaintext.txt	277	81 516 525AbstractFree Full Text Jackson G
0.15615378.12759361.html.plaintext.txt	278	98 8531 8535AbstractFree Full Text Qin K
0.15615378.12759361.html.plaintext.txt	279	278 8888 8896AbstractFree Full Text Vincent B
0.15615378.12759361.html.plaintext.txt	280	275 35612 35616AbstractFree Full Text Bounhar Y
0.15615378.12759361.html.plaintext.txt	281	276 39145 39149AbstractFree Full Text Kuwahara C
0.15615378.12759361.html.plaintext.txt	282	1999 Nature 400 225 226CrossRefMedline Order article via Infotrieve Chiarini L
0.15615378.12759361.html.plaintext.txt	283	21 3317 3326AbstractFree Full Text Zanata S
0.15615378.12759361.html.plaintext.txt	284	21 3307 3316AbstractFree Full Text Yokoyama T
0.15615378.12759361.html.plaintext.txt	285	276 11265 11271AbstractFree Full Text
0.09852033.14754888.html.plaintext.txt	0	Effects Different Experimental Conditions PrPSc Core Generated Protease Digestion IMPLICATIONS FOR STRAIN TYPING AND MOLECULAR CLASSIFICATION OF CJD Silvio Notari Sabina Capellari Armin Giese Ingo Westner Agostino Baruzzi Bernardino Ghetti Pierluigi Gambetti Hans A
0.09852033.14754888.html.plaintext.txt	1	Kretzschmar Piero Parchi
0.09852033.14754888.html.plaintext.txt	2	From Dipartimento di Scienze Neurologiche Universita di Bologna 40123 Bologna Italy Institut fuer Neuropathologie Ludwig Maximilians Universitaet 81377 Muenchen Germany Department Pathology Indiana University Indianapolis Indiana 46202 5120 Institute Pathology Case Western Reserve University Cleveland Ohio 44106
0.09852033.14754888.html.plaintext.txt	3	Received publication December 4 2003 revised form January 28 2004
0.09852033.14754888.html.plaintext.txt	4	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The discovery molecular subtypes pathological prion protein PrPSc provided basis novel classification human transmissible spongiform encephalopathies TSEs potentially powerful method strain typing
0.09852033.14754888.html.plaintext.txt	5	However still significant disparity regarding understanding nomenclature PrPSc types
0.09852033.14754888.html.plaintext.txt	6	In addition still unknown whether specific PrPSc type associated TSE phenotypic variant
0.09852033.14754888.html.plaintext.txt	7	In sporadic Creutzfeldt Jakob disease sCJD five disease phenotypes known two major types PrPSc types 1 2 consistently reproduced
0.09852033.14754888.html.plaintext.txt	8	We analyzed PrPSc properties sCJD variant CJD using high resolution gel electrophoresis system varying experimental conditions
0.09852033.14754888.html.plaintext.txt	9	We found pH varies among CJD brain homogenates standard buffers thereby influencing characteristics protease treated PrPSc
0.09852033.14754888.html.plaintext.txt	10	We also show PrPSc type 1 type 2 heterogeneous species distinguished five molecular subtypes fit current histopathological classification sCJD variants
0.09852033.14754888.html.plaintext.txt	11	Our results shed light previous disparities PrPSc typing provide refined classification human PrPSc types support notion pathological TSE phenotype related PrPSc structure
0.09852033.14754888.html.plaintext.txt	12	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Transmissible spongiform encephalopathies TSEs1 prion diseases phenotypically heterogeneous group neurodegenerative disorders affects humans animals
0.09852033.14754888.html.plaintext.txt	13	Human diseases include Creutzfeldt Jakob disease CJD Gerstmann Straussler Scheinker disease kuru fatal insomnia 1 3
0.09852033.14754888.html.plaintext.txt	14	CJD far common human TSE may occur sporadic disease unknown etiology sCJD disease associated mutations prion protein gene PRNP proven exogenous infection
0.09852033.14754888.html.plaintext.txt	15	The latter group includes variant CJD vCJD distinct disease phenotype believed transmitted cattle humans consumption contaminated meat 3
0.09852033.14754888.html.plaintext.txt	16	The cellular prion protein PrPc host encoded copper membrane bound glycoprotein unknown function key role TSE pathogenesis 4
0.09852033.14754888.html.plaintext.txt	17	There agent replication transmission infectivity absence PrPc expression 5
0.09852033.14754888.html.plaintext.txt	18	Moreover abnormal partially protease resistant isoform PrPSc PrPc specifically accumulates nervous system infection represents hallmark disease 4 6
0.09852033.14754888.html.plaintext.txt	19	The conversion PrPc PrPSc posttranslational event associated increase sheet secondary structure protein 7 8
0.09852033.14754888.html.plaintext.txt	20	CJD like scrapie sheep comprises broad spectrum clinicopathological variants 9
0.09852033.14754888.html.plaintext.txt	21	In scrapie transmitted mice extensively studied TSE strain agent host genotype variability determined polymorphisms coding region PRNP major determinants disease phenotype 10
0.09852033.14754888.html.plaintext.txt	22	Different prion strains transmit diseases syngenic animals differ topography type lesion intracerebral distribution PrPSc
0.09852033.14754888.html.plaintext.txt	23	In humans disease susceptibility phenotypic expression influenced PRNP mutations polymorphism codon 129 encodes either methionine M valine V 11 13
0.09852033.14754888.html.plaintext.txt	24	Distinct agent strains demonstrated 14 17 remain characterized full
0.09852033.14754888.html.plaintext.txt	25	Although uncertainties remain molecular basis TSE strains relationship strains PrP several lines evidence indicate PrPSc exists variety molecular subtypes showing differences conformation glycosylation protease resistance aggregation state 15 18 23 may encode least part strain specific properties
0.09852033.14754888.html.plaintext.txt	26	Furthermore evidence transmission studies indicates different PrPSc types showing distinct physicochemical properties represent genuine biochemical signatures individual strain host genotype interactions
0.09852033.14754888.html.plaintext.txt	27	Because analysis biochemical properties PrPSc much less time consuming bioassays mice unraveling physicochemical properties PrPSc associated TSE strain phenotype
0.09852033.14754888.html.plaintext.txt	28	PrPSc typing undoubtedly become crucial importance strain typing molecular classification TSEs wide implications disease diagnosis epidemiologic surveillance
0.09852033.14754888.html.plaintext.txt	29	Unfortunately significant disparity literature regarding existence distinct human PrPSc types 23 27 extent also true animal TSEs 28 30
0.09852033.14754888.html.plaintext.txt	30	Based differences gel mobility N terminal sequence core fragments generated proteinase K PK Parchi et al
0.09852033.14754888.html.plaintext.txt	31	23 25 originally identified two human PrPSc types named type 1 type 2
0.09852033.14754888.html.plaintext.txt	32	Type 1 relative molecular mass 21 kDa primary cleavage site residue 82 type 2 relative molecular mass 19 kDa primary cleavage residue 97
0.09852033.14754888.html.plaintext.txt	33	In studies however PrPSc type 1 codon 129 MM subjects distinguished 2 subtypes showing less 1 kDa difference mobility 26 27
0.09852033.14754888.html.plaintext.txt	34	26 two PrPSc type 1 subtypes named types 1 2 show indistinguishable fragment sizes PK digestion performed presence 20 mM EDTA thereby representing two distinct conformations acquired PrPSc presence metal ions copper zinc
0.09852033.14754888.html.plaintext.txt	35	In contrast two putative PrPSc subtypes described Zanusso et al
0.09852033.14754888.html.plaintext.txt	36	27 also named types 1 2 although comparable Wadsworth et al
0.09852033.14754888.html.plaintext.txt	37	26 would represent two distinct protein conformations different response pH variations
0.09852033.14754888.html.plaintext.txt	38	one conformation pH dependent
0.09852033.14754888.html.plaintext.txt	39	The rationale study effect metal ions pH PrPSc properties lies finding octapeptide repeat PrPc sequence residues 51 91 Cu 2 binding motif changes conformation presence copper copper binding stoichiometry pH dependent 31 32
0.09852033.14754888.html.plaintext.txt	40	In previous studies PrPSc typing sCJD also reported certain degree heterogeneity within type 1 type 2 samples particularly among type 1 samples codon 129 MM subjects 23 24
0.09852033.14754888.html.plaintext.txt	41	However subtle biochemical differences compared type 1type 2 difference relative molecular mass failed show consistent reproducibility correlation disease pathological phenotype suggesting might related experimental conditions rather intrinsic differences strains
0.09852033.14754888.html.plaintext.txt	42	For example noteworthy various protocols applied define PrPSc properties date included use PK well outside optimal conditions
0.09852033.14754888.html.plaintext.txt	43	5 optimum temperature 37 degrees C 33 34 standardized respect variables might affect activity
0.09852033.14754888.html.plaintext.txt	44	On hand characterization least five distinct pathological sCJD subtypes 9 argues existence two prion strains two PrPSc types
0.09852033.14754888.html.plaintext.txt	45	Thus conceivable application sensitive techniques rigorous experimental conditions lead distinction potential artifacts related sample preparation disease specific biochemical differences suitable refined classification CJD PrPSc types
0.09852033.14754888.html.plaintext.txt	46	To reach goal shed light current PrPSc typing controversies contribute understanding molecular basis TSE strains phenotypic variability examined effect different experimental conditions characteristics PrPSc fragments associated sCJD subtypes vCJD using high resolution gel electrophoresis system
0.09852033.14754888.html.plaintext.txt	47	Particular emphasis given study interplay effects homogenate pH PK concentrationactivity
0.09852033.14754888.html.plaintext.txt	48	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Patients Tissues We studied 75 sCJD cases 4 vCJD cases phenotypically characterized regard clinical histopathological features pattern PrP deposition PRNP genotype Western blot profile PrPSc
0.09852033.14754888.html.plaintext.txt	49	Sporadic CJD subtypes classified according Parchi et al
0.09852033.14754888.html.plaintext.txt	50	They included 40 MM1 5 MV1 10 VV2 10 MV2 5 VV1 5 MM2 cortical
0.09852033.14754888.html.plaintext.txt	51	Brain tissues obtained autopsy kept frozen 80 degrees C use
0.09852033.14754888.html.plaintext.txt	52	Brain samples used frontal cerebral cortex usually middle frontal gyrus
0.09852033.14754888.html.plaintext.txt	53	In 5 MM1 cases tissue also obtained putamen entorhinal cortex hippocampus amygdala
0.09852033.14754888.html.plaintext.txt	54	Molecular Genetics Genomic DNA extracted blood frozen brain tissue
0.09852033.14754888.html.plaintext.txt	55	Genotyping PRNP coding region performed described 9
0.09852033.14754888.html.plaintext.txt	56	Sample Preparation pH Measurement Brain homogenates 10 wv prepared ice following conditions 1 lysis buffer LB 100 mM NaCl 10 mM EDTA 0
0.09852033.14754888.html.plaintext.txt	57	5 sodium deoxycholate 10 mM Tris 2 lysis buffer 100 mM Tris 100 mM NaCl 10 mM EDTA 0
0.09852033.14754888.html.plaintext.txt	58	5 sodium deoxycholate 100 mM Tris 3 PBS Dulbeccos phosphate buffered saline lacking MgCl2 CaCl2 0
0.09852033.14754888.html.plaintext.txt	59	2 gliter KCl 4 PBS 10 fold increase phosphate salt concentration 2
0.09852033.14754888.html.plaintext.txt	60	5 gliter Na2HPO4 5 PBS 10 fold increase phosphate salt concentration 2
0.09852033.14754888.html.plaintext.txt	61	5 gliter Na2HPO4 addition detergent 1 Sarkosyl 1 Nonidet P 40 6 citrate phosphate buffer
0.09852033.14754888.html.plaintext.txt	62	According pKa values PBS buffers prepared pH 5
0.09852033.14754888.html.plaintext.txt	63	0 lysis buffers prepared pH 6
0.09852033.14754888.html.plaintext.txt	64	0 citrate phosphate buffer prepared pH 4
0.09852033.14754888.html.plaintext.txt	65	Because pH Tris buffers changes significantly according buffer temperature lysis buffers titrated desired pH value 37 degrees C
0.09852033.14754888.html.plaintext.txt	66	temperature protease digestion performed
0.09852033.14754888.html.plaintext.txt	67	Because sodium deoxycholate known precipitate acidic pH around 6
0.09852033.14754888.html.plaintext.txt	68	3 used pH values lower 6
0.09852033.14754888.html.plaintext.txt	69	Experiments exploring influence EDTA PK digestion performed using 250 mM EDTA stock solutions pH 7
0.09852033.14754888.html.plaintext.txt	70	Samples treated 37 degrees C PK 20 unitsmg Roche Diagnostics chymotrypsin 1500 unitsmg bovine pancreas Calbiochem cathepsin L 6500 milliunitsmg 1
0.09852033.14754888.html.plaintext.txt	71	1 mgml bovine kidney Calbiochem using various concentrationincubation time combinations concentration range PK 7 10000 microgml incubation time range PK 1 15 h
0.09852033.14754888.html.plaintext.txt	72	PK stock solutions 10 mgml higher prepared storage buffer 50 glycerol 10 mM Tris pH 7
0.09852033.14754888.html.plaintext.txt	73	Small aliquots prepared stored 20 degrees C
0.09852033.14754888.html.plaintext.txt	74	For experiment new aliquot used
0.09852033.14754888.html.plaintext.txt	75	Protease digestion terminated addition 2 mM phenylmethylsulfonyl fluoride
0.09852033.14754888.html.plaintext.txt	76	The pH tissue homogenates measured duplicate using needle electrode Hamilton
0.09852033.14754888.html.plaintext.txt	77	Western Blot 10 brain homogenates resuspended sample buffer final concentration 3 SDS 4 mercaptoethanol 10 glycerol 2 mM EDTA 62
0.09852033.14754888.html.plaintext.txt	78	8 boiled 8 min loading
0.09852033.14754888.html.plaintext.txt	79	Protein samples brain tissue equivalent 0
0.09852033.14754888.html.plaintext.txt	80	2 1 mg wet tissue separated 12 15 SDS polyacrylamide gels 37
0.09852033.14754888.html.plaintext.txt	81	51 acrylamidebisacrylamide using gel electrophoresis apparatus holding running gels different lengths 5
0.09852033.14754888.html.plaintext.txt	82	Proteins transferred Immobilon P Millipore 2 h 60V blocked 10 nonfat milk Tween Tris buffered saline pH 7
0.09852033.14754888.html.plaintext.txt	83	5 probed appropriate antibody
0.09852033.14754888.html.plaintext.txt	84	The monoclonal 3F4 150000 binds PrP residues 108 111 35 used primary antibody
0.09852033.14754888.html.plaintext.txt	85	The immunoreactivity visualized enhanced chemiluminescence Amersham Biosciences Kodak BioMax Light films Eastman Kodak Co
0.09852033.14754888.html.plaintext.txt	86	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Analysis PrPSc Type 1 sCJD MM Subjects The Effect Gel Resolution To examine gel mobility human PrPSc type 1 detail previous studies compared Western blot profiles obtained 12 Tris glycine PAGE gels 5
0.09852033.14754888.html.plaintext.txt	87	5 cm long gels commonly used PrPSc typing analysis obtained using longer gels 15 cm
0.09852033.14754888.html.plaintext.txt	88	In latter condition PrPSc extracted sCJD MM1 showed significant heterogeneity
0.09852033.14754888.html.plaintext.txt	89	This related either number bands electrophoretic mobility represented bands Fig
0.09852033.14754888.html.plaintext.txt	90	View larger version 48K FIG
0.09852033.14754888.html.plaintext.txt	91	Electrophoretic mobility PrPSc type 1 MM subjects generated PK digestion standard lysis buffer pH 7
0.09852033.14754888.html.plaintext.txt	92	Immunoblot analysis frontal cortex homogenates 9 MM1 lanes 1 9 1 VV2 lane 10 subjects shown
0.09852033.14754888.html.plaintext.txt	93	Homogenates prepared standard LB pH 7
0.09852033.14754888.html.plaintext.txt	94	Aliquots digested 100 microgml PK 1 h 37 degrees C
0.09852033.14754888.html.plaintext.txt	95	The actual pH values homogenate shown bottom lane
0.09852033.14754888.html.plaintext.txt	96	c samples run Tris glycine PAGE 12 mini gel 5
0.09852033.14754888.html.plaintext.txt	97	b d samples run Tris glycine PAGE 12 gel 15 cm long
0.09852033.14754888.html.plaintext.txt	98	Approximate molecular masses kilodaltons
0.09852033.14754888.html.plaintext.txt	99	The Effect pH When compared MM1 samples prepared LB pH 7
0.09852033.14754888.html.plaintext.txt	100	4 homogenized LB pH 8
0.09852033.14754888.html.plaintext.txt	101	0 noticed higher heterogeneity gel migration first condition Fig
0.09852033.14754888.html.plaintext.txt	102	This observation prompted us measure pH homogenates
0.09852033.14754888.html.plaintext.txt	103	Samples prepared using standard PBS lysis buffer pH 7
0.09852033.14754888.html.plaintext.txt	104	buffers used date PrPSc typing studies showed unexpected heterogeneous pH values ranging 6
0.09852033.14754888.html.plaintext.txt	105	Similar pH variations also detected homogenates prepared different areas brain Fig
0.09852033.14754888.html.plaintext.txt	106	Homogenates prepared water obviously even acidic Table I
0.09852033.14754888.html.plaintext.txt	107	Interestingly significant correlation pH value homogenate immunoblot profile type 1 sample Fig
0.09852033.14754888.html.plaintext.txt	108	This also true samples obtained different areas brain Fig
0.09852033.14754888.html.plaintext.txt	109	Thus samples brain may also show certain degree heterogeneity brain homogenate pH well electrophoretic mobility PrPSc core fragments
0.09852033.14754888.html.plaintext.txt	110	View table TABLE I Frontal cortex homogenate pH values different buffer conditions mean plus minus S
0.09852033.14754888.html.plaintext.txt	111	We measured actual pH values CJD brain homogenates prepared using different homogenizing solutions lysis buffer 100 mM Tris LB 100 H2O double distilled water corrected pH 7
0.09852033.14754888.html.plaintext.txt	112	Homogenates standard solutions show acidic pH due insufficient buffer capacity strong acidic pH brain tissue see pH values H2O
0.09852033.14754888.html.plaintext.txt	113	Only used solution stronger buffer capacity pH stabilized desired value
0.09852033.14754888.html.plaintext.txt	114	View larger version 71K FIG
0.09852033.14754888.html.plaintext.txt	115	Regional variability electrophoretic mobility PrPSc type 1 MM subject comparison PK digestions performed different pH values
0.09852033.14754888.html.plaintext.txt	116	Immunoblot analysis homogenates five different brain regions MM1 subject shown
0.09852033.14754888.html.plaintext.txt	117	homogenates prepared standard lysis buffer pH 7
0.09852033.14754888.html.plaintext.txt	118	b homogenates prepared standard lysis buffer pH 8
0.09852033.14754888.html.plaintext.txt	119	All aliquots digested 100 microgml PK 1 h 37 degrees C
0.09852033.14754888.html.plaintext.txt	120	The actual pH values homogenates shown bottom lane
0.09852033.14754888.html.plaintext.txt	121	Samples run Tris glycine PAGE 12 mini gel 5
0.09852033.14754888.html.plaintext.txt	122	PUT putamen MFG middle frontal gyrus EC entorhinal cortex Hipp hippocampus AMG amygdala
0.09852033.14754888.html.plaintext.txt	123	Approximate molecular masses kilodaltons
0.09852033.14754888.html.plaintext.txt	124	The result obvious correlation pH type brain area reproduced samples five MM1 subjects
0.09852033.14754888.html.plaintext.txt	125	To analyze detail effect homogenate pH characteristics PrPSc fragments generated PK digestion stabilize pH homogenate desired value
0.09852033.14754888.html.plaintext.txt	126	To aim raised buffer capacity lysis buffer PBS citrate phosphate buffer solutions obtained desired effect increasing 10 fold either Tris phosphate citrate phosphate salt concentration
0.09852033.14754888.html.plaintext.txt	127	We found sCJD MM1 cases immunoblot profile PrPSc core fragments generated PK digestion standard conditions 100 microgml 37 degrees C 1 h varied significantly according homogenate pH showed shift gel mobility pH 6
0.09852033.14754888.html.plaintext.txt	128	7 protein resolved four distinct fragments
0.09852033.14754888.html.plaintext.txt	129	By increasing pH values homogenate obtained progressive disappearance slowest migrating peptides associated parallel increase amount fastest migrating fragments together appearance around pH 7
0.09852033.14754888.html.plaintext.txt	130	2 novel fragment migrated even faster
0.09852033.14754888.html.plaintext.txt	131	Finally additional 6th slower migrating fragment detected digestion acidic pH 5
0.09852033.14754888.html.plaintext.txt	132	3 whereas digestion observed pH 4
0.09852033.14754888.html.plaintext.txt	133	Thus PrPSc core heterogeneity observed MM1 subjects using homogenates prepared standard buffers LB 10 mM Tris standard PBS pH 7
0.09852033.14754888.html.plaintext.txt	134	4 used previous studies 9 24 26 36 clearly related variability homogenate pH Figs
0.09852033.14754888.html.plaintext.txt	135	View larger version 64K FIG
0.09852033.14754888.html.plaintext.txt	136	Effect pH electrophoretic mobility PrPSc type 1 MM subject
0.09852033.14754888.html.plaintext.txt	137	Immunoblot analysis frontal cortex homogenates MM1 subject shown
0.09852033.14754888.html.plaintext.txt	138	Homogenates prepared different solutions high buffer capacities pH values 5
0.09852033.14754888.html.plaintext.txt	139	0 citrate phosphate buffer pH 5
0.09852033.14754888.html.plaintext.txt	140	5 PBS 10x increase phosphate salt concentration plus 1 Sarkosyl pH 6
0.09852033.14754888.html.plaintext.txt	141	0 lysis buffer 100 mM Tris pH BORDER0 6
0.09852033.14754888.html.plaintext.txt	142	All aliquots digested 100 microgml PK 1 h 37 degrees C
0.09852033.14754888.html.plaintext.txt	143	The actual pH values homogenates shown bottom lane
0.09852033.14754888.html.plaintext.txt	144	Samples run Tris glycine PAGE 15 gel 15 cm long
0.09852033.14754888.html.plaintext.txt	145	Approximate molecular masses kilodaltons
0.09852033.14754888.html.plaintext.txt	146	The result reproduced least twice samples 5 MM1 subjects
0.09852033.14754888.html.plaintext.txt	147	The Effect PK Activity Given pH optimum PK basic pH range asked whether multiple PrPSc fragments generated protease digestion acidic pH may least part consequence reduced PK activity
0.09852033.14754888.html.plaintext.txt	148	By exposing samples different PK concentrations found heterogeneity among PrPSc fragments generated PK digestion various pH values could obtained changing PK concentration given pH value
0.09852033.14754888.html.plaintext.txt	149	In particular observed appearance ladder effect type 1 samples digested pH 8
0.09852033.14754888.html.plaintext.txt	150	0 progressively decreasing PK concentration Fig
0.09852033.14754888.html.plaintext.txt	151	Similarly complete disappearance PrPSc fragments higher molecular mass seen digestion acidic pH 6
0.09852033.14754888.html.plaintext.txt	152	7 obtained increasing PK concentration 10 15 times Fig
0.09852033.14754888.html.plaintext.txt	153	View larger version 55K FIG
0.09852033.14754888.html.plaintext.txt	154	Effect PK concentration electrophoretic mobility PrPSc type 1 MM subject
0.09852033.14754888.html.plaintext.txt	155	Immunoblot analysis frontal cortex homogenates MM1 subject shown
0.09852033.14754888.html.plaintext.txt	156	Homogenates prepared lysis buffer 100 mM Tris pH 6
0.09852033.14754888.html.plaintext.txt	157	Aliquots digested 37 degrees C 1 h using different PK concentrations
0.09852033.14754888.html.plaintext.txt	158	Samples run Tris glycine PAGE 15 gel 15 cm long
0.09852033.14754888.html.plaintext.txt	159	Approximate molecular masses kilodaltons
0.09852033.14754888.html.plaintext.txt	160	The result reproduced least twice samples three MM1 subjects
0.09852033.14754888.html.plaintext.txt	161	To determine whether also effect pH PrPSc irrespective effect PK activity used higher PK concentrations varying according pH compensate change protease activity avoid complete PrPSc digestion
0.09852033.14754888.html.plaintext.txt	162	2 PK digestion PrPSc extracted sCJD MM1 showed relative molecular mass 21 kDa pH values higher 7
0.09852033.14754888.html.plaintext.txt	163	3 protein migrated 1 kDa faster Fig
0.09852033.14754888.html.plaintext.txt	164	Both fragments seen pH 7
0.09852033.14754888.html.plaintext.txt	165	All MM1 n 40 subjects analyzed showed shift gel migration
0.09852033.14754888.html.plaintext.txt	166	The shift electrophoretic mobility disappear prolonged PK incubation time almost complete PrPSc digestion Fig
0.09852033.14754888.html.plaintext.txt	167	10 data shown suggesting direct effect pH PrPSc independent effect PK activity
0.09852033.14754888.html.plaintext.txt	168	View larger version 45K FIG
0.09852033.14754888.html.plaintext.txt	169	Effect pH electrophoretic mobility PrPSc type 1 MM subject presence high PK concentration
0.09852033.14754888.html.plaintext.txt	170	Immunoblot analysis frontal cortex homogenates MM1 subject shown
0.09852033.14754888.html.plaintext.txt	171	Homogenates prepared lysis buffer 100 mM Tris pH values 6
0.09852033.14754888.html.plaintext.txt	172	Aliquots digested relatively high PK concentrations 1 h 37 degrees C
0.09852033.14754888.html.plaintext.txt	173	Because maximum efficiency enzyme pH 8 avoid complete digestion PrPSc PK concentration progressively decreased parallel increase pH values lane 1 4 10 mgml lane 5 7 2 mgml lanes 8 9 1 mgml
0.09852033.14754888.html.plaintext.txt	174	Samples run Tris glycine PAGE 15 gel 15 cm long
0.09852033.14754888.html.plaintext.txt	175	Approximate molecular masses kilodaltons
0.09852033.14754888.html.plaintext.txt	176	The result reproduced least twice samples 3 MM1 subjects
0.09852033.14754888.html.plaintext.txt	177	View larger version 56K FIG
0.09852033.14754888.html.plaintext.txt	178	Analysis protease resistance CJD PrPSc types
0.09852033.14754888.html.plaintext.txt	179	Immunoblot analysis frontal cortex homogenates obtained different phenotypic variants CJD shown
0.09852033.14754888.html.plaintext.txt	180	Samples digested 100 microgml PK 37 degrees C 1 h lanes 1 7 panel different concentrations enzyme 37 degrees C 15 h lanes 2 8 100 microgml lanes 3 9 1000 microgml lanes 4 10 3000 microgml lanes 5 11 5000 microgml lanes 6 12 10000 microgml
0.09852033.14754888.html.plaintext.txt	181	Homogenates prepared lysis buffer 100 mM Tris pH 6
0.09852033.14754888.html.plaintext.txt	182	7 lanes 1 6 panel 8
0.09852033.14754888.html.plaintext.txt	183	Samples run Tris glycine PAGE 15 gel 15 cm long
0.09852033.14754888.html.plaintext.txt	184	The result reproduced twice samples least four subjects group
0.09852033.14754888.html.plaintext.txt	185	The Effect Different Proteases To verify whether strong influence pH immunoblot profile PK generated PrPSc fragments mainly related changes PK activity rather pH induced changes PrPSc tested effect proteases cathepsin L whose optimum activity pH 5
0.09852033.14754888.html.plaintext.txt	186	5 chymotrypsin serine protease like PK whose optimum activity around pH 8
0.09852033.14754888.html.plaintext.txt	187	We found chymotrypsin comparable PK respect pattern PrPSc fragments generated sensitivity different pHs Fig
0.09852033.14754888.html.plaintext.txt	188	6 whereas cathepsin L shows pH related effect opposite PK chymotrypsin Fig
0.09852033.14754888.html.plaintext.txt	189	Indeed concentration cathepsin L needed generate single PrPSc fragment much higher pH 6
0.09852033.14754888.html.plaintext.txt	190	As PK however progressive reduction enzyme concentration related appearance multiple PrPSc fragments data shown
0.09852033.14754888.html.plaintext.txt	191	View larger version 54K FIG
0.09852033.14754888.html.plaintext.txt	192	Effect pH digestion PrPSc type 1 MM subject cathepsin L chymotrypsin
0.09852033.14754888.html.plaintext.txt	193	Immunoblot analysis frontal cortex homogenates MM1 subject shown
0.09852033.14754888.html.plaintext.txt	194	Homogenates prepared different pH values using different buffers citrate phosphate pH 4
0.09852033.14754888.html.plaintext.txt	195	0 PBS 10x increase phosphate salt concentration pH 6
0.09852033.14754888.html.plaintext.txt	196	5 lysis buffer 100 mM Tris pH 6
0.09852033.14754888.html.plaintext.txt	197	Digestion performed 37 degrees C 1 h chymotrypsin 100 microgml lanes 1 4 cathepsin L cathepsin L 0
0.09852033.14754888.html.plaintext.txt	198	15 microl microl lanes 5 7
0.09852033.14754888.html.plaintext.txt	199	Samples run Tris glycine PAGE 15 gel 15 cm long
0.09852033.14754888.html.plaintext.txt	200	Approximate molecular masses kilodaltons
0.09852033.14754888.html.plaintext.txt	201	The result reproduced least twice samples 3 MM1 subjects
0.09852033.14754888.html.plaintext.txt	202	The Effect EDTA According Wadsworth et al
0.09852033.14754888.html.plaintext.txt	203	26 PK digestion PrPSc type 1
0.09852033.14754888.html.plaintext.txt	204	types 1 2 designations PrPSc Wadsworth et al
0.09852033.14754888.html.plaintext.txt	205	26 MM subjects presence 20 mM EDTA changes pattern cleavage gives rise fragment lower relative molecular mass
0.09852033.14754888.html.plaintext.txt	206	Considering results effect pH EDTA according protocol Wadsworth et al
0.09852033.14754888.html.plaintext.txt	207	26 prepared basic solution pH 8 added homogenate investigated whether change pH rather EDTA could responsible observed shift gel mobility PrPSc
0.09852033.14754888.html.plaintext.txt	208	Indeed results indicate case Fig
0.09852033.14754888.html.plaintext.txt	209	We measured homogenate pH addition EDTA found addition EDTA prepared stock solution pH 8
0.09852033.14754888.html.plaintext.txt	210	4 significantly increased pH value homogenate 0
0.09852033.14754888.html.plaintext.txt	211	Furthermore able reproduce effect EDTA EDTA solution adjusted pH 7
0.09852033.14754888.html.plaintext.txt	212	0 added homogenate Fig
0.09852033.14754888.html.plaintext.txt	213	A potential influence pH copper chelation activity EDTA unlikely since potential pH diagram copper EDTA system indicates EDTA forms stable copper complexes wide range pH values 37
0.09852033.14754888.html.plaintext.txt	214	In conclusion data argue EDTA 20 mM concentration direct effect pattern PrPSc type 1 cleavage PK
0.09852033.14754888.html.plaintext.txt	215	View larger version 57K FIG
0.09852033.14754888.html.plaintext.txt	216	Effect EDTA electrophoretic mobility PrPSc type 1 MM subject
0.09852033.14754888.html.plaintext.txt	217	Immunoblot analysis frontal cortex homogenates MM1 subject shown
0.09852033.14754888.html.plaintext.txt	218	PK digestions performed PBS pH 8
0.09852033.14754888.html.plaintext.txt	219	4 20 mM EDTA using 250 mM EDTA stock solution tritiated pH 7
0.09852033.14754888.html.plaintext.txt	220	4 20 mM EDTA using 250 mM EDTA stock solution tritiated pH 8
0.09852033.14754888.html.plaintext.txt	221	4 lane 4 lysis buffer pH 8
0.09852033.14754888.html.plaintext.txt	222	All aliquots digested 150 microgml PK 1 h 37 degrees C
0.09852033.14754888.html.plaintext.txt	223	The actual pH values homogenates shown bottom lane
0.09852033.14754888.html.plaintext.txt	224	Samples run Tris glycine PAGE 12 gel 15 cm long
0.09852033.14754888.html.plaintext.txt	225	Approximate molecular masses kilodaltons
0.09852033.14754888.html.plaintext.txt	226	The result reproduced least twice samples 5 MM1 subjects
0.09852033.14754888.html.plaintext.txt	227	Analysis PrPSc Associated sCJD Subtypes MV1 VV1 VV2 MV2 MM2 cortical vCJD PrPSc extracted sCJD MV1 cases showed electrophoretic mobility core fragments including pH dependent shift around pH 7
0.09852033.14754888.html.plaintext.txt	228	2 type 1 MM cases Fig
0.09852033.14754888.html.plaintext.txt	229	A shift gel mobility clearly dependent homogenate pH disappear increasing PK concentrations also observed VV1 subjects
0.09852033.14754888.html.plaintext.txt	230	Indeed PK digestion VV1 samples pH 6
0.09852033.14754888.html.plaintext.txt	231	9 generated doublet 21 20 kDa even relatively high PK concentration used whereas pH 8
0.09852033.14754888.html.plaintext.txt	232	0 fastest migrating fragment detected Fig
0.09852033.14754888.html.plaintext.txt	233	Thus use 15 cm long gel instead mini gel distinguishes PrPSc type 1 VV subjects PrPSc type 1 MM MV subjects Fig
0.09852033.14754888.html.plaintext.txt	234	View larger version 29K FIG
0.09852033.14754888.html.plaintext.txt	235	Distinction subtypes PrPSc type 1 type 2
0.09852033.14754888.html.plaintext.txt	236	Immunoblot analysis frontal cortex homogenates MM1 MV1 VV1 MM2 cortical VV2 MV2 vCJD subjects shown
0.09852033.14754888.html.plaintext.txt	237	Homogenates prepared lysis buffer 100 mM Tris pH 6
0.09852033.14754888.html.plaintext.txt	238	Aliquots digested 2000 microgml PK 1 h 37 degrees C
0.09852033.14754888.html.plaintext.txt	239	Samples run Tris glycine PAGE 15 gel 15 cm long
0.09852033.14754888.html.plaintext.txt	240	Approximate molecular masses kilodaltons
0.09852033.14754888.html.plaintext.txt	241	The result reproduced twice samples least four subjects group
0.09852033.14754888.html.plaintext.txt	242	In contrast PrPSc extracted sCJD subtypes associated PrPSc type 2 VV2 MV2 MM2 cortical vCJD showed much less variability immunoblot profile
0.09852033.14754888.html.plaintext.txt	243	Indeed none type 2 CJD subtypes showed pH dependent shift PrPSc mobility could dissociated PK activity
0.09852033.14754888.html.plaintext.txt	244	4 additional fragments migrating slower 19 kDa generated CJD subtypes standard PK concentration
0.09852033.14754888.html.plaintext.txt	245	100 microgml however disappeared PK activity increased either raising enzyme concentration prolonging incubation time Figs
0.09852033.14754888.html.plaintext.txt	246	The exception rule PrPSc type 2 MV subjects resolved doublet 19 20 kDa even presence higher PK activity indicating immunoblot profile PrPSc MV2 subjects distinct sCJD MM2 VV2 well vCJD Figs
0.09852033.14754888.html.plaintext.txt	247	View larger version 51K FIG
0.09852033.14754888.html.plaintext.txt	248	Effect different PK concentrationpH combinations electrophoretic mobility PrPSc type 2
0.09852033.14754888.html.plaintext.txt	249	Immunoblot analysis frontal cortex homogenates MM2 cortical subject shown
0.09852033.14754888.html.plaintext.txt	250	Homogenates prepared lysis buffer 100 mM Tris pH 6
0.09852033.14754888.html.plaintext.txt	251	Aliquots digested 37 degrees C 1 h using different PK concentrations
0.09852033.14754888.html.plaintext.txt	252	Samples run Tris glycine PAGE 15 gel 15 cm long
0.09852033.14754888.html.plaintext.txt	253	Approximate molecular masses kilodaltons
0.09852033.14754888.html.plaintext.txt	254	The result reproduced least twice samples 3 MM2 cortical subjects
0.09852033.14754888.html.plaintext.txt	255	PrPSc Various CJD Subtypes Differs Degree PK Resistance The observation number fragments obtained PrPSc digested acidic pH given PK concentration varied significantly among samples extracted distinct sCJD subtypes raised possibility distinct PrPSc types differ degree protease resistance
0.09852033.14754888.html.plaintext.txt	256	To answer question compared effect different PK concentrations given pH value
0.09852033.14754888.html.plaintext.txt	257	A qualitative analysis revealed samples extracted different CJD subtypes show varying degrees protease resistance
0.09852033.14754888.html.plaintext.txt	258	In particular PrPSc extracted VV2 vCJD subjects showed highest degree protease resistance Fig
0.09852033.14754888.html.plaintext.txt	259	In contrast type 1 PrPSc extracted VV subjects sensitive PK digestion Fig
0.09852033.14754888.html.plaintext.txt	260	The Effect Various Detergents To evaluate influence detergents PrPSc PK activity compared homogenizing buffers different compositions
0.09852033.14754888.html.plaintext.txt	261	Sarkosyl 1 prevented pH dependent shift electrophoretic mobility seen PrPSc MM1MV1 data shown
0.09852033.14754888.html.plaintext.txt	262	In addition indirect effect PrPSc digestion PK seen Sarkosyl 1 sodium deoxycholate 5 conditions higher concentration PK needed obtain complete PrPSc digestion data shown
0.09852033.14754888.html.plaintext.txt	263	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The results present study shed light previous disparities PrPSc typing provide refined classification human PrPSc types significant implications classification epidemiologic surveillance TSEs humans animals
0.09852033.14754888.html.plaintext.txt	264	We shown due lack sufficient buffer capacities standard Tris PBS buffers significant heterogeneity pH among CJD brain homogenates even prepared brain
0.09852033.14754888.html.plaintext.txt	265	The homogenate pH turn influences size PrPSc core generated protease digestion due combination least three factors
0.09852033.14754888.html.plaintext.txt	266	Protease digestion full length PrPSc step step process yielding fragments various degrees resistance ii PK activity pH dependent iii sCJD MM1 MV1 lesser extent VV1 size PrPSc changes depending whether protease digestion performed pH 7
0.09852033.14754888.html.plaintext.txt	267	Currently significant disparity literature regarding existence distinct human PrPSc types
0.09852033.14754888.html.plaintext.txt	268	After original identification Parchi et al
0.09852033.14754888.html.plaintext.txt	269	24 25 two major PrPSc types named type 1 type 2 sporadic human TSEs two additional classifications human PrPSc types proposed 26 27
0.09852033.14754888.html.plaintext.txt	270	26 PrPSc type 1 MM subjects distinguished 2 subtypes based 0
0.09852033.14754888.html.plaintext.txt	271	5 kDa difference relative molecular mass PrPSc
0.09852033.14754888.html.plaintext.txt	272	However pK digestion performed presence least 20 mM EDTA two PrPSc subtypes show electrophoretic mobility estimated shift 1
0.09852033.14754888.html.plaintext.txt	273	650 kDa first second type respectively
0.09852033.14754888.html.plaintext.txt	274	27 also proposed Parchi et al
0.09852033.14754888.html.plaintext.txt	275	24 PrPSc type 1 includes two protein subtypes distinct conformations strain specific properties
0.09852033.14754888.html.plaintext.txt	276	However variance Wadsworth et al
0.09852033.14754888.html.plaintext.txt	277	26 distinguished two PrPSc subtypes based sensitivity pH variations rather presumed degree binding metal ions
0.09852033.14754888.html.plaintext.txt	278	According study Zanusso et al
0.09852033.14754888.html.plaintext.txt	279	27 60 type 1 samples show pH dependent shift electrophoretic mobility whereas remaining 40 appear unaffected pH variations
0.09852033.14754888.html.plaintext.txt	280	In original descriptions human PrPSc types 23 24 also noticed certain degree PrPSc heterogeneity among subjects belonging sCJD subtype
0.09852033.14754888.html.plaintext.txt	281	particularly among MM1 subjects
0.09852033.14754888.html.plaintext.txt	282	However variance mentioned studies attempt sub classify human PrPSc types based observations degree variability also seen samples taken brain ii molecular heterogeneity correlate distinct phenotypic feature
0.09852033.14754888.html.plaintext.txt	283	By demonstrating heterogeneity human PrPSc type 1 within specific groups MM MV subjects strictly depends pH variations among CJD brain homogenates present study provides reasonable technical explanation PrPSc molecular heterogeneity associated sCJD MM1 MV1
0.09852033.14754888.html.plaintext.txt	284	Thus believe basis present claiming one CJD subtype CJD strain associated molecular combination codon 129 MM genotype PrPSc type 1
0.09852033.14754888.html.plaintext.txt	285	Indeed results clearly show experimental conditions
0.09852033.14754888.html.plaintext.txt	286	homogenate pH PK concentration type detergents carefully controlled electrophoretic mobility PrPSc type 1 MM subjects highly homogenous
0.09852033.14754888.html.plaintext.txt	287	In respect also noteworthy experimental transmission prions pure MM1 subjects non human primates mice given date homogenous results terms incubation time lesion profile 14 16 17
0.09852033.14754888.html.plaintext.txt	288	These results keeping original classification Parchi et al
0.09852033.14754888.html.plaintext.txt	289	9 strongly suggest single major agent strain associated sCJD MM1 subtype
0.09852033.14754888.html.plaintext.txt	290	We cannot provide definite explanation finding Zanusso et al
0.09852033.14754888.html.plaintext.txt	291	27 observed pH dependent shift electrophoretic mobility 60 MM1 subjects
0.09852033.14754888.html.plaintext.txt	292	It significance however perform direct measurement actual pH homogenates
0.09852033.14754888.html.plaintext.txt	293	Thus may unwittingly compared PrPSc core fragments generated different pHs
0.09852033.14754888.html.plaintext.txt	294	It also noteworthy Wadsworth et al
0.09852033.14754888.html.plaintext.txt	295	26 perfect agreement results reported shift electrophoretic mobility sCJD MM subjects either PrPSc type 1 type 2
0.09852033.14754888.html.plaintext.txt	296	corresponding type 1 treated 20 mM EDTA pH 8 PK digestion
0.09852033.14754888.html.plaintext.txt	297	However according results change PK cleavage depends homogenate pH variations rather EDTA
0.09852033.14754888.html.plaintext.txt	298	Our finding decreased pH values brains patients sCJD deserves comment
0.09852033.14754888.html.plaintext.txt	299	The observation raises interesting question whether acidic pH somehow related disease pathogenesis
0.09852033.14754888.html.plaintext.txt	300	Previous studies document decline post mortem human brain pH values positively correlate age death agonal state severity 38 39
0.09852033.14754888.html.plaintext.txt	301	Moreover found non human primates experimentally infected prions suffer agonal state brain pH much less acidic data shown
0.09852033.14754888.html.plaintext.txt	302	Further studies brain metabolites vivo however required provide definitive answer issue
0.09852033.14754888.html.plaintext.txt	303	Our data also shed light current understanding molecular basis human TSE strains phenotypic variability
0.09852033.14754888.html.plaintext.txt	304	Several lines evidence indicate pathological heterogeneity human TSEs related physicochemical properties protease resistant prion protein 24 25
0.09852033.14754888.html.plaintext.txt	305	However whether phenotype indeed related specific PrPSc tertiary quaternary structure still unknown
0.09852033.14754888.html.plaintext.txt	306	In sporadic CJD five phenotypes characterized two major PrPSc types consistently reproduced based difference relative molecular mass PrPSc 9
0.09852033.14754888.html.plaintext.txt	307	By using gels improved resolution different experimental conditions shown PrPSc type 1 codon 129 MM MV subjects distinct physicochemical properties type 1 VV homozygotes
0.09852033.14754888.html.plaintext.txt	308	In addition MM1MV1 VV1 samples PrPSc show pH dependent shift gel mobility
0.09852033.14754888.html.plaintext.txt	309	Our data also show distinct physicochemical properties characterize sCJD subtypes associated PrPSc type 2
0.09852033.14754888.html.plaintext.txt	310	For example PrPSc MV subjects kuru plaques clearly distinguishable type 2s uniquely resolves doublet even relatively high pK concentration used
0.09852033.14754888.html.plaintext.txt	311	Furthermore shown PrPSc VV2 subjects well vCJD display significantly higher protease resistance PrPSc MM2 cortical cases
0.09852033.14754888.html.plaintext.txt	312	Thus analysis protease resistance may allow distinction VV2 MM2 cortical cases without PRNP genotyping helps combination study PrPSc glycoform ratio 36 distinguish vCJD CJD MM2 subtypes
0.09852033.14754888.html.plaintext.txt	313	Taken together data demonstrate specific PrPSc properties associated sCJD pathological phenotype well vCJD supporting notion least human TSEs pathological phenotype related differences PrPSc molecular structure
0.09852033.14754888.html.plaintext.txt	314	By improving molecular distinction sCJD subtypes data also important implications future epidemiological studies etiology sCJD
0.09852033.14754888.html.plaintext.txt	315	Indeed epidemiology sCJD date analyzed considering sCJD single entity might prevented discovery risk factors associated single subgroups sCJD subtypes
0.09852033.14754888.html.plaintext.txt	316	Finally reasonable believe study also contribute standardizing harmonizing PrPSc typing among laboratories represent basis new epidemiologic approach
0.09852033.14754888.html.plaintext.txt	317	In regard wish underline protocol opinion gives best visualization heterogeneity electrophoretic mobility typing among human PrPSc subtypes Fig
0.09852033.14754888.html.plaintext.txt	318	This includes homogenizing solution strong buffer capacity LB 100 mM Tris ii protease digestion pH 6
0.09852033.14754888.html.plaintext.txt	319	9 using relatively high PK concentration
0.09852033.14754888.html.plaintext.txt	320	2 mgml iii use 15 Tris glycine gels 15 cm long running gel
0.09852033.14754888.html.plaintext.txt	321	FOOTNOTES This work supported European Union Grant QLK3 CT 2001 02345 University Bologna Fondi ex
0.09852033.14754888.html.plaintext.txt	322	NIA Grant P30 AG10133 Gino Galletti Foundation
0.09852033.14754888.html.plaintext.txt	323	The costs publication article defrayed part payment page charges
0.09852033.14754888.html.plaintext.txt	324	This article must therefore hereby marked advertisement accordance 18 U
0.09852033.14754888.html.plaintext.txt	325	Section 1734 solely indicate fact
0.09852033.14754888.html.plaintext.txt	326	To correspondence addressed Dipartimento di Scienze Neurologiche Universita di Bologna Via Foscolo 7 40123 Bologna Italy
0.09852033.14754888.html.plaintext.txt	327	39 051 6442151 Fax 39 051 6442214 E mail parchiatneuro
0.09852033.14754888.html.plaintext.txt	328	user domain
0.09852033.14754888.html.plaintext.txt	329	1 The abbreviations used TSE transmissible spongiform encephalopathy PrP prion protein PrPc cellular prion protein PrPSc scrapieprotease resistant prion protein PK proteinase K CJD Creutzfeldt Jakob disease sCJD sporadic CJD vCJD variant CJD PRNP prion protein gene MM1 methionine homozygote codon 129 PrPSc type 1 MV1 methioninevaline heterozygote codon 129 PrPSc type 1 VV1 valine homozygote codon 129 PrPSc type 1 MM2 methionine homozygote codon 129 PrPSc type 2 VV2 valine homozygote codon 129 PrPSc type 2 MV2 methioninevaline heterozygote codon 129 PrPSc type 2 LB lysis buffer PBS Dulbeccos phosphate buffered saline lacking Ca2 Mg2
0.09852033.14754888.html.plaintext.txt	330	James Ironside National CJD Surveillance Unit United Kingdom kindly provided tissues vCJD used study
0.09852033.14754888.html.plaintext.txt	331	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Parchi P
0.09852033.14754888.html.plaintext.txt	332	2000 Neurodegenerative Dementias Clinical Features Pathological Mechanisms Clark C
0.09852033.14754888.html.plaintext.txt	333	2003 Neurodegeneration The Molecular Pathology Dementia Movement Disorders Dickson D
0.09852033.14754888.html.plaintext.txt	334	318 325 ISN Neuropath Press Ironside J
0.09852033.14754888.html.plaintext.txt	335	2003 Neurodegeneration The Molecular Pathology Dementia Movement Disorders Dickson D
0.09852033.14754888.html.plaintext.txt	336	310 317 ISN Neuropath Press Prusiner S
0.09852033.14754888.html.plaintext.txt	337	95 13363 13383AbstractFree Full Text Bueler H
0.09852033.14754888.html.plaintext.txt	338	1993 Cell 73 1339 1347Medline Order article via Infotrieve Bolton D
0.09852033.14754888.html.plaintext.txt	339	1982 Science 218 1309 1311Medline Order article via Infotrieve Pan K
0.09852033.14754888.html.plaintext.txt	340	90 10962 10966Abstract Caughey B
0.09852033.14754888.html.plaintext.txt	341	1991 Biochemistry 30 7672 7680Medline Order article via Infotrieve Parchi P
0.09852033.14754888.html.plaintext.txt	342	59 676 683Medline Order article via Infotrieve Bessen R
0.09852033.14754888.html.plaintext.txt	343	68 7859 7868Abstract Safar J
0.09852033.14754888.html.plaintext.txt	344	4 1157 1165CrossRefMedline Order article via Infotrieve Caughey B
0.09852033.14754888.html.plaintext.txt	345	273 32230 32235AbstractFree Full Text Somerville R
0.09852033.14754888.html.plaintext.txt	346	1997 Nature 386 564Medline Order article via Infotrieve Parchi P
0.09852033.14754888.html.plaintext.txt	347	1997 Nature 386 232 233CrossRefMedline Order article via Infotrieve Parchi P
0.09852033.14754888.html.plaintext.txt	348	39 767 778Medline Order article via Infotrieve Parchi P
0.09852033.14754888.html.plaintext.txt	349	97 10168 10172AbstractFree Full Text Wadsworth J
0.09852033.14754888.html.plaintext.txt	350	1 55 59CrossRefMedline Order article via Infotrieve Zanusso G
0.09852033.14754888.html.plaintext.txt	351	276 40377 40380AbstractFree Full Text Hope J
0.09852033.14754888.html.plaintext.txt	352	284 175 178CrossRefMedline Order article via Infotrieve Kuczius T
0.09852033.14754888.html.plaintext.txt	353	5 406 418Medline Order article via Infotrieve Miura T
0.09852033.14754888.html.plaintext.txt	354	1999 Biochemistry 38 11560 11569CrossRefMedline Order article via Infotrieve Kramer M
0.09852033.14754888.html.plaintext.txt	355	276 16711 16719AbstractFree Full Text Ebeling W
0.09852033.14754888.html.plaintext.txt	356	47 91 97Medline Order article via Infotrieve Naureckiene S
0.09852033.14754888.html.plaintext.txt	357	420 55 67CrossRefMedline Order article via Infotrieve Kascsak R
0.09852033.14754888.html.plaintext.txt	358	61 3688 3693Medline Order article via Infotrieve Collinge J
0.09852033.14754888.html.plaintext.txt	359	1996 Nature 383 685 690CrossRefMedline Order article via Infotrieve Aksu S
0.09852033.14754888.html.plaintext.txt	360	2000 Electrochemistry Mineral Metal Processing V Woods R
0.09852033.14754888.html.plaintext.txt	361	258 269 The Electro chemical Society Pennington NJ Yates C
0.09852033.14754888.html.plaintext.txt	362	55 1624 1630Medline Order article via Infotrieve Harrison P
0.09852033.14754888.html.plaintext.txt	363	200 151 154CrossRefMedline Order article via Infotrieve
0.20848115.16033959.html.plaintext.txt	0	Low frequency PrP genotype 225SF among free ranging mule deer Odocoileus hemionus chronic wasting disease Jean E
0.20848115.16033959.html.plaintext.txt	1	1 Department Veterinary Sciences University Wyoming Wyoming State Veterinary Laboratory 1174 Snowy Range Road Laramie WY 82070 USA 2 Department Forest Range Wildlife Sciences Utah State University Logan UT 84322 5230 USA 3 Colorado Division Wildlife Wildlife Research Center Fort Collins CO 80526 2097 USA
0.20848115.16033959.html.plaintext.txt	2	ABSTRACT Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES The prion protein PrP gene characterized 1482 free ranging mule deer Odocoileus hemionus Wyoming Colorado
0.20848115.16033959.html.plaintext.txt	3	Using DNA sequences 363 deer dimorphisms codons 20 aspartateglycine 225 serine Sphenylalanine F found silent changes occurred codons 131 tyrosine 247 isoleucine
0.20848115.16033959.html.plaintext.txt	4	The remaining samples surveyed codon 225 genotype characterized chronic wasting disease CWD infection status
0.20848115.16033959.html.plaintext.txt	5	A total 112 deer genotype 225SF FF found one CWD positive 1370 225SS 289 positive CWD
0.20848115.16033959.html.plaintext.txt	6	Among CWD negative deer frequency 225SFFF genotypes 9 3 among CWD positive deer 0 3
0.20848115.16033959.html.plaintext.txt	7	For samples combined CWD status independent codon 225 genotype P 0 0001
0.20848115.16033959.html.plaintext.txt	8	The odds deer 225SS genotype CWD infected 30 times greater 95 confidence intervals4 213 225SF deer
0.20848115.16033959.html.plaintext.txt	9	The proportion 225SF animals sampled subpopulations varied 0 18 CWD prevalence varied 0 25
0.20848115.16033959.html.plaintext.txt	10	However relationship observed genotype frequency CWD prevalence different areas
0.20848115.16033959.html.plaintext.txt	11	The PrP sequences experimentally infected mule deer analysed pre existing projects 10 animals found 225SF genotypes positive CWD
0.20848115.16033959.html.plaintext.txt	12	Data available animals suggest 225SF genotype could associated longer incubation periods CWD infection compared 225SS genotype
0.20848115.16033959.html.plaintext.txt	13	Published online ahead print 27 May 2005 DOI 10
0.20848115.16033959.html.plaintext.txt	14	INTRODUCTION Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Chronic wasting disease CWD infectious fatal neurodegenerative disease cervid species North America Williams Young 1980 1982
0.20848115.16033959.html.plaintext.txt	15	One transmissible spongiform encephalopathies TSEs Prusiner 2004 also known prion diseases CWD occurs endemically epidemically Miller et al
0.20848115.16033959.html.plaintext.txt	16	2000 Williams Miller 2002 wild mule deer Odocoileus hemionus white tailed deer Odocoileus virginianus Rocky Mountain elk wapiti Cervus elaphus nelsoni several states USA well captive farmed cervids outside areas Williams 2002 Miller Williams 2004
0.20848115.16033959.html.plaintext.txt	17	Although CWD perceived immediate major threat deer elk populations concern interest several reasons possibility wild herds could gradually destroyed CWD Gross Miller 2001 due persistence infectious agent environment Miller et al
0.20848115.16033959.html.plaintext.txt	18	2002 lethality disease ii unknown nature circumstances disease could affect human iii greater understanding human TSEs could accrue knowing related mammalian prion diseases well understood iv economic impact CWD game farming v possible spread CWD members cervid family worldwide unregulated commerce transport captive animals Williams Miller 2003
0.20848115.16033959.html.plaintext.txt	19	In acquired prion diseases notably scrapie sheep variant Creutzfeldt Jakob disease vCJD humans amino acids encoded certain key positions endogenous host prion protein PrP strongly associated susceptibility TSE infection Goldmann et al
0.20848115.16033959.html.plaintext.txt	20	A study CWD Rocky Mountain elk ORourke et al
0.20848115.16033959.html.plaintext.txt	21	1999 suggested PrP sequence position 132 influences likelihood infection species
0.20848115.16033959.html.plaintext.txt	22	To extent similar influences affect deer Odocoileus spp
0.20848115.16033959.html.plaintext.txt	23	unclear Johnson et al
0.20848115.16033959.html.plaintext.txt	24	If heritable characters influence susceptibility CWD free ranging mule deer abundant three natural hosts within Rocky Mountain endemic area Miller et al
0.20848115.16033959.html.plaintext.txt	25	2000 could important implications understanding epidemiology disease
0.20848115.16033959.html.plaintext.txt	26	We investigated possibility PrP sequences may vary CWD infected uninfected deer wild
0.20848115.16033959.html.plaintext.txt	27	To end determined PrP polymorphisms select populations free ranging mule deer Wyoming Colorado estimated relative abundance one particular polymorphism among CWD infected uninfected animals
0.20848115.16033959.html.plaintext.txt	28	Specifically tested whether CWD status positive negative independent genotype codon 225 constructed regression model test whether population level relationship CWD prevalence 225 genotype among herds sampled
0.20848115.16033959.html.plaintext.txt	29	We also retrospectively analysed experimentally infected deer PrP genotype look possible effects genotype course disease animals
0.20848115.16033959.html.plaintext.txt	30	METHODS Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Animal tissue samples
0.20848115.16033959.html.plaintext.txt	31	We genotyped 1482 free ranging mule deer 13 herd units HUs south eastern Wyoming one data analysis unit DAU Colorado Fig
0.20848115.16033959.html.plaintext.txt	32	1 categorized according CWD infection status
0.20848115.16033959.html.plaintext.txt	33	For analytical purposes regarded HUs DAUs representing biologically distinct deer populations 10 ingress egress populations
0.20848115.16033959.html.plaintext.txt	34	Deer Wyoming sampled conjunction Wyoming Game Fish Departments 2001 2002 2003 CWD harvest surveys tissues used frozen brain 2001 2002 homogenates retropharyngeal lymph node 2003
0.20848115.16033959.html.plaintext.txt	35	For Colorado samples extracted genomic DNA whole blood samples obtained live deer captured released 2002 2004 course various Colorado Division Wildlife research management programmes
0.20848115.16033959.html.plaintext.txt	36	View larger version 32K Fig
0.20848115.16033959.html.plaintext.txt	37	Boundaries locations designations mule deer HUs Wyoming DAU Colorado samples used genotype analysis
0.20848115.16033959.html.plaintext.txt	38	DNA extractions PCR amplifications sequencing
0.20848115.16033959.html.plaintext.txt	39	We extracted total genomic DNA approximately 30 50 mg frozen brain tissue using FastPrep F120 homogenizer FastDNA kit Q Biogene 0 05 ml 15 wv homogenates retropharyngeal lymph nodes using DNeasy kit Qiagen 0 3 ml EDTA treated whole blood using Aqua Pure Genomic DNA kit Bio Rad Laboratories according manufacturers instructions
0.20848115.16033959.html.plaintext.txt	40	The complete open reading frame ORF plus 25 bp 5 flanking sequences 53 bp 3 flanking sequences PrP coding region amplified using PCR 50 microl reaction volumes containing 200 microM dNTP 2 5 units Taq polymerase Qiagen 200 nM forward MD582F 5 ACATGGGCATATGATGCTGACACC 3 reverse MD1479RC 5 ACTACAGGGCTGCAGGTAGATACT 3 primer 2 5 mM MgCl2 1x Qiagen PCR buffer approximately 70 150 ng total genomic DNA
0.20848115.16033959.html.plaintext.txt	41	Reactions thermal cycled PTC 200 MJ Research 94 degrees C 5 min 32 cycles 94 degrees C 7 62 degrees C 15 72 degrees C 30 final cycle 72 degrees C 5 min kept 4 degrees C inspected successful amplification agarose gel electrophoresis submitted DNA sequencing reverse sense primers 12 5 TGGTGGTGACTGTGTGTTGCTTGA 3 3FL1 5 GATTAAGAAGATAATGAAAACAGGAAGG 3 Amplicon Express
0.20848115.16033959.html.plaintext.txt	42	In order find recurring 5 allele frequency polymorphisms deer widespread area examined sequences complete PrP ORF Fig
0.20848115.16033959.html.plaintext.txt	43	2a 363 samples included 244 mule deer 95 CWD negative 149 CWD positive throughout south eastern quarter Wyoming 119 mule deer 105 CWD negative 14 CWD positive Estes Valley Colorado
0.20848115.16033959.html.plaintext.txt	44	We viewed sequence chromatograms checked base calls using Chromas v
0.20848115.16033959.html.plaintext.txt	45	23 software Technelysium Pty made alignments DNA sequences comparisons using SeqMan module LaserGene software DNAStar
0.20848115.16033959.html.plaintext.txt	46	View larger version 15K Fig
0.20848115.16033959.html.plaintext.txt	47	Polymorphic codons mule deer PrP coding region Prnp gene
0.20848115.16033959.html.plaintext.txt	48	Diagram structural features deduced amino acid sequence mule deer prion protein
0.20848115.16033959.html.plaintext.txt	49	Numbers 1 256 diagram indicate amino acid positions translated ORF
0.20848115.16033959.html.plaintext.txt	50	The mature peptide deduced include aa 25 234
0.20848115.16033959.html.plaintext.txt	51	Features positions based similarities mule deer PrP sequence GenBank AY228473 published analyses cited prion proteins species
0.20848115.16033959.html.plaintext.txt	52	The signal peptide cleavage site predicted SignalP 3
0.20848115.16033959.html.plaintext.txt	53	2004 octapeptide repeat region determined inspection translation DNA sequence AY228473 1 2 residues form short two stranded antiparallel sheet 1 2 3 helices Billeter et al
0.20848115.16033959.html.plaintext.txt	54	2005 CHO sites N linked glycosylation Kornfeld Kornfeld 1985 Haraguchi et al
0.20848115.16033959.html.plaintext.txt	55	1989 S S disulfide bond Turk et al
0.20848115.16033959.html.plaintext.txt	56	1988 GPI deduced site cleavage attachment glycosyl phosphatidyl inositol anchor Stahl et al
0.20848115.16033959.html.plaintext.txt	57	b Recurring variable alleles determined DNA sequencing PrP ORF Prnp gene mule deer
0.20848115.16033959.html.plaintext.txt	58	Location polymorphism ii amino acids encoded polymorphic locus single letter amino acid abbreviations iii DNA sequences codons indicated loci iv frequencies allele among sequenced CWD negative samples n400 v frequencies allele among sequenced CWD positive samples n326
0.20848115.16033959.html.plaintext.txt	59	Codon 225 genotyping EcoRI digestion
0.20848115.16033959.html.plaintext.txt	60	To increase sample size statistical analysis PrP genotypes 1119 additional samples selected HUs study areas analysed EcoRI restriction digestion PCR amplified PrP region produced described samples sequenced
0.20848115.16033959.html.plaintext.txt	61	This assay detects codon 225 polymorphism one found mule deer PrP encoded different amino acids mature polypeptide
0.20848115.16033959.html.plaintext.txt	62	Aliquots 10 microl completed PCR reactions incubated 10 U EcoRI New England Biolabs total volume 12 microl containing 50 mM NaCl 100 mM TrisHCl 10 mM MgCl2 0 025 Triton X 100 pH 7 5 37 degrees C 2 16 h followed addition 2 5 microl 6x concentrate gel loading solution Sigma Aldrich per sample inspection products agarose gel electrophoresis
0.20848115.16033959.html.plaintext.txt	63	Occurrence phenylalanine F codon TTC position 225 creates EcoRI recognition sequence cleavage site GAATTC codons 224 225 whereas serine S codon TCC creates DNA sequence GAATCC cut EcoRI
0.20848115.16033959.html.plaintext.txt	64	When PCR products incubated EcoRI presence TTC codon position 225 resulted cleavage fragments predictable sizes search PrP ORF DNA sequence verified sites potentially transformable GAATTC one base change supporting use valid genotyping method
0.20848115.16033959.html.plaintext.txt	65	Samples showed evidence cleavage sequenced verify change
0.20848115.16033959.html.plaintext.txt	66	The 1482 deer genotyped tested CWD subset deer tested 2001 2003 CWD hunter harvest surveys Wyoming 2002 2004 field studies north central Colorado Wolfe et al
0.20848115.16033959.html.plaintext.txt	67	For Wyoming data tissues sampled deer screened CWD infection immunohistochemistry IHC Miller Williams 2002 Wyoming State Veterinary Laboratory Laramie WY 2001 2002 samples CWD ELISA Bio Rad Laboratories Wildlife Disease Laboratory Wyoming Game Fish Department IHC confirmation ELISA positive samples 2003 samples
0.20848115.16033959.html.plaintext.txt	68	For Colorado data IHC performed tonsil biopsies live deer sampled Estes Park 2002 2004 Wolfe et al
0.20848115.16033959.html.plaintext.txt	69	CWD prevalence Wyoming mule deer HUs estimated using data obtained Wyoming Game Fish Department H
0.20848115.16033959.html.plaintext.txt	70	Edwards personal communication CWD prevalence Colorado DAU 10 includes Estes Park harvest samples taken 2001 2003 Colorado Division Wildlife httpwildlife
0.20848115.16033959.html.plaintext.txt	71	Because essentially case control study used odds ratios rather relative risk analyse statistically association CWD status genotype
0.20848115.16033959.html.plaintext.txt	72	In analyses used diploid genotypes rather allele frequencies avoid artificially inflating sample sizes potentially biasing estimates 2 odds ratio statistics Agresti 1996 Sasieni 1997
0.20848115.16033959.html.plaintext.txt	73	We combined genotype 225SF 225FF due low proportion latter genotype samples 0 2
0.20848115.16033959.html.plaintext.txt	74	We used 2x2 contingency tables test whether CWD status positive negative independent 225 genotype PROG FREQ SAS OnlineDoc 8 SAS Institute
0.20848115.16033959.html.plaintext.txt	75	If failed reject null hypothesis would conclude genotype unrelated CWD status
0.20848115.16033959.html.plaintext.txt	76	We conducted analysis data combined Wyoming Colorado separately
0.20848115.16033959.html.plaintext.txt	77	We analyse data individual HU DAU lacked sample size level could meet assumptions 2 analysis
0.20848115.16033959.html.plaintext.txt	78	To test relationship CWD prevalence frequencies 225 genotypes among sampled populations constructed regression model logit transformed CWD prevalence versus proportion 225SF genotype PROG GENMOD SAS Institute
0.20848115.16033959.html.plaintext.txt	79	Our null hypothesis relationship CWD prevalence proportion 225SF genotype
0.20848115.16033959.html.plaintext.txt	80	Type III sum squares used test hypothesis SAS Institute
0.20848115.16033959.html.plaintext.txt	81	Observations experimentally infected mule deer
0.20848115.16033959.html.plaintext.txt	82	Two pre existing projects provided us opportunity assess whether course CWD captive experimentally infected deer different 225SF 225SS genotypic groups
0.20848115.16033959.html.plaintext.txt	83	Williams others unpublished data survival time genotype data obtained eight hand reared mule deer fawns exposed CWD 3 4 months age single oral dose 1 g pooled brain homogenate previously described Sigurdson et al
0.20848115.16033959.html.plaintext.txt	84	The animals later euthanized upon presenting severe clinical signs CWD Williams Young 1992 late stage CWD infection death confirmed necropsy IHC fixed tissues
0.20848115.16033959.html.plaintext.txt	85	We isolated genomic DNA blood samples collected course project obtained PrP sequences described
0.20848115.16033959.html.plaintext.txt	86	Miller unpublished data isolated genomic DNA archived frozen tissues collected necropsy experimentally infected mule deer obtained PrP sequences described
0.20848115.16033959.html.plaintext.txt	87	RESULTS Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Polymorphisms PrP free ranging mule deer DNA sequences protein coding region Prnp gene 363 deer sampled Wyoming Colorado 2001 2003 showed four recurring variable codons two alleles Fig
0.20848115.16033959.html.plaintext.txt	88	2 agreement polymorphisms previously reported mule deer PrP Heaton et al
0.20848115.16033959.html.plaintext.txt	89	Of codon 225 serine Sphenylalanine F encoded different amino acids mature polypeptide Fig
0.20848115.16033959.html.plaintext.txt	90	A single base change codon 20 created substitution polymorphism aspartateglycine amino terminal signal sequence removed membrane translocation Bendtsen et al
0.20848115.16033959.html.plaintext.txt	91	Variations codon 131 tyrosine1tyrosine2 codon 247 isoleucine1isoleucine2 change encoded amino acid
0.20848115.16033959.html.plaintext.txt	92	At four loci one allele abundant one infrequent Fig
0.20848115.16033959.html.plaintext.txt	93	A comparison genotypes found CWD positive CWD negative samples showed one 225SF among CWD positive group
0.20848115.16033959.html.plaintext.txt	94	This suggested 225F allele might represented CWD infected deer low frequency 225F among samples allele frequency 0 033 SFFF genotype frequency 6 3 non random nature sample set made data insufficient determine significant bias existed
0.20848115.16033959.html.plaintext.txt	95	We therefore analysed 1119 additional samples units study area categorized according CWD infection status
0.20848115.16033959.html.plaintext.txt	96	We used simplified method DNA analysis determine codon 225 genotype samples Fig
0.20848115.16033959.html.plaintext.txt	97	View larger version 50K Fig
0.20848115.16033959.html.plaintext.txt	98	Genotype analysis agarose gel electrophoresis EcoRI digestion products
0.20848115.16033959.html.plaintext.txt	99	The 225F polymorphism detected EcoRI cleavage PrP encoding DNA sequence results replacement serine codon TCC phenylalanine codon TTC see Methods
0.20848115.16033959.html.plaintext.txt	100	Lanes 1 7 EcoRI digested PCR amplified DNA containing mule deer PrP protein coding region lane 8 undigested control calculated size 897 bp lane 9 X174HaeIII fragment size markers sizes base pairs indicated right
0.20848115.16033959.html.plaintext.txt	101	Samples lanes 3 5 7 lack EcoRI site remained uncut 225SS genotype DNA lanes 1 2 4 6 contain EcoRI site copies PrP one chromosome retain serine codon 225SF genotype
0.20848115.16033959.html.plaintext.txt	102	The 225FF homozygotes produced one band migrated 719 bp shown
0.20848115.16033959.html.plaintext.txt	103	A fragment corresponding predicted 178 bp cleavage product also detectable arrow
0.20848115.16033959.html.plaintext.txt	104	Statistical analysis The results presented Table 1 continued show lower expected numbers 225SF genotypes among CWD infected animals
0.20848115.16033959.html.plaintext.txt	105	2 analysis performed data combined returned result CWD status independent codon 225 genotype P 0 0001
0.20848115.16033959.html.plaintext.txt	106	In total sample 290 free ranging CWD positive mule deer observed one 225SF individual 0 3 22 expected based overall genotype frequency 7 6 sample
0.20848115.16033959.html.plaintext.txt	107	The odds deer 225SS genotype CWD infected 30 times greater 95 confidence intervals4 213 deer 225SF genotype
0.20848115.16033959.html.plaintext.txt	108	This pattern also held Wyoming P 0 0001 Colorado P0 012 samples analysed separately
0.20848115.16033959.html.plaintext.txt	109	For Wyoming samples odds deer 225SS genotype CWD infected 16 times greater 95 confidence intervals2 119 deer 225SF genotype Colorado samples odds ratio 13 95 confidence intervals1 209
0.20848115.16033959.html.plaintext.txt	110	CWD prevalence genotype data deer management unit
0.20848115.16033959.html.plaintext.txt	111	Estimated CWD prevalence HU DAU harvest samples taken 2001 2003 Wyoming Wyoming Game Fish Department Colorado httpwildlife
0.20848115.16033959.html.plaintext.txt	112	Proportion 225SF genotyped samples HU DAU observed Obs
0.20848115.16033959.html.plaintext.txt	113	numbers 225SF per unit among CWD positive samples also shown
0.20848115.16033959.html.plaintext.txt	114	With odds ratios high considered possible relationship might detected CWD prevalence genotype frequencies
0.20848115.16033959.html.plaintext.txt	115	If 225SF genotype provided degree resistance CWD infection areas high 225SF frequency might expected show low CWD prevalence
0.20848115.16033959.html.plaintext.txt	116	Alternatively CWD provided selective pressure resistant genotype SF genotype might common areas high prevalence
0.20848115.16033959.html.plaintext.txt	117	However neither relationship observed
0.20848115.16033959.html.plaintext.txt	118	Although proportion 225SF individuals CWD prevalence varied among mule deer populations sampled Table 1 slope regression model shown Fig
0.20848115.16033959.html.plaintext.txt	119	4 significantly different 0 P0 228
0.20848115.16033959.html.plaintext.txt	120	View larger version 17K Fig
0.20848115.16033959.html.plaintext.txt	121	Regression logit transformed CWD prevalence versus proportion 225SF genotypes HU DAU mule deer Wyoming Colorado
0.20848115.16033959.html.plaintext.txt	122	CWD prevalence based harvest samples taken 2001 2003 Wyoming Wyoming Game Fish Department Colorado httpwildlife
0.20848115.16033959.html.plaintext.txt	123	Proportion analysed samples 225SF genotype HU DAU given Table 1
0.20848115.16033959.html.plaintext.txt	124	Observations experimentally infected mule deer PrP genotypes Retrospective sequence analysis DNA two groups experimentally infected captive mule deer revealed 10 225SF deer well differences disease development appeared group according codon 225 genotypes
0.20848115.16033959.html.plaintext.txt	125	In first experimental group six eight deer 225SS genotype two 225SF
0.20848115.16033959.html.plaintext.txt	126	The time development severe clinical CWD 225SS deer ranged 19 23 months post inoculation p
0.20848115.16033959.html.plaintext.txt	127	two 225SF deer developed severe symptoms 36 months p
0.20848115.16033959.html.plaintext.txt	128	In second group deer identified eight 225SF animals CWD infected
0.20848115.16033959.html.plaintext.txt	129	Preliminary results small number deer infected 16 months longer indicated PrPCWD detectable CWD ELISA brain tissue 16 months p
0.20848115.16033959.html.plaintext.txt	130	225SS deer 25 months p
0.20848115.16033959.html.plaintext.txt	131	Miller others unpublished data
0.20848115.16033959.html.plaintext.txt	132	DISCUSSION Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Genetics geography Our data show large deficit 225SF genotype among CWD infected mule deer wild demonstrating genotype CWD infection strongly associated also implying low probability CWD infection among free ranging 225SF deer
0.20848115.16033959.html.plaintext.txt	133	It cannot ruled might reflect low probability exposure CWD 225SF animals due possible distribution characteristics mule deer population units endemic area chance clustering related 225SF deer away highly localized infectious sites animals
0.20848115.16033959.html.plaintext.txt	134	The low percentage 225SF genotypes relative 225SS genotypes combined possibly limited total area actually containing infection sources could also reduce exposure probability
0.20848115.16033959.html.plaintext.txt	135	Alternatively lower expected occurrence 225SF genotypes among free ranging CWD infected animals could due lower susceptibility deer natural CWD
0.20848115.16033959.html.plaintext.txt	136	Although 225SF deer fully susceptible experimental challenge orally exposed captive mule deer SF genotype slower develop clinical symptoms CWD neuroinvasion PrPCWD took place later 225SS deer
0.20848115.16033959.html.plaintext.txt	137	This SF genotype effect could manifest slower disease development lengthened incubation period experimental CWD lower probability infection wild although may necessarily manifestations phenomena
0.20848115.16033959.html.plaintext.txt	138	Lengthened survival times apparently slower disease development also observed experimentally infected elk PrP codon 132ML 132LL genotypes T
0.20848115.16033959.html.plaintext.txt	139	Kreeger others unpublished results
0.20848115.16033959.html.plaintext.txt	140	Comparable observations difficult make natural infections among free ranging animals test relative susceptibility 225SF deer CWD sense amount infectious agent required infection carried
0.20848115.16033959.html.plaintext.txt	141	Nevertheless precedent genetic factors affecting susceptibility infectious prion diseases well established Prusiner et al
0.20848115.16033959.html.plaintext.txt	142	The high odds ratios reported possible genetically linked differential susceptibility CWD mule deer consistent high degree influence genotype reported scrapie sheep Hunter 1997 Detwiler Baylis 2003
0.20848115.16033959.html.plaintext.txt	143	Some differences genetics scrapie sheep CWD cervids notable CWD unique TSE occurs wild populations subject genetic drift natural selection rather selectively bred domestic animals
0.20848115.16033959.html.plaintext.txt	144	Also number polymorphic codons deer elk PrP two mule deer one elk three white tailed deer dimorphisms Raymond et al
0.20848115.16033959.html.plaintext.txt	145	2004 low compared number different amino acid positions vary number alleles occur positions domestic sheep breeds worldwide Bossers et al
0.20848115.16033959.html.plaintext.txt	146	2000 Baylis Goldmann 2004
0.20848115.16033959.html.plaintext.txt	147	It noted odds ratios relating 225 genotype CWD mule deer stand contrast low odds ratios previously reported ORourke et al
0.20848115.16033959.html.plaintext.txt	148	2004 genetic susceptibility CWD white tailed deer based three different polymorphisms found species
0.20848115.16033959.html.plaintext.txt	149	Implications CWD transmission If effects observed suggest 225SF genotype associated longer incubation times experimentally infected deer also apply deer naturally acquired CWD could affect transmission CWD areas high proportion 225SF genotype among mule deer become infected
0.20848115.16033959.html.plaintext.txt	150	Increased survival time infected asymptomatic animals might increase period infectious agent shed environment although pointed one 225SF deer study infected rather undergoing asymptomatic protracted subclinical phase
0.20848115.16033959.html.plaintext.txt	151	The possibility dormant infections carrier state TSEs raised connection scrapie ORourke et al
0.20848115.16033959.html.plaintext.txt	152	1997 recently inapparent vCJD infections PrP codon 129VM heterozygous humans 129VV transgenic mice Carrell 2004 Wadsworth et al
0.20848115.16033959.html.plaintext.txt	153	Alternatively slower development CWD could mean 225SF deer require longer times infection reach shedding stage
0.20848115.16033959.html.plaintext.txt	154	This situation could neutral transmission wild could lead decrease CWD prevalence due infected deer dying causes becoming infectious
0.20848115.16033959.html.plaintext.txt	155	This issue remain unresolved learn infectious agent shed CWD infections able measure specific infectivity
0.20848115.16033959.html.plaintext.txt	156	Genotypes 225SF 225FF confer complete resistance Even though 225SF genotype may reduce susceptibility affect course disease clearly confer complete resistance
0.20848115.16033959.html.plaintext.txt	157	Experimental infection 225SF deer appears take place readily oral doses typically administered
0.20848115.16033959.html.plaintext.txt	158	In addition detected one free ranging infected 225SF deer Wyoming analysis subsequent genotyping 234 additional CWD positive samples north central Colorado revealed five 225SF individuals M
0.20848115.16033959.html.plaintext.txt	159	It also important note 225FF homozygous deer resistant evidenced two 225FF deer also found among additional positive samples genotyped
0.20848115.16033959.html.plaintext.txt	160	The 225F allele present low frequencies deer herds sampled free ranging 225FF deer often found surveys e
0.20848115.16033959.html.plaintext.txt	161	three 1482 samples used analysis 225FF accurate assessment relative susceptibility CWD depend work animals currently bred captivity
0.20848115.16033959.html.plaintext.txt	162	CWD prevalence codon 225 genotype frequencies If free ranging 225SF mule deer less likely infected CWD 225SS deer genetic causes increase genotype among deer populations time could contribute decrease CWD
0.20848115.16033959.html.plaintext.txt	163	Alternatively selection 225SS genotype high CWD prevalence could produce areas high disease prevalence high frequency SF genotype
0.20848115.16033959.html.plaintext.txt	164	On overall basis saw relationship proportions SF animals estimated HUs prevalence CWD may necessary compare proportions SF CWD prevalence unit time detect trends
0.20848115.16033959.html.plaintext.txt	165	Whether time scales required observations would feasible known
0.20848115.16033959.html.plaintext.txt	166	CWD estimated present wild cervids 50 years Miller et al
0.20848115.16033959.html.plaintext.txt	167	2000 time effects could work CWD endemic areas may short show reduced disease prevalence areas high SF frequencies
0.20848115.16033959.html.plaintext.txt	168	Also effect could small compared drift mutation CWD exerts low level genetic selection normally long incubation period allows continued reproduction genetic replacement despite disease status
0.20848115.16033959.html.plaintext.txt	169	The fact observe relationship may also due scale observations made
0.20848115.16033959.html.plaintext.txt	170	HUs large relative population units affected variations factors involved disease including genetics Conner Miller 2004
0.20848115.16033959.html.plaintext.txt	171	Variable distribution 225F allele The proportion 225SF genotypes among sampled HUs analysis varied 0 18 highest frequency found DAU 10 Table 1 lowest frequencies throughout Wyoming HUs
0.20848115.16033959.html.plaintext.txt	172	An additional 203 Colorado samples genotyped DAUs 7 9 16 west south D 10 showed 225SF sample proportions 3 11 22 respectively J
0.20848115.16033959.html.plaintext.txt	173	This widely variable frequency 225F allele could localized founder effects legacy demographic bottlenecks created historic past intense market hunting species
0.20848115.16033959.html.plaintext.txt	174	An intriguing alternative reflect selection genotype CWD directional balancing without detectable trends disease prevalence example population genetic differentiation isolation distance
0.20848115.16033959.html.plaintext.txt	175	Characterization mule deer population genetic structure using frequency data selectively neutral loci microsatellites allow us distinguish underlying causes variability
0.20848115.16033959.html.plaintext.txt	176	ACKNOWLEDGEMENTS We thank Justina Pahl Karen Griffin Kari Cramer Sascha Rogers Evguenia Karina excellent technical assistance Hank Edwards WGF survey results data generously allowing access WY hunter survey tissue samples Kirk Nordyke Wyoming HU map data Reg Rothwell Christine Leonard Wyoming hunt areaHU data Tom Baker Michael Sirochman Tracy Sirochman Chad Bishop Darby Finley Andy Holland assistance acquiring blood samples Colorado deer populations Laurie Baeten many others field laboratory efforts conjunction CWD surveys Colorado Kate Loughney Karen Mock helpful comments manuscript
0.20848115.16033959.html.plaintext.txt	177	This work supported National Science FoundationNational Institute Health Grant DEB 0091961 University Wyoming Wyoming Game Fish Department Colorado Division Wildlife
0.20848115.16033959.html.plaintext.txt	178	REFERENCES Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Agresti A
0.20848115.16033959.html.plaintext.txt	179	An Introduction Categorical Data Analysis
0.20848115.16033959.html.plaintext.txt	180	The genetics scrapie sheep goats
0.20848115.16033959.html.plaintext.txt	181	Improved prediction signal peptides SignalP 3
0.20848115.16033959.html.plaintext.txt	182	Prion protein NMR structure species barrier prion diseases
0.20848115.16033959.html.plaintext.txt	183	Proc Natl Acad Sci U S A 94 7281 7285
0.20848115.16033959.html.plaintext.txt	184	Susceptibility sheep scrapie assessed vitro conversion nine naturally occurring variants PrP
0.20848115.16033959.html.plaintext.txt	185	A processed pseudogene contributes apparent mule deer prion gene heterogeneity
0.20848115.16033959.html.plaintext.txt	186	Molecular analysis prion strain variation aetiology new variant CJD
0.20848115.16033959.html.plaintext.txt	187	Movement patterns spatial epidemiology prion disease mule deer population units
0.20848115.16033959.html.plaintext.txt	188	Construction synthetic signals glycosyl phosphatidylinositol anchor attachment
0.20848115.16033959.html.plaintext.txt	189	Analysis amino acid sequence requirements anchoring
0.20848115.16033959.html.plaintext.txt	190	PrP genotype agent effects scrapie change allelic interaction different isolates agent sheep natural host scrapie
0.20848115.16033959.html.plaintext.txt	191	Prion protein NMR structures elk mouseelk hybrids
0.20848115.16033959.html.plaintext.txt	192	Proc Natl Acad Sci U S A 102 646 650
0.20848115.16033959.html.plaintext.txt	193	Chronic wasting disease mule deer Disease dynamics control
0.20848115.16033959.html.plaintext.txt	194	Asparagine linked glycosylation scrapie cellular prion proteins
0.20848115.16033959.html.plaintext.txt	195	Arch Biochem Biophys 274 1 13
0.20848115.16033959.html.plaintext.txt	196	Prion gene sequence variation within diverse groups US sheep beef cattle deer
0.20848115.16033959.html.plaintext.txt	197	PrP genetics sheep implications scrapie BSE
0.20848115.16033959.html.plaintext.txt	198	Trends Microbiol 5 331 334
0.20848115.16033959.html.plaintext.txt	199	The association codon 136 PrP gene variant occurrence natural scrapie
0.20848115.16033959.html.plaintext.txt	200	Prion protein gene heterogeneity free ranging white tailed deer within chronic wasting disease affected region Wisconsin
0.20848115.16033959.html.plaintext.txt	201	Assembly asparagine linked oligosaccharides
0.20848115.16033959.html.plaintext.txt	202	Annu Rev Biochem 54 631 664
0.20848115.16033959.html.plaintext.txt	203	Detection PrPCWD mule deer immunohistochemistry lymphoid tissues
0.20848115.16033959.html.plaintext.txt	204	Chronic wasting disease cervids
0.20848115.16033959.html.plaintext.txt	205	In Mad Cow Disease Related Spongiform Encephalopathies pp
0.20848115.16033959.html.plaintext.txt	206	Epidemiology chronic wasting disease Rocky Mountain elk
0.20848115.16033959.html.plaintext.txt	207	Epizootiology chronic wasting disease free ranging cervids Colorado Wyoming
0.20848115.16033959.html.plaintext.txt	208	Environmental sources prion transmission mule deer
0.20848115.16033959.html.plaintext.txt	209	Emerg Infect Dis 10 1003 1006
0.20848115.16033959.html.plaintext.txt	210	PrP genotypes experimental scrapie orally inoculated Suffolk sheep United States
0.20848115.16033959.html.plaintext.txt	211	PrP genotypes captive free ranging Rocky Mountain elk Cervus elaphus nelsoni chronic wasting disease
0.20848115.16033959.html.plaintext.txt	212	Polymorphisms prion precursor functional gene pseudogene associated susceptibility chronic wasting disease white tailed deer
0.20848115.16033959.html.plaintext.txt	213	An introduction prion biology diseases
0.20848115.16033959.html.plaintext.txt	214	In Prion Biology Diseases 2nd edn pp
0.20848115.16033959.html.plaintext.txt	215	Cold Spring Harbor New York Cold Spring Harbor Laboratory
0.20848115.16033959.html.plaintext.txt	216	Scrapie chronic wasting disease transmissible mink encephalopathy
0.20848115.16033959.html.plaintext.txt	217	In Prion Biology Diseases 2nd edn pp
0.20848115.16033959.html.plaintext.txt	218	Cold Spring Harbor New York Cold Spring Harbor Laboratory
0.20848115.16033959.html.plaintext.txt	219	Evidence molecular barrier limiting susceptibility humans cattle sheep chronic wasting disease
0.20848115.16033959.html.plaintext.txt	220	From genotypes genes doubling sample size
0.20848115.16033959.html.plaintext.txt	221	Oral transmission early lymphoid tropism chronic wasting disease PrPres mule deer fawns Odocoileus hemionus
0.20848115.16033959.html.plaintext.txt	222	Scrapie prion protein contains phosphatidylinositol glycolipid
0.20848115.16033959.html.plaintext.txt	223	Purification properties cellular scrapie hamster prion proteins
0.20848115.16033959.html.plaintext.txt	224	Human prion protein valine 129 prevents expression variant CJD phenotype
0.20848115.16033959.html.plaintext.txt	225	The transmissible spongiform encephalopathies disease risks North America
0.20848115.16033959.html.plaintext.txt	226	Vet Clin North Am Food Anim Pract 18 461 473
0.20848115.16033959.html.plaintext.txt	227	Chronic wasting disease captive mule deer spongiform encephalopathy
0.20848115.16033959.html.plaintext.txt	228	Spongiform encephalopathy Rocky Mountain elk
0.20848115.16033959.html.plaintext.txt	229	Spongiform encephalopathies Cervidae
0.20848115.16033959.html.plaintext.txt	230	Chronic wasting disease deer elk North America
0.20848115.16033959.html.plaintext.txt	231	Transmissible spongiform encephalopathies non domestic animals origin transmission risk factors
0.20848115.16033959.html.plaintext.txt	232	Chronic wasting disease deer elk review recommendations management
0.20848115.16033959.html.plaintext.txt	233	Evaluation antemortem sampling estimate chronic wasting disease prevalence free ranging mule deer
0.20848115.16033959.html.plaintext.txt	234	Feasibility test cull managing chronic wasting disease urban mule deer
0.20848115.16033959.html.plaintext.txt	235	Received 1 April 2005 accepted 20 May 2005
0.10063774.15843404.html.plaintext.txt	0	Altered pre lamin A processing common mechanism leading lipodystrophy Cristina Capanni1 Elisabetta Mattioli2 Marta Columbaro2 Enrico Lucarelli3 Veena K
0.10063774.15843404.html.plaintext.txt	1	Parnaik4 Giuseppe Novelli5 Manfred Wehnert6 Vittoria Cenni2 Nadir M
0.10063774.15843404.html.plaintext.txt	2	Maraldi12 Stefano Squarzoni1 Giovanna Lattanzi1
0.10063774.15843404.html.plaintext.txt	3	1ITOI CNR Unit Bologna co IOR Bologna Italy 2Laboratory Cell Biology Istituti Ortopedici Rizzoli Bologna Italy 3Regeneration Tissue Engineering Laboratory Musculoskeletal Tissue Bank IOR Bologna Italy 4Centre Cellular Molecular Biology Hyderabad 500 007 India 5Department Biopathology Image Diagnostics University Rome Tor Vergata Rome Italy 6Institute Human Genetics University Greifswald Germany
0.10063774.15843404.html.plaintext.txt	4	To correspondence addressed ITOI CNR Unit Bologna co IOR Via di Barbiano 110 I 40136 Bologna Italy
0.10063774.15843404.html.plaintext.txt	5	Tel 39 0516366768 Fax 39 051583593 Email lattanziatjolly
0.10063774.15843404.html.plaintext.txt	6	Received January 20 2005 Accepted April 8 2005
0.10063774.15843404.html.plaintext.txt	7	ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Lipodystrophies heterogeneous group human disorders characterized anomalous distribution body fat associated insulin resistance altered lipid metabolism
0.10063774.15843404.html.plaintext.txt	8	The pathogenetic mechanism inherited lipodystrophies yet clear molecular level linked mutations lamin AC peroxisome proliferator activated receptor PPAR seemingly unrelated proteins
0.10063774.15843404.html.plaintext.txt	9	In study examined lamin AC processing three laminopathies characterized lipodystrophic phenotypes Dunnigan type familial partial lipodystrophy mandibuloacral dysplasia atypical Werners syndrome
0.10063774.15843404.html.plaintext.txt	10	We found lamin A precursor specifically accumulated lipodystrophy cells
0.10063774.15843404.html.plaintext.txt	11	Pre lamin A located nuclear envelope co localized adipocyte transcription factor sterol regulatory element binding protein 1 SREBP1
0.10063774.15843404.html.plaintext.txt	12	Using co immunoprecipitation experiments obtained first demonstration vivo interaction SREBP1 pre lamin A
0.10063774.15843404.html.plaintext.txt	13	Binding SREBP1 lamin A precursor detected patient fibroblasts well control fibroblasts forced accumulate pre lamin A farnesylation inhibitors
0.10063774.15843404.html.plaintext.txt	14	In contrast SREBP1 interact vivo mature lamin A C cultured fibroblasts
0.10063774.15843404.html.plaintext.txt	15	To gain insights effect pre lamin A accumulation adipose tissue inhibited lamin A precursor processing 3T3 L1 pre adipocytes
0.10063774.15843404.html.plaintext.txt	16	Our results show pre lamin A sequesters SREBP1 nuclear rim thus decreasing pool active SREBP1 normally activates PPAR causing impairment pre adipocyte differentiation
0.10063774.15843404.html.plaintext.txt	17	This defect rescued treatment troglitazone known PPAR ligand activating adipogenic program
0.10063774.15843404.html.plaintext.txt	18	INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Lipodystrophies heterogeneous group human disorders characterized anomalous distribution body fat generalized loss adipose tissue 1
0.10063774.15843404.html.plaintext.txt	19	Various degrees insulin resistance associated diseases
0.10063774.15843404.html.plaintext.txt	20	Several types lipodystrophy characterized molecular genetic level including Dunnigan type familial partial lipodystrophy FPLD 2 partial lipodystrophy mandibuloacral dysplasia MAD 3 syndromes partial lipodystrophy cardiomyopathy 4 Berardinelli Seip congenital generalized lipodystrophy 5
0.10063774.15843404.html.plaintext.txt	21	In FPLD MAD lamin AC mutations linked disease 23 whereas form partial lipodystrophy associated PPAR mutations also described 6
0.10063774.15843404.html.plaintext.txt	22	Berardinelli Seip congenital generalized lipodystrophy due mutations seipin endoplasmic reticulum protein 5
0.10063774.15843404.html.plaintext.txt	23	Other lipodystrophies acquired drug induced lipodystrophy syndrome associated use highly active antiretroviral treatment HAART 7 reviewed 1
0.10063774.15843404.html.plaintext.txt	24	In addition progeroid syndromes Hutchinson Gilford progeria HGPS atypical Werners syndrome WS show generalized lipodystrophy often combined insulin resistant diabetes mellitus 8 11
0.10063774.15843404.html.plaintext.txt	25	In recent years two major players emerged possibly involved pathogenesis lipodystrophies
0.10063774.15843404.html.plaintext.txt	26	The first lamin AC nuclear lamina constituent mutated FPLD MAD cells 23 well progeroid syndromes lipodystrophy 8 11
0.10063774.15843404.html.plaintext.txt	27	Moreover mutations ZMPSTE 24 metalloprotease involved lamin A processing 12 cause diseases featuring lipodystrophy phenotype MAD humans 13 MAD resembling phenotype knockout mice 1415 HGPS Markquardt personal communication
0.10063774.15843404.html.plaintext.txt	28	The second emerging protein pathogenesis lipodystrophy sterol regulatory element binding protein 1 SREBP1 transcription factor whose localization transactivation ability appear altered acquired lipodystrophy 716
0.10063774.15843404.html.plaintext.txt	29	In context noteworthy mutations PPAR transcription factor transcribed downstream SREBP1 activation mediates adipocyte differentiation 17 responsible forms partial lipodystrophy 618
0.10063774.15843404.html.plaintext.txt	30	Moreover single point mutation PPAR promoter recently associated FPLD 19
0.10063774.15843404.html.plaintext.txt	31	Lamins A C nuclear lamina proteins obtained alternative splicing LMNA almost ubiquitously expressed differentiated tissues 20
0.10063774.15843404.html.plaintext.txt	32	Before assembled nuclear lamina lamin A undergoes complex post translational modifications including farnesylation C terminus protease cleavage 121321
0.10063774.15843404.html.plaintext.txt	33	Farnesylation pre lamin A necessary following steps protein cleavage metalloproteases fail bind non farnesylated lamin A sequence 15
0.10063774.15843404.html.plaintext.txt	34	Mature lamin A forms heterodimeric complex lamin C 22 appears play structural functional roles completely elucidated 20
0.10063774.15843404.html.plaintext.txt	35	Lamin AC interacts lamin B emerin 23 well constituents nuclear matrix including lamina associated polypeptide LAP 2 alpha 24 nuclear actin 2526 transcription factor E2F protein Rb 27
0.10063774.15843404.html.plaintext.txt	36	An increasing number LMNA mutations give rise several diseases grouped definition laminopathies characterized different tissue specific defects 28
0.10063774.15843404.html.plaintext.txt	37	Besides earlier mentioned disorders affecting adipose tissue andor causing pre mature aging LMNA linked disorders include autosomal dominant Emery Dreifuss muscular dystrophy EDMD 29 limb girdle muscular dystrophy type 1B 30 dilated cardiomyopathy conduction system disease 31 affecting skeletal andor cardiac muscle diseases affecting different tissues Charcot Marie Tooth neuropathy type 2 32
0.10063774.15843404.html.plaintext.txt	38	The pathogenesis EDMD laminopathies extensively investigated recent years 33 37 circumstantial evidence lamin AC interaction either nuclear envelope constituents chromatin may affected diseases 2038 42
0.10063774.15843404.html.plaintext.txt	39	SREBPADD1 initially cloned rat adipose tissue 43 shown activated cultured fibroblasts adipocytes liver 4445
0.10063774.15843404.html.plaintext.txt	40	The human homolog ADD1 SREBP1 plays major role control genes involved adipocyte differentiation whereas closely related factor SREBP2 mostly related cholesterol metabolism 46
0.10063774.15843404.html.plaintext.txt	41	SREBP1 synthesized 125 kDa precursor embedded endoplasmic reticulum membrane
0.10063774.15843404.html.plaintext.txt	42	Depletion cholesterol causes proteolytic cleavage transcriptionally active N terminal portion SREBP1 position allow translocation nucleus 47
0.10063774.15843404.html.plaintext.txt	43	A number published data suggest SREBP1 interacts nuclear envelope undefined site transferred endoplasmic reticulum nuclear interior 48
0.10063774.15843404.html.plaintext.txt	44	Interestingly SREBP1 lamin AC interact vitro 34 suggesting alteration interplay may underlie pathogenic mechanism lipodystrophies
0.10063774.15843404.html.plaintext.txt	45	Recent evidence shows impairment SREBP1 accumulation inside nucleus occurs pre adipocytes treated agent employed HAART causative acquired lipodystrophy 716
0.10063774.15843404.html.plaintext.txt	46	Retention SREBP1 nuclear envelope observed experimental conditions concomitant anomalous accumulation unprocessed lamin A nuclear rim 7
0.10063774.15843404.html.plaintext.txt	47	Downstream SREBP1 retention nuclear envelope activation transcription factor PPAR regulates adipocyte differentiation impaired 16 indicating possible pathogenetic pathway acquired lipodystrophy
0.10063774.15843404.html.plaintext.txt	48	In study evaluated lamin A precursor maturation intermolecular interactions LMNA mutated FPLD MAD WS fibroblasts control fibroblasts
0.10063774.15843404.html.plaintext.txt	49	Our results show pre lamin A processed reduced rate FPLD MAD WS cells leading precursor protein accumulation
0.10063774.15843404.html.plaintext.txt	50	Pre lamin A bound SREBP1 nuclear rim thus limiting translocation transcription factor nuclear interior
0.10063774.15843404.html.plaintext.txt	51	By using 3T3 L1 pre adipocytes cellular model also show forced pre lamin A accumulation reduces rate DNA bound SREBP1 lowers PPAR expression
0.10063774.15843404.html.plaintext.txt	52	The downstream effects reduced PPAR expression rescued troglitazone TZD treatment
0.10063774.15843404.html.plaintext.txt	53	RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Pre lamin A accumulates FPLD MAD WS fibroblasts A faint pre lamin A band detected control skin fibroblasts western blot analysis Fig
0.10063774.15843404.html.plaintext.txt	54	The amount lamin A precursor increased MAD FPLD WS fibroblasts compared controls wild type EDMD2 fibroblasts Fig
0.10063774.15843404.html.plaintext.txt	55	1A whereas lamin AC emerin amounts significantly changed Fig
0.10063774.15843404.html.plaintext.txt	56	Quantitative analysis showed statistically significant increase pre lamin A amount MAD FPLD WS fibroblasts compared control fibroblasts Fig
0.10063774.15843404.html.plaintext.txt	57	Immunofluorescence labeling pre lamin A showed intense nuclear rim staining MAD FPLD WS fibroblasts Fig
0.10063774.15843404.html.plaintext.txt	58	1C whereas precursor protein hardly detectable wild type cells Fig
0.10063774.15843404.html.plaintext.txt	59	Moreover faint pre lamin A staining detected nuclear rim R401C mutated EDMD2 cells Fig
0.10063774.15843404.html.plaintext.txt	60	1C EDMD2 cell lines bearing five different LMNA mutations data shown
0.10063774.15843404.html.plaintext.txt	61	Intra nuclear pre lamin A labeled structures observed MAD FPLD WS fibroblasts Fig
0.10063774.15843404.html.plaintext.txt	62	Mis localization pre lamin A intra nuclear structures observed percentage EDMD2 cells Fig
0.10063774.15843404.html.plaintext.txt	63	Emerin co localized pre lamin A nuclear rim whereas pre lamin A labeled intra nuclear structures co localize emerin lipodystrophy nuclei Fig
0.10063774.15843404.html.plaintext.txt	64	View larger version 40K Figure 1
0.10063774.15843404.html.plaintext.txt	65	Analysis pre lamin A expression localization control laminopathic fibroblasts
0.10063774.15843404.html.plaintext.txt	66	A Western blot analysis pre lamin A untreated skin fibroblasts
0.10063774.15843404.html.plaintext.txt	67	Whole cell lysates control C MAD FPLD WS EDMD2 fibroblasts submitted electrophoresis western blotted probed using anti pre lamin A antibody
0.10063774.15843404.html.plaintext.txt	68	Immunoblotted membranes stripped re probed anti lamin AC anti emerin anti actin antibodies lower panels
0.10063774.15843404.html.plaintext.txt	69	Actin staining shows equal loading samples
0.10063774.15843404.html.plaintext.txt	70	Molecular weight markers reported kilodalton
0.10063774.15843404.html.plaintext.txt	71	B Densitometric analysis pre lamin A immunoblotted bands shown panel A
0.10063774.15843404.html.plaintext.txt	72	Immunoblotted bands quantified densitometry
0.10063774.15843404.html.plaintext.txt	73	At least three independent experiments performed western immunoblot analysis pre lamin A accumulation equal loading samples checked using actin internal loading control data calculated percentage control pre lamin A densitometry obtained experiment
0.10063774.15843404.html.plaintext.txt	74	Values reported percentage control pre lamin A amount mean plus minus SEM three different experiments
0.10063774.15843404.html.plaintext.txt	75	Densitometric values obtained untreated MAD FPLD WS samples significantly different control values calculated Students test P 0
0.10063774.15843404.html.plaintext.txt	76	C Localization pre lamin A control MAD FPLD WS EDMD2 fibroblasts
0.10063774.15843404.html.plaintext.txt	77	Double staining pre lamin A emerin performed anti pre lamin A polyclonal antibody Santa Cruz SC 6214 revealed FITC conjugated secondary antibody anti emerin monoclonal antibody revealed Cy 3 conjugated secondary antibody
0.10063774.15843404.html.plaintext.txt	78	Pictures obtained fluorescence microscopy
0.10063774.15843404.html.plaintext.txt	79	Pre lamin A labeled intra nuclear structures marked arrowheads
0.10063774.15843404.html.plaintext.txt	80	To check whether farnesylation lamin A precursor ongoing process examined cell lines performed mevinolin treatment 21
0.10063774.15843404.html.plaintext.txt	81	Accumulation unprocessed lamin A observed mevinolin treatment examined cell lines compare Fig
0.10063774.15843404.html.plaintext.txt	82	1A higher pre lamin A amount detected FPLD MAD WS fibroblasts western immunoblot compare Fig
0.10063774.15843404.html.plaintext.txt	83	Mature lamin A band slightly reduced mevinolin treated samples whereas lamin C emerin expressions slightly affected mevinolin administration compare Fig
0.10063774.15843404.html.plaintext.txt	84	Densitometric analysis pre lamin A immunoblotted bands showed increase mevinolin treated control laminopathic cell line compared corresponding untreated cell line Fig
0.10063774.15843404.html.plaintext.txt	85	In wild type fibroblasts forced accumulate pre lamin A nuclear lamina invaginations observed Fig
0.10063774.15843404.html.plaintext.txt	86	2C C arrowheads pre lamin A labeled structures detected equatorial plane nucleus Fig
0.10063774.15843404.html.plaintext.txt	87	2C starting nuclear rim Fig
0.10063774.15843404.html.plaintext.txt	88	Nuclear lamina invaginations also observed MAD WS fibroblasts Fig
0.10063774.15843404.html.plaintext.txt	89	2C arrowheads whereas FPLD nuclei showed anomalous pre lamin A aggregates localized nuclear rim Fig
0.10063774.15843404.html.plaintext.txt	90	In mevinolin treated wild type fibroblasts pre lamin A labeled intra nuclear structures partially co localized emerin whereas co localize emerin MAD FPLD WS nuclei Fig
0.10063774.15843404.html.plaintext.txt	91	View larger version 44K Figure 2
0.10063774.15843404.html.plaintext.txt	92	Analysis pre lamin A expression localization mevinolin treated control laminopathic fibroblasts
0.10063774.15843404.html.plaintext.txt	93	A Western blot analysis pre lamin A skin fibroblasts following 18 h mevinolin treatment
0.10063774.15843404.html.plaintext.txt	94	Whole cell lysates control C MAD FPLD WS EDMD2 fibroblasts submitted electrophoresis western blotted probed using anti pre lamin A antibody
0.10063774.15843404.html.plaintext.txt	95	Immunoblotted membranes stripped re probed anti lamin AC anti emerin anti actin antibodies lower panels
0.10063774.15843404.html.plaintext.txt	96	Actin staining shows equal loading samples
0.10063774.15843404.html.plaintext.txt	97	Molecular weight markers reported kilodaltons
0.10063774.15843404.html.plaintext.txt	98	B Densitometric analysis pre lamin A immunoblotted bands shown panel A
0.10063774.15843404.html.plaintext.txt	99	Immunoblotted bands quantified densitometry
0.10063774.15843404.html.plaintext.txt	100	At least three independent experiments performed western immunoblot analysis pre lamin A accumulation
0.10063774.15843404.html.plaintext.txt	101	Equal loading samples checked using actin internal loading control data calculated percentage pre lamin A densitometry measured untreated cell line
0.10063774.15843404.html.plaintext.txt	102	Values reported percentage pre lamin A amount corresponding untreated cell line Fig
0.10063774.15843404.html.plaintext.txt	103	1A B represent means plus minus SEM three different experiments
0.10063774.15843404.html.plaintext.txt	104	Western blotting untreated fibroblasts Fig
0.10063774.15843404.html.plaintext.txt	105	1A mevinolin treated fibroblasts A routinely performed membrane allow comparison results
0.10063774.15843404.html.plaintext.txt	106	C Localization pre lamin A mevinolin treated control MAD FPLD WS fibroblasts
0.10063774.15843404.html.plaintext.txt	107	Double staining pre lamin A emerin performed anti pre lamin A polyclonal antibody Santa Cruz SC 6214 revealed FITC conjugated secondary antibody anti emerin monoclonal antibody revealed Cy 3 conjugated secondary antibody C Localization pre lamin A mevinolin treated wild type nuclei control
0.10063774.15843404.html.plaintext.txt	108	Pictures obtained two different focal planes lamina plane equatorial plane
0.10063774.15843404.html.plaintext.txt	109	Pre lamin A labeled intra nuclear structures shown C C marked arrowheads
0.10063774.15843404.html.plaintext.txt	110	Pictures obtained fluorescence microscopy
0.10063774.15843404.html.plaintext.txt	111	SREBP1 bound pre lamin A vivo SREBP1 detected control laminopathic fibroblasts 125 kDa precursor active cleaved form 68 kDa Fig
0.10063774.15843404.html.plaintext.txt	112	An additional low molecular weight band observed mevinolin treated controls FPLD MAD WS fibroblasts Fig
0.10063774.15843404.html.plaintext.txt	113	In vivo binding pre lamin A active 68 kDa SREBP1 form detected control human fibroblasts following mevinolin treatment Fig
0.10063774.15843404.html.plaintext.txt	114	3A FPLD MAD WS fibroblasts either untreated Fig
0.10063774.15843404.html.plaintext.txt	115	3A mevinolin administration data shown
0.10063774.15843404.html.plaintext.txt	116	Co precipitation SREBP1 pre lamin A observed using either anti pre lamin A anti SREBP1 antibody immunoprecipitate protein complexes Fig
0.10063774.15843404.html.plaintext.txt	117	In contrast failed co immunoprecipitate lamin AC using anti SREBP1 antibody Fig
0.10063774.15843404.html.plaintext.txt	118	Moreover lamin AC co precipitated anti pre lamin A antibody Fig
0.10063774.15843404.html.plaintext.txt	119	An emerin immunoprecipitation performed control showed absence co precipitation SREBP1 Fig
0.10063774.15843404.html.plaintext.txt	120	These results confirmed immunoprecipitation experiments using anti lamin AC antibody Fig
0.10063774.15843404.html.plaintext.txt	121	SREBP1 detected protein complex precipitated anti lamin AC antibody Fig
0.10063774.15843404.html.plaintext.txt	122	It noted fibroblasts expressing high pre lamin A levels cross reactivity anti lamin AC antibody pre lamin A caused immunoprecipitation pre lamin A co precipitation proportional amount SREBP1 anti lamin AC antibody Fig
0.10063774.15843404.html.plaintext.txt	123	Figure 3C shows immunofluorescence labeling SREBP1 wild type MAD FPLD WS EDMD2 fibroblasts
0.10063774.15843404.html.plaintext.txt	124	The transcription factor localized inside nucleus control fibroblasts wild type R401C EDMD2 fibroblasts faint cytoplasmic labeling observed Fig
0.10063774.15843404.html.plaintext.txt	125	In MAD FPLD WS fibroblasts nuclear rim staining also observed Fig
0.10063774.15843404.html.plaintext.txt	126	View larger version 68K Figure 3
0.10063774.15843404.html.plaintext.txt	127	Detection SREBP1 pre lamin A binding human fibroblasts
0.10063774.15843404.html.plaintext.txt	128	Western blot analysis whole lysates control lane 1 mevinolin treated control lane 2 MAD lane 3 FPLD lane 4 WS fibroblasts lane 5 shown left panel whole lysate
0.10063774.15843404.html.plaintext.txt	129	Untreated mevinolin treated control fibroblasts untreated FPLD MAD WS fibroblast lysates subjected immunoprecipitation using anti pre lamin A pre A IP anti SREBP1 antibody SREBP1 IP
0.10063774.15843404.html.plaintext.txt	130	Co immunoprecipitated proteins separated electrophoresis western blotted probed anti pre lamin A anti SREBP1 anti lamin AC antibodies
0.10063774.15843404.html.plaintext.txt	131	Anti emerin antibody used immunoprecipitate protein complexes specificity control emerin IP
0.10063774.15843404.html.plaintext.txt	132	Active SREBP1 detected 68 kDa band uncleaved protein 125 kDa band
0.10063774.15843404.html.plaintext.txt	133	An additional SREBP1 band 68 kDa observed cellular lysates accumulating pre lamin A
0.10063774.15843404.html.plaintext.txt	134	B Untreated lane 1 mevinolin treated lane 2 control fibroblasts untreated MAD lane 3 FPLD lane 4 WS fibroblast lysates lane 5 subjected immunoprecipitation using anti lamin AC antibody lamin AC IP
0.10063774.15843404.html.plaintext.txt	135	Co immunoprecipitated proteins separated electrophoresis western blotted probed anti lamin AC anti SREBP1 antibody
0.10063774.15843404.html.plaintext.txt	136	Protein AG panels AG show absence non specific binding primary antibody omitted immunoprecipitation mixture
0.10063774.15843404.html.plaintext.txt	137	Asterisks panel A B mark pre lamin A band detected anti lamin AC antibody
0.10063774.15843404.html.plaintext.txt	138	Molecular weight markers reported kilodaltons
0.10063774.15843404.html.plaintext.txt	139	C Localization SREBP1 wild type MAD FPLD WS EDMD2 fibroblasts
0.10063774.15843404.html.plaintext.txt	140	SREBP1 labeled anti SREBP1 antibody detected FITC conjugated secondary antibody
0.10063774.15843404.html.plaintext.txt	141	Pictures obtained fluorescence microscopy
0.10063774.15843404.html.plaintext.txt	142	Pre lamin A accumulation 3T3 L1 pre adipocytes causes SREBP1 retention nuclear rim In differentiating 3T3 L1 pre adipocytes sharp SREBP1 68 kDa band detected western blot analysis 125 kDa precursor protein less intensely stained Fig
0.10063774.15843404.html.plaintext.txt	143	Mevinolin treatment caused accumulation pre lamin A whereas SREBP1 level affected Fig
0.10063774.15843404.html.plaintext.txt	144	View larger version 49K Figure 4
0.10063774.15843404.html.plaintext.txt	145	SREBP1 pre lamin A interaction 3T3 L1 pre adipocytes
0.10063774.15843404.html.plaintext.txt	146	A Detection SREBP1 pre lamin A binding 3T3 L1 pre adipocytes
0.10063774.15843404.html.plaintext.txt	147	Cellular lysates 3T3 L1 cells treated mevinolin subjected immunoprecipitation using anti pre lamin A pre A IP lanes 3 4 anti SREBP1 SREBP1 IP lanes 5 6 anti lamin AC antibody AC IP lanes 7 8
0.10063774.15843404.html.plaintext.txt	148	Co precipitated proteins separated electrophoresis western blotted probed anti pre lamin A anti SREBP1 antibodies
0.10063774.15843404.html.plaintext.txt	149	Western blot analysis whole cellular lysate WL used input shown lanes 1 2
0.10063774.15843404.html.plaintext.txt	150	Active SREBP1 detected 68 kDa band uncleaved protein 125 kDa band middle
0.10063774.15843404.html.plaintext.txt	151	Stripped membranes re probed anti lamin AC antibody
0.10063774.15843404.html.plaintext.txt	152	Asterisk lower panel shows pre lamin A band detected anti lamin AC antibody
0.10063774.15843404.html.plaintext.txt	153	Protein AG panel AG shows absence non specific binding primary antibody omitted immunoprecipitation mixture lanes 9 10
0.10063774.15843404.html.plaintext.txt	154	Molecular weight markers reported kilodaltons
0.10063774.15843404.html.plaintext.txt	155	B Biochemical analysis sub cellular distribution SREBP1 pre lamin A untreated mevinolin treated 3T3 L1 pre adipocytes
0.10063774.15843404.html.plaintext.txt	156	Cell pellets resuspended lysis buffer containing 10 mM Tris pH 7
0.10063774.15843404.html.plaintext.txt	157	8 1 NP 40 10 mM 2 mercaptoethanol protease inhibitors
0.10063774.15843404.html.plaintext.txt	158	Separation nuclei N obtained hypotonic shock shearing DNase extraction nuclei performed using 100 Uml DNase soluble fraction DNase nuclear matrix proteins NP separated centrifugation
0.10063774.15843404.html.plaintext.txt	159	Each sub cellular fraction resuspended sample buffer subjected electrophoresis western blot probed anti pre lamin A anti SREBP1 antibodies
0.10063774.15843404.html.plaintext.txt	160	Stripped membranes re probed anti emerin antibody loading control
0.10063774.15843404.html.plaintext.txt	161	Lanes 1 5 represent cytosolic fractions C lanes 2 6 represent purified nuclei N lanes 3 7 represent DNase soluble nuclear fractions DNase lanes 4 8 represent insoluble nuclear fractions NP
0.10063774.15843404.html.plaintext.txt	162	Molecular weight markers reported kilodaltons
0.10063774.15843404.html.plaintext.txt	163	C Densitometric analysis 68 kDa SREBP1 immunoblotted bands shown panel B
0.10063774.15843404.html.plaintext.txt	164	Immunoblotted bands quantified densitometry
0.10063774.15843404.html.plaintext.txt	165	Values reported percentage 68 kDa SREBP1 band detected corresponding untreated adipocyte fraction mean plus minus SEM three different experiments
0.10063774.15843404.html.plaintext.txt	166	Western blotting untreated fibroblast fractions B untreated mevinolin treated fibroblast fractions B mevinolin treated routinely performed membrane allow comparison results
0.10063774.15843404.html.plaintext.txt	167	A stable interaction SREBP1 pre lamin A detected co immunoprecipitation assay differentiating 3T3 L1 adipocytes induced accumulate unprocessed lamin A Fig
0.10063774.15843404.html.plaintext.txt	168	This result obtained using either anti pre lamin A anti SREBP1 antibody co precipitate protein complexes Fig
0.10063774.15843404.html.plaintext.txt	169	Even differentiating 3T3 L1 adipocytes failed detect SREBP1 lamin AC binding Fig
0.10063774.15843404.html.plaintext.txt	170	To investigate role SREBP1 pre lamin A interaction first checked sub cellular distribution SREBP1 3T3 L1 pre adipocytes accumulating pre lamin A
0.10063774.15843404.html.plaintext.txt	171	Faint SREBP1 bands detected cytoplasmic fractions Fig
0.10063774.15843404.html.plaintext.txt	172	4B lanes 1 5 whereas 68 kDa cleaved protein recovered nuclear fractions Fig
0.10063774.15843404.html.plaintext.txt	173	In untreated nuclei 68 kDa active SREBP1 form almost completely solubilized DNase treatment Fig
0.10063774.15843404.html.plaintext.txt	174	4B lane 3 whereas SREBP1 band hardly detectable insoluble nuclear fraction Fig
0.10063774.15843404.html.plaintext.txt	175	In contrast mevinolin treated nuclei active SREBP1 band clearly detected DNase soluble fraction Fig
0.10063774.15843404.html.plaintext.txt	176	4B lane 7 insoluble nuclear fraction Fig
0.10063774.15843404.html.plaintext.txt	177	As expected pre lamin A recovered purified nuclei mevinolin treated cells Fig
0.10063774.15843404.html.plaintext.txt	178	4B lane 6 almost completely retained insoluble nuclear fraction DNase extraction Fig
0.10063774.15843404.html.plaintext.txt	179	Densitometric analysis showed amount activated SREBP1 recovered insoluble nuclear fraction significantly increased 3T3 L1 pre adipocytes accumulating pre lamin A Fig
0.10063774.15843404.html.plaintext.txt	180	SREBP1 retained nuclear rim cells accumulating pre lamin A Double immunofluorescence staining SREBP1 pre lamin A performed Fig
0.10063774.15843404.html.plaintext.txt	181	In untreated 3T3 L1 pre adipocytes Fig
0.10063774.15843404.html.plaintext.txt	182	5A SREBP1 localized inside nucleus Fig
0.10063774.15843404.html.plaintext.txt	183	In mevinolin treated 3T3 L1 pre adipocytes co localization SREBP1 pre lamin A nuclear rim observed Fig
0.10063774.15843404.html.plaintext.txt	184	In untreated nuclei control fibroblasts wild type EDMD2 fibroblasts SREBP1 localized nuclear interior whereas transcription factor also observed nuclear rim MAD FPLD fibroblasts Fig
0.10063774.15843404.html.plaintext.txt	185	To support evidence SREBP1 retention nuclear insoluble fraction pre lamin A situ DNase extraction performed
0.10063774.15843404.html.plaintext.txt	186	Following DNase digestion SREBP1 hardly detectable nuclei 3T3 L1 cells undergo mevinolin treatment yet retained nuclear rim mevinolin treated pre adipocytes co localized pre lamin A Fig
0.10063774.15843404.html.plaintext.txt	187	SREBP1 labeling almost undetectable wild type EDMD2 fibroblasts following DNase treatment whereas observed nuclear rim DNase extracted MAD FPLD fibroblasts Fig
0.10063774.15843404.html.plaintext.txt	188	View larger version 37K Figure 5
0.10063774.15843404.html.plaintext.txt	189	Localization SREBP1 nuclei accumulating pre lamin A
0.10063774.15843404.html.plaintext.txt	190	Cells double stained anti SREBP1 anti pre lamin A antibody
0.10063774.15843404.html.plaintext.txt	191	SREBP1 detected FITC conjugated secondary antibody green pre lamin A detected Cy 3 conjugated secondary antibody red
0.10063774.15843404.html.plaintext.txt	192	A Localization SREBP1 pre lamin A untreated 3T3 mevinolin treated 3T3 L1 pre adipocytes 3T3mev
0.10063774.15843404.html.plaintext.txt	193	B Double immunofluorescence staining SREBP1 pre lamin A wild type control MAD FPLD EDMD2 fibroblasts
0.10063774.15843404.html.plaintext.txt	194	C Localization SREBP1 pre lamin A untreated 3T3 mevinolin treated 3T3 L1 pre adipocytes 3T3mev following situ extraction DNase
0.10063774.15843404.html.plaintext.txt	195	DNase extraction unfixed adherent cells performed using 20 Uml DNase 15 min room temperature
0.10063774.15843404.html.plaintext.txt	196	Cells double stained described earlier
0.10063774.15843404.html.plaintext.txt	197	D Double immunofluorescence staining SREBP1 pre lamin A wild type control MAD FPLD EDMD2 fibroblasts following DNase extraction
0.10063774.15843404.html.plaintext.txt	198	The merged images merge show yellow staining nuclear envelope fibroblasts accumulating SREBP1 pre lamin A nuclear rim
0.10063774.15843404.html.plaintext.txt	199	The reported results representative three independent experiments
0.10063774.15843404.html.plaintext.txt	200	Pre lamin A accumulation reduces PPAR levels 3T3 L1 nuclei impairs adipocyte differentiation rescue TZD treatment Since transcription factor PPAR transcribed following SREBP1 activation pre adipocytes induced differentiate 717 checked PPAR levels differentiating 3T3 L1 cells accumulating pre lamin A
0.10063774.15843404.html.plaintext.txt	201	To rule possibility mevinolin could interfere cholesterol synthesis inhibiting HMG CoA reductase pre lamin A accumulation also obtained using farnesyltransferase inhibitor FTI 277 transfecting cell cultures uncleavable pre lamin A mutant described subsequently
0.10063774.15843404.html.plaintext.txt	202	PPAR expression strongly reduced mevinolin treated 3T3 L1 pre adipocytes determined western blot Fig
0.10063774.15843404.html.plaintext.txt	203	6A immunofluorescence analysis Fig
0.10063774.15843404.html.plaintext.txt	204	Downregulation PPAR also obtained using FTI 277 accumulate pre lamin A data shown
0.10063774.15843404.html.plaintext.txt	205	To support observation transiently transfected 3T3 L1 pre adipocytes FLAG tagged lamin A construct overexpressing uncleavable L648R mutated pre lamin A PPAR downregulated nuclei accumulating FLAG L648R pre lamin A Fig
0.10063774.15843404.html.plaintext.txt	206	Overexpression wild type FLAG lamin A FLAG LA also effective reducing PPAR level Fig
0.10063774.15843404.html.plaintext.txt	207	6B C whereas PPAR expression lowered 3T3 L1 cells overexpressing full length emerin protein used control Fig
0.10063774.15843404.html.plaintext.txt	208	Statistical evaluation results showed percentage PPAR labeled nuclei significantly reduced cells accumulating pre lamin A Fig
0.10063774.15843404.html.plaintext.txt	209	It noted 74 kDa pre lamin A band detected FLAG L648R pre lamin A transfected cells western immunoblot Fig
0.10063774.15843404.html.plaintext.txt	210	On hand accumulation wild type pre lamin A along mature lamin A occurred pre adipocytes overexpressing FLAG LA Fig
0.10063774.15843404.html.plaintext.txt	211	View larger version 32K Figure 6
0.10063774.15843404.html.plaintext.txt	212	Analysis PPAR expression adipocyte differentiation 3T3 L1 pre adipocytes accumulating pre lamin A
0.10063774.15843404.html.plaintext.txt	213	A 3T3 L1 pre adipocytes left untreated c treated mevinolin 18 h mev thereafter allowed differentiate 4 days differentiation medium
0.10063774.15843404.html.plaintext.txt	214	Nuclear lysates obtained hypotonic shock shearing subjected electrophoresis western blot analysis anti PPAR anti pre lamin A antibody
0.10063774.15843404.html.plaintext.txt	215	Immunoblotted membranes stripped re probed anti SREBP1 anti emerin antibody
0.10063774.15843404.html.plaintext.txt	216	The 68 kDa SREBP1 band detected nuclear fractions
0.10063774.15843404.html.plaintext.txt	217	Emerin labeled loading control
0.10063774.15843404.html.plaintext.txt	218	Molecular weight markers reported kilodaltons
0.10063774.15843404.html.plaintext.txt	219	B 3T3 L1 pre adipocytes grown coverslips treated mevinolin transfected indicated constructs allowed differentiate 4 days
0.10063774.15843404.html.plaintext.txt	220	Double immunofluorescence staining pre lamin A PPAR performed mevinolin treated samples mevinolin
0.10063774.15843404.html.plaintext.txt	221	Double staining anti FLAG anti PPAR antibodies performed FLAG LA transfected pre adipocytes FLAG LA L648R lamin A transfected adipocytes FLAG L648R emerin transfected adipocytes FLAG emerin
0.10063774.15843404.html.plaintext.txt	222	DAPI staining allows visualization nuclei
0.10063774.15843404.html.plaintext.txt	223	C Percentage PPAR positive nuclei 3T3 L1 pre adipocytes subjected mevinolin treatment mevinolin treated overexpressing wild type FLAG LA mutated L648R FLAG LA FLAG L648R FLAG emerin
0.10063774.15843404.html.plaintext.txt	224	One thousand nuclei counted per sample data reported percentage counted nuclei plus minus SEM three separate countings performed independent experiments
0.10063774.15843404.html.plaintext.txt	225	D Western blot analysis exogenous proteins expressed 3T3 L1 cells FLAG LA FLAG tagged wild type lamin A FLAG L648R FLAG tagged L648R mutated lamin A FLAG emerin FLAG tagged wild type emerin
0.10063774.15843404.html.plaintext.txt	226	Each construct transfected 3T3 L1 cells
0.10063774.15843404.html.plaintext.txt	227	Cellular lysates subjected western immunoblot using anti FLAG antibody
0.10063774.15843404.html.plaintext.txt	228	The 74 kDa band corresponds FLAG pre lamin A 70 kDa band corresponds FLAG LA 34 kDa band corresponds FLAG emerin
0.10063774.15843404.html.plaintext.txt	229	E Pre adipocyte differentiation evaluated oil red O staining cultured 3T3 L1 cells day 2 differentiation
0.10063774.15843404.html.plaintext.txt	230	3T3 L1 cultures left untreated control treated mevinolin 18 h FTI 277 24 h
0.10063774.15843404.html.plaintext.txt	231	Thereafter cells allowed differentiate 2 days either presence absence 10 microM TZD
0.10063774.15843404.html.plaintext.txt	232	An untreated culture control shown left slide drug treated culture mevinolin FTI 277 shown middle culture treated mevinolin FTI 277 TZD 48 h mevinolinTZD FTI 277TZD shown right
0.10063774.15843404.html.plaintext.txt	233	Oil red O staining increased differentiated cells bearing fat deposits
0.10063774.15843404.html.plaintext.txt	234	Pre lamin A staining representative nuclei 3T3 L1 sample shown lower row pre lamin A
0.10063774.15843404.html.plaintext.txt	235	Each pictures representative three independent experiments
0.10063774.15843404.html.plaintext.txt	236	Accumulation pre lamin A reduced adipocyte differentiation detected oil red O staining mevinolin FTI 277 treated 3T3 L1 cultures Fig
0.10063774.15843404.html.plaintext.txt	237	However 3T3 L1 cells treated PPAR ligand TZD showed positive oil red O staining even accumulation pre lamin A mevinolin FTI 277 treatment Fig
0.10063774.15843404.html.plaintext.txt	238	6E indicating rescue adipogenic differentiation
0.10063774.15843404.html.plaintext.txt	239	DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES The results reported show accumulation pre lamin A specifically occurs lipodystrophy linked laminopathies EDMD2 ii vivo binding pre lamin A adipocyte transcription factor SREBP1 occur detectable cells accumulating pre lamin A iii pre lamin A sequesters SREBP1 nuclear rim thus reducing pool DNA bound active transcription factor iv retention SREBP1 pre lamin A causes downregulation PPAR expression hence reduces rate pre adipocyte differentiation v adipogenic differentiation pre adipocytes accumulating pre lamin A may rescued PPAR agonists
0.10063774.15843404.html.plaintext.txt	240	The overall evaluation results shows common pathogenic mechanism may causative different lipodystrophic phenotypes
0.10063774.15843404.html.plaintext.txt	241	The proposed mechanism involves primarily accumulation pre lamin A selective binding lamin A precursor adipocyte transcription factor SREBP1
0.10063774.15843404.html.plaintext.txt	242	In MAD FPLD WS cells observed accumulation lamin A precursor
0.10063774.15843404.html.plaintext.txt	243	Interestingly amount pre lamin A increased EDMD2 fibroblast cell lines indicating impairment lamin A precursor maturation specifically associated lipodystrophy linked lamin A mutations
0.10063774.15843404.html.plaintext.txt	244	However reason lamin A processing selectively affected R482L R527H S143F LMNA mutations obvious
0.10063774.15843404.html.plaintext.txt	245	At present rule possibility altered interplay pre lamin A farnesyltransferases
0.10063774.15843404.html.plaintext.txt	246	In fact mevinolin treatment effective increasing mutated pre lamin A amount MAD FPLD WS fibroblasts suggesting farnesylation pre lamin A ongoing mechanism cells MAD recessive disease model expressing mutated lamin A
0.10063774.15843404.html.plaintext.txt	247	On hand altered interaction mutated pre lamin A ZPMSTE 24 endoprotease might affect protein processing
0.10063774.15843404.html.plaintext.txt	248	It noteworthy ZPMSTE 24 mutations lead accumulation pre lamin A due impaired cleavage farnesylated protein cause MAD 13 HGPS Markquardt personal communication restrictive dermopathy 49 humans MAD resembling phenotype mice 1415
0.10063774.15843404.html.plaintext.txt	249	We localized pre lamin A labeled intra nuclear structures wild type laminopathic cells accumulating lamin A precursor
0.10063774.15843404.html.plaintext.txt	250	Such structures previously shown wild type cells induced accumulate pre lamin A 2150
0.10063774.15843404.html.plaintext.txt	251	However additional dominant negative effects mutations appear affect differently number shape pre lamin A labeled structures laminopathic cell line
0.10063774.15843404.html.plaintext.txt	252	In case MAD WS fibroblasts pre lamin A containing structures mostly protrude nuclear interior also observed control nuclei whereas R482L FPLD nuclei mostly localized nuclear lamina level
0.10063774.15843404.html.plaintext.txt	253	We recently noticed number pre lamin A labeled intra nuclear structures level lamin A precursor significantly increased older MAD patients though carrying R527H LMNA mutation data shown
0.10063774.15843404.html.plaintext.txt	254	Noticeably pre lamin A labeled structures may co localize emerin wild type EDMD2 nuclei FPLD MAD WS nuclei suggesting disease specific changes intermolecular interactions 42
0.10063774.15843404.html.plaintext.txt	255	Because determined link pre lamin A accumulation LMNA associated lipodystrophies decided investigate whether pre lamin A interacted transcription factor SREBP1 mediates adipocyte differentiation 44
0.10063774.15843404.html.plaintext.txt	256	In vitro binding SREBP1 lamin AC demonstrated Lloyd et al
0.10063774.15843404.html.plaintext.txt	257	34 site interaction mapped aminoacids 227 487 SREBP1 N terminus sequence 34
0.10063774.15843404.html.plaintext.txt	258	In present study demonstrated first time vivo binding lamin A precursor SREBP1
0.10063774.15843404.html.plaintext.txt	259	As expected low molecular weight form SREBP1 interacts pre lamin A indicating involvement nuclear lamina protein localization active transcription factor
0.10063774.15843404.html.plaintext.txt	260	34 performed GST binding assay lamin A peptide spanning aminoacids 389 664 includes pre lamin A C terminal sequence
0.10063774.15843404.html.plaintext.txt	261	Thus results confirm whole unprocessed lamin A molecule required SREBP1 interaction vivo
0.10063774.15843404.html.plaintext.txt	262	The previously suggested reduction lamin A SREBP1 binding affinity caused R482 LMNA mutation 34 appear affect vivo interaction pre lamin A SREBP1
0.10063774.15843404.html.plaintext.txt	263	This might related increased availability pre lamin A FPLD cells could overcome reduced binding affinity caused mutation
0.10063774.15843404.html.plaintext.txt	264	In addition cannot rule possibility different aminoacid substitution R482L instead R482W may differently affect protein interplay 42
0.10063774.15843404.html.plaintext.txt	265	By treating pre adipocytes farnesylation inhibitors obtained suitable cellular model reproduced situation pre lamin A accumulation adipose tissue
0.10063774.15843404.html.plaintext.txt	266	This allowed us investigate biological mechanisms downstream reduced pre lamin A maturation
0.10063774.15843404.html.plaintext.txt	267	We showed retention active SREBP1 nuclear lamina occurs pre adipocytes accumulating pre lamin A demonstrated significantly increased proportion mature SREBP1 found nuclear insoluble fraction following DNase extraction
0.10063774.15843404.html.plaintext.txt	268	Immunofluorescence labeling allowed us show co localization SREBP1 pre lamin A nuclei accumulating pre lamin A
0.10063774.15843404.html.plaintext.txt	269	In fact DNA bound transcription factor disappears control nuclei removal DNA whereas lamina associated SREBP1 still retained nuclei accumulating pre lamin A shows typical nuclear rim staining
0.10063774.15843404.html.plaintext.txt	270	We suggest reduced rate lamin A precursor processing allows detection pre lamin A bound SREBP1 hardly detectable control cell lines undergoing rapid pre lamin A maturation
0.10063774.15843404.html.plaintext.txt	271	It noteworthy SREBP1 nuclear translocation impaired Lmna null mouse cardiomyocytes adipose tissue Lmna null mice 36 indicating nuclear import SREBP1 adipocytes require Lmna products
0.10063774.15843404.html.plaintext.txt	272	These data present results support view SREBP1 pre lamin A interplay physiological role negative regulation SREBP1 nuclear translocation adipose tissue excess accumulation pre lamin A selectively sequesters SREBP1 adipocyte nuclear envelope
0.10063774.15843404.html.plaintext.txt	273	On hand pre lamin A might play positive regulation role SREBP1 nuclear import cell types cardiac myocytes 36
0.10063774.15843404.html.plaintext.txt	274	In agreement hypothesis pre lamin A SREBP1 interplay potentially disrupted LMNA mutations causing AD EDMD 34 might involved nuclear import transcription factor skeletal muscle cells
0.10063774.15843404.html.plaintext.txt	275	Retention SREBP1 nuclear rim previously reported 3T3 F442A pre adipocytes treated Indinavir drug employed HAART causing lipodystrophy side effect 7
0.10063774.15843404.html.plaintext.txt	276	Under experimental conditions 3T3 F442A fibroblasts show increased pre lamin A level reduced PPAR expression 7
0.10063774.15843404.html.plaintext.txt	277	These results strongly suggest retention SREBP1 nuclear rim lipodystrophy cells associated presence increased pre lamin A level irrespective occurrence LMNA mutations
0.10063774.15843404.html.plaintext.txt	278	In fact identification selective stable interplay pre lamin A SREBP1 helps explain pathophysiology acquired inherited lipodystrophy latter due either lamin AC ZMPSTE 24 mutations
0.10063774.15843404.html.plaintext.txt	279	Moreover noteworthy farnesyltransferase inhibitors causing pre lamin A accumulation previously reported impair adipocyte differentiation 5152
0.10063774.15843404.html.plaintext.txt	280	Our results help explaining biological mechanism underlying effect
0.10063774.15843404.html.plaintext.txt	281	A key event adipocyte differentiation induction transcription factor PPAR triggered SREBP1 48
0.10063774.15843404.html.plaintext.txt	282	Downregulation PPAR expression obtained pre adipocytes accumulating lamin A precursor either mevinolin treatment overexpressing uncleavable pre lamin A
0.10063774.15843404.html.plaintext.txt	283	Uncleavable mutants lamin A shown assemble localize nuclear envelope kinetics comparable wild type protein 53
0.10063774.15843404.html.plaintext.txt	284	The L648R lamin A mutant fact localize nuclear envelope could potentially bind SREBP1 observed de farnesylated pre lamin A
0.10063774.15843404.html.plaintext.txt	285	Interestingly reduced PPAR level also observed adipocytes accumulating wild type FLAG pre lamin A
0.10063774.15843404.html.plaintext.txt	286	In latter case increase pre lamin A level directly attributable overexpression exogenous protein
0.10063774.15843404.html.plaintext.txt	287	These results support view excess accumulation pre lamin A sufficient sequester amount SREBP1 even presence mature lamin A
0.10063774.15843404.html.plaintext.txt	288	Thus PPAR induction key step adipocyte differentiation may altered laminopathies featuring lipodystrophy already proposed acquired lipodystrophies 716
0.10063774.15843404.html.plaintext.txt	289	In fact adipocyte differentiation impaired pre lamin A accumulation determined oil red O staining mevinolin FTI 277 treated pre adipocyte cultures
0.10063774.15843404.html.plaintext.txt	290	Given FTI 277 selectively affects pre lamin A processing without interference ras protein farnesylation cholesterol synthesis 54 conclude reduced adipocyte differentiation direct effect pre lamin A accumulation
0.10063774.15843404.html.plaintext.txt	291	It noted highly differentiated cultures affected drug treatment data shown agreement evidence early event adipocyte differentiation pathway PPAR activation affected pre lamin A
0.10063774.15843404.html.plaintext.txt	292	PPAR expression reported regulated dependent body district 55
0.10063774.15843404.html.plaintext.txt	293	This important observation suggests pre lamin A accumulation may elicit different effects different fat depots depending extent PPAR activation required particular area
0.10063774.15843404.html.plaintext.txt	294	This could part explain selective involvement adipose tissue districts partial lipodystrophies
0.10063774.15843404.html.plaintext.txt	295	Treatment 3T3 L1 cells accumulating pre lamin A PPAR ligand TZD elicited rescue adipogenic program
0.10063774.15843404.html.plaintext.txt	296	The latter finding gives important insight possible therapeutic approaches lipodystrophy already reported elicit promising effects 56
0.10063774.15843404.html.plaintext.txt	297	As MAD recessive disease one would expect pre lamin A accumulation even heterozygous state
0.10063774.15843404.html.plaintext.txt	298	percentage cells parents affected individuals bearing one mutated allele 3
0.10063774.15843404.html.plaintext.txt	299	We observe significant increase pre lamin A amount cells
0.10063774.15843404.html.plaintext.txt	300	However study deserves deepening since found overexpression R527H mutated lamin A transfected cells causes accumulation mutated pre lamin A endogenous pre lamin A data shown
0.10063774.15843404.html.plaintext.txt	301	On hand MAD phenotype observed heterozygous individuals strongly supporting view threshold pre lamin A level required activate pathogenic mechanism
0.10063774.15843404.html.plaintext.txt	302	Regarding pathophysiology MAD WS two main questions need investigation
0.10063774.15843404.html.plaintext.txt	303	The first effect elicited accumulation lamin A precursor protein osteoblasts
0.10063774.15843404.html.plaintext.txt	304	In fact bone resorption extremities specific feature MAD phenotype 3 osteoporosis also observed WS patients 11 though might related aging process featuring disease
0.10063774.15843404.html.plaintext.txt	305	We addressing problem evaluating effect high pre lamin A level pre osteocyte differentiation survival
0.10063774.15843404.html.plaintext.txt	306	The open question pathogenetic mechanism leading premature aging phenotype MAD patients mostly WS patients
0.10063774.15843404.html.plaintext.txt	307	We suggest phenotype could dependent anomalous amount pre lamin A altered interaction mutated lamin AC nuclear binding partners
0.10063774.15843404.html.plaintext.txt	308	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Cell culture differentiation Skin biopsies obtained MAD patient carrying R527H lamin AC mutation 3 FPLD patient carrying R482L lamin AC mutation 42 atypical WS patient carrying S143F LMNA mutation EDMD2 patient carrying R401C LMNA mutation unaffected controls following written consent
0.10063774.15843404.html.plaintext.txt	309	Fibroblast cultures established cultured Dulbeccos modified Eagles medium DMEM supplemented 10 fetal calf serum FCS antibiotics
0.10063774.15843404.html.plaintext.txt	310	Cells passages 10 15 employed
0.10063774.15843404.html.plaintext.txt	311	3T3 L1 pre adipocytes obtained European Collection Cell Cultures cultured DMEM plus 10 FCS
0.10063774.15843404.html.plaintext.txt	312	Pre adipocytes approaching confluence induced differentiate incubation 2 days differentiation medium containing DMEM plus 10 FCS 5 microgml insulin 0
0.10063774.15843404.html.plaintext.txt	313	1 mM 3 isobutyl 1 methylxanthine
0.10063774.15843404.html.plaintext.txt	314	Thereafter incubation performed additional 2 days medium excluding dexamethasone 3 isobutyl 1 methylxanthine
0.10063774.15843404.html.plaintext.txt	315	Cells maintained 8 10 days DMEM 10 FCS attain maximal differentiation 57
0.10063774.15843404.html.plaintext.txt	316	Transfection pre adipocyte cultures A full length rat lamin A cDNA encoding pre lamin A expressed CMV promoter tagged 5 end sequence coding FLAG epitope FLAG LA 58
0.10063774.15843404.html.plaintext.txt	317	The L648R point mutation introduced full length rat lamin A cDNA using QuikChange site directed mutagenesis kit Stratagene La Jolla CA USA
0.10063774.15843404.html.plaintext.txt	318	This mutation impairs cleavage pre lamin A ZMPSTE24 endoprotease causes accumulation farnesylated pre lamin A 12
0.10063774.15843404.html.plaintext.txt	319	FLAG LA L648R FLAG lamin A transfected 3T3 L1 pre adipocytes day 0 differentiation
0.10063774.15843404.html.plaintext.txt	320	A FLAG tagged wild type emerin construct used transfect pre adipocytes control
0.10063774.15843404.html.plaintext.txt	321	Transfection 3T3 L1 pre adipocytes performed using FuGene 6 reagent according manufacturers instructions
0.10063774.15843404.html.plaintext.txt	322	Cells fixed day 4 differentiation
0.10063774.15843404.html.plaintext.txt	323	Drug treatments Pre lamin A accumulation human fibroblasts 3T3 L1 adipocytes induced inhibition isoprenoid synthesis 25 microM Mevinolin Sigma 18 h 21
0.10063774.15843404.html.plaintext.txt	324	This drug subtracts substrate farnesyltransferases thus impairing pre lamin A farnesylation required protein processing 59
0.10063774.15843404.html.plaintext.txt	325	Alternatively pre lamin A farnesylation inhibited using peptidomimetic drug FTI 277 Calbiochem selectively impairs pre lamin A farnesylation dosage used 20 microM 24 h 54
0.10063774.15843404.html.plaintext.txt	326	Treatment TZD Sigma performed according published protocols trigger PPAR activation 16
0.10063774.15843404.html.plaintext.txt	327	Briefly 3T3 L1 pre adipocytes induced accumulate pre lamin A 18 h mevinolin treatment 24 h FTI 277 treatment
0.10063774.15843404.html.plaintext.txt	328	Thereafter cells transferred culture medium containing 10 microM TZD incubated 48 h
0.10063774.15843404.html.plaintext.txt	329	Incubation stopped formalin fixation described subsequently
0.10063774.15843404.html.plaintext.txt	330	Sub cellular fractioning DNase treatment Sub cellular fractions obtained previously described 26
0.10063774.15843404.html.plaintext.txt	331	Briefly cell pellet resuspended lysis buffer containing 10 mM Tris pH 7
0.10063774.15843404.html.plaintext.txt	332	8 1 NP 40 10 mM 2 mercaptoethanol protease inhibitors
0.10063774.15843404.html.plaintext.txt	333	Separation nuclei obtained hypotonic shock shearing nuclei obtained pellet 300g centrifugation 4 degrees C
0.10063774.15843404.html.plaintext.txt	334	Other samples treated procedure employed obtain cytoplasmic fraction supernatant
0.10063774.15843404.html.plaintext.txt	335	Cytoplasmic fractions clarified centrifugation 600g
0.10063774.15843404.html.plaintext.txt	336	DNase extraction nuclei performed according published protocols 42 except 100 Uml DNase applied 30 min
0.10063774.15843404.html.plaintext.txt	337	The insoluble nuclear fraction NP Fig
0.10063774.15843404.html.plaintext.txt	338	4 containing nuclear matrix constituents obtained pellet
0.10063774.15843404.html.plaintext.txt	339	Each fraction resuspended loading buffer subjected sodium dodecyl sulphate polyacrylamide gel electrophoresis SDS PAGE western blot analysis
0.10063774.15843404.html.plaintext.txt	340	In situ DNase extraction performed follows
0.10063774.15843404.html.plaintext.txt	341	Unfixed cell cultures washed phosphate buffered saline PBS treated buffer containing 10 mM Tris HCl pH 7
0.10063774.15843404.html.plaintext.txt	342	4 150 mM NaCl 5 mM MgCl2 1 NP 40 1 mM phenylmethylsulfonyl fluoride PMSF 10 microgml leupeptin aprotinin 15 min room temperature
0.10063774.15843404.html.plaintext.txt	343	Detergent treated cells washed twice absence NP 40 subjected DNase treatment 20 Uml 15 min room temperature
0.10063774.15843404.html.plaintext.txt	344	Samples fixed 4 paraformaldehyde processed immunofluorescence labeling
0.10063774.15843404.html.plaintext.txt	345	Antibodies The antibodies employed western blot analysis immunofluorescence labeling follow anti lamin AC monoclonal Novocastra Laboratories NCL LAM AC anti lamin AC goat polyclonal Santa Cruz sc 6215 anti pre lamin A goat polyclonal Santa Cruz sc 6214 15 anti SREBP1 rabbit polyclonal Santa Cruz sc 8984 anti emerin mouse monoclonal Novocastra Laboratories NCL emerin anti PPAR mouse monoclonal Santa Cruz sc 7273 anti actin goat polyclonal Santa Cruz sc 1616 anti FLAG rabbit polyclonal Sigma F 7425
0.10063774.15843404.html.plaintext.txt	346	Western blot immunoprecipitation Western blot analysis cellular lysates human fibrobasts 3T3 L1 pre adipocytes done follows
0.10063774.15843404.html.plaintext.txt	347	Cells lysed buffer containing 1 NP 40 0
0.10063774.15843404.html.plaintext.txt	348	25 sodium deoxycholate 150 mM NaCl 1 mM EGTA 1 mM PMSF 1 mM NaF 1 microM aprotinin leupeptin pepstatin
0.10063774.15843404.html.plaintext.txt	349	Proteins loaded Laemmli sample buffer subjected SDS PAGE followed immunochemical reactions
0.10063774.15843404.html.plaintext.txt	350	For immunoprecipitation analysis human fibroblasts 3T3 L1 pre adipocytes treated buffer containing 50 mM HEPES HCl pH 7
0.10063774.15843404.html.plaintext.txt	351	4 100 mM NaCl 1 NP 40 1 mM PMSF 1 mM dithiothreitol 1
0.10063774.15843404.html.plaintext.txt	352	5 mM MgCl2 10 microM leupeptin pepstatin aprotinin 10 min 4 degrees C
0.10063774.15843404.html.plaintext.txt	353	After sonication cell extracts clarified 12 000g centrifugation 4 degrees C
0.10063774.15843404.html.plaintext.txt	354	Protein AG Sepharose beads incubated anti SREBP1 anti pre lamin A antibodies 14 h 4 degrees C unbound antibodies removed centrifugation
0.10063774.15843404.html.plaintext.txt	355	Cellular extracts incubated antibody coupled Sepharose beads 3 h 4 degrees C
0.10063774.15843404.html.plaintext.txt	356	Immunoprecipitated complexes diluted Laemmli buffer subjected SDS PAGE 6 20 transferred nitrocellulose membrane
0.10063774.15843404.html.plaintext.txt	357	Membranes saturated 5 dried skimmed milk 4 bovine serum albumin BSA incubation primary antibodies performed 1 h room temperature
0.10063774.15843404.html.plaintext.txt	358	Immunoblotted bands revealed Amersham ECL detection system
0.10063774.15843404.html.plaintext.txt	359	Densitometry immunoblotted bands performed Biorad GS 800 calibrated densitometer
0.10063774.15843404.html.plaintext.txt	360	Statistical analysis performed Students test
0.10063774.15843404.html.plaintext.txt	361	Immunofluorescence Human fibroblasts 3T3 L1 pre adipocytes grown coverslips fixed methanol 20 degrees C
0.10063774.15843404.html.plaintext.txt	362	In situ DNase extracted samples fixed 4 paraformaldehyde
0.10063774.15843404.html.plaintext.txt	363	Samples incubated PBS containing 4 BSA saturate non specific binding
0.10063774.15843404.html.plaintext.txt	364	Primary antibodies applied overnight 4 degrees C secondary antibodies applied 1 h room temperature
0.10063774.15843404.html.plaintext.txt	365	Slides mounted anti fade reagent glycerol observed Nikon E 600 fluorescence microscope equipped digital camera
0.10063774.15843404.html.plaintext.txt	366	Pictures elaborated Photoshop 6 software
0.10063774.15843404.html.plaintext.txt	367	Oil red O staining Oil red O staining cultured 3T3 L1 pre adipocytes performed stain lipid droplets
0.10063774.15843404.html.plaintext.txt	368	Cells fixed 1 h room temperature 10 formalin isotonic buffer washed three times distilled water stained 0
0.10063774.15843404.html.plaintext.txt	369	6 wtvol oil red O solution 60 isopropanol 40 water 1 h 22 degrees C
0.10063774.15843404.html.plaintext.txt	370	After washing three times distilled water cells examined microscope 16
0.10063774.15843404.html.plaintext.txt	371	ACKNOWLEDGEMENTS The authors thank Professor E
0.10063774.15843404.html.plaintext.txt	372	Grasso gratefully acknowledged
0.10063774.15843404.html.plaintext.txt	373	This work supported grants Italian Health Ministry P
0.10063774.15843404.html.plaintext.txt	374	2003123 Italian Ministry University Research FIRB Project
0.10063774.15843404.html.plaintext.txt	375	RBNE01JJ45005 MIUR Cofin 2004 Telethon grant G
0.10063774.15843404.html.plaintext.txt	376	grant Fondazione Carisbo Italy
0.10063774.15843404.html.plaintext.txt	377	funded German network muscular dystrophies MD NET research project R8 01GM0302 German Ministry Education Research Germany
0.10063774.15843404.html.plaintext.txt	378	supported Council Scientific Industrial Research India
0.10063774.15843404.html.plaintext.txt	379	REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES Hegele R
0.10063774.15843404.html.plaintext.txt	380	2003 Monogenic forms insulin resistance apertures expose common metabolic syndrome
0.10063774.15843404.html.plaintext.txt	381	2000 LMNA encoding lamin AC mutated partial lipodystrophy
0.10063774.15843404.html.plaintext.txt	382	2002 Mandibuloacral dysplasia caused mutation LMNA encoding lamin AC
0.10063774.15843404.html.plaintext.txt	383	2002 Cardiomyopathy congenital complete lipodystrophy
0.10063774.15843404.html.plaintext.txt	384	2001 Identification gene altered Berardinelli Seip congenital lipodystrophy chromosome 11q13
0.10063774.15843404.html.plaintext.txt	385	2002 PPARG F388L transactivation deficient mutant familial partial lipodystrophy
0.10063774.15843404.html.plaintext.txt	386	2003 Some HIV protease inhibitors alter lamin AC maturation stability SREBP 1 nuclear localization adipocyte differentiation
0.10063774.15843404.html.plaintext.txt	387	et al 2003 Lamin truncation Hutchinson Gilford progeria
0.10063774.15843404.html.plaintext.txt	388	2003 Recurrent de novo point mutations lamin A cause Hutchinson Gilford progeria syndrome
0.10063774.15843404.html.plaintext.txt	389	2003 LMNA mutated Hutchinson Gilford progeria MIM 176670 Wiedemann Rautenstrauch progeroid syndrome MIM 264090
0.10063774.15843404.html.plaintext.txt	390	2003 LMNA mutations atypical Werners syndrome
0.10063774.15843404.html.plaintext.txt	391	2005 Prelamin A endoproteolytic processing vitro recombinant Zmpste24
0.10063774.15843404.html.plaintext.txt	392	2003 Zinc metalloproteinase ZMPSTE24 mutated mandibuloacral dysplasia
0.10063774.15843404.html.plaintext.txt	393	2002 Zmpste24 deficiency mice causes spontaneous bone fractures muscle weakness prelamin A processing defect
0.10063774.15843404.html.plaintext.txt	394	et al 2002 Defective prelamin A processing muscular adipocyte alterations Zmpste24 metalloproteinase deficient mice
0.10063774.15843404.html.plaintext.txt	395	2001 The HIV protease inhibitor indinavir impairs sterol regulatory element binding protein 1 intranuclear localization inhibits preadipocyte differentiation induces insulin resistance
0.10063774.15843404.html.plaintext.txt	396	1998 PPAR gamma adipogenic regulator thiazolidinedione receptor
0.10063774.15843404.html.plaintext.txt	397	2002 A novel heterozygous mutation peroxisome proliferator activated receptor gamma gene patient familial partial lipodystrophy
0.10063774.15843404.html.plaintext.txt	398	2004 A single base mutation peroxisome proliferator activated receptor gamma promoter associated altered vitro expression partial lipodystrophy
0.10063774.15843404.html.plaintext.txt	399	2004 Proteins bind A type lamins integrating isolated clues
0.10063774.15843404.html.plaintext.txt	400	1995 Lamin A precursor localized intranuclear foci
0.10063774.15843404.html.plaintext.txt	401	1998 Nuclear lamins structure assembly interactions
0.10063774.15843404.html.plaintext.txt	402	2001 Interaction emerin nuclear lamins
0.10063774.15843404.html.plaintext.txt	403	2002 Lamin AC binding protein LAP2alpha required nuclear anchorage retinoblastoma protein
0.10063774.15843404.html.plaintext.txt	404	1998 In vitro interaction carboxy terminal domain lamin A actin
0.10063774.15843404.html.plaintext.txt	405	2003 Association emerin nuclear cytoplasmic actin regulated differentiating myoblasts
0.10063774.15843404.html.plaintext.txt	406	1994 The retinoblastoma gene product cell cycle dependent nuclear matrix associated protein
0.10063774.15843404.html.plaintext.txt	407	2003 The strange case lumper lamin AC gene human premature ageing
0.10063774.15843404.html.plaintext.txt	408	1999 Mutations gene encoding lamin AC cause autosomal dominant Emery Dreifuss muscular dystrophy
0.10063774.15843404.html.plaintext.txt	409	2000 Identification mutations gene encoding lamins AC autosomal dominant limb girdle muscular dystrophy atrioventricular conduction disturbances LGMD1B
0.10063774.15843404.html.plaintext.txt	410	1999 Missense mutations rod domain lamin AC gene causes dilated cardiomyopathy conduction system disease
0.10063774.15843404.html.plaintext.txt	411	2002 Homozygous defects LMNA encoding lamin AC nuclear envelope proteins cause autosomal recessive axonal neuropathy human Charcot Marie tooth disorder type 2 mouse
0.10063774.15843404.html.plaintext.txt	412	1999 Loss A type lamin expression compromises nuclear envelope integrity leading muscular dystrophy
0.10063774.15843404.html.plaintext.txt	413	2002 A novel interaction lamin A SREBP1 implications partial lipodystrophy laminopathies
0.10063774.15843404.html.plaintext.txt	414	2002 The Ig like structure C terminal domain lamin AC mutated muscular dystrophies cardiomyopathy partial lipodystrophy
0.10063774.15843404.html.plaintext.txt	415	2004 Defects nuclear structure function promote dilated cardiomyopathy lamin AC deficient mice
0.10063774.15843404.html.plaintext.txt	416	2004 Lamin AC deficiency causes defective nuclear mechanics mechanotransduction
0.10063774.15843404.html.plaintext.txt	417	2001 Nuclear alterations autosomal dominant Emery Dreifuss muscular dystrophy
0.10063774.15843404.html.plaintext.txt	418	2004 New roles lamins nuclear envelope proteins actin nucleus
0.10063774.15843404.html.plaintext.txt	419	2003 The carboxyl terminal region common lamins A C contains DNA binding domain
0.10063774.15843404.html.plaintext.txt	420	Biochemistry 42 4819 4828
0.10063774.15843404.html.plaintext.txt	421	2003 Nuclear envelope alterations fibroblasts LGMD1B patients carrying nonsense Y259X heterozygous homozygous mutation lamin AC gene
0.10063774.15843404.html.plaintext.txt	422	2003 Failure lamin AC functionally assemble R482L mutated familial partial lipodystrophy fibroblasts altered intermolecular interaction emerin implications gene transcription
0.10063774.15843404.html.plaintext.txt	423	1993 ADD1 novel helix loop helix transcription factor associated adipocyte determination differentiation
0.10063774.15843404.html.plaintext.txt	424	1996 ADD1SREBP1 promotes adipocyte differentiation gene expression linked fatty acid metabolism
0.10063774.15843404.html.plaintext.txt	425	1997 Identification glycerol 3 phosphate acyltransferase adipocyte determination differentiation factor 1 sterol regulatory element binding protein responsive gene
0.10063774.15843404.html.plaintext.txt	426	1998 ADD1SREBP1 activates PPARgamma production endogenous ligand
0.10063774.15843404.html.plaintext.txt	427	1994 SREBP 1 membrane bound transcription factor released sterol regulated proteolysis
0.10063774.15843404.html.plaintext.txt	428	2001 Molecular basis partial lipodystrophy prospects therapy
0.10063774.15843404.html.plaintext.txt	429	2004 Lamin A ZMPSTE24 FACE 1 defects cause nuclear disorganization identify restrictive dermopathy lethal neonatal laminopathy
0.10063774.15843404.html.plaintext.txt	430	2005 Laminopathies involvement structural nuclear proteins pathogenesis increasing number human diseases
0.10063774.15843404.html.plaintext.txt	431	1996 3 Hydroxy 3 methylglutaryl coenzyme A reductase inhibitor impairs cell differentiation cultured adipogenic cells 3T3 L1
0.10063774.15843404.html.plaintext.txt	432	2003 Dominant negative alpha subunit farnesyl geranylgeranyl transferase I inhibits insulin induced differentiation 3T3 L1 pre adipocytes
0.10063774.15843404.html.plaintext.txt	433	1994 The role isoprenylation membrane attachment nuclear lamins
0.10063774.15843404.html.plaintext.txt	434	A single point mutation prevents proteolytic cleavage lamin A precursor confers membrane binding properties
0.10063774.15843404.html.plaintext.txt	435	2000 Comparison potential markers farnesyltransferase inhibition
0.10063774.15843404.html.plaintext.txt	436	2002 Regional differences response human pre adipocytes PPARgamma RXRalpha agonists
0.10063774.15843404.html.plaintext.txt	437	2003 Response treatment rosiglitazone familial partial lipodystrophy due mutation LMNA gene
0.10063774.15843404.html.plaintext.txt	438	2001 Cholesterol depletion disrupts caveolae insulin receptor signaling metabolic control via insulin receptor substrate 1 mitogen activated protein kinase control
0.10063774.15843404.html.plaintext.txt	439	2002 Lamin AC speckles mediate spatial organization splicing factor compartments RNA polymerase II transcription
0.10063774.15843404.html.plaintext.txt	440	1990 Differential inhibitory effects lovastatin protein isoprenylation sterol synthesis
0.11677446.15247220.html.plaintext.txt	0	Identification Distinct N terminal Truncated Forms Prion Protein Different Creutzfeldt Jakob Disease Subtypes Gianluigi Zanusso Alessia Farinazzo Frances Prelli Michele Fiorini Matteo Gelati Sergio Ferrari Pier Giorgio Righetti Nicolograve Rizzuto Blas Frangione Salvatore Monaco
0.11677446.15247220.html.plaintext.txt	1	From Departments Neurological Visual Sciences Section Neurology Agricultural Industrial Biotechnologies University Verona 37134 Verona Italy Department Pathology New York University Medical Center New York New York
0.11677446.15247220.html.plaintext.txt	2	Received publication May 17 2004 revised form July 7 2004
0.11677446.15247220.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES In prion diseases cellular prion protein PrPC converted insoluble protease resistant abnormal isoform termed PrPSc
0.11677446.15247220.html.plaintext.txt	4	In different prion strains PrPSc shows distinct sites endogenous exogenous proteolysis generating core fragment named PrP27 30
0.11677446.15247220.html.plaintext.txt	5	Sporadic Creutzfeldt Jakob disease sCJD frequent human prion disease clinically presents variety neurological signs
0.11677446.15247220.html.plaintext.txt	6	As yet clinical variability observed sCJD fully explained molecular studies relating two major types PrP27 30 unglycosylated peptides 21 type 1 19 kDa type 2 amino acid methionine valine position 129
0.11677446.15247220.html.plaintext.txt	7	Recently smaller C terminal fragments migrating 12 13 kDa detected different sCJD phenotypes significance remains unclear
0.11677446.15247220.html.plaintext.txt	8	By using two dimensional immunoblot anti PrP antibodies identified two novel groups protease resistant PrP fragments sCJD brain tissues
0.11677446.15247220.html.plaintext.txt	9	All sCJD cases type 1 PrP27 30 addition MM subjects type 2 PrP27 30 characterized presence unglycosylated PrP fragments 16 17 kDa
0.11677446.15247220.html.plaintext.txt	10	Conversely brain homogenates patients VV MV type 2 PrP27 30 contained fully glycosylated PrP fragments deglycosylation migrated 17
0.11677446.15247220.html.plaintext.txt	11	Interestingly PrP species 17
0.11677446.15247220.html.plaintext.txt	12	5 18 kDa matched deglycosylated forms C1 PrPC fragment associated tissue PrP deposition plaque like aggregates amyloid plaques
0.11677446.15247220.html.plaintext.txt	13	These data show presence multiple PrPSc conformations sCJD addition shed new light correlation sCJD phenotypes disease associated PrP molecules
0.11677446.15247220.html.plaintext.txt	14	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Transmissible spongiform encephalopathies prion diseases mammalian neurodegenerative diseases leading rapidly progressive neurological dysfunction 1
0.11677446.15247220.html.plaintext.txt	15	They include sheep scrapie bovine spongiform encephalopathies Creutzfeldt Jakob disease humans 1 3
0.11677446.15247220.html.plaintext.txt	16	In disorders host cellular prion protein PrPC1 converted abnormal conformer PrPSc biochemically characterized detergent insolubility relative resistance protease treatment 4
0.11677446.15247220.html.plaintext.txt	17	Whereas PrPC sensitive proteinase K PK digestion PrPSc cleaved within N terminal region generates N terminally truncated species referred PrP 27 30 5
0.11677446.15247220.html.plaintext.txt	18	PrPC PrPSc undergo intracellular proteolytic cleavages generation distinct C terminal fragments
0.11677446.15247220.html.plaintext.txt	19	PrPC cleaved amino acids 110111 90 producing 18 kDa fragment named C1 larger fragment 20 kDa 6 7
0.11677446.15247220.html.plaintext.txt	20	Conversely PrPSc cleaved within N flexible region formation fragment referred C2 sharing conformation PrP27 30 6 7
0.11677446.15247220.html.plaintext.txt	21	Recently C terminal PrP fragments 11 12 kDa 12 13 kDa identified iatrogenic 8 sporadic Creutzfeldt Jakob disease sCJD 8 9
0.11677446.15247220.html.plaintext.txt	22	Neuropathological hallmarks transmissible spongiform encephalopathies include spongiosis neuronal loss gliosis accompanied PrPSc deposition synaptic locations rims vacuoles large extracellular amyloid plaques plaque like aggregates 10
0.11677446.15247220.html.plaintext.txt	23	Different patterns PrP deposition intracerebral regional distribution lesions explained existence prion strains identifiable biological properties distinctive physicochemical features PrPSc 1
0.11677446.15247220.html.plaintext.txt	24	sCJD annual incidence 1 1
0.11677446.15247220.html.plaintext.txt	25	5 per million worldwide still unknown etiology prevailing hypotheses suggest disorder triggered pathogenic somatic mutations prion protein gene PRNP random spontaneous changes PrPC conformation 11
0.11677446.15247220.html.plaintext.txt	26	However concern sCJD cases could secondary environmental exposure case case transmission unnoticed food chain contamination suggested occurrence atypical phenotypes spatiotemporal disease clusters 12 increased incidence disorder recently observed Switzerland 13
0.11677446.15247220.html.plaintext.txt	27	Because variability clinical presentation signs evolution neuropathological changes disorder double eponym Creutzfeldt Jakob properly called syndrome rather disease
0.11677446.15247220.html.plaintext.txt	28	Different sCJD phenotypes largely correlate PRNP codon 129 genotype site methionine valine polymorphism distinct PrPSc types 14 currently classified according molecular mass PrP27 30 core fragment turn reflect tertiary structure PrPSc
0.11677446.15247220.html.plaintext.txt	29	However controversial results obtained different authors proposed classification sCJD PrP27 30 two 14 four types 15
0.11677446.15247220.html.plaintext.txt	30	Two main limitations studies use relatively crude technique protein separation SDS PAGE ii detection PrP species antibody recognizing N terminal 109 112 epitope precludes recognition PrP molecules lacking region
0.11677446.15247220.html.plaintext.txt	31	Here studied 32 subjects definite sCJD genotypes PRNP codon 129 different PrPSc types characterize C terminal PrPSc fragments distinct disease phenotypes host genotypes
0.11677446.15247220.html.plaintext.txt	32	Brain homogenates resolved SDS PAGE two dimensional electrophoresis immunoblotted anti PrP antibodies recognizing epitopes located N terminal C terminal regions
0.11677446.15247220.html.plaintext.txt	33	Here report detection novel truncated PrPSc species association distinct PrP27 30 types
0.11677446.15247220.html.plaintext.txt	34	In addition provide evidence sCJD phenotypes PrP amyloid plaques plaque like deposits associated pathological PrP species matching called C1 PrPC fragment
0.11677446.15247220.html.plaintext.txt	35	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Patients Tissue Samples Thirty two cases definite sCJD diagnosed according current criteria investigated present study
0.11677446.15247220.html.plaintext.txt	36	Clinical epidemiological molecular pathological data reported Table I postmortem intervals ranged 4 30 h
0.11677446.15247220.html.plaintext.txt	37	Fresh brain tissues obtained autopsy stored frozen 80 degrees C use
0.11677446.15247220.html.plaintext.txt	38	Genomic DNA extracted frozen brain tissues searched PRNP mutations polymorphic MetVal codon 129
0.11677446.15247220.html.plaintext.txt	39	Neuropathological immunohistochemical studies performed described previously 16
0.11677446.15247220.html.plaintext.txt	40	View table TABLE I Demographic molecular phenotypic features SCJD cases
0.11677446.15247220.html.plaintext.txt	41	Immunoblot Analysis Tissue samples different brain regions including frontal occipital cortices thalamus basal ganglia cerebellum dissolved 9 volumes lysis buffer 100 mM NaCl 10 mM EDTA 05 Nonidet P 40 0
0.11677446.15247220.html.plaintext.txt	42	5 sodium deoxycholate 10 mM Tris pH 5 7
0.11677446.15247220.html.plaintext.txt	43	4 8 clarified centrifugation 1000 x g 10 min
0.11677446.15247220.html.plaintext.txt	44	The supernatant stored 80 degrees C whereas pellet discarded
0.11677446.15247220.html.plaintext.txt	45	Detergent insoluble fractions obtained 2 cycles centrifugation 100000 x g 90 min reported previously 17
0.11677446.15247220.html.plaintext.txt	46	Protease resistance assayed incubating sample aliquots containing 40 microg total protein 100 microgml PK Roche Applied Science 1 h 37 degrees C
0.11677446.15247220.html.plaintext.txt	47	The digestion blocked addition phenylmethylsulfonyl fluoride 3 mM
0.11677446.15247220.html.plaintext.txt	48	The samples deglycosylated N glycosidase F PNGase F according manufacturers instructions Roche Applied Science
0.11677446.15247220.html.plaintext.txt	49	Proteins dissolved sample buffer 3 SDS 3 mercaptoethanol 2 mM EDTA 10 glycerol 62
0.11677446.15247220.html.plaintext.txt	50	4 mg wet tissue loaded onto 12 SDS PAGE gels transferred onto polyvinylidene difluoride membrane Immobilon P Millipore 2 h 60 V
0.11677446.15247220.html.plaintext.txt	51	The membranes blocked 1 nonfat dry milk TBST 10 mM Tris 150 mM NaCl 0
0.11677446.15247220.html.plaintext.txt	52	5 1 h 37 degrees C incubated overnight 4 degrees C appropriate antibodies
0.11677446.15247220.html.plaintext.txt	53	Blots developed enhanced chemiluminescence system ECL Amersham Biosciences PrP visualized autoradiography film Hyperfilm Amersham Biosciences
0.11677446.15247220.html.plaintext.txt	54	The following anti PrP monoclonal antibodies used 3F4 recognizing human PrP residues 109 112 130000 6H4 binding epitope amino acids 144 152 Prionics 15000 SP 214 directed 214 231 sequence human PrP 11000 7
0.11677446.15247220.html.plaintext.txt	55	Two dimensional Gel Electrophoresis For isoelectric focusing using immobilized pH gradients first dimension 8 cm long precast gels linear pH range 3 10 used
0.11677446.15247220.html.plaintext.txt	56	Before isoelectric focusing dry gels swollen 16 h 125 microl buffer 8 M urea 5 mercaptoethanol 2 Nonidet P 40 2 ampholyte containing 10 microl sample equivalent 1 mg wet tissue
0.11677446.15247220.html.plaintext.txt	57	Isoelectric focusing carried 20 degrees C 30 min 500 V 30 min 1000 V 1 h 4000 V cooled horizontal electrophoresis unit IPGphor Amersham Biosciences
0.11677446.15247220.html.plaintext.txt	58	For second dimension immobilized pH gradient strips equilibrated 15 min 50 mmolliter Tris HCl 6 molliter urea 10 glycerol 2 SDS trace bromphenol blue loaded 12 SDS PAGE described previously 17
0.11677446.15247220.html.plaintext.txt	59	Immunoblotting performed described
0.11677446.15247220.html.plaintext.txt	60	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Immunoblot Typing PrP27 30 Brain homogenates subjects either homozygous heterozygous PRNP codon 129 showed two distinct patterns PrPSc electrophoretic migration following treatment proteinase K immunoblot 3F4
0.11677446.15247220.html.plaintext.txt	61	In 18 sCJD cases 15 MM 1 MV 2 VV three major bands corresponding di mono unglycosylated PrPSc species migrated 30 25 21 kDa Fig
0.11677446.15247220.html.plaintext.txt	62	1A lane 1 whereas 14 cases 3 MM 5 MV 6 VV bands detected 28 23 19 kDa zones Fig
0.11677446.15247220.html.plaintext.txt	63	In group following deglycosylation three forms hereafter referred PrPSc triplet reduced size unglycosylated fragment corresponding 21 19 kDa Fig
0.11677446.15247220.html.plaintext.txt	64	These PrPSc species correspond type 1 type 2 PrPSc according nomenclature used others 14
0.11677446.15247220.html.plaintext.txt	65	View larger version 17K FIG
0.11677446.15247220.html.plaintext.txt	66	Western immunoblot PrP27 30 truncated PrP fragments sCJD brains
0.11677446.15247220.html.plaintext.txt	67	Immunoblot analysis PrP27 30 frontal cortex homogenates sCJD subjects type 1 A C odd lanes type 2 PrPSc A C even lanes either untreated treated PNGase
0.11677446.15247220.html.plaintext.txt	68	PK resistant PrP forms detected immunoblots anti PrP antibodies 3F4 A 6H4 B SP 214 C
0.11677446.15247220.html.plaintext.txt	69	The 6H4 antibody recognizes 16 17 kDa unglycosylated C terminal PrP fragment association type 1 PrP27 30 B lane 1 18 kDa form PNGase treated samples sCJD type 2 PrP27 30 B lane 3
0.11677446.15247220.html.plaintext.txt	70	Lower truncated molecular mass PrP forms detected immunoblot SP 214 mostly association type 1 PrP27 30 C
0.11677446.15247220.html.plaintext.txt	71	Immunoblot 6H4 frontal cortex homogenate MM subject pH sensitive PrPSc shows different patterns type 1 PrP27 30 migration serial PK digestion lysis buffer pH 5 D lane 1 pH 8 D lane 2 respectively
0.11677446.15247220.html.plaintext.txt	72	Molecular mass shown kDa
0.11677446.15247220.html.plaintext.txt	73	Immunoblot C terminal PrP Fragments In addition PrPSc triplet observed 3F4 immunoblot 6H4 showed PK resistant PrPSc band migrating 16 17 kDa subjects type 1 PrPSc Fig
0.11677446.15247220.html.plaintext.txt	74	1B lanes 1 3 band similar electrophoretic mobility barely detectable also MM cases type 2 PrPSc MM2 data shown
0.11677446.15247220.html.plaintext.txt	75	The 16 17 kDa C terminal fragment found untreated brain homogenates partially recovered detergent insoluble fraction
0.11677446.15247220.html.plaintext.txt	76	These biochemical features combined absence fragment normal brains suggest truncated form mainly generated aberrant endogenous PrPSc cleavage
0.11677446.15247220.html.plaintext.txt	77	In marked contrast following PK digestion immunoblot 6H4 sCJD brains subjects MV VV codon 129 type 2 PrPSc contained PrPSc triplet Fig
0.11677446.15247220.html.plaintext.txt	78	1B lane 2 16 17 kDa fragment found cases type 1 PrPSc MM2 cases
0.11677446.15247220.html.plaintext.txt	79	However PNGase treatment PK digested samples MV2 VV2 cases showed additional band migrating 18 kDa Fig
0.11677446.15247220.html.plaintext.txt	80	Finally immunoblot SP 214 brain homogenates different sCJD subtypes showed addition PrPSc triplet several PK resistant PrPSc bands lowest molecular mass fragments detected 12 kDa
0.11677446.15247220.html.plaintext.txt	81	The pattern PK resistant PrP species obtained cases type 1 PrPSc disclosed indistinct banding range 12 17 kDa either prior Fig
0.11677446.15247220.html.plaintext.txt	82	1C lane 1 deglycosylation Fig
0.11677446.15247220.html.plaintext.txt	83	1C lane 3 whereas MV2 VV2 subjects Fig
0.11677446.15247220.html.plaintext.txt	84	1C lane 2 fewer truncated fragments seen migrating 18 12 kDa zones PNGase PK treatment Fig
0.11677446.15247220.html.plaintext.txt	85	Effect pH PrP27 30 Truncated PrP Fragments In previous study observed one type PrPSc detected classical form sCJD changes conformation exposure acidic basic pH values 18
0.11677446.15247220.html.plaintext.txt	86	This property likely dependent presence octapeptide repeats PrPSc molecule enabled us distinguish two PrPSc types share identical electrophoretic mobility solubilization lysis buffer pH 7
0.11677446.15247220.html.plaintext.txt	87	Following immunoblot 3F4 PK resistant fragment 21 kDa detected 9 MM subjects 1 VV case migrated slower pH 5 compared migration observed samples solubilized pH 8 Table I
0.11677446.15247220.html.plaintext.txt	88	In contrast PrPSc migration consistently modified 6 MM 1 MV 1 VV cases type 1 PrP27 30 cases type 2 PrP27 30
0.11677446.15247220.html.plaintext.txt	89	To clarify influence octapeptide region determining sensitivity pH brain homogenates single case group sensitive pH exposed consecutive PK digestions first acidic subsequently basic pH
0.11677446.15247220.html.plaintext.txt	90	As expected immunoblots 6H4 showed acidic pH main fragment migrated 22
0.11677446.15247220.html.plaintext.txt	91	5 kDa following digestion pH 8 detected 20 kDa zone effect additional cleavage
0.11677446.15247220.html.plaintext.txt	92	Immunoblots SP 214 recognizing 214 231 C terminal sequence human PrP showed similar results data shown thus suggesting 22
0.11677446.15247220.html.plaintext.txt	93	5 20 kDa bands differ N terminus C terminus
0.11677446.15247220.html.plaintext.txt	94	Conversely electrophoretic migration C terminal fragment 16 17 kDa unaffected serial acidic basic digestion procedures Fig
0.11677446.15247220.html.plaintext.txt	95	1D lanes 1 2 confirming role octapeptide region conferring PrPSc susceptibility conformational changes
0.11677446.15247220.html.plaintext.txt	96	Two dimensional mapping PrP isoforms control sCJD brains Recently provided detailed two dimensional mapping PrPC glycoforms using 3F4 antibody recognizing linear epitope expressed full length PrPC C2 fragment 17
0.11677446.15247220.html.plaintext.txt	97	When analyzing PrPC two dimensions customary di mono unglycosylated bands protein obtained SDS PAGE separated several spots according two independent features isoelectric point reflects net charge mobility determined molecular mass
0.11677446.15247220.html.plaintext.txt	98	In addition two dimensional separation spot assigned glycosylated unglycosylated species based shape configuration tail smear
0.11677446.15247220.html.plaintext.txt	99	Although 6H4 antibody unable detect PrPC molecules two dimensional separation control brain homogenates SP 214 monoclonal antibody revealed several glycosylated unglycosylated PrP forms faster migrating species detected 18 kDa corresponding unglycosylated C1 isoforms Fig
0.11677446.15247220.html.plaintext.txt	100	Negative results obtained 6H4 suggest antibody recognizes conformational rather linear PrP epitope epitope lost solubilization PrP high molar urea
0.11677446.15247220.html.plaintext.txt	101	After PNGase treatment truncated PrPC glycoforms reduced several spots migrating 20 18 kDa zones Fig
0.11677446.15247220.html.plaintext.txt	102	2B corresponding PrP fragments referred C2 C1 respectively
0.11677446.15247220.html.plaintext.txt	103	Differing controls single homogenate cortical areas subcortical nuclei cerebellum sCJD brains showed increased amounts C2 migrating 21 kDa cases type 1 PrPSc 19 kDa type 2 PrPSc presence additional acidic PrP glycoforms low molecular mass unglycosylated species
0.11677446.15247220.html.plaintext.txt	104	The composition electrophoretic migration relative abundance PrP species different among distinct sCJD subtypes
0.11677446.15247220.html.plaintext.txt	105	In particular sCJD cases codon 129 genotypes type 1 PrPSc characterized increased expression unglycosylated PrP forms 12 17 kDa zone opposed low abundance species MM2 subjects prominence low molecular mass acidic PrP glycoforms MV2 VV2 subtypes Fig
0.11677446.15247220.html.plaintext.txt	106	Interestingly truncated PrP species observed different sCJD subtypes partially recovered detergent insoluble fraction different brain areas Fig
0.11677446.15247220.html.plaintext.txt	107	View larger version 48K FIG
0.11677446.15247220.html.plaintext.txt	108	Two dimensional mapping PrP species normal sCJD brains
0.11677446.15247220.html.plaintext.txt	109	Total brain homogenates resolved two dimensional electrophoresis immunoblotted SP 214 antibody
0.11677446.15247220.html.plaintext.txt	110	In normal human brain glycosylated forms full length PrPC resolved several charge isomers 35 28 30 kDa zones pI range 5 8
0.11677446.15247220.html.plaintext.txt	111	The unglycosylated full length PrPC C2 fragment position indicated arrows observed overexposed immunoblots
0.11677446.15247220.html.plaintext.txt	112	Acidic glycoforms 26 27 20 22 kDa represent glycosylated species C2 C1 fragments A
0.11677446.15247220.html.plaintext.txt	113	PNGase treatment reduces truncated PrPC glycoforms two zones 20 18 kDa within pH values 6
0.11677446.15247220.html.plaintext.txt	114	Frontal cortex homogenate MV2 sCJD case show presence 12 14 kDa molecular mass species PrP arrowhead addition low molecular mass acidic glycoforms increased amount C2 fragment C arrow
0.11677446.15247220.html.plaintext.txt	115	Molecular mass markers indicated right pI gradient bottom
0.11677446.15247220.html.plaintext.txt	116	View larger version 45K FIG
0.11677446.15247220.html.plaintext.txt	117	Detergent insoluble PrP truncated fragments sCJD brains
0.11677446.15247220.html.plaintext.txt	118	PrPSc sedimented high speed centrifugation described previously 18 immunoblotted 2 dimensional electrophoresis SP 214 monoclonal antibody
0.11677446.15247220.html.plaintext.txt	119	Occipital cortex homogenates MM1 A MM2 B VV2 C sCJD subjects representative molecular groups indicated left shown
0.11677446.15247220.html.plaintext.txt	120	In A tissues sCJD subject type 1 PrP27 30 show presence 12 14 16 17 kDa unglycosylated species also barely detected also MM2 subjects B
0.11677446.15247220.html.plaintext.txt	121	In C unglycosylated 12 14 kDa spots seen
0.11677446.15247220.html.plaintext.txt	122	Molecular mass markers shown right pI values indicated bottom
0.11677446.15247220.html.plaintext.txt	123	Two dimensional Mapping PK resistant PrP Fragments Different sCJD Subtypes A sextet molecular sCJD subtypes previously recognized based combination two PrP27 30 types three possible PRNP codon 129 genotypes 14
0.11677446.15247220.html.plaintext.txt	124	More recent phenotypic classifications propose six variants consider MM1 MV1 cases single subtype whereas MM2 subjects classified two forms cortical MM2C thalamic MM2T named sporadic fatal insomnia 20
0.11677446.15247220.html.plaintext.txt	125	With exception sporadic fatal insomnia cases available present study molecular phenotypic sCJD subtypes investigated
0.11677446.15247220.html.plaintext.txt	126	PK treated brain homogenates subjects type 1 PrP27 30 genotypes showed addition 30 25 21 kDa glycoforms containing 3F4 epitope Fig
0.11677446.15247220.html.plaintext.txt	127	4 A C E acidic SP 214 positive glycoforms 21 25 kDa showed several spots migrating 16 17 12 14 kDa zones pI 4 5 Fig
0.11677446.15247220.html.plaintext.txt	128	Some variability observed among individual cases relative intensity representation spots migration configuration highly comparable cases
0.11677446.15247220.html.plaintext.txt	129	Additionally slight quantitative qualitative differences seen different brain regions case
0.11677446.15247220.html.plaintext.txt	130	After deglycosylation PK treatment major glycoforms 21 30 kDa reduced 21 kDa pI 6
0.11677446.15247220.html.plaintext.txt	131	2 whereas lower molecular mass species detected 16 17 12 14 kDa zones pI 4
0.11677446.15247220.html.plaintext.txt	132	View larger version 53K FIG
0.11677446.15247220.html.plaintext.txt	133	Two dimensional mapping sCJD brain homogenates PK treatment deglycosylation
0.11677446.15247220.html.plaintext.txt	134	PK resistant PrP products brain homogenates representative sCJD subjects resolved two dimensional gel electrophoresis immunoblotted 3F4 antibody A C E G I SP 214 monoclonal antibody B D F H L PNGase treatment B D F H L
0.11677446.15247220.html.plaintext.txt	135	As shown previously 17 immunoblot 3F4 PK digested frontal cortex homogenates sCJD subjects show presence differently glycosylated PrP charge isomers unglycosylated PrP27 30 species migrating 21 A C E 19 kDa G I different disease phenotypes
0.11677446.15247220.html.plaintext.txt	136	Immunoblot SP 214 PK resistant PrP molecules shows additional unglycosylated PrP spots migrating 16 17 12 14 kDa sCJD subjects type 1 PrP27 30 B D F barely detectable spots identical migration pattern associated type 1 PrP27 30 also seen MM2 subjects H
0.11677446.15247220.html.plaintext.txt	137	Conversely small amounts 12 14 kDa fragments 16 17 kDa spots identified MV2 VV2 sCJD cases L
0.11677446.15247220.html.plaintext.txt	138	In sCJD brains type 1 PrP27 30 PNGase treatment PK digested frontal cortex homogenates showed similar two dimensional pattern PrP species resolved 21 16 17 12 14 kDa zones B D F
0.11677446.15247220.html.plaintext.txt	139	Again similar qualitative pattern truncated PrP species presence small amounts 16 17 12 14 kDa spots seen MM2 cases H
0.11677446.15247220.html.plaintext.txt	140	On contrary two dimensional maps PNGase treated PK digested frontal cortex homogenates MV2 VV2 subjects disclose several spots 18 kDa L
0.11677446.15247220.html.plaintext.txt	141	In MM2C group 3F4 antibody showed differently glycosylated forms PrP27 30 Fig
0.11677446.15247220.html.plaintext.txt	142	4G barely detectable faster migrating PrP forms stained SP 214 antibody sampled brain areas Fig
0.11677446.15247220.html.plaintext.txt	143	After deglycosylation 19 kDa PrPSc core fragment associated low amounts PrP forms showing migration pattern similar found subjects type 1 PrP27 30 Fig
0.11677446.15247220.html.plaintext.txt	144	Finally MV2 VV2 groups major 3F4 positive glycoforms 29 25 19 kDa Fig
0.11677446.15247220.html.plaintext.txt	145	4I associated small amounts 12 14 kDa species recognized SP 214 antibody Fig
0.11677446.15247220.html.plaintext.txt	146	However glycan removal set spots migrating 17
0.11677446.15247220.html.plaintext.txt	147	5 18 kDa detected cortical subcortical brain regions Fig
0.11677446.15247220.html.plaintext.txt	148	Based pI values apparent molecular masses spots matched corresponding C1 PrPC peptides observed deglycosylation normal brain homogenates see Fig
0.11677446.15247220.html.plaintext.txt	149	These results indicate MV2 VV2 cases glycosylated C1 isoforms acquire PK resistance although possibility C1 sized fragments generated upon protease treatment cannot ruled
0.11677446.15247220.html.plaintext.txt	150	On contrary unglycosylated isoforms C1 detected normal pathological brain homogenates see Fig
0.11677446.15247220.html.plaintext.txt	151	2 A C lack detergent insolubility see Fig
0.11677446.15247220.html.plaintext.txt	152	3C PK resistance see Fig
0.11677446.15247220.html.plaintext.txt	153	5 depicts different patterns truncated PrP fragments found association distinct molecular sCJD subtypes
0.11677446.15247220.html.plaintext.txt	154	View larger version 11K FIG
0.11677446.15247220.html.plaintext.txt	155	Schematic diagram PK resistant C terminal PrP core fragments sCJD subtypes
0.11677446.15247220.html.plaintext.txt	156	The 16 17 kDa forms seen sCJD type 1 PrP27 30 A MM2 cases B represented red whereas 12 14 kDa species depicted blue
0.11677446.15247220.html.plaintext.txt	157	In MV2 VV2 groups C1 PrPSc spots shown orange C
0.11677446.15247220.html.plaintext.txt	158	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES The present findings show novel truncated PrP fragments detected distinct molecular sCJD subtypes ii combination PrP27 30 truncated PrP species identify three biochemical patterns disease associated prion protein iii MV2 VV2 subtypes sCJD glycosylated molecules C1 fragment acquire biochemical hallmarks PrPSc
0.11677446.15247220.html.plaintext.txt	159	Using sensitive protein separation techniques Western blot antibodies recognizing C terminal globular domain prion protein identified new protease resistant PrP species brain homogenates sCJD subjects
0.11677446.15247220.html.plaintext.txt	160	These new fragments detected mass interval 16 18 kDa showed two distinct highly reproducible electrophoretic patterns segregating preferentially type 1 type 2 PrP27 30
0.11677446.15247220.html.plaintext.txt	161	The electrophoretic migration newly identified PK resistant PrP products therefore intermediate unglycosylated PrP27 30 fragment currently used classify molecular PrPSc types 12 14 kDa PrP molecules observed sCJD subtypes named CTF 1213 9
0.11677446.15247220.html.plaintext.txt	162	The immunoblot detection low molecular mass PrP fragments untreated whole brain homogenates sCJD subjects indicates fragments generated endogenous proteolytic mechanism
0.11677446.15247220.html.plaintext.txt	163	It also emphasized detergent insolubility molecules lack shift apparent molecular weight PK digestion support view PrP species adopt fully protease resistant conformation vivo
0.11677446.15247220.html.plaintext.txt	164	Taken together present findings point multiple abnormal PrP conformers expressed spreading sCJD strains
0.11677446.15247220.html.plaintext.txt	165	This could result diverse subcellular sites formation alternatively generation PrP conformers full length N terminally truncated PrPC precursors
0.11677446.15247220.html.plaintext.txt	166	Furthermore identification 16 17 12 14 kDa forms subjects genotypes type 1 MM type 2 PrPSc suggests mechanism involved formation forms influenced codon 129 type PrP27 30
0.11677446.15247220.html.plaintext.txt	167	Although three classes PrP fragments characterized present study show biochemical properties pathological PrP remains determined maintain biological properties PrPSc
0.11677446.15247220.html.plaintext.txt	168	A implication identification 16 17 kDa forms related molecular classification PrPSc types encountered sCJD
0.11677446.15247220.html.plaintext.txt	169	The influence several experimental conditions including pH EDTA concentration conformation type 1 PrPSc therefore electrophoretic migration well known 18 19
0.11677446.15247220.html.plaintext.txt	170	On basis propose use conventional Western blot 6H4 antibody able detect accompanying fragment 16 17 kDa cases type 1 PrPSc
0.11677446.15247220.html.plaintext.txt	171	Such standardized molecular classification sCJD would major implications epidemiological studies whereas sophisticated investigations two dimensional mapping PrP sequencing reserved atypical cases
0.11677446.15247220.html.plaintext.txt	172	To date existence distinct strains agent responsible human prion diseases difficult explain biochemical findings two main PrP27 30 conformations microsequencing analyses showing two truncation patterns sporadic inherited acquired diseases 21
0.11677446.15247220.html.plaintext.txt	173	It well known glycans may play role phenotypic determination prion conditions role recently proposed explain differences sporadic fatal insomnia MM2 sCJD two conditions sharing PrP27 30 type PRNP codon 129 22
0.11677446.15247220.html.plaintext.txt	174	However different glycosylation states PrPSc cannot fully account prion diversity
0.11677446.15247220.html.plaintext.txt	175	Recent transmission studies sCJD transgenic mice show three distinct incubation periods different sCJD subtypes 23
0.11677446.15247220.html.plaintext.txt	176	In particular inocula subjects MM1 MV1 incubation times therefore molecular types appear homogeneous group
0.11677446.15247220.html.plaintext.txt	177	MV2 VV2 cases transmitted mice Val position 129 induce disease post inoculum intervals thus suggesting similar biological properties sCJD strains
0.11677446.15247220.html.plaintext.txt	178	On hand MM2 inocula show heterogeneous transmission properties incubation times different groups
0.11677446.15247220.html.plaintext.txt	179	Based biochemical patterns obtained combining PrP27 30 core fragment lower truncated PrP species show three distinct groups disease associated PrP species sCJD type 1 PrPSc MM2 subjects MV2VV2 cases
0.11677446.15247220.html.plaintext.txt	180	Strikingly similar molecular groups PrP species obtained Satoh et al
0.11677446.15247220.html.plaintext.txt	181	8 combining truncated fragments 11 12 kDa type 1 type 2 PrP27 30
0.11677446.15247220.html.plaintext.txt	182	Whether present biochemical findings represent molecular basis different biological properties sCJD strains remains determined
0.11677446.15247220.html.plaintext.txt	183	Despite recognition conformational variants disease associated PrP species experimental naturally occurring prion diseases little known influence different molecules disease phenotype 24
0.11677446.15247220.html.plaintext.txt	184	Although commonly believed PrP27 30 major role modulating sCJD phenotype would interest learn whether different truncated PrPs related specific clinical pathological traits
0.11677446.15247220.html.plaintext.txt	185	Previous studies disclosed internal PrP fragment 7 8 kDa detected patients P102L Gerstmann Straussler Scheinker disease 7 25 C terminal fragment associated familial Creutzfeldt Jakob disease due E200K mutation 26 toxic neurons combination absence PrP expression 27 28
0.11677446.15247220.html.plaintext.txt	186	Here found fully glycosylated PrP fragment closely matching C1 PrPC fragment associated amyloid plaques MV2 cases plaque like PrP deposits VV2 subjects
0.11677446.15247220.html.plaintext.txt	187	On contrary C1 PrPSc observed sCJD subtypes lacking extracellular PrP deposition
0.11677446.15247220.html.plaintext.txt	188	It noteworthy emphasize also determined2 presence C1 PrPSc subjects variant Creutzfeldt Jakob disease condition characterized florid PrP amyloid plaques well newly identified bovine amyloidotic spongiform encephalopathy BASE 3 amyloid free typical bovine spongiform encephalopathy BSE
0.11677446.15247220.html.plaintext.txt	189	Earlier studies shown C1 cell surface glycophosphoinositol anchored protein starting amino acid 110111 human neuroblastoma cells 6 present multiple truncation forms brain tissue 17
0.11677446.15247220.html.plaintext.txt	190	According findings conceivable extracellular release C1 PrPSc could responsible PrP deposition aggregation observed MV2 VV2 sCJD subtypes
0.11677446.15247220.html.plaintext.txt	191	Altogether results show PrP truncated fragments may influence disease phenotype sCJD characterization important molecular definition sCJD subtypes
0.11677446.15247220.html.plaintext.txt	192	FOOTNOTES This work supported grants Italian Ministry Health collaboration contribution Istituto Superiore di Sanita Search infection related endogenous exogenous factors cerebrospinal fluid patients transmissible spongiform encephalopathy Study pathogenic mechanisms neurodegenerative disorders diagnosis development therapeutic approaches
0.11677446.15247220.html.plaintext.txt	193	National Institutes Health Grant AR02584 B
0.11677446.15247220.html.plaintext.txt	194	The costs publication article defrayed part payment page charges
0.11677446.15247220.html.plaintext.txt	195	This article must therefore hereby marked advertisement accordance 18 U
0.11677446.15247220.html.plaintext.txt	196	Section 1734 solely indicate fact
0.11677446.15247220.html.plaintext.txt	197	To correspondence addressed Dept
0.11677446.15247220.html.plaintext.txt	198	Neurological Visual Sciences Section Neurology Policlinico G
0.11677446.15247220.html.plaintext.txt	199	Scuro 10 37134 Verona Italy
0.11677446.15247220.html.plaintext.txt	200	39 045 8074286 Fax 39 045 585933 E mail salvatore
0.11677446.15247220.html.plaintext.txt	201	1 The abbreviations used PrPC cellular prion protein PrPSc scrapie isoform prion protein sCJD sporadic Creutzfeldt Jakob disease MM diglycosylated PrPSc species MV monoglycosylated PrPSc species VV unglycosylated PrPSc species PK proteinase K
0.11677446.15247220.html.plaintext.txt	202	Monaco unpublished observations
0.11677446.15247220.html.plaintext.txt	203	ACKNOWLEDGMENTS We thank Prof
0.11677446.15247220.html.plaintext.txt	204	Marina Bentivoglio critical reading manuscript Dr
0.11677446.15247220.html.plaintext.txt	205	Fabrizio Tagliavini helpful suggestions
0.11677446.15247220.html.plaintext.txt	206	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Prusiner S
0.11677446.15247220.html.plaintext.txt	207	95 13363 13383AbstractFree Full Text Prusiner S
0.11677446.15247220.html.plaintext.txt	208	1997 Science 278 245 251AbstractFree Full Text Casalone C
0.11677446.15247220.html.plaintext.txt	209	101 3065 3070AbstractFree Full Text Prusiner S
0.11677446.15247220.html.plaintext.txt	210	1992 Biochemistry 31 12277 12288Medline Order article via Infotrieve McKinley M
0.11677446.15247220.html.plaintext.txt	211	65 1340 1351Medline Order article via Infotrieve Chen S
0.11677446.15247220.html.plaintext.txt	212	270 19173 19180AbstractFree Full Text Jimenez Huete A
0.11677446.15247220.html.plaintext.txt	213	153 1561 1572AbstractFree Full Text Satoh K
0.11677446.15247220.html.plaintext.txt	214	84 2885 2893AbstractFree Full Text Zou W
0.11677446.15247220.html.plaintext.txt	215	278 40429 40436AbstractFree Full Text DeArmond S
0.11677446.15247220.html.plaintext.txt	216	1999 Neuropathology Prion Diseases Prusiner S
0.11677446.15247220.html.plaintext.txt	217	585 652 Cold Spring Harbor Laboratory Press Cold Spring Harbor NY Prusiner S
0.11677446.15247220.html.plaintext.txt	218	344 1516 1526Free Full Text Collins S
0.11677446.15247220.html.plaintext.txt	219	52 115 118CrossRefMedline Order article via Infotrieve Glatzel M
0.11677446.15247220.html.plaintext.txt	220	2002 Lancet 360 139 141CrossRefMedline Order article via Infotrieve Parchi P
0.11677446.15247220.html.plaintext.txt	221	39 767 778Medline Order article via Infotrieve Hill A
0.11677446.15247220.html.plaintext.txt	222	2003 Brain 126 1333 1346AbstractFree Full Text Zanusso G
0.11677446.15247220.html.plaintext.txt	223	348 711 719AbstractFree Full Text Zanusso G
0.11677446.15247220.html.plaintext.txt	224	2002 Electrophoresis 23 347 3553
0.11677446.15247220.html.plaintext.txt	225	CO2 1 2 WlinktypeDOI CrossRefMedline Order article via Infotrieve Parchi P
0.11677446.15247220.html.plaintext.txt	226	97 10168 10172AbstractFree Full Text Pan T
0.11677446.15247220.html.plaintext.txt	227	276 37284 37288AbstractFree Full Text Korth C
0.11677446.15247220.html.plaintext.txt	228	100 4784 4789AbstractFree Full Text Lawson V
0.11677446.15247220.html.plaintext.txt	229	279 13689 13695AbstractFree Full Text Tagliavini F
0.11677446.15247220.html.plaintext.txt	230	10 513 519Abstract Capellari S
0.11677446.15247220.html.plaintext.txt	231	157 613 622AbstractFree Full Text Forloni G
0.11677446.15247220.html.plaintext.txt	232	1993 Nature 362 543 546CrossRefMedline Order article via Infotrieve Daniels M
0.11677446.15247220.html.plaintext.txt	233	268 6155 6164AbstractFree Full Text
0.25954077.14645931.html.plaintext.txt	0	Transfection prion protein gene suppresses coxsackievirus B3 replication prion protein gene deficient cells Yuko Nakamura1 Akikazu Sakudo1 Keiichi Saeki1 Tomomi Kaneko1 Yoshitsugu Matsumoto1 Antonio Toniolo2 Shigeyoshi Itohara3 Takashi Onodera1
0.25954077.14645931.html.plaintext.txt	1	1 Department Molecular Immunology School Agricultural Life Sciences University Tokyo 1 1 1 Yayoi Bunkyo ku Tokyo 113 8657 Japan 2 Department Clinical Biological Sciences University Insubria Varese Italy 3 Laboratory Behavioural Genetics Brain Science Institute RIKEN Saitama Japan
0.25954077.14645931.html.plaintext.txt	2	Correspondence Takashi Onodera aonoderatmail
0.25954077.14645931.html.plaintext.txt	3	ABSTRACT Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES The susceptibility prion protein gene Prnp null cells coxsackievirus B3 CVB3 investigated
0.25954077.14645931.html.plaintext.txt	4	Primary cultures murine Prnp brain cells sensitive CVBs corresponding cells wild type mice
0.25954077.14645931.html.plaintext.txt	5	The viral susceptibility Prnp null cell line HpL3 4 derived murine hippocampus compared two established cell lines HeLa HEp 2 widely employed CVB3 studies
0.25954077.14645931.html.plaintext.txt	6	After infection CVB3 HpL3 4 cells showed rapid complete cytopathic effect CPE
0.25954077.14645931.html.plaintext.txt	7	CPE developed earlier viruses replicated higher titres HpL3 4 cells compared HeLa HEp 2 cells
0.25954077.14645931.html.plaintext.txt	8	Under semi solid medium plaques developed rapidly CVB3 infected HpL3 4 cells
0.25954077.14645931.html.plaintext.txt	9	To confirm effect Prnp virus infection Prnp cell line Prnp transfected neuronal cell line analysed
0.25954077.14645931.html.plaintext.txt	10	The replication release infectious particles CVB3 Prnp cells significantly effective Prnp transfected cell line
0.25954077.14645931.html.plaintext.txt	11	Levels type I interferon IFN CVB3 infection higher Prnp transfected cell line Prnp cells whereas apoptotic cells obvious Prnp cells Prnp transfected cell line
0.25954077.14645931.html.plaintext.txt	12	These findings suggest absence Prnp retards induction CVB3 induced IFNs resulting enhanced CVB3 production apoptotic cell death
0.25954077.14645931.html.plaintext.txt	13	Furthermore data indicate HpL3 4 cell line may provide novel sensitive system isolation CVB3 clinical specimens
0.25954077.14645931.html.plaintext.txt	14	INTRODUCTION Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES The cellular isoform prion protein PrPC encoded single gene corresponding 250 amino acids highly conserved among vertebrates Prusiner et al
0.25954077.14645931.html.plaintext.txt	15	PrPC expressed neurons glia brain spinal cord well several peripheral tissues leukocytes
0.25954077.14645931.html.plaintext.txt	16	PrPC mRNA first detected brains mice chickens early embryogenesis level increases development Harris et al
0.25954077.14645931.html.plaintext.txt	17	In adult central nervous systems CNS PrPC mRNA widely distributed particularly high concentrations neocortical hippocampal neurons cerebellar Purkinje cells spinal motor neurons DeArmond et al
0.25954077.14645931.html.plaintext.txt	18	Although PrPC localization cell surface may consistent roles adhesion recognition ligand uptake transmembrane signalling function remains defined
0.25954077.14645931.html.plaintext.txt	19	In reports PrP shown interact sulfated glycans Caughey et al
0.25954077.14645931.html.plaintext.txt	20	1994 RNA aptamers Weiss et al
0.25954077.14645931.html.plaintext.txt	21	1997 large nucleic acids Akowitz et al
0.25954077.14645931.html.plaintext.txt	22	1994 Nandi Leclerc 1999 causing formation nucleoprotein complexes similar HIV 1 nucleocapsid RNA complexes formed vitro Darlix et al
0.25954077.14645931.html.plaintext.txt	23	A recent report shows murine leukaemia virus replication accelerates infectious process scrapie Carp et al
0.25954077.14645931.html.plaintext.txt	24	1999 suggesting possible vivo interactions viruses PrP
0.25954077.14645931.html.plaintext.txt	25	These findings prompted us analyse effects PrP expression virus replication CNS cells
0.25954077.14645931.html.plaintext.txt	26	Group B coxsackieviruses CVBs important human pathogens family Picornaviridae
0.25954077.14645931.html.plaintext.txt	27	Most CVB infections asymptomatic different organs may affected e
0.25954077.14645931.html.plaintext.txt	28	Some acute persistent infections especially severe infants Woodruff 1980
0.25954077.14645931.html.plaintext.txt	29	Despite accumulation virological molecular data mechanisms acute chronic tissue damage induced CVBs well understood
0.25954077.14645931.html.plaintext.txt	30	Two observations prompted us investigate replication coxsackievirus B3 CVB3 CNS cells CVBs known affinity newborn tissues may cause encephalomyelitis infants Woodruff 1980 ii PrPC displays RNA binding chaperoning properties may influence virus replication assembly Gabus et al
0.25954077.14645931.html.plaintext.txt	31	Since CVB3 replication occurred rapidly primary cell cultures derived prion protein gene Prnp deficient Prnp mice Prnp animals investigated whether PrPC expression would influence susceptibility CVB3 infection
0.25954077.14645931.html.plaintext.txt	32	Here report established Prnp hippocampal cell line susceptible CVB3 infection two human cell lines HeLa HEp 2 commonly used detection titration agents
0.25954077.14645931.html.plaintext.txt	33	Furthermore role PrPC CVB3 resistance studied following reintroduction Prnp Prnp cell line
0.25954077.14645931.html.plaintext.txt	34	METHODS Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Viruses
0.25954077.14645931.html.plaintext.txt	35	CVB3 Nancy strain obtained ATCC
0.25954077.14645931.html.plaintext.txt	36	Virus stocks prepared cultures HeLa cells ATCC grown Dulbeccos modified Eagles medium DMEM Sigma supplemented 2 mM L glutamine 2 heat inactivated foetal calf serum HI FCS Gibco BRL
0.25954077.14645931.html.plaintext.txt	37	Supernatants collected 3 days post infection p
0.25954077.14645931.html.plaintext.txt	38	centrifuged 1000 g 10 min
0.25954077.14645931.html.plaintext.txt	39	Virus titres determined plaque formation assay HeLa cells
0.25954077.14645931.html.plaintext.txt	40	Virus aliquots stored 80 degrees C use
0.25954077.14645931.html.plaintext.txt	41	Primary cultures prepared brain 3 day old C57BL6 Prnp Prnp mice Kuwahara et al
0.25954077.14645931.html.plaintext.txt	42	Cells isolated triturating tissue pieces Pasteur pipette 10 20 times 1 ml PBS without Ca2 Mg2 Nissui supplemented 1 0 mM sodium pyruvate 10 mM HEPES pH 7 4
0.25954077.14645931.html.plaintext.txt	43	Cell suspensions digested 0 5 trypsin Gibco BRL settling 3 min supernatant centrifuged 1 min 200 g
0.25954077.14645931.html.plaintext.txt	44	Culture dishes coated cold poly L lysine 0 05 mg ml 1 Sigma incubated 1 h room temperature washed sterile water
0.25954077.14645931.html.plaintext.txt	45	Cells seeded coated dishes 2x105 cells cm 2 Neurobasal medium Gibco BRL supplemented L glutamine 0 5 mM glutamate 25 microM B27 supplement Gibco BRL
0.25954077.14645931.html.plaintext.txt	46	Cultures incubated 37 degrees C atmosphere containing 5 CO2
0.25954077.14645931.html.plaintext.txt	47	As reported previously Kuwahara et al
0.25954077.14645931.html.plaintext.txt	48	1999 hippocampus cell line HpL3 4 established Prnp mouse embryonic day 14
0.25954077.14645931.html.plaintext.txt	49	HpL3 4 HeLa HEp 2 cells grown 37 degrees C 5 CO2 DMEM supplemented 2 mM glutamine 10 HI FCS
0.25954077.14645931.html.plaintext.txt	50	Virus infection HpL3 4 HeLa HEp 2 cell lines
0.25954077.14645931.html.plaintext.txt	51	HpL3 4 HeLa HEp 2 cells cultured six well plates infected CVB3 m
0.25954077.14645931.html.plaintext.txt	52	Cultures observed phase contrast microscopy order monitor development cytopathic effect CPE
0.25954077.14645931.html.plaintext.txt	53	Sensitivity HpL3 4 HeLa HEp 2 cells CVB3 induced CPE
0.25954077.14645931.html.plaintext.txt	54	The sensitivity CVB3 induced CPE three different cell lines evaluated measuring virus titre HeLa cell monolayers using microtitre assay 96 well plates
0.25954077.14645931.html.plaintext.txt	55	Duplicated wells infected 50 microl serial 10 fold dilutions virus
0.25954077.14645931.html.plaintext.txt	56	CPE read microscopically day 5 p
0.25954077.14645931.html.plaintext.txt	57	Replication CVB3 HpL3 4 HeLa HEp 2 cells
0.25954077.14645931.html.plaintext.txt	58	Samples supernatant cell cultures collected different times p
0.25954077.14645931.html.plaintext.txt	59	0 3 6 12 24 36 48 72 96 120 144 h stored 80 degrees C
0.25954077.14645931.html.plaintext.txt	60	Intracellular virus released cells cultured 60 mm plates freezing thawing three times 1 ml 2 FCS PBS
0.25954077.14645931.html.plaintext.txt	61	After clarification low speed centrifugation virus containing medium stored 80 degrees C
0.25954077.14645931.html.plaintext.txt	62	Infectious virus measured HeLa cells microtitre assay reported
0.25954077.14645931.html.plaintext.txt	63	Virus titration calculated triplicate representative results four experiments given see Fig
0.25954077.14645931.html.plaintext.txt	64	View larger version 15K Fig
0.25954077.14645931.html.plaintext.txt	65	High susceptibility HpL3 4 cells CVB3 infection
0.25954077.14645931.html.plaintext.txt	66	5 CVB3 highest production infectious virus observed cell lysates HpL3 4 cells dashed line circles
0.25954077.14645931.html.plaintext.txt	67	Release virus supernatant HpL3 4 cell cultures solid line circles also observed
0.25954077.14645931.html.plaintext.txt	68	The virus titres cell lysates HEp 2 cells dashed line diamonds supernatants HEp 2 cells solid line diamonds cell lysates HeLa cells dashed line triangles supernatants HeLa cells solid line triangles also examined
0.25954077.14645931.html.plaintext.txt	69	Plasmid construction gene transfer
0.25954077.14645931.html.plaintext.txt	70	In gene transfer Prnp coding region Prnp cDNA amplified PCR using following primers 5 GCGAATTCCGCCACCATGGCGAACCTTGGCTACTGGCTG 3 5 CACGAATTCCACCTCAATTGAAAGAGCTACAGGTGG 3
0.25954077.14645931.html.plaintext.txt	71	The Kozak consensus sequence boxed BglII linker underlined
0.25954077.14645931.html.plaintext.txt	72	The PCR products cloned pT7Blue vector subcloned multicloning site pIREShyg Clontech
0.25954077.14645931.html.plaintext.txt	73	The resulting constructs pIREShyg PrP pIREShyg transiently transfected HpL3 4 cells lipofection method using Lipofectamine plus Gibco BRL
0.25954077.14645931.html.plaintext.txt	74	These cells selected 10 days complete medium containing 400 microg hygromycin B ml 1 Wako Japan
0.25954077.14645931.html.plaintext.txt	75	The plaque assay performed confluent cell monolayers using six well plates
0.25954077.14645931.html.plaintext.txt	76	HpL3 4 cell monolayers infected CVB3 incubated 1 h 37 degrees C
0.25954077.14645931.html.plaintext.txt	77	After adsorption 1 h 7 degrees C cultures overlaid 3 wv methyl cellulose Sigma Eagles minimal essential medium containing 2 HI FCS
0.25954077.14645931.html.plaintext.txt	78	Cultures incubated 37 degrees C 4 days fixed formalin stained methylene blue
0.25954077.14645931.html.plaintext.txt	79	Cells growing glass coverslips Matsunami Japan fixed 4 paraformaldehyde PBS 30 min room temperature washed three times PBS
0.25954077.14645931.html.plaintext.txt	80	To block non specific binding cells incubated 5 BSA Sigma PBS 1 h
0.25954077.14645931.html.plaintext.txt	81	In order visualize intracellular protein expression permeabilization cells performed blocking solution containing 0 2 saponin
0.25954077.14645931.html.plaintext.txt	82	The samples incubated anti PrP 6H4 antibody Prionics diluted 1 500 anti CVB3 antibody Chemicon diluted 1 500 1 h 37 degrees C 1 BSA PBS washed PBS
0.25954077.14645931.html.plaintext.txt	83	Fluorescein isothiocyanate FITC conjugated anti mouse immunoglobulin antibodies diluted 1 500 incubated cells 1 h 37 degrees C
0.25954077.14645931.html.plaintext.txt	84	After washing PBS indirect immunofluorescence visualized fluorescence microscope
0.25954077.14645931.html.plaintext.txt	85	RT PCR type I interferon IFN
0.25954077.14645931.html.plaintext.txt	86	Total RNA infected cells collected confluent cell culture 60 mm dish using acid guanidinum thiocyanatephenolchloroform method using TRIzol Gibco BRL
0.25954077.14645931.html.plaintext.txt	87	RT PCR type I IFN performed described using primer sets designed amplification IFN 5 CTCAGGAACAAGAGAGCCTT 3 5 GGAAGACAGGGCTCTCCAGA 3 IFN 5 AACAACAGGTGGATCCTCCAC 3 5 GGAAGTTTCTGGTAAGTCTTC 3
0.25954077.14645931.html.plaintext.txt	88	PCR products separated 1 5 agarose gel electrophoresis detected ethidium bromide staining UV transillumination
0.25954077.14645931.html.plaintext.txt	89	Antiviral effect supernatants CVB3 infected cells
0.25954077.14645931.html.plaintext.txt	90	The supernatants infected cells collected 6 h p
0.25954077.14645931.html.plaintext.txt	91	centrifuged 300 g 4 degrees C 10 min
0.25954077.14645931.html.plaintext.txt	92	The IFN containing supernatant medium acidified 4 M HCl 4 degrees C 3 days destroy residual virus neutralized pH 7 0 4 M NaOH
0.25954077.14645931.html.plaintext.txt	93	The HpL3 4 phyg cells incubated samples overnight inoculated CVB3
0.25954077.14645931.html.plaintext.txt	94	The replication CVB3 cell group determined indirect immunofluorescence assay IFA anti CVB3 antibody
0.25954077.14645931.html.plaintext.txt	95	The supernatants cells collected 6 h p
0.25954077.14645931.html.plaintext.txt	96	The acidified neutralized supernatants described assayed antiviral activity protection L929 cells vesicular stomatitis virus VSV induced CPE
0.25954077.14645931.html.plaintext.txt	97	L929 cells six well plates incubated overnight IFN containing supernatants inoculated VSV 37 degrees C 1 h overlaid DMEM containing 3 methyl cellulose 2 HI FCS
0.25954077.14645931.html.plaintext.txt	98	The cultured cells fixed stained methylene blue 4 days later
0.25954077.14645931.html.plaintext.txt	99	Type I IFN concentrations IU ml 1 inferred IFN standard
0.25954077.14645931.html.plaintext.txt	100	The CVB3 infected cells collected 24 h p
0.25954077.14645931.html.plaintext.txt	101	washed PBS centrifugation 200 g 20 min 4 degrees C
0.25954077.14645931.html.plaintext.txt	102	The pellets resuspended 100 microl PBS containing ethidium bromide acridine orange
0.25954077.14645931.html.plaintext.txt	103	These samples observed fluorescent microscopy
0.25954077.14645931.html.plaintext.txt	104	A DNA laddering technique Schatzl et al
0.25954077.14645931.html.plaintext.txt	105	Briefly cells 60 mm dish washed twice PBS lysed 500 microl hypotonic lysis buffer 5 min 5 mM TrisHCl pH 7 5 20 mM EDTA pH 8 0 0 5 Triton X 100
0.25954077.14645931.html.plaintext.txt	106	The lysates centrifuged 10 000 g 30 min
0.25954077.14645931.html.plaintext.txt	107	The supernatants incubated 0 3 mg proteinase K ml 1 60 microg RNase ml 1 30 min 37 degrees C precipitated equal volumes 2 propanol
0.25954077.14645931.html.plaintext.txt	108	After centrifugation 12 000 g 30 min 4 degrees C pellets washed 70 ethanol resuspended TrisEDTA buffer 10 mM TrisHCl pH 7 4 1 mM EDTA pH 8 0 subjected electrophoresis 1 5 agarose gel stained ethidium bromide
0.25954077.14645931.html.plaintext.txt	109	RESULTS Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES CVB infection primary cultures brain cells Primary cultures brains wild type Prnp mice consistently allowed replication CVB3
0.25954077.14645931.html.plaintext.txt	110	An earlier stronger development CPE observed cultures Prnp mice Fig
0.25954077.14645931.html.plaintext.txt	111	1b cultures derived wild type mice Fig
0.25954077.14645931.html.plaintext.txt	112	These observations suggested primary cultures Prnp mice may particularly sensitive CVB infection
0.25954077.14645931.html.plaintext.txt	113	By RT PCR shown primary cultures brains Prnp Prnp mice HpL3 4 HpL3 4 TRPrP cells expressed high levels murine coxsackie adenovirus receptor MCAR transcripts data shown
0.25954077.14645931.html.plaintext.txt	114	View larger version 169K Fig
0.25954077.14645931.html.plaintext.txt	115	Cytopathic effects induced CVB3 infection
0.25954077.14645931.html.plaintext.txt	116	Primary cultures brain cells wild type C57BL6 mice Prnp mice grown DMEM
0.25954077.14645931.html.plaintext.txt	117	After infection CVB3 m
0.25954077.14645931.html.plaintext.txt	118	5 development CPE observed light microscopy
0.25954077.14645931.html.plaintext.txt	119	Two days infection CVB3 cells Prnp mice b showed complete development CPE compared cells wild type mice
0.25954077.14645931.html.plaintext.txt	120	The development CPE detected earlier HpL3 4 cells two cell lines HeLa HEp 2 cells
0.25954077.14645931.html.plaintext.txt	121	CPE HpL3 4 cells vigorous c compared induced HeLa d HEp 2 cells e
0.25954077.14645931.html.plaintext.txt	122	CVB infection HpL3 4 cells caused typical plaque formation representative picture CVB3 induced plaques shown panel f
0.25954077.14645931.html.plaintext.txt	123	CVB replication HpL3 4 HeLa HEp 2 cells To compare sensitivity HpL3 4 HeLa HEp 2 cells CVB3 kinetics virus replication evaluated cell line
0.25954077.14645931.html.plaintext.txt	124	Cultures inoculated virus examined phase contrast microscopy different times p
0.25954077.14645931.html.plaintext.txt	125	Although CPE induced cell lines 48 h p
0.25954077.14645931.html.plaintext.txt	126	CPE HpL3 4 cells 80 Fig
0.25954077.14645931.html.plaintext.txt	127	1c 20 HeLa HEp 2 cells Fig
0.25954077.14645931.html.plaintext.txt	128	Titration extracellular intracellular virus different times p
0.25954077.14645931.html.plaintext.txt	129	used compare sensitivity different cell lines CVB3
0.25954077.14645931.html.plaintext.txt	130	Extracellular intracellular virus titres higher HpL3 4 cells HeLa HEp 2 cell lines Fig
0.25954077.14645931.html.plaintext.txt	131	Thus addition rapid development CPE HpL3 4 cell line characterized ability produce virus titres higher produced HeLa HEp 2 cells
0.25954077.14645931.html.plaintext.txt	132	Plaque formation HpL3 4 cell monolayers induced CVB3 infection Four days CVB3 infection monolayers HpL3 4 cells produced clear viral plaques 2 4 mm diameter semi solid medium Fig
0.25954077.14645931.html.plaintext.txt	133	Plaque formation HpL3 4 cells may thus represent sensitive assay CVB3 titration
0.25954077.14645931.html.plaintext.txt	134	Reduced CVB3 replication presence PrP To confirm observation Prnp cells showed vigorous CPE following infection CVB3 HpL3 4 TRPrP HpL3 4 cells transfected pIREShyg PrP HpL3 4 phyg HpL3 4 cells transfected pIREShyg cell lines established
0.25954077.14645931.html.plaintext.txt	135	Successful expression PrPC HpL3 4 TRPrP cells confirmed IFA anti PrP antibody 6H4 data shown
0.25954077.14645931.html.plaintext.txt	136	Immunofluorescence showed expression PrPC membrane surface HpL3 4 TRPrP HpL3 4 phyg cells
0.25954077.14645931.html.plaintext.txt	137	CVB3 induced CPE rapidly markedly HpL3 4 phyg cells compared HpL3 4 TRPrP cells Fig
0.25954077.14645931.html.plaintext.txt	138	View larger version 140K Fig
0.25954077.14645931.html.plaintext.txt	139	CPE HpL3 4 TRPrP HpL3 4 phyg
0.25954077.14645931.html.plaintext.txt	140	HpL3 4 TRPrP HpL3 4 phyg cells grown 60 mm dishes inoculated CVB3 m
0.25954077.14645931.html.plaintext.txt	141	HpL3 4 phyg cells showed marked CPE b whereas significant CPE appeared HpL3 4 TRPrP cells
0.25954077.14645931.html.plaintext.txt	142	To determine causes differences CPE HpL3 4 TRPrP HpL3 4 phyg cells two analyses performed
0.25954077.14645931.html.plaintext.txt	143	First IFAs CVB3 replication carried compare efficiency CVB3 replication
0.25954077.14645931.html.plaintext.txt	144	An IFA anti CVB3 antibody performed detect intracellular virus replication well titration supernatants reflecting release infectious particles CVB3
0.25954077.14645931.html.plaintext.txt	145	The reduction CVB3 replication HpL3 4 TRPrP cells apparent results IFA Fig
0.25954077.14645931.html.plaintext.txt	146	rounded cells seen equally CVB3 infected HpL3 4 TRPrP HpL3 4 phyg cells shown Fig
0.25954077.14645931.html.plaintext.txt	147	However fields observed immunofluorescence HpL3 4 phyg cells showed positive cells specific fluorescence Fig
0.25954077.14645931.html.plaintext.txt	148	4a HpL3 4 TRPrP cells Fig
0.25954077.14645931.html.plaintext.txt	149	The higher level infectious virus supernatant HpL3 4 phyg cells shown Fig
0.25954077.14645931.html.plaintext.txt	150	View larger version 145K Fig
0.25954077.14645931.html.plaintext.txt	151	Immunofluorescence CVB3 infected HpL3 4 TRPrP HpL3 4 phyg cells
0.25954077.14645931.html.plaintext.txt	152	1 HpL3 4 TRPrP HpL3 4 phyg cells grown coverslips fixed permeabilized
0.25954077.14645931.html.plaintext.txt	153	CVB3 detected anti CVB3 antibody HpL3 4 phyg HpL3 4 TRPrP b cells
0.25954077.14645931.html.plaintext.txt	154	Strong fluorescence observed cytoplasm HpL3 4 phyg cells
0.25954077.14645931.html.plaintext.txt	155	The corresponding phase contrast images cell line shown c d respectively
0.25954077.14645931.html.plaintext.txt	156	View larger version 7K Fig
0.25954077.14645931.html.plaintext.txt	157	CVB3 virus production HpL3 4 TRPrP HpL3 4 phyg cells
0.25954077.14645931.html.plaintext.txt	158	HpL3 4 TRPrP HpL3 4 phyg cells infected CVB3 m
0.25954077.14645931.html.plaintext.txt	159	The supernatants infected HpL3 4 TRPrP black bars HpL3 4 phyg white bars cells collected 12 24 h p
0.25954077.14645931.html.plaintext.txt	160	Virus titres examined TCID50 assay HeLa cells
0.25954077.14645931.html.plaintext.txt	161	At point virus titres HpL3 4 phyg cells higher HpL3 4 TRPrP cells
0.25954077.14645931.html.plaintext.txt	162	Antiviral activity supernatant HpL3 4 TRPrP HpL3 4 phyg cells infected CVB3 To determine mechanism antiviral effects HpL3 4 TRPrP levels type I IFN determined
0.25954077.14645931.html.plaintext.txt	163	At early stage infection CVB3 m
0.25954077.14645931.html.plaintext.txt	164	1 strong signals expression IFN genes observed Fig
0.25954077.14645931.html.plaintext.txt	165	The IFN activity supernatants cell lines calculated microassay Fig
0.25954077.14645931.html.plaintext.txt	166	6b described Methods
0.25954077.14645931.html.plaintext.txt	167	A higher activity detected supernatants HpL3 4 TRPrP cells compared HpL3 4 phyg cells
0.25954077.14645931.html.plaintext.txt	168	The constitutive production IFN non infected cells also studied although levels IFN low
0.25954077.14645931.html.plaintext.txt	169	View larger version 29K Fig
0.25954077.14645931.html.plaintext.txt	170	Expression activity IFN presence absence PrP
0.25954077.14645931.html.plaintext.txt	171	Total RNA samples obtained HpL3 4 TRPrP HpL3 4 phyg cells CVB3 infection m
0.25954077.14645931.html.plaintext.txt	172	PCR products amplified IFN IFN GAPDH specific primers separated 1 5 agarose gel electrophoresis
0.25954077.14645931.html.plaintext.txt	173	No product detected reverse transcriptase omitted
0.25954077.14645931.html.plaintext.txt	174	Lanes 1 4 HpL3 4 TRPrP cells lanes 5 8 HpL3 4 phyg cells
0.25954077.14645931.html.plaintext.txt	175	Lanes 1 5 uninfected cells 0 h lanes 2 6 infected cells 3 h p
0.25954077.14645931.html.plaintext.txt	176	b IFN activity supernatant
0.25954077.14645931.html.plaintext.txt	177	To determine activity IFN samples HpL3 4 TRPrP HpL3 4 phyg cells microassays performed
0.25954077.14645931.html.plaintext.txt	178	The activity type I IFN measured described Methods
0.25954077.14645931.html.plaintext.txt	179	Apoptotic cell death induced CVB3 From results experiments presence PrPC apparently correlates susceptibility virus replication consequent apoptotic cell death
0.25954077.14645931.html.plaintext.txt	180	The higher levels IFN HpL3 4 TRPrP cells may inhibit CVB3 replication CPE production
0.25954077.14645931.html.plaintext.txt	181	Although IFN would interfere virus replication CPE influenced mechanism apoptotic cell death
0.25954077.14645931.html.plaintext.txt	182	To study apoptosis examined staining DNA extracted cells following electrophoresis fragmented apoptotic nuclei evaluated virus infected HpL3 4 phyg cells Fig
0.25954077.14645931.html.plaintext.txt	183	Fragmented nuclei frequently observed HpL3 4 phyg cells whereas none observed HpL3 4 TRPrP cells virus infection Fig
0.25954077.14645931.html.plaintext.txt	184	The DNA laddering assay also showed DNA fragmentation HpL3 4 phyg cells infected CVB3 Fig
0.25954077.14645931.html.plaintext.txt	185	View larger version 66K Fig
0.25954077.14645931.html.plaintext.txt	186	Detection DNA fragmentation HpL3 4 cells infected CVB3
0.25954077.14645931.html.plaintext.txt	187	Ethidium bromide acridine orange staining CVB3 infected HpL3 4 TRPrP HpL3 4 phyg cells m
0.25954077.14645931.html.plaintext.txt	188	b DNA electrophoresis CVB3 infected HpL3 4 TRPrP HpL3 4 phyg cells
0.25954077.14645931.html.plaintext.txt	189	The DNA samples lanes 1 4 derived HpL3 4 TRPrP cells whereas lanes 5 8 derived HpL3 4 phyg cells
0.25954077.14645931.html.plaintext.txt	190	Lanes 1 5 uninfected cells 0 h lanes 2 6 infected cells 12 h p
0.25954077.14645931.html.plaintext.txt	191	DISCUSSION Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES CVB3s high risk human pathogens especially infants Woodruff 1980
0.25954077.14645931.html.plaintext.txt	192	The neonatal mouse brain one susceptible organs CVB3 infection
0.25954077.14645931.html.plaintext.txt	193	Several studies shown CVB induce severe infections CNS newborns Rotbart 1995 Xu Crowell 1996
0.25954077.14645931.html.plaintext.txt	194	In study observed CVB3 infection primary cultures brain cells Prnp mice followed rapid intense development CPE
0.25954077.14645931.html.plaintext.txt	195	The expression MCAR known play major role cellular tropism CVB3 Selinka et al
0.25954077.14645931.html.plaintext.txt	196	MCAR transcripts detected high levels cells cultured neonatal murine brain
0.25954077.14645931.html.plaintext.txt	197	In primary cultures murine Prnp brain cells expression level MCAR appeared decrease age data shown
0.25954077.14645931.html.plaintext.txt	198	Considering vivo data expected primary brain cells newborn mice would highly susceptible CVB3
0.25954077.14645931.html.plaintext.txt	199	Recently PrP demonstrated RNA binding properties analogous certain retrovirus gene products Darlix et al
0.25954077.14645931.html.plaintext.txt	200	The difference CVB3 susceptibility Prnp cells wild type cells indicates possible relationship PrP expression susceptibility virus infection neurons
0.25954077.14645931.html.plaintext.txt	201	In present experiments PrP deficient HpL3 4 cells susceptible CVB3 induced CPE produced higher virus titres HeLa HEp 2 cell lines used comparison
0.25954077.14645931.html.plaintext.txt	202	Similarly susceptibility high level virus production also observed assay using VSV data shown
0.25954077.14645931.html.plaintext.txt	203	HpL3 4 cells also able form plaques CVB3 infection
0.25954077.14645931.html.plaintext.txt	204	Comparative studies Prnp cells indicate viral susceptibility HpL3 4 cell line reflects high level expression MCAR feature common neuronal cell types investigated far also lack PrP gene product
0.25954077.14645931.html.plaintext.txt	205	Although studies warranted define relationship PrP susceptibility CVB3 described Prnp cell line may represent useful tool detecting titrating agents human animal samples
0.25954077.14645931.html.plaintext.txt	206	This study suggests two possible roles PrPC CVB3 infection
0.25954077.14645931.html.plaintext.txt	207	One possibility PrPC increases antiviral activity neurons mediated higher levels IFN activity
0.25954077.14645931.html.plaintext.txt	208	Another loss PrPC stimulates apoptotic signalling pathway
0.25954077.14645931.html.plaintext.txt	209	The results DNA fragmentation indicated induction apoptotic cell death CVB3 infected Prnp cell line
0.25954077.14645931.html.plaintext.txt	210	After Prnp transfection apoptotic cell death suppressed
0.25954077.14645931.html.plaintext.txt	211	From previous publications shown PrPC prevents Bcl 2 mediated apoptosis Kuwahara et al
0.25954077.14645931.html.plaintext.txt	212	1999 PrPC prevents Bax mediated apoptosis Bounhar et al
0.25954077.14645931.html.plaintext.txt	213	CVB3 infection promotes apoptotic cell death heart pancreas cell lines Carthy et al
0.25954077.14645931.html.plaintext.txt	214	Although mechanisms CVB induced apoptotic cell death remain unknown present study apparently showed pronounced apoptotic cell death Prnp cells
0.25954077.14645931.html.plaintext.txt	215	An ongoing study shown CVB3 replication promotes apoptotic cell death via mitochondria dependent pathway Blom et al
0.25954077.14645931.html.plaintext.txt	216	2003 Prnp cells data shown
0.25954077.14645931.html.plaintext.txt	217	Further studies required understand signal transduction via mitochondria
0.25954077.14645931.html.plaintext.txt	218	IFN produced neuronal cells Ward Massa 1995
0.25954077.14645931.html.plaintext.txt	219	PrPC may promote production IFNs neuronal cells cytokines could influence CVB3 replication
0.25954077.14645931.html.plaintext.txt	220	The absence PrPC permits virus replication induces necrotic apoptotic cell death
0.25954077.14645931.html.plaintext.txt	221	2001 reported IFN promotes cell survival activating NF B
0.25954077.14645931.html.plaintext.txt	222	Further investigation antiviral activity PrPC inhibition mechanisms apoptotic cell death necessary elucidate fully function PrPC context virus infection
0.25954077.14645931.html.plaintext.txt	223	ACKNOWLEDGEMENTS This work partly supported grant aid Ministry Education Science Sports Culture Japan Tokyo Japan Fondazione Banca del Monte Milano Italy
0.25954077.14645931.html.plaintext.txt	224	REFERENCES Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Akowitz A
0.25954077.14645931.html.plaintext.txt	225	Endogenous viral complexes long RNA cosediment agent Creutzfeldt Jakob disease
0.25954077.14645931.html.plaintext.txt	226	Nucleic Acids Res 22 1101 1107
0.25954077.14645931.html.plaintext.txt	227	Regional loss mitochondrial membrane potential hepatocytes rapidly followed externalization phosphatidyl serines specific site apoptosis
0.25954077.14645931.html.plaintext.txt	228	J Biol Chem 278 12467 12474
0.25954077.14645931.html.plaintext.txt	229	Prion protein protects human neurons Bax mediated apoptosis
0.25954077.14645931.html.plaintext.txt	230	Scrapie strain specific interactions endogenous murine leukaemia virus
0.25954077.14645931.html.plaintext.txt	231	Caspase activation specific cleavage substrates coxsackievirus B3 induced cytopathic effect Hela cells
0.25954077.14645931.html.plaintext.txt	232	Binding protease sensitive form PrP prion protein sulfated glycosaminoglycan congo red
0.25954077.14645931.html.plaintext.txt	233	Expression apoptosis related proteins experimental coxsackievirus myocarditis
0.25954077.14645931.html.plaintext.txt	234	Cardiovascular Res 38 158 168
0.25954077.14645931.html.plaintext.txt	235	First glimpses structure function relationships nucleocapsid protein retroviruses
0.25954077.14645931.html.plaintext.txt	236	Changes localization brain prion proteins scrapie infection
0.25954077.14645931.html.plaintext.txt	237	The prion protein RNA binding chaperoning properties characteristic nucleocapsid protein NCP7 HIV 1
0.25954077.14645931.html.plaintext.txt	238	J Biol Chem 276 19301 19309
0.25954077.14645931.html.plaintext.txt	239	Localization mRNA chicken prion protein situ hybridization
0.25954077.14645931.html.plaintext.txt	240	Proc Natl Acad Sci U S A 90 4309 4313
0.25954077.14645931.html.plaintext.txt	241	Scrapie prion proteins synthesized neurons
0.25954077.14645931.html.plaintext.txt	242	Prions prevent neuronal cell line death
0.25954077.14645931.html.plaintext.txt	243	The prion protein gene role mouse embryogenesis Development 115 117 122
0.25954077.14645931.html.plaintext.txt	244	Polymerization murine recombinant prion protein nucleic acid solution
0.25954077.14645931.html.plaintext.txt	245	Enteroviral infections central nervous system
0.25954077.14645931.html.plaintext.txt	246	Clin Infect Dis 20 971 981
0.25954077.14645931.html.plaintext.txt	247	A hypothalamic neural cell line persistently infected scrapie prions exhibits apoptosis
0.25954077.14645931.html.plaintext.txt	248	Coxsackie B virus interaction permissive host cells
0.25954077.14645931.html.plaintext.txt	249	Clin Diagn Virol 9 115 112
0.25954077.14645931.html.plaintext.txt	250	Neuron specific regulation major histocompatibility complex class I interferon beta anti viral state genes
0.25954077.14645931.html.plaintext.txt	251	RNA aptamers specifically interact prion protein PrP
0.25954077.14645931.html.plaintext.txt	252	Expression distribution receptors coxsackievirus B3 fetal development Balbc mouse brain cells culture
0.25954077.14645931.html.plaintext.txt	253	Interferon promote cell survival activating nuclear factor B phosphatidylinositol 3 kinase Akt
0.25954077.14645931.html.plaintext.txt	254	J Biol Chem 276 13756 13761
0.25954077.14645931.html.plaintext.txt	255	Prion protein expression different species analysis panel new mAbs
0.25954077.14645931.html.plaintext.txt	256	Proc Natl Acad Sci U S A 95 8812 8816
0.25954077.14645931.html.plaintext.txt	257	Received 12 March 2002 accepted 15 August 2003
0.25954077.14645931.html.plaintext.txt	258	This Article Abstract Full Text PDF Alert article cited Alert correction posted Citation Map Services Email article friend Similar articles journal Similar articles PubMed Alert new issues journal Download citation manager Google Scholar Articles Nakamura Y
0.25954077.14645931.html.plaintext.txt	259	Articles citing Article PubMed PubMed Citation Articles Nakamura Y
0.25954077.14645931.html.plaintext.txt	260	Agricola Articles Nakamura Y
0.25954077.14645931.html.plaintext.txt	261	HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL J MED MICROBIOL ALL SGM JOURNALS
0.24954486.11152682.html.plaintext.txt	0	In Vivo Conversion Cellular Prion Protein Pathogenic Isoforms Monitored Conformation specific Antibodies Takashi Yokoyama Kumiko M
0.24954486.11152682.html.plaintext.txt	1	Kimura Yuko Ushiki Shunji Yamada Akira Morooka Toshiaki Nakashiba Takayuki Sassa Shigeyoshi Itohara
0.24954486.11152682.html.plaintext.txt	2	From National Institute Animal Health Tsukuba Ibaraki 305 0856 Japan Nippi Research Institute Biomatrix Adachi Tokyo 120 8601 Japan Brain Science Institute RIKEN Wako Saitama 351 0198 Japan Institute Virus Research Kyoto University Sakyo ku Kyoto 606 8507 Japan
0.24954486.11152682.html.plaintext.txt	3	Received publication September 25 2000 revised form January 8 2001
0.24954486.11152682.html.plaintext.txt	4	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.24954486.11152682.html.plaintext.txt	5	The central event prion disease thought conformational conversion cellular isoform prion protein PrPC insoluble isoform PrPSc
0.24954486.11152682.html.plaintext.txt	6	We generated polyclonal monoclonal antibodies immunizing PrPC null mice native PrPC
0.24954486.11152682.html.plaintext.txt	7	All seven monoclonal antibodies mAbs immunoprecipitated PrPC immunoprecipitated PrPSc weakly thereby indicating preferential reactivities PrPC solution
0.24954486.11152682.html.plaintext.txt	8	Immunoprecipitation using mAbs revealed marked loss PrPC brains terminal stage illness
0.24954486.11152682.html.plaintext.txt	9	Histoblot analyses using polyclonal antibodies combination pretreatment blots dissociated PrPC PrPSc situ consistently demonstrated decrease PrPC regions PrPSc accumulated
0.24954486.11152682.html.plaintext.txt	10	Interestingly mAbs showed immunohistochemical reactivities abnormal isoforms
0.24954486.11152682.html.plaintext.txt	11	One group mAbs showed reactivity materials accumulated astrocytes group amorphous plaques neuropil
0.24954486.11152682.html.plaintext.txt	12	Epitope mapping indicated single mAbs reactivities multiple epitopes thus implying dual specificities
0.24954486.11152682.html.plaintext.txt	13	This suggests importance octarepeats part PrPC specific conformation
0.24954486.11152682.html.plaintext.txt	14	Our observations support notion loss function PrPC may partly underlie pathogenesis prion diseases
0.24954486.11152682.html.plaintext.txt	15	The conversion PrPC PrPSc may involve multiple steps different sites
0.24954486.11152682.html.plaintext.txt	16	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.24954486.11152682.html.plaintext.txt	17	Prion diseases scrapie sheep goats Creutzfeldt Jakob disease humans transmissible neurodegenerative disorders spongiform encephalopathy
0.24954486.11152682.html.plaintext.txt	18	A major component infectious agent responsible diseases thought post translationally modified form host encoded membrane glycoprotein PrPC1 termed PrPSc 1
0.24954486.11152682.html.plaintext.txt	19	Conformational differences observed PrPC PrPSc
0.24954486.11152682.html.plaintext.txt	20	PrPSc large number sheets diminished helical content compared PrPC 2 4 hence relatively resistant protease digestion
0.24954486.11152682.html.plaintext.txt	21	The protease resistance PrPSc widely accepted physico chemical basis distinguish PrPC PrPSc
0.24954486.11152682.html.plaintext.txt	22	A recent study demonstrated plasminogen selective affinity PrPSc PrPC 5
0.24954486.11152682.html.plaintext.txt	23	It also ideal use antibodies distinguishing conformations PrPC PrPSc
0.24954486.11152682.html.plaintext.txt	24	However since PrPC phylogenetically highly conserved expressed various tissues including immune systems 6 7 immune tolerance means restriction generating antibodies
0.24954486.11152682.html.plaintext.txt	25	To overcome problem workers used mice devoid PrPC generate monoclonal antibodies mAbs prion protein PrP 8 13
0.24954486.11152682.html.plaintext.txt	26	Almost mAbs far obtained recognize PrPSc PrPC
0.24954486.11152682.html.plaintext.txt	27	Exceptionally one mAbs clone 15B3 reported specific PrPSc 11
0.24954486.11152682.html.plaintext.txt	28	To gain insight conversion processes important characterize epitopes reflecting conformational differences PrPC PrPSc
0.24954486.11152682.html.plaintext.txt	29	PrPC expressed cell surface C terminal glycosylphosphatidylinositol anchor expressed tissues uninfected animals
0.24954486.11152682.html.plaintext.txt	30	The function PrPC remained obscure
0.24954486.11152682.html.plaintext.txt	31	However suggested PrPC role normal synaptic function 14 15
0.24954486.11152682.html.plaintext.txt	32	Furthermore ablation prion protein gene Prnp caused cell death circumstances vivo vitro 16 17
0.24954486.11152682.html.plaintext.txt	33	Although recent studies suggested ectopic expression Prnd gene encoding homolog PrPC involved cell death 32 expression PrPC antagonized cell death signaling cases 17 18
0.24954486.11152682.html.plaintext.txt	34	These results raised possibility functional loss PrPC might partly underlie pathogenesis prion diseases
0.24954486.11152682.html.plaintext.txt	35	However expression level mRNA Prnp gene unaltered cases scrapie infection 19
0.24954486.11152682.html.plaintext.txt	36	Thus equilibrium PrPC PrPSc pathogenesis remained examined
0.24954486.11152682.html.plaintext.txt	37	We immunized Prnp mice native PrPC wild type mice Prnp established mAbs PrP
0.24954486.11152682.html.plaintext.txt	38	These mAbs specifically recognized PrPC solution marked decrease PrPC terminal stage illness
0.24954486.11152682.html.plaintext.txt	39	Epitope mapping mAbs polyclonal antibodies mice immunized native PrPC suggested importance octarepeats part PrPC specific conformation
0.24954486.11152682.html.plaintext.txt	40	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.24954486.11152682.html.plaintext.txt	41	Generation Prnp Mice Prnp mice generated homologous recombination described 20
0.24954486.11152682.html.plaintext.txt	42	The entire Prnp gene open reading frame well 3 end intron 2 replaced pgk neo gene cassette
0.24954486.11152682.html.plaintext.txt	43	The resulting allele almost identical generated another group 16
0.24954486.11152682.html.plaintext.txt	44	The homologous recombinant ES clones injected blastocysts C57BL6 mice give rise chimeras
0.24954486.11152682.html.plaintext.txt	45	Mice heterozygous mutation Prnp obtained crossing chimeras C57BL6J mice
0.24954486.11152682.html.plaintext.txt	46	The heterozygotes Prnp intercrossed obtain mutation homozygotes Prnp
0.24954486.11152682.html.plaintext.txt	47	The mouse line maintained backcrossing C57BL6
0.24954486.11152682.html.plaintext.txt	48	Genotypes mice determined Southern blot analysis polymerase chain reaction analysis DNAs prepared tails mice
0.24954486.11152682.html.plaintext.txt	49	The primers used 5 GTACAGTAGACCAGTTGCTC 3 5 CAGAGTCAAGATCTCCTAGT 3 wild type allele 5 CTCGTGCTTTACGGTATCGC 3 5 CAGAGTCAAGATCTCCTAGT 3 mutated allele
0.24954486.11152682.html.plaintext.txt	50	Antibodies Fluorescein isothiocyanate conjugated anti mouse IgG IgM horseradish peroxidase HRP conjugated anti mouse IgM fluorescein isothiocyanate conjugated anti rabbit IgG HRP conjugated anti rabbit IgG antibodies purchased Jackson Immunoresearch Laboratories
0.24954486.11152682.html.plaintext.txt	51	Biotinylated anti mouse IgM antibody purchased Vector Laboratories
0.24954486.11152682.html.plaintext.txt	52	Anti PrP peptide position peptide mouse PrP amino acid residues 213 226 rabbit serum Ab
0.24954486.11152682.html.plaintext.txt	53	Mo VI 21 used reference antibody
0.24954486.11152682.html.plaintext.txt	54	Western Blot Analysis WB WB carried described 21
0.24954486.11152682.html.plaintext.txt	55	In brief mouse brain extracts fractionated SDS polyacrylamide gel electrophoresis blotted onto polyvinylidene difluoride membrane Immobilon P Millipore Corp
0.24954486.11152682.html.plaintext.txt	56	After blocking membrane Block Ace Dainippon Seiyaku blots immersed primary antibodies 37 degrees C 1 h
0.24954486.11152682.html.plaintext.txt	57	Then washing blots incubated either HRP conjugated anti mouse IgG 15000 anti mouse IgM 15000 anti rabbit IgG 15000 developed ECL Western blotting detection reagent Amersham Pharmacia Biotech
0.24954486.11152682.html.plaintext.txt	58	Immunization Fusion Protocols For immunization 10 brain homogenates 2 x 107 thymocytes Prnp mice given intraperitoneally Prnp mice four times 2 3 week intervals
0.24954486.11152682.html.plaintext.txt	59	The brains homogenized RPMI medium centrifuged 3000 rpm 30 min
0.24954486.11152682.html.plaintext.txt	60	The supernatant fraction emulsified Freunds complete incomplete adjuvants first subsequent immunizations respectively
0.24954486.11152682.html.plaintext.txt	61	Thymocytes given intraperitoneally without adjuvants
0.24954486.11152682.html.plaintext.txt	62	The spleen cells immunized mice fused P3U1 mouse myeloma cells P3 x 63Ag8U
0.24954486.11152682.html.plaintext.txt	63	1 cultured described 22
0.24954486.11152682.html.plaintext.txt	64	Subclasses mAbs determined using mouse mAb isotyping kit Amersham Pharmacia Biotech
0.24954486.11152682.html.plaintext.txt	65	PrP recombinant Baculovirus Autographa californica nuclear polyhedrosis virus AcNPV recombinant virus stocks grown assayed monolayers Spodoptera frugiperda ovary cells IPLB SF 21AE SF21AE 23 TC100 medium containing 10 vv fetal bovine serum
0.24954486.11152682.html.plaintext.txt	66	The Prnp open reading frame fragment amplified polymerase chain reaction subcloned BamHI site transfer vector pAcYM1S
0.24954486.11152682.html.plaintext.txt	67	Primers used 5 GGGATCCAGTCATCATGGCGAACCT 3 5 GGGATCCACGAGAAATGCGAAGGAA 3
0.24954486.11152682.html.plaintext.txt	68	SF21AE cells cotransfected AcNPV DNA transfer vector DNA Lipofectin Life Technologies Inc
0.24954486.11152682.html.plaintext.txt	69	recombinant baculovirus PrP AcNPV selected described 24
0.24954486.11152682.html.plaintext.txt	70	The expression recombinant PrP confirmed indirect fluorescent assay IFA WB using Ab
0.24954486.11152682.html.plaintext.txt	71	PrP AcNPV infected cells washed phosphate buffered saline fixed acetone 5 min room temperature
0.24954486.11152682.html.plaintext.txt	72	These fixed cells used screening hybridomas using IFA test see details
0.24954486.11152682.html.plaintext.txt	73	The antigenicity recombinant PrP evaluated immunizing 7 8 week old Prnp Prnp mice PrP AcNPV infected cells
0.24954486.11152682.html.plaintext.txt	74	Scrapie Prions Animals The Obihiro strain scrapie prion PrPSc passaged ICRSlc mice 10 times prepared infected brains homogenized phosphate buffered saline intracerebrally inoculated 3 week old C57BL6 Prnp Prnp mice described 21
0.24954486.11152682.html.plaintext.txt	75	At appropriate time points brains collected used PrPSc extraction immunoprecipitation
0.24954486.11152682.html.plaintext.txt	76	Noninfected brains Prnp Prnp mice served controls
0.24954486.11152682.html.plaintext.txt	77	For histoblot analysis used Sc237 strain scrapie prion passaged Syrian Golden hamsters 10 times
0.24954486.11152682.html.plaintext.txt	78	Three week old hamsters intracerebrally inoculated Sc237 prion described 21
0.24954486.11152682.html.plaintext.txt	79	PrPSc extraction infected animal brains enzyme linked immunosorbent assay ELISA done described 21
0.24954486.11152682.html.plaintext.txt	80	Immunohistochemical Analysis Mouse brains frozen liquid N2 cut 5 microm thick cryosections
0.24954486.11152682.html.plaintext.txt	81	The sections fixed acetone 10 min reacted primary antibodies 30 min
0.24954486.11152682.html.plaintext.txt	82	After washing three times phosphate buffered saline sections incubated fluorescein isothiocyanate conjugated anti mouse IgG IgM
0.24954486.11152682.html.plaintext.txt	83	Recombinant baculovirus infected cells also examined using procedure
0.24954486.11152682.html.plaintext.txt	84	Immunoprecipitation IP The brains homogenized 10 wv 0
0.24954486.11152682.html.plaintext.txt	85	5 sodium deoxycholate 100 mM NaCl 10 mM EDTA 10 mM Tris HCl pH 7
0.24954486.11152682.html.plaintext.txt	86	5 precleared centrifugation 11000 x g 30 min 4 degrees C
0.24954486.11152682.html.plaintext.txt	87	The samples incubated antibodies 4 degrees C 1 h
0.24954486.11152682.html.plaintext.txt	88	The antigen antibody complexes collected beads
0.24954486.11152682.html.plaintext.txt	89	Immuno Assist MG PP Kanto Chemical protein G beads Amersham Pharmacia Biotech used mAbs Ab
0.24954486.11152682.html.plaintext.txt	90	After washing three times beads mixed SDS sample buffer boiled 5 min
0.24954486.11152682.html.plaintext.txt	91	The precipitated PrP detected WB using biotinylated Ab
0.24954486.11152682.html.plaintext.txt	92	Tg streptavidin HRP Life Technologies Inc
0.24954486.11152682.html.plaintext.txt	93	Histoblot Analysis Histoblot analysis done described 25
0.24954486.11152682.html.plaintext.txt	94	Briefly mouse hamster brains frozen liquid N2 8 microm thick cryosections prepared placed glass slides
0.24954486.11152682.html.plaintext.txt	95	The glass slides carrying sections immediately pressed onto Immobilon P membranes 1 min
0.24954486.11152682.html.plaintext.txt	96	The membranes used one following pretreatments 100 microgml proteinase K 1 h 37 degrees C hydrated autoclaving pretreatment 10 min 115 degrees C
0.24954486.11152682.html.plaintext.txt	97	To detect PrPSc hydrated autoclaving pretreatment done following proteinase digestion
0.24954486.11152682.html.plaintext.txt	98	The pretreated membranes incubated Ab
0.24954486.11152682.html.plaintext.txt	99	Bound antibodies detected using HRP conjugated anti mouse IgG chemiluminescence described WB
0.24954486.11152682.html.plaintext.txt	100	Epitope Analysis To determine epitopes antibodies incubated gridded array peptides comprising 122 polypeptides 13 amino acids shifted 2 amino acids covering entire mouse sequence
0.24954486.11152682.html.plaintext.txt	101	The peptides covalently attached COOH termini cellulose support individual spots Jerini Biotools Berlin
0.24954486.11152682.html.plaintext.txt	102	Bound antibodies detected using HRP conjugated anti mouse IgG IgM chemiluminescence described WB
0.24954486.11152682.html.plaintext.txt	103	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.24954486.11152682.html.plaintext.txt	104	Generation Mice Devoid PrPC We generated mice devoid PrPC gene targeting
0.24954486.11152682.html.plaintext.txt	105	1 entire open reading frame 3 end second intron replaced pgk neo gene cassette
0.24954486.11152682.html.plaintext.txt	106	The genotype mice determined either Southern blotting polymerase chain reaction analysis DNA prepared tails mice
0.24954486.11152682.html.plaintext.txt	107	An example Southern blot analysis tail DNAs crosses heterozygotes shown Fig
0.24954486.11152682.html.plaintext.txt	108	Immunoblot analysis lysates cerebra showed absence PrPC Prnp mice reduced level Prnp mice compared findings Prnp mice Fig
0.24954486.11152682.html.plaintext.txt	109	Homozygous mutant mice showed obvious behavioral changes young age appeared normal motor activity
0.24954486.11152682.html.plaintext.txt	110	However aged mice showed tremor ataxia reported 16
0.24954486.11152682.html.plaintext.txt	111	View larger version 43K Fig
0.24954486.11152682.html.plaintext.txt	112	A schematic representations wild type mutated alleles
0.24954486.11152682.html.plaintext.txt	113	The entire coding sequence exon 3 Prnp including splicing acceptor sequence replaced pgk neo gene cassette gene targeting
0.24954486.11152682.html.plaintext.txt	114	Genotypes resulting mice determined either Southern blots polymerase chain reaction
0.24954486.11152682.html.plaintext.txt	115	The 3 probe used indicated thick bars
0.24954486.11152682.html.plaintext.txt	116	The primer sets wild type mutant alleles indicated short arrows
0.24954486.11152682.html.plaintext.txt	117	B Southern blot analysis tail DNAs littermates obtained crossing heterozygotes
0.24954486.11152682.html.plaintext.txt	118	C Western blot analysis brain lysates anti pan PrP antibody Ab
0.24954486.11152682.html.plaintext.txt	119	B BamHI E EcoRI wild type heterozygote homozygote
0.24954486.11152682.html.plaintext.txt	120	Generation Polyclonal Monoclonal Antibodies PrP Prnp mice immunized brain homogenates thymocytes Prnp mice
0.24954486.11152682.html.plaintext.txt	121	The sera immunized mice recognized PrP ELISA WB IFA Table I
0.24954486.11152682.html.plaintext.txt	122	In contrast sera Prnp mice inoculated antigens showed reactivities assays
0.24954486.11152682.html.plaintext.txt	123	Tg served anti pan PrP polyclonal antibodies throughout study
0.24954486.11152682.html.plaintext.txt	124	We attempted generate mAbs using conventional B cell hybridoma technique
0.24954486.11152682.html.plaintext.txt	125	In initial studies wanted screen hybridomas IFA thymocytes Prnp mice ELISA using brain homogenates Prnp mice detect candidate clones secreting mAbs reactive PrP
0.24954486.11152682.html.plaintext.txt	126	This failure attributed limited concentrations antigens
0.24954486.11152682.html.plaintext.txt	127	Thus decided use recombinant proteins expressed baculoviruses
0.24954486.11152682.html.plaintext.txt	128	The recombinant baculovirus PrP AcNPV carrying murine Prnp open reading frame promoter polyhedrin gene plaque purified
0.24954486.11152682.html.plaintext.txt	129	SF21AE cells infected PrP AcNPV showed expression recombinant PrP revealed IFA using Ab
0.24954486.11152682.html.plaintext.txt	130	Tg detected immunoreactive band expected size homogenates infected SF 21 cells Fig
0.24954486.11152682.html.plaintext.txt	131	Furthermore Prnp mice immunized lysates PrP AcNPV infected SF21 cells generated antibodies reactive PrP various forms Table I
0.24954486.11152682.html.plaintext.txt	132	Thus PrP AcNPV infected SF 21 cells could serve antigen screening mAbs
0.24954486.11152682.html.plaintext.txt	133	Splenocytes mice immunized brain homogenates fused P3U1 mouse myeloma cells resulting hybridomas screened IFA PrP AcNPV infected SF21 cells
0.24954486.11152682.html.plaintext.txt	134	Noninfected SF21 cells served controls
0.24954486.11152682.html.plaintext.txt	135	Seven clones hybridomas established
0.24954486.11152682.html.plaintext.txt	136	View table Table I Immunoreactivities sera Prnp mice immunized various antigens
0.24954486.11152682.html.plaintext.txt	137	View larger version 50K Fig
0.24954486.11152682.html.plaintext.txt	138	Expression recombinant PrP baculovirus vector
0.24954486.11152682.html.plaintext.txt	139	SF21AE cells infected recombinant baculovirus PrP AcNPV fixed acetone expression recombinant PrP examined using Ab
0.24954486.11152682.html.plaintext.txt	140	Tg fluorescein isothiocyanate conjugated anti mouse IgG IgM A
0.24954486.11152682.html.plaintext.txt	141	Expressed proteins examined WB Ab
0.24954486.11152682.html.plaintext.txt	142	SF21AE cells lane 1 AcNPV infected SF21AE cells lane 2 PrP AcNPV infected SF21AE cells lane 3
0.24954486.11152682.html.plaintext.txt	143	Characterization mAbs All mAbs reacted neither PrPC PrPSc WB showed weak reaction PrPSc fractions using ELISA
0.24954486.11152682.html.plaintext.txt	144	Despite evidence mAbs react PrP WB immunoreactivity mAbs confirmed immunoprecipitation
0.24954486.11152682.html.plaintext.txt	145	Immunoprecipitates brain lysates mAbs size fractionated blotted onto membrane probed Ab
0.24954486.11152682.html.plaintext.txt	146	All mAbs efficiently immunoprecipitated PrP brain samples wild type healthy mice
0.24954486.11152682.html.plaintext.txt	147	Two mAbs 4A3 11H1 representing two distinct groups showed different properties IFA described later extensively characterized
0.24954486.11152682.html.plaintext.txt	148	Representative data mAbs 4A3 11H1 shown Fig
0.24954486.11152682.html.plaintext.txt	149	These mAbs reacted weakly brain homogenates scrapie affected mice Fig
0.24954486.11152682.html.plaintext.txt	150	No signals detected Prnp brain homogenates Fig
0.24954486.11152682.html.plaintext.txt	151	3A lanes 1 thus indicating PrP specificity immunoreactive bands
0.24954486.11152682.html.plaintext.txt	152	Tg detected larger amounts PrP scrapie infected brains Fig
0.24954486.11152682.html.plaintext.txt	153	These results suggested PrPC selectively identified IP using mAbs
0.24954486.11152682.html.plaintext.txt	154	However none mAbs showed cell surface staining wild type thymocytes data shown Ab
0.24954486.11152682.html.plaintext.txt	155	Sequential IP mAbs Ab
0.24954486.11152682.html.plaintext.txt	156	Tg indicated PrPC immunoprecipitated mAbs subfraction PrPC immunoprecipitated Ab
0.24954486.11152682.html.plaintext.txt	157	On hand sequential immunoprecipitation 4A3 11H1 suggested fraction precipitated mAbs probably identical Fig
0.24954486.11152682.html.plaintext.txt	158	We observed similar results mAbs used
0.24954486.11152682.html.plaintext.txt	159	These results suggest mAbs specific subfraction PrPC
0.24954486.11152682.html.plaintext.txt	160	View larger version 52K Fig
0.24954486.11152682.html.plaintext.txt	161	A immunoprecipitation scrapie affected mock affected mouse brains two mAbs Ab
0.24954486.11152682.html.plaintext.txt	162	Brain homogenates Prnp mice lane 1 mock infected Prnp mice lane 2 scrapie affected Prnp mice lane 3 20 weeks postinfection immunoprecipitated analyzed WB using biotinylated Ab
0.24954486.11152682.html.plaintext.txt	163	Tg PrP scrapie affected mouse brain
0.24954486.11152682.html.plaintext.txt	164	Scrapie affected mice killed 0 9 12 15 20 weeks postinfection
0.24954486.11152682.html.plaintext.txt	165	Brain homogenates examined without proteinase K PK treatment
0.24954486.11152682.html.plaintext.txt	166	PK samples represent total amounts PrPC PrPSc PK samples represent amounts PrPSc
0.24954486.11152682.html.plaintext.txt	167	Note increase proteinase K resistant PrP 20 weeks postinoculation
0.24954486.11152682.html.plaintext.txt	168	C immunoprecipitates samples B
0.24954486.11152682.html.plaintext.txt	169	D brain homogenates used B C immunoprecipitated 11H1 mAb
0.24954486.11152682.html.plaintext.txt	170	In C homogenates immunoprecipitated anti pan PrP Ab
0.24954486.11152682.html.plaintext.txt	171	11H1 reactive PrP markedly decreased 20 weeks postinoculation Ab
0.24954486.11152682.html.plaintext.txt	172	Tg detected larger amount PrP PrPC PrPSc even sample
0.24954486.11152682.html.plaintext.txt	173	View larger version 38K Fig
0.24954486.11152682.html.plaintext.txt	174	Sequential immunoprecipitation PrPC
0.24954486.11152682.html.plaintext.txt	175	Brain homogenates sequentially immunoprecipitated 11H1 4A3 mAbs polyclonal Ab
0.24954486.11152682.html.plaintext.txt	176	Tg precipitated large amount PrPC samples immunoprecipitated mAbs
0.24954486.11152682.html.plaintext.txt	177	On hand mAbs precipitated limited amount PrPC samples
0.24954486.11152682.html.plaintext.txt	178	Dynamics PrPC PrPSc Conversion Brain The findings mAbs immunoprecipitated small amounts PrP infected brains Fig
0.24954486.11152682.html.plaintext.txt	179	3A suggested exhaustion PrPC caused exponential conversion PrPC PrPSc
0.24954486.11152682.html.plaintext.txt	180	Thus measured equilibrium PrPC PrPSc pathogenesis
0.24954486.11152682.html.plaintext.txt	181	Homogenates mouse brains 0 9 12 15 20 weeks postinfection immunoprecipitated mAbs Ab
0.24954486.11152682.html.plaintext.txt	182	Tg probed using biotinylated Ab
0.24954486.11152682.html.plaintext.txt	183	The immunoprecipitates Ab
0.24954486.11152682.html.plaintext.txt	184	Tg might represent total amount PrP Fig
0.24954486.11152682.html.plaintext.txt	185	The total amount PrP also assessed WB without proteinase K pretreatment Fig
0.24954486.11152682.html.plaintext.txt	186	Proteinase K resistant products PrPSc accumulated brains terminal stages illness Fig
0.24954486.11152682.html.plaintext.txt	187	The PrPSc first detected 15 weeks postinfection dramatically increased 20 weeks postinfection Fig
0.24954486.11152682.html.plaintext.txt	188	Consistent WB analysis total PrP immunoprecipitated Ab
0.24954486.11152682.html.plaintext.txt	189	Tg increased within 20 weeks postinfection Fig
0.24954486.11152682.html.plaintext.txt	190	In contrast mAbs related immunoprecipitates reduced dramatically 20 weeks postinfection Fig
0.24954486.11152682.html.plaintext.txt	191	The results obtained mAb 11H1 similar results seen mAb 4A3 data shown
0.24954486.11152682.html.plaintext.txt	192	These results suggested PrPC exhausted conversion PrPSc terminal stage illness
0.24954486.11152682.html.plaintext.txt	193	Spatial Distribution PrPC PrPSc To gain insight regional distribution PrPC PrPSc attempted define conditions discriminate PrPC PrPSc using histoblot analysis
0.24954486.11152682.html.plaintext.txt	194	Without pretreatment membrane diffuse signals observed scrapie affected mock affected wild type mice Fig
0.24954486.11152682.html.plaintext.txt	195	5A first column left
0.24954486.11152682.html.plaintext.txt	196	These signals disappeared proteinase K treatment Fig
0.24954486.11152682.html.plaintext.txt	197	With autoclave pretreatment signal scrapie affected mice enhanced Fig
0.24954486.11152682.html.plaintext.txt	198	5A third column signal mock affected mice slightly reduced
0.24954486.11152682.html.plaintext.txt	199	When autoclave pretreatment followed proteinase K digestion Fig
0.24954486.11152682.html.plaintext.txt	200	5A fourth column signal scrapie affected mice enhanced
0.24954486.11152682.html.plaintext.txt	201	The treatment completely eliminated signal mock affected mice
0.24954486.11152682.html.plaintext.txt	202	No signals detected case Prnp mice regardless pretreatment conditions
0.24954486.11152682.html.plaintext.txt	203	These results indicate signals membrane without pretreatment preferentially represent PrPC PrPSc specifically detected membrane exposed combination hydrated autoclaving proteinase K digestion Fig
0.24954486.11152682.html.plaintext.txt	204	It noted PrPC signal reduced scrapie affected sample particularly cerebral cortex Fig
0.24954486.11152682.html.plaintext.txt	205	To better understand temporal spatial relationships amounts PrPC PrPSc inoculated scrapie prion Sc237 brains hamsters killed 38 80 days inoculation respectively
0.24954486.11152682.html.plaintext.txt	206	Mock infected hamsters also examined controls
0.24954486.11152682.html.plaintext.txt	207	5B PrPC PrPSc present normal hamster brains
0.24954486.11152682.html.plaintext.txt	208	PrPSc deposition first detected thalamus 38 days postinoculation PrPC signal decreased specifically region
0.24954486.11152682.html.plaintext.txt	209	At terminal stage illness PrPSc spread brain regions PrPC signal decreased areas Fig
0.24954486.11152682.html.plaintext.txt	210	The distribution PrPSc revealed histoblot consistent distribution PrPSc plaque deposits detected immunohistochemistry using reference antibody Ab
0.24954486.11152682.html.plaintext.txt	211	The results histoblot IP analyses consistently indicated loss PrPC terminal stage illness
0.24954486.11152682.html.plaintext.txt	212	View larger version 77K Fig
0.24954486.11152682.html.plaintext.txt	213	Regional distribution PrPC PrPSc
0.24954486.11152682.html.plaintext.txt	214	A discrimination PrPC PrPSc histoblot analysis using Ab
0.24954486.11152682.html.plaintext.txt	215	The blots scrapie affected Prnp mock affected Prnp Prnp mouse brain samples reacted Ab
0.24954486.11152682.html.plaintext.txt	216	without pretreatment hydrated autoclaving proteinase K
0.24954486.11152682.html.plaintext.txt	217	PrPC detected nonpretreated membranes far left
0.24954486.11152682.html.plaintext.txt	218	PrPSc specifically detected combination autoclaving proteinase K treatments right hand column
0.24954486.11152682.html.plaintext.txt	219	B temporal examination PrPC PrPSc scrapie affected hamsters using histoblots
0.24954486.11152682.html.plaintext.txt	220	Hamsters inoculated intracerebrally scrapie prion Sc237
0.24954486.11152682.html.plaintext.txt	221	At postinfection day 38 80 brain samples taken
0.24954486.11152682.html.plaintext.txt	222	Mock infected brain also included day 0
0.24954486.11152682.html.plaintext.txt	223	Note decrease PrPC sites PrPSc accumulated
0.24954486.11152682.html.plaintext.txt	224	Immunohistochemical Dissociation Multiple Isoforms Ab
0.24954486.11152682.html.plaintext.txt	225	Tg recognized PrPC Prnp mice Fig
0.24954486.11152682.html.plaintext.txt	226	Homogeneous signals representing PrPC distributed throughout entire brain areas except nuclei
0.24954486.11152682.html.plaintext.txt	227	In scrapie affected mouse brain granulous andor amorphous signals appeared Fig
0.24954486.11152682.html.plaintext.txt	228	Seven mAbs classified two groups terms reactivities distinct materials IFA
0.24954486.11152682.html.plaintext.txt	229	All mAbs showed homogeneous weak signals normal unaffected mouse brain Fig
0.24954486.11152682.html.plaintext.txt	230	6 panels 5 8 Table II agreement reactivities PrPC IP
0.24954486.11152682.html.plaintext.txt	231	However scrapie affected samples four clones 1H8 4A3 6B5 9A8 showed stellar structures Fig
0.24954486.11152682.html.plaintext.txt	232	6 panel 4 Table II others 7H8 8G6 11H1 showed plaque structures neuropil Fig
0.24954486.11152682.html.plaintext.txt	233	Double staining former group together anti GFAP antibody indicated stellar materials PrPs accumulated astrocytes data shown
0.24954486.11152682.html.plaintext.txt	234	There signals Prnp brain samples Fig
0.24954486.11152682.html.plaintext.txt	235	These results suggested mAbs recognized PrPC also abnormal isoforms acetone fixed sections
0.24954486.11152682.html.plaintext.txt	236	View larger version 73K Fig
0.24954486.11152682.html.plaintext.txt	237	Indirect fluorescent assay Ab
0.24954486.11152682.html.plaintext.txt	238	Tg mAbs 4A3 11H1 scrapie affected Prnp mice
0.24954486.11152682.html.plaintext.txt	239	Scrapie affected mock affected Prnp mouse brains rapidly frozen cryosectioned
0.24954486.11152682.html.plaintext.txt	240	Brain samples examined using Ab
0.24954486.11152682.html.plaintext.txt	241	Tg panels 1 3 mAb 4A3 panels 4 6 11H1 panels 7 9 primary antibodies
0.24954486.11152682.html.plaintext.txt	242	Tg detected PrPC throughout entire brain areas indicated smear signals panel 2
0.24954486.11152682.html.plaintext.txt	243	In addition similar signals granulous amorphous signals representing PrPSc observed scrapie affected brain panel 1
0.24954486.11152682.html.plaintext.txt	244	mAbs 4A3 11H1 also weakly revealed PrPC mock affected brain panels 5 8
0.24954486.11152682.html.plaintext.txt	245	These mAbs detected stellar structures plaques respectively panels 4 7
0.24954486.11152682.html.plaintext.txt	246	No signal observed Prnp mice using antibodies panels 3 6 9
0.24954486.11152682.html.plaintext.txt	247	View table Table II Characteristics monoclonal polyclonal antibodies
0.24954486.11152682.html.plaintext.txt	248	Epitope Mapping A single mAb recognizes PrPC certain condition solution recognizes abnormal isoforms another condition acetone fixed tissue section
0.24954486.11152682.html.plaintext.txt	249	To elucidate molecular basis observations determined epitopes recognized mAbs Ab
0.24954486.11152682.html.plaintext.txt	250	Tg using gridded array synthetic peptides consisting 122 13 residue peptides sequentially shifted steps 2 amino acids covering whole mouse PrP sequence Fig
0.24954486.11152682.html.plaintext.txt	251	Tg recognized distinct clusters polypeptides probably reflecting conformation native PrPC used immunogen
0.24954486.11152682.html.plaintext.txt	252	Four discontinuous regions appeared constitute dominant epitopes
0.24954486.11152682.html.plaintext.txt	253	Interestingly mAbs examined recognized multiple discontinuous peptides summarized Fig
0.24954486.11152682.html.plaintext.txt	254	Two mAbs 4A3 11H1 well Ab
0.24954486.11152682.html.plaintext.txt	255	Tg recognized sequences around octarepeat sequences
0.24954486.11152682.html.plaintext.txt	256	In 4A3 1 segment pair tripeptides TGSWG positions 55 57 63 65 71 73 79 81 87 89 seemed constitute epitope
0.24954486.11152682.html.plaintext.txt	257	Two perfect repeats GQPHGGGWG positions 57 65 81 89 repeats containing substituted residue GQPHGGSWG positions 65 73 73 81 preferential epitopes recognized Ab
0.24954486.11152682.html.plaintext.txt	258	mAb 4A3 also recognized different region 4A3 2 GNDWEDR positions 141 147 sequence completely overlapped epitope mAb 15B3 1 specific PrPSc 11
0.24954486.11152682.html.plaintext.txt	259	mAbs 11H1 8G6 also recognized segments 11H1 2 MIHFGND positions 137 143 8G6 1 MSRPMIHFGNDWE positions 133 145 partially overlapped 15B3 1
0.24954486.11152682.html.plaintext.txt	260	Furthermore mAb 11H1 recognized third segment 11H1 3 YYRPVDQYS positions 161 169 complete overlap second epitope mAb 15B3 15B3 2
0.24954486.11152682.html.plaintext.txt	261	mAb 8G6 recognized two segments 8G6 2 QVYYRPVDQ positions 159 167 8G6 3 SNQNNFVHDCV positions 169 179
0.24954486.11152682.html.plaintext.txt	262	In addition octarepeat region Ab
0.24954486.11152682.html.plaintext.txt	263	Tg 2 QWNKP positions 97 101 Ab
0.24954486.11152682.html.plaintext.txt	264	Tg 3 close 15B3 1
0.24954486.11152682.html.plaintext.txt	265	To examine reproducibility experimental system analyzed sera four independent immune mice
0.24954486.11152682.html.plaintext.txt	266	Tg 1 2 detected sera Ab
0.24954486.11152682.html.plaintext.txt	267	Tg 3 detected three four immune sera samples
0.24954486.11152682.html.plaintext.txt	268	These highly reproducible results indicate reliability experimental system
0.24954486.11152682.html.plaintext.txt	269	View larger version 58K Fig
0.24954486.11152682.html.plaintext.txt	270	Epitopes associated PrPC
0.24954486.11152682.html.plaintext.txt	271	Tg reacted gridded array peptides comprising 122 polypeptides 13 amino acids shifted 2 amino acids covering entire mouse sequence
0.24954486.11152682.html.plaintext.txt	272	Epitope numbers antibody indicated lines
0.24954486.11152682.html.plaintext.txt	273	Polypeptide numbers indicated left
0.24954486.11152682.html.plaintext.txt	274	B epitope positions indicated boxes sequences mature murine PrPC positions 23 231 31
0.24954486.11152682.html.plaintext.txt	275	Sequence numbers indicated right
0.24954486.11152682.html.plaintext.txt	276	End sequence numbers also indicated
0.24954486.11152682.html.plaintext.txt	277	Octarepeats positions 51 90 lined sequences
0.24954486.11152682.html.plaintext.txt	278	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES
0.24954486.11152682.html.plaintext.txt	279	To gain insight epitopes representing PrPC conformation vivo conversion processes PrPC PrPSc immunized Prnp mice native PrPC prepared brain homogenates intact thymocytes wild type mice
0.24954486.11152682.html.plaintext.txt	280	With attempt obtained polyclonal antibody named Ab
0.24954486.11152682.html.plaintext.txt	281	Tg highly reactive PrPC PrPSc Table II therefore used pan PrP specific antibody
0.24954486.11152682.html.plaintext.txt	282	Tg none mAbs detected isoforms PrP WB analysis showed weak reactivities partially purified PrPSc samples ELISA Table II
0.24954486.11152682.html.plaintext.txt	283	However mAbs efficiently immunoprecipitated PrP brain lysates noninfected mice scrapie infected mice indicating preferential affinity PrPC solution
0.24954486.11152682.html.plaintext.txt	284	We observed immunoprecipitable PrPC markedly decreased infected brain one fifth one sixth level noninfected brain depending PrPSc accumulation
0.24954486.11152682.html.plaintext.txt	285	At time point observe cell loss magnitude
0.24954486.11152682.html.plaintext.txt	286	Thus loss PrPC probably reflects reduction PrPC per cell rather loss cells diseased brains
0.24954486.11152682.html.plaintext.txt	287	Consistent results also obtained histoblot analyses
0.24954486.11152682.html.plaintext.txt	288	Tg detected diffusely distributed PrPC histoblot without pretreatment Fig
0.24954486.11152682.html.plaintext.txt	289	In contrast antibody specifically detected PrPSc blot exposed hydrated autoclaving partial digestion proteinase K Fig
0.24954486.11152682.html.plaintext.txt	290	The time course study revealed site PrPC decrease correlated site PrPSc depositing Fig
0.24954486.11152682.html.plaintext.txt	291	Although expression level mRNA Prnp gene unchanged scrapie infection 19 results suggest amount PrPC infected brains exhausted conversion PrPC PrPSc thus providing molecular basis notion loss function PrPC may partly account pathogenesis central nervous system 14 18
0.24954486.11152682.html.plaintext.txt	292	Although mAbs used showed preferential affinities PrPC solution divided two groups terms reactivities tissue sections
0.24954486.11152682.html.plaintext.txt	293	In immunohistochemistry acetone fixed scrapie brain mAbs 1H8 4A3 6B5 9A8 recognized stellar structure Fig
0.24954486.11152682.html.plaintext.txt	294	6 panel 4 mAbs 7H8 8G6 11H1 reacted plaque structures neuropil Fig
0.24954486.11152682.html.plaintext.txt	295	In mock samples weak diffuse signal evident
0.24954486.11152682.html.plaintext.txt	296	Stellar plaque structures never observed Fig
0.24954486.11152682.html.plaintext.txt	297	Thus stellar plaque structures might represent disease specific isoforms PrP
0.24954486.11152682.html.plaintext.txt	298	mAb 4A3 recognized isoform accumulates astrocytes Fig
0.24954486.11152682.html.plaintext.txt	299	The PrP may intermediate form converting fully pathogenic PrPSc
0.24954486.11152682.html.plaintext.txt	300	It reported PrPSc first accumulates astrocytes prior development neuropathological changes 26 astrocyte specific induction PrP Prnp mice restores susceptibility scrapie 27
0.24954486.11152682.html.plaintext.txt	301	These data suggest astrocytes play important role scrapie pathogenesis
0.24954486.11152682.html.plaintext.txt	302	The mAb 4A3 may useful study roles astrocytes scrapie disease
0.24954486.11152682.html.plaintext.txt	303	The mAb 11H1 may recognize isoform closely related fully pathogenic PrPSc
0.24954486.11152682.html.plaintext.txt	304	The immunohistochemical staining pattern mAb 11H1 resembled results obtained rabbit polyclonal antibodies synthetic peptide scrapie associated fibrils formalin fixed samples treated either hydrated autoclaving 21 guanidine 28
0.24954486.11152682.html.plaintext.txt	305	Either guanidine hydrated autoclaving pretreatment found essential immunofluorescent detection PrPSc plaques
0.24954486.11152682.html.plaintext.txt	306	Tg facilitated detecting abnormal isoforms PrP solely acetone fixation
0.24954486.11152682.html.plaintext.txt	307	The distinct immunohistochemical staining patterns two groups mAbs suggests conversion PrPC PrPSc involves multiple steps different sites vivo
0.24954486.11152682.html.plaintext.txt	308	The mAbs preferentially reactive PrPC IP immunohistochemically reactive abnormal isoforms PrP
0.24954486.11152682.html.plaintext.txt	309	One intriguing observations mAbs recognized multiple discontinuous linear peptides show apparent similarities Fig
0.24954486.11152682.html.plaintext.txt	310	A similar unusual nature noted PrPSc specific clone 15B3 11
0.24954486.11152682.html.plaintext.txt	311	Clone 15B3 recognized three distinct linear polypeptides
0.24954486.11152682.html.plaintext.txt	312	At least one epitopes recognized three mAbs examined study overlapped one 15B3 epitopes
0.24954486.11152682.html.plaintext.txt	313	Especially segments 4A3 2 11H1 3 completely overlapped epitopes 15B3 1 15B3 2 respectively
0.24954486.11152682.html.plaintext.txt	314	Epitope 8G6 2 closely related 15B3 2 epitope
0.24954486.11152682.html.plaintext.txt	315	We suggest epitopes largely contributed reactivities mAbs abnormal isoforms acetone fixed tissue sections
0.24954486.11152682.html.plaintext.txt	316	Epitopes 15B3 14A3 2 15B3 211H1 38G6 2 may represent isoforms accumulating astrocytes neuropil respectively
0.24954486.11152682.html.plaintext.txt	317	Regarding epitopes specific PrPC octarepeat region notable
0.24954486.11152682.html.plaintext.txt	318	Two three mAbs 4A3 11H1 reacted region octarepeats
0.24954486.11152682.html.plaintext.txt	319	Furthermore results polyclonal antibody Ab
0.24954486.11152682.html.plaintext.txt	320	Tg suggested region likely one major epitopes PrPC
0.24954486.11152682.html.plaintext.txt	321	Because native PrPC used immunogen epitopes recognized Ab
0.24954486.11152682.html.plaintext.txt	322	Tg may reflect conformation PrPC
0.24954486.11152682.html.plaintext.txt	323	A pair tripeptides TGSWG positions 55 57 63 65 71 73 79 81 87 89 seemed constitute epitope mAb 4A3
0.24954486.11152682.html.plaintext.txt	324	Tg recognized two perfect repeats GQPHGGGWG positions 57 65 81 89 repeats carried substitution GQPHGGSWG positions 65 73 73 81
0.24954486.11152682.html.plaintext.txt	325	The substitutions 71 79 residues Gly Ser underlined affect immunoreactivity Ab
0.24954486.11152682.html.plaintext.txt	326	A model suggested octarepeat region constrained four CuII coordinating histidines compact structure 29
0.24954486.11152682.html.plaintext.txt	327	The tripeptides involved 4A3 reactivity located centers loops generated copper binding 29
0.24954486.11152682.html.plaintext.txt	328	The epitopes mAbs generated DNA mediated immunization Prnp mice also located octarepeat region 8
0.24954486.11152682.html.plaintext.txt	329	These results suggest octarepeats important antigenicity PrPC copper may contribute related characteristics
0.24954486.11152682.html.plaintext.txt	330	Consistent notion reported copper enhance restoration proteinase K resistance infectivity denaturation PrPSc guanidine hydrochloride 30
0.24954486.11152682.html.plaintext.txt	331	It noteworthy polyclonal antibodies immunized mutant mice revealed limited regions regard effective epitopes although Prnp mice immunologically intolerant PrP
0.24954486.11152682.html.plaintext.txt	332	We examined sera four independent immune mice observed reproducible results among sera PrPC immunogen
0.24954486.11152682.html.plaintext.txt	333	Tg 2 always detected third one Ab
0.24954486.11152682.html.plaintext.txt	334	Tg 3 detected three four immune sera indicating dominance epitopes
0.24954486.11152682.html.plaintext.txt	335	The NH2 terminal sequences positions 23 40 seldom functioned epitope therefore unstable
0.24954486.11152682.html.plaintext.txt	336	These results suggested amino terminal half PrPC characteristic conformation good agreement findings mAbs characterized
0.24954486.11152682.html.plaintext.txt	337	We also observed distinct epitope patterns PrPSc fractions
0.24954486.11152682.html.plaintext.txt	338	2 This experimental strategy may aid understanding species barrier mechanisms differences infectious prion strains replicated given animal species
0.24954486.11152682.html.plaintext.txt	339	Data experiments using mAbs polyclonal antibodies developed revealed marked decrease PrPC brains animals terminal stage illness thereby providing molecular basis hypothesis loss function PrPC may role pathogenesis prion diseases
0.24954486.11152682.html.plaintext.txt	340	Results epitope mapping immunohistochemical studies suggest conversion PrPC PrPSc may involve multiple steps different sites
0.24954486.11152682.html.plaintext.txt	341	Matsuura technical assistance H
0.24954486.11152682.html.plaintext.txt	342	Nakamura staff animal section National Institute Animal Health maintaining mouse colony H
0.24954486.11152682.html.plaintext.txt	343	Yuasa encouragement M
0.24954486.11152682.html.plaintext.txt	344	Schmerr reading manuscript
0.24954486.11152682.html.plaintext.txt	345	This work supported grants Science Technology Agency Japan Ministry Agriculture Forestry Fisheries Japan
0.24954486.11152682.html.plaintext.txt	346	The costs publication article defrayed part payment page charges
0.24954486.11152682.html.plaintext.txt	347	The article must therefore hereby marked advertisement accordance 18 U
0.24954486.11152682.html.plaintext.txt	348	Section 1734 solely indicate fact
0.24954486.11152682.html.plaintext.txt	349	To correspondence addressed
0.24954486.11152682.html.plaintext.txt	350	81 48 467 9724 Fax 81 48 467 9725 E mail sitoharabrain
0.24954486.11152682.html.plaintext.txt	351	Published JBC Papers Press January 10 2001 DOI 10
0.24954486.11152682.html.plaintext.txt	352	Itohara unpublished observation
0.24954486.11152682.html.plaintext.txt	353	The abbreviations used PrP prion protein mAb monoclonal antibody WB Western blot AcNPV A
0.24954486.11152682.html.plaintext.txt	354	californica nuclear polyhedrosis virus IFA indirect fluorescent assay ELISA enzyme linked immunosorbent assay IP immunoprecipitation
0.24954486.11152682.html.plaintext.txt	355	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1
0.24954486.11152682.html.plaintext.txt	356	1991 Science 252 1515 1522Medline Order article via Infotrieve 2
0.24954486.11152682.html.plaintext.txt	357	1991 Biochemistry 30 7672 7680Medline Order article via Infotrieve 3
0.24954486.11152682.html.plaintext.txt	358	268 20276 20284AbstractFree Full Text 5
0.24954486.11152682.html.plaintext.txt	359	2000 Nature 408 479 483CrossRefMedline Order article via Infotrieve 6
0.24954486.11152682.html.plaintext.txt	360	1990 Cell 61 185 192Medline Order article via Infotrieve 7
0.24954486.11152682.html.plaintext.txt	361	2 725 734Medline Order article via Infotrieve 9
0.24954486.11152682.html.plaintext.txt	362	72 9413 9418AbstractFree Full Text 10
0.24954486.11152682.html.plaintext.txt	363	93 7279 7282AbstractFree Full Text 11
0.24954486.11152682.html.plaintext.txt	364	1997 Nature 390 74 77CrossRefMedline Order article via Infotrieve 12
0.24954486.11152682.html.plaintext.txt	365	95 8812 8816AbstractFree Full Text 13
0.24954486.11152682.html.plaintext.txt	366	265 652 657CrossRefMedline Order article via Infotrieve 14
0.24954486.11152682.html.plaintext.txt	367	1994 Nature 370 295 297CrossRefMedline Order article via Infotrieve 15
0.24954486.11152682.html.plaintext.txt	368	9 197 201Medline Order article via Infotrieve 16
0.24954486.11152682.html.plaintext.txt	369	1996 Nature 380 528 531CrossRefMedline Order article via Infotrieve 17
0.24954486.11152682.html.plaintext.txt	370	1999 Nature 400 225 226CrossRefMedline Order article via Infotrieve 18
0.24954486.11152682.html.plaintext.txt	371	79 689 697Medline Order article via Infotrieve 19
0.24954486.11152682.html.plaintext.txt	372	1985 Cell 40 735 746Medline Order article via Infotrieve 20
0.24954486.11152682.html.plaintext.txt	373	1995 Neuron 14 29 41Medline Order article via Infotrieve 21
0.24954486.11152682.html.plaintext.txt	374	1991 Current Protocols Immunology Coligan J
0.24954486.11152682.html.plaintext.txt	375	1 John Wiley Sons New York 23
0.24954486.11152682.html.plaintext.txt	376	1977 In Vitro 13 213 217Medline Order article via Infotrieve 24
0.24954486.11152682.html.plaintext.txt	377	21 123 139Medline Order article via Infotrieve 25
0.24954486.11152682.html.plaintext.txt	378	16 6057 6065AbstractFree Full Text 28
0.24954486.11152682.html.plaintext.txt	379	96 2042 2047AbstractFree Full Text 30
0.24954486.11152682.html.plaintext.txt	380	273 25545 25547AbstractFree Full Text 31
0.24954486.11152682.html.plaintext.txt	381	1987 Cell 51 651 662Medline Order article via Infotrieve 32
0.24954486.11152682.html.plaintext.txt	382	1999 Science 286 914 915Free Full Text
0.24954486.11152682.html.plaintext.txt	383	Copyright 2001 The American Society Biochemistry Molecular Biology Inc
0.16557215.15722549.html.plaintext.txt	0	Polymorphisms codons 108 189 murine PrP play distinct roles control scrapie incubation time Rona M
0.16557215.15722549.html.plaintext.txt	1	Barron1 Herbert Baybutt1 Nadia L
0.16557215.15722549.html.plaintext.txt	2	Tuzi1 James McCormack1 Declan King1 Richard C
0.16557215.15722549.html.plaintext.txt	3	1 Neuropathogenesis Unit Institute Animal Health Ogston Building West Mains Road Edinburgh EH9 3JF UK 2 Institute Cell Molecular Biology University Edinburgh Edinburgh UK 3 Sir Alastair Currie Cancer Research UK Laboratories Molecular Medicine Centre University Edinburgh Western General Hospital Edinburgh UK
0.16557215.15722549.html.plaintext.txt	4	ABSTRACT Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Susceptibility transmissible spongiform encephalopathies TSEs associated strongly PrP polymorphisms humans sheep rodents
0.16557215.15722549.html.plaintext.txt	5	In mice scrapie incubation time controlled polymorphisms PrP codons 108 leucine phenylalanine 189 threonine valine precise role polymorphism control disease unknown
0.16557215.15722549.html.plaintext.txt	6	The L108F T189V polymorphisms present distinct structural regions PrP thus provide excellent model investigate role PrP structure gene variation TSEs
0.16557215.15722549.html.plaintext.txt	7	Two unique lines transgenic mice 108F 189V targeted separately endogenous murine Prnpa gene produced
0.16557215.15722549.html.plaintext.txt	8	TSE inoculation inbred lines mice expressing allelic combinations codons 108 189 revealed complex relationship PrP allele incubation time
0.16557215.15722549.html.plaintext.txt	9	It established codons 108 189 control TSE incubation time polymorphism plays distinct role disease process
0.16557215.15722549.html.plaintext.txt	10	Comparison ME7 incubation times mouse lines heterozygous codons also identified previously unrecognized intramolecular interaction PrP codons 108 189
0.16557215.15722549.html.plaintext.txt	11	Published online ahead print 5 January 2005 DOI 10
0.16557215.15722549.html.plaintext.txt	12	A supplementary figure showing ME7 301V incubation times mice expressing codon 108 189 polymorphisms available JGV Online
0.16557215.15722549.html.plaintext.txt	13	Present address Department Environment Food Rural Affairs DEFRA Veterinary Research Division TSE Research Unit Dean Stanley Street London UK
0.16557215.15722549.html.plaintext.txt	14	Present address Department Genetics Genomics Roslin Institute Edinburgh UK
0.16557215.15722549.html.plaintext.txt	15	INTRODUCTION Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES The transmissible spongiform encephalopathies TSEs group fatal neurodegenerative diseases include scrapie sheep bovine spongiform encephalopathy cattle chronic wasting disease deer elk Creutzfeldt Jakob disease CJD Gerstmann Straussler Scheinker disease fatal familial insomnia man
0.16557215.15722549.html.plaintext.txt	16	TSE diseases thought caused conversion normal cellular glycoprotein PrPC abnormal disease associated isoform PrPSc accumulates diseased tissue Prusiner 1996
0.16557215.15722549.html.plaintext.txt	17	This conversion PrPC PrPSc accompanied alteration conformation predominantly helix sheet structure development partial resistance digestion proteinase K PK
0.16557215.15722549.html.plaintext.txt	18	It proposed PrPSc constitutes infectivity Prusiner 1982 acts seed template conversion host PrPC PrPSc Jarrett Lansbury 1993 Prusiner 1996 Weissmann 1996
0.16557215.15722549.html.plaintext.txt	19	Whether PrPSc indeed infectious agent remains established conversion PrPC PrPSc clearly critical event pathogenesis diseases
0.16557215.15722549.html.plaintext.txt	20	The host PrP gene Prnp major influence outcome TSE disease
0.16557215.15722549.html.plaintext.txt	21	PrP polymorphisms shown alter incubation time TSE susceptibility mice Moore et al
0.16557215.15722549.html.plaintext.txt	22	Classical genetic analysis control TSE incubation time mice identified presence single gene Sinc encoding two alleles s7 p7 programmed short long incubation times respectively ME7 strain scrapie Dickinson et al
0.16557215.15722549.html.plaintext.txt	23	Similar differences incubation time found NZWLacJ IlnJ mouse strains infected Chandler isolate identifying single locus Prni controlled incubation time linked closely Prnp Carlson et al
0.16557215.15722549.html.plaintext.txt	24	Following isolation characterization gene encoding PrP mice Prnp Basler et al
0.16557215.15722549.html.plaintext.txt	25	1986 mouse strains carrying Sinc s7 shown Prnp gene encoding 108L189T Prnpa carrying Sinc p7 Prnp gene encoding 108F189V Prnpb Westaway et al
0.16557215.15722549.html.plaintext.txt	26	However due different genetic backgrounds lines inbred mice difficult confirm Prnp Sinc Prni genes congruent polymorphisms Prnp responsible control scrapie incubation time mice
0.16557215.15722549.html.plaintext.txt	27	The introduction 108F 189T murine Prnpa gene gene targeting produced line transgenic mice FVFV differed 129Ola parental line targeted polymorphisms
0.16557215.15722549.html.plaintext.txt	28	Inoculation mice TSE infectivity produced incubation times similar Prnpb mice demonstrating Sinc Prni Prnp indeed gene codon 108 andor 189 polymorphisms major factors controlling TSE incubation time mice Moore et al
0.16557215.15722549.html.plaintext.txt	29	2003 Barron Manson 2004
0.16557215.15722549.html.plaintext.txt	30	In order determine individual involvement codon 108 189 polymorphisms disease mechanism control TSE incubation time mice 108F 189V introduced separately murine Prnpa gene gene targeting
0.16557215.15722549.html.plaintext.txt	31	These new alleles designated Prnpa108L189V PrnpLV Prnpa108F189T PrnpFT
0.16557215.15722549.html.plaintext.txt	32	Inoculation mice homozygous Prnpa Prnpb PrnpLV PrnpFT heterozygous crosses mouse scrapie demonstrated involvement polymorphisms control incubation time
0.16557215.15722549.html.plaintext.txt	33	METHODS Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Production targeting vectors
0.16557215.15722549.html.plaintext.txt	34	An 8524 bp 129Ola Prnpa genomic DNA clone spanning PrP exon 3 isolated DASH II 129Ola HM 1 embryonic stem ES cell genomic DNA library cloned pBluescript II
0.16557215.15722549.html.plaintext.txt	35	The wild type PrP open reading frame ORF encoding Prnpa 108L189T modified using vitro mutagenesis express 108F 189V alone rather described previously Moore et al
0.16557215.15722549.html.plaintext.txt	36	Vectors p108F p189V modified introduce HSV TK module LoxP flanked PGKHPRT minigene downstream exon 3 selection Fig
0.16557215.15722549.html.plaintext.txt	37	This resulted generation 15 7 kb constructs p108FLoxPHPRTTK p189VLoxPHPRTTK showing 6 4 kb region 5 homology 1 4 kb region 3 homology flanking LoxPHPRT minigene
0.16557215.15722549.html.plaintext.txt	38	The LoxP flanked HPRT minigene derived pBTLoxPHPRTv2 consists PGK driven HPRT minigene Selfridge et al
0.16557215.15722549.html.plaintext.txt	39	1992 pBTSKII flanked two 38 bp LoxP sites allowing Cre mediated excision LoxP flanked HPRT minigene
0.16557215.15722549.html.plaintext.txt	40	View larger version 15K Fig
0.16557215.15722549.html.plaintext.txt	41	Wild type PrP clones derived 129Ola HM 1 ES cell genomic library amino acids modified site directed mutagenesis
0.16557215.15722549.html.plaintext.txt	42	Targeting vectors constructed introduction PGKHPRT cassette flanked LoxP sites HSVTK cassette selection purposes
0.16557215.15722549.html.plaintext.txt	43	After homologous recombination ES cells PGKHPRT cassette removed Cre recombinase
0.16557215.15722549.html.plaintext.txt	44	Primer pair W262 W6991 used determine successful homologous recombination targeted ES cells
0.16557215.15722549.html.plaintext.txt	45	Primer pair W7878 W6991 used screen Cre mediated deletion PGK HPRT cassette see Methods
0.16557215.15722549.html.plaintext.txt	46	In presence cassette PCR fragment large amplify
0.16557215.15722549.html.plaintext.txt	47	A successfully removed cassette produces PCR product larger wild type allele due retention single LoxP site part pBluescript multiple cloning site Cre recombination
0.16557215.15722549.html.plaintext.txt	48	Presence 108F 189V polymorphism confirmed PCR ORF using primers A996 B188 digestion product MnlI 108F BstEII 189V
0.16557215.15722549.html.plaintext.txt	49	B BamHI E EcoRI P PstI RV EcoRV S SalI
0.16557215.15722549.html.plaintext.txt	50	Generation ES lines mice PrP codon 108 189 alterations
0.16557215.15722549.html.plaintext.txt	51	For experiment 200 microg p108FLoxPHPRTTK p189VLoxPHPRTTK linearized digestion NotI electroporated HM 1 ES cells 50x106 cells 900 V 3 microF
0.16557215.15722549.html.plaintext.txt	52	All tissue culture reagents conditions described previously Thompson et al
0.16557215.15722549.html.plaintext.txt	53	1992 Moore Melton 1995
0.16557215.15722549.html.plaintext.txt	54	ES cells surviving hypoxanthineaminopterinthymidine ganciclovir drug selection screened homologous recombination events PCR primer pair 262W 5 AGCCTACCCTCTGGTAGATTGTCG 3 W6991 5 CCCAATTCTCTCCTTCTAAGGGAG 3 amplify HPRT minigene 94 degrees C 60 66 degrees C 60 72 degrees C 95 35 cycles
0.16557215.15722549.html.plaintext.txt	55	Targeted clones amplified 1 75 kb targeting specific band screened PrP codon 108 189 alterations combination PCR restriction digestion
0.16557215.15722549.html.plaintext.txt	56	The PrP ORF amplified primers A996 5 GTGGCTGGGGACAACCCCAT 3 B188 5 GCCTAGACCACGAGAATGCG 3 generate 624 bp PCR product 94 degrees C 30 65 degrees C 30 72 degrees C 60 35 cycles
0.16557215.15722549.html.plaintext.txt	57	The codon 108 alteration detected loss MnlI site following single nucleotide change CTC TTC
0.16557215.15722549.html.plaintext.txt	58	The codon 189 alteration detected digestion BstEII described previously Moore Melton 1995
0.16557215.15722549.html.plaintext.txt	59	Cre deletion HPRT minigene
0.16557215.15722549.html.plaintext.txt	60	The LoxP flanked PGKHPRT module excised targeted alleles transient transfection ES cells Cre recombinase expression construct pMCCreN Gu et al
0.16557215.15722549.html.plaintext.txt	61	Clones transfected 150 microg pMCCreN 10x106 cells 900 V 3 microF selected 6 thioguanine
0.16557215.15722549.html.plaintext.txt	62	Drug resistant clones screened deletion LoxP flanked HPRT minigene PCR primers W7878 5 AGTCAGGGAGGAGTAACACAGAAGG 3 W6991 94 degrees C 60 66 degrees C 60 72 degrees C 95 35 cycles
0.16557215.15722549.html.plaintext.txt	63	This generated 1 61 kb product wild type allele slightly larger band 1 66 kb HPRT deletant allele
0.16557215.15722549.html.plaintext.txt	64	This size difference arises retention single 38 bp LoxP site portion pBluescript multiple cloning site
0.16557215.15722549.html.plaintext.txt	65	ES cell clones examined Southern analysis expected gene structure absence additional recombination events described previously Moore et al
0.16557215.15722549.html.plaintext.txt	66	Germ line chimeras generated described previously Thompson et al
0.16557215.15722549.html.plaintext.txt	67	Briefly HM 1 ES cells desired alterations introduced BALBc 3 5 day old blastocysts transferred pseudopregnant MF1 recipients
0.16557215.15722549.html.plaintext.txt	68	Chimeras crossed directly 129Ola stock generating mice PrP codon 108 189 alterations co isogenic parental strain 129Ola Hsd Harlan
0.16557215.15722549.html.plaintext.txt	69	Germ line pups screened combination PCR MnlI BstEII restriction digestion described
0.16557215.15722549.html.plaintext.txt	70	129Ola littermates heterozygous targeted PrP allele also wild type deleted HPRT locus HM 1 cells crossed establish line
0.16557215.15722549.html.plaintext.txt	71	Total RNA isolated terminal brains using RNAzol B based guanidinium thiocyanatephenolchloroform extraction method Chomczynski Sacchi 1987
0.16557215.15722549.html.plaintext.txt	72	Total RNA 50 microg separated 1 0 agaroseformaldehyde denaturing gel transferred Hybond N Amersham Biosciences capillary transfer overnight
0.16557215.15722549.html.plaintext.txt	73	RNA fixed membrane baking 80 degrees C 2 h probing
0.16557215.15722549.html.plaintext.txt	74	A 936 bp KpnI EcoRI fragment Prnp exon 3 used generate PrP probe
0.16557215.15722549.html.plaintext.txt	75	Membranes hybridized overnight using ULTRAhyb Ambion
0.16557215.15722549.html.plaintext.txt	76	As loading control membranes reprobed 18S rRNA using 275 bp PCR generated murine DNA fragment
0.16557215.15722549.html.plaintext.txt	77	Homogenates frozen brain tissue 10 wv prepared NP40 buffer 0 5 vv NP40 0 5 wv sodium deoxycholate 150 mM NaCl 50 mM TrisHCl pH 7 5
0.16557215.15722549.html.plaintext.txt	78	Clarified homogenates 10 000 g 10 min 10 degrees C incubated without PK 20 microg ml 1 1 h 37 degrees C reaction terminated addition PMSF 1 mM
0.16557215.15722549.html.plaintext.txt	79	Samples prepared 10 mg ml 1 SDS PAGE sample buffer Novex Invitrogen incubated 90 degrees C 20 min separated 12 4 12 Novex Trisglycine acrylamide gels Invitrogen
0.16557215.15722549.html.plaintext.txt	80	Proteins transferred onto PVDF membrane electroblotting incubated overnight room temperature mouse anti PrP monoclonal antibody 7A12 Li et al
0.16557215.15722549.html.plaintext.txt	81	2000 dilution 50 ng ml 1 rat anti tubulin monoclonal antibody Abcam 250 ng ml 1
0.16557215.15722549.html.plaintext.txt	82	Proteins visualized horseradish peroxidase conjugated anti mouse anti rat secondary antibody diluted 200 ng ml 1 Jackson ImmunoResearch chemiluminescence detection kit Roche Diagnostics
0.16557215.15722549.html.plaintext.txt	83	Membranes exposed X ray film periods ranging 10 10 min
0.16557215.15722549.html.plaintext.txt	84	Inocula prepared brains C57BL mice terminal ME7 scrapie brains VM mice terminal 301V disease
0.16557215.15722549.html.plaintext.txt	85	A 1 homogenate sample prepared sterile saline prior use inoculum
0.16557215.15722549.html.plaintext.txt	86	All mice inoculated intracerebrally 20 microl inoculum anaesthesia
0.16557215.15722549.html.plaintext.txt	87	All experimental protocols submitted Local Ethical Review Committee approval mice inoculated
0.16557215.15722549.html.plaintext.txt	88	All experiments performed licence accordance UK Home Office Regulations Animals Scientific Procedures Act 1986
0.16557215.15722549.html.plaintext.txt	89	Scoring clinical TSE disease
0.16557215.15722549.html.plaintext.txt	90	The presence clinical TSE disease assessed described previously Dickinson et al
0.16557215.15722549.html.plaintext.txt	91	Animals scored clinical disease without reference genotype mouse
0.16557215.15722549.html.plaintext.txt	92	Genotypes confirmed animal PCR analysis tail DNA end experiment
0.16557215.15722549.html.plaintext.txt	93	Incubation times calculated interval inoculation cull due terminal TSE disease
0.16557215.15722549.html.plaintext.txt	94	Mice killed cervical dislocation terminal stage disease termination experiment 600 700 days welfare reasons due intercurrent illness
0.16557215.15722549.html.plaintext.txt	95	Half brains fixed 10 formal saline 48 h followed decontamination 98 formic acid 1 h
0.16557215.15722549.html.plaintext.txt	96	The remaining half brain frozen 70 degrees C biochemical analysis
0.16557215.15722549.html.plaintext.txt	97	Fixed brain tissue dehydrated alcohol impregnated wax 7 h automated processing cycle
0.16557215.15722549.html.plaintext.txt	98	Sections cut coronally four levels mounted Superfrost slides
0.16557215.15722549.html.plaintext.txt	99	Sections haematoxylineosin stained scored vacuolar degeneration scale 0 5 nine standard grey matter areas three standard white matter areas described previously Fraser Dickinson 1967
0.16557215.15722549.html.plaintext.txt	100	A 2 3 cm portion tail removed post mortem mouse
0.16557215.15722549.html.plaintext.txt	101	DNA prepared 1 cm piece tail digestion overnight 37 degrees C tail lysis buffer 300 mM sodium acetate 1 SDS 10 mM Tris pH 8 1 mM EDTA 200 microg PK ml 1 subsequent extraction equal volume phenolchloroform
0.16557215.15722549.html.plaintext.txt	102	DNA precipitated 2 propanol washed 70 ethanol resuspended 100 microl TE buffer 10 mM Tris 1 mM EDTA pH 7 4
0.16557215.15722549.html.plaintext.txt	103	A 605 bp PCR fragment Prnp ORF generated purified tail DNA ORF primer PrP5 5 GTGGCTGGGGACAACCCCAT 3 exon 3 3 untranslated region primer PrP3 5 GCCTAGACCACGAGAATGCG 3
0.16557215.15722549.html.plaintext.txt	104	Cycle conditions 35 cycles 94 degrees C 30 65 degrees C 30 72 degrees C 1 min
0.16557215.15722549.html.plaintext.txt	105	The PrnpLV allele detected absence BstEII site within product compared wild type Prnpa allele
0.16557215.15722549.html.plaintext.txt	106	The PrnpFT allele detected absence MnlI site compared wild type Prnpa allele
0.16557215.15722549.html.plaintext.txt	107	RESULTS Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Construction mouse lines 108F 189V introduced separately Prnpa allele 129Ola derived HM 1 ES cells using Cre Lox gene targeting strategy Lakso et al
0.16557215.15722549.html.plaintext.txt	108	These targeting events produced ES cell clones expressing Prnpa108F189T PrnpFT Prnpa108L189V PrnpLV
0.16557215.15722549.html.plaintext.txt	109	Presence targeted mutations verified loss MnlI restriction site codon 108 CTC TTC alteration loss BstEII restriction site codon 189 ACC GTC alteration Fig
0.16557215.15722549.html.plaintext.txt	110	Southern blot analysis using probes derived intronexon 2 region intron 2 exon 3 confirmed alterations occurred mouse genome targeting data shown
0.16557215.15722549.html.plaintext.txt	111	DNA sequence analysis carried ensure PrnpFT PrnpLV alleles undergone detectable deletions insertions rearrangements targeting process
0.16557215.15722549.html.plaintext.txt	112	However gene targeting strategy resulted retention 38 bp LoxP site small portion pBluescript multiple cloning site 100 bp 2 kb downstream exon 3 Prnp gene Fig
0.16557215.15722549.html.plaintext.txt	113	The LoxP site distant intergenic exons Prnp closely located Prnd doppel thus expected influence expression either gene
0.16557215.15722549.html.plaintext.txt	114	HM 1 ES cell clones bearing targeted PrnpFT PrnpLV alleles injected 3 5 day old BALBc blastocysts create chimeric mice Moore et al
0.16557215.15722549.html.plaintext.txt	115	1995 crossed 129Ola mice establish FTFT LVLV transgenic lines co isogenic 129Ola
0.16557215.15722549.html.plaintext.txt	116	The identical genetic background lines ensured observed alterations incubation time disease pathology direct result targeted mutations due effects genes mice genetic backgrounds
0.16557215.15722549.html.plaintext.txt	117	Expression PrP gene targeted lines Expression levels Prnp mRNA mature PrPC investigated FTFT LVLV brain compared wild type 129Ola mice LTLT existing gene targeted transgenic line expressing Prnpa108F189V FVFV Moore et al
0.16557215.15722549.html.plaintext.txt	118	3 analysis tissues line confirmed expression PrnpFT PrnpLV alleles indicated levels expression three homozygous lines FVFV LVLV FTFT indistinguishable wild type 129Ola mice
0.16557215.15722549.html.plaintext.txt	119	Prnp gene expression therefore affected process gene targeting introduction single polymorphism presence LoxP site 3 Prnp gene
0.16557215.15722549.html.plaintext.txt	120	Thus alteration incubation time neuropathology observed inoculation animals TSE infectivity attributable specific alterations codons 108 189 due differences Prnp gene expression levels
0.16557215.15722549.html.plaintext.txt	121	View larger version 86K Fig
0.16557215.15722549.html.plaintext.txt	122	Northern blot RNA extracted mice expressing codon 108 189 polymorphisms
0.16557215.15722549.html.plaintext.txt	123	Lanes 1 Prnpa 2 PrP 3 PrnpLVFT 4 PrnpFVFV 5 PrnpFV 6 PrnpLTLV 7 PrnpLVLV 8 PrnpLTFT 9 PrnpFTFT 10 Prnpa
0.16557215.15722549.html.plaintext.txt	124	Top panel probed 936 bp KpnI EcoRI fragment Prnp exon 3 bottom panel probed PCR generated 275 bp DNA fragment corresponding 18S rRNA sequence loading control
0.16557215.15722549.html.plaintext.txt	125	View larger version 38K Fig
0.16557215.15722549.html.plaintext.txt	126	Western blot uninfected mice expressing codon 108 189 polymorphisms
0.16557215.15722549.html.plaintext.txt	127	Lanes 1 wild type 129Ola mouse LTLT 2 LVLV mouse 3 FTFT mouse 4 FVFV mouse
0.16557215.15722549.html.plaintext.txt	128	Top panel probed anti PrP monoclonal antibody 7A12 bottom panel probed anti tubulin monoclonal antibody loading control
0.16557215.15722549.html.plaintext.txt	129	Interactions codon 108 189 polymorphisms ME7 scrapie The ME7 strain mouse scrapie passaged mice homozygous Prnpa gene LTLT produces short incubation times Prnpa LTLT mice prolonged incubation times Prnpb FVFV mice
0.16557215.15722549.html.plaintext.txt	130	Following ME7 challenge LTFV mice incubation times 223 days intermediate parental lines LTLT 155 days gene targeted FVFV 295 days
0.16557215.15722549.html.plaintext.txt	131	This pattern allelic interaction recapitulates observed wild type Prnpa Prnpb F1 crosses demonstrates gene targeted FV allele reproduce dominance pattern observed mice wild type PrP alleles
0.16557215.15722549.html.plaintext.txt	132	Incubation times 168 261 days obtained FTFT LVLV lines mice respectively Table 1 distinct wild type LTLT gene targeted FVFV mice indicating neither 108F 189T solely responsible increased incubation time FVFV mice
0.16557215.15722549.html.plaintext.txt	133	The significant change incubation time due T V alteration codon 189 producing difference 100 days LTLT LVLV lines
0.16557215.15722549.html.plaintext.txt	134	A much smaller difference 13 days produced L F polymorphism codon 108 FTFT demonstrating codon 108 189 polymorphisms alter murine scrapie incubation times independently
0.16557215.15722549.html.plaintext.txt	135	Incubation times ME7 301V mice different genetic combinations codons 108 189
0.16557215.15722549.html.plaintext.txt	136	In order assess full effect polymorphisms homozygous heterozygous situations LVLV FTFT mice crossed wild type LTLT mice gene targeted FVFV mice produce full repertoire genetic combinations Table 1
0.16557215.15722549.html.plaintext.txt	137	This breeding strategy produced 10 lines transgenic mice different PrP allelic combination
0.16557215.15722549.html.plaintext.txt	138	Each line mice inoculated intracerebrally ME7 resulting incubation times shown Table 1 Supplementary Figure available JGV Online
0.16557215.15722549.html.plaintext.txt	139	Introducing heterozygosity codons 108 189 revealed control incubation time two polymorphisms straightforward suggested data homozygous lines Table 1
0.16557215.15722549.html.plaintext.txt	140	There obvious pattern allelic combination associated increasing incubation time see Supplementary Figure JGV Online exception two shortest incubation times mice homozygous 189T 155 168 days two longest mice homozygous 189V 295 325 days keeping identity codon 189 source agent LTLT
0.16557215.15722549.html.plaintext.txt	141	However homozygosity codon 189 always produce extreme incubation times LTFT LVLV mice intermediate incubation times 196 261 days respectively Table 1
0.16557215.15722549.html.plaintext.txt	142	An association genotype incubation time identified 10 lines examined allelic combinations either codon 108 codon 189 Table 1
0.16557215.15722549.html.plaintext.txt	143	When lines sorted groups codon 189 genotype 189TT 189VV 189FV effect codon 108 incubation time three groups shortest incubation times occur codon 108 homozygous either L F although shorter two always 108LL matching source inoculum LTLT
0.16557215.15722549.html.plaintext.txt	144	Therefore codon 108 heterozygosity always leads increased incubation times respect combination codon 189 despite inoculum matching one allele codon 108
0.16557215.15722549.html.plaintext.txt	145	Indeed incubation times excess Prnpb FVFV mice observed FVLV mice Table 1 Supplementary Figure available JGV Online
0.16557215.15722549.html.plaintext.txt	146	However sorted codon 108 genotype 108LL 108FF 108LF different pattern incubation time observed
0.16557215.15722549.html.plaintext.txt	147	For three groups homozygosity threonine codon 189 matches source inoculum gives shortest incubation times homozygosity valine match inoculum gives longest incubation times whilst heterozygotes TV produce intermediate incubation times
0.16557215.15722549.html.plaintext.txt	148	Hence codon 108 ME7 incubation times follow pattern LL FF LF whilst codon 189 pattern incubation time TT TV VV
0.16557215.15722549.html.plaintext.txt	149	These results show effect incubation period depends upon combination PrP alleles particularly presence homozygosity heterozygosity codons 108 189 identity source inoculum positions PrP
0.16557215.15722549.html.plaintext.txt	150	Interactions codon 108 189 polymorphisms 301V strain In contrast ME7 challenge LTLT mice inoculated Prnpb FVFV passaged strain 301V long incubation periods 240 days
0.16557215.15722549.html.plaintext.txt	151	Similarly FVFV mice long ME7 incubation periods produce short incubation periods 125 days 301V
0.16557215.15722549.html.plaintext.txt	152	The role codons 108 189 control 301V incubation time explored challenge FTFT LVLV mice
0.16557215.15722549.html.plaintext.txt	153	Incubation times 141 202 days obtained LVLV FTFT lines mice respectively compared 125 days FVFV mice 240 days LTLT mice Table 1
0.16557215.15722549.html.plaintext.txt	154	Hence agreement data obtained inoculations ME7 codons 108 189 responsible control incubation time 301V agent strain
0.16557215.15722549.html.plaintext.txt	155	Similarly ME7 greatest effect produced T V alteration codon 189 100 days reduction
0.16557215.15722549.html.plaintext.txt	156	However L F change produced greater effect incubation time 301V 60 days reduction ME7 showing challenge agent shows identity codon 108 189 results shortest incubation times Table 1
0.16557215.15722549.html.plaintext.txt	157	The full range allelic combinations examined strain TSE agent
0.16557215.15722549.html.plaintext.txt	158	In addition incubation time available LTFT line
0.16557215.15722549.html.plaintext.txt	159	Six LTFT mice culled due welfare reasons 327 377 days showed positive TSE pathology examination brain tissue suggesting incubation time excess LTLT line 240 days
0.16557215.15722549.html.plaintext.txt	160	However combinations examined produced patterns incubation time alteration identical identified ME7 Table 1 Supplementary Figure available JGV Online exception F1 cross LTFV incubation time excess parental lines
0.16557215.15722549.html.plaintext.txt	161	This overdominance characteristic 301V observed TSE strains
0.16557215.15722549.html.plaintext.txt	162	Thus pattern incubation time 301V appears FF LL LF codon 108 VV TV TT codon 189
0.16557215.15722549.html.plaintext.txt	163	This pattern observed ME7 heterozygosity results extended incubation times 108LF intermediate incubation times 189TV
0.16557215.15722549.html.plaintext.txt	164	The shortest incubation times strains agent reveal preference identity genotype donor infectivity LTLT ME7 FVFV 301V
0.16557215.15722549.html.plaintext.txt	165	Effect polymorphisms PrPSc production Detergent homogenates prepared three terminal ME7 brains genotype
0.16557215.15722549.html.plaintext.txt	166	The homogenates treated PK analysed immunoblotting assess levels PK resistant PrP present model
0.16557215.15722549.html.plaintext.txt	167	Equal levels PK resistant PrP detected three mice genotype data shown
0.16557215.15722549.html.plaintext.txt	168	Levels also similar 10 different lines mice Fig
0.16557215.15722549.html.plaintext.txt	169	4 suggesting codon 108 189 polymorphisms effect PrPSc levels brains mice culled clinical ME7 infection
0.16557215.15722549.html.plaintext.txt	170	This also true lines challenged 301V data shown
0.16557215.15722549.html.plaintext.txt	171	View larger version 29K Fig
0.16557215.15722549.html.plaintext.txt	172	Western blot analysis PrPSc levels different allelic combinations inoculated ME7
0.16557215.15722549.html.plaintext.txt	173	Lanes 1 4 ME7 infected homozygous lines 1 LTLT 2 FVFV 3 LVLV 4 FTFT
0.16557215.15722549.html.plaintext.txt	174	Lanes 5 10 ME7 infected heterozygous lines 5 LTFV 6 LVLT 7 LVFV 8 FTLT 9 FTFV 10 FTLV
0.16557215.15722549.html.plaintext.txt	175	All samples treated PK 20 microg ml 1 1 h 37 degrees C
0.16557215.15722549.html.plaintext.txt	176	Blot probed anti PrP monoclonal antibody 7A12
0.16557215.15722549.html.plaintext.txt	177	Equivalent levels PrPSc present lines mice
0.16557215.15722549.html.plaintext.txt	178	Effect polymorphisms vacuolar pathology The targeting vacuolar pathology brain similar allelic combinations infected ME7 Fig
0.16557215.15722549.html.plaintext.txt	179	Thus codon 108 189 polymorphisms host PrP influence distribution vacuolar pathology ME7 strain scrapie
0.16557215.15722549.html.plaintext.txt	180	However polymorphisms appeared affect degree vacuolation
0.16557215.15722549.html.plaintext.txt	181	In general lines containing 189TT LTLT FTFT LTFT 189TV homozygosity 108 LTLV FTFV short incubation times 215 days gave similar vacuolation profiles
0.16557215.15722549.html.plaintext.txt	182	Lines displaying higher vacuolation scores longer incubation times contained 189VV FVFV LVLV FVLV heterozygous 108 189 LVFT
0.16557215.15722549.html.plaintext.txt	183	However LTFV heterozygote gave vacuolation profile similar LTLT mice Fig
0.16557215.15722549.html.plaintext.txt	184	Alternatively observations may simply reflect incubation time disease high degrees vacuolation associated extended incubation times
0.16557215.15722549.html.plaintext.txt	185	View larger version 17K Fig
0.16557215.15722549.html.plaintext.txt	186	Lesion profiles LVLV FTFT transgenic mice infected ME7 301V
0.16557215.15722549.html.plaintext.txt	187	The extent vacuolar change brain assessed semi quantitatively nine areas grey matter three areas white matter lesion profiling described previously Fraser Dickinson 1967
0.16557215.15722549.html.plaintext.txt	188	Animals scored scale 0 5 specific area mean scores calculated minimum six animals shown graphically error bars plus minus SEM
0.16557215.15722549.html.plaintext.txt	189	Grey matter scoring areas 1 dorsal medulla 2 cerebellar cortex 3 superior colliculus 4 hypothalamus 5 medial thalamus 6 hippocampus 7 septum 8 cerebral cortex 9 forebrain cerebral cortex
0.16557215.15722549.html.plaintext.txt	190	White matter scoring areas 1 cerebellar white matter 2 midbrain white matter 3 cerebral peduncle
0.16557215.15722549.html.plaintext.txt	191	ME7 lines profiles similar LTLT mice b ME7 lines profiles similar FVFV mice d 301V lines profiles similar LTLT mice e 301V lines profiles similar FVFV mice c f LTLT FVFV LTFV lines ME7 301V respectively
0.16557215.15722549.html.plaintext.txt	192	The effect codon 108 189 polymorphisms targeting prominent 301V infected lines targeting vacuolation varied LTLT FVFV mice Fig
0.16557215.15722549.html.plaintext.txt	193	189VV mice LVLV 189TV mice homozygous codon 108 LVLT gave profiles similar FVFV mice whilst 189TT mice FTFT LTFT gave profiles similar LTLT mice Fig
0.16557215.15722549.html.plaintext.txt	194	The LTFV heterozygote produced intermediate vacuolation profile Fig
0.16557215.15722549.html.plaintext.txt	195	The degree vacuolation 301V therefore appear controlled codon 108 189 polymorphisms incubation time extended incubation times FTFT LTFT mice resulted lower vacuolation scores areas 7 9 compared FVFV mice Fig
0.16557215.15722549.html.plaintext.txt	196	DISCUSSION Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Previous experiments shown introduction 108F189V murine Prnpa gene major effect TSE disease producing incubation times similar Prnpb mice Sinc s7 derived ME7 139A 79A 301C Sinc p7 derived 301V 22A strains Moore et al
0.16557215.15722549.html.plaintext.txt	197	2003 Barron Manson 2004
0.16557215.15722549.html.plaintext.txt	198	These results showed amino acids 108 189 murine PrP exert major control scrapie incubation time Prnpa Prnpb lines mice could determine whether either polymorphisms responsible control
0.16557215.15722549.html.plaintext.txt	199	By targeting polymorphism separately murine Prnpa gene able analyse specific effects codon 108 189 polymorphisms co isogenic mice independently several different allelic combinations
0.16557215.15722549.html.plaintext.txt	200	Inoculation lines two scrapie strains shown codons 108 189 murine PrP responsible control scrapie incubation time mice incubation times LVLV FTFT mice distinct produced LTLT FVFV mice
0.16557215.15722549.html.plaintext.txt	201	The shortest incubation times obtained PrP expressed alleles matched PrP inoculum LTLT ME7 FVFV 301V
0.16557215.15722549.html.plaintext.txt	202	Correspondingly long incubation times obtained LTLT mice 301V FVFV mice ME7
0.16557215.15722549.html.plaintext.txt	203	However analysis allelic combinations apparent shortened incubation times also obtained lines codon 189 matched source inoculum residues alleles codon 108 homogeneous
0.16557215.15722549.html.plaintext.txt	204	Of shortest incubation times occurred residues codon 108 matched source inoculum
0.16557215.15722549.html.plaintext.txt	205	In lines heterozygous codons 108 189 LT FV molecules one case LV FT molecules expressed shorter incubation times observed line expressing PrP matched source inoculum LTLT ME7
0.16557215.15722549.html.plaintext.txt	206	The importance homozygosity codon 108 identity inoculum codon 189 suggests areas protein play different roles disease process
0.16557215.15722549.html.plaintext.txt	207	The control incubation time thought due PrP sequence identity host donor infectivity
0.16557215.15722549.html.plaintext.txt	208	However results show short incubation times obtained FTFT mice inoculated LTLT derived ME7 LVLV mice inoculated FVFV derived 301V despite sequence incompatibility donor host codon 108
0.16557215.15722549.html.plaintext.txt	209	Hence although codon 108 polymorphisms affect scrapie incubation time independently major control due identity source inoculum codon 189
0.16557215.15722549.html.plaintext.txt	210	The inoculation mice expressing different combinations PrnpLT PrnpFV PrnpLV PrnpFT produced complex series incubation times see Supplementary Figure JGV Online
0.16557215.15722549.html.plaintext.txt	211	It clear addition identity inoculum codon 189 homozygosity codon 108 consistently gave rise shorter incubation times 108LL 108FF expressing lines
0.16557215.15722549.html.plaintext.txt	212	Heterozygosity codon 108 always resulted extended incubation times respect genotype codon 189
0.16557215.15722549.html.plaintext.txt	213	Although series allelic crosses produced experiments described homozygous heterozygous codons 108 189 expression Prnp alleles heterozygote result presence two different PrP populations cell
0.16557215.15722549.html.plaintext.txt	214	It interactions proteins Prnp alleles determine incubation time disease
0.16557215.15722549.html.plaintext.txt	215	Hence nature combination PrP variants recipient may important PrP identity inoculum indicating interactions amino acids 108 189 either different proteins critical part disease propagation
0.16557215.15722549.html.plaintext.txt	216	It proposed production PrPSc two step process involves binding PrP res PK resistant PrP PrP sen PK sensitive PrP followed conversion PrP sen PrP res Caughey 2001
0.16557215.15722549.html.plaintext.txt	217	However unknown process requires PrP amino acid identity
0.16557215.15722549.html.plaintext.txt	218	Cell free conversion experiments shown mouse PrP res 108L111V convert mouse PrP sen expressing 3F4 epitope 108M111M hamster PrP sen also possessing 3F4 epitope even though proteins found bind mouse PrP res Horiuchi et al
0.16557215.15722549.html.plaintext.txt	219	Deletion mutants lacking residues 34 113 MoPrP34 113 also bound mouse PrP res converted albeit reduced efficiency Lawson et al
0.16557215.15722549.html.plaintext.txt	220	These results imply amino acid 108 required either initiation conversion binding PrPSc may involved control rate conversion final conformation PrP res Lawson et al
0.16557215.15722549.html.plaintext.txt	221	Moreover MoPrP34 113 found bind heterologous PrPSc unlike full length molecule prevent conversion homologous PrPC suggesting region involved control conversion binding Lawson et al
0.16557215.15722549.html.plaintext.txt	222	The 34 113 truncation PrPC also found affect solubility molecule loss residues reduced percentage PrP sen seen self aggregate incubated cell free assay conditions absence PrP res
0.16557215.15722549.html.plaintext.txt	223	This region may therefore responsible degree multimerizationaggregation PrP sen may beneficial conversion Lawson et al
0.16557215.15722549.html.plaintext.txt	224	The individual effects codon 108 189 polymorphisms PrP also modelled vitro expressing recombinant 108F189T 108L189V PrP Escherichia coli Brown et al
0.16557215.15722549.html.plaintext.txt	225	These intermediate forms PrP found less stable PrP A 108L189T PrP B 108F189V observed lose normal conformation gain PK resistance time
0.16557215.15722549.html.plaintext.txt	226	It proposed inheritance either 108F 189V alone may disadvantage terms mouse survival mice expressing either polymorphisms separately could potentially develop spontaneous disease Brown et al
0.16557215.15722549.html.plaintext.txt	227	However recently reported existence Prnpc 108F189T expressing line Lloyd et al
0.16557215.15722549.html.plaintext.txt	228	2004 data presented transgenic FTFT LVLV lines show mice viable develop neurological phenotype lifespan
0.16557215.15722549.html.plaintext.txt	229	PrP expressed brains transgenic LTLT FVFV mice PK sensitive expressed levels identical wild type mice genotypes
0.16557215.15722549.html.plaintext.txt	230	These results demonstrate clearly vitro vivo studies produce different outcomes may due difference PrP post translational modification andor physiological environment native protein
0.16557215.15722549.html.plaintext.txt	231	From data presented predict polymorphisms PrP codon 189 control initial interaction binding agent incubation times reflect preference sequence identity host inoculum codon 189 ii polymorphisms codon 108 control rate conversion PrPC PrPSc ability induce multimerization PrPC increase efficiency conversion favoured PrP expressed cell homogeneous N terminal region
0.16557215.15722549.html.plaintext.txt	232	Alternatively preference codon 108 homozygosity may reflect complex interaction host PrPC PrPSc less efficient presence heterogeneous protein populations
0.16557215.15722549.html.plaintext.txt	233	However importance codon 108 homozygosity murine scrapie transmission may explain role PrP codon 129 human TSE disease majority CJD cases occur individuals homozygous methionine valine codon 129 Palmer et al
0.16557215.15722549.html.plaintext.txt	234	There representation MV heterozygotes CJD compared distribution genotypes normal population Palmer et al
0.16557215.15722549.html.plaintext.txt	235	1991 suggesting similar mechanism requiring N terminal homogeneity controls efficiency disease transmission humans
0.16557215.15722549.html.plaintext.txt	236	The results transmissions 108LF189TV lines transgenic mice therefore shown codon 189 polymorphisms exert major control scrapie incubation time efficiency disease transmission increased codon 108 homozygous suggesting multimer PrPC may involved conversion PrP TSE disease
0.16557215.15722549.html.plaintext.txt	237	Several studies suggested involvement PrP dimers disease Priola et al
0.16557215.15722549.html.plaintext.txt	238	1995 Warwicker 1997 2000 Meyer et al
0.16557215.15722549.html.plaintext.txt	239	2003 yet existing dimer models consider dimerization N terminal region PrP due lack structural information available region
0.16557215.15722549.html.plaintext.txt	240	Combined vivo data produced study observations amino acids 90 121 retained PK cleavage PrPSc deletion region affects susceptibility disease Fischer et al
0.16557215.15722549.html.plaintext.txt	241	2001 prove structurally important part molecule involved control disease incubation time
0.16557215.15722549.html.plaintext.txt	242	Analysis LVLV FTFT transgenic mice therefore shown amino acid polymorphisms codons 108 189 murine PrP involved control scrapie incubation time distinct regions PrP may play different roles disease process
0.16557215.15722549.html.plaintext.txt	243	Interactions within single PrP molecule molecules must therefore underlie mechanism incubation times controlled
0.16557215.15722549.html.plaintext.txt	244	Such structural interactions may provide key replication TSE infectivity
0.16557215.15722549.html.plaintext.txt	245	ACKNOWLEDGEMENTS The authors would like thank V
0.16557215.15722549.html.plaintext.txt	246	Murdoch care scoring animals M
0.16557215.15722549.html.plaintext.txt	247	Sy 7A12 monoclonal antibody A
0.16557215.15722549.html.plaintext.txt	248	Liu lesion profile analysis A
0.16557215.15722549.html.plaintext.txt	249	Mack tissue processing sectioning A
0.16557215.15722549.html.plaintext.txt	250	Gill review comment manuscript
0.16557215.15722549.html.plaintext.txt	251	This work supported Research Grant UK Biotechnology Biological Sciences Research Council
0.16557215.15722549.html.plaintext.txt	252	REFERENCES Top ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Alperovitch A
0.16557215.15722549.html.plaintext.txt	253	Codon 129 prion protein genotype sporadic Creutzfeldt Jakob disease
0.16557215.15722549.html.plaintext.txt	254	In Prions Prion Diseases Current Perspectives pp
0.16557215.15722549.html.plaintext.txt	255	Wymondham UK Horizon Bioscience
0.16557215.15722549.html.plaintext.txt	256	Transmission murine scrapie P101L transgenic mice
0.16557215.15722549.html.plaintext.txt	257	Scrapie cellular PrP isoforms encoded chromosomal gene
0.16557215.15722549.html.plaintext.txt	258	Functional structural differences prion protein two alleles prnpa prnpb mouse
0.16557215.15722549.html.plaintext.txt	259	Eur J Biochem 267 2452 2459
0.16557215.15722549.html.plaintext.txt	260	Linkage prion protein scrapie incubation time genes
0.16557215.15722549.html.plaintext.txt	261	Interactions prion protein isoforms kiss death Trends Biochem Sci 26 235 242
0.16557215.15722549.html.plaintext.txt	262	Single step method RNA isolation acid guanidinium thiocyanate phenol chloroform extraction
0.16557215.15722549.html.plaintext.txt	263	Identification gene controls incubation period strains scrapie agent mice
0.16557215.15722549.html.plaintext.txt	264	Prion protein PrP amino proximal deletions restoring susceptibility PrP knockout mice scrapie
0.16557215.15722549.html.plaintext.txt	265	Prion protein devoid octapeptide repeat region restores susceptibility scrapie PrP knockout mice
0.16557215.15722549.html.plaintext.txt	266	Distribution experimentally induced scrapie lesions brain
0.16557215.15722549.html.plaintext.txt	267	Fatal familial insomnia familial Creutzfeldt Jakob disease disease phenotype determined DNA polymorphism
0.16557215.15722549.html.plaintext.txt	268	PrP genotype agent effects scrapie change allelic interaction different isolates agent sheep natural host scrapie
0.16557215.15722549.html.plaintext.txt	269	Independent control immunoglobulin switch recombination individual switch regions evidenced Cre loxP mediated gene targeting
0.16557215.15722549.html.plaintext.txt	270	Interactions heterologous forms prion protein binding inhibition conversion species barriers
0.16557215.15722549.html.plaintext.txt	271	Proc Natl Acad Sci U S A 97 5836 5841
0.16557215.15722549.html.plaintext.txt	272	Structural intermediates putative pathway cellular prion protein pathogenic form
0.16557215.15722549.html.plaintext.txt	273	Seeding one dimensional crystallization amyloid pathogenic mechanism Alzheimers disease scrapie Cell 73 1055 1058
0.16557215.15722549.html.plaintext.txt	274	Targeted oncogene activation site specific recombination transgenic mice
0.16557215.15722549.html.plaintext.txt	275	Proc Natl Acad Sci U S A 89 6232 6236
0.16557215.15722549.html.plaintext.txt	276	N terminal truncation prion protein affects formation conformation abnormal protease resistant prion protein generated vitro
0.16557215.15722549.html.plaintext.txt	277	J Biol Chem 276 35265 35271
0.16557215.15722549.html.plaintext.txt	278	Flexible N terminal region prion protein influences conformation protease resistant prion protein isoforms associated cross species scrapie infection vivo vitro
0.16557215.15722549.html.plaintext.txt	279	J Biol Chem 279 13689 13695
0.16557215.15722549.html.plaintext.txt	280	Identification epitope C terminus normal prion protein whose expression modulated binding events N terminus
0.16557215.15722549.html.plaintext.txt	281	Identification characterization novel mouse prion gene allele
0.16557215.15722549.html.plaintext.txt	282	Molecular cloning complete sequence prion protein cDNA mouse brain infected scrapie agent
0.16557215.15722549.html.plaintext.txt	283	Proc Natl Acad Sci U S A 83 6372 6376
0.16557215.15722549.html.plaintext.txt	284	Soluble dimeric prion protein binds PrPSc vivo antagonizes prion disease
0.16557215.15722549.html.plaintext.txt	285	A monomer dimer equilibrium cellular prion protein PrPC observed recombinant PrP
0.16557215.15722549.html.plaintext.txt	286	J Biol Chem 275 38081 38087
0.16557215.15722549.html.plaintext.txt	287	Models human disease gene targeting
0.16557215.15722549.html.plaintext.txt	288	Biochem Soc Trans 23 398 403
0.16557215.15722549.html.plaintext.txt	289	Double replacement gene targeting production series mouse strains different prion protein gene alterations
0.16557215.15722549.html.plaintext.txt	290	Biotechnology N Y 13 999 1004
0.16557215.15722549.html.plaintext.txt	291	Mice gene targetted prion protein alterations show Prnp Sinc Prni congruent
0.16557215.15722549.html.plaintext.txt	292	Homozygous prion protein genotype predisposes sporadic Creutzfeldt Jakob disease
0.16557215.15722549.html.plaintext.txt	293	A 60 kDa prion protein PrP properties normal scrapie associated forms PrP
0.16557215.15722549.html.plaintext.txt	294	Novel proteinaceous infectious particles cause scrapie
0.16557215.15722549.html.plaintext.txt	295	Molecular biology pathogenesis prion diseases
0.16557215.15722549.html.plaintext.txt	296	Trends Biochem Sci 21 482 487
0.16557215.15722549.html.plaintext.txt	297	Gene targeting using mouse HPRT minigeneHPRT deficient embryonic stem cell system inactivation mouse ERCC 1 gene
0.16557215.15722549.html.plaintext.txt	298	Somat Cell Mol Genet 18 325 336
0.16557215.15722549.html.plaintext.txt	299	Expression amino terminally truncated PrP mouse leading ataxia specific cerebellar lesions
0.16557215.15722549.html.plaintext.txt	300	Identification two prion protein regions modify scrapie incubation time
0.16557215.15722549.html.plaintext.txt	301	Germ line transmission expression corrected HPRT gene produced gene targeting embryonic stem cells
0.16557215.15722549.html.plaintext.txt	302	Species barriers model specific prion protein dimerisation
0.16557215.15722549.html.plaintext.txt	303	Biochem Biophys Res Commun 232 508 512
0.16557215.15722549.html.plaintext.txt	304	Modeling prion protein dimer predictions fibril formation
0.16557215.15722549.html.plaintext.txt	305	Biochem Biophys Res Commun 278 646 652
0.16557215.15722549.html.plaintext.txt	306	Molecular biology transmissible spongiform encephalopathies
0.16557215.15722549.html.plaintext.txt	307	Distinct prion proteins short long scrapie incubation period mice
0.16557215.15722549.html.plaintext.txt	308	Codon 129 genotype new variant CJD
0.16557215.15722549.html.plaintext.txt	309	Received 13 August 2004 accepted 13 December 2004
0.16557215.15722549.html.plaintext.txt	310	This Article Abstract Full Text PDF Supplementary figure Alert article cited Alert correction posted Citation Map Services Email article friend Similar articles journal Similar articles PubMed Alert new issues journal Download citation manager Google Scholar Articles Barron R
0.16557215.15722549.html.plaintext.txt	311	Articles citing Article PubMed PubMed Citation Articles Barron R
0.16557215.15722549.html.plaintext.txt	312	Agricola Articles Barron R
0.16557215.15722549.html.plaintext.txt	313	HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL J MED MICROBIOL ALL SGM JOURNALS
0.10298463.11458009.html.plaintext.txt	0	Cellular prion protein status sheep tissue specific biochemical signatures Mohammed Moudjou1 Yveline Frobert2 Jacques Grassi2 Claude La Bonnardiere1
0.10298463.11458009.html.plaintext.txt	1	Institut National de la Recherche Agronomique INRA Virologie et Immunologie Moleculaires 78352 Jouy en Josas France1 Unite de Pharmacologie et d Immunologie CEA Saclay GifYvette France2
0.10298463.11458009.html.plaintext.txt	2	Author correspondence Mohammed Moudjou
0.10298463.11458009.html.plaintext.txt	3	Abstract Top Abstract Introduction Methods Results Discussion References Expression cellular prion protein PrPC sine qua none development transmissible spongiform encephalopathy thus accumulation illness associated conformer PrPSc
0.10298463.11458009.html.plaintext.txt	4	Therefore tissue distribution PrPC protein level quantitative qualitative terms investigated
0.10298463.11458009.html.plaintext.txt	5	PrPC quantified using two site enzyme immunometric assay calibrated purified ovine recombinant prion protein rPrP
0.10298463.11458009.html.plaintext.txt	6	The PrPC rich tissue brain followed lungs skeletal muscle heart uterus thymus tongue contained 20 50 fold less PrPC brain
0.10298463.11458009.html.plaintext.txt	7	The PrPC content tissues seems comparable sheep
0.10298463.11458009.html.plaintext.txt	8	Other organs however showed different low levels protein depending animal examined
0.10298463.11458009.html.plaintext.txt	9	This also case tissues gastrointestinal tract
0.10298463.11458009.html.plaintext.txt	10	The tissue containing lowest concentration PrPC shown liver PrPC found 564 16000 fold less abundant brain
0.10298463.11458009.html.plaintext.txt	11	PrPC concentrated crude cellular extracts immunoprecipitation using several monoclonal polyclonal anti ovine PrP antibodies
0.10298463.11458009.html.plaintext.txt	12	Interestingly observed isoform profile PrPC tissue specific
0.10298463.11458009.html.plaintext.txt	13	The atypical electrophoretic profile PrPC found skeletal muscle two polypeptides 32 35 kDa detected
0.10298463.11458009.html.plaintext.txt	14	Introduction Top Abstract Introduction Methods Results Discussion References Prion diseases belong family neurodegenerative disorders affect humans animals
0.10298463.11458009.html.plaintext.txt	15	The mechanisms prion transmission yet unravelled
0.10298463.11458009.html.plaintext.txt	16	Nevertheless admitted today one fundamental steps pathogenesis conversion host encoded cellular prion protein PrPC disease associated conformer PrPSc Prusiner 1998 Jackson Clarke 2000
0.10298463.11458009.html.plaintext.txt	17	Transmissible spongiform encephalopathies TSE characterized accumulation PrPSc brain expression PrPC shown crucial transmission disease formation PrPSc Bueler et al
0.10298463.11458009.html.plaintext.txt	18	One emerging hypotheses conversion phenomenon could take place site infectious agent meets PrPC
0.10298463.11458009.html.plaintext.txt	19	The latter shown expressed various domains hamster brain Bendheim et al
0.10298463.11458009.html.plaintext.txt	20	1999 Somerville 1999 several non neuronal tissues rodents Bendheim et al
0.10298463.11458009.html.plaintext.txt	21	1992 cows humans including spleen lymph nodes McBride et al
0.10298463.11458009.html.plaintext.txt	22	1992 squamous epithelia skin upper gastrointestinal tract Pammer et al
0.10298463.11458009.html.plaintext.txt	23	PrPC also detected surface lymphocytes humans mice Cashman et al
0.10298463.11458009.html.plaintext.txt	24	A PrP isoform truncated C terminus detected mature human bovine sperm Shaked et al
0.10298463.11458009.html.plaintext.txt	25	In addition PrPC mRNA shown present tissues tested date humans cattle sheep Goldmann et al
0.10298463.11458009.html.plaintext.txt	26	Nevertheless precise qualitative quantitative studies PrPC expression protein level never carried sheep
0.10298463.11458009.html.plaintext.txt	27	The difficulties investigation principally due lack efficient sensitive methods concentrate detect quantify PrPC non neuronal tissues expression expected low
0.10298463.11458009.html.plaintext.txt	28	1995 made first determination PrPC distribution sheep organs showed PrPC detected several tissues brain
0.10298463.11458009.html.plaintext.txt	29	The ratio PrPC expression brain tissues could however precisely determined time
0.10298463.11458009.html.plaintext.txt	30	Here report first quantification PrPC different tissues sheep using two site enzyme immunometric assay EIA
0.10298463.11458009.html.plaintext.txt	31	Furthermore use simple method immunoprecipitate PrPC crude tissue extract healthy sheep tissue demonstrated isoform profile PrPC tissue specific
0.10298463.11458009.html.plaintext.txt	32	The striking PrPC glycoform profile obtained skeletal muscle
0.10298463.11458009.html.plaintext.txt	33	Methods Top Abstract Introduction Methods Results Discussion References Antibodies
0.10298463.11458009.html.plaintext.txt	34	The anti PrP monoclonal antibodies MAbs used present work 4F2 12F10 Krasemann et al
0.10298463.11458009.html.plaintext.txt	35	1996 obtained Le Reseau Anticorps du Programme Francais de Recherche sur les ESST SAF34 SAF37 produced using hamster scrapie associated fibrils immunogen present 4F2 like specificity octarepeat region Rodolfo et al
0.10298463.11458009.html.plaintext.txt	36	Pc248 obtained immunization PrP mice PrPC purified sheep brain unpublished data
0.10298463.11458009.html.plaintext.txt	37	The anti PrP polyclonal antibody PAb MH44 obtained immunization rabbits ovine recombinant PrP rPrP expressed Escherichia coli purified homogeneity virtue intrinsic capacity bind divalent cations Rezaei et al
0.10298463.11458009.html.plaintext.txt	38	Specific peroxidase conjugated anti rabbit immunoglobulins IgGs purchased BioSys
0.10298463.11458009.html.plaintext.txt	39	Seven 2 year old ewes ewe I PrnP genotype ARQARR positions 136 154 171 ewe II ARQARR ewe III ARQARR ewe IV ARQVRQ ewe V AHQARR ewe VI ARQARR ewe VII ARQARR early stages pregnancy sacrificed controlled conditions organs rapidly removed placed ice maximum 30 min
0.10298463.11458009.html.plaintext.txt	40	After washing PBS organ frozen 80 degrees C use
0.10298463.11458009.html.plaintext.txt	41	The genotype PrnP locus determined codons 136 154 171 Labogena described Elsen et al
0.10298463.11458009.html.plaintext.txt	42	1999 except DNA purified skeletal muscle tissues
0.10298463.11458009.html.plaintext.txt	43	One sample sheep organ homogenized 10 suspension Polytron homogenizer Kinematica two different extraction buffers buffer B 12 5 mM Tris 12 5 mM MES pH 6 8 50 mM NaCl 1 Zwittergent 3 12 TL1 buffer 50 mM Tris HCl pH 7 5 0 5 Triton X 100 0 5 deoxycholate
0.10298463.11458009.html.plaintext.txt	44	Both buffers contained 1 mM PMSF 2 microgml aprotinin leupeptin pepstatin Sigma protease inhibitors
0.10298463.11458009.html.plaintext.txt	45	After centrifuging crude extract 4 degrees C 10 min 4000 g supernatants removed processed
0.10298463.11458009.html.plaintext.txt	46	Quantification PrPC different tissues using two site EIA
0.10298463.11458009.html.plaintext.txt	47	The solid phase EIA technique used present work described detail Rodolfo et al
0.10298463.11458009.html.plaintext.txt	48	Microtitre plates Immunoplate Maxisorp Nunc coated capture IgG MAbs SAF34 SAF37
0.10298463.11458009.html.plaintext.txt	49	The plates saturated EIA buffer 0 1 M potassium phosphate buffer pH 7 4 0 15 M NaCl 0 1 BSA stored 4 degrees C use
0.10298463.11458009.html.plaintext.txt	50	Before use plates washed three times wash buffer 10 mM phosphate buffer pH 7 4 containing 0 05 Tween 20 processed EIA test
0.10298463.11458009.html.plaintext.txt	51	Ovine rPrP VRQ allele purified described Rezaei et al
0.10298463.11458009.html.plaintext.txt	52	2000 used internal plate control produce standard curve ranging 10 0 078 ngml
0.10298463.11458009.html.plaintext.txt	53	Different dilutions extracts corresponding tissue made EIA buffer containing 0 1 Triton X 100 processed time standard protein
0.10298463.11458009.html.plaintext.txt	54	All dilutions duplicated experiment
0.10298463.11458009.html.plaintext.txt	55	After 3 h incubation room temperature mild shaking microtitre plates washed three times wash buffer incubated overnight 4 degrees C tracer antibody
0.10298463.11458009.html.plaintext.txt	56	The latter consists Fab fragments obtained 12F10 IgGs coupled G4 tetramer acetylcholinesterase AchE Grassi et al
0.10298463.11458009.html.plaintext.txt	57	After three washes AchE activity assessed adding Ellman reagent Ellman et al
0.10298463.11458009.html.plaintext.txt	58	1961 measuring absorbance 414 nm automatic reader LabSystems
0.10298463.11458009.html.plaintext.txt	59	Anti PrP MAbs Pc248 4F2 added 500 microl 50 mg tissue equivalent different clarified total extracts obtained described
0.10298463.11458009.html.plaintext.txt	60	The samples incubated 1 h room temperature
0.10298463.11458009.html.plaintext.txt	61	To spin immunocomplexes protein A Sepharose beads Pharmacia Amersham added mixtures incubated 1 h room temperature overnight 4 degrees C rotating wheel
0.10298463.11458009.html.plaintext.txt	62	The beads washed four times corresponding extraction buffer double distilled water dissolving 50 microl 8 M urea 20 mM DTT
0.10298463.11458009.html.plaintext.txt	63	The correct volume 4x Laemmli sample buffer added Laemmli 1970
0.10298463.11458009.html.plaintext.txt	64	The immunoprecipitated PrPC present ureaLaemmli sample buffer diluted deglycosylation buffer 50 mM Tris HCl pH 8 0 1 Nonidet P40 treated 0 5 Uml N glycosidase F Boehringer Mannheim 5 h 37 degrees C
0.10298463.11458009.html.plaintext.txt	65	Samples precipitated 10 trichloroacetic acid washed twice ethanol dissolving Laemmli sample buffer analysis Western blotting
0.10298463.11458009.html.plaintext.txt	66	SDS PAGE performed Miniprotean II Biorad system
0.10298463.11458009.html.plaintext.txt	67	Gel transfer proteins separated SDS PAGE carried using Minigel Transblot Cell system Biorad according manufacturer instructions
0.10298463.11458009.html.plaintext.txt	68	Low molecular mass markers Pharmacia Amersham follows phosphorylase b 94 kDa BSA 67 kDa ovalbumin 43 kDa carbonic anhydrase 30 kDa soybean trypsin inhibitor 20 kDa lactalbumin 14 kDa
0.10298463.11458009.html.plaintext.txt	69	After immunoprecipitation anti PrP MAbs Pc248 4F2 PrPC detected using either purified IgG fraction MH44 PAb biotinylated 4F2 MAb
0.10298463.11458009.html.plaintext.txt	70	PrPC visualized using ECL detection technique specific goat anti rabbit IgGs coupled peroxidase streptavidin coupled peroxidase Pierce respectively
0.10298463.11458009.html.plaintext.txt	71	Protein content determined Bradford method
0.10298463.11458009.html.plaintext.txt	72	Results Top Abstract Introduction Methods Results Discussion References Quantification PrPC different tissues PrPC quantified crude tissue homogenates sensitive quantification test prion protein Rodolfo et al
0.10298463.11458009.html.plaintext.txt	73	In cases quantification test calibrated using ovine rPrP purified E
0.10298463.11458009.html.plaintext.txt	74	This allowed us produce reproducible linear standard curve detection limit 2 5 ngml data shown Rodolfo et al
0.10298463.11458009.html.plaintext.txt	75	The standard curve similar whether rPrP diluted ELISA buffer brain homogenate obtained PrP mice Rodolfo et al
0.10298463.11458009.html.plaintext.txt	76	The detection limit obtained antibodies used present test around 70 pgml
0.10298463.11458009.html.plaintext.txt	77	Two series sheep used carry study
0.10298463.11458009.html.plaintext.txt	78	Fewer organs removed first series ewes I III
0.10298463.11458009.html.plaintext.txt	79	The results sheep tested presented histograms Figs 1 2
0.10298463.11458009.html.plaintext.txt	80	The overall distribution PrPC ewes I III ARQARR gave comparable values exceptions Fig
0.10298463.11458009.html.plaintext.txt	81	Aside brain tissues animals contained significant amounts PrPC lungs heart skeletal muscle although quantities 20 36 34 fold less brain respectively
0.10298463.11458009.html.plaintext.txt	82	Ewe IV ARQVRQ showed difference PrPC distribution compared found tissues ewes I III Figs 1 2
0.10298463.11458009.html.plaintext.txt	83	PrPC content tonsils ewe IV example three four times greater ewes I II
0.10298463.11458009.html.plaintext.txt	84	Furthermore lungs ewe IV contained less PrPC ewes I III
0.10298463.11458009.html.plaintext.txt	85	The uterus found PrPC rich extraneuronal tissue ewe IV
0.10298463.11458009.html.plaintext.txt	86	PrPC also detected salivary glands ewe V mammary glands ewe IV Fig
0.10298463.11458009.html.plaintext.txt	87	However limited number sheep studied conclusion regarding genotype effects level PrPC drawn stage
0.10298463.11458009.html.plaintext.txt	88	View larger version 39K Fig
0.10298463.11458009.html.plaintext.txt	89	PrPC quantification different tissues ewes I III
0.10298463.11458009.html.plaintext.txt	90	The PrPC content brain expressed microgg tissue ngg tissue organs
0.10298463.11458009.html.plaintext.txt	91	The different tissues tested follows tonsil Ts tongue Tg lung Lu heart H liver Li spleen Sp pancreas Pa kidney Ki skeletal muscle SM
0.10298463.11458009.html.plaintext.txt	92	View larger version 51K Fig
0.10298463.11458009.html.plaintext.txt	93	An example PrPC content sheep gastrointestinal tract tissues studied ewes IV V
0.10298463.11458009.html.plaintext.txt	94	The different tissues tested follows tonsil Ts tongue Tg lung Lu heart H liver Li spleen Sp pancreas Pa kidney Ki skeletal muscle SM uterus Ut thymus Tm reticulum Re rumen Ru duodenum Du jejunum Je ileum IL mammary glands Ma salivary glands SG
0.10298463.11458009.html.plaintext.txt	95	PrPC quantified different tissues taken digestive tract ewes IV VI
0.10298463.11458009.html.plaintext.txt	96	However values ewes IV V shown Fig
0.10298463.11458009.html.plaintext.txt	97	PrPC detected tissues tested
0.10298463.11458009.html.plaintext.txt	98	The values obtained ewes V VI along digestive tract however found two four times less quantified ewe IV
0.10298463.11458009.html.plaintext.txt	99	Interestingly observed liver tissue lowest PrPC content 0 3 4 ngg tissue sheep tested
0.10298463.11458009.html.plaintext.txt	100	Tissue specific isoform distribution PrPC To check whether organs differed content PrPC addition biochemical signature protein developed immunoprecipitation method concentrate PrPC whole tissue extracts
0.10298463.11458009.html.plaintext.txt	101	All tissues homogenized wtvol ratio 10
0.10298463.11458009.html.plaintext.txt	102	We first tried detect PrPC classical Western blot using several anti PrP MAbs PAbs
0.10298463.11458009.html.plaintext.txt	103	Only brain extract showed strong labelling PrPC data shown
0.10298463.11458009.html.plaintext.txt	104	However lengthy exposure nitrocellulose membranes detected faint signals PrPC always tissues skeletal muscle tongue lungs heart data shown
0.10298463.11458009.html.plaintext.txt	105	We decided concentrate PrPC immunoprecipitation directly clarified crude tissue extract detection Western blot
0.10298463.11458009.html.plaintext.txt	106	3 shows example comparative immunoprecipitation experiment MAb Pc248 IgG1 anti PrPC unrelated mouse IgG1 tissue extracts ewe VII
0.10298463.11458009.html.plaintext.txt	107	Only results obtained extracts prepared TL1 buffer shown gave best results especially non neuronal tissues
0.10298463.11458009.html.plaintext.txt	108	The control IgG immunoprecipitate PrPC different extracts Fig
0.10298463.11458009.html.plaintext.txt	109	PrPC detected immunoprecipitation Pc248 using two different probes PAb MH44 Fig
0.10298463.11458009.html.plaintext.txt	110	3A obtained injection ovine rPrP rabbits shown specifically recognize PrPC crude brain homogenate different species data shown biotinylated MAb 4F2 Krasemann et al
0.10298463.11458009.html.plaintext.txt	111	In cases PrPC profile obtained although intensity PrPC bands differed slightly tissues depending primary antibody used
0.10298463.11458009.html.plaintext.txt	112	Furthermore pre incubation primary antibodies used Western blot excess purified PrP abolished detection immunoprecipitated PrPC data shown
0.10298463.11458009.html.plaintext.txt	113	Altogether data showed signals obtained Pc248 specific PrPC
0.10298463.11458009.html.plaintext.txt	114	View larger version 46K Fig
0.10298463.11458009.html.plaintext.txt	115	Immunoprecipitation IP PrPC different tissue extracts Pc248 anti PrP MAb A B anti PrP unrelated control mouse IgG C analysed Western blot WB either MH44 anti PrP IgG A C biotinylated 4F2 IgG B
0.10298463.11458009.html.plaintext.txt	116	Tissues taken ewe VII
0.10298463.11458009.html.plaintext.txt	117	Asterisks indicate PrPC doublet detected skeletal muscle homogenate
0.10298463.11458009.html.plaintext.txt	118	The different tissues tested follows brain Br tongue Tg tonsil Ts lung Lu heart H spleen Sp liver Li skeletal muscle SM reticulum Re rumen Ru duodenum Du jejunum Je ileum IL mammary glands Ma pancreas Pa
0.10298463.11458009.html.plaintext.txt	119	Lane Br14 shows fourth dilution PrPC fraction obtained brain distinguish three PrPC glycoforms
0.10298463.11458009.html.plaintext.txt	120	In order confident results obtained Pc248 repeated immunoprecipitation experiment 4F2 purified IgG tissue extracts
0.10298463.11458009.html.plaintext.txt	121	4 kind PrPC profile obtained irrespective Western blot detection probe used visualize immunoprecipitated PrPC biotinylated 4F2 IgG Fig
0.10298463.11458009.html.plaintext.txt	122	View larger version 41K Fig
0.10298463.11458009.html.plaintext.txt	123	PrPC distribution different tissues ewe VII using 4F2 IgG immunoprecipitation IP followed Western blot WB detection either biotinylated 4F2 IgG A MH44 anti PrP PAb IgG B
0.10298463.11458009.html.plaintext.txt	124	The different tissues tested follows brain Br tongue Tg tonsil Ts lung Lu heart H spleen Sp liver Li skeletal muscle SM reticulum Re rumen Ru duodenum Du jejunum Je ileum IL mammary glands Ma
0.10298463.11458009.html.plaintext.txt	125	C IP PrPC H SM Br samples ewes III II indicating specific muscle profile PrPC
0.10298463.11458009.html.plaintext.txt	126	Note difference migration bi monoglycosylated isoforms brain PrPC PrPC doublet observed SM
0.10298463.11458009.html.plaintext.txt	127	Bi mono nonglycosylated B M N isoforms described brain indicated right
0.10298463.11458009.html.plaintext.txt	128	It evident Western blots carried immunoprecipitation several non neuronal tissues showed significant levels PrPC
0.10298463.11458009.html.plaintext.txt	129	A striking tissue specificity qualitative profile different isoforms PrPC obtained
0.10298463.11458009.html.plaintext.txt	130	Actually glycoform signature PrPC brain obtained anti PrP antibodies described literature general characterized presence three bands decreasing intensity representing bi mono unglycosylated isoforms PrP Fig
0.10298463.11458009.html.plaintext.txt	131	In lungs complex profile hyperglycosylated isoforms always observed
0.10298463.11458009.html.plaintext.txt	132	Furthermore band migrating level unglycosylated isoform lungs migrated slightly faster corresponding band brain Figs 4A B 5A
0.10298463.11458009.html.plaintext.txt	133	The second atypical PrPC electrophoretic profile reproducibly observed skeletal muscle clear doublet PrPC detected seven sheep tested Figs 3 4 lanes SM
0.10298463.11458009.html.plaintext.txt	134	The PrPC profile skeletal muscle specific since observed types muscular tissue heart tongue
0.10298463.11458009.html.plaintext.txt	135	In uterus either without myometrium PrPC profile different observed skeletal muscle reminiscent heart PrPC profile data shown
0.10298463.11458009.html.plaintext.txt	136	The two bands skeletal muscle migrated slower bi monoglycosylated isoforms brain 32 kDa skeletal muscle instead 30 kDa brain monoglycosylated band 35 kDa skeletal muscle instead 33 kDa brain biglycosylated band Fig
0.10298463.11458009.html.plaintext.txt	137	The signals obtained spleen kidney often low Figs 1 3
0.10298463.11458009.html.plaintext.txt	138	PrPC significantly detected liver tissue Figs 3 4
0.10298463.11458009.html.plaintext.txt	139	This indicates liver tissue contains lowest amount PrPC within detection limits immuno concentration method described present work
0.10298463.11458009.html.plaintext.txt	140	View larger version 106K Fig
0.10298463.11458009.html.plaintext.txt	141	Sensitivity PrPC brain skeletal muscle lungs treatment N glycosidase F
0.10298463.11458009.html.plaintext.txt	142	PrPC immunoprecipitated MAb 4F2 brain Br skeletal muscle SM lung Lu extracts either A untreated PNGase B incubated N glycosidase F PNGase described Methods
0.10298463.11458009.html.plaintext.txt	143	PrPC detected Western blotting biotinylated 4F2 MAb
0.10298463.11458009.html.plaintext.txt	144	Lanes SM Lu loaded PrPC immunoprecipitated amount tissue extract lane Br represents PrPC obtained third tissue equivalent brain skeletal muscle lungs
0.10298463.11458009.html.plaintext.txt	145	Note nonglycosylated PrPC isoform lungs migrated reduced molecular mass
0.10298463.11458009.html.plaintext.txt	146	Secondly investigated distribution PrPC along digestive tract
0.10298463.11458009.html.plaintext.txt	147	Sections tissue gastrointestinal tract removed second series sheep ewes IV VII
0.10298463.11458009.html.plaintext.txt	148	Only results ewe VII shown
0.10298463.11458009.html.plaintext.txt	149	We observed signals obtained PrPC tissues often diffuse level biglycosylated forms Figs 3 4
0.10298463.11458009.html.plaintext.txt	150	The distribution PrPC along digestive tract shown different one sheep another Fig
0.10298463.11458009.html.plaintext.txt	151	In ewe VII PrPC found along digestive tract PrPC reticulum ileum Figs 3 4 whereas ewe IV PrPC mainly detected reticulum rumen duodenum Fig
0.10298463.11458009.html.plaintext.txt	152	In ewe V PrPC concentrated reticulum rumen Fig
0.10298463.11458009.html.plaintext.txt	153	In order check PrPC isoforms detected tissues corresponded glycoforms carried deglycosylation experiment PrPC immunoprecipitated skeletal muscle lung brain Fig
0.10298463.11458009.html.plaintext.txt	154	Treatment PrPC N glycosidase F resulted simplifying PrPC profile one band probably corresponds nonglycosylated PrPC Fig
0.10298463.11458009.html.plaintext.txt	155	Interestingly nonglycosylated PrPC isoform obtained lung migrated faster obtained brain skeletal muscle
0.10298463.11458009.html.plaintext.txt	156	Discussion Top Abstract Introduction Methods Results Discussion References PrPC expression necessary development TSE Bueler et al
0.10298463.11458009.html.plaintext.txt	157	The spatial sequence events oral infection still completely understood
0.10298463.11458009.html.plaintext.txt	158	Following oral challenge assumed gastrointestinal tract associated lymphoreticular system represent first tissues PrPSc could detected thus corresponding tissues support infection McKinley et al
0.10298463.11458009.html.plaintext.txt	159	1999 Beekes McBride 2000 Andreoletti et al
0.10298463.11458009.html.plaintext.txt	160	PrPC found substrate formation pathology associated conformer PrPSc Weissmann 1996
0.10298463.11458009.html.plaintext.txt	161	The distribution cellular form PrPC non neuronal tissues however well documented sheep
0.10298463.11458009.html.plaintext.txt	162	The quantification test used present work permitted PrPC ratio brain extraneuronal tissues determined
0.10298463.11458009.html.plaintext.txt	163	The EIA test able detect PrPC several crude non neuronal tissue extracts even tenfold dilution
0.10298463.11458009.html.plaintext.txt	164	We mention EIA originally designed detect PrPres post mortem diagnosis bovine spongiform encephalopathy
0.10298463.11458009.html.plaintext.txt	165	In context EIA evaluated European Commission supervised Directorate XXIV Moynagh Schimmel 1999 Moynagh et al
0.10298463.11458009.html.plaintext.txt	166	1999 concluded test sensitive one time
0.10298463.11458009.html.plaintext.txt	167	In general good correlation results obtained EIA observed using immunoprecipitationWestern blot experiment
0.10298463.11458009.html.plaintext.txt	168	The tissue distribution PrPC sheep first studied Horiushi et al
0.10298463.11458009.html.plaintext.txt	169	However Horiushi co workers used microsomal preparations different tissues enrich PrPC
0.10298463.11458009.html.plaintext.txt	170	We recently shown solubilized microsomal PrPC population correspond 16 total brain PrPC unpublished data
0.10298463.11458009.html.plaintext.txt	171	Altogether data prompted us set different procedure could better reflect true PrPC content different tissues qualitative quantitative terms
0.10298463.11458009.html.plaintext.txt	172	In cases PrPC could detected loading 5 mg tissue equivalent per lane almost tissues except liver
0.10298463.11458009.html.plaintext.txt	173	Serial dilutions made tissues richest PrPC content lungs skeletal muscle heart showed could still detect PrPC equivalent 0 5 1 mg tissue data shown
0.10298463.11458009.html.plaintext.txt	174	Similar results obtained immunoprecipitationWestern blot assays using several combinations MAbs PAbs
0.10298463.11458009.html.plaintext.txt	175	Furthermore observed two different anti PrP PAbs MH44 MH48 produced laboratory immunoprecipitated additional faint band 66 kDa skeletal muscle data shown
0.10298463.11458009.html.plaintext.txt	176	This band could correspond dimeric form PrPC present specifically tissue
0.10298463.11458009.html.plaintext.txt	177	Comparable results different animals found several tissues lungs heart skeletal muscle tongue
0.10298463.11458009.html.plaintext.txt	178	Data gastrointestinal tract tissues varied individual sheep
0.10298463.11458009.html.plaintext.txt	179	Given low number sheep tested present work could determine whether relationship animal genotype PrP locus tissue expression PrPC
0.10298463.11458009.html.plaintext.txt	180	Interestingly organs PrPC could immunoprecipitated bands either bi hyperglycosylated isoforms clearly detected
0.10298463.11458009.html.plaintext.txt	181	Nevertheless specific PrPC isoform signature systematically observed skeletal muscle either thigh flank two bands migrating slowly brain mono biglycosylated isoforms Fig
0.10298463.11458009.html.plaintext.txt	182	These two bands correspond PrPC glycoforms deglycosylation resulted one band migrating level nonglycosylated protein obtained brain
0.10298463.11458009.html.plaintext.txt	183	However differences composition length oligosaccharide chains present PrPC could differ brain skeletal muscle could explain difference migration observed mono biglycosylated isoforms two tissues
0.10298463.11458009.html.plaintext.txt	184	Furthermore shown nonglycosylated form obtained lungs migrated faster equivalents brain skeletal muscle
0.10298463.11458009.html.plaintext.txt	185	Whether result N C terminal truncation yet known
0.10298463.11458009.html.plaintext.txt	186	Indeed PrP isoform truncated C terminal observed mature human bovine sperm Shaked et al
0.10298463.11458009.html.plaintext.txt	187	We note pieces skeletal muscle removed careful attention avoid residual nervous fibres
0.10298463.11458009.html.plaintext.txt	188	However neuromuscular junctions probably remained
0.10298463.11458009.html.plaintext.txt	189	Several arguments indicate typical muscular profile described really belongs muscle cells
0.10298463.11458009.html.plaintext.txt	190	PrPC indeed detected developing mouse muscle cells Brown et al
0.10298463.11458009.html.plaintext.txt	191	Furthermore PrPC immunolocalized subsynaptic sarcoplasm neuromuscular junction mammalian muscles Gohel et al
0.10298463.11458009.html.plaintext.txt	192	PrPC also detected immunoblotting skeletal muscle hamster Bendheim et al
0.10298463.11458009.html.plaintext.txt	193	1992 quadriceps muscle homogenates non transgenic mice Westaway et al
0.10298463.11458009.html.plaintext.txt	194	Overexpression hamster PrPC homozygote TgShaPrP7 uninfected older mice resulted spontaneous degeneration central nervous system CNS skeletal muscle neuromyopathy Westaway et al
0.10298463.11458009.html.plaintext.txt	195	Altogether results underline potential role PrPC skeletal muscle cells
0.10298463.11458009.html.plaintext.txt	196	The tissue distribution developmental expression sheep PrP mRNA published Goldmann et al
0.10298463.11458009.html.plaintext.txt	197	No correlation mRNA protein levels however established
0.10298463.11458009.html.plaintext.txt	198	Altogether data reflect either tissue specific regulation mRNA initiation translation andor stability tissue specific PrPC catabolism control
0.10298463.11458009.html.plaintext.txt	199	Our finding supports idea organs infectivity demonstrated tonsil thymus intestine spleen contain PrPC tissues shown support infection skeletal muscle heart Hadlow et al
0.10298463.11458009.html.plaintext.txt	200	Thus like species barrier tissue barrier phenomenon infection might also exist
0.10298463.11458009.html.plaintext.txt	201	Several hypotheses could proposed possible physical andor physiological barriers may preclude infectious agent reaching tissues ii existence co factors necessary achievement PrPC conversion tissues support infection presence inhibitory molecules uninfectious organs could also explain discrepancy iii possible relationship biochemical features PrPC e
0.10298463.11458009.html.plaintext.txt	202	glycoform diversity among tissues unidentified tissue specific PrPC post translational modifications tissue differences PrP clearance susceptibility converted scrapie form still remains open question
0.10298463.11458009.html.plaintext.txt	203	One intriguing phenomena sheep dependence PrnP locus genotype susceptibility scrapie Bossers et al
0.10298463.11458009.html.plaintext.txt	204	It demonstrated animals highly susceptible scrapie homozygote VRQVRQ positions 136 154 171 accumulate PrPSc lymphoid tissue early stages disease Schreuder et al
0.10298463.11458009.html.plaintext.txt	205	1996 1998 van Keulen et al
0.10298463.11458009.html.plaintext.txt	206	Later PrPSc detected CNS
0.10298463.11458009.html.plaintext.txt	207	This sequence PrPSc appearance found sheep moderately susceptible scrapie heterozygote ARRVRQ PrPSc deposits observed CNS
0.10298463.11458009.html.plaintext.txt	208	These results indicate nature protein might play role physiological bolt control conversion events
0.10298463.11458009.html.plaintext.txt	209	In conclusion development biochemical quantitative studies tissue distribution PrPC might allow important advances understanding biochemistry function protein
0.10298463.11458009.html.plaintext.txt	210	Furthermore studies combined immunocytochemical localization PrPC
0.10298463.11458009.html.plaintext.txt	211	The latter point precisely indicate cell type expresses PrPC given organ
0.10298463.11458009.html.plaintext.txt	212	It interesting look accumulation PrPSc cellular level course infection
0.10298463.11458009.html.plaintext.txt	213	This might aid development pre clinical diagnoses TSE
0.10298463.11458009.html.plaintext.txt	214	Acknowledgments We thank H
0.10298463.11458009.html.plaintext.txt	215	Grosclaude providing us recombinant ovine PrP E
0.10298463.11458009.html.plaintext.txt	216	Cluzeaud Pc248 MAb production C
0.10298463.11458009.html.plaintext.txt	217	Fretier helpful advice ELISA experimentation
0.10298463.11458009.html.plaintext.txt	218	Vilette helpful discussion Wendy Brand Williams checking English
0.10298463.11458009.html.plaintext.txt	219	This work supported INRA Le Reseau Francais de Recherche sur les ESST
0.10298463.11458009.html.plaintext.txt	220	References Top Abstract Introduction Methods Results Discussion References Andreoletti O
0.10298463.11458009.html.plaintext.txt	221	Early accumulation PrPSc gut associated lymphoid nervous tissues susceptible sheep Romanov flock natural scrapie
0.10298463.11458009.html.plaintext.txt	222	Journal General Virology 81 3115 3126
0.10298463.11458009.html.plaintext.txt	223	Differential expression cellular prion protein human blood tonsil lymphocytes
0.10298463.11458009.html.plaintext.txt	224	Prion protein abnormally accumulated inclusion body myositis
0.10298463.11458009.html.plaintext.txt	225	Early accumulation pathological PrP enteric nervous system gut associated lymphoid tissue hamsters orally infected scrapie
0.10298463.11458009.html.plaintext.txt	226	Neuroscience Letters 278 181 184
0.10298463.11458009.html.plaintext.txt	227	Nearly ubiquitous tissue distribution scrapie agent precursor protein
0.10298463.11458009.html.plaintext.txt	228	Natural experimental infection nonhuman primates bovine spongiform encephalopathy agents
0.10298463.11458009.html.plaintext.txt	229	Proceedings National Academy Sciences USA 96 4046 4051
0.10298463.11458009.html.plaintext.txt	230	PrP genotypes contribute determining survival times sheep natural scrapie
0.10298463.11458009.html.plaintext.txt	231	Journal General Virology 77 2669 2673
0.10298463.11458009.html.plaintext.txt	232	Prion protein expression muscle cells toxicity prion protein fragment
0.10298463.11458009.html.plaintext.txt	233	European Journal Cell Biology 75 29 37
0.10298463.11458009.html.plaintext.txt	234	Mice devoid PrP resistant scrapie
0.10298463.11458009.html.plaintext.txt	235	Cellular isoform scrapie agent protein participates lymphocyte activation
0.10298463.11458009.html.plaintext.txt	236	BSE risk man pharmaceutical products Position politics German pharmaceutical industry
0.10298463.11458009.html.plaintext.txt	237	In Transmissible Spongiform Encephalopathies Impact Animal Human Health pp
0.10298463.11458009.html.plaintext.txt	238	PrPC glycoform heterogeneity function brain region implications selective targeting neurons prion strains
0.10298463.11458009.html.plaintext.txt	239	Journal Neuropathology Experimental Neurology 58 1000 1009
0.10298463.11458009.html.plaintext.txt	240	A new rapid colorimetric determination acetylcholinesterase activity
0.10298463.11458009.html.plaintext.txt	241	Biochemical Pharmacology 7 88 95
0.10298463.11458009.html.plaintext.txt	242	Genetic susceptibility transmission factors scrapie detailed analysis epidemic closed flock Romanov
0.10298463.11458009.html.plaintext.txt	243	Archives Virology 144 431 445
0.10298463.11458009.html.plaintext.txt	244	Ultrastructural localization cellular prion protein PrPC neuromuscular junction
0.10298463.11458009.html.plaintext.txt	245	Journal Neuroscience Research 55 261 267
0.10298463.11458009.html.plaintext.txt	246	PrP prion gene expression sheep may modulated alternative polyadenylation messenger RNA
0.10298463.11458009.html.plaintext.txt	247	Journal General Virology 80 2275 2283
0.10298463.11458009.html.plaintext.txt	248	Screening monoclonal antibodies using antigen labeled acetylcholinesterase applications peripheral proteins photosystem I
0.10298463.11458009.html.plaintext.txt	249	Analytical Biochemistry 168 436 450
0.10298463.11458009.html.plaintext.txt	250	Natural infection Suffolk sheep scrapie virus
0.10298463.11458009.html.plaintext.txt	251	Journal Infectious Diseases 146 657 664
0.10298463.11458009.html.plaintext.txt	252	A cellular form prion protein PrPC exists many non neuronal tissues sheep
0.10298463.11458009.html.plaintext.txt	253	Journal General Virology 76 2583 2587
0.10298463.11458009.html.plaintext.txt	254	Natural scrapie closed flock Cheviot sheep occurs specific PrP genotypes
0.10298463.11458009.html.plaintext.txt	255	Archives Virology 141 809 824
0.10298463.11458009.html.plaintext.txt	256	Current Opinion Structural Biology 10 69 74
0.10298463.11458009.html.plaintext.txt	257	Generation monoclonal antibodies human prion proteins PrP00 mice
0.10298463.11458009.html.plaintext.txt	258	Cleavage structural proteins assembly bacteriophage T4
0.10298463.11458009.html.plaintext.txt	259	T lymphocyte activation cellular form prion protein
0.10298463.11458009.html.plaintext.txt	260	PrP protein associated follicular dendritic cells spleens lymph nodes uninfected scrapie infected mice
0.10298463.11458009.html.plaintext.txt	261	Journal Pathology 168 413 418
0.10298463.11458009.html.plaintext.txt	262	A protease resistant protein structural component scrapie prion
0.10298463.11458009.html.plaintext.txt	263	Pathogenesis oral route infection mice scrapie bovine spongiform encephalopathy agents
0.10298463.11458009.html.plaintext.txt	264	Journal General Virology 80 3035 3042
0.10298463.11458009.html.plaintext.txt	265	Bovine spongiform encephalopathies
0.10298463.11458009.html.plaintext.txt	266	The evaluation tests diagnosis transmissible spongiform encephalopathy bovines
0.10298463.11458009.html.plaintext.txt	267	In Consumer Policy Consumer Health Protection
0.10298463.11458009.html.plaintext.txt	268	Preliminary report European Commission
0.10298463.11458009.html.plaintext.txt	269	Scientific health opinions Directorate B
0.10298463.11458009.html.plaintext.txt	270	Human keratinocytes express cellular prion related protein vitro inflammatory skin diseases
0.10298463.11458009.html.plaintext.txt	271	American Journal Pathology 153 1353 1358
0.10298463.11458009.html.plaintext.txt	272	Cellular prion protein expressed bovine squamous epithelia skin upper gastrointestinal tract
0.10298463.11458009.html.plaintext.txt	273	Proceeding National Academy Sciences USA 95 13363 13383
0.10298463.11458009.html.plaintext.txt	274	Ablation prion protein PrP gene mice prevents scrapie facilitates production anti PrP antibodies
0.10298463.11458009.html.plaintext.txt	275	Proceedings National Academy Sciences USA 90 10608 10612
0.10298463.11458009.html.plaintext.txt	276	Scrapie infectivity proteinase K resistant prion protein sheep placenta brain spleen lymph node implications transmission antemortem diagnosis
0.10298463.11458009.html.plaintext.txt	277	Journal Infectious Diseases 178 949 953
0.10298463.11458009.html.plaintext.txt	278	High yield purification physico chemical properties full length recombinant allelic variants sheep prion protein linked scrapie susceptibility
0.10298463.11458009.html.plaintext.txt	279	European Journal Biochemistry 267 2833 2839
0.10298463.11458009.html.plaintext.txt	280	Quantitative measurement mammalian cellular prion protein two site immunometric assays using specific monoclonal antibodies
0.10298463.11458009.html.plaintext.txt	281	Journal Immunological Methods press
0.10298463.11458009.html.plaintext.txt	282	Preclinical test prion diseases
0.10298463.11458009.html.plaintext.txt	283	Tonsillar biopsy PrPSc detection preclinical diagnosis scrapie
0.10298463.11458009.html.plaintext.txt	284	Veterinary Records 142 564 568
0.10298463.11458009.html.plaintext.txt	285	A C terminal truncated PrP isoform present mature sperm
0.10298463.11458009.html.plaintext.txt	286	Journal Biological Chemistry 274 32153 32158
0.10298463.11458009.html.plaintext.txt	287	Host transmissible spongiform encephalopathy agent strain control glycosylation PrP
0.10298463.11458009.html.plaintext.txt	288	Journal General Virology 80 1865 1872
0.10298463.11458009.html.plaintext.txt	289	Immunohistochemical detection prion protein lymphoid tissues sheep natural scrapie
0.10298463.11458009.html.plaintext.txt	290	Journal Clinical Microbiology 34 1228 1231
0.10298463.11458009.html.plaintext.txt	291	Scrapie associated prion protein gastrointestinal tract sheep natural scrapie
0.10298463.11458009.html.plaintext.txt	292	Journal Comparative Pathology 121 55 63
0.10298463.11458009.html.plaintext.txt	293	Molecular biology transmissible spongiform encephalopathies
0.10298463.11458009.html.plaintext.txt	294	Degeneration skeletal muscle peripheral nerves central nervous system transgenic mice overexpressing wild type prion protein
0.10298463.11458009.html.plaintext.txt	295	Received 3 April 2001 accepted 8 May 2001
0.1233631.15598926.html.plaintext.txt	0	Editor Chief University Oxford Department Clinical Pharmacology Oxford UK
0.1233631.15598926.html.plaintext.txt	1	Can recollect teenage years Disraeli said The blunders youth preferable triumphs manhood success old age perhaps right unconquerable sense optimism seeming immortality sometime faltering sense self
0.1233631.15598926.html.plaintext.txt	2	Annals Oncology 15 years old year
0.1233631.15598926.html.plaintext.txt	3	This may seem minor achievement compared 340 years Philosophical Transactions Royal Society I know cause satisfaction surprise present birth
0.1233631.15598926.html.plaintext.txt	4	We need speak overmuch conception legend occurred bar I wasnt
0.1233631.15598926.html.plaintext.txt	5	Credit due Franco Cavalli worked make barroom banter reality space 10 years made Annals one worlds leading clinical oncology journals
0.1233631.15598926.html.plaintext.txt	6	It may worthwhile remind recent 1990 far Annals come 15 years
0.1233631.15598926.html.plaintext.txt	7	1990 began George Bush Sr White House Margaret Thatcher 10 Downing Street Nelson Mandela prison
0.1233631.15598926.html.plaintext.txt	8	In Berlin Wall began taken thousands stormed Stasis HQ
0.1233631.15598926.html.plaintext.txt	9	In Britain thousands rioted poll tax government minister fed daughter beefburger television counter rumours mad cow disease
0.1233631.15598926.html.plaintext.txt	10	In August Iraq invaded Kuwait precipitating Gulf War
0.1233631.15598926.html.plaintext.txt	11	In November computer scientist working CERN laboratory Geneva published paper describing something called World Wide Web
0.1233631.15598926.html.plaintext.txt	12	The contribution Annals Oncology world events exactly nil
0.1233631.15598926.html.plaintext.txt	13	To suggest otherwise would hubristic nonsense
0.1233631.15598926.html.plaintext.txt	14	But within clinical oncology Annals made making difference
0.1233631.15598926.html.plaintext.txt	15	Let give numbers 1990 Annals Oncology received 252 manuscripts last year figure nearly 1000
0.1233631.15598926.html.plaintext.txt	16	In 1990 Annals published barely 450 pages last year figure 1800
0.1233631.15598926.html.plaintext.txt	17	In last 5 years alone impact factor journal gone 26 last years increase 3
0.1233631.15598926.html.plaintext.txt	18	605 biggest single year increase record
0.1233631.15598926.html.plaintext.txt	19	Subscriptions journal grown dramatically paralleling growth ESMO advent online journal httpannonc
0.1233631.15598926.html.plaintext.txt	20	org institutional access journal increased hundred paper subscribers several thousand online
0.1233631.15598926.html.plaintext.txt	21	Last year Annals web site served 700 000 full text articles readers world including profit institutions 120 developing middle income countries able apply free receive greatly discounted online access journal initiatives operated Oxford University Press OUP World Health Organisation WHO International Network Availability Scientific Publications
0.1233631.15598926.html.plaintext.txt	22	This year Annals full support ESMO OUP move copyright licence system allow authors retain copyright published articles
0.1233631.15598926.html.plaintext.txt	23	All concerned agree fair right I believe make contribution expanding access Annals
0.1233631.15598926.html.plaintext.txt	24	In parallel development making changes journals website
0.1233631.15598926.html.plaintext.txt	25	Operation website remain inestimable hands Stanford Universitys HighWire Press hope tweak things improve experience expand access
0.1233631.15598926.html.plaintext.txt	26	Significant among tweaks move advance access publication publication ahead print charmingly shorthanded PAP cognoscenti
0.1233631.15598926.html.plaintext.txt	27	This involve accepted article published journals website soon finalised corrected proof becomes available irrespective paper issue assigned
0.1233631.15598926.html.plaintext.txt	28	In way hope able bring important articles Annals readers 4 8 weeks ahead print publication see httpannonc
0.1233631.15598926.html.plaintext.txt	29	I hope clear I place support authors editors referees heart Journal
0.1233631.15598926.html.plaintext.txt	30	Last year awarded Annals Oncology prizes 1 predicted 2 proved worthwhile experience thanks support authors chose Annals place wanted publish research
0.1233631.15598926.html.plaintext.txt	31	The breadth diversity science submitted Annals never ceases astonish significant phase III randomised trials 3 4 early clinical 5 preclinical 6 studies analyses websites complementary medicine 7 important epidemiologic analyses 8
0.1233631.15598926.html.plaintext.txt	32	Similarly I able look many invited editorials e
0.1233631.15598926.html.plaintext.txt	33	11 12 recently published Annals considerable satisfaction
0.1233631.15598926.html.plaintext.txt	34	So Annals Oncology big hearted clever still trying hard fulfill potential 15 years old
0.1233631.15598926.html.plaintext.txt	35	And hopefully still enough honesty humility recognize small part work others made
0.1233631.15598926.html.plaintext.txt	36	A word ear Annals Oncology prizes
0.1233631.15598926.html.plaintext.txt	37	A little citadel light malignant sea darkness
0.1233631.15598926.html.plaintext.txt	38	Fleming GF Filiaci VL Bentley RC et al
0.1233631.15598926.html.plaintext.txt	39	Phase III randomized trial doxorubicin cisplatin versus doxorubicin 24 h paclitaxel filgrastim endometrial carcinoma Gynecologic Oncology Group study
0.1233631.15598926.html.plaintext.txt	40	Ann Oncol 2004 15 1173 1178
0.1233631.15598926.html.plaintext.txt	41	Abratt RP Brune D Dimopoulos M A et al
0.1233631.15598926.html.plaintext.txt	42	Randomised phase III study intravenous vinorelbine plus hormone therapy versus hormone therapy alone hormone refractory prostate cancer
0.1233631.15598926.html.plaintext.txt	43	Ann Oncol 2004 15 1613 1621
0.1233631.15598926.html.plaintext.txt	44	Marshall J Chen H Yang D et al
0.1233631.15598926.html.plaintext.txt	45	A phase I trial Bcl 2 antisense G3139 weekly docetaxel patients advanced breast cancer solid tumors
0.1233631.15598926.html.plaintext.txt	46	Ann Oncol 2004 15 1274 1283
0.1233631.15598926.html.plaintext.txt	47	Rozados VR Sanchez AM Gervasoni SI et al
0.1233631.15598926.html.plaintext.txt	48	Metronomic therapy cyclophosphamide induces rat lymphoma sarcoma regression devoid toxicity
0.1233631.15598926.html.plaintext.txt	49	Ann Oncol 2004 15 1543 1550
0.1233631.15598926.html.plaintext.txt	50	Assessing websites complementary alternative medicine cancer
0.1233631.15598926.html.plaintext.txt	51	Ann Oncol 2004 15 733 742
0.1233631.15598926.html.plaintext.txt	52	Levi F Lucchini F Negri E et al
0.1233631.15598926.html.plaintext.txt	53	Trends cancer mortality European Union accession countries 1980 2000
0.1233631.15598926.html.plaintext.txt	54	Ann Oncol 2004 15 1425 1431
0.1233631.15598926.html.plaintext.txt	55	Andre F le Chevalier T Soria JC
0.1233631.15598926.html.plaintext.txt	56	Her2 neu target lung cancer Ann Oncol 2004 15 3 4
0.1233631.15598926.html.plaintext.txt	57	Obesity breast cancer prognosis expanding body evidence
0.1233631.15598926.html.plaintext.txt	58	Ann Oncol 2004 15 850 851
0.1233631.15598926.html.plaintext.txt	59	Ann Oncol 2004 15 1001 1006
0.1233631.15598926.html.plaintext.txt	60	Primary chemotherapy breast cancer evidence future
0.1233631.15598926.html.plaintext.txt	61	Ann Oncol 2004 15 1161 1171
0.1233631.15598926.html.plaintext.txt	62	This Article Full Text PDF E letters Submit response Alert article cited Alert E letters posted Alert correction posted Services Email article friend Similar articles journal Similar articles ISI Web Science Similar articles PubMed Alert new issues journal Add My Personal Archive Download citation manager Disclaimer Request Permissions Google Scholar Articles Kerr D
0.1233631.15598926.html.plaintext.txt	63	PubMed PubMed Citation Articles Kerr D
0.1233631.15598926.html.plaintext.txt	64	Online ISSN 1569 8041 Print ISSN 0923 7534 Copyright 2006 European Society Medical Oncology Oxford Journals Oxford University Press Site Map Terms Conditions Privacy Policy Frequently Asked Questions Other Oxford University Press sites Oxford University Press American National Biography Booksellers Information Service Childrens Fiction Poetry Childrens Reference Corporate Special Sales Dictionaries Dictionary National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights Permissions Science School Books Social Sciences Very Short Introductions Worlds Classics
0.11926218.14976159.html.plaintext.txt	0	The law mass action applied neurodegenerative disease hypothesis concerning etiology pathogenesis complex diseases Andrew Singleton Amanda Myers John Hardy
0.11926218.14976159.html.plaintext.txt	1	Laboratory Neurogenetics National Institute Aging National Institutes Health Building 10 Room 6C103 MSC1589 Bethesda MD 20892 USA
0.11926218.14976159.html.plaintext.txt	2	Received January 2 2004 Revised February 3 2004 Accepted February 9 2004
0.11926218.14976159.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS AND PREDICTIONS REFERENCES Loci underlying autosomal dominant forms neurodegenerative disease identified prion mutations cause Gerstmann Straussler syndrome hereditary Creuzfeldt Jakob disease tau mutations cause autosomal dominant frontal temporal dementia synuclein mutations cause autosomal dominant Parkinsons disease
0.11926218.14976159.html.plaintext.txt	4	In cases pathogenic mutation protein deposited diseased tissue cases whole protein deposited
0.11926218.14976159.html.plaintext.txt	5	In Alzheimers disease mutations APP presenilin 1 2 cause autosomal dominant disease substrate proteases respectively responsible production deposited peptide Ass
0.11926218.14976159.html.plaintext.txt	6	Thus cases mutations lead disease mechanism involves deposition process
0.11926218.14976159.html.plaintext.txt	7	We briefly review remarkably predictable biology also point seems sporadic forms diseases predisposed genetic variability loci strongly suggesting quantity normal protein produced influences risk sporadic forms disease
0.11926218.14976159.html.plaintext.txt	8	The evidence assertion strongest Parkinsons disease PD genetic variability synuclein expression affects risk developing disease although oldest evidence notion increased expression normal sequence protein lead disease comes observation Alzheimers disease trisomy 21 cases
0.11926218.14976159.html.plaintext.txt	9	From observations make predictions concerning etiology pathogenesis neurodegenerative diseases general
0.11926218.14976159.html.plaintext.txt	10	INTRODUCTION TOP ABSTRACT INTRODUCTION THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS AND PREDICTIONS REFERENCES In last 15 years remarkable progress understanding etiology autosomal dominant neurodegenerative diseases
0.11926218.14976159.html.plaintext.txt	11	The loci underlying autosomal dominant forms Creuzfeldt Jakob disease 1 frontal temporal dementia 2 Parkinsons disease identified 3
0.11926218.14976159.html.plaintext.txt	12	In case underlying locus encoded protein often deposited disease
0.11926218.14976159.html.plaintext.txt	13	In Creuzfeldt Jakob disease prion protein frontal temporal dementia tau Parkinsons disease synuclein
0.11926218.14976159.html.plaintext.txt	14	In Alzheimers disease situation little complex deposited peptide Ass derived fragment APP protein metabolized secretase complex key component complex presenilins mutations either APP presenilin 1 2 lead disease 4 6
0.11926218.14976159.html.plaintext.txt	15	These findings well established driven therapeutics research especially allowed development animal models diseases well defined therapeutic targets 7
0.11926218.14976159.html.plaintext.txt	16	In examples precise pathologic species protein obscure one debated whether deposits intermediate species oligomer responsible
0.11926218.14976159.html.plaintext.txt	17	This extensively investigated balance recent data favoring smaller intermediate species toxic entities 8 however generality fact mutated protein example deposited suggests process pathogenicity related although perhaps separable process deposition
0.11926218.14976159.html.plaintext.txt	18	By studying autosomal dominant forms diseases researchers hope gain insight common sporadic forms mechanistic perspective certainly case
0.11926218.14976159.html.plaintext.txt	19	However perhaps surprisingly last 4 years become clear case many diseases least haplotype Mendelian pathogenic locus influences disease risk sporadic disease
0.11926218.14976159.html.plaintext.txt	20	In review briefly summarise data make predictions concerning etiology pathogenesis neurodegenerative diseases
0.11926218.14976159.html.plaintext.txt	21	First though worth noting haplotypic association means mechanistic perspective absence coding changes haplotypic association implies genetic variability either amount expression protein alternate splicing protein contributes disease risk
0.11926218.14976159.html.plaintext.txt	22	THE DISEASES TOP ABSTRACT INTRODUCTION THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS AND PREDICTIONS REFERENCES Prion diseases The prion gene two common coding variants Caucasian populations one prion M129 prion V129 910
0.11926218.14976159.html.plaintext.txt	23	It long recognized homozygosity codon 129 predisposes sporadic disease presumably necessity prion prion interactions symmetry considerations 910
0.11926218.14976159.html.plaintext.txt	24	However addition well established risk recent genetic data shown prion haplotype confers additional risk idiopathic disease 11 clearly suggesting genetic variability prion expression contributes disease risk
0.11926218.14976159.html.plaintext.txt	25	While genetic data establish whether high expressors low expressors susceptible since prion knockout mice completely resistant disease 12 parsimonious expect express high levels prion protein homozygotes codon 129 susceptible disease
0.11926218.14976159.html.plaintext.txt	26	Alzheimers disease Extensive sequencing APP gene late onset Alzheimers disease failed identify mutations 13
0.11926218.14976159.html.plaintext.txt	27	However analysis data sibpairs affected late onset Alzheimers disease consistently suggested APP locus form disease 1415
0.11926218.14976159.html.plaintext.txt	28	This suggests genetic variability APP locus contributes disease risk although precise variability identified
0.11926218.14976159.html.plaintext.txt	29	Such finding consistent longstanding observation individuals trisomy 21 inevitably develop Alzheimer pathology fifth decade 16 however cases Down syndrome caused triplication chromosome 21 distal APP gene develop Alzheimers disease 17
0.11926218.14976159.html.plaintext.txt	30	Thus three copies APP gene leads Alzheimer pathology fifth decade yet unidentified genetic variability APP locus appears contribute disease risk
0.11926218.14976159.html.plaintext.txt	31	Frontal temporal dementia tangle diseases Mutations tau gene cause many cases autosomal dominant frontal temporal dementia tau pathology
0.11926218.14976159.html.plaintext.txt	32	There many sporadic diseases tau pathology occurs usually tangles also Pick bodies Argyrophilic grains 18
0.11926218.14976159.html.plaintext.txt	33	There two genetic haplotype clades Caucasian populations designated H1 H2 differ intron sizes promoter sequence wobble bases 19
0.11926218.14976159.html.plaintext.txt	34	The H1 haplotype frequency 75 Caucasians thus H1 homozygotes constitute 60 populations
0.11926218.14976159.html.plaintext.txt	35	However individuals one three sporadic tau diseases progressive supranuclear palsy 19 corticobasal degeneration 20 argyrophilic grain disease 21 although Picks disease 22 Guam disease 23 show robust association H1 homozygosity frequency H1 homozygotes 95
0.11926218.14976159.html.plaintext.txt	36	These data show clearly variability either tau expression tau splicing variability contribute disease risk
0.11926218.14976159.html.plaintext.txt	37	In case difficult determine whether control splicing control expression key variable indeed clear many mutations lead Mendelian disease altering alternate splicing 224
0.11926218.14976159.html.plaintext.txt	38	Parkinsons diseaseLewy body dementia Mutations synuclein gene cause autosomal dominant Parkinsons disease synuclein primary component Lewy bodies pathognomic feature Parkinsons disease 25
0.11926218.14976159.html.plaintext.txt	39	Genetic variability synuclein promoter contributes risk sporadic Parkinsons disease 2627 associated promoter allele stronger promoter 28
0.11926218.14976159.html.plaintext.txt	40	Perhaps convincingly triplication whole synuclein locus causes autosomal dominant Parkinsons diseaseLewy body dementia onset age fourth decade 29 duplication locus leads disease fifth decade 30
0.11926218.14976159.html.plaintext.txt	41	Thus Parkinsons disease clear dose relationship synuclein expression disease occurrence normal genetic variability promoter contributing risk typical idiopathic disease multiplications locus causing Mendelian disease onset age determined precise dose
0.11926218.14976159.html.plaintext.txt	42	Protein studies cell lines affected individuals kindreds reveal amount synuclein produced correlates disease A
0.11926218.14976159.html.plaintext.txt	43	METHODOLOGICAL CONSIDERATIONS TOP ABSTRACT INTRODUCTION THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS AND PREDICTIONS REFERENCES The problems assessment haplotypic expression Rigorous assessment impact haplotypic variation quantitative gene expression splicing surprisingly difficult problem 32
0.11926218.14976159.html.plaintext.txt	44	The usual method test variability control expression tie artificial arbitrary reporter construct bacterially derived reporter gene measure transient effect expression tumor derived cell line
0.11926218.14976159.html.plaintext.txt	45	Clearly experiments unlikely yield data direct relevance subtle effects variation gene expression
0.11926218.14976159.html.plaintext.txt	46	The development allele specific gene expression methods 3334 offers hope subtle effects studied although methods arduous require access large numbers well maintained human brain specimens 33
0.11926218.14976159.html.plaintext.txt	47	CONCLUSIONS AND PREDICTIONS TOP ABSTRACT INTRODUCTION THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS AND PREDICTIONS REFERENCES In diseases referred thus strong evidence frank mutations pathologic locus cause autosomal dominant disease protein deposition genetic variability expression normal protein contributes risk idiopathic disease
0.11926218.14976159.html.plaintext.txt	48	In Alzheimers disease deposited protein peptide fragment primary locus mutations cleaving enzyme also lead disease
0.11926218.14976159.html.plaintext.txt	49	These simple observations lead predictions mutant wild type proteins quantitatively different qualitatively different properties cases diseases protein deposition part process polyglutamine diseases ALS genetic variability promoter gene considered factor influencing applicable risk sporadic disease age onset familial disease see 35 suggestions might also case Huntingtons disease polyglutamine diseases deposited fragment cleaved precursor molecule genetic variability cleaving proteases interactors influence stability assessed risk factor loci loci impact risk diseases general may merely cause effect altering levels primary proteins either transcription factors responsible protein breakdown
0.11926218.14976159.html.plaintext.txt	50	While findings unexpected perhaps
0.11926218.14976159.html.plaintext.txt	51	All chemists know power law mass action perhaps surprised us may profound implications determining risks neurodegenerative disease 36
0.11926218.14976159.html.plaintext.txt	52	Of course one therapeutic approach cases therefore would aim reduce concentrations toxic proteins relevant tissue compartment either decreased production increased breakdown
0.11926218.14976159.html.plaintext.txt	53	ACKNOWLEDGEMENTS This work supported NIANIH intramural programme
0.11926218.14976159.html.plaintext.txt	54	FOOTNOTES To correspondence addressed
0.11926218.14976159.html.plaintext.txt	55	Tel 1 3014513829 Fax 1 3014800335 Email hardyjatmail
0.11926218.14976159.html.plaintext.txt	56	REFERENCES TOP ABSTRACT INTRODUCTION THE DISEASES METHODOLOGICAL CONSIDERATIONS CONCLUSIONS AND PREDICTIONS REFERENCES Owen F
0.11926218.14976159.html.plaintext.txt	57	1989 Insertion prion protein gene familial Creutzfeldt Jakob disease
0.11926218.14976159.html.plaintext.txt	58	1998 Coding splice donor site mutations tau cause autosomal dominant dementia FTDP 17
0.11926218.14976159.html.plaintext.txt	59	1997 Mutation synuclein gene identified families Parkinsons disease
0.11926218.14976159.html.plaintext.txt	60	2002 The solved unsolved mysteries genetics early onset Alzheimers disease
0.11926218.14976159.html.plaintext.txt	61	2003 The role presenilin cofactors gamma secretase complex
0.11926218.14976159.html.plaintext.txt	62	2003 Reconstitution gamma secretase activity
0.11926218.14976159.html.plaintext.txt	63	1998 Genetic classification primary neurodegenerative disease
0.11926218.14976159.html.plaintext.txt	64	2002 ADDLs protofibrils missing links Neurobiol
0.11926218.14976159.html.plaintext.txt	65	1991 Homozygous prion protein genotype predisposes sporadic Creutzfeldt Jakob disease
0.11926218.14976159.html.plaintext.txt	66	1991 Genetic predisposition iatrogenic Creutzfeldt Jakob disease
0.11926218.14976159.html.plaintext.txt	67	2001 Sporadic variant Creutzfeldt Jakob disease associated polymorphisms upstream PRNP exon 1
0.11926218.14976159.html.plaintext.txt	68	1993 Mice devoid PrP resistant scrapie
0.11926218.14976159.html.plaintext.txt	69	1995 No evidence common allelic variation amyloid precursor protein APP gene confers susceptibility Alzheimers disease
0.11926218.14976159.html.plaintext.txt	70	1999 Genetic variability amyloid beta precursor protein locus may contribute risk late onset Alzheimers disease
0.11926218.14976159.html.plaintext.txt	71	2001 The amyloid precursor protein locus late onset Alzheimer disease
0.11926218.14976159.html.plaintext.txt	72	1969 Presenile dementia Alzheimers disease mongolism
0.11926218.14976159.html.plaintext.txt	73	1998 Molecular mapping Alzheimer type dementia Downs syndrome
0.11926218.14976159.html.plaintext.txt	74	1998 Tau protein pathology neurodegenerative diseases
0.11926218.14976159.html.plaintext.txt	75	1999 Association extended haplotype tau gene progressive supranuclear palsy
0.11926218.14976159.html.plaintext.txt	76	2001 Corticobasal degeneration progressive supranuclear palsy share common tau haplotype
0.11926218.14976159.html.plaintext.txt	77	2002 Argyrophilic grain disease sporadic 4 repeat tauopathy
0.11926218.14976159.html.plaintext.txt	78	2002 Analysis tau haplotypes Picks disease
0.11926218.14976159.html.plaintext.txt	79	1999 Neurodegenerative diseases Guam analysis tau
0.11926218.14976159.html.plaintext.txt	80	2000 Missing tau mutation identified
0.11926218.14976159.html.plaintext.txt	81	CO2 2linktypeDOI CrossRefMedline
0.11926218.14976159.html.plaintext.txt	82	2000 The alpha synucleinopathies Parkinsons disease dementia Lewy bodies multiple system atrophy
0.11926218.14976159.html.plaintext.txt	83	1999 Increased susceptibility sporadic Parkinsons disease certain combined synucleinapolipoprotein E genotype
0.11926218.14976159.html.plaintext.txt	84	CO2 XlinktypeDOI CrossRefMedline
0.11926218.14976159.html.plaintext.txt	85	2001 Synuclein gene haplotypes associated Parkinsons disease
0.11926218.14976159.html.plaintext.txt	86	2003 Functional analysis intra allelic variation NACP Rep1 synuclein gene
0.11926218.14976159.html.plaintext.txt	87	2003 Synuclein locus triplication causes Parkinsons disease
0.11926218.14976159.html.plaintext.txt	88	2003 Genomic multiplication alpha synuclein gene three kindreds familial Lewy body disease
0.11926218.14976159.html.plaintext.txt	89	American Society Human Genetics
0.11926218.14976159.html.plaintext.txt	90	2003 Synuclein implicated Parkinsons disease present extracellular biological fluids including human plasma
0.11926218.14976159.html.plaintext.txt	91	2003 Functional analysis human promoter polymorphisms
0.11926218.14976159.html.plaintext.txt	92	1997 Distortion allelic expression apolipoprotein E Alzheimers disease
0.11926218.14976159.html.plaintext.txt	93	2002 Allelic variation human gene expression
0.11926218.14976159.html.plaintext.txt	94	1993 The normal Huntington disease HD allele closely linked gene influences age onset HD
0.11926218.14976159.html.plaintext.txt	95	Jr 2003 Molecular crowding accelerates fibrillization synuclein could increase cytoplasmic protein concentration induce Parkinsons disease Biochemistry 41 3855 3860
0.21379416.15467011.html.plaintext.txt	0	Gene expression profiling chronic copper overload reveals upregulation Prnp App Angela D
0.21379416.15467011.html.plaintext.txt	1	Armendariz1 Mauricio Gonzalez2 Alexander V
0.21379416.15467011.html.plaintext.txt	2	1 Department Nutritional Science Toxicology University California Berkeley Berkeley California 2 Instituto de Nutricion y Tecnologia de los Alimentos Universidad de Chile Santiago Santiago Chile
0.21379416.15467011.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES The level copper becomes toxic clear
0.21379416.15467011.html.plaintext.txt	4	Several studies indicated copper causes oxidative stress however tested high levels copper exposure
0.21379416.15467011.html.plaintext.txt	5	We currently limited understanding protective systems operate cells chronically exposed copper
0.21379416.15467011.html.plaintext.txt	6	Additionally limits homeostatic regulation known making difficult define milder effects copper excess
0.21379416.15467011.html.plaintext.txt	7	Furthermore robust assay facilitate diagnosis copper excess distinguish mild moderate severe copper overload needed
0.21379416.15467011.html.plaintext.txt	8	To address issues investigated effects steady state gene expression chronic copper overload cell culture model system using cDNA microarrays
0.21379416.15467011.html.plaintext.txt	9	For study utilized cells genetic models copper overload fibroblast cells two mouse mutants C57BL6 Atp7aMobr C57BL6 Atp7aModap
0.21379416.15467011.html.plaintext.txt	10	These cell lines accumulate copper abnormally high levels normal culture media due defect copper export cell
0.21379416.15467011.html.plaintext.txt	11	We identified 12 differentially expressed genes common using outlier identification methods
0.21379416.15467011.html.plaintext.txt	12	Surprisingly results show evidence oxidative stress copper loaded cells
0.21379416.15467011.html.plaintext.txt	13	In addition candidate components perhaps responsible copper specific homeostatic response identified
0.21379416.15467011.html.plaintext.txt	14	The genes encode prion protein amyloid ss precursor protein two known copper binding proteins upregulated cell lines
0.21379416.15467011.html.plaintext.txt	15	microarray amyloid ss precursor protein prion protein outlier detection bioinformatics Menkes disease
0.21379416.15467011.html.plaintext.txt	16	INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES COPPER IS AN ESSENTIAL TRACE metal serves important catalytic cofactor several enzymes 30
0.21379416.15467011.html.plaintext.txt	17	Copper exist either oxidized CuII reduced CuI state ability copper convert oxidation states accounts essential role many proteins 30
0.21379416.15467011.html.plaintext.txt	18	These copper containing enzymes include CuZn superoxide dismutase SOD1 lysyl oxidase LO cytochrome c oxidase ceruloplasmin Cp tyrosinase involved many important biological processes deficiencies alterations cause disease states 60
0.21379416.15467011.html.plaintext.txt	19	Recently genetic approaches led discovery many mechanisms underlying copper homeostasis 48
0.21379416.15467011.html.plaintext.txt	20	We understanding processes involved copper uptake transport removal beginning understand regulation processes detailed reviews see Refs
0.21379416.15467011.html.plaintext.txt	21	Diseases established link copper metabolism Wilson disease WD Menkes disease amyotrophic lateral sclerosis copper implicated Alzheimer disease AD prion disease drive need better understand copper homeostatic mechanisms
0.21379416.15467011.html.plaintext.txt	22	Although copper clearly essential nutrient metal toxic allowed accumulate excess cellular needs
0.21379416.15467011.html.plaintext.txt	23	The incidence copper toxicosis general population low 6 46
0.21379416.15467011.html.plaintext.txt	24	Acute copper poisoning frequent usually consequence consumption contaminated foodstuffs beverages accidental deliberate ingestion high quantities copper salts
0.21379416.15467011.html.plaintext.txt	25	Acute copper poisoning characterized nausea vomiting gastric pain
0.21379416.15467011.html.plaintext.txt	26	In severe cases intravascular hemolytic anemia acute hepatic failure acute tubular renal failure shock coma death occur 46
0.21379416.15467011.html.plaintext.txt	27	Chronic copper toxicosis may greater concern 6
0.21379416.15467011.html.plaintext.txt	28	Nutritional studies chronic copper overload mice rats shown copper induced liver damage animals 1 19 38
0.21379416.15467011.html.plaintext.txt	29	In addition WD human genetic disorder copper overload characterized gradual hepatic accumulation copper eventually results liver cirrhosis 7
0.21379416.15467011.html.plaintext.txt	30	Other copper overload disorders humans include Indian childhood cirrhosis ICC endemic Tyrolean infantile cirrhosis ETIC idiopathic copper toxicosis ICT
0.21379416.15467011.html.plaintext.txt	31	These diseases result abnormal hepatic copper accumulation result chronic hepatitis hepatic failure 36
0.21379416.15467011.html.plaintext.txt	32	Although liver injury cases copper induced mechanisms excess copper results cellular toxicity fully elucidated
0.21379416.15467011.html.plaintext.txt	33	The increase copper levels especially WD occurs period many years phenotypic consequences reported copper levels extremely elevated
0.21379416.15467011.html.plaintext.txt	34	The lack appreciable pathological changes ever increasing copper levels late disease process suggests compensatory homeostatic mechanisms must exist
0.21379416.15467011.html.plaintext.txt	35	Toxicity resulting copper overload long hypothesized result redox cycling Haber Weiss reaction cuprous ions react H2O2 form highly reactive oxygen species ROS turn catalyze oxidation biomolecules lipids proteins nucleic acids reviewed Refs
0.21379416.15467011.html.plaintext.txt	36	The suspected role ROS copper overload supported observations increased generation lipid peroxidation products well evidence DNA damage hepatocytes reacted ionic copper 6 59
0.21379416.15467011.html.plaintext.txt	37	In vivo studies shown markers lipid peroxidation increased mitochondria livers WD patients 55
0.21379416.15467011.html.plaintext.txt	38	There also evidence lipid peroxidation livers rats chronically fed high copper diets 38 54
0.21379416.15467011.html.plaintext.txt	39	The levels copper becomes toxic clear
0.21379416.15467011.html.plaintext.txt	40	Most studies indicate copper causes oxidative stress tested high levels copper 38 54
0.21379416.15467011.html.plaintext.txt	41	Indeed study diet moderately high levels copper fed rats showed lipid peroxidation 1
0.21379416.15467011.html.plaintext.txt	42	DNA damage often consequence oxidative stress observed copper overload vivo however cirrhotic livers WD patients 21
0.21379416.15467011.html.plaintext.txt	43	Nevertheless incidence hepatocellular carcinoma HCC patients WD higher general population 50
0.21379416.15467011.html.plaintext.txt	44	This raises question whether copper moderately elevated levels results oxidative damage effects levels cells
0.21379416.15467011.html.plaintext.txt	45	Clearly cellular mechanisms protect cell vigorous high levels become overwhelmed
0.21379416.15467011.html.plaintext.txt	46	We currently limited understanding protective systems operate cells chronically exposed copper
0.21379416.15467011.html.plaintext.txt	47	Additionally limits homeostatic regulation known making difficult define milder effects copper excess 3
0.21379416.15467011.html.plaintext.txt	48	Currently early biologically relevant markers copper excess exist
0.21379416.15467011.html.plaintext.txt	49	A robust assay facilitate diagnosis copper excess distinguish mild moderate severe copper overload needed
0.21379416.15467011.html.plaintext.txt	50	To address issues investigated effects steady state gene expression chronic copper overload cell culture model system using cDNA microarray technology
0.21379416.15467011.html.plaintext.txt	51	For study chosen utilize cells genetic model copper overload
0.21379416.15467011.html.plaintext.txt	52	We used fibroblast cells two mouse mutants C57BL6 Atp7aMobr C57BL6 Atp7aModap henceforth referred Mobr Modap respectively simplicity genetic models chronic copper overload
0.21379416.15467011.html.plaintext.txt	53	Cultured cells mice mutations Atp7a represent genetic models moderate cellular copper overload 12 32
0.21379416.15467011.html.plaintext.txt	54	Excess copper normally exported ATP7A copper transporting P type ATPase translocates trans Golgi network TGN plasma membrane presence elevated copper 45
0.21379416.15467011.html.plaintext.txt	55	Mutations ATP7A humans Menkes disease mice mottled mouse lead reduced intestinal basolateral export copper subsequent systemic copper deficiency 33
0.21379416.15467011.html.plaintext.txt	56	All cultured cells tested exception hepatic cells mottled mice accumulate copper abnormally high levels normal culture media 12 32
0.21379416.15467011.html.plaintext.txt	57	Our results show evidence oxidative stress copper loaded cells suggest remarkable cellular compensation
0.21379416.15467011.html.plaintext.txt	58	In addition candidate components perhaps responsible copper specific homeostatic response identified
0.21379416.15467011.html.plaintext.txt	59	MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES Cell culture treatments
0.21379416.15467011.html.plaintext.txt	60	In study used fibroblast cells two mouse mutants severe functional defects ATP7A C57BL6 Atp7aMobr C57BL6 Atp7aModap
0.21379416.15467011.html.plaintext.txt	61	Fibroblasts wild type ATP7A C57BL6 Atp7a used control
0.21379416.15467011.html.plaintext.txt	62	The fibroblast cells kind gift Dr
0.21379416.15467011.html.plaintext.txt	63	Jane Gitschier grown Dulbecco modified Eagle medium DMEM Life Technologies containing 10 fetal bovine serum HyClone supplemented penicillin streptomycin Life Technologies incubated humidified chamber containing 5 CO2 37 degrees C
0.21379416.15467011.html.plaintext.txt	64	Chronic copper overload control fibroblasts achieved treatment 25 microM Cu His media 5 days
0.21379416.15467011.html.plaintext.txt	65	Cells seeded would reach 100 confluence time collection 5 days
0.21379416.15467011.html.plaintext.txt	66	Inductively coupled plasma atomic emission spectrometry
0.21379416.15467011.html.plaintext.txt	67	To measure metal content cells grown 80 90 confluence collected pelleted washed twice PBS
0.21379416.15467011.html.plaintext.txt	68	Ten percent pellet used protein concentration determination Bradford assay Bio Rad
0.21379416.15467011.html.plaintext.txt	69	The remainder pellet digested 1 ml nitric acid Suprapure Merck overnight room temperature
0.21379416.15467011.html.plaintext.txt	70	Samples diluted twice metal free water read triplicate simultaneous inductively coupled plasma atomic emission spectrometer ICP AES Vista AX CCD Varian University California Davis 20
0.21379416.15467011.html.plaintext.txt	71	The sample values normalized total protein content
0.21379416.15467011.html.plaintext.txt	72	RNA isolation cDNA labeling
0.21379416.15467011.html.plaintext.txt	73	Total RNA isolated cells grown 80 90 confluence using TRIzol Reagent Life Technologies
0.21379416.15467011.html.plaintext.txt	74	mRNA subsequently isolated using oligo dT latex beads Qiagen
0.21379416.15467011.html.plaintext.txt	75	The indirect amino allyl labeling protocol found Microarrays
0.21379416.15467011.html.plaintext.txt	76	For experiments cDNA control cell lines labeled Cy3 cDNA mutant cell lines labeled Cy5
0.21379416.15467011.html.plaintext.txt	77	cDNA quantity dye incorporation probe assessed scanning spectrophotometer
0.21379416.15467011.html.plaintext.txt	78	The two dye probes combined concentrated volume 15 20 microl
0.21379416.15467011.html.plaintext.txt	79	SSC SDS added final concentration 2
0.21379416.15467011.html.plaintext.txt	80	The probes denatured 2 min 95 degrees C allowed cool placed postprocessed microarray incubated overnight 60 degrees C
0.21379416.15467011.html.plaintext.txt	81	Postprocessing protocol found The Brown Lab web site httpcmgm
0.21379416.15467011.html.plaintext.txt	82	edupbrownprotocols3postprocess
0.21379416.15467011.html.plaintext.txt	83	After hybridization microarray slides washed room temperature 5 min 1x SSC 0
0.21379416.15467011.html.plaintext.txt	84	2x SSC finally 2 min 0
0.21379416.15467011.html.plaintext.txt	85	1x SSC spin dried
0.21379416.15467011.html.plaintext.txt	86	The microarray experiments carried four times mutant
0.21379416.15467011.html.plaintext.txt	87	control 4 arrays Modap vs
0.21379416.15467011.html.plaintext.txt	88	The four replicates technical replicates
0.21379416.15467011.html.plaintext.txt	89	Several different plates cell line grown simultaneously pooled prior RNA extraction
0.21379416.15467011.html.plaintext.txt	90	The RNA used cell line isolated day however microarray experiments reverse transcription labeling hybridizations done different days
0.21379416.15467011.html.plaintext.txt	91	The microarrays utilized Mobr vs
0.21379416.15467011.html.plaintext.txt	92	control experiments fabricated microarrayer laboratory Edward Rubin Lawrence Berkeley National Laboratory contained 10000 mouse cDNAs
0.21379416.15467011.html.plaintext.txt	93	Microarrays used Modap vs
0.21379416.15467011.html.plaintext.txt	94	control experiments fabricated College Natural Resources Genomics Facility arrays contained 11000 mouse cDNAs Brain Molecular Anatomy Project BMAP library Research Genetics project web site httpbrainest
0.21379416.15467011.html.plaintext.txt	95	UniGene IDs used determine overlap two different arrays
0.21379416.15467011.html.plaintext.txt	96	There 2900 genes appear arrays remaining genes unique array
0.21379416.15467011.html.plaintext.txt	97	Microarray slides scanned either GenePix 4000 Axon Instruments ArrayWorx Applied Precision scanner
0.21379416.15467011.html.plaintext.txt	98	The intensity hybridization values determined using GenePix Pro 3
0.21379416.15467011.html.plaintext.txt	99	0 Axon image analysis software probe channels Cy5 695 nm Cy3 595 nm
0.21379416.15467011.html.plaintext.txt	100	All intensity values background subtracted normalized median channel intensity account dye bias log base 2 transformed
0.21379416.15467011.html.plaintext.txt	101	We recently developed novel approach identify differentially expressed genes two mRNA samples based identification outliers candidate differentially expressed genes 27
0.21379416.15467011.html.plaintext.txt	102	The majority data points appropriate normalization lie vicinity line equivalence scatter plot log2Cy5 vs
0.21379416.15467011.html.plaintext.txt	103	Other data points outliers lie outside vicinity line equivalence considered data points greatest interest since correspond genes noticeably different hybridization intensity
0.21379416.15467011.html.plaintext.txt	104	We apply robust scatter plot smoothers quantify take account distortion data set heteroscedasticity
0.21379416.15467011.html.plaintext.txt	105	We consider outliers analysis represent candidate differentially expressed genes
0.21379416.15467011.html.plaintext.txt	106	We assign confidence P value outlier calculating simultaneous prediction confidence intervals
0.21379416.15467011.html.plaintext.txt	107	27 details data analysis methods
0.21379416.15467011.html.plaintext.txt	108	Total RNA Mobr Modap control fibroblasts extracted according TRIzol reagent protocol Invitrogen
0.21379416.15467011.html.plaintext.txt	109	For Northern blot analysis 10 microg total RNA electophoresed formaldehyde containing agarose 1 gel transferred nylon membrane Hybond N Amersham standard capillary method
0.21379416.15467011.html.plaintext.txt	110	For detection App mRNA membranes probed 896 bp fragment App cDNA
0.21379416.15467011.html.plaintext.txt	111	The primers used amplify probe designed using Primer3 software httpwww genome
0.21379416.15467011.html.plaintext.txt	112	cgi sequences follows 5 3 AAGAACTTGCCCAAAGCTGA forward GTGATGACAATCACGGTTGC reverse 896 bp amplicon
0.21379416.15467011.html.plaintext.txt	113	The probe radiolabeled 32PdCTP random priming method Prime It II Stratagene hybridized membrane 42 degrees C 20 h
0.21379416.15467011.html.plaintext.txt	114	After hybridization membranes washed stringent conditions exposed BioMax film Kodak 70 degrees C
0.21379416.15467011.html.plaintext.txt	115	Autoradiograms evaluated densitometry AlphaEase Alpha Innotech
0.21379416.15467011.html.plaintext.txt	116	Semiquantitative reverse transcriptase polymerase chain reaction
0.21379416.15467011.html.plaintext.txt	117	Validation changes Prnp App gene expression carried semiquantitative reverse transcriptase polymerase chain reaction sq RT PCR
0.21379416.15467011.html.plaintext.txt	118	The housekeeping gene glyceraldehyde 3 phosphate dehydrogenase G3pdh used control
0.21379416.15467011.html.plaintext.txt	119	The G3pdh primers obtained commercial source Clontech Prnp primers designed using Primer3 software
0.21379416.15467011.html.plaintext.txt	120	The sequences 5 3 Prnp primers follows GCATTCTGCCTTCCTAGTGG forward GAGAATGCGAAGGAACAAGC reverse 860 bp amplicon
0.21379416.15467011.html.plaintext.txt	121	Primers App used Northern blot
0.21379416.15467011.html.plaintext.txt	122	Primers Gcl Gpx described elsewhere 13 29 Gcl 427 bp GATTTGGTCAGGGAGTTTCC forward AATGCAGTCAAATCTGGTGG reverse Gpx 537 bp GCTCATTGAGAATGTCGCGTC forward GAGTGCAGCCAGTAATCACC reverse
0.21379416.15467011.html.plaintext.txt	123	Three micrograms total RNA Mobr Modap control fibroblasts reverse transcribed using SuperScript II reverse transcriptase Invitrogen oligo dT primer Operon
0.21379416.15467011.html.plaintext.txt	124	PCR carried using Taq DNA polymerase directed supplier Takara Shuzo
0.21379416.15467011.html.plaintext.txt	125	PCR conditions chosen none transcripts analyzed reached plateau end amplification protocol two sets primers used reaction compete
0.21379416.15467011.html.plaintext.txt	126	An amplification cycle 95 degrees C 45 62 degrees C 45 72 degrees C 2 min performed 100 microl volume
0.21379416.15467011.html.plaintext.txt	127	Following 18 35 cycles 5 microl reaction removed product separated visualized 1
0.21379416.15467011.html.plaintext.txt	128	5 agarose gel containing ethidium bromide
0.21379416.15467011.html.plaintext.txt	129	Scanned gel images ChemiImager 4400 Alpha Innotech imported image analysis software AlphaEase Alpha Innotech density amplified products linear range DNA amplification product calculated values normalized G3pdh housekeeping gene control values
0.21379416.15467011.html.plaintext.txt	130	RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES Mobr Modap fibroblast cell lines copper overloaded
0.21379416.15467011.html.plaintext.txt	131	We measured intracellular copper level mutant cells grown normal media compared control cells confirm copper retention fibroblasts mutants
0.21379416.15467011.html.plaintext.txt	132	Cells used microarray experiments grown concurrently
0.21379416.15467011.html.plaintext.txt	133	Modap Mobr control fibroblast cells growing standard culture conditions collected intracellular copper concentration determined described MATERIALS AND METHODS
0.21379416.15467011.html.plaintext.txt	134	Intracellular copper levels 0
0.21379416.15467011.html.plaintext.txt	135	52 nMmg protein Modap indicating Mobr Modap accumulate three five times copper control cell lines
0.21379416.15467011.html.plaintext.txt	136	These results similar studies 12 32 confirm state copper overload Mobr Modap cell lines
0.21379416.15467011.html.plaintext.txt	137	We also measured intracellular copper levels copper treated control cell lines
0.21379416.15467011.html.plaintext.txt	138	Control cells normal media grown concurrently
0.21379416.15467011.html.plaintext.txt	139	Intracellular copper levels 0
0.21379416.15467011.html.plaintext.txt	140	08 nMmg protein control 25 microM Cu His showing control cells lines 5 days treatment 25 microM Cu His contain similar intracellular copper levels mutant cell lines
0.21379416.15467011.html.plaintext.txt	141	Exploratory microarray analysis
0.21379416.15467011.html.plaintext.txt	142	Gene expression two chronically copper overloaded fibroblast cell lines Mobr Modap compared control fibroblast cell line control using cDNA microarrays containing 10K different genes
0.21379416.15467011.html.plaintext.txt	143	We carried four replicate hybridizations comparison
0.21379416.15467011.html.plaintext.txt	144	Exploratory data analysis done provide assessment quality data set 27
0.21379416.15467011.html.plaintext.txt	145	Distortions data readily apparent using exploratory tools overlooked utilized
0.21379416.15467011.html.plaintext.txt	146	For example multimodal distribution suggests data drawn several populations behaving differently data arising nonhomogenous hybridizations
0.21379416.15467011.html.plaintext.txt	147	The results four exploratory data analysis tools one hybridizations Modap vs
0.21379416.15467011.html.plaintext.txt	148	The results eight individual microarrays found Supplemental Figs
0.21379416.15467011.html.plaintext.txt	149	S1 S4 Supplementary Materials available online Physiological Genomics web site
0.21379416.15467011.html.plaintext.txt	150	1 Inspection box plots Fig
0.21379416.15467011.html.plaintext.txt	151	1A show scale location number outlying observations asymmetry similar channels Cy5 Cy3 data set
0.21379416.15467011.html.plaintext.txt	152	Similarly average shifted histograms Fig
0.21379416.15467011.html.plaintext.txt	153	1B provide information empiric distribution random variable reveal data resembles samples univariate normal distributions channels
0.21379416.15467011.html.plaintext.txt	154	1C compares quantiles empirical data distribution quantiles standard normal distribution
0.21379416.15467011.html.plaintext.txt	155	The majority points QQNP channels data conform closely standard normal distribution except longer tails
0.21379416.15467011.html.plaintext.txt	156	These deviations may due random fluctuations andor systematic variation
0.21379416.15467011.html.plaintext.txt	157	Finally point scatter plot Fig
0.21379416.15467011.html.plaintext.txt	158	1D corresponds one bivariate observation appropriate normalization log transformation
0.21379416.15467011.html.plaintext.txt	159	These results show red green channel intensities data sets highly correlated approximately symmetric distributions appropriate analysis determination candidates differentially expressed genes
0.21379416.15467011.html.plaintext.txt	160	View larger version 23K Fig
0.21379416.15467011.html.plaintext.txt	161	Exploratory data analysis quality control results exploratory analysis one cDNA microarray experiment Modap vs
0.21379416.15467011.html.plaintext.txt	162	Modap labeled Cy5 control Cy3
0.21379416.15467011.html.plaintext.txt	163	The hybridization data examined using following exploratory data analysis tools box plots A average shifted histograms B quantile quantile QQ normal plots C scatter plots D
0.21379416.15467011.html.plaintext.txt	164	Results exploratory data analysis individual microarray experiment available Supplemental Figs
0.21379416.15467011.html.plaintext.txt	165	S1 S4 Physiological Genomics web site
0.21379416.15467011.html.plaintext.txt	166	Detection differentially expressed genes
0.21379416.15467011.html.plaintext.txt	167	We identified differentially expressed genes hybridization outlier identification method see MATERIALS AND METHODS Ref
0.21379416.15467011.html.plaintext.txt	168	We interested genes significantly changed either downregulated copper overloaded cells compared control
0.21379416.15467011.html.plaintext.txt	169	2 majority data points lie vicinity robust linear regression line scatter plot log2Cy5 vs
0.21379416.15467011.html.plaintext.txt	170	These data points signify genes similar transcript behaviors two samples whereas data points lie outside scatter plots correspond genes noticeably different hybridization intensity values
0.21379416.15467011.html.plaintext.txt	171	We determine statistics log2Cy5Cy3sI estimate statistical significance P values every gene candidate differential expression sI robust scale estimator dependent intensity use build simultaneous prediction intervals graphical representation genes outside intervals likely outliers
0.21379416.15467011.html.plaintext.txt	172	Robust scatter plot smoothers used account heteroscedasticity e
0.21379416.15467011.html.plaintext.txt	173	variation residual variance intensity data set
0.21379416.15467011.html.plaintext.txt	174	Red outliers top graph Fig
0.21379416.15467011.html.plaintext.txt	175	2 represent candidate upregulated genes whereas outlying spots blue color bottom represent candidate downregulated genes
0.21379416.15467011.html.plaintext.txt	176	Individual outlier plots data set found supplementary data Supplemental Figs
0.21379416.15467011.html.plaintext.txt	177	We considered data outliers P 0
0.21379416.15467011.html.plaintext.txt	178	05 candidate differentially expressed genes
0.21379416.15467011.html.plaintext.txt	179	We compared candidate genes identified experiment selected genes identified
0.21379416.15467011.html.plaintext.txt	180	05 three repeat hybridizations likely differentially expressed genes
0.21379416.15467011.html.plaintext.txt	181	control experiments 101 genes upregulated 80 genes downregulated least three four experiments
0.21379416.15467011.html.plaintext.txt	182	control experiments 115 25 downregulated genes similar least three four experiments
0.21379416.15467011.html.plaintext.txt	183	The lists genes found supplementary data Supplemental Tables S1 S4
0.21379416.15467011.html.plaintext.txt	184	We found 11 genes upregulated one gene downregulated Modap Mobr cell lines Table 1
0.21379416.15467011.html.plaintext.txt	185	The individual P values experiment 12 genes shown Supplemental Table S5
0.21379416.15467011.html.plaintext.txt	186	View larger version 37K Fig
0.21379416.15467011.html.plaintext.txt	187	Detection differentially expressed genes
0.21379416.15467011.html.plaintext.txt	188	Simultaneous prediction intervals SPI one Modap data set
0.21379416.15467011.html.plaintext.txt	189	The robust resistant linear regression line black calculated using S plus MM estimator
0.21379416.15467011.html.plaintext.txt	190	Then data normalized linear regression making slope 1 intercept 0 subtracting linear trend deal residuals log2Cy5Cy3 27
0.21379416.15467011.html.plaintext.txt	191	Residuals mean MM estimator residuals
0.21379416.15467011.html.plaintext.txt	192	SPIs corrected S plus scatter plot smoother supsmu applied absolute residuals log2Cy5Cy3 reveal dependence residual variance intensity values
0.21379416.15467011.html.plaintext.txt	193	The supsmu based SPIs assume residual heteroscedasticity
0.21379416.15467011.html.plaintext.txt	194	Pink cyan points lie interval upper lower 95 99 SPIs
0.21379416.15467011.html.plaintext.txt	195	Red blue points lie upper lower 99 SPI
0.21379416.15467011.html.plaintext.txt	196	Black points lie upper lower 95 SPI
0.21379416.15467011.html.plaintext.txt	197	The vertical dotted line marks location minima empirical hyperbolas
0.21379416.15467011.html.plaintext.txt	198	Therefore redpink bluecyan black points represent candidate upregulated candidate downregulated unchanged genes respectively
0.21379416.15467011.html.plaintext.txt	199	Genes downregulated Mobr Modap fibroblast cell lines
0.21379416.15467011.html.plaintext.txt	200	Functional classification differentially expressed genes
0.21379416.15467011.html.plaintext.txt	201	Using Gene Ontology classifications found Mouse Genome Informatics web site httpwww
0.21379416.15467011.html.plaintext.txt	202	org Gene Ontology Consortium web site httpwww
0.21379416.15467011.html.plaintext.txt	203	org differentially expressed genes Supplemental Tables S1 S4 grouped according biological processes Fig
0.21379416.15467011.html.plaintext.txt	204	In set differentially expressed genes approximately 50 genes unknown biological processes thus shown pie graphs processes known halves
0.21379416.15467011.html.plaintext.txt	205	Biological processes genes found upregulated depicted Fig
0.21379416.15467011.html.plaintext.txt	206	A pie graph illustrating biological processes downregulated genes Mobr cell lines available Supplemental Fig
0.21379416.15467011.html.plaintext.txt	207	S7 downregulated genes Modap experiment exist illustrated pie graph list functions found Supplemental Table S6
0.21379416.15467011.html.plaintext.txt	208	Over 50 upregulated genes known biological function involved cell growth andor maintenance processes
0.21379416.15467011.html.plaintext.txt	209	This group includes genes play role signal transduction cell cycle regulation cell adhesion etc
0.21379416.15467011.html.plaintext.txt	210	Unexpectedly small portion differentially expressed genes involved response stress
0.21379416.15467011.html.plaintext.txt	211	View larger version 38K Fig
0.21379416.15467011.html.plaintext.txt	212	Functional classifications upregulated genes Mobr Modap cell lines
0.21379416.15467011.html.plaintext.txt	213	Upregulated genes known functions grouped together four major classes cell growth andor maintenance metabolism response stress transport
0.21379416.15467011.html.plaintext.txt	214	Subclasses labeled pie slices Modap A slices p Mobr B
0.21379416.15467011.html.plaintext.txt	215	No evidence oxidative stress related gene expression
0.21379416.15467011.html.plaintext.txt	216	Despite copper levels five times greater control cell lines two chronically copper overloaded cells show evidence changes transcription level oxidative stress genes
0.21379416.15467011.html.plaintext.txt	217	We expected many differentially expressed genes would encoded proteins involved response oxidative stress
0.21379416.15467011.html.plaintext.txt	218	A number oxidative stress responsive transcription factors genes identified reviewed Ref
0.21379416.15467011.html.plaintext.txt	219	However none genes e
0.21379416.15467011.html.plaintext.txt	220	superoxide dismutase catalase cytochrome P 450s DNA damage inducible genes induced repressed either Modap Mobr cells individual lists differentially expressed genes Supplemental Tables S1 S4
0.21379416.15467011.html.plaintext.txt	221	The antioxidant response element ARE responsible induction several genes response oxidants see Ref
0.21379416.15467011.html.plaintext.txt	222	39 review however known ARE responsive genes present arrays namely heme oxygenase glutamate cysteine ligase glutathione S transferases micro glutathione S transferase micro differentially expressed Modap cell line
0.21379416.15467011.html.plaintext.txt	223	Metallothionein 1 MT1 known metal responsive gene upregulated Mobr cells assayed Modap cells expected
0.21379416.15467011.html.plaintext.txt	224	To confirm observations expression two genes glutamylcysteine synthetase Gcs glutathione peroxidase Gpx known induced oxidative stress 28 measured sq RT PCR
0.21379416.15467011.html.plaintext.txt	225	Sq RT PCR showed significant induction either two genes either Mobr Modap cell lines Fig
0.21379416.15467011.html.plaintext.txt	226	View larger version 51K Fig
0.21379416.15467011.html.plaintext.txt	227	Semiquantitative reverse transcriptase polymerase chain reaction sq RT PCR analysis oxidative stress genes Mobr Modap cell lines
0.21379416.15467011.html.plaintext.txt	228	Gpx Gcl gene expression Mobr Modap control cell lines analyzed sq RT PCR described MATERIALS AND METHODS
0.21379416.15467011.html.plaintext.txt	229	The density amplified products A calculated normalized G3pdh housekeeping gene control values
0.21379416.15467011.html.plaintext.txt	230	B plot optical density GpxG3pdh left GclG3pdh right ratios
0.21379416.15467011.html.plaintext.txt	231	Differential expression cytoskeletal cell adhesion related genes
0.21379416.15467011.html.plaintext.txt	232	A surprisingly high number genes related cytoskeletal organization cell adhesion found differentially expressed Mobr Modap experiments
0.21379416.15467011.html.plaintext.txt	233	The majority genes upregulated several downregulated
0.21379416.15467011.html.plaintext.txt	234	Cell adhesion genes comprise 15 16 upregulated genes known functions Modap Mobr cells respectively Fig
0.21379416.15467011.html.plaintext.txt	235	Fifteen percent 8 upregulated genes known functions Modap Mobr cells respectively involved cytoskeleton organization biogenesis Fig
0.21379416.15467011.html.plaintext.txt	236	Cytoskeleton organization biogenesis genes make 14 genes known functions Mobr cells Supplemental Fig
0.21379416.15467011.html.plaintext.txt	237	The list genes respective experiments found Table 2
0.21379416.15467011.html.plaintext.txt	238	Cytoskeleton organizationcell adhesion related genes downregulated Mobr Modap fibroblast cell lines
0.21379416.15467011.html.plaintext.txt	239	Confirmation differential expression App Prnp
0.21379416.15467011.html.plaintext.txt	240	Two genes upregulated Mobr Modap cells Table 1 amyloid ss precursor protein App prion protein Prnp
0.21379416.15467011.html.plaintext.txt	241	Previous research suggests protein products genes may play role copper homeostasis 61 thus chose confirm differential expression
0.21379416.15467011.html.plaintext.txt	242	Significant changes App Prnp detected microarray analysis validated Northern blot analysis sq RT PCR respectively
0.21379416.15467011.html.plaintext.txt	243	Northern blot analysis showed induction App Mobr Modap fibroblast cell lines Fig
0.21379416.15467011.html.plaintext.txt	244	Equal loading samples Northern blot analysis shown Fig
0.21379416.15467011.html.plaintext.txt	245	5B ethidium bromide stained agarose gel shows 28S 18S rRNA bands 10 microg total RNA
0.21379416.15467011.html.plaintext.txt	246	RT PCR showed induction Prnp Mobr Modap cell lines Fig
0.21379416.15467011.html.plaintext.txt	247	For Prnp quantitative analysis performed plot optical density PrnpG3pdh ratios revealed Prnp induced 3
0.21379416.15467011.html.plaintext.txt	248	View larger version 63K Fig
0.21379416.15467011.html.plaintext.txt	249	Northern blot analysis App Mobr Modap cell lines
0.21379416.15467011.html.plaintext.txt	250	RNA isolated analyzed described MATERIALS AND METHODS
0.21379416.15467011.html.plaintext.txt	251	A Northern blot analysis shows expression levels App Mobr Modap control fibroblast cell lines
0.21379416.15467011.html.plaintext.txt	252	B ethidium bromide stained agarose gel shows 28S 18S rRNA bands 10 microg total RNA
0.21379416.15467011.html.plaintext.txt	253	View larger version 45K Fig
0.21379416.15467011.html.plaintext.txt	254	sq RT PCR analysis Prnp Mobr Modap cell lines
0.21379416.15467011.html.plaintext.txt	255	Prnp gene expression Mobr Modap control cell lines analyzed sq RT PCR described MATERIALS AND METHODS
0.21379416.15467011.html.plaintext.txt	256	The density amplified products A calculated normalized G3pdh housekeeping gene control values
0.21379416.15467011.html.plaintext.txt	257	B plot optical density PrnpG3pdh ratios
0.21379416.15467011.html.plaintext.txt	258	To determine whether nutritional chronic copper overload induced expression two genes analyzed sq RT PCR gene expression App Prnp copper treated control cell lines
0.21379416.15467011.html.plaintext.txt	259	Chronic copper treatment wild type control cell lines 25 microM Cu His 5 days induced App gene expression 2
0.21379416.15467011.html.plaintext.txt	260	For comparison App expression also measured Mobr Modap cell lines showed 3 4
0.21379416.15467011.html.plaintext.txt	261	5 fold induction respectively Fig
0.21379416.15467011.html.plaintext.txt	262	No change Prnp gene expression observed copper treated cells data shown
0.21379416.15467011.html.plaintext.txt	263	View larger version 46K Fig
0.21379416.15467011.html.plaintext.txt	264	sq RT PCR analysis App 25 microM Cu treated wild type cells
0.21379416.15467011.html.plaintext.txt	265	App gene expression control copper treated control cell lines analyzed sq RT PCR described MATERIALS AND METHODS
0.21379416.15467011.html.plaintext.txt	266	App expression also analyzed Mobr Modap cell lines comparison
0.21379416.15467011.html.plaintext.txt	267	The density amplified products A calculated normalized G3pdh housekeeping gene control values
0.21379416.15467011.html.plaintext.txt	268	B plot optical density AppG3pdh ratios
0.21379416.15467011.html.plaintext.txt	269	DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES We evaluated study effects chronic copper overload cellular gene expression
0.21379416.15467011.html.plaintext.txt	270	We investigated two independently derived genetic models copper overload containing mutations gene discriminate cell specific effects effects copper
0.21379416.15467011.html.plaintext.txt	271	Both mutations result severe loss function Atp7a gene 33
0.21379416.15467011.html.plaintext.txt	272	Both mutants result cellular defect copper efflux leads similar levels intracellular copper accumulation cultured cells
0.21379416.15467011.html.plaintext.txt	273	These mutant cell lines represent well characterized models cellular copper overload 12 32 thus expected genes differentially expressed mutant cell lines would likely represent copper specific changes
0.21379416.15467011.html.plaintext.txt	274	We acknowledge validation potential biomarkers would needed confirm utility biomarkers chronic copper overload etiologies
0.21379416.15467011.html.plaintext.txt	275	Our results suggest important evaluate effects multiple alleles studies effects genetic models gene expression
0.21379416.15467011.html.plaintext.txt	276	We utilized cDNA microarray technology investigate effects chronic copper overload
0.21379416.15467011.html.plaintext.txt	277	The microarray experiments compared transcripts mutant Mobr Modap control cell line carried four times per mutant
0.21379416.15467011.html.plaintext.txt	278	For analysis individual microarray data sets employed novel data driven approach recently developed laboratory identifying differentially expressed genes
0.21379416.15467011.html.plaintext.txt	279	The resulting lists significantly downregulated genes individual microarray compared showed high reproducibility
0.21379416.15467011.html.plaintext.txt	280	An investigation functions differentially expressed genes led us surprising results
0.21379416.15467011.html.plaintext.txt	281	Copper thought toxic allowed accumulate excess cellular needs ability generate free radicals 6
0.21379416.15467011.html.plaintext.txt	282	Indeed reports copper induced oxidative damage high doses exposure 55
0.21379416.15467011.html.plaintext.txt	283	Hence expected many differentially expressed genes would encoded proteins involved response oxidative stress
0.21379416.15467011.html.plaintext.txt	284	Surprisingly mottled cell lines despite chronically copper overloaded show differential expression oxidative stress genes besides upregulation MT1
0.21379416.15467011.html.plaintext.txt	285	MT1 long known induced copper heavy metals elevated cultured fibroblasts nonhepatic cell lines Menkes patients 25 49 mottled mice 41 upregulated Mobr cells array therefore assayed Modap cells
0.21379416.15467011.html.plaintext.txt	286	In contrast glutathione peroxidase GPX one main intracellular antioxidants glutamylcysteine synthetase GCL regulator glutathione synthesis previously shown upregulated oxidative stress 13 35 induced either two cell lines
0.21379416.15467011.html.plaintext.txt	287	In support findings recent study showed fibroblasts Menkes patients despite intracellular copper levels five times control cells decreased basal oxidative stress efficient protection toward free radicals fibroblasts controls 18
0.21379416.15467011.html.plaintext.txt	288	Their results included measurements redox metal content antioxidant equipment oxidative stress markers showed activity catalase GPX TBARS marker lipid peroxidation production hydrogen peroxide decreased Menkes MNK cells
0.21379416.15467011.html.plaintext.txt	289	Metallothionein production also increased MNK cells
0.21379416.15467011.html.plaintext.txt	290	Together data suggest chronic exposure moderately elevated intracellular levels copper induce oxidative damage cells instead observe evidence adaptive response copper
0.21379416.15467011.html.plaintext.txt	291	A large number differentially expressed genes Mobr Modap cell lines involved cytoskeleton organization cell adhesion Table 2
0.21379416.15467011.html.plaintext.txt	292	The relationship cytoskeletal organization copper metabolism known
0.21379416.15467011.html.plaintext.txt	293	It possible copper may affecting cytoskeleton directly
0.21379416.15467011.html.plaintext.txt	294	Polymerizationdepolymerization actin tubulin regulated part divalent metal ion binding sites generally Ca2 Mg2 thus divalent metals may act potential toxic interferers 58
0.21379416.15467011.html.plaintext.txt	295	Whether copper metal ions actually compete displace Ca2 Mg2 cytoskeleton known evidence zinc arsenic mercury cadmium disrupt actin microtubules intact cells 58
0.21379416.15467011.html.plaintext.txt	296	Another possible explanation expression changes could indirect effect secondary lysyl oxidase LO deficiency
0.21379416.15467011.html.plaintext.txt	297	LO copper containing protein responsible formation lysine derived cross links connective tissue particularly collagen elastin 52
0.21379416.15467011.html.plaintext.txt	298	LO activity shown decreased fibroblasts patients Menkes disease 17 51
0.21379416.15467011.html.plaintext.txt	299	Hence alterations extracellular matrix could downstream effect cytoskeleton lead observed changes gene expression
0.21379416.15467011.html.plaintext.txt	300	Additionally amyloid precursor protein induced models copper overload whose function still undetermined shown interact collagen sharing common binding sites heparin proposed mediator cell matrix cell cell interactions 56
0.21379416.15467011.html.plaintext.txt	301	The changes observed could also due changes function protein
0.21379416.15467011.html.plaintext.txt	302	Furthermore defects trafficking ATP7A protein may leading changes cytoskeletal organization
0.21379416.15467011.html.plaintext.txt	303	Normally ATP7A protein traffics TGN plasma membrane vesicle mediated 45 42
0.21379416.15467011.html.plaintext.txt	304	The molecular mechanisms responsible membrane trafficking ATP7A recently extensive investigation may involve cytoskeletal factors yet identified
0.21379416.15467011.html.plaintext.txt	305	In search genes may involved putative adaptive response investigated specific genes differentially expressed Mobr Modap cell lines
0.21379416.15467011.html.plaintext.txt	306	It important note two different microarrays used set experiments possible significant genes Mobr experiments assayed Modap experiments vice versa
0.21379416.15467011.html.plaintext.txt	307	Nevertheless compared 193 130 reproducible genes mutant 12 genes found similarly differentially expressed mutants Table 1
0.21379416.15467011.html.plaintext.txt	308	Because different microarrays true number similar genes may fact higher
0.21379416.15467011.html.plaintext.txt	309	Interestingly 2 12 genes found upregulated Mobr Modap mutant App Prnp
0.21379416.15467011.html.plaintext.txt	310	The protein products genes involved pathology two neurodegenerative diseases AD prion disease respectively
0.21379416.15467011.html.plaintext.txt	311	The identification copper binding sites proteins suggests possible role copper homeostasis 61
0.21379416.15467011.html.plaintext.txt	312	APP cell surface transmembrane glycoprotein ubiquitously expressed mammalian tissues although function unknown likely play important role normal cell physiology
0.21379416.15467011.html.plaintext.txt	313	APP contains two copper binding sites able reduce CuII CuI vitro 37
0.21379416.15467011.html.plaintext.txt	314	APP precursor ss amyloid Ass peptide constitutes characteristic amyloid plaques AD
0.21379416.15467011.html.plaintext.txt	315	The homeostasis copper significantly altered AD brain 57
0.21379416.15467011.html.plaintext.txt	316	Copper inhibits ss amyloid production stimulating non amyloidogenic pathway APP 5 however vitro copper induces aggregation soluble amyloid peptide suggesting role processing APP amyloid plaque assembly may contribute AD development 24
0.21379416.15467011.html.plaintext.txt	317	App mice increased copper livers cerebral cortex change serum 63
0.21379416.15467011.html.plaintext.txt	318	App neurons less sensitive copper toxicity compared wild type cells 62
0.21379416.15467011.html.plaintext.txt	319	These observations led Strausak et al
0.21379416.15467011.html.plaintext.txt	320	57 suggest amyloid precursor protein could involved release copper cell
0.21379416.15467011.html.plaintext.txt	321	Our results demonstrating upregulation App genetic models nutritional model chronic copper overload support role protein copper homeostasis
0.21379416.15467011.html.plaintext.txt	322	Recently Menkes protein overexpressed human fibroblasts state decreased intracellular copper researchers showed copper depletion significantly reduced APP protein levels downregulated App gene expression 4
0.21379416.15467011.html.plaintext.txt	323	We suggest adaptive response moderately elevated levels copper may involve amyloid precursor protein
0.21379416.15467011.html.plaintext.txt	324	Prion diseases also known transmissible spongiform encephalopathies TSEs include scrapie bovine spongiform encephalopathy BSE Creutzfeldt Jakob disease CJD result fatal neurodegenerative conditions 47
0.21379416.15467011.html.plaintext.txt	325	In prion disease thought pathogenic process related transformation normal cellular prion protein PrPc protease resistant readily aggregated isoform called PrPsc scrapie prion protein 31
0.21379416.15467011.html.plaintext.txt	326	Evidence mounting copper may play role PrPc biology 9
0.21379416.15467011.html.plaintext.txt	327	The Prnp mouse decreased copper levels brain liver whereas copper levels serum increased 10
0.21379416.15467011.html.plaintext.txt	328	In addition cell lines Prnp mice sensitive copper exposure 11
0.21379416.15467011.html.plaintext.txt	329	The prion protein may therefore represent potential copper transporting sequestering protein may prevent copper toxicity 9
0.21379416.15467011.html.plaintext.txt	330	Our results demonstrate upregulation Prnp genetic models nutritional model chronic copper overload
0.21379416.15467011.html.plaintext.txt	331	The copper treated cells although copper loaded still capability export copper whereas mutant cells
0.21379416.15467011.html.plaintext.txt	332	It could prion protein functioning secondarily copper export thus protecting cell copper toxicity copper normal export disrupted
0.21379416.15467011.html.plaintext.txt	333	Additionally cellular distribution copper may different genetic nutritional models may effect prion protein
0.21379416.15467011.html.plaintext.txt	334	Clearly studies role protein copper overload needed
0.21379416.15467011.html.plaintext.txt	335	Copper exposure proposed play role cardiovascular disease cancer addition neurodegenerative diseases 8 16 23 61
0.21379416.15467011.html.plaintext.txt	336	Although overt copper toxicity relatively rare signs moderate copper overload may common 6
0.21379416.15467011.html.plaintext.txt	337	The relationship conditions effects chronic copper exposure adequately assessed possibly due inadequacy current methodology assessment copper status 3 34
0.21379416.15467011.html.plaintext.txt	338	Currently effective measure copper overload besides invasive liver biopsy 36
0.21379416.15467011.html.plaintext.txt	339	Serum ceruloplasmin Cp levels 53 decreased copper deficiency since Cp acute phase protein levels elevated variety inflammatory conditions independent copper levels 34
0.21379416.15467011.html.plaintext.txt	340	Clearly need robust assay facilitate diagnosis copper excess distinguish mild moderate severe copper overload
0.21379416.15467011.html.plaintext.txt	341	Gene expression patterns could serve biomarkers exposure effect 2 40 44
0.21379416.15467011.html.plaintext.txt	342	We compared results published studies January 2004 gene expression effects nutrient xenobiotic exposure mammalian cells found significant overlap differentially expressed genes assayed
0.21379416.15467011.html.plaintext.txt	343	These include studies several metals arsenic cadmium
0.21379416.15467011.html.plaintext.txt	344	Thus suggest genes identified differentially expressed Mobr Modap cells lines may specific chronic copper exposure
0.21379416.15467011.html.plaintext.txt	345	GRANTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES This study funded grants International Copper Association United States Department Agriculture National Resources Inventory Grant 9900815 University California Toxic Substance Research Training Program traineeship A
0.21379416.15467011.html.plaintext.txt	346	ACKNOWLEDGMENTS We thank Erik Gertz Leslie Woodhouse Western Human Nutrition Research Center University California Davis Tuan Nguyen Children Hospital Oakland Research Institute help ICP thank Henri Wintz J
0.21379416.15467011.html.plaintext.txt	347	Kim Helen Poynton reviewing manuscript
0.21379416.15467011.html.plaintext.txt	348	FOOTNOTES Article published online print
0.21379416.15467011.html.plaintext.txt	349	See web site date publication httpphysiolgenomics
0.21379416.15467011.html.plaintext.txt	350	Address reprint requests correspondence C
0.21379416.15467011.html.plaintext.txt	351	Nutritional Science Toxicology Univ
0.21379416.15467011.html.plaintext.txt	352	California Berkeley Berkeley CA 94720 E mail vulpeatberkeley
0.21379416.15467011.html.plaintext.txt	353	1 The Supplemental Material article Supplemental Figs
0.21379416.15467011.html.plaintext.txt	354	S1 S7 Tables S1 S6 available online httpphysiolgenomics
0.21379416.15467011.html.plaintext.txt	355	REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES Aburto EM Cribb AE Fuentealba IC Ikede BO Kibenge FS Markham F
0.21379416.15467011.html.plaintext.txt	356	Morphological biochemical assessment liver response excess dietary copper Fischer 344 rats
0.21379416.15467011.html.plaintext.txt	357	Can J Vet Res 65 97 103 2001
0.21379416.15467011.html.plaintext.txt	358	ISIMedline Amin RP Hamadeh HK Bushel PR Bennett L Afshari CA Paules RS
0.21379416.15467011.html.plaintext.txt	359	Genomic interrogation mechanisms underlying cellular responses toxicants
0.21379416.15467011.html.plaintext.txt	360	Toxicology 181 182 555 563 2002
0.21379416.15467011.html.plaintext.txt	361	CrossRef Araya M Olivares M Pizarro F Gonzalez M Speisky H Uauy R
0.21379416.15467011.html.plaintext.txt	362	Gastrointestinal symptoms blood indicators copper load apparently healthy adults undergoing controlled copper exposure
0.21379416.15467011.html.plaintext.txt	363	Am J Clin Nutr 77 646 650 2003
0.21379416.15467011.html.plaintext.txt	364	AbstractFree Full Text Bellingham SA Lahiri DK Maloney B La Fontaine S Multhaup G Camakaris J
0.21379416.15467011.html.plaintext.txt	365	Copper depletion regulates expression Alzheimer disease amyloid ss precursor protein gene
0.21379416.15467011.html.plaintext.txt	366	Borchardt T Camakaris J Cappai R Masters CL Beyreuther K Multhaup G
0.21379416.15467011.html.plaintext.txt	367	Copper inhibits ss amyloid production stimulates non amyloidogenic pathway amyloid precursor protein secretion
0.21379416.15467011.html.plaintext.txt	368	Biochem J 344 461 467 1999
0.21379416.15467011.html.plaintext.txt	369	CrossRefISIMedline Bremner I
0.21379416.15467011.html.plaintext.txt	370	Manifestations copper excess
0.21379416.15467011.html.plaintext.txt	371	Am J Clin Nutr 67 1069S 1073S 1998
0.21379416.15467011.html.plaintext.txt	372	Wilson disease canine copper toxicosis
0.21379416.15467011.html.plaintext.txt	373	Am J Clin Nutr 67 1087S 1090S 1998
0.21379416.15467011.html.plaintext.txt	374	Abstract Brewer GJ Dick RD Grover DK LeClaire V Tseng M Wicha M Pienta K Redman BG Jahan T Sondak VK Strawderman M LeCarpentier G Merajver SD
0.21379416.15467011.html.plaintext.txt	375	Treatment metastatic cancer tetrathiomolybdate anticopper antiangiogenic agent phase I study
0.21379416.15467011.html.plaintext.txt	376	Clin Cancer Res 6 1 10 2000
0.21379416.15467011.html.plaintext.txt	377	AbstractFree Full Text Brown DR
0.21379416.15467011.html.plaintext.txt	378	Brain Res Bull 55 165 173 2001
0.21379416.15467011.html.plaintext.txt	379	CrossRefISIMedline Brown DR Qin K Herms JW Madlung A Manson J Strome R Fraser PE Kruck T von Bohlen A Schulz Schaeffer W Giese A Westaway D Kretzschmar H
0.21379416.15467011.html.plaintext.txt	380	The cellular prion protein binds copper vivo
0.21379416.15467011.html.plaintext.txt	381	CrossRefISIMedline Brown DR Schmidt B Kretzschmar HA
0.21379416.15467011.html.plaintext.txt	382	Effects copper survival prion protein knockout neurons glia
0.21379416.15467011.html.plaintext.txt	383	J Neurochem 70 1686 1693 1998
0.21379416.15467011.html.plaintext.txt	384	ISIMedline Camakaris J Danks DM Ackland L Cartwright E Borger P Cotton RG
0.21379416.15467011.html.plaintext.txt	385	Altered copper metabolism cultured cells human Menkes syndrome mottled mouse mutants
0.21379416.15467011.html.plaintext.txt	386	Biochem Genet 18 117 131 1980
0.21379416.15467011.html.plaintext.txt	387	ISIMedline Carper D John M Chen Z Subramanian S Wang R Ma W Spector A
0.21379416.15467011.html.plaintext.txt	388	Gene expression analysis H2O2 resistant lens epithelial cell line
0.21379416.15467011.html.plaintext.txt	389	Free Radic Biol Med 31 90 97 2001
0.21379416.15467011.html.plaintext.txt	390	CrossRefISIMedline Dalton TP Shertzer HG Puga A
0.21379416.15467011.html.plaintext.txt	391	Regulation gene expression reactive oxygen
0.21379416.15467011.html.plaintext.txt	392	Annu Rev Pharmacol Toxicol 39 67 101 1999
0.21379416.15467011.html.plaintext.txt	393	CrossRefISIMedline Ercal N Gurer Orhan H Aykin Burns N
0.21379416.15467011.html.plaintext.txt	394	Toxic metals oxidative stress
0.21379416.15467011.html.plaintext.txt	395	Mechanisms involved metal induced oxidative damage
0.21379416.15467011.html.plaintext.txt	396	Curr Top Med Chem 1 529 539 2001
0.21379416.15467011.html.plaintext.txt	397	Medline Ferns GA Lamb DJ Taylor A
0.21379416.15467011.html.plaintext.txt	398	The possible role copper ions atherogenesis Blue Janus
0.21379416.15467011.html.plaintext.txt	399	Atherosclerosis 133 139 152 1997
0.21379416.15467011.html.plaintext.txt	400	CrossRefISIMedline Gacheru S McGee C Uriu Hare JY Kosonen T Packman S Tinker D Krawetz SA Reiser K Keen CL Rucker RB
0.21379416.15467011.html.plaintext.txt	401	Expression accumulation lysyl oxidase elastin type I procollagen human Menkes mottled mouse fibroblasts
0.21379416.15467011.html.plaintext.txt	402	Arch Biochem Biophys 301 325 329 1993
0.21379416.15467011.html.plaintext.txt	403	CrossRefISIMedline Guiraud P Horn N Favier A
0.21379416.15467011.html.plaintext.txt	404	Oxidative stress antioxidant status Menkes cells
0.21379416.15467011.html.plaintext.txt	405	3rd International Meeting Copper Homeostasis Its Disorders Molecular Cellular Aspects Ischia Italy 2002 p
0.21379416.15467011.html.plaintext.txt	406	Hebert CD Elwell MR Travlos GS Fitz CJ Bucher JR
0.21379416.15467011.html.plaintext.txt	407	Subchronic toxicity cupric sulfate administered drinking water feed rats mice
0.21379416.15467011.html.plaintext.txt	408	Fundam Appl Toxicol 21 461 475 1993
0.21379416.15467011.html.plaintext.txt	409	CrossRefISIMedline Hook GR Hosseini JM Elin RJ
0.21379416.15467011.html.plaintext.txt	410	Analytical approaches biomedical elemental analysis
0.21379416.15467011.html.plaintext.txt	411	J Am Coll Nutr 4 599 612 1985
0.21379416.15467011.html.plaintext.txt	412	Abstract Hussain SP Raja K Amstad PA Sawyer M Trudel LJ Wogan GN Hofseth LJ Shields PG Billiar TR Trautwein C Hohler T Galle PR Phillips DH Markin R Marrogi AJ Harris CC
0.21379416.15467011.html.plaintext.txt	413	Increased p53 mutation load nontumorous human liver wilson disease hemochromatosis oxyradical overload diseases
0.21379416.15467011.html.plaintext.txt	414	Proc Natl Acad Sci USA 97 12770 12775 2000
0.21379416.15467011.html.plaintext.txt	415	AbstractFree Full Text Kehrer JP
0.21379416.15467011.html.plaintext.txt	416	The Haber Weiss reaction mechanisms toxicity
0.21379416.15467011.html.plaintext.txt	417	Toxicology 149 43 50 2000
0.21379416.15467011.html.plaintext.txt	418	CrossRefISIMedline Klevay LM
0.21379416.15467011.html.plaintext.txt	419	Cardiovascular disease copper deficiency history
0.21379416.15467011.html.plaintext.txt	420	ISIMedline Kowalik Jankowska T Ruta Dolejsz M Wisniewska K Lankiewicz L Kozlowski H
0.21379416.15467011.html.plaintext.txt	421	Possible involvement copperII Alzheimer disease
0.21379416.15467011.html.plaintext.txt	422	Environ Health Perspect 110 Suppl 5 869 870 2002
0.21379416.15467011.html.plaintext.txt	423	Leone A Pavlakis GN Hamer DH
0.21379416.15467011.html.plaintext.txt	424	Menkes disease abnormal metallothionein gene regulation response copper
0.21379416.15467011.html.plaintext.txt	425	CrossRefISIMedline Llanos RM Mercer JF
0.21379416.15467011.html.plaintext.txt	426	The molecular basis copper homeostasis copper related disorders
0.21379416.15467011.html.plaintext.txt	427	DNA Cell Biol 21 259 270 2002
0.21379416.15467011.html.plaintext.txt	428	CrossRefISIMedline Loguinov AV Mian IS Vulpe CD
0.21379416.15467011.html.plaintext.txt	429	Exploratory differential gene expression analysis microarray experiments limited replication
0.21379416.15467011.html.plaintext.txt	430	Regulation hepatic glutathione synthesis current concepts controversies
0.21379416.15467011.html.plaintext.txt	431	FASEB J 13 1169 1183 1999
0.21379416.15467011.html.plaintext.txt	432	AbstractFree Full Text Maier A Dalton TP Puga A
0.21379416.15467011.html.plaintext.txt	433	Disruption dioxin inducible phase I phase II gene expression patterns cadmium chromium arsenic
0.21379416.15467011.html.plaintext.txt	434	Mol Carcinog 28 225 235 2000
0.21379416.15467011.html.plaintext.txt	435	CrossRefISIMedline Martins VR Brentani RR
0.21379416.15467011.html.plaintext.txt	436	The biology cellular prion protein
0.21379416.15467011.html.plaintext.txt	437	Neurochem Int 41 353 355 2002
0.21379416.15467011.html.plaintext.txt	438	CrossRefISIMedline Masson W Hughes H Papworth D Boyd Y Horn N
0.21379416.15467011.html.plaintext.txt	439	Abnormalities copper accumulation cell lines established nine different alleles mottled found Menkes disease
0.21379416.15467011.html.plaintext.txt	440	J Med Genet 34 729 732 1997
0.21379416.15467011.html.plaintext.txt	441	Abstract Mercer JF Ambrosini L Horton S Gazeas S Grimes A
0.21379416.15467011.html.plaintext.txt	442	Animal models Menkes disease
0.21379416.15467011.html.plaintext.txt	443	Adv Exp Med Biol 448 97 108 1999
0.21379416.15467011.html.plaintext.txt	444	Copper intake assessment copper status
0.21379416.15467011.html.plaintext.txt	445	Am J Clin Nutr 67 1041S 1045S 1998
0.21379416.15467011.html.plaintext.txt	446	Abstract Morgan KT Ni H Brown HR Yoon L Qualls CW Jr Crosby LM Reynolds R Gaskill B Anderson SP Kepler TB Brainard T Liv N Easton M Merrill C Creech D Sprenger D Conner G Johnson PR Fox T Sartor M Richard E Kuruvilla S Casey W Benavides G
0.21379416.15467011.html.plaintext.txt	447	Application cDNA microarray technology vitro toxicology selection genes real time RT PCR based screen oxidative stress Hep G2 cells
0.21379416.15467011.html.plaintext.txt	448	Toxicol Pathol 30 435 451 2002
0.21379416.15467011.html.plaintext.txt	449	CrossRefISIMedline Muller T Muller W Feichtinger H
0.21379416.15467011.html.plaintext.txt	450	Am J Clin Nutr 67 1082S 1086S 1998
0.21379416.15467011.html.plaintext.txt	451	Abstract Multhaup G Schlicksupp A Hesse L Beher D Ruppert T Masters CL Beyreuther K
0.21379416.15467011.html.plaintext.txt	452	The amyloid precursor protein Alzheimer disease reduction copperII copperI
0.21379416.15467011.html.plaintext.txt	453	Science 271 1406 1409 1996
0.21379416.15467011.html.plaintext.txt	454	Abstract Myers BM Prendergast FG Holman R Kuntz SM Larusso NF
0.21379416.15467011.html.plaintext.txt	455	Alterations hepatocyte lysosomes experimental hepatic copper overload rats
0.21379416.15467011.html.plaintext.txt	456	Gastroenterology 105 1814 1823 1993
0.21379416.15467011.html.plaintext.txt	457	ISIMedline Nguyen T Sherratt PJ Pickett CB
0.21379416.15467011.html.plaintext.txt	458	Regulatory mechanisms controlling gene expression mediated antioxidant response element
0.21379416.15467011.html.plaintext.txt	459	Annu Rev Pharmacol Toxicol 43 233 260 2003
0.21379416.15467011.html.plaintext.txt	460	CrossRefISIMedline Nuwaysir EF Bittner M Trent J Barrett JC Afshari CA
0.21379416.15467011.html.plaintext.txt	461	Microarrays toxicology advent toxicogenomics
0.21379416.15467011.html.plaintext.txt	462	Mol Carcinog 24 153 159 1999
0.21379416.15467011.html.plaintext.txt	463	Metallothionein messenger RNA regulation mottled mouse Menkes kinky hair syndrome
0.21379416.15467011.html.plaintext.txt	464	J Clin Invest 79 1338 1342 1987
0.21379416.15467011.html.plaintext.txt	465	ISIMedline Pascale MC Franceschelli S Moltedo O Belleudi F Torrisi MR Bucci C La Fontaine S Mercer JF Leone A
0.21379416.15467011.html.plaintext.txt	466	Endosomal trafficking Menkes copper ATPase ATP7A mediated vesicles containing Rab7 Rab5 GTPase proteins
0.21379416.15467011.html.plaintext.txt	467	Exp Cell Res 291 377 385 2003
0.21379416.15467011.html.plaintext.txt	468	CrossRefISIMedline Pena MM Lee J Thiele DJ
0.21379416.15467011.html.plaintext.txt	469	A delicate balance homeostatic control copper uptake distribution
0.21379416.15467011.html.plaintext.txt	470	J Nutr 129 1251 1260 1999
0.21379416.15467011.html.plaintext.txt	471	AbstractFree Full Text Pennie WD
0.21379416.15467011.html.plaintext.txt	472	Use cDNA microarrays probe understand toxicological consequences altered gene expression
0.21379416.15467011.html.plaintext.txt	473	Toxicol Lett 112 113 473 477 2000
0.21379416.15467011.html.plaintext.txt	474	CrossRef Petris MJ Mercer JF Culvenor JG Lockhart P Gleeson PA Camakaris J
0.21379416.15467011.html.plaintext.txt	475	Ligand regulated transport Menkes copper P type ATPase efflux pump Golgi apparatus plasma membrane novel mechanism regulated trafficking
0.21379416.15467011.html.plaintext.txt	476	Abstract Pizarro F Olivares M Uauy R Contreras P Rebelo A Gidi V
0.21379416.15467011.html.plaintext.txt	477	Acute gastrointestinal effects graded levels copper drinking water
0.21379416.15467011.html.plaintext.txt	478	Environ Health Perspect 107 117 121 1999
0.21379416.15467011.html.plaintext.txt	479	Proc Natl Acad Sci USA 95 13363 13383 1998
0.21379416.15467011.html.plaintext.txt	480	AbstractFree Full Text Puig S Thiele DJ
0.21379416.15467011.html.plaintext.txt	481	Molecular mechanisms copper uptake distribution
0.21379416.15467011.html.plaintext.txt	482	Curr Opin Chem Biol 6 171 180 2002
0.21379416.15467011.html.plaintext.txt	483	CrossRefISIMedline Riordan JR Jolicoeur Paquet L
0.21379416.15467011.html.plaintext.txt	484	Metallothionein accumulation may account intracellular copper retention Menkes disease
0.21379416.15467011.html.plaintext.txt	485	J Biol Chem 257 4639 4645 1982
0.21379416.15467011.html.plaintext.txt	486	AbstractFree Full Text Riordan SM Williams R
0.21379416.15467011.html.plaintext.txt	487	The Wilson disease gene phenotypic diversity
0.21379416.15467011.html.plaintext.txt	488	J Hepatol 34 165 171 2001
0.21379416.15467011.html.plaintext.txt	489	Medline Royce PM Camakaris J Danks DM
0.21379416.15467011.html.plaintext.txt	490	Reduced lysyl oxidase activity skin fibroblasts patients Menkes syndrome
0.21379416.15467011.html.plaintext.txt	491	Biochem J 192 579 586 1980
0.21379416.15467011.html.plaintext.txt	492	ISIMedline Rucker RB Kosonen T Clegg MS Mitchell AE Rucker BR Uriu Hare JY Keen CL
0.21379416.15467011.html.plaintext.txt	493	Copper lysyl oxidase extracellular matrix protein cross linking
0.21379416.15467011.html.plaintext.txt	494	Am J Clin Nutr 67 996S 1002S 1998
0.21379416.15467011.html.plaintext.txt	495	In Laboratory Tests Assessment Nutritional Status 2nd ed
0.21379416.15467011.html.plaintext.txt	496	Sokol RJ Devereaux M Mierau GW Hambidge KM Shikes RH
0.21379416.15467011.html.plaintext.txt	497	Oxidant injury hepatic mitochondrial lipids rats dietary copper overload
0.21379416.15467011.html.plaintext.txt	498	Modification vitamin E deficiency
0.21379416.15467011.html.plaintext.txt	499	Gastroenterology 99 1061 1071 1990
0.21379416.15467011.html.plaintext.txt	500	ISIMedline Sokol RJ Twedt D McKim JM Jr Devereaux MW Karrer FM Kam I von Steigman G Narkewicz MR Bacon BR Britton RS et al
0.21379416.15467011.html.plaintext.txt	501	Oxidant injury hepatic mitochondria patients Wilson disease Bedlington terriers copper toxicosis
0.21379416.15467011.html.plaintext.txt	502	Gastroenterology 107 1788 1798 1994
0.21379416.15467011.html.plaintext.txt	503	ISIMedline Storey E Cappai R
0.21379416.15467011.html.plaintext.txt	504	The amyloid precursor protein Alzheimer disease Ass peptide
0.21379416.15467011.html.plaintext.txt	505	Neuropathol Appl Neurobiol 25 81 97 1999
0.21379416.15467011.html.plaintext.txt	506	CrossRefISIMedline Strausak D Mercer JF Dieter HH Stremmel W Multhaup G
0.21379416.15467011.html.plaintext.txt	507	Copper disorders neurological symptoms Alzheimer Menkes Wilson diseases
0.21379416.15467011.html.plaintext.txt	508	Brain Res Bull 55 175 185 2001
0.21379416.15467011.html.plaintext.txt	509	CrossRefISIMedline Templeton DM
0.21379416.15467011.html.plaintext.txt	510	Metal ions cytoskeleton
0.21379416.15467011.html.plaintext.txt	511	In Molecular Biology Toxicology Metals edited Koropatnick DJ
0.21379416.15467011.html.plaintext.txt	512	New York Taylor Francis 2000 p
0.21379416.15467011.html.plaintext.txt	513	Tsang SY Tam SC Bremner I Burkitt MJ
0.21379416.15467011.html.plaintext.txt	514	Research communication copper 110 phenanthroline induces internucleosomal DNA fragmentation HepG2 cells resulting direct oxidation hydroxyl radical
0.21379416.15467011.html.plaintext.txt	515	ISIMedline Uauy R Olivares M Gonzalez M
0.21379416.15467011.html.plaintext.txt	516	Essentiality copper humans
0.21379416.15467011.html.plaintext.txt	517	Am J Clin Nutr 67 952S 959S 1998
0.21379416.15467011.html.plaintext.txt	518	Abstract Waggoner DJ Bartnikas TB Gitlin JD
0.21379416.15467011.html.plaintext.txt	519	The role copper neurodegenerative disease
0.21379416.15467011.html.plaintext.txt	520	Neurobiol Dis 6 221 230 1999
0.21379416.15467011.html.plaintext.txt	521	CrossRefISIMedline White AR Multhaup G Maher F Bellingham S Camakaris J Zheng H Bush AI Beyreuther K Masters CL Cappai R
0.21379416.15467011.html.plaintext.txt	522	The Alzheimer disease amyloid precursor protein modulates copper induced toxicity oxidative stress primary neuronal cultures
0.21379416.15467011.html.plaintext.txt	523	J Neurosci 19 9170 9179 1999
0.21379416.15467011.html.plaintext.txt	524	AbstractFree Full Text White AR Reyes R Mercer JF Camakaris J Zheng H Bush AI Multhaup G Beyreuther K Masters CL Cappai R
0.21379416.15467011.html.plaintext.txt	525	Copper levels increased cerebral cortex liver APP APLP2 knockout mice
0.21379416.15467011.html.plaintext.txt	526	Brain Res 842 439 444 1999
0.13508143.14681245.html.plaintext.txt	0	Commentary Shaw critique health care still valid K Srinath Reddy
0.13508143.14681245.html.plaintext.txt	1	All India Institute Medical Sciences Ansari Nagar New Delhi 110 029 India
0.13508143.14681245.html.plaintext.txt	2	The preface provided George Bernard Shaw The Doctor Dilemma1 profoundly insightful deliberately provocative essay short comings health care provided doctors deficient scientific thought driven petty profit motives
0.13508143.14681245.html.plaintext.txt	3	It also eloquent espousal ideal public health system devoid flaws
0.13508143.14681245.html.plaintext.txt	4	Though Shaw unduly harsh Pasteur improperly critical efforts eliminate smallpox prototype underpaid doctor driven malpractice longer exists many parts world ideas developed preface great contemporary relevance
0.13508143.14681245.html.plaintext.txt	5	Shaw consistent demand credible evidence hallmark truly scientific mind
0.13508143.14681245.html.plaintext.txt	6	He expresses despair even disgust usual medical practitioner applying methods scientific enquiry principles statistical analysis evaluate efficacy safety treatment methods espouse ill informed enthusiasm willingly inflict unsuspecting public
0.13508143.14681245.html.plaintext.txt	7	The situation improved greatly since Shaw time
0.13508143.14681245.html.plaintext.txt	8	Even evidence constantly accumulates pages prolific research publications average practitioner often distanced message
0.13508143.14681245.html.plaintext.txt	9	Even part message reach often pharmaceutical industry sales promoters lay media aptitude ability subject message serious scientific scrutiny severely deficient
0.13508143.14681245.html.plaintext.txt	10	Shaw protests incorrect use statistics lack matched comparison groups
0.13508143.14681245.html.plaintext.txt	11	He argues convincingly apparent benefits interventions easily demonstrable absence matched comparison group cautions spurious interpretations ought guide medical practice
0.13508143.14681245.html.plaintext.txt	12	He makes good case employing scientific design controlled trial evaluating medical interventions
0.13508143.14681245.html.plaintext.txt	13	He particularly caustic ecological fallacies arise analyses depend time trends take account confounding effects concomitant changes determinants
0.13508143.14681245.html.plaintext.txt	14	The example provides relationship disappearance typhus amputation little finger particularly telling
0.13508143.14681245.html.plaintext.txt	15	The clarity identifies describes confounding factor bedevils causal associations would epidemiologist proud
0.13508143.14681245.html.plaintext.txt	16	He especially emphasizes role socioeconomic status important determinant differences levels health powerful confounder influences effect interventions aim alter health
0.13508143.14681245.html.plaintext.txt	17	His socialist ideology scientific temper blend brilliantly incisive analytical tool dissects contributions poverty deprivation ill health pours convictions passionate piece advocacy urging greater attention broader determinants health
0.13508143.14681245.html.plaintext.txt	18	The adverse health implications low socioeconomic status widely documented virtually areas health nutrition infectious diseases many non communicable diseases
0.13508143.14681245.html.plaintext.txt	19	While Virchow McKeown Marmot may call attention among public health fraternity requires writing power Dickens Shaw stir conscience world take heed initiate action
0.13508143.14681245.html.plaintext.txt	20	The issues related confidence intervals absolute risk also come Shaw preface although specific terms used
0.13508143.14681245.html.plaintext.txt	21	He questions validity drawing conclusions estimates based zero numerator denominator small uses sample size one smallpox vaccination example
0.13508143.14681245.html.plaintext.txt	22	The need estimate confidence intervals use judging possible range effect size associated intervention emphasized often enough statistics
0.13508143.14681245.html.plaintext.txt	23	Yet substantial section published research clinical practice even yet benefited statistical lesson Shaw provides us
0.13508143.14681245.html.plaintext.txt	24	Too often zero numerator exercises seductive appeal clouds judgement upper confidence limit blissfully ignored interpret numbers
0.13508143.14681245.html.plaintext.txt	25	2 Similarly published studies often focus relative risk put spin results trials without informing practising doctor difference likely occur absolute risk event
0.13508143.14681245.html.plaintext.txt	26	Thus measure risk relevant study aetiological associations substituted pseudoscientific sleight hand measure risk relevant decision making individual management clinical practice
0.13508143.14681245.html.plaintext.txt	27	The cruder tricks disturbed Shaw continue dismay us results scientific investigations inaccurately interpreted either ignorance deliberate intent mislead
0.13508143.14681245.html.plaintext.txt	28	Shaw particularly lucid talks benefits attention health need accounted ascribing virtue independent benefit intervention
0.13508143.14681245.html.plaintext.txt	29	The beneficial effects placebos attention bestowed participants clinical trial well described many recent publications clinical research methodology
0.13508143.14681245.html.plaintext.txt	30	That Shaw demanded rigorous proof truly independent contribution made intervention remarkable consider even policy practice frequently swayed results uncontrolled inadequately controlled studies demonstration projects wherein effects co intervention confounding poorly assessed
0.13508143.14681245.html.plaintext.txt	31	Shaw discusses influence demand supply nature medical practice two seemingly contradictory essentially complementary viewpoints
0.13508143.14681245.html.plaintext.txt	32	On one hand laments rightly giving doctor pecuniary interest prescribing costly tests medication surgery motivates manipulate demand suit interests
0.13508143.14681245.html.plaintext.txt	33	That supplier driven demand makes medical care prime example market failure evident present era technology intensive high cost investigations interventions
0.13508143.14681245.html.plaintext.txt	34	At time also argues laity reset nature supply demanding certain types care expressing preference hygienic modes disease prevention
0.13508143.14681245.html.plaintext.txt	35	This true growing market complementary alternative systems medicine demonstrates
0.13508143.14681245.html.plaintext.txt	36	It surprising practitioners modern medicine also warming treatment methods many years scepticism
0.13508143.14681245.html.plaintext.txt	37	The fact great scientific public health interest health promoting effects fresh fruit vegetables well merits Mediterranean diet supports contention doctors recognize need respect conventional wisdom respond research confirm repudiate
0.13508143.14681245.html.plaintext.txt	38	However dominance profit motive provide control health care would still lead manipulate demand maximal extent
0.13508143.14681245.html.plaintext.txt	39	They would employ reductionist research seek protective phytochemicals antioxidants fibre fruits vegetables marketed pills potions
0.13508143.14681245.html.plaintext.txt	40	The imbalance supplier driven demand consumer generated demand would always resolved favour provider till consumers acting communities individuals become better informed assertive resetting demand health care deserve desire
0.13508143.14681245.html.plaintext.txt	41	Shaw finally suggests model wherein pubic health protected promoted Public Health Service comprising Medical Officers Health committed act benefactors community replace petty private tradesmen profiteering illness
0.13508143.14681245.html.plaintext.txt	42	This model partly developed insufficiently applied even countries socialized systems health care hence cannot considered one adequately tried tested
0.13508143.14681245.html.plaintext.txt	43	It tragic therefore model discarded failure national health services dismantled hurry provide free rein privatized commercialized medical care
0.13508143.14681245.html.plaintext.txt	44	Shaw vision even relevant today time writing
0.13508143.14681245.html.plaintext.txt	45	This commodification health care proceeded far sinister levels organization days precarious shabby genteel irresponsible private practitioner perceived principal danger
0.13508143.14681245.html.plaintext.txt	46	The Jekyll Hyde pathway transformation proceeded stages benign family physician greedy private doctor medical cartels larger hospitals present state large corporations control production distribution drugs devices technologies individual doctor robotic sales agent
0.13508143.14681245.html.plaintext.txt	47	As juggernaut commercial medicine rolls individual doctor role becomes inconsequential citizen health forfeit corporate profits
0.13508143.14681245.html.plaintext.txt	48	It tempting speculate Shaw would reacted social forces shaping global health today well new threats public health emerged since time
0.13508143.14681245.html.plaintext.txt	49	The epidemics non communicable diseases sweeping across world driven undesirable elements industrialization urbanization globalization
0.13508143.14681245.html.plaintext.txt	50	From tobacco processed food drugs vaccines language trade threatens dominate discourse public health
0.13508143.14681245.html.plaintext.txt	51	The agents ill health marketed aggressively transnational mega corporations battle win minds money consumers spread many countries
0.13508143.14681245.html.plaintext.txt	52	Even communicable diseases come new forms globalized trade speeds human travel also promotes livestock farming industrial level
0.13508143.14681245.html.plaintext.txt	53	One wonders caustic comments would come Shaw critical pen factors led mad cow disease even sudden acute respiratory syndrome SARS may byproduct expanding animal human interface setting unhygienic livestock breeding commercial purposes
0.13508143.14681245.html.plaintext.txt	54	The solutions needed today therefore go beyond creation responsive responsible Medical Officer Health
0.13508143.14681245.html.plaintext.txt	55	We require broader stronger edifice global public health multiple determinants health addressed influenced perspective peoples health takes precedence corporate wealth
0.13508143.14681245.html.plaintext.txt	56	The mould makes individual doctor needs recast
0.13508143.14681245.html.plaintext.txt	57	Epidemiology economics ethics sadly deficient modern medical training need strengthened doctor emerges portals medical college endowed scientific temper spirit social responsibility ability utilize available resources efficiently promoting better health outcomes
0.13508143.14681245.html.plaintext.txt	58	The role non physician health care providers increased since Shaw time needs strengthened
0.13508143.14681245.html.plaintext.txt	59	Well informed involvement communities health promotion patients self care receiving greater emphasis participatory models health care seek replace prescriptive models
0.13508143.14681245.html.plaintext.txt	60	All components must contribute scientific efficient equitable pattern health care
0.13508143.14681245.html.plaintext.txt	61	Towards end preface Shaw expresses optimism public health get champions needs provide social solution medical problem
0.13508143.14681245.html.plaintext.txt	62	I end commentary hope global consciousness rise ensure triumph public health many threats faces
0.13508143.14681245.html.plaintext.txt	63	References Top References 1 Shaw GB
0.13508143.14681245.html.plaintext.txt	64	Extracts reprinted Int J Epidemiol 200332910 15
0.13508143.14681245.html.plaintext.txt	65	If nothing goes wrong everything right JAMA 19832491743 45
0.13508143.14681245.html.plaintext.txt	66	This Article Extract FREE Full Text PDF Alert article cited Alert correction posted Services Email article friend Similar articles journal Similar articles ISI Web Science Similar articles PubMed Alert new issues journal Add My Personal Archive Download citation manager Request Permissions Google Scholar Articles Reddy K S
0.13508143.14681245.html.plaintext.txt	67	PubMed PubMed Citation Articles Reddy K S
0.13508143.14681245.html.plaintext.txt	68	Online ISSN 1464 3685 Print ISSN 0300 5771 Copyright 2006 International Epidemiological Association Oxford Journals Oxford University Press Site Map Terms Conditions Privacy Policy Frequently Asked Questions Other Oxford University Press sites Oxford University Press American National Biography Booksellers Information Service Childrens Fiction Poetry Childrens Reference Corporate Special Sales Dictionaries Dictionary National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights Permissions Science School Books Social Sciences Very Short Introductions Worlds Classics
0.16906957.12759373.html.plaintext.txt	0	Specific inhibition pathological prion protein accumulation small interfering RNAs Nathalie Daude Mathieu Marella Joelle Chabry
0.16906957.12759373.html.plaintext.txt	1	Institut de Pharmacologie Moleculaire et Cellulaire Unite Mixte de Recherche 6097 Centre National de la Recherche Scientifique
0.16906957.12759373.html.plaintext.txt	2	660 route des lucioles 06560 Valbonne France
0.16906957.12759373.html.plaintext.txt	3	Author correspondence e mail chabryatipmc
0.16906957.12759373.html.plaintext.txt	4	Summary Top Summary Introduction Materials Methods Results Discussion References Development transmissible spongiform encephalopathies TSEs pathogenesis requires presence normal host prion protein PrP sen abnormal pathological proteinase K resistant isoform PrP res
0.16906957.12759373.html.plaintext.txt	5	PrP res forms highly insoluble aggregates self perpetuating properties binding converting PrP sen molecules likeness
0.16906957.12759373.html.plaintext.txt	6	In present report show small interfering RNA siRNA duplexes trigger specific Prnp gene silencing scrapie infected neuroblastoma cells
0.16906957.12759373.html.plaintext.txt	7	A non passaged scrapie infected culture transfected siRNA duplexes depleted PrP sen rapidly loses PrP res content
0.16906957.12759373.html.plaintext.txt	8	The use different murine adapted scrapie strains host cells influence siRNA induced gene silencing efficiency
0.16906957.12759373.html.plaintext.txt	9	More 80 transfected cells positive presence fluorescein labeled siRNA duplexes
0.16906957.12759373.html.plaintext.txt	10	No cytotoxicity associated use siRNA observed time course experiments
0.16906957.12759373.html.plaintext.txt	11	Despite transient abrogation PrP res accumulation results suggest use siRNA may provide new promising therapeutic approach prion diseases
0.16906957.12759373.html.plaintext.txt	12	Key words Transmissible spongiform encephalopathy Prion siRNA Scrapie PrP res PrPsc PrP sen Prnp
0.16906957.12759373.html.plaintext.txt	13	Introduction Top Summary Introduction Materials Methods Results Discussion References Transmissible spongiform encephalopathies TSEs also named prion diseases fatal neurodegenerative diseases including Creutzfeldt Jakob disease humans scrapie sheep goats bovine spongiform encephalopathy cattle Prusiner et al
0.16906957.12759373.html.plaintext.txt	14	1996 Caughey Chesebro 1997
0.16906957.12759373.html.plaintext.txt	15	In affected humans animals TSEs characterized accumulation central nervous system protease resistant isoform PrP res PrPsc host encoded cellular prion protein PrP sen PrPc
0.16906957.12759373.html.plaintext.txt	16	As differences primary sequences could demonstrated PrP sen PrP res isoforms believed differ tertiary structure Stahl et al
0.16906957.12759373.html.plaintext.txt	17	Macromolecular aggregates PrP res thought continuously grow binding PrP sen molecules converting conformation
0.16906957.12759373.html.plaintext.txt	18	Conversion PrP sen PrP res pivotal event etiology TSEs even though mechanisms initiating conversion reaction remain unknown
0.16906957.12759373.html.plaintext.txt	19	Both PrP isoforms PrP sen PrP res believed involved neuropathogenesis TSEs Bueler et al
0.16906957.12759373.html.plaintext.txt	20	Homozygous disruption Prnp gene encoding PrP results complete scrapie resistance mice Bueler et al
0.16906957.12759373.html.plaintext.txt	21	Moreover expression level PrP sen major factor influencing rate replication infectious agent well incubation time TSEs Sakaguchi et al
0.16906957.12759373.html.plaintext.txt	22	The importance PrP sen TSEs also exemplified genetic linkages familial TSEs mutations human Prnp gene Parchi Gambetti 1995
0.16906957.12759373.html.plaintext.txt	23	Chronically scrapie infected cell lines extensively used models selecting anti prion drugs porphyrines Caughey et al
0.16906957.12759373.html.plaintext.txt	24	1998 amphotericin B Mange et al
0.16906957.12759373.html.plaintext.txt	25	2000 quinacrine Doh Ura et al
0.16906957.12759373.html.plaintext.txt	26	Since PrP sen expression essential TSE pathogenesis conversion leading PrP res accumulation studied effect specific Prnp gene silencing molecules scrapie infected neuroblastoma cells N2aS12sc
0.16906957.12759373.html.plaintext.txt	27	Small interfering RNAs siRNAs provide new powerful tools potentially silence targeted gene Elbashir et al
0.16906957.12759373.html.plaintext.txt	28	Because siRNA duplexes trigger specific gene silencing mammalian somatic cells without activation unspecific response analysis gene function cultured cells become possible
0.16906957.12759373.html.plaintext.txt	29	Here show transient transfection siRNA duplexes designed mouse Prnp gene moPrnp causes rapid loss PrP sen expression abrogates PrP res formation N2aS12sc cells
0.16906957.12759373.html.plaintext.txt	30	By contrast scrambled siRNA failed inhibit PrP sen expression PrP res accumulation cells suggesting highly specific siRNA effect
0.16906957.12759373.html.plaintext.txt	31	Finally demonstrate siRNA gene silencing independent host cell types mouse adapted scrapie strain
0.16906957.12759373.html.plaintext.txt	32	Materials Methods Top Summary Introduction Materials Methods Results Discussion References Reagents antibodies Proteinase K PK Pefabloc purchased Boehringer Mannheim
0.16906957.12759373.html.plaintext.txt	33	Dulbeccos modified Eagles medium DMEM Opti MEM trypsin geneticin G418 OligofectamineTM Invitrogen ftal bovine serum FBS BioWest Nuaille France
0.16906957.12759373.html.plaintext.txt	34	Mouse monoclonal antibodies SAF83 SAF84 raised knock mice Manson et al
0.16906957.12759373.html.plaintext.txt	35	1994 immunization scrapie associated fibrils SAF preparation obtained hamster infected brain 263K strain
0.16906957.12759373.html.plaintext.txt	36	SAFs denatured immunization treatment formic acid
0.16906957.12759373.html.plaintext.txt	37	Both antibodies crossreact PrP mammalian species bovine ovine mouse hamster human
0.16906957.12759373.html.plaintext.txt	38	Secondary antibodies conjugated peroxidase Jackson ImmunoResearch West Grove PA
0.16906957.12759373.html.plaintext.txt	39	Cell cultures Neuroblastoma N2a cells expressing mouse PrP subclone 58 cultured Opti MEM containing 10 inactivated FBS FBSi penicillin streptomycin 1 mgl G418
0.16906957.12759373.html.plaintext.txt	40	This cell line named N2aS12sc chronically infected brain homogenates Chandler strain infected mice Nishida et al
0.16906957.12759373.html.plaintext.txt	41	Since treatment N2aS12sc cells Congo Red 1 microgml totally cured cells PrP res Congo Red treated N2aS12 cells used uninfected cells N2aS12
0.16906957.12759373.html.plaintext.txt	42	The GT1 cells infected brain homogenates 22L murine scrapie strain grown Dulbecco modified Eagles medium containing 5 fetal calf serum 5 horse serum penicillin streptomycin
0.16906957.12759373.html.plaintext.txt	43	All cultured cells maintained 37 degrees C 5 CO2 split 14 every 4 days
0.16906957.12759373.html.plaintext.txt	44	siRNA preparation transfection siRNAs corresponding moPrnp gene codon 392 410 synthesized Eurogentec Seraing Belgium
0.16906957.12759373.html.plaintext.txt	45	Typically siRNAs made 19 ribonucleotides followed two extra thymidine bases 3 end overhang strands
0.16906957.12759373.html.plaintext.txt	46	The specific siRNAs sequences used 5 GCC CAG CAA ACC AAA AAC CTT 3 sense scramble 5 CGC ACC AGA ACA AAC ACA CTT 3 sense
0.16906957.12759373.html.plaintext.txt	47	The specific siRNA sense 5 GCC CAG CAA ACC AAA AAC CTT 3 labeled 6 carboxyfluorescein 6 FAM 3 end
0.16906957.12759373.html.plaintext.txt	48	Annealing duplexes siRNA formation performed incubation 92 degrees C 1 minute 50 mM Tris HCl pH 7
0.16906957.12759373.html.plaintext.txt	49	5 containing 100 mM NaCl followed 60 minute incubation room temperature
0.16906957.12759373.html.plaintext.txt	50	The final stock concentration siRNA duplexes 20 microM stored 4 degrees C use
0.16906957.12759373.html.plaintext.txt	51	Twenty four hours transfection cells seeded 10 15 confluence 12 well culture plate appropriate culture medium
0.16906957.12759373.html.plaintext.txt	52	Varying amounts double strand siRNA 1 10 microl mixed corresponding half volume 0
0.16906957.12759373.html.plaintext.txt	53	5 5 microl OligofectamineTM reagent 20 minutes according manufacturers instructions
0.16906957.12759373.html.plaintext.txt	54	The mixture applied cells final volume made 500 microl Opti MEM without FBSi antibiotic
0.16906957.12759373.html.plaintext.txt	55	After incubation 4 hours 37 degrees C 5 CO2 250 microl Opti MEM supplemented 30 FBSi penicillinstreptomycin mixture added
0.16906957.12759373.html.plaintext.txt	56	Cells cultured three days 37 degrees C confluent
0.16906957.12759373.html.plaintext.txt	57	Assay PrP res accumulation N2aS12sc Confluent cultures lysed 10 minutes 4 degrees C lysis buffer 50 mM Tris HCl pH 7
0.16906957.12759373.html.plaintext.txt	58	5 sodium deoxycholate 5 mM EDTA centrifuged 5 minutes 3000 g
0.16906957.12759373.html.plaintext.txt	59	For detection PrP sen one tenth post nuclear supernatants directly mixed volume 2x denaturing loading buffer
0.16906957.12759373.html.plaintext.txt	60	For detection PrP res samples digested 20 microg PK per mg total proteins 30 minutes 37 degrees C
0.16906957.12759373.html.plaintext.txt	61	The digestion stopped adding Pefabloc 1 mM 5 minutes centrifugation 20000 g 90 minutes room temperature
0.16906957.12759373.html.plaintext.txt	62	Pellets resuspended 30 microl denaturing loading buffer sonicated boiled 5 minutes loaded onto 12 polyacrylamide gel
0.16906957.12759373.html.plaintext.txt	63	Proteins separated SDS PAGE electroblotted onto nitrocellulose membrane Protran BA83 Schleicher Schuell
0.16906957.12759373.html.plaintext.txt	64	Membranes treated solution containing 5 nonfat dried milk 20 mM Tris HCl pH 8 100 mM NaCl 0
0.16906957.12759373.html.plaintext.txt	65	1 Tween 20 incubated overnight 4 degrees C appropriate primary antibody
0.16906957.12759373.html.plaintext.txt	66	Blots developed using enhanced chemiluminescence system Pierce Rockford IL exposed X ray films X OMAT AR Kodak
0.16906957.12759373.html.plaintext.txt	67	Densitometry performed National Institutes Health IMAGE software least four independent experiments results expressed percentage control levels
0.16906957.12759373.html.plaintext.txt	68	Confocal microscopy N2aS12 cells grown glass coverslips Lab Tek Opti MEM supplemented 10 FBSi
0.16906957.12759373.html.plaintext.txt	69	Cells transfected described 6 FAM conjugated siRNAs duplexes 400 nM single stranded 6 FAM conjugated siRNA control experiment
0.16906957.12759373.html.plaintext.txt	70	At indicated post transfection times coverslips washed twice phosphate buffered saline PBS fixed paraformaldehyde 3 PBS 10 minutes room temperature
0.16906957.12759373.html.plaintext.txt	71	Cells washed twice PBS incubated PBS containing 50 mM NH4Cl 10 minutes order quench excess free aldehyde groups
0.16906957.12759373.html.plaintext.txt	72	Cells permeabilized PBS containing 0
0.16906957.12759373.html.plaintext.txt	73	1 Triton X 100 1 microgml propidium iodide 10 minutes room temperature
0.16906957.12759373.html.plaintext.txt	74	Coverslips washed twice PBS mounted glass slides mowiol
0.16906957.12759373.html.plaintext.txt	75	Cells analysed using laser scanning confocal inverted microscope Leica TCS SP equipped argon krypton laser
0.16906957.12759373.html.plaintext.txt	76	Samples scanned 488 nm 568 nm excitation wavelength 6 FAM conjugated siRNA propidium iodide respectively
0.16906957.12759373.html.plaintext.txt	77	Images acquired single transcellular optical sections averaged least 8 scans per frame
0.16906957.12759373.html.plaintext.txt	78	Results Top Summary Introduction Materials Methods Results Discussion References It previously shown relative level PrP res production correlates level PrP sen expression
0.16906957.12759373.html.plaintext.txt	79	These observations led us study effect silencing Prnp gene using siRNAs
0.16906957.12759373.html.plaintext.txt	80	We speculated abrogation PrP sen expression may subsequently downregulate abolish PrP res accumulation scrapie infected N2aS12sc cells
0.16906957.12759373.html.plaintext.txt	81	These cells transfected various concentrations moPrnp gene specific siRNA assayed PrP immunoreactivity absence Fig
0.16906957.12759373.html.plaintext.txt	82	The expression PrP sen specifically reduced cognate siRNA duplex dose dependent manner whereas expression unrelated protein ERK unaffected Fig
0.16906957.12759373.html.plaintext.txt	83	Importantly treatment also reduced PrP res levels Fig
0.16906957.12759373.html.plaintext.txt	84	The concentrations Prnp specific siRNA able inhibit 50 PrP sen expression PrP res accumulation IC50 72 100 nM respectively Fig
0.16906957.12759373.html.plaintext.txt	85	Scrambled siRNA unrelated known genes unable perturb amount PrP sen PrP res N2aS12sc cells even high concentrations 400 nM
0.16906957.12759373.html.plaintext.txt	86	Single stranded siRNAs transfected independently N2aS12sc cells also unable diminish expression PrP sen data shown
0.16906957.12759373.html.plaintext.txt	87	View larger version 40K Fig
0.16906957.12759373.html.plaintext.txt	88	Dose response effect siRNA duplexes PrP sen expression PrP res accumulation infected N2aS12sc
0.16906957.12759373.html.plaintext.txt	89	A Immunoblot representative experiment performed transfected N2aS12sc cells absence 0 presence increasing concentrations Prnp gene specific siRNA scrambled siRNA duplexes
0.16906957.12759373.html.plaintext.txt	90	One tenth post nuclear cell lysates directly mixed volume 2x denaturing loading buffer
0.16906957.12759373.html.plaintext.txt	91	PrP sen first detected SAF83 mouse monoclonal antibody
0.16906957.12759373.html.plaintext.txt	92	The blot incubated presence rabbit polyclonal antibodies raised ERK proteins 40 42 kDa control protein loading
0.16906957.12759373.html.plaintext.txt	93	B 90 lysates untransfected siRNAs transfected N2aS12sc cells PK digested described Materials Methods loaded onto 12 polyacrylamide gel
0.16906957.12759373.html.plaintext.txt	94	Partially PK digested PrP res assayed SAF83 monoclonal antibody
0.16906957.12759373.html.plaintext.txt	95	Molecular mass markers indicated left kilodaltons kDa
0.16906957.12759373.html.plaintext.txt	96	C Densitometry analysis performed blots developed exposed described done National Institutes Health IMAGE software
0.16906957.12759373.html.plaintext.txt	97	The results four independent experiments shown expressed percentage control levels plus minus
0.16906957.12759373.html.plaintext.txt	98	To assess whether nature host cell scrapie strain could influence siRNA inhibition effect siRNAs transfected mouse hypothalamic cell line GT 1 chronically infected mouse scrapie strain 22L Nishida et al
0.16906957.12759373.html.plaintext.txt	99	The detectable amounts PrP res also drastically reduced cell line transfection Prnp gene specific siRNA duplexes Fig
0.16906957.12759373.html.plaintext.txt	100	2 IC50 values comparable obtained using N2aS12sc cells IC50 106 nM
0.16906957.12759373.html.plaintext.txt	101	This suggests neither host cell types mouse scrapie strains influence gene silencing effect siRNA
0.16906957.12759373.html.plaintext.txt	102	During time course experiments 4 days cytotoxic effect siRNAs observed
0.16906957.12759373.html.plaintext.txt	103	View larger version 54K Fig
0.16906957.12759373.html.plaintext.txt	104	Effect moPrnp specific siRNA accumulation PrP res GT 1 cells infected 22L mouse scrapie strain
0.16906957.12759373.html.plaintext.txt	105	Infected GT 1 cells transfected absence 0 presence specific scrambled siRNA duplexes
0.16906957.12759373.html.plaintext.txt	106	Four days post transfection cells lysed post nuclear supernatants PK treated described Materials Methods
0.16906957.12759373.html.plaintext.txt	107	PrP res detected SAF83 monoclonal antibody
0.16906957.12759373.html.plaintext.txt	108	The blot developed using enhanced chemiluminescence system exposed x ray film
0.16906957.12759373.html.plaintext.txt	109	Brackets right side indicate immuno detected bands corresponding un mono diglycoforms PrP res
0.16906957.12759373.html.plaintext.txt	110	Molecular mass markers kilodaltons kDa indicated left
0.16906957.12759373.html.plaintext.txt	111	To estimate efficiency siRNA transfections neuroblastoma cells confocal microscopy analysis performed using fluorescein labeled siRNA duplexes Fig
0.16906957.12759373.html.plaintext.txt	112	The percentage fluorescein labeled neuroblastoma cells green reached 82 plus minus 6 early 48 hours post transfection stable 72 hours Fig
0.16906957.12759373.html.plaintext.txt	113	No green fluorescence detected cells transfected fluorescein labeled single stranded RNA shown control experiment Fig
0.16906957.12759373.html.plaintext.txt	114	We also used confocal imaging investigate sub cellular localization fluorescein labeled siRNA duplexes
0.16906957.12759373.html.plaintext.txt	115	Transfected cells exhibited punctate fluorescence pattern largely localised perinuclear cytoplasmic region Fig
0.16906957.12759373.html.plaintext.txt	116	No labeling observed cell surface inside nucleus
0.16906957.12759373.html.plaintext.txt	117	Based transfection efficiency assessment PrP expression found OligofectamineTM efficient transfection reagent siRNA duplexes
0.16906957.12759373.html.plaintext.txt	118	View larger version 98K Fig
0.16906957.12759373.html.plaintext.txt	119	Transfection efficiency sub cellular localization fluorescent siRNA duplex
0.16906957.12759373.html.plaintext.txt	120	A Confocal microscopy images neuroblastoma cells transfected either 400 nM fluorescein conjugated siRNA duplex single strand fluorescein conjugated siRNA control
0.16906957.12759373.html.plaintext.txt	121	At indicated times transfection N2aS12 cells fixed paraformaldehyde stained propidium iodide red 10 minutes room temperature permeabilization conditions
0.16906957.12759373.html.plaintext.txt	122	Images obtained laser scanning confocal microscope
0.16906957.12759373.html.plaintext.txt	123	B A representative fluorescein siRNA positive cell observed described
0.16906957.12759373.html.plaintext.txt	124	The yellow color indicates red propidium iodide green fluorescein dyes superimposed
0.16906957.12759373.html.plaintext.txt	125	The dashed line arrowheads represents Y slice optical section
0.16906957.12759373.html.plaintext.txt	126	Arrows indicate single fluorescent dot
0.16906957.12759373.html.plaintext.txt	127	To determine whether PrP res depletion induced siRNA transient permanent chronically infected N2aS12sc cells transfected 400 nM siRNA cultured either one two weeks two four passages respectively
0.16906957.12759373.html.plaintext.txt	128	Samples assayed Western blot analysis presence PrP isoforms presence absence PK digestion Fig
0.16906957.12759373.html.plaintext.txt	129	PrP sen barely detectable transfected cells passaging levels increased number passages reaching level observed untreated cells four passages
0.16906957.12759373.html.plaintext.txt	130	A single siRNA transfection led complete disappearance PrP res immunoreactivity two passages N2aS12sc cells
0.16906957.12759373.html.plaintext.txt	131	However four passages low levels PK resistant PrP isoform observed N2aS12sc cells
0.16906957.12759373.html.plaintext.txt	132	Our data suggest single exposure N2aS12sc cells siRNA sufficient completely remove pathogenic isoform permanently suppress scrapie infection
0.16906957.12759373.html.plaintext.txt	133	View larger version 47K Fig
0.16906957.12759373.html.plaintext.txt	134	Long term effect Prnp specific siRNA PrP res accumulation
0.16906957.12759373.html.plaintext.txt	135	N2aS12sc cells transfected without 0 400 nM Prnp specific siRNA duplex
0.16906957.12759373.html.plaintext.txt	136	At confluence cells lysed one tenth samples analysed absence PK treatment PK whereas remaining samples PK digested PK
0.16906957.12759373.html.plaintext.txt	137	These samples labeled 0 passage
0.16906957.12759373.html.plaintext.txt	138	Alternatively cells cultured 1 2 weeks splitting 14 every 4 days
0.16906957.12759373.html.plaintext.txt	139	2 4 passages respectively
0.16906957.12759373.html.plaintext.txt	140	PrP sen PrP res levels detected immunoblotting SAF83 monoclonal antibodies described Materials Methods
0.16906957.12759373.html.plaintext.txt	141	Molecular mass markers kilodaltons kDa indicated left
0.16906957.12759373.html.plaintext.txt	142	Discussion Top Summary Introduction Materials Methods Results Discussion References In present report demonstrate abrogation PrP sen synthesis siRNA mediated suppression Prnp gene inhibits formation PrP res chronically scrapie infected cells
0.16906957.12759373.html.plaintext.txt	143	In neuroblastoma cells PrP mRNAs half life approximately 7 hours Pfeifer et al
0.16906957.12759373.html.plaintext.txt	144	1993 PrP sen synthesized degraded relatively rapidly tg 5 hours
0.16906957.12759373.html.plaintext.txt	145	Whereas PrP res aggregates derived PrP sen produced slowly tg 15 hours Borchelt et al
0.16906957.12759373.html.plaintext.txt	146	Several mechanisms may lead PrP res depletion including interference PrP senPrP res interaction Caspi et al
0.16906957.12759373.html.plaintext.txt	147	2001 reversion PrP res PK sensitive state Soto et al
0.16906957.12759373.html.plaintext.txt	148	In addition prevention PrP sen endocytosis cell surface endosomes andor release PrP sen plasma membrane could prevent PrP res accumulation Enari et al
0.16906957.12759373.html.plaintext.txt	149	Expression PrP sen essential sufficient prion propagation pathogenesis Raeber et al
0.16906957.12759373.html.plaintext.txt	150	It suggested earlier suppression PrP expression might potential therapeutic approach prion diseases Bueler et al
0.16906957.12759373.html.plaintext.txt	151	The factors responsible rate strength siRNA induced gene suppression currently unknown
0.16906957.12759373.html.plaintext.txt	152	Here demonstrate siRNA designed moPrnp gene highly specific cells expressing PrP mouse sequence
0.16906957.12759373.html.plaintext.txt	153	The siRNA effect independent scrapie strains host cell type
0.16906957.12759373.html.plaintext.txt	154	Furthermore difference siRNA efficiency observed moPrP overexpressing cells N2aS12 subclone N2a cells expressing endogenous PrP data shown
0.16906957.12759373.html.plaintext.txt	155	The finding exposure chronically infected neuroblastoma cells siRNA results undetectable amounts PrP res 3 4 days suggests cells express proteases degrade PrP res aggregates
0.16906957.12759373.html.plaintext.txt	156	proposed cellular level PrP res determined rate formation substrate PrP sen catabolism Enari et al
0.16906957.12759373.html.plaintext.txt	157	The removal PrP sen could displace equilibrium degradation processes
0.16906957.12759373.html.plaintext.txt	158	An obvious limitation although PrP res levels dramatically decreased acute siRNA exposure cells definitively cured scrapie infection thus chronic treatments longer exposures siRNA may considered future
0.16906957.12759373.html.plaintext.txt	159	We currently performing experiments improve long term effects siRNA duplexes
0.16906957.12759373.html.plaintext.txt	160	Interestingly recent report shown selective suppression gene expression induced siRNA primary mammalian neurons Krichevsky Kosik 2002
0.16906957.12759373.html.plaintext.txt	161	The role PrP interaction putative partners neurons yet clarified
0.16906957.12759373.html.plaintext.txt	162	Thus siRNA technology provide insights understanding physiological functions PrP somatic cultured cells
0.16906957.12759373.html.plaintext.txt	163	Although likely technical difficulties siRNA delivery vivo use inhibit gene expression mice recently reported Lewis et al
0.16906957.12759373.html.plaintext.txt	164	Although efficient powerful brain delivery systems remain found appears likely siRNA technology could constitute new promising strategy therapy TSEs
0.16906957.12759373.html.plaintext.txt	165	Current drug treatments delay prevent appearance clinical symptoms death experimental scrapie infected animals Demaimay et al
0.16906957.12759373.html.plaintext.txt	166	The vivo use siRNA alone combination drugs considered improve life span cure sick animals
0.16906957.12759373.html.plaintext.txt	167	The recent development siRNA technology offers powerful tool ablate specific gene expression wide range mammalian cells including neurons
0.16906957.12759373.html.plaintext.txt	168	Our results show siRNA technique useful dissecting basic mechanisms prion pathogenesis addition obvious potential therapeutic agent
0.16906957.12759373.html.plaintext.txt	169	Ultimately may give effective results therapy numerous neurodegenerative diseases linked expression misfolded endogenous proteins Alzheimers Huntingtons Parkinsons diseases
0.16906957.12759373.html.plaintext.txt	170	Acknowledgments We grateful J
0.16906957.12759373.html.plaintext.txt	171	Lehmann providing us monoclonal antibodies SAFs N2aS12scand GT 1sc cells respectively
0.16906957.12759373.html.plaintext.txt	172	Zsurger help preparation figures R
0.16906957.12759373.html.plaintext.txt	173	Pichot technical assistance
0.16906957.12759373.html.plaintext.txt	174	Very special thanks due M
0.16906957.12759373.html.plaintext.txt	175	Vincent critical reading manuscript
0.16906957.12759373.html.plaintext.txt	176	This work supported Centre National de la Recherche Scientifique Action Concertee Incitative Jeunes Chercheurs 2000 Groupement dInteret Scientifique Infections Prions 2001
0.16906957.12759373.html.plaintext.txt	177	Footnotes These authors contributed equally work
0.16906957.12759373.html.plaintext.txt	178	References Top Summary Introduction Materials Methods Results Discussion References
0.16906957.12759373.html.plaintext.txt	179	Scrapie cellular prion proteins differ kinetics synthesis topology cultured cells
0.16906957.12759373.html.plaintext.txt	180	Normal host prion protein necessary scrapie induced neurotoxicity
0.16906957.12759373.html.plaintext.txt	181	Mice devoid PrP resistant scrapie
0.16906957.12759373.html.plaintext.txt	182	Prion isolate specified allotypic interactions cellular scrapie prion proteins congenic transgenic mice
0.16906957.12759373.html.plaintext.txt	183	The anti prion activity Congo red
0.16906957.12759373.html.plaintext.txt	184	Prion protein transmissible spongiform encephalopathies
0.16906957.12759373.html.plaintext.txt	185	Inhibition protease resistant prion protein formation porphyrins phthalocyanines
0.16906957.12759373.html.plaintext.txt	186	Specific inhibition vitro formation protease resistant prion protein synthetic peptides
0.16906957.12759373.html.plaintext.txt	187	Late treatment polyene antibiotics prolong survival time scrapie infected animals
0.16906957.12759373.html.plaintext.txt	188	Lysosomotropic agents cysteine protease inhibitors inhibit scrapie associated prion protein accumulation
0.16906957.12759373.html.plaintext.txt	189	Duplexes 21 nucleotide RNAs mediate RNA interference cultured mammalian cells
0.16906957.12759373.html.plaintext.txt	190	Scrapie prion protein accumulation scrapie infected neuroblastoma cells abrogated exposure prion protein antibody
0.16906957.12759373.html.plaintext.txt	191	Inhibition interactions interconversions prion protein isoforms peptide fragments C terminal folded domain
0.16906957.12759373.html.plaintext.txt	192	RNAi functions cultured mammalian neurons
0.16906957.12759373.html.plaintext.txt	193	Efficient delivery siRNA inhibition gene expression postnatal mice
0.16906957.12759373.html.plaintext.txt	194	Amphotericin B inhibits generation scrapie isoform prion protein infected cultures
0.16906957.12759373.html.plaintext.txt	195	129Ola mice carrying null mutation PrP abolishes mRNA production developmentally normal
0.16906957.12759373.html.plaintext.txt	196	Filipin prevents pathological prion protein accumulation reducing endocytosis inducing cellular PrP release
0.16906957.12759373.html.plaintext.txt	197	Successful transmission three mouse adapted scrapie strains murine neuroblastoma cell lines overexpressing wild type mouse prion protein
0.16906957.12759373.html.plaintext.txt	198	Kinetics expression prion protein uninfected scrapie infected N2a mouse neuroblastoma cells
0.16906957.12759373.html.plaintext.txt	199	Porphyrin phthalocyanine antiscrapie compounds
0.16906957.12759373.html.plaintext.txt	200	Prion diseases humans animals
0.16906957.12759373.html.plaintext.txt	201	Ectopic expression prion protein PrP T lymphocytes hepatocytes PrP knockout mice insufficient sustain prion replication
0.16906957.12759373.html.plaintext.txt	202	Accumulation proteinase K resistant prion protein PrP restricted expression level normal PrP mice inoculated mouse adapted strain Creutzfeldt Jakob disease agent
0.16906957.12759373.html.plaintext.txt	203	Reversion prion protein conformational changes synthetic beta sheet breaker peptides
0.16906957.12759373.html.plaintext.txt	204	Structural studies scrapie prion protein using mass spectrometry amino acid sequencing
0.16906957.12759373.html.plaintext.txt	205	Knocking prions JCS 2003 116 1304
0.26681036.12519913.html.plaintext.txt	0	Molecular Evolution Mammalian Prion Protein Teun van Rheede Marcel M
0.26681036.12519913.html.plaintext.txt	1	Smolenaars Ole Madsen Wilfried W
0.26681036.12519913.html.plaintext.txt	2	Department Biochemistry NCMLS University Nijmegen The Netherlands
0.26681036.12519913.html.plaintext.txt	3	Abstract TOP Abstract Introduction Materials Methods Results Discussion Acknowledgements Literature Cited Prion protein PrP sequences available six 18 orders placental mammals
0.26681036.12519913.html.plaintext.txt	4	A broader comparison mammalian prions might help understand enigmatic functional pathogenic properties protein
0.26681036.12519913.html.plaintext.txt	5	We therefore determined PrP coding sequences 26 mammalian species include placental orders major subordinal groups
0.26681036.12519913.html.plaintext.txt	6	Glycosylation sites cysteines forming disulfide bridge hydrophobic transmembrane region perfectly conserved
0.26681036.12519913.html.plaintext.txt	7	Also sequences responsible secondary structure elements N C terminal processing precursor protein attachment glycosyl phosphatidylinositol membrane anchor well conserved
0.26681036.12519913.html.plaintext.txt	8	The N terminal region PrP generally contains five six repeats sequence PQHGGGG WGQ alleles two four seven repeats observed species
0.26681036.12519913.html.plaintext.txt	9	This suggests together pattern amino acid replacements repeats regular occurrence repeat expansion contraction
0.26681036.12519913.html.plaintext.txt	10	Histidines implicated copper ion binding proline involved 4 hydroxylation lacking species questions importance normal functioning cellular PrP
0.26681036.12519913.html.plaintext.txt	11	The finding certain species two seven repeats amino acid substitutions related human prion diseases challenges relevance mutations prion pathology
0.26681036.12519913.html.plaintext.txt	12	The gene tree deduced PrP sequences largely agrees species tree indicating major deviations occurred evolution prion gene different placental lineages
0.26681036.12519913.html.plaintext.txt	13	In one species anteater prion pseudogene present addition active gene
0.26681036.12519913.html.plaintext.txt	14	Key Words prion protein concerted evolution BSE Creutzfeldt Jakob pseudogene
0.26681036.12519913.html.plaintext.txt	15	Introduction TOP Abstract Introduction Materials Methods Results Discussion Acknowledgements Literature Cited The prion protein PrP associated various forms transmissible spongiform encephalopathies TSEs mammals
0.26681036.12519913.html.plaintext.txt	16	Because unique features pathogenic protein PrP probably one intensively studied proteins reviewed Prusiner 1998 Harris 1999 Hope 2000 Brown 2001 Collinge 2001 Rudd et al
0.26681036.12519913.html.plaintext.txt	17	Yet remarkably little known normal cellular function precise manner exerts pathogenicity
0.26681036.12519913.html.plaintext.txt	18	The human prion gene PRNP encodes 253 residue precursor protein see fig
0.26681036.12519913.html.plaintext.txt	19	1 intronless open reading frame
0.26681036.12519913.html.plaintext.txt	20	It expressed tissues highest levels found central nervous system notably associated synaptic membranes
0.26681036.12519913.html.plaintext.txt	21	After translocation across endoplasmic reticulum membrane N terminal signal peptide cleaved
0.26681036.12519913.html.plaintext.txt	22	Subsequently hydrophobic peptide C terminus removed transamidation reaction attaches glycosyl phosphatidylinositol GPI moiety prion protein
0.26681036.12519913.html.plaintext.txt	23	The GPI anchor attaches protein outer membrane surface cell
0.26681036.12519913.html.plaintext.txt	24	In addition fully translocated form secPrP two transmembrane variants PrP described CtmPrP NtmPrP highly conserved hydrophobic sequence fig
0.26681036.12519913.html.plaintext.txt	25	1 spans lipid bilayer opposite directions Hegde et al
0.26681036.12519913.html.plaintext.txt	26	NMR measurements established conformation recombinant PrP mouse Riek et al
0.26681036.12519913.html.plaintext.txt	27	1999 bovine Lopez Garcia et al
0.26681036.12519913.html.plaintext.txt	28	2000 closely similar global folds
0.26681036.12519913.html.plaintext.txt	29	The N terminal region largely unstructured flexible residues 37 53 potential form extended polyL proline II PPII helix structure forming hydroxylation site Pro44 Gill et al
0.26681036.12519913.html.plaintext.txt	30	The N terminus comprises segment five six repeats implicated copper binding Brown et al
0.26681036.12519913.html.plaintext.txt	31	The C terminal region forms rigid globular domain containing bundle three helices short two stranded antiparallel ss sheet
0.26681036.12519913.html.plaintext.txt	32	This domain stabilized disulfide bridge comprises two variably occupied N linked glycosylation sites
0.26681036.12519913.html.plaintext.txt	33	View larger version 9K FIG
0.26681036.12519913.html.plaintext.txt	34	Schematic diagram human PrP showing signal peptides black hydrophobic region gray helical regions denoted H1 3 ss strands denoted B1 2
0.26681036.12519913.html.plaintext.txt	35	Indicated sites glycosylation Asn181 Asn197 hydroxylation Pro44 cleavage Lys112His113
0.26681036.12519913.html.plaintext.txt	36	Cysteines 179 214 form disulfide bridge
0.26681036.12519913.html.plaintext.txt	37	The function normal cellular isoform prion protein PrPc remains enigmatic
0.26681036.12519913.html.plaintext.txt	38	PrPc deficient mice develop normally display minor defects attributable higher sensitivity various forms stress Raeber et al
0.26681036.12519913.html.plaintext.txt	39	1998 Brown Nicholas Canevari 2002
0.26681036.12519913.html.plaintext.txt	40	PrPc appears protect programmed cell death Kuwahara et al
0.26681036.12519913.html.plaintext.txt	41	1999 Bax mediated apoptosis Bounhar et al
0.26681036.12519913.html.plaintext.txt	42	PrPc copper binding protein may superoxide dismutase activity
0.26681036.12519913.html.plaintext.txt	43	It thus could protect oxidative damage contribute synaptic homeostasis Brown et al
0.26681036.12519913.html.plaintext.txt	44	Exposure Cu2 ions promotes endocytosis PrPc Sumudhu Perera Hooper 2001
0.26681036.12519913.html.plaintext.txt	45	Furthermore evidence PrPc cell surface receptor signal transduction coupled tyrosine kinase Fyn Mouillet Richard et al
0.26681036.12519913.html.plaintext.txt	46	PrPc cycles rapidly cell surface early endosomes via clathrin coated vesicles many cell surface receptors
0.26681036.12519913.html.plaintext.txt	47	PrPc functioning may modulated removal N terminal domain proteolysis Lys112 His113 Harris 1999
0.26681036.12519913.html.plaintext.txt	48	A conformational change PrPc gives rise pathogenic form PrPsc
0.26681036.12519913.html.plaintext.txt	49	This transition involves dramatic increase ss sheet content 3 40 decrease helical structure 40 30 Cohen Prusiner 1998
0.26681036.12519913.html.plaintext.txt	50	PrPsc relatively resistant chemical heat treatment
0.26681036.12519913.html.plaintext.txt	51	Protease digestion leaves resistant core comprising residues 90 231
0.26681036.12519913.html.plaintext.txt	52	PrPsc catalyzes misfolding PrPc thus leading self amplifying cycle formation insoluble extracellular aggregates
0.26681036.12519913.html.plaintext.txt	53	Inherited sporadic infectious forms prion diseases exist
0.26681036.12519913.html.plaintext.txt	54	Inherited forms associated mutations prion gene enhance transition PrPc PrPsc
0.26681036.12519913.html.plaintext.txt	55	In sporadic cases PrPsc may derive spontaneous misfolding PrPc
0.26681036.12519913.html.plaintext.txt	56	Infectivity occurs pathological transformation hosts PrPc induced PrPsc particles transmitted individuals different species Prusiner 1998
0.26681036.12519913.html.plaintext.txt	57	It important note however PrPsc directly neurotoxic Hill et al
0.26681036.12519913.html.plaintext.txt	58	2000 prion diseased brains contain PrPsc see Stewart Harris 2001
0.26681036.12519913.html.plaintext.txt	59	Interspecies infectivity TSEs varies greatly Prusiner Scott 1997
0.26681036.12519913.html.plaintext.txt	60	Sequence differences PrP donor recipient species play role interspecies susceptibility simply determined overall sequence similarity Goldmann et al
0.26681036.12519913.html.plaintext.txt	61	More important seem prion strains within species isoenergetic conformers PrPsc characterized variations clinical presentation protease resistance Cohen Prusiner 1998
0.26681036.12519913.html.plaintext.txt	62	Strain variation encoded different PrPsc conformations ratios three PrP glycoforms diglycosylated monoglycosylated unglycosylated influenced PrP sequence polymorphisms metal binding Collinge 2001 Priola Lawson 2001
0.26681036.12519913.html.plaintext.txt	63	However precise molecular basis strain variation remains unknown
0.26681036.12519913.html.plaintext.txt	64	Many residues regions prion protein implicated functioning pathogenicity species barrier
0.26681036.12519913.html.plaintext.txt	65	Sequence comparison mammalian prion proteins may help evaluate proposals gain insight molecular evolution PrP
0.26681036.12519913.html.plaintext.txt	66	Previous studies revealed conserved variable regions mammalian PrP well variation repeat number Schatzl et al
0.26681036.12519913.html.plaintext.txt	67	It appeared substitutions implicated prion diseases occur least variable regions residues important species barrier occur restricted region Krakauer Zanotto Pagel 1998
0.26681036.12519913.html.plaintext.txt	68	However present taxon representation mammalian prion sequences heavily biased
0.26681036.12519913.html.plaintext.txt	69	Sequences available many primates artiodactyls subset rodents well rabbit carnivores perissodactyls
0.26681036.12519913.html.plaintext.txt	70	These represent six 18 placental mammalian orders
0.26681036.12519913.html.plaintext.txt	71	Moreover six orders belong two four major clades within Eutheria Murphy et al
0.26681036.12519913.html.plaintext.txt	72	In study extend taxon sampling 26 species include 12 previously unsampled orders
0.26681036.12519913.html.plaintext.txt	73	Combined recent insights mammalian ordinal relationships Murphy et al
0.26681036.12519913.html.plaintext.txt	74	2001 possible better reconstruct molecular evolution mammalian prion
0.26681036.12519913.html.plaintext.txt	75	Materials Methods TOP Abstract Introduction Materials Methods Results Discussion Acknowledgements Literature Cited Taxon Sampling In study included species representing 18 eutherian orders major subgroups speciose orders rodents bats
0.26681036.12519913.html.plaintext.txt	76	New PRNP gene sequences obtained following orders species
0.26681036.12519913.html.plaintext.txt	77	Afrosoricida Amblysomus hottentotus Hottentot golden mole Chrysochloris stuhlmanni Stuhlmanns golden mole N terminus Tenrec ecaudatus common tenrec Cetartiodactyla Hippopotamus amphibius hippopotamus Physeter macrocephalus sperm whale Chiroptera Cynopterus sphinx Indian short nosed fruit bat Macrotus californicus California leaf nosed bat Myotis daubentoni Daubentons bat Dermoptera Cynocephalus variegatus flying lemur Eulipotyphla Erinaceus europaeus Western European hedgehog Hylomys suillus lesser gymnure Sorex cinereus masked shrew Talpa europaea European mole Hyracoidea Procavia capensis rock hyrax Lagomorpha Ochotona princeps American pika Macroscelidea Macroscelides proboscideus short eared elephant shrew Perissodactyla Diceros bicornis black rhino Equus equus horse Pholidota Manis sp
0.26681036.12519913.html.plaintext.txt	78	pangolin Proboscidea Elephas maximus Asian elephant Rodentia Cavia porcellus guinea pig Sciurus vulgaris European red squirrel Spalax ehrenbergi Ehrenbergs mole rat Scandentia Tupaia tana tree shrew Sirenia Trichechus manatus manatee Tubulidentata Orycteropus afer aardvark Xenarthra Cyclopes didactylus silky anteater
0.26681036.12519913.html.plaintext.txt	79	Sequences submitted GenBank accession numbers AY133034 AY133063
0.26681036.12519913.html.plaintext.txt	80	From GenBank extracted PRNP sequences representatives two eutherian orders Carnivora Mustela sp
0.26681036.12519913.html.plaintext.txt	81	mink S46825 Primates Homo sapiens human M13899 Saimiri sciureus squirrel monkey U08310
0.26681036.12519913.html.plaintext.txt	82	1 additional Cetartiodactyla Bos taurus cow AJ298878 Sus scrofa pig L07623 Camelus dromedarius camel Y09760 Ovis aries sheep M31313
0.26681036.12519913.html.plaintext.txt	83	1 Lagomorpha Oryctolagus cuniculus rabbit U28334 Rodentia Mus musculus mouse M13685 well marsupial outgroup Trichosurus vulpecula brush tailed possum L38993
0.26681036.12519913.html.plaintext.txt	84	The available PRNP sequences perissodactyls dolphin Wopfner et al
0.26681036.12519913.html.plaintext.txt	85	1999 represent complete mature protein therefore used
0.26681036.12519913.html.plaintext.txt	86	A prion gene sequence guinea pig present database AF139166 contains conspicuous deletion N terminus
0.26681036.12519913.html.plaintext.txt	87	We therefore determined independent guinea pig sequence acc
0.26681036.12519913.html.plaintext.txt	88	AY133039 found deletion
0.26681036.12519913.html.plaintext.txt	89	For dog Canis familiaris highly dissimilar PRNP sequences present GenBank AF042843 AF022714 group artiodactyls phylogenetic analyses whereas partial dog sequence AF113937 close relatives dog dingo AF113937 gray wolfe AF113939 group carnivores
0.26681036.12519913.html.plaintext.txt	90	Similarly two different cat Felis catus PRNP sequences available AF003087 grouping artiodactyls Y13698 grouping carnivores
0.26681036.12519913.html.plaintext.txt	91	This casts doubt reliability available dog cat sequences
0.26681036.12519913.html.plaintext.txt	92	We therefore choose mink prion sequence genuine carnivore representative analysis
0.26681036.12519913.html.plaintext.txt	93	This sequence corroborated phylogenetic analysis grouping wolf dingo closely related ferret polecat sequences
0.26681036.12519913.html.plaintext.txt	94	PCR Cloning Sequencing Amplification plus minus 700 bp fragment PRNP gene performed primers based known sequences coding N C terminal signal peptides table 1
0.26681036.12519913.html.plaintext.txt	95	This yields open reading frame complete mature protein positions 23 231 fig
0.26681036.12519913.html.plaintext.txt	96	1 apart first two amino acids
0.26681036.12519913.html.plaintext.txt	97	PCR reactions contained approximately 100 ng genomic DNA 375 mM dNTPs Boehringer Mannheim 20 100 pmol primer 0
0.26681036.12519913.html.plaintext.txt	98	5 microl Taq Expand polymerase Expand HF system Roche Diagnostics final volume 50 microl
0.26681036.12519913.html.plaintext.txt	99	The PCR program 95 degrees C 4 min followed 35 cycles 94 degrees C 60 annealing 56 degrees 60 degrees C 60 extension 68 degrees C 90
0.26681036.12519913.html.plaintext.txt	100	Gel extracted PCR fragments Amersham Pharmacia gel extraction kit sequenced directly cloned pGEM T easy vector Promega
0.26681036.12519913.html.plaintext.txt	101	Sequencing reactions performed using Big Dye fluorescent technology run ABI 3700 96 capillary sequencer
0.26681036.12519913.html.plaintext.txt	102	Sequences obtained least two independent PCR reactions bases sequenced least strands
0.26681036.12519913.html.plaintext.txt	103	View table Table 1 Primers Used Amplification Sequencing PrP Gene
0.26681036.12519913.html.plaintext.txt	104	Sequences coding N terminal signal peptide determined PCR technique designed amplify fragment unknown flanking sequence Sorensen et al
0.26681036.12519913.html.plaintext.txt	105	Partially randomized primers used along specific biotinylated primer
0.26681036.12519913.html.plaintext.txt	106	Subsequent purification biotinylated PCR product streptavidine beads Dynal second nested PCR increase specifity
0.26681036.12519913.html.plaintext.txt	107	In case biotinylated primer bio PrPrev nested primer S2rev used table 1
0.26681036.12519913.html.plaintext.txt	108	Applying method 5 coding noncoding sequences obtained Cynopterus sphinx Elephas maximus
0.26681036.12519913.html.plaintext.txt	109	This sequence information used design highly degenerate primer PrPflank table 1 ending adenine start codon
0.26681036.12519913.html.plaintext.txt	110	This primer used amplify N terminal signal peptide sequences 12 species see fig
0.26681036.12519913.html.plaintext.txt	111	The PCR program 95 degrees C two min followed 35 cycles 94 degrees C 30 annealing 50 degrees C 30 extension 68 degrees C 40
0.26681036.12519913.html.plaintext.txt	112	View larger version 90K FIG
0.26681036.12519913.html.plaintext.txt	113	Alignment mammalian prion protein sequences
0.26681036.12519913.html.plaintext.txt	114	Important structural features marked alignment cf
0.26681036.12519913.html.plaintext.txt	115	The numbering deviates figure 1 introduction gaps
0.26681036.12519913.html.plaintext.txt	116	Not species N C terminal sequences determined
0.26681036.12519913.html.plaintext.txt	117	Black shading indicates residues provide evidence repeat homogenization
0.26681036.12519913.html.plaintext.txt	118	Gray shading denotes sequence characteristics discussed text
0.26681036.12519913.html.plaintext.txt	119	Repeats flushed left repeat homogenization allow meaningful alignment apart last one facilitate comparison truncated last repeat bats pangolin sperm whale
0.26681036.12519913.html.plaintext.txt	120	Boxed repeat units denote repeat number polymorphisms mole rat 4 5 repeats squirrel 2 5 repeats anteater 4 5 repeats
0.26681036.12519913.html.plaintext.txt	121	Fruit bat alleles without Gln
0.26681036.12519913.html.plaintext.txt	122	Mutations related spongiforme encephalopathies polymorphisms bold shown alignment
0.26681036.12519913.html.plaintext.txt	123	Asterisks indicate newly determined sequences
0.26681036.12519913.html.plaintext.txt	124	The sequence golden mole N terminal signal peptide C
0.26681036.12519913.html.plaintext.txt	125	stuhlmanni mature protein sequence A
0.26681036.12519913.html.plaintext.txt	126	Phylogenetic Analysis DNA sequences analyzed using Staden package programs PreGAP4 GAP4 httpwww
0.26681036.12519913.html.plaintext.txt	127	Nucleotide amino acid alignments produced using ClustalW adjusted manually
0.26681036.12519913.html.plaintext.txt	128	Positions ambiguous alignment excluded phylogenetic analysis tree figure 3 based nucleotide sequences 570 bp corresponding amino acid positions 27 67 132 263 274 290 figure 2
0.26681036.12519913.html.plaintext.txt	129	View larger version 58K FIG
0.26681036.12519913.html.plaintext.txt	130	Homogenization DNA sequences eutherian prion repeat regions
0.26681036.12519913.html.plaintext.txt	131	Sequences five seven repeats four eulipotyphlans left four rodents middle four representatives eutherian orders right aligned show codons corresponding positions repeat homogeneous within species
0.26681036.12519913.html.plaintext.txt	132	Replacements colored according majority consensus rule
0.26681036.12519913.html.plaintext.txt	133	Synonymous substitutions gray nonsynonymous substitutions black
0.26681036.12519913.html.plaintext.txt	134	Arrows indicate evidence homogenization outlined Results
0.26681036.12519913.html.plaintext.txt	135	We applied maximum likelihood ML Bayesian posterior probability analyses reconstruct phylogenetic trees
0.26681036.12519913.html.plaintext.txt	136	06 Posada Crandall 2001 determine model sequence evolution best fit data maximum likelihood assumption
0.26681036.12519913.html.plaintext.txt	137	The best model general time reversible model gamma distribution eight categories proportion invariable sites GTRG8I
0.26681036.12519913.html.plaintext.txt	138	This model used analyses
0.26681036.12519913.html.plaintext.txt	139	Model parameters ML estimated NJ tree subsequently refined two consecutive rounds heuristic ML tree searches previously found tree starting tree
0.26681036.12519913.html.plaintext.txt	140	The best model parameters used nonparametrically bootstrapped ML search
0.26681036.12519913.html.plaintext.txt	141	To search best ML tree five heuristic tree searches performed four different random starting trees one best ML tree search optimal model parameters starting tree
0.26681036.12519913.html.plaintext.txt	142	All searches converged tree
0.26681036.12519913.html.plaintext.txt	143	Bootstrap analyses included 100 replicates
0.26681036.12519913.html.plaintext.txt	144	In ML analyses tree bisection reconnection branch swapping option used
0.26681036.12519913.html.plaintext.txt	145	The analyses performed PAUP 4
0.26681036.12519913.html.plaintext.txt	146	Bayesian phylogenetic analyses performed using program MrBayes 2
0.26681036.12519913.html.plaintext.txt	147	1 Huelsenbeck Ronquist 2001
0.26681036.12519913.html.plaintext.txt	148	The Metropolis coupled Markov chain Monte Carlo MCMCMC sampling approach used calculate posterior probabilities
0.26681036.12519913.html.plaintext.txt	149	Prior probabilities trees equal starting trees random
0.26681036.12519913.html.plaintext.txt	150	To check consistency results four Markov chains run simultaneously 200000 500000 times
0.26681036.12519913.html.plaintext.txt	151	Tree sampling every 10 generations burn values determined likelihood values
0.26681036.12519913.html.plaintext.txt	152	Results TOP Abstract Introduction Materials Methods Results Discussion Acknowledgements Literature Cited Sequencing PRNP Gene PCR primers designed sequences coding N C terminal signal peptides known eutherian prion proteins
0.26681036.12519913.html.plaintext.txt	153	This allowed us amplify single reaction DNA coding mature protein 26 eutherian species
0.26681036.12519913.html.plaintext.txt	154	In 23 specimens single amplification product obtained three specimens squirrel mole rat anteater yielded double band due length polymorphisms repeat region
0.26681036.12519913.html.plaintext.txt	155	In anteater pseudogene amplified addition normal PRNP gene
0.26681036.12519913.html.plaintext.txt	156	This pseudogene contains two frame shift mutations three stop codons many nonsynonymous substitutions data shown acc
0.26681036.12519913.html.plaintext.txt	157	Since published primate rodent PrP sequences show deletion two residues N terminal signal peptide Schatzl et al
0.26681036.12519913.html.plaintext.txt	158	1999 assessed taxonomic distribution deletion
0.26681036.12519913.html.plaintext.txt	159	This done 14 species representing major superordinal clades using modified PCR technique see Materials Methods
0.26681036.12519913.html.plaintext.txt	160	The amino acid sequences deduced newly determined PRNP genes aligned figure 2 together sequences selected databases represent major eutherian clades
0.26681036.12519913.html.plaintext.txt	161	Characteristics Mammalian Prion Protein Starting N terminus referring position numbering used figure 2 following features noteworthy
0.26681036.12519913.html.plaintext.txt	162	Two length variants N terminal signal peptide observed amongst placental mammals
0.26681036.12519913.html.plaintext.txt	163	The longer one present orders well outgroup marsupial starts consensus sequence MVKSH placentals
0.26681036.12519913.html.plaintext.txt	164	The shorter variant sequence MAN found primates flying lemur tree shrew rabbit rodents form recently recognized clade Euarchontoglires Murphy et al
0.26681036.12519913.html.plaintext.txt	165	The residues flanking signal peptide cleavage site Cys24 Lys25 perfectly conserved presence Gly22 Cys24 positions 3 1 cleavage site agrees consensus residues cleavage enzyme Udenfriend Kodukula 1995
0.26681036.12519913.html.plaintext.txt	166	Immediately repeat region similar deletions occur positions 45 56 guinea pig rodents gymnure related hedgehog
0.26681036.12519913.html.plaintext.txt	167	These deletions probably caused independent unequal crossing events repeated sequence coding GGSRYP positions 38 44 GGNRYP 51 56
0.26681036.12519913.html.plaintext.txt	168	The deletions remove Pro50 4 hydroxylation thought important functional feature Gill et al
0.26681036.12519913.html.plaintext.txt	169	Pro50 also absent mole hedgehog shrew replaced serine tyrosine
0.26681036.12519913.html.plaintext.txt	170	The number repeats varies two one squirrel alleles seven gymnure leaf nosed bat
0.26681036.12519913.html.plaintext.txt	171	The squirrel specimen included study heterozygous alleles two five repeats mole rat anteater alleles four five repeats
0.26681036.12519913.html.plaintext.txt	172	Truncated repeats present leaf nosed Daubentons bat pangolin sperm whale positions 126 130
0.26681036.12519913.html.plaintext.txt	173	In latter three species deletion may triggered Gly runs sites WGQ triplet present last repeat placentals
0.26681036.12519913.html.plaintext.txt	174	The eutherian repeats rigidly conserve consensus sequence PQHGGGG WGQ
0.26681036.12519913.html.plaintext.txt	175	The first repeat always Q following ones H position 2 except incidental repeat Daubentons bat tenrec
0.26681036.12519913.html.plaintext.txt	176	Conspicuous deviating first repeat guinea pig highly conserved N terminal PQG replaced SHS positions 57 59
0.26681036.12519913.html.plaintext.txt	177	The first repeat generally GGGG track
0.26681036.12519913.html.plaintext.txt	178	GGG common repeats GGGG runs even GGGGG runs occur
0.26681036.12519913.html.plaintext.txt	179	Occasional deviations consensus repeat sequence indicative concerted evolution indicated black background fig
0.26681036.12519913.html.plaintext.txt	180	The first four repeats hedgehog PrP duplication C terminal Glutamine Q
0.26681036.12519913.html.plaintext.txt	181	The repeats closely related gymnure extra Q suggesting homogenization repeats divergence gymnure hedgehog
0.26681036.12519913.html.plaintext.txt	182	An incidental extra Q also occurs tree shrew one allele fruit bat
0.26681036.12519913.html.plaintext.txt	183	Other replacements occur mostly Gly runs also suggestive repeat homogenization e
0.26681036.12519913.html.plaintext.txt	184	Gly Ser tree shrew mouse guinea pig pangolin
0.26681036.12519913.html.plaintext.txt	185	Homogenization repeats also apparent DNA level
0.26681036.12519913.html.plaintext.txt	186	In figure 3 repeat units within number species aligned emphasize codon usage corresponding positions repeats similar within species
0.26681036.12519913.html.plaintext.txt	187	For example His residues generally encoded CAT CAC used mole elephant shrew anteater fig
0.26681036.12519913.html.plaintext.txt	188	In eulipotyphlans rodents second Gly generally encoded GGT GGC bat elephant shrew anteater arrow 2
0.26681036.12519913.html.plaintext.txt	189	The third Gly eulipotyphlans encoded GGA GGT rodents GGG elephant shrew GGC anteater arrow 3
0.26681036.12519913.html.plaintext.txt	190	Finally almost Gly residues preceding Trp encoded GGC except anteater uses GGA arrow 4
0.26681036.12519913.html.plaintext.txt	191	At first position codon mouse guinea pig show expansion nonsynonymous substitution G A arrow 5
0.26681036.12519913.html.plaintext.txt	192	In addition homogenization similarity descent certainly plays role structuring repeats
0.26681036.12519913.html.plaintext.txt	193	For example insectivore repeats similar one another repeats distantly related species fig
0.26681036.12519913.html.plaintext.txt	194	Next repeat region sequence 143 163 fig
0.26681036.12519913.html.plaintext.txt	195	2 includes hydrophobic transmembrane segment
0.26681036.12519913.html.plaintext.txt	196	It highly conserved Ala Gly rich region even perfectly
0.26681036.12519913.html.plaintext.txt	197	In structured domain comprising helices ss strands limited almost exclusively conservative replacements observed
0.26681036.12519913.html.plaintext.txt	198	Cys216 Cys252 involved disulfide bridged helix loop helix motif H2 H3 strictly conserved Asn X Thr motifs required N glycosylation Asn218 Asn235
0.26681036.12519913.html.plaintext.txt	199	Considerable variation occurs region immediately preceding GPI anchor site
0.26681036.12519913.html.plaintext.txt	200	This region forms flexible linkage GPI anchor Riek et al
0.26681036.12519913.html.plaintext.txt	201	The GPI attachment Ser position 275 replaced Gly rabbit guinea pig Asn elephant shrew
0.26681036.12519913.html.plaintext.txt	202	However requirements transamidase reaction GPI moiety attached sufficiently flexible either small residues adjacent ones serve attachment sites Udenfriend Kodukula 1995
0.26681036.12519913.html.plaintext.txt	203	Also replacements C terminal signal peptide interfere required hinge including prolines 282 283 stretch hydrophobic residues
0.26681036.12519913.html.plaintext.txt	204	Gene Tree Mammalian PrP Strongly supported discrepancies gene tree corresponding species tree may point interesting features evolution gene particular lineage
0.26681036.12519913.html.plaintext.txt	205	We therefore performed phylogenetic analyses PRNP sequences
0.26681036.12519913.html.plaintext.txt	206	In preliminary analyses rooting tree single marsupial sequence rendered species highly unstable often located implausible places
0.26681036.12519913.html.plaintext.txt	207	Notably position root consistently placed within Afrotheria probably due deviating base compositions resulting long branch attraction
0.26681036.12519913.html.plaintext.txt	208	To minimize problems unrooted analyses performed exclusion marsupial sequence
0.26681036.12519913.html.plaintext.txt	209	The ML tree shown figure 4 reflects constant prominent findings
0.26681036.12519913.html.plaintext.txt	210	The branch lengths reflect accelerated rates substitutions species clades shrew erinaceids tenrec elephant shrew rodents
0.26681036.12519913.html.plaintext.txt	211	The best supported nodes tree mostly correspond unquestioned sister taxa data set hedgehog gymnure Daubentons leaf nosed bats horse rhino sheep cow mouse mole rat human squirrel monkey
0.26681036.12519913.html.plaintext.txt	212	The prion tree supports nesting whale hippo ruminants Cetartiodactyla molecularly well established relationship Gatesy OLeary 2001
0.26681036.12519913.html.plaintext.txt	213	Of phylogenetic interest support grouping flying lemur primates largest current concatenated data set suggests flying lemur sister tree shrew Murphy et al
0.26681036.12519913.html.plaintext.txt	214	Encouraging observation prion tree confirms low support recently recognized major superordinal clades Laurasiatheria Euarchontoglires Afrotheria
0.26681036.12519913.html.plaintext.txt	215	The better supported discrepancy prion tree species tree nesting aardvark within paenungulates although seen Bayesian analysis
0.26681036.12519913.html.plaintext.txt	216	Other oddities nesting tree shrew lagomorphs within rodents poorly supported
0.26681036.12519913.html.plaintext.txt	217	View larger version 27K FIG
0.26681036.12519913.html.plaintext.txt	218	Unrooted maximum likelihood tree based eutherian prion genes
0.26681036.12519913.html.plaintext.txt	219	ML nonparametric bootstrap values Bayesian posterior probabilities shown higher 50 0
0.26681036.12519913.html.plaintext.txt	220	In brackets The repeat numbers observed newly determined PrP sequences reported common sequences
0.26681036.12519913.html.plaintext.txt	221	The four recently recognized major clades eutherian mammals Murphy et al
0.26681036.12519913.html.plaintext.txt	222	For details see Materials Methods
0.26681036.12519913.html.plaintext.txt	223	Comparing indel signal amino acid alignment figure 2 tree figure 4 note short form N terminal PrP signal peptide observed Euarchontoglires concordant tree topology
0.26681036.12519913.html.plaintext.txt	224	Of interest unique deletion residue 137 well conserved motif QWxKP 135 139 hippo sperm whale
0.26681036.12519913.html.plaintext.txt	225	Although molecularly almost unanimously supported morphological evidence remains ambiguous whale hippo clade Gatesy OLeary 2001
0.26681036.12519913.html.plaintext.txt	226	On hand comparing alignment tree also reveals indels vulnerable repeat regions e
0.26681036.12519913.html.plaintext.txt	227	positions 45 56 guinea pig gymnure 126 130 microbats pangolin sperm whale occur parallel
0.26681036.12519913.html.plaintext.txt	228	Discussion TOP Abstract Introduction Materials Methods Results Discussion Acknowledgements Literature Cited Relevance Normal Function Structure PrPc Previous comparative studies established limited sequence variation prion protein primates artiodactyls rodents Schatzl et al
0.26681036.12519913.html.plaintext.txt	229	1999 mostly occurring least hydrophobic regions Krakauer Zanotto Pagel 1998
0.26681036.12519913.html.plaintext.txt	230	Our sequences broaden representation wild type variation amongst eutherian PRNP genes
0.26681036.12519913.html.plaintext.txt	231	Most sequence conservation readily understood relation normal structure functioning PrPc
0.26681036.12519913.html.plaintext.txt	232	This concerns primarily sequences required N C terminal processing nascent protein attachment GPI anchor
0.26681036.12519913.html.plaintext.txt	233	The latter essential cluster PrPc sphingolipid sterol microdomains rafts Muniz Riezman 2000
0.26681036.12519913.html.plaintext.txt	234	The strict conservation Lys147 consistent functional role cleavage occurring site Harris 1999 NB residue numbering throughout discussion refers figure 2
0.26681036.12519913.html.plaintext.txt	235	Conservation also obvious residues involved maintaining tertiary structure C terminal domain
0.26681036.12519913.html.plaintext.txt	236	In domain disulfide bond linking Cys216 Cys252 essential structure PrPc replacement residues results insolubilization Maiti Surewicz 2001
0.26681036.12519913.html.plaintext.txt	237	Asn218 Asn235 must conserved large size dynamic properties two N linked sugars protect large regions extracellular PrP surface proteases nonspecific protein interactions Rudd et al
0.26681036.12519913.html.plaintext.txt	238	In addition oligosaccharides may direct folding routing nascent PrPc ER Priola Lawson 2001
0.26681036.12519913.html.plaintext.txt	239	The strict conservation residues 151 165 suggests essential function hydrophobic region
0.26681036.12519913.html.plaintext.txt	240	These residues form major part transmembrane region CtmPrP NtmPrP
0.26681036.12519913.html.plaintext.txt	241	In vitro systems secPrP NtmPrP equally abundant 40 50 CtmPrP forms remaining 10 Hegde et al
0.26681036.12519913.html.plaintext.txt	242	It likely synthesis three topological forms varies different cell types may influenced sequence differences
0.26681036.12519913.html.plaintext.txt	243	Indeed prion disease related mutations near outside transmembrane region enhance formation CtmPrP Stewart Harris 2001
0.26681036.12519913.html.plaintext.txt	244	Not sequence characteristics implicated functioning PrPc conserved
0.26681036.12519913.html.plaintext.txt	245	Hydroxylation Pro50 suggested epigenetic control mechanism normal PrP functioning Gill et al
0.26681036.12519913.html.plaintext.txt	246	The absence several species residue questions universal importance modification
0.26681036.12519913.html.plaintext.txt	247	The observed variation repeat number sequence direct relevance property PrP bind bivalent metal ions particular copper Brown et al
0.26681036.12519913.html.plaintext.txt	248	1997 possible role copper transport metabolism Pauly Harris 1998
0.26681036.12519913.html.plaintext.txt	249	PrP bind four Cu2 ions imidazol nitrogens histidines repeat region likely bind fifth copper His133 His148 Viles 1999 Kramer et al
0.26681036.12519913.html.plaintext.txt	250	However two might physiologically relevant high affinity binding sites Jackson et al
0.26681036.12519913.html.plaintext.txt	251	Copper binding pH dependent makes PrP suitable internalizing Cu2 ions Miura et al
0.26681036.12519913.html.plaintext.txt	252	Indeed exposure cells physiologically relevant concentrations copper leads rapid endocytosis PrPc
0.26681036.12519913.html.plaintext.txt	253	This cellular response abolished copper binding hindered mutagenesis histidines deletion octarepeats Sumudhu Perera Hooper 2001
0.26681036.12519913.html.plaintext.txt	254	Binding copper ion adds structure flexible repeat region Viles et al
0.26681036.12519913.html.plaintext.txt	255	1999 essential superoxide dismutase like activity PrP Brown et al
0.26681036.12519913.html.plaintext.txt	256	Finally copper ions lead site specific cleavage repeat region mouse PrP exposure cells reactive oxygen species McMahon et al
0.26681036.12519913.html.plaintext.txt	257	Since copper binding appears important modulator functioning processing PrPc interest implicated histidines conserved fig
0.26681036.12519913.html.plaintext.txt	258	The number potential copper binding histidines repeat region low one two repeat squirrel allele
0.26681036.12519913.html.plaintext.txt	259	Also copper binding site around positions His133 His148 perfectly conserved species
0.26681036.12519913.html.plaintext.txt	260	These findings raise question whether many copper ions must bound normal functioning PrPc
0.26681036.12519913.html.plaintext.txt	261	The wild type number repeats five six almost eutherian species species cattle polymorphic five six repeats Schatzl et al
0.26681036.12519913.html.plaintext.txt	262	Alleles four repeats found frequencies 2 human populations Puckett et al
0.26681036.12519913.html.plaintext.txt	263	1991 equally occur primates Schatzl et al
0.26681036.12519913.html.plaintext.txt	264	The finding study animal homozygous four repeats golden mole suggests compatible normal functioning PrPc
0.26681036.12519913.html.plaintext.txt	265	Alleles three repeats common goat Goldmann et al
0.26681036.12519913.html.plaintext.txt	266	Even alleles two repeats reported lemur Gilch Spielhaupter Schatzl 2000 squirrel
0.26681036.12519913.html.plaintext.txt	267	This suggests low number evolutionarily viable least heterozygotes
0.26681036.12519913.html.plaintext.txt	268	The fact study homozygous individuals seven repeats gymnure leaf nosed bat reported demonstrates expansion within normal range
0.26681036.12519913.html.plaintext.txt	269	It appears reduction increase number repeats two seven follow phylogenetic pattern see fig
0.26681036.12519913.html.plaintext.txt	270	This actually expected view observed repeat number polymorphisms within various species
0.26681036.12519913.html.plaintext.txt	271	Expansion contraction repeats clearly frequent mutational process eutherian prion gene
0.26681036.12519913.html.plaintext.txt	272	The mechanisms involved unequal crossing replication slippage Collinge 2001
0.26681036.12519913.html.plaintext.txt	273	This simultaneously lead homogenization substitutions repeat sequences length variation GGG runs repeats
0.26681036.12519913.html.plaintext.txt	274	Selection likely plays role balancing repeat number high enough repeat number needed copper ion binding high repeat number promotes early onset prion disease see
0.26681036.12519913.html.plaintext.txt	275	Relevance Prion Diseases Species Barrier In relation various regions residues PrPc implicated prion pathology observed variety eutherian PrP sequences informative
0.26681036.12519913.html.plaintext.txt	276	It kept mind however sequences may reflect intraspecies sequence variation limited sampling within species
0.26681036.12519913.html.plaintext.txt	277	In human Creutzfeldt Jakob disease CJD Gerstmann Straussler Scheinker disease GSS kuru form part phenotypic spectrum prion diseases Collinge 2001
0.26681036.12519913.html.plaintext.txt	278	More 20 amino acid replacements observed inherited prion diseases fig
0.26681036.12519913.html.plaintext.txt	279	2 prion mutations Prusiner 1998 Collinge 2001 see also SWISSPROT entry P04156
0.26681036.12519913.html.plaintext.txt	280	All mutations pathological significance occur either within adjacent regions secondary structure notably associated second third helix Krakauer Zanotto Pagel 1998 cases appear destabilize PrP structure Prusiner 1998 Liemann Glockshuber 1999
0.26681036.12519913.html.plaintext.txt	281	Consequently replacements associated human prion diseases rarely observed eutherian sequences
0.26681036.12519913.html.plaintext.txt	282	The CJD related mutation V217I present golden mole V241I even found eutherian sequences
0.26681036.12519913.html.plaintext.txt	283	It unlikely conservative replacements cause prion disease
0.26681036.12519913.html.plaintext.txt	284	Also replacements observed positions implicated human prion disease V217T present gymnure F236I Daubentons bat V241M mink V241T elephant V248L guinea pig Q249E microbats
0.26681036.12519913.html.plaintext.txt	285	Although C terminal signal peptide quite variable disease related mutations M276R P282S observed species
0.26681036.12519913.html.plaintext.txt	286	Some amino acid polymorphisms PrP human sheep mouse appear influence onset phenotype prion disease Prusiner 1998 Collinge 2001
0.26681036.12519913.html.plaintext.txt	287	Notably position 166 129 human polymorphic Met Val human PrP modulates protease sensitivity PrPsc Parchi et al
0.26681036.12519913.html.plaintext.txt	288	Heterozygosity site proposed protective effect sporadic acquired prion diseases inherited forms Collinge 2001
0.26681036.12519913.html.plaintext.txt	289	All cases date vCJD novel human variant caused BSE prion strain cattle homozygous Met166
0.26681036.12519913.html.plaintext.txt	290	The fact mammalian PrP sequences found Met position apart Leu hedgehog anteater suggests assumed protective effect codon 166 heterozygosity general feature
0.26681036.12519913.html.plaintext.txt	291	The polymorphic sites known man N208S E257K residues occur positions one species
0.26681036.12519913.html.plaintext.txt	292	Various regions PrPc proposed critical prion formation located part prion protein structured NMR analysis conserved eutherians
0.26681036.12519913.html.plaintext.txt	293	Residues 127 157 play major role PrPcPrPsc interface Cohen Prusiner 1998 also surface regions 156 175 202 211 246 264 may involved initial binding PrPc PrPsc Horiuchi et al
0.26681036.12519913.html.plaintext.txt	294	An antibody directed residues 169 193 blocks interaction Peretz et al
0.26681036.12519913.html.plaintext.txt	295	Interestingly isolated peptide 164 201 adopt two isoenergetic conformations ss ss structures essential feature conformational change PrPc PrPsc Derreumaux 2001
0.26681036.12519913.html.plaintext.txt	296	Residues 205 209 254 258 Q167 Q171 T214 Q218 mouse PrPc postulated bind auxiliary molecule protein X thought facilitate formation PrPsc Kaneko et al
0.26681036.12519913.html.plaintext.txt	297	None residues perfectly conserved sequences
0.26681036.12519913.html.plaintext.txt	298	The species specificity protein X might contribute species barrier promoting slowing prion formation Prusiner 1998
0.26681036.12519913.html.plaintext.txt	299	The role repeat region transition PrPc PrPsc enigmatic
0.26681036.12519913.html.plaintext.txt	300	Transition still proceed deletion repeats although repeat region modulates prion replication pathogenicity Flechsig et al
0.26681036.12519913.html.plaintext.txt	301	Extension normal number five repeats one nine copies observed human prion disease kindreds Collinge 2001
0.26681036.12519913.html.plaintext.txt	302	The higher numbers repeats associated earlier onset disease
0.26681036.12519913.html.plaintext.txt	303	Reduction repeat number four lead prion disease heterozygosity three repeats reported elderly patient suffering rapidly progressive dementia consistent CJD Beck et al
0.26681036.12519913.html.plaintext.txt	304	On hand goats observed animals three repeats succumbed unusual long periods challenged PrPsc Goldmann et al
0.26681036.12519913.html.plaintext.txt	305	Heterozygosity two five repeats found two specimens different lemur species known particularly susceptible TSE Gilch Spielhaupter Schatzl 2000
0.26681036.12519913.html.plaintext.txt	306	Alleles two repeats likely common lemurs squirrel therefore homozygotes may also occur
0.26681036.12519913.html.plaintext.txt	307	However known whether homozygotes viable
0.26681036.12519913.html.plaintext.txt	308	Our finding animals homozygous PrP alleles four seven repeats demonstrates cannot deleterious
0.26681036.12519913.html.plaintext.txt	309	Although repeat numbers two seven thus evolutionarily viable possible humans repeat numbers contribute higher prion disease susceptibility older postreproductive age
0.26681036.12519913.html.plaintext.txt	310	Finally sequence comparisons tell TSE species barrier As mentioned prion strain variation probably important factor
0.26681036.12519913.html.plaintext.txt	311	Inoculated prions preferentially convert PrPc one thermodynamically favored PrPsc conformers
0.26681036.12519913.html.plaintext.txt	312	Species transmission barriers may determined degree overlap subset PrPsc conformers allowed hosts PrP presented donor PrPsc Hill et al
0.26681036.12519913.html.plaintext.txt	313	Strain variation partially determined sequence differences
0.26681036.12519913.html.plaintext.txt	314	1996 pinpointed residues 175 180 182 192 204 important mouse human barrier also residues 221 223 243 245 proposed form epitope involved controlling species barrier Scott et al
0.26681036.12519913.html.plaintext.txt	315	Several residues perfectly conserved therefore contribute species barrier
0.26681036.12519913.html.plaintext.txt	316	In instances two three character states observed e
0.26681036.12519913.html.plaintext.txt	317	positions 175 180 203 fig
0.26681036.12519913.html.plaintext.txt	318	2 distributed without obvious phylogenetic pattern
0.26681036.12519913.html.plaintext.txt	319	When sites would involved species barrier barrier expected independent species relationships
0.26681036.12519913.html.plaintext.txt	320	For example mouse residue Tyr192 155 mouse Asn hamster seems important hamster mouse species barrier Priola Chabry Chan 2001
0.26681036.12519913.html.plaintext.txt	321	At position His present human cow also hippo tenrec
0.26681036.12519913.html.plaintext.txt	322	Species barriers thus could present closely related species could broken distant ones
0.26681036.12519913.html.plaintext.txt	323	Also fact overall topology prion gene tree fig
0.26681036.12519913.html.plaintext.txt	324	4 agrees species tree suggests dramatic sequence changes occurred avoid cross species TSE infectivity
0.26681036.12519913.html.plaintext.txt	325	In conclusion TSE species barrier remains elusive time
0.26681036.12519913.html.plaintext.txt	326	Acknowledgements TOP Abstract Introduction Materials Methods Results Discussion Acknowledgements Literature Cited This work supported grants Netherlands Organization Scientific Research NWO ALW European Commission
0.26681036.12519913.html.plaintext.txt	327	Literature Cited TOP Abstract Introduction Materials Methods Results Discussion Acknowledgements Literature Cited
0.26681036.12519913.html.plaintext.txt	328	Two octapeptide repeat deletion prion protein associated rapidly progressive dementia
0.26681036.12519913.html.plaintext.txt	329	Prion protein protects human neurons Bax mediated apoptosis
0.26681036.12519913.html.plaintext.txt	330	Prion prejudice normal protein synapse
0.26681036.12519913.html.plaintext.txt	331	Lack prion protein expression results neuronal phenotype sensitive stress
0.26681036.12519913.html.plaintext.txt	332	The cellular prion protein binds copper vivo
0.26681036.12519913.html.plaintext.txt	333	Normal prion protein activity like superoxide dismutase
0.26681036.12519913.html.plaintext.txt	334	Pathologic conformations prion proteins
0.26681036.12519913.html.plaintext.txt	335	Prion diseases humans animals causes molecular basis
0.26681036.12519913.html.plaintext.txt	336	Evidence 127 164 region prion proteins two equi energetic conformations beta alpha features
0.26681036.12519913.html.plaintext.txt	337	Prion protein devoid octapeptide repeat region restores susceptibility scrapie PrP knockout mice
0.26681036.12519913.html.plaintext.txt	338	Deciphering whale origins molecules fossils
0.26681036.12519913.html.plaintext.txt	339	Shortest known prion protein allele highly BSE susceptible lemurs
0.26681036.12519913.html.plaintext.txt	340	Post translational hydroxylation N terminus prion protein reveals presence PPII structure vivo
0.26681036.12519913.html.plaintext.txt	341	The shortest known prion protein gene allele occurs goats three octapeptide repeats non pathogenic
0.26681036.12519913.html.plaintext.txt	342	Cell biological studies prion protein
0.26681036.12519913.html.plaintext.txt	343	A transmembrane form prion protein neurodegenerative disease
0.26681036.12519913.html.plaintext.txt	344	Species barrier independent prion replication apparently resistant species
0.26681036.12519913.html.plaintext.txt	345	Prions neurodegenerative diseases
0.26681036.12519913.html.plaintext.txt	346	Interactions heterologous forms prion protein binding inhibition conversion species barriers
0.26681036.12519913.html.plaintext.txt	347	Structural mobility human prion protein probed backbone hydrogen exchange
0.26681036.12519913.html.plaintext.txt	348	MrBayes Bayesian inference phylogenetic trees
0.26681036.12519913.html.plaintext.txt	349	Location properties metal binding sites human prion protein
0.26681036.12519913.html.plaintext.txt	350	Solution structure 142 residue recombinant prion protein corresponding infectious fragment scrapie isoform
0.26681036.12519913.html.plaintext.txt	351	Evidence protein X binding discontinuous epitope cellular prion protein scrapie prion propagation
0.26681036.12519913.html.plaintext.txt	352	Prions progress patterns rates molecular evolution relation spongiform disease
0.26681036.12519913.html.plaintext.txt	353	Prion protein binds copper within physiological concentration range
0.26681036.12519913.html.plaintext.txt	354	Prions prevent neuronal cell line death
0.26681036.12519913.html.plaintext.txt	355	Influence amino acid substitutions related inherited human prion diseases thermodynamic stability cellular prion protein
0.26681036.12519913.html.plaintext.txt	356	Solution structure Syrian hamster prion protein rPrP90 231
0.26681036.12519913.html.plaintext.txt	357	NMR structure bovine prion protein
0.26681036.12519913.html.plaintext.txt	358	The role disulfide bridge folding stability recombinant human prion protein
0.26681036.12519913.html.plaintext.txt	359	Cleavage amino terminus prion protein reactive oxygen species
0.26681036.12519913.html.plaintext.txt	360	Raman spectroscopic study copperII binding mode prion octapeptide pH dependence
0.26681036.12519913.html.plaintext.txt	361	Signal transduction prion protein
0.26681036.12519913.html.plaintext.txt	362	Intracellular transport GPI anchored proteins
0.26681036.12519913.html.plaintext.txt	363	Resolution early placental mammal radiation using Bayesian phylogenetics
0.26681036.12519913.html.plaintext.txt	364	Genetic influence structural variations abnormal prion protein
0.26681036.12519913.html.plaintext.txt	365	Copper stimulates endocytosis prion protein
0.26681036.12519913.html.plaintext.txt	366	Strain specified relative conformational stability scrapie prion protein
0.26681036.12519913.html.plaintext.txt	367	MODELTEST testing model DNA substitution
0.26681036.12519913.html.plaintext.txt	368	Efficient conversion normal prion protein PrP abnormal hamster PrP determined homology amino acid residue 155
0.26681036.12519913.html.plaintext.txt	369	Glycosylation influences cross species formation protease resistant prion protein
0.26681036.12519913.html.plaintext.txt	370	Genomic structure human prion protein gene
0.26681036.12519913.html.plaintext.txt	371	Transgenic knockout mice research prion diseases
0.26681036.12519913.html.plaintext.txt	372	NMR structure mouse prion protein domain PrP121 321
0.26681036.12519913.html.plaintext.txt	373	Prion glycoprotein structure dynamics roles sugars
0.26681036.12519913.html.plaintext.txt	374	Prion protein gene variation among primates
0.26681036.12519913.html.plaintext.txt	375	Identification prion protein epitope modulating transmission bovine spongiform encephalopathy prions transgenic mice
0.26681036.12519913.html.plaintext.txt	376	Amplification sequence analysis DNA flanking integrated proviruses simple two step polymerase chain reaction method
0.26681036.12519913.html.plaintext.txt	377	Most pathogenic mutations alter membrane topology prion protein
0.26681036.12519913.html.plaintext.txt	378	Ablation metal ion induced endocytosis prion protein disease associated mutation octarepeat region
0.26681036.12519913.html.plaintext.txt	379	PAUP phylogenetic analysis using parsimony methods
0.26681036.12519913.html.plaintext.txt	380	Sinauer Associates Sunderland Massachusetts
0.26681036.12519913.html.plaintext.txt	381	How glycosylphosphatidylinositol anchored membrane proteins made
0.26681036.12519913.html.plaintext.txt	382	Copper binding prion protein structural implications four identical cooperative binding sites
0.26681036.12519913.html.plaintext.txt	383	Analysis 27 mammalian 9 avian PrPs reveals high conservation flexible regions prion protein
0.26681036.12519913.html.plaintext.txt	384	Accepted publication September 13 2002
0.21711254.15047710.html.plaintext.txt	0	Molecular Determinants Interaction Mad PAH2 Domain mSin3 Xavier Le Guezennec Gert Vriend Hendrik G
0.21711254.15047710.html.plaintext.txt	1	From Department Molecular Biology Centre Molecular Biomolecular Informatics University Nijmegen 6500 HB Nijmegen The Netherlands
0.21711254.15047710.html.plaintext.txt	2	Received publication December 18 2003 revised form March 16 2004
0.21711254.15047710.html.plaintext.txt	3	ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The Sin3 co repressor acts protein scaffold recruit transcription factors via four highly homologous paired amphipathic helix PAH domains
0.21711254.15047710.html.plaintext.txt	4	PAH2 shown interact strongly Sin3 interacting domain SID tumor suppressor Mad
0.21711254.15047710.html.plaintext.txt	5	This PAH2Mad complex studied extensively NMR molecular determinants dictate specificity interaction remain elucidated
0.21711254.15047710.html.plaintext.txt	6	To uncover residues convey specificity interaction PAH2 Mad PAH2 residues contacted Mad SID introduced PAH1 domain mSin3b tested gain interaction vivo yeast two hybrid setting confirmed cell free system
0.21711254.15047710.html.plaintext.txt	7	This approach led identification PAH2 Phe 7 critical residue
0.21711254.15047710.html.plaintext.txt	8	Stabilization interaction PAH1 Phe 7 Mad SID achieved introducing Val 14 Gln 39 PAH1
0.21711254.15047710.html.plaintext.txt	9	Substitution PAH2 residues contacted Mad SID respective residues PAH1 corroborated extended critical role Phe 7 stabilizing role Val 14 Gln 39
0.21711254.15047710.html.plaintext.txt	10	We conclude Phe 7 critical determinant provides molecular specificity association Sin3 Mad regulating cell growth differentiation
0.21711254.15047710.html.plaintext.txt	11	INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The ordered specificselective recruitment multiprotein complexes intrinsic chromatin remodelling histone modifying activities cis acting DNA elements emerged last decade one major mechanisms regulate transcription cell fate determination 1
0.21711254.15047710.html.plaintext.txt	12	A plethora studies collectively shown acetylation specific N terminal lysine residues core histone tails histone acetyl transferases HATs1 creates chromatin state results transcriptional activation 2
0.21711254.15047710.html.plaintext.txt	13	Removal acetyl moiety histone deacetylases HDACs restores compact state chromatin resulting transcriptional repression
0.21711254.15047710.html.plaintext.txt	14	One players mechanism evolutionary highly conserved ubiquitously expressed co repressor Sin3
0.21711254.15047710.html.plaintext.txt	15	Sin3 acts scaffold protein many complexes presumably contributes repression transcription interacting human class 1 class 2 histone deacetylases HDAC1 HDAC2 Saccharomyces cerevisiae homolog Rpd3 3 9
0.21711254.15047710.html.plaintext.txt	16	Purification Sin3 containing complexes revealed core complex containing HDAC12 pocket binding protein RBP1 Sds3 histone binding proteins RbAp46 RbAp48 accessory proteins SAP30 SAP130 9 13
0.21711254.15047710.html.plaintext.txt	17	A large number transcription factors described recruit Sin3 target genes
0.21711254.15047710.html.plaintext.txt	18	These include Pf1 TIEG2 Opi1 Mnt Mad family members S
0.21711254.15047710.html.plaintext.txt	19	The interaction Mad Sin3 great interest targets deacetylation repression transcription genes required proliferation cells
0.21711254.15047710.html.plaintext.txt	20	Mad belongs basic helix loop helix leucine zipper protein family part MycMadMax network
0.21711254.15047710.html.plaintext.txt	21	The tumor suppressor Mad proto oncogene Myc independently heterodimerizes Max form complexes capable targeting hexanucleotide core sequences 5 CACGTG 3 enhancer box present specific promoters cyclin D2 htert Id2 24 29
0.21711254.15047710.html.plaintext.txt	22	The MycMax heterodimer recruit TRRAPGCN5 complex containing HAT activity proliferating cells opposed MadMax heterodimer recruits Sin3 complex triggering deacetylation histones differentiation 30 32
0.21711254.15047710.html.plaintext.txt	23	Interactions Sin3 transcription factors mediated four PAH domains within Sin3 protein
0.21711254.15047710.html.plaintext.txt	24	Opi1 pf1 N CoR SMRT co repressor described interact PAH1 33 34
0.21711254.15047710.html.plaintext.txt	25	PAH2 reported interact Mad family members Mnt Ume6 well TIEG2 Pf1
0.21711254.15047710.html.plaintext.txt	26	So far PAH3 shown interact SAP30
0.21711254.15047710.html.plaintext.txt	27	Recently glycosylation linked transcriptional repression showing interaction PAH4 O Glc NAc transferase 35
0.21711254.15047710.html.plaintext.txt	28	A minimal conserved binding motif consisting N terminus residue 8 20 Mad1 established interact strongly PAH2 36
0.21711254.15047710.html.plaintext.txt	29	The interaction PAH2 domain Sin3 SID Mad characterized detail NMR
0.21711254.15047710.html.plaintext.txt	30	PAH2 folds wedged four helix bundle structure stabilized upon complex formation Mad SID adopts amphipathic helix 37 38
0.21711254.15047710.html.plaintext.txt	31	Although four domains high degree homology seem interact distinct subsets factors
0.21711254.15047710.html.plaintext.txt	32	Structural prerequisites PAH interactors stable interaction PAH domain seem helicity amphipathicity structural studies shed light role individual residues binding specificity
0.21711254.15047710.html.plaintext.txt	33	Here uncover residues convey specificity interaction PAH2 Mad PAH2 residues contacted Mad SID introduced PAH1 domain mSin3b tested gain interaction
0.21711254.15047710.html.plaintext.txt	34	We report insertion PAH2 specific residue Phe 7 PAH1 conveyed interaction Mad SID
0.21711254.15047710.html.plaintext.txt	35	Stabilization Mad SID interaction PAH1 Phe 7 occurred upon extra insertion Val 14 Gln 39
0.21711254.15047710.html.plaintext.txt	36	Strikingly PAH2 Phe 7 identified critical residue
0.21711254.15047710.html.plaintext.txt	37	Overall established Phe 7 important molecular determinant interaction PAH2 Mad
0.21711254.15047710.html.plaintext.txt	38	EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES PAH1PAH2 Mad SID Binding Assay The Mad SID5 24 fused GB1 domain streptococcal protein G prepared described earlier 37
0.21711254.15047710.html.plaintext.txt	39	GST PAH1 amino acids 34 108 GST PAH2 amino acids 148 252 expressed purified described previously 39
0.21711254.15047710.html.plaintext.txt	40	GST PAH1 PAH2 10 microg incubated ProtG Mad bound IgG Sepharose Amersham Biosciences 150 mM NaCl 20 mM Tris pH 7
0.21711254.15047710.html.plaintext.txt	41	Beads washed 3 times 600 mM KCl O
0.21711254.15047710.html.plaintext.txt	42	2 Nonidet P 40 vv 20 mM Tris pH 7
0.21711254.15047710.html.plaintext.txt	43	GST PAH1 GST PAH2 mutant fusion proteins incubated ProtG Mad 150 mM NaCl 0
0.21711254.15047710.html.plaintext.txt	44	01 SDS 5 mM EDTA 20 mM Tris pH 7
0.21711254.15047710.html.plaintext.txt	45	6 washed three times buffer
0.21711254.15047710.html.plaintext.txt	46	Bound proteins eluted 0
0.21711254.15047710.html.plaintext.txt	47	6 separated SDS gel electrophoresis Coomassie Blue stained
0.21711254.15047710.html.plaintext.txt	48	Cloning Mutagenesis Fragment containing PAH1 PAH2 domain pvzmsin3b cloned PBS SK Stratagene SacII
0.21711254.15047710.html.plaintext.txt	49	EcoRI fragment yielding PBS PAH1 PAH2
0.21711254.15047710.html.plaintext.txt	50	Site directed mutagenesis performed PBS PAH1 PAH2 using QuikChange site directed mutagenesis kit Stratagene following manufacturers protocol
0.21711254.15047710.html.plaintext.txt	51	All mutations confirmed DNA sequencing
0.21711254.15047710.html.plaintext.txt	52	Wild type mutated PAH1 fragments msin3b containing amino acids 25 107 generated PCR primer pair PAH1F97PAH1R97m containing respectively SalI NotI restriction site overhangs
0.21711254.15047710.html.plaintext.txt	53	PAH1F97 composed 5 GTGAGGTCGACCGGAGGGCACGAGAAGCTG 3 PAH1R97m composed 5 GTCAGTAGCGGCCGCCTTGGGGATATCTATACGGTATCCA 3
0.21711254.15047710.html.plaintext.txt	54	Wild type mutated PAH2 fragments msin3b comprising amino acids 136 275 generated PCR using PAH2F97PAH2R97 primer pair containing SalI NotI restriction sites
0.21711254.15047710.html.plaintext.txt	55	PAH2F97 composed 5 GTGAGGTCGACCATGTCCTACAAGGAGGACAGAG 3 PAH2R97 composed 5 GTCAGTAGCGGCCGCAGACACAGGGCGCAGGAGTGA 3
0.21711254.15047710.html.plaintext.txt	56	In frame cloning amplified fragments performed using SalINotI cleaved pCP97 bait vector containing GAL4DNA binding domain 40
0.21711254.15047710.html.plaintext.txt	57	We generated PAH1 PAH2 PCR fragments using primer pair PGEXPAH1 FPGEXPAH1R PGEXPAH2FPGEXPAH2R containing BamH1 EcoR1 restriction sites
0.21711254.15047710.html.plaintext.txt	58	Amplified fragments fused GST using BamH1EcoR1 sites available PGEX 2T Amersham Biosciences
0.21711254.15047710.html.plaintext.txt	59	The amplified fragments follows PGEXPAH1F 5 GTGAGGGATCCGGAGGGCACGAGAAGCTG 3 PGEXPAH1R 5 GTCAGTAGAATTCCTTGGGGATATCTATACGGTATCCA 3 PGEXPAH2F 5 GTGAGGGATCCATGTCCTACAAGGAGGACAGAG 3 PGEXPAH2R 5 GTCAGTAGAATTCAGACACAGGGCGCAGGAGTGA 3
0.21711254.15047710.html.plaintext.txt	60	Mad SID containing protein sequence V5RMNIQMLLEAADYLERRER24 generated annealing phosphorylated oligonucleotides containing RsrII overhangs
0.21711254.15047710.html.plaintext.txt	61	Cloning frame GAL4 activation domain thioredoxin A done using RsrII restriction sites prey vector pADTRX 40
0.21711254.15047710.html.plaintext.txt	62	All constructs confirmed automatic DNA sequencing
0.21711254.15047710.html.plaintext.txt	63	Yeast Two hybrid Assay LiAc transformations performed S
0.21711254.15047710.html.plaintext.txt	64	cerevisiae Y190Clontech according Clontech yeast protocols handbook
0.21711254.15047710.html.plaintext.txt	65	Quantitative galactosidase assay performed using O nitrophenyl D galactopyranoside ONPG substrate
0.21711254.15047710.html.plaintext.txt	66	Fresh transformants grown overnight 5 ml S
0.21711254.15047710.html.plaintext.txt	67	leu trp selective culture medium
0.21711254.15047710.html.plaintext.txt	68	5 ml cells concentrated 5x Z buffer 60 mM Na2HPO4 60 mM NaH2PO4 10 mM KCl 1 mM MgSO4 pH 7
0.21711254.15047710.html.plaintext.txt	69	Cells resuspended 100 microl Z buffer freeze thawed
0.21711254.15047710.html.plaintext.txt	70	7 ml Z buffer 50 mM mercaptoethanol 160 microl 4 mgml ONPG added initiate reaction
0.21711254.15047710.html.plaintext.txt	71	Incubation 30 degrees C 30 min 2 h performed
0.21711254.15047710.html.plaintext.txt	72	Galactosidase units calculated according formula galactosidase units micromol ONPGmin 1 1000 x A420time min x 0
0.21711254.15047710.html.plaintext.txt	73	Experiments repeated least three times triplicate
0.21711254.15047710.html.plaintext.txt	74	RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Mad Preferentially Binds PAH2 Vitro Exclusively Vivo The Sin3a Sin3b co repressors contain four PAH domains mediating protein protein interactions
0.21711254.15047710.html.plaintext.txt	75	Despite significant homology PAH1 PAH2 PAH3 PAH4 domains seem associate distinct proteins
0.21711254.15047710.html.plaintext.txt	76	Clustal alignment revealed significant sequence identity PAH1 PAH2 domains yeast human 45 Fig
0.21711254.15047710.html.plaintext.txt	77	Contact residue analyses NMR structure PAH2 domain mSin3a mSin3b Mad SID revealed number PAH2 specific residues
0.21711254.15047710.html.plaintext.txt	78	Some contact residues conserved PAH1 PAH2 whereas others distinct may provide specificity interaction
0.21711254.15047710.html.plaintext.txt	79	Interestingly exclusively located helices 1 2 Fig
0.21711254.15047710.html.plaintext.txt	80	View larger version 69K FIG
0.21711254.15047710.html.plaintext.txt	81	Mad selectivity PAH1 PAH2 domains vitro vivo
0.21711254.15047710.html.plaintext.txt	82	A multiple sequence alignments PAH1 PAH2 domains sin3
0.21711254.15047710.html.plaintext.txt	83	Alignment generated ClustalW manually improved
0.21711254.15047710.html.plaintext.txt	84	Helical regions PAH2 domains indicated cylinders bottom
0.21711254.15047710.html.plaintext.txt	85	Residues mutated study boxed
0.21711254.15047710.html.plaintext.txt	86	Black dots indicate PAH2 residues involved contacting Mad SID information retrieved NMR structure PAH2 domain msin3a msin3b Protein Data Bank accession numbers 1G1E PDB 1E91 PDB respectively
0.21711254.15047710.html.plaintext.txt	87	B vitro pull assay suggests preferential binding Mad PAH2
0.21711254.15047710.html.plaintext.txt	88	Top panel GST PAH1 GST PAH2 bind separately Mad
0.21711254.15047710.html.plaintext.txt	89	Excess amounts GST PAH1 GST PAH2 incubated IgG Sepharose presence absence ProtG Mad SID5 24 washed extensively
0.21711254.15047710.html.plaintext.txt	90	B bound material eluted separated SDS PAGE Coomassie Blue stained
0.21711254.15047710.html.plaintext.txt	91	Bottom panel Mad preferentially binds PAH2 upon reducing amounts Mad
0.21711254.15047710.html.plaintext.txt	92	C vivo interaction yeast two hybrid assay suggests exclusive interaction Mad PAH2
0.21711254.15047710.html.plaintext.txt	93	G4DBD PAH1 PAH2 transformed yeast prey containing G4AD fused thioredoxin A protein G4AD TRX
0.21711254.15047710.html.plaintext.txt	94	Mad SID5 24 inserted constrained active site loop thioredoxin generate G4AD TRX Mad
0.21711254.15047710.html.plaintext.txt	95	Quantitative galactosidase assays performed using five fresh transformants triplicate
0.21711254.15047710.html.plaintext.txt	96	To assess ability PAH1 PAH2 interact Mad SID domains fused GST purified incubated immobilized ProtG Mad bound IgG Sepharose beads
0.21711254.15047710.html.plaintext.txt	97	When ProtG Mad excess GST PAH2 GST PAH1 able bind Mad SID Fig
0.21711254.15047710.html.plaintext.txt	98	Incubating equal amounts GST PAH1 GST PAH2 decreasing amounts ProtG Mad
0.21711254.15047710.html.plaintext.txt	99	creating competitive setting indicated Mad SID binds preferentially PAH2 vitro
0.21711254.15047710.html.plaintext.txt	100	To ascertain differential interaction vivo performed yeast two hybrid experiments
0.21711254.15047710.html.plaintext.txt	101	The PAH1 PAH2 domains msin3b fused DNA binding domain Gal4 G4DBD used baits
0.21711254.15047710.html.plaintext.txt	102	As prey constrained Mad SID displayed active site loop E
0.21711254.15047710.html.plaintext.txt	103	coli thioredoxin TRX molecule used fused gal4 activation domain G4ADTRX Mad
0.21711254.15047710.html.plaintext.txt	104	PAH2 expression combination Mad resulted robust galactosidase level whereas PAH1 yielded background levels Fig
0.21711254.15047710.html.plaintext.txt	105	This activation mediated G4DBDPAH2 strictly dependent upon presence Mad SID TRX alone resulted background levels
0.21711254.15047710.html.plaintext.txt	106	Thus Mad SID preferentially interacts PAH2 vitro selectively vivo
0.21711254.15047710.html.plaintext.txt	107	Exchange Contact Residues PAH2 PAH1 The observed selective interaction Mad PAH2 vivo yeast two hybrid setting suggests unique residues within PAH2 play selective role binding Mad SID
0.21711254.15047710.html.plaintext.txt	108	We used molecular modeling PAH1 WHAT IF 41 superposition PAH1 model NMR structure PAH2 domain msin3b Mad SID pinpoint potential selective PAH2 residues Fig
0.21711254.15047710.html.plaintext.txt	109	2 may affect binding Mad SID vivo
0.21711254.15047710.html.plaintext.txt	110	This revealed Glu 6 Phe 7 Ile 11 Val 14 Asn 15 Ile 17 Arg 29 Leu 35 His 36 Gln 39 potential selective modifiers
0.21711254.15047710.html.plaintext.txt	111	Therefore performed systematic mutational analysis replacing respective PAH1 residues potentially selective PAH2 residues
0.21711254.15047710.html.plaintext.txt	112	Each mutant fused G4DBD tested yeast two hybrid setting
0.21711254.15047710.html.plaintext.txt	113	View larger version 24K FIG
0.21711254.15047710.html.plaintext.txt	114	PAH1 molecular model derived homology modeling NMR structure PAH2 domain msin3b Mad SID5 24 points potential PAH2 selective residues
0.21711254.15047710.html.plaintext.txt	115	PAH1 residues depicted interface Mad SID mutated respective PAH2 residues described table left panel
0.21711254.15047710.html.plaintext.txt	116	The PAH1 model generated WHAT IF molecular picture generated YASARA 42 POVRAY
0.21711254.15047710.html.plaintext.txt	117	PAH1 displayed blue Mad SID5 24 displayed orange
0.21711254.15047710.html.plaintext.txt	118	Side chains PAH1 residues mutated study shown labeled
0.21711254.15047710.html.plaintext.txt	119	Single amino acid replacement PAH1 revealed one mutation M35L yielded elevated levels galactosidase expression
0.21711254.15047710.html.plaintext.txt	120	5 level obtained PAH2 Mad Fig
0.21711254.15047710.html.plaintext.txt	121	To identify additional residues second cycle single amino acid substitutions performed time context M35L
0.21711254.15047710.html.plaintext.txt	122	Some combinations K36H M35L yielded reduced levels whereas others seemed neutral
0.21711254.15047710.html.plaintext.txt	123	A significant enhancement interaction observed double mutant containing V7F Fig
0.21711254.15047710.html.plaintext.txt	124	Unexpectedly two hybrid assays performed absence Mad absence prey showed PAH1 M35L gained intrinsic transcriptional activity
0.21711254.15047710.html.plaintext.txt	125	On top intrinsic transcriptional activity displayed PAH1 M35L double mutant PAH1 V7FM35L yielded significantly higher galactosidase level dependent upon presence Mad SID
0.21711254.15047710.html.plaintext.txt	126	Apparently intrinsic activity PAH1 M35L elevated overall activity measurable range thereby facilitating detection V7F effect yeast two hybrid assays
0.21711254.15047710.html.plaintext.txt	127	3A interaction PAH1 V7F Mad SID sufficient boost galactosidase levels background
0.21711254.15047710.html.plaintext.txt	128	View larger version 29K FIG
0.21711254.15047710.html.plaintext.txt	129	Phe 7 Val 14 Gln 39 establish specific interaction Mad context PAH1
0.21711254.15047710.html.plaintext.txt	130	The PAH1 mutants indicated fused G4DBD transformed G4ADTRX Mad subjected quantitative galactosidase assay
0.21711254.15047710.html.plaintext.txt	131	Activity displayed relative G4DBD PAH2G4ADTRX Mad set 100
0.21711254.15047710.html.plaintext.txt	132	A single amino acid replacement PAH1 reveals M35L background
0.21711254.15047710.html.plaintext.txt	133	B M35L converts PAH1 weak transcription activator allows detection V7F
0.21711254.15047710.html.plaintext.txt	134	Control experiment G4AD without prey performed G4DBD PAH1 M35L G4DBD PAH1 V7F M35L
0.21711254.15047710.html.plaintext.txt	135	C context PAH1 V7F L14V K39Q enable specific interaction Mad SID
0.21711254.15047710.html.plaintext.txt	136	D context PAH1 V7FL14V K39Q augments interaction Mad SID
0.21711254.15047710.html.plaintext.txt	137	E PAH1 V7FL14VK39Q restores specific interaction Mad SID 30 level PAH2
0.21711254.15047710.html.plaintext.txt	138	Indicated mutants transformed yeast strain Y190 G4AD TRX Mad control G4AD TRX
0.21711254.15047710.html.plaintext.txt	139	Galactosidase units activity standard error indicated
0.21711254.15047710.html.plaintext.txt	140	Results average least five assays
0.21711254.15047710.html.plaintext.txt	141	Given disturbing intrinsic transcriptional activity PAH1 M35L decided re screen second site mutations time context V7F
0.21711254.15047710.html.plaintext.txt	142	Combining PAH1 V7F L14V lesser extent K39Q significantly boosted galactosidase levels whereas combinations remained background levels Fig
0.21711254.15047710.html.plaintext.txt	143	Control experiments showed galactosidase level strictly dependent upon presence Mad SID
0.21711254.15047710.html.plaintext.txt	144	To test whether affinity mutated PAH1 Mad SID could improved third site mutations introduced time context PAH1 V7FL14V Fig
0.21711254.15047710.html.plaintext.txt	145	As expected second screen K39Q increased galactosidase level L11I K36H showed modest effects
0.21711254.15047710.html.plaintext.txt	146	Interaction PAH1 V7FL14VK39Q Mad yielded galactosidase activity 30 obtained PAH2 Mad yeast two hybrid setting
0.21711254.15047710.html.plaintext.txt	147	Remarkably PAH1 L14VK39Q yielded background levels galactosidase thus reinforcing critical role Phe 7 suggesting Val 14 Gln 39 contribute strength interaction represent strongest determinants
0.21711254.15047710.html.plaintext.txt	148	Phe 7 Is Critical PAH2Mad Interaction To corroborate extend importance PAH2 contact residues 7 14 39 interaction Mad SID residues PAH2 mutated amino acid present respective positions PAH1 screened ability interact Mad SID
0.21711254.15047710.html.plaintext.txt	149	Strikingly PAH2 F7V completely abolished interaction Mad SID substantiating critical role Fig
0.21711254.15047710.html.plaintext.txt	150	Single mutations V14L Q39K displayed reduced appreciable level interaction PAH2 Mad 17
0.21711254.15047710.html.plaintext.txt	151	71 respectively PAH2Mad wild type activity
0.21711254.15047710.html.plaintext.txt	152	Remarkably double mutant PAH2 V14LQ39K still supported low level substantial interaction
0.21711254.15047710.html.plaintext.txt	153	When tested context F7V V14L K39Q alone combined remained background level
0.21711254.15047710.html.plaintext.txt	154	We conclude Phe 7 plays key role establishing specific interaction PAH2 Mad SID
0.21711254.15047710.html.plaintext.txt	155	View larger version 18K FIG
0.21711254.15047710.html.plaintext.txt	156	In context PAH2 Phe 7 critical interaction Mad SID
0.21711254.15047710.html.plaintext.txt	157	PAH2 F7V abolished interaction Mad SID vivo
0.21711254.15047710.html.plaintext.txt	158	PAH2 mutated critical positions 7 14 39 toward PAH1 specificity respectively F7V V14L K39Q
0.21711254.15047710.html.plaintext.txt	159	PAH2 indicated mutants fused G4DBD transformed yeast strain Y190 G4AD TRX Mad control G4AD TRX
0.21711254.15047710.html.plaintext.txt	160	Galactosidase units activity standard error indicated
0.21711254.15047710.html.plaintext.txt	161	Results average least five assays
0.21711254.15047710.html.plaintext.txt	162	Structural Determinants Mad SID Constraints versus Helical Propensity In assays Mad SID conformationally constrained insertion surface loop TRX two cysteines
0.21711254.15047710.html.plaintext.txt	163	In native context Mad SID located N terminus Mad freely adopt structure
0.21711254.15047710.html.plaintext.txt	164	Therefore evaluated interaction properties PAH domains Mad SID displayed flexible environment
0.21711254.15047710.html.plaintext.txt	165	To achieve stop codon inserted downstream Mad sequence second cysteine thus creating C terminus
0.21711254.15047710.html.plaintext.txt	166	In C terminal flexible context Mad SID strongly interacted PAH2 detectably PAH1 hence specificity interaction altered context Fig
0.21711254.15047710.html.plaintext.txt	167	The single mutants PAH1 L14V PAH1 K39Q remained background levels Fig
0.21711254.15047710.html.plaintext.txt	168	5B whereas modest reproducible interaction obtained PAH1 V7F
0.21711254.15047710.html.plaintext.txt	169	This modest gain interaction probably due unleashing free helical properties
0.21711254.15047710.html.plaintext.txt	170	Similarly double mutants PAH1 V7FL14V V7FK39Q displayed 3 fold higher activity compared constrained context
0.21711254.15047710.html.plaintext.txt	171	The PAH1 L14VK39Q lacking critical V7F remained background level
0.21711254.15047710.html.plaintext.txt	172	The flexible triple mutant displayed roughly equal galactosidase activity 30 compared constrained version
0.21711254.15047710.html.plaintext.txt	173	These results show free helicity plays important role establishing interaction Mad without phenylalanine position 7 unleashing free helical properties insufficient support interaction
0.21711254.15047710.html.plaintext.txt	174	View larger version 31K FIG
0.21711254.15047710.html.plaintext.txt	175	Free Helicity Mad molecular determinant residues 7 14 39 PAH1 PAH2 domains mSin3b
0.21711254.15047710.html.plaintext.txt	176	The indicated PAH mutants fused G4DBD transformed yeast G4AD TRX Mad C terminal truncated variant G4ADTRX Madstop subjected quantitative galactosidase assay
0.21711254.15047710.html.plaintext.txt	177	Galactosidase units activity standard error indicated
0.21711254.15047710.html.plaintext.txt	178	Results average least five assays
0.21711254.15047710.html.plaintext.txt	179	A free helicity stabilizes interaction PAH2 Mad
0.21711254.15047710.html.plaintext.txt	180	B free helicity provides 3 fold increase levels PAH1 V7FL14V PAH1 V7FK39Q detection PAH1 V7F
0.21711254.15047710.html.plaintext.txt	181	C free helicity compensates V14L Q39K effects PAH2 domain mSin3b
0.21711254.15047710.html.plaintext.txt	182	D IgG pull confirms critical role Phe 7 vitro
0.21711254.15047710.html.plaintext.txt	183	Equal amounts GST PAH1 GST PAH2 mutated proteins incubated fixed amounts ProtG Mad SID5 24 bound IgG Sepharose washed extensively
0.21711254.15047710.html.plaintext.txt	184	Bound material eluted separated SDS PAGE Coomassie Blue stained
0.21711254.15047710.html.plaintext.txt	185	The interaction flexible Mad SID single PAH2 mutants V14L K39Q combination yielded 5 fold higher level galactosidase compared constrained setting Fig
0.21711254.15047710.html.plaintext.txt	186	Mutation F7V abolished interaction observed constrained conditions
0.21711254.15047710.html.plaintext.txt	187	Noticeably gain free movement Mad SID tolerated partially compensated loss interaction V14L Q39K mutation F7V present
0.21711254.15047710.html.plaintext.txt	188	To extend validate cell free system observed role PAH residues 7 14 39 interaction Mad used IgG pull assay
0.21711254.15047710.html.plaintext.txt	189	PAH1 PAH2 mutants fused GST purified incubated fixed amounts immobilized ProtG Mad bound IgG Sepharose beads Fig
0.21711254.15047710.html.plaintext.txt	190	In context PAH1 Phe 7 partially facilitated binding Mad SID enhanced inclusion Val 14 andor Gln 39
0.21711254.15047710.html.plaintext.txt	191	Val 14 context PAH1 displayed binding Mad SID whereas Gln 39 unable support interaction
0.21711254.15047710.html.plaintext.txt	192	Overall vitro data show Phe 7 residue contributes binding followed Val 14 Gln 39
0.21711254.15047710.html.plaintext.txt	193	In reverse situation mutation PAH2 Phe 7 abolished interaction vitro observed yeast two hybrid setting
0.21711254.15047710.html.plaintext.txt	194	Mutating Gln 39 PAH2 slightly affected interaction whereas effect could observed Val 14 mutated
0.21711254.15047710.html.plaintext.txt	195	Combining Phe 7 Gln 39 mutations yielded background levels observed vivo
0.21711254.15047710.html.plaintext.txt	196	Mutations combining Phe 7 Val 14 PAH2 resulted substantial interaction whereas effect could observed combining Val 14 Gln 39
0.21711254.15047710.html.plaintext.txt	197	We conclude phenylalanine position 7 specific critical molecular determinant complex formation PAH2 Mad SID vivo yeast two hybrid assay well vitro direct interaction assay
0.21711254.15047710.html.plaintext.txt	198	DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES In study employed NMR structural information homology modeling direct mutagenesis screen identify amino acids conveying specificity PAH2Mad SID interaction
0.21711254.15047710.html.plaintext.txt	199	Introduction PAH2 contact residues Phe 7 Val 14 Gln 39 corresponding position PAH1 enabled specific interaction Mad SID vivo vitro
0.21711254.15047710.html.plaintext.txt	200	Phe 7 PAH1 domain restores interaction Mad SID free helical environment whereas Val 14 Gln 39 stabilize interaction
0.21711254.15047710.html.plaintext.txt	201	Furthermore showed mutation Val 14 Gln 39 PAH2 critical interaction Mad SID opposed change Phe 7 Val abolished interaction
0.21711254.15047710.html.plaintext.txt	202	Overall results demonstrate large extent Phe 7 conveys specificity interaction PAH2 Mad SID vivo yeast two hybrid setting vitro pull assay
0.21711254.15047710.html.plaintext.txt	203	An analysis interatomic contacts structural units CSU NMR structure PAH2 domain msin3b Mad SID revealed possible molecular contacts Phe 7 Val 14 Gln 39
0.21711254.15047710.html.plaintext.txt	204	Gln 39 side chain displays atomic contacts Leu 13 Mad SID
0.21711254.15047710.html.plaintext.txt	205	Mutating Gln 39 Lys change length side chain changes charge
0.21711254.15047710.html.plaintext.txt	206	Thereby Lys 39 would maintain atomic contacts Leu 13 Mad SID thus provide explanation Gln 39 stabilizing role
0.21711254.15047710.html.plaintext.txt	207	Remarkably Gln 39 displays many hydrophilic hydrophilic contacts PAH2 residues His 36 Thr 37 Tyr 38 Gln 42
0.21711254.15047710.html.plaintext.txt	208	Therefore Gln 39 could important role charge maintenance
0.21711254.15047710.html.plaintext.txt	209	A lysine mutation would lead unilateral positive charge consequence hydrophilic hydrophilic interactions could affected disturb folding PAH2
0.21711254.15047710.html.plaintext.txt	210	Careful inspection NMR structure respect Val 14 residue well CSU analysis show intermolecular contacts conserved residues Leu 12 Ala 15 Ala 16 Leu 19 Mad SID
0.21711254.15047710.html.plaintext.txt	211	It already remarked short side chain Ala 15 Ala 16 Mad SID might play crucial role allowing maintenance PAH2Mad SID interface
0.21711254.15047710.html.plaintext.txt	212	Val 14 fits hole formed Ala 15 Ala 16 Leu 19 Mad SID 38
0.21711254.15047710.html.plaintext.txt	213	Replacement Val 14 leucine would increase side chain length
0.21711254.15047710.html.plaintext.txt	214	This increase could generate distance close 2
0.21711254.15047710.html.plaintext.txt	215	4 A Leu 14 PAH2 Ala 15 Mad SID
0.21711254.15047710.html.plaintext.txt	216	It suggests Leu 14 bumps Mad SID thus explains results PAH2 V14L mutation
0.21711254.15047710.html.plaintext.txt	217	The PAH1 molecular model depicts distance close 2
0.21711254.15047710.html.plaintext.txt	218	2 A Leu 14 Ala 15 2
0.21711254.15047710.html.plaintext.txt	219	Proper contact distances restored introducing PAH1 L14V mutation
0.21711254.15047710.html.plaintext.txt	220	Distance measured close 3
0.21711254.15047710.html.plaintext.txt	221	4 A Val 14 Ala 15 4
0.21711254.15047710.html.plaintext.txt	222	4 A Val 14 Ala 15 Fig
0.21711254.15047710.html.plaintext.txt	223	6 overall strengthening stabilizing role Val 14
0.21711254.15047710.html.plaintext.txt	224	View larger version 45K FIG
0.21711254.15047710.html.plaintext.txt	225	Model interaction PAH1 V7FL14V Mad SID
0.21711254.15047710.html.plaintext.txt	226	PAH1 molecular model generated WHAT IF mutated toward PAH2 specificity generate PAH1 V7FL14V
0.21711254.15047710.html.plaintext.txt	227	Molecular graphics generated using YASARA POVRAY
0.21711254.15047710.html.plaintext.txt	228	PAH1 V7FL14V displayed blue Mad SID5 24 displayed orange
0.21711254.15047710.html.plaintext.txt	229	Distances presumed contact residues indicated A
0.21711254.15047710.html.plaintext.txt	230	Strikingly CSU analysis PAH2 residue Phe 7 depicts contact Mad SID residue Tyr 18
0.21711254.15047710.html.plaintext.txt	231	Careful inspection surrounding PAH1 Phe 7 molecular model suggests contact Mad SID aromatic residue Tyr 18
0.21711254.15047710.html.plaintext.txt	232	7 A measured residues Fig
0.21711254.15047710.html.plaintext.txt	233	Based upon results experiments structural information modeling stacking interaction aromatic rings Phe 7 Tyr 18 likely key complex formation PAH2 Mad
0.21711254.15047710.html.plaintext.txt	234	In conclusion interaction Sin3 co repressor tumor suppressor Mad PAH interactors seems characterized conserved properties amphipathicity helicity reach specificity molecular level residues Phe 7 present PAH2 domain Sin3
0.21711254.15047710.html.plaintext.txt	235	Open questions remain understanding specificity PAH1 PAH3 PAH4 interacting partners
0.21711254.15047710.html.plaintext.txt	236	Consensus sequences PAH interacting protein still unsolved subject many questions
0.21711254.15047710.html.plaintext.txt	237	Ultimately definition specificity every PAH domain provide new way identify residues required needed amphipathic helix motifs Sin3 interacting members enlarging molecular view role Sin3 co repressor complex transcriptional repression cell growth
0.21711254.15047710.html.plaintext.txt	238	FOOTNOTES The costs publication article defrayed part payment page charges
0.21711254.15047710.html.plaintext.txt	239	This article must therefore hereby marked advertisement accordance 18 U
0.21711254.15047710.html.plaintext.txt	240	Section 1734 solely indicate fact
0.21711254.15047710.html.plaintext.txt	241	To correspondence addressed Dept
0.21711254.15047710.html.plaintext.txt	242	Molecular Biology NCMLS 191 University Nijmegen P
0.21711254.15047710.html.plaintext.txt	243	Box 9101 6500 HB Nijmegen The Netherlands
0.21711254.15047710.html.plaintext.txt	244	31 24361 0523 Fax 31 24361 0520 E mail h
0.21711254.15047710.html.plaintext.txt	245	1 The abbreviations used HAT histone acetyl transferase HDAC histone deacetylase PAH paired amphipathic helix domain GST glutathione S transferase SID Sin3 interacting domain ONPG O nitrophenyl D galactopyranoside G4DBD DNA binding domain Gal4 TRX thioredoxin A CSU interatomic contacts structural units G4AD Gal4 activation domain
0.21711254.15047710.html.plaintext.txt	246	ACKNOWLEDGMENTS We thank Edwin Lasonder Micha Willems Michiel Vermeulen GB1 MAD GST PAH1 GST PAH2 setup binding assay
0.21711254.15047710.html.plaintext.txt	247	pAD TRX pCP97 generously given Felix Hoppe Seyler Karin Butz
0.21711254.15047710.html.plaintext.txt	248	Pictures molecular models generated help Elmar Krieger great graphics YASARA
0.21711254.15047710.html.plaintext.txt	249	We also thank members Stunnenberg lab Rein Aasland Chris Spronk critical reading manuscript
0.21711254.15047710.html.plaintext.txt	250	REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Cosma M
0.21711254.15047710.html.plaintext.txt	251	Cell 10 227 236Medline Order article via Infotrieve Grunstein M
0.21711254.15047710.html.plaintext.txt	252	1997 Nature 389 349 352CrossRefMedline Order article via Infotrieve Hassig C
0.21711254.15047710.html.plaintext.txt	253	1997 Cell 89 341 347Medline Order article via Infotrieve Laherty C
0.21711254.15047710.html.plaintext.txt	254	1997 Cell 89 349 356Medline Order article via Infotrieve Zhang Y
0.21711254.15047710.html.plaintext.txt	255	1997 Cell 89 357 364Medline Order article via Infotrieve Kadosh D
0.21711254.15047710.html.plaintext.txt	256	1997 Cell 89 365 371Medline Order article via Infotrieve Kadosh D
0.21711254.15047710.html.plaintext.txt	257	18 5121 5127AbstractFree Full Text Kadosh D
0.21711254.15047710.html.plaintext.txt	258	12 797 805AbstractFree Full Text Zhang Y
0.21711254.15047710.html.plaintext.txt	259	Cell 1 1021 1031Medline Order article via Infotrieve Lai A
0.21711254.15047710.html.plaintext.txt	260	21 2918 2932AbstractFree Full Text Alland L
0.21711254.15047710.html.plaintext.txt	261	22 2743 2750AbstractFree Full Text Fleischer T
0.21711254.15047710.html.plaintext.txt	262	23 3456 3467AbstractFree Full Text Vermeulen M
0.21711254.15047710.html.plaintext.txt	263	24 2364 2372AbstractFree Full Text Yochum G
0.21711254.15047710.html.plaintext.txt	264	21 4110 4118AbstractFree Full Text Zhang J
0.21711254.15047710.html.plaintext.txt	265	21 5041 5049AbstractFree Full Text Naruse Y
0.21711254.15047710.html.plaintext.txt	266	96 13691 13696AbstractFree Full Text Wagner C
0.21711254.15047710.html.plaintext.txt	267	41 155 166CrossRefMedline Order article via Infotrieve Yang S
0.21711254.15047710.html.plaintext.txt	268	21 2802 2814AbstractFree Full Text Yang Q
0.21711254.15047710.html.plaintext.txt	269	345 Pt 2 335 343CrossRefMedline Order article via Infotrieve Wotton D
0.21711254.15047710.html.plaintext.txt	270	2001 Cell Growth Differ
0.21711254.15047710.html.plaintext.txt	271	12 457 463AbstractFree Full Text Hurlin P
0.21711254.15047710.html.plaintext.txt	272	1995 Cell 80 767 776Medline Order article via Infotrieve Schreiber Agus N
0.21711254.15047710.html.plaintext.txt	273	1995 Cell 80 777 786Medline Order article via Infotrieve Blackwood E
0.21711254.15047710.html.plaintext.txt	274	1991 Science 251 1211 1217Medline Order article via Infotrieve Ayer D
0.21711254.15047710.html.plaintext.txt	275	1993 Cell 72 211 222Medline Order article via Infotrieve Bouchard C
0.21711254.15047710.html.plaintext.txt	276	15 2042 2047AbstractFree Full Text Xu D
0.21711254.15047710.html.plaintext.txt	277	98 3826 3831AbstractFree Full Text Nair S
0.21711254.15047710.html.plaintext.txt	278	2003 Cell 112 193 205Medline Order article via Infotrieve Siegel P
0.21711254.15047710.html.plaintext.txt	279	278 35444 35450AbstractFree Full Text McMahon S
0.21711254.15047710.html.plaintext.txt	280	20 556 562AbstractFree Full Text Ayer D
0.21711254.15047710.html.plaintext.txt	281	7 2110 2119Abstract Larsson L
0.21711254.15047710.html.plaintext.txt	282	1994 Oncogene 9 1247 1252Medline Order article via Infotrieve Nagy L
0.21711254.15047710.html.plaintext.txt	283	1997 Cell 89 373 380Medline Order article via Infotrieve Alland L
0.21711254.15047710.html.plaintext.txt	284	1997 Nature 387 49 55CrossRefMedline Order article via Infotrieve Yang X
0.21711254.15047710.html.plaintext.txt	285	2002 Cell 110 69 80Medline Order article via Infotrieve Eilers A
0.21711254.15047710.html.plaintext.txt	286	274 32750 32756AbstractFree Full Text Spronk C
0.21711254.15047710.html.plaintext.txt	287	7 1100 1104CrossRefMedline Order article via Infotrieve Brubaker K
0.21711254.15047710.html.plaintext.txt	288	2000 Cell 103 655 665Medline Order article via Infotrieve Spronk C
0.21711254.15047710.html.plaintext.txt	289	NMR 19 377 378CrossRefMedline Order article via Infotrieve Butz K
0.21711254.15047710.html.plaintext.txt	290	97 6693 6697AbstractFree Full Text Vriend G
0.21711254.15047710.html.plaintext.txt	291	Graphics 8 52 56CrossRefMedline Order article via Infotrieve Krieger E
0.21711254.15047710.html.plaintext.txt	292	2002 Bioinformatics 18 315 318AbstractFree Full Text
